<SEC-DOCUMENT>0001628280-22-030686.txt : 20221122
<SEC-HEADER>0001628280-22-030686.hdr.sgml : 20221122
<ACCEPTANCE-DATETIME>20221122165828
ACCESSION NUMBER:		0001628280-22-030686
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		127
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221122
DATE AS OF CHANGE:		20221122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BECTON DICKINSON & CO
		CENTRAL INDEX KEY:			0000010795
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				220760120
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04802
		FILM NUMBER:		221411270

	BUSINESS ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKES
		STATE:			NJ
		ZIP:			07417-1880
		BUSINESS PHONE:		2018476800

	MAIL ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKE
		STATE:			NJ
		ZIP:			07417
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>bdx-20220930.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:92e3b16d-7e78-4ff6-96a7-c06fc2ba1c8c,g:ca0678f9-8390-47c3-8185-7628d34a94cf,d:a87db9e40d284890bdb9962ca233dca1--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:bdx="http://www.bd.com/20220930" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bdx-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV8zLTEtMS0xLTczNTM1_3ee468e2-259b-48e7-bc10-316196574b76">0000010795</ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV81LTEtMS0xLTczNTM1_ca2711db-8082-4080-b6ae-7b61498ecaae">2022</ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV82LTEtMS0xLTczNTM1_cbb3af46-ac58-478a-8776-3f2ed019993a">FY</ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV83LTEtMS0xLTczNTM1_ef971635-e8f8-4296-aa3c-06e9ab58185f">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="id56b178e0a304ca0929d00a2da01572b_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="i1682e37dc1c64a0493b113eb3051c55d_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i872f6917a0d147b687cc33b9b703c9e5_D20211001-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d">P1Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i19750515c4a74e798e893d0d862cff94_I20200531" decimals="INF" name="bdx:PreferredStockDepositaryShareOwnershipInterestPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84NS9mcmFnOjRiMmEwNmQwNWQ5ZTQxYmQ4N2MwNDQ3ZTI2YmE3YTJjL3RleHRyZWdpb246NGIyYTA2ZDA1ZDllNDFiZDg3YzA0NDdlMjZiYTdhMmNfODI_a8101646-60b5-4a14-8484-086a2e4d83aa">0.05</ix:nonFraction><ix:nonNumeric contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i812d0cfe92a74e4c926610f6e5a3cbba_I20210930" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwNzQ_6fc3030e-d694-47a3-b19e-733ab8915c12">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i644ae4d7f0334a60b2e4791644ea5968_I20210930" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNTk_49d1d0da-0358-48d3-bfc1-913d11e54289">P6M</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bdx-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:DepositarysharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if549031f297645189d2c585e3072d96b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dcf0c18b4fd4e3e980d4799086c4754_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i53c38993858547f68214ac6f1981c2a9_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ic042a8d8207c492790faedff680aa856_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5b40bf72179e46d89af6a51aac9400a0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1596d6db35a42fba0359a8e52d30677_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb0301f3d94544d0a0b72086db59dd14_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d85f871f7b24bc5989ba58c61917188_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72d7bdb2703948fb9aea56ffc9e2f630_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56b178e0a304ca0929d00a2da01572b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a48157deb98419da4fff13ef30cc91e_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1682e37dc1c64a0493b113eb3051c55d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73746dfe5c0f4de7970ccce7ad10430a_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29f71c0bff93492c9a06e0d87133987e_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:CoreTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83533f337ff4fffadbe9a69dc3a40cc_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:CoreTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50001881e1d74dcdb3045e71518d4167_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb8199c4ea0048a5b80be3d9e50c0d1d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872f6917a0d147b687cc33b9b703c9e5_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:PatentsAndTrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id34e1facad0e439181f5dcf5d5566e02_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:PatentsAndTrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic33b9e6159d048938c04eefaef08044d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4396e0c37dc446598a1bfa55a31434e6_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14247198e9224028bedb55ce3b8f7e27_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55f01eb74e224d3b859c08b736035bcc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6750DueFebruary152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i779c08f21c7145b69a3c73a02acd692f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03436c961ff34525b6bc41434568957f_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11ec78990674c6894d07a12d457c3a3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c2d5aa49a1e44eaa4bf7f704ff1fbb1_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296c4706cc7a49a38687e154af3f932b_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a2da253f41c4177934228a9aaffc195_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbef8604488846208cd4c70898654711_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e1811b72dc462ca90c421e6c5b1693_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96ac652372b54cc2b0a28ed29bff1415_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a2a86003dc74c1f8a87c4d5eea38dc7_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd3830836d74dc384331da111f121e9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fe86ad3207e44eaab5c717b3adfdfd5_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695e557a6ab54dc6a2b984723d1f5b0d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c5190a2663a43e8b69d8a097c812132_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib70db9b9f4a14ac4a63c9c3d7e73bb79_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec7a113781f4fb4aa433f0602bfde3f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id25b1e6a88754b688a61cedebd045efe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a446f7eaf1a4201a25d9a14323ee4b7_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3278eb4fc9fd4ab78a70936efe09c5ff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20eaab7a249a452bba784a0d97d26368_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bcfc9afd93e4406acde7e87e4c91af9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if823837bff994f53b3a5363db592ef45_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if05103d8441f420687709be717eefd05_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3372701f199e43b4a16aa17859655059_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dfe8ef22e494c38b101738e66ab9aeb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b63e5f040e4730acddca14376db61c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id268265b76c749d98058721c42dd6cb5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbfab1f7a9b4460bbb2f2a22a0ed163b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia491d443536f43b2af506a739dee74b6_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie55426e09f694ffa9902855677354b87_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e686d9a958e4abfa40bfcc0f5d10cc0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>bdx:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i2c6dfb0a55d44433a2844ec28c42f5aa_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87fdf496dd9c4a699a19e0513d7508e2_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2926409bcc984aedaa96af46597e2232_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dee112885e048f6a1cef87525afc79a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:OpenMarketRepurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i332d46aaf70f439cb962e214fd3556a0_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:OpenMarketRepurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ad38254f42f4c66b77c1874165accec_I20130924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab8c2436670412a85779aa99a37f277_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50429935632644db80c7dc6d4f800a3c_I20200501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874a17754f954b0aaac2d06381e5d650_I20200501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id918b6957659494e9efb8db5e471b658_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c47e1c7c8914741831ba4850ee25a8d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1ad1063cff2d4269b4177860de2bbad9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff86925da2a4bdbb08d87f5bf1b9465_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57dbdcd63dc545d4baab7bc7c3def523_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c005f6696a4b2a8f4b480077d64866_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie20e47c06987495d84a42d36f5689682_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2fd6969bcd47aea595469cbf1b4625_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10fb59521c574bcb96b82afd9f75ede2_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628f61d1728942a88bd889c7c55ed5f4_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf1f5eafac44cf9a31dc274fe75fe4d_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfb3dc5bbdd43f1abaff2e47b4b3e33_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if78c1bc79b104d2495d52f06e7adbeb8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe826a47e2d4911b649299e360599da_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d4272367454973a102f31f0e0b1d5b_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8624f6524b87417d877a3fbc3734696a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99c576cb7f54d77a264bc0be07c9bf4_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a15e922161c4d5dac1d1b05a8cd6abb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65b38b186e5043618d914e134f92606d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd731e1f79d247e8ae5e661b7d8187be_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3be5ebcb0a4e7da15aa197384cbb6d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43597b9d90b04086b5e4094193e3b542_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ca936d1eee4110babd87515b79a272_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0caad212afff4342a5acce2a8aa1d437_D20201031-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-31</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19750515c4a74e798e893d0d862cff94_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e27cb8b41d348d5b69f42feadb89ef6_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i395595affb2f4499b423f227d60c2864_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3faee5241614bc983e8159206dea8d8_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9b42263d2584a45bc56b83ecc8101d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>bdx:claim</xbrli:measure></xbrli:unit><xbrli:context id="i512eb62a6b814cd0946e34a3d047f29f_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide1ced632f4c4c4da4b51289c20a7f1f_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf37d2f9a26470d958d196cc629fd83_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a754ef030a48b1aab1469d1d78d783_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bdx:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>bdx:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="ie414e39c203f4c4382406af500826854_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f59c7321f84d4abd684a04e126995a_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8c12f02b6648b68f67c0af95c1adf6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05606745f26d460ab811bbfdfa341821_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ba30fee8c84bc8a2dbb50e36515c04_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bdx:segment</xbrli:measure></xbrli:unit><xbrli:unit id="customer"><xbrli:measure>bdx:customer</xbrli:measure></xbrli:unit><xbrli:context id="i5f132fdd2c874a8ea74c3db787eff159_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8be3457e675a41b8a5e579e487b37547_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af1f356b20e49379832866f40ae6116_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5bb7c3f33f14b26877a5ad97b466f75_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0818d4aa51794a308ee5ea7be2a3a7bf_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5df34fd9a8fb4515a6d4f206a9b62bbf_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2beda1c25ab64fb6be6cc0c3ea77c714_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6964534d6074e42bf64a587550cf196_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6ab2283f1148cdb39df341b7bab34c_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aedd1e139b541e98f03ec93291aad7b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaefde29495b1437da1094baba80dcc28_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4044de927e14db4b4cdce3edf5fe533_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0226cc65ff074b9cb210e20467df9c6c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa8ecc6259cf4f9e9dcaa8280e0c1e38_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7354695f422344c2ba6f5510554cf892_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if82cf0e2b8114957a8de4ed614f509d9_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe3d23b34c44614b6bfae0c5d45b788_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c683a785824afeaad05fc9abf980e8_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cceb75d2179413db04451287ff26d63_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a2212a30e9348f29aec9f73842587fd_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91213219f96b4e26aca1922999345c5b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d3bb31dc01f431bbbe77ccd87e88642_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d656df397a54965af2508ec9e8b3a88_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i682ce949e79b4a869956e036cd9bbabf_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75503ddf3285429bbb602ab773ba94ce_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bb11d08c5e6468d9b86ce13b8fb8672_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3183d1ded7447c9addc009095eff141_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28f35065e14842b2982be7930f62d9a7_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i648c7b7f63e14fff8db4327cf366bf0c_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i547ae1919acd49f194300b3f92921e7c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbbdd8603eed4090a62b2e5f722efe1d_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf12495d432e44f0ac940dc4cd4a1bf3_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d2acdc038e1415886e86c9c35738e32_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied344f3898da40c787f80afb27167829_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i216e3978b71a433ea3ecaed35cef49df_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i083aac29dff54d05b5ab473be2896793_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ed5952700034df3acc6ffaab543b2b7_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20d0df9f4974473aab54f9423735e45c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac87ce71d824958b1a47906a97cb26d_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11561312578a41cd8558a5081f0c997a_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd17f4c74ddd45aa9d4c2660931a2cbd_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3a84f9891e141d490be8fb0dbc5a1b2_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0adb04ada42a45edb77b3846d949a297_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44752f5a1ac45f9905b7477cb8d8150_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5edc49a9068445e690657c19b9757ed7_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d856fcb0a2148e18bb6926e29e6de05_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c44be99e502431faec4f344ca7026e7_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i612cd43d382c4a63a4498b9c0925333a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d137b4783048aa9d0a5092249d0c19_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a850278578a41d7920dd6f66b22ec55_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05325a1bdf804752849157781245e34b_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf241dca0b84231aacab9d4db1bf47e_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i116d0d51fa5f4ad8b5f121a6aa909b47_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14f6db0dfcd4424ab591090a6f110ddc_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2bd86d8f5245e596ba87a9603d3935_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9bb88f9b2cb4d1d895fc3044878e01d_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if62d47452c1b4b0d95b99aad7c976bc0_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6146d44a3e1a4c6fb1e3f608f1d1772d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5917d24437144be6a23c46c167d8dfee_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ffb12715a314f46bf61eff967b00a1c_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic90104d61c104e8b8865d7d2f9e10896_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51d737eb47f4b3b9da6d19bc2611a64_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18417c03d14049dea16257ba06dc47fe_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f9183974c94388a49de9124319a764_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d68a774d0014ef1abfeda302c81fae1_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e67d37c2bb94c2b801879dcd7a19a15_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i605b912cf85647a9bb587ef76f45e2a1_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id920980d4c7449ea8825bf277a0b1ac2_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5d0087bcc4b4ddebf55ddab6f10de11_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8e5f71dc1cd426cae0de4618593bcf1_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4a41270d5b4661a5a303eececadc77_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ada28ecbf74a4395c3277f87c00cdf_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ed2fe03fc548a8a71570a5afe88eb6_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3166ef7bf441d88c8166e8bda58fc7_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7c4592ec094ac2bf07eb5e61394cce_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a5c15ae71594004b4fb831a208ea9b4_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa16b425c5d484e8fd114f782a112f5_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide0078adc3714de98cb99a9ec2f7004d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee2d0c4137b14439a21515cf1257e833_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i756a093d417b4e5d9930034095f6c8a0_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718323b7442949ebaae15d9d98b8e56e_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i053e66e661bf401da0e58b9ee1ce56a3_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e64a7564cd48a185c5cfb1671f55a4_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia26a2ea3671e4bbda2393ffce1464f31_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcfa5db82af24e78ae9358db41c6e7b5_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i770e87f1fd6a40d7ab6f0cf8f9423ff9_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c32fb02472b41579f71cf3a6edb41c8_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0d63e4e362e403b8e8e33d15aeb4129_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6faafb39d1af4514a46e525041b2d4ea_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib84d4ce3a1704c82a573ffc14f62e02f_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic07db86337a54d37b2f1f39b5c7a798d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c554f2bb4764f148a7b5f7e8b47a21e_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9464fd80b304787a7572a9a2904106a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2274cfe1148048b1a906c0b62d5b0ff1_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a0912d23474f249022aec3aba2e54d_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1feff546e94e4e799fd1e5ff2a6122b1_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f424962ed74433ca2e842f15385c7ce_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e92a6ff8c554267a457b7ddb0579546_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f6ebe1084e4654990728705d852739_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087866702b1043ad930869066b7ebb1c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica689edbbe6c4cfdab402371fb6c387e_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib65439a3c12d453385854062d6818ee7_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe2818605fc44918a60597464387f709_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i938377c8c70a4325b957640e0929f503_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf30fdbac78429f9a446f70c25b7be1_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id40539fa62924c86bbbb010189f67b04_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad4eeacf775b49548f56b317cb763ba4_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10191e30c4364d2eaeff9b074fad7661_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18583ef90cc241e4bf98d850f3c5ecbd_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f992e63e5074f08920c5d9d5d2dcfad_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96fc867ea3a54208a98744fec84eb274_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e483eb99c7c4b6497a405226527c370_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba39a8a5d76549f5869166e9f4200fc3_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1de7b15fe4d4f0daa2e984903815934_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf717fc531104fa8afeb2f4134bf483d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if71d28c3e62a46c9a905d0174d34dce7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d2afe4861c4a3e9820f0da284c2e26_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4663fdc221d47b9a6c6e31fa080b355_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11eb132003cd49cf9c750bee96c9d6ba_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5afb79183c5543d798cf072178bc024a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e3d42c7945a4497a141565ec8971e5d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc73ad9d66924344a539a3a87b464261_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820d3d2264834cbebc2fa459cd563e8c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68c8e2684ba049d78fb1ad3565e6b339_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae50cb57e95446c6b92fb35fafe9f9da_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81362db95912497e859aa74adfeff72b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b105c0c4f50427f8410867a9ec1bf65_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6968aa8bf59f445c9ff26455961aed57_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee987dab8c144399f2ff0d88aa15f7b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032efb1d86ce48d0909296f8cca53459_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if421c3b8ea2a4e7ab527e52a891f26c5_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54aab8ed6b4e47aebcac9e9c927310b7_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8660d76f8bf1403894faec3ddd4176a0_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5645bcb73774a2284d8ac4c0ac3dea0_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6835087ad8c4728bb6473612b2cf0bf_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d179fae935c4c82a01090f5b56e975c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd69a3a2f71e4c5fa5e480606c3addb6_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb8b9befe2884f62abaad02f5835561b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bf08a9c8e8b4394a3000593ba05da14_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b9f84be28aa4054929a2360fb4e6192_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91be43483d0f4b4b8867902706c778e4_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:CRBardIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1878f37315d04b1a98cbf4c1d0819498_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0817d59aef3845269f35d7e2afcd203d_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c2acdab6234d67848433db1d1dbd37_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f651512be74e1d93a7c0f9cac1e296_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ef9393893346008a24448385a34a5c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i033e6a9eb88b43d980fc575fa72123e5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i873b906d317a431aa87a7b6cf2fd045c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i358a67c5d4ed43109765477c30e7c234_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0326d51b048d49febfbe800191bb36de_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4349c1158a974223aa831dfcf0b2cbc7_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5d3a7a2e0c64e4d98235396301e0718_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifedfc8723a1240dfbd527fddd8610509_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6fba700db34620b0019217a8d9bd97_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77101b3b3d014aba884daaeaf179c10d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61da2eb734a14d15a43cbf10837c8938_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eca0f828ddd427091f4d296a8e807d2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f9080405314d2e819b92e79feeced8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb88817d6194a5599afdee43da767bf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e39bf2e8f1844b993cce4161a84bbff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85a5bc5228934abba8c145aa315e0721_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79c926c9a5c9445eb3a6bf1d48ed24dd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:DiversifiedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i582bf51e2db142748e01d1a6c1978b1e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239cacefc1034e98bffbb2d59ac35059_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6210559eed0744c68524b1092620ea9b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4c7d62af45d419593ad86b92e3629e7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9a3bd23935f48b7a00e226a1a8352d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia338360d4785452caa35968390747a10_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73449f7073ff4ea4b40ee726a2e5769c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a3349146ec64e71add05da653f9c92a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f4fd5eb5f494b16af19555193bf5090_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cb9c8a5a3d44e929e8cda49c3e35a5d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa7674e8eddd403f9b0b11baa9aca925_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6dfbd58f525441b9ab54c2dea102ed7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecbe41070dc14cd6a796c56f4121218b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6780e627c7f4ad7a05cef6b81219d95_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973ba4ea52044ec7867cce4732e8a723_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f1806f061cb417cace44cee66ae6850_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56a1e5bf0a745c08a12f76dc30bd149_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd94643846d24bf3b6f8c33987fc6390_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673ea0978cf446da9469a52c417caebb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia149edac1bcb40f2af757eed837bd3b9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba651878aa3c4951be900f73b0631b94_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae4848b2eb0143ee85a0d7c2d47b4988_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d9bb16f4d74508bc6dbaf0a2455b14_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c3151253d64e2d96bee25ce449a710_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i719813f3bd404e79b168659b6c3aa573_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1efe0d2e80664df283e57a2eb36423d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6bb763598f346d88eb4b80147200d91_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b9f12bdbc124812844603fbd09891ed_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i455fc00619a649a694accccb414c0a84_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d921cd67c5a4c2eb5567320f4476c60_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6535e7d25cd749aa8937a2539be0e13f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb2f87afa95408a8c56d4a9cd130b30_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27cde783e1a94eea98b321d147b8ec5f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4291d87672cd4a8981f4a360a1a9cab7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c8f69ef20e449fa397139f39242dee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0e5c0cdc22a4b0e8ba6a3fb3f6e98c5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8407f1e21df94016a5bb2c0aedad66ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667449f6ee774b11a6b45b97aab6b6b3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c2adc69ec24c689ad7bfe5695d5c71_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i036c7ba8e62a4a75a8b86e314ed59903_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d858f56b814ba1b31e8997945e8cdb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc3d5d859364765991baf5fbdaaf07d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i273c42bd2bf74bef9f62c4b634918468_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014f9d02b0cb4bbe8c31fc0740a83fc0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16f46d749384f4e91a03d0dc970acd5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0ad93bd71254bd594fee877344663f1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2764df47883b467ba943ad7a7c3151c6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08b479cb794b4b389dd8f0417d748da4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d4bc96a4b642139265cbec59eef4cb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85e1a6e235d47cdbf1b177b7f97c4af_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c0de9d4d0e4fae8c6fc8ec55fd02b0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b3ba666c714449895f2c46717ad2d3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id58ed1b77b8640d0b897e7b00007953f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0333656249994d2e8cb26e6f79d7e84d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cfd65d075cf414585bf6fc6b7f9c5b0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce10790ce4c4090abab20b16d6ee85f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3a877768014f80bca7f2823c09c2fd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e30739c488347d5afed7d7c698d4c16_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2705f413b5fa4853aa0711dca58567d1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a14e8e06e8e4781bb2fc8daf0319362_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia616e09bfcf3438ca18d99c58fbeb7de_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cac4e61a856422aa1854bbcaadf4fd6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic923216224064e2989e7625f0081c9a2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib37ee945ff0c49afa819e5fd6c33170a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db92b9a655f421789d5d94454ef800c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf30a237339b4595ae6d08ec2d172296_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8adc411abc471c8fab1c8a0b21f5ed_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444540566d5f4120ba0a990210e5f64d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibafc5baf0e3d4db98950714ff7bbaccd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24356b45f51845f99b3c235579c7c492_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36e04951f0304cc297da29bf9cb5603f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35528802fb404e6bbcbb6b97543f94ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8598d43c36df40e0aa15aa3578b1c46e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1bc9fbebdd24e2688fede6c4875c0bb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5291e425d6544e199671d3329659b30f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73098c61ad6b497e9b56e6e64edc8560_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f2ac9dc44f64a518a26cb809ccb8ba3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04064a31b8074c7cbf784060b303d4db_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie92c7234473544eebb1751ee0a1eabc0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0a623813ee4a369e7ef5993fdb798f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93d9e0ee20514594b6508a2572ce4abd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28aae561f41544a7804bc0b0cb92a718_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70be1a5baac547589f9472c81e2340e1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45261a2b5664434b82d1b3f8454fa79_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cfc59ab57674136bbe1362cca826076_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3fc09f7eb6045808fa6cfccba5222f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fde7c7c7d5e4fbe8a6182d7ed99551a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a14466de2744d68148b941f153e261_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f673aa33144145a0153caf0934a902_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47af4c545a444e8795cd4b3e68071385_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44cb6133b3eb45ca89b4fae7bb30718a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8d05e1487049f8b27438df7c030bc3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idedc37ddaff7492cb156a22eaef9b092_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cec3d47afff4c80b568b9f7e523a109_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262df50ecd024aa69410723c273b05e8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib914a13ded684ed08743c7d0696e8553_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9f5a16ace249d18941f898a5576de4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0056a4535007448985354b76b514a039_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ee0fc2accb4da6a9e43977a7b69739_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12cd1badd0ce408c9dcafe27cdd0b20d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51bf8cb12ca749c1bd187ce00a9784dd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6a1882f3af34faa9ad2c58364443d10_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d771de4a2a64a89be0c9be153b39a3e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8c753d7231b4002823e9b6267dacc21_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa45c1dcfeb64edfa242186776836f16_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e03a1a02086479b88a10af5e3588934_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieedb758d47d44d4ebe6fcf3edd65171b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6a0f7f5b6d447ea7d5613cd52fe51e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0ed4b3cc36b4b0f8e5f2f0c8bf77444_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13fc5e1747844a0b806dfd7f80523096_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8d9c2809b447ae90dc16848ca76dbf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75eff2d032c147f597c9f1aceaa27650_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb13d84cf3d4430cacae3505887fce63_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31345d49e9284acfb9ed91fd24ff7205_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib609d1579e1d40deb0c57bde81e1c157_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f502cd5c7c4fdcb18d0d7479d2adcd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f30bff63dd044afa703c76950e345a9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic59dde4d198a4f0c9421510d392f0fe6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b3c1ec961624dc6a6e82d3a6d0655f5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia77e1ad42f2446289384890caf166680_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide2b5962b6fc4b6cab48b61c74e89ee3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f02684e4ee849debf8d23e25e6b3324_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie43bdb14f100444eba25dc4dae16f103_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c02b9046aeb43f39af9743b56405a07_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958a0bea104d4e37948dbed0e1c77969_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d2c088bf8424db2abcf78de54392802_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b70728ec7204a2ebbcda87de7fe7488_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7f9e7335b7e40cba7435a11709f59c8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a64d513dfc400f813fa199a196be91_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic432f2c8faa84d159c41bc4deaa713ab_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i132718db1a49414a9da23528a50fcd53_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f5c87ee09245789101d5ca6586a174_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic76c5930de334d2983e06187d224acc8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6fe3a69bb248dfbf2c20fb3768e09b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f72fdffe684f18a08ab20e7ef102ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838c06881c964d85af7dbc6c561a7832_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3184ac9582b94e1aad158d05fb2af57d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d4dcca7281c4dc4a61fcb80d9cd4ba9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c273f849dd44f598cb4953836e7f267_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f5a4ae568f84d1bb02bfe3259a2505a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7bd76a6d1e431ab6c836a81216e1f4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb0e474760e4334840048d6bbea75b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6720785a53e1430586156e7d0d274c13_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1733e031b7cf47a58f991e2e2c3bba38_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08d119384b84ecd9c631a9d7482199d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52b537bc93854335acc883c0be1997c8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fbe9e927d274f4f83ca7d77571c65bb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc5d9a9b2b444698454e67d6b6125b5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680d42b90e8248cb8ec139cafaa4fd6f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4ba4121b644ba8b30f226395dad876_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieee3af2d2f704f59849f8185896c26d9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519814dded634cab821a6e70f12b6b5a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie04b3467aa854cb9aafaccbd60d72ba5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68b0d1120e5a41fca6070da9daf0aaa1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38fa75e726e4beda0abe761dee7c2d5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed18c587c624003af2e081a0af4732f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27cfd7e9cd8640a3853756ce9e70e604_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b0f58312f094de18638daec1ed57a5b_D20220718-20220718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16146e90cf574d438dbf17e714f1b029_I20220718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaead122bd3794f52a9b62332837beb42_I20220718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e7b819e08c4816b263b7a5251235af_I20220718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafe15d6e33ea490590f7e9a69b2b17d9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib61a5ebabc2b43e6bc2cd5e8d0c216f2_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idebc6318303940928ab393f2213c259c_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic952af233f8f4bc18cc9102330586496_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i783d4c7f3e5a45edbd97c95a6a89786e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea7227b64729441fa3f00eb141b51740_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17e9dff542174b32865501500ace45c5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4ae8b1d50eb4bc6a284a520fe49663b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ad5a700227d4b0e92d99a7616f2178b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba567a48b404c3ab9acaa56ed5af44b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib122ecb689334b1fb324ee12c1cc2522_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22adc29e67d0453da5b441bc62d60fad_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7898a78b2b045e0a8fbcc5061436d03_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b8a27c308b4a97925c0a22163ab63a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9123b3bda6243a2a49be47ee2010afe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if296896edaf84700a94f43cf10109fd1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d9ef80e7d740e98803dffc38dc1875_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08fc3788b4f494fab5bba68fdd3f971_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83079dddc9604de9b744f8de96e981e8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i313ea0dffdb34c468e5b8d9fb727160e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09cbfdc3b91b4f0a938cae0e75b85bbc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie95aa9d4507c48a8aa4ecf6660ad1bb8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a8586120ec4ee3b816bd6e84c99d26_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b06cbe7ebf74441ad1135e8a4099d4c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i154a1248141a444db4764c62730b8fe8_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e7b422811cd4eacbfca8abd88d6e929_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2e02302174c424e83e466e2024ad82a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3b8ceb1a99f4a2db99cb4f7b7466475_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i755a5d90f3814df4b21a068f5395ce3f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ad49caca1134d10b7917ed7da76c3c1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7be2a3f223eb4dd1a902692b9d00ee3c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9aae2ecc3b743ee8b3b99bcb96a572c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b65da53d1249ec90a0398fbf799f3b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b1e06b3f4724fbe8ed56758a473c1d6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0362b4098b8b4067bb006f7b4a31ae00_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21cb6aa32d1f481981628ab9194b1087_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46bfa1d6a2ed48c58d0b334930a15be9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a796cfd479247d9aed9717103f579c5_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i636b7d8d6ac1434884437455e4abece1_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ba69d3b809426383ff74cd52d2d5d6_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82fb06354e254a39957ee2c588fb1109_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d5a944ccec4ed6a09939ea678a2ce2_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cb3f4d815394a569ef25a97b6547ade_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ad6655541f44f868773ab9598f2389a_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i711fe8ef0e6b434ba332d1783ca67ae8_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia06bc3660c334df6ad4d8fb329decb0d_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaac60c046f35441f9fedd46ad3c40d4d_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477ce66329a84971b9ed1654697676df_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i713da180c69b463b9d60a20b18530ae8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47367bb6b2924151bb0cb2e2a24e2c4c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb49035180454921878d3e554660eafb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i492a77d89eef44f5a423a69591c4fcb1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd49df5862fc48f89ee6373a56f0a57d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330f829063eb4447ad6bc4456ceff4ec_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide9bbd27a0cd44dcb98a452d6c22b67f_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i648b8dfd6eb548adbbd2d21365d6cde8_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i277928b220f44e7784ead40b68440c9f_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312ec77e4d634c4ea325786b43d11b2f_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e86db53cbf48f1950b3278e95c83d9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fb827478bd461a8787df84f27802af_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5f7f7d4aa34c8a8fe7242aaf64fce7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a8bd1261794f438b0bd13c92aeb774_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3617b6fd6934a64af7e251d421562bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f42f3eb9b7429faccfa0ee07b6c3d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1401DueMay232023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3348e3185c3a4d8faf23b030ca9b058a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1401DueMay232023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92d3fd233174393a0c8985d57b80ac0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i702a0883d82245dfb5727457b4bf121e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12bf8edf84ca4a9490012af58b404885_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b7239cbb2b4caa96217145ed318c6a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95c59b4820ac446795f35fc603f13926_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a63b521162435da95e767ab599c1d3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic410939d905842db8f020e0dd78f97ad_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1935866626bf4551abb766287f4f12bb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad2f735852d14c1aa5af472705bd220f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd801a10d19e41d48e55e40566722456_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eaa388c48eb48529b863b1dad0c7c66_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.02dueMay242025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb65fb27ea394d7bab72c0b7eacb98e7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.02dueMay242025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c4aa1f41194aa4802d0e4036ca000d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9406b7f8b0d4bcb819b52eef9ed6c98_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68bc0f1d591947e198044880214c84e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i365b69b186eb4841aeadfd7470683467_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i071e4371c19b435eabf32db0df89d6b8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6.700dueDecember12026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d41b365cba499bbdc2091259476a27_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6.700dueDecember12026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05fd68b08a7b426eb6811e05f0b4a888_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eb793b910104ba58a06b3d19b079980_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53130d0da5f34bd5a6206bb574cd0646_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.700dueJune62027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcea25fd00bb44f49a60939195013440_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.700dueJune62027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38ea59a9bc0045368162126cf4bedf68_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05399f1c63e149d4950728ad77213bd5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1712e718c2c4f059e63b730ad6912b7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i985f9c0cd4e740d3aa74db4e83626a95_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd7ed43ce46648ddad0381b46f2d1b52_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief27c89ab80f4c94b4ad781ba05245ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597528406ad4432080c7b790975f5a70_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2823DueMay202030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9850b5968694db493ee80a1a80fc434_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2823DueMay202030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3605fcabb8994cffb101c033d2307325_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1957DueFebruary112031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7bccee58c364c979aa7b39b610a38ab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1957DueFebruary112031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4298DueAugust222032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie17bfcc9d30b4c22988228770a9646df_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4298DueAugust222032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i686038d3973d4dd3b99c9b7c97fdda7a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23650c82023d4075b7451afcab116d86_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602de84cb42e475798daa51154634938_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac145c8106242f789a62759ee65edc0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4f072271fd54749be6519ce7a4cb656_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83e438c828a47659e4ba879ee36b614_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ad1135b73947ef9ed5193babf7878e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6229439c652442adbe136afeff494f38_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f5624d7d8e14e90943f68d463e69f40_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaa71c7f48a44190bbfc9f05ea58cfb9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.875dueMay152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib71ac3489c92480f87da9461658618ea_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.875dueMay152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372bc258ba0740cb8d556e4188e7d392_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i569682f1363b43b89ccf1234c5278a9f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a74c7bd3dcf442eae90093915052162_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.669DueJune62047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia718f431cd534f328b232c9f48b09e22_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.669DueJune62047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3695003b616b4e0d81066f1f96ec98c6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0d22cd43c3455081ebb8c94a57c5b9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ea78107cfd48079574408788ac59cf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d9c4caf0fe4fe0890096aea18a076d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbe00aadffe4e36a0990b8bfd4542ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b97cd83431a46e9b8ff128d63380b1e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763be4649bed40309ea0a989f6d8495f_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes5000DueFebruary152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief9c3d8df6124fd9ae43c6a9f513637b_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6750DueFebruary152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0969e888373e4049877b7174d7c5bddd_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7543d2dde946539fa775f189e5666f_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia025880105b44439b3c131cb16841016_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3cc867b1a746999043d8c1873c5582_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bdx:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2153de5b147d447da55f5389dd07896d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82c168f755943beb76474f81ed94633_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1957DueFebruary112031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3125DueNovember82021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if092f20bc6ba47ee829e82597aec9760_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i26010aaa94984bc6b48f50c2340e67af_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie33b2738d7da4d69943646d03c93abc3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31af2fbf9574b50a43cb3846510c6a5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96c8b23a3f8e4af4ae8c1da6663b9bdc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3860e3f6433948fe91197f9214f8ee03_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebef67ca020b4e9190319bea0f3427b3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c6939f1f5044d25973438c5911a2a59_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f7d0235eba84a0698944deb7ab704a7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c474d65be064b50ab5658c993941100_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51961b234cd24495af06e60749af2c1c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id280f6f5f1b54db287e925bcaab334b3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfdde262f537472fb65210d2b884f533_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafab5391deac4533b6a6ac832b19ac87_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d239a7d2eab44538b07a8dbbcd8458d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if530e7153ede42babf75d9614ea2fed3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7602efcbb12497fa6ca035a193d108a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32b723311b347478e48a35ca4f68e40_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd421b62f5a4ac2bf277725abb3c4dd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d32099e1bf4a3fa5b0b39913d35e39_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca62f76cd424ac899783fac2a96e623_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b9cf2d374194df6ae4c79f04396b60d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c7f7af69c647e89fe2fbce62dcc9e0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0ffa05b17304f47881712e6c344e328_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e5fbb72ed545d0a517f8558fbba67b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1049aeeb644c24b6c34fb4411c861a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f59f936a894ffba8eb3a14ba54e55b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.300dueMarch12023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1906af748d804698a67a96838cf98239_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.300dueMarch12023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id102f0302f614bf08fe037344bc095d2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.300dueMarch12023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i198b3d81101443ecbb89d876818dc429_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ce76d4d39314f31a725cb2fb4405f44_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d69b67e36644b9aafbaf1de869fc363_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5115502651348ca9ad2cab73680d5c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b0ec6988641447b8dbfe586f04fa9c5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ff9e2355d1b44a4856d7f25dd014220_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b17ea17825849b884fccaffccfcd7c8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3125DueNovember82021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i524df8ec8e694ff09698ff2542b4ace8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3125DueNovember82021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35d044f774d64179a6b3b2b850e72570_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaad9390901e9440ab8f2487e7732dd8f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9861ef1ad04469090e0fb052180295c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33f931afdb7747e393d4a4978e51673e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e35f9e011d44588b3b8b920a77a0bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cc4f6959fee4f399833aef85a382ac2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b78638dd6be44b198ad670fa48ac3d0_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f4c3f3aeef48c7a0b365d3718eba1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812d0cfe92a74e4c926610f6e5a3cbba_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SaleLeasebackTransactionDescriptionAxis">bdx:SaleLeasebackTransactionTermOfContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28abfbeeca0f4ef0a684b8b4d60fd993_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SaleLeasebackTransactionDescriptionAxis">bdx:SaleLeasebackTransactionTermOfContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i644ae4d7f0334a60b2e4791644ea5968_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c659996ff364a5889ca74df9594897c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b4aeecbf34445895456d33566115a6_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0089a582278743878e90b9ca5e0e2c89_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9f9865f93104f3ea7954370b74f7d79_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329bff29919e4afd9a9bdec6c58ae755_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba943512d69048e5bf48aa7426358b78_D20191001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05b402904eee4442982827a336b690c8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9ee8a265ed45f7bcd1a5b2a45da743_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4026aaac83c04f90b25918ecc8f53b9a_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5c357468b445299d75577a1038cd20_D20201001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i686e25e2d18c4aad801c33d834ed7b23_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26517beec32f4052bdb7d8b798ad21eb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i722514c7a4114a04aa38c850c0f296e7_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dfe227a5f864820bdf92afbd17f990a_D20211001-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b12d1fd67f455baf6f93c8c91f52ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia98b2ad1fc1143869d44f1bd24b9aaec_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia87db9e40d284890bdb9962ca233dca1_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYy_e4601e3d-f7c4-43db-ba1a-2e0a67db192e">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY3_21937dd1-002c-4326-8f2c-9021099bacaf">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yMTU_be7e5956-afb5-4061-ab4b-4734c14d832c"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yMTU_f5260b0f-c915-4ded-852a-d3e72a25e475">September 30</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYz_834c7637-3099-457f-b8f2-535fbc77b4ed">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER:   <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY4_eadd0b02-a401-4052-80e8-50291cf9c261">001-4802</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY0_f0722e52-8a8f-401f-b75a-c0bc32f765a5">BECTON, DICKINSON AND COMPANY</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:15.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8wLTAtMS0xLTczNTM1_a51c6a9f-882e-4024-9296-128bd7ad6285">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8wLTQtMS0xLTczNTM1_bd56623c-dcae-430e-9e8e-238cbc38440e">22-0760120</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTAtMS0xLTczNTM1_8859cc2f-26b4-4b60-8dee-32d84b656d6a">1 Becton Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTEtMS0xLTczNTM1_7ba0f25d-db69-4d33-a507-3167412fc4d4">Franklin Lakes,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTItMS0xLTczNTM1_ec69485d-6bed-41cf-8cd8-733a0cd0e1a8">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTQtMS0xLTczNTM1_216ad604-c04d-4d92-bad3-0e7e3e9256a4">07417-1880</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY1_7815ed04-14b3-491a-9a44-19eadb539f49">201</ix:nonNumeric>) <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY2_a1d4cb92-7938-4c09-babb-35d3d792335c">847-6800</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xLTAtMS0xLTczNTM1_5b091959-ad73-406d-a833-a06bb6f3cce0">Common stock, par value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xLTItMS0xLTczNTM1_c1c9bb7d-1eac-42b1-a557-41ce61f235b7">BDX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xLTQtMS0xLTczNTM1_5e56d021-921e-4271-837c-225f22871355">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8yLTAtMS0xLTczNTM1_f2dd0eac-b51f-4a0d-a3ea-8e3e6937b484">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8yLTItMS0xLTczNTM1_7a611e6c-003f-4219-a18f-8335fd7b45f5">BDXB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8yLTQtMS0xLTczNTM1_68d92f44-1eeb-42fc-9af6-6433a9759e92">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8zLTAtMS0xLTczNTM1_2a675ef6-e858-405a-986d-bd6082de3c0a">1.000% Notes due December 15, 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8zLTItMS0xLTczNTM1_9f65e95d-25a3-4905-8808-179f61ebb52b">BDX22A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8zLTQtMS0xLTczNTM1_c7d1c49e-1902-40fb-a554-cc4635f5a58a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV80LTAtMS0xLTczNTM1_216f6b68-df74-49c0-9386-8fdbdacdd6f6">1.900% Notes due December 15, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV80LTItMS0xLTczNTM1_f9c163d0-2bd6-43ed-82c9-5d689daae472">BDX26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV80LTQtMS0xLTczNTM1_5e0be22d-3604-4109-aeb5-d4bdc5e85abe">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV81LTAtMS0xLTczNTM1_b8074a28-ea8b-4d7a-8c82-e1f68ca3ace2">1.401% Notes due May 24, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV81LTItMS0xLTczNTM1_d9b5feff-7f78-4b5b-bbb8-1b2efacb7297">BDX23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV81LTQtMS0xLTczNTM1_123cfcbd-691b-449f-b387-cef8c4daa9f6">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV82LTAtMS0xLTczNTM1_0721b1b9-e789-45c5-8b46-ab133a873b49">3.020% Notes due May 24, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV82LTItMS0xLTczNTM1_c297dc31-fe62-4b15-9960-bbe7de798500">BDX25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV82LTQtMS0xLTczNTM1_351eb472-a075-4f8b-8224-d297f92df7f9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV83LTAtMS0xLTczNTM1_91abafa3-094a-4dba-97a4-b32e4537df83">0.632% Notes due June 4, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV83LTItMS0xLTczNTM1_ae568c08-b2ac-4b25-a178-4020b80a5391">BDX/23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV83LTQtMS0xLTczNTM1_ba71ad55-0529-4aa2-b305-0db6fa200ceb">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV84LTAtMS0xLTczNTM1_3aaea639-b0d8-485d-aa34-54374d172e66">1.208% Notes due June 4, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV84LTItMS0xLTczNTM1_4f0bf7cd-6979-4c54-b9dd-074c8e316f57">BDX/26A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV84LTQtMS0xLTczNTM1_ea7b46c8-ede4-4968-8600-a852007edc48">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV85LTAtMS0xLTczNTM1_42fc5329-0dff-4c80-b123-de7a4863b9ac">1.213% Notes due February 12, 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV85LTItMS0xLTczNTM1_575ce098-86ff-4fa4-b10c-bd2a048db136">BDX/36</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV85LTQtMS0xLTczNTM1_317e70e8-1c95-4deb-852c-07490b414c29">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if549031f297645189d2c585e3072d96b_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMC0wLTEtMS03MzUzNQ_8fb464c5-ae53-4d56-99a5-e8a97ab1b67f">0.000% Notes due August 13, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if549031f297645189d2c585e3072d96b_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMC0yLTEtMS03MzUzNQ_14348461-d5e8-4660-bf80-ceb9cee8c15d">BDX23B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if549031f297645189d2c585e3072d96b_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMC00LTEtMS03MzUzNQ_aaa4e451-a49f-4d70-abaa-6f425244bbb8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMS0wLTEtMS03MzUzNQ_73ba1c5c-6034-4a84-a11d-af5f923406f0">0.034% Notes due August 13, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMS0yLTEtMS03MzUzNQ_0c0cb20f-6021-4b81-aafd-5e8f98bc4170">BDX25A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMS00LTEtMS03MzUzNQ_19cb8944-400e-41e2-912b-0a184f04aad6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">None</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY5_0161ba0c-8bdf-4960-a772-8400eb3821d1">Yes</ix:nonNumeric>&#160;&#160;&#9745;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzU4_425f57c1-224a-48ab-b472-0d75ef574a4f">No</ix:nonNumeric>&#160;&#160;&#9745;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzU5_845cf6a1-a449-4b2d-acc0-a8970a36b30c">Yes</ix:nonNumeric>&#160;&#160;&#9745;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzU3_9a5ca62e-77d4-461a-9224-e8b2b73e2cb6">Yes</ix:nonNumeric>&#160;&#160;&#9745;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a "large accelerated filer," an "accelerated filer," a "non-accelerated filer," a "smaller reporting company," or an "emerging growth company."  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.632%"><tr><td style="width:1.0%"></td><td style="width:24.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6MWY0MzVjNWJhOWM2NDkxM2IyZjE5OGE1MDViYmI3YmIvdGFibGVyYW5nZToxZjQzNWM1YmE5YzY0OTEzYjJmMTk4YTUwNWJiYjdiYl8wLTAtMS0xLTczNTM1_5ab72f0c-7906-43a6-a8f0-f47bc6dda9c3">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6MWY0MzVjNWJhOWM2NDkxM2IyZjE5OGE1MDViYmI3YmIvdGFibGVyYW5nZToxZjQzNWM1YmE5YzY0OTEzYjJmMTk4YTUwNWJiYjdiYl8yLTItMS0xLTczNTM1_e86ef5fc-9401-435e-b168-21a98d722083">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6MWY0MzVjNWJhOWM2NDkxM2IyZjE5OGE1MDViYmI3YmIvdGFibGVyYW5nZToxZjQzNWM1YmE5YzY0OTEzYjJmMTk4YTUwNWJiYjdiYl80LTEwLTEtMS03MzUzNQ_3649b115-9640-4cf1-bf3e-12c5d00a7b5d">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.          <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYw_bd59e729-2201-4d82-8bfe-3a55b25afc51">&#9745;</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYx_f0b33235-e1fd-466d-8cd7-920ccab6d19d">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9745;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of March 31, 2022, the aggregate market value of the registrant&#8217;s outstanding common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i5dcf0c18b4fd4e3e980d4799086c4754_I20220331" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNDgx_1dea42de-1204-46d2-b3ea-7dc2d87b0891">74,865,947,637</ix:nonFraction>.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of October&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i53c38993858547f68214ac6f1981c2a9_I20221031" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNDk1_353f2e95-dd7c-4508-994c-a25628b989dc">283,375,793</ix:nonFraction> shares of the registrant&#8217;s common stock were outstanding.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Documents Incorporated by Reference. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Proxy Statement for the Annual Meeting of Shareholders to be held January&#160;24, 2023 are incorporated by reference into Part III hereof.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.400%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_16">Item&#160;1. Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_19">Item&#160;1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_19">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_22">Item&#160;1B. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_22">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_25">Item&#160;2. Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_25">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_28">Item&#160;3. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_28">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_31">Item&#160;4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_31">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_34">Information About Our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_34">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_37">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_37">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_40">Item&#160;5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_40">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_43">Item&#160;6. (Reserved)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_43">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_46">Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_46">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_49">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_49">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_52">Item&#160;8. Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_52">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_133">Item&#160;9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_133">106</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_136">Item&#160;9A. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_136">106</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_139">Item&#160;9B. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_139">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_142">Item 9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_142">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_145">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_148">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_148">Item&#160;10. Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_148">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_151">Item&#160;11. Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_151">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_154">Item&#160;12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_154">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_157">Item&#160;13. Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_157">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_160">Item&#160;14. Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_160">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_163">PART IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_163">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_166">Item&#160;15. Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_166">109</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_169">Item 16.  Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_166">109</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_172">EXHIBIT INDEX</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_172">110</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_175">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia87db9e40d284890bdb9962ca233dca1_175">115</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;&#160;1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Becton, Dickinson and Company (also referred to herein as "BD") was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD&#8217;s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201)&#160;847-6800. All references in this Form 10-K to "BD", "the Company", "we", "our" or "us" refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.  We provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; and advancing cellular research and applications.</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s operations consist of three worldwide business segments: BD Medical, BD Life Sciences and BD Interventional. Information with respect to BD&#8217;s business segments is included in Note 8 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data, and is incorporated herein by reference.</span></div><div style="margin-top:5pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BD Medical</span></div><div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD Medical produces a broad array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The primary customers served by BD Medical are hospitals and clinics; physicians&#8217; office practices; consumers and retail pharmacies; governmental and nonprofit public health agencies; pharmaceutical companies; and healthcare workers. BD Medical consists of the following organizational units:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Organizational Unit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Principal Product Lines</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery<br/>Solutions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral intravenous ("IV") catheters (conventional, safety); advanced peripheral catheters (guidewire assisted peripherally inserted venous catheters, midline catheters, port access); central lines (peripherally inserted central catheters); acute dialysis catheters; vascular access technology (ultrasonic imaging);  vascular care (lock solutions, prefilled flush syringes, disinfecting caps); vascular preparation (skin antiseptics, dressings, securement); needle-free IV connectors and extensions sets; closed-system drug transfer devices; hazardous drug detection; conventional and safety hypodermic syringes and needles, anesthesia needles (spinal, epidural) and trays; enteral syringes; and sharps disposal systems.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Management <br/>Solutions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">IV medication safety and infusion therapy delivery systems, including infusion pumps, dedicated disposables, and IV fluids; medication compounding workflow systems; automated medication dispensing;&#160;automated supply management systems; medication inventory optimization and tracking systems; informatics and analytics solutions for enterprise medication management; and pharmacy automation systems.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prefillable drug delivery systems - prefillable syringes, safety, shielding and self-injection systems and support services (combination product testing, technical and regulatory) - provided to pharmaceutical companies for use as containers for injectable pharmaceutical products, which are then placed on the market as drug/device combinations.</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="padding-left:22.5pt"><span><br/></span></div><div style="padding-left:22.5pt"><span><br/></span></div><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BD Life Sciences</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers.  In addition, BD Life Sciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes.  That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases.  The primary customers served by BD Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians&#8217; office practices; retail pharmacies; academic and government institutions; and pharmaceutical and biotechnology companies. With the emergency use authorization approval of the At Home COVID-19 test, BD Life Sciences also serves patients directly. BD Life Sciences consists of the following organizational units:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Organizational Unit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Principal Product Lines</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women&#8217;s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems and HPV tests for cervical cancer screening and genotyping; rapid diagnostic assays for testing of respiratory infections at the point of care; microbiology laboratory automation; and plated media for clinical and industrial applications.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fluorescence-activated cell sorters and analyzers; antibodies and kits for performing cell analysis; reagent systems for life science research; solutions for high-throughput single-cell gene expression analysis; and clinical oncology, immunological (HIV) and transplantation diagnostic/monitoring reagents and analyzers.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:3pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BD Interventional</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD Interventional provides vascular, urology, oncology and surgical specialty products that are intended, with the exception of the V. Mueller&#8482; surgical and laparoscopic instrumentation products, to be used once and then discarded or are either temporarily or permanently implanted.  The primary customers served by BD Interventional are hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via our Homecare business.  BD Interventional consists of the following organizational units:</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Organizational Unit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Principal Product Lines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hernia and soft tissue repair, biological grafts, bioresorbable grafts, biosurgery, and other surgical products, BD ChloraPrep&#8482; surgical infection prevention products, and V. Mueller&#8482; surgical and laparoscopic instrumentation products.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Percutaneous transluminal angioplasty (&#8220;PTA&#8221;) balloon catheters, radio frequency ablation catheters, peripheral vascular stents, self-expanding and balloon-expandable stent grafts, vascular grafts, drug coated balloons, ports, biopsy, chronic dialysis, feeding, inferior vena catheter filters, endovascular fistula creation devices and drainage products, and atherectomy and thrombectomy systems.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Urine management &amp; measurement devices, urological drainage products, intermittent catheters, kidney stone management devices, Targeted Temperature Management, and fecal management devices. </span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 18, 2022, BD completed the acquisition of Parata Systems (&#8220;Parata&#8221;), an innovative provider of pharmacy automation solutions, for total cash consideration of $1.548&#160;billion.  Since the acquisition date, financial results for Parata's product offerings are being reported within results for the Medical segment&#8217;s Medication Management Solutions unit.  Additional information regarding this acquisition is contained in Note 11 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data, which is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Spin-Off of Diabetes Care</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, BD completed the separation and distribution of Embecta Corp. (&#8220;Embecta&#8221;), formerly BD's Diabetes Care business, into a separate, publicly-traded company.  The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment), as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in our consolidated financial statements for all periods prior to the spin-off date of April 1, 2022. Additional disclosures regarding our spin-off of the Diabetes Care business are provided in Note 2 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data, which is incorporated herein by reference.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Operations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s products are manufactured and sold worldwide. For reporting purposes, we organize our operations outside the United States as follows: EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, and Australia and New Zealand); Latin America (which includes Mexico, Central America, the Caribbean and South America); and Canada. BD has manufacturing operations outside the United States in Bosnia and Herzegovina, Brazil, Canada, China, Dominican Republic, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Mexico, the Netherlands, Singapore, Spain, and the United Kingdom. Geographic information with respect to BD&#8217;s operations is included under the heading &#8220;Geographic Information&#8221; in Note 8 to the consolidated financial statements included in Item 8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign economic conditions and exchange rate fluctuations have caused the profitability related to foreign revenues to fluctuate more than the profitability related to domestic revenues. BD believes its activities in some countries outside the United States involve greater risk than its domestic business due to the factors cited herein, as well as the economic environment, local commercial and economic policies and political uncertainties. See further discussion of these risks in Item 1A. Risk Factors.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s products are marketed and distributed in the United States and internationally through independent distribution channels, as well as directly to hospitals and other healthcare related institutions by BD and independent sales representatives. BD uses acute care, non-acute care, laboratory and drug wholesaler distributors to broadly support our overall disposable product demand from our end user customers in the United States, while our capital equipment is mostly sold direct to our end user customers.  In international markets, products are distributed either directly or through distributors, with the practice varying by country. Order backlog is not usually material to BD&#8217;s business inasmuch as orders for BD products generally are received and filled on a current basis. BD&#8217;s worldwide sales are not generally seasonal, with the exception of certain medical devices in the Medication Delivery Solutions business unit, and flu diagnostic products in the Integrated Diagnostic Systems business unit, both of which relate to seasonal diseases such as influenza. In order to service its customers, optimize logistics, lower facilities costs and reduce finished goods inventory levels, BD operates consolidated distribution facilities globally. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials and Components</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD purchases many different types of raw materials and components, including plastics, glass, metals, textiles, paper products, agricultural products, electronic and mechanical sub-assemblies and various biological, chemical and petrochemical products. BD seeks to ensure continuity of supply by securing multiple options for sourcing. However, there are situations where raw materials and components are only available from one supplier, which are referred to as sole sourced. The use of sole sourced materials and components may be due to sourcing of proprietary and/or patented technology and processes that are intended to provide a unique market differentiation to our product. In other cases, while a raw material or component can be sourced from multiple manufacturers, only one supplier is qualified due to quality assurance, cost or other considerations. In order to provide alternate sources, BD must complete a rigorous qualification process, which most often includes completion of regulatory registration and approval. If clinical trials are not required, this qualification process can take 3-18 months depending on the criticality of the change. When clinical trials are required, this process may lengthen the qualification phase from one to three years. BD continuously assesses its sole sourced raw materials and components, and maintains business continuity plans with its suppliers. BD&#8217;s continuity plans may include securing secondary supply with alternate suppliers, qualification of alternate manufacturing facilities, maintaining contingency stock, internal development of supply and establishment of technology escrow accounts. While BD works closely with its suppliers, no assurance can be given that these efforts will be successful, and there may be events that cause supply interruption, reduction or termination that adversely impacts BD&#8217;s ability to manufacture and sell certain products. See further discussion of the risks related to the supply chain and raw materials in Item 1A. Risk Factors.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD conducts its research and development (&#8220;R&amp;D&#8221;) activities at its operating units and across global enterprise centers of excellence located in the United States, India, China, Singapore, and Ireland. The majority of BD&#8217;s R&amp;D activities are conducted in North America. Outside North America, BD has a significant R&amp;D presence in Greater Asia and Europe. BD also collaborates with certain universities, medical centers and other entities on R&amp;D programs and retains individual consultants and partners to support its efforts in specialized fields.&#160; </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property and Licenses</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD owns significant intellectual property, including patents, patent applications, technology, trade secrets, know-how, copyrights and trademarks in the United States and other countries. BD is also licensed under domestic and foreign patents, patent applications, technology, trade secrets, know-how, copyrights and trademarks owned by others. In the aggregate, these intellectual property assets and licenses are of material importance to BD&#8217;s business. BD believes, however, that no single patent, technology, trademark, intellectual property asset or license is material in relation to BD&#8217;s business as a whole, or to any business segment.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD operates in the increasingly complex and challenging medical technology marketplace. Technological advances and scientific discoveries have accelerated the pace of change in medical technology, the regulatory environment of medical products is becoming more complex and vigorous, and economic conditions have resulted in a challenging market. Companies of varying sizes compete in the global medical technology field. Some are more specialized than BD with respect to particular markets, and some have greater financial resources than BD. New companies have entered the field, particularly in the areas of molecular diagnostics, non-traditional point of care and at-home testing, safety-engineered devices and in the life sciences, and established companies have diversified their business activities into the medical technology area. Other firms engaged in the distribution of medical technology products have become manufacturers of medical devices and instruments as well. Acquisitions and collaborations by and among companies seeking a competitive advantage also affect the competitive environment. In addition, the entry into the market of low-cost manufacturers has created increased pricing pressures.  BD competes in this evolving marketplace on the basis of many factors, including price, quality, innovation, service, reputation, distribution and promotion. The impact of these factors on BD&#8217;s competitive position varies among BD&#8217;s various product offerings. In order to remain competitive in the industries in which it operates, BD continues to make investments in R&amp;D, quality management, quality improvement, product innovation, manufacturing and supply chain investments to boost supply reliability and productivity improvement in support of its core strategies.  See further discussion of the risks relating to competition in the medical technology industry in Item&#160;1A. Risk Factors.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third-Party Reimbursement</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement is an important strategic consideration in the development and marketing of medical technology. Obtaining coverage, coding and payment is critical to the commercial success of a new product or procedure. Difficulty in achieving market access can lead to slow adoption in the marketplace and inadequate payment levels that can continue for months or even years.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of BD&#8217;s customers rely on third-party payers, including government programs and private health insurance plans, to reimburse some or all of the cost of the procedures, products and services they provide. Vertical integration has created a very concentrated market among commercial third-party payers in the U.S.  Global payers are increasingly focused on strategies to control spending on healthcare and reward improvements in quality and patient outcomes.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD is actively engaged in identifying and communicating value propositions of its products for payer, provider, and patient stakeholders, and it employs various efforts and resources to attempt to positively impact coverage, coding and payment pathways. However, BD has no direct control over payer decision-making with respect to coverage and payment levels for BD products. The manner and level of reimbursement in any given case may depend on the site of care, the procedure(s) performed, the final patient diagnosis, the device(s) and/or drug(s) utilized, the available budget, or a combination of these factors, and coverage and payment levels are determined at each payer&#8217;s discretion. As BD&#8217;s product offerings are diverse across a variety of healthcare settings, they are affected to varying degrees by the many payment pathways that impact the decisions of healthcare providers regarding which medical products they purchase and the prices they are willing to pay for those products. Therefore, changes in reimbursement levels or methods may either positively or negatively impact sales of BD products in any given country for any given product. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As government programs expand healthcare coverage for their citizens, they have at the same time sought to control costs by limiting the amount of reimbursement they will pay for particular procedures, products or services. In addition, most payers are seeking price predictability in order to mitigate future exposure to manufacturer price increases. This is coupled with an increase in high deductible private insurance plans, which transfer more pricing exposure and burden directly to the patient.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Many payers both in the U.S. and globally have developed specific payment and delivery mechanisms to support these cost control efforts and to focus on paying for value. These mechanisms include payment reductions, pay for performance measures, quality-based performance payments, restrictive coverage policies, bidding and tender mechanics, studies to compare the effectiveness of therapies and use of technology </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assessments. These changes, whether the result of legislation, new strategic alliances or market consolidations, have created an increased emphasis on the delivery of more cost-effective and quality-driven healthcare. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, as a result of the Patient Protection and Affordable Care Act (&#8220;PPACA&#8221;), the U.S. has implemented value-based payment methodologies and has created alternative payment models such as bundled payments to continue to drive improved value. We see other governments around the world considering similar bundling reform measures, with the utilization of the Diagnosis Related Gro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up (&#8220;DRG&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a payment mechanism to drive toward quality and resource-based reimbursement becoming more common in regions outside the U.S.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD's operations are global and are affected by complex state, federal and international laws relating to healthcare, environmental protection, occupational health and safety, antitrust, anti-corruption, marketing, fraud and abuse (including anti-kickback and false claims laws), export control, product safety and efficacy, employment, privacy and other areas. </span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s medical technology products and operations are subject to regulation by the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and various other federal and state agencies, as well as by foreign governmental agencies. These agencies enforce laws and regulations that govern the development, testing, manufacturing, labeling, advertising, marketing and distribution, and market surveillance of BD&#8217;s medical products. The scope of the activities of these agencies, particularly in the Europe, Japan, and Asia Pacific regions in which BD operates, has been increasing.</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD actively maintains Quality Systems that establish standards for its product design, manufacturing, and distribution processes, in accordance with ISO standards and FDA regulation. Prior to marketing or selling most of its products, BD must secure authorization from the FDA and counterpart foreign regulatory agencies. Following the introduction of a product, these agencies engage in periodic reviews and inspections of BD&#8217;s quality systems, as well as product performance and advertising and promotional materials. These regulatory controls, as well as any changes in agency policies, can affect the time and cost associated with the development, introduction and continued availability of new and existing products. Where possible, BD anticipates these factors in its product development and planning processes. These agencies have the authority to take various administrative and legal actions against BD, such as product recalls, product seizures and other civil and criminal sanctions, for violations of applicable requirements. BD also undertakes voluntary compliance actions, such as voluntary recalls.</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD also is subject to various federal and state laws, and laws outside the United States, concerning healthcare fraud and abuse (including false claims laws and anti-kickback laws), global anti-corruption, transportation, safety and health, and customs and exports. Many of the agencies enforcing these laws have increased their enforcement activities with respect to medical device manufacturers in recent years. This is part of a general trend toward increased regulation and enforcement activity within and outside the United States.</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the federal government has enacted the Sunshine Act provisions requiring BD to publicly report gifts and payments made to physicians and teaching hospitals. Countries outside the United States have enacted similar local laws requiring medical device companies to report transfers of value to healthcare providers licensed in those countries. Failure to comply with these laws could result in a range of fines, penalties and/or other sanctions.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent Decree with FDA</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our infusion pump organizational unit is operating under an amended consent decree entered into by CareFusion with the FDA in 2007. CareFusion&#8217;s consent decree with the FDA is related to its Alaris&#8482; SE infusion pumps. In February 2009, CareFusion and the FDA amended the consent decree (the &#8220;Consent Decree&#8221;) to include all infusion pumps manufactured by or for CareFusion 303, Inc., the organizational unit that manufactures and sells BD Alaris&#8482; infusion pumps in the United States. The Consent Decree does not apply to intravenous administration sets and accessories.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following an inspection that began in March 2020 of our Medication Management Systems facility (CareFusion 303, Inc.) in San Diego, California, the FDA issued to BD a Form 483 Notice (the &#8220;Form 483 Notice&#8221;) that contains a number of observations of non-conformance with the FDA&#8217;s quality system regulations. In December 2021, the FDA issued to CareFusion 303, Inc. a letter of non-compliance with respect to the Consent Decree (the &#8220;Non-Compliance Letter&#8221;) stating that, among other things, it had determined that certain of BD&#8217;s corrective actions with respect to the Form 483 Notice appeared to be adequate, some were still in progress such that adequacy could not be determined yet, and certain others were not adequate (e.g., complaint handling and corrective and preventive actions (&#8220;CAPA&#8221;), design verification and medical device reporting). Per the terms of the Non-Compliance Letter, CareFusion 303, Inc. provided the FDA with a proposed comprehensive corrective action plan and has retained an independent expert to conduct periodic audits of the CareFusion 303, Inc. infusion pump facilities over the next four years. CareFusion 303, Inc. will update its corrective action plan to address any observations that may arise during the course of these audits. The FDA&#8217;s review of the items raised in the Form 483 Notice and Non-Compliance Letter remains ongoing, and no assurances can be given regarding further action by the FDA as a result of the observations, including but not limited to action pursuant to the Consent Decree, or that corrective actions proposed by CareFusion 303, Inc. will be adequate to address these observations. Additionally, we cannot currently predict the amount of additional monetary investment that will be incurred to resolve this matter or the matter&#8217;s ultimate impact on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consent Decree authorizes the FDA, in the event of any violations in the future, to order us to cease manufacturing and distributing infusion pumps, recall products and take other actions. We may be required to pay damages of $15,000 per day per violation if we fail to comply with any provision of the Consent Decree, up to $15 million per year. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be obligated to pay more costs in the future because, among other things, the FDA may determine that we are not fully compliant with the Consent Decree and Non-Compliance Letter and therefore impose penalties under the Consent Decree, and/or we may also be subject to future proceedings and litigation relating to the matters addressed in the Consent Decree, including, but not limited to, additional fines, penalties, other monetary remedies, and expansion of the terms of the Consent Decree. As of September 30, 2022, we do not believe that a loss is probable in connection with the Consent Decree, and accordingly, we have no accruals associated with compliance with the Consent Decree. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are undertaking certain remediation of our BD Alaris&#8482; System, and are currently shipping the product in the U.S. only in cases of medical necessity and to remediate recalled software versions.  As previously disclosed, we submitted our 510(k) premarket notification to the FDA for the BD Alaris&#8482; System in April 2021. The 510(k) submission is intended to bring the regulatory clearance for the BD Alaris&#8482; System up-to-date, address open recall issues, and provide other updates and features, including a new version of BD Alaris&#8482; System software that will provide clinical, operational and cybersecurity updates. We will not be able to fully resume commercial operations for the BD Alaris&#8482; System in the U.S. until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FDA Warning Letter</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2018, BD received a Warning Letter from the FDA with respect to our former BD Preanalytical Systems ("PAS") unit, citing certain alleged violations of quality system regulations and of law. The Warning Letter states that, until BD resolves the outstanding issues covered by the Warning Letter, the FDA will not clear or approve any premarket submissions for Class III devices to which the non-conformances are reasonably related or grant requests for certificates to foreign governments. BD has worked closely with the FDA and implemented corrective actions to address the quality management system concerns identified in the warning letter. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FDA conducted a subsequent inspection of PAS, which it classified as Voluntary Action Indicated, which means the FDA will not take or recommend any administrative or regulatory action as a result of the unit&#8217;s response to the observations associated with the quality management concerns in the inspection. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD continues to work with the FDA to generate additional clinical evidence and file 510(k)s as remaining commitments associated with the Warning Letter. In January 2022, BD received FDA clearance for </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its BD Vacutainer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ACD Blood Collection Tubes used in immunohematology. The FDA review of these remaining commitments is ongoing, and no assurances can be given regarding further action by the FDA as a result of these commitments, including but not limited to action pursuant to the Warning Letter.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ethylene Oxide/Consent Order - Covington, Georgia, USA</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2019, BD entered into a consent order with the Environmental Protection Division of the Georgia Department of Natural Resources (the &#8220;EPD&#8221;), following the filing of a complaint and motion for temporary restraining order by the EPD seeking to enjoin BD from continuing sterilization operations at its Covington, Georgia facility.  Under the terms of the consent order,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which has been amended two times upon mutual agreement of BD and EPD, BD voluntarily agreed to a nu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mber of operational changes at its Covington and Madison, Georgia facilities, as well as at its distribution center in Covington, designed to further reduce ethylene oxide emissions, including but not limited to operating at a reduced capacity until successful implementation of fugitive emission control technology, ongoing ambient air monitoring and operational controls at such facilities. Following submission of data relating to the implementation of these operational changes, BD was permitted to return to normal operations in December 2021 at its facilities in Georgia in accordance with the operating conditions set forth in its permit applications, including a condition to continue ambient air monitoring. However, BD&#8217;s sterilization operations in Georgia remain subject to the EPD&#8217;s final approval of BD&#8217;s air permit applications and could be subject to additional restrictions.  BD has business continuity plans in place to mitigate the impact of any additional restrictions on our operations at these facilities, although it is possible that these plans will not be able to fully offset such impact, especially considering the reduced capacity of third-party sterilization service providers and the regulatory timelines associated with transferring sterilization operations for regulated products.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At a broader level, there is increased focus on the use and emission of ethylene oxide by the U.S. Environmental Protection Agency and state environmental regulatory agencies. Additional regulatory requirements associated with the use and emission of ethylene oxide may be imposed in the future, either domestically or outside the U.S. Ethylene oxide is the most frequently used sterilant for medical devices and healthcare products in the U.S., and in certain cases is the only option to sterilize critical medical device products for the safe administration to patients. This increased regulation could require BD or sterilization service providers, including providers used by BD, to temporarily suspend operations to install additional fugitive emissions control technology, limit the use of ethylene oxide or take other actions, which would impact BD&#8217;s operations and further reduce the available capacity to sterilize medical devices and healthcare products, and could also result in additional costs. A few states have filed lawsuits to require additional air quality controls and expand limitations on the use of ethylene oxide at sterilization facilities. For example, in December 2020, the State of New Mexico filed a lawsuit seeking a temporary restraining order and a preliminary and permanent injunction against a major medical device sterilizer, which sterilizes certain of our surgery products, to reduce ethylene oxide emissions associated with their sterilization process. On the federal level, in late 2019, the U.S. Environmental Protection Agency provided notice that it would be conducting rulemaking to reconsider federal regulations applicable to the use and emission of ethylene oxide, and there continues to be increased focus on the use and emission of ethylene oxide on the federal level. In anticipation of these proposed revisions to federal air regulations for commercial sterilizers in the U.S., BD is installing fugitive emissions controls at our facilities in East Columbus, NE and Sandy, UT.  It is possible that there may also be increased regulation outside the U.S.  If any existing regulatory requirements or any such proceedings or rulemaking result in the suspension or interruption of sterilization operations at BD or at medical device sterilizers used by BD, or otherwise limit the availability of third-party sterilization capacity, this could interrupt or otherwise adversely impact production of certain of our products or lead to civil litigation or other claims against BD. BD has business continuity plans in place to mitigate the impact of any such disruptions, although these plans may not be able to fully offset such impact, for the reasons noted above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of risks relating to the regulations to which we are subject, see Item 1A. Risk Factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At BD, our associates are guided by our Purpose of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">advancing the world of health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and The BD WAY, our cultural foundation that encompasses our core values, leadership commitments and the mindset we bring to our work.  Our associates are empowered to contribute their unique ideas and experiences to fuel innovation and improve patient outcomes. As of September 30, 2022, BD is comprised of approximately 77,000 associates located in over 62 countries. Attracting, developing and retaining talented people in technical, marketing, sales, research and other positions is crucial to executing our strategy and our ability to compete effectively in a highly competitive medical technology industry.  Our ability to recruit and retain such talent depends on several factors, including compensation and benefits, talent development and career opportunities, and our unique culture.  To that end, we continually invest in our associates in order to be an employer of choice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inclusion, Diversity &amp; Equity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to have our workforce reflect the communities we live and work in and the customers and patients we serve. Our associates possess a broad range of thoughts and experiences which have helped BD achieve our leadership position in the medical technology industry and the global marketplace. A key component of our journey to continually build a better BD is our commitment to global inclusion, diversity and equity (&#8220;ID&amp;E&#8221;). We believe this commitment, coupled with our purpose and culture, allows us to better understand patient and customer needs and develop innovative technologies to meet those needs. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continue to demonstrate progress in expanding the diverse representation of our workforce, we seek to continuously improve.  Each year, we establish annual corporate ID&amp;E goals to improve hiring, development, advancement, and retention of diverse talent at every level of the organization to further our culture of inclusion. In addition, our executive leaders serve as sponsors to our eight global Associate Resource Groups (&#8220;ARGs&#8221;). Our ARGs are empowered to set strategic goals aligned with their mission and centered around efforts to advance our company, our local communities and each BD associates&#8217; career, while driving acceptance, allyship and professional development opportunities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Externally, we are building on our existing momentum and remain involved in industry ID&amp;E efforts with the Advanced Medical Technology Association (&#8220;AdvaMed&#8221;) to improve diversity in the medical technology industry. We remain committed to sustaining meaningful, long-term strategic partnerships and programs to help ensure that we are advancing the health of our people and patient communities. Through the BD Helping Build Healthy Communities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> initiative, which is funded by BD and the BD Foundation, and implemented jointly by Direct Relief and the National Association of Community Health Centers, we have provided 52 awards to community health centers in 20 states since 2013, with a total commitment of $22.6 million in cash and product donations to advance health equity in the U.S. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These collective efforts have garnered recognition from respected organizations across the country, including Best Places to Work for Disability and LGBTQ Inclusion, Bloomberg&#8217;s Gender Equality Index, Diversity Inc.&#8217;s Noteworthy Companies and from Forbes - Best Employers for Diversity, Best Large Employers and World&#8217;s Best Employer awards. While we celebrate the recognition we have received, we remain committed and accountable to the work required within our company and beyond our corporate walls to build belonging, acceptance and equity for all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BD 2022 Workforce Diversity Representation</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gender (Global)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-Over-Year Improvement</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Race (U.S. Only)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-Over-Year Improvement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+3%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All associates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+4%</span></td></tr></table></div><div style="margin-top:4pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the above table, we define &#8220;executives&#8221; as associates in positions of vice president and above.  &#8220;Management&#8221; positions are defined as those in manager, director or equivalent roles.  Information regarding race and gender is based on information provided by associates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Associate Growth and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At BD we hold ourselves and each other accountable for learning and growing every day, which underscores our growth mindset culture.  Our commitment to continuous improvement helps us become the best version of ourselves and we invest significant resources to develop talent with the right capabilities to deliver the growth and innovation needed to support our strategy and customers. Our enhanced Strategic Organizational Planning process is focused on building the organizational capabilities required in the years to come, and we offer associates and managers a number of tools to help in their personal and professional development, including career development plans, mentoring programs and in-house learning opportunities, including BD University, our in-house continuing education program that follows a "leaders-as-teachers" approach.  Our deeply-rooted practice of investing in our next generation of leaders offers associates a number of leadership development programs, including programs dedicated to specific areas, such as finance and technology. We offer a suite of programs to help our more than 8,000 People Managers to become even more efficient as managers, and we are beginning to roll-out programs focused on building servant leaders who create work environments that facilitate growth and success. We have also applied our growth mindset philosophy to our performance management approach with an increased focus on continuous learning and development. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Associate Engagement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we strive to be an employer of choice, we believe it is critical that our associates are informed, engaged and have the opportunity to provide feedback.  We communicate frequently and transparently with our associates through a variety of communication methods, including video and written communications, town hall meetings, associate surveys and our company intranet, and acknowledge individual contributions to BD through a number of rewards and recognition award programs.  Feedback from associates indicates that these engagement efforts keep associates informed about our strategy, culture and purpose and motivated to do their best work.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to helping associates stay engaged, we also work to foster and reinforce an inclusive culture where diverse perspectives are valued. This year, our ARGs continued to host company-wide dialogues and panel sessions to advance our business and cultural priorities and engage associates on timely topics on racial injustice, career progression, critical race theory, LGBTQIA+ education and equity, eliminating bias, healthcare inequity and access, and mental/emotional well-being during turbulent times. We continue to engage in discussions as a company on intersectionality, inclusion and belonging. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek ongoing feedback to better understand what we are doing well and how we can improve the associate experience. In addition to encouraging a speak-up culture between associates, their managers, and cross-functional teams, we conduct employee engagement surveys to provide all associates with an opportunity to share their perspective and we take appropriate action in response.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a long-standing history of associate volunteerism that we believe has had an impact on local and global communities. Through our public-private partnerships and collaborations with non-government organizations, we sponsor volunteer trips and other meaningful volunteer opportunities to help communities around the world and increase health equity and access for all people.  On a local front, associates are </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">encouraged and empowered to serve organizations and causes that are important to them.  This includes a matching gift program, paid time off to volunteer, and an award program to give grants to non-profit organizations in honor of associates who engage in exceptional volunteer efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation, Benefits and Well-being</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total rewards program is designed to attract and retain top talent and to incentivize performance aligned with our business strategy and values. We offer a comprehensive total rewards program aimed at promoting overall well-being in support of the varying health, home-life and financial needs of our diverse and global associates.  Through our integrated global approach to well-being, we provide support, education, and resources to empower associates across all geographies to prioritize their well-being and build resilience in the physical, emotional, financial, and social areas of life. To enable associates to take action in support of their overall well-being, our total rewards packages (which vary by location) include market-competitive pay, broad-based stock grants and bonuses, healthcare benefits, pension and retirement savings plans, paid time off and family leave, flexible work schedules, on-site health and fitness centers, free physicals and flu vaccinations, well-being education and resources, Employee Assistance Programs and other mental health support and resources. Each year we review and implement program enhancements and investments to ensure our benefits are inclusive and representative of the needs of BD associates and their families. Additionally, over the last several years in the U.S., we have increased efforts to mitigate the impact of rising healthcare costs and to offer more affordable benefit options, with a specific focus on affordability for BD associates earning $50,000 per year or less.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD is also committed to compensating all associates fairly and equitably for their contributions to company performance. Aligned with our priority focus on pay equity, we regularly conduct comprehensive audits, internal and external analyses, salary benchmarking and bias assessments to identify and remedy unexplained disparities. For fiscal year 2021, we conducted a global pay equity assessment for associates in 57 countries, representing approximately 70% of BD&#8217;s global salaried associate population and found that our female associates in 2021 earned an average of 99 cents for every $1 earned by male associates in the U.S., and 98 cents globally.  We consider these results as a baseline for our commitment to achieving 100% gender pay equity and we are actively working to close remaining pay gaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD maintains a website at www.bd.com. BD makes available its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K (and amendments to those reports) as soon as reasonably practicable after those reports are electronically filed with, or furnished to, the Securities and Exchange Commission (&#8220;SEC&#8221;). These filings may be obtained and printed free of charge at www.bd.com/investors. </span></div><div style="margin-top:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the written charters of the Audit Committee; the Compensation and Human Capital Committee; the Corporate Governance and Nominating Committee; the Executive Committee; and the Quality and Regulatory Committee of the Board of Directors, BD&#8217;s Corporate Governance Principles and its Code of Conduct, are available and may be printed free of charge at BD&#8217;s website at investors.bd.com/corporate-governance. Printed copies of these materials, this 2022 Annual Report on Form 10-K, and BD&#8217;s reports and statements filed with, or furnished to, the SEC, may also be obtained, without charge, by contacting the Corporate Secretary, BD, 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, telephone 201-847-6800. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. </span></div><div style="margin-top:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD also routinely posts important information for investors on its website at www.bd.com/investors. BD may use this website as a means of disclosing material, non-public information and for complying with its disclosure obligations under Regulation FD adopted by the SEC. Accordingly, investors should monitor the Investor Relations portion of BD&#8217;s website noted above, in addition to following BD&#8217;s press releases, SEC filings, and public conference calls and webcasts. Our website and the information contained therein or connected thereto shall not be deemed to be incorporated into this Annual Report.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:4.5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD and its representatives may from time-to-time make certain forward-looking statements in publicly-released materials, both written and oral, including statements contained in filings with the SEC and in its reports to shareholders. Additional information regarding BD&#8217;s forward-looking statements is contained in Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_19"></div><div style="margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;&#160;1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Risk Factors.</span></div><div style="margin-top:4.4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investment in BD involves a variety of risks and uncertainties. The following describes some of the material risks that could adversely affect BD&#8217;s business, financial condition, operating results or cash flows.  We may also be adversely impacted by other risks not presently known to us or that we currently consider immaterial.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business, Economic and Industry Risks</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with public health crises, such as pandemics and epidemics, including the COVID-19 pandemic, which may continue to have a material adverse effect on our business. The nature and extent of future impacts are highly uncertain and unpredictable.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to risks associated with public health crises, such as pandemics and epidemics, including the COVID-19 pandemic.  While many countries around the world have removed or reduced the restrictions taken in response to the COVID-19 pandemic, the emergence of new variants of the SARS-CoV-2 virus may result in new governmental lockdowns, quarantine requirements or other restrictions to slow the spread of the virus.  This could result in significant reductions in the demand for certain of our products due to reductions in elective and non-essential procedures, lower utilization of routine testing and related specimen collection, reduced capital spend by customers, decreases in research activity due to laboratory closures and reduced clinical testing, as well as hospital and clinical occupancy and healthcare system staffing shortages. These measures could also include determinations that our or our suppliers&#8217; facilities are not essential businesses, which could result in closures or other restrictions that significantly disrupt our operations or those of distributors or suppliers in our supply chain. In addition, any such measures could also impact the global</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">economy more broadly, for example by leading to further economic slowdowns. While COVID-19 case volumes have decreased in the U.S and certain other countries, the global outlook remains uncertain as case counts fluctuate and vaccination and booster rates remain relatively low in many parts of the world. Going forward, medical procedure rates may vary by country based on regional infection and vaccination and booster rates, hospital occupancy and staffing levels, transportation limitations, quarantines and other restrictions, and the emergence of new variants of the SARS-CoV-2 virus. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the COVID-19 pandemic has impacted our global supply chain network, and we may continue to experience significant challenges in our network, including shortages in supply or disruptions or delays in shipments, as well as price increases, of certain materials or components used in our products. The COVID-19 pandemic has escalated challenges that existed for global healthcare systems prior to the pandemic, including budget constraints and staffing shortages, particularly shortages of nursing staff, that could impact the future demand for our products and services. As COVID-19 conditions have improved, there have been increases in demand for certain of our products, which may pose challenges to our supply chain and could adversely affect our business. In addition, in response to the pandemic we developed and launched multiple products for the detection and identification of COVID-19, including tests for our BD Max&#8482; molecular System and BD Veritor&#8482; Plus System, and there are a number of factors, including vaccination and booster rates and the availability of competitive products, that have impacted in the past, and could impact in the future, the level of demand and pricing for our COVID-19 diagnostics testing. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope and duration of  any future public health crisis, including the potential emergence of new variants of the SARS-CoV-2 virus, the pace at which government restrictions are imposed and lifted, the scope of  additional actions taken to mitigate the spread of disease, global vaccination and booster rates, the speed and extent to which global markets and utilization rates for our products fully recover from the disruptions caused by such a public health crisis, and the impact of these factors on our business, financial condition and results of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations, will depend on future developments that are highly uncertain and cannot be predicted with confidence.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic or other public health crises adversely affect our operations and global economic conditions more generally, it may also have the effect of heightening many of the other risks described herein.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global economic conditions, including inflation and supply chain disruptions, could continue to adversely affect our operations.</span></div><div style="margin-top:4.4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General global economic downturns and macroeconomic trends, including heightened inflation, capital market volatility, interest rate and currency rate fluctuations, and economic slowdown or recession, may result in unfavorable conditions that could negatively affect demand for our products and exacerbate some of the other risks that affect our business, financial condition and results of operations.  Both domestic and international markets experienced significant inflationary pressures in fiscal year 2022 and inflation rates in the U.S., as well as in other countries in which we operate, are currently expected to continue at elevated levels for the near-term. In addition, the Federal Reserve in the U.S. and other central banks in various countries have raised, and may again raise, interest rates in response to concerns about inflation, which, coupled with reduced government spending and volatility in financial markets, may have the effect of further increasing economic uncertainty and heightening these risks. Interest rate increases or other government actions taken to reduce inflation could also result in recessionary pressures in many parts of the world. Furthermore, currency exchange rates have been especially volatile in the recent past, and these currency fluctuations have affected, and may continue to affect, the reported value of our assets and liabilities, as well as our cash flows.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also experienced significant challenges in our global supply chain, including shortages in supply, or disruptions or delays in shipments, of certain materials or components used in our products, and related price increases.  While to date, we have been able to manage the challenges associated with these delays and shortages without significant disruption to our business, no assurance can be given that these efforts will continue to be successful. Deterioration in the domestic or international economic environment, particularly in emerging markets and countries with government-sponsored healthcare systems, may cause decreased demand for our products and services and increased competition, which could result in lower sales volume and lower prices for our products, longer sales cycles, and slower adoption of new technologies, as well as increase the cost of operating our business or contribute to disruptions in our supply chain. In addition, we have previously experienced delays in collecting government receivables in certain countries due to economic conditions, and we may experience similar delays in the future in these and other countries or regions experiencing financial problems.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The medical technology industry is very competitive.</span></div><div style="margin-top:4.4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global company that faces significant competition from a wide range of existing competitors and new market entrants.  These include large medical device companies with multiple product lines, some of which may have greater financial and marketing resources than we do, as well as firms which are more specialized than we are with respect to particular markets or product lines. Non-traditional entrants, such as technology companies, are also entering into the healthcare industry and some may have greater financial and marketing resources than we do. We face competition across all our product lines and in each market in which our products are sold on the basis of product features, clinical or economic outcomes, product quality, availability, price, services and other factors. Our ability to compete is also impacted by changing customer preferences and requirements, such as increased demand for more environmentally friendly products and for products incorporating digital capabilities, as well as changes in the ways healthcare services are delivered (including the transition of more care from acute to non-acute settings and increased focus on chronic disease management). The shift of care from acute to non-acute settings may also place financial pressure on hospitals and broader healthcare systems that could result in less demand for our products and services.  Cost containment efforts by governments and the private sector are also resulting in increased emphasis on products that reduce costs, improve clinical results and expand patient access. Changes in regulatory or market standards, including without limitation cybersecurity requirements, often require significant investment to maintain compliance to relevant standards.  Our ability to remain competitive will depend on how well we meet these </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changing market, regulatory and cybersecurity demands in terms of our product offerings and marketing approaches.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology industry is also subject to rapid technological change, discovery and frequent product introductions. The development of new or improved products, processes or technologies by other companies (such as needle-free injection technology) that provide better features, pricing, clinical outcomes or economic value may render our products or proposed products obsolete or less competitive. In some instances, competitors, including pharmaceutical companies, also offer (or are attempting to develop) alternative therapies for disease states that may be delivered without a medical device. Lower cost producers have also created pricing pressure, particularly in developing markets.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology industry has also experienced a significant amount of consolidation, resulting in companies with greater scale and market presence than BD. Traditional distributors are also manufacturers of medical devices, providing another source of competition. In addition, healthcare systems and other providers are consolidating, resulting in greater purchasing power for these companies. As a result, competition among medical device suppliers to provide goods and services has increased. Group purchasing organizations and integrated health delivery networks have also served to concentrate purchasing decisions for some customers, which has led to downward pricing pressure for medical device suppliers. Further consolidation in the industry could intensify competition among medical device suppliers and exert additional pressure on the demand for and prices of our products.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to foreign currency exchange risk.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial amount of our revenue is derived from international operations, and we anticipate that a significant portion of our future sales will continue to come from outside the U.S.  The revenues we report with respect to our operations outside the U.S. may be adversely affected by fluctuations in foreign currency exchange rates, which are caused by a number of factors, including changes in a country's political and economic policies and inflationary conditions.   </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in exchange rates between the U.S. dollar and other currencies may also affect the reported value of BD&#8217;s assets and liabilities, as well as our cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A discussion of the financial impact of exchange rate fluctuations and the ways and extent to which we may attempt to address any impact is contained in Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. Any exchange rate hedging activities we engage in may only offset a portion of the adverse financial impact resulting from unfavorable changes in foreign currency exchange rates. We cannot predict with any certainty changes in foreign currency exchange rates or the degree to which we can effectively mitigate these risks.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in reimbursement practices of third-party payers or other cost containment measures could affect the demand for our products and the prices at which they are sold.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales depend, in part, on the extent to which healthcare providers and facilities are reimbursed by government authorities (including Medicare, Medicaid and comparable foreign programs) and private insurers for the costs of our products. The coverage policies and reimbursement levels of third-party payers, which can vary among public and private sources and by country, may affect which products customers purchase and the prices they are willing to pay for those products in a particular jurisdiction. Reimbursement rates can also affect the market acceptance rate of new technologies and products. Reforms to reimbursement systems in the U.S. or abroad, changes in coverage or reimbursement rates by private payers, or adverse decisions relating to our products by administrators of these systems could significantly reduce reimbursement for procedures using our products or result in denial of reimbursement for those products, which could adversely affect customer demand or the price customers are willing to pay for such products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Third-Party Reimbursement&#8221; under Item 1. Business.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initiatives to limit the growth of healthcare costs in the U.S. and other countries where we do business may also put industry-wide pressure on medical device or clinical diagnostic pricing. In the U.S., these include, among others, value-based purchasing and managed care arrangements. Governments in China and other countries are also using various mechanisms to control healthcare expenditures, including increased use of competitive bidding and tenders as well as price regulation. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth is dependent in part upon the development of new products, and there can be no assurance that such products will be developed.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant element of our strategy is to increase revenue growth by focusing on innovation and new product development. New product development requires significant investment in R&amp;D, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products and technologies, successfully complete clinical trials, obtain regulatory approvals and reimbursement in the U.S. and abroad, manufacture products in a cost-effective manner, obtain appropriate intellectual property protections, and gain and maintain market acceptance of our products. In addition, patents attained by others can preclude or delay our commercialization of a product. There can be no assurance that any products now in development, or that we may seek to develop in the future, will achieve technological feasibility, obtain regulatory approval or gain market acceptance. If we are unable to develop and launch new products, our ability to maintain or expand our market position in the markets in which we participate may be negatively impacted. Additionally, the ongoing global semiconductor chip and component shortage could impact certain critical components of our R&amp;D process, which could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international operations subject us to certain business risks.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial amount of our sales come from our operations outside the U.S., and we intend to continue to pursue growth opportunities in foreign markets, especially in emerging markets. Our foreign operations subject us to certain commercial, political and financial risks. In addition to fluctuations in foreign currency exchange (discussed above), our business in these foreign markets is subject to general political conditions, including any political instability (such as those resulting from war, terrorism and insurrections) and general economic conditions in these markets, such as inflation, deflation, interest rate volatility and credit availability. Additionally, a number of factors, including U.S. relations with the governments of the foreign countries in which we operate, changes to international trade agreements and treaties, increases in trade protectionism, or the weakening or loss of certain intellectual property protection rights in some countries, may affect our business, financial condition and results of operations. Foreign  regulatory requirements, including those related to the testing, authorization, and labeling of products and import or export licensing requirements, could affect the availability of our products in these markets. In addition to these broader market conditions, our operations may also be impacted by a variety of local factors, such as competition from local companies, local product preferences and requirements, and changes in local healthcare payment systems and healthcare delivery systems. We also experience longer payment terms for account receivables in foreign jurisdictions than we experience in the U.S., and we face increased difficulty in establishing, staffing and managing our foreign operations.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our operations outside the U.S. also depends, in part, on our ability to make necessary infrastructure enhancements to, among other things, our production facilities and sales and distribution networks.  These and other factors may adversely impact our ability to pursue our growth strategy in these markets.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our international operations are governed by the U.S. Foreign Corrupt Practices Act and similar foreign anti-corruption laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more enforcement proceedings by U.S. and foreign governmental agencies and the imposition of significant fines and penalties. While we have implemented policies and procedures relating to compliance with these laws, our international operations, which often involve customer relationships with foreign governments, create the risk that there may be unauthorized payments or offers of payments made by employees, consultants, sales agents or distributors. Any alleged or actual violations of these laws may subject us to government investigations and significant criminal or civil sanctions and other liabilities, and negatively affect our reputation.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:4.4pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reductions in customers&#8217; research budgets or government funding may adversely affect our business.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell products to researchers at pharmaceutical and biotechnology companies, academic institutions, government laboratories and private foundations. Research and development spending of our customers can fluctuate based on spending priorities and general economic conditions. A number of these customers are also dependent for their funding upon grants from U.S. government agencies, such as the U.S. National Institutes of Health (&#8220;NIH&#8221;) and similar agencies in other countries. The level of government funding of research and development is unpredictable. For instance, certain NIH grants have been frozen or otherwise unavailable for extended periods. The availability of governmental research funding may be adversely affected by economic conditions and governmental spending reductions, particularly during periods of economic uncertainty. Any reduction or delay in governmental funding could cause our customers to delay or forego purchases of our products.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We need to attract and retain key employees to be competitive.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively depends upon our ability to attract and retain executives and other key employees. Competition for experienced employees, particularly for persons with specialized skills, can be intense. Additionally, we need qualified managers and skilled employees with technical, manufacturing and distribution experience to operate our business successfully. Our ability to recruit and retain such talent will depend on a number of factors, including how BD&#8217;s compensation, benefits, work location and work environment compares with those offered by our competitors and other local employers. There has been an overall tightening and increasingly competitive labor market. A sustained labor shortage or increased turnover rates within our employee base could lead to increased costs, such as an increase in overtime necessary to meet demand and increased wages and benefit costs to attract and retain skilled employees, and could negatively affect our ability to efficiently operate our manufacturing and distribution facilities and overall business. If we cannot effectively recruit and retain qualified executives and skilled employees, we could encounter operational disruptions or other negative consequences to our business, financial condition or results of operations. </span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The military conflict between Russia and Ukraine may adversely affect our business, financial condition and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The military conflict in Ukraine has increased global economic and political uncertainty. Furthermore, governments in the U.S., United Kingdom, and European Union have each imposed export controls on certain products and financial and economic sanctions on certain industry sectors and parties in Russia, and additional controls and sanctions could be enacted in the future. We are continuing to actively monitor the situation in Russia and Ukraine and assess its impact on our business, including our suppliers and customers. We have no manufacturing facilities or significant operations in Russia or Ukraine and as such, to date, the conflict has not had a material impact on our business, financial condition or results of operations. However, it is possible that the conflict in Ukraine may escalate or expand, and the scope, extent and duration of the military action, current or future sanctions and resulting market and geopolitical disruptions could be significant. We cannot predict the impact the conflict may have on the global economy or our business, financial condition and operations in the future. The Russia and Ukraine conflict may also heighten the impact of other risks factors described herein. These potential effects could include but are not limited to increased inflation; volatility in prices for transportation, energy, commodities and other raw materials; constraints on the availability for us and our suppliers of commodities and other raw materials, including cobalt and energy sources; disruptions in the global supply chain; decreased demand for certain of our products; disruptions to our global technology infrastructure, including through cyberattacks, ransom attacks or cyber-intrusion; adverse changes in international trade policies and relations; increased exposure to foreign currency fluctuations; and constraints, volatility or disruptions in the credit and capital markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operational Risks</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breaches or breakdowns of our information and technology systems could have a material adverse effect on our operations.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly reliant upon a number of information and technology systems to operate our business. We process, transmit, and store electronic information in our day-to-day operations, including </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sensitive personal or proprietary information. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we rely on networks and services, including internet sites, cloud and software-as-a-service (&#8220;SaaS&#8221;) solutions, data hosting and processing facilities, tools and other hardware, software (including open-source software) and technical applications and platforms, including some that are managed, hosted, provided and/or used by third-party providers, to assist in conducting our business. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products include information systems that collect data regarding patients and patient therapy on behalf of our customers and some connect to our systems for maintenance purposes. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cyberattacks continue to increase in their frequency, sophistication and intensity, and are becoming increasingly difficult to detect for periods of time, especially as they relate to attacks on third-party providers or their vendors. Such attacks are often carried out by motivated and highly skilled actors, who are increasingly well-resourced. Our information systems, as well as those of various third parties on which we rely, have been subjected to, and are likely to continue to experience, a variety of attacks including but not limited to malicious code execution, and cyber- or phishing- attacks. We have also experienced instances of unauthorized access to our systems in the past and expect to be subject to similar cyberattacks in the future. In this increasingly hostile environment, we, or our third-party providers, could suffer a loss or disclosure of certain business information (or information regarding third parties stored in our systems) due to any number of causes ranging from catastrophic events or power outages to improper data handling or security breaches. These breaches and cyberattacks could result in our intellectual property and other confidential or proprietary information being accessed, destroyed or stolen, which could adversely affect our competitive position in the market. Likewise, we or our third-party providers could suffer disruption of our operations and other significant negative consequences, including increased costs for security measures or remediation, lost revenue, manufacturing challenges or disruption, diversion of management attention, reputational damage, litigation and damage to our relationships with vendors, business partners and customers. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unauthorized tampering, adulteration or interference with our products may also create issues with product functionality that could result in a loss of data, risk to patient safety and product recalls or field actions. Cyberattacks could also result in unauthorized access to our systems and products, which could also impact our compliance with privacy and other laws and regulations and could result in actions by regulatory bodies or civil litigation. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have made investments to address these threats and continue to dedicate significant resources to protect against unauthorized access of our systems and products, and we continue to work with government authorities and third-party providers to detect and reduce the risk of future cyber incidents, cyberattacks are becoming more sophisticated, frequent and adaptive. There can be no assurances that these protective measures will prevent future attacks that could have a material adverse impact on our business.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost volatility could adversely affect our operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be negatively impacted by volatility in the cost of raw materials, components, labor, freight and energy that, in turn, increases the costs of producing and distributing our products. New laws or regulations adopted in response to climate change could also increase energy and transportation costs, as well as the costs of certain raw materials and components. In particular, we purchase supplies of resins, which are oil-based components used in the manufacture of certain products, and any significant increases in resin costs, whether due to inflationary pressure, supply constraints, regulatory changes or otherwise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could adversely impact future operating results. Increases in oil prices can also increase our packaging and transportation costs. The costs of raw materials, transportation, construction, services, and energy necessary for the production and distribution of our products continues to increase and be volatile. These prices may continue to fluctuate based on many factors beyond our control, including but not limited to, changes in general economic conditions, labor costs, transportation costs, competition and currency exchange rates. While we have implemented cost containment measures, selective price increases and taken other actions to mitigate these inflationary pressures in our supply chain, we may not be able to completely offset all the increases in our operational costs.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:4.4pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A reduction or interruption in the supply of certain raw materials and components could adversely affect our operating results.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase many different types of raw materials and components used in our products, some of which are not available from multiple sources. In addition, for quality assurance, cost-effectiveness and other reasons, certain raw materials and components are purchased from sole suppliers. The price and supply of these materials and components may be impacted or disrupted for reasons beyond our control, including supplier shutdowns, supplier capacity constraints, transportation delays, inflationary pricing pressures, work stoppages, labor shortages, geopolitical developments and governmental regulatory actions. We have experienced, and may continue to experience, significant challenges to our global transportation channels and other aspects of our global supply chain network, including to the cost and availability of raw materials and components due to shortages and cost inflation. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. and other governments may enact or use laws and regulations, such as the Defense Production Act or export restrictions, to ensure availability of needed COVID-19 testing and vaccination delivery devices or to address other national emergencies. Any such action may impact our global supply chain network. While we work with suppliers to ensure continuity of supply and service, no assurance can be given that these efforts will be successful. In addition, due to regulatory requirements relating to the qualification of suppliers, we may not be able to establish additional or replacement sources on a timely basis or without excessive cost. The termination, reduction or interruption in supply of these raw materials and components could adversely impact our ability to manufacture and sell certain of our products, which could have an adverse impact on our business, financial condition and results of operations.  </span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interruption of our manufacturing or sterilization operations could adversely affect our business.  </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have manufacturing sites all over the world. In some instances, however, the manufacturing of certain of our product lines is concentrated in one or more of our plants. Interruption to our manufacturing operations resulting from weather or natural disasters, regulatory requirements, equipment failure or other issues in our manufacturing process, could adversely affect our ability to manufacture our products. In some instances, we may not be able to transition manufacturing to other BD sites or a third party to replace the lost production. A significant interruption of our manufacturing operations could result in lost revenues and damage to our relationships with customers.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of our products require sterilization prior to sale, and we utilize both BD facilities and third parties for this process. In some instances, only a few facilities are qualified under applicable regulations to conduct this sterilization. To the extent we or our third-party providers are unable to sterilize our products, whether due to lack of capacity, availability of materials for sterilization (including cobalt), regulatory requirements or otherwise, we may be unable to transition sterilization to other sites or modalities in a timely or cost-effective manner, or at all, which could have an adverse impact on our operating results and financial condition.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At a broader level, there is increased focus on the use and emission of ethylene oxide by the U.S. Environmental Protection Agency and state environmental regulatory agencies. Additional regulatory requirements associated with the use and emission of ethylene oxide for sterilization may be imposed in the future, both domestically and outside the U.S. This increased regulation could require BD or sterilization service providers, including providers used by BD, to temporarily suspend operations to install additional fugitive emissions control technology, limit the use of ethylene oxide or take other actions, which would impact BD&#8217;s operations and further reduce the available capacity to sterilize medical devices and healthcare products, and could also result in additional costs. Governmental agencies may also regulate the use and emission of ethylene oxide. If any existing regulatory requirements or any such regulatory actions or rulemaking result in the suspension or interruption of sterilization operations at BD or at medical device sterilizers used by BD, or otherwise limit the availability of third-party sterilization capacity, this could interrupt or otherwise adversely impact production of certain of our products or lead to civil litigation or other claims against BD. BD has business continuity plans in place to mitigate the impact of any such disruption, although these plans may not be able to fully offset such impact, for the reasons noted above. See &#8220;Item 1. Business - Regulation&#8221; for a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discussion of the consent order BD entered into with the Environmental Protection Division of the Georgia Department of Natural Resources and the risk related to sterilization operations generally.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Climate change, or legal, regulatory or market measures to address climate change, could adversely affect our business, financial condition or results of operations.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases (&#8220;GHG&#8221;) in the atmosphere may present risks to our business and operations. Extreme weather or other conditions, such as hurricanes, tornadoes, windstorms, wildfires or flooding, which may result from climate change could adversely impact our operations and supply chain, including the availability and cost of raw materials and components required for the operation of our business, and human capital issues for BD and companies within our supply chain. In addition, access to and pricing of certain natural resources, such as water, could impact our manufacturing operations. Such conditions could also result in physical damage to our products, plants and distribution centers, as well as the infrastructure and facilities of our suppliers and of hospitals, medical care facilities and other customers. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been increased focus by federal, international, state and local regulatory and legislative bodies to combat and/or limit the effects of climate change through a variety of means, including regulating greenhouse gas emissions (and the establishment of enhanced internal processes or systems to track them), policies mandating or promoting the use of renewable or zero-carbon energy and sustainability initiatives, and additional taxes on fuel and energy. If legislation or regulations are enacted or promulgated in the United States or in any other jurisdiction in which we do business that impose more stringent restrictions and requirements than our current legal or regulatory obligations, we and companies in our supply chain may experience increased compliance burdens and costs to meet the regulatory obligations, which could cause disruption in the sourcing, manufacturing and distribution of our products and adversely affect our business, financial condition or results of operations. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the impacts of climate change may further influence customer preferences and requirements, such as increased demand for products with lower environmental footprints, and for companies to produce and demonstrate progress against GHG reduction plans and targets. Failure to provide climate-friendly products or demonstrate GHG reductions could potentially result in loss of market share.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal, Quality and Regulatory Risks</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to lawsuits.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are or have been a defendant in a number of lawsuits, including, among others, purported class action lawsuits for alleged antitrust violations and violations of federal securities laws, product liability claims (which may involve lawsuits seeking class action status or seeking to establish multi-district litigation proceedings, including pending claims relating to our hernia repair implant products, surgical continence and pelvic organ prolapse products for women and vena cava filter products), and suits alleging patent infringement. We have also been subject to government subpoenas and civil investigative demands seeking information with respect to alleged violations of law, including in connection with federal and/or state healthcare programs (such as Medicare or Medicaid), federal contracting requirements and/or sales and marketing practices. A more detailed description of certain litigation to which we are a party is contained in Note 6 to the consolidated financial statements included in Item 8. Financial Statements and Supplementary Data. We could be subject to additional lawsuits, governmental investigations, subpoenas and civil investigative demands in the future. Any such lawsuits, governmental investigations, subpoenas and civil investigative demands could ultimately have a material adverse effect on our results of operations, financial condition and liquidity, and could distract management from the operations of the business. </span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves established for estimated losses with respect to legal proceedings do not represent an exact calculation of our actual liability, but instead represent our estimate of the probable loss at the time the reserve is established. Due to the inherent uncertainty of litigation and our underlying loss reserve estimates, additional reserves may be established or current reserves may be significantly increased from time-to-time. Also, in some instances, we are not able to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which we are a party. In view of these uncertainties, we could incur charges materially in </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excess of any currently established accruals and, to the extent available, excess liability insurance. Any such future charges, individually or in the aggregate, could have a material adverse effect on our results of operations, financial condition and/or liquidity.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to certain litigation, we believe that some settlements and judgments, as well as legal defense costs, may be covered in whole or in part under applicable insurance policies with a limited number of insurance companies, or, in some circumstances, indemnification obligations owed to us by other parties. However, amounts recovered under these arrangements may be less than the stated coverage limits or less than otherwise expected and may not be adequate to cover damages and/or costs. In addition, there is no guarantee that insurers or other parties will pay claims or that coverage or indemnity will be otherwise available. Also, for certain product liability claims or lawsuits, BD does not maintain or has limited remaining insurance coverage, and we may not be able to obtain additional insurance on acceptable terms or at all that will provide adequate protection against potential liabilities.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive regulation.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are global and are affected by complex state, federal and international laws relating to healthcare, environmental protection, occupational health and safety, antitrust, anti-corruption, marketing, fraud and abuse (including anti-kickback and false claims laws), export control, product safety and efficacy, employment, privacy and other areas. Violations of these laws can result in criminal or civil sanctions, including substantial fines and, in some cases, exclusion from participation in healthcare programs such as Medicare and Medicaid. Environmental laws, particularly with respect to climate change and the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate closures of, or changes to, our manufacturing plants or processes or those of our suppliers, or result in liability to BD. The enactment of additional laws in the future may increase our compliance costs or otherwise adversely impact our operations and financial performance.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to extensive regulation by the FDA pursuant to the Federal Food, Drug and Cosmetic Act, by comparable agencies in foreign countries, and by other regulatory agencies and governing bodies. Most of our products must receive clearance or approval from the FDA or counterpart regulatory agencies in other countries before they can be marketed or sold. The process for obtaining marketing approval or clearance may require us to incur significant costs in terms of time and resources, and these costs have been increasing due to increased requirements from the FDA and comparable governing bodies for supporting data for submissions. The regulatory process may also require changes to our products or result in limitations on the indicated uses of our products. Governmental agencies may also impose new requirements regarding registration, including, but not limited to, labeling updates or changes to prohibited materials that require us to modify or re-register products already on the market or otherwise impact our ability to market our products in those countries.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the introduction of a product, these agencies also periodically review our manufacturing processes and product performance. Our failure to comply with the applicable good manufacturing practices, adverse event reporting and other post market requirements of these agencies could delay or prevent the production, marketing or sale of our products and result in delays or suspensions of regulatory clearances, warning letters or consent decrees, closure of manufacturing sites, import bans, seizures or recalls of products, civil or criminal sanctions and damage to our reputation. More stringent oversight by the FDA and other agencies in recent years has resulted in increased enforcement activity, which increases our compliance risk.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are operating under an amended consent decree with the FDA, entered into by CareFusion in 2007 and amended in 2009, that affects our BD Alaris&#8482; infusion pump business in the U.S. We are also currently operating under a warning letter issued by the FDA. For more information regarding the consent decree and warning letter, see &#8220;Regulation&#8221; under Item 1. Business.</span></div><div style="margin-top:6.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, we are undertaking certain remediation of our BD Alaris&#8482; System, and are currently shipping the product in the U.S. only in cases of medical necessity and to remediate recalled software versions. We will not be able to fully resume commercial operations for the BD Alaris&#8482; System in the U.S. until a 510(k) submission relating to the product has been cleared by the FDA. No assurance can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the European Union (&#8220;EU&#8221;) has adopted the EU Medical Device Regulation (the &#8220;EU MDR&#8221;) and the In Vitro Diagnostic Regulation (the &#8220;EU IVDR&#8221;), each of which impose stricter requirements for the marketing and sale of medical devices, including in the area of clinical evidence requirements, quality systems and post-market surveillance. The EU MDR has been fully operational for previously approved self-certified medical devices since May 2021, and companies have until May 2024 to meet the requirements for medical devices with a valid conformity assessment certificate. The EU IVDR has been fully applicable for manufacturers of in vitro diagnostic medical devices since May 2022. Complying with and maintaining devices under these regulations requires us to incur significant expenditures. Additionally, the availability of EU notified body services certified to the new requirements is limited, which may delay the marketing approval for some of our products under the EU MDR. Any such delays, or any failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to EU conformity requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to complex and frequently changing privacy and data protection laws, rules and regulations in the U.S. as well as in all other regions where BD operates, regarding the collection, use, storage, transfer and other processing of personal information. These privacy, security and data protection laws and regulations could impose significant limitations, require changes to our policies, practices, and processes and in some cases impose restrictions on our use or storage of personal information. These limitations and restrictions could require us to modify current or future products or services, which may harm our future financial results. Any actual or perceived noncompliance with these laws, rules and regulations, our internal policies and procedures or our contracts governing the processing of personal information could result in significant consequences for BD, including, among other things, business interruption, sanctions and significant pecuniary fines, regulatory inquiries and investigations, adverse publicity, loss of competitive advantage and customer trust, as well as privacy litigation and civil lawsuits with damages.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The importance of privacy laws, rules and regulations for the healthcare and med-tech industry specifically is constantly growing, as personal data has become an integral part of doing business in our sector, and the legal standards are evolving and becoming more complex worldwide.  For instance, the European General Data Protection Regulation (the &#8220;GDPR&#8221;), applicable as of 2018 and still one of the strictest and most comprehensive privacy laws in the world, is being continuously enforced, and increasingly heavy fines are now being levied on businesses. Fines for noncompliance with the GDPR can amount to up to &#8364;20 million or 4% of the total worldwide annual turnover from the preceding financial year (whichever is higher) and may be imposed in conjunction with the exercise of the authority&#8217;s investigatory and corrective powers. The GDPR&#8217;s extraterritorial scope makes it applicable to our U.S.-based legal entities whenever our business activities, systems and products process the personal data of EU residents.  Additionally, privacy laws, rules and regulations are also rapidly developing in other regions, including China, Brazil, South Korea, and is expanding through the U.S., state by state (e.g., California, Virginia, Colorado, Connecticut, Utah), in parallel with federal privacy laws protecting sensitive health information.  These varying laws, rules, regulations and industry standards impact BD businesses to the extent they rely on the use of personal data and create significant compliance challenges while maintaining our global reach. In addition, certain privacy and data protection laws may apply to us indirectly through our customers, manufacturers, suppliers or other third-party partners. For example, non-compliance with applicable laws or regulations by a third-party partner that is processing personal data on our behalf may be deemed non-compliance by us or a failure by us to conduct proper due diligence on the third party. We also could be subject to additional expenses and liabilities in the event of an information security incident, including a cybersecurity breach, or the failure of an information technology system owned or operated by us or a third party with which we partner or its vendor.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defects or quality issues associated with our products could adversely affect the results of our operations.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design, manufacture and marketing of medical devices involve certain inherent risks. Manufacturing or design defects, component failures, unapproved or improper use of our products, or inadequate disclosure of risks or other information relating to the use of our products can lead to injury or other serious adverse events. Such events have in the past and could in the future lead to recalls or safety alerts relating to our products (either voluntary or as required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. A recall could result </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in significant costs and lost sales and customers, enforcement actions and/or investigations by state and federal governments or other enforcement bodies, as well as negative publicity and damage to our reputation that could reduce future demand for our products. Personal injuries relating to the use of our products can also result in significant product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in regulatory approval of new products or the imposition of post-market approval requirements.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations are dependent in part on patents and other intellectual property assets.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our businesses rely on patent, trademark and other intellectual property assets. These intellectual property assets, in the aggregate, are of material importance to our business. We can lose the protection afforded by these intellectual property assets through patent expirations, legal challenges or governmental action. Patents attained by competitors, particularly as patents on our products expire, may also adversely affect our competitive position. In addition, competitors may seek to invalidate patents on our products or claim that our products infringe upon, misappropriate or otherwise violate their intellectual property, which could result in a loss of competitive advantage or the payment of significant legal fees, damage awards and past or future royalties, as well as injunctions against future sales of our products. We also operate in countries that do not protect intellectual property rights to the same extent as in the U.S., which could make it easier for competitors to compete with us in those countries. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trade secrets and proprietary know-how with which we seek to protect our products, in part, by confidentiality agreements with certain employees, consultants and other parties. These agreements may not adequately protect our trade secrets and other proprietary rights. These agreements may be breached and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently developed by our competitors.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of a significant portion of our portfolio of intellectual property assets may have an adverse effect on our earnings, financial condition or cash flows.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Indebtedness </span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to service all of our indebtedness.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on cash on hand and cash flows from operations to make scheduled debt payments. However, our ability to generate sufficient cash flow from operations of the combined Company and to utilize other methods to make scheduled payments will depend on a range of economic, competitive and business factors, many of which are outside of our control. There can be no assurance that these sources will be adequate. If we are unable to service our indebtedness and fund our operations, we will be forced to reduce or delay capital expenditures, seek additional capital, sell assets or refinance our indebtedness. Any such action may not be successful and we may be unable to service our indebtedness and fund our operations, which could have a material adverse effect on our business, financial condition or results of operations. Additionally, we may not be able to refinance existing debt on favorable or comparable terms. </span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The agreements that govern our indebtedness impose restrictions that may affect our ability to operate our businesses.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements that govern our indebtedness contain various affirmative and negative covenants that may, subject to certain significant exceptions, restrict the ability of certain of our subsidiaries to incur debt and the ability of us and certain of our subsidiaries to, among other things, have liens on our property, and/or merge or consolidate with any other person or sell or convey certain of our assets to any one person, engage in certain transactions with affiliates and change the nature of our business. In addition, the agreements also require us to comply with certain financial covenants, including financial ratios. Our ability and the ability of our subsidiaries to comply with these provisions may be affected by events beyond our control. Failure to comply with these covenants could result in an event of default, which, if not cured or waived, could accelerate our repayment obligations and could result in a default and acceleration under other agreements containing cross-default provisions. Under these circumstances, we might not have sufficient funds or other resources to satisfy all of our obligations.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to the Spin-off of Embecta Corp.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks relating to spin-off of Embecta Corp. </span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On April 1, 2022, we completed the spin-off of Embecta Corp. (Embecta) (NASDAQ: EMBC), which holds our former Diabetes Care business and is now one of the world&#8217;s largest pure-play diabetes management companies in the world. The spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes.  If any facts, assumptions, representations, and undertakings from BD and Embecta regarding the past and future conduct of their respective businesses and other matters are incorrect or not otherwise satisfied, the spin-off may not qualify for tax-free treatment, which could result in significant U.S. federal income tax liabilities for BD and its shareholders. Additionally, there can be no assurances that BD will be able to  achieve the full strategic and financial benefits that are expected to result from the spin-off.</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Business Risks</span></div><div style="margin-top:4.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot guarantee that any of our strategic acquisitions, investments or alliances will be successful.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to supplement our internal growth through strategic acquisitions, investments and alliances. Such transactions are inherently risky, and the integration of any newly-acquired business requires significant effort and management attention. The success of any acquisition, investment or alliance may be affected by a number of factors, including our ability to properly assess and value the potential business opportunity or to successfully integrate any business we may acquire into our existing business. There can be no assurance that any past or future transaction will be successful. </span></div><div style="margin-top:4.4pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Natural disasters, war and other events beyond our control could disrupt our business and adversely affect our future revenues and operating income.</span></div><div style="margin-top:4.4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural disasters, such as hurricanes, tornadoes, windstorms, earthquakes, wildfires and floods and other extreme weather events (including those caused by climate change), war, global health crises, terrorism, social or political unrest, labor disruptions and international conflicts and other events beyond our control, and actions taken by the U.S. and other governments or by our customers or suppliers in response to such events, could cause significant economic disruption and political and social instability in the U.S. and areas outside of the U.S. in which we operate. These events could result in decreased demand for our products, adversely affect our manufacturing and distribution capabilities, or increase the costs for or cause interruptions in the supply of materials from our suppliers.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information About our Executive Officers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a list of the executive officers of BD, their ages and all positions and offices held by each of them during the past five years. There is no family relationship between any executive officer or director of BD. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman since April 2021; Chief Executive Officer since January 2020; President since April 2017; Chief Operating Officer from October 2018 to January 2020; and Executive Vice President and President - Medical Segment from October 2014 to April 2017. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Byrd</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and President, Interventional Segment since September 2022; Worldwide President, BD Medication Delivery Solutions from March 2019 to September 2022; Worldwide President, Preanalytical Systems from December 2016 to February 2019.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer since September 2021; Vice President, Investor Relations, Johnson &amp; Johnson from August 2018 to September 2021; Chief Financial Officer, North America Hospital Medical Devices, Johnson &amp; Johnson from June 2017 to August 2018; and Vice President, Finance, North America, Johnson &amp; Johnson Consumer, March 2014 to June 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antoine C. Ezell</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, President, North America and Chief Marketing Officer since October 2020; Executive Vice President and Chief Marketing Officer from January 2020 to October 2020; Vice President, Connected Care and Insulins, Eli Lilly and Company from January 2019 to January 2020; and prior thereto, Vice President, Enterprise Capabilities and Solutions, Eli Lilly; Chief Marketing Officer, Elanco Animal Health; and Chief Customer Officer, Eli Lilly.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Garrison</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and President, Medical Segment since September 2022; Worldwide President, BD Medication Management Solutions from March 2020 to September 2022; Worldwide President, BD Surgery from December 2018 to March 2020; Vice President and General Manager Worldwide Infusion Systems from July 2016 to December 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roland Goette</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and President, EMEA since May 2017; and President, Europe from October 2014 to May 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David B. Hickey</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive Vice President and President, Life Sciences Segment since January 2021; President, Integrated Diagnostics Solutions from October 2019 to January 2021; and President, Diagnostic Systems from July 2016 to September 2019.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Samrat S. Khichi</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive Vice President, Corporate Development, Public Policy, Regulatory Affairs and General Counsel since September 2021; Executive Vice President, Public Policy, Regulatory Affairs and General Counsel from May 2019 to September 2021; Executive Vice President and General Counsel from December 2017 to May 2019; and Senior Vice President, General Counsel and Corporate Secretary, C.R. Bard, Inc. from July 2014 to December 2017.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pavan Mocherla</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive Vice President and President, Greater Asia since July 2022; Country General Manager, South Asia/Managing Director from December 2017 to June 2022; Vice President of Strategic Innovation for Greater Asia from August 2017 to December 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shana Neal</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive Vice President and Chief People Officer since April 2022; Chief Human Resources Officer of Owens &amp; Minor from April 2018 to March 2022; Senior Vice President, Human Resources of BD from January 2017 to March 2018.</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;&#160;1B.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments.</span></div><div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_25"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Properties.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BD&#8217;s executive offices are located in Franklin Lakes, New Jersey. As of September 30, 2022, BD owned or leased 334 facilities throughout the world, comprising approximately 25,651,266 square feet of manufacturing, warehousing, administrative, and research facilities. The U.S. facilities, including those in Puerto Rico, comprise approximately 8,020,022 square feet of owned and 4,666,986 square feet of leased space. The international facilities comprise approximately 9,556,871 square feet of owned and 3,407,387 square feet of leased space. Sales offices and distribution centers included in the total square footage are also located throughout the world.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operations in each of BD&#8217;s business segments are conducted at both U.S. and international locations. Particularly in the international marketplace, facilities often serve more than one business segment and are used for multiple purposes, such as administrative/sales, manufacturing and/or warehousing/distribution. BD generally seeks to own its manufacturing facilities, although some are leased. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD believes that its facilities are of good construction and in good physical condition, are suitable and adequate for the operations conducted at those facilities, and are, with minor exceptions, fully utilized and operating at normal capacity.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. facilities are located in Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington D.C., Washington, Wisconsin, and Puerto Rico.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The international facilities are as follows: </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Europe, Middle East, Africa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which includes facilities in Austria, Belgium, Bosnia, the Czech Republic, Denmark, Egypt, England, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Israel, Italy, Kenya, Luxembourg, Netherlands, Norway, Pakistan, Poland, Portugal, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the United Arab Emirates and Zambia. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greater Asia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which includes facilities in Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, New Zealand, Pakistan, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which includes facilities in Argentina, Brazil, Chile, Colombia, the Dominican Republic, Mexico, Peru and Uruguay. </span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div id="ia87db9e40d284890bdb9962ca233dca1_28"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to certain legal proceedings is included in Note 6 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data, and is incorporated herein by reference.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_31"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Item&#160;5.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s common stock is listed on the New York Stock Exchange under the symbol "BDX".  As of October 31, 2022, there were approximately 11,400 shareholders of record.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth certain information regarding BD&#8217;s purchases of its common stock during the fiscal quarter ended September&#160;30, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:29.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.088%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.933%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares<br/>Purchased(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Price<br/>Paid<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares<br/>Purchased as Part of<br/>Publicly Announced<br/>Plans or Programs (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Number<br/>of Shares that<br/>May Yet be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July&#160;1-31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August&#160;1-31, 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$256.00</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,179,753&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September&#160;1-30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$256.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953,133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$256.00</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953,133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Shares purchased includes an initial delivery of 1,573,378  shares of our common stock received in August 2022 upon payment of $500 million under an accelerated share repurchase (&#8220;ASR&#8221;) agreement,  which was executed in August 2022, and an additional 379,755 shares in September 2022 based upon final settlement of the ASR agreement. The total average price paid per share in the table above reflects the volume weighted average price of BD's shares over the term of the ASR agreement. Additional disclosures regarding our share repurchase transactions are provided in Note 4 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10&#160;million shares, which has been fully utilized as of September 30, 2022, and a repurchase program authorized by the Board of Directors in November 2021 for up to an additional 10&#160;million shares of BD common stock, for which there is no expiration date.</span></div><div style="margin-top:9pt;text-indent:31.5pt"><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserved)</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_46"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following commentary should be read in conjunction with the consolidated financial statements and accompanying notes presented in this report. Within the tables presented throughout this discussion, certain columns may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. References to years throughout this discussion relate to our fiscal years, which end on September&#160;30.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of the Company and Business Segments</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Becton, Dickinson and Company (&#8220;BD&#8221;) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's organizational structure is based upon three principal business segments, BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;).</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, Australia and New Zealand); Latin America (which includes Mexico, Central America, the Caribbean and South America); and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and certain countries within Greater Asia. We are primarily focused on certain countries whose healthcare systems are expanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Objectives</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BD remains focused on delivering durable growth, creating shareholder value and making appropriate investments for the future. BD 2025, our vehicle for value creation, is anchored in three key pillars: grow, simplify and empower. BD's management team aligns our operating model and investments with these key strategic pillars through continuous focus on the following underlying objectives:</span></div><div style="margin-top:3pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Grow</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Developing and maintaining a strong portfolio of leading products and solutions that address significant unmet clinical needs, improve outcomes, and reduce costs;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Focusing on our core products, services and solutions that deliver greater benefits to patients, healthcare workers and researchers;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28pt">Investing in research and development that leads to and expands category leadership, as well as results in a robust product pipeline;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28pt">Accelerating innovation in smart connected care, enabling new care settings and improving chronic disease outcomes;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Leveraging our global scale to expand our reach in providing access to affordable medical technologies around the world, including emerging markets;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27.3pt">Supplementing our internal growth through strategic acquisitions in faster growing market segments;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Driving an efficient capital structure and strong shareholder returns.</span></div><div style="margin-top:3pt;text-indent:11.25pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Simplify</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28pt">Driving operating effectiveness and margin expansion by increasing factory productivity and asset efficiencies;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Reducing complexity and improving customer experience by rationalizing our product portfolio and through the simplification and optimization of our operating model;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Making strategic investments to advance quality culture and our core quality management system to serve our patients and ensure we are a best-in-class, proactive quality-driven organization;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Working across our supply chain to responsibly source materials and goods, as well as to reduce environmental impacts;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Creating more resilient operations through investments in an enterprise-wide renewable energy strategy;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Focusing on cash management in order to improve balance sheet productivity.</span></div><div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Empower</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Fostering a purpose-driven culture with a focus on positive impact to all stakeholders&#8211;customers, patients, employees and communities;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Improving our ability to serve customers and enhance customer experiences through the digitalization of internal processes and go-to-market approaches;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Driving sustainability initiatives within our organizational units to support enterprise-wide collaboration towards our sustainability strategy; </span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Cultivating an inclusive work environment that welcomes and celebrates diverse talent and perspectives;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">Growing and enabling talent through training, development and reskilling strategies.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the outcomes of these strategies as well as BD&#8217;s financial condition and operating performance, management generally reviews forecast data, monthly actual results, including segment sales, and other similar information. We also consider trends related to certain key financial data, including gross profit margin, selling and administrative expense, investment in research and development, return on invested capital, and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BD&#8217;s Spin-Off of Diabetes Care</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, BD completed the separation and distribution of Embecta, formerly BD's Diabetes Care business, into a separate, publicly-traded company.  The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment), as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in our consolidated financial statements for all periods prior to the spin-off date of April 1, 2022. Additional disclosures regarding our spin-off of the Diabetes Care business are provided in Note 2 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Trends Affecting Results of Operations</span></div><div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, our products are manufactured and sold worldwide, which exposes our operations, supply chain and suppliers to various global macroeconomic factors. The factors which were most impactful to our fiscal year 2022 results and that continue to be impactful to our operating results include the following: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inflation, which has increased the costs of raw materials, components, labor, energy, and logistical services; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Availability of skilled labor (especially in North America), global energy sources, raw materials and electronic components; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Constrained logistics capacity related to the movement of goods around the globe.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2022, the shortages of certain raw materials and components, delays in global transportation and labor shortages in our manufacturing facilities increased lead times for some of our product </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offerings. Also, significant inflationary pressures impacted our supply chain costs in certain areas throughout 2022. We experienced higher costs for raw materials, particularly resins, as well as for electronic components and freight. These increased costs put pressure on our operating expenses and the costs of our investments.  We have been mitigating these inflationary pressures through the following:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Driving strategic procurement initiatives to leverage alternative sources of raw material and transportation;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing cost-containment measures, as well as intensifying continuous improvement and restructuring programs in our manufacturing and distribution facilities;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing strategic product line rationalization programs as part of our simplification strategy; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Optimizing our sales through product allocation and customer management.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continued to drive volatile global economic conditions during our fiscal year 2022. Utilization rates for most of our products have recovered compared to pre-pandemic levels; however, future resurgences in COVID-19 infections or new strains of the virus may affect the prioritization of non-acute versus acute healthcare utilization, which may temporarily weaken future demand for certain of our products and increase the demand for other of our products. The pandemic has contributed to the inflationary pressures and supply chain disruptions discussed above and these challenges could persist if governments impose lockdowns, quarantine requirements and other restrictions in order to control rates of COVID-19 infections, such as in China. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the pandemic has escalated challenges that existed for global healthcare systems prior to the pandemic, including budget constraints and staffing shortages, particularly shortages of nursing staff.  Changes in the ways healthcare services are delivered, including the transition of more care from acute to non-acute settings and increased focus on chronic disease management, may place additional financial pressure on hospitals and the broader healthcare system.  Healthcare institutions may take actions to mitigate any persistent pressures on their budgets and such actions could impact the future demand for our products and services. Additionally, staffing shortages within healthcare systems may affect the prioritization of healthcare services, which could also impact the demand for certain of our products.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical conditions may also impact our operations. Our operations in Russia and Ukraine are not material to our financial results, and as such, the conflict between Russia and Ukraine did not materially impact our results of operations in 2022.  However, the continuation of the Russia-Ukraine military conflict and/or an escalation of the conflict beyond its current scope may further weaken the global economy and could result in additional inflationary pressures and supply chain constraints, including the unavailability and cost of energy. Due to the significant uncertainty that exists relative to the duration and overall impact of the macroeconomic factors discussed above, our future operating performance, particularly in the short-term, may be subject to volatility. The impacts of macroeconomic conditions on our business, results of operations, financial condition and cash flows are dependent on certain factors, including those discussed in Item 1A. Risk Factors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Financial Results</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Worldwide revenues in 2022 of $18.870 billion decreased&#160;1.4%&#160;from the prior-year period. This decrease reflected the following impacts:</span></div><div style="margin-top:6pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"><tr><td style="width:1.0%"></td><td style="width:71.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.758%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in current-period revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period-over-period decline in revenues related to COVID-19-only testing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pricing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in revenues from the prior-year period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While resurgences of COVID-19 infections have continued to occur in various countries around the world, demand for our SARS-CoV-2 diagnostics tests and injection devices used for COVID-19 vaccinations has declined from the peak testing and vaccination levels reached earlier in the pandemic.  As such, our fiscal year 2022 revenues in our Life Sciences segment reflected sales related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Plus, BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> At-Home and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Systems of $511 million, compared with revenues from such testing products in 2021 of $1.956 billion.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volume in 2022 was driven by demand for our core products and reflected strong demand across all of our segments&#8217; units, particularly in the Medical segment&#8217;s Medication Delivery Solutions and Pharmaceutical Systems units, as well as in the Life Sciences segment&#8217;s Integrated Diagnostic Solutions unit.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in research and development, strategic tuck-in acquisitions, geographic expansion, and new product programs to drive further revenue and profit growth. Our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, and continue to improve operating efficiency and organizational effectiveness. As further discussed above, current global economic conditions have been relatively volatile due to various macroeconomic factors. We are mitigating the inflationary pressures on our businesses through the various strategies discussed above. However, there can be no assurance that we will be able to effectively mitigate such inflationary pressures in future periods, and an inability to offset inflationary pressures, at least in part, through the strategies discussed above could adversely impact our results of operations.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial position remains strong, with cash flows from continuing operating activities totaling $2.471 billion in 2022. At September&#160;30, 2022, we had $1.167 billion in cash and equivalents and short-term investments, including restricted cash.  We continued to return value to our shareholders in the form of dividends. During fiscal year 2022, we paid cash dividends of $1.082 billion, including $992 million paid to common shareholders and $90 million paid to preferred shareholders. We also repurchased approximately $500 million of our common stock during fiscal year 2022.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of such period.  A stronger U.S. dollar, compared to the prior-year period, resulted in an unfavorable foreign currency translation impact to our revenues during 2022. The flow of foreign currency impacts to our earnings depends on various factors including our inventory turnover, our ability to leverage our global supply chain and the current-period mix of our sales, from both a product and geographic perspective. These factors resulted in a favorable foreign currency impact to earnings during 2022. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our results of operations on both a reported and a foreign currency-neutral basis, which excludes the impact of fluctuations in foreign currency exchange rates. As exchange rates are an important factor in understanding period-to-period comparisons, we believe the presentation of results on a foreign currency-neutral basis in addition to reported results helps improve investors&#8217; ability to understand our operating results and evaluate our performance in comparison to prior periods. Foreign currency-neutral ("FXN") information compares results between periods as if exchange rates had remained constant period-over-period. We use results on a foreign currency-neutral basis as one measure to evaluate our performance. We calculate foreign currency-neutral percentages by converting our current-period local currency financial results using the prior-period foreign currency exchange rates and comparing these adjusted amounts to our current-period results. These results should be considered in addition to, not as a substitute for, results reported in accordance with U.S. generally accepted accounting principles ("GAAP"). Results on a foreign currency-neutral basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with U.S. GAAP.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes Medical revenues by organizational unit:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"><tr><td style="width:1.0%"></td><td style="width:16.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.442%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.442%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Medical revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,841&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,637&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:20.41pt">Prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Medication Delivery Solutions unit&#8217;s revenue growth in 2022 reflected strong global sales of catheters and vascular care products, which were particularly driven by competitive gains for peripherally inserted intravenous catheter and flush products. Fiscal year 2022 revenues in the Medication Management Solutions unit reflected strong growth in global placements of dispensing systems, partially offset by an unfavorable comparison to the prior-year period, which benefited from pandemic-related demand for infusion pumps and sets.  Our acquisition of Parata Systems in 2022 also contributed to revenue growth in the Medication Management Solutions unit.  The Pharmaceutical Systems unit&#8217;s strong revenue growth in 2022 reflected continued high demand for our prefillable solutions in the high-growth markets for biologic drugs and vaccines.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Medical segment&#8217;s revenue growth in 2021 was aided by a favorable comparison to 2020, which was impacted by COVID-19 pandemic-related declines, particularly in the United States and China. These prior-year pandemic-related declines impacted our Medication Delivery Solutions unit. Fiscal year 2021 revenue growth in the Medication Delivery Solutions unit reflected strong demand for our core offerings, including U.S. demand for catheters and vascular care products, as well as strong global demand for syringes resulting from COVID-19 vaccination efforts. In the Medication Management Solutions unit, lower revenues in 2021 reflected an unfavorable comparison to 2020, which benefited from global pandemic-related infusion pump orders. The Pharmaceutical Systems unit&#8217;s revenue growth in 2021 was enabled by capacity expansion efforts and was driven by continued strong demand for our pre-filled devices, which reflected the vial to pre-filled device conversion for biologics, vaccines, and other injectable drugs.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical segment operating income was as follows:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment operating income as % of Medical revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:27pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment's operating income in 2022 was driven by improved gross profit margin and lower operating expenses.  Operating income in 2021 was primarily driven by improved gross profit margin.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Medical segment&#8217;s higher gross profit margin in 2022 compared with 2021 primarily reflected the following:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Favorable product mix with higher sales of high value-added products in the Medication Delivery Systems and Medication Management Solutions units.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Lower manufacturing costs resulting from continuous improvement projects which enhanced the efficiency of our operations, as well as favorable impacts from price and foreign currency translation; partially offset by</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.81pt">Higher raw material and freight costs, a noncash asset impairment charge of $54 million recorded to write down the carrying value of certain fixed assets, as well as charges of $72 million recorded in 2022 for estimated future costs within the Medication Management Solutions unit associated with remediation efforts related to Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, compared with charges of $56 million in 2021.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Medical segment&#8217;s higher gross profit margin in 2021 compared with 2020 primarily reflected the following:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A favorable comparison to 2020, which was unfavorably impacted by increased levels of manufacturing overhead costs that were recognized in the period because of the COVID-19 pandemic, rather than capitalized within inventory, and $244 million of net charges recorded in 2020, compared with charges of $56 million in 2021, for remediation efforts related to Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, as also discussed above;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Lower manufacturing costs resulting from continuous improvement projects which enhanced the efficiency of our operations;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The unfavorable impacts from foreign currency translation, investments in simplification and other cost saving initiatives, higher raw material and freight costs, as well as product quality remediation expenses.   </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling and administrative expense as a percentage of revenues in 2022 was lower compared with 2021, which reflected efforts to contain certain selling, travel and other administrative activities, partially offset by higher shipping costs.  Selling and administrative expense as a percentage of revenues in 2021 was flat compared with 2020 primarily due to the increase in revenues in 2021, offset by higher travel and other administrative costs compared with 2020, which benefited from cost containment measures enacted in response to the COVID-19 pandemic.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense as a percentage of revenues was lower in 2022 compared with 2021, which reflected revenue growth that outpaced the timing of project spending.  Research and development expense as a percentage of revenues was higher in 2021 compared with 2020, which reflected our commitment to research and development through continued reinvestment into our growth initiatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Life Sciences Segment</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes Life Sciences revenues by organizational unit:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Life Sciences revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Integrated Diagnostic Solutions unit&#8217;s revenues related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus, BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At-Home and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Systems in 2022 of $511 million, were lower as compared with revenues from such testing products in 2021 of $1.956 billion. The Integrated Diagnostic Solutions unit&#8217;s fiscal year 2022 revenues benefited from wide clinical adoption of our broader respiratory panel and the expanded base of instruments we installed during the peak levels of the pandemic to facilitate COVID-19-only testing.  The Integrated Diagnostic Solutions unit&#8217;s revenues also reflected growth in sales of our specimen management products due to a recovery of routine lab testing to pre-pandemic levels. The Biosciences unit's revenue growth in 2022 was driven by strong growth in sales of our reagents and instruments, including our recently launched research instruments. Demand for the Biosciences unit&#8217;s research reagents was favorably impacted by continued adoption of the unit&#8217;s e-commerce platform.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Life Sciences segment's revenues in 2021 primarily reflected a favorable comparison to 2020, which was significantly impacted by pandemic-related declines in both units. Revenue growth in the Integrated Diagnostic Solutions unit was also driven by sales related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Systems. Routine diagnostic testing levels in the Integrated Diagnostic Solutions unit continued to improve over the course of 2021 and the unit benefited from high demand for our specimen management portfolio, automated blood cultures and ID/AST testing solutions. The Biosciences unit's revenue growth in 2021 benefited from strong demand for instruments and reagents as lab utilization returned to normal levels.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life Sciences segment operating income was as follows:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:51.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment operating income as % of Life Sciences revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:27pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Life Sciences segment's operating income in 2022 was driven by lower gross profit margin and higher operating expenses as a percentage of revenues. Operating income in 2021 reflected improved gross profit margin and operating expense performance.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Life Sciences segment&#8217;s lower gross profit margin in 2022 compared with 2021 primarily reflected the following:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The decline in COVID-19-only testing revenues compared with the prior-period, as well as higher raw material and freight costs; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">A favorable comparison to the prior-year period, which reflected approximately $93 million of excess and obsolete inventory expenses related to COVID-19-only testing inventory, as well as favorable impacts in 2022 from continuous improvement projects in our manufacturing facilities, price, product mix, foreign currency translation and a one-time benefit from licensing income.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Life Sciences segment&#8217;s higher gross profit margin in fiscal year 2021 compared with 2020 primarily reflected the following:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A favorable impact on product mix from the Integrated Diagnostic Solutions unit's sales related to COVID-19 testing and the recovery of demand for other products with higher margins;  </span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A favorable comparison to the prior-year period which was unfavorably impacted by increased levels of manufacturing overhead costs that were recognized in the period because of the COVID-19 pandemic, rather than capitalized within inventory;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The unfavorable impacts of foreign currency translation and the recognition of approximately $93 million of excess and obsolete inventory expenses, as noted above.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling and administrative expense as a percentage of revenues in 2022 was higher compared with 2021 primarily due to the current-period decline in revenues. Selling and administrative expense as a percentage of Life Sciences revenues in&#160;2021 was lower compared with 2020 primarily due to the increase in revenues in 2021, partially offset by higher travel and other administrative costs compared with 2020, which benefited from cost containment measures enacted in response to the COVID-19 pandemic, as well as higher shipping costs and selling costs in 2021 associated with COVID-19 testing solutions.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense as a percentage of revenues was higher in 2022 compared with 2021, primarily due to the current-period decline in revenues.  Research and development expense as a percentage of revenues in 2021&#160;was lower compared with 2020, primarily due to the increase in revenues in 2021, partially offset by additional investments in COVID-19 testing solutions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Segment</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes Interventional revenues by organizational unit:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:18.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Interventional revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,464&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,762&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;text-indent:45pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Surgery unit&#8217;s revenues in 2022 reflected strong global sales of our advanced repair and reconstruction platforms, as well as a benefit from the unit&#8217;s fiscal year 2021 acquisition of Tepha, Inc. Fiscal year 2022 revenues in the Peripheral Intervention unit reflected strong sales of our oncology products and growth attributable to the unit&#8217;s fiscal year 2022 acquisition of Venclose, Inc. and the relaunch of our Venovo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system. The Peripheral Intervention unit&#8217;s revenues in 2022 were unfavorably impacted during the second half of the fiscal year by supply constraints and hospital labor shortages.  The Urology and Critical Care unit&#8217;s revenue growth in 2022 was driven by strong demand for acute urology products.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interventional segment's revenues in 2021 reflected a favorable comparison to 2020, which was significantly impacted by pandemic-related declines in our Surgery and Peripheral Intervention units. Fiscal year 2021 revenue growth in the Interventional segment was also driven by stronger market demand for the Surgery unit&#8217;s infection prevention platform and the Peripheral Intervention unit's oncology products.  Revenues in the Peripheral Intervention unit additionally benefited from sales attributable to its fiscal year 2020 acquisition of Straub Medical AG.  Fiscal year 2021 revenue growth in our Surgery and Peripheral Intervention units was unfavorably impacted by resurgences in COVID-19 infections. The Urology and Critical Care unit&#8217;s growth in 2021 showed strong demand for acute urology products and the unit's targeted temperature management portfolio.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional segment operating income was as follows:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment operating income as % of Interventional revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interventional segment's operating income in 2022 and 2021 was primarily driven by improved gross profit margin.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Interventional segment&#8217;s higher gross profit margin in 2022 compared with 2021 primarily reflected favorable impacts from price, favorable product mix and foreign currency translation, which were partially offset by higher freight costs.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Interventional segment&#8217;s higher gross profit margin in 2021 compared with 2020 primarily reflected the recovery of demand for products with higher margins and a favorable comparison to the prior-year period, which was unfavorably impacted by increased levels of manufacturing overhead costs that were recognized in the period because of the COVID-19 pandemic, rather than capitalized within inventory.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling and administrative expense as a percentage of revenues was higher in 2022 compared with 2021, as the prior-year period benefited from the curtailment of certain selling, travel and other administrative activities due to the COVID-19 pandemic in the prior year.  Selling and administrative expense as a percentage of revenues in 2021&#160;was lower compared with 2020 primarily due the recovery of segment revenues.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense as a percentage of revenues was lower in 2022 compared with 2021, as the increase in current-period revenues outpaced the timing of project spending.  Research and development expense as a percentage of revenues was higher in 2021 compared with 2020 which primarily reflected reinvestment into our growth initiatives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenues</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s worldwide revenues by geography were as follows:  </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,074&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenue growth in 2022 was driven by strong sales in all of the Medical segment&#8217;s units, as well as in the Interventional segment&#8217;s Surgery and Urology and Critical Care units.  U.S. revenue growth in 2022 was unfavorably impacted by a comparison to 2021, which substantially benefited from sales in the Life Sciences segment's Integrated Diagnostic Solutions unit related to COVID-19-only diagnostic testing, as further discussed above.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenue growth in 2021 was primarily driven by sales related to COVID-19-only diagnostic testing in the Life Sciences segment's Integrated Diagnostic Solutions unit.  Strong fiscal year 2021 U.S. revenue growth in the Medical segment&#8217;s Medication Delivery Solutions unit and the Interventional segment&#8217;s Surgery and Peripheral Intervention units reflected favorable comparisons to prior-year period results, which were impacted </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by COVID-19 pandemic-related declines, as well as growth attributable to core products.  U.S. revenue growth in 2021 also reflected strong demand in the Interventional segment&#8217;s Urology and Critical Care unit. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decline in international revenues in 2022 was primarily driven by an unfavorable comparison to 2021, which substantially benefited from sales in the Life Sciences segment's Integrated Diagnostic Solutions unit related to COVID-19-only diagnostic testing, as further discussed above. This fiscal year 2022 decline in international revenues was partially offset by strong sales in all of the Medical segment&#8217;s units, as well as in the Life Sciences segment&#8217;s Biosciences unit and the Interventional segment&#8217;s Surgery and Peripheral Intervention units.  </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenue growth in 2021 was largely driven by COVID-19-only diagnostic testing-related sales in the Life Sciences segment's Integrated Diagnostic Solutions unit, as discussed further above, and by demand in the Medical segment&#8217;s Pharmaceutical Systems unit. Fiscal year 2021 international revenue growth was also driven by results in the Medical segment&#8217;s Medication Delivery Solutions and the Interventional segment&#8217;s Peripheral Intervention unit due to favorable comparisons to prior-year period results, which were impacted by COVID-19 pandemic-related declines, and growth attributable to core products. Fiscal year 2021 international revenue growth was unfavorably impacted by a decline in the Medical segment&#8217;s Medication Management Solutions unit, as further discussed above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging market revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging market revenues in 2022 primarily reflected strong growth in Latin America and China, despite an unfavorable impact from pandemic-related lockdowns in China during 2022.  Revenues in emerging markets in 2021 benefited from a favorable comparison to 2020 which was impacted by COVID-19 pandemic-related declines.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Specified Items</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reflected in the financial results for 2022, 2021 and 2020 were the following specified items:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:63.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction gain/loss, product and other litigation-related matters </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment gains/losses and asset impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European regulatory initiative-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impacts of debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total specified items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  tax impact of specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax impact of specified items</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Represents amounts associated with integration and restructuring activities which are primarily recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are further discussed below.  </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">Represents costs recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and incurred in connection with the separation of BD's former Diabetes Care business.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Includes amortization and other adjustments related to the purchase accounting for acquisitions. BD&#8217;s amortization expense is recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">Includes certain amounts recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which are detailed further below.  The amounts in 2022, 2021 and 2020 also included net charges of $72 million, $56 million and $244 million, respectively, which were recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the estimate of probable future product remediation costs, as further discussed below.  The amount in 2022 additionally includes pension settlement costs of $73 million which were recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Includes non-cash (gains) losses recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to certain investments. The amounts in 2022 and 2020 included total charges of $54 million and $98 million, respectively, recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain assets.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.51pt">Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of previously incurred costs and/or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit Margin</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparison of gross profit margins in 2022 and 2021 and the comparison of gross profit margins in 2021 and 2020 reflected the following impacts:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.500%"><tr><td style="width:1.0%"></td><td style="width:70.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.032%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin % prior-year period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of purchase accounting adjustments and other specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin % current-year period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of other specified items on gross profit margin in 2022 included a non-cash asset impairment charge of $54 million in the Medical segment, as well as net charges of $72 million, compared with charges of $56 million in 2021, recorded for estimated future costs within the Medication Management Solutions unit associated with remediation efforts related to Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps.  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating performance in 2022 and 2021 reflected favorable impacts attributable to our ongoing continuous improvement projects.  Operating performance in 2022 and 2021 were unfavorably impacted by higher raw material costs. Operating performance in 2022 was also impacted by higher labor costs, as well as by the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Favorable impacts attributable to price, the optimization of our product mix, and the recovery of pre-pandemic demand for products with higher margins;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A favorable comparison to 2021, which included approximately $93 million of excess and obsolete inventory expenses related to COVID-19-only testing inventory which were recognized by the Integrated Diagnostic Solutions unit.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating performance in 2021 additionally reflected the following:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The recovery of demand for products with higher margins and the Integrated Diagnostic Solutions unit's COVID-19-only testing sales.  We re-invested over $200 million of the profits from these sales into our BD 2025 strategy focus on growth, simplification and empowerment. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A favorable comparison to 2020 which was unfavorably impacted by increased levels of manufacturing overhead costs that were recognized in the period because of the COVID-19 pandemic, rather than capitalized within inventory; partially offset by</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The $93 million of excess and obsolete inventory expenses related to COVID-19-only testing inventory noted above. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses in 2022, 2021 and 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"><tr><td style="width:1.0%"></td><td style="width:52.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase&#160;(decrease)&#160;in&#160;basis&#160;points</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022&#160;vs.&#160;2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021&#160;vs.&#160;2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Selling and administrative</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher selling and administrative expense as a percentage of revenues in 2022 compared with 2021 primarily reflected higher shipping and selling costs in the current-year period, partially offset by a decrease in our deferred compensation plan liability due to market performance and favorable foreign currency translation. The investment losses on deferred compensation plan assets were recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and administrative expense as a percentage of revenues in 2021 was lower compared with 2020 due to the recovery of revenues in 2021. Selling and administrative expense as a percentage of revenues in 2021 was unfavorably impacted by foreign currency translation and higher shipping costs as a result of expedited shipments relating to COVID-19, as well as by higher selling, travel and other administrative costs compared with 2020, which benefited from cost containment measures enacted in response to the COVID-19 pandemic.  </span></div><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Research and development</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense as a percentage of revenues in 2022 primarily reflected the timing of project spending. Research and development expense as a percentage of revenues in 2021 was higher compared with 2020 which reflected our reinvestment of COVID-19 testing-related sales profits into our growth initiatives and additional investments in COVID-19 testing solutions, as further discussed above. Spending in 2022, 2021 and 2020 reflected our continued commitment to invest in new products and platforms. </span></div><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisitions and other restructurings</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense in 2022 included restructuring costs related to simplification and other cost saving initiatives, as well as system integration costs. Restructuring expenses in 2022 included non-cash asset impairment charges of $19 million, as further discussed in Note 15 to the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data. Costs in 2021 and 2020 included restructuring costs related to simplification and other cost saving initiatives, as well as restructuring and integration costs incurred due to our acquisition of C.R. Bard, Inc. in the first quarter of fiscal year 2018. For further disclosures regarding the costs relating to restructurings, refer to Note 12 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:6pt;text-indent:11.25pt"><span><br/></span></div><div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other operating expense, net</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense in 2022, 2021 and 2020 included the following items which are further discussed in the Notes to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data:</span></div><div style="margin-top:6pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to record product liability reserves, including related defense costs (See Note 6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on sale-leaseback transactions (See Note 18)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation-related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-indent:-13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Interest Expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.833%"><tr><td style="width:1.0%"></td><td style="width:36.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.984%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower interest expense in 2022 and 2021 compared with the prior-year periods reflected lower overall interest rates on debt outstanding during 2022 and 2021, as well as the impact of debt repayments, particularly in 2021. Additional disclosures regarding our financing arrangements and debt instruments are provided in Note 16 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax rates for continuing operations in 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.000%"><tr><td style="width:1.0%"></td><td style="width:63.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate for continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impact, in basis points, from specified items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for continuing operations in 2022 primarily reflected a tax impact from specified items that was less favorable compared with the benefits associated with specified items recognized in 2021.  The effective income tax rate for continuing operations in 2021 reflected the impact of discrete tax items, as well as an impact from specified items in 2021 that was more favorable compared with the benefit associated with specified items in 2020.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income and Diluted Earnings per Share from Continuing Operations</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income and diluted earnings per share from continuing operations in 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:58.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from continuing operations (Millions of dollars)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable impact-specified items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable (unfavorable) impact-foreign currency translation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instrument Market Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We selectively use financial instruments to manage market risk, primarily foreign currency exchange risk and interest rate risk relating to our ongoing business operations. The counterparties to these contracts are highly rated financial institutions. We do not enter into financial instruments for trading or speculative purposes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD and its subsidiaries transact business in various foreign currencies throughout Europe, Greater Asia, Canada and Latin America. We face foreign currency exposure from the effect of fluctuating exchange rates on payables and receivables relating to transactions that are denominated in currencies other than our functional currency. These payables and receivables primarily arise from intercompany transactions. We hedge substantially all such exposures, primarily through the use of forward contracts.  We have also hedged the currency exposure associated with investments in certain foreign subsidiaries with instruments such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts.  We also face currency exposure that arises from translating the results of our worldwide operations, including sales, to the U.S. dollar at exchange rates that have fluctuated from the beginning of a reporting period.  We did not enter into contracts to hedge cash flows against these foreign currency fluctuations in fiscal year 2022 or 2021.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments are recorded on our balance sheet at fair value. For foreign currency derivatives, market risk is determined by calculating the impact on fair value of an assumed change in foreign exchange rates relative to the U.S. dollar. Fair values were estimated based upon observable inputs, specifically spot currency rates and foreign currency prices for similar assets and liabilities.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the foreign currency derivative instruments outstanding at September&#160;30, 2022 and 2021, the impact that changes in the U.S. dollar would have on pre-tax earnings was estimated as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.000%"><tr><td style="width:1.0%"></td><td style="width:59.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase&#160;(decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions&#160;of&#160;dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% appreciation in U.S. dollar</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% depreciation in U.S. dollar</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These calculations do not reflect the impact of exchange gains or losses on the underlying transactions that would substantially offset the results of the derivative instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When managing interest rate exposures, we strive to achieve an appropriate balance between fixed and floating rate instruments.&#160;We may enter into interest rate swaps to help maintain this balance and manage debt and interest-bearing investments in tandem, since these items have an offsetting impact on interest rate exposure.&#160;For interest rate derivative instruments, fair values are measured based upon the present value of expected future cash flows using market-based observable inputs including credit risk and interest rate yield </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">curves.&#160;Market risk for these instruments is determined by calculating the impact to fair value of an assumed change in interest rates across all maturities.&#160;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact that changes in interest rates would have on interest rate derivatives outstanding at September&#160;30, 2022 and 2021, as well as the effect that changes in interest rates would have on our earnings or cash flows over a one-year period, based upon our overall interest rate exposure, were estimated as follows:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.000%"><tr><td style="width:1.0%"></td><td style="width:37.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.570%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) to fair value of interest rate derivatives outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) to earnings or cash flows</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions&#160;of&#160;dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% increase in interest rates</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% decrease in interest rates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strong financial position and cash flow performance have provided us with the capacity to accelerate our innovation pipeline through investments in research and development, as well as through strategic acquisitions. We believe that our available cash and cash equivalents, our ability to generate operating cash flow, and if needed, our access to borrowings from our financing facilities provide us with sufficient liquidity to satisfy our foreseeable operating needs.  The following table summarizes our consolidated statement of cash flows in 2022, 2021 and 2020:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.000%"><tr><td style="width:1.0%"></td><td style="width:56.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used for) continuing operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Operating Activities</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in 2022 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash. This net use of cash primarily reflected higher levels of inventory and prepaid expenses, as well as lower levels of accounts payable and accrued expenses. Cash flows from continuing operating activities in 2022 additionally reflected a discretionary cash contribution of $134 million to fund our pension obligation.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in 2021 reflected higher net income, which was driven by strong revenue performance, adjusted by a change in operating assets and liabilities that was a net source of cash. This net source of cash primarily reflected higher levels of accounts payable and accrued expenses, partially offset by higher levels of prepaid expenses, inventory and trade receivables.  Cash flows from continuing operating activities in 2021 additionally reflected a $16 million discretionary cash contribution to fund our pension obligation.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in 2020 reflected net income, adjusted by a change in operating assets and liabilities that was a net source of cash. This net source of cash primarily reflected higher levels of accounts payable and accrued expenses and lower levels of prepaid expenses, partially offset by higher levels of inventory and trade receivables.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Investing Activities</span></div><div style="margin-top:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Capital expenditures</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in capital expenditures are focused on projects that enhance our cost structure and manufacturing capabilities, as well as support our BD 2025 strategy for growth and simplification.&#160;Capital </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenditures of $973 million, $1.194 billion and $769 million in 2022, 2021 and 2020, respectively, primarily related to manufacturing capacity expansions.  Details of spending by segment are contained in Note 8 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisitions</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash outflows for acquisitions in 2022 included a cash payment of $1.548&#160;billion associated with our acquisition of Parata Systems in the fourth quarter of 2022, as well as cash payments relating to various strategic acquisitions we have executed as part of our growth strategy, including our acquisitions of MedKeeper, Scanwell Health, Inc, Tissuemed, Ltd., and Venclose, Inc. Cash outflows for acquisitions in 2021 and 2020 included cash payments relating to the strategic acquisitions of Tepha, Inc. and Straub Medical AG, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Financing Activities</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash from continuing financing activities in 2022, 2021 and 2020 included the following significant cash flows:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:69.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash inflow (outflow)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in credit facility borrowings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt and term loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution from Embecta Corp. (see Note 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfer of cash to Embecta upon spin-off</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt and term loans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuances of equity securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,048)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the equity and debt-related financing activities detailed above are provided in Notes 4 and 16 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="text-indent:11.25pt"><span><br/></span></div><div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Debt-Related Activities</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain measures relating to our total debt were as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.666%"><tr><td style="width:1.0%"></td><td style="width:52.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (Millions of dollars)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt as a percentage of total capital (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#160;Represents shareholders&#8217; equity, net non-current deferred income tax liabilities, and debt.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding our debt instruments are provided in Note 16 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Short-term Investments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, total worldwide cash and equivalents and short-term investments, including restricted cash, were $1.167 billion. Approximately half of these assets were held outside of the United States. We regularly review the amount of cash and short-term investments held outside of the United States and our historical foreign earnings are used to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. To fund cash needs in the United States, we rely on ongoing cash flow from U.S. operations, access to capital markets and remittances from foreign subsidiaries of earnings that are not considered to be permanently reinvested.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Facilities</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a five-year senior unsecured revolving credit facility in place which will expire in September 2026. The credit facility provides borrowings of up to $2.75 billion, with separate sub-limits of $100 million for letters of credit and swingline loans. The expiration date of the credit facility may be extended for up to two additional one year periods, subject to certain restrictions (including the consent of the lenders). The credit facility provides that we may, subject to additional commitments by lenders, request an additional $500 million of financing, for a maximum aggregate commitment under the credit facility of up to $3.25 billion. Proceeds from this facility may be used for general corporate purposes. There were no borrowings outstanding under the revolving credit facility at September&#160;30, 2022.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement for our revolving credit facility contains the following financial covenants. We were in compliance with these covenants, as applicable, as of&#160;September&#160;30, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are required to have a leverage coverage ratio of no more than:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.25-to-1 as of the last day of each fiscal quarter following the closing of the credit facility; or</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.75-to-1 for the four full fiscal quarters following the consummation of a material acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have informal lines of credit outside the United States. We may, from time to time, access the commercial paper market as we manage working capital over the normal course of our business activities.  We had $230 million commercial paper borrowings outstanding as of&#160;September&#160;30, 2022.  Also, over the normal course of our business activities, we transfer certain trade receivable assets to third parties under factoring agreements. Additional disclosures regarding sales of trade receivable assets are provided in Note 15 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Access to Capital and Credit Ratings</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate credit ratings with the rating agencies Standard &amp; Poor's Ratings Services (&#8220;S&amp;P&#8221;), Moody's Investor Service (&#8220;Moody's&#8221;) and Fitch Ratings (&#8220;Fitch&#8221;) were as follows at September&#160;30, 2022:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.500%"><tr><td style="width:1.0%"></td><td style="width:40.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Moody&#8217;s</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fitch</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ratings:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Unsecured Debt</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BBB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baa2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BBB</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F2</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, Moody&#8217;s Investors Service (&#8220;Moody&#8217;s&#8221;) upgraded our senior unsecured rating to Baa2 from Baa3. Moody&#8217;s also updated BD&#8217;s commercial paper rating to P-2 from P-3 and revised its outlook on our ratings from Positive to Stable. Also in June 2022, Fitch Ratings (&#8220;Fitch&#8221;) upgraded our senior unsecured rating to BBB from BBB- and revised its outlook on our ratings from Positive to Stable. In addition, Fitch assigned us with a commercial paper rating of F2. Our corporate credit ratings with Standard &amp; Poor's Ratings Services at September&#160;30, 2022 were unchanged compared with our ratings at September 30, 2021.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower corporate debt ratings and downgrades of our corporate credit ratings or other credit ratings may increase our cost of borrowing. We believe that given our debt ratings, our financial management policies, our ability to generate cash flow and the non-cyclical, geographically diversified nature of our businesses, we would have access to additional short-term and long-term capital should the need arise. A rating reflects only the view of a rating agency and is not a recommendation to buy, sell or hold securities. Ratings can be revised upward or downward at any time by a rating agency if such rating agency decides that circumstances warrant such a change.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into contracts and commitments that obligate us to make payments in the future. Information regarding our obligations under purchase, debt and lease arrangements are provided in Notes 6, 16 and 18, respectively, to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion supplements the descriptions of our accounting policies contained in Note 1 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.  The preparation of the consolidated financial statements requires management to use estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Some of those judgments can be subjective and complex and, consequently, actual results could differ from those estimates. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. For any given estimate or assumption made by management, it is possible that other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Actual results that differ from management&#8217;s estimates could have an unfavorable effect on our consolidated financial statements. Management believes the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of the consolidated financial statements:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement. Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized when customer acceptance of these installed products has been confirmed. For certain service arrangements, including extended warranty and software maintenance contracts, revenue is recognized ratably over the contract term. The majority of revenues relating to extended warranty contracts associated with certain instruments and equipment is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over a longer period.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our agreements with customers within certain organizational units including Medication Management Solutions, Integrated Diagnostic Solutions and Biosciences, contain multiple performance obligations including both products and certain services noted above. Determining whether products and services are considered distinct performance obligations that should be accounted for separately may require judgment.  The transaction price for these agreements is allocated to each performance obligation based upon its relative standalone selling price. Standalone selling price is the amount at which we would sell a promised good or service separately to a customer. We generally estimate standalone selling prices using list prices and a consideration of typical discounts offered to customers.  The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross revenues are subject to a variety of deductions, which include rebates and sales discounts. These deductions represent estimates of the related obligations and judgment is required when determining the impact </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on gross revenues for a reporting period. Additional factors considered in the estimate of our rebate liability include the quantification of inventory that is either in stock at or in transit to our distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Assets</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill assets are subject to impairment reviews at least annually, or whenever indicators of impairment arise. Intangible assets with finite lives, including developed technology, and other long-lived assets, are periodically reviewed for impairment when impairment indicators are present.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. Our reporting units generally represent one level below reporting segments. Our review of goodwill for each reporting unit compares the fair value of the reporting unit, estimated using an income approach, with its carrying value. Our annual goodwill impairment test performed on July 1, 2022 did not result in any impairment charges, as the fair value of each reporting unit exceeded its carrying value.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally use the income approach to derive the fair value for impairment assessments. This approach calculates fair value by estimating future cash flows attributable to the assets and then discounting these cash flows to a present value using a risk-adjusted discount rate. We selected this method because we believe the income approach most appropriately measures the value of our income producing assets. This approach requires significant management judgment with respect to future volume, revenue and expense growth rates, changes in working capital use, appropriate discount rates, terminal values and other assumptions and estimates. The estimates and assumptions used are consistent with BD&#8217;s business plans. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the asset. Actual results may differ from management&#8217;s estimates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in our tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, we record accruals for uncertain tax positions based on the technical support for the positions, our past audit experience with similar situations, and the potential interest and penalties related to the matters. BD&#8217;s effective tax rate in any given period could be impacted if, upon resolution with taxing authorities, we prevailed in positions for which reserves have been established, or we were required to pay amounts in excess of established reserves.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed our needs in the United States for possible repatriation of undistributed earnings of our foreign subsidiaries and we continue to invest foreign subsidiaries earnings outside of the United States to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs.     As a result, we are permanently reinvested with respect to all of our historical foreign earnings as of September&#160;30, 2022.  Additional disclosures regarding our accounting for income taxes are provided in Note 17 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters, as further discussed in Note 6 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data. We assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of probable losses. We establish accruals to the extent probable future losses are estimable (in </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the case of environmental matters, without considering possible third-party recoveries). A determination of the amount of accruals for these contingencies is made after careful analysis of each individual matter. When appropriate, the accrual is developed with the consultation of outside counsel and, as in the case of certain mass tort litigation, the expertise of an actuarial specialist regarding the nature, timing and extent of each matter. The accruals may change in the future due to new developments in each matter or changes in our litigation strategy.  We record expected recoveries from product liability insurance carriers or other parties when realization of recovery is deemed probable.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the uncertain nature of litigation generally, we are not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which we are a party. In view of these uncertainties, we could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on BD&#8217;s consolidated results of operations and consolidated net cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefit Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant net pension and other postretirement and postemployment benefit obligations that are measured using actuarial valuations which include assumptions for the discount rate and the expected return on plan assets. These assumptions have a significant effect on the amounts reported. In addition to the analysis below, see Note 10 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data for additional discussion.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is selected each year based on investment grade bonds and other factors as of the measurement date (September 30). Specifically for the U.S. plans, we will use a discount rate of 5.62% for 2023, which was based on an actuarially-determined, company-specific yield curve to measure liabilities as of the measurement date.  To calculate the pension expense in 2023, we will apply the individual spot rates along the yield curve that correspond with the timing of each future cash outflow for benefit payments in order to calculate interest cost and service cost. Additional disclosures regarding the method to be used in calculating the interest cost and service cost components of pension expense for 2023 are provided in Note 10 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data.  The expected long-term rate of return on plan assets assumption, although reviewed each year, changes less frequently due to the long-term nature of the assumption. This assumption does not impact the measurement of assets or liabilities as of the measurement date; rather, it is used only in the calculation of pension expense. To determine the expected long-term rate of return on pension plan assets, we consider many factors, including our historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations. We will use a long-term expected rate of return on plan assets assumption of 7.25% for the U.S. pension plan in 2023. We believe our discount rate and expected long-term rate of return on plan assets assumptions are appropriate based upon the above factors.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sensitivity to changes in key assumptions for our U.S. pension and other postretirement and postemployment plans are as follows:</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Discount rate &#8212; A change of plus (minus) 25 basis points, with other assumptions held constant, would have an estimated $7&#160;million favorable (unfavorable) impact on the total U.S. net pension and other postretirement and postemployment benefit plan costs.  This estimate assumes no change in the shape or steepness of the company-specific yield curve used to plot the individual spot rates that will be applied to the future cash outflows for future benefit payments in order to calculate interest and service cost.</span></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected return on plan assets &#8212; A change of plus (minus) 25 basis points, with other assumptions held constant, would have an estimated $4&#160;million favorable (unfavorable) impact on U.S. pension plan costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes forward-looking statements within the meaning of the federal securities laws. BD and its representatives may also, from time to time, make certain forward-looking statements in publicly released </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materials, both written and oral, including statements contained in filings with the Securities and Exchange Commission, press releases, and our reports to shareholders. Forward-looking statements may be identified by the use of words such as &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;estimate&#8221; and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.  All statements that address our future operating performance or events or developments that we expect or anticipate will occur in the future are forward-looking statements.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are, and will be, based on management&#8217;s then-current views and assumptions regarding future events, developments and operating performance, and speak only as of their dates. Investors should realize that if underlying assumptions prove inaccurate, or risks or uncertainties materialize, actual results could vary materially from our expectations and projections. Investors are therefore cautioned not to place undue reliance on any forward-looking statements. Furthermore, we undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events and developments or otherwise, except as required by applicable law or regulations.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements. The Russia and Ukraine conflict may also heighten the impact of certain of these factors described below and the Risk Factors in Item&#160;1A. Risk Factors in this report. For further discussion of certain of these factors, see Item&#160;1A. Risk Factors in this report and our subsequent Quarterly Reports on Form 10-Q.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of inflation and disruptions in our global supply chain on BD and our suppliers (particularly sole-source suppliers and providers of sterilization services), including fluctuations in the cost and availability of oil-based resins and other raw materials, as well as certain components, used in the production or sterilization of our products, transportation constraints and delays, product shortages, energy shortages or increased energy costs, labor shortages in the United States and elsewhere, and increased operating and labor costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any impact the COVID-19 pandemic, including resurgences in COVID-19 infections or new strains of the virus or additional or extended lockdowns or other restrictions imposed by government entities, may have on our business, the global economy and the global healthcare system. This may include decreases in the demand for our products, disruptions to our operations or the operations of our suppliers and customers (including employee absenteeism) or disruptions to our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Factors such as the rate of vaccination, the effectiveness of vaccines against different strains, the rate of infections, and competitive factors that could impact the demand and pricing for our COVID-19 diagnostics testing.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:line-through">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General global, regional or national economic downturns and macroeconomic trends, including heightened inflation, capital market volatility, interest rate and currency rate fluctuations, and economic slowdown or recession, that may result in unfavorable conditions that could negatively affect demand for our products and services, impact the prices we can charge for our products and services, or impair our ability to produce our products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the way healthcare services are delivered, including transition of more care from acute to non-acute settings and increased focus on chronic disease management, which may affect the demand for our products and services. Additionally, budget constraints and staffing shortages, particularly shortages of nursing staff may affect the prioritization of healthcare services, which could also impact the demand for certain of our products and services.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive factors that could adversely affect our operations, including new product introductions and technologies (for example, new forms of drug delivery) by our current or future competitors, consolidation or strategic alliances among healthcare companies, distributors and/or payers of healthcare to improve their competitive position or develop new models for the delivery of healthcare, increased </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pricing pressure due to the impact of low-cost manufacturers, patents attained by competitors (particularly as patents on our products expire), new entrants into our markets and changes in the practice of medicine.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks relating to our overall level of indebtedness, including our ability to service our debt and refinance our indebtedness, which is dependent upon the capital markets and the overall macroeconomic environment and our financial condition at such time.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The adverse financial impact resulting from unfavorable changes in foreign currency exchange rates.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as our earnings forecasts are based on projected sales volumes and pricing of many product types, some of which are more profitable than others.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in reimbursement practices of governments or third-party payers, or adverse decisions relating to our products by such payers, which could reduce demand for our products or the price we can charge for such products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost-containment efforts in the U.S. or in other countries in which we do business, such as alternative payment reform and increased use of competitive bidding and tenders, including, without limitation, any expansion of the volume-based procurement process in China or implementation of similar cost-containment efforts.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the domestic and foreign healthcare industry or in medical practices that result in a reduction in procedures using our products or increased pricing pressures, including cost-reduction measures instituted by and the continued consolidation among healthcare providers.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing customer preferences and requirements, such as increased demand for products with lower environmental footprint, and for companies to produce and demonstrate progress against GHG reduction plans and targets.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in U.S. federal laws and policies that could affect fiscal and tax policies, healthcare and international trade, including import and export regulation and international trade agreements. In particular, tariffs or other trade barriers imposed by the U.S. or other countries could adversely impact our supply chain costs or otherwise adversely impact our results of operations.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risks associated with the spin-off of our former Diabetes Care business, including factors that could adversely affect our ability to realize the expected benefits of the spin-off, or the qualification of the spin-off as a tax-free transaction for U.S. federal income tax purposes.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches of our information systems or our products, which could impair our ability to conduct business, result in the loss of BD trade secrets or otherwise compromise sensitive information of BD or its customers, suppliers and other business partners, or of customers' patients, including sensitive personal data, or result in product efficacy or safety concerns for certain of our products, and result in actions by regulatory bodies or civil litigation.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain regulatory approvals and registrations in the United States and abroad, obtain intellectual property protection for our products, obtain coverage and adequate reimbursement for new products, or gain and maintain market approval of products, as well as the possibility of infringement claims by competitors with respect to patents or other intellectual property rights, all of which could preclude or delay commercialization of a product. Delays in obtaining necessary approvals or clearances from the FDA or other regulatory agencies or changes in the regulatory process may also delay product launches and increase development costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of business combinations or divestitures, including any volatility in earnings relating to acquisition-related costs, and our ability to successfully integrate any business we may acquire.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to penetrate or expand our operations in emerging markets, which depends on local economic and political conditions, and how well we are able to make necessary infrastructure enhancements to production facilities and distribution networks.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conditions in international markets, including social and political conditions, civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures, difficulties in protecting and enforcing our intellectual property rights and governmental expropriation of assets. Our international operations also increase our compliance risks, including risks under the Foreign Corrupt Practices Act and other anti-corruption laws, as well as regulatory and privacy laws.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deficit reduction efforts or other actions that reduce the availability of government funding for healthcare and research, which could weaken demand for our products and result in additional pricing pressures, as well as create potential collection risks associated with such sales.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in university or U.S. and international governmental funding and policies for life sciences research.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in the demand for products we sell to pharmaceutical companies that are used to manufacture, or are sold with, the products of such companies, as a result of funding constraints, consolidation or otherwise.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effects of regulatory or other events that adversely impact our supply chain, including our ability to manufacture (including sterilize) our products (particularly where production of a product line or sterilization operations are concentrated in one or more plants), source materials or components or services from suppliers (including sole-source suppliers) that are needed for such manufacturing (including sterilization), or provide products to our customers, including events that impact key distributors. </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Natural disasters, including the impacts of climate change, hurricanes, tornadoes, windstorms, fires, earthquakes and floods and other extreme weather events, global health pandemics, war, terrorism, labor disruptions and international conflicts that could cause significant economic disruption and political and social instability, resulting in decreased demand for our products, or adversely affecting our manufacturing and distribution capabilities or causing interruptions in our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pending and potential future litigation or other proceedings asserting, and/or investigations concerning and/or subpoenas and requests seeking information with respect to, alleged violations of law (including in connection with federal and/or state healthcare programs (such as Medicare or Medicaid) and/or sales and marketing practices (such as investigative subpoenas and the civil investigative demands received by BD)), potential anti-corruption and related internal control violations under the Foreign Corrupt Practices Act, antitrust claims, securities law claims, product liability (which may involve lawsuits seeking class action status or seeking to establish multi-district litigation proceedings, including pending claims relating to our hernia repair implant products, surgical continence products for women and vena cava filter products), claims with respect to environmental matters, data privacy breaches and patent infringement, and the availability or collectability of insurance relating to any such claims.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New or changing laws and regulations affecting our domestic and foreign operations, or changes in enforcement practices, including laws relating to trade, monetary and fiscal policies, taxation (including tax reforms that could adversely impact multinational corporations), sales practices, environmental protection, price controls, and licensing and regulatory requirements for new products and products in the post-marketing phase. In particular, the U.S. and other countries may impose new requirements regarding registration, labeling or prohibited materials that may require us to re-register products already on the market or otherwise impact our ability to market our products. Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes or those of our suppliers, or result in liability to BD.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product efficacy or safety concerns regarding our products resulting in product holds or recalls, regulatory action on the part of the FDA or foreign counterparts (including restrictions on future product clearances and civil penalties), declining sales and product liability claims, and damage to our reputation. As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA. The Consent Decree authorizes the FDA, in the event of any violations in the future, to order our U.S. infusion pump business to cease manufacturing and distributing products, recall products or take other actions, and order the payment of significant monetary damages if the business subject to the decree fails to comply with any provision of the Consent Decree. We are undertaking certain remediation of our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, and are currently shipping the product in the U.S., only in cases of medical necessity and to remediate recalled software versions. We will not be able to fully resume commercial operations for the BD Alaris System in the U.S. until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of adverse media exposure or other publicity regarding BD&#8217;s business or operations, including the effect on BD&#8217;s reputation or demand for its products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of market fluctuations on the value of assets in BD&#8217;s pension plans and on actuarial interest rate and asset return assumptions, which could require BD to make additional contributions to the plans or increase our pension plan expense.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain the anticipated benefits of restructuring programs, if any, that we may undertake.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issuance of new or revised accounting standards by the FASB or the SEC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_49"></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is included in Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, and in Notes 1, 14 and 15 to the consolidated financial statements contained in Item&#160;8. Financial Statements and Supplementary Data, and is incorporated herein by reference.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data.</span></div><div style="text-align:center"><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_55"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Reports of Management</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Responsibilities</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial statements have been prepared by management in conformity with U.S. generally accepted accounting principles and include, where required, amounts based on the best estimates and judgments of management. The integrity and objectivity of data in the financial statements and elsewhere in this Annual Report are the responsibility of management.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fulfilling its responsibilities for the integrity of the data presented and to safeguard the Company&#8217;s assets, management employs a system of internal accounting controls designed to provide reasonable assurance, at appropriate cost, that the Company&#8217;s assets are protected and that transactions are appropriately authorized, recorded and summarized. This system of control is supported by the selection of qualified personnel, by organizational assignments that provide appropriate delegation of authority and division of responsibilities, and by the dissemination of written policies and procedures. This control structure is further reinforced by a program of internal audits, including a policy that requires responsive action by management.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors monitors the internal control system, including internal accounting and financial reporting controls, through its Audit Committee, which consists of four independent Directors. The Audit Committee meets periodically with the independent registered public accounting firm, the internal auditors and management to review the work of each and to satisfy itself that they are properly discharging their responsibilities. The independent registered public accounting firm and the internal auditors have full and free access to the Audit Committee and meet with its members, with and without management present, to discuss the scope and results of their audits including internal control, auditing and financial reporting matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Act of 1934, as amended. Management conducted an assessment of the effectiveness of internal control over financial reporting based on the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company's assessment of the effectiveness of internal control over financial reporting and the criteria noted above, management concluded that internal control over financial reporting was effective as of September&#160;30, 2022.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements and internal control over financial reporting have been audited by Ernst&#160;&amp; Young LLP, an independent registered public accounting firm. Ernst&#160;&amp; Young&#8217;s reports with respect to fairness of the presentation of the financial statements, and the effectiveness of internal control over financial reporting, are included herein.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.901%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas E. Polen</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher J. DelOrefice</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and President</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President, Controller and Chief Accounting Officer</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Becton, Dickinson and Company</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Becton, Dickinson and Company (the Company) as of September 30, 2022 and 2021, the related consolidated statements of income, comprehensive income and cash flows for each of the three years in the period ended September 30, 2022, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at September 30, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of September 30, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework)&#160;and our report dated November&#160;22, 2022 expressed an unqualified opinion thereon.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimation of Product Liability Reserves </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 6 to the consolidated financial statements, the Company is a defendant in various product liability matters in which the plaintiffs allege a wide variety of claims associated with the use of certain Company devices. At September 30, 2022, the Company&#8217;s product liability reserves totaled approximately $2.1 billion. The Company engaged an actuarial specialist to perform an analysis to estimate the outstanding liability for indemnity costs related to claims arising from these product liability matters. The methods used by the Company to estimate these reserves are based on reported claims, historical settlement amounts, and stage of litigation, among other items. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s estimate of certain of the Company&#8217;s product liability reserves and the related disclosure was challenging due to the significant judgment required to determine the methods used to estimate the amount of unreported product liability claims and the indemnity costs and the key assumptions utilized in those methods given the stages of these matters and the amount of claims history. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the controls over the Company&#8217;s evaluation of the product liability reserves. For example, we tested controls over management's review of the methods, significant assumptions and the underlying data used by the actuary to estimate the product liability reserves.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To evaluate management&#8217;s estimate of the product liability reserves, our audit procedures included, among others, testing the completeness and accuracy of the underlying data used by management's actuarial specialist to estimate the amount of unreported claims and the indemnity cost. For example, we compared filed and settled claims data to legal letters obtained from external counsel, and, on a sample basis, compared settlement amounts to the underlying agreements. In addition, we involved our actuarial specialists to assist us in evaluating the methods used to estimate the unreported claims and the indemnity cost used in the calculation of the product liability reserves. We have also assessed the adequacy of the Company&#8217;s disclosures in relation to these matters.</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income taxes &#8212; Uncertain tax positions </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 17 to the consolidated financial statements, the Company conducts business in numerous countries and as a result, files tax returns in those locations. Uncertain tax positions may arise for multiple reasons including, but not limited to, the interpretation of global tax rules and regulations. The Company uses judgment to (1) determine whether, based on the technical merits, a tax position is more likely than not to be sustained and (2) measure the amount of tax benefit that qualifies for recognition. The Company has recorded a liability of $348 million related to uncertain tax positions as of September 30, 2022. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty in predicting the resolution of these tax matters, auditing the Company&#8217;s uncertain tax positions involved complex analysis and auditor judgment. This also required the use of tax subject matter resources to determine whether the more likely than not criteria was met.</span></div><div><span><br/></span></div><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over management&#8217;s accounting for uncertain tax positions, including assessment of the technical merits of tax positions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To evaluate whether the technical merits of uncertain tax positions are more likely than not sustainable, our audit procedures included, among others, evaluation of applicable tax law, tax regulations and other regulatory guidance by our tax subject matter professionals. We also involved our tax subject matter professionals in verifying our understanding of the relevant facts and analysis, by assessing the Company&#8217;s correspondence with the relevant tax authorities and evaluating third-party advice obtained by the Company. We also evaluated the adequacy of the Company&#8217;s income tax disclosures included in Note 17 to the consolidated financial statements in relation to these matters.</span></div><div><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.500%"><tr><td style="width:1.0%"></td><td style="width:2.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV81OC9mcmFnOmQ3YmNlOTIzZTRmNjQzYTJhNTllYWVmMDA4MTVjNjM2L3RhYmxlOjkwYzhlYjgyM2VhNzQxZmI4NTUzMzVlNzNiMmY3MGUyL3RhYmxlcmFuZ2U6OTBjOGViODIzZWE3NDFmYjg1NTMzNWU3M2IyZjcwZTJfMC0xLTEtMS05MDU3MQ_46805cee-88db-4127-bb9e-09aaa32294ca">ERNST&#160;&amp; YOUNG LLP</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company's auditor since 1959.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV81OC9mcmFnOmQ3YmNlOTIzZTRmNjQzYTJhNTllYWVmMDA4MTVjNjM2L3RhYmxlOjkwYzhlYjgyM2VhNzQxZmI4NTUzMzVlNzNiMmY3MGUyL3RhYmxlcmFuZ2U6OTBjOGViODIzZWE3NDFmYjg1NTMzNWU3M2IyZjcwZTJfNC0wLTEtMS05MDUzOA_1d91d7a9-e6aa-473d-b90e-e7c6bd2f7c8f">New York, New York</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Becton, Dickinson and Company</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Becton, Dickinson and Company&#8217;s internal control over financial reporting as of September 30, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), (the COSO criteria). In our opinion, Becton, Dickinson and Company (the Company) maintained, in all material respects, effective internal control over financial reporting as of September 30, 2022, based on the COSO criteria.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company&#160;as of September 30, 2022 and 2021, the related consolidated statements of income, comprehensive income and cash flows for each of the three years in the period ended September 30, 2022, and the related notes&#160;and our report dated November&#160;22, 2022 expressed an unqualified opinion thereon.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.666%"><tr><td style="width:1.0%"></td><td style="width:49.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ERNST&#160;&amp; YOUNG LLP</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, New York</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended September&#160;30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars, except per share amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMS0xLTEtMS03MzUzNQ_44189e68-120b-4fe6-9452-777dba53f376">18,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMS0zLTEtMS03MzUzNQ_1d0f925f-b9c1-4725-99c8-30a0533b5271">19,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMS01LTEtMS03MzUzNQ_2d6b80a0-d699-4253-95f8-56a2c827ad53">16,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMy0xLTEtMS03MzUzNQ_984b7130-d3e6-415a-a585-4f92c89e6c4f">10,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMy0zLTEtMS03MzUzNQ_936fb879-b350-4634-8f26-83e6ef92a54a">10,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMy01LTEtMS03MzUzNQ_9642db15-ee21-4d47-948d-151761f27378">9,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNC0xLTEtMS03MzUzNQ_91de4963-ddac-4af8-9a91-18f9e5c50f5d">4,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNC0zLTEtMS03MzUzNQ_f98a24aa-e749-4f49-ad29-e7ae0cbec6ce">4,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNC01LTEtMS03MzUzNQ_2100713e-3826-457f-aea2-a2a2dd6678bc">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNS0xLTEtMS03MzUzNQ_e13f6184-1ef3-4975-a935-c9feb0d952ae">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNS0zLTEtMS03MzUzNQ_218dd718-053c-4f2a-a9b0-799259f475b6">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNS01LTEtMS03MzUzNQ_7e3b13f1-64f4-44f0-b15e-8d2df1653220">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNi0xLTEtMS03MzUzNQ_c6e37a40-2d37-4fdd-9d61-c7567292ac38">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNi0zLTEtMS03MzUzNQ_5d19084a-f662-4340-ad0e-b3a2dfb1e0ed">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNi01LTEtMS03MzUzNQ_96c320f1-34ba-460b-a5d9-2cecd8990a68">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNy0xLTEtMS03MzUzNQ_9d5653d7-0612-4197-b5f2-212f79eef2f1">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNy0zLTEtMS03MzUzNQ_fb0c9ec4-32df-4306-9b6c-d8842ab135ac">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNy01LTEtMS03MzUzNQ_a4ef703e-5e8c-42f1-bd8c-4c6f791f2dcd">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOC0xLTEtMS03MzUzNQ_674e5e80-5d5d-456c-b69e-7069c3a20ee3">16,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOC0zLTEtMS03MzUzNQ_a4ecdf77-c860-4547-bfe6-611cc8a0d34c">16,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOC01LTEtMS03MzUzNQ_eceb538a-58e6-4c20-ad6e-94f27180d5a5">15,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOS0xLTEtMS03MzUzNQ_f7181e5d-a9fb-407b-891d-d17bdb2b2a7e">2,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOS0zLTEtMS03MzUzNQ_52bfc691-ee81-4106-ad84-8c14fc7c1532">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOS01LTEtMS03MzUzNQ_5ab0ca80-e622-45bc-9d20-8640553587f4">912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTAtMS0xLTEtNzM1MzU_559acaeb-c2a6-4cbd-92cd-65c3a68af00a">398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTAtMy0xLTEtNzM1MzU_bce3a65b-483d-4223-a312-badcdc7c4238">469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTAtNS0xLTEtNzM1MzU_dd755fc7-70e6-4d61-ad01-0a133f8ab3ad">528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTEtMS0xLTEtNzM1MzU_5e56f61c-ef9f-406c-8450-81f871167736">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTEtMy0xLTEtNzM1MzU_db9fb261-7509-41a7-b35d-9e99e25b183d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTEtNS0xLTEtNzM1MzU_5de96577-bd95-48af-9a10-c1a3297d0614">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTItMS0xLTEtNzM1MzU_b2c7c434-20ad-4367-9213-9176ea185cc2">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTItMy0xLTEtNzM1MzU_8391fbc8-75b5-4635-8a31-e47ef8cfcd83">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTItNS0xLTEtNzM1MzU_ef555dc3-9c1e-41e1-97d3-f8ce9d20a7aa">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTMtMS0xLTEtNzM1MzU_637521ec-374f-4caa-8946-2f489374be03">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTMtMy0xLTEtNzM1MzU_07efcf59-28f1-405d-aec3-4a8d1a88feef">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTMtNS0xLTEtNzM1MzU_bc0fedd1-48c7-48b2-b876-fd56970d468c">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTQtMS0xLTEtNzM1MzU_24f8e29f-e869-4f95-8384-c06505804633">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTQtMy0xLTEtNzM1MzU_5dde8b03-dcf1-4e6d-9476-3f502a990951">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTQtNS0xLTEtNzM1MzU_04747fbf-6d36-4cac-8915-5dc654f72d95">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income from Continuing Operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMS0xLTEtODg0NDk_c2250b6f-5f72-4425-8408-89997da2e982">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMy0xLTEtODg0NDk_ed9b959b-863d-44bf-992b-844f816f12e4">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtNS0xLTEtODg0NDk_49d1116c-81e6-4ccc-8401-158bf642c8a7">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMS0xLTEtODg0NDk_19d082c5-9314-4c91-87fb-3382f433b779">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMy0xLTEtODg0NDk_ea13bdf0-204c-425e-90fb-ee3d96626284">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtNS0xLTEtODg0NDk_798a4838-b89b-42e8-8e8c-c4662b29dcd9">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMS0xLTEtNzM1MzU_db749c14-a1a8-44d1-83a1-43843d623486">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMy0xLTEtNzM1MzU_13a252f8-51d8-4a5f-b6ac-70acba885c2b">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtNS0xLTEtNzM1MzU_4a9b7f8c-32e0-498c-a2c7-5249163688b3">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMS0xLTEtNzM1MzU_6320e8d0-86f2-4047-9402-4a2ea2a8424e">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMy0xLTEtNzM1MzU_17f000fe-e861-456e-a469-6bc85f6d80d7">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtNS0xLTEtNzM1MzU_b9d99587-6cc3-4083-b2af-b9eb509240d8">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income applicable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTctMS0xLTEtNzM1MzU_28f2ae26-19e9-4472-bc35-bcf9e7cbbc36">1,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTctMy0xLTEtNzM1MzU_45a1a4de-a914-4c29-b138-d8bcd95fd141">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTctNS0xLTEtNzM1MzU_cc2027f8-8959-463f-ac79-3333ad8a131f">767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjItMS0xLTEtODg0ODM_e069835c-44a8-4400-9223-d5cd2878f276">5.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjItMy0xLTEtODg0ODM_4e6d87cb-0a1b-4dc0-88b2-107cf2fcd44b">5.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjItNS0xLTEtODg0ODM_7e527e5e-e9e1-4b98-8d90-23360b048598">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjMtMS0xLTEtODg0ODM_f3f65bbb-70f5-4a36-a255-61924027d4d8">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjMtMy0xLTEtODg0ODM_a2bbf542-4fea-4269-aadf-595a7b9136bb">1.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjMtNS0xLTEtODg0ODM_a684dda4-a7a3-49f7-b102-a6c704046323">1.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTktMS0xLTEtNzM1MzU_d318e350-269a-4b5c-82a0-0a053617e0ab">5.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTktMy0xLTEtNzM1MzU_4450eb6a-0c6e-4500-9852-08027b78c3fc">6.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTktNS0xLTEtNzM1MzU_a56a1e78-dfbe-449e-86c3-859adaf25b57">2.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjctMS0xLTEtODg0ODk_c637bc87-7a15-45a0-af28-45b2313cc9ae">5.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjctMy0xLTEtODg0ODk_6eeb3d4c-2982-4254-8f35-58f755571943">5.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjctNS0xLTEtODg0ODk_66018d40-e6b3-498f-9108-927c578dae01">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjgtMS0xLTEtODg0ODk_0c4c2f16-5547-470c-93c6-c06e288e6853">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjgtMy0xLTEtODg0ODk_2c2ca8e5-ed01-4ce1-97e0-4ebf501c7be7">1.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjgtNS0xLTEtODg0ODk_3ce82fae-0d89-4139-9cc6-0afe9b83be07">1.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjEtMS0xLTEtNzM1MzU_99faff64-2855-491d-a48a-81af6d687745">5.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjEtMy0xLTEtNzM1MzU_b7fb5074-d008-4364-b845-19ccadf3f295">6.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjEtNS0xLTEtNzM1MzU_e3c830a9-d453-48f4-b6be-d009905144ef">2.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:323pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended September&#160;30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMS0xLTEtMS03MzUzNQ_db749c14-a1a8-44d1-83a1-43843d623486">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMS0zLTEtMS03MzUzNQ_82a47aaa-a53f-4d93-acb3-25a3507a4fa2">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMS01LTEtMS03MzUzNQ_e24e207c-0841-4b62-b3a8-969e44f992a2">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income (Loss), Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMy0xLTEtMS03MzUzNQ_c883e940-b963-465a-acad-eaa366f640b3">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMy0zLTEtMS03MzUzNQ_7d6b3553-2134-4f48-9032-f37f3a19c302">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMy01LTEtMS03MzUzNQ_c7848e36-2416-4c85-87c2-f061a606f721">161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and postretirement plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNC0xLTEtMS03MzUzNQ_e3bc0d29-71f8-4aeb-b882-01b599fbe780">210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNC0zLTEtMS03MzUzNQ_605b9c42-9d28-4fd7-8089-0a023169edd8">255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNC01LTEtMS03MzUzNQ_11f6188f-5b51-44cd-8fca-4eca4dfc638e">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNS0xLTEtMS03MzUzNQ_5891c3c4-d0f6-4e3a-9925-e9dc904928d7">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNS0zLTEtMS03MzUzNQ_ad979cbf-d5eb-40c5-b47e-e7ca7df5c7ad">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNS01LTEtMS03MzUzNQ_fd1bf89c-a9f8-4010-be24-329b9f975095">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income (Loss), Net of Tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNi0xLTEtMS03MzUzNQ_00c8495d-fffa-45f3-9a71-1e3015703eff">600</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNi0zLTEtMS03MzUzNQ_9c5e4864-b3d9-4c59-b7f0-96d3ed374f7e">460</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNi01LTEtMS03MzUzNQ_24179c5a-3e31-4d20-b5cb-9c7f4e5e698f">265</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNy0xLTEtMS03MzUzNQ_b2ce1beb-9783-42f7-9041-355c61cb95c2">2,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNy0zLTEtMS03MzUzNQ_823e8b2e-218a-4daa-9cae-433996eface0">2,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNy01LTEtMS03MzUzNQ_4013846f-ceac-429e-8838-2a2074d73c36">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:323pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September&#160;30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"><tr><td style="width:1.0%"></td><td style="width:65.901%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Millions of dollars, except per share amounts and numbers of shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMy0xLTEtMS03MzUzNQ_8ae72a17-1bcd-4b87-a748-d6f63628c0aa">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMy0zLTEtMS03MzUzNQ_9cf34f64-de8c-4d32-8508-86e00b63eb0b">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNC0xLTEtMS03MzUzNQ_8f25294b-d6a2-4148-b7c6-d86775734f1e">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNC0zLTEtMS03MzUzNQ_7756253c-6019-4c91-846b-c21283395c68">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNS0xLTEtMS03MzUzNQ_54f40e96-a676-42d2-a9d9-98f78001e968">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNS0zLTEtMS03MzUzNQ_91b27f60-95ef-4ce6-9ac0-bba827bf99bc">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNi0xLTEtMS03MzUzNQ_fa3dc557-6fd4-48d6-b28d-0f8c78910e31">2,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNi0zLTEtMS03MzUzNQ_7e750694-fce8-41dc-be77-b666e7788b1e">2,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNy0xLTEtMS03MzUzNQ_ca411e3a-9423-42d9-afc0-7e6ef33144c2">3,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNy0zLTEtMS03MzUzNQ_0b2d3be9-23cf-4d6c-bac1-4a341e37d5f6">2,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfOS0xLTEtMS03MzUzNQ_052137a0-130f-4d5d-b15b-114991a25ec0">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfOS0zLTEtMS03MzUzNQ_de7c1f3e-39d9-4fc1-b92b-878dd1657fca">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets of discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMS0xLTEtODg1MzA_9fd3493e-bfd9-46a8-ad5c-e96a28f5521a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMy0xLTEtODg1MzA_3575e5c7-4175-40dd-91d1-122bf75a864c">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMS0xLTEtNzM1MzU_a7225ed4-237e-4b83-8ea5-e7fa5618861b">8,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMy0xLTEtNzM1MzU_08001b86-65f8-47b1-9082-a7e7bae14822">8,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTEtMS0xLTEtNzM1MzU_948d2386-5231-4092-b8dc-672a5dff3142">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTEtMy0xLTEtNzM1MzU_c7ceb3bf-44ab-4127-8d6f-063e7aaa0a23">6,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTItMS0xLTEtNzM1MzU_ed55e76d-ef21-4153-9c87-39533a30c90c">24,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTItMy0xLTEtNzM1MzU_f237df1a-ae3b-422e-bc3f-1fd4759a4afc">23,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed Technology, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTMtMS0xLTEtNzM1MzU_ddea7063-117c-4d23-a9ae-5174ed5a2ac3">9,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTMtMy0xLTEtNzM1MzU_ba73e22a-1e05-414e-ab4d-7e14c56261b8">9,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer Relationships, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTQtMS0xLTEtNzM1MzU_499eb812-54dc-44a8-9d3f-3fb1c54c599f">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTQtMy0xLTEtNzM1MzU_07ca28ad-f350-40b8-9b81-ac205becb9fc">2,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Intangibles, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTUtMS0xLTEtNzM1MzU_aba35967-1645-4479-82e2-955851dc18c7">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTUtMy0xLTEtNzM1MzU_d5536f64-854b-4533-b611-27192308152b">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTYtMS0xLTEtNzM1MzU_29edb1a7-9f2f-41fd-8bea-f39a3e3af6fd">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTYtMy0xLTEtNzM1MzU_f9adbe33-fb06-4e62-a9a8-2b0c6d9b2916">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent Assets of Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTgtMS0xLTEtODg1NDQ_d145e81c-5a7a-44e1-b63d-2183c51842a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTgtMy0xLTEtODg1NDQ_1790bffb-9b54-4c22-ab23-146f2ceed074">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTctMS0xLTEtNzM1MzU_c4b9f27c-5141-4c26-b045-1acd60c62e0a">52,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTctMy0xLTEtNzM1MzU_6ec8998a-32cd-42ac-8ec1-27bd9c6e8e9d">53,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjAtMS0xLTEtNzM1MzU_bb070eb6-44cd-4d60-b048-f6d4c81cbb30">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjAtMy0xLTEtNzM1MzU_a596f471-1f12-48dd-814a-6807a323e3e0">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjEtMS0xLTEtNzM1MzU_67faa10a-a7b0-4185-8719-ac2402c2fabb">1,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjEtMy0xLTEtNzM1MzU_d2b08c4a-8e07-4516-87c1-08e2d3b6c7ae">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjItMS0xLTEtNzM1MzU_7d32d06a-5db4-4e7e-8fe2-bfaadcc509c1">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjItMy0xLTEtNzM1MzU_b11a0b36-1473-434d-b5b8-5c4da05121fe">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjMtMS0xLTEtNzM1MzU_9f29fea8-f44c-4774-b4d2-5de766660a3c">1,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjMtMy0xLTEtNzM1MzU_9cb9e066-c157-47b9-8998-c1ba06c9dba8">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjQtMS0xLTEtNzM1MzU_5204d1fa-01ab-4e4b-92d3-2c2c36cdf75e">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjQtMy0xLTEtNzM1MzU_3e1347b7-6925-4133-82e4-dc1834e6576e">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities of discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMS0xLTEtODg1NTc_de095094-ce99-404c-9b6a-c0ab4858e1da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMy0xLTEtODg1NTc_2ff4e87e-47f9-4eeb-afc7-46e07dfa2b3f">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjYtMS0xLTEtNzM1MzU_1c889b25-c6ff-4bd3-9e58-8ebe805b42c7">7,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjYtMy0xLTEtNzM1MzU_b76705a6-64b9-4867-87c2-0b4676a1389a">6,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjctMS0xLTEtNzM1MzU_b3768978-de2e-4e81-8716-d941e5c8555a">13,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjctMy0xLTEtNzM1MzU_206e1dc4-9706-487a-af84-e49083a9a1a0">17,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-Term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMS0xLTEtNzM1MzU_99874d97-d1ab-4ef0-b711-5aa70f2c23ec">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMy0xLTEtNzM1MzU_fcccfd54-e0e3-419d-9e59-b4faabd3c000">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjktMS0xLTEtNzM1MzU_8fca1dfa-e386-4722-9900-bf08d10a25f3">5,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjktMy0xLTEtNzM1MzU_3189cb52-d308-472c-8d5a-fab347e6765d">5,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent Liabilities of Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMS0xLTEtODg1NzI_74a53240-5dbb-4064-be20-842a6c2fe6a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMy0xLTEtODg1NzI_b17ac9bf-3eb4-46fc-9869-fb192eabaaf3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and Contingencies (See Note 6)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzAtMS0xLTEtNzM1MzU_0916c063-144d-4b7f-b0ec-7eec77a92031"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzAtMy0xLTEtNzM1MzU_d7ff0481-6e4b-410b-a01b-c21dda4ddc7d"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock (See Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzItMS0xLTEtNzM1MzU_00a98e78-5f8f-44c8-a896-6dd404a65d7b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzItMy0xLTEtNzM1MzU_98383f1b-6401-4ed7-904f-716553c43405">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl8xOQ_3618169b-0e9e-4944-8023-d1cbad0233f0"><ix:nonFraction unitRef="usdPerShare" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl8xOQ_4ed03f50-4a7b-40c8-93ff-d7815cb9956a">1</ix:nonFraction></ix:nonFraction> par value: authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl80Ng_18994d94-4ebc-4b66-a6ef-afd89028462b"><ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl80Ng_b97a53b1-9e6f-4343-bdd6-1253ea0ca4e0">640,000,000</ix:nonFraction></ix:nonFraction> shares; issued &#8212; <ix:nonFraction unitRef="shares" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl82Ng_4c4180bc-1d16-4f16-98ff-b11eee92aae7"><ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl82Ng_793add55-733c-450e-b372-fc82d0b86226">364,639,901</ix:nonFraction></ix:nonFraction> shares in 2022 and 2021.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMS0xLTEtNzM1MzU_af197474-d2fb-4572-9ca2-c99e3db2106a">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMy0xLTEtNzM1MzU_600ee642-34c0-423a-ae41-670af6ae311c">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzQtMS0xLTEtNzM1MzU_5985752a-269b-43a0-a991-e533b88c7254">19,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzQtMy0xLTEtNzM1MzU_23b08b57-9c00-4725-91cb-c582a1fffc9f">19,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzUtMS0xLTEtNzM1MzU_0faad345-9937-487a-86b0-9b2341dde1f5">15,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzUtMy0xLTEtNzM1MzU_0511a1a9-f4eb-4558-8639-0dc865211fee">13,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzYtMS0xLTEtNzM1MzU_a3c77d9e-3ada-49a3-b8e6-f5961951cf8c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzYtMy0xLTEtNzM1MzU_c448f3c5-bd3d-4d59-a893-762e48b8545a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock &#8212; <ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplODg0YmJlYTZiZTc0MTU5OTA5OTIwOWVhZWNjNTI1Y180MQ_cced015f-d66d-4000-b3f8-fb60982f9af9">81,283,191</ix:nonFraction> shares in 2022 and <ix:nonFraction unitRef="shares" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplODg0YmJlYTZiZTc0MTU5OTA5OTIwOWVhZWNjNTI1Y182Mw_0e8c0966-5227-451c-b6be-14c06c808b09">80,163,949</ix:nonFraction> shares in 2021.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMS0xLTEtNzM1MzU_f3f94b9c-29b5-4cc8-bc5c-5c689ec39fc5">8,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMy0xLTEtNzM1MzU_fffce676-ad79-4108-8873-e8191504b34e">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzgtMS0xLTEtNzM1MzU_46387707-7a07-4f41-b7a2-fb2dfd1f9ed1">1,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzgtMy0xLTEtNzM1MzU_30db0d1b-d4ee-4c4f-adde-622d02e28dec">2,088</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzktMS0xLTEtNzM1MzU_8b19774d-5912-464e-8e9d-58a6645bb4ea">25,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzktMy0xLTEtNzM1MzU_75241c34-31ab-4c4d-b34d-9bb346613c27">23,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNDAtMS0xLTEtNzM1MzU_01e9f57b-cdc5-4ae1-80a1-9a09403f70f2">52,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNDAtMy0xLTEtNzM1MzU_3f33459c-a105-4dda-aa61-6a2067414ab3">53,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:323pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended September&#160;30</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMi0xLTEtMS03MzUzNQ_db749c14-a1a8-44d1-83a1-43843d623486">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMi0zLTEtMS03MzUzNQ_13a252f8-51d8-4a5f-b6ac-70acba885c2b">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMi01LTEtMS03MzUzNQ_4a9b7f8c-32e0-498c-a2c7-5249163688b3">874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMy0xLTEtMS05MDMzMA_19d082c5-9314-4c91-87fb-3382f433b779">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMy0zLTEtMS05MDMzMA_ea13bdf0-204c-425e-90fb-ee3d96626284">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMy01LTEtMS05MDMzMA_798a4838-b89b-42e8-8e8c-c4662b29dcd9">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0xLTEtMS05MDMzMA_c2250b6f-5f72-4425-8408-89997da2e982">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0zLTEtMS05MDMzMA_ed9b959b-863d-44bf-992b-844f816f12e4">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC01LTEtMS05MDMzMA_49d1116c-81e6-4ccc-8401-158bf642c8a7">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0xLTEtMS03MzUzNQ_635d6f2f-947c-4d91-a9fe-5040c9bc1fc5">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0zLTEtMS03MzUzNQ_4404d39e-26bc-4048-921c-07732cfba6e5">2,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC01LTEtMS03MzUzNQ_4d82d971-22a8-4ca3-9d8e-16fb4634611e">2,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNS0xLTEtMS03MzUzNQ_f36aa3de-cc29-4aa6-ae7d-2309bf682f4f">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNS0zLTEtMS03MzUzNQ_f1bcbc7d-5a0a-497e-9144-9470ebf54735">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNS01LTEtMS03MzUzNQ_29aaf0a1-95d8-4b7a-b1c0-bdcacf81af30">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNi0xLTEtMS03MzUzNQ_80bcedf9-b8cb-47ef-86b1-1bd8c5d4e2e9">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNi0zLTEtMS03MzUzNQ_b918acf3-b303-4345-959e-aaf216fe1c5e">301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNi01LTEtMS03MzUzNQ_62310aae-bb11-458d-b642-772c186ea4bb">308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfOC0xLTEtMS03MzUzNQ_3ae609d7-f026-4375-a2a0-568b2939ceaf">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfOC0zLTEtMS03MzUzNQ_b0f13fee-0a8e-4c92-8bcd-e3f487c5ffc2">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfOC01LTEtMS03MzUzNQ_d410e06d-8640-4f36-89e0-5d234ec845b1">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTAtMS0xLTEtNzM1MzU_8b794bb0-df84-45d3-be82-038de2d8d974">631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTAtMy0xLTEtNzM1MzU_bf6a29ed-8104-46bb-a492-6d91d90de942">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTAtNS0xLTEtNzM1MzU_13d0b2ad-36ba-426d-94ad-53b459822ab4">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTEtMS0xLTEtNzM1MzU_e91ab48f-b2c0-445b-98b4-b92a810646c4">436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTEtMy0xLTEtNzM1MzU_35fa68a3-6efc-4be1-bc5c-cabf8f1f0129">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTEtNS0xLTEtNzM1MzU_89c712ba-1ef6-4a11-af2a-c6eba117fdd1">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, income taxes and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTItMS0xLTEtNzM1MzU_9b155fd0-78d9-4225-ad13-f6ebd4827461">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTItMy0xLTEtNzM1MzU_d232e329-1f52-40a6-840b-06cd9f767915">660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTItNS0xLTEtNzM1MzU_9eb50800-7028-4fbe-ace5-2474649da623">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTMtMS0xLTEtNzM1MzU_75638ca8-2bf2-43e8-836e-d571435c0d38">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTMtMy0xLTEtNzM1MzU_a7e85b6b-0a53-4103-8872-53ae7da35b6b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTMtNS0xLTEtNzM1MzU_a1dc7fb6-ee3f-4b57-83e3-b6cd817f5d0d">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Excess tax benefits from payments under share-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTQtMS0xLTEtNzM1MzU_81adc323-a1ae-4f9a-b175-710567fb31da">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTQtMy0xLTEtNzM1MzU_d1e055fa-fed2-4c56-a0f5-9a90037eee55">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTQtNS0xLTEtNzM1MzU_4b608f60-3321-4e51-b1e5-850f88070144">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product liability-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTctMS0xLTEtNzM1MzU_13c21dd5-53c7-480a-b0db-2ca93f0c3d7e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTctMy0xLTEtNzM1MzU_488dccec-50d1-4c35-9a23-84d44f785633">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTctNS0xLTEtNzM1MzU_0b97ae2b-f2ed-4fec-b0da-3089eff2cd4a">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTgtMS0xLTEtNzM1MzU_181db0fd-39ca-4e96-8992-d8c2db775b36">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTgtMy0xLTEtNzM1MzU_ab893feb-6114-4cd7-b1c9-40ecfe79f53b">414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTgtNS0xLTEtNzM1MzU_b671ebca-ee14-4658-8aea-102dcd551e2f">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Cash Provided by Continuing Operating Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTktMS0xLTEtNzM1MzU_2d1c0935-bb93-4678-930f-13fb3e4a0c47">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTktMy0xLTEtNzM1MzU_eeb9346d-9d20-4e12-808d-1e21e3f20a72">4,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTktNS0xLTEtNzM1MzU_dc6f1064-2e1a-481c-9c6c-2dac3cde2eae">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjEtMS0xLTEtNzM1MzU_7d7d06ba-c6c8-45cb-bee7-8c211211a482">973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjEtMy0xLTEtNzM1MzU_f60354f1-9fa9-4b1e-9aee-64bff5a601c6">1,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjEtNS0xLTEtNzM1MzU_4d8c341e-76f3-47d2-ba48-73b3c83e24e8">769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjMtMS0xLTEtNzM1MzU_eafec5c2-dc9e-4a9f-9b70-68c003bf8825">2,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjMtMy0xLTEtNzM1MzU_382bc0af-d4e0-44b6-81ba-315bc783140c">508</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjMtNS0xLTEtNzM1MzU_d7d933bd-7de3-4301-8dac-3b40db0f9d5f">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjUtMS0xLTEtNzM1MzU_2c8f38bf-f733-4abb-8879-3cdbe0cf996d">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjUtMy0xLTEtNzM1MzU_86364a80-cecd-4e6f-a579-5655f955e1e7">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjUtNS0xLTEtNzM1MzU_1026e1b3-2a85-489a-ae3c-1d12f5af3fbc">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Cash Used for Continuing Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjYtMS0xLTEtNzM1MzU_cd0eb0e7-e522-4b51-9110-25cf260b1415">3,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjYtMy0xLTEtNzM1MzU_35bde159-9de8-4746-a882-a91c04549308">1,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjYtNS0xLTEtNzM1MzU_66b8551f-62e0-478b-b287-3c916e2cf362">1,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMS0xLTEtMTIwMzcw_be9d7a54-3742-41b3-bed1-ef3c2dba933e">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMy0xLTEtMTIyOTgy_b40066fb-259b-4f63-8e7e-beec0e5138df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtNS0xLTEtMTIyOTgy_06cdea4c-9519-41db-b069-ab251db0b51c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in credit facility borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjgtMS0xLTEtNzM1MzU_8f124427-fa60-45f9-98f3-df3a25205099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjgtMy0xLTEtNzM1MzU_d5b50ca0-3afe-4632-a2fe-7b5a6983d117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjgtNS0xLTEtNzM1MzU_4623131d-7495-4f23-9095-d9c96f3518b8">485</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from long-term debt and term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjktMS0xLTEtNzM1MzU_a744a027-73bb-41b8-8032-01a7dfc9ed74">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjktMy0xLTEtNzM1MzU_a0446dfa-70a6-4b63-8d95-8a6dba3d54ee">4,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjktNS0xLTEtNzM1MzU_9ad4d7a9-7a53-4f20-9927-a7040b5639d9">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution from Embecta Corp. (see Note 2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="bdx:ProceedsFromSpinoffTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMS0xLTEtMTAyNTEy_2d857ea0-2754-4398-a5b6-b0658638a0aa">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:ProceedsFromSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMy0xLTEtMTAyNTEy_48962d0f-cdca-46a1-a0d8-ff261d546d88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:ProceedsFromSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItNS0xLTEtMTAyNTEy_8f83e823-1dc9-42fa-9140-b1318227ddc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net transfer of cash to Embecta upon spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="bdx:CashTransferRelatedToSpinoffTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMS0xLTEtMTAyNTEy_8bec0e21-1454-4abe-a09a-6e68d562ba88">265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:CashTransferRelatedToSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMy0xLTEtMTAyNTEy_c71a37fe-459e-44f7-9d1a-7e1efd4e3204">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:CashTransferRelatedToSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtNS0xLTEtMTAyNTEy_ff3ac70d-ce87-48d7-94ff-3df31d8fcf45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of debt and term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMS0xLTEtNzM1MzU_b131774f-0bc3-423f-a104-7fcd00eba7b0">805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMy0xLTEtNzM1MzU_df6ef679-5942-443d-ac72-b3d1ebcfc6c2">5,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtNS0xLTEtNzM1MzU_f39b1488-3d71-4e9d-8151-de369aab1fd0">4,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzEtMS0xLTEtNzM1MzU_3ab0ed42-ab7c-4d87-ba2c-e6104450ce9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzEtMy0xLTEtNzM1MzU_5572dd1f-5ce3-4248-8135-488aec5c9153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzEtNS0xLTEtNzM1MzU_e808c77a-39b3-4d4c-9ce2-4b8cc39c340b">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMS0xLTEtNzM1MzU_ea51ab30-fa43-4969-9e61-dee7d1c0c32a">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMy0xLTEtNzM1MzU_7820b48e-641c-432f-84d1-8d9d010730b4">1,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItNS0xLTEtNzM1MzU_5b9d497b-b346-41d1-9fb2-ee613330ffc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMS0xLTEtNzM1MzU_ca557321-ebe8-4f11-a370-0099ab2fd7bc">1,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMy0xLTEtNzM1MzU_d5a8f855-fdda-4323-9925-a15619398bb0">1,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtNS0xLTEtNzM1MzU_8e7b157d-ef40-462b-afad-98544703e217">1,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzQtMS0xLTEtNzM1MzU_0242a33a-1bd2-424e-93f1-34091470e5c2">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzQtMy0xLTEtNzM1MzU_eb65649a-8fd4-4882-9752-7d25702db74e">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzQtNS0xLTEtNzM1MzU_1f507694-838f-4120-a2d8-9bb0542cfad4">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Cash (Used for) Provided by Continuing Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzUtMS0xLTEtNzM1MzU_bb441706-25be-4891-9e2a-fb98ec2ebcbd">736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzUtMy0xLTEtNzM1MzU_da127f25-8069-4525-b26a-90c4270f44dc">3,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzUtNS0xLTEtNzM1MzU_2e31b051-f4d1-4a1d-beb7-95aa34b152ba">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued Operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMS0xLTEtOTA0MTY_d4da1177-ab7a-45e4-a574-a18efa4311eb">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMy0xLTEtOTA0MTY_a5a5fd87-9279-4e35-aad7-bd576e1fc31f">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktNS0xLTEtOTA0MTY_6507e3e2-359b-46b6-8754-1bba2c265595">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDAtMS0xLTEtOTA0MTY_ccaff83c-e60f-4ac5-a50b-9b816091b1c5">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDAtMy0xLTEtOTA0MTY_e5162487-3798-453a-9752-a2e0f9b54676">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDAtNS0xLTEtOTA0MTY_7826537a-ee8d-44c7-8f85-d7de8ddfbee7">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDEtMS0xLTEtOTA0MTY_b75f2e66-fe8a-43be-b396-1b572636bf1f">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDEtMy0xLTEtOTA0MTY_6b06f8cb-39d1-4139-bbc6-dab4dd59c743">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDEtNS0xLTEtOTA0MTY_fb4438af-6675-4687-9685-6b21b46736ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Cash Provided by Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDItMS0xLTEtOTA0MTY_019993a3-c5b1-4349-b0d2-d547951c0b96">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDItMy0xLTEtOTA0MTY_0deaf973-214e-47d1-9e57-7c631a1ae200">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDItNS0xLTEtOTA0MTY_f12fb87f-62ba-4f52-aa27-f3a90c628d6a">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzYtMS0xLTEtNzM1MzU_9940d3ce-2496-4e1b-8cd3-46ed4539069b">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzYtMy0xLTEtNzM1MzU_ff5ead18-d60b-48cf-a98f-da7b100ba9e5">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzYtNS0xLTEtNzM1MzU_974b03ff-be0f-4b83-aceb-e6efd8a28234">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (Decrease) Increase in Cash and Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzctMS0xLTEtNzM1MzU_8ed37445-d605-435c-b915-7f0d4c4a2933">1,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzctMy0xLTEtNzM1MzU_cfe1ba1b-ab7b-4324-a414-185d7fec642a">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzctNS0xLTEtNzM1MzU_ce8f8ef5-6a4b-4abf-ae3d-35bffaeb90dc">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening Cash and Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzgtMS0xLTEtNzM1MzU_42e32abf-9253-4e10-b47e-fb7bc4a5ea82">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzgtMy0xLTEtNzM1MzU_270b90fd-359a-4ea9-a093-240ee8bdcd28">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzgtNS0xLTEtNzM1MzU_1a4802fd-bfb3-456c-9fbf-36c1ab003926">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing Cash and Equivalents and Restricted Cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMS0xLTEtNzM1MzU_2b4bc647-f455-4473-8f59-56cd7ce99c46">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMy0xLTEtNzM1MzU_b4e2572d-a2eb-482d-913a-d5cfb1b87b54">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktNS0xLTEtNzM1MzU_1eb25635-8887-4f08-9281-aaef72cedde6">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:323pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_73"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Millions of dollars, except per share amounts or as otherwise specified</span></div><div><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0ODQ_dee6c126-6cba-4364-8b16-d2e6da4838da" continuedAt="i2199a4ddd428477f96e825f6d8a3d051" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i2199a4ddd428477f96e825f6d8a3d051" continuedAt="idd2e53fb3d264a1a934c502e9fd5deab"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0Mzg_e96f15fc-b94d-4d73-ad5e-6e3ae6e452ad" escape="true"><div style="margin-top:5pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the "Company" or "BD") have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company and the historical results of the Diabetes Care business that was contributed in the spin-off have been reflected as discontinued operations in the Company&#8217;s consolidated financial statements for all periods prior to the spin-off date. Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet as of September 30, 2021. Additional disclosures regarding the spin-off are provided in Note 2.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NDY_1f09dd37-e5d3-45f3-b279-ceb7a1c5d1da" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the Company&#8217;s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzOTU_6428eb77-a01f-428c-a7e8-2dfca80a106b" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MjQ_0aed000d-5852-4206-97ad-bc919f93cf4c" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash restricted from withdrawal and usage and largely represents funds that are restricted for certain product liability matters assumed in the acquisition of C.R. Bard, Inc. ("Bard"), which are further discussed in Note 6.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzODk_e4fee41d-a39b-453d-bb56-58f3e762e666" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#8217;s estimate of expected credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is  not collectable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NTQ_d5823119-66a5-4096-8714-5542a8fecd62" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MDU_65b3ebf5-9a56-4e9e-b7ee-418f556b27c6" continuedAt="i765d0f5670fa4bd7ba6500bedba9536f" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="idd2e53fb3d264a1a934c502e9fd5deab" continuedAt="i16a7169c67f743ecaee771eff5232900"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i765d0f5670fa4bd7ba6500bedba9536f">which range from <ix:nonNumeric contextRef="i3d85f871f7b24bc5989ba58c61917188_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI1Nw_eb493ac4-f5c5-42f0-b70e-eb9e7542e475">20</ix:nonNumeric> to <ix:nonNumeric contextRef="i72d7bdb2703948fb9aea56ffc9e2f630_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjA0NzMxMzk2NzY3OA_0d5142e7-08f7-4ce1-95e3-3c02dd0fe667">45</ix:nonNumeric> years for buildings, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd">four</span> to <ix:nonNumeric contextRef="i1a48157deb98419da4fff13ef30cc91e_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjA0NzMxMzk2NzY4MA_9d3a986f-31a5-4993-913b-803643d8e435">13</ix:nonNumeric> years for machinery and equipment and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1">one</span> to <ix:nonNumeric contextRef="i73746dfe5c0f4de7970ccce7ad10430a_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjA0NzMxMzk2NzY3OQ_92edf15d-7516-480f-9484-3f66292dbbd2">20</ix:nonNumeric> years for leasehold improvements.</ix:continuation> Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjQyMA_fa767e9c-8d89-4e06-ae7b-0bf3d4bf4237">672</ix:nonFraction> million, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjQyNA_15f6ff76-05e1-4dad-888e-91eb9b5b4c28">689</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjQzMQ_affe5ff7-482d-414b-807b-ff62a34a3f1b">608</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in fiscal years 2022, 2021 and 2020, respectively.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzOTc_5c92cedd-1140-45c4-a901-aaad57e43625" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unamortized intangible assets include goodwill that arises from acquisitions of businesses. The Company reviews goodwill for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  The Company&#8217;s reporting units generally represent one level below reporting segments. The Company reviews goodwill for each reporting unit by comparing the fair value of the reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2022 indicated that all identified reporting units&#8217; fair values exceeded their respective carrying values. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from <ix:nonNumeric contextRef="i29f71c0bff93492c9a06e0d87133987e_D20211001-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzcwNA_8bb0e60e-f70f-4c73-8936-a50cf4f5cf8a">15</ix:nonNumeric> to <ix:nonNumeric contextRef="if83533f337ff4fffadbe9a69dc3a40cc_D20211001-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzcxMA_d84ca6b2-57f6-4c89-8ee5-fde78efc4b4c">20</ix:nonNumeric> years, using the straight-line method. Customer relationship assets are generally amortized over periods ranging from <ix:nonNumeric contextRef="i50001881e1d74dcdb3045e71518d4167_D20211001-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzgzMg_d1e42004-7f46-4014-9edb-fa75d591527a">10</ix:nonNumeric> to <ix:nonNumeric contextRef="icb8199c4ea0048a5b80be3d9e50c0d1d_D20211001-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzgzOA_d6aa44d2-ef64-47e9-9df4-8cee56906773">15</ix:nonNumeric> years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d">one</span> to <ix:nonNumeric contextRef="id34e1facad0e439181f5dcf5d5566e02_D20211001-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwNg_4a6a4251-862b-4313-bf64-230d6133f4ca">40</ix:nonNumeric> years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#8217;s carrying value exceeds its calculated fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MTE_ac5b7f1b-1cf4-473f-abfc-2502d11b7f97" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, foreign subsidiaries&#8217; functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates.  The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NjQ_93621524-b8e2-4189-afc4-ee733a248aa7" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from product sales when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized upon customer acceptance of these installed products. Revenue for certain service arrangements, including extended warranty and software maintenance contracts, is recognized ratably over the contract term. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Variable consideration such as rebates, sales discounts and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices, and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease transactions with customers are evaluated and classified as either operating or sales-type leases. Generally, these arrangements are accounted for as operating leases and therefore, revenue is recognized at the contracted rate over the rental period defined within the customer agreement.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i16a7169c67f743ecaee771eff5232900" continuedAt="idb370bf4c4b34033b10e6d4f878884b2"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the Company's accounting for revenue recognition are provided in Note 7.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers its shipping and handling costs to be contract fulfillment costs and records them within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and administrative expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping expense was $<ix:nonFraction unitRef="usd" contextRef="ic33b9e6159d048938c04eefaef08044d_D20211001-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjk5OA_a2415480-3560-4883-a897-53895aed5842">751</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4396e0c37dc446598a1bfa55a31434e6_D20201001-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNzAwMg_948515c6-9151-4d88-8f9a-6af714ba7e68">641</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i14247198e9224028bedb55ce3b8f7e27_D20191001-20200930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNzAwOQ_fc4093b7-b264-4921-96a9-272c845c7590">538</ix:nonFraction> million in 2022, 2021 and 2020, respectively. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0ODY_37b38d10-2b63-44bc-a1ea-b71e56d7e47e" continuedAt="i11b671f1d85f49b98e71b51119862106" escape="true">Contingencies</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i11b671f1d85f49b98e71b51119862106" continuedAt="ica722e51f4974d588ed77f568fbdbba1">The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries). </ix:continuation> Additional disclosures regarding the Company's accounting for contingencies are provided in Note 6.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MzM_baf92c66-0e8e-4a23-bd70-c6e85ae9b135" continuedAt="i3f85dc50165a41eca7912cab94b6967a" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f85dc50165a41eca7912cab94b6967a">All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met. Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows. Cash flows for all other derivatives, including undesignated hedges, are classified in the same line item as the cash flows of the related hedged item, which is generally within operating or financing activities.</ix:continuation> Additional disclosures regarding the Company's accounting for derivative instruments are provided in Note 14.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzOTI_bd726176-bb18-4673-861f-64f140786e55" escape="true"><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reviewed its needs in the United States for possible repatriation of undistributed earnings of its foreign subsidiaries and continues to invest foreign subsidiaries earnings outside of the United States to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. As a result, the Company is permanently reinvested with respect to all of its historical foreign earnings as of September 30, 2022. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable because of the complexities associated with its hypothetical calculation. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Additional disclosures regarding the Company's accounting for income taxes are provided in Note 17.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act was enacted on December 22, 2017 and subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to account for its GILTI tax due as a period expense in the year the tax is incurred.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="idb370bf4c4b34033b10e6d4f878884b2"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MTY_4b29e5bf-c58d-45bb-bdda-3d4a3ba0beeb" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share are computed by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In computing diluted earnings per share, only potential common shares that are dilutive (i.e., those that reduce earnings per share or increase loss per share) are included in the calculation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NzM_f01044f4-a77c-425b-8e98-984a30574c84" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#8217;s fair value measurements are provided in Notes 10 and 15.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212; Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Level 2 &#8212; Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Level 3 &#8212; Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NzQ_9243f7e6-e52d-402c-b331-66cd025b2ae6" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.</span></div></ix:nonNumeric></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_1467"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18zMjk4NTM0ODk1ODEz_b13ef1cb-d8d0-4d97-a9fe-d161a750238c" continuedAt="if1fbc349bc1c4275b2254f69cdedcb26" escape="true">Spin-Off of Embecta Corp.</ix:nonNumeric></span></div><ix:continuation id="if1fbc349bc1c4275b2254f69cdedcb26" continuedAt="i4b8a71388aa147bc97b1db573b6270f1"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (&#8220;Embecta&#8221;) through a distribution of Embecta&#8217;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;) to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes.  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embecta&#8217;s distributions on March 31, 2022 to the Company in connection with the spin-off included the issuance of $<ix:nonFraction unitRef="usd" contextRef="i55f01eb74e224d3b859c08b736035bcc_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjQ0NTEw_4f1ddbf8-0e14-4c96-9528-873543b4135b">200</ix:nonFraction>&#160;million of senior unsecured notes to the Company and a</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash distribution of approximately $<ix:nonFraction unitRef="usd" contextRef="i779c08f21c7145b69a3c73a02acd692f_I20220331" decimals="-6" name="bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjMyMDMy_69564494-aa3c-412e-96f3-8c3dffa6bba8">1.266</ix:nonFraction>&#160;billion. Additional disclosures regarding the various financing transactions entered into by Embecta and related to the spin-off are provided in Note 16.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#8217;s consolidated statements of income during the fiscal year ended September 30, 2022 as a result of these agreements were immaterial.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4b8a71388aa147bc97b1db573b6270f1" continuedAt="i560506bab2bb46b3a8a030b3f9e0d23a"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment) that was contributed to Embecta in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#8217;s consolidated financial statements for all periods prior to the spin-off date of April 1, 2022.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjM0OTc0_b91b4428-f11e-4c5f-9b97-1c2d13782b34" continuedAt="ice7f83a8ee79482cb24b1714a4fbbe82" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as follows:</span></ix:nonNumeric></div><div style="margin-top:9pt"><ix:continuation id="ice7f83a8ee79482cb24b1714a4fbbe82" continuedAt="id7dc6cd9f9fb4b78b99501be2aae311d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:54.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8yLTEtMS0xLTg4Njc1_ff670dd8-8ffb-4693-8204-0939feb8fd47">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8yLTMtMS0xLTg4Njc1_068cd45e-ac7d-4314-94a8-c8374d017cd1">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xLTUtMS0xLTg4NzA0_e06168c9-bc8e-4ce6-bfab-b4157a606ee2">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8zLTEtMS0xLTg4Njc1_dbeed85c-c8ff-425a-938c-d1b3e1d4bb8e">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8zLTMtMS0xLTg4Njc1_0578cc25-fb5a-4170-81c3-86e087189c93">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8yLTUtMS0xLTg4NzA0_3f761a4b-1225-4c05-bbd1-f5866e1ec8de">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV80LTEtMS0xLTg4Njc1_3a5b3aad-1b37-435d-86d6-b2774beb871d">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV80LTMtMS0xLTg4Njc1_03656eec-0324-44ec-a7ae-cc84c7bf8d67">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8zLTUtMS0xLTg4NzA0_4fc679fe-efcb-4557-ab3b-a7ca2a712eac">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTEtMS0xLTg4Njc1_b768eccb-07e0-450d-89d0-4bfc8f4109e2">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTMtMS0xLTg4Njc1_3333fe75-539c-40c6-8dd8-fb6fdafb815d">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV80LTUtMS0xLTg4NzA0_f170253e-f90a-4bcd-9995-01c104e3b7ed">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTEtMS0xLTkxNjkx_f064d35a-89e5-4be4-9e68-54aaead7a1b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTMtMS0xLTkxNjkx_7cdacda6-07b0-47b6-9053-4815bbdf551e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTUtMS0xLTkxNjkx_29c9ca11-e1cf-4a61-b4d8-af3c9b8e9901">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" sign="-" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV83LTEtMS0xLTg4Njc1_3903f618-a067-435b-bbdd-d10c926011dc">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" sign="-" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV83LTMtMS0xLTg4Njc1_bfb0071a-5745-4b9f-9cde-bd1f103bc931">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV82LTUtMS0xLTg4NzA0_424aae3c-04b0-4b54-bc50-7c209fa2958a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV84LTEtMS0xLTg4Njc1_adc20806-06f1-43eb-b87e-48b9a43a998e">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV84LTMtMS0xLTg4Njc1_92b7a680-959d-48dd-b94f-e0b2bb6976bf">569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV83LTUtMS0xLTg4NzA0_2d25f32e-0887-4b4f-9188-7704936a6657">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV85LTEtMS0xLTg4Njc1_2bd0b600-ab02-4e3a-aab6-0922f9d03bfa">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV85LTMtMS0xLTg4Njc1_5c03cc2a-ffc9-4fe6-b124-162a8da04828">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV84LTUtMS0xLTg4NzA0_b3910d9d-c01c-4894-9c26-9363bc8940d7">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMC0xLTEtMS04ODY3NQ_dafed2e9-cf28-4d20-bc5a-02c0010184dd">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMC0zLTEtMS04ODY3NQ_703ef49e-3fd2-4f90-9cac-09039db87b19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV85LTUtMS0xLTg4NzA0_bb469685-d31e-4151-bf47-45643f85dc30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMi0xLTEtMS04ODY3NQ_7ea353d9-555e-4850-b8e1-e4aa4060fe1c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMi0zLTEtMS04ODY3NQ_ed6a470d-46b4-4291-889b-7aabb91be3c6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMS01LTEtMS04ODcwNA_cf322216-b262-4bf2-9207-291e48e210c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMy0xLTEtMS04ODY3NQ_59d85c86-e965-4f8a-8efb-9b1018471fa2">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMy0zLTEtMS04ODY3NQ_36bb72de-6883-46ca-9385-ab2b89e989ef">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMi01LTEtMS04ODcwNA_f8df7899-3a5c-4637-b468-f37754d6d8bb">571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNC0xLTEtMS04ODY3NQ_7beb30b5-6501-4f20-b1e6-7e716d6d17e7">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNC0zLTEtMS04ODY3NQ_0c090903-439e-4306-9233-84ab41300742">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMy01LTEtMS04ODcwNA_54bb6ba2-a965-417c-ab79-bd826d8670d8">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNS0xLTEtMS04ODY3NQ_95c2420b-19e7-42ef-8238-05229d13aede">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNS0zLTEtMS04ODY3NQ_958e9bc8-3b8c-4484-b2b7-9d010e8939fb">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNC01LTEtMS04ODcwNA_438d706b-83ff-4a26-acb8-ebd71ca10a04">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7dc6cd9f9fb4b78b99501be2aae311d" continuedAt="i81477a0ec3c444aa998f90b3bcdd4a4b">   </ix:continuation>&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended September 30, 2022, the Company incurred </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjQ3ODIx_2f5d7a59-514c-4643-87a4-2f68e5093387">30</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of expense which included costs to execute the spin-off and other costs for related residual activities. These costs are recorded within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income from Discontinued Operations, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended September 30, 2022. Separation costs incurred by the Company prior to the spin-off date, including those for consulting, legal, tax and other advisory services associated with the spin-off, were previously recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are now included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from continuing operations were recast to reflect previously eliminated intercompany transactions that occurred between BD and Embecta and that resulted in a third party sale in the same period. The impacts of these transactions to Embecta are also reflected as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i560506bab2bb46b3a8a030b3f9e0d23a"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><ix:continuation id="i81477a0ec3c444aa998f90b3bcdd4a4b"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet at September 30, 2021:   </span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"><tr><td style="width:1.0%"></td><td style="width:79.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.881%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8yLTEtMS0xLTg4NzM2_5cea9d00-a84c-40c1-b26b-1bde36be07e0">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8zLTEtMS0xLTg4NzM2_479c4813-5964-4247-94f3-ab31124565bb">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF80LTEtMS0xLTg4NzM2_129e3c40-5a86-4181-a2c4-c92b8035e3b7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets of Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF81LTEtMS0xLTg4NzM2_0f1d5812-ad4b-427e-a55f-4484fd9b620a">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF82LTEtMS0xLTg4NzM2_b90657f6-c14d-42d7-95a7-d14a152a40f3">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and Other Intangibles, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF83LTEtMS0xLTg4NzM2_d8defe68-7ad5-4fc5-bb8f-2edb6f7c7c65">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xMS0xLTEtMS04ODczNg_ce29639e-08d5-4ec7-8bc0-fcc21b8dfe02">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Assets of Discontinued Operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xMi0xLTEtMS04ODg3Mg_af640346-3ce5-40c2-aed5-85d8c971d47e">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xNC0xLTEtMS04ODczNg_c47ee0fa-fc4e-4ec0-aec2-225245da4c74">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xNS0xLTEtMS04ODczNg_555845e6-2c01-440c-962f-a2be7f3a90b7">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xNi0xLTEtMS04ODczNg_962fae31-d06c-4df8-9066-cd593765441e">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities of Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xOC0xLTEtMS04ODczNg_4348443a-7b78-4042-9b0c-6edd2e3c4b6f">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xOS0xLTEtMS04ODczNg_92792a0e-2625-4b39-bfb6-47a1914599ba">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Liabilities of Discontinued Operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8yMC0xLTEtMS04ODg3Mg_1ad301ba-0f51-4f88-8eeb-4e7d5a100a51">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its distribution of net liabilities to Embecta as an increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retained earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amount recorded reflected the carrying amounts, as of April 1, 2022, of the net liabilities distributed and included $<ix:nonFraction unitRef="usd" contextRef="i5c2d5aa49a1e44eaa4bf7f704ff1fbb1_I20220401" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjM0ODcx_f8b5e401-6544-4fa0-9be0-91dd0ebcf814">1.650</ix:nonFraction>&#160;billion of debt issued by Embecta, as further discussed above and in Note 16, as well as $<ix:nonFraction unitRef="usd" contextRef="i296c4706cc7a49a38687e154af3f932b_D20220401-20220401" decimals="-6" name="bdx:CashTransferRelatedToSpinoffTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjQ4MDU3_ff6b95dd-dae4-4556-91c7-22ec3f2d8469">265</ix:nonFraction>&#160;million of cash. The Company also recorded a net decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i2a2da253f41c4177934228a9aaffc195_D20220401-20220401" decimals="-6" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjM0OTM2_0b692ffa-3a7b-4f68-a1f4-b81577acdf19">251</ix:nonFraction>&#160;million to derecognize foreign currency translation losses which were attributable to Embecta.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83OS9mcmFnOjQ5ZDk2ZWYzMGM2YTQwODI4OTYyYTQzMDY1YTVhYTQ1L3RleHRyZWdpb246NDlkOTZlZjMwYzZhNDA4Mjg5NjJhNDMwNjVhNWFhNDVfNTMyOA_a3b3e210-5f89-4c49-a6e8-60abdd8826e6" continuedAt="i5b0f4320abab4fccbf5e1bd2437d75ce" escape="true"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83OS9mcmFnOjQ5ZDk2ZWYzMGM2YTQwODI4OTYyYTQzMDY1YTVhYTQ1L3RleHRyZWdpb246NDlkOTZlZjMwYzZhNDA4Mjg5NjJhNDMwNjVhNWFhNDVfNTMyOQ_61b3a80f-6121-41d5-84a6-43954e8975aa" continuedAt="ic7789381ede04fe69bd99b52729c718c" escape="true">Accounting Changes</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i5b0f4320abab4fccbf5e1bd2437d75ce" continuedAt="i829182096b3146c68a714d0c61c42c64"><ix:continuation id="ic7789381ede04fe69bd99b52729c718c" continuedAt="ibd7f848ab2954954a009fb05763be1dc"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Principles Adopted</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2022, the Company early-adopted an accounting standard update issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), which requires an entity to apply the provisions of Accounting Standard Codification Topic 606, "Revenue from Contracts with Customers,&#8221; (&#8220;ASC 606&#8221;) when recognizing and measuring contract assets and contract liabilities acquired in a business combination. The Company&#8217;s adoption of this accounting standard update for business combinations that occurred during fiscal year 2022 did not have a material impact on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard which requires earlier recognition of credit losses on loans and other financial instruments held by entities, including trade receivables.  The new standard requires entities to measure all expected credit losses for financial assets held at each reporting date based on historical experience, current conditions, and reasonable and supportable forecasts.  The Company&#8217;s adoption of </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i829182096b3146c68a714d0c61c42c64"><ix:continuation id="ibd7f848ab2954954a009fb05763be1dc"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">this accounting standard on October 1, 2020, using the modified retrospective method, did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Principles Not Yet Adopted</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued a new accounting standard update that requires additional qualitative and quantitative disclosures surrounding supplier finance programs intended to help investors better consider the effect of these programs on a company's working capital, liquidity, and cash flows over time. This update is effective for fiscal years beginning after December 15, 2022, including interim periods, except for the disclosure. Early adoption is permitted. The Company is currently evaluating the impact this update will have on its disclosures.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNjA0NzMxMzk3NDY0OA_4c5a122f-efe8-4405-bc5c-525c4ee9a93a" continuedAt="ia29a5e8c2cd9428ba4ad075c1a751f2e" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="ia29a5e8c2cd9428ba4ad075c1a751f2e" continuedAt="ie9e76040e9d548f6bbf79cc0bc03f9f2"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDUxNA_250d7648-b752-4ced-896b-32e182e5ee19" continuedAt="i5e4790ba3bd943f39e3e73e21a4fd600" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders&#8217; equity were as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.737%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbef8604488846208cd4c70898654711_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi0xLTEtMS03MzUzNQ_b02fee57-6edc-4165-98a4-746acdbb21ae">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e1811b72dc462ca90c421e6c5b1693_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi0zLTEtMS03MzUzNQ_bf1e0112-33ec-455e-9ac7-89135d7bce73">16,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ac652372b54cc2b0a28ed29bff1415_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi01LTEtMS03MzUzNQ_662f777c-9ae2-4ffa-8bc2-46e2e906bf08">12,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a86003dc74c1f8a87c4d5eea38dc7_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi03LTEtMS03MzUzNQ_6836863f-24f4-42e2-9740-48f9c3585410">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6cd3830836d74dc384331da111f121e9_I20190930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi05LTEtMS03MzUzNQ_794673f8-05b5-484b-894f-7adc849b9f9b">76,260</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd3830836d74dc384331da111f121e9_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi0xMS0xLTEtNzM1MzU_2b30c29d-f1a2-4128-85e1-2d7134ac86d7">6,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMy01LTEtMS03MzUzNQ_1c74067d-3c5e-4e83-acd8-1ffa40aa82b1">874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($<ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNS0wLTEtMS03MzUzNS90ZXh0cmVnaW9uOmEwYjIxZTk5YzFjYzRkZjhiNDQ3MjNhMGIyYjNjNDMwXzEy_42f86689-e91f-4eef-8bba-51c054340886">3.16</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNS01LTEtMS03MzUzNQ_9852bc9e-c060-4aed-8dd0-14e7d1f3763d">888</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNi01LTEtMS03MzUzNQ_8ac28522-8299-4274-9cd0-5b8227e5a18b">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares converted to common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe86ad3207e44eaab5c717b3adfdfd5_D20191001-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOC0xLTEtMS03NDQ4Ng_5faaf0b1-1dba-4e2f-9377-6179e16d3eab">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOC0zLTEtMS03NDQ4Ng_12972e77-a910-4f44-aeab-1ca15ea13de1">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public equity offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe86ad3207e44eaab5c717b3adfdfd5_D20191001-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOS0xLTEtMS03NDQ4Ng_633ed340-9d27-499f-8ee6-8ecc216ba794">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOS0zLTEtMS03NDQ4Ng_a34c94df-8497-495f-8c55-a13f55190c5c">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNy0zLTEtMS03MzUzNQ_d36bb279-6da5-4d09-b570-f29d544bf684">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNy05LTEtMS03MzUzNQ_f706d8ad-f127-445a-a06e-1d07c2b8a32e">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNy0xMS0xLTEtNzM1MzU_40f21b45-5c38-4947-91dd-2b19801a461e">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOC0zLTEtMS03MzUzNQ_bde9780f-4110-4db5-ba18-895d0f1ee1e8">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOS05LTEtMS03MzUzNQ_de5b8ae5-a64a-4bae-a384-ef016061bae3">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695e557a6ab54dc6a2b984723d1f5b0d_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtMS0xLTEtNzM1MzU_c583c8c3-b656-4559-b4c9-2fab40ea74e3">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5190a2663a43e8b69d8a097c812132_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtMy0xLTEtNzM1MzU_2a982d5a-d1a0-46bf-bbed-0190a2cc3fb3">19,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib70db9b9f4a14ac4a63c9c3d7e73bb79_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtNS0xLTEtNzM1MzU_7f059ee2-d144-4620-875a-723da37d17f7">12,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec7a113781f4fb4aa433f0602bfde3f_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtNy0xLTEtNzM1MzU_b55e5171-713c-4480-a814-a14155c7da05">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id25b1e6a88754b688a61cedebd045efe_I20200930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtOS0xLTEtNzM1MzU_81411d1f-504d-4abc-b7aa-de5ca9d0786f">74,623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id25b1e6a88754b688a61cedebd045efe_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtMTEtMS0xLTczNTM1_8e249e48-88e0-4565-a9a2-102fb162354a">6,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTItNS0xLTEtNzM1MzU_82848d5a-15ae-4bef-b2c6-5d9a256c97c5">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($<ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyZDRkYmEzMTlhZDU0MzI2OWE4ZmZlOGQ5ZjIzYTk2NF8xMg_ed7824a8-4d62-4836-9739-8976f7fcfe88">3.32</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTQtNS0xLTEtNzM1MzU_5096ba69-b199-41a3-8b11-a5b85aae7733">958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTUtNS0xLTEtNzM1MzU_772e0633-3eaf-46a6-95ee-83e66ebdefe8">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTktMy0xLTEtNzM1MzU_3e686dc9-4d93-40aa-a010-8e51f1cfb232">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTktOS0xLTEtNzM1MzU_1a8a7f05-063e-41a8-8a41-a54d291ad527">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTktMTEtMS0xLTczNTM1_08af3f8f-9ba1-41ae-b4b9-ed0290eeb259">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjAtMy0xLTEtNzM1MzU_c3d13b29-b908-4736-80f6-f845425d3a05">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjEtOS0xLTEtNzM1MzU_35c94542-d063-4ced-9409-3f016ce657db">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMy0xLTEtNzQ1NDM_b22cd731-75ab-427a-aad1-16b43deed251">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItOS0xLTEtNzQ1NDM_41119f51-ac56-414a-8f77-adf91fb288be">6,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMTEtMS0xLTc0NTQz_47e4ba1d-23f2-47fe-85e1-ff4b9ae3be73">1,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of change in accounting principle (see Note 3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a446f7eaf1a4201a25d9a14323ee4b7_D20201001-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjMtNS0xLTEtNzQ1NDM_9601d546-f448-4279-8caa-24e59bf3e62b">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3278eb4fc9fd4ab78a70936efe09c5ff_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMS0xLTEtNzM1MzU_b07cd145-0a79-4a1f-92fe-1092b45d61e0">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20eaab7a249a452bba784a0d97d26368_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMy0xLTEtNzM1MzU_8bcdbcb3-e8b5-426b-99e3-f17e12045187">19,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bcfc9afd93e4406acde7e87e4c91af9_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItNS0xLTEtNzM1MzU_ea4e8d10-35dd-44cf-8839-8e177d245f1c">13,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if823837bff994f53b3a5363db592ef45_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItNy0xLTEtNzM1MzU_8a92d98b-87b8-444e-a25e-1d8b3da63cba">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if05103d8441f420687709be717eefd05_I20210930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItOS0xLTEtNzM1MzU_fd1b0a48-8fe4-4e7e-b89c-84ca9f0c9e25">80,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05103d8441f420687709be717eefd05_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMTEtMS0xLTczNTM1_6c4e479a-6e33-4316-a1a2-5599aa090262">7,723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjMtNS0xLTEtNzM1MzU_d38e109c-ea99-464d-93e0-ce6fbaced37f">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($<ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjUtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpkMmQzYjE3YWJmMjQ0NzA4OGQyNWNhMjE3NmYwOThiZl8xMg_0952d7a2-01b2-439f-90da-00cef407c6f2">3.48</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjUtNS0xLTEtNzM1MzU_6138c245-5910-485e-87e6-911f0ee466d0">992</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjYtNS0xLTEtNzM1MzU_f023886f-5fde-4d68-adf4-01fa617d7e00">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctMy0xLTEtNzM1MzU_946c4ead-021c-41db-9a11-76b543a89519">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctNS0xLTEtNzM1MzU_4361e8e0-b428-463d-8997-8af8b9e43c81">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctOS0xLTEtNzM1MzU_8663424c-01fd-43d8-80c6-7a79e9074661">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctMTEtMS0xLTczNTM1_54387096-a6be-4b6c-8474-e655b084ab21">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjgtMy0xLTEtNzM1MzU_44fa2a46-3a23-4075-9640-57d230eb8dd8">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930" decimals="-3" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjktOS0xLTEtNzM1MzU_ecd23a70-4655-4917-b3a4-bc0be6009a2d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzAtMy0xLTEtNzM1MzU_6cd8e92b-9fbe-48b7-a9e6-4a97d2f5e241">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzAtOS0xLTEtNzM1MzU_8f071122-0bfa-4f67-add5-ed6ea124419d">2,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzAtMTEtMS0xLTczNTM1_b9b29271-8082-45a6-9c25-4f39a751752c">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off of Embecta (See Note 2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930" decimals="-6" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzMtNS0xLTEtODkyNjM_9018f531-d665-4d0c-bfbc-125f6c281d66">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3372701f199e43b4a16aa17859655059_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItMS0xLTEtNzM1MzU_c615b6ab-8693-468f-b24f-458f8b218449">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dfe8ef22e494c38b101738e66ab9aeb_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItMy0xLTEtNzM1MzU_78be678e-6fca-44d9-b046-3a84773873f8">19,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b63e5f040e4730acddca14376db61c_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItNS0xLTEtNzM1MzU_e974fbcb-9600-42bb-b820-c907af5fa3b1">15,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id268265b76c749d98058721c42dd6cb5_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItNy0xLTEtNzM1MzU_ac781160-9fe6-4c8a-9e45-ac3a621c4fd6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifbfab1f7a9b4460bbb2f2a22a0ed163b_I20220930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItOS0xLTEtNzM1MzU_472c56bb-e5d4-4cda-bbf9-62dd7e542813">81,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbfab1f7a9b4460bbb2f2a22a0ed163b_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItMTEtMS0xLTczNTM1_6bc94031-ba26-471d-9bea-a0a476fa6a35">8,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e4790ba3bd943f39e3e73e21a4fd600" continuedAt="i2df21fa754f24c93a38af90ef6e905fb">(a)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt"><ix:continuation id="i2df21fa754f24c93a38af90ef6e905fb">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.</ix:continuation>  </span></div></ix:continuation><div style="margin-top:1pt;padding-left:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie9e76040e9d548f6bbf79cc0bc03f9f2" continuedAt="ica83415c107740c794e46fd136f94e27"><div style="margin-top:9pt;padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal year 2022, the Company executed an accelerated share repurchase (&#8220;ASR&#8221;) agreement in which <ix:nonFraction unitRef="shares" contextRef="ia491d443536f43b2af506a739dee74b6_D20211001-20220930" decimals="-3" name="bdx:TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzI2Nw_b50890b9-667b-4eba-9c1c-d550e580c051">1.953</ix:nonFraction>&#160;million common shares were repurchased and delivered in fiscal year 2022 for $<ix:nonFraction unitRef="usd" contextRef="ie55426e09f694ffa9902855677354b87_I20220930" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzI4Mg_d0bd894b-1be4-489e-a12c-218ec9ed1858">500</ix:nonFraction>&#160;million, which was recorded as an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, the Company executed <ix:nonFraction unitRef="agreement" contextRef="i6e686d9a958e4abfa40bfcc0f5d10cc0_I20210930" decimals="INF" name="bdx:NumberOfTransactions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzQxMw_f061b682-d82e-4ce9-944c-e2fc365a072c">two</ix:nonFraction> ASR agreements to repurchase common shares totaling $<ix:nonFraction unitRef="usd" contextRef="i6e686d9a958e4abfa40bfcc0f5d10cc0_I20210930" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzI5Nw_a4677e89-bced-42ac-b590-706768b2578a">1.250</ix:nonFraction>&#160;billion, of which $<ix:nonFraction unitRef="usd" contextRef="i2c6dfb0a55d44433a2844ec28c42f5aa_D20201001-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzMxMw_41ce9bf4-2027-47b8-9b96-6d4b098b274b">1.100</ix:nonFraction>&#160;billion settled in fiscal year 2021 and $<ix:nonFraction unitRef="usd" contextRef="i87fdf496dd9c4a699a19e0513d7508e2_D20211001-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzMyOQ_188ca0d8-64e0-4d03-9a88-c3354009d3a8">150</ix:nonFraction>&#160;million settled in fiscal year 2022. Total shares delivered in 2021 under the ASR agreements were <ix:nonFraction unitRef="shares" contextRef="i2926409bcc984aedaa96af46597e2232_D20201001-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM0Mw_c258ce0a-ac25-489b-8b4a-a65d762482bc">4.577</ix:nonFraction>&#160;million shares. At September 30, 2021, the pending delivery of <ix:nonFraction unitRef="shares" contextRef="ia491d443536f43b2af506a739dee74b6_D20211001-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM1OA_ddb9c52c-4cef-4338-bd07-461aa1ca5ac4">462</ix:nonFraction>&#160;thousand shares on one of the agreements was reflected as a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital in excess of par value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to recognize a net share-settled forward sale contract indexed to the Company's own common stock. Upon final settlement of the repurchase agreement and the forward sale contract during the first quarter of fiscal year 2022, the final settlement amount was recorded as an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and an offsetting increase to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Capital in excess of par value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also repurchased approximately <ix:nonFraction unitRef="shares" contextRef="i7dee112885e048f6a1cef87525afc79a_D20201001-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM3Mg_0e205325-b4c6-4e56-adc4-13f212e263c8">2.066</ix:nonFraction>&#160;million shares of its common stock during fiscal year 2021 through open market repurchases, which were recorded as a $<ix:nonFraction unitRef="usd" contextRef="i332d46aaf70f439cb962e214fd3556a0_D20201001-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM4Nw_4203c97b-5cbc-4863-a67f-500bbb6b58b3">500</ix:nonFraction>&#160;million increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The share repurchases discussed above were made</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="i4ad38254f42f4c66b77c1874165accec_I20130924" decimals="-6" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNjA0NzMxMzk3NDY2OA_d0bf4ffb-d145-4647-b914-9ca6ef62b4f5">10</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares, which has been fully utilized, and a repurchase program authorized by the Board of Directors in November 2021 for up to an additional <ix:nonFraction unitRef="shares" contextRef="i9ab8c2436670412a85779aa99a37f277_I20211130" decimals="-6" name="bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzQwMQ_2636c4de-ae5b-47cd-9d56-c65dfb4b132e">10</ix:nonFraction>&#160;million shares of BD common stock, for which there is no expiration date.</span></div><div style="margin-top:9pt;padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common and Preferred Stock Conversions and Offerings</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with their terms, the Company's <ix:nonFraction unitRef="shares" contextRef="i50429935632644db80c7dc6d4f800a3c_I20200501" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMTkwOA_c8bcc6aa-be25-4f77-8aef-c8da3121e5b7">2.475</ix:nonFraction>&#160;million mandatory convertible preferred shares that were issued in May 2017 in connection with the Company's acquisition of Bard were converted into <ix:nonFraction unitRef="shares" contextRef="i874a17754f954b0aaac2d06381e5d650_I20200501" decimals="-3" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjA1Mg_51d8e475-30b8-4c7d-b2ea-83f46a4304f3">11.703</ix:nonFraction>&#160;million shares of BD common stock on the mandatory conversion date of May 1, 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in May 2020, the Company completed registered public offerings of equity securities including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="shares" contextRef="id918b6957659494e9efb8db5e471b658_D20200501-20200531" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjIzMA_611a0564-eed2-4900-a8b6-40015540f65e">6.250</ix:nonFraction>&#160;million shares of the Company's common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="id918b6957659494e9efb8db5e471b658_D20200501-20200531" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjI5MA_d4994ff9-b382-4707-95cb-533e22b9f0f9">1.459</ix:nonFraction>&#160;billion (gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="id918b6957659494e9efb8db5e471b658_D20200501-20200531" decimals="-6" name="bdx:GrossProceedsFromIssuanceOfEquity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjMxMg_ac988c70-96ca-442a-93d6-75691549a7b4">1.500</ix:nonFraction>&#160;billion).</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="shares" contextRef="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjMxNw_b8cad03c-cdb7-476b-a5b9-3dba9c3cd11a">1.500</ix:nonFraction>&#160;million shares of the Company's mandatory convertible preferred stock (ownership is held in the form of depositary shares, each representing a 1/20th interest in a share of preferred stock) for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjUyMg_0c0c8d24-f44d-4221-91b6-8cc4622ff3d6">1.459</ix:nonFraction>&#160;billion (gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531" decimals="-6" name="bdx:GrossProceedsFromIssuanceOfEquity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjU0NA_c137ee6a-8921-4095-b8aa-39c85a4fbcd2">1.500</ix:nonFraction>&#160;billion).  If and when declared, dividends on the mandatory convertible preferred stock will be payable on a cumulative basis at an annual rate of <ix:nonFraction unitRef="number" contextRef="i6c47e1c7c8914741831ba4850ee25a8d_D20211001-20220930" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjY4Ng_1daa2637-8928-4f7c-a5a3-2d0e024e61b4">6.00</ix:nonFraction>% on the liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1ad1063cff2d4269b4177860de2bbad9_I20220930" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjcyMg_b362f173-1f44-493f-b914-50e79d99be25">1,000</ix:nonFraction> per preferred share ($<ix:nonFraction unitRef="usd" contextRef="i1ad1063cff2d4269b4177860de2bbad9_I20220930" decimals="INF" name="bdx:DepositaryShareLiquidation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjc0Ng_bf69944c-90ea-4a08-bbb6-f95dc2a66724">50</ix:nonFraction> per depositary share).  The shares of preferred stock are convertible to a minimum of <ix:nonFraction unitRef="shares" contextRef="i7ff86925da2a4bdbb08d87f5bf1b9465_I20220930" decimals="-5" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjgzNQ_476a0136-1bce-40bf-8c21-6690d16c0564">5.3</ix:nonFraction>&#160;million and up to a maximum of <ix:nonFraction unitRef="shares" contextRef="i57dbdcd63dc545d4baab7bc7c3def523_I20220930" decimals="-5" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjg2MQ_90bc7b5f-0bfe-43f8-9332-65bd14d86ffd">6.4</ix:nonFraction>&#160;million shares of Company common stock at an exchange ratio, based on the market price of the Company&#8217;s common stock at the date of conversion, and no later than the mandatory conversion date of June 1, 2023.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ica83415c107740c794e46fd136f94e27"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDUxNg_b9a61b4d-9326-4a61-80a8-ac1fe4856383" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.333%"><tr><td style="width:1.0%"></td><td style="width:47.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.741%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS0xLTEtMS03MzUzNQ_1d507651-e19b-4a7c-ba0a-748aff11989c">2,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78c005f6696a4b2a8f4b480077d64866_I20190930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS0zLTEtMS03MzUzNQ_115fcea6-17bc-4c2e-ad40-09fcd934aa95">1,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie20e47c06987495d84a42d36f5689682_I20190930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS01LTEtMS03MzUzNQ_4913c04d-d0ac-49d4-a74a-cb395727623d">1,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf2fd6969bcd47aea595469cbf1b4625_I20190930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS03LTEtMS03MzUzNQ_09978b0b-9de0-4b2a-9d7d-436b17c615fa">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi0xLTEtMS03MzUzNQ_1d84816c-538e-40b8-ab96-c9fa798132e3">338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10fb59521c574bcb96b82afd9f75ede2_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi0zLTEtMS03MzUzNQ_045f286c-6797-4555-92fb-0264df0fe8ef">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i628f61d1728942a88bd889c7c55ed5f4_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi01LTEtMS03MzUzNQ_385ce652-10a6-476f-bbd7-7fbf15469527">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf1f5eafac44cf9a31dc274fe75fe4d_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi03LTEtMS03MzUzNQ_e849fad1-0551-4600-898e-41f4af545f3d">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy0xLTEtMS03MzUzNQ_f4ba6a41-44da-4091-a9ad-9e24e27ea616">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10fb59521c574bcb96b82afd9f75ede2_D20191001-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy0zLTEtMS03MzUzNQ_fc89765e-4cf2-40ce-8bc4-9a077aee35e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i628f61d1728942a88bd889c7c55ed5f4_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy01LTEtMS03MzUzNQ_2874d719-ee89-4ebf-8946-f1972a0b768b">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf1f5eafac44cf9a31dc274fe75fe4d_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy03LTEtMS03MzUzNQ_a46c347f-b308-4699-b711-a0f94e8d1cb7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC0xLTEtMS03MzUzNQ_6994d158-2c15-4468-9408-70607a939482">2,548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacfb3dc5bbdd43f1abaff2e47b4b3e33_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC0zLTEtMS03MzUzNQ_68b3614e-1be1-4f4b-afca-c4d10ba98d1d">1,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if78c1bc79b104d2495d52f06e7adbeb8_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC01LTEtMS03MzUzNQ_a3ee0bb3-5aa0-47c0-9a2a-f9982b941e52">1,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebe826a47e2d4911b649299e360599da_I20200930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC03LTEtMS03MzUzNQ_366d5e9b-1cf4-4787-9d55-2ca8e5260bae">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS0xLTEtMS03MzUzNQ_3033cfd7-08f9-454a-a360-58843774673c">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d4272367454973a102f31f0e0b1d5b_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS0zLTEtMS03MzUzNQ_8ae5133b-5802-4e80-9338-b16b84100f2e">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8624f6524b87417d877a3fbc3734696a_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS01LTEtMS03MzUzNQ_9824fa83-14f8-48e1-a5ae-3c600292e24e">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99c576cb7f54d77a264bc0be07c9bf4_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS03LTEtMS03MzUzNQ_aaf3b708-08d7-4703-b537-ce8483d39e7e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi0xLTEtMS03MzUzNQ_d5e451a7-4cb8-4657-8f02-c7948a4bf985">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d4272367454973a102f31f0e0b1d5b_D20201001-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi0zLTEtMS03MzUzNQ_4b5b4b0d-6203-42a8-9bf9-2a742a5ab003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8624f6524b87417d877a3fbc3734696a_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi01LTEtMS03MzUzNQ_dfd09be3-1b56-4a83-a23b-3a189a295cc8">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99c576cb7f54d77a264bc0be07c9bf4_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi03LTEtMS03MzUzNQ_14f07df9-447a-4870-861d-2c199286ca22">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy0xLTEtMS03MzUzNQ_86110eae-179a-44b3-b157-566094851624">2,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a15e922161c4d5dac1d1b05a8cd6abb_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy0zLTEtMS03MzUzNQ_e33c5a79-8359-4ef4-8450-8e93885cc600">1,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65b38b186e5043618d914e134f92606d_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy01LTEtMS03MzUzNQ_0b1611d3-cd4b-429a-84df-fd4760078912">784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd731e1f79d247e8ae5e661b7d8187be_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy03LTEtMS03MzUzNQ_45efef35-79a9-4306-8310-be1e1ccb50bb">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC0xLTEtMS03MzUzNQ_634dc464-87aa-43d6-be2d-1c8aa963a453">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC0zLTEtMS03MzUzNQ_c8650f13-9bee-4be5-94ce-49bb2a2d955c">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC01LTEtMS03MzUzNQ_f8eb7d30-64d9-4f19-b0f9-9494fdf6cc57">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC03LTEtMS03MzUzNQ_c5c1e39d-30c1-44cd-b19e-06821c27bce5">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS0xLTEtMS03MzUzNQ_643df64e-9b75-4bdf-8914-909b2542d543">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS0zLTEtMS03MzUzNQ_db83b176-6cd8-4061-bb9c-f959fc003311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS01LTEtMS03MzUzNQ_0c3a9452-3107-46f8-b18e-490e2004ab56">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS03LTEtMS03MzUzNQ_87793ff5-3f22-4994-bea4-ed774343324f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off of Embecta (See Note 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMS0xLTEtODkzMDY_52d65f72-5540-4c54-825d-04df65cf1507">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930" decimals="-6" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMy0xLTEtODkzMDY_a6b7892c-9bff-4c86-b772-dfdee0920abd">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930" decimals="-6" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNS0xLTEtODkzMDY_c4568075-0016-4ee1-a214-8604330f040f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930" decimals="-6" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNy0xLTEtODkzMDY_d0cd8c4b-71aa-49b1-8837-ea81d7573a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMS0xLTEtNzM1MzU_415353d0-fb67-4fdd-9833-7eb9166b1be1">1,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3be5ebcb0a4e7da15aa197384cbb6d_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMy0xLTEtNzM1MzU_a4c09b6c-d084-460e-a43e-927f3b2f405c">987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43597b9d90b04086b5e4094193e3b542_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNS0xLTEtNzM1MzU_1a2c2b94-10c7-4718-bd45-bfb496d32ee0">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ca936d1eee4110babd87515b79a272_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNy0xLTEtNzM1MzU_f794e091-ea92-4602-9252-72136bcbf818">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of foreign currency translation recognized in other comprehensive income during the years ended September 30, 2022, 2021 and 2020 included net gains (losses) relating to net investment hedges, as further discussed in Note 14. Other comprehensive income relating to benefit plans during the year ended September 30, 2021 included a net gain of $<ix:nonFraction unitRef="usd" contextRef="i0caad212afff4342a5acce2a8aa1d437_D20201031-20201031" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMzQ5Nw_1fb466c1-1847-4b38-96cb-aee47d5e74a4">24</ix:nonFraction>&#160;million recognized as a result of the Company&#8217;s remeasurement, as of October 31, 2020, of the legacy Bard U.S. defined pension benefit plan upon its merger with the BD defined benefit cash balance pension plan in the first quarter of fiscal year 2021. The amounts recognized in other comprehensive income relating to cash flow hedges in 2022, 2021 and 2020 related to forward starting interest rate swaps. Additional disclosures regarding the Company's derivatives are provided in Note 14.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDUyMw_422eac48-9262-4181-aaf8-d15407d85a04" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income before reclassifications were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"><tr><td style="width:1.0%"></td><td style="width:55.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjYxMDVhYjM2YjFjMjQ2ZWM5YmU3NjNmN2QyOGFiZGVkL3RhYmxlcmFuZ2U6NjEwNWFiMzZiMWMyNDZlYzliZTc2M2Y3ZDI4YWJkZWRfMi0xLTEtMS03MzUzNQ_ca1fafe8-f2a5-4f41-9e24-61e71a6a64d2">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjYxMDVhYjM2YjFjMjQ2ZWM5YmU3NjNmN2QyOGFiZGVkL3RhYmxlcmFuZ2U6NjEwNWFiMzZiMWMyNDZlYzliZTc2M2Y3ZDI4YWJkZWRfMi0zLTEtMS03MzUzNQ_653267f2-73bc-4cac-a32a-7c8c3a231ab0">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjYxMDVhYjM2YjFjMjQ2ZWM5YmU3NjNmN2QyOGFiZGVkL3RhYmxlcmFuZ2U6NjEwNWFiMzZiMWMyNDZlYzliZTc2M2Y3ZDI4YWJkZWRfMi01LTEtMS03MzUzNQ_22ebf0d6-b95b-44a2-972b-a5606fcb1b22">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for cash flow hedges recognized in other comprehensive income before reclassifications in 2022, 2021 and 2020 were immaterial to the Company's consolidated financial results.  The tax impacts for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges in 2022, 2021 and 2020 were also immaterial to the Company's consolidated financial results.</span></div></ix:continuation><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"><tr><td style="width:1.0%"></td><td style="width:55.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfOTYx_32d59694-6efa-4ab5-9fcd-07f8dc735c66" continuedAt="i6f581d8472024cb19191cb933a6cc50f" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i6f581d8472024cb19191cb933a6cc50f"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfOTYz_93279cae-70b0-4d78-9bb7-e7afab2a810a" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.666%"><tr><td style="width:1.0%"></td><td style="width:65.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMS0xLTEtMS03MzUzNQ_7793e532-47ab-401e-8fd2-9209e171cba9">285,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMS0zLTEtMS03MzUzNQ_3b70d9fd-56af-4fca-8cef-81571ed47271">289,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMS01LTEtMS03MzUzNQ_9334c167-0992-4810-93fe-939707d6ee62">278,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans (a) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMi0xLTEtMS03MzUzNQ_c2bc98c4-ddab-4aed-9385-c451f4331a02">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMi0zLTEtMS03MzUzNQ_dec37260-75b0-4953-aacc-111b57ca13fb">2,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMi01LTEtMS03MzUzNQ_a63202e7-ff74-49f1-b4be-2da9e1f8f1e9">3,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0xLTEtMS0xMDY3NDY_6a5a2b65-922b-4afa-aaa8-9a2ef3a83372">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0zLTEtMS0xMDY3NTM_be36983a-f86b-4832-8e75-bd76ed42621b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy01LTEtMS0xMDY3NjA_b3539873-0cca-40ff-8c36-f7d0d7168984">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8212; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0xLTEtMS03MzUzNQ_9eb731c7-ff68-4a17-a2d0-5bae0d15ea94">287,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0zLTEtMS03MzUzNQ_e1615816-56d0-4dad-a3d7-5e91b9d4bada">292,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy01LTEtMS03MzUzNQ_2ab1acad-10e4-4d0b-8e8b-a9c0419f5e55">282,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">In 2022, 2021 and 2020, dilutive share equivalents associated with mandatory convertible preferred stock of <ix:nonFraction unitRef="shares" contextRef="i4e27cb8b41d348d5b69f42feadb89ef6_D20211001-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfMzEw_e8de9aef-9e31-446f-9112-34b986e1da90">6</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i395595affb2f4499b423f227d60c2864_D20201001-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfMzE0_432da32d-d0cf-4322-9552-d50a98a7e608">6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic3faee5241614bc983e8159206dea8d8_D20191001-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfMzIx_56887461-c0af-4fea-8511-9199e985d1a4">9</ix:nonFraction> million, respectively, were excluded from the diluted shares outstanding calculation because the result would have been antidilutive. The issuance of the convertible preferred stock is further discussed in Note 4.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">In both 2021 and 2020, <ix:nonFraction unitRef="shares" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfNTUz_16d5967b-9e2c-4705-a863-de77acdcdf95"><ix:nonFraction unitRef="shares" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfNTUz_27fa7885-bafd-48d5-8f93-5a75337d4b1a">1</ix:nonFraction></ix:nonFraction>&#160;million of certain share-based compensation awards were excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2022, <ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfNzgy_de509e71-4288-4404-b830-cc5ceb51d09f">no</ix:nonFraction> such awards were excluded from the diluted earnings per share calculation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the Company&#8217;s share-based compensation are provided in Note 9.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed.</span></div></ix:nonNumeric></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_91"></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Note 6 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjEyNTY_db607bf0-6075-4ecb-a3ec-f7beba586bac" continuedAt="ia9b76107430c49519969bed1a77803a4" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ia9b76107430c49519969bed1a77803a4" continuedAt="i2a4bc9f3a80d4bd7ab53d76bc1045f53"><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain future purchase commitments entered in the normal course of business to meet operational and capital requirements. As of September&#160;30, 2022, these commitments aggregated to approximately $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:LongTermPurchaseCommitmentAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjUy_d68927fe-0614-4444-97fd-153eb1f320fa">1.521</ix:nonFraction> billion and will be expended over the next several years.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. <ix:continuation id="ica722e51f4974d588ed77f568fbdbba1" continuedAt="i38b0e68b34554b59b2d2ce486b9d3505">Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved. </ix:continuation></span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company is defending approximately <ix:nonFraction unitRef="claim" contextRef="ie9b42263d2584a45bc56b83ecc8101d4_I20220930" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjU1Nw_71b802d5-6d53-41f6-bfbd-d6d72f8fea06">31,445</ix:nonFraction> product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;).  The </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2a4bc9f3a80d4bd7ab53d76bc1045f53" continuedAt="i195cb539a1ea4da1af41ccd8881b5518"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions.  In addition, those claims include multiple putative class actions in Canada.  Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  </span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The second hernia MDL bellwether resulted in a $<ix:nonFraction unitRef="usd" contextRef="i512eb62a6b814cd0946e34a3d047f29f_D20220401-20220430" decimals="-3" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTA5OTUxMTY2ODUwMA_5ed672d0-db3f-41ee-8e26-4723d85322a6">255</ix:nonFraction>&#160;thousand verdict in April 2022. </span></div><div style="padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The first bellwether trial in RI resulted in a $<ix:nonFraction unitRef="usd" contextRef="ide1ced632f4c4c4da4b51289c20a7f1f_D20220801-20220831" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfOTM0NTg0ODg3NzY0NA_03cc7f9c-0676-4cef-bd3e-e554c797d1af">4.8</ix:nonFraction> million verdict in August 2022, which the Company plans to appeal. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in state and/or federal courts, including two additional bellwether trials in the MDL in February 2023 and May 2023.  The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation. As of September&#160;30, 2022, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also as of September&#160;30, 2022, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. The plaintiff filed a second amended complaint to add certain additional factual allegations on February 3, 2021. This complaint was dismissed on the Company&#8217;s motion on September 15, 2021. The court&#8217;s dismissal order, however, gave plaintiff an opportunity to replead, which it did on October 29, 2021. The Company moved to dismiss the newly amended pleading on December 16, 2021. That motion was granted in part and denied in part, as the court permitted certain aspects of the case to proceed. An answer with affirmative defenses was thereafter filed on October 3, 2022. The Company believes that it has strong defenses to the remaining allegations and it intends to defend itself vigorously. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, a civil action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, Ronald Jankowski, derivatively on behalf of the Company, against its individual directors and certain of its officers.  The complaint seeks recovery for breach of fiduciary duties by directors and various officers; violations of the Securities Exchange </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i195cb539a1ea4da1af41ccd8881b5518" continuedAt="ic511d2e10b5b44429ea5202be1adae24"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Act of 1934, including sections 10(b), 14(a) and 21D; and insider trading.  In general, the complaint also alleges, among other things, that various directors and/or officers caused the Company to issue purportedly misleading statements and SEC filings regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, and issue a purportedly misleading proxy statement.  The complaint seeks damages, including restitution and disgorgement of profits, and an injunction requiring the Company to undertake remedial measures with respect to certain corporate governance and internal procedures.  A second derivative action, Schranz v. Polen, et al., Civ. No 2:21-cv-01081 (D. N.J.), was filed on January 24, 2021, and the two actions were consolidated.  In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the Jankowski and Schranz consolidated actions, and demanded, among other things, that the Board of Directors pursue civil action against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters.  Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands.  The special committee&#8217;s determination has been communicated to counsel for the shareholders.  Should the shareholders continue to pursue their claims in court, the Company will take appropriate steps to seek dismissal of the complaints.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics has filed a notice of appeal. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps. The Company is cooperating with the SEC and responding to these requests.  The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests.  </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018. The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters.  The Company&#8217;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation.  As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has been sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place.  The plaintiffs in those cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $<ix:nonFraction unitRef="usd" contextRef="i2cf37d2f9a26470d958d196cc629fd83_D20211001-20220930" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfNjA0NzMxNDAxMDM3OQ_06848fc3-8ba7-4532-b670-c7afa5f558d4">250,000</ix:nonFraction> per claimant.  The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. There are currently approximately <ix:nonFraction unitRef="lawsuit" contextRef="i55a754ef030a48b1aab1469d1d78d783_D20211001-20220930" decimals="0" name="bdx:NumberOfEtOSterilizationLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTgxMzc_824f60ad-0b31-410e-bf7b-9d247559dd41">210</ix:nonFraction> of such suits involving approximately <ix:nonFraction unitRef="plaintiff" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMzg0ODI5MDc0ODU4Mw_7ff48805-55ae-4ed6-b953-9550a4897ecf">310</ix:nonFraction> plaintiffs; approximately <ix:nonFraction unitRef="lawsuit" contextRef="i55a754ef030a48b1aab1469d1d78d783_D20211001-20220930" decimals="INF" name="bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMzg0ODI5MDc1NDgxNA_02999eb0-1d29-4daa-8e54-4d0d62f2ed80">44</ix:nonFraction> of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic511d2e10b5b44429ea5202be1adae24" continuedAt="i277a265e564641058cc580e117cc3232"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Company.  The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.  The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows.  Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal years 2022, 2021, and 2020, the Company recorded pre-tax charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of approximately $<ix:nonFraction unitRef="usd" contextRef="ie414e39c203f4c4382406af500826854_D20211001-20220930" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTkyMTU_391ab6db-3281-4e30-8cd0-618986f16a72">21</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTkyMTk_e0fe9d31-a1da-40eb-89db-a6a4e3eb0436">361</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i08f59c7321f84d4abd684a04e126995a_D20191001-20200930" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTkyMjc_00b33e5f-3a89-49aa-8406-59dbc8560100">378</ix:nonFraction>&#160;million, respectively, related to certain of the product liability matters discussed above under the heading &#8220;Product Liability Matters,&#8221; including the related legal defense costs. The Company recorded these charges based on additional information obtained during fiscal years 2022, 2021, and 2020 including, but not limited to: the nature, quantity, and quality of unfiled and filed claims; the continued rate of claims being filed in certain product liability matters; the status of certain settlement discussions with plaintiffs&#8217; counsel; the allegations and documentation supporting or refuting such allegations; publicly available information regarding similar medical device mass tort settlements; historical information regarding other product liability settlements involving the Company; and the stage of litigation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjAxNzc_14d6895e-3a5d-4949-b407-0547e13c0f06">2.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfNDM5ODA0NjU1MjQyOQ_7d26252b-ff67-4181-b707-70b36f066847">2.5</ix:nonFraction> billion at September&#160;30, 2022 and 2021, respectively. These accruals, which are generally long-term in nature, are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the Company's consolidated balance sheets.  </span></div></ix:continuation><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i38b0e68b34554b59b2d2ce486b9d3505"><ix:continuation id="i277a265e564641058cc580e117cc3232">In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and /or consolidated cash flows</ix:continuation>.</ix:continuation></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfODAwMA_ec979ad4-3b6a-426e-86a4-28315ce245a8" continuedAt="i48665d691131480298ad24b4c2afe915" escape="true">Revenues</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i48665d691131480298ad24b4c2afe915" continuedAt="i8e4b5735cc9a4f788d5155e53bd1f69c">The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales </ix:continuation></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8e4b5735cc9a4f788d5155e53bd1f69c" continuedAt="i114007f0660d4d99b0440130696c13bd"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfODAwMQ_4fb8e81e-61b4-4952-94c8-7b35f307cab0" continuedAt="i8ca2ff2952bc4db1a917e26977a093b9" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Timing of Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized when customer acceptance of these installed products has been confirmed. For certain service arrangements, including extended warranty and software maintenance contracts, revenue is recognized ratably over the contract term. The majority of revenues relating to extended warranty contracts associated with certain instruments and equipment is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over a longer period.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. The Company considers its shipping and handling costs to be costs of contract fulfillment and has made the accounting policy election to record these costs within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms extended to the Company's customers are based upon commercially reasonable terms for the markets in which the Company's products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectable. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company's agreements with its end-user customers. Additional factors considered in the estimate of the Company's rebate liability include the quantification of inventory that is either in stock at or in transit to the Company's distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. The Company&#8217;s rebate liability at September&#160;30, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfMzk0Ng_5fd0243f-1564-496d-9378-f465212c1d0a">525</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfMzk1Mw_a2a18ebe-6e9c-472e-8685-3de3db069b5c">500</ix:nonFraction>&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues. Additional disclosures relating to sales discounts and sales returns are provided in Note 19.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's agreements with customers within certain organizational units including Medication Management Solutions, Integrated Diagnostic Solutions and Biosciences, contain multiple performance obligations including both products and certain services noted above. The transaction price for these agreements is allocated to each performance obligation based upon its relative standalone selling price. Standalone selling price is the amount at which the Company would sell a promised good or service separately to a customer. The </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i114007f0660d4d99b0440130696c13bd"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ca2ff2952bc4db1a917e26977a093b9">Company generally estimates standalone selling prices using its list prices and a consideration of typical discounts offered to customers.</ix:continuation> </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the majority of the Company's products and services, the Company typically does not incur costs to fulfill a contract in advance of providing the customer with goods or services. Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's consolidated balance sheets. The Company's costs to obtain contracts are comprised of sales commissions which are paid to the Company's employees or third party agents.  The majority of the sales commissions incurred by the Company relate to revenue that is recognized over a period that is less than one year and as such, the Company has elected a practical expedient provided under ASC 606 to record the majority of its expense associated with sales commissions as it is incurred. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's consolidated balance sheets.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records contract liabilities for unearned revenue that is allocated to performance obligations such as extended warranty and software maintenance contracts, which are performed over time as discussed further above. These contract liabilities are immaterial to the Company's consolidated financial results. The Company's liability for product warranties provided under its agreements with customers is not material to its consolidated balance sheets. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts, which are further discussed above, and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided, are estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="i4a8c12f02b6648b68f67c0af95c1adf6_I20220930" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfNzEyNA_f2f642f3-4574-4c2f-b546-b6eae3ab0533">2.5</ix:nonFraction> billion at September&#160;30, 2022. The Company expects to recognize the majority of this revenue over the next <ix:nonNumeric contextRef="i05606745f26d460ab811bbfdfa341821_I20220930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfNzIxMQ_0536fca9-9754-415c-8f0f-6ae8ddf251c7">three years</ix:nonNumeric>.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="ib7ba30fee8c84bc8a2dbb50e36515c04_I20220930" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfNzc3MA_0d2e9628-f7ad-4960-828c-aa8d14ad37d9">1.9</ix:nonFraction> billion&#160;at&#160;September&#160;30, 2022. This revenue will be recognized over the customer relationship periods. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 8.</span></div></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM1Mg_0db7143d-f8ff-42c5-a8d2-46f2485e1714" continuedAt="ie255270312244c71aa4c9344f7a01693" escape="true">Segment Data</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie255270312244c71aa4c9344f7a01693" continuedAt="i425bfa37e2fd4de99cdd1b67dff0f90d">The Company's organizational structure is based upon <ix:nonFraction unitRef="segment" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfODA_65ef4f24-6eab-48e8-a8cd-57a74c217598">three</ix:nonFraction> worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional ("Interventional"). The Company&#8217;s segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.</ix:continuation></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i425bfa37e2fd4de99cdd1b67dff0f90d" continuedAt="iad4fdf94b447413c82e6f896ba704f68"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical produces a broad array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The primary customers served by Medical are hospitals and clinics; physicians&#8217; office practices; consumer and retail pharmacies; governmental and nonprofit public health agencies; pharmaceutical companies; and healthcare workers. Medical consists of the following organizational units: Medication Delivery Solutions; Medication Management Solutions; Pharmaceutical Systems.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Life Sciences</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. In addition, Life Sciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases. The primary customers served by Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians&#8217; office practices; retail pharmacies; academic and government institutions; and pharmaceutical and biotechnology companies. With the emergency use authorization approval of the BD Veritor&#8482; At-Home COVID-19 Test, Life Sciences also serves patients directly. Life Sciences consists of the following organizational units: Integrated Diagnostic Solutions and Biosciences.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional provides vascular, urology, oncology and surgical specialty products that are intended, with the exception of the V. Mueller</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical and laparoscopic instrumentation products, to be used once and then discarded or are either temporarily or permanently implanted. The primary customers served by Interventional are hospitals, individual healthcare professionals, extended care facilities, alternate site facilities and patients via the segment's Homecare business. Interventional consists of the following organizational units: Surgery; Peripheral Intervention; Urology and Critical Care.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Segment Information</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. <ix:nonFraction unitRef="customer" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="INF" name="bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMjgzNg_2ec10256-ff9e-4cc7-ac64-daaa9a142250"><ix:nonFraction unitRef="customer" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="INF" name="bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMjgzNg_3c4a981d-97c6-420a-9e87-e0f6ac4baaa9"><ix:nonFraction unitRef="customer" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="INF" name="bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMjgzNg_814a1b17-dbbc-49b5-89f6-63dc3645b2ad">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> customer accounted for 10% or more of revenues in any of the three years presented.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment disclosures are on a performance basis consistent with internal management reporting.  The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income, which represents revenues reduced by product costs and operating expenses. The Company&#8217;s chief operating decision maker does not receive any asset information by business segment and, as such, the Company does not report asset information by business segment.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet as of September 30, 2021. See Note 2 for further information.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iad4fdf94b447413c82e6f896ba704f68" continuedAt="ic817c854273c47049771d6c80b975499"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM1Mw_9353496d-a813-416a-8880-ae5f2c4e7a38" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for the Company&#8217;s segments is detailed below. The Company has no material intersegment revenues.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:13.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.923%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f132fdd2c874a8ea74c3db787eff159_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xLTEtMS03MzUzNQ_18e21fee-6a2d-4e56-9f91-64c5b8a860ab">2,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be3457e675a41b8a5e579e487b37547_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0zLTEtMS03MzUzNQ_cef74b0c-fa48-4110-b76b-253af9048528">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af1f356b20e49379832866f40ae6116_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy01LTEtMS03MzUzNQ_3f24ce78-1d09-4195-9515-f85d8602fe7d">4,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5bb7c3f33f14b26877a5ad97b466f75_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy03LTEtMS03MzUzNQ_2bd542cf-c8c5-4872-9f34-061cb52e8c1a">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0818d4aa51794a308ee5ea7be2a3a7bf_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy05LTEtMS03MzUzNQ_096d6aec-8eae-4d57-871b-63a937068b1d">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df34fd9a8fb4515a6d4f206a9b62bbf_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xMS0xLTEtNzM1MzU_de9e22fe-9adb-4e10-ace9-a3209fb51185">4,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2beda1c25ab64fb6be6cc0c3ea77c714_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xMy0xLTEtNzM1MzU_4560f685-4149-446c-86f0-c62ed8f6a69f">1,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6964534d6074e42bf64a587550cf196_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xNS0xLTEtNzM1MzU_80696a73-bc64-4257-ab27-eec0da4a592f">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a6ab2283f1148cdb39df341b7bab34c_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xNy0xLTEtNzM1MzU_e57b2edd-083e-409a-8e37-ee705892b747">3,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aedd1e139b541e98f03ec93291aad7b_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xLTEtMS03MzUzNQ_db94e1cc-6eca-4963-a67d-ac74b4863076">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaefde29495b1437da1094baba80dcc28_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0zLTEtMS03MzUzNQ_4ba0e759-2f7c-4382-9b95-de435fa793f0">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4044de927e14db4b4cdce3edf5fe533_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC01LTEtMS03MzUzNQ_54ec07e1-e612-4d1d-9f6f-f6f7d4907eb1">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0226cc65ff074b9cb210e20467df9c6c_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC03LTEtMS03MzUzNQ_7761e0af-c64f-47f0-a1e3-0ef82bb1b848">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa8ecc6259cf4f9e9dcaa8280e0c1e38_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC05LTEtMS03MzUzNQ_09683440-31a1-465a-b440-85e92e94de3c">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7354695f422344c2ba6f5510554cf892_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xMS0xLTEtNzM1MzU_67d0b206-25bc-473f-9608-b304cfc7caf5">2,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if82cf0e2b8114957a8de4ed614f509d9_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xMy0xLTEtNzM1MzU_a52fb3dd-4190-4cc4-8283-e3dcd425092c">1,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe3d23b34c44614b6bfae0c5d45b788_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xNS0xLTEtNzM1MzU_eabc1ea5-d259-4571-baf9-e73bb702ab6a">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c683a785824afeaad05fc9abf980e8_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xNy0xLTEtNzM1MzU_40e6e520-11cc-44d4-b1ad-0eafddb2b7a9">2,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cceb75d2179413db04451287ff26d63_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xLTEtMS03MzUzNQ_43a9178d-5a04-4f1d-af57-2fff2e15919f">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2212a30e9348f29aec9f73842587fd_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0zLTEtMS03MzUzNQ_4e5e73ed-6a82-4853-994b-655c5ca905c1">1,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91213219f96b4e26aca1922999345c5b_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi01LTEtMS03MzUzNQ_5b06339f-5ed8-48ba-b5c2-7d5e86980d9f">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3bb31dc01f431bbbe77ccd87e88642_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi03LTEtMS03MzUzNQ_3edf5869-0f4f-449a-b6bb-678eb3a38bc3">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d656df397a54965af2508ec9e8b3a88_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi05LTEtMS03MzUzNQ_85e1b064-089d-472c-b1b7-ab71208d17e1">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682ce949e79b4a869956e036cd9bbabf_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xMS0xLTEtNzM1MzU_a96c3230-c58d-404d-b0d0-e9fd555ac879">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75503ddf3285429bbb602ab773ba94ce_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xMy0xLTEtNzM1MzU_b636d17f-4edf-43bd-b8a8-b378e05c886f">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bb11d08c5e6468d9b86ce13b8fb8672_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xNS0xLTEtNzM1MzU_e1ccbd96-df1e-429b-98fd-6f05a01637f6">1,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3183d1ded7447c9addc009095eff141_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xNy0xLTEtNzM1MzU_e7a43383-337b-4d73-84ba-7060f3c064b7">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f35065e14842b2982be7930f62d9a7_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xLTEtMS03MzUzNQ_92103eb0-5004-4e70-a2be-8297602032ba">4,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i648c7b7f63e14fff8db4327cf366bf0c_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0zLTEtMS03MzUzNQ_10abadbe-d02e-470e-8a0c-77898c997855">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy01LTEtMS03MzUzNQ_76ae0d8f-a1db-4adf-8e92-ea218b1476a3">8,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547ae1919acd49f194300b3f92921e7c_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy03LTEtMS03MzUzNQ_d4929fc9-5a0a-4b8a-aec4-cba5d041f39e">4,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbdd8603eed4090a62b2e5f722efe1d_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy05LTEtMS03MzUzNQ_11969c68-d47d-4db4-8668-b6bc091fea77">3,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xMS0xLTEtNzM1MzU_770599cb-9686-4aaa-840d-ba6e30e7ce42">8,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12495d432e44f0ac940dc4cd4a1bf3_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xMy0xLTEtNzM1MzU_6c69f8d9-0441-44c7-87ba-af42a3841ea7">4,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2acdc038e1415886e86c9c35738e32_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xNS0xLTEtNzM1MzU_f642bed9-676d-4385-aedf-5a1149db7795">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xNy0xLTEtNzM1MzU_258fd45d-1725-46a5-85c7-b31788c9bd1c">7,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied344f3898da40c787f80afb27167829_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMS0xLTEtNzM1MzU_4a4c2880-bfae-4812-b918-e873e1f4ba90">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216e3978b71a433ea3ecaed35cef49df_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMy0xLTEtNzM1MzU_62637033-c455-4673-adde-1a98438f0687">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083aac29dff54d05b5ab473be2896793_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtNS0xLTEtNzM1MzU_6882ce2a-4162-41c5-ab35-5bb966be2561">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed5952700034df3acc6ffaab543b2b7_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtNy0xLTEtNzM1MzU_58ec17e4-4c05-47b2-bd27-538869d8f885">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20d0df9f4974473aab54f9423735e45c_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtOS0xLTEtNzM1MzU_9becea2c-9451-4b00-b3fd-50aba151c606">2,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac87ce71d824958b1a47906a97cb26d_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTEtMS0xLTczNTM1_551d4414-cd22-4872-89a1-46c01a8526e8">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11561312578a41cd8558a5081f0c997a_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTMtMS0xLTczNTM1_ee0072eb-d548-4c47-b558-d3411d5ef157">1,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd17f4c74ddd45aa9d4c2660931a2cbd_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTUtMS0xLTczNTM1_4961e36d-5007-4b35-9fb7-6c8b7f555120">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a84f9891e141d490be8fb0dbc5a1b2_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTctMS0xLTczNTM1_3840b89c-49a0-4935-94c2-8825f350e6e9">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0adb04ada42a45edb77b3846d949a297_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMS0xLTEtNzM1MzU_9b7bdf98-2706-4e43-a2df-b1f2fd534111">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie44752f5a1ac45f9905b7477cb8d8150_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMy0xLTEtNzM1MzU_b267803b-7576-4801-a3af-7dea43ca2f37">838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc49a9068445e690657c19b9757ed7_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtNS0xLTEtNzM1MzU_755d4302-f466-48d0-9334-77d27b791230">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d856fcb0a2148e18bb6926e29e6de05_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtNy0xLTEtNzM1MzU_ec237afb-97ab-4fe2-8758-ca8605c0dc33">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c44be99e502431faec4f344ca7026e7_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtOS0xLTEtNzM1MzU_ed2dfc41-a0d4-49f5-a671-8c7b178e4063">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612cd43d382c4a63a4498b9c0925333a_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTEtMS0xLTczNTM1_e2add7c8-612b-4676-a8e1-309546573ab5">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d137b4783048aa9d0a5092249d0c19_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTMtMS0xLTczNTM1_72d4d8c1-a8d9-4b9c-acdb-75e60c550d4d">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a850278578a41d7920dd6f66b22ec55_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTUtMS0xLTczNTM1_74911f6b-6cc5-4cd9-8e0b-044f8dfd0e93">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05325a1bdf804752849157781245e34b_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTctMS0xLTczNTM1_b03c65a1-f8bc-4736-8412-af2f0591b146">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf241dca0b84231aacab9d4db1bf47e_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMS0xLTEtNzM1MzU_5d98ed52-9c6e-41b4-8995-f675e285ea52">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i116d0d51fa5f4ad8b5f121a6aa909b47_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMy0xLTEtNzM1MzU_7120a4a8-222b-49ed-a555-c58a25f1b6a7">2,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItNS0xLTEtNzM1MzU_609adc07-ccda-4307-878f-0f057c2453b6">5,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14f6db0dfcd4424ab591090a6f110ddc_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItNy0xLTEtNzM1MzU_f81e9e99-3491-44d2-9239-a88f2ec780c9">2,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2bd86d8f5245e596ba87a9603d3935_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItOS0xLTEtNzM1MzU_eb1b50ec-1c2e-4aa3-a5a0-f3ad4a92290b">3,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTEtMS0xLTczNTM1_497a7fff-0fb4-44f5-9a57-d706da055de7">6,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bb88f9b2cb4d1d895fc3044878e01d_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTMtMS0xLTczNTM1_9520123a-58bd-4366-a110-7958b31aab04">2,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62d47452c1b4b0d95b99aad7c976bc0_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTUtMS0xLTczNTM1_8c6e4e4d-0d3c-4c64-a650-56bbc8ecf4b7">2,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTctMS0xLTczNTM1_59b192d5-d081-4953-85ff-e007f31040ac">4,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgery </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6146d44a3e1a4c6fb1e3f608f1d1772d_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMS0xLTEtNzM1MzU_5d37e141-a189-4f7e-b971-912481c5a37d">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5917d24437144be6a23c46c167d8dfee_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMy0xLTEtNzM1MzU_bc521191-d7c6-4581-a5a2-3dfb568ef353">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffb12715a314f46bf61eff967b00a1c_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtNS0xLTEtNzM1MzU_0855923f-7272-4070-96c8-b4af0be6ca3d">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90104d61c104e8b8865d7d2f9e10896_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtNy0xLTEtNzM1MzU_5752dc2d-bf4c-48b7-ba7a-c27ec589fe93">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51d737eb47f4b3b9da6d19bc2611a64_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtOS0xLTEtNzM1MzU_ece5dd49-87e7-463e-a69e-544b048e1e3f">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18417c03d14049dea16257ba06dc47fe_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTEtMS0xLTczNTM1_8a133323-c7a9-4b9f-af5b-5bdbffacad78">1,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f9183974c94388a49de9124319a764_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTMtMS0xLTczNTM1_e3257817-98fb-43ff-865c-7cd5b779441c">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d68a774d0014ef1abfeda302c81fae1_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTUtMS0xLTczNTM1_0658774b-6055-4fc7-a585-baedc3747fec">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e67d37c2bb94c2b801879dcd7a19a15_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTctMS0xLTczNTM1_f2e36a14-aa5b-46ab-978c-d73e4015e44c">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605b912cf85647a9bb587ef76f45e2a1_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMS0xLTEtNzM1MzU_f30475ed-7e77-410f-b03b-74de001d03fc">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id920980d4c7449ea8825bf277a0b1ac2_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMy0xLTEtNzM1MzU_87d48691-7d60-4431-ab92-cff6360fae3f">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5d0087bcc4b4ddebf55ddab6f10de11_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtNS0xLTEtNzM1MzU_3a603d34-8ee3-4aa7-aac5-0ec661d09359">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e5f71dc1cd426cae0de4618593bcf1_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtNy0xLTEtNzM1MzU_a3eb33f4-5f86-450d-858e-aa939179c715">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4a41270d5b4661a5a303eececadc77_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtOS0xLTEtNzM1MzU_ff69b07d-52f8-4c01-90d3-a79e818250fa">780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ada28ecbf74a4395c3277f87c00cdf_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTEtMS0xLTczNTM1_53dfbd47-0016-48b4-9357-36d629b64024">1,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ed2fe03fc548a8a71570a5afe88eb6_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTMtMS0xLTczNTM1_6192aeb4-9727-4494-b13f-5c238fc89185">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f3166ef7bf441d88c8166e8bda58fc7_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTUtMS0xLTczNTM1_823fe3fa-d8b3-4039-b0f6-fc448b93b279">640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7c4592ec094ac2bf07eb5e61394cce_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTctMS0xLTczNTM1_6a0a9dcd-030f-4d9d-913e-996c7f3ebc94">1,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5c15ae71594004b4fb831a208ea9b4_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMS0xLTEtNzM1MzU_2d94f241-623f-40d3-b4c3-c4e29c445a41">986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa16b425c5d484e8fd114f782a112f5_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMy0xLTEtNzM1MzU_bd1dcce1-a30d-4cd5-9e59-f014c87ca558">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide0078adc3714de98cb99a9ec2f7004d_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctNS0xLTEtNzM1MzU_b19d45cf-5d25-4b08-af50-630b39c473a4">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee2d0c4137b14439a21515cf1257e833_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctNy0xLTEtNzM1MzU_1882a67b-f060-4671-b445-2ef435f6b87a">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i756a093d417b4e5d9930034095f6c8a0_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctOS0xLTEtNzM1MzU_e04a8fd8-3928-48f9-80d2-3601eaa30f75">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718323b7442949ebaae15d9d98b8e56e_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTEtMS0xLTczNTM1_12748355-0027-4219-b16e-026a7483942c">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i053e66e661bf401da0e58b9ee1ce56a3_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTMtMS0xLTczNTM1_7931443f-0475-47bd-92c0-3d42449b57ac">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e64a7564cd48a185c5cfb1671f55a4_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTUtMS0xLTczNTM1_630a92b9-9611-48bc-91e9-5258f9314fa9">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia26a2ea3671e4bbda2393ffce1464f31_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTctMS0xLTczNTM1_fb925b28-b65a-4f7f-80b8-bc7723226262">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcfa5db82af24e78ae9358db41c6e7b5_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMS0xLTEtNzM1MzU_1312a565-abfa-4dd8-9d68-2b208ab74aee">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770e87f1fd6a40d7ab6f0cf8f9423ff9_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMy0xLTEtNzM1MzU_bf025ee2-f43b-45ec-8335-cf4e0b9f42d7">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtNS0xLTEtNzM1MzU_88481912-b9b9-46c1-a892-18b330e69d22">4,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c32fb02472b41579f71cf3a6edb41c8_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtNy0xLTEtNzM1MzU_a2ed89c8-f59a-4a0b-8e0d-69b443c452b6">2,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d63e4e362e403b8e8e33d15aeb4129_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtOS0xLTEtNzM1MzU_fb9fef48-0a0e-4c6d-af50-68c706c32788">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTEtMS0xLTczNTM1_3d44423e-c043-47c5-9bc8-ca0060b96e77">4,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6faafb39d1af4514a46e525041b2d4ea_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTMtMS0xLTczNTM1_dc514c07-ae00-4da4-9486-f1edc3aca88d">2,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84d4ce3a1704c82a573ffc14f62e02f_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTUtMS0xLTczNTM1_76cba5bb-b2df-42f9-86ea-da3f689918ca">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTctMS0xLTczNTM1_5faf9590-1d51-410b-9dbc-f34dad8ae5cf">3,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Company revenues from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMS0xLTEtNzM1MzU_f6e7ed5a-7658-46a9-a538-39260456ce5d">10,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07db86337a54d37b2f1f39b5c7a798d_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMy0xLTEtNzM1MzU_8ad71f48-7312-4c7b-8302-7e72245b567f">8,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtNS0xLTEtNzM1MzU_44189e68-120b-4fe6-9452-777dba53f376">18,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c554f2bb4764f148a7b5f7e8b47a21e_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtNy0xLTEtNzM1MzU_77287b10-e196-4136-a9fd-47044a7b3fad">10,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9464fd80b304787a7572a9a2904106a_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtOS0xLTEtNzM1MzU_5162e55d-87d0-4a0a-b33b-9771fd9a4b2d">8,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTEtMS0xLTczNTM1_1d0f925f-b9c1-4725-99c8-30a0533b5271">19,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2274cfe1148048b1a906c0b62d5b0ff1_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTMtMS0xLTczNTM1_f3f40162-b661-45f6-86c5-e26bafdf8319">9,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a0912d23474f249022aec3aba2e54d_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTUtMS0xLTczNTM1_327745c2-f564-46e2-856c-ace52861ca1b">6,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTctMS0xLTczNTM1_2d6b80a0-d699-4253-95f8-56a2c827ad53">16,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM0OA_32e960ba-c72d-4e20-baa1-ae2d1605f803" continuedAt="i45d161e57d1f4b9281827e197931c02d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of segment operating income to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Continuing Operations before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and segment information for both capital expenditures and depreciation and amortization.  Certain prior-period amounts have been recast to reflect the spin-off of the Diabetes Care business in fiscal year 2022, as noted above.</span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center;text-indent:36pt"><span><br/></span></div><ix:continuation id="ic817c854273c47049771d6c80b975499" continuedAt="i4e6fc3b828194201889ba34f62b5a421"><ix:continuation id="i45d161e57d1f4b9281827e197931c02d" continuedAt="ib8274fff62114e0bb0104054297a5169"><div style="margin-top:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a) (b) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMi0xLTEtMS03MzUzNQ_bec8a172-f5dc-463f-a4e9-7b01beb72e0b">2,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMi0zLTEtMS03MzUzNQ_93d22ed4-9cb3-4c65-a38c-d952945bf9af">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMi01LTEtMS03MzUzNQ_42fba268-0b6d-417a-b092-1bd6b0b48967">1,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMy0xLTEtMS03MzUzNQ_ffa2a336-5255-4b8f-b5fa-33060cf42b6e">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMy0zLTEtMS03MzUzNQ_6c0dabba-33d6-40de-8723-b8108c1a5876">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMy01LTEtMS03MzUzNQ_386f1181-635e-41f0-925c-0ea3eb0d9d83">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNC0xLTEtMS03MzUzNQ_f4c6500a-3d22-4249-ac6b-31f5b6c5a3d3">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNC0zLTEtMS03MzUzNQ_c6ee9d10-776f-4517-a9d8-41f668e70de6">933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNC01LTEtMS03MzUzNQ_6d1f438c-0470-4648-bd98-51cf3bf30d5b">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1feff546e94e4e799fd1e5ff2a6122b1_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNS0xLTEtMS03MzUzNQ_a9267339-ec7c-42b9-98ef-04bfd49d4c5e">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f424962ed74433ca2e842f15385c7ce_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNS0zLTEtMS03MzUzNQ_7d8e9378-76a0-4fa4-ac24-ba1a35678ed9">5,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e92a6ff8c554267a457b7ddb0579546_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNS01LTEtMS03MzUzNQ_1c3b5ea0-409e-4062-8549-f61affcfc664">3,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20f6ebe1084e4654990728705d852739_D20211001-20220930" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNi0xLTEtMS03MzUzNQ_dea345c4-3ec5-4700-bbed-6fef40628dfa">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i087866702b1043ad930869066b7ebb1c_D20201001-20210930" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNi0zLTEtMS03MzUzNQ_f5e4fe38-27b5-4c8f-ba35-b843d8271a31">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica689edbbe6c4cfdab402371fb6c387e_D20191001-20200930" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNi01LTEtMS03MzUzNQ_a8bf6d18-d56f-473a-a903-52666ea683b9">299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20f6ebe1084e4654990728705d852739_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOC0xLTEtMS03MzUzNQ_b4eef166-4990-4da4-b676-4c10aef9111b">382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i087866702b1043ad930869066b7ebb1c_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOC0zLTEtMS03MzUzNQ_23762f33-1ebf-4311-bd13-46b85fc5c837">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica689edbbe6c4cfdab402371fb6c387e_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOC01LTEtMS03MzUzNQ_20356612-b035-45f3-8a9c-75b69f5f57c9">521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib65439a3c12d453385854062d6818ee7_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOS0xLTEtMS03MzUzNQ_3a4fa76f-f70e-4999-90b8-b6a6e24ee387">2,668</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe2818605fc44918a60597464387f709_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOS0zLTEtMS03MzUzNQ_d858e2c1-f388-4218-be9e-8c69df867cd5">2,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOS01LTEtMS03MzUzNQ_b13ec3b4-8ed1-42c0-b9e2-6961361a5714">2,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTAtMS0xLTEtNzM1MzU_637521ec-374f-4caa-8946-2f489374be03">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTAtMy0xLTEtNzM1MzU_07efcf59-28f1-405d-aec3-4a8d1a88feef">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTAtNS0xLTEtNzM1MzU_bc0fedd1-48c7-48b2-b876-fd56970d468c">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTItMS0xLTEtNzM1MzU_9ce5c149-ad7b-4267-ae63-bf3fe9ea19dc">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTItMy0xLTEtNzM1MzU_75bc10f2-9fcc-4c7a-9768-0a1f22862539">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTItNS0xLTEtNzM1MzU_6115fa7c-55f8-4bc8-9c26-eb99e78c8aef">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTMtMS0xLTEtNzM1MzU_5a22f3b5-3315-4c4b-b37b-dacdd121791b">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTMtMy0xLTEtNzM1MzU_676d0b2a-5242-4f25-b655-d3b2387cb48e">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTMtNS0xLTEtNzM1MzU_5f947c0d-90f2-46e6-8e3a-cf9229e1d1d9">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTQtMS0xLTEtNzM1MzU_ce4751ec-cc18-4f81-8348-cfce6f337fe0">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTQtMy0xLTEtNzM1MzU_e7ba38b2-b09f-480c-84d5-433063d8c7c4">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTQtNS0xLTEtNzM1MzU_cf347415-6a23-4a2f-abdc-34efd82a129a">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65439a3c12d453385854062d6818ee7_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTUtMS0xLTEtNzM1MzU_d07a3f19-f9b4-4288-8cde-ac2f3be438a9">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2818605fc44918a60597464387f709_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTUtMy0xLTEtNzM1MzU_78c5f9d5-fa8d-4449-a6c7-7126f4511bec">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTUtNS0xLTEtNzM1MzU_0c8282d8-47f7-484b-be1e-68ec860f8b4b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Capital Expenditures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTYtMS0xLTEtNzM1MzU_4ee70ee0-e8b6-4b4f-9dca-0cf702b7e272">973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTYtMy0xLTEtNzM1MzU_7e589d01-7487-4555-8dc7-43bac5c570ce">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTYtNS0xLTEtNzM1MzU_66bc0bc7-f1a6-4439-b693-5f1e9fe2124e">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTgtMS0xLTEtNzM1MzU_c934d31b-5155-435d-bb4b-29210265ebb6">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTgtMy0xLTEtNzM1MzU_4d65ad3d-e61c-44f3-af5f-32c65398491a">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTgtNS0xLTEtNzM1MzU_472da3eb-f1c9-45ec-9f6a-a448588c56a4">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTktMS0xLTEtNzM1MzU_2af8e625-38c8-4d20-a352-1aab764043d3">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTktMy0xLTEtNzM1MzU_223dd3aa-4b51-4997-95e4-73c65feb8a9f">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTktNS0xLTEtNzM1MzU_544d83f5-6b41-49e0-a1bf-8e55ea70c7bc">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjAtMS0xLTEtNzM1MzU_8ec7701d-f7ce-4520-8b0f-cf07d0d81e45">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjAtMy0xLTEtNzM1MzU_3443d7e6-0610-4851-b21b-255f22404298">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjAtNS0xLTEtNzM1MzU_87b38ef8-ff62-4bbb-802e-375c87810f85">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65439a3c12d453385854062d6818ee7_D20211001-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjEtMS0xLTEtNzM1MzU_4561471b-7851-4764-a976-c12f15345d07">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2818605fc44918a60597464387f709_D20201001-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjEtMy0xLTEtNzM1MzU_57cd3288-7d1d-4e2e-928b-f143b44ef1f8">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjEtNS0xLTEtNzM1MzU_4b9b087c-20c8-49e3-928a-1def5470fbd9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Depreciation and Amortization</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjItMS0xLTEtNzM1MzU_635d6f2f-947c-4d91-a9fe-5040c9bc1fc5">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjItMy0xLTEtNzM1MzU_4404d39e-26bc-4048-921c-07732cfba6e5">2,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjItNS0xLTEtNzM1MzU_4d82d971-22a8-4ca3-9d8e-16fb4634611e">2,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts in 2022, 2021 and 2020 include charges of $<ix:nonFraction unitRef="usd" contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMzU4Ng_cfd621e0-365f-42b5-b1aa-50b3ab8e1310">72</ix:nonFraction>&#160;million $<ix:nonFraction unitRef="usd" contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMTA5OTUxMTYzNDk4Mw_d2aecd96-545a-4f76-b96b-79a07d4852be">56</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMzU5Mw_f3ea7228-a02f-40c0-ba8b-183cbd7dc9c8">244</ix:nonFraction>&#160;million, respectively, recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the estimate of costs associated with remediation efforts for BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps in the Medication Management Solutions unit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The amount in 2022 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMTA5OTUxMTYzNTgyMQ_0ea7ceef-9a48-4ff9-bcb9-5590cdc11092">54</ix:nonFraction>&#160;million to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit.  The amount in 2020 included $<ix:nonFraction unitRef="usd" contextRef="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMzgyMQ_0a5e9627-1e9e-4f4a-b6d2-276bd03959b4">41</ix:nonFraction>&#160;million of charges to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units.  These charges were recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amount in 2020 included charges of $<ix:nonFraction unitRef="usd" contextRef="i938377c8c70a4325b957640e0929f503_D20191001-20200930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDMzMg_80340cc2-b5c9-4659-9794-7172d226bb89">57</ix:nonFraction>&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units.  </span></div></ix:continuation><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><ix:continuation id="ib8274fff62114e0bb0104054297a5169" continuedAt="iec577ff92ae041d59643af5139495cc7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts in 2022, 2021 and 2020 also include pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDczNg_e3611ce9-3f3d-472b-a1ad-9a0aede62dfa">21</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDc0MA_72e4ec1d-d4d7-4301-907e-1ff27dcf1cd2">361</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i08f59c7321f84d4abd684a04e126995a_D20191001-20200930" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDc0Nw_4ea2fdeb-c7fc-4c10-bb11-a4036d46f276">378</ix:nonFraction> million, recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iec577ff92ae041d59643af5139495cc7">respectively, related to certain product liability matters, which is further discussed in Note 6.</ix:continuation> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The countries in which the Company has local revenue-generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, and Australia and New Zealand); and Other, which is comprised of Latin America (which includes Mexico, Central America, the Caribbean and South America) and Canada.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4e6fc3b828194201889ba34f62b5a421"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM1MA_ce72221b-73c4-49c0-a8d5-79f224b43dea" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues to unaffiliated customers are generally based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows revenues from continuing operations and long-lived assets of continuing operations by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMi0xLTEtMS03MzUzNQ_603fa2b1-a66a-46ae-ba66-96f6712dc5de">10,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c554f2bb4764f148a7b5f7e8b47a21e_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMi0zLTEtMS03MzUzNQ_29818c75-758c-48a8-ac11-ee45c45e0a54">10,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2274cfe1148048b1a906c0b62d5b0ff1_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMi01LTEtMS03MzUzNQ_b1227002-0f10-4523-8b54-e49592e4e610">9,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf30fdbac78429f9a446f70c25b7be1_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMy0xLTEtMS03MzUzNQ_7913a21e-b4b8-44fb-9576-4a25edce6566">4,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40539fa62924c86bbbb010189f67b04_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMy0zLTEtMS03MzUzNQ_27f73c2f-e956-47b1-a636-e53cd71599b9">4,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4eeacf775b49548f56b317cb763ba4_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMy01LTEtMS03MzUzNQ_338b63f8-7c8c-43d2-a2ba-7b04e984579a">3,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10191e30c4364d2eaeff9b074fad7661_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNC0xLTEtMS03MzUzNQ_54427644-20bc-48c9-a50c-f7d578318cb7">3,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18583ef90cc241e4bf98d850f3c5ecbd_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNC0zLTEtMS03MzUzNQ_d45c293f-72c7-4de2-8502-04bfb5953d5f">3,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f992e63e5074f08920c5d9d5d2dcfad_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNC01LTEtMS03MzUzNQ_47911770-7a2d-42dc-b501-96eee3fc8ec5">2,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96fc867ea3a54208a98744fec84eb274_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNS0xLTEtMS03MzUzNQ_597a0ed2-acfd-4994-b0f1-385d5fd766e8">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e483eb99c7c4b6497a405226527c370_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNS0zLTEtMS03MzUzNQ_5c49a8c3-6889-49b5-b005-109988e42bfc">1,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba39a8a5d76549f5869166e9f4200fc3_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNS01LTEtMS03MzUzNQ_d48cff29-80e0-4820-a3af-7be45fad8807">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNi0xLTEtMS03MzUzNQ_44189e68-120b-4fe6-9452-777dba53f376">18,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNi0zLTEtMS03MzUzNQ_1d0f925f-b9c1-4725-99c8-30a0533b5271">19,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNi01LTEtMS03MzUzNQ_2d6b80a0-d699-4253-95f8-56a2c827ad53">16,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1de7b15fe4d4f0daa2e984903815934_I20220930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOC0xLTEtMS03MzUzNQ_04dbef14-b683-47e9-8d65-0bb28aa96c5f">36,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf717fc531104fa8afeb2f4134bf483d_I20210930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOC0zLTEtMS03MzUzNQ_b5014511-9b37-46ec-8ebf-932454f8d49d">35,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71d28c3e62a46c9a905d0174d34dce7_I20200930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOC01LTEtMS03MzUzNQ_797a0959-7b3a-48c8-ab46-df66c8efd125">36,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d2afe4861c4a3e9820f0da284c2e26_I20220930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOS0xLTEtMS03MzUzNQ_c9aaa72d-b911-4f49-ae11-f530aa1a933d">5,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4663fdc221d47b9a6c6e31fa080b355_I20210930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOS0zLTEtMS03MzUzNQ_8aab214a-1773-452a-a083-fe62aed58afc">5,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11eb132003cd49cf9c750bee96c9d6ba_I20200930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOS01LTEtMS03MzUzNQ_718bf4bf-997c-445a-adbd-17ba2cbbd270">5,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5afb79183c5543d798cf072178bc024a_I20220930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTAtMS0xLTEtNzM1MzU_18be1c4f-1723-4f9d-9aa8-9db52d9feef5">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e3d42c7945a4497a141565ec8971e5d_I20210930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTAtMy0xLTEtNzM1MzU_a30d6271-04be-4ac5-85ba-7e9548a8b422">1,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc73ad9d66924344a539a3a87b464261_I20200930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTAtNS0xLTEtNzM1MzU_18aa40b0-cc37-47cc-908c-f389a925ed89">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820d3d2264834cbebc2fa459cd563e8c_I20220930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTEtMS0xLTEtNzM1MzU_d8d2acf0-2854-4870-8f79-cc78c2328ed5">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c8e2684ba049d78fb1ad3565e6b339_I20210930" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTEtMy0xLTEtNzM1MzU_58d0fe71-2b4c-44c8-9259-d80201904d7c">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae50cb57e95446c6b92fb35fafe9f9da_I20200930" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTEtNS0xLTEtNzM1MzU_32f0d100-aa82-4a7a-9205-1032e3da068e">753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81362db95912497e859aa74adfeff72b_I20220930" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTItMS0xLTEtNzM1MzU_8208dd89-b27b-42de-942d-951e39031bc4">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b105c0c4f50427f8410867a9ec1bf65_I20210930" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTItMy0xLTEtNzM1MzU_7ceb78f2-898b-47af-957a-c5ac6e0f38b2">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6968aa8bf59f445c9ff26455961aed57_I20200930" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTItNS0xLTEtNzM1MzU_d4ec7428-1a2c-45ed-8839-9f2e66cc00b6">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTMtMS0xLTEtNzM1MzU_a51946aa-1fee-463c-8945-7720434b4210">44,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTMtMy0xLTEtNzM1MzU_99d6c4f9-5f58-4bd7-9499-83efd5157829">44,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTMtNS0xLTEtNzM1MzU_2e4223e2-e7ec-44bf-95be-fa6297343bfa">44,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MjQ_a2e40e7e-8d43-4274-a844-990974f00fb3" continuedAt="i75f9bf7c76804d5f83f2c70094ea28a8" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i75f9bf7c76804d5f83f2c70094ea28a8" continuedAt="id0a8ad8e92e44226a41db1efd498a26f"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (&#8220;2004 Plan&#8221;), which provides long-term incentive compensation to employees and directors consisting of: stock appreciation rights (&#8220;SARs&#8221;), performance-based restricted stock units, time-vested restricted stock units and other stock awards.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based payments is recognized as compensation expense in net income.  BD estimates forfeitures based on experience at the time of grant and adjusts expense to reflect actual forfeiture</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MzE_04e44452-d340-4d54-b1bb-27f4dfae6c68" continuedAt="i075220e61a7449769567600e284057f5" escape="true">The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i075220e61a7449769567600e284057f5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:49.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee987dab8c144399f2ff0d88aa15f7b_D20211001-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzEtMS0xLTEtNzM1MzU_b96cc44d-7ee6-4565-86e6-c038608cb6af">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032efb1d86ce48d0909296f8cca53459_D20201001-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzEtMy0xLTEtNzM1MzU_5c6c5b7f-2df2-4ca2-9ce8-0a6c554506ac">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if421c3b8ea2a4e7ab527e52a891f26c5_D20191001-20200930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzEtNS0xLTEtNzM1MzU_49b55297-5b7b-4a52-bbd2-922af25a4f3c">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54aab8ed6b4e47aebcac9e9c927310b7_D20211001-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzItMS0xLTEtNzM1MzU_c16e6b36-3e1a-4aba-a9c1-e7a802f193e9">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8660d76f8bf1403894faec3ddd4176a0_D20201001-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzItMy0xLTEtNzM1MzU_93816f52-ae14-459d-aad8-52858353752a">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5645bcb73774a2284d8ac4c0ac3dea0_D20191001-20200930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzItNS0xLTEtNzM1MzU_95460adf-5083-4c11-b652-5c5d3c89ef88">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6835087ad8c4728bb6473612b2cf0bf_D20211001-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzMtMS0xLTEtNzM1MzU_2f87768c-c037-4c95-a6b9-067a283d7044">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d179fae935c4c82a01090f5b56e975c_D20201001-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzMtMy0xLTEtNzM1MzU_76db3702-f6d8-47b1-83b8-463dfcb46864">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd69a3a2f71e4c5fa5e480606c3addb6_D20191001-20200930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzMtNS0xLTEtNzM1MzU_edf1a035-924a-4506-a08a-408b5a5764f8">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and other restructurings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8b9befe2884f62abaad02f5835561b_D20211001-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzQtMS0xLTEtNzM1MzU_be6fb239-a623-4554-a399-5635ab665278">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf08a9c8e8b4394a3000593ba05da14_D20201001-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzQtMy0xLTEtNzM1MzU_f3eecb29-3714-43ad-8011-39c7d669f051">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b9f84be28aa4054929a2360fb4e6192_D20191001-20200930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzQtNS0xLTEtNzM1MzU_b728cae8-6297-4b75-bb6d-5bd92ec0ac01">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzUtMS0xLTEtNzM1MzU_072bd0a7-2ddf-4a90-8de9-679355d7e07f">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzUtMy0xLTEtNzM1MzU_56e8ac5c-2631-4b16-8ba6-68126c7cf441">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzUtNS0xLTEtNzM1MzU_f8fe5082-6da5-4af7-9710-b5cebc05fc8e">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit associated with share-based compensation costs recognized</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzctMS0xLTEtNzM1MzU_2cceec4f-6c0d-4425-ae88-a157f561003f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzctMy0xLTEtNzM1MzU_040e91b1-b792-4d9d-b518-067e95c655d0">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzctNS0xLTEtNzM1MzU_50c283f3-36fa-4957-8eed-cd2f437194a5">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense includes pre-tax compensation expense included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that was not material in 2022, 2021 and 2020. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the Company's acquisition of Bard in 2018, certain pre-acquisition equity awards of Bard were converted into either BD SARs or BD restricted stock awards, as applicable. These awards have substantially the same terms and conditions as the converted Bard awards immediately prior to the acquisition date. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id0a8ad8e92e44226a41db1efd498a26f" continuedAt="i8b93007d0a8b4ca0af37fb29e02bc3d8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i91be43483d0f4b4b8867902706c778e4_D20191001-20200930" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzEwNzk_ef441527-9738-4674-a45a-2756b7541ee2">16</ix:nonFraction>&#160;million associated with these replacement awards was recorded in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and other restructurings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2020.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs generally vest over a period of <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzE1MDQ_a0b21342-42f1-4372-a446-944cd27796fe">four years</ix:nonNumeric> and have a term of <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzE1MjY_341b3af7-b519-4b91-955c-0b2653963559">ten years</ix:nonNumeric>.  <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MjA_33082a7a-54e9-4ca9-b978-63a31161aab9" continuedAt="iaa15d2200cd340999793d2172d83f1bc" escape="true">The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="iaa15d2200cd340999793d2172d83f1bc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzEtMS0xLTEtNzM1MzU_8347a8d5-bd22-4f6f-ba79-22d3cec2b7e8">1.41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzEtMy0xLTEtNzM1MzU_54783abd-db24-44cf-85e1-fcb87bf4c4f2">0.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzEtNS0xLTEtNzM1MzU_bf9bcc72-d56c-40b0-af53-f5bc27bfa560">1.69</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzItMS0xLTEtNzM1MzU_2e0511f1-ae44-4965-9de1-9fd5b81404e3">22.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzItMy0xLTEtNzM1MzU_7e4b2072-31bc-4ae2-b888-fec649518c90">23.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzItNS0xLTEtNzM1MzU_7a2ba21a-a3c5-4863-8bda-08a8b5f08940">19.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzMtMS0xLTEtNzM1MzU_b6fb4825-e562-465a-be63-e64ea7451518">1.42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzMtMy0xLTEtNzM1MzU_5ea7ce00-65fc-4375-a372-d81e7a3b7ab8">1.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzMtNS0xLTEtNzM1MzU_d630358a-0978-4b25-b753-079749e90482">1.24</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzQtMS0xLTEtNzM1MzU_4e71a8b2-8a89-4256-8209-178a3e7a71b6">7.3</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzQtMy0xLTEtNzM1MzU_2a655a1e-4f3c-41ad-94a4-bd2d847d85e7">7.4</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzQtNS0xLTEtNzM1MzU_ece52012-db62-45a0-9669-1a6f42ccd811">7.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value derived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzUtMS0xLTEtNzM1MzU_5c424f9b-c5df-449e-9f36-6be4cf24f653">49.45</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzUtMy0xLTEtNzM1MzU_da29a56d-5f11-4139-8d24-37c948fa1e2b">44.38</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzUtNS0xLTEtNzM1MzU_d12ccfa7-bc98-4dab-93cc-704bb2b6fda3">48.82</ix:nonFraction></span></td></tr></table></ix:continuation></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility is based upon historical volatility for the Company&#8217;s common stock and other factors. The expected life of SARs granted is derived from the output of the lattice-based model, using assumed exercise rates based on historical exercise and termination patterns, and represents the period of time that SARs granted are expected to be outstanding. The risk-free interest rate used is based upon the published U.S. Treasury yield curve in effect at the time of grant for instruments with a similar life. The dividend yield is based upon the most recently declared quarterly dividend as of the grant date. The Company issued <ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-5" name="bdx:StockIssuedUnderStockAppreciationRightsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzIzNzk_3afdc518-ca75-481f-ad40-5d508b361f34">0.7</ix:nonFraction> million shares during 2022 to satisfy the SARs exercised.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MDY_76315b3c-55ce-4e14-b71a-d45112fb66c9" continuedAt="ic08c2de477424db483a0ea052fcc7dea" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of SARs outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SARs (in<br/>thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual&#160;Term<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(Millions<br/>of dollars)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzEtMS0xLTEtNzM1MzU_6945bc25-5e80-48b0-955f-af04b4c696e1">6,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzEtMy0xLTEtNzM1MzU_b1dd4767-675e-42bf-8081-66d1d25735b9">179.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzItMS0xLTEtNzM1MzU_20916e5e-00ce-4322-a0a1-81d9adf0bc53">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzItMy0xLTEtNzM1MzU_306b9f1e-3f78-4c38-8822-308a39d723a7">245.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzMtMS0xLTEtNzM1MzU_67ce2f3e-cb94-40cb-8fde-0d33cc689ae6">1,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzMtMy0xLTEtNzM1MzU_dab6cab6-aad0-4900-9b83-8216b0f4a99a">125.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzQtMS0xLTEtNzM1MzU_cfa18d29-0347-4d8e-aad4-2114571d3a23">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzQtMy0xLTEtNzM1MzU_00df0804-4516-48cf-bf99-f245c7ae5241">234.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards transferred to Embecta at spin-off (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMS0xLTEtMTEwMjA0_62e3994e-b9ef-44cc-9e11-8d7ebf4ee9ef">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMy0xLTEtMTEwMTkw_1c0e33af-ecc9-485e-80a9-81d8d951687d">239.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to BD awards related to the spin-off of Embecta  (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtMS0xLTEtMTEwMTk3_434efd62-e928-4a4d-b2fa-1b4e010aa271">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMS0xLTEtNzM1MzU_1072d220-282a-4865-bcef-fb333ecc945a">5,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMy0xLTEtNzM1MzU_6f91e3fc-4252-44cf-9880-89f47bb2c2b8">197.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtNS0xLTEtNzM1MzU_ba73f28b-450b-4627-b804-d3e4d286cb98">5.66</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtNy0xLTEtNzM1MzU_679ce25f-77ed-4dc1-92bc-1725728d5bcc">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at September&#160;30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtMS0xLTEtNzM1MzU_eeab8606-b9d0-4829-be0b-ae1783ac287c">5,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtMy0xLTEtNzM1MzU_472fa890-880d-4855-9676-7c591b56a5a8">196.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtNS0xLTEtNzM1MzU_16c825a9-81d0-4a6f-be6f-c6d05e1f6f9f">5.58</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtNy0xLTEtNzM1MzU_8ed0cfea-5bb2-4948-b8a8-1cbb25226826">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctMS0xLTEtNzM1MzU_6d823f5a-1664-4c82-9e7b-a82b7e3a2124">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctMy0xLTEtNzM1MzU_9c2ab6fc-39bb-47a1-b181-d7bb291870d5">180.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctNS0xLTEtNzM1MzU_2b28e633-ad3d-4867-98b0-309802ddd934">4.51</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctNy0xLTEtNzM1MzU_6568159c-ecdc-4099-a65b-24a5d18ad580">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8b93007d0a8b4ca0af37fb29e02bc3d8" continuedAt="i5ef67f395275422197ebb65a1b0cdebd"><ix:continuation id="ic08c2de477424db483a0ea052fcc7dea"><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD SARs which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.</span></div></ix:continuation><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY3OTY_f94a7610-fbc4-4ffd-9238-a6e779d675b8" escape="true"><div style="margin-top:4pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of SARs exercised during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.666%"><tr><td style="width:1.0%"></td><td style="width:60.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of SARs exercised</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzEtMS0xLTEtNzM1MzU_9b537d2c-8e15-48dc-97a6-144342b49b4e">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzEtMy0xLTEtNzM1MzU_2d3766da-d73a-4dc4-a25f-37a009f7008c">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzEtNS0xLTEtNzM1MzU_b6aa344e-fa28-40ee-8d71-b126b53970f1">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of SARs vested</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="bdx:FairValueOfStockAppreciationRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzMtMS0xLTEtNzM1MzU_1a016a0b-2de6-4db6-8945-335133e33fdf">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:FairValueOfStockAppreciationRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzMtMy0xLTEtNzM1MzU_2183e18a-5496-4985-9dc1-8cda8a30d8b3">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:FairValueOfStockAppreciationRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzMtNS0xLTEtNzM1MzU_941c799f-be8f-4714-9b48-400e2fa3e03e">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based and Time-Vested Restricted Stock Units</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance-based restricted stock units cliff vest <ix:nonNumeric contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzI3MDI_92c3d6ab-f3d0-484d-b4e2-fd818c00e21f">three years</ix:nonNumeric> after the date of grant. These units are tied to the Company&#8217;s performance against pre-established targets over a performance period of <ix:nonNumeric contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" name="bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzI4NDI_f92bc812-fdc5-4f07-ad5c-06af0e64772c">three years</ix:nonNumeric>. The performance measures for fiscal years 2022, 2021 and 2020 were average annual currency-neutral revenue growth and average annual return on invested capital, with the combined factor subject to adjustment based on the Company's relative total shareholder return (measures the Company&#8217;s stock performance during the performance period against that of peer companies). Under the Company&#8217;s long-term incentive program, the actual payout under these awards may vary from <ix:nonFraction unitRef="number" contextRef="i1878f37315d04b1a98cbf4c1d0819498_D20211001-20220930" decimals="2" name="bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzM0NDA_a58b3602-aeb8-42d5-a29a-5bd683394952">zero</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i0817d59aef3845269f35d7e2afcd203d_D20211001-20220930" decimals="2" name="bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzM0NDY_c85a6028-abd8-4e47-b555-b726999b5182">200</ix:nonFraction>% of an employee&#8217;s target payout, based on the Company&#8217;s actual performance over the performance period of <ix:nonNumeric contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" name="bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzM1NTQ_f92bc812-fdc5-4f07-ad5c-06af0e64772c">three years</ix:nonNumeric>. In fiscal years 2021 and 2020, the Company also issued additional performance-based time-vested units to certain key executives, which cliff vest three years after the date of grant and are tied to the Company&#8217;s performance against average annual growth in the Company&#8217;s Adjusted EPS over a performance period of three years. No shares will be issuable if the performance targets have not been met. The fair value is based on the market price of the Company&#8217;s stock on the date of grant. Compensation cost initially recognized assumes that the target payout level will be achieved and is adjusted for subsequent changes in the expected outcome of performance-related conditions. For units for which the performance conditions are modified after the date of grant, any incremental increase in the fair value of the modified units, over the original units, is recorded as compensation expense on the date of the modification for vested units, or over the remaining performance period for units not yet vested.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time-vested restricted stock unit awards vest on a graded basis over a period of <ix:nonNumeric contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzQ2NTI_c98e6c3d-8b1f-49b5-a8de-f58f43903d92">three years</ix:nonNumeric>, except for certain key executives of the Company, including the executive officers, for which such units generally vest <ix:nonNumeric contextRef="i79c2acdab6234d67848433db1d1dbd37_D20211001-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzQ3NzY_9a26e5d9-25c0-4f4b-a5e6-f274c8bf89be">one year</ix:nonNumeric> following the employee&#8217;s retirement. The related share-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all time-vested restricted stock units is based on the market value of the Company&#8217;s stock on the date of grant.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5ef67f395275422197ebb65a1b0cdebd" continuedAt="i1a88f454cdad43e7a0ae595f611a3eef"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4Mjc_9c34725c-e057-4979-82b0-d5066032378a" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock units outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.166%"><tr><td style="width:1.0%"></td><td style="width:40.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Units&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Grant<br/>Date&#160;Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Units&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Grant<br/>Date&#160;Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6f651512be74e1d93a7c0f9cac1e296_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItMS0xLTEtNzM1MzU_96f4a51e-7865-4065-a999-3389a5e9528d">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6f651512be74e1d93a7c0f9cac1e296_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItNC0xLTEtNzM1MzU_93160aa3-7cc1-4b97-a7ca-466b76258848">231.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15ef9393893346008a24448385a34a5c_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItNi0xLTEtNzM1MzU_d01b3b38-ebe6-4cad-8b47-37bf3aa51082">1,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i15ef9393893346008a24448385a34a5c_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItOC0xLTEtNzM1MzU_b64d5eb8-643e-4724-beba-b75cf51ea294">221.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtMS0xLTEtNzM1MzU_16657256-ebb5-4f66-891c-345ac72cb3e1">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtNC0xLTEtNzM1MzU_bae0045f-65c8-4de1-ac95-5d30ab651595">242.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtNi0xLTEtNzM1MzU_44b59bdd-1ca3-40db-8a6f-2189682531c9">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtOC0xLTEtNzM1MzU_0ecb8371-ff2c-4e76-b60e-3823e3620258">239.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtMS0xLTEtNzM1MzU_7a190ea9-69c2-4fd8-aa3a-1c7d19c55389">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtNC0xLTEtNzM1MzU_c16cb404-86e6-4d2c-a743-4773b6785920">237.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtNi0xLTEtNzM1MzU_13d45120-7155-4b36-a7ba-51946ee4a857">524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtOC0xLTEtNzM1MzU_f69679ea-d92a-4682-9e8d-3b7a62751037">224.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtMS0xLTEtNzM1MzU_f21d157d-61c5-4cb3-8049-5fc7c6c69b3d">369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtNC0xLTEtNzM1MzU_76997aab-b865-4ef9-bb14-6b2d807c881f">235.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtNi0xLTEtNzM1MzU_04461bb9-cdd2-4155-a0f2-fbf67b9e0e31">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtOC0xLTEtNzM1MzU_88f79685-fa95-4ce8-b43f-043e30c00bb1">228.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards transferred to Embecta at spin-off (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtMS0xLTEtMTEwMjYz_9f5703c8-b56f-4e53-bf30-67b7e644deaa">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNC0xLTEtMTEwMjcw_6b6b9627-7464-4d3a-b318-8ea94d3b200c">234.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNi0xLTEtMTEwMjc3_d424663e-6a89-467a-86fb-2b1d2394fe06">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtOC0xLTEtMTEwMjg0_ec9b3c75-824f-4774-907c-e30736e5aa00">237.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to BD awards related to the spin-off of Embecta (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctMS0xLTEtMTEwMjYz_ac94bda8-3511-4c23-bdbe-30b40e953aae">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctNi0xLTEtMTEwMjc3_1f0f863f-f1a8-4796-99aa-1d826e594c3e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i033e6a9eb88b43d980fc575fa72123e5_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtMS0xLTEtNzM1MzU_96d47ec4-a0de-4d99-a499-047038d91142">934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i033e6a9eb88b43d980fc575fa72123e5_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNC0xLTEtNzM1MzU_34741610-c542-4b74-a868-ffd9ba8f52a1">230.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i873b906d317a431aa87a7b6cf2fd045c_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNi0xLTEtNzM1MzU_a77c4e80-036c-48b6-b7a3-4e097c003059">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i873b906d317a431aa87a7b6cf2fd045c_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtOC0xLTEtNzM1MzU_605b25d0-6a3b-4a6d-97bd-4e5e634b9cff">224.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at September&#160;30</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctMS0xLTEtNzM1MzU_5700ec0b-45a0-4619-b43d-ca29faa504b7">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctNC0xLTEtNzM1MzU_d345b6a0-2b21-4388-a964-05314add2624">229.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-3" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctNi0xLTEtNzM1MzU_4b279333-0a31-4efc-af8d-3ca88a3885b6">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="2" name="bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctOC0xLTEtNzM1MzU_3fdff769-22f5-45a2-b0d3-66f4dcbb3072">224.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD restricted stock units which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Based on <ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzUyMzE_d2f17a1b-14e9-4acb-899a-de4550de916e">200</ix:nonFraction>% of target payout for performance based restricted units and <ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzUyOTQ_58279074-fdf8-4af4-abec-2911198c63b6"><ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzUyOTQ_851d35d3-9a86-4e5d-9e01-ac61f91584f4">100</ix:nonFraction></ix:nonFraction>% of the performance based time-vested units.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net of expected forfeited units and units in excess of the expected performance payout of <ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:ExpectedForfeitedPerformanceBasedRestrictedStockUnits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU0MzE_fb6a9a12-62f2-45b3-bd1e-d88bc3dec15f">65</ix:nonFraction> thousand and <ix:nonFraction unitRef="shares" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-3" name="bdx:UnitsInExcessOfExpectedPerformancePayout" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU0Mzg_aeeaac38-114f-449a-8473-270f189d9f4d">386</ix:nonFraction> thousand shares, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MTg_98354745-4577-4e9b-8e03-9ed36205a394" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of restricted stock units granted during the years 2022, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"><tr><td style="width:1.0%"></td><td style="width:35.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.343%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItMS0xLTEtNzM1MzU_4320abdf-580a-4ab5-ad14-a176df125b80">242.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i358a67c5d4ed43109765477c30e7c234_D20201001-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItMy0xLTEtNzM1MzU_04102c58-ca6e-45bb-8a47-b563cf0061f2">216.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0326d51b048d49febfbe800191bb36de_D20191001-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItNS0xLTEtNzM1MzU_48b83de0-848e-40bb-afca-3679889761da">245.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItNy0xLTEtNzM1MzU_e023796b-0e05-432a-a74d-ce7974dd078e">239.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4349c1158a974223aa831dfcf0b2cbc7_D20201001-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItOS0xLTEtNzM1MzU_b95d2b32-c156-49ca-9f83-b73ce5fe2850">223.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5d3a7a2e0c64e4d98235396301e0718_D20191001-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItMTEtMS0xLTczNTM1_3a796a2f-f92b-43c8-b29f-2e3264a32b55">249.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MzY_f7105fa0-eb74-42d8-8692-f93f9c286f09" escape="true"><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of stock units vested during 2022, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"></td><td style="width:37.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.713%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.717%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of units vested</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItMS0xLTEtNzM1MzU_6cde339a-2f4d-4efe-9206-512afa81f706">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i358a67c5d4ed43109765477c30e7c234_D20201001-20210930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItMy0xLTEtNzM1MzU_f7c240bd-793e-4a50-b42c-15c374876f1b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0326d51b048d49febfbe800191bb36de_D20191001-20200930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItNS0xLTEtNzM1MzU_3436a43e-70c1-4b76-838b-432f2a5db19e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItNy0xLTEtNzM1MzU_1b896447-96db-474a-b93d-2793a97e9404">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4349c1158a974223aa831dfcf0b2cbc7_D20201001-20210930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItOS0xLTEtNzM1MzU_061dc87b-0008-426f-b2a6-38588335fa83">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5d3a7a2e0c64e4d98235396301e0718_D20191001-20200930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItMTEtMS0xLTczNTM1_07181088-66a5-4a6a-9b65-24305ef48a13">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the weighted average remaining vesting term of performance-based and time vested restricted stock units is <ix:nonNumeric contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU3ODU_bf136da2-72de-47e7-aef8-bbd8b8859300">1.23</ix:nonNumeric> and <ix:nonNumeric contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU3OTI_7873821a-0f97-472f-89d8-40b84a0db172">0.90</ix:nonNumeric> years, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Compensation Expense and Other Stock Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of unrecognized compensation expense for all non-vested share-based awards as of September&#160;30, 2022, is approximately $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU5ODU_d0f57821-d2d1-43d3-886e-c647fb94e2d4">253</ix:nonFraction> million, which is expected to be recognized over a weighted-average remaining life of approximately <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzYwODA_5d39d256-fcd7-4a2c-86cc-24c296400ddc">1.9</ix:nonNumeric> years. At September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzYwOTg_824423eb-7a03-4a94-ae1c-146df67281b9">7.2</ix:nonFraction> million shares were authorized for future grants under the 2004 Plan. The Company has a policy of satisfying share-based payments through </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1a88f454cdad43e7a0ae595f611a3eef"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">either open market purchases or shares held in treasury. At September&#160;30, 2022, the Company has sufficient shares held in treasury to satisfy these payments.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="ifedfc8723a1240dfbd527fddd8610509_I20220930" decimals="-3" name="us-gaap:CommonStockSharesHeldInEmployeeTrustShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzYzODU_3b73bbc6-7155-4115-a459-01d46e1a2b94">101</ix:nonFraction> thousand shares were held in trust relative to a Director's Deferral plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis. Also as of September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-3" name="bdx:SharesIssuableUnderDeferredCompensationPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY1Nzg_258a00b0-d963-49ee-b89b-a2042fe5aa9b">231</ix:nonFraction> thousand shares were issuable under a Deferred Compensation Plan that allows certain highly-compensated employees, including executive officers, to defer salary, annual incentive awards and certain equity-based compensation.</span></div></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzAy_6d0e52f1-8ca4-4fa0-a5d9-ee95fe655f3b" continuedAt="i2f4373fc1af949b5ae4351f8369b92d9" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="i2f4373fc1af949b5ae4351f8369b92d9" continuedAt="ib76fcb2deeef4306bbdb976e50115a46"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> on its consolidated statements of income, with the exception of certain amounts for termination benefits, curtailments and settlements related to the spin-off of Embecta, which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income from Discontinued Operations, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and were not material. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of employees to Embecta in connection with the spin-off triggered remeasurements of some of the Company&#8217;s benefit plans. These remeasurements, which were calculated using discount rates and asset values as of the date of the spin-off, did not materially impact the Company&#8217;s benefit obligation. The remeasurements also resulted in a related adjustment to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive loss.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. Postretirement healthcare and life insurance benefits provided to qualifying domestic retirees as well as other postretirement benefit plans in international countries are not material. The measurement date used for the Company&#8217;s employee benefit plans is September&#160;30.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Company&#8217;s conclusion to merge the legacy Bard pension plan into the BD defined benefit cash balance pension plan, the assets and liabilities of the legacy Bard U.S. defined pension benefit plan were remeasured as of October 31, 2020. Amendments to this plan were approved and communicated to affected employees in the first quarter of fiscal year 2021. The legacy Bard U.S. pension plan has been frozen to prevent new participants since January 1, 2011. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2018, the legacy BD U.S. pension plan was frozen to limit the participation of employees who are hired or re-hired by the Company, or who transfer employment to the Company, on or after January 1, 2018.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzA3_7034217a-cb63-46f2-960b-d93d202f6d98" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost for the years ended September&#160;30 included the following components:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.500%"><tr><td style="width:1.0%"></td><td style="width:59.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzItMS0xLTEtNzM1MzU_e276d922-273b-4b46-b65f-c7ce80b25196">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzItMy0xLTEtNzM1MzU_6153dc78-1607-48a5-a43c-8efe85cd3c7b">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzItNS0xLTEtNzM1MzU_a1aae394-49ec-475c-b5bb-4682fca955e5">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzMtMS0xLTEtNzM1MzU_03b7c8b4-29eb-453d-aa25-7be35b2d31f6">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzMtMy0xLTEtNzM1MzU_7196e039-4fd0-4ebe-8fd4-fe7b3fc30737">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzMtNS0xLTEtNzM1MzU_63671f1d-4508-428f-8d2c-3f1d4b1545b7">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzQtMS0xLTEtNzM1MzU_0c1c8678-da53-440e-98a7-6480d38e3c3b">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzQtMy0xLTEtNzM1MzU_0d257c30-f607-4a4e-85e7-3c0fd23f5474">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzQtNS0xLTEtNzM1MzU_a493afac-8fa3-4567-8bc2-ef321cb95844">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzUtMS0xLTEtNzM1MzU_a864cc08-eb8e-484f-8f4a-8b71d833d06e">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzUtMy0xLTEtNzM1MzU_a8ccdafc-4429-439f-8be9-96d207c63dde">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzUtNS0xLTEtNzM1MzU_90019ddc-76f8-4904-a774-36a5788813e3">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzYtMS0xLTEtNzM1MzU_455f8294-c0b0-4434-ba29-fd27b42a0f5d">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzYtMy0xLTEtNzM1MzU_6e572237-ca04-4804-8a7a-051ff2c589b5">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzYtNS0xLTEtNzM1MzU_48f2de81-aaac-478e-b751-228d40ef13eb">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzctMS0xLTEtNzM1MzU_fcaf9072-81ac-4c25-aebc-fc0e622af865">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzctMy0xLTEtNzM1MzU_5713ecab-3903-47cb-9b7b-5c9ea083e2fa">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzctNS0xLTEtNzM1MzU_69c828eb-1c37-42c9-a42a-4ad435c9f9af">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzgtMS0xLTEtNzM1MzU_a628eeb5-6a85-4174-b63a-6832fadea2c7">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzgtMy0xLTEtNzM1MzU_3437c09f-77e1-46a8-877d-7aa48671f643">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzgtNS0xLTEtNzM1MzU_b9f41fae-8da3-4282-8bb5-e578fe7ec604">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost included in the preceding table that is attributable to international plans</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzEwLTEtMS0xLTczNTM1_dc455733-aaf0-433c-962f-6f9850b783e9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzEwLTMtMS0xLTczNTM1_85ebe404-2b55-4bbd-b3d8-a79748bd1d60">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzEwLTUtMS0xLTczNTM1_2cdb2a76-e16b-492a-8ea4-7718ab1963c8">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:31.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in prior periods. The settlement loss recorded in </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib76fcb2deeef4306bbdb976e50115a46" continuedAt="i2449cf640b8644ec9fd5120fb0862f78"><div style="margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 included lump sum benefit payments associated with Company&#8217;s U.S. pension plan. The Company recognizes pension settlements when payments from the plan exceed the sum of service and interest cost components of net periodic pension cost associated with the plan for the fiscal year. A curtailment loss in 2021, related to freezing a pension plan in Europe, was recorded when the loss was probable and estimable. </span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNjk4_be76c1bf-6959-4e0b-a092-cca9303c64dd" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in benefit obligation, change in fair value of pension plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.666%"><tr><td style="width:1.0%"></td><td style="width:70.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMtMS0xLTEtNzM1MzU_b6747c11-6628-4c18-a0cf-c7b1544a23c5">3,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6fba700db34620b0019217a8d9bd97_I20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMtMy0xLTEtNzM1MzU_dbebb74a-876c-4ae2-a1d0-91125c8d693f">3,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzQtMS0xLTEtNzM1MzU_d86f0b80-7645-4616-901b-ce60c29ab7ec">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzQtMy0xLTEtNzM1MzU_d88cfe89-e33b-40cc-886c-c81310554dd0">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzUtMS0xLTEtNzM1MzU_0fa84920-4494-4b20-84ee-cdb62d13936c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzUtMy0xLTEtNzM1MzU_b03e8d2d-11f5-4b81-9e26-e7bd8b8e7170">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzYtMS0xLTEtNzM1MzU_554ad3df-2c01-4f38-99f0-5eaec4e46c99">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzYtMy0xLTEtNzM1MzU_7e647c59-4319-4f55-8bfe-5dfcac4e67a5">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzctMS0xLTEtNzM1MzU_4ae954ed-ba2c-4495-9f76-1659f15c95d7">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzctMy0xLTEtNzM1MzU_7bd028d3-fa43-412e-8a16-1a6cdc82fd4b">156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Embecta spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="bdx:DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzgtMS0xLTEtNzM1MzU_079ce041-3747-412d-9df9-94f132dd530d">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="bdx:DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzgtMy0xLTEtNzM1MzU_6274488d-2703-4ee1-b84b-703196f9c145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzktMS0xLTEtNzM1MzU_6c2bc9b9-1e55-459a-a12a-86a586284bb9">1,007</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzktMy0xLTEtNzM1MzU_db995a65-2ea1-4c6e-a287-a38564f51475">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments/settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="bdx:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEwLTEtMS0xLTczNTM1_4e6d227f-ffc1-40a0-86ee-8fdc9e3c7b40">246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEwLTMtMS0xLTczNTM1_c880be59-c811-4999-9e45-426b8570e57b">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, includes translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzExLTEtMS0xLTczNTM1_faef3212-495c-4e24-a6aa-1f6226d7e89f">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzExLTMtMS0xLTczNTM1_5907f507-af94-41d5-98df-7b765f84031d">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at September&#160;30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEyLTEtMS0xLTczNTM1_17b38a55-c483-419b-9089-e214daa5e8a7">2,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEyLTMtMS0xLTczNTM1_658109e9-6faa-461b-befb-67774e2af851">3,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE0LTEtMS0xLTczNTM1_eb72978b-9632-4a38-a81d-aef489f36077">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6fba700db34620b0019217a8d9bd97_I20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE0LTMtMS0xLTczNTM1_bad6dca4-634c-4a24-892e-8389e7a36510">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE1LTEtMS0xLTczNTM1_477dea7e-f356-4c7e-b410-86a10b6d3523">740</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE1LTMtMS0xLTczNTM1_aa2addc7-c004-433a-a336-e6bd09114781">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE2LTEtMS0xLTczNTM1_4d69ebd6-74e8-4920-8018-afa8ac6f2e26">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE2LTMtMS0xLTczNTM1_f65cf02b-4b6b-471a-a6b8-17448afc1ef3">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE3LTEtMS0xLTczNTM1_ae6424d7-c464-4aca-8681-831065610fa9">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE3LTMtMS0xLTczNTM1_7602dcd6-c6db-4e9f-b3eb-42aa7b537d04">156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Embecta spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="bdx:DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE4LTEtMS0xLTczNTM1_ff50151f-580f-417a-9a2c-65d800995a62">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="bdx:DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE4LTMtMS0xLTczNTM1_47c2e7e8-2faf-4209-bd65-716058023c0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE5LTEtMS0xLTczNTM1_9c9b9d06-147d-41af-a639-30f78fa4ee9d">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE5LTMtMS0xLTczNTM1_dd785f3d-46bb-4a3f-84e1-73056b762715">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, includes translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIwLTEtMS0xLTczNTM1_52f746c0-428d-490c-9931-7ab9ae6bce02">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIwLTMtMS0xLTczNTM1_f27cb4f1-7285-479d-a958-638949d412b0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at September&#160;30</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIxLTEtMS0xLTczNTM1_7cd88371-5ea9-4cef-a1ef-40e26a328bf5">2,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIxLTMtMS0xLTczNTM1_bc8b7b7a-bf3e-43d7-bb1f-7df3e3f283dd">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status at September&#160;30:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfunded benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIzLTEtMS0xLTczNTM1_c12905d3-f60c-4a9e-9dae-f14aa849506d">392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIzLTMtMS0xLTczNTM1_ad0e05f3-8ff7-4dcd-ab91-1aa14fb1c223">667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized in the Consolidated Balance<br/>Sheets at September&#160;30:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI1LTEtMS0xLTczNTM1_b265ac69-5cee-4d1e-a923-0541bac99c9a">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI1LTMtMS0xLTczNTM1_6ac21028-fa26-4230-bb2d-2cc1ac3bcc71">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI2LTEtMS0xLTczNTM1_1ebad84f-8456-42db-a820-12c49d99ed6f">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI2LTMtMS0xLTczNTM1_096597bd-7e02-4ceb-b7e3-a8b75918d0a8">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI3LTEtMS0xLTczNTM1_8047a30d-776d-45bb-bf89-dee0aaeb4fc2">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI3LTMtMS0xLTczNTM1_3464a433-5bde-4ac9-94ef-10278b0f465c">667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI4LTEtMS0xLTczNTM1_b927bd2b-9803-4ea7-979b-9b6478531393">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI4LTMtMS0xLTczNTM1_14245e37-54c9-4cd3-9325-9418c4dacd3f">667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized in Accumulated other<br/>comprehensive income (loss) before income taxes at September&#160;30:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMxLTEtMS0xLTczNTM1_d9df7bcc-d6ed-4e01-a381-43a36fe4a01d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMxLTMtMS0xLTczNTM1_c58c2bc0-6a2a-4abe-a286-e11a34b1bcbb">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMyLTEtMS0xLTczNTM1_6c03c108-ea42-4e78-b16a-8031e6bcb5ff">728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMyLTMtMS0xLTczNTM1_4dca8f32-4857-4240-8c2b-91c5de4263e6">972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMzLTEtMS0xLTczNTM1_79aa1140-0575-405a-8e57-c1153fa14a88">704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMzLTMtMS0xLTczNTM1_aa880a0e-9f38-4bc8-ae2a-4e6f2a5bc15c">931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2449cf640b8644ec9fd5120fb0862f78" continuedAt="if1b5198a8119487da52e52181b7d648e"><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International pension plan assets at fair value included in the preceding table were $<ix:nonFraction unitRef="usd" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI0MDU_fb4057b5-4f30-4f2f-90ee-37e46b6f9949">705</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI0MTI_29613373-9809-405a-b1f7-40b123296314">1.033</ix:nonFraction> billion at September&#160;30, 2022 and 2021, respectively. The international pension plan projected benefit obligations were $<ix:nonFraction unitRef="usd" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI1MTA_de889454-a4d8-46ad-a337-3b14c471d6cb">772</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI1MTc_fb01c205-6e49-462f-96d7-ee7b76b13950">1.320</ix:nonFraction> billion at September&#160;30, 2022 and 2021, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit obligation associated with postretirement healthcare and life insurance plans provided to qualifying domestic retirees, which was largely recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Employee Benefit Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i61da2eb734a14d15a43cbf10837c8938_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI3NTU_eb0e244a-809d-4a5d-8161-f2d1cdbdc42a">101</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i8eca0f828ddd427091f4d296a8e807d2_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI3NjI_78bbdbce-d872-4e44-b384-1f6edcdfb4cc">138</ix:nonFraction> million at September&#160;30, 2022 and 2021, respectively.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzI4_162df7cd-06e0-4566-b5e7-13069b6cccae" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated&#160;Benefit<br/>Obligation&#160;Exceeds&#160;the<br/>Fair&#160;Value&#160;of&#160;Plan&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Projected&#160;Benefit<br/>Obligation&#160;Exceeds&#160;the<br/>Fair&#160;Value&#160;of&#160;Plan&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItMS0xLTEtMTMxMjQ1_b65eacfb-213a-4e06-acfe-2d734242ce60">2,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItMy0xLTEtMTMxMjQ3_53061d49-13ab-494b-bcd7-22c44afe6376">3,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItNS0xLTEtNzM1MzU_4e149d61-7c2c-407f-a297-524fc5216ea6">2,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItNy0xLTEtNzM1MzU_bc5f3651-cff0-4a26-bd88-3e9a34f7bd2b">3,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzMtMS0xLTEtNzM1MzU_5a1640dc-4921-415c-bc72-e2dba7ba6873">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzMtMy0xLTEtNzM1MzU_51579041-3c89-40f3-bad6-d3b581ee06ce">3,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtMS0xLTEtNzM1MzU_bd0632ed-edce-42c7-a9eb-8a4cc29d764f">1,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtMy0xLTEtNzM1MzU_a89d7189-e74a-4b00-9bf6-32290c2524ef">2,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtNS0xLTEtNzM1MzU_d0f2d1d9-3c4a-4016-9457-db1a7d635248">1,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtNy0xLTEtNzM1MzU_d51e20c7-2130-438b-8212-3627d3501f0f">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzMw_07832738-493d-4ba5-87ae-edf37ca35d79" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average assumptions used in determining pension plan information were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.333%"><tr><td style="width:1.0%"></td><td style="width:56.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzMtMS0xLTEtNzM1MzU_3f810900-c2a4-4534-ab8c-98ce860f54fc">2.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzMtMy0xLTEtNzM1MzU_f0c775e0-a2fd-41a2-9bf5-fa6a2246254f">2.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzMtNS0xLTEtNzM1MzU_78f3fc2e-0f3c-4cff-aeb1-ad03e9df1b34">3.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzQtMS0xLTEtNzM1MzU_b9216138-501e-46dd-b417-4f2a11fd7783">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzQtMy0xLTEtNzM1MzU_8c7c4e3a-4c44-4427-a82a-cac12e7982de">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzQtNS0xLTEtNzM1MzU_c7591cc9-0370-4bf3-a024-765f010f1e06">1.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzYtMS0xLTEtNzM1MzU_1a6563cf-5605-4d07-9e56-e8b3f2362d83">6.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzYtMy0xLTEtNzM1MzU_b7f19975-1b5c-41fe-b141-28670a11efda">6.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzYtNS0xLTEtNzM1MzU_73871270-f190-4aa0-9d37-0d1cf1e5f2ae">7.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzctMS0xLTEtNzM1MzU_8f7932aa-77a7-4ccf-9218-532c9a9ee05d">4.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzctMy0xLTEtNzM1MzU_5eae6030-e359-47d2-b0df-b4048e7f237e">4.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzctNS0xLTEtNzM1MzU_c661e937-23a4-4b79-b305-978463eaf9a9">5.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzktMS0xLTEtNzM1MzU_261658d5-383e-4596-913e-de96453c94fe">4.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzktMy0xLTEtNzM1MzU_afc08e37-ed89-47ed-bfe5-d05fddff3766">4.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzktNS0xLTEtNzM1MzU_2e633b70-0c8f-4e2f-ad0f-cb866467b540">4.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEwLTEtMS0xLTczNTM1_d3ae365a-7ae0-4c27-a9ae-d54fa124ea26">2.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEwLTMtMS0xLTczNTM1_9ef71765-ace7-4cc2-ace0-08985c64b701">2.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEwLTUtMS0xLTczNTM1_1fc5d6dc-7154-4e59-886e-84bfe5b24b7f">2.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance plan interest crediting rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEyLTEtMS0xLTczNTM1_386c7ddd-7787-435d-8d58-cfa41b3d256f">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEyLTMtMS0xLTczNTM1_9fe83706-6af6-4ee9-8a91-33f9f76464b8">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEyLTUtMS0xLTczNTM1_40053ff7-5c55-4f21-8ef0-0546f5d16a68">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEzLTEtMS0xLTczNTM1_1697d93b-2f31-4abd-9ba3-6d92a44f0a62">2.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEzLTMtMS0xLTczNTM1_3dfa42b8-83bd-4306-b89f-24dd19085653">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEzLTUtMS0xLTczNTM1_7c88b5eb-b7b9-4baf-b248-2fd045dcccf0">1.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53f9080405314d2e819b92e79feeced8_I20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE2LTEtMS0xLTczNTM1_1864fd33-731e-4fc9-8977-8a326cb3250b">5.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE2LTMtMS0xLTczNTM1_21249f31-e922-4c10-af0f-52dbd7b1d3bf">2.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE2LTUtMS0xLTczNTM1_0c5c81d3-8066-4f50-996c-b17d603a7ac9">2.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE3LTEtMS0xLTczNTM1_fbb91eae-1835-43a0-902c-a43f9337e023">4.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE3LTMtMS0xLTczNTM1_1de40278-d425-41e6-a9d9-6914bb8e15bd">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e39bf2e8f1844b993cce4161a84bbff_I20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE3LTUtMS0xLTczNTM1_8daa0f1a-5b7d-4262-835e-040c6ad35842">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53f9080405314d2e819b92e79feeced8_I20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE5LTEtMS0xLTczNTM1_a8ad9e49-48a0-4c36-8bde-c946ca0c1d24">4.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE5LTMtMS0xLTczNTM1_715b8681-2699-47f5-ac35-b5c4201b60dd">4.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE5LTUtMS0xLTczNTM1_bd4296f2-5867-430f-b378-fce84586b406">4.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIwLTEtMS0xLTczNTM1_a3c530bb-4e10-49fc-94e0-cc93554591a4">2.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIwLTMtMS0xLTczNTM1_8cce196c-fdc7-4257-a8fa-0e203c991715">2.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e39bf2e8f1844b993cce4161a84bbff_I20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIwLTUtMS0xLTczNTM1_17144f2e-0a29-4ef4-a825-7ccbb7d18f19">2.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance plan interest crediting rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53f9080405314d2e819b92e79feeced8_I20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIyLTEtMS0xLTczNTM1_0895d97f-e44c-435c-b28b-125332c99816">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIyLTMtMS0xLTczNTM1_514c25a6-e745-48b6-a2ff-489aa29f8254">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIyLTUtMS0xLTczNTM1_8eae5ad9-2992-47f4-9f3d-76abbe998b96">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIzLTEtMS0xLTczNTM1_d8a012db-71d1-4f61-bc91-22d45c2e136e">1.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIzLTMtMS0xLTczNTM1_86e07997-43f3-4447-b5c8-69cc5a1100fb">2.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e39bf2e8f1844b993cce4161a84bbff_I20200930" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIzLTUtMS0xLTczNTM1_8c20cab3-23c1-4be2-9ca3-4508c4d49122">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company calculated the service and interest components utilizing an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if1b5198a8119487da52e52181b7d648e" continuedAt="i17d08bda7454425db9fc16553b1a3ee0"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expected Rate of Return on Plan Assets</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers many factors, including historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expected Funding</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s funding policy for its defined benefit pension plans is to contribute amounts sufficient to meet legal funding requirements, plus any additional amounts that may be appropriate considering the funded status of the plans, tax consequences, the cash flow generated by the Company and other factors. The Company made discretionary contributions to its BD U.S. pension plan of $<ix:nonFraction unitRef="usd" contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzQxNjg_659d8896-0f10-4096-8f8d-48f6d5085385">134</ix:nonFraction> million during fiscal year 2022. The Company did not make any required contributions in 2022 and does not anticipate any significant required contributions to its pension plans in fiscal year 2023.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzA5_96164cf3-1f36-4693-baa3-3f4467c1c4d6" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.333%"><tr><td style="width:1.0%"></td><td style="width:63.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension<br/>Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzEtMS0xLTEtNzM1MzU_888c735d-0e23-4797-afb6-b6da34e78255">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzItMS0xLTEtNzM1MzU_ced62cb0-7ad6-4607-a2b6-0c9e96481dd9">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzMtMS0xLTEtNzM1MzU_a0143463-2eed-4714-b7d2-247fb2b6998f">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzQtMS0xLTEtNzM1MzU_7160934d-24f0-42e4-bd1b-5e1f8ff875be">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzUtMS0xLTEtNzM1MzU_aed0314e-0679-49e3-af21-416eeb7fd562">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzYtMS0xLTEtNzM1MzU_91ae805f-7219-4af9-a547-810f086b91af">945</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments associated with postretirement healthcare plans are immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s primary objective is to achieve returns sufficient to meet future benefit obligations. It seeks to generate above market returns by investing in more volatile asset classes such as equities while at the same time controlling risk through diversification in non-correlated asset classes and through allocations to more stable asset classes like fixed income.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">U.S. Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. pension plans comprise <ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="bdx:PercentOfAssetsDomesticPlans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzQ5OTA_27a96b24-586e-4ad6-8b25-243391bc2f91">69</ix:nonFraction>% of total benefit plan investments, based on September&#160;30, 2022 market values, and have a target asset mix of <ix:nonFraction unitRef="number" contextRef="i85a5bc5228934abba8c145aa315e0721_I20220930" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzUwODY_d1932588-ffaf-4020-9239-2e13f1372a89">45</ix:nonFraction>% fixed income, <ix:nonFraction unitRef="number" contextRef="i79c926c9a5c9445eb3a6bf1d48ed24dd_I20220930" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzUxMDM_5c8e17e3-0fac-47e0-b616-2e433b1a58aa">21</ix:nonFraction>% diversifying investments and <ix:nonFraction unitRef="number" contextRef="i582bf51e2db142748e01d1a6c1978b1e_I20220930" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzUxMzU_ed3781e5-6629-4df6-835b-f0289659e5ec">34</ix:nonFraction>% equities. This mix was established based on an analysis of projected benefit payments and estimates of long-term returns, volatilities and correlations for various asset classes. The asset allocations to diversifying investments include high-yield bonds, hedge funds, real estate, infrastructure, leveraged loans and emerging markets bonds.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The actual portfolio investment mix may, from time to time, deviate from the established target mix due to various factors such as normal market fluctuations, the reliance on estimates in connection with the determination of allocations and normal portfolio activity such as additions and withdrawals. Rebalancing of the asset portfolio on a quarterly basis is required to address any allocations that deviate from the established target allocations in excess of defined allowable ranges. The target allocations are subject to periodic review, including a review of the asset portfolio&#8217;s performance, by the named fiduciary of the plans. Any tactical deviations from the established asset mix require the approval of the named fiduciary.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. plans may enter into both exchange traded and non-exchange traded derivative transactions in order to manage interest rate exposure, volatility, term structure of interest rates, and sector and currency </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i17d08bda7454425db9fc16553b1a3ee0" continuedAt="id466fe7d2e81409a970ffe81ba555853"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exposures within the fixed income portfolios. The Company has established minimum credit quality standards for counterparties in such transactions.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNjk5_5e51ab06-b494-4fc9-bae4-3f54b9bdf6b4" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021. The categorization of fund investments is based upon the categorization of these funds&#8217; underlying assets.  </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.490%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total U.S.<br/>Plan Asset<br/>Balances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i239cacefc1034e98bffbb2d59ac35059_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMS0xLTEtNzM1MzU_873f95e2-64de-468d-98e3-c814184a39c3">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6210559eed0744c68524b1092620ea9b_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMy0xLTEtNzM1MzU_5be2c3fa-455e-4ac8-8c26-24a3e846ef89">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c7d62af45d419593ad86b92e3629e7_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtNS0xLTEtNzM1MzU_7ba82d57-b514-476e-8648-5f307e6105e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a3bd23935f48b7a00e226a1a8352d6_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtNy0xLTEtNzM1MzU_5430927b-021e-4d7c-9e24-81eaaa30d808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia338360d4785452caa35968390747a10_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtOS0xLTEtNzM1MzU_0be654ef-5235-465f-adc0-9eaa03ccf7b8">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73449f7073ff4ea4b40ee726a2e5769c_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTEtMS0xLTczNTM1_f0e999c6-cc71-44c6-bbe4-50dafa3ff4a4">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3349146ec64e71add05da653f9c92a_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTMtMS0xLTczNTM1_727d714f-6a9e-4350-ae5d-8587822f75ea">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4fd5eb5f494b16af19555193bf5090_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTUtMS0xLTczNTM1_12ca041d-8107-423b-9d7c-495f98d7f1f7">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb9c8a5a3d44e929e8cda49c3e35a5d_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTctMS0xLTczNTM1_a3583598-9ceb-4736-b0dd-d30b6448f3e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7674e8eddd403f9b0b11baa9aca925_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTktMS0xLTczNTM1_3681f415-638f-4aa1-83af-b02f7464ea06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6dfbd58f525441b9ab54c2dea102ed7_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMS0xLTEtNzM1MzU_91a6acdc-e364-4d5e-894e-cb51a3652304">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbe41070dc14cd6a796c56f4121218b_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMy0xLTEtNzM1MzU_4825c1e8-337d-4c43-b710-f6cfb4c2acc2">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6780e627c7f4ad7a05cef6b81219d95_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtNS0xLTEtNzM1MzU_af6017c1-21fe-45f6-bf8c-19c81a3acf6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973ba4ea52044ec7867cce4732e8a723_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtNy0xLTEtNzM1MzU_139e66fe-0d82-44e6-8547-4447aab92a75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f1806f061cb417cace44cee66ae6850_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtOS0xLTEtNzM1MzU_dfeabd16-c16c-436f-babb-5bf7c203b5e8">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56a1e5bf0a745c08a12f76dc30bd149_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTEtMS0xLTczNTM1_1f013990-44af-417b-9352-f3e2a018017a">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd94643846d24bf3b6f8c33987fc6390_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTMtMS0xLTczNTM1_ef5e27e7-2e71-4ec8-9098-594ad235545b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673ea0978cf446da9469a52c417caebb_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTUtMS0xLTczNTM1_cb982a46-8a5b-48a8-8288-9404662840c4">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia149edac1bcb40f2af757eed837bd3b9_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTctMS0xLTczNTM1_1ecaf50a-53b4-43df-abaf-05efd89fc7ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba651878aa3c4951be900f73b0631b94_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTktMS0xLTczNTM1_ca7a9311-d72b-4216-a2e6-cd41a5a6865c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4848b2eb0143ee85a0d7c2d47b4988_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMS0xLTEtNzM1MzU_97fed894-0413-41b7-bb6f-92e99aece15f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5d9bb16f4d74508bc6dbaf0a2455b14_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMy0xLTEtNzM1MzU_cc06f004-c9ce-4ac5-b753-a0592f1cf8d8">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c3151253d64e2d96bee25ce449a710_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctNS0xLTEtNzM1MzU_b69d8fe3-7b0b-4901-8481-b67721eeefc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i719813f3bd404e79b168659b6c3aa573_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctNy0xLTEtNzM1MzU_e8fea6f6-ee53-4cc8-9cb7-f64ece88b90e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1efe0d2e80664df283e57a2eb36423d4_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctOS0xLTEtNzM1MzU_7fee239b-38b8-4968-ad46-25c7f19934bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bb763598f346d88eb4b80147200d91_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTEtMS0xLTczNTM1_fb358b2b-6ec9-459d-9ace-c443174c82be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b9f12bdbc124812844603fbd09891ed_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTMtMS0xLTczNTM1_556f64c1-835a-44cd-b5bd-54597af92115">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455fc00619a649a694accccb414c0a84_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTUtMS0xLTczNTM1_8eadef85-b2a5-472e-bfed-808acb510ee2">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d921cd67c5a4c2eb5567320f4476c60_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTctMS0xLTczNTM1_40e71335-51bf-4a9b-bd67-4f00eaab446a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6535e7d25cd749aa8937a2539be0e13f_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTktMS0xLTczNTM1_56c9b3c0-8aa7-4f6e-ad4f-415503ff66ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fb2f87afa95408a8c56d4a9cd130b30_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMS0xLTEtNzM1MzU_68fc0813-36fb-43ae-91ee-5c92ed5a10f9">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27cde783e1a94eea98b321d147b8ec5f_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMy0xLTEtNzM1MzU_f5540c05-8e6b-4937-938e-611485068587">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4291d87672cd4a8981f4a360a1a9cab7_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtNS0xLTEtNzM1MzU_439b9ffe-0af3-4fde-bff2-e23d3727ca5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8f69ef20e449fa397139f39242dee_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtNy0xLTEtNzM1MzU_a457571d-1106-4dff-869b-fe115cf67b38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e5c0cdc22a4b0e8ba6a3fb3f6e98c5_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtOS0xLTEtNzM1MzU_5420d966-eb5b-457e-9d02-af514b827b6d">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8407f1e21df94016a5bb2c0aedad66ae_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTEtMS0xLTczNTM1_e0e89188-6d5d-489e-8577-0cb59ac9e164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667449f6ee774b11a6b45b97aab6b6b3_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTMtMS0xLTczNTM1_4381471e-0c58-470f-8538-73df8a45621e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c2adc69ec24c689ad7bfe5695d5c71_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTUtMS0xLTczNTM1_22726436-052e-4d0d-a67b-6239e40637f2">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036c7ba8e62a4a75a8b86e314ed59903_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTctMS0xLTczNTM1_458fab68-8005-4f9e-ae25-2f9fea8ca4da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d858f56b814ba1b31e8997945e8cdb_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTktMS0xLTczNTM1_13da3739-6c4c-4f4e-8f4e-7abff4135d1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc3d5d859364765991baf5fbdaaf07d_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMS0xLTEtNzM1MzU_030e3da0-5658-4295-b2b6-fef72a64aa2c">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273c42bd2bf74bef9f62c4b634918468_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMy0xLTEtNzM1MzU_aa0c142d-058b-4b17-93e5-8ec6aa6dbd61">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014f9d02b0cb4bbe8c31fc0740a83fc0_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktNS0xLTEtNzM1MzU_8d113be4-93a6-4b11-beea-a4f648bbdff7">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic16f46d749384f4e91a03d0dc970acd5_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktNy0xLTEtNzM1MzU_3b61cfbd-e6b6-4ccc-925d-8ece3b40c7e7">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ad93bd71254bd594fee877344663f1_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktOS0xLTEtNzM1MzU_80b2ee00-7913-49ae-a7e3-a865fb624b5b">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2764df47883b467ba943ad7a7c3151c6_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTEtMS0xLTczNTM1_391170dc-ca88-4503-866e-69f3946382ab">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b479cb794b4b389dd8f0417d748da4_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTMtMS0xLTczNTM1_e2353292-b947-4597-a356-e7a15f8ea5fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d4bc96a4b642139265cbec59eef4cb_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTUtMS0xLTczNTM1_fe58acc4-9439-4910-8fe4-6bf481284dcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85e1a6e235d47cdbf1b177b7f97c4af_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTctMS0xLTczNTM1_fb6203ad-2e48-4523-83e0-9d2d9e4bd861">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c0de9d4d0e4fae8c6fc8ec55fd02b0_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTktMS0xLTczNTM1_36437ef0-620c-489c-bc37-e514b26f4a0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b3ba666c714449895f2c46717ad2d3_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTEtMS0xLTczNTM1_397fa244-d90d-443b-9bdf-611662b9f731">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id58ed1b77b8640d0b897e7b00007953f_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTMtMS0xLTczNTM1_af7d8b21-d8c1-4f25-a44b-9bb4a4a3a000">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0333656249994d2e8cb26e6f79d7e84d_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTUtMS0xLTczNTM1_f72b6998-6d89-4aa9-94a4-b04ae1b431f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cfd65d075cf414585bf6fc6b7f9c5b0_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTctMS0xLTczNTM1_b9b59950-24af-4922-9a6c-5fe8c594893a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce10790ce4c4090abab20b16d6ee85f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTktMS0xLTczNTM1_47c32f22-e185-47ab-944c-bbf7046513bc">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e3a877768014f80bca7f2823c09c2fd_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTExLTEtMS03MzUzNQ_da72caab-c042-493c-abcd-e16f042ad2e7">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e30739c488347d5afed7d7c698d4c16_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTEzLTEtMS03MzUzNQ_0ea000b7-2bc9-4f24-a34e-a0fcf51e30c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2705f413b5fa4853aa0711dca58567d1_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTE1LTEtMS03MzUzNQ_d23a9acc-c952-4e36-af7c-4e154c76b6a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a14e8e06e8e4781bb2fc8daf0319362_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTE3LTEtMS03MzUzNQ_e6e17b18-c9f1-4b57-916a-feca64e7ab5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia616e09bfcf3438ca18d99c58fbeb7de_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTE5LTEtMS03MzUzNQ_16bd4acd-5fab-4199-ad23-e5e6545733ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cac4e61a856422aa1854bbcaadf4fd6_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTEtMS0xLTczNTM1_18396aa1-b87e-4932-a708-abdd4477c54c">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic923216224064e2989e7625f0081c9a2_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTMtMS0xLTczNTM1_be6dbabf-2676-4a94-a3de-4889c8cb318f">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37ee945ff0c49afa819e5fd6c33170a_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTUtMS0xLTczNTM1_9aa4c76f-da55-4920-8ad7-a2b4605c19ba">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db92b9a655f421789d5d94454ef800c_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTctMS0xLTczNTM1_17efdbb6-4d18-4099-932f-36164b5bc2d8">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf30a237339b4595ae6d08ec2d172296_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTktMS0xLTczNTM1_a8cad310-043d-4d65-bc1d-9f5fa4fcb66e">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8adc411abc471c8fab1c8a0b21f5ed_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTExLTEtMS03MzUzNQ_f8887c8d-fda7-4aff-b0a0-0dea7fac4a6e">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444540566d5f4120ba0a990210e5f64d_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTEzLTEtMS03MzUzNQ_a55d9102-cd0f-48a4-b199-7101d6677260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafc5baf0e3d4db98950714ff7bbaccd_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTE1LTEtMS03MzUzNQ_427f8569-f3d2-49c3-a8bd-ce4f5097b0ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24356b45f51845f99b3c235579c7c492_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTE3LTEtMS03MzUzNQ_82b8252c-5a3b-4782-9c2d-4af08b2bf953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36e04951f0304cc297da29bf9cb5603f_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTE5LTEtMS03MzUzNQ_481244cb-3c69-4b27-9b7e-02efec31842c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f9080405314d2e819b92e79feeced8_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTEtMS0xLTczNTM1_fda2b27b-1dd3-41db-a670-383030af7f06">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTMtMS0xLTczNTM1_92305139-648c-4172-a1cf-abfde0a8e101">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35528802fb404e6bbcbb6b97543f94ef_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTUtMS0xLTczNTM1_a5a29cb5-5840-4a5a-801c-a7790605cab8">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8598d43c36df40e0aa15aa3578b1c46e_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTctMS0xLTczNTM1_f3a4d587-f2a5-4a23-aaad-8a7269950b57">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bc9fbebdd24e2688fede6c4875c0bb_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTktMS0xLTczNTM1_e5e21804-8aa2-40aa-b468-ac0849d7c1a0">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5291e425d6544e199671d3329659b30f_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTExLTEtMS03MzUzNQ_630a79af-0756-413d-9653-a1f94ec629fa">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73098c61ad6b497e9b56e6e64edc8560_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTEzLTEtMS03MzUzNQ_d22de54d-4004-4f4f-ba7e-0013d77a437b">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2ac9dc44f64a518a26cb809ccb8ba3_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTE1LTEtMS03MzUzNQ_1b68f7aa-77d5-4178-b129-b6d1e8819cb7">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04064a31b8074c7cbf784060b303d4db_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTE3LTEtMS03MzUzNQ_e3b541f4-8ebc-42c1-adf3-2d4280cf584d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92c7234473544eebb1751ee0a1eabc0_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTE5LTEtMS03MzUzNQ_9cc9d630-41d2-4710-8dda-9fbe499eba41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt">As per applicable disclosure requirements, certain investments that were measured at net asset value per share or its equivalent have not been categorized within the fair value hierarchy.  Values of such assets are based on the corroborated net asset value provided by the fund administrator.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Income Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. pension plan assets categorized above as fixed income securities include fund investments comprised of corporate and government and agency investments. Investments in corporate bonds are diversified across industry and sector and consist of investment-grade, as well as high-yield debt instruments. U.S. government investments consist of obligations of the U.S. Treasury, other U.S. government agencies, state governments and local municipalities. Assets categorized as foreign government and agency debt securities included investments in developed and emerging markets.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The values of fixed income investments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. A portion of the fixed income instruments classified within Level 2 are valued based upon estimated prices from independent vendors&#8217; pricing models and these prices are derived from market observable sources including: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. pension plan assets categorized as equity securities consist of fund investments in publicly-traded U.S. and non-U.S. equity securities. In order to achieve appropriate diversification, these portfolios are invested across market sectors, investment styles, capitalization weights and geographic regions. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id466fe7d2e81409a970ffe81ba555853" continuedAt="i530143b395074519b4e10db5687dcd29"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments are traded or have a readily determinable fair value based on published prices obtained from fund managers which represent the price at which the instruments can be redeemed at period end. The U.S. pension plan has no future funding commitments associated with these investments and has the right to redeem them upon one day&#8217;s notice, at any time and without restriction.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the U.S. plans&#8217; assets consists of investments in cash and cash equivalents, primarily to accommodate liquidity requirements relating to trade settlement and benefit payment activity, and the values of these assets are based upon quoted market prices.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other U.S. pension plan assets include fund investments comprised of hedge funds. The values of such instruments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">International Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International plan assets comprise <ix:nonFraction unitRef="number" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="2" name="bdx:PercentOfPlanAssetsForeignPlans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzk3NTA_573dfb76-9da0-4e95-a423-1da3dae4c64d">31</ix:nonFraction>% of the Company&#8217;s total benefit plan assets, based on market value at September&#160;30, 2022. Such plans have local independent fiduciary committees, with responsibility for development and oversight of investment policy, including asset allocation decisions.  In making such decisions, consideration is given to local regulations, investment practices and funding rules.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzAx_b5367e23-402c-499c-b481-90105ee6f3cd" continuedAt="i34ad8217f1394abbaf8eb6cacde07731" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value measurements of international plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.333%"><tr><td style="width:1.0%"></td><td style="width:18.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;International<br/>Plan Asset<br/>Balances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3 (a)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0a623813ee4a369e7ef5993fdb798f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMS0xLTEtNzM1MzU_e84dcfc4-872b-4877-9302-805b6fd1ed4e">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d9e0ee20514594b6508a2572ce4abd_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMy0xLTEtNzM1MzU_027935e6-c931-44a3-b27c-6fc33c19bce4">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28aae561f41544a7804bc0b0cb92a718_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtOS0xLTEtNzM1MzU_54873a3b-1ca5-4cff-9e69-877aec8c558a">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70be1a5baac547589f9472c81e2340e1_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTEtMS0xLTczNTM1_2daea339-b272-42a5-b4c9-b72f8cc7bb3b">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie45261a2b5664434b82d1b3f8454fa79_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTMtMS0xLTczNTM1_cc7cd55e-02eb-47d8-b9b9-ebb47840672a">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cfc59ab57674136bbe1362cca826076_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTUtMS0xLTczNTM1_cf67904e-a6fa-43b1-8e6b-89b2e9faabae">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3fc09f7eb6045808fa6cfccba5222f3_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTctMS0xLTczNTM1_97b3490c-511c-40ee-9a05-56f9cdcda39a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fde7c7c7d5e4fbe8a6182d7ed99551a_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTktMS0xLTczNTM1_74d65981-b5ee-45d7-9f0d-e23f27f37ade">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48a14466de2744d68148b941f153e261_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMS0xLTEtNzM1MzU_9cfa2757-c628-4122-9ed2-14f4b741a9d0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f673aa33144145a0153caf0934a902_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMy0xLTEtNzM1MzU_a542a553-fdef-49d7-a343-9b55438c784c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47af4c545a444e8795cd4b3e68071385_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtOS0xLTEtNzM1MzU_a7981065-e200-4f90-8c7d-ded7b7765c9e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44cb6133b3eb45ca89b4fae7bb30718a_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTEtMS0xLTczNTM1_fda2c1d9-5c04-4875-906b-cde8758a0b61">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8d05e1487049f8b27438df7c030bc3_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTMtMS0xLTczNTM1_8ac4fc2d-a062-4ea2-85ab-8b54fb40de5e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idedc37ddaff7492cb156a22eaef9b092_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTUtMS0xLTczNTM1_40e8c156-9654-42a7-a59d-fe793032c773">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cec3d47afff4c80b568b9f7e523a109_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTctMS0xLTczNTM1_aa38b583-b5e3-494f-9054-b1f38be0d127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262df50ecd024aa69410723c273b05e8_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTktMS0xLTczNTM1_c95b0d65-8352-4206-a3e7-290b8449a83d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib914a13ded684ed08743c7d0696e8553_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMS0xLTEtNzM1MzU_fc8b1a9a-7355-430f-a6f6-6176dda72f9a">180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9f5a16ace249d18941f898a5576de4_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMy0xLTEtNzM1MzU_d2ea62f3-576d-45d0-baea-9be9eb5bf09a">264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0056a4535007448985354b76b514a039_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtOS0xLTEtNzM1MzU_bb08c134-0cd3-476b-8643-77e8fd9770dd">167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ee0fc2accb4da6a9e43977a7b69739_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTEtMS0xLTczNTM1_a74a3def-d6ba-4dfa-9215-7029b9c57d42">249</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12cd1badd0ce408c9dcafe27cdd0b20d_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTMtMS0xLTczNTM1_e5f6b035-5e1c-47aa-8602-f774b7cba723">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51bf8cb12ca749c1bd187ce00a9784dd_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTUtMS0xLTczNTM1_c3a2279c-a03d-4c07-997b-43130eacee58">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a1882f3af34faa9ad2c58364443d10_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTctMS0xLTczNTM1_b44d82b1-9276-40a2-81c7-d2d5553df51f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d771de4a2a64a89be0c9be153b39a3e_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTktMS0xLTczNTM1_265fd959-666c-42e4-bc89-ed05efb1eb87">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c753d7231b4002823e9b6267dacc21_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMS0xLTEtNzM1MzU_7b1c2fff-2e52-45f4-b9ba-0612feeac3f6">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa45c1dcfeb64edfa242186776836f16_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMy0xLTEtNzM1MzU_fc3e6a85-00ab-4951-b388-6edb7cc8969e">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e03a1a02086479b88a10af5e3588934_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctOS0xLTEtNzM1MzU_a421134d-f08a-46ec-853d-73ce750a87f8">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieedb758d47d44d4ebe6fcf3edd65171b_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTEtMS0xLTczNTM1_7e12e82f-f345-48b4-bdae-aad128f44c0e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6a0f7f5b6d447ea7d5613cd52fe51e_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTMtMS0xLTczNTM1_433a2786-422d-4358-a453-8cb1cfd88e6e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ed4b3cc36b4b0f8e5f2f0c8bf77444_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTUtMS0xLTczNTM1_01d44fbd-1300-454a-a7e9-e43125672311">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fc5e1747844a0b806dfd7f80523096_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTctMS0xLTczNTM1_5815e3a9-6f4b-4eb6-b29c-c113e1c88d6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8d9c2809b447ae90dc16848ca76dbf_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTktMS0xLTczNTM1_7ebae161-f93f-421f-ace4-6dd10d328e21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75eff2d032c147f597c9f1aceaa27650_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMS0xLTEtNzM1MzU_8516b74d-9e63-4a54-9ad7-322d28f0ac76">190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb13d84cf3d4430cacae3505887fce63_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMy0xLTEtNzM1MzU_8988ee76-cc20-45d4-9ca3-991e7376ae9a">297</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31345d49e9284acfb9ed91fd24ff7205_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtOS0xLTEtNzM1MzU_768c08cc-73cd-4c4f-acf3-dfdb2dc16a74">190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib609d1579e1d40deb0c57bde81e1c157_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTEtMS0xLTczNTM1_df7cbda0-e4a7-4e5f-92b3-ee00e9b92e10">297</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f502cd5c7c4fdcb18d0d7479d2adcd_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTMtMS0xLTczNTM1_bec1c9bc-ca8e-4ec1-b3f4-b880f0f1a460">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f30bff63dd044afa703c76950e345a9_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTUtMS0xLTczNTM1_dd3a434b-3fbe-44a0-aef2-8fe8ca14757a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59dde4d198a4f0c9421510d392f0fe6_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTctMS0xLTczNTM1_65a889d7-0171-4a61-9df3-f065a7005e49">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b3c1ec961624dc6a6e82d3a6d0655f5_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTktMS0xLTczNTM1_947e0630-e0ba-492b-a741-6b038c4116ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77e1ad42f2446289384890caf166680_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMS0xLTEtNzM1MzU_20f2a4c9-a228-4deb-aa92-8ff30d449fe7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2b5962b6fc4b6cab48b61c74e89ee3_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMy0xLTEtNzM1MzU_20329ee8-69fb-425e-8de6-57f4aa72d35a">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f02684e4ee849debf8d23e25e6b3324_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktOS0xLTEtNzM1MzU_93d19f59-8a35-4d24-9d6b-31bcd7c42a04">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43bdb14f100444eba25dc4dae16f103_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTEtMS0xLTczNTM1_16b63f2a-8fd8-426d-8035-27b9674533f7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c02b9046aeb43f39af9743b56405a07_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTMtMS0xLTczNTM1_312e9f4c-8e45-441f-a728-f3ee988dd4db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958a0bea104d4e37948dbed0e1c77969_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTUtMS0xLTczNTM1_1de68065-34f3-43d9-8ce6-7c78d3188ef7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d2c088bf8424db2abcf78de54392802_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTctMS0xLTczNTM1_157734d2-4c57-499f-969e-1f742c214000">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b70728ec7204a2ebbcda87de7fe7488_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTktMS0xLTczNTM1_3d23891e-13e5-4d72-8577-29fcdaed8f34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f9e7335b7e40cba7435a11709f59c8_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTEtMS0xLTczNTM1_f873a1af-eb99-4c4f-b3e4-e358fa95a541">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a64d513dfc400f813fa199a196be91_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTMtMS0xLTczNTM1_9322052a-6ebc-4288-a22a-71866cbb1555">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic432f2c8faa84d159c41bc4deaa713ab_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTktMS0xLTczNTM1_7c147cec-ed4f-42fd-bba5-02cc127d1181">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i132718db1a49414a9da23528a50fcd53_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTExLTEtMS03MzUzNQ_7d70d626-07b9-4db4-8b32-938f122416fa">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f5c87ee09245789101d5ca6586a174_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTEzLTEtMS03MzUzNQ_ffe81089-68b2-4916-970d-11ada1fa8af5">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76c5930de334d2983e06187d224acc8_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTE1LTEtMS03MzUzNQ_6fa4e520-21cc-4d31-8c02-96202028853c">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6fe3a69bb248dfbf2c20fb3768e09b_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTE3LTEtMS03MzUzNQ_6c385e32-d8f5-420f-9285-8df3347fdaec">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f72fdffe684f18a08ab20e7ef102ee_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTE5LTEtMS03MzUzNQ_142d6c47-1518-438b-a668-37d4157be9cf">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838c06881c964d85af7dbc6c561a7832_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTEtMS0xLTczNTM1_c2cb79bb-4368-4e72-a883-3db44481dca3">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3184ac9582b94e1aad158d05fb2af57d_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTMtMS0xLTczNTM1_506163a1-91e4-43aa-9b81-6fd1dcbfef57">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4dcca7281c4dc4a61fcb80d9cd4ba9_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTktMS0xLTczNTM1_959329eb-e568-41b4-ba0a-07096a1acbb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c273f849dd44f598cb4953836e7f267_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTExLTEtMS03MzUzNQ_746a2a7d-5449-4b2c-acdf-d971b2a49fd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5a4ae568f84d1bb02bfe3259a2505a_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTEzLTEtMS03MzUzNQ_23c2b1d0-3433-47dd-bdf0-aa9624400ecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7bd76a6d1e431ab6c836a81216e1f4_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTE1LTEtMS03MzUzNQ_c30ef1cf-893a-43e2-8a05-14fdf7cdf010">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb0e474760e4334840048d6bbea75b2_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTE3LTEtMS03MzUzNQ_8f7bf132-ff9c-458c-8aa0-622f4b243be9">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6720785a53e1430586156e7d0d274c13_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTE5LTEtMS03MzUzNQ_0b76f44d-e5d9-4465-94e4-81927d8b1506">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1733e031b7cf47a58f991e2e2c3bba38_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTEtMS0xLTczNTM1_8515549f-dc47-4cf1-93a0-374d4185723a">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08d119384b84ecd9c631a9d7482199d_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTMtMS0xLTczNTM1_c413e534-540a-42c0-a4d1-6378675685ce">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b537bc93854335acc883c0be1997c8_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTktMS0xLTczNTM1_071f31b0-8074-456e-8d95-53d8d976120e">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fbe9e927d274f4f83ca7d77571c65bb_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTExLTEtMS03MzUzNQ_f97eb2a0-84a5-49e3-926e-d6174de8ee85">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc5d9a9b2b444698454e67d6b6125b5_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTEzLTEtMS03MzUzNQ_d469712d-4d4c-4cf6-8ac1-63df94cb7e8b">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680d42b90e8248cb8ec139cafaa4fd6f_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTE1LTEtMS03MzUzNQ_18aebca1-3f53-4f0f-ae84-d2e2f5b513e6">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4ba4121b644ba8b30f226395dad876_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTE3LTEtMS03MzUzNQ_ae2ce45e-8993-488a-a29e-6f7c7b895cc7">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieee3af2d2f704f59849f8185896c26d9_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTE5LTEtMS03MzUzNQ_a117993d-adf9-4576-972f-ac45237c80fe">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTEtMS0xLTczNTM1_a185d066-8e0b-43f4-b0e9-89c3e98b0e0a">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTMtMS0xLTczNTM1_c4de945f-380c-4a03-9664-bcf0924922d8">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519814dded634cab821a6e70f12b6b5a_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTktMS0xLTczNTM1_1487804e-9abf-4a8a-a06b-7587c2465ebc">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b3467aa854cb9aafaccbd60d72ba5_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTExLTEtMS03MzUzNQ_85c1e7c8-92bc-43c4-931a-4a6a2f73e69e">765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68b0d1120e5a41fca6070da9daf0aaa1_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTEzLTEtMS03MzUzNQ_87cd9f74-1b00-4b92-8fd8-253f75fcc52b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38fa75e726e4beda0abe761dee7c2d5_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTE1LTEtMS03MzUzNQ_4f12dabe-6192-4a7e-a603-6daf68dc8850">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed18c587c624003af2e081a0af4732f_I20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTE3LTEtMS03MzUzNQ_d11bc932-f71f-4cc9-a515-c83c47e2d9e1">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27cfd7e9cd8640a3853756ce9e70e604_I20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTE5LTEtMS03MzUzNQ_65a0f25d-803f-461e-8273-1a6ba151fe73">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i530143b395074519b4e10db5687dcd29"><div style="margin-top:1pt;padding-left:36pt;text-indent:-18pt"><ix:continuation id="i34ad8217f1394abbaf8eb6cacde07731"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Changes in the fair value of international pension assets measured using Level 3 inputs for the years ended September&#160;30, 2022 and 2021 were immaterial.</span></ix:continuation></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Income Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income investments held by international pension plans include corporate, U.S. government and non-U.S. government securities. The values of fixed income securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Values of investments classified within Level 2 are based upon estimated prices from independent vendors&#8217; pricing models and these prices are derived from market observable sources.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities included in the international plan assets consist of publicly-traded U.S. and non-U.S. equity securities. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded or have a readily determinable fair value based on published prices obtained from fund managers which represent the price at which the instruments can be redeemed at period end. The international plans holding these securities have no future funding commitments associated with these investments and has the right to redeem them upon one day&#8217;s notice, at any time and without restriction.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The international plans hold a portion of assets in cash and cash equivalents, in order to accommodate liquidity requirements and the values are based upon quoted market prices. Real estate investments consist of investments in funds holding an interest in real properties and the corresponding values represent the estimated fair value based on the fair value of the underlying investment value or cost, adjusted for any accumulated earnings or losses.  The values of insurance contracts approximately represent cash surrender value. Other investments include fund investments for which values are based upon either quoted market prices or market observable sources.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of voluntary defined contribution plans which provide for a Company match or contribution was $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNDQ2_b8636e3c-717a-4139-90d8-d040f6fcb9be">178</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNDU2_3bbc8270-d092-4868-b343-05b3d5743b2e">153</ix:nonFraction> million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNDY5_defc72e8-289a-42f6-9a57-173ae7ecb6e2">111</ix:nonFraction> million in 2020. As a short term measure to preserve cash and reduce costs, the Company's matching contributions were temporarily suspended effective May 1, 2020 and matching contributions were reinstated in October 2020.</span></div></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_1486"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF8xMDk5NTExNjI4NDEw_5bd599e6-ef4e-4261-a597-1dcf6700d266" continuedAt="i7a56a2e4bbbf4b27bc6fd75acda3aab3" escape="true">Acquisitions</ix:nonNumeric></span></div><ix:continuation id="i7a56a2e4bbbf4b27bc6fd75acda3aab3" continuedAt="i279118c7fe8b4c01b7192933526fed0b"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 18, 2022, the Company completed the acquisition of Parata Systems (&#8220;Parata&#8221;), an innovative provider of pharmacy automation solutions, for total cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i1b0f58312f094de18638daec1ed57a5b_D20220718-20220718" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF8xMDk5NTExNjI4Mzk1_633b2e29-a9d0-4c34-a92d-18bb77d935ff">1.548</ix:nonFraction>&#160;billion. Since the acquisition date, financial results for Parata's product offerings are being reported within results for the Medical segment&#8217;s Medication Management Solutions unit. The acquisition was accounted for under the acquisition method of accounting for business combinations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary allocations of the purchase price provide a reasonable basis for estimating the fair values of assets acquired and liabilities assumed. These provisional estimates may be adjusted upon the availability of further information regarding events or circumstances that existed at the acquisition date. Such adjustments may be significant. The fair value of the assets acquired and the liabilities assumed resulted in the recognition of developed technology intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i16146e90cf574d438dbf17e714f1b029_I20220718" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODYw_f8581caa-1e79-440d-9b6a-687c5d008c5f">628</ix:nonFraction>&#160;million, customer relationships intangible asset of $<ix:nonFraction unitRef="usd" contextRef="iaead122bd3794f52a9b62332837beb42_I20220718" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODI3_f2fb13b1-ac39-460e-b744-a39865952565">161</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ic5e7b819e08c4816b263b7a5251235af_I20220718" decimals="-6" name="bdx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODQ0_b5af150b-742f-401e-80d0-b97e3c6d9074">12</ix:nonFraction>&#160;million of other net assets. The excess of the purchase price over fair value of the acquired net assets was recorded as goodwill of $<ix:nonFraction unitRef="usd" contextRef="ic5e7b819e08c4816b263b7a5251235af_I20220718" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODEw_97993e14-6dd7-480f-81e0-45e19f10252a">746</ix:nonFraction>&#160;million, which related to synergies expected to be gained from leveraging the existing presence of the Company&#8217;s sales and marketing teams in pharmacies and acute care facilities, the broader coverage of the Company&#8217;s legacy sales and marketing teams, and revenue and cash flow projections associated with future technologies. A portion of the goodwill is deductible for tax purposes.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i279118c7fe8b4c01b7192933526fed0b">In addition to the Parata acquisition discussed above, the Company has completed various other acquisitions during fiscal years 2022 and 2021 which were not material individually or in the aggregate, including Parata.</ix:continuation></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90ZXh0cmVnaW9uOjVmZDA5ZTQzOGY2YTQxOTlhM2YwOWE4ZGQyZWE4NTgxXzEwOTk_4b79ead9-cc29-40dd-86a8-794762500dd5" continuedAt="i54adb97703224a94a49bf2c4f335bda9" escape="true">Business Restructuring Charges</ix:nonNumeric></span></div><ix:continuation id="i54adb97703224a94a49bf2c4f335bda9"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company's simplification and other cost saving initiatives that are part of its strategic objectives, along with the 2018 acquisition of Bard, the Company incurred restructuring costs which were largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and other restructurings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on its consolidated statements of income. The simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments.  <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90ZXh0cmVnaW9uOjVmZDA5ZTQzOGY2YTQxOTlhM2YwOWE4ZGQyZWE4NTgxXzExMDM_009c19c2-9d92-46a3-86a2-9b551bda50b0" continuedAt="i872597250bb14d19b27cfe476bcecec0" escape="true">Restructuring liability activity in 2022, 2021 and 2020&#160;was as follows:</ix:nonNumeric></span></div><ix:continuation id="i872597250bb14d19b27cfe476bcecec0"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:400.50pt"><tr><td style="width:1.0pt"></td><td style="width:142.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:78.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:78.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:78.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other (a)(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total (a)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe15d6e33ea490590f7e9a69b2b17d9_I20190930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzItMy0xLTEtNzM1MzU_e9a77a0b-e2af-4148-ac6c-3ec7029cbb25">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61a5ebabc2b43e6bc2cd5e8d0c216f2_I20190930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzItNy0xLTEtNzM1MzU_8ff9dc83-ebf3-4d25-a14e-976d56a8f70d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzItMTEtMS0xLTczNTM1_ef8c4bd4-482b-4493-bd83-0590425aaee6">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idebc6318303940928ab393f2213c259c_D20191001-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzMtMy0xLTEtNzM1MzU_a0a4905f-5b9e-49c8-8f3b-1bd9c72d7450">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic952af233f8f4bc18cc9102330586496_D20191001-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzMtNy0xLTEtNzM1MzU_c0a04305-5be5-4dce-a210-07e5ab23e185">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzMtMTEtMS0xLTczNTM1_d4e9dfdd-dbc9-45c1-b261-7baa169258d0">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idebc6318303940928ab393f2213c259c_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzQtMy0xLTEtNzM1MzU_f20a82bd-01a1-48a0-b2e6-d7f59b77e5ee">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic952af233f8f4bc18cc9102330586496_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzQtNy0xLTEtNzM1MzU_dd3f3c03-5cf3-4089-89c1-cc3c525f683d">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzQtMTEtMS0xLTczNTM1_22fa36ca-192b-411a-a566-d3168f3056f3">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idebc6318303940928ab393f2213c259c_D20191001-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzUtMy0xLTEtNzM1MzU_7b3ec0e8-0c9e-4589-9283-2254b7b72087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic952af233f8f4bc18cc9102330586496_D20191001-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzUtNy0xLTEtNzM1MzU_59d8d1f2-bf09-4166-b5d5-25d7e8218b73">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzUtMTEtMS0xLTczNTM1_98da9f60-cb65-4e91-8314-4329c7568042">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783d4c7f3e5a45edbd97c95a6a89786e_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzctMy0xLTEtNzM1MzU_c44e62f1-b4d9-4197-bd78-4b57d20c0f07">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7227b64729441fa3f00eb141b51740_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzctNy0xLTEtNzM1MzU_3af4a303-27df-48cd-8553-5cc50201c473">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzctMTEtMS0xLTczNTM1_d6a5a583-97de-4ec5-94c0-d7a8e44ade58">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzgtMy0xLTEtNzM1MzU_44de8182-4d53-4ba0-b174-364048b22bc1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzgtNy0xLTEtNzM1MzU_cea7dfa4-2c6a-4a84-a0f0-1e2d8eae17b7">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzgtMTEtMS0xLTczNTM1_97889532-9bc2-44e0-ad50-a4d725b679be">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzktMy0xLTEtNzM1MzU_bbbed433-6fea-4c26-8026-2682a42d45a7">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzktNy0xLTEtNzM1MzU_2359f74a-6588-4c71-921a-ce3dbd4431d9">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzktMTEtMS0xLTczNTM1_f4bdf6b5-2792-427c-8a50-e5e05106491d">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEwLTMtMS0xLTczNTM1_254503e5-fce2-46be-a004-add1d1f7de55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEwLTctMS0xLTczNTM1_95f628e6-19bd-408c-94f9-abd96b594b24">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEwLTExLTEtMS03MzUzNQ_a1c0d113-53ac-430c-a969-9205d49c212b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e9dff542174b32865501500ace45c5_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEyLTMtMS0xLTczNTM1_67b8f496-acae-417d-9842-f574ba9ebc12">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ae8b1d50eb4bc6a284a520fe49663b_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEyLTctMS0xLTczNTM1_269ab07f-072d-42a5-80b2-d2ba95641c52">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEyLTExLTEtMS03MzUzNQ_b4676ff7-dba4-4302-abde-2f7ddfcd77e9">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEzLTMtMS0xLTczNTM1_6512312f-0785-49ff-834f-5516a8087dc8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEzLTctMS0xLTczNTM1_4f163d22-3405-4b52-8fd6-fda2f722a61f">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEzLTExLTEtMS03MzUzNQ_5908a72e-74e1-4b5a-a64b-5ba42faf718c">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE0LTMtMS0xLTczNTM1_be410049-5609-47ba-8655-d6f99a31385e">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE0LTctMS0xLTczNTM1_8c98f8c2-cbf2-4474-b398-4a7e40adcb4b">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE0LTExLTEtMS03MzUzNQ_2fbb3f60-6b08-4a97-b8af-2eae99c2aada">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE1LTMtMS0xLTczNTM1_24929c40-f14d-4f40-bfed-fc5a17c26be9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE1LTctMS0xLTczNTM1_c70a0c9b-4c4a-4498-9c70-b9fd9b3c0f94">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE1LTExLTEtMS03MzUzNQ_52b8c7e2-d781-477f-8c72-bdccb4f1737b">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE2LTMtMS0xLTczNTM1_bc0459e6-3b86-47dd-969f-880d39e86727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE2LTctMS0xLTczNTM1_e99398b9-5692-43f7-a015-4c53ecf2a9e8">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE2LTExLTEtMS03MzUzNQ_141ef01a-5330-432e-8dae-5d19ffe88107">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5a700227d4b0e92d99a7616f2178b_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE3LTMtMS0xLTczNTM1_c3537ad1-4a4a-4c57-92dc-c4acaaada003">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ba567a48b404c3ab9acaa56ed5af44b_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE3LTctMS0xLTczNTM1_0ae5071e-2a8a-4bb7-b664-8836ee6393ab">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE3LTExLTEtMS03MzUzNQ_e0d7e5af-7dbe-411f-b4d4-f657fac9f9f5">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Restructuring costs in 2022, 2021 and 2020 included expenses primarily related to simplification and other cost saving initiatives.  Restructuring costs in 2021 and 2020 also included expenses related to the acquisition of Bard in fiscal year 2018.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Expenses in 2020 largely represented the costs associated with the conversion of certain pre-acquisition equity awards of Bard which, to encourage post-acquisition employee retention, were converted to BD equity awards with substantially the same terms and conditions as were applicable under such Bard awards immediately prior to the acquisition date.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzUyOQ_3a806860-b760-4946-b9fa-9ecfefff8fe2" continuedAt="i7bfacc4a05dc44be93e50ef1cafe2719" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i7bfacc4a05dc44be93e50ef1cafe2719" continuedAt="i9a94e8f8a8c54337be7eb6c04a6a43c2"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets related to the former Diabetes Care business have been reclassified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncurrent Assets of Discontinued Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for prior year periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, see Note 2.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzUzMw_07e6c148-4f71-4d3d-927c-5524b45d758a" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets at September&#160;30 consisted of:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtMS0xLTEtNzM1MzU_91431bb8-a60c-4bd5-ae55-754906e57e29">15,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtMy0xLTEtNzM1MzU_4e68da77-c581-4fac-9927-ebe1050a0159">5,979</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtNS0xLTEtNzM1MzU_b26daef4-e8e8-4086-a25e-96ceb24d0f50">9,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122ecb689334b1fb324ee12c1cc2522_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtNy0xLTEtNzM1MzU_c944b1f4-8e81-40db-9229-8b314da95ceb">14,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib122ecb689334b1fb324ee12c1cc2522_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtOS0xLTEtNzM1MzU_45652438-a846-4c02-8b29-3d1dd481235d">4,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122ecb689334b1fb324ee12c1cc2522_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtMTEtMS0xLTczNTM1_fef97bd1-eb2a-4fae-b2db-ddde1944899f">9,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22adc29e67d0453da5b441bc62d60fad_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtMS0xLTEtNzM1MzU_5d46c6d5-cb98-459d-beef-2473768643c4">4,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22adc29e67d0453da5b441bc62d60fad_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtMy0xLTEtNzM1MzU_b0978e54-7637-4986-ae42-abfaa08eef9f">2,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22adc29e67d0453da5b441bc62d60fad_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtNS0xLTEtNzM1MzU_cd83858b-3bd9-487b-a1d6-4b710540e159">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtNy0xLTEtNzM1MzU_70aaabf4-5337-4568-9f9e-3a5acfd801d0">4,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtOS0xLTEtNzM1MzU_df262dc2-d3b7-44eb-bf13-ff0f09601618">1,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtMTEtMS0xLTczNTM1_f2152c33-15f3-4f28-a4ac-cbfacf30c687">2,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7898a78b2b045e0a8fbcc5061436d03_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtMS0xLTEtNzM1MzU_12c8b58a-7379-48c3-91ea-d38d75390a42">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7898a78b2b045e0a8fbcc5061436d03_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtMy0xLTEtNzM1MzU_4fe4662a-4858-4982-ac6a-9d682a6032f8">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7898a78b2b045e0a8fbcc5061436d03_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtNS0xLTEtNzM1MzU_9e743372-8c3a-40fd-a2d6-ae15692375da">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtNy0xLTEtNzM1MzU_625a77e4-093b-4229-936b-9da804a3ee59">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtOS0xLTEtNzM1MzU_ac22c3e8-32a3-4ded-99e9-a20d26f1b99b">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtMTEtMS0xLTczNTM1_72008402-da48-4142-8e38-f2ed7aed2208">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b8a27c308b4a97925c0a22163ab63a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtMS0xLTEtNzM1MzU_9693d111-4cd9-4315-86c8-b6a8abbd216d">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b8a27c308b4a97925c0a22163ab63a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtMy0xLTEtNzM1MzU_796d8e83-af9f-46ae-9b59-fc7ca47adbbb">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b8a27c308b4a97925c0a22163ab63a_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtNS0xLTEtNzM1MzU_aec38b2e-0886-4e1e-acaa-de295293e006">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9123b3bda6243a2a49be47ee2010afe_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtNy0xLTEtNzM1MzU_a656eac1-e708-4391-b677-c266f5315ec4">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9123b3bda6243a2a49be47ee2010afe_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtOS0xLTEtNzM1MzU_00cb41f1-aa68-48ea-8aa6-68df5e5d5d26">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9123b3bda6243a2a49be47ee2010afe_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtMTEtMS0xLTczNTM1_9a7c3970-e886-483a-bfb9-21aaa226edea">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if296896edaf84700a94f43cf10109fd1_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctMS0xLTEtNzM1MzU_546570c6-1d6d-44c9-bc51-8b9582a8123d">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if296896edaf84700a94f43cf10109fd1_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctMy0xLTEtNzM1MzU_08afbef2-aea8-4e89-a64e-b24c278b37b2">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if296896edaf84700a94f43cf10109fd1_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctNS0xLTEtNzM1MzU_47fbba7c-b232-484d-bfa8-6498bc4ba557">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d9ef80e7d740e98803dffc38dc1875_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctNy0xLTEtNzM1MzU_1efe0c65-8e19-446c-bf47-7b0a74c4ddbc">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d9ef80e7d740e98803dffc38dc1875_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctOS0xLTEtNzM1MzU_e208a2f1-dd3a-44da-9183-b9821c21294d">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d9ef80e7d740e98803dffc38dc1875_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctMTEtMS0xLTczNTM1_7712372e-6eb2-4d59-8c02-b9fb8d891250">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtMS0xLTEtNzM1MzU_b815172d-ba71-4b90-961e-44664b2d61b7">20,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtMy0xLTEtNzM1MzU_962c76aa-78b8-49c9-9ccd-adfff56243ad">8,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtNS0xLTEtNzM1MzU_5bba0269-c7ee-4be1-a0c9-c4dee1c078d9">12,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtNy0xLTEtNzM1MzU_343f07e5-340f-4fd8-873f-4548a277ff24">20,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtOS0xLTEtNzM1MzU_109a2856-9461-4abe-9d55-1514e0232000">7,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtMTEtMS0xLTczNTM1_7f4d4980-f32a-418c-9913-5a0d75ea39df">12,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08fc3788b4f494fab5bba68fdd3f971_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzExLTEtMS0xLTczNTM1_8f01bc99-7699-4d89-83bb-5100f4c2866f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83079dddc9604de9b744f8de96e981e8_I20210930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzExLTctMS0xLTczNTM1_ab0111e5-1166-4ef9-8f4d-a31444055b0d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313ea0dffdb34c468e5b8d9fb727160e_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEyLTEtMS0xLTczNTM1_98cb7282-3b45-49f0-8663-e92edde9e9f1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09cbfdc3b91b4f0a938cae0e75b85bbc_I20210930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEyLTctMS0xLTczNTM1_e91969c2-c466-4492-9cae-5b411c7a9739">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEzLTEtMS0xLTczNTM1_3eb99c06-63b5-4809-8fc6-454cd4f84e4d">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEzLTctMS0xLTczNTM1_3f1e19c2-ef5a-48cb-a31d-ac6d8adb1f96">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzEyMA_29fdbc9d-2092-48ed-9245-9abe571bdc24">1.430</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzEyNA_2d7bedc5-69ae-4223-ba9f-02b2ba943ce9">1.402</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzEzMQ_bae30488-1820-4efd-bb98-dbabf1192967">1.384</ix:nonFraction> billion in 2022, 2021 and 2020, respectively.  The estimated aggregate amortization expense for the fiscal years ending September&#160;30, 2023 to 2027 are as follows: 2023 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzI4NA_d7b62bb9-2b7a-4efb-ac6a-91557f521941">1.385</ix:nonFraction> billion; 2024 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzI5Mw_6cf79f4b-6bfb-4eb2-bf2d-307caa3c1acc">1.382</ix:nonFraction> billion; 2025 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzMwMg_4bf7357e-f0cb-435b-946e-0623a98165cf">1.381</ix:nonFraction> billion; 2026 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzMxMQ_449d30c2-cdc1-4778-81f8-72ca66705830">1.350</ix:nonFraction> billion; 2027 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzMyMA_02b2c656-c29a-4534-b6a5-2c8896c188bc">1.292</ix:nonFraction> billion.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzUyMg_4940c53d-0648-4d48-9b70-f46737a98f07" continuedAt="id09b3df0540847acbeaedcb36e96ecde" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95aa9d4507c48a8aa4ecf6660ad1bb8_I20200930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtMS0xLTEtNzM1MzU_677889bc-7a6d-4ca2-876b-6c7030af6768">10,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a8586120ec4ee3b816bd6e84c99d26_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtMy0xLTEtNzM1MzU_cb6b0f21-9c18-4dea-99be-8a5cbbd8217a">837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b06cbe7ebf74441ad1135e8a4099d4c_I20200930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtNS0xLTEtNzM1MzU_f5a5ee8b-2ca8-4b4b-8af4-aa15fc845875">12,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtNy0xLTEtNzM1MzU_0502169c-b99c-4fdf-8803-9daaf51d1607">23,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItMS0xLTEtNzM1MzU_e8434f8a-4b12-4139-af9a-73fdea216979">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItMy0xLTEtNzM1MzU_36bab7f6-846e-4652-b7dc-6186358514f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154a1248141a444db4764c62730b8fe8_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItNS0xLTEtNzM1MzU_e28cfee9-b839-47e9-b0e4-d89e3061d431">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItNy0xLTEtNzM1MzU_4f1d12f7-cfd7-40cc-8ada-464ff45dfa4e">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtMS0xLTEtNzM1MzU_fcd35baf-a0ae-47f5-832a-e609dfe257b5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtMy0xLTEtNzM1MzU_bbb15b96-d404-4345-93f8-4e4d6980522e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154a1248141a444db4764c62730b8fe8_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtNS0xLTEtNzM1MzU_60eb33ab-580c-44a7-88a0-cd682a2e265f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtNy0xLTEtNzM1MzU_91f8cca8-d222-44be-9cbb-e921d5e4d6d1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtMS0xLTEtNzM1MzU_f177fc68-a67d-4927-9b64-b67d73ea2036">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtMy0xLTEtNzM1MzU_66216710-306b-4c4e-81de-cda9205dcf73">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i154a1248141a444db4764c62730b8fe8_D20201001-20210930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtNS0xLTEtNzM1MzU_33992315-8527-4282-be6d-1f1e0c6a7c18">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtNy0xLTEtNzM1MzU_dad0b94d-39dd-4804-86e9-b83e0a10a659">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7b422811cd4eacbfca8abd88d6e929_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctMS0xLTEtNzM1MzU_b3607229-d665-4678-95ee-c22138231586">10,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e02302174c424e83e466e2024ad82a_I20210930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctMy0xLTEtNzM1MzU_41ff844e-3ad7-4620-b816-648f720b672d">836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b8ceb1a99f4a2db99cb4f7b7466475_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctNS0xLTEtNzM1MzU_67f1a1ac-f46c-4895-95d5-cc5f8b7676da">12,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctNy0xLTEtNzM1MzU_18f11ae4-bfeb-4c02-a323-2025bc6d0a8f">23,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtMS0xLTEtNzM1MzU_78ab3741-2903-4431-b543-21e36a63f974">814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtMy0xLTEtNzM1MzU_8a035284-0ae4-40ed-8483-c41bbc8ae944">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtNS0xLTEtNzM1MzU_f44438db-22d5-41a2-ac56-addfda08609a">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtNy0xLTEtNzM1MzU_11f703cf-b090-447c-ad6b-842e5b6f4a6a">1,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTEtMS0xLTczNTM1_87b8e27c-ed8e-4048-89ea-82f92a04baf7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTMtMS0xLTczNTM1_7451db28-96b5-4cdb-8a9d-36d20d9e1682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTUtMS0xLTczNTM1_a51b38d7-af71-4efe-b966-1d0c3e1b06ea">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTctMS0xLTczNTM1_5d17ebda-df7e-4411-a030-62f95b40881b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTEtMS0xLTczNTM1_051a23e3-d58d-4433-9e96-8c54411eee39">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTMtMS0xLTczNTM1_2af77623-6440-40db-a722-966f91363f58">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTUtMS0xLTczNTM1_48892bca-74b8-4e0e-abbb-46f531489515">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTctMS0xLTczNTM1_0c05e882-4e86-42ba-9a68-8e9bdf7d214a">337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755a5d90f3814df4b21a068f5395ce3f_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTEtMS0xLTczNTM1_f8e2041b-df29-4dfc-880d-cf78dcb0a2b7">10,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad49caca1134d10b7917ed7da76c3c1_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTMtMS0xLTczNTM1_aa07cb58-7ac6-4484-895b-0cc88f3228a5">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be2a3f223eb4dd1a902692b9d00ee3c_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTUtMS0xLTczNTM1_5544f705-a9b3-472a-a2f2-76db52aa181a">12,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTctMS0xLTczNTM1_c0593dee-6e07-4810-af29-ca296ede8d81">24,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9a94e8f8a8c54337be7eb6c04a6a43c2" continuedAt="i946870d6fb484fc0a7b7ce0d8517a96e"><ix:continuation id="id09b3df0540847acbeaedcb36e96ecde" continuedAt="ib4d3402b30cc4d32873c8b1bdab49296">(b)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i946870d6fb484fc0a7b7ce0d8517a96e"><ix:continuation id="ib4d3402b30cc4d32873c8b1bdab49296">Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</ix:continuation></ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY3NDQ_7eca1307-d45c-42bb-b9db-947a2f4558df" continuedAt="i8b3cec9499c84fc9a2cdeb84799570b6" escape="true">Derivative Instruments and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="i8b3cec9499c84fc9a2cdeb84799570b6" continuedAt="i10b9a0790b2a4ab5b432ebe7d7d598cf"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.  The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at September&#160;30, 2022 and 2021 were not material. The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments&#160;with certain instruments such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts.  </span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY3Mzg_9fe51948-4ae1-4c50-b365-fd2addccb959" continuedAt="iac0f2601d15e420298e2c48a7ba58d33" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.000%"><tr><td style="width:1.0%"></td><td style="width:36.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9aae2ecc3b743ee8b3b99bcb96a572c_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzEtMy0xLTEtNzM1MzU_c2579e6f-2741-4cfc-962f-a227bdd6c326">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b65da53d1249ec90a0398fbf799f3b_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzEtNS0xLTEtNzM1MzU_6b0d9f8a-019c-484e-81f1-d11e527e0865">2,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e06b3f4724fbe8ed56758a473c1d6_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzItMy0xLTEtNzM1MzU_6786a998-019b-4e72-bbb5-0e7f9ebefe09">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0362b4098b8b4067bb006f7b4a31ae00_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzItNS0xLTEtNzM1MzU_e9cb0b5b-b6a1-4038-888b-980b269914e3">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21cb6aa32d1f481981628ab9194b1087_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzMtMy0xLTEtNzM1MzU_7636b48e-9956-4bdb-bd30-27dd2b061a5d">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46bfa1d6a2ed48c58d0b334930a15be9_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzMtNS0xLTEtNzM1MzU_5eddd70d-dc19-4b03-9f35-d1f73b88e073">1,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the years ending September&#160;30, 2022, 2021 and 2020 are detailed in Note 19.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries. </span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the termination of a net investment hedge, any net gain or loss included in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated. </span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY3NDI_0e07e0a1-d7db-4de1-b69f-df63bf2d5d48" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges as of September&#160;30, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.166%"><tr><td style="width:1.0%"></td><td style="width:49.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a796cfd479247d9aed9717103f579c5_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzEtMS0xLTEtNzM1MzU_70cdc4d7-6c17-45ae-adfa-ecd0ed864b7d">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636b7d8d6ac1434884437455e4abece1_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzEtMy0xLTEtNzM1MzU_72de11f6-713f-4e0b-b6b8-30d668abdae5">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20ba69d3b809426383ff74cd52d2d5d6_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzEtNS0xLTEtNzM1MzU_e063bb35-15eb-4fd0-98c5-c8812bd4163b">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82fb06354e254a39957ee2c588fb1109_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzItMS0xLTEtNzM1MzU_1844f08c-ef74-421a-9fb0-f2b4f6f3eb86">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79d5a944ccec4ed6a09939ea678a2ce2_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzItMy0xLTEtNzM1MzU_d4b9096e-3269-477c-a02b-1d3eb459baf6">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cb3f4d815394a569ef25a97b6547ade_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzItNS0xLTEtNzM1MzU_64d9fefa-6460-4db5-bd12-ee60631dd3b3">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts in 2022 and 2021 include a gain of $<ix:nonFraction unitRef="usd" contextRef="i0ad6655541f44f868773ab9598f2389a_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzkzNDU4NDg4NDU0MDM_0f0ba3f8-9bfb-462c-8df1-e1b86f75b1c6">46</ix:nonFraction>&#160;million and a loss of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i711fe8ef0e6b434ba332d1783ca67ae8_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzI5Mzc_4c185401-68cf-4f91-b432-efef50e716c3">35</ix:nonFraction>&#160;million, respectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recognized on terminated cross-currency swaps.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i10b9a0790b2a4ab5b432ebe7d7d598cf"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a mix of fixed and variable rate debt, which is further discussed in Note 16, to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.  These swaps are designated as either cash flow or fair value hedges.  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;attributable to those derivatives is reclassified into earnings over the remaining life of the hedged debt.&#160;The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during 2022, 2021 and 2020, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded net after-tax gains (losses) of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzEwOTk1MTE2MzU4ODQ_8e88ce51-391f-4ca0-a592-13d16b583322">92</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $<ix:nonFraction unitRef="usd" contextRef="ia06bc3660c334df6ad4d8fb329decb0d_D20201001-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzQ1NTA_d27e8e81-ba8e-41aa-a9c0-9ecdd159e513">72</ix:nonFraction>&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="iaac60c046f35441f9fedd46ad3c40d4d_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzQ1NTc_f51bb714-d046-41aa-8322-e077a299898c">75</ix:nonFraction>)&#160;million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate-related cash flow hedges during the years ended September&#160;30, 2022, 2021 and 2020, respectively. The gains recorded during fiscal year 2022 included a net after-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930" decimals="-6" name="bdx:OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzM4NDgyOTA3MDU3Njk_954a2890-219c-4699-9d1e-9e69927c2d5f">41</ix:nonFraction>&#160;million that was realized upon the Company&#8217;s termination of $<ix:nonFraction unitRef="usd" contextRef="i477ce66329a84971b9ed1654697676df_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzM4NDgyOTA3MDU3ODU_75c7a852-8567-4070-af34-cff07fee456f">500</ix:nonFraction>&#160;million of forward starting interest rate swaps.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates. The amounts recorded during the years ended September&#160;30, 2022 and 2021 for changes in fair value of these hedges were immaterial to the Company's consolidated financial results.</span></div><ix:continuation id="iac0f2601d15e420298e2c48a7ba58d33" continuedAt="i05b4254d6d1b490e8ce8e3927fe93886"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows: </span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713da180c69b463b9d60a20b18530ae8_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzEtMy0xLTEtNzM1MzU_1a84a813-e422-4cd8-98c7-0c623e078cb7">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47367bb6b2924151bb0cb2e2a24e2c4c_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzEtNS0xLTEtNzM1MzU_edc11bfc-cd0c-4a80-a1a9-bb5abb69ed48">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ce66329a84971b9ed1654697676df_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzItMy0xLTEtNzM1MzU_fcaad659-b4b7-4893-9edb-64ce15fe3296">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb49035180454921878d3e554660eafb_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzItNS0xLTEtNzM1MzU_94d552e8-cefb-482e-a7c9-ee43623ebe4d">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div></ix:continuation><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i05b4254d6d1b490e8ce8e3927fe93886" continuedAt="icf4ac20b42ed40ecb2de262077d1a4af">(b)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt"><ix:continuation id="icf4ac20b42ed40ecb2de262077d1a4af">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</ix:continuation>  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company&#8217;s commodity derivative forward contracts at September&#160;30, 2022 were not material, and there were <ix:nonFraction unitRef="usd" contextRef="i492a77d89eef44f5a423a69591c4fcb1_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY2NTI_48b14d71-d871-45a8-a9cb-ecc9665d5772"><ix:nonFraction unitRef="usd" contextRef="idd49df5862fc48f89ee6373a56f0a57d_I20210930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY2NTI_876c9c2c-555b-475c-8034-16bb5d55e12c">no</ix:nonFraction></ix:nonFraction> outstanding commodity derivative forward contracts at September 30, 2021. </span></div></ix:continuation><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"><tr><td style="width:1.0%"></td><td style="width:62.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.333%"><tr><td style="width:1.0%"></td><td style="width:72.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.674%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"><tr><td style="width:1.0%"></td><td style="width:61.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.000%"><tr><td style="width:1.0%"></td><td style="width:34.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.657%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODI_146ae8d4-a856-4df8-ab96-175fcc3a57fd" continuedAt="i2079a23d4f4c4d6cbf436782a9e015ea" escape="true">Financial Instruments and Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i2079a23d4f4c4d6cbf436782a9e015ea" continuedAt="iaec8c990483e471c9c037520403b6511"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODY_1cb78b5b-2d0c-4216-87ee-33c5ff121397" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September&#160;30, 2022 and 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzEtMS0xLTEtNzM1MzU_8ae72a17-1bcd-4b87-a748-d6f63628c0aa">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzEtMy0xLTEtNzM1MzU_9cf34f64-de8c-4d32-8508-86e00b63eb0b">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzItMS0xLTEtNzM1MzU_8f25294b-d6a2-4148-b7c6-d86775734f1e">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzItMy0xLTEtNzM1MzU_7756253c-6019-4c91-846b-c21283395c68">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzMtMS0xLTEtNzM1MzU_2564121e-d9e8-4d49-bcac-4347391ad2f8">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzMtMy0xLTEtNzM1MzU_80191670-867b-43dd-8ae1-de5d4e3180ee">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3NzA_912ffae2-095d-498e-9661-73e82b49bebb" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts and ultra-short bond fund (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzEtMy0xLTEtNzM1MzU_10da611f-d243-4e3a-a3a7-4279df726b8b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzEtNS0xLTEtNzM1MzU_6e06f925-dee9-4b6d-9f69-44baf6020b8e">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzItMy0xLTEtNzM1MzU_270a1b0c-fb96-4220-9453-06430e5b2de2">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzItNS0xLTEtNzM1MzU_46dfad1d-7bb6-4259-8260-46b99a2e3fc0">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzMtMy0xLTEtNzM1MzU_622d9eb4-ef87-4388-955d-e96b0914c83a">12,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzMtNS0xLTEtNzM1MzU_b1092140-2ef5-420c-846d-0c819fff29c3">18,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets. The institutional money market accounts permit daily redemption.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODE_4d9ee795-d76e-41fe-8e90-0ddb3145d486" escape="true">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments</ix:nonNumeric></span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than <ix:nonNumeric contextRef="i330f829063eb4447ad6bc4456ceff4ec_D20211001-20220930" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzk5Nw_f8996a3c-bc08-45fe-8959-54ce7aa9b5c3">three months</ix:nonNumeric> and less than <ix:nonNumeric contextRef="ide9bbd27a0cd44dcb98a452d6c22b67f_D20211001-20220930" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwMTQ_53822d16-2ce7-4896-b9af-374fa9edf830">one year</ix:nonNumeric>. All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonrecurring Fair Value Measurements</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2022, the Company recorded non-cash asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i648b8dfd6eb548adbbd2d21365d6cde8_D20211001-20220930" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwOTk1MTE2MzQwNzU_97917e1c-272a-46d5-ac27-b154a3f5c38a">11</ix:nonFraction>&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Life Sciences segment, $<ix:nonFraction unitRef="usd" contextRef="i277928b220f44e7784ead40b68440c9f_D20211001-20220930" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwOTk1MTE2MzQwODg_d8c0de21-e8b3-4139-8006-84a67fd41bfd">19</ix:nonFraction>&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment and $<ix:nonFraction unitRef="usd" contextRef="i312ec77e4d634c4ea325786b43d11b2f_D20211001-20220930" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwOTk1MTE2MzMxODE_1a97096c-e484-410b-9b74-9308fce66b56">54</ix:nonFraction>&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Medical segment to write down the carrying value of certain fixed assets. In fiscal year 2021, the Company recorded charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i032efb1d86ce48d0909296f8cca53459_D20201001-20210930" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEzMjA_74b507fb-a215-48a4-9547-4f0ad87be66d">40</ix:nonFraction>&#160;million to write down the carrying value of certain fixed assets.  In fiscal year 2020, the Company recorded charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i938377c8c70a4325b957640e0929f503_D20191001-20200930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzE0NjA_80340cc2-b5c9-4659-9794-7172d226bb89">57</ix:nonFraction>&#160;million to write down the carrying values of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units, and $<ix:nonFraction unitRef="usd" contextRef="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzE2MDI_0a5e9627-1e9e-4f4a-b6d2-276bd03959b4">41</ix:nonFraction>&#160;million to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units. The amounts recognized in 2022, 2021 and 2020 were recorded&#160;to adjust the carrying amount of assets to the assets' fair values, which were estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODc_67ffd4d4-bed3-4519-af12-718f2079b4a9" continuedAt="i7f70a8da53574175a6d84c443cda31c0" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company&#8217;s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company&#8217;s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iaec8c990483e471c9c037520403b6511"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7f70a8da53574175a6d84c443cda31c0">The Company continually evaluates its accounts receivables for potential collection risks, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.</ix:continuation></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received. The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results. <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3NzQ_c67111d8-85c2-4e1b-b97a-b5bf1c887fe6" continuedAt="i5f2e5459a7674a2fa3d6b45a6adffb17" escape="true">The amounts transferred and yet to be remitted under factoring arrangements are provided below. </ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i5f2e5459a7674a2fa3d6b45a6adffb17"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzEtMS0xLTEtNzM1MzU_d52a9b3d-a06d-4c69-ba39-ca9f49c02c3b">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzEtMy0xLTEtNzM1MzU_a4713eb7-8ec4-43cb-b882-c86572d02d36">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzEtNS0xLTEtNzYyNTI_b0a021a4-f735-41ac-b87b-b949a324ab52">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzItMS0xLTEtNzM1MzU_ec3be924-c2f8-4504-a74d-eb6a29fa7371">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzItMy0xLTEtNzM1MzU_b3b44156-63ef-4f8c-bda4-bb09e1b301ad">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></ix:continuation></div></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMjE_aa2fcdeb-050c-4f32-b758-c40d57eec58e" continuedAt="i8ecc50e045da4f12a3d3ffb0f24480a2" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="i8ecc50e045da4f12a3d3ffb0f24480a2" continuedAt="i221665637dd546658429f33437cf88b0"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current debt obligations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMDc_39d87bae-28f6-4f12-a689-46c67af680f4" continuedAt="i994e946edc0f4ab59564a699f44af271" escape="true">The carrying value of </ix:nonNumeric></span><ix:continuation id="i994e946edc0f4ab59564a699f44af271" continuedAt="i0e504bebb9114583925d9fa1acd6b60f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current debt obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of unamortized debt issuance costs, at September&#160;30 consisted of:</span></ix:continuation></div><ix:continuation id="i0e504bebb9114583925d9fa1acd6b60f"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"><tr><td style="width:1.0%"></td><td style="width:52.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e86db53cbf48f1950b3278e95c83d9_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzEtMy0xLTEtMTI3NDIw_f44fabb4-a2d6-4f37-8148-198274e6f562">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fb827478bd461a8787df84f27802af_I20210930" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzEtNS0xLTEtMTI3NDIw_72373cc1-ba92-43b4-8c28-8dfab48189bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzItMC0xLTEtNzYzMjYvdGV4dHJlZ2lvbjo0MmRhYzhkODQ5Mzg0YTlhOGQxZDM1ZmY5NjFhOGQ5M180_188879fb-2e87-4856-b76d-959e5f805dd0">1.000</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzItMy0xLTEtNzYzODg_b28e3cce-31e4-4406-aa1b-d62eb8a89dc6">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5f7f7d4aa34c8a8fe7242aaf64fce7_I20210930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzItNS0xLTEtNzYzODg_f012142e-9419-4b9c-9722-38fcd3f56250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate Notes due June 6, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a8bd1261794f438b0bd13c92aeb774_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzMtMy0xLTEtNzM1MzU_e4a808c4-d7f7-4122-9fad-54abdb0fcb89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3617b6fd6934a64af7e251d421562bc_I20210930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzMtNS0xLTEtNzM1MzU_a518a267-fc8b-403a-acbb-47bc813c6a5b">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19f42f3eb9b7429faccfa0ee07b6c3d8_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzQtMC0xLTEtMTIyMDk0L3RleHRyZWdpb246ZjlkOTU5N2E3ZjdkNDFhY2JmOWExYmNmNjI1ZmZlMThfMzg0ODI5MDY5NzI1NQ_c1729f36-a103-4014-bce0-4236e30e3a13">1.401</ix:nonFraction>% Notes due May 24, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f42f3eb9b7429faccfa0ee07b6c3d8_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzQtMy0xLTEtMTIyMDc5_f704baef-fcbf-49f0-a479-ae460ac6428c">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3348e3185c3a4d8faf23b030ca9b058a_I20210930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzQtNS0xLTEtMTIyMDc5_71b5848c-477e-4d28-aa18-6ccdb94578f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtMC0xLTEtMTIyMTAwL3RleHRyZWdpb246ZmQyMjY4NDA1ZDVmNGExZGJjODUzYzNiY2I3MDFiZjdfMzg0ODI5MDY5NzI1NQ_d52a3b63-5e8b-4d3d-9af7-3bc9fa0fd643">0.632</ix:nonFraction>% Notes due June 4, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtMy0xLTEtMTIyMDc5_93ca9b23-9190-47f8-8fbf-98fda6369753">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702a0883d82245dfb5727457b4bf121e_I20210930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtNS0xLTEtMTIyMDc5_f055919e-ef92-4d90-884a-8f396cf71f9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzYtMC0xLTEtMTIyMTEzL3RleHRyZWdpb246MzY0MWVjZmE0ZWE5NGYyMzk5ZjhjODNhOGU1MDIxNzJfMzg0ODI5MDY5NzI1OA_170a9416-d5a8-4f3b-953f-a2f8acc71eb3">0.000</ix:nonFraction>% Notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzYtMy0xLTEtMTIyMDc5_fec9596d-69b7-494c-af9d-86b761fe5266">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b7239cbb2b4caa96217145ed318c6a_I20210930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzYtNS0xLTEtMTIyMDc5_925828b4-f4f2-4889-b76b-41412837c487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtMy0xLTEtNzM1MzU_3cb165d4-192e-4d1b-90ea-bd3919abd345">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtNS0xLTEtNzM1MzU_c1362cfa-4ad7-45fd-81fd-43c2fcb625e5">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All of the aggregate principal amount outstanding was retired during 2022, as further discussed below.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average interest rates for current debt obligations were <ix:nonFraction unitRef="number" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzMxNA_96c0ff20-920c-4e5e-b663-129968ac4742">1.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzMyMQ_0fc2f372-e33b-4337-bca8-6d05df2f852b">1.15</ix:nonFraction>% at September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, the Company may access the commercial paper market as it manages working capital over the normal course of its business activities. The Company utilized commercial paper borrowings in the fourth quarter of  fiscal year 2022 of which $<ix:nonFraction unitRef="usd" contextRef="i73e86db53cbf48f1950b3278e95c83d9_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzY1OTcwNjk3Nzc0Njk_99472741-44b8-4c66-9eac-33232fc36ede">230</ix:nonFraction>&#160;million was outstanding as of September&#160;30, 2022. There were <ix:nonFraction unitRef="usd" contextRef="i03fb827478bd461a8787df84f27802af_I20210930" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzkzNDU4NDg4NDQyOTc_d25aca54-3c02-4202-8173-d234be562605">no</ix:nonFraction> such borrowings outstanding as of September 30, 2021.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i221665637dd546658429f33437cf88b0" continuedAt="i06d78fa93c5241fc9b45ebd6985fa25b"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term debt</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMTE_06f82cbb-9ae0-4c60-822b-ca955c37a64a" continuedAt="i3b47e724336341bdbb8108ba0879cff6" escape="true">The carrying value of </ix:nonNumeric></span><ix:continuation id="i3b47e724336341bdbb8108ba0879cff6" continuedAt="i2f6d7505396043efbe68e6c0aba62f6a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of unamortized debt issuance costs, at September&#160;30 consisted of:</span></ix:continuation></div><ix:continuation id="i2f6d7505396043efbe68e6c0aba62f6a"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"><tr><td style="width:1.0%"></td><td style="width:52.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo4NGQwMGNlZTdkOGM0M2JhYjVlZjI3NDFkOTExMzVjOV80_188879fb-2e87-4856-b76d-959e5f805dd0">1.000</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzQtMy0xLTEtNzM1MzU_89aa34f2-534e-408b-b1b9-01ac3804ca68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5f7f7d4aa34c8a8fe7242aaf64fce7_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzQtNS0xLTEtNzM1MzU_345bbc79-b0d2-4c2b-aac0-a78c2a7e6e2b">579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95c59b4820ac446795f35fc603f13926_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjZmI5MDllZGVkODM0MTlmYmIxY2Y1MTAwMTE3Y2IwN180_e5cddbbc-40fb-416f-9214-966da652113d">1.401</ix:nonFraction>% Notes due May 24, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c59b4820ac446795f35fc603f13926_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzctMy0xLTEtNzM1MzU_7efe7ae2-0906-4be9-82b5-19c507fe8bc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a63b521162435da95e767ab599c1d3_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzctNS0xLTEtNzM1MzU_d095e6a8-ab81-4ade-bd94-63a39f91ced4">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjowOGNiZDk1YjRmYmM0ZTI3YThmNjUxNzUxYjg5NzJkYV80_9e6c51a8-5ba9-43f4-b181-95685fd7a3b3">0.632</ix:nonFraction>% Notes due June 4, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzgtMy0xLTEtNzM1MzU_c710c5b0-14de-4c22-bf67-b9e19575b206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702a0883d82245dfb5727457b4bf121e_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzgtNS0xLTEtNzM1MzU_6a113ba7-7325-40bf-8271-e98212177ab8">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzktMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1MWZlZDFkNGY0Y2Y0OWVjODY2OGE4Zjc3MWIxNWJhN180_87f85af1-012f-4360-85a6-f52eabff4739">0.000</ix:nonFraction>% Notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzktMy0xLTEtNzM1MzU_b1a19c37-2dbe-4750-aad9-8f7710ccbe36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b7239cbb2b4caa96217145ed318c6a_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzktNS0xLTEtNzM1MzU_8191cb3a-89e2-4559-a309-e1a4a1f1ac53">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic410939d905842db8f020e0dd78f97ad_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEwLTAtMS0xLTczNTM1L3RleHRyZWdpb246MTcyYjA0NTVlZGM1NDE3ZGJlOTFlMjkzMTBkYjQ5YzFfNA_92e58b20-d08b-4e5a-9252-0c35b1fa8d6e">3.875</ix:nonFraction>% Notes due May 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic410939d905842db8f020e0dd78f97ad_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEwLTMtMS0xLTczNTM1_63d4a532-6247-4f52-9680-2a3f5d144ce9">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEwLTUtMS0xLTczNTM1_9f88f56b-8acc-4a11-a948-9c57d3da45c0">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1935866626bf4551abb766287f4f12bb_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzExLTAtMS0xLTczNTM1L3RleHRyZWdpb246NjQ5YzJjY2RkZTA2NDhjZmE2MTg3N2M2OTg0MzE1OTJfNA_c12aef63-e20e-47cc-9a50-fe77176dae5e">3.363</ix:nonFraction>% Notes due June 6, 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1935866626bf4551abb766287f4f12bb_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzExLTMtMS0xLTczNTM1_34ebf06b-2d86-47bf-b504-c27d7ac2a52a">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzExLTUtMS0xLTczNTM1_f0d0ed38-4498-45b4-87f0-1366520a84f7">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd801a10d19e41d48e55e40566722456_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEyLTAtMS0xLTczNTM1L3RleHRyZWdpb246MzdjNDY3NDlkZWE0NDMwOWJiYWIxZGViODg5YzRkNzVfNA_02e78ac2-9285-4f91-ae16-8046f9b10975">3.734</ix:nonFraction>% Notes due December 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd801a10d19e41d48e55e40566722456_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEyLTMtMS0xLTczNTM1_9e5da7f2-4985-45c9-b442-36cebaf9308f">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEyLTUtMS0xLTczNTM1_7a1d4f57-4349-41b1-9303-c31e143a38c3">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5eaa388c48eb48529b863b1dad0c7c66_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEzLTAtMS0xLTczNTM1L3RleHRyZWdpb246OTc5Mjk1OGRlMmJmNDMyOTliYTc1OTA5YWJlNzZlNGFfNA_208497c9-bec8-4b12-8d57-06ce3bdaeb4f">3.020</ix:nonFraction>% Notes due May 24, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eaa388c48eb48529b863b1dad0c7c66_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEzLTMtMS0xLTczNTM1_ad4a6db5-efb7-40f0-bc56-3c3d995dd436">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb65fb27ea394d7bab72c0b7eacb98e7_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEzLTUtMS0xLTczNTM1_d0747207-2e1a-48f1-a139-023dcba8c7c0">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83c4aa1f41194aa4802d0e4036ca000d_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE0LTAtMS0xLTczNTM1L3RleHRyZWdpb246NDMzYjQxYThjMTcwNGU5Y2EyOTE4ZDM4MDYxODE3NGZfNA_b7507579-adcc-453e-9db7-570cf0d0eb2e">0.034</ix:nonFraction>% Notes due August 13, 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c4aa1f41194aa4802d0e4036ca000d_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE0LTMtMS0xLTczNTM1_9a2bd7a9-8991-42a1-8cb2-6924f770c662">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9406b7f8b0d4bcb819b52eef9ed6c98_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE0LTUtMS0xLTczNTM1_3fd718e0-2145-4806-a1e5-e970ff57fbdd">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68bc0f1d591947e198044880214c84e2_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE1LTAtMS0xLTczNTM1L3RleHRyZWdpb246MjQ5NTE3MmRmNDE3NDQwZTk1M2RhZDhjNGNjNzM1ZGRfNA_6e6c91d5-59f6-4fac-beb3-ae8d296d796f">1.208</ix:nonFraction>% Notes due June 4, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bc0f1d591947e198044880214c84e2_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE1LTMtMS0xLTczNTM1_2f164cac-8ea9-451d-b41f-43fa93dfe386">583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i365b69b186eb4841aeadfd7470683467_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE1LTUtMS0xLTczNTM1_0da616b6-b53d-41a3-acdb-5944c12dd90c">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i071e4371c19b435eabf32db0df89d6b8_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE2LTAtMS0xLTczNTM1L3RleHRyZWdpb246NTkzZTczZWFlZmEzNDhlMDhmZTk1ZDM2NDBhMDFlNzVfNA_2251c8d6-fe79-4cc0-aedd-b1a3cafc997c">6.700</ix:nonFraction>% Notes due December 1, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071e4371c19b435eabf32db0df89d6b8_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE2LTMtMS0xLTczNTM1_6acc201b-f6f1-420e-a4cc-d722561e4fa6">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d41b365cba499bbdc2091259476a27_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE2LTUtMS0xLTczNTM1_8db4fd40-3864-41a0-b9e3-2edf13134d78">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05fd68b08a7b426eb6811e05f0b4a888_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE3LTAtMS0xLTczNTM1L3RleHRyZWdpb246M2U4NmNjZTc0MmMxNDUxYWIwZTMzY2IzYWE1YmE1N2RfNA_c6416ab4-1caa-4bdf-9f5d-fd5d1af95cdf">1.900</ix:nonFraction>% Notes due December 15, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fd68b08a7b426eb6811e05f0b4a888_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE3LTMtMS0xLTczNTM1_a69e8de4-1dc8-411b-b56c-51c14318bef5">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb793b910104ba58a06b3d19b079980_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE3LTUtMS0xLTczNTM1_689d08f0-1e6e-4692-a449-5693af62b451">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53130d0da5f34bd5a6206bb574cd0646_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE4LTAtMS0xLTczNTM1L3RleHRyZWdpb246MjBiOWU4MDhhMDI0NGRlY2FjYTI4YTAwN2IzMDkyNTlfNA_12371d29-3d5b-432a-bb42-5f36ec628d20">3.700</ix:nonFraction>% Notes due June 6, 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53130d0da5f34bd5a6206bb574cd0646_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE4LTMtMS0xLTczNTM1_07833df0-d0da-41f0-8b8d-4d878ddf9c4d">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcea25fd00bb44f49a60939195013440_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE4LTUtMS0xLTczNTM1_973948c5-747a-43ea-8b83-77e50aeffd6e">1,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE5LTAtMS0xLTczNTM1L3RleHRyZWdpb246NDVlZDg3NDEyNTkzNDRiZjgyZDNiZDgyNTcxMTBlYTlfNA_babfac03-1470-44e3-b244-47d4c7ed5aff">7.000</ix:nonFraction>% Debentures due August&#160;1, 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE5LTMtMS0xLTczNTM1_1494cc94-eab5-4a60-865e-ab7c9062ed7d">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05399f1c63e149d4950728ad77213bd5_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE5LTUtMS0xLTczNTM1_2f0ceb90-4129-4938-85b4-b5f33c7af49b">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTAtMS0xLTczNTM1L3RleHRyZWdpb246YjFjODNiMWIyYjYyNGFmNDg5N2E0ODk4ZGUxZTAyMzZfNA_034a0f23-193c-448b-b6c9-5fe34b930326">6.700</ix:nonFraction>% Debentures due August&#160;1, 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTMtMS0xLTczNTM1_de863a15-7d65-451b-847f-a4dd01e17e55">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i985f9c0cd4e740d3aa74db4e83626a95_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTUtMS0xLTczNTM1_feace972-5a39-4b8b-bf0c-4957fe8fc64f">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd7ed43ce46648ddad0381b46f2d1b52_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIxLTAtMS0xLTczNTM1L3RleHRyZWdpb246NDkxY2U3NTJhMmE4NGE4NDk4ZDhlNGM1MTgzYzNiMGFfNA_4a1874f8-7bf1-4a3f-8931-3cb3a4bb8853">0.334</ix:nonFraction>% Notes due August 13, 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7ed43ce46648ddad0381b46f2d1b52_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIxLTMtMS0xLTczNTM1_76b98c10-e551-4c3b-9924-dd0e521463c3">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief27c89ab80f4c94b4ad781ba05245ae_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIxLTUtMS0xLTczNTM1_c7c7cbc0-cede-4d35-aa88-5b558f89eab9">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i597528406ad4432080c7b790975f5a70_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIyLTAtMS0xLTczNTM1L3RleHRyZWdpb246NTc0ZjU3ODliNjRhNDc4MzlhMGNlMWU4ZTQ3MDVkY2NfNA_4ce6c54b-7ba3-4f35-a157-7045db18b410">2.823</ix:nonFraction>% Notes due May 20, 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597528406ad4432080c7b790975f5a70_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIyLTMtMS0xLTczNTM1_bba3374d-5946-4211-bc7a-889255b5bfa7">745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9850b5968694db493ee80a1a80fc434_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIyLTUtMS0xLTczNTM1_43d88abf-505c-412c-8e87-f37e031dae20">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3605fcabb8994cffb101c033d2307325_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIzLTAtMS0xLTczNTM1L3RleHRyZWdpb246ZDJkMWU4M2RhNjY4NDM3Yjk2YWE0Yjk4ZDJmYjc0ZmJfNA_b11cf45e-e3c0-4465-b1db-72776616a317">1.957</ix:nonFraction>% Notes due February 11, 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3605fcabb8994cffb101c033d2307325_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIzLTMtMS0xLTczNTM1_621b31ca-ec68-45b5-84c4-9be9d3a669d3">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bccee58c364c979aa7b39b610a38ab_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIzLTUtMS0xLTczNTM1_1cd0516b-fdce-42ad-982a-373af81daf0b">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTAtMS0xLTEwNTc3MS90ZXh0cmVnaW9uOjYzNjg3OTNkM2QwZDQ4ZWY4MzllZGM4Yjk0ODdiNmNmXzQ_c6a29db4-b8e1-48a7-91c3-b21055859ebe">4.298</ix:nonFraction>% Notes due August 22, 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTMtMS0xLTEwNTc2NQ_e6dd4f32-0585-40a9-abd1-f6a14e682c92">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie17bfcc9d30b4c22988228770a9646df_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTUtMS0xLTEwNTc2NQ_a8b0ed12-da6a-4a74-bce8-a073b1c4981e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i686038d3973d4dd3b99c9b7c97fdda7a_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI0LTAtMS0xLTczNTM1L3RleHRyZWdpb246NDVlMWI2NTViZWJjNDMwNWI1NGFiZjczN2UzMjJlOTdfNA_283e8047-9049-45cd-bf67-e2462da6d8ac">1.213</ix:nonFraction>% Notes due February 12, 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23650c82023d4075b7451afcab116d86_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI0LTMtMS0xLTczNTM1_fdd09068-4e11-438a-859f-14e6b4dc5630">580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602de84cb42e475798daa51154634938_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI0LTUtMS0xLTczNTM1_d8e18978-128b-407e-a612-31d0b200a091">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI1LTAtMS0xLTczNTM1L3RleHRyZWdpb246ZmRkNzJkNzRjNjVjNGY3ZGFlM2Q2OTk2MWYxZWY4NDZfNA_a7c2a846-cd8e-4c16-ba62-c4a9b7310fcb">6.000</ix:nonFraction>% Notes due May&#160;15, 2039</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI1LTMtMS0xLTczNTM1_1efe9cf5-fa05-4584-9c82-f6cdc7c3dd99">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f072271fd54749be6519ce7a4cb656_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI1LTUtMS0xLTczNTM1_01c85f1f-5616-4615-87f3-97e3731c1e89">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id83e438c828a47659e4ba879ee36b614_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI2LTAtMS0xLTczNTM1L3RleHRyZWdpb246MWRlYWVlZDA1ODYwNGZkZmIzZjQ5NmQ0ZDk3YjBhNjRfNA_3101370d-b855-48c9-bbd0-e170e9547f2a">5.000</ix:nonFraction>% Notes due November&#160;12, 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83e438c828a47659e4ba879ee36b614_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI2LTMtMS0xLTczNTM1_8e1fb521-8f1e-42f1-9815-ba5144c12b93">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ad1135b73947ef9ed5193babf7878e_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI2LTUtMS0xLTczNTM1_04198951-e93e-4f66-aa41-8729f35b09f8">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6229439c652442adbe136afeff494f38_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI3LTAtMS0xLTczNTM1L3RleHRyZWdpb246YmFjYjg5ZGI2NDk3NDgzZGJkNzNjMjU3N2NjOTk5NzdfNA_fb610759-e385-4125-991b-2f312a48483b">1.336</ix:nonFraction>% Notes due August 13, 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6229439c652442adbe136afeff494f38_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI3LTMtMS0xLTczNTM1_97066453-3736-4358-9c95-6476a0dca0ed">869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5624d7d8e14e90943f68d463e69f40_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI3LTUtMS0xLTczNTM1_9e9bf3aa-ef6e-492c-ac78-4f9e2583af95">1,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifaa71c7f48a44190bbfc9f05ea58cfb9_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI4LTAtMS0xLTczNTM1L3RleHRyZWdpb246YTNjNDI0ZGJlYTQ0NDNlNjlmOWY0ZDljYjhlYzJkNjJfNA_d31f285c-e18b-427b-a77b-b04e28d5631c">4.875</ix:nonFraction>% Notes due May 15, 2044</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaa71c7f48a44190bbfc9f05ea58cfb9_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI4LTMtMS0xLTczNTM1_f18d7264-db1a-483a-a2cf-122faa2693c1">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ac3489c92480f87da9461658618ea_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI4LTUtMS0xLTczNTM1_4c15a358-9193-4cde-9033-a5e1bcb6cf12">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI5LTAtMS0xLTczNTM1L3RleHRyZWdpb246MDUxOGFjMTgwMGRhNDdhOTliNmY3NGYyODg0OTNhOWNfNA_7e149b21-79c1-47a6-ab2e-a9aa2658b716">4.685</ix:nonFraction>% Notes due December 15, 2044</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI5LTMtMS0xLTczNTM1_7bee6db7-7e9e-48a3-872b-a2f9d978f0ef">911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569682f1363b43b89ccf1234c5278a9f_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI5LTUtMS0xLTczNTM1_9d647fea-bbfe-4fd7-b87c-5ffb7da7ba0f">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a74c7bd3dcf442eae90093915052162_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMwLTAtMS0xLTczNTM1L3RleHRyZWdpb246ZmUwMDgzYjRiMTZhNDFmZmEzOGQ4NjEwNDA0NDU1YTJfNA_dffeb5ae-4f97-453b-a3fb-bd7632976ac2">4.669</ix:nonFraction>% Notes due June 6, 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a74c7bd3dcf442eae90093915052162_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMwLTMtMS0xLTczNTM1_644deafd-2096-4274-9cc1-db97c1951559">1,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia718f431cd534f328b232c9f48b09e22_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMwLTUtMS0xLTczNTM1_7f400e84-5e82-4a54-92b1-9088e84dd78e">1,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMxLTAtMS0xLTczNTM1L3RleHRyZWdpb246MmFlMGZjZjk5YjIyNDJjYWEyMTk4NGQzYWE5MjdlYzZfNA_e6befd63-82e0-4051-a481-dd823b88b1f6">3.794</ix:nonFraction>% Notes due May 20, 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMxLTMtMS0xLTczNTM1_4a90b918-cacd-4f33-935e-1063602c2f09">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0d22cd43c3455081ebb8c94a57c5b9_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMxLTUtMS0xLTczNTM1_3eb3ac7a-ef28-4adf-8e6a-1f15fd9361cc">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-Term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMzLTMtMS0xLTczNTM1_2d2f5e05-23ae-4b36-a117-fe046db2fa8f">13,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMzLTUtMS0xLTczNTM1_1e9c5437-69c7-485c-8d78-c06798982804">17,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">A portion of the aggregate principal amount outstanding was retired during 2022, as further discussed below.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents notes issued during 2022, as further discussed below.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate annual maturities of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including interest during the fiscal years ending September&#160;30, 2023 to 2027 are as follows: 2023 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgwNA_95f1d146-caa3-4d60-9a1b-ae71538cd672">439</ix:nonFraction> million; 2024 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgxMw_e3c4b223-8501-4446-8349-a9452309d77f">1.574</ix:nonFraction> billion; 2025 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgyMg_d9931236-6b07-4ecd-bbf6-79b3e94d0934">2.019</ix:nonFraction> billion; 2026 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgzMQ_8bef8f93-fd80-4a30-b0a1-c098c1c42b90">951</ix:nonFraction> million; 2027 &#8212; $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzg0MA_0143882c-092a-4ad1-8f43-366998bb1c49">2.801</ix:nonFraction> billion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current credit facilities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal year 2021, the Company refinanced its <ix:nonNumeric contextRef="ic7ea78107cfd48079574408788ac59cf_D20210701-20210930" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQyOTY_89bec9e3-14bf-4915-8581-9fcef71fe174">five-year</ix:nonNumeric> senior unsecured revolving credit facility that was to expire in December 2022, with a new <ix:nonNumeric contextRef="ic7ea78107cfd48079574408788ac59cf_D20210701-20210930" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMTg_0a3642e5-bba1-49fe-8919-ad8c0dbc4ceb">five-year</ix:nonNumeric> senior unsecured revolving credit facility that will expire in September 2026. The credit facility provides borrowings of up to $<ix:nonFraction unitRef="usd" contextRef="i74d9c4caf0fe4fe0890096aea18a076d_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzExODc_454b7e52-ea14-4f88-894f-26cd0ed3a819">2.75</ix:nonFraction>&#160;billion, with separate sub-limits of $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:SwinglineLoansIssuableUnderCreditFacility" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEyMTk_02f52338-0f74-4f0e-814d-9433109a6344"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:LettersOfCreditIssuableUnderCreditFacility" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEyMTk_b1b5316f-af22-4d84-af90-54580a3fec0d">100</ix:nonFraction></ix:nonFraction>&#160;million for letters of credit and swingline loans. The expiration date of the </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i06d78fa93c5241fc9b45ebd6985fa25b" continuedAt="i77563e2e22ed4df492d4bc4ce9612887"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">credit facility may be extended for up to two additional one year periods, subject to certain restrictions, including the consent of the lenders. The credit facility provides that the Company may, subject to additional commitments by lenders, request an additional $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE1NTk_cb1acf9b-2dc1-4851-a2e6-f29bb8e228e9">500</ix:nonFraction>&#160;million of financing, for a maximum aggregate commitment under the credit facility of up to $<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE2NDY_08df4860-bdec-4d81-8a5b-5857d4676b8b">3.25</ix:nonFraction>&#160;billion. Proceeds from this facility may be used for general corporate purposes. There were <ix:nonFraction unitRef="usd" contextRef="i9bbe00aadffe4e36a0990b8bfd4542ca_I20220930" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE3MzM_647abdd1-2ec2-448a-91eb-f99634be31d2"><ix:nonFraction unitRef="usd" contextRef="i5b97cd83431a46e9b8ff128d63380b1e_I20210930" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE3MzM_8f0d4265-c644-4376-925f-28ad0cc639ac">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under the Company&#8217;s revolving credit facilities as of September&#160;30, 2022 and 2021. In addition, the Company has informal lines of credit outside of the United States. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Spin-off-related debt transactions</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Embecta, as a wholly-owned subsidiary of the Company, issued $<ix:nonFraction unitRef="usd" contextRef="i763be4649bed40309ea0a989f6d8495f_I20220228" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyMzQ_fc0a4d5f-8c4a-4d1a-86a5-e7d34510e22f">500</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i763be4649bed40309ea0a989f6d8495f_I20220228" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNDg_07a21121-a07d-4a29-a30f-56a58a817522">5.000</ix:nonFraction>% senior secured notes due February 15, 2030, in advance of the Company&#8217;s spin-off of Embecta, which is further discussed in Note 2.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, Embecta entered into an indenture dated April 1, 2022 to issue $<ix:nonFraction unitRef="usd" contextRef="ief9c3d8df6124fd9ae43c6a9f513637b_I20220401" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNTY_eafbcf01-710c-4a53-a33a-13b7aab5c7b6">200</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="ief9c3d8df6124fd9ae43c6a9f513637b_I20220401" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNzA_32f7a58b-9d54-4393-883f-ab31a6e745dd">6.750</ix:nonFraction>% senior secured notes due February 15, 2030. These notes were issued to the Company as part of the consideration for assets transferred to Embecta in connection with the spin-off. After the spin-off was effective on April 1, 2022, the Company exchanged these notes for $<ix:nonFraction unitRef="usd" contextRef="i0969e888373e4049877b7174d7c5bddd_I20220401" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNzg_ccfc8911-4e69-4274-b1a5-6191723b5fed">199</ix:nonFraction>&#160;million of the aggregate principal amount outstanding on the Company&#8217;s Floating Rate Notes due June 6, 2022, which were purchased through a tender offer. The carrying value of the long-term notes tendered was $<ix:nonFraction unitRef="usd" contextRef="ida7543d2dde946539fa775f189e5666f_I20220401" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyOTI_97c5fee8-e9e1-4bd9-9365-1a92d4d61532">199</ix:nonFraction>&#160;million, and the Company recognized a loss on this debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="ia025880105b44439b3c131cb16841016_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzMDY_81cacedb-3095-4bd6-83d2-fb2ea476125c">2</ix:nonFraction>&#160;million, which was recorded in the third quarter of fiscal year 2022 within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on the Company&#8217;s consolidated statements of income.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in connection with the spin-off, on March 31, 2022, Embecta issued a senior secured term loan facility with an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i7c3cc867b1a746999043d8c1873c5582_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzNDA_dd2ecddd-616a-4be2-b8b1-8b1d3cecadd7">950</ix:nonFraction>&#160;million and a senior secured revolving credit facility providing borrowings of up to $<ix:nonFraction unitRef="usd" contextRef="i2153de5b147d447da55f5389dd07896d_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzMjY_de461cf3-93c7-4914-a4b8-74d7537c8370">500</ix:nonFraction>&#160;million that was undrawn at March 31, 2022 and at the spin-off date. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The senior secured notes and credit agreement for the term loan and revolving credit facilities were guaranteed on an unsecured, unsubordinated basis solely by the Company prior to the spin-off date.  The Company&#8217;s guarantees automatically and unconditionally terminated upon the consummation of the spin-off on April 1, 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, Embecta used a portion of the proceeds from the financing transactions discussed above to make a cash distribution of approximately $<ix:nonFraction unitRef="usd" contextRef="i779c08f21c7145b69a3c73a02acd692f_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzNTQ_58070dfd-94ed-4de8-a34b-fcdfe4e51555">1.266</ix:nonFraction>&#160;billion to the Company.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i77563e2e22ed4df492d4bc4ce9612887" continuedAt="i5f52bd4426014c13864a47aa88cab394"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt issuances</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:ScheduleOfDebtIssuancesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMTI_b021b9a6-9f9c-434f-91a6-7a84e8b8dd35" continuedAt="i49b2f09816f74aef9b78a0f30e55abde" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued the following U.S. dollar-denominated debt during fiscal years 2022 and 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtMC0xLTEtMTA0MzMwL3RleHRyZWdpb246YWVjY2FhYjliMzNjNDkwNDg3MjNiOTY4YTM1NTE0ZDlfNDM5ODA0NjUxMTE2Mw_aac1a020-e1e3-4ac9-97da-047ac4d5b877">4.298</ix:nonFraction>% notes due August 22, 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtNC0xLTEtMTA0MzI0_e25c00b3-35b5-47b7-a41c-9fc4fa07bf8c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib82c168f755943beb76474f81ed94633_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyMjAwOTgzYTc1ZWE0Nzk0YjQ1MGYwMjgyMmExMTlmYV80Mzk4MDQ2NTExMTc3_a02271ea-6333-4e90-97bc-b22bbe72adca">1.957</ix:nonFraction>% notes due February 11, 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82c168f755943beb76474f81ed94633_I20210331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtNC0xLTEtNzM1MzU_3d95e92c-5424-4f80-8f9d-f93204caf27f">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of <ix:nonFraction unitRef="number" contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtNi0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplYzMwMWQzM2U4ZTU0YTE1YWNkYzQxOTUzNzA4NDNiMF8xMDk5NTExNjI3ODI1_9efe08e9-095c-445c-9127-a499c7632c5f">3.125</ix:nonFraction>% notes due November 8, 2021</span></div></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued the following Euro-denominated debt during fiscal year 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of Euros)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6b7239cbb2b4caa96217145ed318c6a_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjOWZlMDI5MjY4ZDc0MmI5YjA4MDJjZjRiM2UyZTQ2YV80OTQ3ODAyMzI1MDI0_a3152ef2-958b-47d6-bfbb-2fb70b44a1a9">0.000</ix:nonFraction>% notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if092f20bc6ba47ee829e82597aec9760_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzEtNC0xLTEtNzM1MzU_5c60914f-103e-4953-ac1f-38f28a2c68c8">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26010aaa94984bc6b48f50c2340e67af_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzEtNi0xLTEtNzM1MzU_41314b8b-e502-4169-a381-fecf92de4c00">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonFraction unitRef="number" contextRef="ia9406b7f8b0d4bcb819b52eef9ed6c98_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpmMDQ1Mzg0ZTMzYzI0ZGU1YjIwNjdkNWFmNjhkY2Y4NV80OTQ3ODAyMzI1MDQ0_5eaac8ec-bc5d-4094-b216-e6bd50d641e8">0.034</ix:nonFraction>% notes due August 13, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie33b2738d7da4d69943646d03c93abc3_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzItNC0xLTEtNzM1MzU_44d47cf4-708c-4e32-8f45-0b8fdf09d070">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31af2fbf9574b50a43cb3846510c6a5_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzItNi0xLTEtNzM1MzU_6657799c-2582-417d-8657-8c1aa43f393e">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in fiscal year 2021, Becton Dickinson Euro Finance S.&#224; r.l., a private limited liability company (soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e), which is an indirect, wholly-owned finance subsidiary of the Company, issued Euro-denominated notes, listed below, which are fully and unconditionally guaranteed on a senior unsecured basis by the Company.  No other of the Company's subsidiaries provide any guarantees with respect to these notes.  The indenture covenants included a limitation on liens and a restriction on sale and leasebacks, change of control and consolidation, merger and sale of assets covenants.  These covenants are subject to a number of exceptions, limitations and qualifications.  The indenture does not restrict the Company, Becton Dickinson Euro Finance S.&#224; r.l., or any other of the Company's subsidiaries from incurring additional debt or other liabilities, including additional senior debt.  Additionally, the indenture does not restrict Becton Dickinson Euro Finance S.&#224; r.l. and the Company from granting security interests over its assets.  <ix:continuation id="i49b2f09816f74aef9b78a0f30e55abde" continuedAt="i8505223e403f4d44b5f1c5faf90e88a8">The notes issued by Becton Dickinson Euro Finance S.&#224; r.l included the following:</ix:continuation></span></div><div style="margin-top:6pt;text-align:center;text-indent:24.75pt"><ix:continuation id="i8505223e403f4d44b5f1c5faf90e88a8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of Euros)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief27c89ab80f4c94b4ad781ba05245ae_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxODkxNWM1ZGE3Y2Y0N2IwYWQ3NmZmNTY2ZGY1YmU5OF80Mzk4MDQ2NTExMTM2_82e3891f-3b1e-494c-a7a6-7c9e06c60b0b">0.334</ix:nonFraction>% notes due August 13, 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i96c8b23a3f8e4af4ae8c1da6663b9bdc_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzEtNC0xLTEtNzM1MzU_ce51a60b-9b0d-4bca-bb64-0da708a19bc0">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3860e3f6433948fe91197f9214f8ee03_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzEtNi0xLTEtNzM1MzU_082addd5-1c19-4aef-9d61-f304178ff582">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f5624d7d8e14e90943f68d463e69f40_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplOGE5MzgyNzE3YTQ0OTk0YjFmZWVmMTRhNGYzMDIzY180OTQ3ODAyMzI1MDI0_fa86c2e9-6e1d-484b-8739-f1f479a63b7c">1.336</ix:nonFraction>% notes due August 13, 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iebef67ca020b4e9190319bea0f3427b3_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzItNC0xLTEtNzM1MzU_3065da83-30b5-4a88-b945-5e5a5535c8b1">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6939f1f5044d25973438c5911a2a59_I20210930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzItNi0xLTEtNzM1MzU_3377a420-de67-4925-b66c-bb16c53e1032">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i686038d3973d4dd3b99c9b7c97fdda7a_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1M2VjNjc3NDY2NjA0MTdhODJhZDIxZDRmODA5MGEwMV80OTQ3ODAyMzI1MDM0_3a490424-58c3-4d83-8ff4-5c1d2add39e8">1.213</ix:nonFraction>% notes due February 12, 2036</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6f7d0235eba84a0698944deb7ab704a7_I20210331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtNC0xLTEtNzM1MzU_716c2912-80f0-44ea-8fad-fe37f3d800b5">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c474d65be064b50ab5658c993941100_I20210331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtNi0xLTEtNzM1MzU_fce3bc40-2d0c-489f-99bb-72b8626cf45a">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of  <ix:nonFraction unitRef="number" contextRef="i51961b234cd24495af06e60749af2c1c_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtOC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo4ODdjMTc3YzIzMDE0NmMwOGI2Y2QwN2M0MTU4MGE4OF8xMDk5NTExNjI3ODIy_1f9b562c-39d2-42c0-b7cb-0fafcafa5418">0.174</ix:nonFraction>% notes due June 4, 2021</span></div></td></tr></table></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt retirements</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQyOTk_fb1bb396-c00a-4cac-aa75-b284e610a0c8" continuedAt="i92fe828b98784090ba78444fbb7adf7e" escape="true">On August 8, 2022, the Company commenced a series of tender offers to purchase for cash, certain of its outstanding senior notes. Proceeds from the notes issued in the fourth quarter of fiscal year 2022 plus cash on </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5f52bd4426014c13864a47aa88cab394" continuedAt="i3b53983870c740009c29b68e55b14a99"><ix:continuation id="i92fe828b98784090ba78444fbb7adf7e"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hand were used to pay for the tender offers. As a result of the tender, the Company&#8217;s retirements of debt in fiscal year 2022 included the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"><tr><td style="width:1.0%"></td><td style="width:39.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal, interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market price of retirement (a)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) loss recognized to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItMC0xLTEtNzY0MzIvdGV4dHJlZ2lvbjpiMGU1YjU0YjMyMGE0MTc1YTE2YTdlZTI1YzUwN2UyNF8xMDk5NTExNjI3ODI5_bc86da77-3938-479f-9464-5bce3660246a">190</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItMC0xLTEtNzY0MzIvdGV4dHJlZ2lvbjpiMGU1YjU0YjMyMGE0MTc1YTE2YTdlZTI1YzUwN2UyNF8xMDk5NTExNjI3ODQx_e6befd63-82e0-4051-a481-dd823b88b1f6">3.794</ix:nonFraction>% notes due 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id280f6f5f1b54db287e925bcaab334b3_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItNC0xLTEtMTA1NzI1_5a99f8ef-e895-4734-9f75-9199ad968af1">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItNi0xLTEtMTA1NzI1_a359cc2e-4c2f-478f-a20e-f0522b747fec">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfdde262f537472fb65210d2b884f533_D20220701-20220930" decimals="-6" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItOC0xLTEtMTA1NzI1_fab162dc-b770-4c04-8138-c2ef7a785134">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtMC0xLTEtMTA1NjY1L3RleHRyZWdpb246MmM0OTBiYzgyNDAwNDUxZTlkYzdiM2RiNWQxMzM1ZmJfMTA5OTUxMTYyNzgzMg_23d19f4c-2d86-417f-b92e-7a465aaf1f06">52</ix:nonFraction>&#160;million  of <ix:nonFraction unitRef="number" contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtMC0xLTEtMTA1NjY1L3RleHRyZWdpb246MmM0OTBiYzgyNDAwNDUxZTlkYzdiM2RiNWQxMzM1ZmJfMTA5OTUxMTYyNzg0NQ_babfac03-1470-44e3-b244-47d4c7ed5aff">7.000</ix:nonFraction>% debentures due 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafab5391deac4533b6a6ac832b19ac87_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtNC0xLTEtMTA1NzI3_ab95b95c-209a-4240-8567-fa440c841d86">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtNi0xLTEtMTA1NzI3_bf79d714-3d6b-4b52-bc1b-43e563744676">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d239a7d2eab44538b07a8dbbcd8458d_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtOC0xLTEtMTA1NzI3_2a24057c-74d6-417b-b68c-546ea16bd319">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtMC0xLTEtMTA1NjcxL3RleHRyZWdpb246MDBiYTk0Njk3Y2FjNGJkYzg4Y2FkZWIwNzA5YTE2ZGNfMTA5OTUxMTYyNzgzMg_345e0058-3971-4775-9809-bb3084530c67">55</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtMC0xLTEtMTA1NjcxL3RleHRyZWdpb246MDBiYTk0Njk3Y2FjNGJkYzg4Y2FkZWIwNzA5YTE2ZGNfMTA5OTUxMTYyNzg0NA_034a0f23-193c-448b-b6c9-5fe34b930326">6.700</ix:nonFraction>% debentures due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if530e7153ede42babf75d9614ea2fed3_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtNC0xLTEtMTA1NzI3_3395a1d5-7cdc-450d-a31c-c4a109deac90">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtNi0xLTEtMTA1NzI3_e5c5b613-5505-4839-a78b-3355a34e1161">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7602efcbb12497fa6ca035a193d108a_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtOC0xLTEtMTA1NzI3_bef00d71-fb85-42d9-8ef6-49fe14d8693a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtMC0xLTEtMTA1Njc3L3RleHRyZWdpb246OWQ3M2M1ZmY0ZjAyNGRhZWE5YjllMmVhYzIyMmY5YjRfMTA5OTUxMTYyNzgyOQ_2ff4f8cb-faed-4e7d-8b3d-7ee2e5d8fb47">127</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtMC0xLTEtMTA1Njc3L3RleHRyZWdpb246OWQ3M2M1ZmY0ZjAyNGRhZWE5YjllMmVhYzIyMmY5YjRfMTA5OTUxMTYyNzg0MQ_a7c2a846-cd8e-4c16-ba62-c4a9b7310fcb">6.000</ix:nonFraction>% notes due 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32b723311b347478e48a35ca4f68e40_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtNC0xLTEtMTA1NzI3_7750e866-c470-42e9-9fd6-879b0e6b58b3">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtNi0xLTEtMTA1NzI3_77896ec1-2939-42d2-921c-d390840db761">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd421b62f5a4ac2bf277725abb3c4dd_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtOC0xLTEtMTA1NzI3_36e3a222-c0a8-46b8-9b7f-c3437ac7e2e3">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id83e438c828a47659e4ba879ee36b614_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtMC0xLTEtMTA1NjgzL3RleHRyZWdpb246MGNhMWIyOGI1MjhjNDA5NGJmY2YxZDNmOTY3NTQ5ZDFfMTA5OTUxMTYyNzgyNw_3a2cce11-32d3-4ac3-974c-660e3b6065c1">34</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="id83e438c828a47659e4ba879ee36b614_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtMC0xLTEtMTA1NjgzL3RleHRyZWdpb246MGNhMWIyOGI1MjhjNDA5NGJmY2YxZDNmOTY3NTQ5ZDFfMTA5OTUxMTYyNzgzOQ_3101370d-b855-48c9-bbd0-e170e9547f2a">5.000</ix:nonFraction>% notes due 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d32099e1bf4a3fa5b0b39913d35e39_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtNC0xLTEtMTA1NzI3_888d2109-fdbf-437f-82bb-1e9d52ec96f3">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83e438c828a47659e4ba879ee36b614_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtNi0xLTEtMTA1NzI3_d3fe19c6-c84e-4a65-8647-6807360d1d5f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca62f76cd424ac899783fac2a96e623_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtOC0xLTEtMTA1NzI3_113bb3f2-da7e-4449-826a-0d030ac0c2c5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctMC0xLTEtMTA1Njg5L3RleHRyZWdpb246YzFmYWI4MGI3M2YzNDA5ZmFiOGNmZjhiYjU0MWE3YjVfMTA5OTUxMTYyNzgyNw_e23c354d-dbd8-4ce6-9832-b4821c821a57">42</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctMC0xLTEtMTA1Njg5L3RleHRyZWdpb246YzFmYWI4MGI3M2YzNDA5ZmFiOGNmZjhiYjU0MWE3YjVfMTA5OTUxMTYyNzgzOQ_7e149b21-79c1-47a6-ab2e-a9aa2658b716">4.685</ix:nonFraction>% notes due 2044</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9cf2d374194df6ae4c79f04396b60d_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctNC0xLTEtMTA1NzI3_0adef942-df11-44df-b442-1beee4af0273">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctNi0xLTEtMTA1NzI3_6649b3df-4a14-4024-87f8-762419e9b7e2">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4c7f7af69c647e89fe2fbce62dcc9e0_D20220701-20220930" decimals="-6" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctOC0xLTEtMTA1NzI3_2581f754-2e87-491c-856a-f1e43e4b6503">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included accrued interest, related premiums, fees and expenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Debt retirement was accounted for as an early debt extinguishment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To mitigate the impact of rate volatility on the total tender cash spend, the Company executed reverse Treasury locks that were unwound concurrent with the tender at a loss of $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="bdx:BdxGainlossfromreversetrasurylocks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzM4NDgyOTA3MDcwMDY_248c2332-546d-49b8-a981-d4349ead4118">17</ix:nonFraction>&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s retirements of debt in fiscal year 2021 included the following:</span></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"><tr><td style="width:1.0%"></td><td style="width:39.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(Millions of dollars)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal, interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market price of retirement (a)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loss recognized to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if0ffa05b17304f47881712e6c344e328_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNjI3ODFjNDAwMzQ0ZjczYTU3NWIwNGUzMTM0NTAzY18xMDk5NTExNjI3ODEy_0145e7ac-9caa-4d97-af25-389b45fe1ec7">1.535</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="if0ffa05b17304f47881712e6c344e328_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNjI3ODFjNDAwMzQ0ZjczYTU3NWIwNGUzMTM0NTAzY18xMDk5NTExNjI3ODIx_72a101fd-a51b-42e6-aa0f-3ef61a3135f6">2.894</ix:nonFraction>% notes due June 6, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e5fbb72ed545d0a517f8558fbba67b_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItNC0xLTEtNzM1MzU_5f676a42-89f0-4cc3-a2ea-6e9698f12035">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0ffa05b17304f47881712e6c344e328_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItNi0xLTEtNzM1MzU_811520ff-3fc0-46e5-96a8-0ed2f35e926e">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1049aeeb644c24b6c34fb4411c861a_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItOC0xLTEtNzM1MzU_ea871daa-de7f-4b5f-b53f-4001c860c96d">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i18f59f936a894ffba8eb3a14ba54e55b_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphNjhkNTJmNDdhZDE0Zjk3ODRlOTM2YWY4ZTkzOGMzN18xMDk5NTExNjI3ODEz_8b67ee6b-2014-4a9a-97f1-3d48448590a4">294</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i18f59f936a894ffba8eb3a14ba54e55b_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphNjhkNTJmNDdhZDE0Zjk3ODRlOTM2YWY4ZTkzOGMzN18xMDk5NTExNjI3ODE5_de452fa6-b483-4e65-a463-be9c62d5dcb7">3.300</ix:nonFraction>% notes due March 1, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1906af748d804698a67a96838cf98239_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtNC0xLTEtNzM1MzU_071754e8-06c0-4ce9-9c29-7a599160b9cd">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f59f936a894ffba8eb3a14ba54e55b_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtNi0xLTEtNzM1MzU_71f32fdc-9e1b-44fb-a77f-ea516e3743c5">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id102f0302f614bf08fe037344bc095d2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtOC0xLTEtNzM1MzU_79a94cc0-6fca-4877-9bd2-4b6a324d0e71">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphZjdlYzM5NWI1NDg0MzJjOTIyMjI3ZDg2NmFhNzA5MF80_612a91d0-8d08-4d84-ba14-b7c2b875040f">33</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphZjdlYzM5NWI1NDg0MzJjOTIyMjI3ZDg2NmFhNzA5MF80Mzk4MDQ2NTExMTM5_5425c3f7-cbee-4984-b551-59b46913b8ac">3.875</ix:nonFraction>% notes due May 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198b3d81101443ecbb89d876818dc429_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtNC0xLTEtNzM1MzU_9d9d1dc6-1d85-451b-b612-66747e8e8f13">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtNi0xLTEtNzM1MzU_61b933c8-0acf-4729-a81c-2c961ec8ab7f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce76d4d39314f31a725cb2fb4405f44_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtOC0xLTEtNzM1MzU_d280cfca-f3e4-4dba-a47e-45847e83f4cb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo2ODdlYTc5NzA2MmQ0YTQyODMwOTFjZTJhZmM0MTkzOF80_2854e5cc-cd4d-404c-86e3-2f0281abdebe">500</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo2ODdlYTc5NzA2MmQ0YTQyODMwOTFjZTJhZmM0MTkzOF80Mzk4MDQ2NTExMTQ0_203770a4-ec89-43bf-9e4a-87fe300d0445">3.734</ix:nonFraction>% notes due December 15, 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d69b67e36644b9aafbaf1de869fc363_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtNC0xLTEtNzM1MzU_c9877d6e-6b1f-45db-a3ef-25d8dbdf49f1">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtNi0xLTEtNzM1MzU_ec554180-57e2-4118-abc2-e65523bc5cf5">546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5115502651348ca9ad2cab73680d5c2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtOC0xLTEtNzM1MzU_f084d728-07f5-4f3b-b22a-623378ff9c18">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjYjY3NjQ1MTI0ZTg0MDdlYjczNjFhNmM2MmFhNTVjY180_a1464d24-96d3-4c00-82c1-bec2ff644068">752</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjYjY3NjQ1MTI0ZTg0MDdlYjczNjFhNmM2MmFhNTVjY180Mzk4MDQ2NTExMTM5_7c0fef19-0944-409f-bee8-f0999a7c6e3a">3.363</ix:nonFraction>% notes due June 6, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ec6988641447b8dbfe586f04fa9c5_I20210930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtNC0xLTEtNzM1MzU_47acba9b-21e0-47c6-be6f-1057116deb78">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtNi0xLTEtNzM1MzU_9770631a-7e89-47aa-895a-e2c46a018cf2">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff9e2355d1b44a4856d7f25dd014220_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtOC0xLTEtNzM1MzU_86a6840e-49b3-4f56-9057-b2f0f277675b">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1ODZjZTdiMmRhMmI0NTdlOTE3NjdkYmJjN2ZhZDljM18xMDk5NTExNjI3ODE2_cf3e73bd-466f-4e54-8ad7-3481a03c5816">1.0</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1ODZjZTdiMmRhMmI0NTdlOTE3NjdkYmJjN2ZhZDljM180Mzk4MDQ2NTExMTU2_a885ac03-cd74-4787-bbbd-906e812c79ed">3.125</ix:nonFraction>% notes due November 8, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b17ea17825849b884fccaffccfcd7c8_I20210331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctNC0xLTEtNzM1MzU_2767b1cd-161c-408e-bddf-f5e5fe50c44b">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctNi0xLTEtNzM1MzU_261bced5-acfe-4556-8a24-3922f188e131">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i524df8ec8e694ff09698ff2542b4ace8_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctOC0xLTEtNzM1MzU_3a4b9fc5-1841-444e-9bf3-1a4553627181">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i35d044f774d64179a6b3b2b850e72570_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxNDIwMzRiMGM0ODg0MWY4OTFhYTkzMzJiOGI0NTk1YV8xMDk5NTExNjI3ODI0_3e55239f-8ca4-4a94-8d69-fec85e5294d5">600</ix:nonFraction> million Euros ($<ix:nonFraction unitRef="usd" contextRef="iaad9390901e9440ab8f2487e7732dd8f_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxNDIwMzRiMGM0ODg0MWY4OTFhYTkzMzJiOGI0NTk1YV8xMDk5NTExNjI3ODMx_6b399a7d-837c-489f-ba9f-1e025317ba62">728</ix:nonFraction> million) of <ix:nonFraction unitRef="number" contextRef="i51961b234cd24495af06e60749af2c1c_I20210331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxNDIwMzRiMGM0ODg0MWY4OTFhYTkzMzJiOGI0NTk1YV80Mzk4MDQ2NTExMTY4_9d2c8b0b-b14f-49e4-8ffc-f99428cc1bed">0.174</ix:nonFraction>% notes due June 4, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9861ef1ad04469090e0fb052180295c_I20210331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtNC0xLTEtNzM1MzU_51aebea7-9a39-4745-b439-4aa4060cb573">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51961b234cd24495af06e60749af2c1c_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtNi0xLTEtNzM1MzU_e8164cb1-7f3f-4736-8e4c-3ee1455e1882">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f931afdb7747e393d4a4978e51673e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtOC0xLTEtNzM1MzU_d9f7b816-1414-4638-9518-7cc5182d7bbb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i98e35f9e011d44588b3b8b920a77a0bf_I20201231" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplNTMzNDM1YWY0ODc0OGYzYmQxZGMwMGNjZjQ5ZjM2Y18xMDk5NTExNjI3ODEy_bbee86f8-9f8a-4407-9465-184d114bd98a">265</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i98e35f9e011d44588b3b8b920a77a0bf_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplNTMzNDM1YWY0ODc0OGYzYmQxZGMwMGNjZjQ5ZjM2Y180Mzk4MDQ2NTExMTQ5_6e71028f-1421-427b-ae5c-0c00f3b1ca01">2.894</ix:nonFraction>% notes due June 6, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc4f6959fee4f399833aef85a382ac2_I20201231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktNC0xLTEtNzM1MzU_60b1c5c8-6f2e-4972-99b2-e6811ff85e08">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e35f9e011d44588b3b8b920a77a0bf_I20201231" decimals="-6" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktNi0xLTEtNzM1MzU_1395614c-ea0f-42c0-8029-7ee3263193d1">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b78638dd6be44b198ad670fa48ac3d0_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktOC0xLTEtNzM1MzU_be161ce3-0800-47d9-bd38-bf9d62b3847e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included accrued interest, related premiums, fees and expenses.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">All debt retirements in fiscal year 2021 were accounted for as early debt extinguishments.</span></div></ix:continuation></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3b53983870c740009c29b68e55b14a99"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Capitalized interest</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes interest costs as a component of the cost of construction in progress. <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:InterestCostsIncurredTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMDI_63ae35f3-1293-4f67-8af2-e8ba840bb0d8" continuedAt="ie49478727645403fbbcf19cbfd8b7fca" escape="true">A summary of interest costs and payments for the years ended September&#160;30 is as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie49478727645403fbbcf19cbfd8b7fca"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.833%"><tr><td style="width:1.0%"></td><td style="width:48.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzEtMS0xLTEtNzM1MzU_ac7805fa-a8a2-4d00-a0dd-f1782075275f">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzEtMy0xLTEtNzM1MzU_54c55a12-9da7-4e18-827d-b3922b8cf628">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzEtNS0xLTEtNzM1MzU_bc03cf8f-4ced-462c-91e0-c9e6087b1119">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzItMS0xLTEtNzM1MzU_6c29c59c-58c2-4179-917b-4289bc9584ae">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzItMy0xLTEtNzM1MzU_f121a867-7c49-497a-ba70-d58a71b2abf4">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzItNS0xLTEtNzM1MzU_3a1b8bdd-259b-4046-8c54-e75bd73c5f81">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:InterestCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzMtMS0xLTEtNzM1MzU_d005a5d9-0ea2-480d-9cab-69eb7bbc0d42">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:InterestCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzMtMy0xLTEtNzM1MzU_3ac7976a-a9d9-40ad-a68f-af154211fa32">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:InterestCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzMtNS0xLTEtNzM1MzU_ef34780c-e418-4fd6-b666-18c33bce3b6c">571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of amounts capitalized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzQtMS0xLTEtNzM1MzU_33e0cdfe-7f0c-4e5f-9b17-8d10e5473dd1">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzQtMy0xLTEtNzM1MzU_386c70f4-b3ba-49a2-946d-1003ec0d8641">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzQtNS0xLTEtNzM1MzU_bbbcf3f0-f69c-4d7e-a9a3-41b41e2d794c">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MjQ_841b2c0b-e90b-476e-9462-a26c2685e7f3" continuedAt="icdac17bb6a3f4b61a3063e3d2cd52293" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="icdac17bb6a3f4b61a3063e3d2cd52293" continuedAt="ie7a5dbab7bb04fa8988a2f773d9ea7c2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MDY_e78ca752-1ae0-4303-92a6-295d42225412" continuedAt="i935c04b84fdf448d89f0a06b45698e66" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes the years ended September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzItMS0xLTEtNzM1MzU_abc879f6-9da7-4800-9fdc-f54234ad0219">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzItMy0xLTEtNzM1MzU_c4fbe605-be43-4a92-980c-db8a4e298e63">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzItNS0xLTEtNzM1MzU_ce6ff8c1-bd62-4c1e-a843-1b5f383abdfe">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzMtMS0xLTEtNzM1MzU_945f3c40-31dc-444b-9183-f30c7b980109">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzMtMy0xLTEtNzM1MzU_2d1c4351-b55c-4b33-afe0-1a06b8fbdb90">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzMtNS0xLTEtNzM1MzU_a8fcedcf-c7f4-4f27-8feb-7b1b27957847">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzQtMS0xLTEtNzM1MzU_148d1b16-8d3d-4e51-9b09-4007cc42083d">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzQtMy0xLTEtNzM1MzU_3bd64c1f-6228-4c31-ac7b-60e848adc23f">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzQtNS0xLTEtNzM1MzU_682c235e-13d8-4b00-9075-47883a7d5ef5">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzUtMS0xLTEtNzM1MzU_7766985d-9e72-4a0b-b6dd-db4fb0963b6a">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzUtMy0xLTEtNzM1MzU_de5a916b-8454-41b7-8785-592b80e3ee2c">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzUtNS0xLTEtNzM1MzU_50f34145-5175-45bb-ba95-7fc7e1df3e1d">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzctMS0xLTEtNzM1MzU_bf67550e-b1a0-476d-afb8-e3a93945af95">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzctMy0xLTEtNzM1MzU_cb25b5f7-f190-428a-b641-98bff8ca89eb">284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzctNS0xLTEtNzM1MzU_dc525058-7d51-48fd-886d-472456b3cdb4">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzgtMS0xLTEtNzM1MzU_9d0f70ba-5522-4c45-a784-70f8fb9354f1">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzgtMy0xLTEtNzM1MzU_2877ae7b-cdf7-4301-9c6c-0837160aab93">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzgtNS0xLTEtNzM1MzU_23016bc7-4e50-444a-af6e-f5f7cacd762d">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzktMS0xLTEtNzM1MzU_1b966d84-40b0-4a6a-8da4-ec8952240234">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzktMy0xLTEtNzM1MzU_05b64d7c-84f7-4e5c-97bd-6e01bca5df96">280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzktNS0xLTEtNzM1MzU_7fa379a5-0fc3-4d03-ab5e-84252422bd4b">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzEwLTEtMS0xLTczNTM1_24f8e29f-e869-4f95-8384-c06505804633">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzEwLTMtMS0xLTczNTM1_c48f886b-0a98-400b-9be7-dc50e0da7c01">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzEwLTUtMS0xLTczNTM1_62d8fdb2-815f-4968-89e5-fe3e393ad229">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MDM_ef29c55b-19a0-4219-a641-6a241ce5833f" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Continuing Operations Before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the years ended September&#160;30 consisted of:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, including Puerto Rico</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzEtMS0xLTEtNzM1MzU_c72b048e-10c5-4b1f-a864-f89fa97dacec">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzEtMy0xLTEtNzM1MzU_52d0241b-119e-485e-b2ea-894ffdb7ce79">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzEtNS0xLTEtNzM1MzU_b0f9ed22-9c2a-4ff8-89b2-5261056d7122">579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzItMS0xLTEtNzM1MzU_576e76f7-250e-4462-aa6a-812014a9bd0e">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzItMy0xLTEtNzM1MzU_3d27e0d9-032b-4d54-a699-688c650ed3c0">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzItNS0xLTEtNzM1MzU_fef3262f-460f-4f20-a25c-b21f8a1e149b">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzMtMS0xLTEtNzM1MzU_637521ec-374f-4caa-8946-2f489374be03">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzMtMy0xLTEtNzM1MzU_82d7cc1f-fe8f-4e8f-bea5-e0ee07143755">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzMtNS0xLTEtNzM1MzU_f1e3df70-4dca-4eed-a11e-282601508b72">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU0OTQ_0d346ee4-fca6-4944-91a8-0d34bd430a5d" continuedAt="i06e27edf04a448ed8da55a69f116fb05" escape="true">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company believes it is reasonably possible that the amount of unrecognized benefits will change due to one or more of the following events in the next twelve months: expiring statutes, audit activity, tax payments, other </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie7a5dbab7bb04fa8988a2f773d9ea7c2" continuedAt="ieeac3309ba8745cd8b6a16776601bdca"><ix:continuation id="i06e27edf04a448ed8da55a69f116fb05"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activity, or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:62.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEtMS0xLTEtNzM1MzU_ba64a2d9-3eec-4d61-bab5-3f053ef70d9b">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEtMy0xLTEtNzM1MzU_0d45d17e-e455-4b62-97e2-26124325b3a1">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEtNS0xLTEtNzM1MzU_95b28381-a012-41cc-87b3-58065d56ac1f">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzItMS0xLTEtNzM1MzU_dd0a8c3b-c46f-4e25-b872-661680068415">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzItMy0xLTEtNzM1MzU_acad2fd3-0647-4ee8-802a-97d97d30e9ca">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzItNS0xLTEtNzM1MzU_13f74e0a-c3d5-41bd-b2bf-c27c03a7417a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzMtMS0xLTEtNzM1MzU_2b8e9f44-706c-42fc-9b68-3e2f4f3ee684">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzMtMy0xLTEtNzM1MzU_d40d1a6a-2f8c-4345-9a7d-b917aa3ca61a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzMtNS0xLTEtNzM1MzU_4f36dfc2-6926-447e-8624-5b6a8fe4b12a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzQtMS0xLTEtNzM1MzU_513f2732-448e-42ce-965a-18c24a3371b2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzQtMy0xLTEtNzM1MzU_865c70dd-007f-4dd0-ad7b-f800f91d70bc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzQtNS0xLTEtNzM1MzU_dc57f633-fc81-4cca-99d6-adeb74a371ea">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases due to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzUtMS0xLTEtNzM1MzU_cc0d30f3-9bfe-4716-a97f-ba538d9be348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzUtMy0xLTEtNzM1MzU_6a78cff6-82a9-44a8-a96d-3c9a38053b72">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzUtNS0xLTEtNzM1MzU_8277d27e-3f52-412b-8cfd-036fb5116968">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to settlements with tax authorities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzYtMS0xLTEtNzM1MzU_ddd6c1ac-3222-4dcd-8f1a-ad2dcc469cec">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzYtMy0xLTEtNzM1MzU_e97a27ac-b4a5-4671-8a33-c0548bef8f62">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzYtNS0xLTEtNzM1MzU_e2279713-72ba-41f7-b9bf-9f97a59f9a2e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzctMS0xLTEtNzM1MzU_20c60ba3-dc8b-42f5-92fd-c3e78d372c15">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzctMy0xLTEtNzM1MzU_11083b01-cc9c-42f3-b49f-f81631c44fd2">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzctNS0xLTEtNzM1MzU_8e968558-acd7-4fe8-979d-0953b830d979">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzgtMS0xLTEtNzM1MzU_95671279-6596-46c6-b912-cf5f337219b1">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzgtMy0xLTEtNzM1MzU_300dcf33-ca47-4216-925e-99c7ec314e74">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzgtNS0xLTEtNzM1MzU_f4d943c4-ad93-4247-81a9-f319fe3f1acb">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits that would affect the effective tax rate if recognized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEwLTEtMS0xLTczNTM1_15685dcc-c64a-42af-9729-dc97861e04d3">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEwLTMtMS0xLTczNTM1_eddadba6-95c7-4e47-a3fc-9d1f84334f30">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEwLTUtMS0xLTczNTM1_07883ddb-ae30-4d70-80b3-69afd75ec375">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the Company's acquisition of CareFusion in 2015, the Company became a party to a tax matters agreement with Cardinal Health resulting from Cardinal Health's spin-off of CareFusion in fiscal year 2010.  Under the tax matters agreement, the Company is obligated to indemnify Cardinal Health for certain tax exposures and transaction taxes prior to CareFusion&#8217;s spin-off from Cardinal Health.  The indemnification payable is approximately $<ix:nonFraction unitRef="usd" contextRef="ib3f4c3f3aeef48c7a0b365d3718eba1a_I20220930" decimals="-6" name="bdx:IndemnificationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzI1NjU_2cfceeea-82fc-4f41-8023-a78abf1f1551">124</ix:nonFraction> million at September 30, 2022 and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheet.</span></div><ix:continuation id="i935c04b84fdf448d89f0a06b45698e66"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following were included for the years ended September&#160;30 as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision (benefit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated statements of income.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and penalties associated with unrecognized tax benefits</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo3NWNmZDI5OGQwZjk0YjcwOTkxMGM3ZWMxNDI3ZWMzNi90YWJsZXJhbmdlOjc1Y2ZkMjk4ZDBmOTRiNzA5OTEwYzdlYzE0MjdlYzM2XzEtMS0xLTEtNzM1MzU_8fd044d5-beb9-4ae4-8ad5-8a280d7aff9a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo3NWNmZDI5OGQwZjk0YjcwOTkxMGM3ZWMxNDI3ZWMzNi90YWJsZXJhbmdlOjc1Y2ZkMjk4ZDBmOTRiNzA5OTEwYzdlYzE0MjdlYzM2XzEtMy0xLTEtNzM1MzU_e3a5f7a7-f89e-4440-ad6a-89c4d3bb4f76">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo3NWNmZDI5OGQwZjk0YjcwOTkxMGM3ZWMxNDI3ZWMzNi90YWJsZXJhbmdlOjc1Y2ZkMjk4ZDBmOTRiNzA5OTEwYzdlYzE0MjdlYzM2XzEtNS0xLTEtNzM1MzU_8c16957b-b85a-4ec7-8acb-524870c5dd7e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. The IRS has completed its audit for the BD legacy fiscal year 2014, BD combined company fiscal years 2015 and 2017 and CareFusion legacy fiscal years 2010 through short period 2015. With regard to Bard, all examinations have been completed through short period 2017. The IRS has commenced its review of BD&#8217;s fiscal years 2018 through 2020. For the other major tax jurisdictions where the Company conducts business, tax years are generally open after 2015.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ieeac3309ba8745cd8b6a16776601bdca" continuedAt="i0eeba6e608cc46688d6fe9a0b1f544f8"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MTk_a457b594-366f-4cd4-85bb-fbdce48d529b" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes at September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzItMS0xLTEtNzM1MzU_181c6e4f-ea01-4773-92fb-a378b7ab2da0">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzItNS0xLTEtNzM1MzU_ef8c365f-aea2-4f6b-b198-1b858f303d7a">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzMtMy0xLTEtNzM1MzU_f0c86665-3e36-425c-bdfa-34d86c78160b">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzMtNy0xLTEtNzM1MzU_0a3a27dd-b417-431d-a9db-41ec71482753">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzQtMy0xLTEtNzM1MzU_1138a6fc-8358-4b62-9022-b4c8344a9827">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzQtNy0xLTEtNzM1MzU_1e3c15ba-e144-414f-ab1c-549a49369760">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsOtherTaxCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzUtMS0xLTEtNzM1MzU_aa6adcb6-a51e-4b50-8e3a-1d92081bd5e4">2,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsOtherTaxCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzUtNS0xLTEtNzM1MzU_a87ec130-2c43-45c7-9df0-6271e17d9a77">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product recall and liability reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzYtMS0xLTEtNzM1MzU_711b77b5-eca6-4796-80ef-33cfa4b2e7b3">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzYtNS0xLTEtNzM1MzU_34518b3a-4c8e-4f03-a52c-c969bd396a33">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctMS0xLTEtNzM1MzU_000f2b99-d9c5-4c1f-b63f-0ad9c42179a2">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctMy0xLTEtNzM1MzU_93fb89fa-4b1f-49e4-9fa6-603daff1af94">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctNS0xLTEtNzM1MzU_f9bce7a8-48e4-4a86-a4d3-41b62c6cfefc">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctNy0xLTEtNzM1MzU_55acab35-52b3-432d-9869-d75c83468faa">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtMS0xLTEtNzM1MzU_2e022a11-7d54-41d8-93a3-4cdabdb73cbe">3,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="bdx:DeferredTaxLiabilitiesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtMy0xLTEtNzM1MzU_c759f10c-cc5d-45d9-b945-d5f00495d641">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtNS0xLTEtNzM1MzU_bf1bf2c4-12ed-42da-9510-74d7d19d6a87">3,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="bdx:DeferredTaxLiabilitiesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtNy0xLTEtNzM1MzU_2fffba6d-0c2b-44c8-95e3-c49926d8f31f">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzktMS0xLTEtNzM1MzU_0a670138-3e44-4400-b19e-842aa93da5d5">2,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzktNS0xLTEtNzM1MzU_d6c05525-fc0d-43bc-8e1a-9e919085e1da">2,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (a)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTEtMS0xLTczNTM1_0419ccf0-6645-4555-81d1-3456951d03d8">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTMtMS0xLTczNTM1_8d33004e-1de5-4aa7-9fb8-f5edb171403c">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTUtMS0xLTczNTM1_e7c20ba9-4132-4352-8d29-90512e5a5558">1,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTctMS0xLTczNTM1_8c335e82-5c93-4e1c-8942-d13f103077a5">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Net deferred tax assets are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and net deferred tax liabilities are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated balance sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. The Company asserts indefinite reinvestment for all historical unremitted foreign earnings as of September 30, 2022. Deferred taxes have not been provided on undistributed earnings of foreign subsidiaries as of September&#160;30, 2022 since the determination of the total amount of unrecognized deferred tax liability is not practicable.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, deferred tax assets have been established as a result of net operating losses and credit carryforwards with expiration dates from 2023 to an unlimited expiration date. Valuation allowances have been established as a result of an evaluation of the uncertainty associated with the realization of certain deferred tax assets on these losses and credit carryforwards. The valuation allowance at September 30, 2022 is primarily the result of foreign losses due to the Company&#8217;s global re-organization of its foreign entities and these generally have no expiration date. Valuation allowances are also maintained with respect to deferred tax assets for certain state carryforwards that may not be realized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rate Reconciliation</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MjE_79bf6947-ca1d-45b0-953c-5a9bf6c8c307" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory tax rate to the Company&#8217;s effective income tax rate for continuing operations was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"><tr><td style="width:1.0%"></td><td style="width:61.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEtMS0xLTEtNzM1MzU_b2327b65-e90a-47b2-865c-505976d3d758">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEtMy0xLTEtNzM1MzU_41c8ca2f-3ed5-479f-9123-979262d08645">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEtNS0xLTEtNzM1MzU_a0b96974-7cce-444c-a5ee-d02e27614ac7">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzMtMS0xLTEtNzM1MzU_e8221e27-c8a5-419c-9642-71fee524e9eb">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzMtMy0xLTEtNzM1MzU_9296f023-1f6c-413e-83e8-5582a173db5d">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzMtNS0xLTEtNzM1MzU_4242eb55-02d5-4c78-9fc2-cc0ada625d14">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzQtMS0xLTEtNzM1MzU_2932a9f0-840c-4545-ba27-81bbfe1181f2">7.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzQtMy0xLTEtNzM1MzU_3a9f7e61-cfee-4e01-9b69-cfeecaa26359">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzQtNS0xLTEtNzM1MzU_8ec6a0ce-07a6-4659-b894-0f5730dd4f6e">17.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzUtMS0xLTEtNzM1MzU_75a1418a-cf96-4791-a66a-db88fface81d">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzUtMy0xLTEtNzM1MzU_0707b786-e6eb-4d1d-9eab-7f8470d70db2">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzUtNS0xLTEtNzM1MzU_61d8019d-7898-49fd-b5a0-4a13cf044d4c">44.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Research Credits and FDII/Domestic Production Activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzYtMS0xLTEtNzM1MzU_6fa14109-2f5e-4d90-a478-2b547f78ffd8">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzYtMy0xLTEtNzM1MzU_205c8024-05c0-45eb-a9e8-3f25cd5ae9e9">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzYtNS0xLTEtNzM1MzU_cf1abbd5-a997-4c5f-9cf5-3ed8426320d3">11.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" sign="-" name="bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzctMS0xLTEtNzM1MzU_cffe3170-a716-42bd-b78f-37e73fade1f0">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" name="bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzctMy0xLTEtNzM1MzU_47de1f51-9882-40d5-b517-b8128f0358dd">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" sign="-" name="bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzctNS0xLTEtNzM1MzU_f6160a6d-0285-45ce-a820-5ca03dff5010">10.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of gain on divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzgtMS0xLTEtNzM1MzU_74a11de7-97da-459c-b4b1-f34ff3f5a7f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzgtMy0xLTEtNzM1MzU_b2561f00-2082-42a3-9305-c0105ebeb50f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzgtNS0xLTEtNzM1MzU_133d7843-3b8d-49fb-b766-19aca1d1d3ea">10.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of valuation allowance release</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEwLTEtMS0xLTczNTM1_b18c3270-a8da-4363-a61d-17a0e519ef52">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEwLTMtMS0xLTczNTM1_90b6a3a5-f7bc-4482-b29e-70874b617fb4">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEwLTUtMS0xLTczNTM1_6a1f21e6-8d04-4c75-862d-89aa626f0594">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE0LTEtMS0xLTczNTM1_ef34bffa-93fd-460a-87c4-601322fe0deb">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE0LTMtMS0xLTczNTM1_ad960d75-0531-4af1-95a1-533cf0a4aeaa">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE0LTUtMS0xLTczNTM1_97b4c38e-f092-45ba-bdb5-8f50709cd169">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE1LTEtMS0xLTczNTM1_31d4e4bf-e16e-4173-8e9f-c34f86328468">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE1LTMtMS0xLTczNTM1_f5f4d792-2a83-46af-9930-809ed4c98c97">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE1LTUtMS0xLTczNTM1_75a57368-639e-4a1b-9ced-a0c338966796">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuations in the Company&#8217;s reported tax rates are primarily due to the geographical mix of income attributable to foreign countries that have income tax rates that vary from the U.S. tax rate.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0eeba6e608cc46688d6fe9a0b1f544f8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Holidays and Payments</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:SummaryOfIncomeTaxHolidayTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU0OTI_a94ef7ea-fe77-4c9c-9903-d126bede7daa" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approximate tax impacts related to tax holidays in various countries in which the Company does business are provided below. The tax holidays expire at various dates through 2028. The Company&#8217;s income tax payments, net of refunds are also provided below.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.666%"><tr><td style="width:1.0%"></td><td style="width:45.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact related to tax holidays</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzEtMS0xLTEtNzM1MzU_d977904a-b028-414a-a71b-c297512ee586">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzEtMy0xLTEtNzM1MzU_47151e70-a72b-4d7b-9718-7af4c5e6cc2b">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzEtNS0xLTEtNzM1MzU_42fd6f0f-1048-4b64-a364-99cea5b6d803">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of tax holiday on diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzItMS0xLTEtNzM1MzU_3c9426ff-7858-4a04-9135-0fa51cabf907">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzItMy0xLTEtNzM1MzU_7db4d0d4-4bd2-47ce-a885-21f2b8791d38">0.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzItNS0xLTEtNzM1MzU_30d3ff14-47e6-4b9b-a7ef-94e82bd6ba79">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payments, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzMtMS0xLTEtNzM1MzU_dc57e864-88c4-430c-9f0d-93b1fa416ef4">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzMtMy0xLTEtNzM1MzU_70d522d6-4cbf-4198-9227-4e1cb8fa86f6">671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzMtNS0xLTEtNzM1MzU_110a18ab-5190-42bc-bf09-981d17efe8de">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzg_1536350a-9126-4fa6-9212-e1c5c599d879" continuedAt="ib5301b2e83534558bd9c12e47f064cb8" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="ib5301b2e83534558bd9c12e47f064cb8" continuedAt="i8b0e53bd8d1b4ea1879c1a79974a1e76"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases real estate, vehicles and other equipment which are used in the Company&#8217;s manufacturing, administrative and research and development activities.  <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzk_f9b51496-228c-45b4-a86f-ff3eeee47669" continuedAt="i5a726f65c51545df9e85470f6d20852e" escape="true">The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration.  The Company&#8217;s lease arrangements are generally classified as operating leases.  These arrangements have remaining terms ranging from less than <ix:nonNumeric contextRef="i7ff86925da2a4bdbb08d87f5bf1b9465_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzUyMw_12b3aa4d-b995-4272-b8f5-3e73cf66d168">one year</ix:nonNumeric> to approximately <ix:nonNumeric contextRef="i57dbdcd63dc545d4baab7bc7c3def523_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzU0Mw_fa71f400-9faa-4f55-ae8d-1313ee48fc86">25</ix:nonNumeric> years and the weighted-average remaining lease term of the Company&#8217;s leases is approximately <ix:nonNumeric contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzYzMw_ced8452f-e3a0-4f74-9ebd-72eb87cbc188">6.8</ix:nonNumeric> years.  An option to renew or terminate the current term of a lease arrangement is included in the lease term if the Company is reasonably certain to exercise that option.</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5a726f65c51545df9e85470f6d20852e"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ShortTermLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzY_351294cb-7aee-4855-9584-ea60a606c493" escape="true">The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.</ix:nonNumeric>  For the longer-term lease arrangements that are recognized on the Company&#8217;s consolidated balance sheet, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease.  These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement.</ix:continuation> The costs associated with the Company&#8217;s short-term leases, as well as variable costs relating to the Company&#8217;s lease arrangements, are not material to its consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. The weighted-average incremental borrowing rate that has been applied to measure the Company&#8217;s lease liabilities is <ix:nonFraction unitRef="number" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzIwMDI_d63fb745-4b89-4cf8-9e43-fae16c17d371">2.3</ix:nonFraction>%.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease costs recorded in its consolidated statements of income for the years ended September&#160;30, 2022, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzEwOTk1MTE2MzA5Nzg_16c7e74e-4ab6-4cb5-9f19-b66704a39011">138</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzIxMTc_7abcbbd7-4f4f-4707-ac0f-08d9720e8cc3">132</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzIxMjQ_57b790f5-cb95-444c-b6e0-300406430a2a">131</ix:nonFraction>&#160;million, respectively.  Cash payments arising from the Company&#8217;s lease arrangements are reflected on its consolidated statement of cash flows as outflows used for operating activities.  <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="bdx:SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzc_b43c2122-5f32-4afd-96b5-9a6fcca63592" continuedAt="i954138750cd94499980436adab2a0a04" escape="true">The right-of-use assets and lease liabilities recognized on the Company&#8217;s consolidated balance sheet as of September&#160;30, 2022 and 2021 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i954138750cd94499980436adab2a0a04"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9">Other Assets</span></span></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMS0xLTEtNzM1MzU_d78153d8-8ae0-46f8-9e38-ef494b974aaf">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMy0xLTEtNzM1MzU_bb9ad178-c764-46fe-9a6e-c4027212b612">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108">Accrued expenses</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMS0xLTEtNzM1MzU_7a285269-01f4-4ead-8d5d-b2c7db079a98">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMy0xLTEtNzM1MzU_5214ead2-799f-4efd-861a-6bbd775988ce">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce">Deferred Income Taxes and Other Liabilities</span></span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMS0xLTEtNzM1MzU_956298bc-bf19-4510-8b55-c65b26e81c42">384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMy0xLTEtNzM1MzU_47c073a6-48cd-4b72-a6b3-eb277f61fe37">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8b0e53bd8d1b4ea1879c1a79974a1e76"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzQ_f06a0ab1-786e-4d30-bb17-c06b73bc9cd3" escape="true"><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.166%"><tr><td style="width:1.0%"></td><td style="width:64.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzEtMS0xLTEtNzM1MzU_9f96364b-d029-4626-9b6b-89b8af569d8a">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzItMS0xLTEtNzM1MzU_443b7ed4-07c7-4d70-ba73-0bb2c3b09326">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzMtMS0xLTEtNzM1MzU_9a0d93d9-571e-47ef-83d2-6b09cc1c3c7c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzQtMS0xLTEtNzM1MzU_f10dbb83-ecfa-47bb-9941-da7541cf0751">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzUtMS0xLTEtNzM1MzU_43bead46-59d6-44a5-900a-fbcbe4b635cd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzYtMS0xLTEtNzM1MzU_047352bd-8ddf-4c81-88a4-35ff1878997f">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total payments due</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzctMS0xLTEtNzM1MzU_951c61d8-a5ed-4ad8-bb4c-7ccd6037a859">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzgtMS0xLTEtNzM1MzU_c8d70c9c-f82e-41a7-92f0-4ebed800ee05">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzktMS0xLTEtNzM1MzU_571f2aad-e528-4f85-9fcb-c92a2369f231">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale-Leaseback Transactions</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2021, the Company sold certain properties and concurrently entered into operating lease arrangements for each property, which met the requirements for sale-leaseback accounting.  The Company recorded gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="bdx:GrossProceedsFromSaleLeasebackTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzI5MjI_406f7f34-a47c-4442-81a0-d42d1ea7aa82">225</ix:nonFraction>&#160;million related to the transactions and pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930" decimals="-6" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzI5NzQ_32729754-0353-4f86-a916-3487623b454e">158</ix:nonFraction>&#160;million were recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The lease agreements have initial lease terms between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwNzQ_6fc3030e-d694-47a3-b19e-733ab8915c12">two</span> and <ix:nonNumeric contextRef="i28abfbeeca0f4ef0a684b8b4d60fd993_I20210930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwODE_81ce6713-614b-484d-b56b-a3b3fc400d14">three years</ix:nonNumeric> and include options for the Company to extend the leases for an additional <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNTk_49d1d0da-0358-48d3-bfc1-913d11e54289">six</span>-to-<ix:nonNumeric contextRef="i9c659996ff364a5889ca74df9594897c_I20210930" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzE0ODQzNDA2OTc4MzY2_2f10c17b-9773-4b79-9240-0033a88fbbbe">twelve months</ix:nonNumeric>.</span></div></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19 &#8212; <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExODQ_2c3c8cec-b616-46f6-8486-c70a2f13e6b4" continuedAt="i7d5a39698ae84ec69b09be4775a6ed9e" escape="true">Supplemental Financial Information</ix:nonNumeric></span></div><ix:continuation id="i7d5a39698ae84ec69b09be4775a6ed9e" continuedAt="i10a9544199e04141bde870a3516f03f4"><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExOTY_de0b093b-e8e8-4b0c-aa0c-add6cca05e14" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.666%"><tr><td style="width:1.0%"></td><td style="width:68.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investment (losses) gains, net (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEtMS0xLTEtNzM1MzU_006088df-bd5a-477b-96a1-7972a6e1f32d">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEtMy0xLTEtNzM1MzU_68af35a5-b21e-4e06-9b79-eb4db9ccc8ce">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEtNS0xLTEtNzM1MzU_c2897569-b9c0-41d6-b12a-43e342ab293e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930" decimals="-6" sign="-" name="bdx:DeferredCompensationInvestmentIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzItMS0xLTEtNzM1MzU_e9901593-26d3-446e-8c88-272c70d60e5c">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930" decimals="-6" name="bdx:DeferredCompensationInvestmentIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzItMy0xLTEtNzM1MzU_ec023c34-fcb8-4e81-884d-6307b0efdd47">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b4aeecbf34445895456d33566115a6_D20191001-20200930" decimals="-6" name="bdx:DeferredCompensationInvestmentIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzItNS0xLTEtNzM1MzU_d4b8f6e4-e144-412a-88a4-e6871319c8c4">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension and postretirement benefit cost (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzMtMS0xLTEtNzM1MzU_ecfc2f51-1331-4b58-9fd9-0d87a84bc6b0">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzMtMy0xLTEtNzM1MzU_c58eaf3d-bedf-4143-a068-979d64d16908">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b4aeecbf34445895456d33566115a6_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzMtNS0xLTEtNzM1MzU_abf1d3ff-dfe1-4b65-968a-53ad11481b0b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses on undesignated foreign exchange derivatives, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzQtMS0xLTEtNzM1MzU_e85b4f63-b0ba-4d21-bbb7-e8ae24205819">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzQtMy0xLTEtNzM1MzU_11216193-df15-4add-8f29-920b8432b046">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzQtNS0xLTEtNzM1MzU_8efe681c-fe7d-4f2d-afba-ce1ef04ce473">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impacts of debt extinguishment (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzUtMS0xLTEtNzM1MzU_5f2241e6-bbee-4407-b1fb-da06eabebc62">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzUtMy0xLTEtNzM1MzU_7c61b2cd-e1b4-4e10-b837-f5df74f960f5">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzUtNS0xLTEtNzM1MzU_12139a3b-75a8-462c-a9f5-89c4b44cfeae">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta service agreements income, net (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930" decimals="-6" name="bdx:EmbectaServicesAgreementIncomeLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzctMS0xLTEtNzM1MzU_797e48dd-10d3-4a93-968e-04809278b9d6">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930" decimals="-6" name="bdx:EmbectaServicesAgreementIncomeLossNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzctMy0xLTEtNzM1MzU_d35fb089-0ee8-46ae-a1b4-83424c35053b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b4aeecbf34445895456d33566115a6_D20191001-20200930" decimals="-6" name="bdx:EmbectaServicesAgreementIncomeLossNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzctNS0xLTEtNzM1MzU_26eca5c4-9709-4aec-abdc-8ba4e7de71b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEwLTEtMS0xLTczNTM1_79cacc9d-ab8b-4949-974a-5216dee44165">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEwLTMtMS0xLTczNTM1_3f7d6c07-661c-48bb-9f7f-73c71bc50d25">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEwLTUtMS0xLTczNTM1_c5dea3db-52b4-42ea-b6c4-e5f2e73d2215">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzExLTEtMS0xLTczNTM1_b2c7c434-20ad-4367-9213-9176ea185cc2">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzExLTMtMS0xLTczNTM1_8391fbc8-75b5-4635-8a31-e47ef8cfcd83">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzExLTUtMS0xLTczNTM1_ef555dc3-9c1e-41e1-97d3-f8ce9d20a7aa">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts include gains (losses) recognized on changes to the fair value of certain equity investments.  The amounts in 2022 and 2020 also include a loss and gain, respectively, on the sale of equity investments. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents all components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, including U.S. pension settlement expense of $<ix:nonFraction unitRef="usd" contextRef="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930" decimals="-6" name="bdx:PensionSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzkzNDU4NDg4MzgxMjA_6910cff8-7cb6-41a3-af72-d136144394bc">73</ix:nonFraction>&#160;million in fiscal year 2022.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents losses recognized upon the extinguishment of certain senior notes, as further discussed in Note 16.   </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Consists of net income from transition and logistics service agreements with Embecta following the spin-off of the former diabetes care business in fiscal year 2022, as further discussed in Note 2.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements&#160;&#8212;&#160;(Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Becton, Dickinson and Company</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i10a9544199e04141bde870a3516f03f4"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables, Net</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExOTc_ee617b5b-e0fb-4b1d-afb6-b6909b07c386" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in 2022, 2021 and 2020 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance&#160;for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance&#160;for<br/>Cash<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0089a582278743878e90b9ca5e0e2c89_I20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEtMS0xLTEtNzM1MzU_87245f79-a073-45e8-9b69-f1e35f221c7e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9f9865f93104f3ea7954370b74f7d79_I20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEtMy0xLTEtNzM1MzU_348be280-c540-44d6-9060-f8adac9220e3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEtNS0xLTEtNzM1MzU_44fc7821-3e6a-41ee-839b-d107d44b1c60">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329bff29919e4afd9a9bdec6c58ae755_D20191001-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzItMS0xLTEtNzM1MzU_7d7dd623-adcc-470d-8d14-3253ecc2d10a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba943512d69048e5bf48aa7426358b78_D20191001-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzItMy0xLTEtNzM1MzU_2a975877-6078-45fa-9bad-60d15e1b3287">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzItNS0xLTEtNzM1MzU_0f9e232e-ea84-42b1-85c8-d664cd6251f3">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i329bff29919e4afd9a9bdec6c58ae755_D20191001-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzMtMS0xLTEtNzM1MzU_bb8108fd-baa7-4708-bc96-a1f4d538448e">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba943512d69048e5bf48aa7426358b78_D20191001-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzMtMy0xLTEtNzM1MzU_cbbe412a-9fdb-43b0-bfd3-d4b3ec1d5a76">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzMtNS0xLTEtNzM1MzU_8c461d9f-bf41-420e-905b-43e8b2c8b1f2">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b402904eee4442982827a336b690c8_I20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzQtMS0xLTEtNzM1MzU_916ade21-62ae-44df-a7af-948ffb7c1120">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9ee8a265ed45f7bcd1a5b2a45da743_I20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzQtMy0xLTEtNzM1MzU_4ddd506d-cf0e-4345-bb6d-782e83768c65">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzQtNS0xLTEtNzM1MzU_5305d7cf-0767-4df4-a538-b8aaa2bcd2c8">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026aaac83c04f90b25918ecc8f53b9a_D20201001-20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzUtMS0xLTEtNzM1MzU_bdc1b406-e493-4eab-a28b-1e982f325699">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5c357468b445299d75577a1038cd20_D20201001-20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzUtMy0xLTEtNzM1MzU_bc39d541-7252-4478-9718-fb266cbd3b8a">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzUtNS0xLTEtNzM1MzU_37f4a3c8-654b-4da2-a951-2f19c0664400">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4026aaac83c04f90b25918ecc8f53b9a_D20201001-20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzYtMS0xLTEtNzM1MzU_a168d429-399b-4eaa-adb2-6783c1abbc8a">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5c357468b445299d75577a1038cd20_D20201001-20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzYtMy0xLTEtNzM1MzU_1b8436ec-a93d-4701-8b90-9368c0ec490d">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzYtNS0xLTEtNzM1MzU_b0defda3-0ae1-476e-aea6-d589c9f82aa7">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i686e25e2d18c4aad801c33d834ed7b23_I20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzctMS0xLTEtNzM1MzU_e9e85b30-eb01-4c92-a3f6-60cfca06b6c6">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26517beec32f4052bdb7d8b798ad21eb_I20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzctMy0xLTEtNzM1MzU_473c2b4a-89a6-4197-b98b-3bf4565b5a75">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzctNS0xLTEtNzM1MzU_cb37f828-6e39-4b1f-aa9d-4d8fd4f63d54">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722514c7a4114a04aa38c850c0f296e7_D20211001-20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzgtMS0xLTEtNzM1MzU_721a23ff-5411-460e-8cf1-ce00126879e7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfe227a5f864820bdf92afbd17f990a_D20211001-20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzgtMy0xLTEtNzM1MzU_3537c382-9b11-404c-addc-1a7a0310cbaf">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzgtNS0xLTEtNzM1MzU_b158c38f-a264-483b-aac0-1896ae6eba57">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i722514c7a4114a04aa38c850c0f296e7_D20211001-20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzktMS0xLTEtNzM1MzU_f80671ab-4805-4af5-8539-6b4dfe7df2be">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dfe227a5f864820bdf92afbd17f990a_D20211001-20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzktMy0xLTEtNzM1MzU_a89778a0-e07a-4323-b348-542713af81fb">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzktNS0xLTEtNzM1MzU_b8391266-ecf3-43f2-822c-3b718a7a1b56">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b12d1fd67f455baf6f93c8c91f52ef_I20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEwLTEtMS0xLTczNTM1_2064c2cc-0890-4278-a080-911f151730b9">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98b2ad1fc1143869d44f1bd24b9aaec_I20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEwLTMtMS0xLTczNTM1_a441cf8f-26fb-438d-ba66-585bb413d0a4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEwLTUtMS0xLTczNTM1_3fa20758-52f0-4818-b5f3-7b9123e62261">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Accounts written off.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExODU_228c16fb-823a-4d9f-863e-9ab8c0ed27f7" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at September&#160;30 consisted of:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzEtMS0xLTEtNzM1MzU_56badc5b-83ae-4878-8af1-2b7785fe8f08">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzEtMy0xLTEtNzM1MzU_645d21f4-a0ac-4455-8986-7cade74f1501">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzItMS0xLTEtNzM1MzU_abbe580f-bc3e-4877-9447-a5a9df8ceff5">397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzItMy0xLTEtNzM1MzU_b4ddb25b-74fd-426a-ba8f-71891db38855">381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzMtMS0xLTEtNzM1MzU_a43acf96-18a9-48cb-a951-5beeff0b7f46">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzMtMy0xLTEtNzM1MzU_10e6d18f-c31e-4ef5-a7bf-41077e024690">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzQtMS0xLTEtNzM1MzU_7b3f582b-c81b-49b2-8c08-e8fbd73bb9a6">3,224</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzQtMy0xLTEtNzM1MzU_0dd160e4-ac93-4d23-8e84-3dc0eaac8fd4">2,743</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, Net</span></div><ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExOTM_a74a3086-71db-4ad7-b150-b5dbd95251e1" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, Plant and Equipment, Net at September&#160;30 consisted of:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzEtMS0xLTEtNzM1MzU_2f42b069-e8f2-43b5-b88c-8a608c4e410d">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzEtMy0xLTEtNzM1MzU_9f9ddb19-4616-4e76-98e9-11b1c95d8ea2">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzItMS0xLTEtNzM1MzU_1e9fbe33-9f1b-4ad6-b902-ceeff126b8f5">3,252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzItMy0xLTEtNzM1MzU_8566fb28-1f44-45bf-859f-373089e8622d">3,140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzMtMS0xLTEtNzM1MzU_9847f6ce-4b31-4b6b-aa7f-5c421680305b">8,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzMtMy0xLTEtNzM1MzU_c89347e7-27c1-4346-b3e8-781ae5d49498">8,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzQtMS0xLTEtNzM1MzU_d4ae9e62-133c-4238-bc7c-f46ce96adf2c">266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzQtMy0xLTEtNzM1MzU_504bb383-a844-416f-8e89-481f80108b99">234</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzUtMS0xLTEtNzM1MzU_8eafbadf-5820-4c7c-96c6-5c4b4362e2d9">12,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzUtMy0xLTEtNzM1MzU_40bd2a4c-e0a5-40aa-bf61-add79a9f3534">12,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzYtMS0xLTEtNzM1MzU_37ff3039-efcb-46e9-91f2-03496928038d">6,402</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzYtMy0xLTEtNzM1MzU_b1800e0e-826b-474b-a641-070d2487a74d">6,090</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzctMS0xLTEtNzM1MzU_632d17de-b4b6-477e-a5b4-5c0eed9fda82">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzctMy0xLTEtNzM1MzU_e95063b3-5fce-4c69-b24c-02b5ec03c296">6,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ia87db9e40d284890bdb9962ca233dca1_133"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_136"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was conducted by BD&#8217;s management, with the participation of BD&#8217;s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of BD&#8217;s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of September&#160;30, 2022. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">design and operation of these disclosure controls and procedures were, as of the end of the period covered by this report, effective and designed to ensure that material information relating to BD and its consolidated subsidiaries would be made known to them by others within these entities.  There were no changes in our internal control over financial reporting during the fiscal quarter ended September&#160;30, 2022 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to materially affect, BD&#8217;s internal control over financial reporting.  </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting and the Report of Independent Registered Public Accounting Firm are contained in Item&#160;8. Financial Statements and Supplementary Data, and are incorporated herein by reference.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_139"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Information.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_142"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9C.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Not applicable.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_145"></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_148"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;10.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information relating to BD&#8217;s directors and nominees for director required by this item will be contained under the caption &#8220;Proposal 1: Election of Directors&#8221; in a definitive proxy statement involving the election of directors, which the registrant will file with the SEC not later than 120 days after September&#160;30, 2022 (the &#8220;2023 Proxy Statement&#8221;), and such information is incorporated herein by reference.  Information relating to the Audit Committee of the BD Board of Directors required by this item will be contained under the caption &#8220;The Board and committees of the Board - Audit Committee&#8221;, and information regarding BD&#8217;s code of ethics required by this item will be contained under the heading &#8220;The Board and committees of the Board - ESG - Code of Conduct&#8221;, in BD&#8217;s 2023 Proxy statement, and such information is incorporated herein by reference. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information relating to executive officers required by this item is included herein in Part I under the caption &#8220;Information about our Executive Officers.&#8221; </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other information required by this item will be contained under the caption &#8220;Ownership of BD Common Stock&#8221; in BD&#8217;s 2023 Proxy Statement, and such information is incorporated herein by reference.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_151"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained under the captions &#8220;Executive Compensation,&#8221; &#8220;Report of the Compensation and Human Capital Committee,&#8221; &#8220;Compensation of Named Executive Officers&#8221;, &#8220;Non&#8209;management director compensation,&#8221; and &#8220;CEO Pay Ratio" in BD&#8217;s 2023 Proxy Statement, and such information is incorporated herein by reference.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_154"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;12.&#160;&#160;&#160;&#160;    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained under the caption &#8220;Ownership of BD Common Stock&#8221; in BD&#8217;s 2023 Proxy Statement, and such information is incorporated herein by reference.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_157"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained under the caption &#8220;The Board and committees of the Board - Related person transactions&#8221; in BD&#8217;s 2023 Proxy Statement, and such information is incorporated herein by reference.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div id="ia87db9e40d284890bdb9962ca233dca1_160"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principal Accounting Fees and Services.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained under the caption &#8220;Proposal 2. Ratification of Selection of Independent Registered Public Accounting Firm&#8221; in BD&#8217;s 2023 Proxy Statement, and such information is incorporated herein by reference.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_163"></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_166"></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits, Financial Statement Schedules.</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following consolidated financial statements of BD are included in Item&#160;8 of this report:</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Reports of Independent Registered Public Accounting Firm (PCAOB ID: <ix:nonNumeric contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNjYvZnJhZzoyZDE1ODQ5MTYxYWQ0NDM4OTNhMjMyM2FjNzM2ZDY4Yi90ZXh0cmVnaW9uOjJkMTU4NDkxNjFhZDQ0Mzg5M2EyMzIzYWM3MzZkNjhiXzgyNDYzMzcyMDk0MzE_493afaa8-c86e-4d99-a8d0-140aec7ecf75">42</ix:nonNumeric>)</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Consolidated Statements of Income &#8212; Years ended September&#160;30, 2022, 2021 and 2020</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Consolidated Statements of Comprehensive Income &#8212; Years ended September&#160;30, 2022, 2021 and 2020</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Consolidated Balance Sheets &#8212; September&#160;30, 2022 and 2021</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Consolidated Statements of Cash Flows &#8212; Years ended September&#160;30, 2022, 2021 and 2020</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">Notes to Consolidated Financial Statements</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.84pt">Financial Statement Schedules</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 19 to the Consolidated Financial Statements included in Item&#160;8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:5pt;padding-left:49.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.84pt">Exhibits</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the Exhibit Index below for a list of all management contracts, compensatory plans and arrangements required by this item, and all other Exhibits filed or incorporated by reference as a part of this report.</span></div><div id="ia87db9e40d284890bdb9962ca233dca1_169"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.  Form 10-K Summary</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;BD is not providing summary information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_172"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Method of Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000010795/000001079519000009/ex312312018.htm">3(a)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Certificate of Incorporation, dated as of January&#160;30, 2019.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 3 to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the period ended December 31, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012446/nt10012113x7_ex4-1.htm">3(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to the Company&#8217;s Restated Certificate of Incorporation, filed with the New Jersey Secretary of State and effective May 21, 2020.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registration statement on Form 8-A filed by the Company on May 26, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079522000065/by-lawsasofseptember202022.htm">3(c)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By-Laws, as amended as of September 20, 2022.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 3.1 to the registrant&#8217;s Current Report on Form 8-K filed on September 23, 2022.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/0000950130-97-003384.txt">4(a)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of March 1, 1997, between the registrant and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank).</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4(a) to Form 8-K filed by the registrant on July&#160;31, 1997.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/0000950130-97-003384.txt">4(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 7.000% Debentures due August 1, 2027.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4(d) to the registrant&#8217;s Current Report on Form 8-K filed on July 31, 1997.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/0000950130-98-003805.txt">4(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 6.700% Debentures due August 1, 2028.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4(d) to the registrant&#8217;s Current Report on Form 8-K filed on July 29, 1999.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000095012309008739/y77160exv4w2.htm">4(d)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 6.000% Notes due May 15, 2039.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant's Current Report on Form 8-K filed on May 13, 2009.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000095012310104702/y87674exv4w2.htm">4(e)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 5.000% Notes due November 12, 2040.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant&#8217;s Current Report on Form 8-K filed on November 12, 2010.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000119312514442073/d837485dex44.htm">4(f)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.734% Notes due December 15, 2024.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.4 to the registrant&#8217;s Current Report on Form 8-K filed on December 15, 2014.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312514442073/d837485dex45.htm">4(g)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 4.685% Notes due December 15, 2044.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.5 to the registrant&#8217;s Current Report on Form 8-K filed on December 15, 2014.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000119312515156851/d915554dex45.htm">4(h)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.875% Senior Notes due May 15, 2024.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.5 to the registrant&#8217;s Current Report on Form 8-K filed on April 29, 2015.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000119312515156851/d915554dex46.htm">4(i)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 4.875% Senior Notes due May 15, 2044.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.6 to the registrant&#8217;s Current Report on Form 8-K filed on April 29, 2015.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312516789747/d310032dex41.htm">4(j)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.000% Notes due December 15, 2022.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on December 9, 2016.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312516789747/d310032dex42.htm">4(k)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.900% Notes due December 15, 2026.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant's Current Report on Form 8-K filed on December 9, 2016.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Method of Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-5.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-5.htm">l</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-5.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.363% Notes due June 6, 2024.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.5 to the registrant&#8217;s Current Report on Form 8-K filed on June 6, 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-6.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-6.htm">m</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-6.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.700% Notes due June 6, 2027.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.6 to the registrant&#8217;s Current Report on Form 8-K filed on June 6, 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-7.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-7.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036117024005/s001721x2_ex4-7.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 4.669% Notes due June 6, 2047.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.7 to the registrant&#8217;s Current Report on Form 8-K filed on June 6, 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000156761917001035/s001681x3_8a12b.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000156761917001035/s001681x3_8a12b.htm">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000156761917001035/s001681x3_8a12b.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Certificate for the 6.000% Mandatory Convertible Preferred Stock, Series B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant&#8217;s registration statement on Form 8-A filed on May 26, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012446/nt10012113x7_ex4-3.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012446/nt10012113x7_ex4-3.htm">p</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012446/nt10012113x7_ex4-3.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit Agreement, dated as of May 26, 2020, among Becton, Dickinson and Company and Computershare Inc. and Computershare Trust Company, N.A., acting jointly as depositary and Computershare Trust Company, N.A., acting as Registrar and Transfer Agent, on behalf of the holders from time to time of the depositary receipts described therein.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.3 to the registrant&#8217;s registration statement on Form 8-A filed on May 26, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000156761917001035/s001681x3_8a12b.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000156761917001035/s001681x3_8a12b.htm">q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000156761917001035/s001681x3_8a12b.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Depositary Receipt for the Depositary Shares.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.4 to the registrant&#8217;s registration statement on Form 8-A filed on May 26, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312517383523/d517273dex44.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312517383523/d517273dex44.htm">r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312517383523/d517273dex44.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 6.700% Notes due December 1, 2026.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.4 to the registrant's Current Report on Form 8-K filed on December 29, 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/0000009892-96-000013.txt">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/0000009892-96-000013.txt">s</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/0000009892-96-000013.txt">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of December 1, 1996 between C.R. Bard, Inc. and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to C.R. Bard, Inc.'s Registration Statement on Form S-3 (File No. 333-05997).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/000119312517179095/d377270dex42.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/000119312517179095/d377270dex42.htm">t</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/000119312517179095/d377270dex42.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Supplemental Indenture, dated May&#160;18, 2017, between C. R. Bard, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K of C.R. Bard, Inc. filed on May 23, 2017.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036118025542/s002291x1_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036118025542/s002291x1_ex4-1.htm">u</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036118025542/s002291x1_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.401% Notes due May 24, 2023.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on May 24, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036118025542/s002291x1_ex4-2.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036118025542/s002291x1_ex4-2.htm">v</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036118025542/s002291x1_ex4-2.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.020% Notes due May 24, 2025.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant's Current Report on Form 8-K filed on May 24, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119009390/nt10001947x1_ex4-7.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119009390/nt10001947x1_ex4-7.htm">w</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119009390/nt10001947x1_ex4-7.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of May 17, 2019, among Becton Dickinson Euro Finance S.&#224; r.l. (&#8220;Becton Finance&#8221;), as issuer, Becton, Dickinson and Company, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.7 to the registrant&#8217;s Post-Effective Amendment to the Registration Statement on Form S-3 filed on May 17, 2019.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-1.htm">x</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Supplemental Indenture, dated as of June 4, 2019, among Becton Finance, as issuer, Becton, Dickinson and Company, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on June 4, 2019.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-3.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-3.htm">y</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-3.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 0.632% Note due June 4, 2023.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.3 to the registrant's Current Report on Form 8-K filed on June 4, 2019.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Method of Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-4.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-4.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-4.htm">z</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036119010401/nc10002034x4_ex4-4.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.208% Note due June 4, 2026.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.4 to the registrant's Current Report on Form 8-K filed on June 4, 2019.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/nc10012106x1_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/nc10012106x1_ex4-1.htm">aa</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/nc10012106x1_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2.823% Notes due May 20, 2030.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant&#8217;s Current Report on Form 8-K filed on May 20, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/nc10012106x1_ex4-2.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/nc10012106x1_ex4-2.htm">bb</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/nc10012106x1_ex4-2.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.794% Notes due May 20, 2050.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant&#8217;s Current Report on Form 8-K filed on May 20, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004377/nt10019789x6_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004377/nt10019789x6_ex4-1.htm">cc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004377/nt10019789x6_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.957% Notes due February 11, 2031.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on February 11, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004715/nt10019789x8_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004715/nt10019789x8_ex4-1.htm">dd</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004715/nt10019789x8_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Supplemental Indenture, dated as of February 12, 2021, among Becton Finance, as issuer, Becton, Dickinson and Company, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on February 12, 2021. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004715/nt10019789x8_ex4-2.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004715/nt10019789x8_ex4-2.htm">ee</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121004715/nt10019789x8_ex4-2.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.213% Note due February 12, 2036.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant's Current Report on Form 8-K filed on February 12, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-1.htm">ff</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Supplemental Indenture, dated as of August 13, 2021, among Becton Finance, as issuer, Becton, Dickinson and Company, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on August 13, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-2.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-2.htm">gg</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-2.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 0.334% Notes due August 13, 2028.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant's Current Report on Form 8-K filed on August 13, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-3.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-3.htm">hh</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028306/ny20000253x8_ex4-3.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 1.336% Notes due August 13, 2041.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.3 to the registrant's Current Report on Form 8-K filed on August 13, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028170/ny20000253x9_ex4-2.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028170/ny20000253x9_ex4-2.htm">ii</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028170/ny20000253x9_ex4-2.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 0.000% Notes due August 13, 2023.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.2 to the registrant&#8217;s registration statement on Form 8-A filed on August 13, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028170/ny20000253x9_ex4-3.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028170/ny20000253x9_ex4-3.htm">jj</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121028170/ny20000253x9_ex4-3.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 0.034% Notes due August 13, 2025.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.3 to the registrant&#8217;s registration statement on Form 8-A filed on August 13, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036122030495/ny20004957x5_ex4-1.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036122030495/ny20004957x5_ex4-1.htm">kk</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036122030495/ny20004957x5_ex4-1.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 4.298% Notes due August 22, 2032.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 to the registrant's Current Report on Form 8-K filed on August 22, 2022.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex4ll.htm">4(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex4ll.htm">ll</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex4ll.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of the Registrant&#8217;s Securities.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report. </span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Method of Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000119312513456802/d573385dex10aii.htm">10(a)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Employment Agreement with executive officers relating to employment following a change of control of the registrant (without tax reimbursement provisions).*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10(a)(ii) to the registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended September 30, 2013.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000095011706000569/ex10.htm">10(b)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Award Plan, as amended and restated as of January&#160;31, 2006.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10(a) to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the period ended December&#160;31, 2005.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bdperformanceincentiveplan.htm">10(c)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance Incentive Plan, as amended and restated August 30, 2022.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000010795/000001079520000027/ex10106302020bddeferre.htm">10(d)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Compensation and Retirement Benefit Restoration Plan, as amended as of May 1, 2020.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the period ended June 30, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/10795/000119312514431004/d829403dex102.htm">10(e)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1996 Directors&#8217; Deferral Plan, as amended and restated as of November 25, 2014.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.2 to the registrant's Current Report on Form 8-K filed on December 2, 2014.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079520000027/ex10206302020polentime.htm">10(f)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aircraft Time Sharing Agreement dated June 5, 2020, between the registrant and Thomas E. Polen.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.2 to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the period ended June 30, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079522000017/ex10a2004employeeanddirect.htm">10(g)(i)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2004 Employee and Director Equity-Based Compensation Plan, as amended and restated as of November 23, 2021.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10(a) to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the period ended December 31, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079520000003/frenchaddendumjanuary2.htm">10(g)(ii)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French Addendum to the 2004 Employee and Director Equity-Based Compensation Plan dated January 21, 2019.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.2 to the registrant's Current Report on Form 8-K filed on January 31, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079520000055/a9-30x2020ex10giiinext.htm">10(g)(iii)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terms of Awards under 2004 Employee and Director Equity-Based Compensation Plan and Stock Award Plan.*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10(g)(iii) to the registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended September 30, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000119312515002891/d848311dex101.htm">10(h)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Commercial Paper Dealer Agreement.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Current Report on Form 8-K filed on January 6, 2015.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000119312509187778/dex103.htm">10(i)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Matters Agreement, dated August 31, 2009, by and between Cardinal Health, Inc. and CareFusion Corporation.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 to Cardinal Health, Inc.&#8217;s Current Report on Form 8-K filed on September 4, 2009.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079518000036/a2018-09x30ex10o.htm">10(j)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term sheet, dated August 25, 2017, between the registrant and Samrat Khichi.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10(o) to the registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended September 30, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/0000009892-94-000009.txt">10(k)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C. R. Bard, Inc. Supplemental Executive Retirement Plan, dated as of July 13, 1988.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10p to the C.R. Bard, Inc. Annual Report on Form 10-K for the fiscal year ended December 31, 1993.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/000119312505213110/dex10be.htm">10(l)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Insurance/Retirement Plan Agreement (as Amended and Restated) between C.R. Bard, Inc. and its executive officers.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10be to the C.R. Bard, Inc. Quarterly Report on Form 10-Q for the period ended September 30, 2005.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Method of Filing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/9892/000119312511044634/dex10bw.htm">10(m)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2005 Directors&#8217; Stock Award Plan of C. R. Bard, Inc. (as Amended and Restated).*<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10bw to the C.R. Bard, Inc. Annual Report on Form 10-K for the fiscal year ended December 31, 2010.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000001079521000091/a09-30x2021ex10n.htm">10(n)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter Agreement, dated August 4, 2021, between the registrant and Christopher DelOrefice.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10(n) to the registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended September 30, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10795/000114036121032587/ny20000253x11_ex10-1.htm">10(o)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Credit Agreement, dated as of September 24, 2021, by and among Becton, Dickinson and Company, the other entities party thereto and Citibank, N.A., as administrative agent.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Current Report on Form&#160;8-K filed September 27, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advisoryboardconsultingagr.htm">10(p)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advisory Board Consulting Agreement, dated October 31, 2022, by and between the registrant and Claire M. Fraser.*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex21.htm">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the registrant.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex22.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiary Issuer of Guaranteed Securities.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex23.htm">23</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of independent registered public accounting firm.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_175">24</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included on signature page.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex31.htm">31</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to SEC Rule&#160;13(a)-14(a).</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09-30x2022ex32.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to Section 1350 of Chapter 63 of Title 18 of the U.S. Code.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from this report, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">*&#160;&#160;&#160;&#160;Denotes a management contract or compensatory plan or arrangement.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Copies of any Exhibits not accompanying this Form 10-K are available at a charge of 10 cents per page by contacting: Investor Relations, Becton, Dickinson and Company, 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, Phone: 1-800-284-6845.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><div id="ia87db9e40d284890bdb9962ca233dca1_175"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt;text-indent:256.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ECTON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ICKINSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OMPANY</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;G</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ARY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AZIO</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary DeFazio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Corporate Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated:  November&#160;22, 2022</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned hereby constitutes and appoints Thomas E. Polen, Samrat S. Khichi, Christopher J. DelOrefice and Gary DeFazio, and each of them, acting individually and without the other, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign the Company&#8217;s Annual Report on Form 10-K for the Company&#8217;s fiscal year ended September 30, 2022, and any amendments thereto, each in such form as they or any one of them may approve, and to file the same with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done so that such Annual Report shall comply with the Securities Exchange Act of 1934, as amended, and the applicable Rules and Regulations adopted or issued pursuant thereto, as fully and to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or resubstitute, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Power of Attorney shall not revoke any powers of attorney previously executed by the undersigned.  This Power of Attorney shall not be revoked by any subsequent power of attorney that the undersigned may execute, unless such subsequent power of attorney specifically provides that it revokes this Power of Attorney by referring to the date of the undersigned&#8217;s execution of this Power of Attorney.  For the avoidance of doubt, whenever two or more powers of attorney granting the powers specified herein are valid, the agents appointed on each shall act separately unless otherwise specified.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1934, as amended, this Annual Report and Power of Attorney have been signed as of November&#160;22, 2022  by the following persons in the capacities indicated.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Capacity</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;THOMAS E. POLEN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief&#160;Executive&#160;Officer and President</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal&#160;Executive&#160;Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;CHRISTOPHER J. DELOREFICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal&#160;Financial&#160;Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;THOMAS J. SPOEREL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Controller</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas J. Spoerel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal&#160;Accounting Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia87db9e40d284890bdb9962ca233dca1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Capacity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;WILLIAM M. BROWN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Brown</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;CATHERINE M. BURZIK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catherine M. Burzik</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;CARRIE L. BYINGTON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie L. Byington</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;R. ANDREW ECKERT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Andrew Eckert</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;CLAIRE M. FRASER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claire M. Fraser</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;JEFFREY W. HENDERSON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;CHRISTOPHER JONES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Jones</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;MARSHALL O. LARSEN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marshall O. Larsen</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;TIMOTHY M. RING</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy M. Ring</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;BERTRAM L. SCOTT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bertram L. Scott</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.LL
<SEQUENCE>2
<FILENAME>a09-30x2022ex4ll.htm
<DESCRIPTION>EX-4.LL
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8c368e9eaf5045c6b92de3f9a7d1bd2a_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4(ll)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of November 22, 2022, Becton, Dickinson and Company (&#8220;BD&#8221;) has (i) common stock, par value $1.00 (the &#8220;common stock&#8221;), (ii) depositary shares (the &#8220;depository shares&#8221;), each of which represents a 1&#47;20th interest in a share of 6.00% mandatory convertible preferred stock, series B, par value $1.00 per share (the &#8220;mandatory convertible preferred stock&#8221;), (iii) the 1.000% notes due 2022 (the &#8220;1.000% 2022 notes&#8221;), (iv) the 0.000% notes due 2023 (the &#8220;0.000% 2023 notes&#8221;), (v) the 1.401% notes due 2023 (the &#8220;1.401% 2023 notes&#8221;), (vi) the 0.034% notes due 2025 (the &#8220;0.034% 2025 notes&#8221;), (vii) the 3.020% notes due 2025 (the &#8220;3.020% 2025 notes&#8221;) and (viii) the 1.900% notes due 2026 (the &#8220;1.900% 2026 notes,&#8221; and together with the 1.000% 2022 notes, the 0.000% 2023 notes, the 1.401% 2023 notes, the 0.034% 2025 notes and the 3.020% 2025 notes, the &#8220;BD notes&#8221;) registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). As used in the &#8220;Description of Capital Stock of Becton, Dickinson and Company&#8221; section, the &#8220;Description of the Debt Securities of Becton, Dickinson and Company&#8221; section and the &#8220;Description of Depositary Shares of Becton, Dickinson and Company,&#8221; the terms &#8220;BD,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to BD and not its subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of November 22, 2022, Becton Dickinson Euro Finance S.&#224; r.l. (&#8220;Becton Finance&#8221;) has (i) the 0.632% notes due 2023 (the &#8220;0.632% 2023 notes&#8221;), (ii) the 1.208% notes due 2026 (the &#8220;1.208% 2026 notes&#8221;) and (iii) the 1.213% notes due 2036 (the &#8220;1.213% 2036 notes,&#8221; and together with the 0.632% 2023 notes and the 1.208% 2026 notes, the &#8220;Becton Finance notes&#8221;) registered under Section 12 of the Exchange Act. The BD notes and Becton Finance notes are collectively referred to herein as the &#8220;notes.&#8221; As used in the &#8220;Description of Debt Securities of Becton Dickinson Euro Finance S.&#224; r.l.&#8221; section, the terms &#8220;Becton Finance,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Becton Finance and not its subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following descriptions of the common stock, the depository shares, the mandatory convertible preferred stock and the notes are summaries and do not purport to be complete. The descriptions of the common stock and the mandatory convertible preferred stock are subject to and qualified in their entirety by reference to BD&#8217;s restated certificate of incorporation, as amended (the &#8220;restated certificate of incorporation&#8221;), and BD&#8217;s amended and restated by-laws (the &#8220;by-laws&#8221;). The description of the depositary shares is subject to and qualified in its entirety by the deposit agreement among BD, Computershare Inc. and its wholly owned subsidiary Computershare Trust Company, N.A., jointly acting as bank depositary, and the holders from time to time of the depositary shares (the &#8220;deposit agreement&#8221;). The description of the BD notes is subject to and qualified in its entirety by reference to the indenture, dated as of March 1, 1997, between BD and The Bank of New York Mellon Trust Company, N.A., as successor to JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), as trustee (the &#8220;BD indenture&#8221;). The description of the Becton Finance notes is subject to and qualified in its entirety by reference to the indenture, dated as of May 17, 2019, among Becton Finance, as issuer, BD, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#8220;Becton Finance indenture&#8221;). The restated certificate of incorporation, the by-laws, the deposit agreement, the BD indenture and the Becton Finance indenture are each exhibits to the Annual Report on Form 10-K of which this Exhibit 4(ll) is a part. We encourage you to read the restated certificate of incorporation, the by-laws, the deposit agreement, the BD indenture, the Becton Finance indenture and the applicable provisions of New Jersey law. </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF CAPITAL STOCK OF BECTON, DICKINSON AND COMPANY</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the restated certificate of incorporation, we have 640,000,000 shares of authorized common stock, $1.00 par value per share and 5,000,000 shares of authorized preferred stock, $1.00 par value per share, of which we have outstanding 1,500,000 shares of our mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our by-laws also provide that only the Chairman of the Board, the Chief Executive Officer, the board of directors or shareholders who collectively own 25% or more of the voting power of BD&#8217;s outstanding stock entitled to vote on the matters to be brought may call special meetings of the stockholders.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Listing</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our outstanding shares of common stock are listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;BDX.&#8221; Any additional common stock we issue also will be listed on the NYSE.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Dividends</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of our common stock are entitled to receive dividends when, as and if declared by our board of directors out of any funds legally available for dividends. We pay dividends on our common stock only if we have paid or provided for dividends on any outstanding series of preferred stock for all prior periods.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Voting</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of our common stock are entitled to one vote for each share that they hold and are vested with all of the voting power except as our board of directors may provide in the future with respect to any class or series of preferred stock that the board of directors may hereafter authorize.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fully Paid</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding shares of our common stock are validly issued, fully paid and non-assessable. Any additional common stock we issue will also be fully paid and non-assessable. Holders of our common stock are not, and will not be, subject to any liability as stockholders.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other Rights</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We notify common shareholders of any shareholders&#8217; meetings according to applicable law. If we liquidate, dissolve or wind-up our business, either voluntarily or not, common shareholders will share equally in the assets remaining after we pay our creditors and preferred shareholders. The holders of common stock have no preemptive rights to purchase our shares of stock. Shares of common stock are not subject to any redemption or sinking fund provisions and are not convertible into any of our other securities.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mandatory Convertible Preferred Stock</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Ranking</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The mandatory convertible preferred stock, with respect to dividend rights and the rights to distribution of assets upon our liquidation, winding-up or dissolution, ranks&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">senior to our common stock and to each other class of capital stock or series of preferred stock established after the original issue date of the mandatory convertible preferred stock (which we refer to as the &#8220;issue date&#8221;), the terms of which do not expressly provide that such class or series ranks senior to, or on a parity with, the mandatory convertible preferred stock as to dividend rights and&#47;or rights to distribution of assets upon our liquidation, dissolution or winding-up (which we refer to collectively as &#8220;junior stock&#8221;)&#894;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">equally with any class of capital stock or series of preferred stock established after the issue date, the terms of which expressly provide that such class or series will rank equally with the mandatory convertible preferred stock as to dividend rights and&#47;or rights to distribution of assets upon our liquidation, dissolution or winding-up, in each case without regard to whether dividends accrue cumulatively or non-cumulatively (which we refer to collectively as &#8220;parity stock&#8221;)&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">junior to each class of capital stock or series of preferred stock established after the issue date, the terms of which expressly provide that such class or series will rank senior to the mandatory convertible preferred stock as to dividend rights and&#47;or rights to distribution of assets upon our liquidation, dissolution or winding-up&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">junior to our existing and future indebtedness and other liabilities (including trade payables).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, the mandatory convertible preferred stock, with respect to dividend rights or rights to distribution of assets upon our liquidation, winding-up or dissolution, is structurally subordinated to existing and future indebtedness of our subsidiaries. </font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Dividends</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the rights of holders of any class or series of our capital stock ranking senior to the mandatory convertible preferred stock with respect to dividends, holders of shares of the mandatory convertible preferred stock are entitled to receive, when, as and if declared by our board of directors or an authorized committee of our board of directors and to the extent lawful, cumulative dividends at an annual rate of 6.00% of the initial liquidation preference of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 per share of mandatory convertible preferred stock (equivalent to $60 per year per share). We may pay such dividends in cash, by delivery of shares of our common stock or by payment or delivery, as the case may be, of any combination of cash and our common stock, at our election, as described under &#8220;&#8212;Method of payment of dividends&#8221; below. If declared, dividends on the mandatory convertible preferred stock are payable quarterly on the first business day of each of March, June, September and December of each year, commencing on September 1, 2020 and ending on June 1, 2023 (each, a &#8220;dividend payment date&#8221;), at such annual rate, and accumulate from the most recent date as to which dividends have been paid, whether or not in any dividend period or periods there have been funds or stock lawfully available for the payment of such dividends. If a dividend payment date falls on any day other than a business day, declared dividends for such dividend payment date are payable on the first business day immediately following such dividend payment date, without any interest, dividends or other payment in lieu of interest accruing with respect to this delay. A &#8220;dividend period&#8221; refers to a period commencing on, and including, a dividend payment date (or if no dividend payment date has occurred, commencing on, and including, the issue date), and ending on, and including, the day immediately preceding the next succeeding dividend payment date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A &#8220;business day&#8221; means any day other than a Saturday or Sunday or other day on which commercial banks in New York City are authorized or required by law or executive order to close. Any accumulated and unpaid dividends from any preceding dividend period can be declared and paid on a date determined by the board of directors or an authorized committee of our board of directors in its sole discretion.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends are payable to holders of record as they appear on our stock register at 5&#58;00 p.m., New York City time, on the 15th calendar day of the month immediately preceding the month in which such dividend payment falls or such other record date fixed by our board of directors or any duly authorized committee thereof that is not more than 60 nor less than 10 days prior to such dividend payment date, but only to the extent a dividend has been declared to be payable on such dividend payment date (each, a &#8220;regular record date&#8221;), except that dividends payable on the mandatory conversion date, as defined below, are payable to the holders presenting the mandatory convertible preferred stock for conversion. The regular record date applies regardless of whether it is a business day.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable on the mandatory convertible preferred stock for each full dividend period are computed by dividing the annual dividend rate by four. Dividends payable on the mandatory convertible preferred stock for any period other than a full dividend period are prorated based upon the actual number of days elapsed during the period and computed on the basis of a 360-day year consisting of twelve 30-day months. Each quarterly dividend on the mandatory convertible preferred stock, when, as and if declared, are $15.00 per share (based on the annual dividend rate of 6.00% and an initial liquidation preference of $1,000 per share). Accumulated dividends on shares of mandatory convertible preferred stock do not bear interest if they are paid subsequent to the applicable dividend payment date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No dividend is declared or paid upon, or any sum of cash or number of shares of our common stock set apart for the payment of dividends upon, any outstanding shares of mandatory convertible preferred stock with respect to any dividend period unless all dividends for all preceding dividend periods have been declared and paid, or declared and a sum of cash or number of shares sufficient for the payment thereof has been set apart, for the payment of such dividends, upon all outstanding shares of the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No dividend is paid upon any outstanding shares of mandatory convertible preferred stock unless and until our board of directors, or an authorized committee of our board of directors, declares a dividend payable with respect to the mandatory convertible preferred stock. Our ability to declare and pay dividends and make other distributions with respect to our capital stock, including the mandatory convertible preferred stock, may be restricted by the terms of financing arrangements that we enter into in the future. In addition, our ability to declare and pay dividends may be limited by applicable New Jersey law. </font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Method of payment of dividends</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the limitations described below, we may pay any declared dividend (or any portion of any declared dividend) on the mandatory convertible preferred stock (either for a current dividend period or for any prior dividend period), including in connection with the payment of declared and unpaid dividends pursuant to the provisions described under &#8220;&#8212;Conversion rights&#8212;Mandatory conversion,&#8221; &#8220;&#8212;Conversion rights&#8212;Early conversion at the option of the holder,&#8221; and &#8220;&#8212;Conversion rights&#8212;Early conversion at the option of the holder upon a fundamental change,&#8221; determined in our sole discretion&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in cash&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by delivery of shares of our common stock&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">through payment or delivery, as the case may be, of any combination of cash and shares of our common stock&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that in the case of conversion upon and following a fundamental change that is a reorganization event (as defined below), dividends otherwise payable in shares of our common stock may be paid by delivery of units of exchange property, as described under &#8220;&#8212;Recapitalizations, reclassifications and changes of our common stock&#8221;&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, that if our board of directors may not lawfully authorize payment of all or any portion of such accumulated and unpaid dividends in cash, it is required to authorize payment of such dividends in shares of our common stock or units of exchange property, as the case may be, if lawfully permitted to do so.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We intend to make each payment of a declared dividend on the shares of mandatory convertible preferred stock in cash, except to the extent we elect to make all or any portion of such payment in shares of our common stock. We will give holders of the mandatory convertible preferred stock notice of any such election and the portion of such payment to be made in cash, if any, and the portion that will be made in shares of our common stock no later than 10 scheduled trading days (as defined below) prior to the dividend payment date for such dividend&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that if we do not provide timely notice of this election, we will be deemed to have elected to pay the relevant dividend in cash. If we elect to make any such payment of a declared dividend, or any portion thereof, in shares of our common stock, such shares will be valued for such purpose, in the case of any dividend payment or portion thereof, at 97% of the average VWAP per share of our common stock over the five consecutive trading day (as defined below) period beginning on and including the seventh scheduled trading day (as defined below) prior to the applicable dividend payment date (the &#8220;dividend payment average price&#8221;). If the relevant dividend payment date occurs on or prior to the last trading day of such five consecutive trading day period, delivery of the shares of our common stock owed in respect of the dividend due on such dividend payment date will be deferred until the business day immediately following the last trading day of such five consecutive trading day period.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">However, in no event will the number of shares of our common stock delivered in connection with any dividend, including any dividend payable in connection with a conversion, exceed a number equal to the total dividend payment divided by $84.00, which amount represents approximately 35% of the initial price (as defined below), subject to adjustment in a manner inversely proportional to any anti-dilution adjustment to each fixed conversion rate (such dollar amount, as adjusted, the &#8220;floor price&#8221;). To the extent that the amount of the dividend as to which we have elected to deliver shares of our common stock in lieu of paying cash exceeds the product of the number of shares of our common stock delivered in connection with such dividend and 97% of the dividend payment average price, we will, if we are legally able to do so, pay such excess amount in cash.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fractional shares of our common stock will be delivered to the holders of the mandatory convertible preferred stock in payment or partial payment of a dividend. We will instead pay a cash adjustment (computed to the nearest cent) based on the dividend payment average price with respect to such dividend.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To the extent a shelf registration statement is required in our reasonable judgment in connection with the issuance of shares of our common stock issued as payment of dividends on the shares of mandatory convertible preferred stock (including dividends paid in connection with a conversion) or resales of such shares by holders thereof that are not &#8220;affiliates&#8221; of ours (and have not been our &#8220;affiliates&#8221; during the immediately preceding three months) for purposes of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), we will, to the extent such a shelf registration statement is not currently filed and effective, use our commercially reasonable efforts to file and maintain the effectiveness of such a shelf registration statement until the earlier of such time as all such shares of our common stock have been resold thereunder and such time as all such shares would be freely tradable pursuant to Rule 144 under the Securities Act without registration by holders thereof that are not &#8220;affiliates&#8221; of ours (and have not been our &#8220;affiliates&#8221; during the immediately preceding three months) for purposes of the Securities Act. To the extent applicable, we will also use our commercially reasonable efforts to have such shares of our common stock qualified or registered under applicable U.S. state securities laws, if required, and approved for listing on the NYSE (or if shares of our common stock are not listed on the NYSE, on the principal other U.S. national or regional securities exchange on which shares of our common stock are then listed).</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Definitions</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this section, the following terms have the meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Volume weighted average price&#8221; or &#8220;VWAP&#8221; per share of our common stock on any trading day means such price as displayed under the heading &#8220;Bloomberg VWAP&#8221; on Bloomberg (or any successor service) page BDX &#60;Equity&#62; AQR (or its equivalent successor if such page is not available) in respect of the period from the scheduled open to 4&#58;00 p.m., New York City time, on such trading day&#59; or, if such price is not available, the volume weighted average price means the market value per share of our common stock on such trading day as determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">purpose. The &#8220;average VWAP&#8221; means, for any period, the average of the volume weighted average prices for each trading day in such period.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A &#8220;trading day&#8221; is any day on which&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">there is no market disruption event (as defined below)&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the NYSE is open for trading, or, if our common stock (or any other security into which the mandatory convertible preferred stock becomes convertible in connection with any reorganization event) is not listed on the NYSE, any day on which the principal national securities exchange on which our common stock (or such other security) is listed is open for trading, or, if the common stock (or such other security) is not listed on a national securities exchange, any business day. A &#8220;trading day&#8221; only includes those days that have a scheduled closing time of 4&#58;00 p.m., New York City time, or the then standard closing time for regular trading on the relevant exchange or trading system.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A &#8220;market disruption event&#8221; means any of the following events&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any suspension of, or limitation imposed on, trading by the relevant exchange or quotation system during any period or periods aggregating one half-hour or longer and whether by reason of movements in price exceeding limits permitted by the relevant exchange or quotation system or otherwise relating to our common stock (or any other security into which the mandatory convertible preferred stock becomes convertible in connection with any reorganization event) or in futures or option contracts relating to our common stock (or such other security) on the relevant exchange or quotation system&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any event (other than a failure to open or a closure as described below) that disrupts or impairs the ability of market participants during any period or periods aggregating one half-hour or longer in general to effect transactions in, or obtain market values for, our common stock (or any other security into which the mandatory convertible preferred stock becomes convertible in connection with any reorganization event) on the relevant exchange or quotation system or futures or options contracts relating to our common stock (or such other security) on any relevant exchange or quotation system&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the failure to open of one of the exchanges or quotation systems on which futures or options contracts relating to our common stock (or any other security into which the mandatory convertible preferred stock becomes convertible in connection with any reorganization event) are traded or the closure of such exchange or quotation system prior to its respective scheduled closing time for the regular trading session on such day (without regard to after-hours or other trading outside the regular trading session hours) unless such earlier closing time is announced by such exchange or quotation system at least one hour prior to the earlier of the actual closing time for the regular trading session on such day and the submission deadline for orders to be entered into such exchange or quotation system for execution at the actual closing time on such day.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of the first two bullets of the definition of &#8220;market disruption event&#8221; above, the relevant exchange or quotation system is the NYSE&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that if our common stock (or any other security into which the mandatory convertible preferred stock becomes convertible in connection with any reorganization event) is not listed on the NYSE, such relevant exchange or quotation system will be the principal national securities exchange on which our common stock (or such other security) is then listed for trading.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A &#8220;scheduled trading day&#8221; is any day that is scheduled to be a trading day, except that if our common stock is not listed on a national securities exchange, &#8220;scheduled trading day&#8221; means a business day.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Dividend stopper</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">So long as any share of mandatory convertible preferred stock remains outstanding&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">no dividend or distribution will be declared or paid on our common stock or any other shares of junior stock, except dividends payable solely in shares of our common stock or other junior stock or rights to acquire the same&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">no dividend or distribution will be declared or paid on our parity stock, except as provided below&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">no common stock, junior stock or parity stock will be, directly or indirectly, purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries, in each case, unless all accumulated and unpaid dividends for all past dividend periods, including the latest completed dividend period, on all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">outstanding shares of the mandatory convertible preferred stock have been or are contemporaneously declared and paid in full (or have been declared and a sufficient sum of cash and&#47;or number of shares of our common stock for the payment thereof has been set aside for the benefit of the holders of shares of the mandatory convertible preferred stock on the applicable regular record date).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The limitations on distributions described in the immediately preceding paragraph do not apply to&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">redemptions, purchases or other acquisitions of shares of our common stock or other junior stock in connection with the administration of any employee benefit plan or other incentive plan, including employment contracts, in the ordinary course of business (including purchases of shares of our common stock in lieu of tax withholding and purchases of shares to offset the share dilution amount (as defined below) pursuant to a publicly announced repurchase plan)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that any purchases to offset the share dilution amount cannot exceed the share dilution amount&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any dividends or distributions of rights or junior stock in connection with a stockholders&#8217; rights plan or any redemption or repurchase of rights pursuant to any stockholders&#8217; rights plan&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">purchases of shares of common stock or junior stock pursuant to contractually binding requirements to buy the same existing prior to the preceding dividend period&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the acquisition by us or any of our subsidiaries of record ownership in junior stock or parity stock for the beneficial ownership of any other persons (other than for the beneficial ownership by us or any of our subsidiaries), including as trustees or custodians&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any exchange or conversion of junior stock for or into other junior stock or of parity stock for or into other parity stock (with the same or lesser aggregate liquidation preference) or junior stock and, in each case, the payment of cash solely in lieu of fractional shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Share dilution amount&#8221; means the increase in the number of diluted shares outstanding (determined in accordance with generally accepted accounting principles in the United States, and as measured from the date of our consolidated financial statements most recently filed with the SEC prior to the issue date) resulting from the grant, vesting or exercise of equity-based compensation to employees, directors or consultants and equitably adjusted for any stock split, stock dividend, reverse stock split, reclassification or similar transaction.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When dividends are not declared and paid (or declared and a sufficient sum of cash and&#47;or number of shares of our common stock for payment thereof set aside for the benefit of the holders thereof on the applicable regular record date) on any dividend payment date (or, in the case of parity stock having dividend payment dates different from such dividend payment dates, on a dividend payment date falling within a dividend period related to such dividend payment date) in full upon the mandatory convertible preferred stock and any shares of parity stock, all dividends declared on the mandatory convertible preferred stock and all such parity stock and payable on such dividend payment date (or, in the case of parity stock having dividend payment dates different from such dividend payment dates, on a dividend payment date falling within a dividend period related to such dividend payment date) are declared and paid pro rata so that the respective amounts of such dividends declared bear the same ratio to each other as all accumulated and unpaid dividends per share on the shares of the mandatory convertible preferred stock and all parity stock payable on such dividend payment date (or, in the case of parity stock having dividend payment dates different from such dividend payment dates, on a dividend payment date falling within a dividend period related to such dividend payment date) (subject to their having been declared by our board of directors or a duly authorized committee of our board of directors out of lawfully available funds and including, in the case of parity stock that bears cumulative dividends, all accrued but unpaid dividends) bear to each other. If our board of directors or a duly authorized committee of our board of directors determines not to declare and pay any dividend or a full dividend on a dividend payment date, we will provide 10 business days&#8217; written notice to the holders of the mandatory convertible preferred stock prior to such dividend payment date, or as reasonably practicable thereafter.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the foregoing, dividends (payable in cash, securities or other property) as may be determined by our board of directors or any duly authorized committee of our board of directors may be declared and paid on any securities, including our common stock and other junior stock, from time to time out of any funds lawfully available for such payment, and holders of the mandatory convertible preferred stock are not entitled to participate in any such dividends.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">No optional redemption</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The mandatory convertible preferred stock is not be redeemable or subject to any sinking fund or other similar provision. However, at our option, we may purchase or otherwise acquire (including in an exchange transaction) the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">mandatory convertible preferred stock from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Conversion rights</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mandatory conversion</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each outstanding share of the mandatory convertible preferred stock will automatically convert on June 1, 2023 (the &#8220;mandatory conversion date&#8221;) into a number of shares of our common stock equal to the conversion rate described below, unless such share of the mandatory convertible preferred stock has been converted in the manner described in &#8220;&#8212;Early conversion at the option of the holder&#8221; or &#8220;&#8212;Early conversion at the option of the holder upon a fundamental change&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that if the mandatory conversion date is not a business day, the mandatory conversion date will be postponed to the following business day and&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, that if any scheduled trading day during the period used to determine the applicable market value pursuant to the definition below is not a trading day, the mandatory conversion date will be postponed by the number of such scheduled trading days that are not trading days during such period.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The conversion rate, which is the number of shares of common stock issuable upon conversion of each share of the mandatory convertible preferred stock on the applicable conversion date (excluding shares of common stock, if any, issued in respect of accumulated and unpaid dividends), will be as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the applicable market value of our common stock is equal to or greater than $288.00, which we refer to as the &#8220;threshold appreciation price,&#8221; then the conversion rate will be 3.4722 shares of our common stock per share of mandatory convertible preferred stock (the &#8220;minimum conversion rate&#8221;), which is equal to $1,000 divided by the threshold appreciation price&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the applicable market value of our common stock is less than the threshold appreciation price but greater than $240.00 (i.e., the initial price), then the conversion rate will be equal to $1,000 divided by the applicable market value of our common stock&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the applicable market value of our common stock is less than or equal to the initial price, then the conversion rate will be 4.1666 shares of common stock per share of mandatory convertible preferred stock, which we refer to as the &#8220;maximum conversion rate,&#8221; which is equal to $1,000 divided by the initial price.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We refer to the minimum conversion rate and the maximum conversion rate collectively as the &#8220;fixed conversion rates.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If prior to the mandatory conversion date we have not declared all or any portion of the accumulated dividends on the mandatory convertible preferred stock, the conversion rate will be adjusted so that holders will receive an additional number of shares of our common stock equal to the amount of such accumulated dividends (the &#8220;additional conversion amount&#8221;) divided by the greater of the floor price and 97% of the dividend payment average price. To the extent that the additional conversion amount exceeds the product of such number of additional shares and the applicable market value, we will, if we are legally able to do so, declare and pay such excess amount in cash pro rata to the holders of the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The &#8220;applicable market value&#8221; of our common stock is the average VWAP per share of our common stock for the 20 consecutive trading day period commencing on and including the 22nd scheduled trading day prior to the mandatory conversion date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial price is $240.00. The threshold appreciation price is $288.00, which represents approximately a 20% appreciation over the initial price. Each of the fixed conversion rates, the initial price, the threshold appreciation price, the floor price and the applicable market value are subject to adjustment as described under &#8220;&#8212;Conversion rate adjustments&#8221; below.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on the foregoing, if the market price of our common stock on the mandatory conversion date (subject to postponement as described above) is the same as the applicable market value, the aggregate market value of the shares of our common stock a holder of mandatory convertible preferred stock receives upon mandatory conversion (other than any shares of our common stock received in connection with any dividend payment) will be&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">greater than the initial liquidation preference of the mandatory convertible preferred stock, if the applicable market value is greater than the threshold appreciation price&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">equal to the initial liquidation preference of the mandatory convertible preferred stock, if the applicable market value is less than or equal to the threshold appreciation price and greater than or equal to the initial price&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">less than the initial liquidation preference of the mandatory convertible preferred stock, if the applicable market value is less than the initial price.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Early conversion at the option of the holder</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of the mandatory convertible preferred stock have the right to convert the mandatory convertible preferred stock, in whole or in part (but in no event less than one share of mandatory convertible preferred stock), at any time prior to the mandatory conversion date, other than during the fundamental change conversion period (as defined below), into shares of our common stock at the minimum conversion rate of 3.4722 shares of our common stock per share of the mandatory convertible preferred stock, subject to adjustment as described under &#8220;&#8212;Conversion rate adjustments&#8221; below.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If, as of the effective date of any early conversion (the &#8220;early conversion date&#8221;), we have not declared all or any portion of the accumulated dividends for all dividend periods ending on a dividend payment date prior to such early conversion date, the conversion rate for such early conversion will be adjusted so that holders converting their shares of mandatory convertible preferred stock at such time receive an additional number of shares of our common stock equal to such amount of accumulated and unpaid dividends for such prior dividend periods, divided by the greater of the floor price and the average VWAP per share of our common stock over the 20 consecutive trading day period commencing on and including the 22nd scheduled trading day prior to the early conversion date (the &#8220;early conversion average price&#8221;). If, in respect of any early conversion date, the third business day immediately following such early conversion date occurs on or prior to the last trading day of such 20 consecutive trading day period, delivery of the shares of our common stock owed in respect of such early conversion will be deferred until the business day immediately following the last trading day of such 20 consecutive trading day period. To the extent that the cash amount of the accumulated and unpaid dividends for prior dividend periods ending on a dividend payment date prior to the relevant early conversion date exceeds the product of the number of additional shares added to the conversion rate and the early conversion average price, we will not have any obligation to pay the shortfall in cash.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as described above, upon any optional conversion of any mandatory convertible preferred stock, we will make no payment or allowance for unpaid dividends on such mandatory convertible preferred stock, unless such early conversion date occurs after the regular record date for a declared dividend and on or prior to the immediately succeeding dividend payment date, in which case such dividend will be paid on such dividend payment date to the holder of record of the converted shares of mandatory convertible preferred stock as of such regular record date, as described under &#8220;&#8212;Dividends&#8221; above.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Early conversion at the option of the holder upon a fundamental change</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If a &#8220;fundamental change&#8221; (as defined below) occurs on or prior to the mandatory conversion date, holders of the mandatory convertible preferred stock have the right to&#58;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;convert their mandatory convertible preferred stock, in whole or in part (but in no event less than one share of mandatory convertible preferred stock )&#58;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;into shares of our common stock at the conversion rate determined using the table below (the &#8220;fundamental change conversion rate&#8221;)&#59; or </font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;into units of exchange property based on the fundamental change conversion rate if the fundamental change also constitutes a reorganization event described under &#8220;Recapitalizations, reclassifications and changes of our common stock&#8221;&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;with respect to such converted shares, receive a fundamental change dividend make-whole amount (as defined below) payable in cash or shares of our common stock (or, if applicable, units of exchange property)&#59; and </font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;with respect to such converted shares, receive the accumulated dividend amount (as defined below) payable in cash or shares of our common stock (or, if applicable, units of exchange property).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">subject, in the case of clauses (2) and (3) above, to certain limitations with respect to the number of shares of our common stock that we are required to deliver, all as described below in &#8220;&#8212;Fundamental change dividend make-whole amount and accumulated dividend amount.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding clauses (2) and (3) above, if the effective date of a fundamental change or the relevant fundamental change conversion date falls during a dividend period for which we have declared a dividend on the mandatory convertible preferred stock, we will pay such dividend on the relevant dividend payment date to the holders of record on the immediately preceding regular record date, as described in &#8220;&#8212;Dividends.&#8221; In such case the accumulated dividend amount will not include the amount of such dividend, and the fundamental change dividend make-whole amount will not include the present value of such dividend.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To exercise this right, holders must submit their mandatory convertible preferred stock for conversion at any time during the period (the &#8220;fundamental change conversion period&#8221;) from, and including, the effective date of such fundamental change (as defined below) (the &#8220;effective date&#8221;) to, but excluding, the earlier of (x) the mandatory conversion date and (y) the date selected by us that is not less than 30 and not more than 60 calendar days after the effective date (the &#8220;fundamental change conversion date&#8221;). Holders of mandatory convertible preferred stock who do not submit their shares for conversion during the fundamental change conversion period will not be entitled to convert their mandatory convertible preferred stock at the fundamental change conversion rate or to receive the fundamental change dividend make-whole amount or, in connection with the fundamental change, the accumulated dividend amount.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We will notify holders, to the extent practicable, at least 20 calendar days prior to the anticipated effective date of such fundamental change, but in any event not later than two business days following our becoming aware of the occurrence of a fundamental change&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that we will not be required to deliver such notice before such date that we would otherwise be required to deliver notice pursuant to the applicable securities laws or the rules of any securities exchange on which shares of our common stock are then traded (the &#8220;fundamental change company notice&#8221;). Such fundamental change company notice will state, among other things, whether we have elected to satisfy all or any portion of accumulated and unpaid dividends through the delivery of shares of our common stock or units of exchange property, as the case may be, and, if so, the portion thereof (as a percentage) that will be satisfied through the delivery of shares of our common stock or units of exchange property.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The table below sets forth the fundamental change conversion rate per share of mandatory convertible preferred stock based on the effective date of the fundamental change and the stock price paid (or deemed paid) per share of our common stock in the fundamental change (as described below).</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Effective date</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$120.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$140.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$160.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$180.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$200.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$220.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$240.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$250.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$260.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$270.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$288.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$300.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$325.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$350.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">$400.00</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">June 1, 2021</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.8744</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.8653</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.8323</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.7832</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.7259</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.6673</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.6122</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5869</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5635</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5420</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5082</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4891</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4573</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4348</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4095</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">June 1, 2022</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.0323</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.0343</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.0149</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.9711</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.9057</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.8270</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.7452</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.7060</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.6691</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.6348</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5813</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5517</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.5044</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4735</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4438</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">June 1, 2023</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1666</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.9999</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.8461</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.7036</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4721</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4722</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4722</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4722</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.4722</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The exact stock price and effective date may not be set forth in the table, in which case&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the stock price is between two stock price amounts in the table or the effective date is between two dates in the table, the fundamental change conversion rate will be determined by straight-line interpolation between the fundamental change conversion rates set forth for the higher and lower stock price amounts and the two dates, as applicable, based on a 365-day year&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the stock price is greater than $400.00 per share (subject to adjustment as described below), then the fundamental change conversion rate will be the minimum conversion rate, subject to adjustment as set forth under &#8220;&#8212;Conversion rate adjustments&#8221;&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the stock price is less than $120.00 per share (subject to adjustment as described below) (the &#8220;minimum stock price&#8221;), then the fundamental change conversion rate will be determined as if the stock price equaled the minimum stock price, and if the effective date is between two dates on the table, using straight-line interpolation, as described herein, subject to adjustment.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The &#8220;stock price&#8221; in the fundamental change will equal&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in the case of a fundamental change described in clause (2) of the definition of &#8220;fundamental change&#8221; below in which the holders of our common stock receive only cash in the fundamental change, the cash amount paid per share of our common stock&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">otherwise, the average VWAP per share of our common stock over the five consecutive trading day period ending on, and including, the trading day immediately preceding the effective date of the fundamental change (the &#8220;fundamental change market value&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The stock prices set forth in the first row of the table (i.e., the column headers) will be adjusted as of any date on which the fixed conversion rates of the mandatory convertible preferred stock are adjusted. The adjusted stock prices will equal the stock prices applicable immediately prior to such adjustment multiplied by a fraction, the numerator of which is the minimum conversion rate immediately prior to the adjustment giving rise to the stock price adjustment and the denominator of which is the minimum conversion rate as so adjusted. Each of the conversion rates in the table will be subject to adjustment in the same manner as each fixed conversion rate as set forth under &#8220;Conversion rate adjustments.&#8221;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A &#8220;fundamental change&#8221; is deemed to have occurred if any of the following occurs&#58;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;a &#8220;person&#8221; or &#8220;group&#8221; within the meaning of Section 13(d) of the Exchange Act, other than us, our subsidiaries and our or their employee benefit plans, files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect &#8220;beneficial owner,&#8221; as defined in Rule 13d-3 under the Exchange Act, of our common stock representing more than 50% of the voting power of our common stock or we otherwise become aware of such ownership&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the consummation of (A) any recapitalization, reclassification or change of our common stock (other than a change only in par value, from par value to no par value or from no par value to par value, or changes resulting from a subdivision or combination of our common stock) as a result of which our common stock would be converted into, or exchanged for, or represent solely the right to receive, stock, other securities, other property or assets&#59; (B) any share exchange, consolidation or merger of us pursuant to which our common stock is converted into, or exchanged for, or represent solely the right to receive, stock, other securities, other property or assets&#59; or (C) any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of us and our subsidiaries, taken as a whole, to any person other than one of our wholly-owned subsidiaries&#59; provided that, with respect to clause (B), any transaction pursuant to which the holders of 50% or more of the total voting power of all shares of our capital stock entitled to vote generally in elections of directors immediately prior to such transaction have the right to exercise, directly or indirectly, 50% or more of the total voting power of all capital stock (or other securities issued in such transaction) entitled to vote generally in elections of directors of the continuing or surviving person or the parent entity thereof immediately after giving effect to such transaction, in substantially the same proportions as such ownership immediately prior to such transaction will not constitute a fundamental change&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;our stockholders approve any plan or proposal for the liquidation or dissolution of us&#59; or</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;our common stock (or, following a reorganization event (as defined below), any common stock, depositary receipts or other securities representing common equity interests into which the mandatory convertible preferred stock becomes convertible in connection with such reorganization event) ceases to be listed on any of the NYSE, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors) or another U.S. national securities exchange.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A transaction or transactions described in clause (1) or (2) above will not constitute a fundamental change, however, if at least 90% of the consideration received or to be received by our common stockholders (excluding cash payments for fractional shares or pursuant to appraisal rights) in connection with such transaction or transactions consists of shares of common stock that are listed on any of the NYSE, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors) or another U.S. national securities exchange, or will be so listed when issued or exchanged in connection with such transaction or transactions, and as a result of such transaction or transactions the mandatory convertible preferred stock becomes convertible into such consideration, excluding cash payments for fractional shares. For the purposes of this definition of &#8220;fundamental change,&#8221; any transaction or event that constitutes a fundamental change under both clause (1) and clause (2) above will be deemed to constitute a fundamental change solely under clause (2) of this definition of &#8220;fundamental change.&#8221;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fundamental change dividend make-whole amount and accumulated dividend amount</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For any shares of mandatory convertible preferred stock that are converted during the fundamental change conversion period, in addition to the common stock issuable upon conversion at the fundamental change conversion rate, we may, at our option&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;pay holders in cash, to the extent we are legally permitted to do so and not prohibited by the terms of our indebtedness, the present value, computed using a discount rate of 5.00% per annum, of all dividend payments on such holders&#8217; shares of mandatory convertible preferred stock for all the remaining dividend periods (excluding any accumulated and unpaid dividends for all dividend periods ending on or prior to the dividend payment date preceding the effective date of the fundamental change as well as dividends accumulated to the effective date of the fundamental change) from such effective date to but excluding the mandatory conversion date (the &#8220;fundamental change dividend make-whole amount&#8221;)&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;increase the number of shares of common stock to be issued on conversion by a number equal to (x) the fundamental change dividend make-whole amount divided by (y) the greater of the floor price and 97% of the stock price&#59; or</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;pay the fundamental change dividend make whole amount in a combination of cash and shares of our common stock in accordance with the provisions of clauses (1) and (2) above.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, for any shares of mandatory convertible preferred stock that are converted during the fundamental change conversion period, to the extent that, as of the effective date of the fundamental change, we have not declared any or all of the accumulated dividends on the mandatory convertible preferred stock as of such effective date (including accumulated and unpaid dividends for all dividend periods ending on or prior to the dividend payment date preceding the effective date of the fundamental change as well as dividends accumulated to the effective date of the fundamental change, the &#8220;accumulated dividend amount&#8221;), holders who convert mandatory convertible preferred stock within the fundamental change conversion period will be entitled to receive such accumulated dividend amount upon conversion. The accumulated dividend amount will be payable at our election in either&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">cash, to the extent we are legally permitted to do so and not prohibited by the terms of our indebtedness&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">an additional number shares of our of common stock equal to (x) the accumulated dividend amount divided by (y) the greater of the floor price and 97% of the stock price&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">a combination of cash and shares of our common stock in accordance with the provisions of the preceding two bullets.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We will pay the fundamental change dividend make-whole amount and the accumulated dividend amount in cash, except to the extent we elect on or prior to the second business day following the effective date of a fundamental change (as further described in, and subject to, the next paragraph) to make all or any portion of such payments in shares of our common stock. In addition, if we elect to deliver shares of our common stock in respect of all or any portion of the fundamental change dividend make-whole amount or accumulated dividend amount, to the extent that the fundamental change dividend make-whole amount or the accumulated dividend amount or any portion thereof paid by delivery of shares of our common stock exceeds the product of the number of additional shares we deliver in respect thereof and 97% of the stock price, we will, if we are legally able to do so, declare and pay such excess amount in cash.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not later than the second business day following the effective date of a fundamental change (or, if we provide notice to holders of the fundamental change after the effective date of a fundamental change as described above, on the date we give holders notice of the effective date of a fundamental change), we will notify holders of&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the fundamental change conversion rate&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the fundamental change dividend make-whole amount and whether we will satisfy such amount through the payment of cash, the delivery of shares of our common stock or a combination thereof, specifying the combination, if applicable&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the accumulated dividend amount as of the effective date of the fundamental change and whether we will satisfy such amount through the payment of cash, the delivery of shares of our common stock or a combination thereof, specifying the combination, if applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our obligation to adjust the conversion rate in connection with a fundamental change and pay the fundamental change dividend make-whole amount (whether in cash or shares of our common stock or any combination thereof) could be considered a penalty, in which case the enforceability thereof would be subject to general principles of reasonableness of economic remedies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Conversion procedures</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any outstanding shares of mandatory convertible preferred stock automatically convert into shares of our common stock on the mandatory conversion date (subject to postponement as described above under &#8220;&#8212;Mandatory conversion&#8221;). The person or persons entitled to receive the shares of our common stock issuable upon conversion of the mandatory convertible preferred stock will be treated as the record holder(s) of such shares as of 5&#58;00 p.m., New York City time, on the mandatory conversion date (subject to postponement as described above under &#8220;&#8212;Mandatory conversion&#8221;). Except as provided under &#8220;&#8212;Conversion rate adjustments&#8221;, prior to 5&#58;00 p.m., New York City time, on the mandatory conversion date, the shares of our common stock issuable upon conversion of the mandatory convertible preferred stock will not be outstanding for any purpose and holders of the mandatory convertible preferred stock have no rights with respect to such shares of common stock, including, without limitation, voting rights, rights to participate in tender offers and rights to receive any dividends or other distributions on our common stock, in each case by virtue of holding the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If a holder elects to convert its shares of mandatory convertible preferred stock prior to the mandatory conversion date, in the manner described in &#8220;&#8212;Early conversion at the option of the holder,&#8221; or &#8220;&#8212;Early conversion at the option of the holder upon a fundamental change,&#8221; the holder must observe the following conversion procedures&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the shares of mandatory convertible preferred stock are in global form, to convert its shares of mandatory convertible preferred stock a holder must deliver to DTC the appropriate instruction form for conversion pursuant to DTC&#8217;s conversion program and, if required, pay all transfer taxes or duties, if any&#894; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the shares of mandatory convertible preferred stock are held in certificated form, such holder must comply with certain procedures set forth in our restated certificate of incorporation or the certificate of amendment establishing the terms of the mandatory convertible preferred stock (the &#8220;certificate of amendment&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The conversion date will be the date on which the converting holder has satisfied the foregoing requirements. A holder who converts its shares of mandatory convertible preferred stock is not be required to pay any taxes or duties relating to the issuance or delivery of shares of our common stock if such holder exercises its conversion rights, but such holder will be required to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of the shares of common stock in a name other than its own.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock will be issued and delivered only after all applicable taxes and duties, if any, payable by the converting holder have been paid in full and will be issued on the later of the third business day immediately succeeding the conversion date and the business day after such holder has paid in full all applicable taxes and duties, if any.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The person or persons entitled to receive the common stock issuable upon conversion of the mandatory convertible preferred stock prior to the mandatory conversion date will be treated as the record holder(s) of such shares as of 5&#58;00 p.m., New York City time, on the applicable conversion date. Except as provided under &#8220;&#8212;Conversion rate adjustments&#8221;, prior to 5&#58;00 p.m., New York City time, on the applicable conversion date, the common stock issuable upon conversion of the mandatory convertible preferred stock will not be outstanding for any purpose and a holder of the mandatory convertible preferred stock will have no rights with respect to such common stock, including voting rights, rights to participate in tender offers and rights to receive any dividends or other distributions on the common stock, by virtue of holding the mandatory convertible preferred stock. No fractional shares of our common stock will be issued to holders of shares of the mandatory convertible preferred stock upon conversion. In lieu of any fractional shares of common stock otherwise issuable upon conversion (including in connection with a dividend payment), that holder will be entitled to receive an amount in cash (computed to the nearest cent) based on the VWAP per share of our common stock on the trading day immediately preceding the applicable conversion date. If more than one share of the mandatory convertible preferred stock is surrendered for conversion at one time by or for the same holder, the number of full shares of our common stock issuable upon conversion thereof will be computed on the basis of the aggregate number of shares of the mandatory convertible preferred stock so surrendered.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Conversion rate adjustments</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each fixed conversion rate will be adjusted from time to time as follows&#58;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;If we issue our common stock as a dividend or distribution to all or substantially all holders of our common stock, or if we effect a subdivision or combination (including, without limitation, a stock split or a reverse stock split) of our common stock, each fixed conversion rate will be adjusted based on the following formula&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.846%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.234%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#61; CR0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">x</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:1.41pt;vertical-align:baseline">1</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Where,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately prior to 5&#58;00 p.m., New York City time, on the record date (as defined below) for such dividend or distribution or immediately prior to 9&#58;00 a.m., New York City time, on the effective date for such subdivision or combination, as the case may be&#59;</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately after 5&#58;00 p.m., New York City time, on such record date or immediately after 9&#58;00 a.m., New York City time, on such effective date, as the case may be&#59;</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of our common stock outstanding immediately prior to 5&#58;00 p.m., New York City time, on such record date or immediately prior to 9&#58;00 a.m., New York City time, on such effective date, as the case may be, and prior to giving effect to such event&#59; and</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of our common stock that would be outstanding immediately after, and solely as a result of, such dividend, distribution, subdivision or combination.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any adjustment made under this clause (i) will become effective immediately after 5&#58;00 p.m., New York City time, on the record date for such dividend or distribution, or immediately after 9&#58;00 a.m., New York City time, on the effective date for such subdivision or combination, as the case may be. If any dividend, distribution, subdivision or combination of the type described in this clause (i) is declared but not so paid or made, each fixed conversion rate will be immediately readjusted, effective as of the earlier of (a) the date our board of directors or a duly authorized committee thereof determines not to pay or make such dividend, distribution, subdivision or combination and (b) the date the dividend or distribution was to be paid or the date the subdivision or combination was to have been effective, to the fixed conversion rate that would then be in effect if such dividend, distribution, subdivision or combination had not been declared.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;If we issue to all or substantially all holders of our common stock any rights, options or warrants entitling them for a period expiring 60 calendar days or less from the date of issuance of such rights, options or warrants to subscribe for or purchase shares of our common stock at less than the average VWAP per share of our common stock for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement for such issuance, each fixed conversion rate will be increased based on the following formula&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:30.769%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#61; CR0x</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(OS0 + X)</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(OS0 + Y)</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">where,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately prior to 5&#58;00 p.m., New York City time, on the record date for such issuance&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately after 5&#58;00 p.m., New York City time, on such record date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of our common stock outstanding immediately prior to 5&#58;00 p.m., New York City time, on such record date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of our common stock issuable pursuant to such rights, options or warrants&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Y</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the aggregate price payable to exercise such rights, options or warrants, divided by the average VWAP per share of our common stock for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement for such issuance.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any increase in the fixed conversion rates made pursuant to this clause (ii) will become effective immediately after 5&#58;00 p.m., New York City time, on the record date for such issuance. To the extent such rights, options or warrants are not exercised prior to their expiration or termination, each fixed conversion rate will be decreased, effective as of the date of such expiration or termination, to the fixed conversion rate that would then be in effect had the increase </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of common stock actually delivered. If such rights, options or warrants are not so issued, each fixed conversion rate will be decreased, effective as of the earlier of (a) the date our board of directors or a duly authorized committee thereof determines not to issue such rights, options or warrants and (b) the date such rights, options or warrants were to have been issued, to the fixed conversion rate that would then be in effect if such issuance had not been announced.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this clause (ii), in determining whether any rights, options or warrants entitle the holders thereof to subscribe for or purchase shares of our common stock at less than average VWAP per share of our common stock for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement for such issuance, and in determining the aggregate price payable to exercise such rights, options or warrants, we will take into account any consideration we receive for such rights, options or warrants and any amount payable on exercise thereof, with the value of such consideration, if other than cash, to be determined by our board of directors or a duly authorized committee thereof, which determination will be final.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;If we pay a dividend or other distribution to all or substantially all holders of our common stock of shares of our capital stock (other than our common stock), evidences of our indebtedness, our assets or rights to acquire our capital stock, our indebtedness or our assets, excluding&#58;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any dividend, distribution or issuance as to which an adjustment was effected pursuant to clause (i) or (ii) above&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;dividends or distributions paid exclusively in cash as to which an adjustment was effected pursuant to clause (iv) below&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;spin-offs&#8221; as to which the provisions set forth below in this clause (iii) apply&#59; and</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;any dividends or distributions in connection with a reorganization event that is included in exchange property (as described below),</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">then each fixed conversion rate will be increased based on the following formula&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.846%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.234%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#61; CR0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">x</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:1.41pt;vertical-align:baseline">0</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- FMV</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately prior to 5&#58;00 p.m., New York City time, on the record date for such dividend or distribution&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately after 5&#58;00 p.m., New York City time, on such record date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the average VWAP per share of our common stock for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the ex-dividend date for such dividend or distribution&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FMV</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fair market value (as determined in good faith by our board of directors or a duly authorized committee thereof, which determination will be final) on the ex-dividend date for such dividend or distribution of shares of our capital stock (other than our common stock), evidences of our indebtedness, our assets or rights to acquire our capital stock, our indebtedness or our assets, expressed as an amount per share of our common stock.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If our board of directors or a duly authorized committee thereof determines the &#8220;FMV&#8221; (as defined above) of any dividend or other distribution for purposes of this clause (iii) by referring to the actual or when-issued trading market for any securities, it will consider the prices in such market of such securities for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the ex-dividend date for such dividend or distribution.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if &#8220;FMV&#8221; (as defined above) is equal to or greater than &#8220;SP0&#8221; (as defined above), in lieu of the foregoing increase, each holder of shares of the mandatory convertible preferred stock will receive, in respect of each share thereof, at the same time and upon the same terms as holders of our common stock and solely as a result of holding shares of mandatory convertible preferred stock, the amount and kind of shares of our capital stock (other than our common stock), evidences of our indebtedness, our assets or rights to acquire our capital stock, our indebtedness or our assets that such holder would have received if such holder owned a number of shares of our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">common stock equal to the maximum conversion rate in effect immediately prior to the close of business on the ex-dividend date for such dividend or other distribution.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any increase made under the portion of this clause (iii) above will become effective immediately after 5&#58;00 p.m., New York City time, on the record date for such dividend or other distribution. If such dividend or other distribution is not so paid or made, each fixed conversion rate will be decreased, effective as of the earlier of (a) the date our board of directors or a duly authorized committee thereof determines not to pay the dividend or other distribution and (b) the date such dividend or distribution was to have been paid, to the fixed conversion rate that would then be in effect if the dividend or other distribution had not been declared.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the transaction that gives rise to an adjustment pursuant to this clause (iii) is one pursuant to which the payment of a dividend or other distribution on our common stock consists of shares of capital stock of, or similar equity interests in, a subsidiary or other business unit of ours (i.e., a spin-off) that are, or, when issued, will be, traded on a U.S. national securities exchange or a reasonably comparable non-U.S. equivalent, then each fixed conversion rate will be increased based on the following formula&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.846%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.234%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#61; CR0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">x</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FMV + MP)</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">where,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect at 5&#58;00 p.m., New York City time, on the tenth trading day immediately following, and including, the ex-dividend date for such dividend or distribution&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately after 5&#58;00 p.m., New York City time, on the tenth trading day immediately following, and including, the ex-dividend date for such dividend or distribution&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FMV</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the average VWAP per share of such capital stock or similar equity interests distributed to holders of our common stock applicable to one share of our common stock over the 10 consecutive trading day period commencing on, and including, the ex- dividend date for such dividend or distribution&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the average VWAP per share of our common stock over the 10 consecutive trading day period commencing on, and including, the ex-dividend date for such dividend or distribution.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The adjustment to each fixed conversion rate under the immediately preceding paragraph will occur at 5&#58;00 p.m., New York City time, on the 10th consecutive trading day immediately following, and including, the ex-dividend date for such dividend or distribution, but will be given effect as of 9&#58;00 a.m., New York City time, on the date immediately following the record date for such dividend or distribution. Because we will make the adjustments to the fixed conversion rates at the end of the 10 consecutive trading day period with retroactive effect, we will delay the settlement of any conversion of shares of the mandatory convertible preferred stock if the conversion date occurs after the record date for such dividend or other distribution and prior to the end of such 10 consecutive trading day period. In such event, we will deliver the shares of common stock issuable in respect of such conversion (based on the adjusted fixed conversion rates as described above) on the first business day immediately following the last trading day of such 10 consecutive trading day period.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;we pay a distribution consisting exclusively of cash to all or substantially all holders of our common stock, excluding any regular quarterly cash dividends or distributions of up to $0.79 per share of our common stock (the &#8220;initial dividend threshold&#8221;), each fixed conversion rate will be increased based on the following formula&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.846%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.234%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#61; CR0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">x</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:1.41pt;vertical-align:baseline">0</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; C)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately prior to 5&#58;00 p.m., New York City time, on the record date for such distribution&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately after 5&#58;00 p.m., New York City time, on the record date for such distribution&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the average VWAP per share of our common stock over the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the ex-dividend date for such distribution&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">an amount of cash per share of our common stock we distribute to holders of our common stock&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> that in the case of a regular quarterly cash dividend or distribution, such amount will only include the amount of such dividend or distribution in excess of the initial dividend threshold.</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if &#8220;C&#8221; (as defined above) is equal to or greater than &#8220;SP0&#8221; (as defined above), in lieu of the foregoing increase, each holder of shares of the mandatory convertible preferred stock receives, in respect of each share thereof, at the same time and upon the same terms as holders of shares of our common stock and solely as a result of holding shares of mandatory convertible preferred stock, the amount of cash that such holder would have received if such holder owned a number of shares of our common stock equal to the maximum conversion rate in effect immediately prior to 5&#58;00 p.m., New York City time, on the record date for such distribution.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The initial dividend threshold is subject to adjustment in a manner inversely proportional to adjustments to the fixed conversion rates&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that no adjustment will be made to the initial dividend threshold for any adjustment made to the fixed conversion rates under this clause (iv).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any adjustment to the fixed conversion rates pursuant to this clause (iv) will become effective immediately after 5&#58;00 p.m., New York City time, on the record date for such distribution. If such distribution is not so paid, the fixed conversion rates will be decreased, effective as of the earlier of (a) the date our board of directors or a duly authorized committee thereof determines not to pay such dividend and (b) the date such dividend was to have been paid, to the fixed conversion rates that would then be in effect if such distribution had not been declared.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;If we or one or more of our subsidiaries purchases our common stock pursuant to a tender offer or exchange offer pursuant to a Schedule TO or registration statement on Form S-4 for our common stock (excluding, for the avoidance of doubt, any securities convertible or exchangeable for our common stock, and except as provided below) and the cash and value of any other consideration included in the payment per share of our common stock validly tendered or exchanged exceeds the average VWAP per share of our common stock over the 10 consecutive trading day period commencing on, and including, the trading day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer (the &#8220;expiration date&#8221;), each fixed conversion rate will be increased based on the following formula&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.576%"><tr><td style="width:1.0%"></td><td style="width:36.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.063%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#61; CR0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">x</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(FMV+(SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:1.41pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">x OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:1.41pt;vertical-align:baseline">1))</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(SP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">where,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.380%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately prior to 5&#58;00 p.m., New York City time, on the tenth trading day immediately following, and including, the trading day next succeeding the expiration date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fixed conversion rate in effect immediately after 5&#58;00 p.m., New York City time, on the tenth trading day immediately following, and including, the trading day next succeeding the expiration date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FMV</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fair market value (as determined in good faith by our board of directors or a duly authorized committee thereof) as of the expiration date of the aggregate value of all cash and any other consideration paid or payable for shares of our common stock validly tendered or exchanged and not withdrawn as of the expiration date (the &#8220;purchased shares&#8221;)&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of our common stock outstanding as of the last time tenders or exchanges may be made pursuant to such tender or exchange offer (the &#8220;expiration time&#8221;), less any purchased shares&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">0</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of our common stock outstanding at the expiration time, including any purchased shares&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SP1</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#61;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the average VWAP per share of our common stock over the 10 consecutive trading day period commencing on, and including, the trading day next succeeding the expiration date.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The adjustment to each fixed conversion rate under the immediately preceding paragraph will occur at 5&#58;00 p.m., New York City time, on the 10th consecutive trading day immediately following, and including, the trading day immediately following the expiration date, but will be given effect as of 9&#58;00 a.m., New York City time, on the expiration date. Because we will make the adjustments to the fixed conversion rates at the end of the 10 consecutive trading day period with retroactive effect, we will delay the settlement of any conversion of shares of the mandatory convertible preferred stock if the conversion date occurs during such 10 consecutive trading day period. In such event, we will deliver the shares of common stock issuable in respect of such conversion (based on the adjusted fixed conversion rates as described above) on the first business day immediately following the last trading day of such 10 consecutive trading day period.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Record date&#8221; means, solely for purposes of a conversion rate adjustment, with respect to any dividend, distribution or other transaction or event in which the holders of our common stock have the right to receive any cash, securities or other property or in which our common stock (or other applicable security) is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of our common stock entitled to receive such cash, securities or other property (whether such date is fixed by our board of directors or by statute, contract or otherwise).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Ex-dividend date&#8221; means the first date on which the shares of common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance or distribution in question or, if applicable, from the seller of such common stock (in the form of due bills or otherwise) as determined by such exchange or market.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we have in effect a stockholder rights plan while any shares of the mandatory convertible preferred stock remain outstanding, holders of shares of the mandatory convertible preferred stock receive, upon a conversion of shares of the mandatory convertible preferred stock, in addition to common stock, rights under our stockholder rights agreement unless, prior to such conversion, the rights have expired, terminated or been redeemed or unless the rights have separated from our common stock. If the rights provided for in our rights plan have separated from our common stock in accordance with the provisions of the applicable rights agreement so that holders of shares of the mandatory convertible preferred stock would not be entitled to receive any rights in respect of our common stock, if any, that we are required to deliver upon conversion of shares of the mandatory convertible preferred stock, each fixed conversion rate will be adjusted at the time of separation as if we had made a distribution to all holders of our common stock of shares of our capital stock (other than our common stock), evidences of our indebtedness, our assets or rights to acquire our capital stock, our indebtedness or our assets pursuant to paragraph (iii) above, subject to readjustment upon the subsequent expiration, termination or redemption of the rights. A distribution of rights pursuant to a rights plan will not trigger a conversion rate adjustment pursuant to paragraphs (ii) or (iii) above. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, no adjustment to the fixed conversion rates need be made if holders of shares of the mandatory convertible preferred stock participate in the transaction that would otherwise require an adjustment (other than in the case of a share split or share combination), at the same time, upon the same terms and otherwise on the same basis as holders of our common stock and solely as a result of holding shares of the mandatory convertible preferred stock, as if such holders held a number of shares of our common stock equal to the maximum conversion rate as of the record date for such transaction, multiplied by the number of shares of the mandatory convertible preferred stock held by such holders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The fixed conversion rates will not be adjusted under this &#8220;&#8212;Conversion Rate Adjustments&#8221; section except as provided above. Without limiting the foregoing, the fixed conversion rates will not be adjusted under this &#8220;&#8212;Conversion Rate Adjustments&#8221; section for&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the issuance of any shares of our common stock (or rights with respect thereto) pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on our securities and the investment of additional optional amounts in our common stock under any plan&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the issuance of any shares of our common stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit plan, employee agreement or arrangement or program of ours or any of our subsidiaries&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the issuance of any shares of our common stock pursuant to any option, warrant, right, or exercisable, exchangeable or convertible security outstanding as of the issue date&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">a change solely in the par value of our common stock&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">stock repurchases that are not tender offers, including structured or derivative transactions&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">as a result of a tender offer solely to holders of fewer than 100 shares of our common stock&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">a tender or exchange offer by a person other than us or one or more of our subsidiaries&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the payment of dividends on the mandatory convertible preferred stock, whether in cash or in shares of our common stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All required calculations (including adjustments to the fixed conversion rates) will be made to the nearest cent or 1&#47;10,000th of a share.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, we may make such increases in each fixed conversion rate as we deem advisable in order to avoid or diminish any income tax to holders of our common stock resulting from any dividend or distribution of our shares (or issuance of rights or warrants to acquire our shares) or from any event treated as such for income tax purposes or for any other reason. We may only make such a discretionary adjustment if we make the same proportionate adjustment to each fixed conversion rate.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We will be required, within 10 business days after the conversion rate is adjusted, to provide or cause to be provided written notice of the adjustment to the holders of shares of mandatory convertible preferred stock. We will also be required to deliver a statement setting forth in reasonable detail the method by which the adjustment to each fixed conversion rate was determined and setting forth each revised fixed conversion rate.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior to the mandatory conversion date, no adjustment in a fixed conversion rate will be required unless the adjustment would require an increase or decrease of at least one percent in such fixed conversion rate. If any adjustment is not required to be made because it would not change the fixed conversion rates by at least one percent, then the adjustment will be carried forward and taken into account in any subsequent adjustment&#59; provided, however, that on the earlier of the mandatory conversion date, an early conversion date and the effective date of a fundamental change, adjustments to the fixed conversion rates will be made with respect to any such adjustment carried forward that has not been taken into account before such date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an adjustment is made to the fixed conversion rates, an inversely proportional adjustment also will be made (x) to the threshold appreciation price and the initial price solely for the purposes of determining which clause of the definition of the conversion rate will apply on the conversion date and (y) to the floor price. Because (a) the applicable market value is an average VWAP per share of our common stock over a 20 consecutive trading day period, and (b) the fundamental change market value is an average VWAP per share of our common stock over a five consecutive trading day period, we will make appropriate adjustments (including, without limitation, to the VWAP per share used to calculate the applicable market value and the fundamental change market value, as the case may be) to account for any adjustments to the fixed conversion rates that become effective during the period in which the applicable market value or the fundamental change market value, as the case may be, is being calculated.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Recapitalizations, reclassifications and changes of our common stock</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any reclassification of our common stock (other than changes only in par value or resulting from a subdivision or combination)&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any consolidation or merger of us with or into another person or any statutory exchange or binding share exchange&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any sale, transfer, lease or conveyance to another person of all or substantially all the property and assets of us and our subsidiaries&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in each case, as a result of which the shares of our common stock are exchanged for, or converted into, other securities, property or assets (including cash or any combination thereof) (any such event, a &#8220;reorganization event&#8221;), then, at the effective time of such reorganization event, each share of mandatory convertible preferred stock outstanding immediately prior to such reorganization event will become, without the consent of the holders of the mandatory convertible preferred stock, convertible into the kind and amount of such other securities, property or assets (including cash or any combination thereof) that a holder of a number of shares of common stock equal to the relevant conversion rate immediately prior to such transaction would have owned or been entitled to receive (the &#8220;exchange property&#8221;) in such reorganization event, and, at the effective time of such reorganization event, we will, without the consent of the holders of the mandatory convertible preferred stock, amend the certificate of amendment to provide for such change in the convertibility of the mandatory convertible preferred stock &#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that if the kind and amount of exchange property receivable upon such reorganization event is not the same for each share of our common stock held immediately prior to such reorganization event, then the exchange property receivable upon such reorganization event will be deemed to be the weighted average of the types and amounts of consideration received by the holders of our common stock that affirmatively make an election with respect to the kind and amount of exchange property so receivable (or of all such holders if none makes an election). The conversion rate then in effect will be applied on the applicable conversion date to the amount of such exchange property received per share of our common stock in the reorganization event (a &#8220;unit of exchange property&#8221;), as determined in accordance with this section. For the purpose of determining and calculating the conversion rate, the value of a unit of exchange property will be determined in good faith by our board of directors or a duly authorized committee thereof, except that if a unit of exchange property includes common stock or American Depositary Receipts (&#8220;ADRs&#8221;) that are traded on a U.S. national securities exchange, the value of such common stock or ADRs will be the average VWAP for a share of such common stock or a single ADR, as the case may be, for the 20 consecutive trading day period commencing on and including the 22nd scheduled trading day prior to the mandatory conversion date (or for the purpose of determining the stock price in connection with a fundamental change, the value of such common stock or ADRs will be the average VWAP for a share of such common stock or a single ADR, as the case may be, for the five consecutive trading day period ending on, and including, the trading day immediately preceding the effective date). For the purpose of paying accumulated and unpaid dividends in units of exchange property as contemplated under &#8220;&#8212;Method of payment of dividends,&#8221; the value of a unit of exchange property (other than cash) will equal 97% of the value determined pursuant to the immediately preceding sentence.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The above provisions of this section similarly apply to successive reorganization events and the &#8220;&#8212;Conversion rights&#8212;Conversion rate adjustments&#8221; section applies to any shares of our capital stock (or of any successor) received by the holders of our common stock in any such reorganization event.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amendment to the certificate of amendment providing that the mandatory convertible preferred stock will be convertible into exchange property will also provide for anti-dilution and other adjustments that are as nearly equivalent as possible to the adjustments described under &#8220;&#8212;Conversion rights-Conversion rate adjustments&#8221; above. We will agree in the certificate of amendment for the mandatory convertible preferred stock not to become a party to any such transaction unless its terms are consistent with the foregoing.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with any adjustment to the conversion rate described above, we will also adjust the initial dividend threshold (as defined under &#8220;&#8212;Conversion rights&#8212;Conversion rate adjustments&#8221;) based on the number of shares of common stock comprising the exchange property and (if applicable) the value of any non-stock consideration comprising the exchange property.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We (or any successor of us) will, as soon as reasonably practicable (but in any event within five business days) after the occurrence of any reorganization event, provide written notice to the holders of the mandatory convertible preferred stock of such occurrence of such event and of the kind and amount of the cash, securities or other property that constitute the exchange property. Failure to deliver such notice will not affect the operation of this section or the effectiveness of such transaction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Liquidation preference</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of our liquidation, dissolution or winding-up, whether voluntary or involuntary, each holder of shares of the mandatory convertible preferred stock are entitled to receive out of our assets available for distribution to our stockholders, subject to rights of our creditors, before any payment or distribution is made to holders of junior stock (including our common stock), payment in full of the amount of $1,000 per share of the mandatory convertible preferred stock, plus an amount equal to any accumulated and unpaid dividends, whether or not declared, on such shares to (but not including) the date fixed for liquidation, dissolution or winding-up. If in any such distribution our assets or proceeds thereof are not sufficient to pay in full the amounts payable with respect to all outstanding shares of the mandatory convertible preferred stock and any other stock ranking equally with the mandatory convertible preferred stock as to such distribution, the holders of shares of the mandatory convertible preferred stock and such other stock will share ratably in any such distribution in proportion to the full accumulated and unpaid respective distributions to which they are entitled. After payment of the full amount of the liquidation preference, including an amount equal to any accumulated and unpaid dividends, to which they are entitled, the holders of the mandatory convertible preferred stock have no right or claim to any of our remaining assets.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neither the sale, lease or exchange (for cash, securities or other property) of all or substantially all our assets, nor our merger or consolidation with any other corporation or other entity, will be deemed to be a liquidation, dissolution or winding-up of our company.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The certificate of amendment does not contain any provision requiring funds to be set aside to protect the liquidation preference of the mandatory convertible preferred stock even though it is substantially in excess of the par value thereof.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Voting rights</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The holders of shares of the mandatory convertible preferred stock have no voting rights in respect of such shares except as set forth below or as otherwise required by law or our restated certificate of incorporation from time to time. In matters where holders of the mandatory convertible preferred stock are entitled to vote, each share of the mandatory convertible preferred stock is entitled to one vote.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Preferred directors</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whenever, at any time or times, dividends payable on the shares of the mandatory convertible preferred stock have not been paid for an aggregate of six or more dividend periods, whether or not consecutive (an &#8220;event of non-payment&#8221;), the holders of the mandatory convertible preferred stock have the right, with holders of shares of any one or more other classes or series of outstanding parity stock upon which like voting rights have been conferred and are exercisable at the time, voting together as a class (and with voting rights allocated pro rata based on the liquidation preference of each such class or series), to elect two directors (together, the &#8220;preferred directors&#8221; and each, a &#8220;preferred director&#8221;) at the next annual meeting or special meeting of our stockholders and at each subsequent annual meeting or special meeting of our stockholders until all accumulated and unpaid dividends have been paid in full on the mandatory convertible preferred stock, at which time such right will terminate, except as otherwise expressly provided by law, subject to re-vesting in the event of each and every event of non-payment&#894; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that it will be a qualification for election for any preferred director that (i) the election of such preferred director will not cause us to violate any corporate governance requirements of any securities exchange or other trading facility on which our equity securities may then be listed or traded, including that we have a majority of independent directors and (ii) such preferred director will not be prohibited or disqualified from serving as a director on our board by any applicable state or federal law, rule or regulation.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon any termination of the right set forth in the immediately preceding paragraph, the preferred directors will cease to be qualified as directors, the term of office of all preferred directors then in office will terminate immediately, and the authorized number of directors will be reduced by the number of preferred directors elected as described above.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any preferred director may be removed at any time, with or without cause, and any vacancy created thereby may be filled, only at a meeting of our stockholders at which this is a permitted action by the affirmative vote of the holders of a majority in voting power of the shares of the mandatory convertible preferred stock at the time outstanding voting separately as a class together with the holders of shares of parity stock upon which like voting rights have been conferred and are exercisable at the time (and with voting rights allocated pro rata based on the liquidation preference of each such class or series), to the extent the voting rights of such holders described above are then exercisable. If the office of any preferred director becomes vacant for any reason other than removal from office as described above, the remaining preferred director may choose a successor who will hold office for the unexpired term in respect of which such vacancy occurred. In no event may the filling of a vacancy be permitted if such filling of such vacancy would cause us to violate (i) any corporate governance requirements of any securities exchange or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other trading facility on which our equity securities may then be listed or traded, including that we have a majority of independent directors or (ii) any applicable state or federal law, rule or regulation.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At any time after the right of the holders of the mandatory convertible preferred stock to elect directors has become vested and is continuing but a meeting of our stockholders to elect such directors has not yet been held, or if a vacancy exists in the office of any such preferred director that has not been filled by the remaining preferred director, our board of directors may, but is not required to, call a special meeting of the holders of the mandatory convertible preferred stock and any one or more classes or series of outstanding parity stock upon which like voting rights have been conferred and are exercisable at the time, for the purpose of electing the directors that such holders are entitled to elect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that in the event our board of directors does not call such special meeting, such election will be held at the next annual meeting. At any such meeting held for the purpose of electing such a director (whether at an annual meeting or special meeting), the presence in person or by proxy of the holders of shares representing at least a majority of the voting power of the mandatory convertible preferred stock and any parity stock having similar voting rights will be required to constitute a quorum of the mandatory convertible preferred stock and any parity stock having similar voting rights. The affirmative vote of the holders of the mandatory convertible preferred stock and any parity stock having similar voting rights constituting a majority of the voting power of such shares present at such meeting, in person or by proxy, will be sufficient to elect any such director.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">When a supermajority vote is required</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition to any other vote or consent of stockholders required by law or our restated certificate of incorporation, so long as any shares of mandatory convertible preferred stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds in voting power of the outstanding shares of the mandatory convertible preferred stock and all other parity stock having similar voting rights that are exercisable at the time (subject to the last paragraph of this section &#8220;&#8212;When a supermajority vote is required&#8221;), voting as a single class (and with voting rights allocated pro rata based on the liquidation preference of each such class or series), given in person or by proxy, either in writing without a meeting or by vote at any meeting called for such purpose, or by written consent in lieu of such meeting&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">amend or alter our restated certificate of incorporation or the certificate of amendment to authorize or create or increase the authorized amount of, or any issuance of, any shares of, or any securities convertible into or exchangeable or exercisable for shares of, any class or series of our capital stock ranking senior to the mandatory convertible preferred stock with respect to either or both the payment of dividends and&#47;or the distribution of assets on our liquidation, dissolution or winding-up&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">amend, alter or repeal any provision of our restated certificate of incorporation or certificate of amendment (including, unless no vote on such merger or consolidation is required in accordance with the following bullet, any amendment, alteration or repeal by means of a merger, consolidation or otherwise, but excluding any amendment providing that the mandatory convertible preferred stock will be convertible into exchange property as described under &#8220;&#8212;Recapitalizations, reclassifications and changes of our common stock&#8221;) so as to adversely affect the rights, preferences, privileges or voting powers of the mandatory convertible preferred stock&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">consummate a binding share exchange, a reclassification involving the mandatory convertible preferred stock, or a merger or consolidation of us with another corporation or other entity, unless in each case (x) the mandatory convertible preferred stock remain outstanding or, in the case of any such merger or consolidation with respect to which we are not the surviving or resulting entity, is converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) the mandatory convertible preferred stock remaining outstanding or such new preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the mandatory convertible preferred stock immediately prior to such consummation, taken as a whole&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that the creation and issuance, or an increase in the authorized or issued amount, whether pursuant to pre-emptive or similar rights or otherwise, of any series of preferred stock, or any securities convertible into or exchangeable or exercisable for any other series of preferred stock (including the mandatory convertible preferred stock ), ranking equally with and&#47;or junior to the mandatory convertible preferred stock with respect to the payment of dividends (whether such dividends are cumulative or non-cumulative) and the distribution of assets upon our liquidation, dissolution or winding-up, will not be deemed to adversely affect the rights, preferences or voting powers, and will not require the affirmative vote or consent of, the holders of the shares of the mandatory convertible preferred stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified above would adversely affect one or more but not all series of parity stock (including the mandatory convertible preferred stock for this purpose), then only the one or more series of parity stock adversely affected and entitled to vote, rather than all series of parity stock, will vote as a class.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without the consent of the holders of the mandatory convertible preferred stock, so long as such action does not adversely affect the special rights, preferences, privileges or voting powers of the mandatory convertible preferred stock, and limitations and restrictions thereof, we may amend, alter, supplement, or repeal any terms of the mandatory convertible preferred stock for the following purposes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to cure any ambiguity or mistake, or to correct or supplement any provision contained in the certificate of amendment establishing the terms of the mandatory convertible preferred stock that may be defective or inconsistent with any other provision contained in such certificate of amendment&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to make any provision with respect to matters or questions relating to the mandatory convertible preferred stock that is not inconsistent with the provisions of the certificate of amendment establishing the terms of the mandatory convertible preferred stock &#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to waive any of our rights with respect thereto&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">that any such amendment, alteration, supplement or repeal of any terms of the mandatory convertible preferred stock (x) effected in order to conform the terms thereof to the description of the terms of the mandatory convertible preferred stock set forth under &#8220;Description of Mandatory Convertible Preferred Stock&#8221; in the preliminary prospectus supplement, dated May 19, 2020, related to the offering of the mandatory convertible preferred stock, as supplemented by the related pricing term sheet, or (y) required pursuant to &#8220;&#8212;Recapitalizations, reclassifications and changes of our common stock&#8221; to provide that the mandatory convertible preferred stock be convertible into exchange property, in each case, will be deemed not to adversely affect the special rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the mandatory convertible preferred stock.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Reservation of common stock</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are required to at all times reserve and keep available out of the authorized and unissued shares of common stock, solely for issuance, the full number of shares of common stock issuable upon payment of accumulated and unpaid dividends and upon conversion of the mandatory convertible preferred stock at the maximum conversion rate then in effect.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-Takeover Provisions</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain provisions in our restated certificate of incorporation and by-laws, as well as certain provisions of New Jersey law, may make more difficult or discourage a takeover of our business.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Certain Provisions of Our Restated Certificate of Incorporation and By-laws</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We currently have the following provisions in our restated certificate of incorporation and by-laws which could be considered &#8220;anti-takeover&#8221; provisions&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">an authorization for the issuance of blank check preferred stock. Our board of directors can set the voting rights, redemption rights, conversion rights and other rights relating to such preferred stock and could issue such stock in either private or public transactions. In some circumstances, the blank check preferred stock could be issued and have the effect of preventing a merger, tender offer or other takeover attempt that the board of directors opposes&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">providing advanced written notice procedures and limitations with respect to shareholder proposals and the nomination of candidates for election as directors other than nominations made by or at the direction of our board of directors&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">providing a statement that special meetings of our shareholders may only be called by the Chairman of our board of directors, the Chief Executive Officer or our board of directors, or on request in writing of shareholders of record owning 25% or more of the voting power of our outstanding capital stock entitled to vote (limited to shares owned, directly or indirectly, by any shareholder that constitutes such person&#8217;s net long position), and providing that a special meeting will not be held if (a) the meeting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">request is delivered during the period commencing 90 days prior to the first anniversary of the date of the immediately preceding annual meeting of shareholders and ending on the earlier of (x) the date of the next annual meeting or (y) 30 days after the first anniversary of the date of the previous annual meeting&#59; (b) an annual or special meeting of shareholders that included an identical or substantially similar item of business (as determined in good faith by the our board of directors) was held not more than 120 days before the special meeting request was received or will be included on the agenda at an annual or special meeting of shareholders to be held within 90 days after the special meeting request is delivered and (c) our board of directors has called or will call for an annual or special meeting of shareholders within 30 days after the request is received and has determined that the business to be conducted at such meeting includes an identical or substantially similar item of business&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">allowing our directors to fill vacancies on our board of directors, including vacancies resulting from removal or enlargement of our board of directors&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">granting our board of directors the authority to amend and repeal our by-laws without a stockholder vote&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">permitting a majority of our board of directors to fix the number of directors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These provisions may have the effect of delaying, deferring or preventing a change in control.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Anti-Takeover Effects of the New Jersey Shareholders Protection Act</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to Section 14A-10A of the New Jersey Shareholders Protection Act, a type of anti-takeover statute designed to protect stockholders against coercive, unfair or inadequate tender offers and other abusive tactics and to encourage any person contemplating a business combination with us to negotiate with our board of directors for the fair and equitable treatment of all stockholders. Subject to certain qualifications and exceptions, the statute prohibits an interested stockholder of a corporation from effecting a business combination with the corporation for a period of five years unless the corporation&#8217;s board of directors approved the combination prior to the stockholder becoming an interested stockholder. In addition, but not in limitation of the five-year restriction, if applicable, corporations covered by the New Jersey statute may not engage at any time in a business combination with any interested stockholder of that corporation unless the combination is approved by the board of directors prior to the interested stockholder&#8217;s stock acquisition date, the combination receives the approval of two-thirds of the voting stock of the corporation not beneficially owned by the interested stockholder or the combination meets minimum financial terms specified by the statute.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An &#8220;interested stockholder&#8221; is defined to include any beneficial owner of 10% or more of the voting power of the outstanding voting stock of the corporation and any affiliate or associate of the corporation who within the prior five year period has at any time owned 10% or more of the voting power of the then outstanding stock of the corporation.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;business combination&#8221; is defined broadly to include, among other things&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the merger or consolidation of the corporation with the interested stockholder or any corporation that is or after the merger or consolidation would be an affiliate or associate of the interested stockholder,</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the sale, lease, exchange, mortgage, pledge, transfer or other disposition to an interested stockholder or any affiliate or associate of the interested stockholder of 10% or more of the corporation&#8217;s assets, or</font></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the issuance or transfer to an interested stockholder or any affiliate or associate of the interested stockholder of 5% or more of the aggregate market value of the stock of the corporation.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effect of the statute is to protect non-tendering, post-acquisition minority stockholders from mergers in which they will be &#8220;squeezed out&#8221; after the merger, by prohibiting transactions in which an acquirer could favor itself at the expense of minority stockholders. The statute generally applies to corporations that are organized under New Jersey law, and have a class of stock registered or traded on a national securities exchange or registered with the SEC pursuant to Section 12(g) of the Exchange Act.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer Agent and Registrar</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The transfer agent, registrar, conversion and dividend disbursing agent for shares of the mandatory convertible preferred stock and the transfer agent and registrar for shares of our common stock is Computershare Trust Company, N.A.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF DEPOSITARY SHARES OF BECTON, DICKINSON AND COMPANY</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each depositary share represents a 1&#47;20th interest in a share of the mandatory convertible preferred stock and was initially evidenced by a global security. Subject to the terms of the deposit agreement, the depositary shares are entitled to all rights and preferences of the mandatory convertible preferred stock, including conversion, dividend, liquidation and voting rights, in proportion to the fraction of a share of the mandatory convertible preferred stock those depositary shares represent.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In this section, references to &#8220;holders&#8221; of depositary shares mean those who have depositary shares registered in their own names on the books maintained by the bank depositary and not indirect holders who own beneficial interests in depositary shares registered in the street name of, or issued in book-entry form through, DTC prior to mandatory conversion of the mandatory convertible preferred stock. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Conversion</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Because each depositary share represents a 1&#47;20th interest in a share of the mandatory convertible preferred stock, a holder of depositary shares may elect to convert depositary shares only in lots of 20 depositary shares, either on an early conversion date at the minimum conversion rate of 0.1736 shares of our common stock per depositary share, subject to adjustment, or during a fundamental change conversion period at the fundamental change conversion rate, as described below. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table sets forth the fundamental change conversion rate per depositary share, subject to adjustment based on the effective date of the fundamental change and the stock price in the fundamental change&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.85pt;padding-right:1.65pt;text-indent:-7.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective Date</font></div></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$120.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$140.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$160.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$180.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$200.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$220.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$240.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$250.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$260.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$270.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$288.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$300.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$325.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$350.00</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$400.00</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.85pt;padding-right:1.65pt;text-indent:-7.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2021</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1937</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1933</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1916</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1892</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1863</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1834</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1806</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1793</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1782</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1771</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1754</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1745</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1729</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1717</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1705</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.85pt;padding-right:1.65pt;text-indent:-7.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2022</font></div></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2016</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2017</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2007</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1986</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1953</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1914</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1873</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1853</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1835</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1817</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1791</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1776</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1752</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1737</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1722</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.85pt;padding-right:1.65pt;text-indent:-7.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2023</font></div></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2083</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2000</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1923</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1852</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1736</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1736</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1736</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1736</font></td><td colspan="3" style="padding:2px 1pt 2px 2.67pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1736</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The exact stock price and effective dates may not be set forth in the table, in which case&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the stock price is between two stock prices on the table or the effective date is between two effective dates on the table, the fundamental change conversion rate per depositary share will be determined by straight-line interpolation between the fundamental change conversion rates per depositary share set forth for the higher and lower stock prices and the earlier and later effective dates, as applicable, based on a 365-day year&#894;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the stock price is greater than $400.00 per share (subject to adjustment in the same manner as the column headings of the table above), then the fundamental change conversion rate per depositary share will be the minimum conversion rate, divided by 20, subject to adjustment&#894; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if the stock price is less than $120.00 per share (subject to adjustment in the same manner as the column headings of the table above), then the fundamental change conversion rate per depositary share will be determined (1) as if the stock price equaled the minimum stock price, and if the effective date is between two dates on the table, using straight-line interpolation, as described herein, and (2), divided by 20, subject to adjustment.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On any conversion date for the mandatory convertible preferred stock, each depositary share corresponding to the shares of mandatory convertible preferred stock so converted will be entitled to receive 1&#47;20th of the number of shares of our common stock and the amount of any cash received by the bank depositary upon conversion of each share of the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table illustrates the conversion rate per depositary share on the mandatory conversion date, subject to adjustment based on the applicable market value of our common stock&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Market Value of our Common Stock on the Mandatory Conversion Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Conversion Rate Per Depositary Share</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equal to or greater than the threshold appreciation price.</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1736 shares.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than the threshold appreciation price but greater than the initial price.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Between 0.1736 and 0.2083 shares, determined by dividing $50 by the applicable market value of our common stock.</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to the initial price.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2083 shares.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After delivery of our common stock by the transfer agent to the bank depositary following conversion of the mandatory convertible preferred stock, the bank depositary will transfer the proportional number of shares of our common stock to the holders of depositary shares by book-entry transfer through DTC or, if the holders&#8217; interests are in certificated depositary receipts, by delivery of common stock certificates for such number of shares of our common stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If we are required to withhold on distributions of common stock in respect of dividends in arrears or in respect of the net present value of future dividends to a holder and pay the applicable withholding taxes, we may, at our option, or an applicable withholding agent may, withhold such taxes from payments of cash or shares of common stock payable to such holder.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fractional shares</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fractional shares of common stock will be issued to holders of our depositary shares upon conversion. In lieu of any fractional shares of common stock otherwise issuable upon conversion (including in connection with a dividend payment), that holder will be entitled to receive an amount in cash (computed to the nearest cent) based on the VWAP per share of our common stock on the trading day immediately preceding the applicable conversion date. If more than one depositary share is surrendered for conversion at one time by or for the same holder, the number of full shares of our common stock issuable upon conversion thereof will be computed on the basis of the aggregate number of depositary shares so surrendered.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividends and other distributions</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each dividend paid on a depositary share will be in an amount equal to 1&#47;20th of the dividend paid on the related share of the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The bank depositary will deliver any cash or shares of common stock it receives in respect of dividends on the mandatory convertible preferred stock to the holders of the depositary shares in such amounts as are, as nearly as practicable, in proportion to the number of outstanding depositary shares held by such holders, on the date of receipt or as soon as practicable thereafter.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The dividend payable on each dividend payment date, if declared, is expected to be approximately $0.75 per depositary share (based on the annual dividend rate of 6.00%, each depositary share representing a 1&#47;20th interest in a share of the mandatory convertible preferred stock and a liquidation preference of the mandatory convertible preferred stock of $1,000 per share).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regular record dates for the payment of dividends and other matters relating to the depositary shares will be the same as the corresponding regular record dates for the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fractional shares of common stock will be delivered to the holders of our depositary shares in payment or partial payment of a dividend. We will instead pay a cash adjustment (computed to the nearest cent) based on the dividend payment average price with respect to such dividend. The number of shares of common stock issuable in connection with the payment of such dividend amount to a holder of more than one depositary share will be computed on the basis of the aggregate number of depositary shares of such holder.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amount paid as dividends or otherwise distributable by the bank depositary with respect to the depositary shares or the underlying mandatory convertible preferred stock will be reduced by any amounts required to be withheld by us or the bank depositary on account of taxes or other governmental charges. The bank depositary may refuse to make any payment or distribution, or any transfer, exchange, or withdrawal of any depositary shares or the shares of the mandatory convertible preferred stock until such taxes or other governmental charges are paid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No Redemption</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our depositary shares are not redeemable or subject to any sinking fund or other similar provision. However, at our option, we may purchase or otherwise acquire (including in an exchange transaction) the depositary shares from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Voting the Mandatory Convertible Preferred Stock </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Because each depositary share represents a 1&#47;20th interest in a share of the mandatory convertible preferred stock, holders of depositary receipts are entitled to 1&#47;20th of a vote per share of mandatory convertible preferred stock under those circumstances in which holders of the mandatory convertible preferred stock are entitled to a vote.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">When the bank depositary receives notice of any meeting at which the holders of the mandatory convertible preferred stock are entitled to vote, the bank depositary will send the notice to the record holders of the depositary shares relating to the mandatory convertible preferred stock. Each record holder of depositary shares on the record date (which is the same date as the record date for the mandatory convertible preferred stock ) may instruct the bank depositary as to how to vote the amount of the mandatory convertible preferred stock represented by such holder&#8217;s depositary shares in accordance with these instructions. The bank depositary will endeavor, insofar as practicable, to vote the amount of the mandatory convertible preferred stock represented by such depositary shares in accordance with these instructions, and we will take all actions the bank depositary deems necessary in order to enable the bank depositary to do so. The bank depositary will abstain from voting shares of the mandatory convertible preferred stock to the extent it does not receive specific instructions from the holders of depositary shares representing the mandatory convertible preferred stock.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, any depositary shares, or any shares of mandatory convertible preferred stock represented by such depositary shares, that are owned by us, by any of our subsidiaries or by any person or entity directly or indirectly controlling or controlled by or under direct or indirect common control with us or any of our subsidiaries will be disregarded and deemed not to be outstanding for the purpose of any vote at any meeting at which the holders of the mandatory convertible preferred stock are entitled to vote.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Modification, amendment and termination</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without the consent of the holders of the depositary shares, we may amend, alter or supplement the deposit agreement or any certificate representing the depositary shares for the following purposes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to cure any ambiguity, omission, inconsistency or mistake in any such agreement or instrument&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to make any provision with respect to matters or questions relating to the depositary shares that is not inconsistent with the provisions of the deposit agreement and that does not adversely affect the rights, preferences, privileges or voting powers of any holder of the depositary shares&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to make any change reasonably necessary, in our reasonable determination, to comply with the procedures of the bank depositary and that does not adversely affect the rights, preferences, privileges or voting powers of any holder of the depositary shares&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to make any other change that does not adversely affect the rights, preferences, privileges or voting powers of any holder of the depositary shares (other than any holder that consents to such change).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, without the consent of the holders of the depositary shares, we may amend, alter, supplement or repeal any terms of the depositary shares to conform the terms of the depositary shares to the description of the depository shares in the prospectus supplement for the depositary shares, as further supplemented and&#47;or amended by the related pricing term sheet.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The deposit agreement may be terminated by us or the bank depositary only if (a) all outstanding depositary shares have been cancelled, upon conversion of the mandatory convertible preferred stock or otherwise, or (b) there has been made a final distribution in respect of the mandatory convertible preferred stock in connection with any liquidation, dissolution or winding up of us and such distribution will have been distributed to the record holders of the depositary receipts pursuant to the deposit agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charges of bank depositary</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangements. We also paid the charges of the bank depositary in connection with the initial deposit of the mandatory convertible preferred stock. Holders of depositary receipts are required to pay other transfer and other taxes and governmental charges and any other charges, including a fee for the withdrawal of shares of mandatory convertible preferred stock upon surrender of depositary receipts, as are expressly provided in the deposit agreement to be for their accounts.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Withdrawal rights</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A holder of 20 depositary shares may withdraw the share of mandatory convertible preferred stock corresponding to such depositary shares, and any cash or other property represented by such depositary shares. A holder who withdraws shares of mandatory convertible preferred stock (and any such cash or other property) is not required to pay any taxes or duties relating to the issuance or delivery of such shares of mandatory convertible preferred stock (and any such cash or other property), except that such holder is required to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of such shares of mandatory convertible preferred stock (and any such cash or other property) in a name other than the name of such holder. Holders of shares of the mandatory convertible preferred stock do not have the right under the deposit agreement to deposit such shares with the bank depositary in exchange for depositary shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Listing</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The depositary shares are listed on the NYSE under the symbol &#8220;BDXB.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form and notice</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The mandatory convertible preferred stock was issued in registered form to the bank depositary, and the depositary shares were issued in book-entry only form through DTC prior to the conversion of the mandatory convertible preferred stock. The bank depositary will forward to the holders of depositary shares all reports, notices and communications from us that are delivered to the bank depositary and that we are required to furnish to the holders of the mandatory convertible preferred stock.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF DEBT SECURITIES OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BECTON, DICKINSON AND COMPANY</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference should be made to the indenture, dated as of March 1, 1997, between BD and The Bank of New York Mellon Trust Company, N.A., as successor to JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), which we refer to as the BD indenture. The following description is a summary of selected portions of the BD indenture. It does not restate the BD indenture, and the BD indenture, not this description, define the rights of a holder of the BD notes.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Terms of the BD Notes</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registered holder of a BD note is treated as its owner for all purposes. Only registered holders of BD notes have rights under the BD indenture governing the BD notes. The BD indenture and the BD notes are governed by the laws of the State of New York. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.000% 2022 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 1.000% 2022 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.000% Notes due 2022</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;500,000,000</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; December 15, 2022</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; December 9, 2016</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; December 15</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record date for interest&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.000% 2022 notes are listed on the NYSE under the symbol &#8220;BDX22A&#8221;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">0.000% 2023 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 0.000% 2023 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 0.000% Notes due 2023</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;400,000,000</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13, 2023</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 0.000% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13, 2021</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">First interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13, 2022</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record dates for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The 0.000% 2023 notes are listed on the NYSE under the symbol &#8220;BDX23B&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.401% 2023 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 1.401% 2023 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.401% Notes due 2023</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;300,000,000 million</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; May 24, 2023</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.401% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; May 24, 2018</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; May 24</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record date for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The 1.401% 2023 notes are listed on the NYSE under the symbol &#8220;BDX23A&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">0.034% 2025 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 0.034% 2025 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 0.034% Notes due 2025</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;500,000,000</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13, 2025</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 0.034% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13, 2021</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">First interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; August 13, 2022</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record dates for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The 0.034% 2025 notes are listed on the NYSE under the symbol &#8220;BDX25A&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">3.020% 2025 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 3.020% 2025 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 3.020% Notes due 2025</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#163;250,000,000 million</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; May 24, 2025</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 3.020% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; GBP</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#163;100,000 and integral multiples of &#163;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; May 24, 2018</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; May 24 and November 24</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record dates for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The business day preceding the applicable interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The 3.020% 2025 notes are listed on the NYSE under the symbol &#8220;BDX25&#8221;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.900% 2026 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 1.900% 2026 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.900% Notes due 2026</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;500,000,000</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; December 15, 2026</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900% per annum</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; December 9, 2016</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; December 15</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record date for interest&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.900% 2026 notes are listed on the NYSE under the symbol &#8220;BDX26&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An event of default for a particular series of BD notes under the BD indenture does not necessarily constitute an event of default for any other series of BD notes or for any other series of debt securities under the BD indenture.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional BD Notes</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may, without notice to or consent of the holders or beneficial owners of any series of the BD notes, issue additional BD notes of such series having the same ranking, interest rate, maturity and&#47;or other terms as the applicable series of BD notes. Any such additional BD notes issued should be considered under the BD indenture fungible with and part of the same series of BD notes under the BD indenture as the applicable series of BD notes. In the event any additional BD notes are not fungible with the BD notes of the applicable series for U.S. federal income tax purposes, such nonfungible additional BD notes will be issued with a separate CUSIP number so that they are distinguishable from the applicable series of BD notes.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance in Euro</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or the euro is no longer used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions within the international banking community, then all payments in respect of the 1.000% 2022 notes, the 0.000% 2023 notes, the 1.401% 2023 notes, the 0.034% 2025 notes and the 1.900% 2026 notes (collectively, the &#8220;Euro BD notes&#8221;) will be made in U.S. dollars until the euro is again available to us or so used.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second business day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the most recent euro&#47;U.S. dollar exchange rate available on or prior to the second business day prior to the relevant payment date, as determined by us in our sole discretion. Any payment in respect of any series of Euro BD notes so made in U.S. dollars will not constitute an event of default under the applicable Euro BD notes or the BD indenture. Neither the trustee nor the paying agent have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance in GBP</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If GBP is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or GBP is no longer used by the United Kingdom as currency or for the settlement of transactions by public institutions within the international banking community, then all payments in respect of the 3.020% 2025 notes will be made in U.S. dollars until GBP is again available to us or so used.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amount payable on any date in GBP will be converted into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second business day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the most recent GBP&#47;U.S. dollar exchange rate available on or prior to the second business day prior to the relevant payment date, as determined by us in our sole discretion. Any payment in respect of the 3.020% 2025 notes so made in U.S. dollars will not constitute an event of default under the 3.020% 2025 notes or the BD indenture. Neither the trustee nor the paying agent have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest on the BD Notes</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We make interest payments to the person in whose name each series of BD notes are registered on the business day preceding the interest payment date of each year. The rights of holders of beneficial interests of the BD notes to receive the payments of interest on such BD notes are subject to the applicable procedures of Clearstream and Euroclear.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any interest payment date is not a business day, payment of interest is made on the next day that is a business day and no interest accrues as a result of such delayed payment on amounts payable from and after such interest payment date to the next succeeding business day. For the purposes of the BD notes, &#8220;business day&#8221; means any day that is not a Saturday or Sunday and that is not a day on which banking institutions are authorized or obligated by law or executive order to close in the City of New York or London and on which the Trans-European Automated Real-time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, operates. Interest on each series of the BD notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on such series of the BD notes (or from the original issuance date of the applicable series of BD notes, if no interest has been paid on such series of BD notes), to but excluding the next scheduled interest payment date. This payment convention is referred to as ACTUAL&#47;ACTUAL (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Optional Redemption</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may, at our option, redeem each series of the BD notes, in whole or in part, (i) at any time prior to November 15, 2022 (one month prior to the maturity date) with respect to the 1.000% 2022 notes, (ii) at any time with respect to the 0.000% 2023 notes, (iii) at any time prior to April 24, 2023 (one month prior to the maturity date) with respect to the 1.401% 2023 notes, (iv) at any time prior to July 13, 2025 (one month prior to the maturity date) with respect to the 0.034% 2025 notes, (v) at any time prior to February 24, 2025 (three months prior to the maturity date) with respect to the 3.020% 2025 notes and (vi) at any time prior September 15, 2026 (three months prior to the maturity date) with respect to the 1.900% 2026 notes. The redemption price, as determined by us, will be equal to the greater of&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">100% of the principal amount of the applicable series of BD notes to be redeemed&#894; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the sum of the present values of the remaining scheduled payments on the applicable series of BD notes being redeemed, discounting such payments to the redemption date on an annual basis (ACTUAL&#47;ACTUAL (ICMA)) at the applicable comparable government bond rate, plus (i) 20 basis points in the case of the 1.000% 2022 notes, (ii) 10 basis points in the case of the 0.000% 2023 notes, (iii) 25 basis points in the case of the 1.401% 2023 notes, (iv) 15 basis points in the case of the 0.034% 2025 notes, (v) 25 basis points in the case of the 3.020% 2025 notes and (vi) 25 basis points in the case of the 1.900% 2026 notes, in each case, plus accrued and unpaid interest to, but excluding, the date of redemption on the principal balance of the applicable series of BD notes being redeemed. The trustee has no responsibility for calculating the redemption price.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At any time on or after (i) November 15, 2022 (one month prior to the maturity date) with respect to the 1.000% 2022 notes, (ii) April 24, 2023 (one month prior to the maturity date) with respect to the 1.401% 2023 notes, (iii) July 13, 2025 (one month prior to the maturity date) with respect to the 0.034% 2025 notes, (iv) February 24, 2025 (three months prior to the maturity date) with respect to the 3.020% 2025 notes and (v) September 15, 2026 (three months prior to the maturity date) with respect to the 1.900% 2026 notes, we may redeem such series of BD notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the applicable series of BD notes to be redeemed, plus accrued and unpaid interest to the date of redemption on the principal balance of the applicable series of BD notes being redeemed.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;comparable government bond rate&#8221; means the yield to maturity, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), on the third business day prior to the date fixed for redemption, of the comparable government bond (as defined below) on the basis of the middle market price of the comparable government bond prevailing at 11&#58;00 a.m. (London time) on such business day as determined by an independent investment bank selected by us.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;comparable government bond&#8221; means, in relation to any comparable government bond rate calculation, at the discretion of an independent investment bank selected by us, (i) with respect to the applicable series of Euro BD notes, a German federal government bond whose maturity is closest to the maturity of the applicable series of Euro BD notes to be redeemed, or if such independent investment bank in its discretion determines that such similar bond is not in issue, such other German federal government bond as such independent investment bank may, with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">advice of three brokers of, and&#47;or market makers in, German federal government bonds selected by us, determine to be appropriate for determining the comparable government bond rate and (ii) with respect to the 3.020% 2025 notes, a United Kingdom government bond whose maturity is closest to the maturity of the 3.020% 2025 notes, or if such independent investment bank in its discretion determines that such similar bond is not in issue, such other United Kingdom government bond as such independent investment bank may, with the advice of three brokers of, and&#47;or market makers in, United Kingdom government bonds selected by us, determine to be appropriate for determining the comparable government bond rate.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;remaining scheduled payments,&#8221; means, with respect to any series of BD notes, the remaining scheduled payments of the principal and interest on the applicable series of BD notes called for redemption that would be due after the related redemption date but for such redemption up to August 13, 2023 with respect to the 0.000% 2023 notes and July 13, 2025 with respect to the 0.034% 2025 notes&#894; provided, however, that, if such redemption date is not an interest payment date with respect to such BD notes, the amount of the next scheduled interest payment thereon will be reduced by the amount of interest accrued thereon to such redemption date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notice of any redemption will be mailed or otherwise transmitted in accordance with the applicable procedures of Euroclear or Clearstream to (i) the holders of the 0.000% 2023 notes and the 0.034% 2025 notes not less than 10 days and not more than 30 days before the redemption date of the 0.000% 2023 notes and the 0.034% 2025 notes, as applicable, being redeemed and (ii) the holders of the 1.900% 2026 notes, the 1.000% 2022 notes, the 1.401% 2023 notes, the 3.020% 2025 notes and the 1.900% 2026 notes not less than 30 days and not more than 60 days before the redemption date of the 1.900% 2026 notes, the 1.000% 2022 notes, the 1.401% 2023 notes, the 3.020% 2025 notes and the 1.900% 2026 notes, as applicable, being redeemed. Unless we default on payment of the redemption price, on and after the redemption date, the applicable series of BD notes or any portion of such BD notes called for redemption will stop accruing interest. On or before any redemption date, we will deposit with the paying agent or the trustee money sufficient to pay the accrued interest on the applicable series of BD notes to be redeemed and their redemption price. A partial redemption of any series of BD notes may be effected pursuant to applicable procedures of the depository or the paying agent, and may provide for the selection for redemption of portions (equal to the minimum authorized denomination for such BD notes or any integral multiple of (i) with respect to the Euro BD notes, &#8364;1,000 in excess thereof and (ii) with respect to the 3.020% 2025 notes, &#163;1,000 in excess thereof) of the principal amount of such BD notes of a denomination larger than the minimum authorized denomination for such BD notes.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Offer to Repurchase Upon Change of Control Triggering Event</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon the occurrence of a Change of Control Triggering Event with respect to any series of BD notes, unless we have exercised our right to redeem the applicable series of BD notes as described under &#8220;&#8212;Optional Redemption&#8221; above or &#8220;&#8212;Redemption for Tax Reasons,&#8221; each holder of outstanding BD notes of the applicable series will have the right to require us to purchase all or a portion of that holder&#8217;s BD notes (in integral multiples of (i) &#8364;1,000 in excess thereof, with respect to the Euro BD notes and (ii) &#163;1,000 in excess thereof, with respect to the 3.020% 2025 notes) pursuant to the offer described below (the &#8220;Change of Control Offer&#8221;), at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to, but excluding, the date of purchase, subject to the rights of holders of such BD notes on the relevant record date to receive interest due on the relevant interest payment date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 30 days following the date upon which the Change of Control Triggering Event has occurred with respect to any series of BD notes, or at our option, prior to any Change of Control but after the public announcement of the pending Change of Control, we will be required to send in accordance with the applicable procedures of Euroclear or Clearstream, a notice to each holder of BD notes of the applicable series, with a copy to the trustee, which notice will govern the terms of the Change of Control Offer. The notice will state, among other things, the purchase date, which must be no earlier than 30 days nor later than 60 days from the date the notice is sent, other than as may be required by law (the &#8220;Change of Control Payment Date&#8221;). The notice, if sent prior to the date of consummation of the Change of Control, will state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of a series of BD notes electing to have their BD notes purchased pursuant to a Change of Control Offer will be required to surrender their BD notes, with the form entitled &#8220;Option of Holder to Elect Purchase&#8221; on the reverse of the BD note completed, to the paying agent at the address specified in the notice, or transfer their BD notes to the trustee by book-entry transfer pursuant to the applicable procedures of the paying agent, prior to the close of business on the third business day prior to the Change of Control Payment Date. The Change of Control Offer may be accepted for less than the entire principal amount of a particular BD note, but in that event the principal amount of such BD note remaining outstanding after repurchase must be equal to (i) &#8364;100,000 or an integral multiple of &#8364;1,000 in excess thereof, with respect to the Euro BD notes and (ii) &#163;100,000 or an integral multiple of &#163;1,000 in excess thereof, with respect to the 3.020% 2025 notes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are not required to make a Change of Control Offer with respect to a series of BD notes if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made by us and that third party purchases all BD notes of the applicable series properly tendered and not withdrawn under its offer. To the extent that the provisions of any securities laws or regulations conflict with the provisions herein, we are required to comply with the applicable securities laws and regulations and are not deemed to have breached our obligations under the provisions herein by virtue of such conflicts.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this section, the following terms have the meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any one of the following&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the assets of BD and its subsidiaries taken as a whole to any Person (including any &#8220;person&#8221; (as that term is used in Section 13 (d)(3) of the Exchange Act)) other than to BD or one of its subsidiaries&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">(i) with respect to the 0.000% 2023 notes and 0.034% 2025 notes, the consummation of any transaction (including without limitation, any merger or consolidation) the result of which is that any Person (including any &#8220;person&#8221;(as that term is used in Section 13(d)(3) of the Exchange Act)), other than us or one of our subsidiaries, becomes the &#8220;beneficial owner&#8221;(as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the outstanding Voting Stock of BD or other Voting Stock into which BD&#8217;s Voting Stock is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares and (ii) with respect to the 1.000% 2022 notes, the 1.401% 2023 notes, the 3.020% 2025 notes and 1.900% 2026 notes, the consummation of any transaction (including without limitation, any merger or consolidation) the result of which is that any Person (including any &#8220;person&#8221;(as that term is used in Section 13(d)(3) of the Exchange Act)) becomes the &#8220;beneficial owner&#8221;(as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the outstanding Voting Stock of BD, measured by voting power rather than number of shares&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">BD consolidates with, or merges with or into, any Person, or any Person consolidates with, or merges with or into, BD, in any such event pursuant to a transaction in which any of the outstanding Voting Stock of BD or such other Person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Voting Stock of BD outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving Person immediately after giving effect to the transaction&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the adoption of a plan relating to the liquidation or dissolution of BD.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) BD becomes a direct or indirect wholly-owned subsidiary of a holding company and (b) (x) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of BD&#8217;s Voting Stock immediately prior to that transaction or (y) immediately following that transaction, no Person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Change of Control Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a series of BD notes are rated below Investment Grade by each of the Rating Agencies on any date during the period (the &#8220;Trigger Period&#8221;) commencing on the date of the first public announcement by BD of any Change of Control (or pending Change of Control) and ending 60 days following consummation of that Change of Control (which Trigger Period will be extended following consummation of a Change of Control (i) with respect to the 0.000% 2023 notes, the 1.401% 2023 notes, the 0.034% 2025 notes and the 3.020% 2025 notes, for so long as any of the Rating Agencies has publicly announced that it is considering a possible ratings downgrade and the downgrade would result in a Change of Control Triggering Event and (ii) with respect to the 1.000% 2022 notes and the 1.900% 2026 notes, for so long as any of the Rating Agencies has publicly announced that it is considering a possible ratings downgrade). Unless at least two of the Rating Agencies are providing a rating for a series of BD notes at the commencement of any Trigger Period, the BD notes of such series will be deemed to be rated below Investment Grade by the Rating Agencies during that Trigger Period. Notwithstanding the foregoing, no Change of Control Triggering Event will be deemed to have occurred in connection with (i) any particular Change of Control unless and until such Change of Control has actually been consummated or (ii) any reduction in rating if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform (i) with respect the 0.000% 2023 notes and the 0.034% 2025 notes, us in writing at our request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, a Change of Control (whether or not the Change of Control has occurred at the time of the reduction in rating) and (ii) with respect to the 1.000% 2022 notes, the 1.401% 2023 notes, the 3.020% 2025 notes and the 1.900% 2026 notes, the trustee in writing at its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, a Change of Control (whether or not the Change of Control has occurred at the time of the reduction in rating).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fitch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Fitch Ratings, Inc. and its successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Investment Grade</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to the 0.000% 2023 notes, the 1.401% 2023 notes, the 0.034% 2025 notes and the 3.020% 2025 notes, a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating category of Moody&#8217;s)&#59; and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating category of S&#38;P)&#59; and a rating of BBB- or better by Fitch (or its equivalent under any successor rating category of Fitch) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by BD in accordance with the applicable definition of &#8220;Rating Agency&#8221; and (ii) with respect to the 1.000% 2022 notes and the 1.900% 2026 notes, a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating category of Moody&#8217;s)&#59; and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating category of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by BD in accordance with the applicable definition of &#8220;Rating Agency.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any individual, corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company or government or other entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rating Agency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means each of (i) Fitch, Moody&#8217;s and S&#38;P with respect to the 0.000% 2023 notes, the 1.401% 2023 notes, the 0.034% 2025 notes and the 3.020% 2025 notes&#59; provided, that if any of Fitch, Moody&#8217;s or S&#38;P ceases to provide rating services to issuers or investors or fails to make a rating of the 0.000% 2023 notes, the 1.401% 2023 notes, the 0.034% 2025 notes or the 3.020% 2025 notes, as applicable, publicly available for reasons outside of BD&#8217;s control, BD may appoint a replacement for that Rating Agency and (ii) Moody&#8217;s and S&#38;P with the respect to the 1.000% 2022 notes and the 1.900% 2026 notes&#59; provided, that if any of Moody&#8217;s or S&#38;P ceases to provide rating services to issuers or investors or fails to make a rating of the 1.000% 2022 notes or the 1.900% 2026 notes, as applicable, publicly available for reasons outside of BD&#8217;s control, BD may appoint a replacement for that Rating Agency.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means S&#38;P Global Ratings and its successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; of any specified Person as of any date means the capital stock of that Person that is at the time entitled to vote generally in the election of the board of directors of that Person.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment of Additional Amounts</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We pay, subject to the exceptions and limitations set forth below, as additional interest on each series of BD notes such additional amounts as are necessary in order that the net payment by us or a paying agent of the principal of and interest on each of the BD notes to a holder who is not a United States person (as defined below), after withholding or deduction solely with respect to any present or future tax, assessment or other governmental charge imposed by the United States or a taxing authority in the United States, is not be less than the amount provided in the BD notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts does not apply&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such BD note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder, or a person holding a power over an estate or trust administered by a fiduciary holder, being treated as&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being or having been present in, or engaged in a trade or business in, the United States, or having or having had a permanent establishment in the United States&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of such BD notes, the receipt of any payment in respect of such BD notes or the enforcement of any rights under the BD indenture), including being or having been a citizen of the United States or treated as being or having been a resident thereof&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for United States federal income tax purposes, a foreign tax exempt organization, or a corporation that has accumulated earnings to avoid United States federal income tax&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being or having been a &#8220;10-percent shareholder&#8221;, as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), or any successor provision, of us&#59; or</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, within the meaning of section 881(c)(3) of the Code or any successor provision&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any holder that is not the sole beneficial owner of such BD notes, or a portion of such BD notes, or that is a fiduciary, partnership or limited liability company, but only to the extent that a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership or limited liability company would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of such BD notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any estate, inheritance, gift, sales, excise, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that would not have been imposed but for the presentation by the holder of any BD note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax assessment or other governmental charge required to be withheld or deducted that is imposed on a payment pursuant to sections 1471 through 1474 of the Code (or any amended or successor version of such sections that is substantively comparable and not materially more onerous to comply with), any Treasury Regulations promulgated thereunder, or any other official interpretations thereof (collectively, &#8220;FATCA&#8221;), any agreement (including any intergovernmental agreement) entered into in connection therewith, or any law, regulation or other official guidance enacted in any jurisdiction implementing FATCA or an intergovernmental agreement in respect of FATCA&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that is imposed by reason of the failure of the beneficial owner to fulfill the statement requirements of section 871(h) or section 881(c) of the Code&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax imposed pursuant to section 871(h)(6) or section 881(c)(6) of the Code (or any amended or successor provisions)&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in the case of any combination of the above bulleted items under this heading &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to pay additional amounts in respect of any tax, assessment or other governmental charge.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, any state thereof, and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for United States federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state thereof or the District of Columbia (other than a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption for Tax Reasons</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If, as a result of any change in, or amendment to, the laws of the United States, or the official interpretation thereof, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described under the heading &#8220;&#8212;Payment of Additional Amounts&#8221; with respect to any series of BD notes, then we may at any time at our option redeem, in whole, but not in part, the BD notes of such series on not less than 30 nor more than 60 days&#8217; prior notice, at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest on the BD notes to be redeemed to, but excluding, the date fixed for redemption.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Priority</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The BD notes are our senior unsecured obligations, rank equally in right of payment with all of our other senior unsecured indebtedness and are effectively subordinated in right of payment to all of our existing and future secured indebtedness (to the extent of the value of the collateral securing such indebtedness).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The BD notes are also structurally subordinated to all obligations of our subsidiaries with respect to the assets of such subsidiaries, other than any subsidiaries that may guarantee the BD notes in the future.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clearance Systems</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The BD notes have the following codes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.000% 2022 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS1531345376</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 153134537</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 075887 BN8</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">0.000% 2023 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS2375836470</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 237583647</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 075887 CM9</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.401% 2023 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS1822506272</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 182250627</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 075887 CH0</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">0.034% 2025 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS2375836553</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 237583655</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 075887 CN7</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;margin-top:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">3.020% 2025 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS1822506439</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 182250643</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 075887 CG2</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.900% 2026 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS1531347661</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 153134766</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 075887 BP3</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF DEBT SECURITIES OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BECTON DICKINSON EURO FINANCE S.&#192; R.L.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference should be made to the indenture, dated as of May 17, 2019, between Becton Finance, as issuer, BD, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee, which we refer to as the &#8220;Becton Finance indenture.&#8221; The following description is a summary of selected portions of the Becton Finance indenture. It does not restate the Becton Finance indenture, and the Becton Finance indenture, not this description, define the rights of a holder of the Becton Finance notes.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Terms of the Becton Finance Notes</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registered holder of a Becton Finance note is treated as its owner for all purposes. Only registered holders of Becton Finance notes have rights under the Becton Finance indenture governing the Becton Finance notes. The Becton Finance indenture, the Becton Finance notes and the guarantees thereof are governed by the laws of the State of New York. The provisions of articles 470-1 to 470-19 (inclusive) of the Luxembourg law of 10 August 1915 on commercial companies, as amended, are expressly excluded.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">0.632% 2023 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 0.632% 2023 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 0.632% Notes due 2023</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Guarantor of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Becton, Dickinson and Company</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;800 million</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; June 4, 2023</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.632% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; June 4, 2019</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; June 4</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record date for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 0.632% 2023 notes are listed on the NYSE under the symbol &#8220;BDX&#47;23A&#8221;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.208% 2026 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 1.208% 2026 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.208% Notes due 2026</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Guarantor of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Becton, Dickinson and Company</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; &#8364;600 million</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; June 4, 2026</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.208% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; June 4, 2019</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; June 4</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record date for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.208% 2026 notes are listed on the NYSE under the symbol &#8220;BDX&#47;26&#47;A&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.213% 2036 Notes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The specific terms of the 1.213% 2036 notes are as follows&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Title of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.213% notes due 2036</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Guarantor of the notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Becton, Dickinson and Company</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Total principal amount issued&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8364;600 million</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Maturity date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; February 12, 2036</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; 1.213% per annum</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Currency of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Euro</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Form and Denomination&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully registered form, minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 in excess thereof</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Date interest started accruing&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> February 12, 2021</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Interest payment date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> February 12</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">First interest payment date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> February 12, 2022</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Regular record date for interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The business day preceding the interest payment date</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58; The 1.213% 2036 notes are listed on the NYSE under the symbol &#8220;BDX&#47;36&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An event of default for a particular series of Becton Finance notes under the Becton Finance indenture does not necessarily constitute an event of default for other series of Becton Finance notes or for any other series of debt securities under the Becton Finance indenture.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Becton Finance Notes</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may, without notice to or consent of the holders or beneficial owners of any series of the Becton Finance notes of such series, issue additional Becton Finance notes of the applicable series having the same ranking, interest rate, maturity and&#47;or other terms as the applicable series of Becton Finance notes. Any such additional Becton Finance notes issued should be considered under the Becton Finance indenture fungible with and part of the same series of Becton Finance notes under the Becton Finance indenture as the applicable series of Becton Finance notes. In the event any additional Becton Finance notes are not fungible with the Becton Finance notes of the applicable series for U.S. federal income tax purposes, such nonfungible additional Becton Finance notes will be issued with a separate CUSIP number so that they are distinguishable from the applicable series of Becton Finance notes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantees</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BD fully and unconditionally guarantees (1) the full and punctual payment when due, whether at stated maturity, by acceleration, by redemption or otherwise, of all obligations of Becton Finance under the Becton Finance indenture (including obligations to the trustee) and the Becton Finance notes, whether for payment of principal of, or interest on or premium, if any, on, the Becton Finance notes and all other monetary obligations of Becton Finance under the Becton Finance indenture and the Becton Finance notes and (2) the full and punctual performance within applicable grace periods of all other obligations of Becton Finance whether for fees, expenses, indemnification or otherwise under the Becton Finance indenture and the Becton Finance notes. Any obligation of BD to make a payment may be satisfied by causing Becton Finance to make such payment. The guarantees are a senior unsecured obligation of BD and are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with all of its other senior unsecured obligations.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance in Euro</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the euro is unavailable to us or, in the case of the guarantees, BD, due to the imposition of exchange controls or other circumstances beyond our or BD&#8217;s control or the euro is no longer used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions within the international banking community, then all payments in respect of the Becton Finance notes or the guarantees will be made in U.S. dollars until the euro is again available to us or, in the case of the guarantees, BD, or so used.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second business day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the most recent euro&#47;U.S. dollar exchange rate available on or prior to the second business day prior to the relevant payment date, as determined by us in our sole discretion. Any payment in respect of any series of Becton Finance notes so made in U.S. dollars will not constitute an event of default under the applicable Becton Finance notes or the Becton Finance indenture. Neither the trustee nor the paying agent have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest on the Becton Finance Notes</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We or, in the case of the guarantees, BD, make interest payments to the person in whose name each series of Becton Finance notes are registered on the business day preceding the interest payment date of each year. The rights of holders of beneficial interests of the Becton Finance notes to receive the payments of interest on such Becton Finance notes are subject to the applicable procedures of Clearstream and Euroclear.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any interest payment date is not a business day, payment of interest is made on the next day that is a business day and no interest accrues as a result of such delayed payment on amounts payable from and after such interest payment date to the next succeeding business day. For the purposes of the Becton Finance notes, &#8220;business day&#8221; means any day that is not a Saturday or Sunday and that is not a day on which banking institutions are authorized or obligated by law or executive order to close in the City of New York or London and on which the Trans-European Automated Real-time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, operates. Interest on each series of the Becton Finance notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on such series of Becton Finance notes (or from the original issuance date of the applicable series of Becton Finance notes, if no interest has been paid on such series of Becton Finance notes), to but excluding the next scheduled interest payment date. This payment convention is referred to as ACTUAL&#47;ACTUAL (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Optional Redemption</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We may, at our option, redeem each series of Becton Finance notes, in whole or in part, at any time prior to (i) May 4, 2023 (one month prior to the maturity date) with respect to the 0.632% 2023 notes, (ii) March 4, 2026 (three months prior to the maturity date) with respect to the 1.208% 2026 notes and (iii) November 12, 2035 with respect to the 1.213% 2036 notes. The redemption price, as determined by us, will be equal to the greater of&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">100% of the principal amount of the applicable series of Becton Finance notes to be redeemed&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the sum of the present values of the remaining scheduled payments on the applicable series of Becton Finance notes being redeemed, discounting such payments to the redemption date on an annual basis (ACTUAL&#47;ACTUAL (ICMA)) at the applicable comparable government bond rate, plus (i) 20 basis points </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in the case of the 0.632% 2023 notes, (ii) 25 basis points in the case of the 1.208% 2026 notes and (iii) 25 basis points in the case of the 1.213% 2036 notes, in each case, plus accrued and unpaid interest to, but excluding the date of redemption on the principal balance of the applicable series of Becton Finance notes being redeemed. The trustee has no responsibility for calculating the redemption price.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At any time on or after (i) May 4, 2023 (one month prior to the maturity date) with respect to the 0.632% 2023 notes, (ii) March 4, 2026 (three months prior to the maturity date) with respect to the 1.208% 2026 notes and (iii) November 12, 2035 with respect to the 1.213% 2036 notes, we may redeem such series of Becton Finance notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the applicable series of Becton Finance notes to be redeemed, plus accrued and unpaid interest to the date of redemption on the principal balance of the applicable series of Becton Finance notes being redeemed.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;comparable government bond rate&#8221; means the yield to maturity, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), on the third business day prior to the date fixed for redemption, of the comparable government bond (as defined below) on the basis of the middle market price of the comparable government bond prevailing at 11&#58;00 a.m. (London time) on such business day as determined by an independent investment bank selected by us.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;comparable government bond&#8221; means, in relation to any comparable government bond rate calculation, at the discretion of an independent investment bank selected by us, a German federal government bond whose maturity is closest to the maturity of the applicable series of Becton Finance notes to be redeemed (assuming with respect to the 1.213% 2036 notes, that such 1.213% 2036 notes to be redeemed matured on November 12, 2035), or if such independent investment bank in its discretion determines that such similar bond is not in issue, such other German federal government bond as such independent investment bank may, with the advice of three brokers of, and&#47;or market makers in, German federal government bonds selected by us, determine to be appropriate for determining the comparable government bond rate.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The term &#8220;remaining scheduled payments,&#8221; means, with respect to any series of Becton Finance notes, the remaining scheduled payments of the principal and interest on the applicable series of Becton Finance notes called for redemption that would be due after the related redemption date but for such redemption up to (i) May 4, 2023 (one month prior to the maturity date) with respect to the 0.632% 2023 notes, (ii) March 4, 2026 (three months prior to the maturity date) with respect to the 1.208% 2026 notes and (iii) November 12, 2035 with respect to the 1.213% 2036 notes&#59; provided, however, that, if such redemption date is not an interest payment date with respect to such Becton Finance notes, the amount of the next scheduled interest payment thereon will be reduced by the amount of interest accrued thereon to such redemption date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notice of any redemption will be mailed or otherwise transmitted in accordance with the applicable procedures of Euroclear or Clearstream to (i) the holders of the 1.213% 2036 notes not less than 10 days and not more than 30 days before the redemption date of the 1.213% 2036 notes being redeemed and (ii) the holders of the 0.632% 2023 notes and the 1.208% 2026 notes not less than 30 days and not more than 60 days before the redemption date of the 0.632% 2023 notes and the 1.208% 2026 notes, as applicable, being redeemed. Unless we default on payment of the redemption price, on and after the redemption date, the applicable series of Becton Finance notes or any portion of such Becton Finance notes called for redemption will stop accruing interest. On or before any redemption date, we will deposit with the paying agent or the trustee money sufficient to pay the accrued interest on the Becton Finance notes to be redeemed and their redemption price. A partial redemption of any series of Becton Finance notes may be effected pursuant to applicable depositary procedures or by such method as the paying agent deems fair and appropriate in accordance with the applicable procedures of Clearstream and Euroclear and may provide for the selection for redemption of portions (equal to the minimum authorized denomination for such Becton Finance notes or any integral multiple of &#8364;1,000 in excess thereof) of the principal amount of such Becton Finance notes of a denomination larger than the minimum authorized denomination for such Becton Finance notes.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Offer to Repurchase Upon Change of Control Triggering Event</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon the occurrence of a Change of Control Triggering Event with respect to any series of Becton Finance notes, unless we have exercised our right to redeem the applicable series of Becton Finance notes as described under &#8220;&#8212;Optional Redemption&#8221; above or &#8220;&#8212;Redemption for Tax Reasons,&#8221; each holder of outstanding Becton Finance notes of the applicable series will have the right to require us to purchase all or a portion of that holder&#8217;s Becton Finance notes (in integral multiples of &#8364;1,000) pursuant to the offer described below (the &#8220;Change of Control Offer&#8221;), at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to, but excluding, the date of purchase, subject to the rights of holders of such Becton Finance notes on the relevant record date to receive interest due on the relevant interest payment date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 30 days following the date upon which the Change of Control Triggering Event has occurred with respect to any series of Becton Finance notes, or at our option, prior to any Change of Control but after the public announcement of the pending Change of Control, we will be required to send in accordance with the applicable procedures of Euroclear or Clearstream, a notice to each holder of Becton Finance notes of the applicable series, with a copy to the trustee, which notice will govern the terms of the Change of Control Offer. The notice will state, among other things, the purchase date, which must be no earlier than 30 days nor later than 60 days from the date the notice is sent, other than as may be required by law (the &#8220;Change of Control Payment Date&#8221;). The notice, if sent prior to the date of consummation of the Change of Control, will state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of a series of Becton Finance notes electing to have their Becton Finance notes purchased pursuant to a Change of Control Offer will be required to surrender their Becton Finance notes, with the form entitled &#8220;Option of Holder to Elect Purchase&#8221; on the reverse of the Becton Finance note completed, to the paying agent at the address specified in the notice, or transfer their Becton Finance notes to the trustee by book-entry transfer pursuant to the applicable procedures of the paying agent, prior to the close of business on the third business day prior to the Change of Control Payment Date. The Change of Control Offer may be accepted for less than the entire principal amount of a particular Becton Finance note, but in that event the principal amount of such Becton Finance note remaining outstanding after repurchase must be equal to &#8364;100,000 or an integral multiple of &#8364;1,000 in excess thereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are not required to make a Change of Control Offer with respect to a series of Becton Finance notes if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made by us and that third party purchases all Becton Finance notes of the applicable series properly tendered and not withdrawn under its offer. To the extent that the provisions of any securities laws or regulations conflict with the provisions herein, we are required to comply with the applicable securities laws and regulations and are not deemed to have breached our obligations under the provisions herein by virtue of such conflicts.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this section, the following terms have the meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any one of the following&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the assets of BD and its subsidiaries taken as a whole to any Person (including any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act)) other than to BD or one of its subsidiaries&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the consummation of any transaction (including without limitation, any merger or consolidation) the result of which is that any Person (including any &#8220;person&#8221;(as that term is used in Section 13(d)(3) of the Exchange Act)) becomes the &#8220;beneficial owner&#8221;(as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the outstanding Voting Stock of BD, measured by voting power rather than number of shares&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">BD consolidates with, or merges with or into, any Person, or any Person consolidates with, or merges with or into, BD, in any such event pursuant to a transaction in which any of the outstanding Voting Stock of BD or such other Person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Voting Stock of BD outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving Person immediately after giving effect to the transaction&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the adoption of a plan relating to the liquidation or dissolution of BD.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) BD becomes a direct or indirect wholly-owned subsidiary of a holding company and (b) (x) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of BD&#8217;s Voting Stock immediately prior to that transaction or (y) immediately following that transaction, no Person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Change of Control Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a series of Becton Finance notes are rated below Investment Grade by each of the Rating Agencies on any date during the period (the &#8220;Trigger Period&#8221;) commencing on the date of the first public announcement by BD of any Change of Control (or pending Change of Control) and ending 60 days following consummation of that Change of Control (which Trigger Period will be extended following consummation of a Change of Control for so long as any of the Rating Agencies has publicly announced that it is considering a possible ratings downgrade and the downgrade would result in a Change of Control Triggering Event). Unless at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">least two of the Rating Agencies are providing a rating for a series of Becton Finance notes at the commencement of any Trigger Period, the Becton Finance notes of such series will be deemed to be rated below Investment Grade by the Rating Agencies during that Trigger Period. Notwithstanding the foregoing, no Change of Control Triggering Event will be deemed to have occurred in connection with (i) any particular Change of Control unless and until such Change of Control has actually been consummated or (ii) any reduction in rating if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform us in writing at our request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, a Change of Control (whether or not the Change of Control has occurred at the time of the reduction in rating).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fitch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Fitch Ratings, Inc. and its successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Investment Grade</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating category of Moody&#8217;s)&#59; and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating category of S&#38;P)&#59; and a rating of BBB- or better by Fitch (or its equivalent under any successor rating category of Fitch) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by BD in accordance with the definition of &#8220;Rating Agency.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any individual, corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company or government or other entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rating Agency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means each of Fitch, Moody&#8217;s and S&#38;P&#59; provided, that if any of Fitch, Moody&#8217;s or S&#38;P ceases to provide rating services to issuers or investors or fails to make a rating of a series of Becton Finance notes publicly available for reasons outside of our or BD&#8217;s control, we may appoint a replacement for that Rating Agency.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means S&#38;P Global Ratings and its successors.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; of any specified Person as of any date means the capital stock of that Person that is at the time entitled to vote generally in the election of the board of directors of that Person.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment of Additional Amounts</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We or, in the case of the guarantee, BD, pay, subject to the exceptions and limitations set forth below, as additional interest on each series of Becton Finance notes such additional amounts as are necessary in order that the net payment by us or a paying agent of the principal of and interest on each of the Becton Finance notes to a holder, after withholding or deduction solely with respect to any present or future tax, assessment or other governmental charge imposed by Luxembourg, the United States or any other jurisdiction in which Becton Finance or BD or, in each case, any successor thereof (including a continuing Person formed by a consolidation with Becton Finance or BD, into which Becton Finance or BD is merged, or that acquires or leases all or substantially all of the property and assets of Becton Finance or BD) may be organized, as applicable, or any political subdivision thereof or therein having the power to tax (a &#8220;Taxing Jurisdiction&#8221;), is not less than the amount provided in the Becton Finance notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts does not apply&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such Becton Finance note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder, or a person holding a power over an estate or trust administered by a fiduciary holder, being treated as&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being or having been present in, or engaged in a trade or business in, the relevant Taxing Jurisdiction, or having or having had a permanent establishment in such Taxing Jurisdiction&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">having a current or former connection with the relevant Taxing Jurisdiction (other than a connection arising solely as a result of the ownership of such Becton Finance notes, the receipt of any payment in respect of such Becton Finance notes or the enforcement of any rights under the Becton Finance indenture), including being or having been a citizen of such Taxing Jurisdiction or treated as being or having been a resident thereof&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for United States federal income tax purposes, a foreign tax exempt organization, or a corporation that has accumulated earnings to avoid United States federal income tax&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being or having been a &#8220;10-percent shareholder&#8221;, as defined in section 871(h)(3) of the Code, or any successor provision, of us or BD&#59; or</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, within the meaning of section 881(c)(3) of the Code or any successor provision&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any holder that is not the sole beneficial owner of such Becton Finance notes, or a portion of such Becton Finance notes, or that is a fiduciary, partnership or limited liability company, but only to the extent that a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership or limited liability company would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the relevant Taxing Jurisdiction of the holder or beneficial owner of such Becton Finance notes, if compliance is required by statute, by regulation of the relevant Taxing Jurisdiction or any taxing authority therein or by an applicable income tax treaty to which the relevant Taxing Jurisdiction is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any estate, inheritance, gift, sales, excise, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax, assessment or other governmental charge that would not have been imposed but for the presentation by the holder of any Becton Finance note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to any tax assessment or other governmental charge required to be withheld or deducted that is imposed on a payment pursuant to sections 1471 through 1474 of the Code (or any amended or successor version of such sections that is substantively comparable and not materially more onerous to comply with), any Treasury Regulations promulgated thereunder, or any other official interpretations thereof (collectively, &#8220;FATCA&#8221;), any agreement (including any intergovernmental agreement) entered into in connection therewith, or any law, regulation or other official guidance enacted in any jurisdiction implementing FATCA or an intergovernmental agreement in respect of FATCA&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any tax assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any tax, assessment or other governmental charge that is imposed by reason of the failure of the beneficial owner to fulfill the statement requirements of section 871(h) or section 881(c) of the Code&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any tax imposed pursuant to section 871(h)(6) or section 881(c)(6) of the Code (or any amended or successor provisions)&#59; or</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in the case of any combination of the above bulleted items under this heading &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we or BD are not required to pay additional amounts in respect of any tax, assessment or other governmental charge.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, any state thereof, and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States for United States federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state thereof or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redemption for Tax Reasons</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If, as a result of a change in law, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described under the heading &#8220;&#8212;Payment of Additional Amounts&#8221; with respect to any series of Becton Finance notes, then we may at any time at our option redeem, in whole, but not in part, the Becton Finance notes of such series on not less than 30 nor more than 60 days&#8217; prior notice, at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest on the Becton Finance notes to be redeemed to, but excluding, the date fixed for redemption. For this purpose, &#8220;change in law&#8221; means any change in, or amendment to, the laws of a Taxing Jurisdiction, or an official interpretation thereof that is announced or becomes effective on or after (i) with respect to the United States and Luxembourg as the initial applicable Taxing Jurisdictions, the date of the initial issuance of the applicable series of Becton Finance notes or (ii) with respect to any other Taxing Jurisdiction, the date on which such jurisdiction becomes a Taxing Jurisdiction for Becton Finance or BD, as applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clearance Systems</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Becton Finance notes have the following codes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">0.632% 2023 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS2002532567</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 200253256</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 07589L AB3</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Financial Short Name&#58; BECTON DICKINSO&#47;.632EUR NT 20230604, or as updated on the website of the Association of National Numbering Agencies (ANNA) or alternatively sourced from the responsible National Numbering Agency that assigned the ISIN</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Classification of Financial Instruments Code&#58; DYFXXR, or as updated on the website of the Association of National Numbering Agencies (ANNA) or alternatively sourced from the responsible National Numbering Agency that assigned the ISIN</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.208% 2026 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS2002532724</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 200253272</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 07589L AC1</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Financial Short Name&#58; BECTON DICKINSO&#47;1.208EUR NT 2026060, or as updated on the website of the Association of National Numbering Agencies (ANNA) or alternatively sourced from the responsible National Numbering Agency that assigned the ISIN</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Classification of Financial Instruments Code&#58; DYFXXR, or as updated on the website of the Association of National Numbering Agencies (ANNA) or alternatively sourced from the responsible National Numbering Agency that assigned the ISIN</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">1.213% 2036 Notes&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ISIN&#58; XS2298459426</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Common Code&#58; 229845942</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">CUSIP Number&#58; 07589L AD9</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Financial Short Name&#58; BECTON DICKINSO&#47;ASST BKD 22001231</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Classification of Financial Instruments Code&#58; DAFNFR</font></div><div style="margin-top:0.1pt;padding-left:36pt;text-align:justify;text-indent:-0.18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.C
<SEQUENCE>3
<FILENAME>bdperformanceincentiveplan.htm
<DESCRIPTION>EX-10.C
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8d22bea02356444b92b4b859fe01f3df_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10(c)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BECTON, DICKINSON AND COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERFORMANCE INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AMENDED AND RESTATED EFFECTIVE AS OF AUGUST 30, 2022</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PURPOSE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The purpose of the Performance Incentive Plan (the &#8220;Plan&#8221;) is to provide annual incentive payments to associates for their contribution to the Company&#8217;s successful financial performance and the accomplishment of strategic objectives.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything in this plan to the contrary, the payment of annual incentives, if any, is solely within the discretion of the PIP Steering Committee and the Board of Directors, except that payment in excess of the plan guidelines will not be made. No employee has any vested right to any such payment. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PIP STEERING COMMITTEE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The PIP Steering Committee will be responsible for administering this Plan, except that the Compensation and Human Capital Committee of the Board of Directors (the &#34;Compensation Committee&#34;) will be responsible for administering this Plan with respect to the Chief Executive Officer of the Company and other members of the Executive Leadership Team (the &#34;ExLT&#34;) and for selection and approval of total Company metrics, targets, and payouts, as specified herein.  The PIP Steering Committee will consist of no less than three persons, including the Chief Executive Officer, Chief Financial Officer, and Chief People Officer and such other senior executives as are designated from time to time by the Chief Executive Officer. The Chief People Officer shall have authority to act on behalf of the PIP Steering Committee with respect to all matters under this Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ELIGIBILITY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Participation in any particular fiscal year is generally restricted to employees of the Company and its worldwide subsidiaries in Job Group 4 and above positions (other than those covered under other incentive plans or sales incentive plans) and other key positions as may be approved by the PIP Steering Committee.  Current employees promoted to, and persons newly hired to, eligible positions during a particular fiscal year may be considered for a pro-rata bonus&#59; provided that such employees are promoted to, or newly hired to, eligible positions on or before July 1 of the particular fiscal year.  Persons employed by companies acquired by the Company which have pre-existing incentive, profit sharing or similar programs will not participate in this Plan until and unless those plans are superseded by this Plan. For the avoidance of doubt, employees who transferred out of the Company due to a divestiture of a subsidiary or business unit during the fiscal year will not be eligible for an incentive payment under this Plan with respect to the fiscal year in which the spin-off occurs, except as otherwise determined by the Compensation Committee. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PARTICIPATION LEVELS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Plan targets for eligible employees are determined based upon the scope and responsibilities of the position. Plan targets for eligible employees who have received a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">promotion or other role change during the applicable year will be pro-rated based on the eligible employee&#8217;s time in each role.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DETERMINATION OF PERFORMANCE CRITERIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Prior to or shortly following the beginning of a fiscal year, the Compensation Committee shall establish financial and strategic criteria, targets and related formula(s) with respect to the total Company, which shall apply to the ExLT and other applicable associates, and the PIP Steering Committee shall establish financial and strategic criteria, targets and related formula(s) tied to results below total Company, including targets related to segment, business unit, region, and&#47;or country performance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INCENTIVE CALCULATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Incentive payments shall be made under the Plan based upon total Company, segment, business unit, region, and&#47;or country performance, as applicable, as measured against the financial and strategic criteria and targets established as set forth above. Subject to the terms of this Plan as set forth herein, Incentive Payments for individual participants shall generally be equal to the applicable final business modifier (i.e. the percentage of achievement of the financial and strategic criteria and targets upon application of the applicable pre-approved formula) multiplied by the participant's target and salary or earnings, as applicable. For participants approved for Exceptional Impact (discussed below), this calculation is also increased by a set Exceptional Impact Reward Percentage to determine each recipient&#8217;s Incentive Payment.  For participants who have been designated as needing performance remediation, this calculation will be reduced by a set percentage. For the ExLT, the Compensation Committee (and in the case of the Chief Executive Officer, the independent directors of the Board) shall approve the final incentive payment amount in its sole discretion after considering the formula noted above. For the avoidance of doubt, the final incentive payment for any ExLT member, as determined by the Compensation Committee or the Board, as applicable, may greater or less than the amount determined pursuant to the formula noted above. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DETERMINATION OF FUNDING LEVELS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Funding levels relating to ExLT incentive payments shall be determined by the Compensation Committee based on total Company performance as measured against the corporate financial and strategic performance targets in accordance with the formula established by the Compensation Committee. Funding levels tied to incentive payments below total Company shall be determined by the PIP Steering Committee based on the satisfaction of the performance targets in accordance with the formula established by the PIP Steering Committee at the beginning of the Fiscal Year. These funding levels are adjusted both upwards (for performance above target) and downwards (for performance below target).  With respect to total Company, the Compensation Committee has the discretion to make adjustments to the Company&#8217;s operating results for unbudgeted items that are not considered part of BD&#8217;s ordinary operations and other events that significantly impacted BD&#8217;s performance. Similarly, the PIP Steering Committee has this same discretion for results below total Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DETERMINATION OF INCENTIVE POOLS AND FINAL INCENTIVES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Theoretical Incentive and Exceptional Impact Pool</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Following the close of each fiscal year, a hypothetical incentive pool will be established assuming achievement at 100% of target for participants, and the PIP Steering Committee will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hold back an amount of the hypothetical incentive pool, in an amount determined by the PIP Steering Committee in its sole discretion, to be established as an Exceptional Impact Pool.  For purposes of determining the hypothetical incentive pool, the target for participants who have had a salary, individual target, or status change during the applicable fiscal year will be pro-rated based on the period during the year that the original salary, individual target, or status and the adjusted salary, individual target, or status was applicable.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Final Business Modifiers </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Following the close of each fiscal year, the Compensation Committee (with respect to incentives based on total Company performance) and the PIP Steering Committee (with respect to incentives based on segment, business unit, region and&#47;or country performance) will determine the final achievement level of the financial and strategic performance targets and will apply the formula established by the Compensation Committee or PIP Steering Committee, as applicable, to determine the final business modifiers for the applicable fiscal year.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;Communication</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The operating unit and performance results will be communicated throughout the organization to the extent that the Company deems appropriate and subject to any confidentiality concerns.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;Incentive Payment Recommendations</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The ExLT will review and approve the list of designated participants below the ExLT who have had exceptional impact during the fiscal year for an additional amount to be paid through the Exceptional Impact Pool. The Compensation Committee will review and approve any ExLT participants who are considered to have had exceptional impact during the fiscal year and who will be eligible for an additional amount to be paid through the Exceptional Impact Pool, and will determine, for such ExLT participants, the Exceptional Impact Reward Percentage that will apply to such ExLT participants. ExLT members who have been designated as needing performance remediation will receive a reduced incentive amount, as determined by the Compensation Committee in its sole discretion.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For all participants below the ExLT, the PIP Steering Committee determines the Exceptional Impact Percentange. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The PIP Steering Committee will apply the final business modifiers, and Exceptional Impact Reward Percentage to the individual incentive targets as applicable to determine the final incentive amounts for participants (other than the ExLT). Participants who have been designated as needing performance remediation will receive a reduced incentive amount.  The Compensation Committee will approve the final total Company business modifier and will determine the final incentive payments for the ExLT (inclusive of Exceptional Impact awards)  in its sole discretion. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participants who have been on an approved leave of absence during the fiscal year may have their incentive amounts pro-rated based on Company policy in the applicable region or country. No individual may receive an incentive payment in excess of 200% of the their target incentive. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FINAL REVIEW AND APPROVAL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;All incentive payments for the participants other than the ExLT will be reviewed and approved by the Chief Executive Officer, in the aggregate or on a case-by-case basis, as appropriate.  In the case of the ExLT, recommendations will be subject to final review and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">approval by the Compensation Committee(and in the case of the Chief Executive Officer, the independent directors of the Board). The Compensation Committee (and the Board, as applicable) has the discretion to reduce payouts based on any factors it deems appropriate, including whether an individual has taken unnecessary or excessive risk.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Payment</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Incentives will generally be paid by January of the calendar year following the year in which they are awarded (unless deferred by the participant). Except in cases of death, disability, retirement, or involuntary terminations due to the elimination of employees&#8217; position, no incentive payments will be made to individuals who are not active employees on the final day of the fiscal year.  Employees who are terminated for cause prior to the distribution date will forfeit their incentives.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;If an employee is terminated by reason of death, disability, or retirement, his or her incentive payment will paid in or around January of the calendar year following the year in which it was awarded and will be based on applicable business performance and pro-rated based on the number of days the employee was actively at work during the fiscal year in which the incentive payment was awarded.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Incentives awarded to any employee who dies prior to the distribution date may be made to the employee's estate or beneficiares at the discretion of management.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If a U.S.-based employee has experienced a Termination Due to Workforce Restructuring, as determined in accordance with the U.S. BD Severance Plan, or an employee who is not a U.S.-based employee is terminated by reason of an involuntary termination due to the elimination of the employee&#8217;s position, as determined in the sole discretion of the applicable Human Resources business partner, such employee may receive a pro-rated incentive payment at the target level of performance based on his or her individual incentive target and salary or earnings as applicable.   In the event that an employee shall receive a pro-rated incentive payment under this paragraph, the incentive payment will be pro-rated based on the number of days the employee was actively at work during the fiscal year in which the incentive payment was awarded and be paid in accordance with the following&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  if the employee is a U.S.-based employee, the pro-rated incentive payment shall be paid under, in accordance with, and subject to, the terms of the U.S. BD Severance Plan and subject to the Plan Administrator of the U.S. BD Severance Plan&#8217;s discretion to eliminate or modify such pro-rated incentive payment&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  if the employee is not a U.S.-based employee, the pro-rated incentive payment shall be paid under the Plan in accordance with applicable law, subject to local rules, practices, procedures, and limitations that would provide for a lesser benefit (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, probationary periods)&#59; provided that the lead Human Resources business partner and the Regional Total Rewards Director may, in their sole and absolute discretion, authorize a pro-rated incentive payment that is different from the amount otherwise set forth in this Plan or determine that an individual is not entitled to a pro-rated incentive payment&#59; and, provided further that the payment of any incentive under this subsection shall also be in satisfaction of any local severance plan, arrangement, or law that requires the payment of bonus (or any similar compensation) as part of severance or separation pay. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, participants in the ExLT, including the Chief Executive Officer, are eligible to receive a pro-rated bonus pursuant to this Plan unless they are a participant in or a party to a separate plan, agreement, or arrangement that was approved by the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Exceptions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Any recommendations for exceptions to the provisions of the Plan must be submitted to the PIP Steering Committee for review and are subject to final approval by the Chief Executive Officer.  Any exceptions applicable to the ExLT are further subject to approval by the Compensation Committee (and in the case of the Chief Executive Officer, the independent directors of the Board).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RECOVERY OF INCENTIVE PAYMENTS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any incentive payment approved under this Plan shall be subject to the terms of the Company&#8217;s Policy Regarding the Recovery of Compensation, , as the same may be subsequently amended (the &#8220;Policy&#8221;)&#59; provided, that no amendment to the Policy shall adversely affect the rights of an employee with respect to any incentive payment that is approved in accordance with this Plan prior to such amendment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.P
<SEQUENCE>4
<FILENAME>advisoryboardconsultingagr.htm
<DESCRIPTION>EX-10.P
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0ed0c35ad79846288f82a977344a3578_1"></div><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:right"><img alt="image_0.jpg" src="image_0.jpg" style="height:9px;margin-bottom:5pt;vertical-align:text-bottom;width:9px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10(p)</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ADVISORY BOARD CONSULTING AGREEMENT</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Advisory Board Consulting Agreement (&#8220;Agreement&#8221;) is made and entered into on October 31, 2022 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), by and between Becton, Dickinson and Company, a New Jersey corporation with an address at One Becton Drive, Franklin Lakes, NJ 07417 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">BD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and Claire M. Fraser, with an address of &#91;***&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (each of BD and Consultant being a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, BD has formed a Scientific Advisory Board </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;SAB&#8221;) to advise BD on matters relating to new and potentially disruptive technologies, trends and breakthrough innovation, guidance on changes in healthcare practice and delivery, identification and sourcing of new technologies that align with BD&#8217;s growth strategy, supporting BD&#8217;s culture of innovation and evaluating and advising on BD&#8217;s innovation portfolio and roadmap to drive innovation investment and revenue growth and related matters (collectively, the </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Field&#8221;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; and</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, BD wishes to have the benefit of the Consultant&#8217;s knowledge and experience by having Consultant serve, and Consultant wishes to serve, on the SAB </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in accordance with the terms and conditions set forth herein&#59; </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties agree as follows&#58;</font></div><div style="margin-bottom:11pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt">SERVICES TO BE PERFORMED</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">BD hereby agrees to retain the Consultant as a consultant, and the Consultant shall serve the Company as a consultant and a member of the SAB, upon the terms and conditions set forth herein.  As a member of the SAB, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consultant shall provide BD her advice and perspective relating to the Field and shall serve as co-chair of the SAB (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  It is understood that as a member of the SAB, members of the SAB, including the Consultant, have no decision-making or voting authority with respect to any matters considered by the SAB, and that any recommendations made by the SAB or the Consultant are subject to the review, consideration and final approval of BD management or the BD board of directors, as appropriate. </font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">It is expected that the SAB will meet on a quarterly basis and Consultant shall use her reasonable efforts to participate in each SAB meeting, either in person or by means of remote communication.  Consultant shall also make herself available to consult with BD outside of SAB meetings as reasonably requested by BD.  Consultant&#8217;s point of contact at BD shall be Elizabeth McCombs. </font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">Notwithstanding anything else in this Agreement to the contrary, the parties agree that the Consultant shall not be required to provide more than eight (8) hours of Services per week, or provide more than twenty-five (25) hours of Services per month.</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">Consultant represents and warrants that Consultant is under no obligation to any third party that would interfere with Consultant rendering to BD the Services as herein defined or which would be inconsistent with any of Consultant&#8217;s representations or obligations under this Agreement.</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">Consultant represents and warrants that Consultant has not been ineligible and is not currently excluded, debarred, or otherwise ineligible to participate or under investigation related to federal health care programs as defined in 42 U.S.C. &#167; 1320a-7b(f) (&#8220;Federal Health Care Programs&#8221;) or generally from federal procurement and non-procurement programs, and does not appear on any list of prohibited persons maintained by the United States or other applicable government or Government Authority (&#8220;Prohibited Lists&#8221;), including the list of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Specially Designated Nationals and Other Blocked Persons&#8221; maintained by the U.S. Department of Treasury, and the &#8220;Denied Persons List&#8221; maintained by the U.S. Bureau of Industry &#38; Security.  </font></div><div style="margin-bottom:11pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt">PAYMENT FOR SERVICES</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">In consideration for Consultant providing the Services described above in accordance with the terms of this Agreement, BD shall pay Consultant a fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Consulting Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) at a rate of nine thousand five hundred dollars ($9,500) per year, payable in quarterly installments, with the first installment being paid on or about October 31, 2022. </font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">BD shall reimburse Consultant for Consultant&#8217;s reasonable travel, lodging, meal and other out-of-pocket expenses incurred in connection with her performance of the Services.  Consultant shall provide BD with appropriate invoices or other evidence of such expenses.</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.65pt">Consultant acknowledges and agrees that the compensation payable hereunder represents BD&#8217;s full and complete obligation for any and all Services to be rendered by Consultant under this Agreement.&#160; </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3,&#160;&#160;&#160;&#160;TERM</font></div><div style="margin-bottom:11pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the terms and conditions hereof, the term of the Consultant&#8217;s consulting arrangement and service on the SAB shall commence on the Effective Date and shall continue through September 30, 2023, subject to earlier termination as provided herein. This Agreement may be renewed by mutual consent of both parties. </font></div><div style="margin-bottom:11pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;Either party may terminate this Agreement with or without cause prior to its termination date upon notice to the other party.  In the event of an early termination of this Agreement, the Consultant shall be entitled to payment for services performed prior to the effective date of termination.  </font></div><div style="margin-bottom:11pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;Sections 4, 5, 6 and 7 of this Agreement shall survive any termination of this Agreement. </font></div><div style="margin-bottom:11pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.5pt">CONFIDENTIAL INFORMATION</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean and include, any confidential and proprietary information relating to BD, including without limitation, the business, technology, products, processes of BD or its vendors or customers.</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2&#160;&#160;&#160;&#160;Confidential Information may be written, documentary, recorded, or otherwise fixed in a tangible medium, electronically, orally or visually, and includes Confidential Information disclosed by BD to Consultant or acquired by Consultant directly or indirectly from BD.</font></div><div style="margin-bottom:11pt;padding-left:50.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3&#160;&#160;&#160;&#160;Consultant agrees to maintain the Confidential Information in strict secrecy and confidence, to not disclose Confidential Information to a third party other than other members of the SAB, and to use Confidential Information only for purpose of providing the Services.  </font></div><div style="margin-bottom:11pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,4&#160;&#160;&#160;&#160;The obligations of Consultant set forth in Section 3 shall not apply to any information that&#58;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;was known by Consultant at or prior to the Effective Date, except to the extent unlawfully appropriated by Consultant, such prior knowledge being evidenced by contemporaneous written evidence of same&#59; or</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;is or becomes generally known in the trade or business pertaining to such information or otherwise becomes publicly known at or after the time of disclosure by BD, through no wrongful act of Consultant&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;is received by Consultant from a third party, prior to the Effective Date and without restriction&#59; or</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;is developed by Consultant independent of any Confidential Information, as evidenced by contemporaneous written evidence of the same.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.5&#160;&#160;&#160;&#160;Confidential Information may be disclosed, without breaching this Agreement, to the extent such Confidential Information is required to be disclosed by a court or judicial or governmental authority of competent jurisdiction, or by any applicable law, rule or regulation, and in such event, only after Consultant provides prompt written notice to BD so as to enable BD to resist any such required disclosure and&#47;or to obtain suitable protection regarding such required disclosure.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.6&#160;&#160;&#160;&#160;All Confidential Information disclosed by BD shall be deemed and shall remain the sole and exclusive property of BD.  All tangible Confidential Information, including all copies and samples, shall promptly be destroyed or returned to BD upon written request from BD.  </font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7&#160;&#160;&#160;&#160;Other than information relating to the Services provided by Consultant to BD, which shall be deemed BD Confidential Information, BD personnel are not authorized to receive Consultant&#8217;s information in confidence.  All other communications from Consultant to BD, except for BD Confidential Information, are considered to be made on a non-confidential basis.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9&#160;&#160;&#160;&#160;Nothing contained herein shall be construed, either expressly or implicitly, to grant to Consultant any right or license under any patent, copyright, trademark, trade secret or other proprietary right now or hereinafter owned or controlled by BD.</font></div><div style="margin-bottom:11pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.&#160;&#160;&#160;&#160;DISCLOSURE AND ASSIGNMENT OF INTELLECTUAL PROPERTY</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1&#160;&#160;&#160;&#160;All patentable and unpatentable inventions, discoveries, improvements, design rights, works of authorship, copyrights, trade secrets, know-how and any equivalents thereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8220;Intellectual Property&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) conceived, made, or developed by Consultant during or in connection with activities under this Agreement, or which arise out of Confidential Information of BD provided to and&#47;or otherwise acquired by Consultant pursuant to this Agreement, shall be the sole and exclusive property of BD without further compensation to Consultant.  In addition, Consultant shall execute and deliver to BD all descriptions, applications, assignments and other documents and instruments necessary or proper to carry out the provisions of this Agreement, without further compensation, and Consultant shall cooperate with and assist BD or its nominees in all reasonable ways and at all reasonable times to aid BD in obtaining, maintaining, defending and enforcing all Intellectual Property in the United States and elsewhere.  Such Intellectual Property shall be deemed Confidential Information for purposes of this Agreement.  </font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2&#160;&#160;&#160;&#160;Consultant shall and does hereby irrevocably grant and assign to BD the entire assignable right, title and interest, without further compensation, in and to any and all of the Intellectual Property referred to in Section 5.1 above, together with&#58; (a) the right to apply for patents and&#47;or copyright registrations thereon in any and all countries of the world&#59; and (b) the entire right, title and interest in and to any and all applications for patents and copyright registrations which may be prepared or filed thereon at BD&#8217;s discretion and expense, and in and to any and all of the eventuating patents and copyright registrations.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3&#160;&#160;&#160;&#160;Nothing contained herein shall be construed to grant to Consultant any rights to BD technology or any license under any BD patent, copyright or trademark now or hereinafter in existence except for the limited purposes set forth herein.  BD shall be free to use all information that Consultant conveys or otherwise discloses to it without any further obligation to Consultant.</font></div><div style="margin-bottom:11pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDEMNIFICATION</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1&#160;&#160;&#160;&#160;BD agrees to indemnify, defend and hold harmless Consultant from any and all damages, liabilities or expenses (including without limitation, attorneys' fees and any expenses incurred in establishing a right to indemnification hereunder) that the Consultant may incur arising from any claim, action, suit or proceeding relating to the performance of the Services under this Agreement, except to the extent they result from the bad faith of the Consultant.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.&#160;&#160;&#160;&#160;RELATIONSHIP OF PARTIES</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1&#160;&#160;&#160;&#160;This Agreement does not create an employer-employee relationship between BD and Consultant.  Consultant shall not hold himself out as an agent or representative of BD.  Consultant agrees that all services herein shall be rendered as an independent contractor, and Consultant shall have no authority to negotiate or execute agreements on behalf of BD or otherwise bind or obligate BD in any manner.  In addition, Consultant shall not be eligible to participate in any employee benefit program of BD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Agreement is intended to create, or shall be construed as creating, any type of fiduciary relationship between Consultant and BD, except that Consultant shall be bound by the confidentiality obligations set forth herein.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.&#160;&#160;&#160;&#160;MISCELLANEOUS</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1&#160;&#160;&#160;&#160;All notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail to the address set forth above or sent by electronic mail to the address provided by the other party.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,2&#160;&#160;&#160;&#160;This Agreement may not be assigned by Consultant without the written consent of BD.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3&#160;&#160;&#160;&#160;Consultant agrees and understands that in order to comply with applicable law or BD policies and processes, BD may disclose the existence of this Agreement and any payments made hereunder.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4&#160;&#160;&#160;&#160;This Agreement shall be binding upon and inure to the benefit of the successors and assigns of BD and shall be binding upon and inure to the benefit of the successors and assigns of Consultant. </font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5&#160;&#160;&#160;&#160;The failure or delay of either party to enforce at any time any provision of this Agreement shall not constitute a waiver of such party's right thereafter to enforce each and every provision of this Agreement.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6&#160;&#160;&#160;&#160;This Agreement is to be governed by and construed in accordance with New Jersey law, without giving effect to the principles of conflict of laws.  </font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7&#160;&#160;&#160;&#160;Singular terms shall be construed as plural, and vice versa, where the context requires, and the headings or titles of the Sections or Subsections of this Agreement are for convenience only and shall not be used as an aid in construction of any provision hereof.  </font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8&#160;&#160;&#160;&#160;If any provision of this Agreement is declared void or unenforceable by a court of competent jurisdiction, such provision will be severed from this Agreement, and the balance of the Agreement will remain in full force and effect.</font></div><div style="margin-bottom:11pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.9&#160;&#160;&#160;&#160;This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font></div><div style="margin-bottom:11pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:11pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signatures on following page&#93;</font></div><div style="margin-bottom:11pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.</font></div><div><font><br></font></div><div style="margin-bottom:24pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:3.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONSULTANT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BECTON, DICKINSON AND COMPANY</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Claire M. Fraser                   </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Joseph M. Smith, MD, PhD    </font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">  Claire M. Fraser                   </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Joseph M. Smith, MD, PhD</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Scientific Officer</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>5
<FILENAME>a09-30x2022ex21.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i035b50b6350a45df826671c49e7ff3bd_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">US Subsidiaries of Becton, Dickinson and Company</font></td></tr><tr style="height:13pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Entity</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Jurisdiction</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Accuri Cytometers, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Adaptec Medical Devices LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Alverix, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Access Systems, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Acquisition Sub, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard ASDI, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Brachytherapy, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Devices, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Global Holdings I LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Global Holdings II LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Global Holdings III LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard IP Holdings Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard MRL Acquisition Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Peripheral Vascular, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Ventures LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BDX INO LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Biosciences, Systems and Reagents Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings I Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings II LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings IV LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings V LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings VI LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings VII LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Holdings VIII LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Infusion Therapy Systems Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Korea Holding, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Malaysia, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Oregon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Matrex Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Overseas Services Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Venture LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bridger Biomed, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Montana</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">C. R. Bard, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cardal II, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion 213, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion 2200, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion 2201, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion 302, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion 303, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Manufacturing, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Resources, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cell Analysis Systems, Inc</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Illinois</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cellular Research, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Chudy Group, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CRISI Medical Systems, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cytognos Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Davol Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">DVL Acquisition Sub, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dymax Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Echo Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Enturican, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Kansas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">FJ International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Oregon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">FlowCardia, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">FlowCardia, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">FlowJo LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Oregon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Franklin Lakes Enterprises, L.L.C.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Galatea Surgical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gesco International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gesco International, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">GSL Solutions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">GSL Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">HandyLab, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">IBD Holdings LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Iontophoretics Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">JoHome LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Oregon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Liberator Health and Education Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Liberator Health and Wellness, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Liberator Medical Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Liberator Medical Supply, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Loma Vista Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Loma Vista Medical, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Lutonix, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medafor, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Minnesota</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MedChem Products, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Massachusetts</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medegen, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Med-Design Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Med Design Investment Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medinservice.com, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medivance, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Med-Safe Systems, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">NAT Diagnostics Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Navarre Biomedical, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Minnesota</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Navarre Biomedical, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Minnesota</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Neomend, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">NOW Medical Distribution, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">NOW Medical Distribution, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Omega Biosystems Incorporated</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Parata Systems, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pembroke Blocker LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pembroke Foreign Blocker LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pembroke Parent LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PharMingen</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ProSeed, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PureWick Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Roberts Laboratories, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Rochester Medical Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Minnesota</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Safety Syringes Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Safety Syringes, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Scanwell Health Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SenoRx, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SenoRx, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Shield Healthcare Centers, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sirigen, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Specialized Cooperative Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Specialized Health Products International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Specialized Health Products International, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Specialized Health Products, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Surgical Site Solutions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Wisconsin</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Synergy Medical USA Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Targa Buyer, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Targa International Holdco, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Targa Parent Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tepha, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tri-County Medical &#38; Ostomy Supplies, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">TriPath Imaging, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">TVA Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Vascular Pathways, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Velano Vascular, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Venclose, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Venetec International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Venetec International, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Y-Med, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Y-Med, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Non-US Subsidiaries of Becton, Dickinson and Company</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Entity</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Jurisdiction</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard (Thailand) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Australia Pty. Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia, New South Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bard Brasil Ind&#250;stria e Com&#233;rcio de Produtos Para a Sa&#250;de Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil, Sao Paolo</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Canada Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada, Ontario</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Dublin ITC Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Finance B.V. &#38; Co. KG.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Healthcare R&#38;D Corp Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China, Shanghai</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Hellas S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Greece</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Holdings Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Hong Kong Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard India Healthcare Pvt. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">India, Maharashtra</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard International Holdings, B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Malaysia Healthcare Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Medical Devices (Beijing) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Medical R&#38;D (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China, Shanghai</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Medical SA (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa, Johannesburg, Gauteng</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Mexico Realty, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Chihuahua</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Pacific Health Care Company Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Taiwan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Produtos Plasticos e Medicos Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Reynosa, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Tamaulipas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Shannon Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bard Sourcing Office Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Holding S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Infection Prevention BV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Hermosillo S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Hermosillo, Sonora</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Kiestra BV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Rapid Diagnostic (Suzhou) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD San Luis Potosi, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, San Luis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD Switzerland Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BD West Africa Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ghana</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson A.G.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson A&#47;S</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Denmark</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton, Dickinson and Company, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Argentina S.R.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Argentina</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Asia Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Asia Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Austria GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Austria Holdings GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Benelux N.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton, Dickinson B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson B.V. Saudi Limited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Canada Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Caribe Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Croatia d.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Croatia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Czechia s.r.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson de Colombia Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Colombia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson de Mexico, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson del Uruguay S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Uruguay</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing Belgium BVBA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing Denmark A&#47;S</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Denmark</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing Norway</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing Spain S.L.U.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Dispensing UK Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Distribution Center N.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson East Africa Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Kenya</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Euro Finance Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Europe Holdings S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Foreign Sales Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Barbados</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson France S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson (Gibraltar) Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson (Gibraltar) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson (Gibraltar) Management Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson GSA Beteilgungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Guatemala S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Guatemala</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Holdings Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Holdings Pte Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Hungary Kft.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">India, Maharashtra</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton, Dickinson Industrias Cirurgicas, Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Infusion Therapy AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Infusion Therapy Holdings UK Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Becton Dickinson Infusion Therapy Systems Inc., S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Sonora</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Infusion Therapy UK</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Insulin Syringe, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson International Holdings Pte Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson International Holdings II Pte Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson International Holdings III Pte Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Israel Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Italia S.p.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Ithalat Ihracat Limited Sirketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Global Services Centre Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Korea Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Luxembourg Finance S.a.r.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Luxembourg Global Holdings Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Luxembourg Holdings II S.a.r.L</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Luxembourg Holdings III S.a.r.L</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Luxembourg Holdings V S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Management GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson (Mauritius) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mauritius</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Medical (S) Pte Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Medical Devices (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Medical Devices (Suzhou) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Medical Products Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Medical Technology (Jiangsu) Co. Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Netherlands Global Holdings II C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Netherlands Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Netherlands Holdings II B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Norway AS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson O.Y.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Finland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Pakistan (Pvt) Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pakistan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Philippines, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Philippines</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Polska Sp.z.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Portugal, Unipessoal, Lda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson (Pty) Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Research Centre Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Rowa Germany GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Rowa Italy Srl</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Sample Collection GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Scot Financing LP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Scotland</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Scot Financing LLP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Scotland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Slovakia s.r.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Sweden AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Sweden Holdings AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Switzerland Global Holdings SarL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Technology Campus India</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson (Thailand) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson UK Financing I Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson UK Financing II Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson U.K. Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Venezuela, C.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Venezuela</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Vostok LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Worldwide Investments Sa.r.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Becton Dickinson Zambia Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Zambia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Benex Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">C. R. Bard Do Brasil Produtos Medicos Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Asia (HK) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion (Barbados) SrL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Barbados</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion BH 335 d.o.o. Cazin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bosnia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Care Fusion Development Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion D.R. 203 Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">CareFusion (Shanghai) Commercial and Trading Co. Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion France 309 S.A.S.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Israel 330 Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Italy 312 S.p.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Mexico 215 SA de CV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Netherlands 328 B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Netherlands 503 B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Netherlands 504 B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion Netherlands Financing 283 C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion U.K. 305 Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CareFusion U.K. 306 Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Carmel Pharma AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Clearstream Technologies Group Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Clearstream Technologies Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CME Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CME Medical (UK) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">CME UK (Holdings) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Corporativo BD de Mexico, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cytognos Spain S.L.U.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cytognos UK Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">DLD (Bermuda) Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Davol International Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Davol Surgical Innovations, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Chihuahua</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Distribuidora BD Mexico, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dutch American Manufacturers (D.A.M.) B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Echo Healthcare Canada ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Embo Medical Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Enturia de M&#233;xico S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gamer Lasertechnik GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">GenCell Biosystems Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">GeneOhm Sciences Canada ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Kabushiki Kaisha Medicon (Medicon, Inc.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Limited Liability Company Bard Rus</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Russian Federation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Nippon Becton Dickinson Company, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PreAnalytiX GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pristine Access Technologies, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">P.R.C.(Isialys) Societe a responsabilitie limitee (Societe a associe unique)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Procesos para Esterilizacion, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Productos Bard de Mexico, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Mexico City</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Productos Para el Cuidado de la Salud, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Sonora</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PT Becton Dickinson Indonesia</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Indonesia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sendal, S.L.U.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sirigen II Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sistemas M&#233;dicos ALARIS, S.A. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico, Baja</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Straub Medical AG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Synergy Medical BRG Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Synergy Medical Europe Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tissuemed Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">TVA Medical GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Vas-Cath Incorporated</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada, Ontario</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>6
<FILENAME>a09-30x2022ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic7fd02e0f5a74259a29a19be0e5caed9_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 22</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Subsidiary Issuer of Guaranteed Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">As of September 30, 2022, Becton, Dickinson and Company (&#8220;BD&#8221;) is the guarantor of the senior unsecured registered notes listed below issued by Becton Dickinson Euro Finance S.&#224; r.l. (&#8220;BD Finance&#8221;). BD owns, directly or indirectly, 100% of BD Finance.</font></div><div><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Becton Dickinson Euro Finance S.&#224; r.l. </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">0.334% Notes due August 13, 2028</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.336% Notes due August 13, 2041</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.213% Notes due February 12, 2036</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.208% Notes due June 4, 2026</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">0.632% Notes due June 4, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>7
<FILENAME>a09-30x2022ex23.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0ae5f6951e154ea793160fd8657b754a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58; </font></div><div style="margin-top:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Registration Statements on Form S-8 Nos. 33-23055, 33-33791, 33-64115, 333-11885, 333-16091, 333-118235, 333-147594, 333-161129, 333-161215, 333-170821, 333-199830, 333-214780, 333-218179, 333-229619, 333-250960 and 333-250961 of Becton, Dickinson and Company&#59; and</font></div><div style="margin-top:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Registration Statement on Form S-3 No. 333-255829 of Becton, Dickinson and Company and Becton Dickinson Euro Finance S.&#224; r.l.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated November 22, 2022, with respect to the consolidated financial statements of Becton, Dickinson and Company and the effectiveness of internal control over financial reporting of Becton, Dickinson and Company included in this Annual Report (Form&#160;10-K) of Becton, Dickinson and Company for the year ended September 30, 2022.&#160;&#160;&#160;&#160;</font></div><div style="margin-top:5pt"><font><br></font></div><div style="margin-top:14pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; ERNST &#38; YOUNG LLP</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, New York</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 22, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>8
<FILENAME>a09-30x2022ex31.htm
<DESCRIPTION>EX-31
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i84db6a0c6c614464bc09fe8ba3717126_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas E. Polen, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of Becton, Dickinson and Company&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting, and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;22, 2022</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and President</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher J. DelOrefice, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of Becton, Dickinson and Company&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;22, 2022</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer </font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>9
<FILENAME>a09-30x2022ex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i52a09d56b47f4350b68b025d0bf4ed0d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Annual Report on Form 10-K of Becton, Dickinson and Company for the fiscal year ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas E. Polen, the Chief Executive Officer of Becton, Dickinson and Company, certify that&#58;</font></div><div style="margin-top:5pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. such Report fully complies with the requirements of Section&#160;13(a) of the Exchange Act&#59; and</font></div><div style="margin-top:5pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.684%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;22, 2022</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas E. Polen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Polen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Annual Report on Form 10-K of Becton, Dickinson and Company for the fiscal year ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section&#160;1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher J. DelOrefice, the Chief Financial Officer of Becton, Dickinson and Company, certify that&#58;</font></div><div style="margin-top:5pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. such Report fully complies with the requirements of Section&#160;13(a) of the Exchange Act&#59; and</font></div><div style="margin-top:5pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;22, 2022</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>bdx-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:92e3b16d-7e78-4ff6-96a7-c06fc2ba1c8c,g:ca0678f9-8390-47c3-8185-7628d34a94cf-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bdx="http://www.bd.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bd.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bd.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.bd.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.bd.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000003 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.bd.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.bd.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorp" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorp">
        <link:definition>0000009 - Disclosure - Spin-Off of Embecta Corp.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingChanges" roleURI="http://www.bd.com/role/AccountingChanges">
        <link:definition>0000010 - Disclosure - Accounting Changes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.bd.com/role/ShareholdersEquity">
        <link:definition>0000011 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShare" roleURI="http://www.bd.com/role/EarningsperShare">
        <link:definition>0000012 - Disclosure - Earnings per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bd.com/role/CommitmentsandContingencies">
        <link:definition>0000013 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.bd.com/role/Revenues">
        <link:definition>0000014 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentData" roleURI="http://www.bd.com/role/SegmentData">
        <link:definition>0000015 - Disclosure - Segment Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.bd.com/role/ShareBasedCompensation">
        <link:definition>0000016 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.bd.com/role/BenefitPlans">
        <link:definition>0000017 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.bd.com/role/Acquisitions">
        <link:definition>0000018 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringCharges" roleURI="http://www.bd.com/role/BusinessRestructuringCharges">
        <link:definition>0000019 - Disclosure - Business Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.bd.com/role/IntangibleAssets">
        <link:definition>0000020 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities">
        <link:definition>0000021 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurements" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements">
        <link:definition>0000022 - Disclosure - Financial Instruments and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.bd.com/role/Debt">
        <link:definition>0000023 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bd.com/role/IncomeTaxes">
        <link:definition>0000024 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.bd.com/role/Leases">
        <link:definition>0000025 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformation" roleURI="http://www.bd.com/role/SupplementalFinancialInformation">
        <link:definition>0000026 - Disclosure - Supplemental Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpTables" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpTables">
        <link:definition>0000028 - Disclosure - Spin-Off of Embecta Corp. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.bd.com/role/ShareholdersEquityTables">
        <link:definition>0000029 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareTables" roleURI="http://www.bd.com/role/EarningsperShareTables">
        <link:definition>0000030 - Disclosure - Earnings per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataTables" roleURI="http://www.bd.com/role/SegmentDataTables">
        <link:definition>0000031 - Disclosure - Segment Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.bd.com/role/ShareBasedCompensationTables">
        <link:definition>0000032 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.bd.com/role/BenefitPlansTables">
        <link:definition>0000033 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringChargesTables" roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables">
        <link:definition>0000034 - Disclosure - Business Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.bd.com/role/IntangibleAssetsTables">
        <link:definition>0000035 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>0000036 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTables" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables">
        <link:definition>0000037 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.bd.com/role/DebtTables">
        <link:definition>0000038 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bd.com/role/IncomeTaxesTables">
        <link:definition>0000039 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.bd.com/role/LeasesTables">
        <link:definition>0000040 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.bd.com/role/SupplementalFinancialInformationTables">
        <link:definition>0000041 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>0000042 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpAdditionalInformationDetails" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails">
        <link:definition>0000043 - Disclosure - Spin-Off of Embecta Corp. - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpDetails" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpDetails">
        <link:definition>0000044 - Disclosure - Spin-Off of Embecta Corp. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails">
        <link:definition>0000045 - Disclosure - Spin-Off of Embecta Corp. - Assets and Liabilities of Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail" roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail">
        <link:definition>0000046 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII" roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII">
        <link:definition>0000047 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail II)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAdditionalInformationDetail" roleURI="http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail">
        <link:definition>0000048 - Disclosure - Shareholders' Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail" roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail">
        <link:definition>0000049 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail" roleURI="http://www.bd.com/role/ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail">
        <link:definition>0000050 - Disclosure - Shareholders' Equity - Other Comprehensive Income (Loss), Tax (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails" roleURI="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails">
        <link:definition>0000051 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails" roleURI="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails">
        <link:definition>0000052 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share Footnotes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>0000053 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails" roleURI="http://www.bd.com/role/RevenuesDetails">
        <link:definition>0000054 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails_1" roleURI="http://www.bd.com/role/RevenuesDetails_1">
        <link:definition>0000054 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataAdditionalInformationDetail" roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail">
        <link:definition>0000055 - Disclosure - Segment Data - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataSegmentDataRevenuesbyGeographicAreasDetails" roleURI="http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails">
        <link:definition>0000056 - Disclosure - Segment Data Segment Data - Revenues by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataFinancialInformationforCompanysSegmentsDetail" roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail">
        <link:definition>0000057 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail" roleURI="http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail">
        <link:definition>0000058 - Disclosure - Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail" roleURI="http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail">
        <link:definition>0000059 - Disclosure - Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalInformationDetail" roleURI="http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail">
        <link:definition>0000060 - Disclosure - Share-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail" roleURI="http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail">
        <link:definition>0000061 - Disclosure - Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofSARsOutstandingDetail" roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail">
        <link:definition>0000062 - Disclosure - Share-Based Compensation - Summary of SARs Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofSARsExercisedDetails" roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails">
        <link:definition>0000063 - Disclosure - Share-Based Compensation Summary of SARs Exercised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail" roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail">
        <link:definition>0000064 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails" roleURI="http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails">
        <link:definition>0000065 - Disclosure - Share-Based Compensation Weighted Average Grant Date Fair Value of Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationFairValueofStockUnitsVestedDetails" roleURI="http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails">
        <link:definition>0000066 - Disclosure - Share-Based Compensation Fair Value of Stock Units Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNetPensionandOtherPostretirementCostDetail" roleURI="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail">
        <link:definition>0000067 - Disclosure - Benefit Plans - Net Pension and Other Postretirement Cost (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" roleURI="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail">
        <link:definition>0000068 - Disclosure - Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAdditionalInformationDetail" roleURI="http://www.bd.com/role/BenefitPlansAdditionalInformationDetail">
        <link:definition>0000069 - Disclosure - Benefit Plans - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail" roleURI="http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail">
        <link:definition>0000070 - Disclosure - Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail" roleURI="http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail">
        <link:definition>0000071 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansExpectedBenefitPaymentsDetail" roleURI="http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail">
        <link:definition>0000072 - Disclosure - Benefit Plans - Expected Benefit Payments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansFairValueMeasurementsofPlanAssetsDetail" roleURI="http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail">
        <link:definition>0000073 - Disclosure - Benefit Plans - Fair Value Measurements of Plan Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDetail" roleURI="http://www.bd.com/role/AcquisitionsDetail">
        <link:definition>0000074 - Disclosure - Acquisitions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessRestructuringChargesChangesinRestructuringBalanceDetail" roleURI="http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail">
        <link:definition>0000075 - Disclosure - Business Restructuring Charges - Changes in Restructuring Balance (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsComponentsofIntangibleAssetsDetail" roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail">
        <link:definition>0000076 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAdditionalInformationDetail" roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail">
        <link:definition>0000077 - Disclosure - Intangible Assets - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
        <link:definition>0000078 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
        <link:definition>0000079 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
        <link:definition>0000080 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
        <link:definition>0000081 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails">
        <link:definition>0000082 - Disclosure - Financial Instruments and Fair Value Measurement - Cash and Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>0000083 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
        <link:definition>0000084 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails">
        <link:definition>0000085 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofShortTermDebtDetail" roleURI="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail">
        <link:definition>0000086 - Disclosure - Debt - Summary of Short-Term Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationDetail" roleURI="http://www.bd.com/role/DebtAdditionalInformationDetail">
        <link:definition>0000087 - Disclosure - Debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofLongTermDebtDetail" roleURI="http://www.bd.com/role/DebtSummaryofLongTermDebtDetail">
        <link:definition>0000088 - Disclosure - Debt - Summary of Long-Term Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtIssuancesDetails" roleURI="http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails">
        <link:definition>0000089 - Disclosure - Debt - Schedule of Debt Issuances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtExtinguishmentsofDebtDetails" roleURI="http://www.bd.com/role/DebtExtinguishmentsofDebtDetails">
        <link:definition>0000090 - Disclosure - Debt - Extinguishments of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofInterestCostsandPaymentsDetail" roleURI="http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail">
        <link:definition>0000091 - Disclosure - Debt - Summary of Interest Costs and Payments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail" roleURI="http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail">
        <link:definition>0000092 - Disclosure - Income Taxes - Provision for Income Taxes from Continuing Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail" roleURI="http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail">
        <link:definition>0000093 - Disclosure - Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>0000094 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail" roleURI="http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail">
        <link:definition>0000095 - Disclosure - Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredIncomeTaxesDetail" roleURI="http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail">
        <link:definition>0000096 - Disclosure - Income Taxes - Deferred Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail" roleURI="http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail">
        <link:definition>0000097 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofIncomeTaxHolidayDetails" roleURI="http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails">
        <link:definition>0000098 - Disclosure - Income Taxes - Summary of Income Tax Holiday (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.bd.com/role/LeasesDetails">
        <link:definition>0000099 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails" roleURI="http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails">
        <link:definition>0000100 - Disclosure - Leases - Supplemental Balance Sheet Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLesseeOperatingLeaseLiabilityMaturityDetails" roleURI="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails">
        <link:definition>0000101 - Disclosure - Leases - Lessee, Operating Lease, Liability, Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1" roleURI="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1">
        <link:definition>0000101 - Disclosure - Leases - Lessee, Operating Lease, Liability, Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationOtherIncomeExpenseNetDetail" roleURI="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail">
        <link:definition>0000102 - Disclosure - Supplemental Financial Information - Other Income (Expense), Net (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail" roleURI="http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail">
        <link:definition>0000103 - Disclosure - Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationInventoriesDetail" roleURI="http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail">
        <link:definition>0000104 - Disclosure - Supplemental Financial Information - Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail" roleURI="http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail">
        <link:definition>0000105 - Disclosure - Supplemental Financial Information - Property, Plant and Equipment, Net (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_StockIssuedUnderStockAppreciationRightsExercised" abstract="false" name="StockIssuedUnderStockAppreciationRightsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_LifeSciencesMember" abstract="true" name="LifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes3.300dueMarch12023Member" abstract="true" name="Notes3.300dueMarch12023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_OthersCountryMember" abstract="true" name="OthersCountryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_MedicationDeliverySolutionsMember" abstract="true" name="MedicationDeliverySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes0.632dueJune42023Member" abstract="true" name="Notes0.632dueJune42023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DeferredCompensationInvestmentIncomeExpense" abstract="false" name="DeferredCompensationInvestmentIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_DepositarysharesMember" abstract="true" name="DepositarysharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" abstract="false" name="DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_Notes3.020dueMay242025Member" abstract="true" name="Notes3.020dueMay242025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_PeripheralInterventionMember" abstract="true" name="PeripheralInterventionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_CoreAndDevelopedTechnologyNet" abstract="false" name="CoreAndDevelopedTechnologyNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_BiosciencesMember" abstract="true" name="BiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_LettersOfCreditIssuableUnderCreditFacility" abstract="false" name="LettersOfCreditIssuableUnderCreditFacility" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" abstract="true" name="InvestmentsMeasuredAtNetAssetValuePerShareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_ParataSystemsMember" abstract="true" name="ParataSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_GrossProceedsFromIssuanceOfEquity" abstract="false" name="GrossProceedsFromIssuanceOfEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_CommonStockHeldInTrustsNetShares" abstract="false" name="CommonStockHeldInTrustsNetShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_Notes1213DueFebruary122036Member" abstract="true" name="Notes1213DueFebruary122036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ProductRightsMember" abstract="true" name="ProductRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes6750DueFebruary152030Member" abstract="true" name="Notes6750DueFebruary152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_InterventionalMember" abstract="true" name="InterventionalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_OpenMarketRepurchasesMember" abstract="true" name="OpenMarketRepurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" abstract="false" name="PreferredStockDepositaryShareOwnershipInterestPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_CashTransferRelatedToSpinoffTransaction" abstract="false" name="CashTransferRelatedToSpinoffTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes2894DueJune62022Member" abstract="true" name="Notes2894DueJune62022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes1401DueMay232023Member" abstract="true" name="Notes1401DueMay232023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DeferredTaxLiabilitiesGross" abstract="false" name="DeferredTaxLiabilitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes1.401dueMay242023Member" abstract="true" name="Notes1.401dueMay242023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FairValueOfStockAppreciationRights" abstract="false" name="FairValueOfStockAppreciationRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_InterestCostsIncurredTableTableTextBlock" abstract="false" name="InterestCostsIncurredTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_CRBardIncMember" abstract="true" name="CRBardIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DebenturesDue2027Member" abstract="true" name="DebenturesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" abstract="true" name="AcquisitionRelatedCostsAndRestructuringChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_PensionSettlementExpense" abstract="false" name="PensionSettlementExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_GrossProceedsFromSaleLeasebackTransaction" abstract="false" name="GrossProceedsFromSaleLeasebackTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationDebt" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_PatentsAndTrademarksMember" abstract="true" name="PatentsAndTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FloatingRateNotesDueJune62022Member" abstract="true" name="FloatingRateNotesDueJune62022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes5000DueFebruary152030Member" abstract="true" name="Notes5000DueFebruary152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes2823DueMay202030Member" abstract="true" name="Notes2823DueMay202030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_AcquisitionRelatedCostsAndRestructuringCharges" abstract="false" name="AcquisitionRelatedCostsAndRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_UrologyandCriticalCareMember" abstract="true" name="UrologyandCriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_RestrictedStockUnitsPerformancePsuMember" abstract="true" name="RestrictedStockUnitsPerformancePsuMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes4.875dueMay152044Member" abstract="true" name="Notes4.875dueMay152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_PercentOfAssetsDomesticPlans" abstract="false" name="PercentOfAssetsDomesticPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_Notes1336DueAugust132041Member" abstract="true" name="Notes1336DueAugust132041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_AcceleratedShareRepurchaseProgramMember" abstract="true" name="AcceleratedShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes1.208dueJune42026Member" abstract="true" name="Notes1.208dueJune42026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DiversifiedMember" abstract="true" name="DiversifiedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_HerniaProductClaimsMember" abstract="true" name="HerniaProductClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_IndemnificationLiabilityNoncurrent" abstract="false" name="IndemnificationLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" abstract="false" name="NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_DepositaryShareLiquidation" abstract="false" name="DepositaryShareLiquidation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes3.875dueMay152024Member" abstract="true" name="Notes3.875dueMay152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NumberOfEtOSterilizationLawsuits" abstract="false" name="NumberOfEtOSterilizationLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_SharesIssuableUnderDeferredCompensationPlan" abstract="false" name="SharesIssuableUnderDeferredCompensationPlan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_IncomeTaxTable" abstract="true" name="IncomeTaxTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_ProductsandorServicesMember" abstract="true" name="ProductsandorServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_TransfersOfFinancialAssetsDuringThePeriod" abstract="false" name="TransfersOfFinancialAssetsDuringThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes0334DueAugust132028Member" abstract="true" name="Notes0334DueAugust132028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" abstract="false" name="ExpectedForfeitedPerformanceBasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" abstract="true" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" abstract="false" name="TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_Notes6.700dueDecember12026Member" abstract="true" name="Notes6.700dueDecember12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_ProceedsFromSpinoffTransaction" abstract="false" name="ProceedsFromSpinoffTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" abstract="false" name="PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_PercentOfPlanAssetsForeignPlans" abstract="false" name="PercentOfPlanAssetsForeignPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_Notes3.363DueJune62024Member" abstract="true" name="Notes3.363DueJune62024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_BdxGainlossfromreversetrasurylocks" abstract="false" name="BdxGainlossfromreversetrasurylocks" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_FixedToFloatingMember" abstract="true" name="FixedToFloatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes4.669DueJune62047Member" abstract="true" name="Notes4.669DueJune62047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_EmbectaServicesAgreementIncomeLossNet" abstract="false" name="EmbectaServicesAgreementIncomeLossNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_CommonStockSharesHeldInEmployeeTrust1" abstract="false" name="CommonStockSharesHeldInEmployeeTrust1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" abstract="false" name="StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" abstract="false" name="PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_OrganizationalUnitDomain" abstract="true" name="OrganizationalUnitDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_InsuranceContractInvestmentsMember" abstract="true" name="InsuranceContractInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_OrganizationalUnitAxis" abstract="true" name="OrganizationalUnitAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_Notes3125DueNovember82021Member" abstract="true" name="Notes3125DueNovember82021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" abstract="false" name="LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_TerminatedCurrencySwapMember" abstract="true" name="TerminatedCurrencySwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NumberOfTransactions" abstract="false" name="NumberOfTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_MedicationManagementSolutionsMember" abstract="true" name="MedicationManagementSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes3.734DueDecember152024Member" abstract="true" name="Notes3.734DueDecember152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" abstract="false" name="DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_Notes1.000dueDecember152022Member" abstract="true" name="Notes1.000dueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0034DueAugust132025Member" abstract="true" name="Notes0034DueAugust132025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" abstract="true" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_IncreaseDecreaseinPensionBenefitObligation" abstract="false" name="IncreaseDecreaseinPensionBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_CoreTechnologiesMember" abstract="true" name="CoreTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" abstract="false" name="EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_OtherFixedIncomeMember" abstract="true" name="OtherFixedIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes0.174dueJune42021Member" abstract="true" name="Notes0.174dueJune42021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_IncomeTaxLineItems" abstract="true" name="IncomeTaxLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes3.700dueJune62027Member" abstract="true" name="Notes3.700dueJune62027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_SaleLeasebackTransactionTermOfContractMember" abstract="true" name="SaleLeasebackTransactionTermOfContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_UnitsInExcessOfExpectedPerformancePayout" abstract="false" name="UnitsInExcessOfExpectedPerformancePayout" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" abstract="false" name="ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_IntegratedDiagnosticSolutionsMember" abstract="true" name="IntegratedDiagnosticSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ScheduleOfDebtIssuancesTableTextBlock" abstract="false" name="ScheduleOfDebtIssuancesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_Notes4298DueAugust222032Member" abstract="true" name="Notes4298DueAugust222032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" abstract="true" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_Notes1.900dueDecember152026Member" abstract="true" name="Notes1.900dueDecember152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_SwinglineLoansIssuableUnderCreditFacility" abstract="false" name="SwinglineLoansIssuableUnderCreditFacility" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ReserveforCashDiscountsMember" abstract="true" name="ReserveforCashDiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" abstract="false" name="SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_NotesDue2040Member" abstract="true" name="NotesDue2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" abstract="false" name="NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdx_MaturityPeriodOfShortTermInvestment" abstract="false" name="MaturityPeriodOfShortTermInvestment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" abstract="false" name="FairValueOfDebtClassifiedFromLongTermToShortTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_DebenturesDue2028Member" abstract="true" name="DebenturesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdx_PharmaceuticalSystemsMember" abstract="true" name="PharmaceuticalSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bdx_Notes1957DueFebruary112031Member" abstract="true" name="Notes1957DueFebruary112031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes4.685dueDecember152044Member" abstract="true" name="Notes4.685dueDecember152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" abstract="false" name="DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" abstract="false" name="DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_GwinnettCountyGeorgiaMember" abstract="true" name="GwinnettCountyGeorgiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" abstract="false" name="DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes0000DueAugust132023Member" abstract="true" name="Notes0000DueAugust132023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes3.02dueMay242025Member" abstract="true" name="Notes3.02dueMay242025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" abstract="false" name="ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdx_ContractWithCustomerRebateLiability" abstract="false" name="ContractWithCustomerRebateLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" abstract="true" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdx_SurgeryMember" abstract="true" name="SurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_FiniteLivedCustomerRelationshipsNet" abstract="false" name="FiniteLivedCustomerRelationshipsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdx_Notes3794DueMay202050Member" abstract="true" name="Notes3794DueMay202050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="bdx_OtherPensionPlanInvestmentsMember" abstract="true" name="OtherPensionPlanInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_NotesDue2039Member" abstract="true" name="NotesDue2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>bdx-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:92e3b16d-7e78-4ff6-96a7-c06fc2ba1c8c,g:ca0678f9-8390-47c3-8185-7628d34a94cf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_16336c66-1485-4df4-b6cb-22d791fd6120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82878208-3a8b-4a79-8a85-dd272c122d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_16336c66-1485-4df4-b6cb-22d791fd6120" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82878208-3a8b-4a79-8a85-dd272c122d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_209146ea-3727-42c2-8240-dd7fdfe18bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_16336c66-1485-4df4-b6cb-22d791fd6120" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_209146ea-3727-42c2-8240-dd7fdfe18bbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_59138a6a-fd1a-4833-8798-d98be7e13fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8e350e22-1f25-4c4a-8c97-b697e2970fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_59138a6a-fd1a-4833-8798-d98be7e13fa5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_8e350e22-1f25-4c4a-8c97-b697e2970fc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_96ced0c7-b917-4350-82a9-627d11c81517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_59138a6a-fd1a-4833-8798-d98be7e13fa5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_96ced0c7-b917-4350-82a9-627d11c81517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8ed658d9-1c5f-4350-b744-7aa271d17fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_aa108247-ea50-4b0a-8482-d6f9bfd8fe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_8ed658d9-1c5f-4350-b744-7aa271d17fb6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_aa108247-ea50-4b0a-8482-d6f9bfd8fe7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_dd3842dd-287a-41e0-a019-bb92f12b8f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_8ed658d9-1c5f-4350-b744-7aa271d17fb6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_dd3842dd-287a-41e0-a019-bb92f12b8f6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b5447b5e-2cfa-4df8-bae6-4f0b9ea3c22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_82c87ce2-f833-4f4f-9895-22922e78ba7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b5447b5e-2cfa-4df8-bae6-4f0b9ea3c22b" xlink:to="loc_us-gaap_Revenues_82c87ce2-f833-4f4f-9895-22922e78ba7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_4e189706-49c6-4ee8-9a90-2c80448c3f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b5447b5e-2cfa-4df8-bae6-4f0b9ea3c22b" xlink:to="loc_us-gaap_CostsAndExpenses_4e189706-49c6-4ee8-9a90-2c80448c3f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b9e08c3e-47aa-4582-830f-f5369b1221c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d30d2898-f65b-4b33-aab9-eb86d03628bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b9e08c3e-47aa-4582-830f-f5369b1221c8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d30d2898-f65b-4b33-aab9-eb86d03628bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd1a3900-8f2d-4dd4-8887-cf6dc5f23d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b9e08c3e-47aa-4582-830f-f5369b1221c8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd1a3900-8f2d-4dd4-8887-cf6dc5f23d18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_06123f7b-4ce6-4ec8-9f35-4dab95fddc01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b9e08c3e-47aa-4582-830f-f5369b1221c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_06123f7b-4ce6-4ec8-9f35-4dab95fddc01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_00b9b09e-8182-4904-a543-a97f0a4e4743" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b9e08c3e-47aa-4582-830f-f5369b1221c8" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_00b9b09e-8182-4904-a543-a97f0a4e4743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_748ca623-f200-463a-963e-5819f0aeb54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b9e08c3e-47aa-4582-830f-f5369b1221c8" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_748ca623-f200-463a-963e-5819f0aeb54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1699affb-b08a-4c50-8b4c-030cf782609b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a9ff1ee3-3fbf-4def-9a6b-18cdd2838a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_1699affb-b08a-4c50-8b4c-030cf782609b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a9ff1ee3-3fbf-4def-9a6b-18cdd2838a77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_36f810c2-3571-4402-9753-0b0027b0b132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_1699affb-b08a-4c50-8b4c-030cf782609b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_36f810c2-3571-4402-9753-0b0027b0b132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c6673fce-036d-4660-a0a0-707d56d6e0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3658bd82-4919-404f-8699-f66f5f419b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c6673fce-036d-4660-a0a0-707d56d6e0ff" xlink:to="loc_us-gaap_NetIncomeLoss_3658bd82-4919-404f-8699-f66f5f419b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_54351de8-71de-4080-9c15-556fd00b8124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c6673fce-036d-4660-a0a0-707d56d6e0ff" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_54351de8-71de-4080-9c15-556fd00b8124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a6ff243e-2b7c-4e1b-bca2-d28bf4e7d677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9397777a-898b-4911-93fd-dc35af34e4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a6ff243e-2b7c-4e1b-bca2-d28bf4e7d677" xlink:to="loc_us-gaap_OperatingIncomeLoss_9397777a-898b-4911-93fd-dc35af34e4e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1bec4313-ed9c-442c-90d5-1e1b54e23f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a6ff243e-2b7c-4e1b-bca2-d28bf4e7d677" xlink:to="loc_us-gaap_InterestExpense_1bec4313-ed9c-442c-90d5-1e1b54e23f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_ea02a32f-5f6f-431c-a167-84e767316df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a6ff243e-2b7c-4e1b-bca2-d28bf4e7d677" xlink:to="loc_us-gaap_InvestmentIncomeInterest_ea02a32f-5f6f-431c-a167-84e767316df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dc382a56-58fc-4084-8b97-932742dca85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a6ff243e-2b7c-4e1b-bca2-d28bf4e7d677" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dc382a56-58fc-4084-8b97-932742dca85f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_411221bc-4003-45b6-870e-478b0162ca84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_450f32a7-03b8-4884-bf32-abdefe2327ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_411221bc-4003-45b6-870e-478b0162ca84" xlink:to="loc_us-gaap_NetIncomeLoss_450f32a7-03b8-4884-bf32-abdefe2327ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a8c06929-a8b2-4a44-b81e-935645695338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_411221bc-4003-45b6-870e-478b0162ca84" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a8c06929-a8b2-4a44-b81e-935645695338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85fa1ec6-e928-4d68-b5c4-2d049b22cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e4928469-8644-402c-97dd-3e2a111edb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85fa1ec6-e928-4d68-b5c4-2d049b22cfec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e4928469-8644-402c-97dd-3e2a111edb82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6c783e05-d59c-4d2d-992e-9882f37e93f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85fa1ec6-e928-4d68-b5c4-2d049b22cfec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6c783e05-d59c-4d2d-992e-9882f37e93f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_de49ce85-fffd-4d51-8811-2e12d1303571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85fa1ec6-e928-4d68-b5c4-2d049b22cfec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_de49ce85-fffd-4d51-8811-2e12d1303571" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e1b3a449-5233-4feb-92fc-b08b13e4876e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_us-gaap_PreferredStockValue_e1b3a449-5233-4feb-92fc-b08b13e4876e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5b4c124d-842d-4eda-b16e-59ea7ccaa578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_us-gaap_CommonStockValue_5b4c124d-842d-4eda-b16e-59ea7ccaa578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ab15a5da-7b54-4f6f-a3ef-4130e73f547a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ab15a5da-7b54-4f6f-a3ef-4130e73f547a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a3619c80-9452-4512-beb1-821b1e7cc89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a3619c80-9452-4512-beb1-821b1e7cc89b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_d1736c0b-4662-436c-97bb-59a0223b84c5" xlink:href="bdx-20220930.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_d1736c0b-4662-436c-97bb-59a0223b84c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_aa335990-4e95-40e8-805e-db8b20d59ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_us-gaap_TreasuryStockValue_aa335990-4e95-40e8-805e-db8b20d59ad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f25756aa-5124-4c34-825f-8b164b826568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ff426242-9480-4e28-8955-8749152603c0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f25756aa-5124-4c34-825f-8b164b826568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_67fbe436-fe69-47aa-a36b-87b10a3f4f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:to="loc_us-gaap_AccountsPayableCurrent_67fbe436-fe69-47aa-a36b-87b10a3f4f63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6e421cd9-4664-42e6-b50a-a251e7e96365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6e421cd9-4664-42e6-b50a-a251e7e96365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3bbb1765-3a48-4e6c-972f-da75d431fc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3bbb1765-3a48-4e6c-972f-da75d431fc9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_8c4a39a1-adeb-4804-ae5d-f93822dfefb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:to="loc_us-gaap_DebtCurrent_8c4a39a1-adeb-4804-ae5d-f93822dfefb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_426385eb-faff-46bd-941c-19425aa2cbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_426385eb-faff-46bd-941c-19425aa2cbf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_15a1f524-2ff8-49c8-88f1-e4e94b70e558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_94f93246-0ac9-45e0-9f7e-50bc87e2e9f9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_15a1f524-2ff8-49c8-88f1-e4e94b70e558" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c298242a-295f-459c-acbf-f2de1b0a6d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c298242a-295f-459c-acbf-f2de1b0a6d25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_b02c304f-7828-4e1f-8ca8-18baead58760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_b02c304f-7828-4e1f-8ca8-18baead58760" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_f54f5436-8788-463b-83c3-c0a73021afd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_OtherShortTermInvestments_f54f5436-8788-463b-83c3-c0a73021afd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5147324f-0efb-4f44-a7e0-728664db104e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5147324f-0efb-4f44-a7e0-728664db104e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d797aa12-3225-47d5-84cd-cb44ba02b53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_InventoryNet_d797aa12-3225-47d5-84cd-cb44ba02b53a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1f63e69c-57a4-4b13-8110-2e5fcde58e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_OtherAssetsCurrent_1f63e69c-57a4-4b13-8110-2e5fcde58e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_71f5670e-a428-4baa-89cf-0e05c19f0549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c6892587-8dea-4182-9e98-0e4e9d3984a6" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_71f5670e-a428-4baa-89cf-0e05c19f0549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_030f5027-1afe-4889-81c0-84f62bbd4a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_030f5027-1afe-4889-81c0-84f62bbd4a33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9a095a25-f18f-4877-a27e-10b338899128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9a095a25-f18f-4877-a27e-10b338899128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e01b2a93-441a-4fcb-9056-5082b315df76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_us-gaap_Goodwill_e01b2a93-441a-4fcb-9056-5082b315df76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet_6bb6803c-fa09-4d72-91b6-7b8aa612931f" xlink:href="bdx-20220930.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_bdx_CoreAndDevelopedTechnologyNet_6bb6803c-fa09-4d72-91b6-7b8aa612931f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet_eb65576b-5b47-4925-9294-33085901b423" xlink:href="bdx-20220930.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_bdx_FiniteLivedCustomerRelationshipsNet_eb65576b-5b47-4925-9294-33085901b423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3f4efdc5-f8d8-4993-aae4-7f3be34a24ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_us-gaap_AssetsCurrent_3f4efdc5-f8d8-4993-aae4-7f3be34a24ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_a44fdb7f-d167-481c-8fe8-cd0291b342d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_a44fdb7f-d167-481c-8fe8-cd0291b342d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0ecfedf0-6535-46bb-a3a1-2275ba15cae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d08869fe-c76d-4540-8fdd-0b711c2f1a23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0ecfedf0-6535-46bb-a3a1-2275ba15cae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_05787641-a924-45ea-bfa7-12f1a2264798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_LiabilitiesCurrent_05787641-a924-45ea-bfa7-12f1a2264798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b27935d1-90f6-4ba1-be64-c7f2300386dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b27935d1-90f6-4ba1-be64-c7f2300386dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d3772237-15a4-472d-8ea6-c8303f78e8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_StockholdersEquity_d3772237-15a4-472d-8ea6-c8303f78e8b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fb20c008-2092-44e9-8bcd-5a006fe9a5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fb20c008-2092-44e9-8bcd-5a006fe9a5fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_10b96643-8fcb-4013-bfbb-dc040bbfea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_10b96643-8fcb-4013-bfbb-dc040bbfea4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_956d8031-9082-46d3-a57e-ab250ecfe775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_956d8031-9082-46d3-a57e-ab250ecfe775" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ccf6d4ed-0c8e-4e2e-8ba8-19e0ce61ccd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8d468d8c-b3ec-4a02-84ab-285898a2cc38" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ccf6d4ed-0c8e-4e2e-8ba8-19e0ce61ccd3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e934814b-225b-460f-bc91-39f71619d397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_ShareBasedCompensation_e934814b-225b-460f-bc91-39f71619d397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e58488b5-4ddc-4c50-a5cd-48428e548282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e58488b5-4ddc-4c50-a5cd-48428e548282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_378c4ac1-71f9-40ab-a103-7394bce5c7fd" xlink:href="bdx-20220930.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_378c4ac1-71f9-40ab-a103-7394bce5c7fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c95c692e-17c1-420b-a15b-a6ab473b40cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c95c692e-17c1-420b-a15b-a6ab473b40cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_cc4f009b-0cfe-41a8-9c4a-46bed53592c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_cc4f009b-0cfe-41a8-9c4a-46bed53592c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_3297e393-5a0f-4825-b5a0-145d0d5f403f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_3297e393-5a0f-4825-b5a0-145d0d5f403f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_96e06b29-3f5c-4803-acc5-9e0cb30ada51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_96e06b29-3f5c-4803-acc5-9e0cb30ada51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_e9e94b37-96f4-466f-89e0-64b314108000" xlink:href="bdx-20220930.xsd#bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_e9e94b37-96f4-466f-89e0-64b314108000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_83a69b3b-36c2-4498-aa0c-377647d5483f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_83a69b3b-36c2-4498-aa0c-377647d5483f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e11f8334-4938-46b6-8365-6b1f502f9653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e11f8334-4938-46b6-8365-6b1f502f9653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d5294fdf-359b-4893-b2de-b2a3983a5a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d5294fdf-359b-4893-b2de-b2a3983a5a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_7ecec218-dfe8-4689-9a13-46b9bd9f2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_5dda35d4-0e50-49f6-8b95-884a5fefc7f6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_7ecec218-dfe8-4689-9a13-46b9bd9f2b6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_53f3da31-3741-44c4-b826-79728839d199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d5bd76ff-2748-4478-9ff3-a718365af1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_53f3da31-3741-44c4-b826-79728839d199" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d5bd76ff-2748-4478-9ff3-a718365af1c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e70d7fb6-08c1-4ac3-b2db-85cb08c21c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_53f3da31-3741-44c4-b826-79728839d199" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e70d7fb6-08c1-4ac3-b2db-85cb08c21c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bfea8d6e-cbc9-4181-a4ce-77ca6a704fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_53f3da31-3741-44c4-b826-79728839d199" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bfea8d6e-cbc9-4181-a4ce-77ca6a704fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23503aae-4207-452d-b9d7-84e2c1da8962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_0e8aa374-68fe-47d9-b9fa-c64ee6c0564e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23503aae-4207-452d-b9d7-84e2c1da8962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_0e8aa374-68fe-47d9-b9fa-c64ee6c0564e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_ee629983-f03a-4649-a6f7-e0285866f705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23503aae-4207-452d-b9d7-84e2c1da8962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_ee629983-f03a-4649-a6f7-e0285866f705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_896193a9-2c6f-42d5-89ba-6a3fd0b346eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23503aae-4207-452d-b9d7-84e2c1da8962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_896193a9-2c6f-42d5-89ba-6a3fd0b346eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a50d5c8-4e07-4fad-940e-e9b7a7080cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23503aae-4207-452d-b9d7-84e2c1da8962" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a50d5c8-4e07-4fad-940e-e9b7a7080cf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_ea71e5ea-0d2a-4e21-94c4-6b961a50a1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23503aae-4207-452d-b9d7-84e2c1da8962" xlink:to="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_ea71e5ea-0d2a-4e21-94c4-6b961a50a1d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7945afff-1c6a-4deb-96e0-7d24b3e7c4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7945afff-1c6a-4deb-96e0-7d24b3e7c4f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5189a164-4e0a-481f-b675-482e23b9e8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5189a164-4e0a-481f-b675-482e23b9e8e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1474b7b2-0797-42a9-bafd-1c095b14aeae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1474b7b2-0797-42a9-bafd-1c095b14aeae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_538f2eb1-a1d2-4c66-b7d7-f5753bd1a8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_538f2eb1-a1d2-4c66-b7d7-f5753bd1a8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_5bfd531a-cd13-4ca9-8ffc-6bcf26235598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_5bfd531a-cd13-4ca9-8ffc-6bcf26235598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsFromSpinoffTransaction_90645192-f8da-4731-9624-fe2a87dce5a4" xlink:href="bdx-20220930.xsd#bdx_ProceedsFromSpinoffTransaction"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_bdx_ProceedsFromSpinoffTransaction_90645192-f8da-4731-9624-fe2a87dce5a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CashTransferRelatedToSpinoffTransaction_4a187eac-5620-40a7-be5f-9b775d9f3275" xlink:href="bdx-20220930.xsd#bdx_CashTransferRelatedToSpinoffTransaction"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_bdx_CashTransferRelatedToSpinoffTransaction_4a187eac-5620-40a7-be5f-9b775d9f3275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_48f726e8-5b34-43ba-a44a-514167dffff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_48f726e8-5b34-43ba-a44a-514167dffff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_052318c9-5925-4e42-bc05-0ac969fa8102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_052318c9-5925-4e42-bc05-0ac969fa8102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0ac86e0a-16b6-49e2-9df0-863b505120c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_a699b8f6-aff3-430f-bcc8-c38922553171" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0ac86e0a-16b6-49e2-9df0-863b505120c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_e0262c62-387b-4232-806f-174c9431612a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_8f92158c-7dcb-4e61-8ade-795e6c638f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_e0262c62-387b-4232-806f-174c9431612a" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_8f92158c-7dcb-4e61-8ade-795e6c638f4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_71a018ed-90d4-42c2-b841-6367bb9cd3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_e0262c62-387b-4232-806f-174c9431612a" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_71a018ed-90d4-42c2-b841-6367bb9cd3f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_8b1d8bc6-9a6a-47f8-95e6-a86c1af00d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_e0262c62-387b-4232-806f-174c9431612a" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_8b1d8bc6-9a6a-47f8-95e6-a86c1af00d24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_0dd94288-dde9-4803-8e7b-7f5948f4524d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_88b7c17d-b546-4cef-ba13-9d6e0ce76843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_0dd94288-dde9-4803-8e7b-7f5948f4524d" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_88b7c17d-b546-4cef-ba13-9d6e0ce76843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_afb12515-ce91-414b-b382-a902dde48dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_0dd94288-dde9-4803-8e7b-7f5948f4524d" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_afb12515-ce91-414b-b382-a902dde48dd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_41ce6bbb-fc34-4add-b1d9-a1f58bc63615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_b6ce219b-f410-4723-8608-2ec960419896" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_41ce6bbb-fc34-4add-b1d9-a1f58bc63615" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_b6ce219b-f410-4723-8608-2ec960419896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_d462799b-e644-453e-b2d4-e08ddafd6329" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_41ce6bbb-fc34-4add-b1d9-a1f58bc63615" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_d462799b-e644-453e-b2d4-e08ddafd6329" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_a4a29186-733f-44bf-accd-c1ef2b454650" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_41ce6bbb-fc34-4add-b1d9-a1f58bc63615" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_a4a29186-733f-44bf-accd-c1ef2b454650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_d6cb6c4c-a3df-41b9-8976-f7278e90aa8d" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_41ce6bbb-fc34-4add-b1d9-a1f58bc63615" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_d6cb6c4c-a3df-41b9-8976-f7278e90aa8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_0c9f8023-22f9-4778-a183-e402f5ffcab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_41ce6bbb-fc34-4add-b1d9-a1f58bc63615" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_0c9f8023-22f9-4778-a183-e402f5ffcab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8b264b9d-620b-48f5-941e-a6fe5adc5a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b2b740a0-f89a-4248-8c7f-18aa74b45250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8b264b9d-620b-48f5-941e-a6fe5adc5a31" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b2b740a0-f89a-4248-8c7f-18aa74b45250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_102f9afb-6db1-43be-a659-32304836b4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8b264b9d-620b-48f5-941e-a6fe5adc5a31" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_102f9afb-6db1-43be-a659-32304836b4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_6369f489-9b5e-41dd-b288-77b5f259fa2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_86b25f81-20fc-486f-a2d7-ead4ed799037" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_6369f489-9b5e-41dd-b288-77b5f259fa2d" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_86b25f81-20fc-486f-a2d7-ead4ed799037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_3760c8bd-1a7e-4402-9f3c-d11dcb931f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_6369f489-9b5e-41dd-b288-77b5f259fa2d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_3760c8bd-1a7e-4402-9f3c-d11dcb931f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_bd2a17e2-73c0-42f4-b646-949f2584b223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_6369f489-9b5e-41dd-b288-77b5f259fa2d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_bd2a17e2-73c0-42f4-b646-949f2584b223" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_58f36d23-ec9e-42f1-80d1-2c1d18783509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2b83124d-f767-4f17-b7dd-41c32bfdfae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_58f36d23-ec9e-42f1-80d1-2c1d18783509" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_2b83124d-f767-4f17-b7dd-41c32bfdfae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_a8081ad0-d6af-4bbf-a7a3-1424f33d8023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_f59bb240-fb89-4dd7-9795-85f309a4a97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_a8081ad0-d6af-4bbf-a7a3-1424f33d8023" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_f59bb240-fb89-4dd7-9795-85f309a4a97e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_25976de8-f972-4034-ad79-da78358cbbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_a8081ad0-d6af-4bbf-a7a3-1424f33d8023" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_25976de8-f972-4034-ad79-da78358cbbfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0223336e-305b-4cf5-b563-b93e62c1aba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_a8081ad0-d6af-4bbf-a7a3-1424f33d8023" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0223336e-305b-4cf5-b563-b93e62c1aba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_cc4df820-f159-4e1a-a404-614299c1192e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_afdc5d6c-2db8-482b-8282-cdc8ef6aae85" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_cc4df820-f159-4e1a-a404-614299c1192e" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_afdc5d6c-2db8-482b-8282-cdc8ef6aae85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_c9281a86-8e8c-47e3-9444-b282ce06e88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_cc4df820-f159-4e1a-a404-614299c1192e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_c9281a86-8e8c-47e3-9444-b282ce06e88d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_193d8b3d-220f-4659-82ba-c04d1408130e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_cc4df820-f159-4e1a-a404-614299c1192e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_193d8b3d-220f-4659-82ba-c04d1408130e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c4973ee7-bac7-4154-b3a5-86970c9f7bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6f70df5c-13ae-49e0-ae83-0573bbaea979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c4973ee7-bac7-4154-b3a5-86970c9f7bcf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6f70df5c-13ae-49e0-ae83-0573bbaea979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9786a11-aa8c-49c1-825e-80c8f408ec37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c4973ee7-bac7-4154-b3a5-86970c9f7bcf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9786a11-aa8c-49c1-825e-80c8f408ec37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_6f049dc1-19ad-4808-a6af-281f2e445d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c4973ee7-bac7-4154-b3a5-86970c9f7bcf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_6f049dc1-19ad-4808-a6af-281f2e445d88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_944385de-8356-4a3f-8dee-b50f858f59fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67f48330-2714-4eb4-91c1-66abe1c7b1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_944385de-8356-4a3f-8dee-b50f858f59fb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67f48330-2714-4eb4-91c1-66abe1c7b1c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3bbcfa66-37af-4da9-950d-903b009d3557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_944385de-8356-4a3f-8dee-b50f858f59fb" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3bbcfa66-37af-4da9-950d-903b009d3557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_310287b2-8903-4c62-b446-20a9020eb742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_944385de-8356-4a3f-8dee-b50f858f59fb" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_310287b2-8903-4c62-b446-20a9020eb742" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c56d1788-1a06-4b3f-b099-2baec3c150b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_3f63cdaf-df40-4627-968b-4576ca34373c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c56d1788-1a06-4b3f-b099-2baec3c150b1" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_3f63cdaf-df40-4627-968b-4576ca34373c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84c1bfc0-dec8-46ed-8db2-282d911d86d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c56d1788-1a06-4b3f-b099-2baec3c150b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84c1bfc0-dec8-46ed-8db2-282d911d86d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_251c0dfe-16f8-4ed6-af55-d88989e78614" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c56d1788-1a06-4b3f-b099-2baec3c150b1" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_251c0dfe-16f8-4ed6-af55-d88989e78614" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansNetPensionandOtherPostretirementCostDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6d5105d9-a733-4ed7-a702-dff94aec556d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6d5105d9-a733-4ed7-a702-dff94aec556d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_6a330151-02ff-4e1e-8128-2e1235fb2940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_6a330151-02ff-4e1e-8128-2e1235fb2940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8b13be7b-23bf-41b4-8a47-2838cdbf16e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8b13be7b-23bf-41b4-8a47-2838cdbf16e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_386adbfa-6e3f-45b9-bd98-e5c4fd92caf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_386adbfa-6e3f-45b9-bd98-e5c4fd92caf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_800fa534-c8b7-42da-964e-a5f5709cbd63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_800fa534-c8b7-42da-964e-a5f5709cbd63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_203a427a-c171-4ae5-a3fc-12cfa6fcc84e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_468444fc-bc48-4486-8138-259d014ddc7d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_203a427a-c171-4ae5-a3fc-12cfa6fcc84e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_9c3b8669-420a-4c14-8673-18bf99dc96b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4c056f7a-10fb-459d-8478-bf526df21837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_9c3b8669-420a-4c14-8673-18bf99dc96b8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4c056f7a-10fb-459d-8478-bf526df21837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_36ecefc2-c54c-4cc7-8907-59410ec5d78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_9c3b8669-420a-4c14-8673-18bf99dc96b8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_36ecefc2-c54c-4cc7-8907-59410ec5d78c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_fa2b5d70-675f-443d-ae0b-e66c3d309875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_9c3b8669-420a-4c14-8673-18bf99dc96b8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_fa2b5d70-675f-443d-ae0b-e66c3d309875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_98bf653b-8257-4d2c-bb91-63b53ffbb6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_8ef32b40-e261-4505-b5cf-839dd24a24e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_98bf653b-8257-4d2c-bb91-63b53ffbb6c5" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_8ef32b40-e261-4505-b5cf-839dd24a24e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_b5e30ed3-d2f9-4248-966f-d778dc07c11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_98bf653b-8257-4d2c-bb91-63b53ffbb6c5" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_b5e30ed3-d2f9-4248-966f-d778dc07c11b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e6c089d7-ad7c-4337-ab94-81673a632c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f116e337-a5a5-4be4-a85c-cf2d5e09df06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e6c089d7-ad7c-4337-ab94-81673a632c57" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f116e337-a5a5-4be4-a85c-cf2d5e09df06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5900fc77-f248-4bd5-809a-b4e5ebeac6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e6c089d7-ad7c-4337-ab94-81673a632c57" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5900fc77-f248-4bd5-809a-b4e5ebeac6c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d60fd1f5-cfec-4e70-9014-87f07ed50788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1cb47800-1447-4ce8-b79e-df242c1be597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d60fd1f5-cfec-4e70-9014-87f07ed50788" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1cb47800-1447-4ce8-b79e-df242c1be597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ca424328-57a5-4ee0-b4ca-6be894a87b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d60fd1f5-cfec-4e70-9014-87f07ed50788" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ca424328-57a5-4ee0-b4ca-6be894a87b52" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d02c4f9-762e-4294-b6e7-d9429f2f579b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_14e7e77e-d6f4-452f-874f-81467bdfa28b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d02c4f9-762e-4294-b6e7-d9429f2f579b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_14e7e77e-d6f4-452f-874f-81467bdfa28b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_c9359902-34dd-43a5-9304-875bf61396b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d02c4f9-762e-4294-b6e7-d9429f2f579b" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_c9359902-34dd-43a5-9304-875bf61396b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtSummaryofShortTermDebtDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3ca200b6-0805-4fed-9a2f-9abfcf5e784a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_35df76d5-b7cc-4a5d-9ea4-b2c54cacbbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_3ca200b6-0805-4fed-9a2f-9abfcf5e784a" xlink:to="loc_us-gaap_LongTermDebtCurrent_35df76d5-b7cc-4a5d-9ea4-b2c54cacbbd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6cf939bc-83a8-4ff6-b1d8-af42bd3127ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_3ca200b6-0805-4fed-9a2f-9abfcf5e784a" xlink:to="loc_us-gaap_ShortTermBorrowings_6cf939bc-83a8-4ff6-b1d8-af42bd3127ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c4485194-793c-465d-93f5-ab8a852e7e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3057ad86-b3d0-4001-820f-c4b514bdbe66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c4485194-793c-465d-93f5-ab8a852e7e66" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3057ad86-b3d0-4001-820f-c4b514bdbe66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e2f9f24c-f740-43ac-bf2e-69c50a42f8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c4485194-793c-465d-93f5-ab8a852e7e66" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e2f9f24c-f740-43ac-bf2e-69c50a42f8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_de0615c6-a706-45ed-a44f-b2efdcec7c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c4485194-793c-465d-93f5-ab8a852e7e66" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_de0615c6-a706-45ed-a44f-b2efdcec7c1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6358981-63a9-4546-89c3-44012df06250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ea23878a-6790-4014-8516-b3ce371b1f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c6358981-63a9-4546-89c3-44012df06250" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ea23878a-6790-4014-8516-b3ce371b1f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_449e345c-2051-48c3-ab29-beb8e0c77b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c6358981-63a9-4546-89c3-44012df06250" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_449e345c-2051-48c3-ab29-beb8e0c77b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8e022bdf-70d1-4089-87f3-dd04a52a0c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_bc0199af-5090-41dd-8443-ef1531f5b280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8e022bdf-70d1-4089-87f3-dd04a52a0c0d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_bc0199af-5090-41dd-8443-ef1531f5b280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9bfd114a-9d60-4efb-8915-2698d517af68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8e022bdf-70d1-4089-87f3-dd04a52a0c0d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9bfd114a-9d60-4efb-8915-2698d517af68" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d331cb8-3c59-47b0-8b3b-010ea1b00954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5b07986f-5b61-4ec7-bf1a-a05c91770b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d331cb8-3c59-47b0-8b3b-010ea1b00954" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5b07986f-5b61-4ec7-bf1a-a05c91770b19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_cf991803-2b80-4200-bd43-d399d46dd0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d331cb8-3c59-47b0-8b3b-010ea1b00954" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_cf991803-2b80-4200-bd43-d399d46dd0a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesDeferredIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredTaxLiabilitiesGross_4f4d9002-d1f0-4abc-a591-1ad12bede75d" xlink:href="bdx-20220930.xsd#bdx_DeferredTaxLiabilitiesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5b6c8c07-828c-458d-904a-c322dd1d2ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bdx_DeferredTaxLiabilitiesGross_4f4d9002-d1f0-4abc-a591-1ad12bede75d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5b6c8c07-828c-458d-904a-c322dd1d2ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_3c8623c2-8595-4704-8c79-5039e6b97dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bdx_DeferredTaxLiabilitiesGross_4f4d9002-d1f0-4abc-a591-1ad12bede75d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_3c8623c2-8595-4704-8c79-5039e6b97dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_1146bf70-4688-4db0-b250-5e12e7af2221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bdx_DeferredTaxLiabilitiesGross_4f4d9002-d1f0-4abc-a591-1ad12bede75d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_1146bf70-4688-4db0-b250-5e12e7af2221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_22bb788a-9ab4-424a-af99-7bcf8e5742e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3e57e9d6-f8da-4bec-8a4b-15aa79434dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_22bb788a-9ab4-424a-af99-7bcf8e5742e9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3e57e9d6-f8da-4bec-8a4b-15aa79434dda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_28653ad1-a7d5-4a31-b6cc-b81daa098903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_22bb788a-9ab4-424a-af99-7bcf8e5742e9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_28653ad1-a7d5-4a31-b6cc-b81daa098903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e56f2a38-123b-47fd-9c89-ea834702ed4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7f9a4c4e-65e4-4270-bded-3d440de97e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e56f2a38-123b-47fd-9c89-ea834702ed4a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7f9a4c4e-65e4-4270-bded-3d440de97e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_17c83b86-6b9e-47b0-b4d7-24ef63dd3e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e56f2a38-123b-47fd-9c89-ea834702ed4a" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_17c83b86-6b9e-47b0-b4d7-24ef63dd3e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_cae706d6-7f65-41ce-a827-28930e1404b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e56f2a38-123b-47fd-9c89-ea834702ed4a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_cae706d6-7f65-41ce-a827-28930e1404b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2fa7e7ec-e260-4ed3-9529-cae6f47d23b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e56f2a38-123b-47fd-9c89-ea834702ed4a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2fa7e7ec-e260-4ed3-9529-cae6f47d23b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b86eb06e-b19c-4c30-a890-4c2247c84b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredTaxLiabilitiesGross_ee3d5816-3acd-4698-abdd-c93edb9385e4" xlink:href="bdx-20220930.xsd#bdx_DeferredTaxLiabilitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b86eb06e-b19c-4c30-a890-4c2247c84b8e" xlink:to="loc_bdx_DeferredTaxLiabilitiesGross_ee3d5816-3acd-4698-abdd-c93edb9385e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_170660cb-2b8d-4e8e-866e-1ca418b45bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_170660cb-2b8d-4e8e-866e-1ca418b45bfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c821876a-abf7-4d01-8fea-e5812e7a81ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c821876a-abf7-4d01-8fea-e5812e7a81ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b4e142d2-0592-4753-aa55-0ab54ae4d2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b4e142d2-0592-4753-aa55-0ab54ae4d2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_6d0cea01-67fa-463c-ba01-f0df760840c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_6d0cea01-67fa-463c-ba01-f0df760840c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_8e8b90c8-a2b0-49de-a4bf-f2e0de868286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_8e8b90c8-a2b0-49de-a4bf-f2e0de868286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_5d542755-5566-4133-9158-af794d6e6b46" xlink:href="bdx-20220930.xsd#bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_5d542755-5566-4133-9158-af794d6e6b46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_73840c5c-50e9-4f6b-8388-638854a71fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_73840c5c-50e9-4f6b-8388-638854a71fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_53cfd0e9-81ce-40b4-b183-84cbd1ac96d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_53cfd0e9-81ce-40b4-b183-84cbd1ac96d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bd15d057-1384-4bb7-b754-80ba287553e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a746bba-536e-41d2-bc73-42fed60626dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bd15d057-1384-4bb7-b754-80ba287553e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesLesseeOperatingLeaseLiabilityMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_99df4b44-2790-4c79-b887-a426349d76a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_99df4b44-2790-4c79-b887-a426349d76a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b55a2773-9c3b-4561-b8b4-0f86365890b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b55a2773-9c3b-4561-b8b4-0f86365890b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c4ecb5ad-dd43-4d1f-ae51-d9d1a7b0c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c4ecb5ad-dd43-4d1f-ae51-d9d1a7b0c43b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9ef273ee-05dd-42a5-aad0-23e043f2d513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9ef273ee-05dd-42a5-aad0-23e043f2d513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_91bf872f-6f86-4a3d-bf51-030689a32247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_91bf872f-6f86-4a3d-bf51-030689a32247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fbcb921e-4f3d-46ac-a2a9-7c93f3bce67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a472c53d-1adc-4ff8-89d5-2ca2c57059d1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fbcb921e-4f3d-46ac-a2a9-7c93f3bce67f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_15f7b286-ec31-4a64-975f-56104306dc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3a82fa7d-c7d5-452d-acd9-1556f0d07eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_15f7b286-ec31-4a64-975f-56104306dc95" xlink:to="loc_us-gaap_OperatingLeaseLiability_3a82fa7d-c7d5-452d-acd9-1556f0d07eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_abe8e105-4436-4df2-be64-58921f09cedb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_15f7b286-ec31-4a64-975f-56104306dc95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_abe8e105-4436-4df2-be64-58921f09cedb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationOtherIncomeExpenseNetDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_2251b54d-5798-4a9f-ae70-4ea8fb634ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_2251b54d-5798-4a9f-ae70-4ea8fb634ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_43386d82-5769-48ac-81d4-77cf072933ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_us-gaap_OtherNonoperatingExpense_43386d82-5769-48ac-81d4-77cf072933ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9aaf687e-3137-4d36-81c2-c499cda0378a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9aaf687e-3137-4d36-81c2-c499cda0378a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_1923bd2f-107e-4570-bd3e-31224cc1cd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_1923bd2f-107e-4570-bd3e-31224cc1cd7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_da485a20-9b80-4b07-b0a2-8db50757801c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_da485a20-9b80-4b07-b0a2-8db50757801c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredCompensationInvestmentIncomeExpense_4fc9a74f-be9f-4a34-9847-e523790a3587" xlink:href="bdx-20220930.xsd#bdx_DeferredCompensationInvestmentIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_bdx_DeferredCompensationInvestmentIncomeExpense_4fc9a74f-be9f-4a34-9847-e523790a3587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EmbectaServicesAgreementIncomeLossNet_8606d6b7-0a08-4167-825c-e61c0b43089e" xlink:href="bdx-20220930.xsd#bdx_EmbectaServicesAgreementIncomeLossNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_a0c87e96-5098-4fae-ade8-aaf1aae83e21" xlink:to="loc_bdx_EmbectaServicesAgreementIncomeLossNet_8606d6b7-0a08-4167-825c-e61c0b43089e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_da9f50a0-9af1-476e-898d-61a8e9f80001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_560c191b-5662-4559-b0db-3e70efb59823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_da9f50a0-9af1-476e-898d-61a8e9f80001" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_560c191b-5662-4559-b0db-3e70efb59823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_08ce9b47-5147-4f7e-b0af-b04fdeafd5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_da9f50a0-9af1-476e-898d-61a8e9f80001" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_08ce9b47-5147-4f7e-b0af-b04fdeafd5fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1ffaf6de-5498-4a19-89bd-b94e2d81255a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_da9f50a0-9af1-476e-898d-61a8e9f80001" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1ffaf6de-5498-4a19-89bd-b94e2d81255a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"/>
  <link:calculationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1a0c7f4-23ea-45cb-b8fc-3836caf1baed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_12bbe4b7-316f-47cc-90f5-f44d64c045b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a1a0c7f4-23ea-45cb-b8fc-3836caf1baed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_12bbe4b7-316f-47cc-90f5-f44d64c045b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_13990f50-3ca8-4f9d-9129-3ed3c075eaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a1a0c7f4-23ea-45cb-b8fc-3836caf1baed" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_13990f50-3ca8-4f9d-9129-3ed3c075eaeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fd480ee8-4077-46b3-9073-a717ecc21b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e79307ad-181b-4569-99a5-5972e32cf21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fd480ee8-4077-46b3-9073-a717ecc21b9f" xlink:to="loc_us-gaap_Land_e79307ad-181b-4569-99a5-5972e32cf21a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_a8dca808-b732-4e87-8d99-9e0bab2c29be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fd480ee8-4077-46b3-9073-a717ecc21b9f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_a8dca808-b732-4e87-8d99-9e0bab2c29be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_f5582603-1c38-41cb-b1a0-65e52f4853b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fd480ee8-4077-46b3-9073-a717ecc21b9f" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_f5582603-1c38-41cb-b1a0-65e52f4853b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_dad04019-50b8-4add-b868-391e6829a3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fd480ee8-4077-46b3-9073-a717ecc21b9f" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_dad04019-50b8-4add-b868-391e6829a3e9" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>bdx-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:92e3b16d-7e78-4ff6-96a7-c06fc2ba1c8c,g:ca0678f9-8390-47c3-8185-7628d34a94cf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20220930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended" id="i0dbb9bca4f9b4c12a39ebc30d138cf59_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3ccb7cd7-39c1-445a-b222-0911cbbf541d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentType_3ccb7cd7-39c1-445a-b222-0911cbbf541d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_ec28e457-834f-4a66-9682-3519ed400c19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentAnnualReport_ec28e457-834f-4a66-9682-3519ed400c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_183d941c-a96f-4712-9126-506615457ef6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentPeriodEndDate_183d941c-a96f-4712-9126-506615457ef6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9bb50404-079e-4798-9d2c-e4c3c6ad5d75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_CurrentFiscalYearEndDate_9bb50404-079e-4798-9d2c-e4c3c6ad5d75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a8906d50-29f7-4fcc-a0fb-ed286b589cf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentTransitionReport_a8906d50-29f7-4fcc-a0fb-ed286b589cf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c365f2c3-3507-401b-9479-365c9befe51a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityFileNumber_c365f2c3-3507-401b-9479-365c9befe51a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5e77f3ab-67a9-4859-aba6-d1f7be13d4f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityRegistrantName_5e77f3ab-67a9-4859-aba6-d1f7be13d4f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ea6a12b4-1ec9-4d6a-80cb-1cb6b1f38664" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityCentralIndexKey_ea6a12b4-1ec9-4d6a-80cb-1cb6b1f38664" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9bbd945f-78e3-4012-a2d2-562121e68708" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentFiscalYearFocus_9bbd945f-78e3-4012-a2d2-562121e68708" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_79bc0e1d-445b-4fa7-baa2-83d121de0aec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_79bc0e1d-445b-4fa7-baa2-83d121de0aec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a78cf400-4f25-4b8b-9d29-3fca3695ab36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_AmendmentFlag_a78cf400-4f25-4b8b-9d29-3fca3695ab36" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3802f78c-d35f-43ce-b544-be661646eb62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3802f78c-d35f-43ce-b544-be661646eb62" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_87b9b251-4b55-42a6-b75e-4721d9d0b2a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityTaxIdentificationNumber_87b9b251-4b55-42a6-b75e-4721d9d0b2a7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fbf244bc-c088-4005-92e0-82ffdda8ff38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressAddressLine1_fbf244bc-c088-4005-92e0-82ffdda8ff38" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1b96001b-9544-4806-9d11-4be97510db01" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressCityOrTown_1b96001b-9544-4806-9d11-4be97510db01" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5089db34-77e1-4772-9e65-0c9de66246b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressStateOrProvince_5089db34-77e1-4772-9e65-0c9de66246b4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_babb9c60-466c-4fb3-ab9a-1a3c326deb4b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressPostalZipCode_babb9c60-466c-4fb3-ab9a-1a3c326deb4b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_19d66106-bd0a-4fca-8d46-eb8d2e4d01ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_CityAreaCode_19d66106-bd0a-4fca-8d46-eb8d2e4d01ee" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_282cbead-d28b-4f16-a57a-b34217721e75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_LocalPhoneNumber_282cbead-d28b-4f16-a57a-b34217721e75" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d0f8b7c8-ac79-49cd-802e-ea7c4149947a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_Security12bTitle_d0f8b7c8-ac79-49cd-802e-ea7c4149947a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_19df6d4d-b9e2-45fe-a052-04a8ae5d5220" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_TradingSymbol_19df6d4d-b9e2-45fe-a052-04a8ae5d5220" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6253ac49-446f-42fa-8b8e-164d974edc0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_SecurityExchangeName_6253ac49-446f-42fa-8b8e-164d974edc0c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a496214a-acfa-4312-aa78-f22e80fb27b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a496214a-acfa-4312-aa78-f22e80fb27b8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_b4fa2efb-2f58-4caa-a667-eaf1d271efaf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityVoluntaryFilers_b4fa2efb-2f58-4caa-a667-eaf1d271efaf" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8d9f71b0-dfe5-4ebf-90ff-a66ee43dd6fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityCurrentReportingStatus_8d9f71b0-dfe5-4ebf-90ff-a66ee43dd6fa" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c5bf2724-ffc8-4e14-ba7f-e70c9d304eb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityInteractiveDataCurrent_c5bf2724-ffc8-4e14-ba7f-e70c9d304eb0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a82c8cff-fea1-4128-b93c-de89f28729b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityFilerCategory_a82c8cff-fea1-4128-b93c-de89f28729b3" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d0589a3b-7dd9-4d4e-a89b-6c258ba87555" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntitySmallBusiness_d0589a3b-7dd9-4d4e-a89b-6c258ba87555" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4843e9f5-c5c0-4bf8-85b6-d90e807775ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityEmergingGrowthCompany_4843e9f5-c5c0-4bf8-85b6-d90e807775ea" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_68c88a30-18e4-4293-aee5-05b25bfb6465" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_IcfrAuditorAttestationFlag_68c88a30-18e4-4293-aee5-05b25bfb6465" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_369ca797-45ae-413f-ab49-e031c10b6494" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityShellCompany_369ca797-45ae-413f-ab49-e031c10b6494" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_defa016e-46f0-4aab-ad0a-01581cd0e251" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityPublicFloat_defa016e-46f0-4aab-ad0a-01581cd0e251" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_be7c21a4-ce62-4cde-a315-b1a84043dfcf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_be7c21a4-ce62-4cde-a315-b1a84043dfcf" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b36cfe11-e438-4e8f-b138-21f4121dc9cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:to="loc_us-gaap_ClassOfStockDomain_b36cfe11-e438-4e8f-b138-21f4121dc9cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:to="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_92668b82-ec15-442d-bbd2-87b0d5cacca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_us-gaap_CommonStockMember_92668b82-ec15-442d-bbd2-87b0d5cacca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DepositarysharesMember_35102a14-29f6-4386-b268-37b78aa67c3c" xlink:href="bdx-20220930.xsd#bdx_DepositarysharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_DepositarysharesMember_35102a14-29f6-4386-b268-37b78aa67c3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_9bdeed48-eb2a-4400-bd17-d283faf6de5b" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_9bdeed48-eb2a-4400-bd17-d283faf6de5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_c70c6fdb-e1b0-4f43-9cad-83c9075c60ff" xlink:href="bdx-20220930.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_c70c6fdb-e1b0-4f43-9cad-83c9075c60ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_eb521dba-8e8f-4c79-a4e9-0536bf53ad4b" xlink:href="bdx-20220930.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.401dueMay242023Member_eb521dba-8e8f-4c79-a4e9-0536bf53ad4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_60226d05-79de-4919-ac4f-9ee19f2251b9" xlink:href="bdx-20220930.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes3.020dueMay242025Member_60226d05-79de-4919-ac4f-9ee19f2251b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_26b23fff-82c3-4dd2-b859-b5ff78829bab" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes0.632dueJune42023Member_26b23fff-82c3-4dd2-b859-b5ff78829bab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_4e04c8d5-aca7-402f-b0b8-59ccaf2baab9" xlink:href="bdx-20220930.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.208dueJune42026Member_4e04c8d5-aca7-402f-b0b8-59ccaf2baab9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_feabfd46-fae3-43b1-b768-844602f2ba07" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_feabfd46-fae3-43b1-b768-844602f2ba07" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_52218df5-04e1-489e-862a-e6f2d3d80e92" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes0000DueAugust132023Member_52218df5-04e1-489e-862a-e6f2d3d80e92" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_dd0ceb06-6929-4c39-856e-46ca9d6f7238" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes0034DueAugust132025Member_dd0ceb06-6929-4c39-856e-46ca9d6f7238" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:to="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_fc2617c3-9e9b-4056-8c8a-cab60ac94825_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:to="loc_dei_ExchangeDomain_fc2617c3-9e9b-4056-8c8a-cab60ac94825_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_e6f6bfe8-f2b1-497d-ba8f-2b1ae28da04a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:to="loc_dei_ExchangeDomain_e6f6bfe8-f2b1-497d-ba8f-2b1ae28da04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_dd572343-17f4-443b-9fad-d7617057452e" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_e6f6bfe8-f2b1-497d-ba8f-2b1ae28da04a" xlink:to="loc_exch_XNYS_dd572343-17f4-443b-9fad-d7617057452e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" id="i1aa233d5b03a42388951c0598d84ef13_SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_15e13846-85f0-4638-a2d1-d7d6c06e9e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_15e13846-85f0-4638-a2d1-d7d6c06e9e13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_29e10c8c-b2dd-48fe-912c-c0ddb714216f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_Depreciation_29e10c8c-b2dd-48fe-912c-c0ddb714216f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6c978a4b-4bde-4e0e-bed4-c43ec998229a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6c978a4b-4bde-4e0e-bed4-c43ec998229a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94bb0a98-0791-4fdd-97dd-87412880d528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94bb0a98-0791-4fdd-97dd-87412880d528" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc35113d-66a8-45ce-a45f-1e934e579672_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:to="loc_srt_RangeMember_cc35113d-66a8-45ce-a45f-1e934e579672_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:to="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_19bc2b58-ec63-48fc-b675-1b48803e9b97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:to="loc_srt_MinimumMember_19bc2b58-ec63-48fc-b675-1b48803e9b97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_830d25f0-3816-4f78-a858-a9ffe1eb8a34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:to="loc_srt_MaximumMember_830d25f0-3816-4f78-a858-a9ffe1eb8a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ef7c33f-3ab0-43d3-9017-02fd98247c3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ef7c33f-3ab0-43d3-9017-02fd98247c3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8a552795-77db-4f6a-adfa-7379500d0f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:to="loc_us-gaap_BuildingMember_8a552795-77db-4f6a-adfa-7379500d0f88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1cbd4e86-00b4-46a6-82db-afbf5420eade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1cbd4e86-00b4-46a6-82db-afbf5420eade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_558cfb4d-ab62-4d36-871f-dbba5e28a907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_558cfb4d-ab62-4d36-871f-dbba5e28a907" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f69a750-1dac-4a1d-ba4f-7168adf78838_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f69a750-1dac-4a1d-ba4f-7168adf78838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreTechnologiesMember_9cfef7a6-49f2-4df0-90ad-abf61554de23" xlink:href="bdx-20220930.xsd#bdx_CoreTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:to="loc_bdx_CoreTechnologiesMember_9cfef7a6-49f2-4df0-90ad-abf61554de23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_77488fe1-7183-4fab-b419-8c3bfd423b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:to="loc_us-gaap_CustomerRelationshipsMember_77488fe1-7183-4fab-b419-8c3bfd423b28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PatentsAndTrademarksMember_ce8dee36-1736-484b-a9ce-29ff2c4cd6a1" xlink:href="bdx-20220930.xsd#bdx_PatentsAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:to="loc_bdx_PatentsAndTrademarksMember_ce8dee36-1736-484b-a9ce-29ff2c4cd6a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:to="loc_srt_ProductsAndServicesDomain_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1ae25d18-3cd6-4708-85c4-e7a98235cdc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:to="loc_srt_ProductsAndServicesDomain_1ae25d18-3cd6-4708-85c4-e7a98235cdc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_897ff289-8387-459b-bcc5-3548e78bcd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1ae25d18-3cd6-4708-85c4-e7a98235cdc0" xlink:to="loc_us-gaap_ShippingAndHandlingMember_897ff289-8387-459b-bcc5-3548e78bcd82" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="extended" id="ia5b3a281be3040abbbe234ed47082519_SpinOffofEmbectaCorpAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3dacda18-be9c-4da8-9c61-64e5e9b9688b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3dacda18-be9c-4da8-9c61-64e5e9b9688b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_c0a91375-f275-4547-9c40-52ca1656b73e" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_c0a91375-f275-4547-9c40-52ca1656b73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_f3438110-9b45-41dd-8659-73f94397687c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_f3438110-9b45-41dd-8659-73f94397687c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_71f01905-4df2-4ff1-9f86-a62fe8ad615d" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_71f01905-4df2-4ff1-9f86-a62fe8ad615d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CashTransferRelatedToSpinoffTransaction_0aa70c1a-1306-4f04-a96b-7aa7520211f8" xlink:href="bdx-20220930.xsd#bdx_CashTransferRelatedToSpinoffTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_bdx_CashTransferRelatedToSpinoffTransaction_0aa70c1a-1306-4f04-a96b-7aa7520211f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_194c4d3b-e182-4fb9-853b-1faca1cd4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_194c4d3b-e182-4fb9-853b-1faca1cd4ea0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:to="loc_us-gaap_EquityComponentDomain_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d3bf3d1-831f-4076-8613-5d4ff51fa454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:to="loc_us-gaap_EquityComponentDomain_7d3bf3d1-831f-4076-8613-5d4ff51fa454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86480aea-50ca-4329-865a-79da0aab8ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7d3bf3d1-831f-4076-8613-5d4ff51fa454" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86480aea-50ca-4329-865a-79da0aab8ee0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fc82c3ca-a648-4185-b876-3e96233ee26b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fc82c3ca-a648-4185-b876-3e96233ee26b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb0f126c-ff8a-44c4-b5f8-2fe0905718d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb0f126c-ff8a-44c4-b5f8-2fe0905718d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member_f6f7ef7f-1273-46ba-b7a2-69e8588cbb3c" xlink:href="bdx-20220930.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eb0f126c-ff8a-44c4-b5f8-2fe0905718d3" xlink:to="loc_bdx_Notes6750DueFebruary152030Member_f6f7ef7f-1273-46ba-b7a2-69e8588cbb3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8607a250-b376-4936-b0fc-d59ccdec60e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8607a250-b376-4936-b0fc-d59ccdec60e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_36da3015-03ae-43b9-ac3a-497283a85fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_36da3015-03ae-43b9-ac3a-497283a85fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_122d38e9-7a56-42e9-a9cd-48b3e07ffa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_36da3015-03ae-43b9-ac3a-497283a85fe2" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_122d38e9-7a56-42e9-a9cd-48b3e07ffa9e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpDetails" xlink:type="extended" id="i490b16018e064bebab09fe1cb5979a75_SpinOffofEmbectaCorpDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_75707b76-aa71-4ecb-b9ba-a14644ea0c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_75707b76-aa71-4ecb-b9ba-a14644ea0c3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_099c2872-fa42-49b8-a916-6a5699f8b7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_099c2872-fa42-49b8-a916-6a5699f8b7d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_99bc70fa-b990-466a-a22d-9741ae2a432d" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_99bc70fa-b990-466a-a22d-9741ae2a432d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_394cac2f-025b-451b-8057-e7b127de1bc6" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_394cac2f-025b-451b-8057-e7b127de1bc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_16584a61-c629-446f-ba6e-6ab71a931fef" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_16584a61-c629-446f-ba6e-6ab71a931fef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_551c82f1-c218-48f2-8d5c-8d71604f7ff0" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_551c82f1-c218-48f2-8d5c-8d71604f7ff0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_cbd4bc55-285c-4bcf-b354-97ac0b73ae5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_cbd4bc55-285c-4bcf-b354-97ac0b73ae5d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_43d846f6-9369-46cd-b040-134dfd6728f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_43d846f6-9369-46cd-b040-134dfd6728f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_6c875795-b625-4f10-a71d-461a7776af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_6c875795-b625-4f10-a71d-461a7776af1f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_51093a71-46a7-4ef2-b973-e943e73eac07" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_51093a71-46a7-4ef2-b973-e943e73eac07" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9d4509c8-12ef-4e22-904d-16da95540465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9d4509c8-12ef-4e22-904d-16da95540465" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_75196883-0198-4e47-8864-5b0fee42a84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_75196883-0198-4e47-8864-5b0fee42a84d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2d2070a4-9ca9-4565-89c4-4e7c677d2945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2d2070a4-9ca9-4565-89c4-4e7c677d2945" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d6ef9748-7012-4516-9d91-04f9477480a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d6ef9748-7012-4516-9d91-04f9477480a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_aac25e55-e8ed-4cef-b534-d733afb340e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_aac25e55-e8ed-4cef-b534-d733afb340e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d5fa0fda-a8c4-433b-abbf-8ab3fcddc791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_aac25e55-e8ed-4cef-b534-d733afb340e8" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d5fa0fda-a8c4-433b-abbf-8ab3fcddc791" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="extended" id="ica0005f22dbb4dddaa9cf5fcc06dc82b_SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_e2f97fd3-7f51-45b9-be7b-ac9c261b0863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_e2f97fd3-7f51-45b9-be7b-ac9c261b0863" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_43fa64b8-9da8-4e71-8214-efd98de6bb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_43fa64b8-9da8-4e71-8214-efd98de6bb29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_ece5b093-524d-47c8-bb5f-26a08d953f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_ece5b093-524d-47c8-bb5f-26a08d953f80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_aef3a941-6221-467e-82dc-327fac6bd2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_aef3a941-6221-467e-82dc-327fac6bd2ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_8f4d5d54-939c-49cc-be5f-bac820d1ef21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_8f4d5d54-939c-49cc-be5f-bac820d1ef21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fdbacb6d-525d-4310-af7d-228483617589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fdbacb6d-525d-4310-af7d-228483617589" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_3bfc2df1-0deb-4a7a-b755-8c9fa1eb503e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_3bfc2df1-0deb-4a7a-b755-8c9fa1eb503e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_236afec1-b4c8-4937-881b-bdc5aaf22077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_236afec1-b4c8-4937-881b-bdc5aaf22077" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_1f52b476-9d0a-4434-9d08-702613e078f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_1f52b476-9d0a-4434-9d08-702613e078f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bb079a73-96b1-4007-8db3-6b112c6989dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bb079a73-96b1-4007-8db3-6b112c6989dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_519038e7-0f5c-4a36-9a16-adb43cda5f87" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_519038e7-0f5c-4a36-9a16-adb43cda5f87" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4b326db9-6716-41d0-9ef1-d37445cd5871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4b326db9-6716-41d0-9ef1-d37445cd5871" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_4aef5ffc-3af3-4572-8ba8-c35f4902a712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_4aef5ffc-3af3-4572-8ba8-c35f4902a712" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_be0e28e5-517c-4bae-afd4-a70832187be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_be0e28e5-517c-4bae-afd4-a70832187be0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9426a833-1925-47e9-a7ea-c0885a0a512b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9426a833-1925-47e9-a7ea-c0885a0a512b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0ad123cd-41d5-4274-adf0-90dfe340dffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0ad123cd-41d5-4274-adf0-90dfe340dffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember_5086c307-ac73-4b73-82b3-43a0fbe03237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0ad123cd-41d5-4274-adf0-90dfe340dffb" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember_5086c307-ac73-4b73-82b3-43a0fbe03237" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail" xlink:type="extended" id="i7d99da74e77741119f3b38425ecf1de5_ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6af1d011-8d78-4a82-8551-3904eaf2083e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6af1d011-8d78-4a82-8551-3904eaf2083e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_320b17cf-2fae-4463-b55c-465c932b6095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquity_320b17cf-2fae-4463-b55c-465c932b6095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_7bc3fe4a-77b6-4f00-8b96-1b2bda760b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockShares_7bc3fe4a-77b6-4f00-8b96-1b2bda760b2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6926dca7-4c83-41c2-aaa2-bdff14317877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_NetIncomeLoss_6926dca7-4c83-41c2-aaa2-bdff14317877" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3458c82b-09b9-47d5-9020-f0a66832d9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_DividendsCommonStockCash_3458c82b-09b9-47d5-9020-f0a66832d9a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_0bcf1b31-a01a-4d54-ba18-fa6b35608805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_DividendsPreferredStock_0bcf1b31-a01a-4d54-ba18-fa6b35608805" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_54e15013-b168-49db-b213-381067b11564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_54e15013-b168-49db-b213-381067b11564" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10daf19a-d8ab-4e84-a73c-a75c07093dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10daf19a-d8ab-4e84-a73c-a75c07093dbd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2eb06574-9b74-40ca-bdfc-586ee6216a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2eb06574-9b74-40ca-bdfc-586ee6216a21" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c5018b9a-a788-46fb-b368-e28481023b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c5018b9a-a788-46fb-b368-e28481023b22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4937b991-e816-4602-8f0e-9366996c40af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4937b991-e816-4602-8f0e-9366996c40af" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares_38f2d80a-9900-4ff7-bf1d-d87a3c9684c1" xlink:href="bdx-20220930.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_bdx_CommonStockHeldInTrustsNetShares_38f2d80a-9900-4ff7-bf1d-d87a3c9684c1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_28479278-3703-422d-93f4-046b12429bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_28479278-3703-422d-93f4-046b12429bcd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b3468e99-8e07-4f9a-8b36-a233c570429f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b3468e99-8e07-4f9a-8b36-a233c570429f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_97a78c4a-8398-43fc-b7b2-cefbc0cc346c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquityOther_97a78c4a-8398-43fc-b7b2-cefbc0cc346c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_76bb0173-142d-4a2c-8635-5e4c4d7cbbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_76bb0173-142d-4a2c-8635-5e4c4d7cbbbd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1499d166-9564-48b8-9d5e-a12a744108f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_617b91a4-8bd3-4e25-99e4-8334a5b2539b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6af1d011-8d78-4a82-8551-3904eaf2083e" xlink:to="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:to="loc_us-gaap_EquityComponentDomain_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:to="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4c41b16c-33db-42c6-a520-091278429a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_CommonStockMember_4c41b16c-33db-42c6-a520-091278429a3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_02be0dc6-4b49-42c3-b9fd-bbfbdc6969d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_02be0dc6-4b49-42c3-b9fd-bbfbdc6969d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_39ae885f-48a0-493e-b411-58d320d726a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_RetainedEarningsMember_39ae885f-48a0-493e-b411-58d320d726a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_69505be6-10c9-4a92-8afc-241f2d9eaab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_69505be6-10c9-4a92-8afc-241f2d9eaab0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b1f355b9-c540-45c6-a2db-3f1c1465463c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_TreasuryStockMember_b1f355b9-c540-45c6-a2db-3f1c1465463c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_47011dde-2b5d-4995-8162-675dc1ed4d10_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_47011dde-2b5d-4995-8162-675dc1ed4d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4a87b359-3461-4804-bb6d-e8f69432bcc3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4a87b359-3461-4804-bb6d-e8f69432bcc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c072d1a5-030c-4263-8fe7-10ec20824608" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4a87b359-3461-4804-bb6d-e8f69432bcc3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c072d1a5-030c-4263-8fe7-10ec20824608" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail" xlink:type="extended" id="i5bd3ced846d948d18a068c8aab222332_ShareholdersEquityAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_ef890f64-5141-444c-9710-55dcf70f037f" xlink:href="bdx-20220930.xsd#bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_ef890f64-5141-444c-9710-55dcf70f037f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bd01146b-d8da-4c7a-84cb-d581387c56ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bd01146b-d8da-4c7a-84cb-d581387c56ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfTransactions_63a48dfd-d29e-49de-b56d-54b51e9aee5e" xlink:href="bdx-20220930.xsd#bdx_NumberOfTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_NumberOfTransactions_63a48dfd-d29e-49de-b56d-54b51e9aee5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_363d301a-8903-4860-8d77-7b7b9998c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_363d301a-8903-4860-8d77-7b7b9998c7ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ebe45267-13fc-42cd-8c8d-ce0f1b2c0015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ebe45267-13fc-42cd-8c8d-ce0f1b2c0015" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c76e5c79-fd2b-4d50-b195-190fc25ed385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c76e5c79-fd2b-4d50-b195-190fc25ed385" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_09181398-e030-4c42-9eaa-548970908c44" xlink:href="bdx-20220930.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_09181398-e030-4c42-9eaa-548970908c44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d70696be-85e2-4da8-9d47-059129e5fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d70696be-85e2-4da8-9d47-059129e5fbb5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e90f1111-c905-44bd-a81e-23ef94ef922b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e90f1111-c905-44bd-a81e-23ef94ef922b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ca5adb48-cd08-4651-abfd-8145088dbced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ca5adb48-cd08-4651-abfd-8145088dbced" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GrossProceedsFromIssuanceOfEquity_edb5cb80-2bd4-469a-a97b-c989f40f239a" xlink:href="bdx-20220930.xsd#bdx_GrossProceedsFromIssuanceOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_GrossProceedsFromIssuanceOfEquity_edb5cb80-2bd4-469a-a97b-c989f40f239a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_df946d2d-f367-4d3e-9dc7-eaa6ddbd8d0f" xlink:href="bdx-20220930.xsd#bdx_PreferredStockDepositaryShareOwnershipInterestPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_df946d2d-f367-4d3e-9dc7-eaa6ddbd8d0f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_9c1d5683-8310-4eb4-a26b-0c18766befab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_9c1d5683-8310-4eb4-a26b-0c18766befab" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_05b07e0d-9d54-4f27-addf-8371dca1a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_05b07e0d-9d54-4f27-addf-8371dca1a1ef" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_840fdf31-0be6-4d2a-83b0-44d70a068ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_840fdf31-0be6-4d2a-83b0-44d70a068ba8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DepositaryShareLiquidation_30fba6ac-76c0-4a07-a59a-ae3d611936ca" xlink:href="bdx-20220930.xsd#bdx_DepositaryShareLiquidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_DepositaryShareLiquidation_30fba6ac-76c0-4a07-a59a-ae3d611936ca" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5d19d4fd-1b49-4273-a53a-f11254066b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5d19d4fd-1b49-4273-a53a-f11254066b74" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8ee70158-d1aa-46e4-be59-e4c68fc728f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:to="loc_us-gaap_ClassOfStockDomain_8ee70158-d1aa-46e4-be59-e4c68fc728f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:to="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_657cfdc0-dfd2-47c7-a70c-acd51d835971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_657cfdc0-dfd2-47c7-a70c-acd51d835971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ebfbdff9-dc1c-495f-8553-84593ec298ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:to="loc_us-gaap_CommonStockMember_ebfbdff9-dc1c-495f-8553-84593ec298ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d804214c-8d58-4128-b15d-2ade98522b07_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:to="loc_srt_RangeMember_d804214c-8d58-4128-b15d-2ade98522b07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:to="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b43eb176-4381-4e77-82b9-3b8bfac91af0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:to="loc_srt_MinimumMember_b43eb176-4381-4e77-82b9-3b8bfac91af0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7efd489-5fce-4ed4-a53b-c39cba6f38a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:to="loc_srt_MaximumMember_a7efd489-5fce-4ed4-a53b-c39cba6f38a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_81393483-a7b2-4b65-b7e7-344177e21949_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:to="loc_us-gaap_EquityComponentDomain_81393483-a7b2-4b65-b7e7-344177e21949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:to="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_9f0571a4-687e-49ef-9122-6b1be203182b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:to="loc_us-gaap_TreasuryStockMember_9f0571a4-687e-49ef-9122-6b1be203182b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2cdd83e6-4d0b-46cc-8a79-14c31cef3666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2cdd83e6-4d0b-46cc-8a79-14c31cef3666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5792090e-0e45-4ff7-9e05-cd642cc6ffef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5792090e-0e45-4ff7-9e05-cd642cc6ffef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcceleratedShareRepurchaseProgramMember_5f17fd35-0e6e-490c-95de-346396223ded" xlink:href="bdx-20220930.xsd#bdx_AcceleratedShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:to="loc_bdx_AcceleratedShareRepurchaseProgramMember_5f17fd35-0e6e-490c-95de-346396223ded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OpenMarketRepurchasesMember_fa2ecace-9bd1-4577-b918-fb408d28ac17" xlink:href="bdx-20220930.xsd#bdx_OpenMarketRepurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:to="loc_bdx_OpenMarketRepurchasesMember_fa2ecace-9bd1-4577-b918-fb408d28ac17" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail" xlink:type="extended" id="i6904f0fa1d8d4056bcb323e3a61c6ca1_ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7288483f-8f67-409d-ae5d-e37aee05f5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7288483f-8f67-409d-ae5d-e37aee05f5e0" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_185eed77-0616-47a9-888d-b81257131b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_185eed77-0616-47a9-888d-b81257131b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52a342aa-f185-4a65-81c0-e45f71c6260c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52a342aa-f185-4a65-81c0-e45f71c6260c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bbe407a3-4b59-4cb0-84d3-4c6f400881f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bbe407a3-4b59-4cb0-84d3-4c6f400881f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_c3fd0c17-3a74-460f-b7b6-4727cfeccb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_c3fd0c17-3a74-460f-b7b6-4727cfeccb4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5396a60f-9159-4296-8462-4273c7123c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7288483f-8f67-409d-ae5d-e37aee05f5e0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8f657ae3-4305-4881-9f72-f94180abc595_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:to="loc_us-gaap_EquityComponentDomain_8f657ae3-4305-4881-9f72-f94180abc595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:to="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8ce90628-0e51-4e70-8b94-de869e025862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8ce90628-0e51-4e70-8b94-de869e025862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0e98bbe9-e75a-4bc7-badf-35e4cd286f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0e98bbe9-e75a-4bc7-badf-35e4cd286f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15dd2d7c-d5f4-4487-a889-db3a8f00b822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15dd2d7c-d5f4-4487-a889-db3a8f00b822" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails" xlink:type="extended" id="ie99b52308aeb4455ab5c337ba2718662_EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be8f0c9a-9315-4326-ab35-a1e4f555085f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7e5f32a6-4b9b-4370-ade1-d60512e89d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be8f0c9a-9315-4326-ab35-a1e4f555085f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7e5f32a6-4b9b-4370-ade1-d60512e89d08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be8f0c9a-9315-4326-ab35-a1e4f555085f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b90424a6-54df-468a-b7ee-dd80a3b926a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b90424a6-54df-468a-b7ee-dd80a3b926a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b472458a-f892-4264-aa87-261a942611c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b472458a-f892-4264-aa87-261a942611c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_9ad34bce-4530-41b0-8967-2f57a7eb591e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b472458a-f892-4264-aa87-261a942611c2" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_9ad34bce-4530-41b0-8967-2f57a7eb591e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended" id="i68b072cd006641669220e6c5ce0991f8_CommitmentsandContingenciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_f767e4b7-0bd4-4c80-801d-640fd5790c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_f767e4b7-0bd4-4c80-801d-640fd5790c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_61dd1653-c262-4be1-bfce-9af1583ae1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_61dd1653-c262-4be1-bfce-9af1583ae1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_05e07075-8e3e-4d44-86e6-a928bd89f98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_05e07075-8e3e-4d44-86e6-a928bd89f98b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a67ee596-e3d5-4d04-bf8c-f077510e6263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a67ee596-e3d5-4d04-bf8c-f077510e6263" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuits_5068ad67-cdc3-4f11-9965-fc5ddb641dcb" xlink:href="bdx-20220930.xsd#bdx_NumberOfEtOSterilizationLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuits_5068ad67-cdc3-4f11-9965-fc5ddb641dcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_fe656934-99e1-4a69-8407-12743b3aa774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_fe656934-99e1-4a69-8407-12743b3aa774" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_dd2d35fd-c70f-4d88-964b-31135aab2378" xlink:href="bdx-20220930.xsd#bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_dd2d35fd-c70f-4d88-964b-31135aab2378" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_b61b81ad-9f17-42da-b516-2e45a207de97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_b61b81ad-9f17-42da-b516-2e45a207de97" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bfb04b2b-42de-4745-ac8d-e8c77b097f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bfb04b2b-42de-4745-ac8d-e8c77b097f83" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5e6d3b69-2800-4c6e-8dfb-614be2f055e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5e6d3b69-2800-4c6e-8dfb-614be2f055e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0a47d1a8-b61b-439a-b03e-fa8815a810d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0a47d1a8-b61b-439a-b03e-fa8815a810d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember_fc83a546-e0a7-4703-a06e-ca3173b1bc4b" xlink:href="bdx-20220930.xsd#bdx_HerniaProductClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0a47d1a8-b61b-439a-b03e-fa8815a810d7" xlink:to="loc_bdx_HerniaProductClaimsMember_fc83a546-e0a7-4703-a06e-ca3173b1bc4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1f03c556-1f51-423b-845e-9ea189f51bfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1f03c556-1f51-423b-845e-9ea189f51bfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0448c2a8-3c38-4b1f-98e8-ad990bc1cc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0448c2a8-3c38-4b1f-98e8-ad990bc1cc10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_cc780a04-8b51-4da2-93f7-0066956fbe05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0448c2a8-3c38-4b1f-98e8-ad990bc1cc10" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_cc780a04-8b51-4da2-93f7-0066956fbe05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8318ef8e-4363-44cd-89b5-39af163b3153_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:to="loc_srt_SegmentGeographicalDomain_8318ef8e-4363-44cd-89b5-39af163b3153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8fa6ee67-8a7a-4320-9a1f-5bd73e1e72f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:to="loc_srt_SegmentGeographicalDomain_8fa6ee67-8a7a-4320-9a1f-5bd73e1e72f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GwinnettCountyGeorgiaMember_9a0583ee-455c-411a-898b-68d21d806366" xlink:href="bdx-20220930.xsd#bdx_GwinnettCountyGeorgiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8fa6ee67-8a7a-4320-9a1f-5bd73e1e72f6" xlink:to="loc_bdx_GwinnettCountyGeorgiaMember_9a0583ee-455c-411a-898b-68d21d806366" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_46d5c3ae-5afd-4fbf-87fc-437e9a60d189_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:to="loc_srt_RangeMember_46d5c3ae-5afd-4fbf-87fc-437e9a60d189_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea1bf39c-8bdd-4450-9506-7671d3be9b72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:to="loc_srt_RangeMember_ea1bf39c-8bdd-4450-9506-7671d3be9b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b803c66f-04b6-4e14-81e6-a76afcf8328f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ea1bf39c-8bdd-4450-9506-7671d3be9b72" xlink:to="loc_srt_MaximumMember_b803c66f-04b6-4e14-81e6-a76afcf8328f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#RevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/RevenuesDetails" xlink:type="extended" id="i0c188f6350bb4b3ba1caeb4ac4ff8407_RevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_b7d7bc89-c0e0-4995-afe8-f0031d20564e" xlink:href="bdx-20220930.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_b7d7bc89-c0e0-4995-afe8-f0031d20564e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_08b929ef-7570-4a70-bd08-9e24da5da5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_08b929ef-7570-4a70-bd08-9e24da5da5f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b9e06cb7-d209-451d-a37a-5f68ab63a469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b9e06cb7-d209-451d-a37a-5f68ab63a469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8120956f-63cc-4072-a45f-483d0fa4d0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8120956f-63cc-4072-a45f-483d0fa4d0b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:to="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d290b6a1-e174-473e-a08a-2e295e28594d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:to="loc_srt_ProductsAndServicesDomain_d290b6a1-e174-473e-a08a-2e295e28594d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:to="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_9536ce9a-0a1d-4918-a6d9-fcf797c70b36" xlink:href="bdx-20220930.xsd#bdx_ProductsandorServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:to="loc_bdx_ProductsandorServicesMember_9536ce9a-0a1d-4918-a6d9-fcf797c70b36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_92405b7b-079f-4d4b-8822-8b7d71ed005c" xlink:href="bdx-20220930.xsd#bdx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:to="loc_bdx_ConsumablesMember_92405b7b-079f-4d4b-8822-8b7d71ed005c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails_1" xlink:type="simple" xlink:href="bdx-20220930.xsd#RevenuesDetails_1"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/RevenuesDetails_1" xlink:type="extended" id="i2369358ecb174f529dcf899da4a9179e_RevenuesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_b7d7bc89-c0e0-4995-afe8-f0031d20564e" xlink:href="bdx-20220930.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_b7d7bc89-c0e0-4995-afe8-f0031d20564e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_08b929ef-7570-4a70-bd08-9e24da5da5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_08b929ef-7570-4a70-bd08-9e24da5da5f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b9e06cb7-d209-451d-a37a-5f68ab63a469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b9e06cb7-d209-451d-a37a-5f68ab63a469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:to="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d290b6a1-e174-473e-a08a-2e295e28594d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:to="loc_srt_ProductsAndServicesDomain_d290b6a1-e174-473e-a08a-2e295e28594d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:to="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_9536ce9a-0a1d-4918-a6d9-fcf797c70b36" xlink:href="bdx-20220930.xsd#bdx_ProductsandorServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:to="loc_bdx_ProductsandorServicesMember_9536ce9a-0a1d-4918-a6d9-fcf797c70b36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_92405b7b-079f-4d4b-8822-8b7d71ed005c" xlink:href="bdx-20220930.xsd#bdx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:to="loc_bdx_ConsumablesMember_92405b7b-079f-4d4b-8822-8b7d71ed005c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="extended" id="i6513b53da25d4a0f8582401607adc01e_SegmentDataAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_895ab66d-19cb-415a-96bf-abb0afe1d3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_NumberOfOperatingSegments_895ab66d-19cb-415a-96bf-abb0afe1d3a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_659036f0-20f9-4147-86a0-87365061acb1" xlink:href="bdx-20220930.xsd#bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_659036f0-20f9-4147-86a0-87365061acb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_0745ce82-e828-4f98-8e94-943710d6666d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_InventoryRecallExpense_0745ce82-e828-4f98-8e94-943710d6666d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e328ebf2-1b39-48f7-b13b-776e35a79eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e328ebf2-1b39-48f7-b13b-776e35a79eac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_9982e1b1-c091-460c-8008-b1bc5e2c4fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_AssetImpairmentCharges_9982e1b1-c091-460c-8008-b1bc5e2c4fb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_7b5c5397-664e-487e-a126-fd54e34388ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_7b5c5397-664e-487e-a126-fd54e34388ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fa31c4ef-1502-440b-ab87-afa451528290_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fa31c4ef-1502-440b-ab87-afa451528290_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_41e7dd0c-191c-4f4f-a44c-a9c71dfff6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_41e7dd0c-191c-4f4f-a44c-a9c71dfff6c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_7f26a43d-d630-4a19-815b-7f2a730de30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_41e7dd0c-191c-4f4f-a44c-a9c71dfff6c2" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_7f26a43d-d630-4a19-815b-7f2a730de30e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82986ecf-505b-4c73-a1c0-fe60349e1d18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:to="loc_us-gaap_SegmentDomain_82986ecf-505b-4c73-a1c0-fe60349e1d18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:to="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_fd75bef8-05a3-43a0-b473-48f86b5c4c25" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:to="loc_bdx_MedicalMember_fd75bef8-05a3-43a0-b473-48f86b5c4c25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_e34446b8-241d-4fca-a84a-f7824367857c" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:to="loc_bdx_LifeSciencesMember_e34446b8-241d-4fca-a84a-f7824367857c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails" xlink:type="extended" id="id306deae24f24d8fa5685f4a326197d6_SegmentDataSegmentDataRevenuesbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_680ae127-cf7b-4573-92bd-89b7e0e33a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_eb32bcf4-f87b-44ce-9929-4609ce2e38f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_680ae127-cf7b-4573-92bd-89b7e0e33a60" xlink:to="loc_us-gaap_Revenues_eb32bcf4-f87b-44ce-9929-4609ce2e38f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_680ae127-cf7b-4573-92bd-89b7e0e33a60" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5_default" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:to="loc_bdx_OrganizationalUnitDomain_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:to="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember_b193c07a-21e0-43df-8cc0-4db1a85418da" xlink:href="bdx-20220930.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_MedicationDeliverySolutionsMember_b193c07a-21e0-43df-8cc0-4db1a85418da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember_edcfeb42-3a17-4a7b-b491-96b0b457d1e3" xlink:href="bdx-20220930.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_MedicationManagementSolutionsMember_edcfeb42-3a17-4a7b-b491-96b0b457d1e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember_440e0352-f6d0-4542-9918-60b036048b55" xlink:href="bdx-20220930.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_PharmaceuticalSystemsMember_440e0352-f6d0-4542-9918-60b036048b55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember_7e15c9a4-2823-4679-bb77-c11f0fbfe017" xlink:href="bdx-20220930.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_IntegratedDiagnosticSolutionsMember_7e15c9a4-2823-4679-bb77-c11f0fbfe017" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember_f6e406aa-300b-4fa0-8920-859022163843" xlink:href="bdx-20220930.xsd#bdx_BiosciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_BiosciencesMember_f6e406aa-300b-4fa0-8920-859022163843" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember_572c4f63-ae83-4879-9723-9e6360417f2a" xlink:href="bdx-20220930.xsd#bdx_SurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_SurgeryMember_572c4f63-ae83-4879-9723-9e6360417f2a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember_b02ab10a-f7e1-4716-b72c-a182816f8d13" xlink:href="bdx-20220930.xsd#bdx_PeripheralInterventionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_PeripheralInterventionMember_b02ab10a-f7e1-4716-b72c-a182816f8d13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember_19459fa4-08a4-4773-ade2-c611483eae31" xlink:href="bdx-20220930.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_UrologyandCriticalCareMember_19459fa4-08a4-4773-ade2-c611483eae31" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:to="loc_srt_SegmentGeographicalDomain_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:to="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4f9eb52e-6ecd-47d3-a036-c679e2620f07" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:to="loc_country_US_4f9eb52e-6ecd-47d3-a036-c679e2620f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_38723988-6772-479b-9269-5312f64250c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:to="loc_us-gaap_NonUsMember_38723988-6772-479b-9269-5312f64250c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_24f1e3ea-69a8-4af4-9a48-5a48f11694c8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:to="loc_srt_ConsolidationItemsDomain_24f1e3ea-69a8-4af4-9a48-5a48f11694c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cf840c5f-ae91-4c90-a8ad-9be856a8cead" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:to="loc_srt_ConsolidationItemsDomain_cf840c5f-ae91-4c90-a8ad-9be856a8cead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5c099191-4b36-4e47-a0bf-bc090e38984a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cf840c5f-ae91-4c90-a8ad-9be856a8cead" xlink:to="loc_us-gaap_OperatingSegmentsMember_5c099191-4b36-4e47-a0bf-bc090e38984a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_925bcd27-f066-4483-b5fc-73246ccf0ad7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:to="loc_us-gaap_SegmentDomain_925bcd27-f066-4483-b5fc-73246ccf0ad7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:to="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_d2760679-e0a3-4e44-a97b-f74ff724ab04" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:to="loc_bdx_MedicalMember_d2760679-e0a3-4e44-a97b-f74ff724ab04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_82286364-1ff8-46a3-a54d-11a87c8469d8" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:to="loc_bdx_LifeSciencesMember_82286364-1ff8-46a3-a54d-11a87c8469d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_907d428d-a6f2-4cd3-b9aa-255a4d8af90e" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:to="loc_bdx_InterventionalMember_907d428d-a6f2-4cd3-b9aa-255a4d8af90e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended" id="i172941dd24624ed390f4d7aa980a7645_SegmentDataFinancialInformationforCompanysSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a49d39a-0e5e-4e1a-bb82-1d69d82be0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a49d39a-0e5e-4e1a-bb82-1d69d82be0dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_0d9e9093-f31f-41b2-9886-028df220587b" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_0d9e9093-f31f-41b2-9886-028df220587b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ef9112b2-65e7-4235-a404-4a2cb7c33f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ef9112b2-65e7-4235-a404-4a2cb7c33f69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5265a135-842e-4747-aa6a-e46dc23a9f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5265a135-842e-4747-aa6a-e46dc23a9f15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5218b282-7dbd-4ccc-b8c0-8401bfa5018a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5218b282-7dbd-4ccc-b8c0-8401bfa5018a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_be06599a-1a93-4106-a335-d6c14bc80e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_be06599a-1a93-4106-a335-d6c14bc80e32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:to="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_83efca39-75bd-484b-81b9-46152533353b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:to="loc_srt_ConsolidationItemsDomain_83efca39-75bd-484b-81b9-46152533353b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:to="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_015a137e-afa6-401c-a7d6-cd43f3348dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:to="loc_us-gaap_OperatingSegmentsMember_015a137e-afa6-401c-a7d6-cd43f3348dfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_1e409dea-7662-483a-9906-dbf0d0aaa674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_1e409dea-7662-483a-9906-dbf0d0aaa674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c55b53c8-49ed-4eeb-9ff8-567bb24e9e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c55b53c8-49ed-4eeb-9ff8-567bb24e9e0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:to="loc_us-gaap_SegmentDomain_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:to="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_3c8c235e-504a-4cc7-8f84-97b6750c57d0" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:to="loc_bdx_MedicalMember_3c8c235e-504a-4cc7-8f84-97b6750c57d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_1636f9b9-fd68-4608-bc7c-27d28037891a" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:to="loc_bdx_LifeSciencesMember_1636f9b9-fd68-4608-bc7c-27d28037891a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_67e8cfe5-4224-4803-8ae1-ade988a3a4c2" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:to="loc_bdx_InterventionalMember_67e8cfe5-4224-4803-8ae1-ade988a3a4c2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail" xlink:type="extended" id="i97f0be8a48894fd8bbf325cbc07704d0_SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dea7c51c-a6dd-48fa-9fd6-2f0af671f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:to="loc_us-gaap_Revenues_dea7c51c-a6dd-48fa-9fd6-2f0af671f30e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_ab4ee424-3b6b-477e-916d-0601047cf711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:to="loc_us-gaap_NoncurrentAssets_ab4ee424-3b6b-477e-916d-0601047cf711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:to="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c1706c19-83bd-4ee6-a765-19272a78e4b7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:to="loc_srt_SegmentGeographicalDomain_c1706c19-83bd-4ee6-a765-19272a78e4b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:to="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_64f51422-0d11-435a-8c55-6240426f91e0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_country_US_64f51422-0d11-435a-8c55-6240426f91e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_21b89a84-58d6-4c5c-b65e-e91e34d46ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_us-gaap_EMEAMember_21b89a84-58d6-4c5c-b65e-e91e34d46ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_71f845b3-62c8-47d9-8e05-464c4f6dfe5f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_srt_AsiaMember_71f845b3-62c8-47d9-8e05-464c4f6dfe5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OthersCountryMember_e2ea61fc-bdc6-4f21-af1b-bbea701f022c" xlink:href="bdx-20220930.xsd#bdx_OthersCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_bdx_OthersCountryMember_e2ea61fc-bdc6-4f21-af1b-bbea701f022c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bec2ed3-3f9e-44e6-815c-60eebe867cc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:to="loc_us-gaap_SegmentDomain_8bec2ed3-3f9e-44e6-815c-60eebe867cc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e31f9119-2de8-4583-9b05-b9778a12082f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:to="loc_us-gaap_SegmentDomain_e31f9119-2de8-4583-9b05-b9778a12082f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_b5aca7d3-5c1e-4308-9220-a8ccd0ec1a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e31f9119-2de8-4583-9b05-b9778a12082f" xlink:to="loc_us-gaap_CorporateMember_b5aca7d3-5c1e-4308-9220-a8ccd0ec1a1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail" xlink:type="extended" id="ib8d25241344b4240b9286e8362fc1c9f_ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0586f7fb-62e5-432e-a63a-d0c27f4925e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0586f7fb-62e5-432e-a63a-d0c27f4925e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_569dd5d7-81a0-4474-a841-6826f1cca701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_569dd5d7-81a0-4474-a841-6826f1cca701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29785beb-6648-409d-bdd6-d3c146ab50c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_29785beb-6648-409d-bdd6-d3c146ab50c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2891fd37-7c8e-4bd8-99e4-87ec4fc1e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_us-gaap_CostOfSalesMember_2891fd37-7c8e-4bd8-99e4-87ec4fc1e05b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_297d1245-c414-4787-bc49-1b76b3d1e9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_297d1245-c414-4787-bc49-1b76b3d1e9ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_811c54ae-99ab-42e5-b282-4d96f8af795f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_811c54ae-99ab-42e5-b282-4d96f8af795f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_2bcbfc25-7add-49bb-ab07-2016a9d77c53" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_2bcbfc25-7add-49bb-ab07-2016a9d77c53" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="i789b315f00b3408daad3fd27b622f86e_ShareBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b98dc00-7877-47e9-9ca0-7fba87342d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b98dc00-7877-47e9-9ca0-7fba87342d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_a4d92b75-c7a8-4768-a3c3-90f1c5ee5b69" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_a4d92b75-c7a8-4768-a3c3-90f1c5ee5b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_db1845dd-a0c0-4ba5-a379-4861cbcf93cf" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_db1845dd-a0c0-4ba5-a379-4861cbcf93cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockIssuedUnderStockAppreciationRightsExercised_1c5089ee-4180-48b2-a8ec-0d40694fbe62" xlink:href="bdx-20220930.xsd#bdx_StockIssuedUnderStockAppreciationRightsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_StockIssuedUnderStockAppreciationRightsExercised_1c5089ee-4180-48b2-a8ec-0d40694fbe62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fbf1ef4d-a9a6-40ec-a3f0-303380b8b071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fbf1ef4d-a9a6-40ec-a3f0-303380b8b071" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_7b5ba99e-9f00-46b5-984c-d033fdb3e9a1" xlink:href="bdx-20220930.xsd#bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_7b5ba99e-9f00-46b5-984c-d033fdb3e9a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_d5d3b2a1-2e66-4a87-acdf-caea5fa72999" xlink:href="bdx-20220930.xsd#bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_d5d3b2a1-2e66-4a87-acdf-caea5fa72999" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_2c601fa7-654c-4b21-bd2e-00f3a802e37a" xlink:href="bdx-20220930.xsd#bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_2c601fa7-654c-4b21-bd2e-00f3a802e37a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_0124817a-c235-4948-941b-1fae4346d46a" xlink:href="bdx-20220930.xsd#bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_0124817a-c235-4948-941b-1fae4346d46a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_f53098a0-43cf-42ea-adb6-9e16c974407a" xlink:href="bdx-20220930.xsd#bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_f53098a0-43cf-42ea-adb6-9e16c974407a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UnitsInExcessOfExpectedPerformancePayout_0adcb9be-71ca-474a-9012-69d903f1d4c1" xlink:href="bdx-20220930.xsd#bdx_UnitsInExcessOfExpectedPerformancePayout"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_UnitsInExcessOfExpectedPerformancePayout_0adcb9be-71ca-474a-9012-69d903f1d4c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_a25bb369-ee5c-46a2-b753-d7ac226f30be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_a25bb369-ee5c-46a2-b753-d7ac226f30be" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4f6eaee8-475b-4b6c-96b9-f699ec072774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4f6eaee8-475b-4b6c-96b9-f699ec072774" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f3ef871c-b47b-4478-8530-d6bb6f3ccd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f3ef871c-b47b-4478-8530-d6bb6f3ccd9b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8dda14db-3d23-49f8-a7b3-75c9b85a8550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8dda14db-3d23-49f8-a7b3-75c9b85a8550" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_3f69d517-56b9-4541-bf2e-8bf6e990d90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrustShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_3f69d517-56b9-4541-bf2e-8bf6e990d90e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharesIssuableUnderDeferredCompensationPlan_3f862e84-d811-4c9a-a543-1c3bbcfc8b06" xlink:href="bdx-20220930.xsd#bdx_SharesIssuableUnderDeferredCompensationPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_SharesIssuableUnderDeferredCompensationPlan_3f862e84-d811-4c9a-a543-1c3bbcfc8b06" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8cab8844-2ec7-4784-a0c9-11b6f58a92e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8cab8844-2ec7-4784-a0c9-11b6f58a92e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_466f91bd-0024-4c37-b513-6a149962d1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_466f91bd-0024-4c37-b513-6a149962d1ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_425c87ad-455b-418a-96bc-ce95587b167d" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_466f91bd-0024-4c37-b513-6a149962d1ac" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_425c87ad-455b-418a-96bc-ce95587b167d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe5d000e-97e8-4038-9e2a-5979fca2ab90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe5d000e-97e8-4038-9e2a-5979fca2ab90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a3b428b-6c16-4bfb-aadf-30fd5e122e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a3b428b-6c16-4bfb-aadf-30fd5e122e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CRBardIncMember_4c20f79e-ce43-45ba-96b8-ef43b5d2ffdc" xlink:href="bdx-20220930.xsd#bdx_CRBardIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a3b428b-6c16-4bfb-aadf-30fd5e122e16" xlink:to="loc_bdx_CRBardIncMember_4c20f79e-ce43-45ba-96b8-ef43b5d2ffdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ecf2333-52d8-4f5c-8fe8-67786f090d49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ecf2333-52d8-4f5c-8fe8-67786f090d49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_871ded36-5e3b-4a0d-a2f8-b3f06217beb9" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_871ded36-5e3b-4a0d-a2f8-b3f06217beb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_38bef3f7-0b37-4980-b98c-ab34af16844b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_38bef3f7-0b37-4980-b98c-ab34af16844b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_80338de8-48ae-415a-a403-88de0158f6c8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:to="loc_srt_RangeMember_80338de8-48ae-415a-a403-88de0158f6c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:to="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31bd7158-89b1-412c-aa32-a9beba090e28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:to="loc_srt_MinimumMember_31bd7158-89b1-412c-aa32-a9beba090e28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e946fd09-93f6-4252-9df6-7aafb1f57727" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:to="loc_srt_MaximumMember_e946fd09-93f6-4252-9df6-7aafb1f57727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_dd67a20e-0abe-44a4-b051-56238d4ce6a2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_dd67a20e-0abe-44a4-b051-56238d4ce6a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_304ed344-fb65-4722-8d38-26756da4f271" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:to="loc_srt_ExecutiveOfficerMember_304ed344-fb65-4722-8d38-26756da4f271" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_514caf1a-60e0-4228-9337-b0437a078449" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:to="loc_srt_DirectorMember_514caf1a-60e0-4228-9337-b0437a078449" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail" xlink:type="extended" id="ia9e99433e43e49eb9a6f70dc8eda63fe_ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8589c264-b5e0-4c29-8d92-7d693913981e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8589c264-b5e0-4c29-8d92-7d693913981e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_254baadf-6b3f-47b5-9df0-c1b8185b7949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_254baadf-6b3f-47b5-9df0-c1b8185b7949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8d945e60-a413-42e1-82f4-ea98c62e75ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8d945e60-a413-42e1-82f4-ea98c62e75ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_378c6ca1-c6b7-454b-9b79-ca922e6634ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_378c6ca1-c6b7-454b-9b79-ca922e6634ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_191dc535-848c-4a8b-b326-0d3ebe889a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_191dc535-848c-4a8b-b326-0d3ebe889a59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:to="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a4ed511-ae08-475c-b2f0-45f8cfe6560f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a4ed511-ae08-475c-b2f0-45f8cfe6560f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_696563c3-b1ef-4220-8239-90efa3844a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_696563c3-b1ef-4220-8239-90efa3844a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_59304d6e-d5bf-4f93-9f09-00b41366607c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_696563c3-b1ef-4220-8239-90efa3844a44" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_59304d6e-d5bf-4f93-9f09-00b41366607c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail" xlink:type="extended" id="ieb78481229dd489a813f34e08e463fe7_ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bb632b95-4a28-4e9e-8728-d2f1f5b82465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bb632b95-4a28-4e9e-8728-d2f1f5b82465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2f62e736-f36c-470e-9813-bbc865716ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2f62e736-f36c-470e-9813-bbc865716ce9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9f91ad6e-7ed2-42cc-864a-e0cb3186b2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9f91ad6e-7ed2-42cc-864a-e0cb3186b2cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c34c102-d151-43bf-8984-e4098d26879b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c34c102-d151-43bf-8984-e4098d26879b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_3ec8b63f-b540-4e20-a548-f0f888ea1671" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_3ec8b63f-b540-4e20-a548-f0f888ea1671" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_0b7deb32-4af0-4b07-abca-57fdb1f54c8a" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_0b7deb32-4af0-4b07-abca-57fdb1f54c8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75230209-0108-4d1c-847d-b02efb848f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_502d3ffc-10ef-4e79-9b68-4f6f8d778417" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_502d3ffc-10ef-4e79-9b68-4f6f8d778417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ec48c39-881e-4a46-b52e-8bc2ea211aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ec48c39-881e-4a46-b52e-8bc2ea211aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e96dfd4-bdef-417d-898e-1d2a30ce7c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e96dfd4-bdef-417d-898e-1d2a30ce7c99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6a1cc7a8-366d-4404-8ab3-e5ad65c56a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6a1cc7a8-366d-4404-8ab3-e5ad65c56a2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_900c19c4-80d0-416f-a7c5-6c797f724366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_900c19c4-80d0-416f-a7c5-6c797f724366" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_160476b5-e6ff-46ad-9433-15cd09626308" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_160476b5-e6ff-46ad-9433-15cd09626308" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3006952-8c69-4a60-a04a-49bf88f42436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_23da7571-a943-43a1-8c84-b653d6fef082" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_23da7571-a943-43a1-8c84-b653d6fef082" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:to="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3724202-510c-44a7-84ff-155cb58067d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3724202-510c-44a7-84ff-155cb58067d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_c5f3f7ca-3c2a-415b-9ae8-dddab674be6c" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_c5f3f7ca-3c2a-415b-9ae8-dddab674be6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f595b2-3fed-48e6-b20a-3848f14063a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f595b2-3fed-48e6-b20a-3848f14063a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails" xlink:type="extended" id="i685d7936c9f94d4791b9656fdb6aa8c4_ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_3252108e-ef44-4ea9-aceb-d202bf0ebb5d" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c6a3464a-6155-4876-bfe6-d8af6a9ce0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_3252108e-ef44-4ea9-aceb-d202bf0ebb5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c6a3464a-6155-4876-bfe6-d8af6a9ce0fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_3252108e-ef44-4ea9-aceb-d202bf0ebb5d" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:to="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1ca524e-510a-4a2d-8a19-39fc26e23c19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1ca524e-510a-4a2d-8a19-39fc26e23c19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_102058cc-36e7-424d-b42f-45a5c13c9d53" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_102058cc-36e7-424d-b42f-45a5c13c9d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e05d6329-2262-40ee-ac1a-dcb0fd3bdc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e05d6329-2262-40ee-ac1a-dcb0fd3bdc66" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationFairValueofStockUnitsVestedDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails" xlink:type="extended" id="i4044a307e8804d209e114f457acb5a62_ShareBasedCompensationFairValueofStockUnitsVestedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_b738fa6b-f2e0-43aa-bf16-9e5b754955de" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_16bae132-697f-4b88-8a01-2ccf9b41b133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_b738fa6b-f2e0-43aa-bf16-9e5b754955de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_16bae132-697f-4b88-8a01-2ccf9b41b133" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_b738fa6b-f2e0-43aa-bf16-9e5b754955de" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:to="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd79a646-9d35-4380-9df9-28402eae28a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd79a646-9d35-4380-9df9-28402eae28a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_a401cbbe-1640-4fe6-a86c-733da8ec9175" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_a401cbbe-1640-4fe6-a86c-733da8ec9175" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0254eac8-39b3-4ef5-896a-318baa0f7040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0254eac8-39b3-4ef5-896a-318baa0f7040" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansNetPensionandOtherPostretirementCostDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail" xlink:type="extended" id="i019e9d86ad7844a99c4cef7b643da115_BenefitPlansNetPensionandOtherPostretirementCostDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_82e33f2f-a09f-4925-8544-6dcecdf05627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_82e33f2f-a09f-4925-8544-6dcecdf05627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_793dac2d-cae9-4d6c-a8f6-c73ec1d74e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_793dac2d-cae9-4d6c-a8f6-c73ec1d74e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ac68e775-2ff4-4616-8673-f3f843bbabb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ac68e775-2ff4-4616-8673-f3f843bbabb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_96a997f8-596e-410d-b233-180b8ecb86d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_96a997f8-596e-410d-b233-180b8ecb86d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e0f7aa84-a85c-4fdb-8a46-56f23a7b4b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e0f7aa84-a85c-4fdb-8a46-56f23a7b4b90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_8d7c305a-9c5a-4081-966d-30de911545f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_8d7c305a-9c5a-4081-966d-30de911545f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0d3d3d65-1e6d-4c6d-824c-4d87f1966515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0d3d3d65-1e6d-4c6d-824c-4d87f1966515" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_631985fa-9274-401f-ba27-854109af4750_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_631985fa-9274-401f-ba27-854109af4750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7eaddb55-064a-46d9-9803-3d4e25d2bcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7eaddb55-064a-46d9-9803-3d4e25d2bcc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_01b5fd9f-abee-4082-9ea2-03e048e5bd11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7eaddb55-064a-46d9-9803-3d4e25d2bcc1" xlink:to="loc_us-gaap_ForeignPlanMember_01b5fd9f-abee-4082-9ea2-03e048e5bd11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0da79012-8859-458e-ae9e-10bec7fc2a38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0da79012-8859-458e-ae9e-10bec7fc2a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_db3855ba-86b8-47e0-b679-eec3ddd5cd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_db3855ba-86b8-47e0-b679-eec3ddd5cd7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9f66a495-a7e4-48b8-bb92-41afca1f1fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_db3855ba-86b8-47e0-b679-eec3ddd5cd7c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9f66a495-a7e4-48b8-bb92-41afca1f1fe6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" xlink:type="extended" id="i459dc7f008a549b781f6a752cbeb687a_BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3497ca6d-19ce-4c2f-989f-206d1bf090f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3497ca6d-19ce-4c2f-989f-206d1bf090f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_20ddba74-472d-4bd1-949a-fd0cd0302686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_20ddba74-472d-4bd1-949a-fd0cd0302686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_4a2d4cf1-1608-4509-a5bc-15baa3a98949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_4a2d4cf1-1608-4509-a5bc-15baa3a98949" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f15197ce-65e5-45a2-938f-e113d138fa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f15197ce-65e5-45a2-938f-e113d138fa84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_81955605-526c-4c51-908d-e0a64db53451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_81955605-526c-4c51-908d-e0a64db53451" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_6c0ed20d-c062-44b6-93a3-db2d7c3ed5a5" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_6c0ed20d-c062-44b6-93a3-db2d7c3ed5a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7f30fee3-a531-4824-be49-9533fe6228a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7f30fee3-a531-4824-be49-9533fe6228a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_9b37d8b6-d91b-4526-bc4c-7e77eda51f37" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_9b37d8b6-d91b-4526-bc4c-7e77eda51f37" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_b5fec210-2d08-4eaf-9c13-fa76678aa751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_b5fec210-2d08-4eaf-9c13-fa76678aa751" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherChanges_102df230-4ae1-4ffa-900a-e31b2e63dc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherChanges_102df230-4ae1-4ffa-900a-e31b2e63dc69" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e7454c11-6250-4e60-b923-41e11e5fe03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ff0374c5-8909-494a-9a2c-8a7d23b3e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ff0374c5-8909-494a-9a2c-8a7d23b3e30c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_6065f1f7-9ea8-4e9f-b4d0-ce5fdfe0ce78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_6065f1f7-9ea8-4e9f-b4d0-ce5fdfe0ce78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5527aac3-dfb4-4845-be22-9de4a986224a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5527aac3-dfb4-4845-be22-9de4a986224a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0f21d805-2b95-46c9-b44e-228be065b4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0f21d805-2b95-46c9-b44e-228be065b4f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_6bab9c95-7853-42a3-bd0d-4bade7af1035" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_6bab9c95-7853-42a3-bd0d-4bade7af1035" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3fe9f58a-e7f3-46b9-bcfc-316b91420ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3fe9f58a-e7f3-46b9-bcfc-316b91420ed9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ca34a860-6967-4181-a80f-fc170473a1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ca34a860-6967-4181-a80f-fc170473a1b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e925b633-83b9-45a4-8b4c-1408fe36fbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_4646f67f-123d-498e-9778-7b8f12932dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_4646f67f-123d-498e-9778-7b8f12932dde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_a3ffa520-41ec-4c9b-a609-6285304d7c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_4646f67f-123d-498e-9778-7b8f12932dde" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_a3ffa520-41ec-4c9b-a609-6285304d7c2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f9318467-6097-428f-9b70-d6f6fd121bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f9318467-6097-428f-9b70-d6f6fd121bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_5f5071ff-7b1b-4772-9fe3-259987a02d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_5f5071ff-7b1b-4772-9fe3-259987a02d9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d364f5a7-22f5-4b52-87df-878418da73d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d364f5a7-22f5-4b52-87df-878418da73d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7479f9ef-bf07-4c36-a8d4-bfa967d40417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7479f9ef-bf07-4c36-a8d4-bfa967d40417" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_001ad0ea-c55d-42cb-90db-15e60d0fd3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_001ad0ea-c55d-42cb-90db-15e60d0fd3b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_22e04109-9f9c-42f4-87f7-275ccf67aa05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_22e04109-9f9c-42f4-87f7-275ccf67aa05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e6e81f29-550d-4e86-844b-ad70d7123bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e6e81f29-550d-4e86-844b-ad70d7123bc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ff037e85-553d-4890-85c2-f1b0bb06a32b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ff037e85-553d-4890-85c2-f1b0bb06a32b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3ad59a36-42f1-4594-a611-b5073f6005ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3ad59a36-42f1-4594-a611-b5073f6005ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d565626c-6e06-486d-9179-383794e18a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3ad59a36-42f1-4594-a611-b5073f6005ef" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d565626c-6e06-486d-9179-383794e18a5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansAdditionalInformationDetail" xlink:type="extended" id="ie168762f617e472ea147da73c548066c_BenefitPlansAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b815f95d-e1e8-48de-a9f3-9c05d0cf5be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b815f95d-e1e8-48de-a9f3-9c05d0cf5be9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_da0b486e-b0e5-4475-ab14-6808f42f94d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_da0b486e-b0e5-4475-ab14-6808f42f94d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a4a5a1c9-85d8-4483-933b-4ed242e74b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a4a5a1c9-85d8-4483-933b-4ed242e74b1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentOfAssetsDomesticPlans_cf6aa992-3bd8-4c45-97a6-30d68456c60b" xlink:href="bdx-20220930.xsd#bdx_PercentOfAssetsDomesticPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_bdx_PercentOfAssetsDomesticPlans_cf6aa992-3bd8-4c45-97a6-30d68456c60b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d6b0c2c2-78b2-4a57-b839-5664b147806c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d6b0c2c2-78b2-4a57-b839-5664b147806c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentOfPlanAssetsForeignPlans_59965110-03f9-424a-84dc-b3f850db97aa" xlink:href="bdx-20220930.xsd#bdx_PercentOfPlanAssetsForeignPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_bdx_PercentOfPlanAssetsForeignPlans_59965110-03f9-424a-84dc-b3f850db97aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_0cf8c5f7-8f63-4dd1-b0ba-85255776a118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_0cf8c5f7-8f63-4dd1-b0ba-85255776a118" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0b800883-3ffa-4751-b329-808d163cc5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:to="loc_us-gaap_ForeignPlanMember_0b800883-3ffa-4751-b329-808d163cc5c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c32548cf-2f87-4f3a-b9ad-308994660006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:to="loc_us-gaap_DomesticPlanMember_c32548cf-2f87-4f3a-b9ad-308994660006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1dba32de-1099-4cc3-b361-faca5c4ca1aa" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_c32548cf-2f87-4f3a-b9ad-308994660006" xlink:to="loc_country_US_1dba32de-1099-4cc3-b361-faca5c4ca1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c225f444-a066-4f1c-a03d-3f723b015bfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c225f444-a066-4f1c-a03d-3f723b015bfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_47681b73-1f6d-4423-a272-f16e4c931820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_47681b73-1f6d-4423-a272-f16e4c931820" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5132a4c3-6392-4d2c-a21f-1eeb3e4fa0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5132a4c3-6392-4d2c-a21f-1eeb3e4fa0e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_36adf0b7-13bb-4bbb-959f-1777bbd33b8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_36adf0b7-13bb-4bbb-959f-1777bbd33b8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_c85e357b-7bd3-4acb-a5a5-190a889b083d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:to="loc_us-gaap_FixedIncomeFundsMember_c85e357b-7bd3-4acb-a5a5-190a889b083d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DiversifiedMember_fb70eae3-9153-41b4-86c7-cd22f484ad22" xlink:href="bdx-20220930.xsd#bdx_DiversifiedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:to="loc_bdx_DiversifiedMember_fb70eae3-9153-41b4-86c7-cd22f484ad22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d037674b-961a-42c0-a787-10bcc6fcf30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d037674b-961a-42c0-a787-10bcc6fcf30e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail" xlink:type="extended" id="i9b7e7db426714ebf93aad62bca3cb425_BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8c364dde-a4d4-4600-85a7-0a00c006ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8c364dde-a4d4-4600-85a7-0a00c006ad8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_91d08e25-8151-4a5f-a96a-53247fe24b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_91d08e25-8151-4a5f-a96a-53247fe24b0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_76cb9177-22fb-49fc-b4c5-de75590905f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_76cb9177-22fb-49fc-b4c5-de75590905f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_89240bc1-253b-4ee1-9eb1-a6336d197b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_89240bc1-253b-4ee1-9eb1-a6336d197b47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_cfd187f0-2c0c-4f70-9477-3c8ffb6e7c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_cfd187f0-2c0c-4f70-9477-3c8ffb6e7c7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ee9cfa0b-fbe6-4e88-8cf8-178e78f6987e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ee9cfa0b-fbe6-4e88-8cf8-178e78f6987e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate_68b033d4-e6cf-44a4-8b8b-8d75817788c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate_68b033d4-e6cf-44a4-8b8b-8d75817788c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1cbb20b2-7e6d-42b1-99a2-41737f57e76b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1cbb20b2-7e6d-42b1-99a2-41737f57e76b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_fba893df-99c4-4205-8534-2df456dbdb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:to="loc_us-gaap_DomesticPlanMember_fba893df-99c4-4205-8534-2df456dbdb7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6431c6b3-741c-480a-8216-5d53e416e441" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_fba893df-99c4-4205-8534-2df456dbdb7d" xlink:to="loc_country_US_6431c6b3-741c-480a-8216-5d53e416e441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_7d1b27d5-4f11-41a3-b7f5-a68f34cb95b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:to="loc_us-gaap_ForeignPlanMember_7d1b27d5-4f11-41a3-b7f5-a68f34cb95b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7a839fbd-709d-4c9b-ac1e-9780ba3956ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7a839fbd-709d-4c9b-ac1e-9780ba3956ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_36adff9f-b489-4a76-a9fc-3f9a642fc590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_36adff9f-b489-4a76-a9fc-3f9a642fc590" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4b97f51c-3129-43c7-a0cb-f96e234b4726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_36adff9f-b489-4a76-a9fc-3f9a642fc590" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4b97f51c-3129-43c7-a0cb-f96e234b4726" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansExpectedBenefitPaymentsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail" xlink:type="extended" id="id9d200a02f5b442b9ddb068cc8803a19_BenefitPlansExpectedBenefitPaymentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_95796897-7fcd-4063-b7ba-fd921e5ac944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_95796897-7fcd-4063-b7ba-fd921e5ac944" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3f768a91-ecfa-43ed-a947-1425279d0de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3f768a91-ecfa-43ed-a947-1425279d0de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e6f62bd4-392b-44de-bb9a-4eba4e09d111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e6f62bd4-392b-44de-bb9a-4eba4e09d111" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_054799c1-b435-4f6f-94bf-59eccbc6bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_054799c1-b435-4f6f-94bf-59eccbc6bc39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c3c293b7-9909-4bf8-82e4-0a1d533110c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c3c293b7-9909-4bf8-82e4-0a1d533110c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_edcae0eb-d1f5-43a2-a6a4-ac2eaf81e50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_edcae0eb-d1f5-43a2-a6a4-ac2eaf81e50b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a787d44e-1aa3-474d-b58c-15f3247dbf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a787d44e-1aa3-474d-b58c-15f3247dbf96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2112aed0-47eb-4160-84c5-c7370961bb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a787d44e-1aa3-474d-b58c-15f3247dbf96" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2112aed0-47eb-4160-84c5-c7370961bb0b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansFairValueMeasurementsofPlanAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail" xlink:type="extended" id="ibc7bb2ae4133494981dc5aeb2bd71883_BenefitPlansFairValueMeasurementsofPlanAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f4f26abd-c4b9-40d7-9e6d-45851b6e705e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b6b7c905-6865-4c34-950c-7038575138a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f4f26abd-c4b9-40d7-9e6d-45851b6e705e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b6b7c905-6865-4c34-950c-7038575138a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f4f26abd-c4b9-40d7-9e6d-45851b6e705e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0c6070dd-563a-4054-8fa2-806076b4df11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0c6070dd-563a-4054-8fa2-806076b4df11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_eb7eb0db-e8ea-46ee-84d1-41f89ee55071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_eb7eb0db-e8ea-46ee-84d1-41f89ee55071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a5f61642-b32e-484d-93f9-cb44b5e57fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_eb7eb0db-e8ea-46ee-84d1-41f89ee55071" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a5f61642-b32e-484d-93f9-cb44b5e57fa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ff81307-6855-44c1-8cea-e5c7556da1df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ff81307-6855-44c1-8cea-e5c7556da1df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bcc62903-94dc-4c5f-a1f9-126ebefa5d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bcc62903-94dc-4c5f-a1f9-126ebefa5d26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_08c3f102-1212-42ea-9f5c-78f0c49b07ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_08c3f102-1212-42ea-9f5c-78f0c49b07ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_94b176d5-0ead-4a92-9d3c-988c5d787fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_94b176d5-0ead-4a92-9d3c-988c5d787fd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4283038f-a181-4fc9-b93c-fd498aaf2bb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4283038f-a181-4fc9-b93c-fd498aaf2bb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_79fface5-40a4-4f5e-9459-49426afdf80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_79fface5-40a4-4f5e-9459-49426afdf80e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_0d048d40-6304-4dc7-99e9-afa871d4bcd3" xlink:href="bdx-20220930.xsd#bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_79fface5-40a4-4f5e-9459-49426afdf80e" xlink:to="loc_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_0d048d40-6304-4dc7-99e9-afa871d4bcd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8c9016a8-d394-4877-9945-97ae50d483f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8c9016a8-d394-4877-9945-97ae50d483f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_86791123-408d-42c0-9a70-3de1306c90f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:to="loc_us-gaap_DomesticPlanMember_86791123-408d-42c0-9a70-3de1306c90f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cacdc5b3-ff91-4531-b45b-c0fada3ee40b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_86791123-408d-42c0-9a70-3de1306c90f2" xlink:to="loc_country_US_cacdc5b3-ff91-4531-b45b-c0fada3ee40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_acfb2dd1-969f-428e-b53c-959484cae276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:to="loc_us-gaap_ForeignPlanMember_acfb2dd1-969f-428e-b53c-959484cae276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_31218dda-8ba6-4fcc-9f78-4498c06bceb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_31218dda-8ba6-4fcc-9f78-4498c06bceb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_93da106b-da73-49ad-9ec0-dda03901b6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_93da106b-da73-49ad-9ec0-dda03901b6b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_196943cc-5ab7-4c67-9e35-4468336b5b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_196943cc-5ab7-4c67-9e35-4468336b5b9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherFixedIncomeMember_882e0beb-4cc2-48aa-8775-4550098bf8e3" xlink:href="bdx-20220930.xsd#bdx_OtherFixedIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_bdx_OtherFixedIncomeMember_882e0beb-4cc2-48aa-8775-4550098bf8e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e803304a-5f09-42c4-8847-7da44e6452e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e803304a-5f09-42c4-8847-7da44e6452e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_656d5df3-8bd6-4abb-baf1-92f5d840b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_656d5df3-8bd6-4abb-baf1-92f5d840b0d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherPensionPlanInvestmentsMember_c6b702f0-f7ee-4d3b-b242-4e6115779b4c" xlink:href="bdx-20220930.xsd#bdx_OtherPensionPlanInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_bdx_OtherPensionPlanInvestmentsMember_c6b702f0-f7ee-4d3b-b242-4e6115779b4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_cba15bdb-2391-43fe-8209-df060ac72042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_cba15bdb-2391-43fe-8209-df060ac72042" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InsuranceContractInvestmentsMember_a15aba19-a34e-4054-a7ce-6a78effdc73b" xlink:href="bdx-20220930.xsd#bdx_InsuranceContractInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_bdx_InsuranceContractInvestmentsMember_a15aba19-a34e-4054-a7ce-6a78effdc73b" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/AcquisitionsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#AcquisitionsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/AcquisitionsDetail" xlink:type="extended" id="ie8c6fabd221f40cbb5d37e57e7c1dc9e_AcquisitionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_83940ea1-692d-4da1-ba29-321987c631f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_83940ea1-692d-4da1-ba29-321987c631f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9cb4d066-4be9-4062-83b3-969fdc687414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9cb4d066-4be9-4062-83b3-969fdc687414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_37147963-1de3-43fc-b0d9-9beaa882eb19" xlink:href="bdx-20220930.xsd#bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_37147963-1de3-43fc-b0d9-9beaa882eb19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b74f4efa-1446-4723-9dfe-03551d3704ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_Goodwill_b74f4efa-1446-4723-9dfe-03551d3704ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_354c88de-183e-4665-b456-436deed8754d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_354c88de-183e-4665-b456-436deed8754d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36d5ec9e-67c5-4e29-b70b-f63a6b72f626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36d5ec9e-67c5-4e29-b70b-f63a6b72f626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ParataSystemsMember_c5b9d509-e4d6-4c42-9dd6-c86f5129989d" xlink:href="bdx-20220930.xsd#bdx_ParataSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36d5ec9e-67c5-4e29-b70b-f63a6b72f626" xlink:to="loc_bdx_ParataSystemsMember_c5b9d509-e4d6-4c42-9dd6-c86f5129989d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86c4b010-50ac-4ada-91ff-b95ae2da4f99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86c4b010-50ac-4ada-91ff-b95ae2da4f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_bb2b84fb-bc9b-40f6-b9d9-287f65d12834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_bb2b84fb-bc9b-40f6-b9d9-287f65d12834" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_63b87b00-199d-4e1b-bc06-a9ee80aca5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:to="loc_us-gaap_CustomerRelationshipsMember_63b87b00-199d-4e1b-bc06-a9ee80aca5d8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BusinessRestructuringChargesChangesinRestructuringBalanceDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail" xlink:type="extended" id="if1da6bd6a1e3462c8cf62da0c185c908_BusinessRestructuringChargesChangesinRestructuringBalanceDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c03a58d5-423a-4647-95ee-63e5f08d3679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c03a58d5-423a-4647-95ee-63e5f08d3679" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_935300cd-3f7b-4a0a-b84f-e2118c509dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserve_935300cd-3f7b-4a0a-b84f-e2118c509dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d76c6838-c034-4217-9f5e-dd177836847f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringCharges_d76c6838-c034-4217-9f5e-dd177836847f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_da43760e-c0e4-45f9-88dd-6ea52f18e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_PaymentsForRestructuring_da43760e-c0e4-45f9-88dd-6ea52f18e5b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_725521bd-a67e-4ad4-9f53-b12462bb98b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_725521bd-a67e-4ad4-9f53-b12462bb98b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_eb226c6b-cee1-45c5-a0ec-52a6d62c41e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_eb226c6b-cee1-45c5-a0ec-52a6d62c41e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_743447b4-cc9c-4878-8d76-4e7ac11958bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c03a58d5-423a-4647-95ee-63e5f08d3679" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c0e6a58f-62ba-4ed5-9788-41e636bc895c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c0e6a58f-62ba-4ed5-9788-41e636bc895c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_ff91d64d-400a-4895-a454-fc8e88449eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_ff91d64d-400a-4895-a454-fc8e88449eff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_68801588-a56c-4094-841b-b7ef5f6a496e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:to="loc_us-gaap_OtherRestructuringMember_68801588-a56c-4094-841b-b7ef5f6a496e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended" id="i290c900cdf26470a9c9b445340040813_IntangibleAssetsComponentsofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:href="bdx-20220930.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f26dd884-d5b7-4fde-897c-7989a1d453ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f26dd884-d5b7-4fde-897c-7989a1d453ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dbeb6a11-f3f5-4e6c-9274-3a0398b63670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dbeb6a11-f3f5-4e6c-9274-3a0398b63670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5e6b4e4-90b8-48a9-bd27-c9bcce4da5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5e6b4e4-90b8-48a9-bd27-c9bcce4da5c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9bcbb868-fbc8-4395-b0b2-937a66912b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9bcbb868-fbc8-4395-b0b2-937a66912b6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:href="bdx-20220930.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_494ec741-c25b-4f69-919e-28a72e8905fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_494ec741-c25b-4f69-919e-28a72e8905fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ec9725cd-d31c-4861-86ea-fba93fe00f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ec9725cd-d31c-4861-86ea-fba93fe00f62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3c9b26c1-cafb-4b71-b38e-2b1d20ec8b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3c9b26c1-cafb-4b71-b38e-2b1d20ec8b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductRightsMember_ab4d9eb1-0ac0-4dbf-bede-615e95dacc5a" xlink:href="bdx-20220930.xsd#bdx_ProductRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_bdx_ProductRightsMember_ab4d9eb1-0ac0-4dbf-bede-615e95dacc5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_2772efc5-41c7-4eeb-9b62-ade9e584832f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_TrademarksMember_2772efc5-41c7-4eeb-9b62-ade9e584832f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_b2d29d5d-de48-4606-bea9-27c393a6854e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_IntellectualPropertyMember_b2d29d5d-de48-4606-bea9-27c393a6854e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_8b3c6181-c8e3-43be-83fd-0d889dde8f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_8b3c6181-c8e3-43be-83fd-0d889dde8f5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_38b8f8fe-b6ec-482f-8c75-e86b7a159a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:to="loc_us-gaap_TrademarksMember_38b8f8fe-b6ec-482f-8c75-e86b7a159a6c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="extended" id="i9890e16bd0fd427e80cce4ede6af68c3_IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_410fbb8f-cb25-42fe-a148-f02701245f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_410fbb8f-cb25-42fe-a148-f02701245f1b" xlink:to="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_155cdc16-119c-4b06-bd44-bfa54523ec08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_Goodwill_155cdc16-119c-4b06-bd44-bfa54523ec08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_7df26021-f299-4c42-8bfa-a4a68fd785ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_7df26021-f299-4c42-8bfa-a4a68fd785ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3c6339de-c079-4428-80f5-26eba3584043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3c6339de-c079-4428-80f5-26eba3584043" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_30300f7b-d198-4ed4-b96b-e21bed52c320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_30300f7b-d198-4ed4-b96b-e21bed52c320" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_226c23a2-e4dd-4fa5-8d1b-37a7455193e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_410fbb8f-cb25-42fe-a148-f02701245f1b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_986fc34f-815f-448f-8ace-735664efd485_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:to="loc_us-gaap_SegmentDomain_986fc34f-815f-448f-8ace-735664efd485_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:to="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_dcc2eb1b-3ed7-45ff-95a8-e4767146a309" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:to="loc_bdx_MedicalMember_dcc2eb1b-3ed7-45ff-95a8-e4767146a309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_fc9810a4-0741-4976-92a9-d2b307f73214" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:to="loc_bdx_LifeSciencesMember_fc9810a4-0741-4976-92a9-d2b307f73214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_27516294-0254-4d5a-a831-d91e4fb41155" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:to="loc_bdx_InterventionalMember_27516294-0254-4d5a-a831-d91e4fb41155" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="extended" id="i36f25916a4974acca36f5177fd684294_DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_27fbd8d7-7701-4bdd-80f9-6e3db04ab900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4ddb7a5a-b4ba-4d30-8e42-ffab184f4a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_27fbd8d7-7701-4bdd-80f9-6e3db04ab900" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4ddb7a5a-b4ba-4d30-8e42-ffab184f4a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_27fbd8d7-7701-4bdd-80f9-6e3db04ab900" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5ef757c-0c01-4c41-90f4-5d427574238d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5ef757c-0c01-4c41-90f4-5d427574238d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3ecfc078-1d9b-49a4-98a0-d71377c45ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3ecfc078-1d9b-49a4-98a0-d71377c45ae6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2da2edae-5833-4bc1-ba8a-c02172ab98a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_us-gaap_CurrencySwapMember_2da2edae-5833-4bc1-ba8a-c02172ab98a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember_245f39b4-22ec-4062-8965-6923f46a18e8" xlink:href="bdx-20220930.xsd#bdx_FixedToFloatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_bdx_FixedToFloatingMember_245f39b4-22ec-4062-8965-6923f46a18e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_87c6aa11-fb86-4dbb-b496-a6edab8bb98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_us-gaap_InterestRateSwapMember_87c6aa11-fb86-4dbb-b496-a6edab8bb98b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e410e7e-5637-4d33-8e23-2b6f391ad967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e410e7e-5637-4d33-8e23-2b6f391ad967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_8dca3105-faeb-4b2a-8213-f41795527c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e410e7e-5637-4d33-8e23-2b6f391ad967" xlink:to="loc_us-gaap_DebtMember_8dca3105-faeb-4b2a-8213-f41795527c39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e8350076-f723-43f8-8e6a-c8a21d8c27eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e8350076-f723-43f8-8e6a-c8a21d8c27eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_550d8c47-8d0d-469f-8fd6-be919fa8e5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:to="loc_us-gaap_FairValueHedgingMember_550d8c47-8d0d-469f-8fd6-be919fa8e5f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e9a14fb0-7651-48ea-b65e-60d2fe77c52d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e9a14fb0-7651-48ea-b65e-60d2fe77c52d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended" id="ifc9a266b28014620897a60cbec01ceec_DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_0e754dd9-94ba-473f-a3c4-0cf2904e3b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_0e754dd9-94ba-473f-a3c4-0cf2904e3b66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_af95ae32-3aaa-4d34-a20c-9caa02278e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_us-gaap_DerivativeNotionalAmount_af95ae32-3aaa-4d34-a20c-9caa02278e10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_cc1467c3-89db-446d-9de9-071d450a2b3e" xlink:href="bdx-20220930.xsd#bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_cc1467c3-89db-446d-9de9-071d450a2b3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1de69d60-fb11-431e-8ad8-004421c31914_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1de69d60-fb11-431e-8ad8-004421c31914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d0274ea7-6567-49fb-af8d-5bc9f85b3c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:to="loc_us-gaap_InterestRateSwapMember_d0274ea7-6567-49fb-af8d-5bc9f85b3c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_757eec52-8e8f-4fdc-bf4d-e4a339e07df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:to="loc_us-gaap_CommodityContractMember_757eec52-8e8f-4fdc-bf4d-e4a339e07df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c8aebbab-5bf1-4583-b618-81477fb3334a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c8aebbab-5bf1-4583-b618-81477fb3334a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7e47c0d0-7c36-4e9b-a71f-7a0046f35973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7e47c0d0-7c36-4e9b-a71f-7a0046f35973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_026765a4-2b06-44f0-98c9-d7e17221b611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7e47c0d0-7c36-4e9b-a71f-7a0046f35973" xlink:to="loc_us-gaap_CashFlowHedgingMember_026765a4-2b06-44f0-98c9-d7e17221b611" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="extended" id="i8b1ce345cd854b6199b38057c3521dc2_DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_131d0abe-92f8-4606-ab00-6d3f45d7dbec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_131d0abe-92f8-4606-ab00-6d3f45d7dbec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_45d8a473-314f-4082-8c86-f6120e3a1f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_45d8a473-314f-4082-8c86-f6120e3a1f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7c03d75b-74c4-4e66-8007-8d3d42433145_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7c03d75b-74c4-4e66-8007-8d3d42433145_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_86429815-127e-46d9-82d8-78b382078a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:to="loc_us-gaap_ForeignExchangeContractMember_86429815-127e-46d9-82d8-78b382078a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_e5a54d65-b2ff-438f-8405-48d5c1e78bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:to="loc_us-gaap_CurrencySwapMember_e5a54d65-b2ff-438f-8405-48d5c1e78bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TerminatedCurrencySwapMember_886b5738-3597-4fc0-a711-046c7db30ab2" xlink:href="bdx-20220930.xsd#bdx_TerminatedCurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:to="loc_bdx_TerminatedCurrencySwapMember_886b5738-3597-4fc0-a711-046c7db30ab2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i15ef54e4b8d54001bc44b6e31d25ccd4_FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment_1bccfc35-1ada-4ce5-a9a6-061b28b644db" xlink:href="bdx-20220930.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_bdx_MaturityPeriodOfShortTermInvestment_1bccfc35-1ada-4ce5-a9a6-061b28b644db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5d705a6d-b364-49ce-a511-4f1c7fbb4689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_us-gaap_AssetImpairmentCharges_5d705a6d-b364-49ce-a511-4f1c7fbb4689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1315cf02-fe2c-46fa-b925-5ca8492350d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1315cf02-fe2c-46fa-b925-5ca8492350d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:to="loc_us-gaap_SegmentDomain_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:to="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_3785468a-abe4-4251-b58c-e22840f76dba" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:to="loc_bdx_LifeSciencesMember_3785468a-abe4-4251-b58c-e22840f76dba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_0c3448cc-c703-41d1-bb19-71fdd1b48405" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:to="loc_bdx_MedicalMember_0c3448cc-c703-41d1-bb19-71fdd1b48405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c261eb0-c0f8-4704-9940-2f0763175130_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:to="loc_srt_RangeMember_8c261eb0-c0f8-4704-9940-2f0763175130_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:to="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55bb036c-2740-4733-bbe6-a6e82f57be80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:to="loc_srt_MinimumMember_55bb036c-2740-4733-bbe6-a6e82f57be80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ee97a82f-bb6f-416a-8ebc-c577b2ad39e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:to="loc_srt_MaximumMember_ee97a82f-bb6f-416a-8ebc-c577b2ad39e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3aa2f21f-f21d-451f-ab82-95f0b481fa71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:to="loc_us-gaap_CostOfSalesMember_3aa2f21f-f21d-451f-ab82-95f0b481fa71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_6cba8c4d-9cf6-4cdd-b12c-84e13238e464" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_6cba8c4d-9cf6-4cdd-b12c-84e13238e464" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtSummaryofShortTermDebtDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail" xlink:type="extended" id="id34ea5bcce864a25a824386894197c6f_DebtSummaryofShortTermDebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a5463fc-0b9c-4a56-98a7-fc096e3365c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a5463fc-0b9c-4a56-98a7-fc096e3365c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c725d678-d116-4dd8-84ce-b0a872163abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_ShortTermBorrowings_c725d678-d116-4dd8-84ce-b0a872163abb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e3e2fa4f-ce18-43c5-b54a-0a06ca214f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_LongTermDebtCurrent_e3e2fa4f-ce18-43c5-b54a-0a06ca214f44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_24b84cab-665d-4eaf-9c81-ffaa815a7718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_DebtCurrent_24b84cab-665d-4eaf-9c81-ffaa815a7718" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:to="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3212911a-28ef-405c-967b-7e9bd2bbcc39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3212911a-28ef-405c-967b-7e9bd2bbcc39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_86f1fdc7-7d15-48f2-8a5c-c997108d50d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_us-gaap_CommercialPaperMember_86f1fdc7-7d15-48f2-8a5c-c997108d50d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_1a857745-2f8c-4720-95a5-9a77bfcb816f" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_1a857745-2f8c-4720-95a5-9a77bfcb816f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member_03b01cf7-3352-44bd-9489-a39ca0e5fd67" xlink:href="bdx-20220930.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_FloatingRateNotesDueJune62022Member_03b01cf7-3352-44bd-9489-a39ca0e5fd67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1401DueMay232023Member_4dd094cb-b3b3-4f23-8dbf-c4b428f1a83f" xlink:href="bdx-20220930.xsd#bdx_Notes1401DueMay232023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes1401DueMay232023Member_4dd094cb-b3b3-4f23-8dbf-c4b428f1a83f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_988d768a-fb3e-46ae-ac24-d8abfd6fb8bc" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes0.632dueJune42023Member_988d768a-fb3e-46ae-ac24-d8abfd6fb8bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_430bb8c3-899e-4e5d-9fe8-fc6e8f1523ab" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes0000DueAugust132023Member_430bb8c3-899e-4e5d-9fe8-fc6e8f1523ab" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtAdditionalInformationDetail" xlink:type="extended" id="i7e7a2d131dc94ced8c4abf56c24b9bad_DebtAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_db99a554-3ceb-4ae0-bb28-b2d383ff18ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_db99a554-3ceb-4ae0-bb28-b2d383ff18ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_eb769fa6-6525-43a8-b2e9-c8a4f8724886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_ShortTermBorrowings_eb769fa6-6525-43a8-b2e9-c8a4f8724886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_67604e24-b73a-4dd8-95ce-cd1ead30b9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_67604e24-b73a-4dd8-95ce-cd1ead30b9ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_54c17a36-b0f3-47e1-b460-978366220047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_54c17a36-b0f3-47e1-b460-978366220047" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ac01c3a8-3911-426e-b5ad-abf45f132ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ac01c3a8-3911-426e-b5ad-abf45f132ef3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d41ced65-94a9-4154-90bc-7bd939af3fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d41ced65-94a9-4154-90bc-7bd939af3fa4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5fe72d7c-a255-4f04-8456-20caa8a5ec01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5fe72d7c-a255-4f04-8456-20caa8a5ec01" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_0f3427b2-e890-4019-b062-cf7940b7332f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentTerm_0f3427b2-e890-4019-b062-cf7940b7332f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_e13cf6db-5616-4178-9e2f-58f53883fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_e13cf6db-5616-4178-9e2f-58f53883fa39" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LettersOfCreditIssuableUnderCreditFacility_8f8fb8db-bef4-4ada-ac31-36e04e072f9f" xlink:href="bdx-20220930.xsd#bdx_LettersOfCreditIssuableUnderCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_bdx_LettersOfCreditIssuableUnderCreditFacility_8f8fb8db-bef4-4ada-ac31-36e04e072f9f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SwinglineLoansIssuableUnderCreditFacility_0f6cb89c-d6c4-48e5-bba2-c2b9878a9e95" xlink:href="bdx-20220930.xsd#bdx_SwinglineLoansIssuableUnderCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_bdx_SwinglineLoansIssuableUnderCreditFacility_0f6cb89c-d6c4-48e5-bba2-c2b9878a9e95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_6d75991a-5f04-49bc-9d20-dc6f23fb2c66" xlink:href="bdx-20220930.xsd#bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_6d75991a-5f04-49bc-9d20-dc6f23fb2c66" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac8becc3-1e1d-4a79-a0d5-80d042c6ea67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac8becc3-1e1d-4a79-a0d5-80d042c6ea67" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_961435a0-4bad-43e0-af52-af4ca629fd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LineOfCredit_961435a0-4bad-43e0-af52-af4ca629fd6c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_41e8cd77-69f8-4c43-aeca-f6943b90888f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_41e8cd77-69f8-4c43-aeca-f6943b90888f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c5fc6a6a-19ce-479a-80d7-373d9d9a9622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c5fc6a6a-19ce-479a-80d7-373d9d9a9622" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_8e97050f-bfd9-4a94-b388-163174c94f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_8e97050f-bfd9-4a94-b388-163174c94f45" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5e69850f-2b59-4548-81e3-b61e1077c0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5e69850f-2b59-4548-81e3-b61e1077c0cb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_82cfc766-446b-4455-b384-b33da7e0eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_82cfc766-446b-4455-b384-b33da7e0eedc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2254894d-239b-4d90-9df9-c4331c100ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2254894d-239b-4d90-9df9-c4331c100ec2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_41597adc-c3b4-46da-9ba2-4900ff8cbe32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:to="loc_us-gaap_CreditFacilityDomain_41597adc-c3b4-46da-9ba2-4900ff8cbe32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:to="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ff44ba1b-b34d-4da1-afc1-6465ecbf9d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ff44ba1b-b34d-4da1-afc1-6465ecbf9d04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TermLoanFacilityMember_98ed6a2f-169e-4ee4-b302-90ab0214f7fc" xlink:href="bdx-20220930.xsd#bdx_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:to="loc_bdx_TermLoanFacilityMember_98ed6a2f-169e-4ee4-b302-90ab0214f7fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5987233a-c13f-4d7b-9060-df72fd921353_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5987233a-c13f-4d7b-9060-df72fd921353_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_01582799-7c37-4114-8428-0d9832b08245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_us-gaap_CommercialPaperMember_01582799-7c37-4114-8428-0d9832b08245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes5000DueFebruary152030Member_91e67d21-598f-494b-a595-a8ac5eb69dff" xlink:href="bdx-20220930.xsd#bdx_Notes5000DueFebruary152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_bdx_Notes5000DueFebruary152030Member_91e67d21-598f-494b-a595-a8ac5eb69dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member_f17c9732-a4aa-4f47-80ae-1c313421c876" xlink:href="bdx-20220930.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_bdx_Notes6750DueFebruary152030Member_f17c9732-a4aa-4f47-80ae-1c313421c876" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member_c296f695-9d86-491e-b305-6dd47db7b827" xlink:href="bdx-20220930.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_bdx_FloatingRateNotesDueJune62022Member_c296f695-9d86-491e-b305-6dd47db7b827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_77c3e473-dd53-4805-a352-604bb4cc90dc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:to="loc_srt_RangeMember_77c3e473-dd53-4805-a352-604bb4cc90dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94b65371-cd74-4a71-b321-6869f57da0ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:to="loc_srt_RangeMember_94b65371-cd74-4a71-b321-6869f57da0ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d85ba27-c9ba-49e9-a3b1-1dd28fbadb49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_94b65371-cd74-4a71-b321-6869f57da0ac" xlink:to="loc_srt_MaximumMember_2d85ba27-c9ba-49e9-a3b1-1dd28fbadb49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a49e0840-19c1-4353-a886-158c892a41c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a49e0840-19c1-4353-a886-158c892a41c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_8faa661c-d6ac-4a1b-8e18-0152fb6e1380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_8faa661c-d6ac-4a1b-8e18-0152fb6e1380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_9f54e9a2-df55-427f-9aea-02c321c4b971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_8faa661c-d6ac-4a1b-8e18-0152fb6e1380" xlink:to="loc_us-gaap_LongTermDebtMember_9f54e9a2-df55-427f-9aea-02c321c4b971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2e98c293-ac46-43d3-9319-69c86f3807cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2e98c293-ac46-43d3-9319-69c86f3807cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2ac89117-ac07-47eb-8ad6-f400720bccde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2ac89117-ac07-47eb-8ad6-f400720bccde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d6d4dcb3-5ac3-4018-8511-5f0278497c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2ac89117-ac07-47eb-8ad6-f400720bccde" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d6d4dcb3-5ac3-4018-8511-5f0278497c04" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtSummaryofLongTermDebtDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtSummaryofLongTermDebtDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtSummaryofLongTermDebtDetail" xlink:type="extended" id="iedc7a73586e64315a3ee06819b2ef2c4_DebtSummaryofLongTermDebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6176be5e-44ec-46d5-99dd-73fd8121293d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6176be5e-44ec-46d5-99dd-73fd8121293d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e985b197-cbbf-48a9-99e4-c8e35a50f501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e985b197-cbbf-48a9-99e4-c8e35a50f501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:to="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:to="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_306547db-b1d0-48e5-b6f0-6d365835d66a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_306547db-b1d0-48e5-b6f0-6d365835d66a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_97738ab7-d812-459f-a32c-a8d88a9cba30" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_97738ab7-d812-459f-a32c-a8d88a9cba30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_5205bb5b-1158-4587-be77-58190a606e25" xlink:href="bdx-20220930.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.401dueMay242023Member_5205bb5b-1158-4587-be77-58190a606e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_1939324a-7706-4c20-8374-e04667b59f24" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0.632dueJune42023Member_1939324a-7706-4c20-8374-e04667b59f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_c2ffaf02-9dac-4bec-832a-0c2a48c79a34" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0000DueAugust132023Member_c2ffaf02-9dac-4bec-832a-0c2a48c79a34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.875dueMay152024Member_8fb78981-583c-4889-aa04-07487bb593c6" xlink:href="bdx-20220930.xsd#bdx_Notes3.875dueMay152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.875dueMay152024Member_8fb78981-583c-4889-aa04-07487bb593c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.363DueJune62024Member_7d48e2b3-b78a-4350-a997-512db5490add" xlink:href="bdx-20220930.xsd#bdx_Notes3.363DueJune62024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.363DueJune62024Member_7d48e2b3-b78a-4350-a997-512db5490add" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.734DueDecember152024Member_4c0e86ea-7944-4364-bbd6-0edda6de849e" xlink:href="bdx-20220930.xsd#bdx_Notes3.734DueDecember152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.734DueDecember152024Member_4c0e86ea-7944-4364-bbd6-0edda6de849e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.02dueMay242025Member_d5371464-3980-4f72-9b2f-080d8a91e8b5" xlink:href="bdx-20220930.xsd#bdx_Notes3.02dueMay242025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.02dueMay242025Member_d5371464-3980-4f72-9b2f-080d8a91e8b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_e6e82782-83e5-4e67-9e57-0a5717bf3d5d" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0034DueAugust132025Member_e6e82782-83e5-4e67-9e57-0a5717bf3d5d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_b142a5f8-21f1-4c7d-94e1-7c1166e3b49a" xlink:href="bdx-20220930.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.208dueJune42026Member_b142a5f8-21f1-4c7d-94e1-7c1166e3b49a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6.700dueDecember12026Member_21d00cf8-4569-4cfc-91d1-1c2d35374b54" xlink:href="bdx-20220930.xsd#bdx_Notes6.700dueDecember12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes6.700dueDecember12026Member_21d00cf8-4569-4cfc-91d1-1c2d35374b54" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_919fa1d0-5491-4560-ba91-ca2a461393d2" xlink:href="bdx-20220930.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_919fa1d0-5491-4560-ba91-ca2a461393d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.700dueJune62027Member_105f7f79-6d49-4990-b256-a2005d485c95" xlink:href="bdx-20220930.xsd#bdx_Notes3.700dueJune62027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.700dueJune62027Member_105f7f79-6d49-4990-b256-a2005d485c95" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2027Member_6dc5d97d-3cb1-410e-9e0e-f472171de799" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_DebenturesDue2027Member_6dc5d97d-3cb1-410e-9e0e-f472171de799" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2028Member_a22b4903-1714-4261-bba2-5e8ef0d752c8" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_DebenturesDue2028Member_a22b4903-1714-4261-bba2-5e8ef0d752c8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0334DueAugust132028Member_8cfde1d5-24a4-494a-bc5e-269f3877a865" xlink:href="bdx-20220930.xsd#bdx_Notes0334DueAugust132028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0334DueAugust132028Member_8cfde1d5-24a4-494a-bc5e-269f3877a865" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes2823DueMay202030Member_7337c7f6-5a41-40a4-80a0-f940f827f61e" xlink:href="bdx-20220930.xsd#bdx_Notes2823DueMay202030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes2823DueMay202030Member_7337c7f6-5a41-40a4-80a0-f940f827f61e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1957DueFebruary112031Member_0ea54f5e-38a5-43b3-94cf-a7c8f6305ec5" xlink:href="bdx-20220930.xsd#bdx_Notes1957DueFebruary112031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1957DueFebruary112031Member_0ea54f5e-38a5-43b3-94cf-a7c8f6305ec5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4298DueAugust222032Member_d99a49b1-6619-46f4-a627-db7e36e3fbcb" xlink:href="bdx-20220930.xsd#bdx_Notes4298DueAugust222032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4298DueAugust222032Member_d99a49b1-6619-46f4-a627-db7e36e3fbcb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_2781274b-d2bb-4e3d-8f0c-1d067507501f" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_2781274b-d2bb-4e3d-8f0c-1d067507501f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2039Member_0ae05f62-54d1-477d-8159-a55c749334f7" xlink:href="bdx-20220930.xsd#bdx_NotesDue2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_NotesDue2039Member_0ae05f62-54d1-477d-8159-a55c749334f7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2040Member_47d7b065-9cf5-4564-b058-06fc15d8a8c9" xlink:href="bdx-20220930.xsd#bdx_NotesDue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_NotesDue2040Member_47d7b065-9cf5-4564-b058-06fc15d8a8c9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1336DueAugust132041Member_79f5a281-0dc0-4025-aef0-bbe33ec91809" xlink:href="bdx-20220930.xsd#bdx_Notes1336DueAugust132041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1336DueAugust132041Member_79f5a281-0dc0-4025-aef0-bbe33ec91809" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.875dueMay152044Member_2c5a6ee1-22dd-4e16-840e-51aab3a12cd6" xlink:href="bdx-20220930.xsd#bdx_Notes4.875dueMay152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4.875dueMay152044Member_2c5a6ee1-22dd-4e16-840e-51aab3a12cd6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.685dueDecember152044Member_1de24ab0-d572-4e95-905b-526028a8d742" xlink:href="bdx-20220930.xsd#bdx_Notes4.685dueDecember152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4.685dueDecember152044Member_1de24ab0-d572-4e95-905b-526028a8d742" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.669DueJune62047Member_675a48e0-99c1-45a8-bcac-d839e9dc2181" xlink:href="bdx-20220930.xsd#bdx_Notes4.669DueJune62047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4.669DueJune62047Member_675a48e0-99c1-45a8-bcac-d839e9dc2181" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3794DueMay202050Member_24d1dc4f-3059-4435-9a63-159a8d52c8f6" xlink:href="bdx-20220930.xsd#bdx_Notes3794DueMay202050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3794DueMay202050Member_24d1dc4f-3059-4435-9a63-159a8d52c8f6" xlink:type="arc" order="26"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtScheduleofDebtIssuancesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails" xlink:type="extended" id="id9bcf43603e44757ab81cdbbd743904b_DebtScheduleofDebtIssuancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5ea2e61d-5d8e-4562-aea9-bb6a900d7c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5ea2e61d-5d8e-4562-aea9-bb6a900d7c4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3a1dc614-a9b1-4496-9b89-2828ca4471e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3a1dc614-a9b1-4496-9b89-2828ca4471e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:to="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:to="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4298DueAugust222032Member_91c2c310-ce3d-442b-a4bf-3213f9d00357" xlink:href="bdx-20220930.xsd#bdx_Notes4298DueAugust222032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes4298DueAugust222032Member_91c2c310-ce3d-442b-a4bf-3213f9d00357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1957DueFebruary112031Member_7a446249-30bd-416e-9b80-32411768e0ef" xlink:href="bdx-20220930.xsd#bdx_Notes1957DueFebruary112031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes1957DueFebruary112031Member_7a446249-30bd-416e-9b80-32411768e0ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3125DueNovember82021Member_438a6223-e800-4089-9524-4fc2985c30d7" xlink:href="bdx-20220930.xsd#bdx_Notes3125DueNovember82021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes3125DueNovember82021Member_438a6223-e800-4089-9524-4fc2985c30d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_4f197726-98d8-4531-a468-5848d70cbf07" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0000DueAugust132023Member_4f197726-98d8-4531-a468-5848d70cbf07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_e71c6d18-05da-4e83-a61d-56a4d07b17ce" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0034DueAugust132025Member_e71c6d18-05da-4e83-a61d-56a4d07b17ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0334DueAugust132028Member_f23c464d-6dd4-4f5c-8ce7-42ee6753b425" xlink:href="bdx-20220930.xsd#bdx_Notes0334DueAugust132028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0334DueAugust132028Member_f23c464d-6dd4-4f5c-8ce7-42ee6753b425" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1336DueAugust132041Member_a1ebaacc-75ca-49b7-92f6-abf6de91adff" xlink:href="bdx-20220930.xsd#bdx_Notes1336DueAugust132041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes1336DueAugust132041Member_a1ebaacc-75ca-49b7-92f6-abf6de91adff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_6a9fa2d5-bc86-40d7-8cc0-0536948fade9" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_6a9fa2d5-bc86-40d7-8cc0-0536948fade9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.174dueJune42021Member_b4cb4240-aea2-430b-b6df-13257fa82e5e" xlink:href="bdx-20220930.xsd#bdx_Notes0.174dueJune42021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0.174dueJune42021Member_b4cb4240-aea2-430b-b6df-13257fa82e5e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:to="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_cc7113c4-812d-4fbb-8055-dded1121f18a_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:to="loc_currency_AllCurrenciesDomain_cc7113c4-812d-4fbb-8055-dded1121f18a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:to="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_3f9c4e13-ce6b-45ff-a9e9-580f3aad4a34" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:to="loc_currency_EUR_3f9c4e13-ce6b-45ff-a9e9-580f3aad4a34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_90d6f58d-f0ab-4709-afd5-e8de0965dec4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:to="loc_currency_USD_90d6f58d-f0ab-4709-afd5-e8de0965dec4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtExtinguishmentsofDebtDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtExtinguishmentsofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/DebtExtinguishmentsofDebtDetails" xlink:type="extended" id="idf8b97b17ef24b49984202f23cf8f38d_DebtExtinguishmentsofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_a47f6ddb-a465-4ce5-b1c3-dde33a5f25e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_a47f6ddb-a465-4ce5-b1c3-dde33a5f25e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d8068aa5-ef92-4263-9d30-0281253f9223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d8068aa5-ef92-4263-9d30-0281253f9223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_33605fdb-958a-4c9a-8f09-73e5e3938b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_33605fdb-958a-4c9a-8f09-73e5e3938b79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_3e3335bd-35bf-4039-9727-6e4190506925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_3e3335bd-35bf-4039-9727-6e4190506925" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_acad96c3-48c3-41f8-8696-33dba8cbfe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_acad96c3-48c3-41f8-8696-33dba8cbfe2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BdxGainlossfromreversetrasurylocks_fa05c7d2-351f-4a09-9526-5c266554522f" xlink:href="bdx-20220930.xsd#bdx_BdxGainlossfromreversetrasurylocks"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_bdx_BdxGainlossfromreversetrasurylocks_fa05c7d2-351f-4a09-9526-5c266554522f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_91867228-abc0-48ef-9c38-e13e2c08a573_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_91867228-abc0-48ef-9c38-e13e2c08a573_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3794DueMay202050Member_a41d7bb7-9ded-4d05-a5f0-c8c3d67fd210" xlink:href="bdx-20220930.xsd#bdx_Notes3794DueMay202050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3794DueMay202050Member_a41d7bb7-9ded-4d05-a5f0-c8c3d67fd210" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2027Member_4945187c-4bd0-4678-8e92-1f0f7c5367ad" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_DebenturesDue2027Member_4945187c-4bd0-4678-8e92-1f0f7c5367ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2028Member_bd30f2fd-2800-43f8-97fe-4d85d1dd010e" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_DebenturesDue2028Member_bd30f2fd-2800-43f8-97fe-4d85d1dd010e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2039Member_384f0567-c1eb-4024-bdcb-81b72dc398cf" xlink:href="bdx-20220930.xsd#bdx_NotesDue2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_NotesDue2039Member_384f0567-c1eb-4024-bdcb-81b72dc398cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2040Member_538afa31-e54c-480f-9d6c-ca7db63f5154" xlink:href="bdx-20220930.xsd#bdx_NotesDue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_NotesDue2040Member_538afa31-e54c-480f-9d6c-ca7db63f5154" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.685dueDecember152044Member_089db4b3-015a-472a-8f00-7ce623e6627d" xlink:href="bdx-20220930.xsd#bdx_Notes4.685dueDecember152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes4.685dueDecember152044Member_089db4b3-015a-472a-8f00-7ce623e6627d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes2894DueJune62022Member_286c78d2-5d63-45e2-8287-d9814be81e37" xlink:href="bdx-20220930.xsd#bdx_Notes2894DueJune62022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes2894DueJune62022Member_286c78d2-5d63-45e2-8287-d9814be81e37" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.300dueMarch12023Member_a9a4feff-9f7d-447b-a5e8-b1c08459f8b6" xlink:href="bdx-20220930.xsd#bdx_Notes3.300dueMarch12023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.300dueMarch12023Member_a9a4feff-9f7d-447b-a5e8-b1c08459f8b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.875dueMay152024Member_56917ea9-70fe-4018-a6b5-5c53b46f8c33" xlink:href="bdx-20220930.xsd#bdx_Notes3.875dueMay152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.875dueMay152024Member_56917ea9-70fe-4018-a6b5-5c53b46f8c33" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.734DueDecember152024Member_725573f5-dcb5-4d6b-b4a1-3988f4fb5548" xlink:href="bdx-20220930.xsd#bdx_Notes3.734DueDecember152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.734DueDecember152024Member_725573f5-dcb5-4d6b-b4a1-3988f4fb5548" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.363DueJune62024Member_fdba2013-ffea-4a8f-9ef6-8cea94408437" xlink:href="bdx-20220930.xsd#bdx_Notes3.363DueJune62024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.363DueJune62024Member_fdba2013-ffea-4a8f-9ef6-8cea94408437" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3125DueNovember82021Member_3a77c564-1898-421a-8196-a8146ac071d7" xlink:href="bdx-20220930.xsd#bdx_Notes3125DueNovember82021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3125DueNovember82021Member_3a77c564-1898-421a-8196-a8146ac071d7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.174dueJune42021Member_f25c9ef9-1207-43eb-ba7b-60ef4f9de1e9" xlink:href="bdx-20220930.xsd#bdx_Notes0.174dueJune42021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes0.174dueJune42021Member_f25c9ef9-1207-43eb-ba7b-60ef4f9de1e9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_315c0455-55e8-4b70-aff2-0f7c609d3fc0_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:to="loc_currency_AllCurrenciesDomain_315c0455-55e8-4b70-aff2-0f7c609d3fc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:to="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7c2f001d-364a-4be8-a1ac-821ab0899a3c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:to="loc_currency_EUR_7c2f001d-364a-4be8-a1ac-821ab0899a3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_29558ea0-9496-4892-95d9-6f6bdba110f8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:to="loc_currency_USD_29558ea0-9496-4892-95d9-6f6bdba110f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_6bb132ab-7ba5-41c1-834a-80479c48a325_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_6bb132ab-7ba5-41c1-834a-80479c48a325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1bb0698e-79d3-427c-9efa-a68be35fa7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1bb0698e-79d3-427c-9efa-a68be35fa7ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_31f93121-ba68-4952-b730-c27f16a89ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1bb0698e-79d3-427c-9efa-a68be35fa7ed" xlink:to="loc_us-gaap_LongTermDebtMember_31f93121-ba68-4952-b730-c27f16a89ad1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended" id="i1308cc3e7b9f4848915ceee26182e8dd_IncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncomeTaxLineItems_33a8809f-b1eb-4ea9-bc52-c07d37f4ac11" xlink:href="bdx-20220930.xsd#bdx_IncomeTaxLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IndemnificationLiabilityNoncurrent_9f231d44-c08e-44d9-9ecf-bd7dc5fb7eaa" xlink:href="bdx-20220930.xsd#bdx_IndemnificationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdx_IncomeTaxLineItems_33a8809f-b1eb-4ea9-bc52-c07d37f4ac11" xlink:to="loc_bdx_IndemnificationLiabilityNoncurrent_9f231d44-c08e-44d9-9ecf-bd7dc5fb7eaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:href="bdx-20220930.xsd#bdx_IncomeTaxTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bdx_IncomeTaxLineItems_33a8809f-b1eb-4ea9-bc52-c07d37f4ac11" xlink:to="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_03b07416-9c63-4635-a4e3-5468fe79ee81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_03b07416-9c63-4635-a4e3-5468fe79ee81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1779f514-3417-4c8f-a742-5a3b6872fc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1779f514-3417-4c8f-a742-5a3b6872fc9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_656b4dee-6a8f-4171-93e1-9c637f2673ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1779f514-3417-4c8f-a742-5a3b6872fc9a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_656b4dee-6a8f-4171-93e1-9c637f2673ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/LeasesDetails" xlink:type="extended" id="ic01406515e7e4cada45205f93556793b_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_934de97a-3034-4afa-a232-5242f4766a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_934de97a-3034-4afa-a232-5242f4766a45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7be7c7ad-ef48-4a33-9a55-ca8d9db87788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7be7c7ad-ef48-4a33-9a55-ca8d9db87788" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5ece3c30-145c-4ab2-94ac-2b903364510d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5ece3c30-145c-4ab2-94ac-2b903364510d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_32714957-29d7-4b40-816c-d600ba6d67dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_OperatingLeaseCost_32714957-29d7-4b40-816c-d600ba6d67dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GrossProceedsFromSaleLeasebackTransaction_cf209eaf-02f2-48c6-a870-8652ae747e50" xlink:href="bdx-20220930.xsd#bdx_GrossProceedsFromSaleLeasebackTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_bdx_GrossProceedsFromSaleLeasebackTransaction_cf209eaf-02f2-48c6-a870-8652ae747e50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_f473f27b-85f1-40df-ae78-4c68b0a742c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_f473f27b-85f1-40df-ae78-4c68b0a742c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_79a163cb-14ee-46da-b0cc-8f5fd6c104f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_79a163cb-14ee-46da-b0cc-8f5fd6c104f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aa46488f-de0b-45b5-8ee7-f5384b568d40_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:to="loc_srt_RangeMember_aa46488f-de0b-45b5-8ee7-f5384b568d40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:to="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1a582fea-93e8-4ea4-93ff-cdc3a8856a5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:to="loc_srt_MinimumMember_1a582fea-93e8-4ea4-93ff-cdc3a8856a5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5314a736-9b49-4452-bc2a-5123f504f3ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:to="loc_srt_MaximumMember_5314a736-9b49-4452-bc2a-5123f504f3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2cf9ef00-9a0d-43d8-a899-2b57803e4f84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2cf9ef00-9a0d-43d8-a899-2b57803e4f84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8641c613-f192-456a-86b6-22d1686bb36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8641c613-f192-456a-86b6-22d1686bb36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_abfc917f-76e1-418b-85c5-5b2b3e36a816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8641c613-f192-456a-86b6-22d1686bb36e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_abfc917f-76e1-418b-85c5-5b2b3e36a816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNameDomain_1fb531a0-ef57-4bdf-99e1-5df75e2b8073_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:to="loc_us-gaap_SaleLeasebackTransactionNameDomain_1fb531a0-ef57-4bdf-99e1-5df75e2b8073_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNameDomain_f9681a5e-a3e9-4875-8e1d-3460bb082fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:to="loc_us-gaap_SaleLeasebackTransactionNameDomain_f9681a5e-a3e9-4875-8e1d-3460bb082fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SaleLeasebackTransactionTermOfContractMember_d75162d1-6bf5-4f2c-b695-b0d1b5832e5b" xlink:href="bdx-20220930.xsd#bdx_SaleLeasebackTransactionTermOfContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleLeasebackTransactionNameDomain_f9681a5e-a3e9-4875-8e1d-3460bb082fbd" xlink:to="loc_bdx_SaleLeasebackTransactionTermOfContractMember_d75162d1-6bf5-4f2c-b695-b0d1b5832e5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationOtherIncomeExpenseNetDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail" xlink:type="extended" id="ica374bea901144a9a0e58ad6b3d4c5ad_SupplementalFinancialInformationOtherIncomeExpenseNetDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4e8d9b68-9638-41fa-91b2-f366f038c058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4e8d9b68-9638-41fa-91b2-f366f038c058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredCompensationInvestmentIncomeExpense_e485c5ff-ee4a-4a67-8955-eefbea38ddad" xlink:href="bdx-20220930.xsd#bdx_DeferredCompensationInvestmentIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_bdx_DeferredCompensationInvestmentIncomeExpense_e485c5ff-ee4a-4a67-8955-eefbea38ddad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a42a14a-6727-467d-9e46-65c23c6fbc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a42a14a-6727-467d-9e46-65c23c6fbc9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_0f9a7131-2324-46f0-971a-0a94a2488ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_0f9a7131-2324-46f0-971a-0a94a2488ab1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_5821edcb-0e1a-4694-95e6-53d648ce0d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_5821edcb-0e1a-4694-95e6-53d648ce0d4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EmbectaServicesAgreementIncomeLossNet_bebf9ec2-26a1-4e39-837e-f401e596874d" xlink:href="bdx-20220930.xsd#bdx_EmbectaServicesAgreementIncomeLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_bdx_EmbectaServicesAgreementIncomeLossNet_bebf9ec2-26a1-4e39-837e-f401e596874d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_befacdba-a627-46f4-a0d1-900176ed6057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_OtherNonoperatingExpense_befacdba-a627-46f4-a0d1-900176ed6057" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_31ebe132-5425-4cbe-82b7-601d032cd66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_31ebe132-5425-4cbe-82b7-601d032cd66d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PensionSettlementExpense_9a9ea472-9210-4c0d-8779-85112f292410" xlink:href="bdx-20220930.xsd#bdx_PensionSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_bdx_PensionSettlementExpense_9a9ea472-9210-4c0d-8779-85112f292410" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cfe32228-7e8a-4b44-87f2-d707a27e3f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cfe32228-7e8a-4b44-87f2-d707a27e3f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_f223fbfe-42d9-4bfc-bf21-f967447696bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cfe32228-7e8a-4b44-87f2-d707a27e3f39" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_f223fbfe-42d9-4bfc-bf21-f967447696bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:to="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_44a46646-9cb8-4ae0-b47e-44d3de1868c2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:to="loc_srt_SegmentGeographicalDomain_44a46646-9cb8-4ae0-b47e-44d3de1868c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_842f967d-d41e-4893-8efb-09f7b8d22785" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:to="loc_srt_SegmentGeographicalDomain_842f967d-d41e-4893-8efb-09f7b8d22785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_18466986-3a5a-4a04-9020-c1f82307e503" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_842f967d-d41e-4893-8efb-09f7b8d22785" xlink:to="loc_country_US_18466986-3a5a-4a04-9020-c1f82307e503" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail" xlink:type="extended" id="i92ae69d69ec9432f91ce8b6bb3331aaa_SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_13871325-1c5b-4351-a809-5b235c8dcbdd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_13871325-1c5b-4351-a809-5b235c8dcbdd" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b517dac8-e23b-45d6-9787-7190997b830f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b517dac8-e23b-45d6-9787-7190997b830f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8997af5d-e24e-4abf-b6fa-78d599e7a68c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8997af5d-e24e-4abf-b6fa-78d599e7a68c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_ee39128a-6ee1-49d3-9b12-d54859b30277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_ee39128a-6ee1-49d3-9b12-d54859b30277" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_33652afe-063c-43d1-abf3-a2b013e4a983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_13871325-1c5b-4351-a809-5b235c8dcbdd" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_0d42d80f-ed8f-4389-966e-aad030289ac7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_0d42d80f-ed8f-4389-966e-aad030289ac7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_cb4ed2e5-2dd7-4224-b38c-cc6a8c309567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_cb4ed2e5-2dd7-4224-b38c-cc6a8c309567" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ReserveforCashDiscountsMember_3d83634e-9c3c-4187-ab76-236f17b271b7" xlink:href="bdx-20220930.xsd#bdx_ReserveforCashDiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:to="loc_bdx_ReserveforCashDiscountsMember_3d83634e-9c3c-4187-ab76-236f17b271b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>bdx-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:92e3b16d-7e78-4ff6-96a7-c06fc2ba1c8c,g:ca0678f9-8390-47c3-8185-7628d34a94cf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_6ad4014d-f03f-45fe-ac5a-a948b7285527_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_84aa6a24-20be-4fba-bac1-bf5e0da37809_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:to="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_e91b83c7-1244-4a72-8522-fd297f8d990f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock_ef28c2a5-bcfc-4a0a-9c73-826cce116aba_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuances</link:label>
    <link:label id="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock_label_en-US" xlink:label="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuances [Table Text Block]</link:label>
    <link:label id="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock_documentation_en-US" xlink:label="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfDebtIssuancesTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfDebtIssuancesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfDebtIssuancesTableTextBlock" xlink:to="lab_bdx_ScheduleOfDebtIssuancesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_a79b15e0-5f8e-4820-b6e7-d9f69ee32e64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_538e70e4-6a26-471e-b948-b76202b9c1c4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_d26d8ffa-006e-42b8-b8df-058e13ad919d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_b54e1408-747f-4742-a524-2984d5a54b31_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leaseholds and Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_818ff79a-1998-46e6-a791-e2b0462ad1d2_terseLabel_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems</link:label>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_label_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems [Member]</link:label>
    <link:label id="lab_bdx_PharmaceuticalSystemsMember_documentation_en-US" xlink:label="lab_bdx_PharmaceuticalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember" xlink:href="bdx-20220930.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PharmaceuticalSystemsMember" xlink:to="lab_bdx_PharmaceuticalSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_6a49d36a-569a-4045-aa0d-aacc5725ea3c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_be16eb47-9f64-49e4-876d-77f2e9a9ef57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Certain Components of Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_56350f17-dd33-48c6-a882-21683a0f1486_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_1ad77ae7-a5cc-44c8-97ab-ea0d730bc806_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans with Accumulated Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_338c336d-9297-4135-9ed9-c0ba77f7b9f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_e51b89db-718c-43af-b779-724df29e8e52_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_c00a9ac7-1f64-4ffe-9dbe-c5a66fac2858_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_4ac014df-bb8a-41b2-ba51-e8ec5e62a4b2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_59a19a2f-50c2-4ee8-ad2b-e9feb8eaa1ce_terseLabel_en-US" xlink:label="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shares to be Delivered Under Accelerated Share Repurchase Program</link:label>
    <link:label id="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_label_en-US" xlink:label="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shares to be Delivered Under Accelerated Share Repurchase Program</link:label>
    <link:label id="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_documentation_en-US" xlink:label="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shares to be Delivered Under Accelerated Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" xlink:href="bdx-20220930.xsd#bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" xlink:to="lab_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b998a275-63c2-4dc4-b5f2-d4176cf6f671_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_3a9afd0c-fb69-4b60-bcdd-24c51ed5ef88_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, aggregate intrinsic value, vested and expected to vest</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate intrinsic value for stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_08063f8b-b7bf-45fc-959f-0d557d518903_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_8ea72c49-f953-44f6-9dd5-f62e738f505d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_ad7e7055-2f78-4e94-81ec-382e978690ce_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_28842db2-cabe-4ce7-9f60-0c555d47c55b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0dfaa8cf-a7f7-49c4-a6f7-53f43122bda1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_9e957b36-849d-4d71-b63c-9023a6630df9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_7732b36c-05d0-41b5-83cc-2f31d5d75494_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_7a9839f9-9d27-4a09-a96c-e353f940fe38_terseLabel_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.900% Notes due December 15, 2026</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_label_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member" xlink:href="bdx-20220930.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.900dueDecember152026Member" xlink:to="lab_bdx_Notes1.900dueDecember152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_46b344c9-9b0d-4b34-a321-c7b06448c0f9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded Status at September&#160;30:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStock_eda42979-5539-471d-b396-695008851162_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStock" xlink:to="lab_us-gaap_DividendsPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ba813521-0428-46af-afd1-d716698b09fb_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local, including Puerto Rico</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_4c36cd89-e318-46f8-8130-e18dc1c4d6d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_4d1c49df-ddd2-4934-8523-f3460ed62683_periodStartLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, beginning balance (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_220b122b-b965-4794-8a09-c2b2f025a504_periodEndLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, ending balance (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Number</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of stock appreciation rights that validly exist and are outstanding as of the balance sheet date, including vested options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e384bdff-f799-4aca-bb25-350a560989d7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_b02fe17a-364c-46f0-bbb2-fd2ab8ae9363_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_df20fbbc-ed98-4662-9671-bb714f8ed41a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FairValueOfStockAppreciationRights_65e248c2-77eb-4802-97b4-b8bdb7f4bc89_terseLabel_en-US" xlink:label="lab_bdx_FairValueOfStockAppreciationRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of SARs vested</link:label>
    <link:label id="lab_bdx_FairValueOfStockAppreciationRights_label_en-US" xlink:label="lab_bdx_FairValueOfStockAppreciationRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Stock Appreciation Rights</link:label>
    <link:label id="lab_bdx_FairValueOfStockAppreciationRights_documentation_en-US" xlink:label="lab_bdx_FairValueOfStockAppreciationRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total fair value of stock appreciation rights that have vested during the fiscal year period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfStockAppreciationRights" xlink:href="bdx-20220930.xsd#bdx_FairValueOfStockAppreciationRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FairValueOfStockAppreciationRights" xlink:to="lab_bdx_FairValueOfStockAppreciationRights" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OthersCountryMember_1e4c2b64-6a3c-4926-8208-90e240e759cd_terseLabel_en-US" xlink:label="lab_bdx_OthersCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bdx_OthersCountryMember_label_en-US" xlink:label="lab_bdx_OthersCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others Country [Member]</link:label>
    <link:label id="lab_bdx_OthersCountryMember_documentation_en-US" xlink:label="lab_bdx_OthersCountryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others Country [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OthersCountryMember" xlink:href="bdx-20220930.xsd#bdx_OthersCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OthersCountryMember" xlink:to="lab_bdx_OthersCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_b180116c-61e8-4076-aec5-d03716048967_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_87508125-126b-4b50-aedf-b7b12c892e1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_281dc03b-1b33-4e0e-89eb-cf819b075392_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cb0dc56c-1910-4d78-a973-7d848d5f2489_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2bbc1562-b099-476a-bc32-a8adcdc791af_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_54871a03-151c-47dc-bde1-53467399711f_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_2c64241c-7d86-491b-89cf-d58db2e38a69_terseLabel_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate liability</link:label>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_label_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Rebate Liability</link:label>
    <link:label id="lab_bdx_ContractWithCustomerRebateLiability_documentation_en-US" xlink:label="lab_bdx_ContractWithCustomerRebateLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Rebate Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability" xlink:href="bdx-20220930.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ContractWithCustomerRebateLiability" xlink:to="lab_bdx_ContractWithCustomerRebateLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock_5dd170de-be33-48e5-8424-1d47bc12aa6e_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised [Table Text Block]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the intrinsic value, tax benefits, and fair value of stock appreciation rights exercised during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_34d410b4-ce5b-432d-ab6f-203f54ce6f9e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue_c945f358-001c-4cf7-b366-2414590f2cef_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of SARs exercised</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total accumulated difference between fair values of underlying shares on dates of exercise and exercise price on stock appreciation rights which were exercised during the reporting period under the plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_71618599-e1e5-4e7d-b9ca-9b1f1c4656d9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_17196479-47aa-4adf-a505-8b244474b84f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_6f80c01f-83e1-45cb-bd25-5eaa98280a23_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ce718b4d-ff3c-4b70-99fe-1d7ef780f607_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning fair value</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b3febe32-2d80-4173-8e9c-511c10cab257_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending fair value</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c89bcc8d-8cd7-4ca6-bf1d-477599a54f57_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets at fair value</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3ab8147e-7d7a-4fbb-939a-be13db493262_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1b541f65-74e8-40b5-b5d0-1dd894f29dd8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_945661ff-2841-4433-a28a-15da59114064_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0d4f463f-bcb4-44c0-afc1-f88744dd37fb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_LettersOfCreditIssuableUnderCreditFacility_f6525654-6958-4880-a77c-84a540d310c4_terseLabel_en-US" xlink:label="lab_bdx_LettersOfCreditIssuableUnderCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters Of Credit Issuable Under Credit Facility</link:label>
    <link:label id="lab_bdx_LettersOfCreditIssuableUnderCreditFacility_label_en-US" xlink:label="lab_bdx_LettersOfCreditIssuableUnderCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters Of Credit Issuable Under Credit Facility</link:label>
    <link:label id="lab_bdx_LettersOfCreditIssuableUnderCreditFacility_documentation_en-US" xlink:label="lab_bdx_LettersOfCreditIssuableUnderCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit amount issuable under credit facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LettersOfCreditIssuableUnderCreditFacility" xlink:href="bdx-20220930.xsd#bdx_LettersOfCreditIssuableUnderCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_LettersOfCreditIssuableUnderCreditFacility" xlink:to="lab_bdx_LettersOfCreditIssuableUnderCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_8107a66e-4882-4427-abb6-8723dd52eba1_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a1bfba6c-b16f-4166-a65b-070e23b856d6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PercentOfPlanAssetsForeignPlans_b15f712d-21aa-431f-9eef-2b0dc4177a3a_terseLabel_en-US" xlink:label="lab_bdx_PercentOfPlanAssetsForeignPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total plan assets foreign plans</link:label>
    <link:label id="lab_bdx_PercentOfPlanAssetsForeignPlans_label_en-US" xlink:label="lab_bdx_PercentOfPlanAssetsForeignPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Plan Assets Foreign Plans</link:label>
    <link:label id="lab_bdx_PercentOfPlanAssetsForeignPlans_documentation_en-US" xlink:label="lab_bdx_PercentOfPlanAssetsForeignPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to foreign pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentOfPlanAssetsForeignPlans" xlink:href="bdx-20220930.xsd#bdx_PercentOfPlanAssetsForeignPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PercentOfPlanAssetsForeignPlans" xlink:to="lab_bdx_PercentOfPlanAssetsForeignPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_6c65e464-92d9-4fbc-adcd-e4278ae28589_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_d09a4e94-8c2d-49f8-b0cd-f8c57433d820_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_fa09cd48-e3bc-4460-bbe7-0bf62d46b116_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to settlements with tax authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_91043517-9d8a-448f-a899-9cc96989bb92_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3a22dff3-68dd-4f0a-8399-803a8b92885e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities recorded in Payables, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_7140a5b0-ee48-41a9-8cc8-0a128d024b98_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_7f5ef279-c5ad-4c73-82ef-4277e9bc6b12_terseLabel_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.632% Notes due June 4, 2023</link:label>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_label_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes0.632dueJune42023Member_documentation_en-US" xlink:label="lab_bdx_Notes0.632dueJune42023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.632% due June 4, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0.632dueJune42023Member" xlink:to="lab_bdx_Notes0.632dueJune42023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_87c56ee5-5bb4-417b-a6d4-b58956994cae_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e6d564f2-7550-457a-8aa7-d73ed98fdf74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_1820ce63-b08b-4ecc-9d01-1435313171af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermInvestments" xlink:to="lab_us-gaap_OtherShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_24d4109e-19cf-4898-af67-81b52fa03798_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e1358a8a-d147-4a9b-a994-bdd87bde7e9c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f90898c5-6f34-4e76-a0b5-8993e524fba8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_1fef386c-bdc9-4ccb-b797-4598a8205297_terseLabel_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock held in trusts, net (shares)</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_label_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Held In Trusts Net Shares</link:label>
    <link:label id="lab_bdx_CommonStockHeldInTrustsNetShares_documentation_en-US" xlink:label="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock shares held in trust.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares" xlink:href="bdx-20220930.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockHeldInTrustsNetShares" xlink:to="lab_bdx_CommonStockHeldInTrustsNetShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_ba798dca-2884-4de7-9efc-2cdb4c6cca68_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_fdc5ce8f-46ce-4828-851e-0c33b7f64fa0_terseLabel_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships, Net</link:label>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_label_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Customer Relationships Net</link:label>
    <link:label id="lab_bdx_FiniteLivedCustomerRelationshipsNet_documentation_en-US" xlink:label="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet" xlink:href="bdx-20220930.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteLivedCustomerRelationshipsNet" xlink:to="lab_bdx_FiniteLivedCustomerRelationshipsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_bf095b59-2772-4afd-871c-f3f317c43b44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OrganizationalUnitDomain_1ce45333-0870-4d4a-a259-4f88f9139b43_terseLabel_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Domain]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitDomain_label_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Domain]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitDomain_documentation_en-US" xlink:label="lab_bdx_OrganizationalUnitDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Organizational Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OrganizationalUnitDomain" xlink:to="lab_bdx_OrganizationalUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice_820cdbc8-16a5-4978-a597-de6a3e7de8cd_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, forfeited, canceled or expired (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Forfeited In Period Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average price of stock appreciation rights that were forfeited during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0bd46eb8-6eff-4aa5-bc8a-6d2b2b7ec37b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92563dd8-4659-499f-a0e2-1a5f37664164_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_fbf2a477-6170-4949-9931-aeafbbbd6ab5_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility due December 29, 2022</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7a9f21c1-2d9f-44d2-b8ec-d716efe7c0ed_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bccc8a76-77e2-4606-9eca-353162fa9c28_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_d8b67e98-65f7-4a91-b20f-58a5b37d3b96_terseLabel_en-US" xlink:label="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers accounted for 10% or more of revenues (customers)</link:label>
    <link:label id="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_label_en-US" xlink:label="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customer Accounted For Ten Percent Or More Of Revenue</link:label>
    <link:label id="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_documentation_en-US" xlink:label="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customer Accounted For Ten Percent Or More Of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" xlink:href="bdx-20220930.xsd#bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" xlink:to="lab_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_5cff51a9-70c2-497b-9148-60b5c883b47c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46910f22-4aa5-4e6b-bd71-715d4c461dac_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_31ba1091-3d6e-40a8-a33b-a18fc8e5f4aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units exercise price, beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b4dea7bb-66a0-4779-9883-8e4fe8824a6d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units exercise price, ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProductsandorServicesMember_1f377b19-b7f1-4a99-99ff-35da522a5fd5_terseLabel_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services</link:label>
    <link:label id="lab_bdx_ProductsandorServicesMember_label_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services [Member]</link:label>
    <link:label id="lab_bdx_ProductsandorServicesMember_documentation_en-US" xlink:label="lab_bdx_ProductsandorServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and/or Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember" xlink:href="bdx-20220930.xsd#bdx_ProductsandorServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProductsandorServicesMember" xlink:to="lab_bdx_ProductsandorServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_81904c11-0042-470a-a10b-b50aedd52645_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bf6180f4-4b08-4417-addf-79009e4e3b8e_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, vested and expected to vest (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average exercise price of stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8a02e776-4fdc-4021-81d8-945d65d54b33_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_55b63e82-06b1-44a1-b63d-2985567223ff_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_30f874ca-5aac-4a40-8231-888f47a4a1da_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfTransactions_d5696f83-e58b-43ed-8faa-0f8b7a12fcf4_terseLabel_en-US" xlink:label="lab_bdx_NumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Transactions</link:label>
    <link:label id="lab_bdx_NumberOfTransactions_label_en-US" xlink:label="lab_bdx_NumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Transactions</link:label>
    <link:label id="lab_bdx_NumberOfTransactions_documentation_en-US" xlink:label="lab_bdx_NumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfTransactions" xlink:href="bdx-20220930.xsd#bdx_NumberOfTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfTransactions" xlink:to="lab_bdx_NumberOfTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod_3207358c-d99a-4371-aa1f-52613b64a810_negatedLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, exercised (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stock appreciation rights exercised during the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28b8e3d2-5a00-4c68-9155-9ff30c8aebab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_6a79b2e0-195e-4bca-93b4-1e3586f64733_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_dc4f4687-083c-49fe-886b-8409db9f1c93_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_6cdc3f23-28a1-4ca0-92c5-2a448f77c5e7_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and Financing Receivables</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_527f710b-5715-44d8-be5c-bc4cf79c7a6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_77a2dd14-38b6-4c80-a4de-3f53e817c4b8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3b764cbc-4b11-41ea-89e1-5a23bf1e1b5a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_fd46dc32-e00e-4776-a209-b4aeaedb59f7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_66d0ecd0-32ef-41ff-b311-faed1cd4d44b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.02dueMay242025Member_d8f61b21-c5d9-49e4-8eef-48b2bd025743_terseLabel_en-US" xlink:label="lab_bdx_Notes3.02dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.020% Notes due May 24, 2025</link:label>
    <link:label id="lab_bdx_Notes3.02dueMay242025Member_label_en-US" xlink:label="lab_bdx_Notes3.02dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.02% due May 24, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.02dueMay242025Member_documentation_en-US" xlink:label="lab_bdx_Notes3.02dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.02% due May 24, 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.02dueMay242025Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.02dueMay242025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.02dueMay242025Member" xlink:to="lab_bdx_Notes3.02dueMay242025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_a4f59e7a-6b6c-4803-acda-c23abd18eeeb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation exceeds the fair value of plan assets, fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_9070ed51-05a2-45c2-a97b-f66f9009e0e2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_bfca172a-067e-48ea-8420-13cdf8cfe7ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign income tax at rates other than 21%</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_d898eaf4-217a-46ad-a634-9c3d6b62e4a2_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_RestrictedStockUnitsPerformancePsuMember_1b50c7d2-c65b-44b6-955a-4a18533fd3e9_terseLabel_en-US" xlink:label="lab_bdx_RestrictedStockUnitsPerformancePsuMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:label id="lab_bdx_RestrictedStockUnitsPerformancePsuMember_label_en-US" xlink:label="lab_bdx_RestrictedStockUnitsPerformancePsuMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Performance Psu [Member]</link:label>
    <link:label id="lab_bdx_RestrictedStockUnitsPerformancePsuMember_documentation_en-US" xlink:label="lab_bdx_RestrictedStockUnitsPerformancePsuMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time and when specified performance conditions are met.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_RestrictedStockUnitsPerformancePsuMember" xlink:to="lab_bdx_RestrictedStockUnitsPerformancePsuMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_60aa86cb-5300-409c-8979-1323918ae513_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c96a4f3f-12ef-4ce2-84a1-80552184cf70_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1825f38d-2685-49c7-85d5-a61ba4cba4f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_99f4a0f7-4cbd-400f-9eda-3b38a566c0cc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_574062b1-04ac-4ca6-81af-cafb68342219_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_0be1ea32-0da4-407d-855f-faff9e2d5de7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of gain on divestitures</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_40b50b15-c412-4fff-92d0-6e61f0db4e94_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7f5f0689-d812-48b5-b040-5b0a78c4e5fd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of valuation allowance release</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b936f35c-275d-4a0a-b922-c8224e5897af_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining life non-vested share-based awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes6.700dueDecember12026Member_226639a1-7dc1-45e7-b8de-a898be022642_terseLabel_en-US" xlink:label="lab_bdx_Notes6.700dueDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.700% Notes due December 1, 2026</link:label>
    <link:label id="lab_bdx_Notes6.700dueDecember12026Member_label_en-US" xlink:label="lab_bdx_Notes6.700dueDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.700% due December 1, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes6.700dueDecember12026Member_documentation_en-US" xlink:label="lab_bdx_Notes6.700dueDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.700% due December 1, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6.700dueDecember12026Member" xlink:href="bdx-20220930.xsd#bdx_Notes6.700dueDecember12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes6.700dueDecember12026Member" xlink:to="lab_bdx_Notes6.700dueDecember12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_8e39f8fa-cfb3-4efa-bb70-593390d89e68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash settlements</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7499d409-5431-4e71-afd2-f7daba99e00a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss before reclassifications, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f2180dec-09f1-4350-86ec-04551d3c51ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cb02e396-ed9b-4e4b-be27-f4b64bb5d637_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity registrant name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_fc879f14-7fdc-4cb6-97e3-8ec0340e597e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b2e509a4-137c-4d7e-9f60-b24dc712b36b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9146c600-f5d1-417b-b742-0633cf228928_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionDescriptionAxis_0c36049b-ef84-4add-9c9b-2cb531b1f8df_terseLabel_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Description [Axis]</link:label>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis" xlink:to="lab_us-gaap_SaleLeasebackTransactionDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7eb5ca49-5e37-408f-9094-cb4bef2abac9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_009b455f-92f5-4539-a577-36a2fd99a347_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_fc57f7ec-49ce-4dc9-82d7-dd0b31a3b328_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_a2385bbf-8152-4c2a-9c06-4a8f767bcf63_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_6cdd574a-e0b2-4153-b5f4-397f79a59647_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_82eefc07-a3fd-470e-808f-3e66cc27c1bd_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice_1ef5b996-00ed-46a0-8444-c9ddef2c17fb_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, exercised (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average price at which option holders exercised stock appreciation awards during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9d04facf-9e00-4e32-9847-9729ed6ad52e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity emerging growth company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7f3f9626-68cc-46b3-9e91-28209f9fcf91_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_b9ea8025-b0a8-4936-a04f-0e5184ead959_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_cd40d1e1-b56b-4a4e-8bb8-2740cefda60c_terseLabel_en-US" xlink:label="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance payout, percent</link:label>
    <link:label id="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_label_en-US" xlink:label="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Payout, Percent</link:label>
    <link:label id="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_documentation_en-US" xlink:label="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Payout, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" xlink:href="bdx-20220930.xsd#bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" xlink:to="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_37b3bc04-33de-457c-b1c0-6198bd8ef32b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_bd5d0d60-6e60-48d0-9f33-06e83c0c13b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b9e026a0-ddb7-471d-920a-a5762c40780d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c6a89010-f9be-47f6-9f92-6f31b73106f9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_c62ca475-3df9-40c6-9d1b-48dcf745c0b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Research Credits and FDII/Domestic Production Activities</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_e411e73a-0a02-457c-99e0-fef38eef0c43_terseLabel_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Embecta spin-off</link:label>
    <link:label id="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_label_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets</link:label>
    <link:label id="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_documentation_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change to plan assets which arose from business combination and/or divestiture transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" xlink:to="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7915a13d-4415-4ea8-a1db-aa2307ef0961_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated aggregate amortization expense in 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3fd6ed71-5652-42c1-aa22-23ce2cd503a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_AcceleratedShareRepurchaseProgramMember_dea01f1e-7248-465e-9b79-d73dfecc3387_terseLabel_en-US" xlink:label="lab_bdx_AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program</link:label>
    <link:label id="lab_bdx_AcceleratedShareRepurchaseProgramMember_label_en-US" xlink:label="lab_bdx_AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program [Member]</link:label>
    <link:label id="lab_bdx_AcceleratedShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_bdx_AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcceleratedShareRepurchaseProgramMember" xlink:href="bdx-20220930.xsd#bdx_AcceleratedShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_AcceleratedShareRepurchaseProgramMember" xlink:to="lab_bdx_AcceleratedShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9a2e33fa-9796-4968-b431-7dd1fdf17c01_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_aa91dafb-f89c-4a92-9376-d9d809317d4f_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.700dueJune62027Member_34dd753d-7870-4f68-a10c-bb60cdf44332_terseLabel_en-US" xlink:label="lab_bdx_Notes3.700dueJune62027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% Notes due June 6, 2027</link:label>
    <link:label id="lab_bdx_Notes3.700dueJune62027Member_label_en-US" xlink:label="lab_bdx_Notes3.700dueJune62027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.700% due June 6, 2027 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.700dueJune62027Member_documentation_en-US" xlink:label="lab_bdx_Notes3.700dueJune62027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.700% due June 6, 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.700dueJune62027Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.700dueJune62027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.700dueJune62027Member" xlink:to="lab_bdx_Notes3.700dueJune62027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_b527a89c-aebe-43a4-8e0c-fce029c3e38b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_07f4e6a6-62c3-4372-b69c-1fe1559c0f3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, sock units (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89354d4b-7d1d-4298-aa41-b17971d0916e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_ae869368-1487-4eb4-8eb9-5fd2929c5dd1_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Line Items]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Line Items]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_05b0a3ae-259f-4eb3-901d-d1ffe940768e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_04a93485-5148-4ea2-af1d-e510af626339_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_b872916f-b2fb-4682-be9a-9f2dba755920_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b8bad20b-e41b-475d-a0c8-25982abfe27c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_3ea2961e-6d84-405a-93d7-ed411f2cd85f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cd6ced80-14d1-432e-ad33-cbfb6f77d680_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_c70d1f1a-2886-4050-96e0-049d74999d9e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_dd6823af-4db1-4662-9842-1ae4cf5f9021_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_ca8e797e-c86b-42d7-adc3-65d5a8526fc9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent Liabilities of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_23c3f8ca-e090-4774-b11d-4ce6cd10db71_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent Liabilities of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ce8ab4f5-eadb-4b58-9651-e37d833708d5_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_HerniaProductClaimsMember_43c22edf-7c46-4835-97fa-19bb5ef3f2fa_terseLabel_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims</link:label>
    <link:label id="lab_bdx_HerniaProductClaimsMember_label_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims [Member]</link:label>
    <link:label id="lab_bdx_HerniaProductClaimsMember_documentation_en-US" xlink:label="lab_bdx_HerniaProductClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HerniaProductClaims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember" xlink:href="bdx-20220930.xsd#bdx_HerniaProductClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_HerniaProductClaimsMember" xlink:to="lab_bdx_HerniaProductClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtLineItems_97635da0-0bb7-4b77-a6e8-b9036c7bb856_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems" xlink:to="lab_us-gaap_ExtinguishmentOfDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_73c656a7-5dea-45f4-a051-7fdded8f09d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7e9aba67-0b5d-4478-a436-5c35b639cef5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of restricted stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3404669d-ea9c-4926-af5e-da30b923b430_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8ed576aa-832d-490e-b7f9-fdb49dbf7b00_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_53fe7a4c-e454-4a00-b734-4e2471c9070b_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and All Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_InterestCostsIncurredTableTableTextBlock_574d9e2b-8850-415a-8148-27c9231440bd_terseLabel_en-US" xlink:label="lab_bdx_InterestCostsIncurredTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Interest Costs and Payments</link:label>
    <link:label id="lab_bdx_InterestCostsIncurredTableTableTextBlock_label_en-US" xlink:label="lab_bdx_InterestCostsIncurredTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Incurred Table [Table Text Block]</link:label>
    <link:label id="lab_bdx_InterestCostsIncurredTableTableTextBlock_documentation_en-US" xlink:label="lab_bdx_InterestCostsIncurredTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of interest costs and payments for the periods presented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterestCostsIncurredTableTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_InterestCostsIncurredTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_InterestCostsIncurredTableTableTextBlock" xlink:to="lab_bdx_InterestCostsIncurredTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_b84b632f-c9b8-40a2-bb85-76df45eee237_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6867a241-bbe7-4fa5-8813-77893f10907f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_53472970-28d5-416b-927f-072d9e3cef39_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeasesPolicyTextBlock_c87f0471-7ad2-433f-9ee7-3fdef96f455b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Leases</link:label>
    <link:label id="lab_us-gaap_ShortTermLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortTermLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeasesPolicyTextBlock" xlink:to="lab_us-gaap_ShortTermLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_959b4790-ddd2-4d74-bb76-832a3b22e2b2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_66bc5d1a-bde5-4471-b61c-fb2b2a9b1c5f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e1f365d3-a37c-4a4b-968e-a06728d62247_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity current reporting status</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b4020138-792e-41ca-95ce-948e0952db2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_f55a8f9a-bae4-4d44-a275-4f12576b9935_terseLabel_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment</link:label>
    <link:label id="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_label_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment</link:label>
    <link:label id="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_documentation_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" xlink:to="lab_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_dac16812-d4f6-4006-802f-8b21f19df697_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock_96549ae0-7a8c-4909-a765-c0780aa90573_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted [Table Text Block]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_646d4476-724d-464e-a56d-fa09b613f825_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation and other plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_3925bfe0-ccad-4ec6-a739-73f7d4c76010_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs vesting period</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Award Vesting Period</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of the period of time over which an employee's right to exercise an stock appreciation right is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, which may be expressed in a variety of ways (for example, in years, month and year).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember_6ab9fab8-963f-447b-85f0-4a1d064a5dcd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_95265ca2-2db9-4a44-b7e6-5261312ab992_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DebenturesDue2027Member_d343b643-0f0a-4993-bfb5-4de950ea5a0d_terseLabel_en-US" xlink:label="lab_bdx_DebenturesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.000% Debentures due August&#160;1, 2027</link:label>
    <link:label id="lab_bdx_DebenturesDue2027Member_label_en-US" xlink:label="lab_bdx_DebenturesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debentures Due 2027 [Member]</link:label>
    <link:label id="lab_bdx_DebenturesDue2027Member_documentation_en-US" xlink:label="lab_bdx_DebenturesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debentures due 2027.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2027Member" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DebenturesDue2027Member" xlink:to="lab_bdx_DebenturesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_63a6e313-03ff-4048-b243-007e0f448db6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_c95484cb-751f-40b1-91b9-7794780a78cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_79693249-b80a-4f1f-b010-78348e06e690_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_69e1478f-5317-4bcc-8a1c-b0f5cb9cfe45_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_751f8032-5e82-48bd-8f3f-f5d9191cd2b2_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ea3e3820-d629-4713-878a-3ae02242c310_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_ba5c5560-9316-470e-918a-a6e496ec09f3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits interest and penalties reflected in current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_43da9838-449e-4e50-b625-530a10588240_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_69a91b9d-e1d6-40e9-bbb9-ee6e0ad80561_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_42f00300-6e2c-4a00-893e-daf3d08ad452_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_e7121834-a309-4bfd-93a1-c1d199e76c40_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards transferred to Embecta at the spin-off of Embecta (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred in Spinoff Transaction, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred in Spinoff Transaction, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_71612bdb-a7e7-4616-9899-e26cbaaba664_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_237b491d-40dc-4020-ae79-c3c9ae436cc5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document fiscal year focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_d71846b6-25c3-4af8-81d4-c6c194a114a8_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_eaebddf7-4c23-4ab7-ad11-a1e7a1610beb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_7527d451-dd35-45b7-929c-624a20fa8811_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta spin-off adjustment (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Spin-Off Adjustment</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Spin-Off Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.875dueMay152024Member_56773b81-5013-452d-8ea2-8ee9a6f9b87d_terseLabel_en-US" xlink:label="lab_bdx_Notes3.875dueMay152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% Notes due May 15, 2024</link:label>
    <link:label id="lab_bdx_Notes3.875dueMay152024Member_label_en-US" xlink:label="lab_bdx_Notes3.875dueMay152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.875% due May 15, 2024 Member</link:label>
    <link:label id="lab_bdx_Notes3.875dueMay152024Member_documentation_en-US" xlink:label="lab_bdx_Notes3.875dueMay152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.875% due May 15, 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.875dueMay152024Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.875dueMay152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.875dueMay152024Member" xlink:to="lab_bdx_Notes3.875dueMay152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes4298DueAugust222032Member_e89c3a48-61a4-470f-a661-74b389a6e292_terseLabel_en-US" xlink:label="lab_bdx_Notes4298DueAugust222032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.298% Notes due August 22, 2032</link:label>
    <link:label id="lab_bdx_Notes4298DueAugust222032Member_label_en-US" xlink:label="lab_bdx_Notes4298DueAugust222032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.298% due August 22, 2032 [Member]</link:label>
    <link:label id="lab_bdx_Notes4298DueAugust222032Member_documentation_en-US" xlink:label="lab_bdx_Notes4298DueAugust222032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.298% due August 22, 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4298DueAugust222032Member" xlink:href="bdx-20220930.xsd#bdx_Notes4298DueAugust222032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes4298DueAugust222032Member" xlink:to="lab_bdx_Notes4298DueAugust222032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_e3b3947e-0c94-4768-afb8-2703471a7480_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca2facdc-f14b-479c-aa38-c3e264c1758b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1b5934db-2cfa-47b1-80c6-5fd8fe1e9c34_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_34b65f54-fae3-4186-a3a0-9a669584682f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_f89878fd-2bc0-4ebb-906d-e74453a912f3_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_df38ac23-8739-4b99-a2c3-7e374741aeed_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average remaining contractual term</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average remaining contractual term for outstanding stock appreciation rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d77cc6eb-87dc-444c-a15e-9d35459ec117_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_efbc9c0f-5f41-4d38-96c3-576d5adac14d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_90d3643a-1859-4441-8b3a-46468944d23a_terseLabel_en-US" xlink:label="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Depositary Share Ownership Interest, Percentage</link:label>
    <link:label id="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_label_en-US" xlink:label="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Depositary Share Ownership Interest, Percentage</link:label>
    <link:label id="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_documentation_en-US" xlink:label="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest per depositary share of the Company's preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" xlink:href="bdx-20220930.xsd#bdx_PreferredStockDepositaryShareOwnershipInterestPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" xlink:to="lab_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3305edc7-c929-4243-b397-7df515911059_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_64650cf3-6155-4fa8-8606-5531b3dc122d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_058c9839-eea1-43fa-889e-e2fce43a88c9_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_69343663-23b9-4a1d-8820-ce9f64cfe6b3_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_64caf287-cc7d-4827-b06a-06abbabf6fe1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury, shares (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_f1fe6fdf-ad5c-48d2-985f-4a23478ed54c_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_e798856e-35e4-45bf-a5a2-0d0dc99abda8_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cb3e5dc8-94c3-4738-97a9-0339320083e6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fae532ba-f56a-4daa-8734-b983c0cfdc5a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3d414f29-457b-4aee-8baa-a55ce717e3c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1b408423-758f-42fe-a8ed-4570dd97d167_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_1ffe3eb3-c8bb-4526-a050-e6f3e78d6d1f_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_00bdb97a-0df8-41ff-a14a-4a4ad848ceb8_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f9318e8b-11a2-48db-b33d-45414fefa205_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_fae9fd65-a2bb-43f6-acfa-454de5f52d0f_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity public float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_5f6f63da-4d46-4b12-b948-04b62a7590d9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ce9bc9fd-5f58-41ec-90dd-dfed9f31aafa_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_db4d3b6c-4dc8-4e9a-9e3b-adf978b80c50_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c9087b7-ca24-4e49-af6f-4d6fec443fd4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SharesIssuableUnderDeferredCompensationPlan_1ffa07b3-4da5-4fba-8c42-0e170de0a959_terseLabel_en-US" xlink:label="lab_bdx_SharesIssuableUnderDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable under deferred compensation plan</link:label>
    <link:label id="lab_bdx_SharesIssuableUnderDeferredCompensationPlan_label_en-US" xlink:label="lab_bdx_SharesIssuableUnderDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issuable Under Deferred Compensation Plan</link:label>
    <link:label id="lab_bdx_SharesIssuableUnderDeferredCompensationPlan_documentation_en-US" xlink:label="lab_bdx_SharesIssuableUnderDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issuable under the Company's Deferred Compensation Plan that allows highly-compensated employees to defer salary, annual incentive awards and certain equity-based compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharesIssuableUnderDeferredCompensationPlan" xlink:href="bdx-20220930.xsd#bdx_SharesIssuableUnderDeferredCompensationPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SharesIssuableUnderDeferredCompensationPlan" xlink:to="lab_bdx_SharesIssuableUnderDeferredCompensationPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2df52d83-5ca6-4328-b25f-af4569d05c91_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_5f39e493-883c-4cc6-aabf-d9d69251717d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_4edf206a-35c6-441e-95ea-d0623de19989_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; $1 par value: authorized &#8212; 640,000,000 shares; issued &#8212; 364,639,901 shares in 2022 and 2021.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock_db5e0239-1602-4e28-b8f7-4bc65ca568c2_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table Text Block]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_136c54ca-df28-44de-b2c7-f1e05add0b71_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6ef64d6d-8ffc-4793-87f9-d673c0349163_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ccc34281-ac4d-403c-83e3-91c5c2ca29ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_fd920bf5-b24e-4486-96a2-e989124e9d54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_27401d4f-6628-4f81-b04e-158c195ce45a_negatedTerseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_8a83fa64-2630-4a72-bb5e-d633d8694b0f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_91dcdf17-7e0e-48db-99fa-32d3980e761e_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries, wages and related items</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_517e4689-036c-48d2-8dec-5822c5d0461e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation exceeds the fair value of plan assets, accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_24a68b9f-82bf-4b64-b094-b1753447a4a9_terseLabel_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits, allege injury from unrelated defendants</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_label_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_documentation_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:href="bdx-20220930.xsd#bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:to="lab_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd9d7db8-6864-494a-8fa5-2000fbbf5af4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_611d887b-8cee-4002-b86b-07bd470cf51d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec2d8b17-828d-4b5f-8f05-41356a9cd3e1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_46102059-f97b-4920-b6d0-5c1fcb1b03e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f4dde7be-6cb7-47c1-bb98-50b50f0984f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FixedToFloatingMember_d130eeb8-b3be-45ca-8e27-07f1abd54a67_terseLabel_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating</link:label>
    <link:label id="lab_bdx_FixedToFloatingMember_label_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating [Member]</link:label>
    <link:label id="lab_bdx_FixedToFloatingMember_documentation_en-US" xlink:label="lab_bdx_FixedToFloatingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed To Floating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember" xlink:href="bdx-20220930.xsd#bdx_FixedToFloatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FixedToFloatingMember" xlink:to="lab_bdx_FixedToFloatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9d2f795a-1214-4528-b718-252ff74d83cd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes4.685dueDecember152044Member_ec56b0e5-4ebc-4c83-92c5-e513e5ded60a_terseLabel_en-US" xlink:label="lab_bdx_Notes4.685dueDecember152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.685% Notes due December 15, 2044</link:label>
    <link:label id="lab_bdx_Notes4.685dueDecember152044Member_label_en-US" xlink:label="lab_bdx_Notes4.685dueDecember152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.685% due December 15, 2044 [Member]</link:label>
    <link:label id="lab_bdx_Notes4.685dueDecember152044Member_documentation_en-US" xlink:label="lab_bdx_Notes4.685dueDecember152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.685% due December 15, 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.685dueDecember152044Member" xlink:href="bdx-20220930.xsd#bdx_Notes4.685dueDecember152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes4.685dueDecember152044Member" xlink:to="lab_bdx_Notes4.685dueDecember152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_f9f722f4-b836-4c92-bc8a-b49bef709d49_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fdd7d2d1-7c77-44e8-8073-7a685a718a94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_388c46d1-12a5-4ac4-a132-ab1dd0816056_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining vesting term</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f87ec364-a26e-49cf-858b-a19d4fbd21eb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_04a650c0-47db-4ebe-96fd-f4057319c32f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_53ccfebe-f09a-403a-b9c3-df1788bd05dc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_a3d54f98-5f44-43e0-8cba-3a9dede61525_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OrganizationalUnitAxis_eba97efa-bba4-495f-b826-6b2978b3275b_terseLabel_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitAxis_label_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit [Axis]</link:label>
    <link:label id="lab_bdx_OrganizationalUnitAxis_documentation_en-US" xlink:label="lab_bdx_OrganizationalUnitAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OrganizationalUnitAxis" xlink:to="lab_bdx_OrganizationalUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_690edf99-4b82-4362-a6ad-c6221591e742_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9ee65770-843e-4590-a029-4b9703f7f157_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IndemnificationLiabilityNoncurrent_ed549957-f968-4455-a829-a16b35d68a95_terseLabel_en-US" xlink:label="lab_bdx_IndemnificationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liability, non-current</link:label>
    <link:label id="lab_bdx_IndemnificationLiabilityNoncurrent_label_en-US" xlink:label="lab_bdx_IndemnificationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Liability, Non-current</link:label>
    <link:label id="lab_bdx_IndemnificationLiabilityNoncurrent_documentation_en-US" xlink:label="lab_bdx_IndemnificationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Liability, Non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IndemnificationLiabilityNoncurrent" xlink:href="bdx-20220930.xsd#bdx_IndemnificationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IndemnificationLiabilityNoncurrent" xlink:to="lab_bdx_IndemnificationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_8c11cc76-7e96-495c-9b4b-a8513a05d674_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ParataSystemsMember_ef4a3d39-56b9-4a27-9878-87307a2b4ed5_terseLabel_en-US" xlink:label="lab_bdx_ParataSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parata Systems</link:label>
    <link:label id="lab_bdx_ParataSystemsMember_label_en-US" xlink:label="lab_bdx_ParataSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parata Systems [Member]</link:label>
    <link:label id="lab_bdx_ParataSystemsMember_documentation_en-US" xlink:label="lab_bdx_ParataSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parata Systems</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ParataSystemsMember" xlink:href="bdx-20220930.xsd#bdx_ParataSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ParataSystemsMember" xlink:to="lab_bdx_ParataSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_d0f8632c-83c2-407a-a784-aad7e3b6be7a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Continuing Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_f062e00f-8a70-4fd8-9140-b7bdd9c0b69f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_3c23efed-4bd2-434f-88ef-10de6d2e05b4_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Consideration, Cash</link:label>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_label_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Consideration, Cash</link:label>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_documentation_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Consideration, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:to="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c67b895-69bd-4a81-8932-37a2415897b3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_7494609c-c9e7-4efc-8c4d-cee053db6750_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_08f1ee62-8ac6-47ea-b758-cff11aad3f69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_6c86f4a2-e6f1-4a6a-885b-fecfac0e32f5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9cad778f-59e4-4740-9cd8-4fff6c621ed0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b0cc005a-3fdc-4847-b6d1-33f8cab9c77c_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_b20cf564-21ed-41ff-ba6e-6bf05613b094_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity forward contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_75ac20b5-1f78-42a7-8d38-b7daea5d0888_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1d116cf-8efe-499b-8c7d-9baf069a22e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b2474552-f60f-46e2-923c-3d6f969fde77_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6dab5836-202e-49d6-b0ce-6f9be88b526d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_e006dea2-fc4f-4c7f-a76e-7edc0010d949_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average remaining contractual term, vested and expected to vest</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average remaining contractual term for stock appreciation rights that are fully vested or are expected to vest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_cf08c0b7-53b2-4a2c-aee4-e4a5b51e40bd_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_02b85c03-8662-4ba6-955c-6a222fc67cd8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt and term loans</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_050a4f12-b987-4e8a-8fbe-eb204cf4ebcd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_509fd0bb-c5c6-43a3-918e-4c81d1b5b8fa_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5ef0618a-b30b-4fb0-9fb9-e6c8e801570d_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock &#8212; 81,283,191 shares in 2022 and 80,163,949 shares in 2021.</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_03f67478-29bb-4e1b-b5d0-a6c1b3f7ce59_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3c6b4cf2-2742-4c05-bde0-f2cdd48fc9c2_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension and postretirement plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b829bbc7-ff7a-41ac-8f7a-d9f3ce0d922c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_c75d7bcb-3070-48d2-b45e-ecf255cedea6_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_af3ab8e9-1b30-4bbe-893d-13aec4dd4e19_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-Based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c240f7d8-bb07-4163-a9e3-27b996bd208e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6f5ed5ee-bfd5-4aaf-8694-57192ac803c3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c41c817f-9301-410d-9e71-26aa50d77eed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_982410f4-4ac5-457b-a24d-e46fd907525a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_2d9141dc-5e7a-4510-94f7-8d016403e62f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_616d5f8d-070f-459a-aba9-b47af1aac677_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_276cbcea-aaab-462d-b7f3-93bea36b92ad_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SaleLeasebackTransactionTermOfContractMember_c576067c-eeaa-492c-a116-8cc75c8b9989_terseLabel_en-US" xlink:label="lab_bdx_SaleLeasebackTransactionTermOfContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Term of Contract</link:label>
    <link:label id="lab_bdx_SaleLeasebackTransactionTermOfContractMember_label_en-US" xlink:label="lab_bdx_SaleLeasebackTransactionTermOfContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Term of Contract [Member]</link:label>
    <link:label id="lab_bdx_SaleLeasebackTransactionTermOfContractMember_documentation_en-US" xlink:label="lab_bdx_SaleLeasebackTransactionTermOfContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SaleLeasebackTransactionTermOfContractMember" xlink:href="bdx-20220930.xsd#bdx_SaleLeasebackTransactionTermOfContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SaleLeasebackTransactionTermOfContractMember" xlink:to="lab_bdx_SaleLeasebackTransactionTermOfContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_85c14ac7-5f89-4213-86c8-659ff4e010b8_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_d953b015-83f1-46c7-ac3c-d9ee8bb3fdc3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_28ae97c7-aa40-40ff-936d-e0cd9626c7a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_2be38836-f558-4605-b86e-6e3cd2430ea9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_53515a13-91ea-47f6-836f-00d69ef3ba23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_2f5270fa-b481-493e-aa60-100c8bc0df1e_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Line Items]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Line Items]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cf4364a4-fe6f-4ea4-bab5-db48ecf14c83_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_14605d6a-3e64-44a2-a970-1f1d2a1def87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Pension and Other Postretirement Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_b414bce1-1175-4543-b118-3d47a9b506da_terseLabel_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_documentation_en-US" xlink:label="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:href="bdx-20220930.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:to="lab_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_e2a31323-cf71-440d-b6d2-10c09c9adebb_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_AuditInformationAbstract_b443906e-9421-4c9d-9c6f-1d70f08404b5_terseLabel_en-US" xlink:label="lab_bdx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_bdx_AuditInformationAbstract_label_en-US" xlink:label="lab_bdx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_bdx_AuditInformationAbstract_documentation_en-US" xlink:label="lab_bdx_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AuditInformationAbstract" xlink:href="bdx-20220930.xsd#bdx_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_AuditInformationAbstract" xlink:to="lab_bdx_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a84966d4-f49d-448a-8812-ae4b8fd8b5e4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_7f1f0c24-f063-4481-8d0b-c90c170b8c27_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_9854becc-1940-4d17-9343-90f614baaba9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferral plan, shares held in trust</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Held in Employee Trust, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrustShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:to="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_948ad57c-9560-4791-9737-4f031eeee72e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f524e39a-d07d-4016-b913-891d26fc36d1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0.174dueJune42021Member_2ca815e3-6d6c-4526-9f8b-0f1b3c18119e_terseLabel_en-US" xlink:label="lab_bdx_Notes0.174dueJune42021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.174% due June 4, 2021</link:label>
    <link:label id="lab_bdx_Notes0.174dueJune42021Member_label_en-US" xlink:label="lab_bdx_Notes0.174dueJune42021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.174% due June 4, 2021 [Member]</link:label>
    <link:label id="lab_bdx_Notes0.174dueJune42021Member_documentation_en-US" xlink:label="lab_bdx_Notes0.174dueJune42021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.174% due June 4, 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.174dueJune42021Member" xlink:href="bdx-20220930.xsd#bdx_Notes0.174dueJune42021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0.174dueJune42021Member" xlink:to="lab_bdx_Notes0.174dueJune42021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_65a68f23-8f29-4e5e-bff6-1a59b7f19a27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3a17932d-74fe-46c5-bad1-54762beefb4c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_5f473f14-c2e8-45ae-925f-cba3af2a6bb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gross Amounts of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_14210f8e-b2ae-40ba-85cb-485c839a3dfa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Assumptions Determining Pension Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_4292ee4e-b408-40df-b545-dc7bb8e026d2_terseLabel_en-US" xlink:label="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Asset Value</link:label>
    <link:label id="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Measured At Net Asset Value Per Share [Member]</link:label>
    <link:label id="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_documentation_en-US" xlink:label="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments measured at net asset value per share or its equivalent. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" xlink:href="bdx-20220930.xsd#bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5abad54c-e734-441c-a7af-dd499c5b31ae_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fd447a86-8821-4ac7-a56f-9f0c8543ce21_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised_7816100b-b0ff-4aef-8566-69b9349d2abf_terseLabel_en-US" xlink:label="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued under SARs exercised (in shares)</link:label>
    <link:label id="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised_label_en-US" xlink:label="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued Under Stock Appreciation Rights Exercised</link:label>
    <link:label id="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised_documentation_en-US" xlink:label="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued to satisfy stock appreciation rights exercised during the current year's period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockIssuedUnderStockAppreciationRightsExercised" xlink:href="bdx-20220930.xsd#bdx_StockIssuedUnderStockAppreciationRightsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_StockIssuedUnderStockAppreciationRightsExercised" xlink:to="lab_bdx_StockIssuedUnderStockAppreciationRightsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_5efb48ae-68a1-4899-a9b5-50f395e42fd9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a416f4cf-01f4-4b97-8cb4-b06af4979fda_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProductRightsMember_773f361a-9189-4465-a2d6-120f2ae93bcc_terseLabel_en-US" xlink:label="lab_bdx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product rights</link:label>
    <link:label id="lab_bdx_ProductRightsMember_label_en-US" xlink:label="lab_bdx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights [Member]</link:label>
    <link:label id="lab_bdx_ProductRightsMember_documentation_en-US" xlink:label="lab_bdx_ProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired technological intellectual property and know how, as well as product marketing rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductRightsMember" xlink:href="bdx-20220930.xsd#bdx_ProductRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProductRightsMember" xlink:to="lab_bdx_ProductRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_143db041-eeaf-443a-bc1e-eaf36f6803c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_fd54e0a4-1dc0-4658-b671-515e936e6858_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_a7034b2b-8b76-4829-9275-45d307b67d07_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_a545f267-32fe-4bcf-ab26-991bf5f38678_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a15a9819-276a-46dd-a74c-d56a15e36dac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_35ed7a91-1871-480d-965c-83ff41fea4b8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average common shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f1d5937c-91cd-4a39-b537-89f755a14a38_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CashTransferRelatedToSpinoffTransaction_483367d1-3251-4950-b98f-bb2f0bd3f79f_negatedTerseLabel_en-US" xlink:label="lab_bdx_CashTransferRelatedToSpinoffTransaction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfer of cash to Embecta upon spin-off</link:label>
    <link:label id="lab_bdx_CashTransferRelatedToSpinoffTransaction_a578de4c-7ab4-4065-b495-933a114d3f0f_terseLabel_en-US" xlink:label="lab_bdx_CashTransferRelatedToSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Transfer Related to Spinoff Transaction</link:label>
    <link:label id="lab_bdx_CashTransferRelatedToSpinoffTransaction_label_en-US" xlink:label="lab_bdx_CashTransferRelatedToSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Transfer Related to Spinoff Transaction</link:label>
    <link:label id="lab_bdx_CashTransferRelatedToSpinoffTransaction_documentation_en-US" xlink:label="lab_bdx_CashTransferRelatedToSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Transfer Related to Spinoff Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CashTransferRelatedToSpinoffTransaction" xlink:href="bdx-20220930.xsd#bdx_CashTransferRelatedToSpinoffTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CashTransferRelatedToSpinoffTransaction" xlink:to="lab_bdx_CashTransferRelatedToSpinoffTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_e968049b-e072-4a37-99c9-9cd2e10febbd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_53e238d4-f29c-4c1c-9d41-584b8ec727e2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f40eb836-cd71-4210-9d3c-c30d08799c59_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Target allocation percentage for asset mix</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4dcf0807-b6fd-4281-bb6a-3dc4099d31eb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_61b6bba5-e9bd-42ca-babd-e6d9a1f2deb9_negatedTerseLabel_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Embecta spin-off</link:label>
    <link:label id="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_label_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation</link:label>
    <link:label id="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_documentation_en-US" xlink:label="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes to benefit obligation which arose from business combination and/or divestiture transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" xlink:to="lab_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_f7b3cc8c-c30a-4cbb-82a1-f74550e38184_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock (See Note 4)</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_f0082534-8609-4186-a5d6-ca3144c3ad5c_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity well-known seasoned issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_60b77e05-c0ef-4b63-a463-b32311f24c06_negatedTerseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards transferred to Embecta at spin-off (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred due to Spinoff Transaction</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred due to Spinoff Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_fd7a8765-b92a-44ec-81d6-a48059922553_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_c6b33bb5-dfa3-48ee-b2a5-412ee9cb008d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_341ee0c7-4ae5-4233-9bd7-cabda84fe295_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_27d48a60-714d-4b0b-8890-ca360ebcd5bd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_66344660-620d-4f77-9ca9-b0ec2d1d63fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2c49aeb7-f9ce-4e37-9b57-8a95e6602ee9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_1ea544de-77d3-4ce3-8a37-96c40cfd4d2b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_527899b6-b7c1-4c9a-b7c9-f094cd51f256_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_c070d472-9595-4f7f-9d6f-8b03ae739efc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Cost Relating to Share-Based Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_b4bd4ab8-e497-4f4a-832d-44b62be7abc7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_9af0a44d-0cec-41ee-997b-ec793f709daf_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, includes translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_6abe1211-8e49-4887-9bb1-1f6deaacefe5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2dd33714-44d8-403e-94af-73786ca52165_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive share equivalents from Series C preferred shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_9f54df52-329a-4581-bf7f-8da1dee44eb6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b3015add-f076-4ef4-afb7-40357fbece51_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ec6072cc-d8e8-49d1-9381-bdd7218733e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_8e0f7baf-22bd-48a1-9aaa-f92be2c36dbc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_b7598058-e9fa-40f9-b5d1-0b5d50bafd2a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_eeffa335-3b76-4acd-bec2-f963073eca5c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_29a98d00-4301-4126-82aa-674f06183ae1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_55f86751-9e25-458f-ad0a-b8b103ac0afd_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3ff54cb6-0f55-48a7-95a7-22f96b7ff4c6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm_ea59a007-5105-4ec0-aed7-20b46725b8c9_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average remaining contractual term, exercisable</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average remaining contractual term for stock appreciation rights that are exercisable as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_37d7ad64-f609-43d0-b6a9-f7198e5833c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_265fba32-d790-45a8-aa13-8b6af743bc1a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current fiscal year end date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue_3c61c8c5-fe7a-4559-88ea-de446c1214af_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, aggregate intrinsic value</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Intrinsic Value</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate intrinsic value for outstanding stock appreciation rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteSpinoffTransaction_1d0a2a6b-4380-4f59-8284-e810e523396c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-off of Embecta (See Note 2)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteSpinoffTransaction_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Spinoff Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:to="lab_us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_4000be8d-3432-4513-9559-d64f825444e0_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Debt</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Debt</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationDebt" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationDebt" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NotesDue2039Member_cb068d7a-e7ba-4699-8de8-8f04d9f12b12_terseLabel_en-US" xlink:label="lab_bdx_NotesDue2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.000% Notes due May&#160;15, 2039</link:label>
    <link:label id="lab_bdx_NotesDue2039Member_label_en-US" xlink:label="lab_bdx_NotesDue2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2039 [Member]</link:label>
    <link:label id="lab_bdx_NotesDue2039Member_documentation_en-US" xlink:label="lab_bdx_NotesDue2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2039.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2039Member" xlink:href="bdx-20220930.xsd#bdx_NotesDue2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NotesDue2039Member" xlink:to="lab_bdx_NotesDue2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a6636614-9f19-482e-bdcc-3d930f0cb4be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3522530f-7679-4415-b174-939c603a6539_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9beaa74f-47b1-4dc9-bc1e-3aeafc0ce01e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_864514eb-6c65-4cc5-9cf2-856b095c0513_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DeferredTaxLiabilitiesGross_43f5eab7-c3af-4662-b112-0570ad386715_totalLabel_en-US" xlink:label="lab_bdx_DeferredTaxLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, liabilities, gross</link:label>
    <link:label id="lab_bdx_DeferredTaxLiabilitiesGross_label_en-US" xlink:label="lab_bdx_DeferredTaxLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Gross</link:label>
    <link:label id="lab_bdx_DeferredTaxLiabilitiesGross_documentation_en-US" xlink:label="lab_bdx_DeferredTaxLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total cumulative amount of all deferred tax liabilities as presented in the table of deferred income taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredTaxLiabilitiesGross" xlink:href="bdx-20220930.xsd#bdx_DeferredTaxLiabilitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DeferredTaxLiabilitiesGross" xlink:to="lab_bdx_DeferredTaxLiabilitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_InsuranceContractInvestmentsMember_ade060e3-dadb-42d9-9a80-2e0064098201_terseLabel_en-US" xlink:label="lab_bdx_InsuranceContractInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance contracts</link:label>
    <link:label id="lab_bdx_InsuranceContractInvestmentsMember_label_en-US" xlink:label="lab_bdx_InsuranceContractInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contract Investments [Member]</link:label>
    <link:label id="lab_bdx_InsuranceContractInvestmentsMember_documentation_en-US" xlink:label="lab_bdx_InsuranceContractInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments held in insurance contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InsuranceContractInvestmentsMember" xlink:href="bdx-20220930.xsd#bdx_InsuranceContractInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_InsuranceContractInvestmentsMember" xlink:to="lab_bdx_InsuranceContractInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_79be0135-b73f-4f05-955e-ffbe7fe80a1c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6602f151-a235-4952-ac72-6f0d4548a17b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Performance-Based Restricted Stock Units Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c5a6d9da-9f3e-40e5-bb65-bdcb0d583b4e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-Off of Embecta Corp.</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f0bad5dc-c340-44bb-bb3d-8ea231a3f9ef_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_51fce5b2-4407-45bd-9bd8-eb142a28407f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_332cc07a-f36f-47ce-b3cd-9a5b4fe08451_negatedTerseLabel_en-US" xlink:label="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from payments under share-based compensation plans</link:label>
    <link:label id="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_label_en-US" xlink:label="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Tax Benefit From Payments Under Share Based Compensation Operating Activities</link:label>
    <link:label id="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_documentation_en-US" xlink:label="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" xlink:href="bdx-20220930.xsd#bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" xlink:to="lab_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3794DueMay202050Member_a9a6279b-55e7-4979-9aea-2663077b7d2b_terseLabel_en-US" xlink:label="lab_bdx_Notes3794DueMay202050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.794% Notes due May 20, 2050</link:label>
    <link:label id="lab_bdx_Notes3794DueMay202050Member_label_en-US" xlink:label="lab_bdx_Notes3794DueMay202050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.794% due May 20, 2050 [Member]</link:label>
    <link:label id="lab_bdx_Notes3794DueMay202050Member_documentation_en-US" xlink:label="lab_bdx_Notes3794DueMay202050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.794% due May 20, 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3794DueMay202050Member" xlink:href="bdx-20220930.xsd#bdx_Notes3794DueMay202050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3794DueMay202050Member" xlink:to="lab_bdx_Notes3794DueMay202050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_c73f89f1-0d6e-4a83-b5ca-fb5df8d6d73d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government and agency-Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_71abe147-124f-438d-aeea-9aa71987976a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_835c5961-aba0-44d9-bc95-44114885efbd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_29a91522-1db0-407b-a9f8-07b99e3a7d37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db6dd643-5392-4d6f-91e5-bfcd0d5b5b71_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_366423fd-1c26-4deb-bd27-dec1f7e63f91_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c831a1d5-4c1e-41c3-8052-13b404aa91d4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_f054327c-50d8-4a15-bb05-2163141ff7f8_periodStartLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, beginning balance (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_218b2513-aebc-4eb1-9eb9-b6545f2b5e14_periodEndLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, ending balance (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average price of shares reserved for issuance under stock appreciation right incentive compensation plan that validly exist and are outstanding as of the balance sheet date, including vested options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_c4685170-4107-42ce-a89a-8d82c3cf7c60_negatedLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_3a2fdc23-0d6c-4b7d-97d9-fc25e83f6689_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_4ff18cc3-569c-456d-a89b-fdeb28d12951_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="lab_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_d84caf54-582d-4b17-ae96-80ebb4d12f33_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4c449818-3bc8-46e1-9ec9-66d9e3e4f4bf_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributed, stock units (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b7d3966b-bef5-46ab-af4b-74dceb1b3923_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c60db61-f111-4caf-9c80-c1a809b05ecf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares were authorized for future grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PeripheralInterventionMember_f6067938-b47e-4f62-95f4-c4039295f186_terseLabel_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention</link:label>
    <link:label id="lab_bdx_PeripheralInterventionMember_label_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention [Member]</link:label>
    <link:label id="lab_bdx_PeripheralInterventionMember_documentation_en-US" xlink:label="lab_bdx_PeripheralInterventionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Intervention [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember" xlink:href="bdx-20220930.xsd#bdx_PeripheralInterventionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PeripheralInterventionMember" xlink:to="lab_bdx_PeripheralInterventionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_e648d09a-16fb-4605-b27a-c18b3146879f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_9502b4f4-22ab-4316-8f43-88b64d0e6f80_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units, vested and expected to vest at ending balance (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_1d842493-c7a6-45ea-a00b-531eac1c732d_terseLabel_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions</link:label>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_label_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions [Member]</link:label>
    <link:label id="lab_bdx_IntegratedDiagnosticSolutionsMember_documentation_en-US" xlink:label="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated Diagnostic Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember" xlink:href="bdx-20220930.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IntegratedDiagnosticSolutionsMember" xlink:to="lab_bdx_IntegratedDiagnosticSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_4412d70b-e164-4104-a765-03cfbec6cba4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and benefits, assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_93f85a99-5a10-4efb-87d2-c6e09f0cd439_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_c38021eb-0d58-486d-9d11-c6a967057c27_terseLabel_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period of short-term investments at the time of purchase</link:label>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_label_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Period Of Short Term Investment</link:label>
    <link:label id="lab_bdx_MaturityPeriodOfShortTermInvestment_documentation_en-US" xlink:label="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment" xlink:href="bdx-20220930.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MaturityPeriodOfShortTermInvestment" xlink:to="lab_bdx_MaturityPeriodOfShortTermInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_a566dcb1-92b1-40d5-af48-0ddbf37618ea_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment/settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ae60c540-5b00-44b0-ada5-e70fac65d1c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaMember_ca2914dc-ddba-4f68-a80c-7ba2a81e8d5f_terseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater Asia</link:label>
    <link:label id="lab_srt_AsiaMember_label_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaMember" xlink:to="lab_srt_AsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f740c94c-006f-4970-bd2b-cfe854b8c068_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Decrease) Increase in Cash and Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_53ebf457-5364-43f9-9d9c-203fc64b073b_terseLabel_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.020% Notes due May 24, 2025</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_label_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_documentation_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.020dueMay242025Member" xlink:to="lab_bdx_Notes3.020dueMay242025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IncomeTaxTable_77e02508-ce6b-432a-84f8-2c165382573d_terseLabel_en-US" xlink:label="lab_bdx_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_bdx_IncomeTaxTable_label_en-US" xlink:label="lab_bdx_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_bdx_IncomeTaxTable_documentation_en-US" xlink:label="lab_bdx_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncomeTaxTable" xlink:href="bdx-20220930.xsd#bdx_IncomeTaxTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IncomeTaxTable" xlink:to="lab_bdx_IncomeTaxTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_8fb87ccc-f79f-4b37-a2b5-c24536a0a37a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangibles, Net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_18eeed4e-678e-4817-9620-bd4a3c9c9d54_terseLabel_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology, Net</link:label>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_label_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core And Developed Technology Net</link:label>
    <link:label id="lab_bdx_CoreAndDevelopedTechnologyNet_documentation_en-US" xlink:label="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet" xlink:href="bdx-20220930.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CoreAndDevelopedTechnologyNet" xlink:to="lab_bdx_CoreAndDevelopedTechnologyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_35ef619d-a376-4dc2-98ac-4bf0ffefeb35_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity central index key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_a5f3ff7e-316a-438e-b49b-ac6849e48e5b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_7d0c9d7e-4631-4ab1-8e41-9619dfb0328c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aeb1ac87-0ed6-48d6-b4ca-b3b4f4ccaf12_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_54053e3f-815c-4724-9d28-30a8104e82d8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to acquisitions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ea5ec45f-6640-45e5-8552-ccc898811e84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a125c970-d782-44e7-a248-71b4b4ccfb8a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_c6f7a385-dd50-4e07-80aa-77b8ac33787a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_46d04bd0-0e94-4e0c-9fbb-875996a4c3dc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8ed0ebaa-01d7-46b6-a15b-e57cb1cde7b9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0abce9aa-07d6-4faa-bdbf-3b097a1fa0dd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_fa78dce8-9cb4-4831-acc2-73b92a65cd6b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice_8a7f2b4c-1b96-4cf3-a0df-50f5a55b4a1f_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, granted (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average fair value at grant date for stock appreciation rights issued during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OtherPensionPlanInvestmentsMember_e0c3b970-d59d-4579-bbda-dbe6d571e4e9_terseLabel_en-US" xlink:label="lab_bdx_OtherPensionPlanInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bdx_OtherPensionPlanInvestmentsMember_label_en-US" xlink:label="lab_bdx_OtherPensionPlanInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension Plan Investments [Member]</link:label>
    <link:label id="lab_bdx_OtherPensionPlanInvestmentsMember_documentation_en-US" xlink:label="lab_bdx_OtherPensionPlanInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in securities other than equity or debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherPensionPlanInvestmentsMember" xlink:href="bdx-20220930.xsd#bdx_OtherPensionPlanInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OtherPensionPlanInvestmentsMember" xlink:to="lab_bdx_OtherPensionPlanInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_0fbec801-f828-4026-92ee-bbd7c4396490_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount recognized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_BiosciencesMember_13295a88-3f50-48e5-99c3-86d349ea4bb7_terseLabel_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences</link:label>
    <link:label id="lab_bdx_BiosciencesMember_label_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences [Member]</link:label>
    <link:label id="lab_bdx_BiosciencesMember_documentation_en-US" xlink:label="lab_bdx_BiosciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember" xlink:href="bdx-20220930.xsd#bdx_BiosciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_BiosciencesMember" xlink:to="lab_bdx_BiosciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_e0c9b924-7627-4a1b-892d-9451752d471e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a10fd609-a46a-489d-9080-a4c325d996e0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt, 2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_05dc9260-9eec-4d61-a7b7-9ba90bf119f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_7460eb9c-70a2-4d9f-8b73-4945bebb4b91_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LoansPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableFairValueDisclosure" xlink:to="lab_us-gaap_LoansPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6703dca4-c4f6-4b14-95d8-49ca3b890dab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_078bf090-a5cd-4508-897e-7cd78440bf2b_terseLabel_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration and restructuring expense</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_label_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Costs And Restructuring Charges</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges_documentation_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:to="lab_bdx_AcquisitionRelatedCostsAndRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_abff4a25-72c3-46e6-8c62-09ee8ece179f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5e7e18c0-9144-4876-a449-10c77cb77af4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Capital Expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_2e9a67f5-287d-4d22-be0c-a5df16038b9f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment and fixtures</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_d845feb9-f6ac-421f-8bfe-7547fc7218c9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate future purchase commitments</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Purchase Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0f7b5948-4d57-4323-aac7-5bed7405471f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated aggregate amortization expense in 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_ba7869ab-c12e-4b9b-9054-026b510eed5d_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_b08e3f06-6176-4243-87ce-bbebb81fd29d_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_7953f30a-5017-458f-8c6e-8db0c3bd4476_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ReserveforCashDiscountsMember_36af4331-f090-4f41-9757-7e77563b700b_terseLabel_en-US" xlink:label="lab_bdx_ReserveforCashDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance&#160;for Cash Discounts</link:label>
    <link:label id="lab_bdx_ReserveforCashDiscountsMember_label_en-US" xlink:label="lab_bdx_ReserveforCashDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Cash Discounts [Member]</link:label>
    <link:label id="lab_bdx_ReserveforCashDiscountsMember_documentation_en-US" xlink:label="lab_bdx_ReserveforCashDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of sales revenue which the Entity expects that it will not receive because customers may pay a reduced price if they make their payment within a certain timeframe offered by the Entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ReserveforCashDiscountsMember" xlink:href="bdx-20220930.xsd#bdx_ReserveforCashDiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ReserveforCashDiscountsMember" xlink:to="lab_bdx_ReserveforCashDiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e39c8b52-74bc-4c39-aae9-35fb4b9a0c0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;Postretirement&#160;Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_70431cc8-b3c8-45ba-96a7-3b4e85f9ee22_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified into income, net of taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_729cb1ba-47be-45c7-9434-d10c72ee438c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3b4290cd-9dc6-400e-a9f7-c6fb9cc883b9_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_e86a6fef-2228-4d26-a638-1979a4c933ae_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3c466e53-dd48-4189-8e9d-c4050c74f379_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_493f97ef-c053-45f4-83bd-de675add8c63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionNameDomain_a55a12aa-7977-42ec-a3b0-978c6b2a711e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionNameDomain_label_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleLeasebackTransactionNameDomain" xlink:to="lab_us-gaap_SaleLeasebackTransactionNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fc87b39b-7b10-4ef1-9e39-35394368ad2c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b4092dd9-12bf-4053-a425-dbec29f639ac_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt, 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_dcefb4b2-35dd-4ce4-9691-7ee52736f7dd_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_ce96c773-2ac5-4e84-8d3a-59febc75fc9d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a2fe03fb-9006-4609-adda-a7745bbee129_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_88b898c6-40e7-4455-b98c-d08feac7b527_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_f1cfc454-39e7-4a21-9db4-37142428d93a_terseLabel_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and other restructurings</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_label_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Costs And Restructuring Charges [Member]</link:label>
    <link:label id="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_documentation_en-US" xlink:label="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primary financial statement caption in which the reported facts about Acquisition And Other Restructuring costs have been included.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" xlink:to="lab_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ce73d47b-f955-42c0-9762-c10d63e7638d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_7e0ab3a7-6ec1-40a1-990a-eeb6cf4d2f71_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability-related charges</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_105095fa-6a6a-4520-985e-3a883d28d34e_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions and other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_a3c6ab2b-8b26-459f-82f1-fe61a79e68fb_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_db0085d4-0c7e-4fcb-a9df-fcebde25c79d_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_e3ead2f5-897b-406a-93bd-282110e1ec92_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_ba8d2e18-d90a-43dc-a54b-83d9a2afb4ae_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_label_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]</link:label>
    <link:label id="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_documentation_en-US" xlink:label="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" xlink:to="lab_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock_783b125f-e8c4-4431-bc28-a71580792cf5_terseLabel_en-US" xlink:label="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information Related to Leases</link:label>
    <link:label id="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock_label_en-US" xlink:label="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information Related to Leases [Table Text Block]</link:label>
    <link:label id="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock_documentation_en-US" xlink:label="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information Related to Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" xlink:to="lab_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2351e445-59ec-4fe4-8206-8183f897b619_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of equity securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0c571f3c-6f05-4940-98c6-33747b0445ca_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_e7a2908f-b464-418e-9236-0fc4527b33f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_66595372-697f-4b17-8ec4-aa5e61ed0114_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_702a01ce-133a-4bdf-a94a-6a176cf43fd2_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_eaf61a97-a679-4221-9f13-4c75e392b70a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_906088ee-54fc-4bf5-a8b8-cb46ce85093c_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dbabb742-5d1f-40eb-9106-0551b66ab3ff_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_01cd974e-8f85-4a08-a09f-e862f8a1c04d_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber_bcaa0765-5a88-4479-b873-4fac5f7066de_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, Exercisable at ending balance (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Number</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of exercisable stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_8700b14e-2174-4140-a747-6788d3cf6d03_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4fae3529-2413-4b87-8ae9-ae12ff3f3c66_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dd295e43-2c22-4829-bdbb-48c85746bee1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_23424159-ccfc-4ac4-aded-d0cec997ad65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5237da9b-1583-49ec-944b-63a6a0eabce0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e7a7edbf-d2ef-4be3-b0c9-c158ef0bf74e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_d08cd1c3-3a4b-4f5b-a6e5-a6e71772a2b8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1213DueFebruary122036Member_24e50130-2814-4049-8c0f-1eb3649415aa_terseLabel_en-US" xlink:label="lab_bdx_Notes1213DueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.213% Notes due February 12, 2036</link:label>
    <link:label id="lab_bdx_Notes1213DueFebruary122036Member_label_en-US" xlink:label="lab_bdx_Notes1213DueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% due February 12, 2036 [Member]</link:label>
    <link:label id="lab_bdx_Notes1213DueFebruary122036Member_documentation_en-US" xlink:label="lab_bdx_Notes1213DueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.213% due February 12, 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1213DueFebruary122036Member" xlink:to="lab_bdx_Notes1213DueFebruary122036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_1dc498ed-a6c7-4305-aa11-0455a3b3ebe9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_d3c77b54-b858-4613-8b8d-69ad51d3c6e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ConsumablesMember_f1154fa3-3826-4267-aa17-ed65ae146831_terseLabel_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_bdx_ConsumablesMember_label_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_bdx_ConsumablesMember_documentation_en-US" xlink:label="lab_bdx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember" xlink:href="bdx-20220930.xsd#bdx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ConsumablesMember" xlink:to="lab_bdx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_52982047-c8cf-47c8-a810-469f8e70cd23_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SurgeryMember_f003d257-cf87-4220-a0e8-16040516d21d_terseLabel_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery</link:label>
    <link:label id="lab_bdx_SurgeryMember_label_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:label id="lab_bdx_SurgeryMember_documentation_en-US" xlink:label="lab_bdx_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember" xlink:href="bdx-20220930.xsd#bdx_SurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SurgeryMember" xlink:to="lab_bdx_SurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_6634abe1-2d77-4b98-b9b9-52b396a46fa0_terseLabel_en-US" xlink:label="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based</link:label>
    <link:label id="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_label_en-US" xlink:label="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based</link:label>
    <link:label id="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_documentation_en-US" xlink:label="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" xlink:href="bdx-20220930.xsd#bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" xlink:to="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_e1342daf-1ee4-4bc9-8446-c2a0de3f2c69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_e0968c61-9c6a-4ba3-b36f-e0aa3baa67f6_terseLabel_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions</link:label>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_label_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions [Member]</link:label>
    <link:label id="lab_bdx_MedicationDeliverySolutionsMember_documentation_en-US" xlink:label="lab_bdx_MedicationDeliverySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember" xlink:href="bdx-20220930.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicationDeliverySolutionsMember" xlink:to="lab_bdx_MedicationDeliverySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_b99f70bd-d234-4861-9516-0c5c1a366aa5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_c3e9cefd-3b9d-40aa-b442-738de7a463b4_terseLabel_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="bdx-20220930.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PensionSettlementExpense_82a5e857-4385-42cf-a9a4-2f2e5cf47075_terseLabel_en-US" xlink:label="lab_bdx_PensionSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement Expense</link:label>
    <link:label id="lab_bdx_PensionSettlementExpense_label_en-US" xlink:label="lab_bdx_PensionSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement Expense</link:label>
    <link:label id="lab_bdx_PensionSettlementExpense_documentation_en-US" xlink:label="lab_bdx_PensionSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Settlement Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PensionSettlementExpense" xlink:href="bdx-20220930.xsd#bdx_PensionSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PensionSettlementExpense" xlink:to="lab_bdx_PensionSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ff7610f6-540b-41f4-9ba2-1bb4ace7f594_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_a6bb0c18-ce72-433a-92e4-3779b8872f7c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExecutiveOfficerMember_bb11b5ad-40a2-464a-a86e-5f5262d1eb7e_terseLabel_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officer</link:label>
    <link:label id="lab_srt_ExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember" xlink:to="lab_srt_ExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_851ced74-f09b-4872-93e4-26aed15316ed_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of principal business segments (segments)</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_3a0a6a9e-0680-496b-a946-d46f104bf43a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_813d7e43-afde-4873-b16c-7c1e8948d32d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_fb0ffc43-e82b-4d68-92dc-bcf81c187b28_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_d7dca7c6-722f-4201-b758-26373b53cfb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_0e0a7feb-53cf-42a6-89f9-4d956d6eef98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_9ec740db-b4de-44ad-be23-f32d6ee825df_terseLabel_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_label_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Held in Employee Trust1</link:label>
    <link:label id="lab_bdx_CommonStockSharesHeldInEmployeeTrust1_documentation_en-US" xlink:label="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:href="bdx-20220930.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:to="lab_bdx_CommonStockSharesHeldInEmployeeTrust1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_4ecc3cbd-5893-4d6a-a328-399a513bbf65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_faa6fed9-2ec2-40ea-be82-6fcedbc74735_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bbdf4530-0793-4f73-83c8-a1d0e7f13e5c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cc96ed1c-13fb-4c51-bb7e-f0091462c74c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004453eb-063b-4a2f-a8a1-8c57d4203de4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_88d865f9-9248-4bb7-adc9-e9aaff3a534e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_28f77b14-524e-4c5f-a1e3-303b48566d77_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_3805b66a-39d2-4b67-ac09-aca74c601831_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber_4a5587d6-87c1-426d-b146-c2e9f722d81d_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, Vested and expected to vest at ending balance (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Number</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_2719daf1-c27b-4457-8b87-83b95612a2a9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_b9867bb6-7d49-413c-aa5b-598b2c88453e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Employee Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_bdeaaeaf-89aa-4d03-8c6d-e2cd431fe8c6_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Employee Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4d2203f7-08e7-4f1d-b2c6-5468375da447_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_f35ddc45-91e9-41d9-b807-faa8a58fd944_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9dd41739-92aa-4010-b84b-9d59a78c48b4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6e2cf729-3803-412b-b67b-31b2cd15fb4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_f43bb5ac-8baf-49bd-8e87-83408f4b26c4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent Assets of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_3cebabda-090a-4c0e-abf7-85076eaaae56_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f2860049-3afb-4f22-a6e2-062ff1ed52ef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_9fb6aec3-bbe4-46b4-a4a8-54583d0da186_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PercentOfAssetsDomesticPlans_18487cdd-f5e6-42f7-9a0a-1e4362d4879a_terseLabel_en-US" xlink:label="lab_bdx_PercentOfAssetsDomesticPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total assets domestic plans</link:label>
    <link:label id="lab_bdx_PercentOfAssetsDomesticPlans_label_en-US" xlink:label="lab_bdx_PercentOfAssetsDomesticPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Assets Domestic Plans</link:label>
    <link:label id="lab_bdx_PercentOfAssetsDomesticPlans_documentation_en-US" xlink:label="lab_bdx_PercentOfAssetsDomesticPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to domestic pension plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentOfAssetsDomesticPlans" xlink:href="bdx-20220930.xsd#bdx_PercentOfAssetsDomesticPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PercentOfAssetsDomesticPlans" xlink:to="lab_bdx_PercentOfAssetsDomesticPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_bb16e441-86db-4392-8f78-10d56b92878c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0ab18a57-1ab1-4919-b61c-6a4ee2971799_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes2894DueJune62022Member_8efe85fd-771b-4696-8233-2436f92003b6_terseLabel_en-US" xlink:label="lab_bdx_Notes2894DueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 2.894% due June 6, 2022</link:label>
    <link:label id="lab_bdx_Notes2894DueJune62022Member_label_en-US" xlink:label="lab_bdx_Notes2894DueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 2.894% due June 6, 2022 [Member]</link:label>
    <link:label id="lab_bdx_Notes2894DueJune62022Member_documentation_en-US" xlink:label="lab_bdx_Notes2894DueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 2.894% due June 6, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes2894DueJune62022Member" xlink:href="bdx-20220930.xsd#bdx_Notes2894DueJune62022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes2894DueJune62022Member" xlink:to="lab_bdx_Notes2894DueJune62022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_3e262d63-2843-4dd6-b89b-3f36fc6f5948_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_bd136442-6667-432a-be0b-c11d66460782_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0331da51-042c-49c2-9a52-aa6aca1f581d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity shell company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_UnitsInExcessOfExpectedPerformancePayout_44e466c2-64d2-497f-b2dd-da703b0b8c2a_terseLabel_en-US" xlink:label="lab_bdx_UnitsInExcessOfExpectedPerformancePayout" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units In Excess Of Expected Performance Payout</link:label>
    <link:label id="lab_bdx_UnitsInExcessOfExpectedPerformancePayout_label_en-US" xlink:label="lab_bdx_UnitsInExcessOfExpectedPerformancePayout" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units In Excess Of Expected Performance Payout</link:label>
    <link:label id="lab_bdx_UnitsInExcessOfExpectedPerformancePayout_documentation_en-US" xlink:label="lab_bdx_UnitsInExcessOfExpectedPerformancePayout" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment of units in excess of expected performance to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UnitsInExcessOfExpectedPerformancePayout" xlink:href="bdx-20220930.xsd#bdx_UnitsInExcessOfExpectedPerformancePayout"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_UnitsInExcessOfExpectedPerformancePayout" xlink:to="lab_bdx_UnitsInExcessOfExpectedPerformancePayout" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_e78e9a00-12ed-4ec6-b431-7c6f77ecfb59_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases due to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicalMember_ff3b2d74-27ec-4774-92c8-ef274e1832d7_terseLabel_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_bdx_MedicalMember_label_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_bdx_MedicalMember_documentation_en-US" xlink:label="lab_bdx_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicalMember" xlink:to="lab_bdx_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_7f5ee804-df95-4685-ab67-ebd2e248298e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements of U.S. Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ab94b80a-16c9-4fb6-9bff-317467d9f0b3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d8fac75e-3a82-422c-ab89-37c701bf8104_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b61458f4-cf36-46b1-a708-aadf2f36a77b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt, 2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_23fee91d-f6cb-487a-a7cd-8bc578b51cbe_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_f3be8901-f76c-4abe-92f7-97b3095e2246_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_986433bc-7d62-42f3-bdd4-d85f41037aaa_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_85d0be82-3558-497f-bba1-6a74a6892585_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document period end date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_e48ab16d-0027-4809-ae3e-269e97133497_terseLabel_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.208% Notes due June 4, 2026</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_label_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member" xlink:href="bdx-20220930.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.208dueJune42026Member" xlink:to="lab_bdx_Notes1.208dueJune42026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8650072d-7106-47a3-9507-a5658ee69300_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8dba71ec-df25-4107-97ba-5adcc9371375_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_b53043b7-5b09-43c2-8f7a-41d65bd0b525_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash (Used for) Provided by Continuing Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c52fb1ac-ecb9-4d27-9e13-87eb33722f00_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a25ef4cf-f0ac-4f04-a8b1-a52f7ee914bc_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_bc7c2f63-0269-45a3-8e82-4dfed3fafdcb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4f9dadcf-406e-4176-ad8e-495567f8f6d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_f1bca520-2e8a-4fe2-857c-422673c4f844_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_00fcf8b2-95ab-4051-a2b5-f48b84f17190_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod_25622bd0-6ca1-4e84-8a55-1f3ce0c58dde_negatedLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, forfeited, canceled or expired (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Forfeited In Period</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of stock appreciation rights that were forfeited during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_f0fda859-4dd2-4c8c-be9e-665c78be4cac_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Research and Development Expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Research and Development Expense</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8057c4ee-4b11-450d-8ef7-d71ff77538f6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_72011024-1dcb-4933-be6a-9edfd6c1fc23_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_abd76a43-14ea-4a58-b022-5cd02077c5c7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries, wages and related items</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes4.669DueJune62047Member_09917f71-4f27-4f20-8e6d-656a08d923a7_terseLabel_en-US" xlink:label="lab_bdx_Notes4.669DueJune62047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.669% Notes due June 6, 2047</link:label>
    <link:label id="lab_bdx_Notes4.669DueJune62047Member_label_en-US" xlink:label="lab_bdx_Notes4.669DueJune62047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.669% Due June 6, 2047 [Member]</link:label>
    <link:label id="lab_bdx_Notes4.669DueJune62047Member_documentation_en-US" xlink:label="lab_bdx_Notes4.669DueJune62047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.669% Due June 6, 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.669DueJune62047Member" xlink:href="bdx-20220930.xsd#bdx_Notes4.669DueJune62047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes4.669DueJune62047Member" xlink:to="lab_bdx_Notes4.669DueJune62047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1eb1541a-67ed-471e-9db1-fff582f3cf5f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_708f067f-5ec5-4b51-839b-2046a0bac184_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_a684eaea-643e-4fcb-9e1e-07a02e594fce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4e9be090-d495-4039-94de-5323aba71010_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9cf5d72d-96b5-4b46-8d40-8dead2400f0f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_62f2ae1e-0291-46d8-b82e-c6b436cb5796_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_a38c7b1d-ec52-4391-9ef0-9cb40a80c094_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Short-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DebenturesDue2028Member_53cf9ee3-2f17-4b09-937d-a2443fd00d38_terseLabel_en-US" xlink:label="lab_bdx_DebenturesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.700% Debentures due August&#160;1, 2028</link:label>
    <link:label id="lab_bdx_DebenturesDue2028Member_label_en-US" xlink:label="lab_bdx_DebenturesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debentures Due 2028 [Member]</link:label>
    <link:label id="lab_bdx_DebenturesDue2028Member_documentation_en-US" xlink:label="lab_bdx_DebenturesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debentures due 2028.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2028Member" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DebenturesDue2028Member" xlink:to="lab_bdx_DebenturesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_94d29974-147e-4fbe-93d9-34b38898ce61_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes2823DueMay202030Member_471d76a8-dc11-4efd-894f-a66ed329cc0c_terseLabel_en-US" xlink:label="lab_bdx_Notes2823DueMay202030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.823% Notes due May 20, 2030</link:label>
    <link:label id="lab_bdx_Notes2823DueMay202030Member_label_en-US" xlink:label="lab_bdx_Notes2823DueMay202030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 2.823% due May 20, 2030 [Member]</link:label>
    <link:label id="lab_bdx_Notes2823DueMay202030Member_documentation_en-US" xlink:label="lab_bdx_Notes2823DueMay202030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 2.823% due May 20, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes2823DueMay202030Member" xlink:href="bdx-20220930.xsd#bdx_Notes2823DueMay202030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes2823DueMay202030Member" xlink:to="lab_bdx_Notes2823DueMay202030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cea96e-687b-43b6-85d7-931ca58ea07a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_5331a934-5757-477a-890a-509eea41dc56_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Period Expense</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Period Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:to="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_751d9558-28bc-4205-ba95-53ee1a0143e2_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_376436a0-cb77-40fe-a5c5-f6ab9c70b561_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized in the Consolidated Balance Sheets at September&#160;30:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_0388722f-d90a-474b-bce5-345797934e6d_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1c4551ca-dd00-4f11-987b-ee9c7516b49c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_76baaf1e-f678-4b38-b356-8b4cfb35ae7e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_915dce1c-2aa7-4ac7-bff1-349a2be0b0ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DepositarysharesMember_505d53c3-a381-4418-bc39-21c449a68f5c_terseLabel_en-US" xlink:label="lab_bdx_DepositarysharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary shares [Member]</link:label>
    <link:label id="lab_bdx_DepositarysharesMember_label_en-US" xlink:label="lab_bdx_DepositarysharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary shares [Member]</link:label>
    <link:label id="lab_bdx_DepositarysharesMember_documentation_en-US" xlink:label="lab_bdx_DepositarysharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DepositarysharesMember" xlink:href="bdx-20220930.xsd#bdx_DepositarysharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DepositarysharesMember" xlink:to="lab_bdx_DepositarysharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9f3a4004-c803-4950-b17b-3dd24ad8d4a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_7089492a-b4cc-41e1-9e23-2eca8ac2dddb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_3aeed183-d0fe-49f9-aa2a-1dec542ab26d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_bf509d17-d645-4d0f-836c-30e52cb8abb3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1336DueAugust132041Member_57355f23-8a33-42d1-a50a-d10015dd9e70_terseLabel_en-US" xlink:label="lab_bdx_Notes1336DueAugust132041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.336% Notes due August 13, 2041</link:label>
    <link:label id="lab_bdx_Notes1336DueAugust132041Member_label_en-US" xlink:label="lab_bdx_Notes1336DueAugust132041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.336 due August 13, 2041 [Member]</link:label>
    <link:label id="lab_bdx_Notes1336DueAugust132041Member_documentation_en-US" xlink:label="lab_bdx_Notes1336DueAugust132041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.336 due August 13, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1336DueAugust132041Member" xlink:href="bdx-20220930.xsd#bdx_Notes1336DueAugust132041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1336DueAugust132041Member" xlink:to="lab_bdx_Notes1336DueAugust132041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7084cd4c-ac59-455d-97b7-d554880cc37c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9af6413e-034f-48c7-b3f9-cb0fd9d19473_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2cb689bc-0383-47ab-a7e9-e708daeb31d7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028-2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_db219008-714c-41a5-9811-f60cc8b7e527_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_7838fb83-d447-453c-a158-61788d4356f8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c0546b6a-8072-458d-ad66-82bb3fd04c46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_e52816cd-2090-4642-b440-5bd992d09c09_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_f16fc8fc-3ce2-4f5b-b490-a31d051d4744_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_b5c19479-b10f-4f0a-b208-fdfd35d4ef84_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DepositaryShareLiquidation_c353932e-d7f6-4c61-ad71-1eb87db18f19_terseLabel_en-US" xlink:label="lab_bdx_DepositaryShareLiquidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary Share Liquidation</link:label>
    <link:label id="lab_bdx_DepositaryShareLiquidation_label_en-US" xlink:label="lab_bdx_DepositaryShareLiquidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depositary Share Liquidation</link:label>
    <link:label id="lab_bdx_DepositaryShareLiquidation_documentation_en-US" xlink:label="lab_bdx_DepositaryShareLiquidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The per share liquidation preference (or restrictions) of depositary shares (which represent nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer and that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DepositaryShareLiquidation" xlink:href="bdx-20220930.xsd#bdx_DepositaryShareLiquidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DepositaryShareLiquidation" xlink:to="lab_bdx_DepositaryShareLiquidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_50a6d1ae-b214-4a6e-8bd9-e396444a0dc2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_a40c07fb-f829-4cef-be7a-5b81b00e5f9d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_57650bb0-dd47-4e66-81e7-2f98b73114ac_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3b8a76a9-b7cf-4a6c-91ba-0cdc9bf8cf82_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ProceedsFromSpinoffTransaction_12a2e17b-3257-48ce-ac9e-46ca4eb2fae9_terseLabel_en-US" xlink:label="lab_bdx_ProceedsFromSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution from Embecta Corp. (see Note 2)</link:label>
    <link:label id="lab_bdx_ProceedsFromSpinoffTransaction_label_en-US" xlink:label="lab_bdx_ProceedsFromSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Spinoff Transaction</link:label>
    <link:label id="lab_bdx_ProceedsFromSpinoffTransaction_documentation_en-US" xlink:label="lab_bdx_ProceedsFromSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Spinoff Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsFromSpinoffTransaction" xlink:href="bdx-20220930.xsd#bdx_ProceedsFromSpinoffTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ProceedsFromSpinoffTransaction" xlink:to="lab_bdx_ProceedsFromSpinoffTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_0e00a61d-cc93-4f78-83e5-76a57d6be0a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Income Tax Benefits Per Share</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Income Tax Benefits Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:to="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_3ff6d9a2-0fe4-4768-9ff5-959aef3d6b93_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_3928bd8e-2d8b-4459-9822-5c757aeb8264_terseLabel_en-US" xlink:label="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets</link:label>
    <link:label id="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_label_en-US" xlink:label="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets</link:label>
    <link:label id="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_documentation_en-US" xlink:label="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" xlink:href="bdx-20220930.xsd#bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" xlink:to="lab_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_404a5c3f-18a1-4f7e-86a4-b76de50148b7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Vested Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_140502a9-7caf-496c-bb1d-4844d92c7fc5_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_12602b90-5de7-426c-a456-ca43457d9774_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Institutional money market investments</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_52afaf2e-464b-46a4-a4f2-f5f5e46feee9_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_9078fb43-22b3-4c71-9096-7513f44c08c3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_fab10ac8-134e-48bd-9171-c9612a566bd7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_41e9eb8e-e1da-4034-9300-148b5049f0ba_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DeferredCompensationInvestmentIncomeExpense_0c3dc476-6f8a-4c05-97a6-ab47efef5cb6_terseLabel_en-US" xlink:label="lab_bdx_DeferredCompensationInvestmentIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Investment Income (Expense)</link:label>
    <link:label id="lab_bdx_DeferredCompensationInvestmentIncomeExpense_label_en-US" xlink:label="lab_bdx_DeferredCompensationInvestmentIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Investment Income (Expense)</link:label>
    <link:label id="lab_bdx_DeferredCompensationInvestmentIncomeExpense_documentation_en-US" xlink:label="lab_bdx_DeferredCompensationInvestmentIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Investment Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredCompensationInvestmentIncomeExpense" xlink:href="bdx-20220930.xsd#bdx_DeferredCompensationInvestmentIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DeferredCompensationInvestmentIncomeExpense" xlink:to="lab_bdx_DeferredCompensationInvestmentIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_00573b86-c329-4835-9d73-58a089c0d6aa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_aa0832a9-d225-4b3c-b0a4-063d4bd3ed2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Goodwill by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8b3468af-7981-4239-92ca-40b4d2f4f761_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_797cc350-83f1-4d15-9b31-1655b6d78c6e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_7ca5ec05-8263-498c-9670-0b025ca65e11_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_94718949-3e1b-4833-8747-b21b796cfa0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit&#160;Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_c4133380-6bc9-4cd2-abc8-c27baf3adc8a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation exceeds the fair value of plan assets, fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_6ca88aaa-be9b-46bf-8515-a4fa1508d308_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a73c94dc-353a-466c-8e53-01a097cd60e7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_79d12013-f296-4302-8500-8e9995b4b501_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_37e9aa2c-93d5-4091-9900-34c5013ee390_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_79f4bfd3-2a61-4526-a58d-391d3cdb1511_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b23e09e2-ead5-4774-b433-3f7fd4a22cb4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_e57d76c3-51bc-4b77-991e-910a2b5e14db_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c334408c-6198-4c63-bb52-d54795cd2e3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, canceled or expired, stock units exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice_e8297bea-e854-4519-b56b-e61d4aa6810c_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta spin-off adjustment (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction, Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_a56876a3-5a9d-4c45-bb8b-08f62070cec9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1e6892b0-2c25-430c-bcda-b705eda59801_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_EmbectaServicesAgreementIncomeLossNet_6db5c88d-e905-4b8f-832f-e70c4ba6bffe_terseLabel_en-US" xlink:label="lab_bdx_EmbectaServicesAgreementIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta services agreement income, net</link:label>
    <link:label id="lab_bdx_EmbectaServicesAgreementIncomeLossNet_label_en-US" xlink:label="lab_bdx_EmbectaServicesAgreementIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta Services Agreement Income (Loss), Net</link:label>
    <link:label id="lab_bdx_EmbectaServicesAgreementIncomeLossNet_documentation_en-US" xlink:label="lab_bdx_EmbectaServicesAgreementIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta Services Agreement Income (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EmbectaServicesAgreementIncomeLossNet" xlink:href="bdx-20220930.xsd#bdx_EmbectaServicesAgreementIncomeLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_EmbectaServicesAgreementIncomeLossNet" xlink:to="lab_bdx_EmbectaServicesAgreementIncomeLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_9639ad1e-1e18-44da-a6e6-1724b27bfe42_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1e33e97b-04c5-4fb1-817e-635b56a52351_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated aggregate amortization expense in 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_dd8aa3fd-83b1-4149-89fe-f27ad2d6d146_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt, 2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f9df64b6-20c7-40ea-b644-f08991c6a8e1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_24a36e6f-87ce-4204-a79c-207590d05d83_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_e5fa020f-838d-4957-9a78-f0cc569d6f9b_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends, common</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.000dueDecember152022Member_81dfa51f-14d3-4472-8f88-e4580e4b6394_terseLabel_en-US" xlink:label="lab_bdx_Notes1.000dueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due December 15, 2022</link:label>
    <link:label id="lab_bdx_Notes1.000dueDecember152022Member_label_en-US" xlink:label="lab_bdx_Notes1.000dueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.000% due December 15, 2022 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.000dueDecember152022Member_documentation_en-US" xlink:label="lab_bdx_Notes1.000dueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.000% due December 15, 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.000dueDecember152022Member" xlink:to="lab_bdx_Notes1.000dueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_28121c58-4987-4437-927c-4329385b192c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock&#160; Issued at&#160;Par&#160;Value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_edcd7ad8-e79f-4828-83e1-9ebdda6f44b0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_059e68c2-0bef-45d0-b4a4-098a5ee17696_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OpenMarketRepurchasesMember_663c6b63-cf77-481b-880b-857bd2f660ad_terseLabel_en-US" xlink:label="lab_bdx_OpenMarketRepurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Repurchases</link:label>
    <link:label id="lab_bdx_OpenMarketRepurchasesMember_label_en-US" xlink:label="lab_bdx_OpenMarketRepurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Repurchases [Member]</link:label>
    <link:label id="lab_bdx_OpenMarketRepurchasesMember_documentation_en-US" xlink:label="lab_bdx_OpenMarketRepurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OpenMarketRepurchasesMember" xlink:href="bdx-20220930.xsd#bdx_OpenMarketRepurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OpenMarketRepurchasesMember" xlink:to="lab_bdx_OpenMarketRepurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_aa804ee3-185f-4efb-aad7-b74ec4b2ae30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40f9537d-eef4-4c36-951d-a9c8742e7b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributed, stock units exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_a7e4f645-3c1e-4fa7-9df5-e3aa8be1b077_terseLabel_en-US" xlink:label="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Maximum Additional Principal Amount Commitments</link:label>
    <link:label id="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_label_en-US" xlink:label="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Maximum Additional Principal Amount Commitments</link:label>
    <link:label id="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_documentation_en-US" xlink:label="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional funding available, subject to additional commitments made by lenders, under Company's syndicated credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" xlink:href="bdx-20220930.xsd#bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" xlink:to="lab_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_42a25b24-df2c-477d-831b-30e9823be9c1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities recorded in Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_GrossProceedsFromSaleLeasebackTransaction_f1268897-d0cf-429b-80b3-877a6cce8651_terseLabel_en-US" xlink:label="lab_bdx_GrossProceedsFromSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds from Sale Leaseback Transaction</link:label>
    <link:label id="lab_bdx_GrossProceedsFromSaleLeasebackTransaction_label_en-US" xlink:label="lab_bdx_GrossProceedsFromSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds from Sale Leaseback Transaction</link:label>
    <link:label id="lab_bdx_GrossProceedsFromSaleLeasebackTransaction_documentation_en-US" xlink:label="lab_bdx_GrossProceedsFromSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds from Sale Leaseback Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GrossProceedsFromSaleLeasebackTransaction" xlink:href="bdx-20220930.xsd#bdx_GrossProceedsFromSaleLeasebackTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_GrossProceedsFromSaleLeasebackTransaction" xlink:to="lab_bdx_GrossProceedsFromSaleLeasebackTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0334DueAugust132028Member_4176714f-945c-42a7-8363-e93d85c53aac_terseLabel_en-US" xlink:label="lab_bdx_Notes0334DueAugust132028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.334% Notes due August 13, 2028</link:label>
    <link:label id="lab_bdx_Notes0334DueAugust132028Member_label_en-US" xlink:label="lab_bdx_Notes0334DueAugust132028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.334% due August 13, 2028 [Member]</link:label>
    <link:label id="lab_bdx_Notes0334DueAugust132028Member_documentation_en-US" xlink:label="lab_bdx_Notes0334DueAugust132028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.334% due August 13, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0334DueAugust132028Member" xlink:href="bdx-20220930.xsd#bdx_Notes0334DueAugust132028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0334DueAugust132028Member" xlink:to="lab_bdx_Notes0334DueAugust132028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_9dfd173a-6e76-4ce2-a979-d06201f776c1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of the savings incentive plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f9c824e9-31f3-4c61-847f-bcaee76f1c6a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_7889a5f9-c44c-405f-a298-28522797e824_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_7f1e76a4-dcb6-4dbb-a2b5-6362afcf223d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d9d4a34e-d745-42fe-9dda-6ce853d99778_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_79e41cee-c3b4-406a-8621-461b2c563dc5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_f5719252-b492-4ac7-badd-37e9568ba582_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_57d58700-f89c-4652-9629-2d10dc5d8430_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a6a7a23b-5a9d-460b-a55f-5a7c41a21de6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_InterventionalMember_0fbb6a52-84f3-4278-950a-e5f7726f6a85_terseLabel_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional</link:label>
    <link:label id="lab_bdx_InterventionalMember_label_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional [Member]</link:label>
    <link:label id="lab_bdx_InterventionalMember_documentation_en-US" xlink:label="lab_bdx_InterventionalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_InterventionalMember" xlink:to="lab_bdx_InterventionalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_1eeba858-4dfa-43a5-bcfd-234bac5ead8d_terseLabel_en-US" xlink:label="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected forfeited performance-based restricted stock units (shares)</link:label>
    <link:label id="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_label_en-US" xlink:label="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Forfeited Performance Based Restricted Stock Units</link:label>
    <link:label id="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment of expected forfeitures to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" xlink:href="bdx-20220930.xsd#bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" xlink:to="lab_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fdfb3f68-e4c3-4691-8d70-d82d798f9fca_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_BdxGainlossfromreversetrasurylocks_7e7debb0-ae1e-436e-8d21-bba877ad8b66_terseLabel_en-US" xlink:label="lab_bdx_BdxGainlossfromreversetrasurylocks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bdx:Gain(loss)fromreversetrasurylocks</link:label>
    <link:label id="lab_bdx_BdxGainlossfromreversetrasurylocks_label_en-US" xlink:label="lab_bdx_BdxGainlossfromreversetrasurylocks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bdx:Gain(loss)fromreversetrasurylocks</link:label>
    <link:label id="lab_bdx_BdxGainlossfromreversetrasurylocks_documentation_en-US" xlink:label="lab_bdx_BdxGainlossfromreversetrasurylocks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bdx:Gain(loss)fromreversetrasurylocks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BdxGainlossfromreversetrasurylocks" xlink:href="bdx-20220930.xsd#bdx_BdxGainlossfromreversetrasurylocks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_BdxGainlossfromreversetrasurylocks" xlink:to="lab_bdx_BdxGainlossfromreversetrasurylocks" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d48b2eee-95c8-4771-9917-6c2e7963babd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units, beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_780d5663-0e65-4ee5-8130-52b0c8933062_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units, ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8811a920-197a-4c22-b9ae-ecafe9fa3353_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_d6b31b1e-4829-4be1-8d7c-c5d9351c7cd1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a04afa4a-78d2-49f6-8ae6-2534df67b736_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3125DueNovember82021Member_2508aa1b-e074-41f3-914d-f3a33c9d5baa_terseLabel_en-US" xlink:label="lab_bdx_Notes3125DueNovember82021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.125% due November 8, 2021</link:label>
    <link:label id="lab_bdx_Notes3125DueNovember82021Member_label_en-US" xlink:label="lab_bdx_Notes3125DueNovember82021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.125% due November 8, 2021 [Member]</link:label>
    <link:label id="lab_bdx_Notes3125DueNovember82021Member_documentation_en-US" xlink:label="lab_bdx_Notes3125DueNovember82021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.125% due November 8, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3125DueNovember82021Member" xlink:href="bdx-20220930.xsd#bdx_Notes3125DueNovember82021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3125DueNovember82021Member" xlink:to="lab_bdx_Notes3125DueNovember82021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4989cb12-f612-43a0-9bfa-c8e6fdab18f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets recorded in Other Assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_de4913de-a714-4a38-a03d-d4e790344e3c_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.363DueJune62024Member_d1347563-7bdd-4a26-a54e-db149d9edb90_terseLabel_en-US" xlink:label="lab_bdx_Notes3.363DueJune62024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.363% Notes due June 6, 2024</link:label>
    <link:label id="lab_bdx_Notes3.363DueJune62024Member_label_en-US" xlink:label="lab_bdx_Notes3.363DueJune62024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.363% Due June 6, 2024 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.363DueJune62024Member_documentation_en-US" xlink:label="lab_bdx_Notes3.363DueJune62024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.363% Due June 6, 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.363DueJune62024Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.363DueJune62024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.363DueJune62024Member" xlink:to="lab_bdx_Notes3.363DueJune62024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_1798a1eb-f656-4131-8924-dd343db34522_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_aebd524b-1cc7-428a-a68a-1708e1d6994e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_030cc265-b9f6-4d99-a5db-f2154ea9f8b8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod_4168412d-1767-4161-8c03-024118bc12ba_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, granted (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of stock appreciation rights granted during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_00a09423-282d-4107-b54a-096d9d584158_terseLabel_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care</link:label>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_label_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care [Member]</link:label>
    <link:label id="lab_bdx_UrologyandCriticalCareMember_documentation_en-US" xlink:label="lab_bdx_UrologyandCriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology and Critical Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember" xlink:href="bdx-20220930.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_UrologyandCriticalCareMember" xlink:to="lab_bdx_UrologyandCriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ca365e9f-d62d-4f08-a03c-f8c655983475_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b553b892-245b-42f4-91b2-6440ceb7518e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice_09d4ef8c-b315-4606-9a8c-3bbe6cbafc38_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, weighted average exercise price, exercisable (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Weighted Average Exercise Price</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of stock appreciation rights outstanding and currently exercisable under the award plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_c63edbf6-a5c5-45f6-b635-21cc7e3f33f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_16c4cc72-777b-40bd-b04c-88a4957fa5af_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Principle Adopted and New Accounting Principles Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.300dueMarch12023Member_ac11ab63-2942-45ca-bf17-4e8b7e2d815b_terseLabel_en-US" xlink:label="lab_bdx_Notes3.300dueMarch12023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.300% due March 1, 2023</link:label>
    <link:label id="lab_bdx_Notes3.300dueMarch12023Member_label_en-US" xlink:label="lab_bdx_Notes3.300dueMarch12023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.300% due March 1, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.300dueMarch12023Member_documentation_en-US" xlink:label="lab_bdx_Notes3.300dueMarch12023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.300% due March 1, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.300dueMarch12023Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.300dueMarch12023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.300dueMarch12023Member" xlink:to="lab_bdx_Notes3.300dueMarch12023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8c800ae4-084f-4a98-bac5-06e17b8ec3f6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_2ea34438-4697-4da4-b414-a8e7e6ad1722_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock_35395f5f-1d3e-4e48-a452-1015b9f5243e_terseLabel_en-US" xlink:label="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements of Foreign Plan Assets</link:label>
    <link:label id="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock_label_en-US" xlink:label="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allocation Of Foreign Plan Assets Table [Table Text Block]</link:label>
    <link:label id="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock_documentation_en-US" xlink:label="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the major categories of plan assets of foreign pension plans and/or other foreign employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" xlink:to="lab_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_91699d56-93ad-4eb6-bd20-a0206351a14e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate_16a859a0-3232-4c0e-bc05-58ad9e0cf4c1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_5e97303b-060a-4d57-afc9-5ec95ccd4980_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3e7b7782-871e-4f2d-afa0-f40bf4251c72_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_dad74ffa-383a-478e-8f95-3e8bb07a21a3_terseLabel_en-US" xlink:label="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_label_en-US" xlink:label="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Period</link:label>
    <link:label id="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_documentation_en-US" xlink:label="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" xlink:href="bdx-20220930.xsd#bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" xlink:to="lab_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b35fd90d-2c1b-4326-8425-90d3e7d326f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e960a97e-f050-4ea6-80f3-985b32a13767_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d2db0bcb-0adc-41f0-aca7-7c5f61a9406e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess&#160;of Par&#160;Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3b8e3d84-6d37-4bb4-998b-088a8d09b040_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document fiscal period focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_05f342ac-eb93-40f6-92fb-5a7bbb121915_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_772360a3-357f-4807-aaed-18f1b2560310_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average common and common equivalent shares outstanding - assuming dilution (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CRBardIncMember_0d6a80f4-8a27-414f-881d-3d3ac5b8b6fe_terseLabel_en-US" xlink:label="lab_bdx_CRBardIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CR Bard Inc</link:label>
    <link:label id="lab_bdx_CRBardIncMember_label_en-US" xlink:label="lab_bdx_CRBardIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CR Bard Inc [Member]</link:label>
    <link:label id="lab_bdx_CRBardIncMember_documentation_en-US" xlink:label="lab_bdx_CRBardIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C.R. Bard Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CRBardIncMember" xlink:href="bdx-20220930.xsd#bdx_CRBardIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CRBardIncMember" xlink:to="lab_bdx_CRBardIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_4196f017-d083-4034-9715-706908ab6447_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7b7d49ca-3861-4d6b-93c4-69b554f0ee15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a7e321f9-869c-41da-ad2a-cb7fbf84ca60_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PatentsAndTrademarksMember_3cc1c230-4def-407d-a130-15202a2f09fb_terseLabel_en-US" xlink:label="lab_bdx_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Trademarks, and Other</link:label>
    <link:label id="lab_bdx_PatentsAndTrademarksMember_label_en-US" xlink:label="lab_bdx_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks [Member]</link:label>
    <link:label id="lab_bdx_PatentsAndTrademarksMember_documentation_en-US" xlink:label="lab_bdx_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PatentsAndTrademarksMember" xlink:href="bdx-20220930.xsd#bdx_PatentsAndTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PatentsAndTrademarksMember" xlink:to="lab_bdx_PatentsAndTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_4d838c73-7f5f-4ccf-85b6-0695bdcff9da_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividend per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_649651d9-292c-45eb-b886-1af05596ac4a_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_392e02db-f468-4224-a5ed-8858bad5cc36_terseLabel_en-US" xlink:label="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based</link:label>
    <link:label id="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_label_en-US" xlink:label="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based</link:label>
    <link:label id="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_documentation_en-US" xlink:label="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of target payout on which performance-based restricted stock units are based.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" xlink:href="bdx-20220930.xsd#bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" xlink:to="lab_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction_4087278b-f433-42c6-9eec-5a9608e18b48_negatedTerseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta spin-off adjustment (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f70b931a-99d7-4c6f-b032-5fb22c9911f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value derived (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_951792bd-211f-4f3c-b27f-e5d78d4020f6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, stock units weighted average grant date fair value (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_02254cd2-8872-42a0-bb4c-70eace94c2de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax reductions related to tax holidays</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_d03ba7fb-fd41-4bd1-8212-79fb339e3d27_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e81cac44-6c2a-4072-82ca-c2e111b2efbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_51116eaf-6313-4fc9-84ed-c31341c72597_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FloatingRateNotesDueJune62022Member_e23d1391-9cc6-4d27-8621-3dadce6ebb4d_terseLabel_en-US" xlink:label="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due June 6, 2022</link:label>
    <link:label id="lab_bdx_FloatingRateNotesDueJune62022Member_label_en-US" xlink:label="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due June 6, 2022 [Member]</link:label>
    <link:label id="lab_bdx_FloatingRateNotesDueJune62022Member_documentation_en-US" xlink:label="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due June 6, 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member" xlink:href="bdx-20220930.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FloatingRateNotesDueJune62022Member" xlink:to="lab_bdx_FloatingRateNotesDueJune62022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_65d2d878-2283-4945-8299-e98c4186e756_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes6750DueFebruary152030Member_320c1811-6252-4334-b316-f773159a6b14_terseLabel_en-US" xlink:label="lab_bdx_Notes6750DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.750% due February 15, 2030</link:label>
    <link:label id="lab_bdx_Notes6750DueFebruary152030Member_label_en-US" xlink:label="lab_bdx_Notes6750DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.750% due February 15, 2030 [Member]</link:label>
    <link:label id="lab_bdx_Notes6750DueFebruary152030Member_documentation_en-US" xlink:label="lab_bdx_Notes6750DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 6.750% due February 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member" xlink:href="bdx-20220930.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes6750DueFebruary152030Member" xlink:to="lab_bdx_Notes6750DueFebruary152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_c23f26f4-3d21-4265-a59c-9c4b93d51b64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dd497bf6-42a3-4fd6-86e4-9f343e82f76c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dfaf0808-4b12-4656-b37f-b2e468f65e70_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b2c63154-666a-42fb-8c30-b30c3dcb0ff3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt and term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ef8d099f-ec6e-4a8f-ae67-c3e80cba96b2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income applicable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e08efe15-d657-4479-bb1e-aa3b148e3505_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_71ddd952-a68c-4ac8-9c97-9cfc8b229a89_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities of discontinued operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c6892233-55e0-4303-8117-10e1f0792e33_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities of discontinued operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_6f26f821-1e51-47e4-856f-94fe15bfe89a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized in Accumulated other comprehensive income (loss) before income taxes at September&#160;30:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_04aaf281-1841-46a9-a757-2d81bbba70e2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_23cf4bce-fa73-4e6e-a6f3-b6b725f2a034_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6d83aefa-ccd4-44fe-ab2c-cfc291591d8c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_94b37840-6113-4066-a595-2217ec981771_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_2e86e593-a0ec-4cae-8625-123c5b1c9ba5_terseLabel_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.401% Notes due May 24, 2023</link:label>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_label_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.401dueMay242023Member_documentation_en-US" xlink:label="lab_bdx_Notes1.401dueMay242023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 24, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member" xlink:href="bdx-20220930.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.401dueMay242023Member" xlink:to="lab_bdx_Notes1.401dueMay242023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_74775268-ef9e-4eaf-9c4f-de46c16e202a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_GrossProceedsFromIssuanceOfEquity_be1611f6-2197-4e83-82ba-365c88fdd5de_terseLabel_en-US" xlink:label="lab_bdx_GrossProceedsFromIssuanceOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds from Issuance of Equity</link:label>
    <link:label id="lab_bdx_GrossProceedsFromIssuanceOfEquity_label_en-US" xlink:label="lab_bdx_GrossProceedsFromIssuanceOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds from Issuance of Equity</link:label>
    <link:label id="lab_bdx_GrossProceedsFromIssuanceOfEquity_documentation_en-US" xlink:label="lab_bdx_GrossProceedsFromIssuanceOfEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The gross cash proceeds from the additional capital contribution to the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GrossProceedsFromIssuanceOfEquity" xlink:href="bdx-20220930.xsd#bdx_GrossProceedsFromIssuanceOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_GrossProceedsFromIssuanceOfEquity" xlink:to="lab_bdx_GrossProceedsFromIssuanceOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_b84401dc-cc06-4ea6-a898-9e2370f43b69_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used for Continuing Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_60ea2eda-6d97-40ec-afb2-46d13c8ee2cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Information for Company's Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7bbf4b47-ff22-423b-8b20-0d2f384e530b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_562f980b-2a39-4bff-be09-58620a8be135_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs terms of award</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Terms Of Award</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The date when stock appreciation rights expire as specified in the award agreement, which may be presented in a variety of ways (for example, year, month and year, day, month and year, quarter of a year).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.734DueDecember152024Member_e999015b-7128-4514-8ef7-0630ffe5ef55_terseLabel_en-US" xlink:label="lab_bdx_Notes3.734DueDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.734% Notes due December 15, 2024</link:label>
    <link:label id="lab_bdx_Notes3.734DueDecember152024Member_label_en-US" xlink:label="lab_bdx_Notes3.734DueDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.734% Due December 15, 2024 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.734DueDecember152024Member_documentation_en-US" xlink:label="lab_bdx_Notes3.734DueDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 3.734% Due December 15, 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.734DueDecember152024Member" xlink:href="bdx-20220930.xsd#bdx_Notes3.734DueDecember152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.734DueDecember152024Member" xlink:to="lab_bdx_Notes3.734DueDecember152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_bf8ca1ed-5a9a-41f7-810d-3000dd158352_terseLabel_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Notes due August 13, 2023</link:label>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_label_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes0000DueAugust132023Member_documentation_en-US" xlink:label="lab_bdx_Notes0000DueAugust132023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.000% due August 13, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0000DueAugust132023Member" xlink:to="lab_bdx_Notes0000DueAugust132023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_04fd4971-645c-486f-84e2-dc9daf1d5b5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations, Net of Tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_cea73ff3-9486-438f-b44a-11ef3073070d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Discontinued Operations, Net of Tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue_aa11c8b0-9380-438c-ad1c-f2b98c82250e_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, aggregate intrinsic value, exercisable</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Intrinsic Value</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate intrinsic value for stock appreciation rights that are exercisable as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_7e75f04a-ee6a-4114-b9de-2c8f85aed990_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_eeb4f069-ea38-4d50-b48d-b956c382f114_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of SARs Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_03d5e953-f149-4ea6-bc9c-a6957afd6783_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Benefit Obligation, Change in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_7019ac0e-895f-4ffd-a36d-51a01de8cd55_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5e2c6dde-e889-4d44-b33d-e1b96c7f7ad1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_bc9fa6b5-0cee-408f-9b74-b79db4463c52_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f8fea6a3-95f0-4e52-b45b-9fa88b6bca1b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_2ca2f933-2220-417f-974d-a594325b7c0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_17e4a528-a962-416a-9ba0-8cebfb36ad43_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_3fc95cd3-72cd-48bf-be5f-d3a8d73f21c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_16af4544-1714-4653-8472-445d19b5a127_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4dd31615-48a5-41ea-84a2-436625fe3f77_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3c66bc6e-756a-4848-9626-2ed64250064d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e34a4edc-899d-4bfa-a85d-373ab9df89cd_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_50cdea09-e34f-43a4-8cd8-06e69ad510fa_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes5000DueFebruary152030Member_b8069174-6bb1-49cf-bf26-aa25751bcf20_terseLabel_en-US" xlink:label="lab_bdx_Notes5000DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 5.000% due February 15, 2030</link:label>
    <link:label id="lab_bdx_Notes5000DueFebruary152030Member_label_en-US" xlink:label="lab_bdx_Notes5000DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 5.000% due February 15, 2030 [Member]</link:label>
    <link:label id="lab_bdx_Notes5000DueFebruary152030Member_documentation_en-US" xlink:label="lab_bdx_Notes5000DueFebruary152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 5.000% due February 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes5000DueFebruary152030Member" xlink:href="bdx-20220930.xsd#bdx_Notes5000DueFebruary152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes5000DueFebruary152030Member" xlink:to="lab_bdx_Notes5000DueFebruary152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_3e585034-9b23-4132-89f0-1f0658077036_terseLabel_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_label_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:label id="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod_documentation_en-US" xlink:label="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers of financial assets during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:href="bdx-20220930.xsd#bdx_TransfersOfFinancialAssetsDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:to="lab_bdx_TransfersOfFinancialAssetsDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_45908b9a-25a7-46c7-9da7-66fb9c63c194_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TermLoanFacilityMember_cdcefaef-7df1-41fd-831c-2d1369abc9f2_terseLabel_en-US" xlink:label="lab_bdx_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_bdx_TermLoanFacilityMember_label_en-US" xlink:label="lab_bdx_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_bdx_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_bdx_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TermLoanFacilityMember" xlink:href="bdx-20220930.xsd#bdx_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TermLoanFacilityMember" xlink:to="lab_bdx_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_e3c676a7-7b99-49bf-a447-90c8bbadfb62_terseLabel_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions</link:label>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_label_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions [Member]</link:label>
    <link:label id="lab_bdx_MedicationManagementSolutionsMember_documentation_en-US" xlink:label="lab_bdx_MedicationManagementSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Management Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember" xlink:href="bdx-20220930.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_MedicationManagementSolutionsMember" xlink:to="lab_bdx_MedicationManagementSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d4c32c3f-8ca6-46b0-b9ff-e65bf93c4ada_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, canceled or expired, stock units (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_2270c59e-6b2d-4f95-bf51-3010fa9b3d53_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_documentation_en-US" xlink:label="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" xlink:to="lab_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_4871f26b-c8ac-4c50-9082-4abe5026a06f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_50e9b468-3d61-4d9c-abd1-e76455682601_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_cf59bb2d-4a93-4b60-82fd-0c9f52dc7cf8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_dc9b0c76-d847-443b-9d69-0da8dfc3ec49_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_TerminatedCurrencySwapMember_aede9e1a-b62b-48c1-bede-911a0eba797a_terseLabel_en-US" xlink:label="lab_bdx_TerminatedCurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Currency Swap</link:label>
    <link:label id="lab_bdx_TerminatedCurrencySwapMember_label_en-US" xlink:label="lab_bdx_TerminatedCurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Currency Swap [Member]</link:label>
    <link:label id="lab_bdx_TerminatedCurrencySwapMember_documentation_en-US" xlink:label="lab_bdx_TerminatedCurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Currency Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TerminatedCurrencySwapMember" xlink:href="bdx-20220930.xsd#bdx_TerminatedCurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_TerminatedCurrencySwapMember" xlink:to="lab_bdx_TerminatedCurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4ed469c2-429e-4bcf-9141-bb37ec6628a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_478a75db-ac86-4e3c-bedf-3fc2d5674ca2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0dbc31e9-85b3-4f2d-a8c8-7b4580a76847_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income, beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eebdf8ed-7fdb-4755-816b-02d52270fd08_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income, ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d9ad16df-0d5b-48f2-ac7f-6e64f32161c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_983c61bb-d245-4eb8-ad9c-3ccf694c21ef_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7a5b5180-a7ba-47a8-8e66-d0da845a79f4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7c1d0067-d30d-4ce5-8e7f-ad4688367cb6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f00c6740-d7a3-450a-9b60-d7e594e4df35_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity small business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1beacd94-c88f-4198-bfe6-47277ff4f7f4_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_11dd64f6-705e-486b-9d70-056d6a47ba8b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_829b6231-846b-4981-9653-89a4b92182fc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense for all non-vested share-based awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes4.875dueMay152044Member_7a98b9d8-50cf-4824-8ca4-da646f4325dd_terseLabel_en-US" xlink:label="lab_bdx_Notes4.875dueMay152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% Notes due May 15, 2044</link:label>
    <link:label id="lab_bdx_Notes4.875dueMay152044Member_label_en-US" xlink:label="lab_bdx_Notes4.875dueMay152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.875% due May 15, 2044 [Member]</link:label>
    <link:label id="lab_bdx_Notes4.875dueMay152044Member_documentation_en-US" xlink:label="lab_bdx_Notes4.875dueMay152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 4.875% due May 15, 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.875dueMay152044Member" xlink:href="bdx-20220930.xsd#bdx_Notes4.875dueMay152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes4.875dueMay152044Member" xlink:to="lab_bdx_Notes4.875dueMay152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_8721adfc-4c7f-4f66-a2f6-4c08c5f636fc_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_223ff43b-191b-4b5d-a3f9-78238e6958c1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_282c94a0-0ba8-449e-93d6-4d3221c60ccb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_a6090d23-5e18-4a76-b149-a0eb21d4bc8f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_70f17a77-f095-4a87-8d5a-e51dfea1d7bf_terseLabel_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Acquisition Related Costs and Restructuring Charges</link:label>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_label_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operation, Acquisition Related Costs and Restructuring Charges</link:label>
    <link:label id="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_documentation_en-US" xlink:label="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" xlink:to="lab_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_bde0f270-8b3f-4eb5-969d-b6a5312d51cc_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_a2974bcb-459a-4886-ae51-104d7da71ef5_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Financing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_fdb186f4-5f1f-46c0-a101-a244c3a409ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_23e61377-5143-451d-91b5-bae68f049c2a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5882bcaa-b291-4fb0-8ed7-1457e0939b7d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation plans, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_31b4755e-d551-43b6-a315-61945ae120fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f334eee6-c82a-4dae-a4d5-62d7ec49a43f_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government and agency-U.S.</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_2ef47421-2270-4c85-a78f-45e748bcfc86_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_3b293e01-54df-43e3-ba6c-67830bd63259_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_c1355454-6111-4645-9e24-acc4d4633f23_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c8a86f31-f0ce-4293-9a6c-099905b3b740_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated aggregate amortization expense in 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_82aa7241-95dc-4978-b5d0-cb47634ccad0_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds</link:label>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeFundsMember" xlink:to="lab_us-gaap_FixedIncomeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_0bbc2ddd-deff-4139-a2f0-bd7dd97393df_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1957DueFebruary112031Member_41ee8e7a-1ddc-4bc7-a544-68d4588fc31f_terseLabel_en-US" xlink:label="lab_bdx_Notes1957DueFebruary112031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.957% Notes due February 11, 2031</link:label>
    <link:label id="lab_bdx_Notes1957DueFebruary112031Member_label_en-US" xlink:label="lab_bdx_Notes1957DueFebruary112031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.957% due February 11, 2031 [Member]</link:label>
    <link:label id="lab_bdx_Notes1957DueFebruary112031Member_documentation_en-US" xlink:label="lab_bdx_Notes1957DueFebruary112031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.957% due February 11, 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1957DueFebruary112031Member" xlink:href="bdx-20220930.xsd#bdx_Notes1957DueFebruary112031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1957DueFebruary112031Member" xlink:to="lab_bdx_Notes1957DueFebruary112031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_7b8310cc-7d88-4c90-a726-152c0d0f1c16_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_590fdf5c-dc21-4972-a86f-d5200fe9a358_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and credit carryforwards, assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other Tax Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_efe50223-770d-426c-aba9-60264749cc49_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in credit facility borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_81075b34-32f9-455b-8d12-bbdd05198f97_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_f7eb41cd-9621-4f5c-b21d-ed021467f43d_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units, vested and expected to vest at ending balance, exercise price (USD per share)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4e52a4dd-5833-4ffe-a9e3-114b816f590d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt, 2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_e7e95179-cafc-4da1-931a-80275e6e565a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_6f9abd18-2cf2-4f8d-a9d5-a659b2c74095_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_cc7c1112-afb6-4f6a-ab63-a3b883b827f4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity filer category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_be788229-b25d-443a-9f69-2bbca7a759e9_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2f9afc57-ae41-4f81-9dfa-3a4de101ac3e_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a8bf1346-aed7-446c-a2f4-aff0dcf17220_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost relating to share-based payments</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b7ce554e-ad44-442a-b172-ba846861405b_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7d117db7-bf41-49bf-ab62-95dbcdc70be7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (See Note 6)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8f5ded99-461e-4173-a449-5f7c26135130_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_8b0f43f3-8cd4-4c82-9eac-3958fc632a22_terseLabel_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt classified from long term to short term</link:label>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_label_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Debt Classified From Long Term To Short Term</link:label>
    <link:label id="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_documentation_en-US" xlink:label="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Debt Classified From Long Term To Short Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:href="bdx-20220930.xsd#bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:to="lab_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_40db5065-8868-4c83-9f9a-7f0dc5545ae8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets of discontinued operations</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_64b64bf7-d1f3-4543-9371-3f141ea9125a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets of discontinued operations</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_7a974e80-36f4-42fb-8ff8-1a511ee1bacf_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OtherFixedIncomeMember_c21bafab-01ad-4593-b215-18077b964e71_terseLabel_en-US" xlink:label="lab_bdx_OtherFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other fixed income</link:label>
    <link:label id="lab_bdx_OtherFixedIncomeMember_label_en-US" xlink:label="lab_bdx_OtherFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Fixed Income [Member]</link:label>
    <link:label id="lab_bdx_OtherFixedIncomeMember_documentation_en-US" xlink:label="lab_bdx_OtherFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Fixed Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherFixedIncomeMember" xlink:href="bdx-20220930.xsd#bdx_OtherFixedIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OtherFixedIncomeMember" xlink:to="lab_bdx_OtherFixedIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8e4aac13-54f8-473c-8d09-90679d0e34ee_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_37261d1a-2f59-44e3-9b9d-35e5fc3efff5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_ff7d4104-0078-4650-a925-d3bc053bb42f_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_db8ffe5d-6855-44d8-b626-c951e3f499e0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a62b4297-f0f6-407f-a9e4-4447a092de2f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_732b1d08-e76d-45c2-89ad-448b6146f899_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_f262f302-c263-47aa-9409-7d4768c1dd63_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_7a208cd9-d8a9-4d47-9291-dde6b3db2b27_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity voluntary filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable_53cf325a-c48a-4e25-9678-1efdb002b2ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:to="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95149af3-2a73-43db-9f15-fd892f1a9af4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_f1374043-4cbd-430a-bbca-b57a1ef19d17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_02dd4f45-6fb3-4c69-952a-3b814dada926_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_9500c0fa-a2dc-4fea-b32b-d1d44ee7a6a0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_9cbbb06f-5b2c-4f17-ab4d-93f6878e2aa8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherChanges_3f560332-f480-4c5a-b2e7-1a1735d8a03b_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherChanges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, includes translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherChanges_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanOtherChanges" xlink:to="lab_us-gaap_DefinedBenefitPlanOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_448e850c-ab49-4455-9859-7ab0f25bbf6e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4b58a5fe-b566-4e93-a611-2c0cf36b0926_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fab45b0e-2e7b-4147-9502-855fa1475ab7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsIncurred_b459cb13-662c-44f6-8406-9b12fa2e66f1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest costs</link:label>
    <link:label id="lab_us-gaap_InterestCostsIncurred_label_en-US" xlink:label="lab_us-gaap_InterestCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsIncurred" xlink:to="lab_us-gaap_InterestCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8b6a0ccd-01e7-4cdb-a05a-d0a6df31ddba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d37b7ab0-b24f-4f91-abe5-ec73e65406e9_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_72c9d9c5-0456-44a3-85ab-9aa8d473047d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_DiversifiedMember_be8388e1-5b0f-4bed-a207-8d3b6623ce39_terseLabel_en-US" xlink:label="lab_bdx_DiversifiedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified</link:label>
    <link:label id="lab_bdx_DiversifiedMember_label_en-US" xlink:label="lab_bdx_DiversifiedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified [Member]</link:label>
    <link:label id="lab_bdx_DiversifiedMember_documentation_en-US" xlink:label="lab_bdx_DiversifiedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DiversifiedMember" xlink:href="bdx-20220930.xsd#bdx_DiversifiedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_DiversifiedMember" xlink:to="lab_bdx_DiversifiedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0bad080a-97de-47a8-9072-78fc431a2b31_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_51a3e06e-e95b-4e3b-8fc5-4c1e751f998f_terseLabel_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension obligation</link:label>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_label_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Pension Benefit Obligation</link:label>
    <link:label id="lab_bdx_IncreaseDecreaseinPensionBenefitObligation_documentation_en-US" xlink:label="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in obligation for pension benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:href="bdx-20220930.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:to="lab_bdx_IncreaseDecreaseinPensionBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_a0d5821d-4a5a-4d84-b78f-84740885095c_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_470a90a5-63fe-4e31-b3f7-8e9303be07c5_terseLabel_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.034% Notes due August 13, 2025</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_label_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_documentation_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0034DueAugust132025Member" xlink:to="lab_bdx_Notes0034DueAugust132025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_0001c490-9872-480e-bda0-bb4f94b49bac_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, assets, gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4e5c401c-ae29-4b8e-860a-df37fb6d7d40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income from Continuing Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_a457f4fe-0ae0-432c-9cff-8ef2bce2f671_terseLabel_en-US" xlink:label="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net after-tax gain upon termination of contract</link:label>
    <link:label id="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss) Upon Termination Of Derivative Instrument, After Reclassification And Tax, Parent</link:label>
    <link:label id="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_documentation_en-US" xlink:label="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss) Upon Termination Of Derivative Instrument, After Reclassification And Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" xlink:href="bdx-20220930.xsd#bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" xlink:to="lab_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxHolidayTextBlock_d83989fb-ede4-4c37-a404-edd1388e1b2d_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxHolidayTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Holiday</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxHolidayTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxHolidayTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Holiday [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxHolidayTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxHolidayTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxHolidayTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxHolidayTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3884a6a0-16a3-4d60-a31e-99bba49c22bc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_cd7547a0-664e-4262-8699-f60041121d72_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted Earnings per Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_dd44ab41-a155-4853-a9c2-1bdd4067fc7b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8a03f133-aea7-4b7f-b3a4-1e9cc36897f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_3614033c-f945-4fb5-b405-c5131ca2e2f0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_091387e2-cb3a-47f9-a45c-a33ad764c453_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_cb5b5bf5-c8db-420b-899e-1797a0c00abc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_b9cd41e4-7478-4a34-868d-c8224a936836_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and other</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment_60311ff3-7bec-4938-974f-f29c989041ff_terseLabel_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to BD awards related to the spin-off of Embecta (shares)</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment_label_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Spin-Off Adjustment</link:label>
    <link:label id="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment_documentation_en-US" xlink:label="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Spin-Off Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" xlink:to="lab_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_9ac6aaf6-0d2a-4f9a-9b04-e5befb6460ba_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_a3b3ca1b-dffa-4ac0-978c-ed935ab70677_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuits_d1ac99c8-fe42-4306-8c7e-34d39921fae8_terseLabel_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuits_label_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits</link:label>
    <link:label id="lab_bdx_NumberOfEtOSterilizationLawsuits_documentation_en-US" xlink:label="lab_bdx_NumberOfEtOSterilizationLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of EtO Sterilization Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuits" xlink:href="bdx-20220930.xsd#bdx_NumberOfEtOSterilizationLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NumberOfEtOSterilizationLawsuits" xlink:to="lab_bdx_NumberOfEtOSterilizationLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_0b847b56-4387-4ed6-a6cd-727fe65a85fd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_457f7c85-475c-4546-a563-33b6a03221ab_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at October&#160;1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c7cf99eb-e366-4ccd-86a5-0cbe5f6a75c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September&#160;30</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_8c02e4a6-51bc-42c1-8dfa-d26a828ea91e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_172a93e6-831a-4c7e-bbd9-fb16b7de1b34_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic, including Puerto Rico</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_02cc1869-217e-42e5-9b83-d6f8413ab150_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6d1cf14b-ec62-4cf8-aab6-6bf50a23045e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_57253cec-c360-4e77-bec2-6977335f0df1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_9201c2e6-e690-4c8e-acea-2bc2448b24de_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Preferred Stock and Preference Stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Preferred Stock and Preference Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3b6a779d-a787-4ae1-84df-df4cb58a4503_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4d500094-cc53-444c-8dca-770377e02692_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e2a4701a-ba45-4ba7-b32b-0ae126a5b783_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_39fed284-1921-4c3d-b36d-b33d068c5d48_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3361d492-4e47-40ff-b83f-4d1c102c2dc2_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_eb7821aa-ac3d-4b73-91ad-eb1a30b16c91_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_7ca300e6-3562-431c-b599-3980278644ee_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to operations</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_c28ba2d4-d346-46e1-ac45-56b2aba9595a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_NotesDue2040Member_90de27cb-3d1b-45c1-93fc-7b27ab25b470_terseLabel_en-US" xlink:label="lab_bdx_NotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.000% Notes due November&#160;12, 2040</link:label>
    <link:label id="lab_bdx_NotesDue2040Member_label_en-US" xlink:label="lab_bdx_NotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2040 [Member]</link:label>
    <link:label id="lab_bdx_NotesDue2040Member_documentation_en-US" xlink:label="lab_bdx_NotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2040.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2040Member" xlink:href="bdx-20220930.xsd#bdx_NotesDue2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_NotesDue2040Member" xlink:to="lab_bdx_NotesDue2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_0ae88300-8bf2-46bc-917c-d3ed4b1bc9c1_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_CoreTechnologiesMember_235c55b5-4c8d-4f2c-b309-a460d0e41eeb_terseLabel_en-US" xlink:label="lab_bdx_CoreTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core and Developed Technology</link:label>
    <link:label id="lab_bdx_CoreTechnologiesMember_label_en-US" xlink:label="lab_bdx_CoreTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technologies [Member]</link:label>
    <link:label id="lab_bdx_CoreTechnologiesMember_documentation_en-US" xlink:label="lab_bdx_CoreTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreTechnologiesMember" xlink:href="bdx-20220930.xsd#bdx_CoreTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_CoreTechnologiesMember" xlink:to="lab_bdx_CoreTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_9be37947-a8da-44ba-b4ee-ece278072a7d_terseLabel_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:href="bdx-20220930.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0813b13c-7e18-4cee-a0b3-73b27d5026b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_7368d03b-e16d-4756-95bd-e938cde0cb7d_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_502c88ea-df75-4eb6-8b74-a4e9adcf1788_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_5a5eedb0-ea0c-4ec2-a686-af072ca6d4c5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7538d595-b9a7-4637-a6d8-ec9edc0199cb_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_IncomeTaxLineItems_9eca19a0-14c0-4b0f-b83f-8a901b565918_terseLabel_en-US" xlink:label="lab_bdx_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_bdx_IncomeTaxLineItems_label_en-US" xlink:label="lab_bdx_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_bdx_IncomeTaxLineItems_documentation_en-US" xlink:label="lab_bdx_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncomeTaxLineItems" xlink:href="bdx-20220930.xsd#bdx_IncomeTaxLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_IncomeTaxLineItems" xlink:to="lab_bdx_IncomeTaxLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_23a48b52-5298-41e4-90e6-bc47ab048e84_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_49682033-7f27-4295-9c11-4e115c3d854b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_cbad139f-9365-42e3-9b75-d6cb09f2b046_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_LifeSciencesMember_995c87bc-e088-4a39-8a94-7da37539a229_terseLabel_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_label_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences [Member]</link:label>
    <link:label id="lab_bdx_LifeSciencesMember_documentation_en-US" xlink:label="lab_bdx_LifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_LifeSciencesMember" xlink:to="lab_bdx_LifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6741d80e-9343-4f1a-9242-68b7dfbe6e1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring Accrual Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e2cfd948-5c0c-49b9-a8f7-89c92497a779_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive share equivalents from share-based plans (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2ea31cc6-bacf-4887-85e7-eb8c818907da_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b1db15e2-5c23-4de1-b308-d97354fa5cff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_ce323894-2659-4b05-bab6-8014ae4be9af_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_122a6185-36da-4466-b15b-173c280b1ac0_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_04377ab3-ffea-4eb7-bbaa-16cda7897899_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ea5a1a1c-74a8-4b88-a0b4-6e3aaf632cea_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated aggregate amortization expense in 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_abd38f6f-5ff7-4c61-9851-2be0f3d1b787_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation exceeds the fair value of plan assets, projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_17d44621-e9f2-45cc-a39a-b7c19fdefb22_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance&#160;for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b8b4ae8a-aa23-4a0f-8b84-282c373addb7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_GwinnettCountyGeorgiaMember_0a464703-c0e5-4d7d-9d4b-5020f2f71318_terseLabel_en-US" xlink:label="lab_bdx_GwinnettCountyGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gwinnett County, Georgia</link:label>
    <link:label id="lab_bdx_GwinnettCountyGeorgiaMember_label_en-US" xlink:label="lab_bdx_GwinnettCountyGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gwinnett County, Georgia [Member]</link:label>
    <link:label id="lab_bdx_GwinnettCountyGeorgiaMember_documentation_en-US" xlink:label="lab_bdx_GwinnettCountyGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gwinnett County, Georgia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GwinnettCountyGeorgiaMember" xlink:href="bdx-20220930.xsd#bdx_GwinnettCountyGeorgiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_GwinnettCountyGeorgiaMember" xlink:to="lab_bdx_GwinnettCountyGeorgiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_b5d51193-6274-4413-a86c-ba6886f1d354_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_aeeca3f5-4c61-4ced-838f-69a6362faf2d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_311597a1-27cb-442d-a37c-0c0f6cdba7d7_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount recognized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3381e3d2-039f-46c3-b8ec-9afbef6674c3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_13c9d57e-8126-4485-929d-487af490b519_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1401DueMay232023Member_2e0ae304-0663-47b7-b6e0-274c15a8ad66_terseLabel_en-US" xlink:label="lab_bdx_Notes1401DueMay232023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 23, 2023</link:label>
    <link:label id="lab_bdx_Notes1401DueMay232023Member_label_en-US" xlink:label="lab_bdx_Notes1401DueMay232023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 23, 2023 [Member]</link:label>
    <link:label id="lab_bdx_Notes1401DueMay232023Member_documentation_en-US" xlink:label="lab_bdx_Notes1401DueMay232023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 1.401% due May 23, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1401DueMay232023Member" xlink:href="bdx-20220930.xsd#bdx_Notes1401DueMay232023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1401DueMay232023Member" xlink:to="lab_bdx_Notes1401DueMay232023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_3c5c7aa7-f0dd-4b4c-bdbd-b0664a2de432_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtMember_4303cb18-42bc-49a4-89d6-bdaa15aacb00_terseLabel_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtMember_label_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtMember" xlink:to="lab_us-gaap_DebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_SwinglineLoansIssuableUnderCreditFacility_f7aca9a9-98ed-421f-8a89-e10d1808161f_terseLabel_en-US" xlink:label="lab_bdx_SwinglineLoansIssuableUnderCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loans Issuable Under Credit Facility</link:label>
    <link:label id="lab_bdx_SwinglineLoansIssuableUnderCreditFacility_label_en-US" xlink:label="lab_bdx_SwinglineLoansIssuableUnderCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loans Issuable Under Credit Facility</link:label>
    <link:label id="lab_bdx_SwinglineLoansIssuableUnderCreditFacility_documentation_en-US" xlink:label="lab_bdx_SwinglineLoansIssuableUnderCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loans Issuable Under Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SwinglineLoansIssuableUnderCreditFacility" xlink:href="bdx-20220930.xsd#bdx_SwinglineLoansIssuableUnderCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_SwinglineLoansIssuableUnderCreditFacility" xlink:to="lab_bdx_SwinglineLoansIssuableUnderCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRecallExpense_cbd67195-8609-43ad-8b7e-356bce604721_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense" xlink:to="lab_us-gaap_InventoryRecallExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_7cada13c-616a-4dab-a38d-47841c30e61e_terseLabel_en-US" xlink:label="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of share-based compensation</link:label>
    <link:label id="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_label_en-US" xlink:label="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Benefit From Share-Based Compensation</link:label>
    <link:label id="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_documentation_en-US" xlink:label="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Benefit From Share-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" xlink:href="bdx-20220930.xsd#bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" xlink:to="lab_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_c56cd7fe-4cd7-4d8e-ac01-285d8d0db445_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_e236891d-7acf-4a85-b6d3-b50cb80cc306_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_fec8ff78-e2a4-47d9-a1bb-a9aeddf11c53_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_9b1a3c4f-febf-437b-898d-f427c63b87d0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_b9b124eb-a50e-4648-8bff-6f72e7d07da6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_cc569d3c-101c-4a24-8721-016f7d487f31_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation exceeds the fair value of plan assets, projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>bdx-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:92e3b16d-7e78-4ff6-96a7-c06fc2ba1c8c,g:ca0678f9-8390-47c3-8185-7628d34a94cf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7d7956bf-9c44-428a-a6c6-65e298aabfa3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d7956bf-9c44-428a-a6c6-65e298aabfa3" xlink:to="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b36cfe11-e438-4e8f-b138-21f4121dc9cd" xlink:to="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_92668b82-ec15-442d-bbd2-87b0d5cacca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_us-gaap_CommonStockMember_92668b82-ec15-442d-bbd2-87b0d5cacca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DepositarysharesMember_35102a14-29f6-4386-b268-37b78aa67c3c" xlink:href="bdx-20220930.xsd#bdx_DepositarysharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_DepositarysharesMember_35102a14-29f6-4386-b268-37b78aa67c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_9bdeed48-eb2a-4400-bd17-d283faf6de5b" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_9bdeed48-eb2a-4400-bd17-d283faf6de5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_c70c6fdb-e1b0-4f43-9cad-83c9075c60ff" xlink:href="bdx-20220930.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_c70c6fdb-e1b0-4f43-9cad-83c9075c60ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_eb521dba-8e8f-4c79-a4e9-0536bf53ad4b" xlink:href="bdx-20220930.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.401dueMay242023Member_eb521dba-8e8f-4c79-a4e9-0536bf53ad4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_60226d05-79de-4919-ac4f-9ee19f2251b9" xlink:href="bdx-20220930.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes3.020dueMay242025Member_60226d05-79de-4919-ac4f-9ee19f2251b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_26b23fff-82c3-4dd2-b859-b5ff78829bab" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes0.632dueJune42023Member_26b23fff-82c3-4dd2-b859-b5ff78829bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_4e04c8d5-aca7-402f-b0b8-59ccaf2baab9" xlink:href="bdx-20220930.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1.208dueJune42026Member_4e04c8d5-aca7-402f-b0b8-59ccaf2baab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_feabfd46-fae3-43b1-b768-844602f2ba07" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_feabfd46-fae3-43b1-b768-844602f2ba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_52218df5-04e1-489e-862a-e6f2d3d80e92" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes0000DueAugust132023Member_52218df5-04e1-489e-862a-e6f2d3d80e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_dd0ceb06-6929-4c39-856e-46ca9d6f7238" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f55bbcb-9a5e-4235-b0a1-c3ab196b6b16" xlink:to="loc_bdx_Notes0034DueAugust132025Member_dd0ceb06-6929-4c39-856e-46ca9d6f7238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:to="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_e6f6bfe8-f2b1-497d-ba8f-2b1ae28da04a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_fc2617c3-9e9b-4056-8c8a-cab60ac94825" xlink:to="loc_dei_ExchangeDomain_e6f6bfe8-f2b1-497d-ba8f-2b1ae28da04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_dd572343-17f4-443b-9fad-d7617057452e" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_e6f6bfe8-f2b1-497d-ba8f-2b1ae28da04a" xlink:to="loc_exch_XNYS_dd572343-17f4-443b-9fad-d7617057452e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c6372188-40c9-43d2-aab0-eef64ad326a8" xlink:to="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3ccb7cd7-39c1-445a-b222-0911cbbf541d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentType_3ccb7cd7-39c1-445a-b222-0911cbbf541d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_ec28e457-834f-4a66-9682-3519ed400c19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentAnnualReport_ec28e457-834f-4a66-9682-3519ed400c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_183d941c-a96f-4712-9126-506615457ef6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentPeriodEndDate_183d941c-a96f-4712-9126-506615457ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9bb50404-079e-4798-9d2c-e4c3c6ad5d75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_CurrentFiscalYearEndDate_9bb50404-079e-4798-9d2c-e4c3c6ad5d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a8906d50-29f7-4fcc-a0fb-ed286b589cf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentTransitionReport_a8906d50-29f7-4fcc-a0fb-ed286b589cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c365f2c3-3507-401b-9479-365c9befe51a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityFileNumber_c365f2c3-3507-401b-9479-365c9befe51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5e77f3ab-67a9-4859-aba6-d1f7be13d4f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityRegistrantName_5e77f3ab-67a9-4859-aba6-d1f7be13d4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ea6a12b4-1ec9-4d6a-80cb-1cb6b1f38664" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityCentralIndexKey_ea6a12b4-1ec9-4d6a-80cb-1cb6b1f38664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9bbd945f-78e3-4012-a2d2-562121e68708" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentFiscalYearFocus_9bbd945f-78e3-4012-a2d2-562121e68708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_79bc0e1d-445b-4fa7-baa2-83d121de0aec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_79bc0e1d-445b-4fa7-baa2-83d121de0aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a78cf400-4f25-4b8b-9d29-3fca3695ab36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_AmendmentFlag_a78cf400-4f25-4b8b-9d29-3fca3695ab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3802f78c-d35f-43ce-b544-be661646eb62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3802f78c-d35f-43ce-b544-be661646eb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_87b9b251-4b55-42a6-b75e-4721d9d0b2a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityTaxIdentificationNumber_87b9b251-4b55-42a6-b75e-4721d9d0b2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fbf244bc-c088-4005-92e0-82ffdda8ff38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressAddressLine1_fbf244bc-c088-4005-92e0-82ffdda8ff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1b96001b-9544-4806-9d11-4be97510db01" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressCityOrTown_1b96001b-9544-4806-9d11-4be97510db01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5089db34-77e1-4772-9e65-0c9de66246b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressStateOrProvince_5089db34-77e1-4772-9e65-0c9de66246b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_babb9c60-466c-4fb3-ab9a-1a3c326deb4b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityAddressPostalZipCode_babb9c60-466c-4fb3-ab9a-1a3c326deb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_19d66106-bd0a-4fca-8d46-eb8d2e4d01ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_CityAreaCode_19d66106-bd0a-4fca-8d46-eb8d2e4d01ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_282cbead-d28b-4f16-a57a-b34217721e75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_LocalPhoneNumber_282cbead-d28b-4f16-a57a-b34217721e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d0f8b7c8-ac79-49cd-802e-ea7c4149947a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_Security12bTitle_d0f8b7c8-ac79-49cd-802e-ea7c4149947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_19df6d4d-b9e2-45fe-a052-04a8ae5d5220" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_TradingSymbol_19df6d4d-b9e2-45fe-a052-04a8ae5d5220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6253ac49-446f-42fa-8b8e-164d974edc0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_SecurityExchangeName_6253ac49-446f-42fa-8b8e-164d974edc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a496214a-acfa-4312-aa78-f22e80fb27b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a496214a-acfa-4312-aa78-f22e80fb27b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_b4fa2efb-2f58-4caa-a667-eaf1d271efaf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityVoluntaryFilers_b4fa2efb-2f58-4caa-a667-eaf1d271efaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8d9f71b0-dfe5-4ebf-90ff-a66ee43dd6fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityCurrentReportingStatus_8d9f71b0-dfe5-4ebf-90ff-a66ee43dd6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c5bf2724-ffc8-4e14-ba7f-e70c9d304eb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityInteractiveDataCurrent_c5bf2724-ffc8-4e14-ba7f-e70c9d304eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a82c8cff-fea1-4128-b93c-de89f28729b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityFilerCategory_a82c8cff-fea1-4128-b93c-de89f28729b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d0589a3b-7dd9-4d4e-a89b-6c258ba87555" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntitySmallBusiness_d0589a3b-7dd9-4d4e-a89b-6c258ba87555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4843e9f5-c5c0-4bf8-85b6-d90e807775ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityEmergingGrowthCompany_4843e9f5-c5c0-4bf8-85b6-d90e807775ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_68c88a30-18e4-4293-aee5-05b25bfb6465" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_IcfrAuditorAttestationFlag_68c88a30-18e4-4293-aee5-05b25bfb6465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_369ca797-45ae-413f-ab49-e031c10b6494" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityShellCompany_369ca797-45ae-413f-ab49-e031c10b6494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_defa016e-46f0-4aab-ad0a-01581cd0e251" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityPublicFloat_defa016e-46f0-4aab-ad0a-01581cd0e251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_be7c21a4-ce62-4cde-a315-b1a84043dfcf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_953cec33-21b1-4804-904c-92d95ceb00b7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_be7c21a4-ce62-4cde-a315-b1a84043dfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/AuditInformation" xlink:type="simple" xlink:href="bdx-20220930.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AuditInformationAbstract_3587f8b5-5a85-45b5-92dd-d7912f965e88" xlink:href="bdx-20220930.xsd#bdx_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_88c65149-1547-4e3a-8b5d-bc9a66ea8312" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_AuditInformationAbstract_3587f8b5-5a85-45b5-92dd-d7912f965e88" xlink:to="loc_dei_AuditorName_88c65149-1547-4e3a-8b5d-bc9a66ea8312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_e8264cf5-9bb3-4bbd-8081-b7c33f4dfc67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_AuditInformationAbstract_3587f8b5-5a85-45b5-92dd-d7912f965e88" xlink:to="loc_dei_AuditorFirmId_e8264cf5-9bb3-4bbd-8081-b7c33f4dfc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_dbb71163-978c-4842-af36-97aa3ebfa6ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_AuditInformationAbstract_3587f8b5-5a85-45b5-92dd-d7912f965e88" xlink:to="loc_dei_AuditorLocation_dbb71163-978c-4842-af36-97aa3ebfa6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_891d9e3c-7d19-4c8f-86eb-5ece3b55dde9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_Revenues_891d9e3c-7d19-4c8f-86eb-5ece3b55dde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3aeea2ad-0e5f-40ae-a69c-f3211c22c881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3aeea2ad-0e5f-40ae-a69c-f3211c22c881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5b208125-49b0-4a52-b0e5-56e0ab63e0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5b208125-49b0-4a52-b0e5-56e0ab63e0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2cfd4a26-5f1f-4a59-9a24-a10c2c33231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2cfd4a26-5f1f-4a59-9a24-a10c2c33231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_e7e60e59-5c59-4d08-a85b-d058e938ccdc" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_e7e60e59-5c59-4d08-a85b-d058e938ccdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_c0914029-34ce-4556-89cd-6a4fec6fe8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_c0914029-34ce-4556-89cd-6a4fec6fe8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_671fca32-1b4e-4066-8ea4-9a45ecdf4cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_CostsAndExpenses_671fca32-1b4e-4066-8ea4-9a45ecdf4cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ba8c006-3a5b-4138-8e09-3bac41f25685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_OperatingIncomeLoss_7ba8c006-3a5b-4138-8e09-3bac41f25685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e62d1916-1f23-4efd-aaa5-479dacf47464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_InterestExpense_e62d1916-1f23-4efd-aaa5-479dacf47464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_af9c76f6-440f-49b1-aabd-3f79b145b3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_InvestmentIncomeInterest_af9c76f6-440f-49b1-aabd-3f79b145b3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e98fa7eb-af4d-46a7-b249-e9415d7cd691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e98fa7eb-af4d-46a7-b249-e9415d7cd691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9dba70f1-0f2d-4300-88ed-7574f28509f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9dba70f1-0f2d-4300-88ed-7574f28509f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5a01c9e2-bb70-4443-8608-6549d821cbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5a01c9e2-bb70-4443-8608-6549d821cbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_edacc841-ca7a-40c3-847c-461c990e251c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_edacc841-ca7a-40c3-847c-461c990e251c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_9b9c0c11-96ff-45c4-8825-34f379e61dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_9b9c0c11-96ff-45c4-8825-34f379e61dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67f934d6-d17f-4901-8ddd-7d65a3fe8c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_NetIncomeLoss_67f934d6-d17f-4901-8ddd-7d65a3fe8c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_528576cc-6f32-423c-8919-922f118f7a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_528576cc-6f32-423c-8919-922f118f7a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_449e1cc5-8bc5-4cad-bf95-c9c68eb4b51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_449e1cc5-8bc5-4cad-bf95-c9c68eb4b51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_d328fce9-28c9-4bb5-b6fc-74e6da56b11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_d328fce9-28c9-4bb5-b6fc-74e6da56b11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_6e18f2bf-8877-4b23-9d3c-4ed619f88abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d328fce9-28c9-4bb5-b6fc-74e6da56b11a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_6e18f2bf-8877-4b23-9d3c-4ed619f88abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_252ba5e1-d683-4717-a869-c63a0b5ffc37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d328fce9-28c9-4bb5-b6fc-74e6da56b11a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_252ba5e1-d683-4717-a869-c63a0b5ffc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b0b154c3-833f-4a00-8220-24364838f8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d328fce9-28c9-4bb5-b6fc-74e6da56b11a" xlink:to="loc_us-gaap_EarningsPerShareBasic_b0b154c3-833f-4a00-8220-24364838f8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_109ae854-76ca-498d-bbb2-51c5c7355b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1640202e-54f6-4dd6-b7dd-6a05aeedfa24" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_109ae854-76ca-498d-bbb2-51c5c7355b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6222f0ee-30a8-4008-8479-fc397173dbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_109ae854-76ca-498d-bbb2-51c5c7355b35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6222f0ee-30a8-4008-8479-fc397173dbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_070d604c-4bbd-4523-8c5a-ed65ed17f7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_109ae854-76ca-498d-bbb2-51c5c7355b35" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_070d604c-4bbd-4523-8c5a-ed65ed17f7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0e2cd4c6-2fa9-4242-bbc5-7240e781c48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_109ae854-76ca-498d-bbb2-51c5c7355b35" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0e2cd4c6-2fa9-4242-bbc5-7240e781c48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e840871-57b0-4211-9637-ef9c677b8e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76ca0095-426d-49d1-88f6-5758b96d043c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e840871-57b0-4211-9637-ef9c677b8e38" xlink:to="loc_us-gaap_NetIncomeLoss_76ca0095-426d-49d1-88f6-5758b96d043c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c687626-a1b8-44d6-8fc8-0038d5f28bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e840871-57b0-4211-9637-ef9c677b8e38" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c687626-a1b8-44d6-8fc8-0038d5f28bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_609df485-b392-4de7-bf27-a19c43d54c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c687626-a1b8-44d6-8fc8-0038d5f28bea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_609df485-b392-4de7-bf27-a19c43d54c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_732e9442-75fb-4887-82ca-8902d016a5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c687626-a1b8-44d6-8fc8-0038d5f28bea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_732e9442-75fb-4887-82ca-8902d016a5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_b80eee56-fe8d-4ba9-a868-97f69b9e08a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c687626-a1b8-44d6-8fc8-0038d5f28bea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_b80eee56-fe8d-4ba9-a868-97f69b9e08a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_78cd989f-a93e-454b-8d26-b8554a12d054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5c687626-a1b8-44d6-8fc8-0038d5f28bea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_78cd989f-a93e-454b-8d26-b8554a12d054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_817e5dcb-564e-4135-b52b-dd095b277ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e840871-57b0-4211-9637-ef9c677b8e38" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_817e5dcb-564e-4135-b52b-dd095b277ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_63025e66-4ea8-4b88-a783-30c274864bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63025e66-4ea8-4b88-a783-30c274864bcc" xlink:to="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cecd1d2f-01da-4db0-a9f7-8c697737d8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cecd1d2f-01da-4db0-a9f7-8c697737d8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_1c010fbd-a9ed-41b9-9787-6637e4975209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_1c010fbd-a9ed-41b9-9787-6637e4975209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_b2ebcca6-271e-463e-9a6a-eccc2bf0f4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_OtherShortTermInvestments_b2ebcca6-271e-463e-9a6a-eccc2bf0f4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_617d1b1e-2b5b-4639-abf1-c79109b4b70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_617d1b1e-2b5b-4639-abf1-c79109b4b70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c5197ea9-551a-4c6a-bea2-6757ef90083e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_InventoryNet_c5197ea9-551a-4c6a-bea2-6757ef90083e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e8216cf5-da86-4545-95e2-d6af64f0154e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_OtherAssetsCurrent_e8216cf5-da86-4545-95e2-d6af64f0154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0da8ab61-76c0-4876-ab89-a118f4ff62cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0da8ab61-76c0-4876-ab89-a118f4ff62cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b761bef2-087d-4d89-b5c6-71da806ac9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_25a7f1f6-3126-48ba-b9fd-fbe0bbf6f8bc" xlink:to="loc_us-gaap_AssetsCurrent_b761bef2-087d-4d89-b5c6-71da806ac9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7b9ee1b7-8a1a-4d67-88f7-8f151ef54752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7b9ee1b7-8a1a-4d67-88f7-8f151ef54752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4ffc0d40-dc40-4975-8673-3a517f6eb5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_Goodwill_4ffc0d40-dc40-4975-8673-3a517f6eb5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreAndDevelopedTechnologyNet_d79b04f7-a28d-4963-ad3e-8fbb3a3cb4ff" xlink:href="bdx-20220930.xsd#bdx_CoreAndDevelopedTechnologyNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_bdx_CoreAndDevelopedTechnologyNet_d79b04f7-a28d-4963-ad3e-8fbb3a3cb4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteLivedCustomerRelationshipsNet_d6652629-43d1-43b2-836d-e30f1c9fb4a9" xlink:href="bdx-20220930.xsd#bdx_FiniteLivedCustomerRelationshipsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_bdx_FiniteLivedCustomerRelationshipsNet_d6652629-43d1-43b2-836d-e30f1c9fb4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_7990aa2e-e561-4e68-b513-a6f298e19796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_7990aa2e-e561-4e68-b513-a6f298e19796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_af8936be-4d22-4e15-94cb-07014c89dbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_af8936be-4d22-4e15-94cb-07014c89dbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_b8f26715-f4f5-41e7-b88f-35059daf5af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_b8f26715-f4f5-41e7-b88f-35059daf5af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e770a0f5-79fb-4da0-b215-d42c5ba59d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_32cd3a2a-116b-4c38-8565-6e9817da695a" xlink:to="loc_us-gaap_Assets_e770a0f5-79fb-4da0-b215-d42c5ba59d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63025e66-4ea8-4b88-a783-30c274864bcc" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_eae35fa0-5f48-4981-be19-ce27f7b18a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_DebtCurrent_eae35fa0-5f48-4981-be19-ce27f7b18a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3714c9fa-7152-44db-a486-0030ca815cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_AccountsPayableCurrent_3714c9fa-7152-44db-a486-0030ca815cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_79feb6f2-6c28-44f1-9b00-21f97e74b56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_79feb6f2-6c28-44f1-9b00-21f97e74b56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_46cbb556-c912-45f9-8ec8-6f59d0b8b3db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_46cbb556-c912-45f9-8ec8-6f59d0b8b3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_81544093-c0a7-4711-a7d5-56227e676597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_81544093-c0a7-4711-a7d5-56227e676597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a05d3254-5ad8-411b-b0e4-3c11d9e58200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a05d3254-5ad8-411b-b0e4-3c11d9e58200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6a291421-e5e2-4a47-ac20-3bfc657d6fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dfe9141d-b74f-490f-9eaa-892ea7958e72" xlink:to="loc_us-gaap_LiabilitiesCurrent_6a291421-e5e2-4a47-ac20-3bfc657d6fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_49f27c34-7199-4490-9053-d11bd3c048cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_49f27c34-7199-4490-9053-d11bd3c048cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d11ed3fb-55de-4715-b139-4d61342ce747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d11ed3fb-55de-4715-b139-4d61342ce747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_37c07379-48d6-470a-9b8c-a931c193b570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_37c07379-48d6-470a-9b8c-a931c193b570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_c3221949-9658-4162-8d5c-0d7f0f8d2a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_c3221949-9658-4162-8d5c-0d7f0f8d2a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e45612f5-9c1c-4ddb-8adc-2fc159fbd253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e45612f5-9c1c-4ddb-8adc-2fc159fbd253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6fcbf2ab-8eb1-41e2-8e23-d64586f58cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_PreferredStockValue_6fcbf2ab-8eb1-41e2-8e23-d64586f58cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f1bd4831-cfa9-412a-9de7-1e579b100ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_CommonStockValue_f1bd4831-cfa9-412a-9de7-1e579b100ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2acd18ee-1bcc-42b1-87b9-97860e98e6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2acd18ee-1bcc-42b1-87b9-97860e98e6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cb4ae7f8-67f1-4eb9-a68d-fcda98a60ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cb4ae7f8-67f1-4eb9-a68d-fcda98a60ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_741c9917-6802-40e3-840a-db54c42ab099" xlink:href="bdx-20220930.xsd#bdx_CommonStockSharesHeldInEmployeeTrust1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_bdx_CommonStockSharesHeldInEmployeeTrust1_741c9917-6802-40e3-840a-db54c42ab099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9867c283-a4e4-4a70-bf97-e04ad34b6771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_TreasuryStockValue_9867c283-a4e4-4a70-bf97-e04ad34b6771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4f080718-6483-4963-ab83-ff15242f4599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4f080718-6483-4963-ab83-ff15242f4599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_be414d15-0d87-4df7-9e08-0bfc2967d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bdfedb9f-ca00-473b-b106-8d8b06729ff3" xlink:to="loc_us-gaap_StockholdersEquity_be414d15-0d87-4df7-9e08-0bfc2967d399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b440f35-b940-471a-b01e-68ebf8a954c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ac8edf6-14a1-4a4f-baad-2e69dbc545d8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b440f35-b940-471a-b01e-68ebf8a954c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_22b4993b-b3de-4255-acc2-e5d04c900687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_713ce903-8806-4c0a-8740-6c5fe28984db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22b4993b-b3de-4255-acc2-e5d04c900687" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_713ce903-8806-4c0a-8740-6c5fe28984db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7aba9a7c-3d14-492a-b34a-55e16278e8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22b4993b-b3de-4255-acc2-e5d04c900687" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7aba9a7c-3d14-492a-b34a-55e16278e8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_765e8b14-73fa-4051-a0f8-9affbf601dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22b4993b-b3de-4255-acc2-e5d04c900687" xlink:to="loc_us-gaap_CommonStockSharesIssued_765e8b14-73fa-4051-a0f8-9affbf601dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9dd74549-6d1f-41cb-967f-f0c02e72b44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22b4993b-b3de-4255-acc2-e5d04c900687" xlink:to="loc_us-gaap_TreasuryStockShares_9dd74549-6d1f-41cb-967f-f0c02e72b44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdx-20220930.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_371ecfc5-3f07-4942-a642-afeb78c899bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:to="loc_us-gaap_NetIncomeLoss_371ecfc5-3f07-4942-a642-afeb78c899bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_686e61c3-5e7c-401b-af38-7042806d617c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_686e61c3-5e7c-401b-af38-7042806d617c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8822a6ea-ce6e-4db4-afdc-98c7d87555c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_8822a6ea-ce6e-4db4-afdc-98c7d87555c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_296d24c4-6185-458a-989c-f39d97e58c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_296d24c4-6185-458a-989c-f39d97e58c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7f00fc53-e2d9-493b-8382-2bc777055af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_us-gaap_ShareBasedCompensation_7f00fc53-e2d9-493b-8382-2bc777055af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_65fa82c5-e532-49a9-93e1-0724a9744b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_65fa82c5-e532-49a9-93e1-0724a9744b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4ea3fd29-d68c-4500-b01e-3c27e8890c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4ea3fd29-d68c-4500-b01e-3c27e8890c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_af415aa7-fd45-4625-9547-12538e9758c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4ea3fd29-d68c-4500-b01e-3c27e8890c69" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_af415aa7-fd45-4625-9547-12538e9758c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3046a27c-a0c0-414a-977a-1b70eb12669e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4ea3fd29-d68c-4500-b01e-3c27e8890c69" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3046a27c-a0c0-414a-977a-1b70eb12669e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5a68950d-a11b-400f-83e5-69fd5d872514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4ea3fd29-d68c-4500-b01e-3c27e8890c69" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5a68950d-a11b-400f-83e5-69fd5d872514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6a36b863-4442-44ff-86f7-bfaaf3c33a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4ea3fd29-d68c-4500-b01e-3c27e8890c69" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6a36b863-4442-44ff-86f7-bfaaf3c33a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_93c92bea-cac4-4e62-abcd-21dfeacdf5cd" xlink:href="bdx-20220930.xsd#bdx_IncreaseDecreaseinPensionBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_bdx_IncreaseDecreaseinPensionBenefitObligation_93c92bea-cac4-4e62-abcd-21dfeacdf5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_0d0b22d7-ac65-4e50-bd90-178bc0c22162" xlink:href="bdx-20220930.xsd#bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities_0d0b22d7-ac65-4e50-bd90-178bc0c22162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_668f2257-2b12-4370-8734-4ac644590460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_668f2257-2b12-4370-8734-4ac644590460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f421c90c-4391-44d9-a1b5-269b1119f67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e8a8735-de19-4db4-8487-b439db1d8f57" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f421c90c-4391-44d9-a1b5-269b1119f67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ec43a22b-941a-4d1b-b017-85749b92e50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_f2b029e8-a4de-405f-b9fc-4e698076d274" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ec43a22b-941a-4d1b-b017-85749b92e50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_637f0656-f8ac-45cc-8158-f9acb98706a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_637f0656-f8ac-45cc-8158-f9acb98706a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_61451e19-d545-436d-ad3c-3a0e07b513a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_637f0656-f8ac-45cc-8158-f9acb98706a4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_61451e19-d545-436d-ad3c-3a0e07b513a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f7925757-8b14-46d2-8615-d382f14e4ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_637f0656-f8ac-45cc-8158-f9acb98706a4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f7925757-8b14-46d2-8615-d382f14e4ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1da93f33-6722-4314-ad96-35e1eadd5751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_637f0656-f8ac-45cc-8158-f9acb98706a4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1da93f33-6722-4314-ad96-35e1eadd5751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_f87302c8-a365-4b8e-9b60-bc5c36bda258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_637f0656-f8ac-45cc-8158-f9acb98706a4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_f87302c8-a365-4b8e-9b60-bc5c36bda258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_42109956-bd29-4570-8019-91422ed71646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_42109956-bd29-4570-8019-91422ed71646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_f19c3663-e541-47a4-846d-572e0c87af8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_f19c3663-e541-47a4-846d-572e0c87af8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_06419ce5-cc85-4f5e-906c-8c973477d60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_06419ce5-cc85-4f5e-906c-8c973477d60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProceedsFromSpinoffTransaction_90035d69-1323-4b2b-b4cd-f5060bcb6b4b" xlink:href="bdx-20220930.xsd#bdx_ProceedsFromSpinoffTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_bdx_ProceedsFromSpinoffTransaction_90035d69-1323-4b2b-b4cd-f5060bcb6b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CashTransferRelatedToSpinoffTransaction_38da10b0-dc5b-42e6-a030-827e97bed20c" xlink:href="bdx-20220930.xsd#bdx_CashTransferRelatedToSpinoffTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_bdx_CashTransferRelatedToSpinoffTransaction_38da10b0-dc5b-42e6-a030-827e97bed20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_006a7009-357e-4184-9a47-b9e8681ba87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_006a7009-357e-4184-9a47-b9e8681ba87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_06d96e10-3442-42ee-a50c-2609dc70df06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_06d96e10-3442-42ee-a50c-2609dc70df06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_14225bbd-60e1-4d07-93a6-38d8c4fe6c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_14225bbd-60e1-4d07-93a6-38d8c4fe6c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_f0270707-f932-47ad-8962-f35ee1abddce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_f0270707-f932-47ad-8962-f35ee1abddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_06921110-e41b-46ba-9188-a267aed11974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_06921110-e41b-46ba-9188-a267aed11974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_9a282cf0-c6dd-4ecd-9187-d1d54a43613d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_2086af7b-3e16-4b98-af85-8922c35c040a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_9a282cf0-c6dd-4ecd-9187-d1d54a43613d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_fb3d85a3-7375-447b-bd74-a6b040b14d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_fb3d85a3-7375-447b-bd74-a6b040b14d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_8d6565ed-2c85-4e7e-8b9b-6c9cdebe40dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_8d6565ed-2c85-4e7e-8b9b-6c9cdebe40dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_d2aeef85-1a2d-41ea-896f-49f75bac869b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_d2aeef85-1a2d-41ea-896f-49f75bac869b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_c143e42c-6273-4565-a1d2-b45816b492b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_c143e42c-6273-4565-a1d2-b45816b492b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eea3a011-6a65-4394-be13-43315cf891ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eea3a011-6a65-4394-be13-43315cf891ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fa74d1eb-04b3-435e-b96b-eca3cdcec8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fa74d1eb-04b3-435e-b96b-eca3cdcec8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25ebbe46-0a46-4e0b-9791-5d9561b0c1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25ebbe46-0a46-4e0b-9791-5d9561b0c1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ef54429-7ecb-45a1-af80-3fe705606734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ea6a47c0-c8f8-4ded-a002-ecdc3765c9dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ef54429-7ecb-45a1-af80-3fe705606734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="bdx-20220930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d9a6cb4d-fc13-42ec-a4c0-e4e2ed33f7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_edde229a-9232-44f1-b9a1-5f66cf96676f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9a6cb4d-fc13-42ec-a4c0-e4e2ed33f7dd" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_edde229a-9232-44f1-b9a1-5f66cf96676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorp" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorp"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorp" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_01c5295c-5ab8-4790-a916-0d83546a1605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_46bc8aff-08e3-493a-ab65-d36d0df45a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_01c5295c-5ab8-4790-a916-0d83546a1605" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_46bc8aff-08e3-493a-ab65-d36d0df45a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/AccountingChanges" xlink:type="simple" xlink:href="bdx-20220930.xsd#AccountingChanges"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/AccountingChanges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_a8f4ed4d-99c0-45bf-b5cb-1262f11bb188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a13c8208-abec-44e1-9f46-9965ab38e0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_a8f4ed4d-99c0-45bf-b5cb-1262f11bb188" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a13c8208-abec-44e1-9f46-9965ab38e0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1d6df937-341d-4ef5-b14e-9b167fd7612d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_75f5a6c4-9c4e-4b48-8a5e-16a65c050281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1d6df937-341d-4ef5-b14e-9b167fd7612d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_75f5a6c4-9c4e-4b48-8a5e-16a65c050281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsperShare" xlink:type="simple" xlink:href="bdx-20220930.xsd#EarningsperShare"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e6920422-4eeb-4e81-84f3-b53630de0cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_10ca21f1-5df6-40c3-85a4-d3ac8cfb2362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e6920422-4eeb-4e81-84f3-b53630de0cfa" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_10ca21f1-5df6-40c3-85a4-d3ac8cfb2362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bdx-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a2418d6-ecfd-4083-bc50-5f516cb6b04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eafdd4be-922e-409c-96f1-1eb84ba91a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a2418d6-ecfd-4083-bc50-5f516cb6b04f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eafdd4be-922e-409c-96f1-1eb84ba91a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Revenues" xlink:type="simple" xlink:href="bdx-20220930.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b292c285-a1f3-48b8-9b8a-b12003d73c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c52a9a68-de40-4ca0-8e0e-de373a07d51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b292c285-a1f3-48b8-9b8a-b12003d73c41" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c52a9a68-de40-4ca0-8e0e-de373a07d51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentData" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentData"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d47793b2-ecbd-44fa-afdf-4e8d92bdabea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d68bdf93-77dc-477e-9544-60b8e9464eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d47793b2-ecbd-44fa-afdf-4e8d92bdabea" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d68bdf93-77dc-477e-9544-60b8e9464eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec9bb75e-476e-4067-a4e9-4f37315da5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_25f2552b-e6ac-43f7-905f-23e6076e5752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec9bb75e-476e-4067-a4e9-4f37315da5e5" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_25f2552b-e6ac-43f7-905f-23e6076e5752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlans" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f81ed661-a7a7-4edc-acab-c416e5860242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d124ed8f-a45e-4776-9801-5ba9bfeffcca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f81ed661-a7a7-4edc-acab-c416e5860242" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d124ed8f-a45e-4776-9801-5ba9bfeffcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Acquisitions" xlink:type="simple" xlink:href="bdx-20220930.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_890a4581-7389-4088-97d4-1fd9f2ae7f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_37872fe9-6d3b-4c23-baa6-42ba8592bfb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_890a4581-7389-4088-97d4-1fd9f2ae7f42" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_37872fe9-6d3b-4c23-baa6-42ba8592bfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringCharges" xlink:type="simple" xlink:href="bdx-20220930.xsd#BusinessRestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_45be2af0-666f-41aa-840c-233277e6a5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f84b568d-948f-46d5-a81f-a2a4f2bc1235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_45be2af0-666f-41aa-840c-233277e6a5c6" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f84b568d-948f-46d5-a81f-a2a4f2bc1235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssets" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c21fb119-13dd-41e0-83ad-b04dc1acc095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c04e5e90-6600-46c8-87b6-0c3239784a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c21fb119-13dd-41e0-83ad-b04dc1acc095" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c04e5e90-6600-46c8-87b6-0c3239784a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40bb8f04-f5cc-4a81-aa35-1f9d067fc3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_852745de-c60a-4189-a759-2809a110cdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40bb8f04-f5cc-4a81-aa35-1f9d067fc3c4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_852745de-c60a-4189-a759-2809a110cdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f6cb897b-1b50-4ecc-8b9b-a529bf657345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8bfad4d3-4028-44db-9a45-0e83a6257f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6cb897b-1b50-4ecc-8b9b-a529bf657345" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8bfad4d3-4028-44db-9a45-0e83a6257f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Debt" xlink:type="simple" xlink:href="bdx-20220930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cb1c0a8d-44df-4554-b433-b189f16d821d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8523174c-8f4a-454f-b9be-311e36093dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cb1c0a8d-44df-4554-b433-b189f16d821d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8523174c-8f4a-454f-b9be-311e36093dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6c0135b7-4c43-483f-96d9-0f743eaff0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_17808862-db87-46ff-91b0-55d414a254e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c0135b7-4c43-483f-96d9-0f743eaff0a1" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_17808862-db87-46ff-91b0-55d414a254e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/Leases" xlink:type="simple" xlink:href="bdx-20220930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0e2c7192-6cb0-4bdb-895e-8fa46e1efb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f7e7fbf9-5339-42cb-bf02-6a63d16f22f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e2c7192-6cb0-4bdb-895e-8fa46e1efb16" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f7e7fbf9-5339-42cb-bf02-6a63d16f22f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c15f8347-fb20-4369-b5ee-5366aedfaa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_d0725796-f19a-4215-897d-86e9804ed4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c15f8347-fb20-4369-b5ee-5366aedfaa6a" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_d0725796-f19a-4215-897d-86e9804ed4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bdx-20220930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_47995a9a-13f0-4eb2-a4d1-4e72c9db5446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_47995a9a-13f0-4eb2-a4d1-4e72c9db5446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_df12a4b6-4ff3-4aee-92d8-5f9158e919a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_df12a4b6-4ff3-4aee-92d8-5f9158e919a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_cf1d8108-8bdc-46d4-997e-e7e6454d34ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_cf1d8108-8bdc-46d4-997e-e7e6454d34ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b1479621-abc5-4c3c-9df8-59b637bc7d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b1479621-abc5-4c3c-9df8-59b637bc7d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_6d7b599a-d4f2-4681-b7c1-3d85d06681bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_6d7b599a-d4f2-4681-b7c1-3d85d06681bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_12468642-1571-4f59-aea0-06e73fd637b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_12468642-1571-4f59-aea0-06e73fd637b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2bfdb87c-718b-47ae-bb6f-b59550d5a0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2bfdb87c-718b-47ae-bb6f-b59550d5a0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4d4dba9c-4a5c-44ac-b852-39f60ad05adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4d4dba9c-4a5c-44ac-b852-39f60ad05adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e62f6192-07ec-41c0-ae33-690d617d948b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e62f6192-07ec-41c0-ae33-690d617d948b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8edd781c-b006-4e15-83c2-63dcea822ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8edd781c-b006-4e15-83c2-63dcea822ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_851415f0-b721-4230-b01c-f881b78ea4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_851415f0-b721-4230-b01c-f881b78ea4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_df8481c8-eab9-4a90-8c63-afe9e842e06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_df8481c8-eab9-4a90-8c63-afe9e842e06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_3e73cd54-c3f4-4fbb-b1e9-1134e3b14afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_3e73cd54-c3f4-4fbb-b1e9-1134e3b14afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_8b2025dd-b850-458c-b5c0-60372d8db36b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_8b2025dd-b850-458c-b5c0-60372d8db36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2aae95e4-7655-4651-b354-7b542422fc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2aae95e4-7655-4651-b354-7b542422fc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4378ae29-b7cd-4c4e-9a8d-ab03f5a829b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_UseOfEstimates_4378ae29-b7cd-4c4e-9a8d-ab03f5a829b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e3337bb-6b72-44f2-9c37-7599c4746db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e3337bb-6b72-44f2-9c37-7599c4746db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1afe8422-a58f-4b96-8cc6-23e6ac4dae82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1afe8422-a58f-4b96-8cc6-23e6ac4dae82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_e409f48c-0e23-45ce-b74b-e88eba102897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_e409f48c-0e23-45ce-b74b-e88eba102897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_c76f5287-ec5f-4bbd-a516-8d2a205d7ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_c76f5287-ec5f-4bbd-a516-8d2a205d7ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_17d23e57-cdaf-4cec-abb1-dc21a451d9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_17d23e57-cdaf-4cec-abb1-dc21a451d9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeasesPolicyTextBlock_e9ba04ef-4e9b-4e3a-919e-029d3abccfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeasesPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_541d9f26-6ce3-4987-ab51-75472b310e0f" xlink:to="loc_us-gaap_ShortTermLeasesPolicyTextBlock_e9ba04ef-4e9b-4e3a-919e-029d3abccfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b95eb5ae-1449-4925-ad3e-ca649417f08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_f8dbc2f8-9d4f-4ecc-afd4-9f39634a491c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b95eb5ae-1449-4925-ad3e-ca649417f08d" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_f8dbc2f8-9d4f-4ecc-afd4-9f39634a491c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1c5781a9-d85f-4d37-8828-7146051e4f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_8c819f82-2498-41ef-95e3-529aecb2fbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1c5781a9-d85f-4d37-8828-7146051e4f50" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_8c819f82-2498-41ef-95e3-529aecb2fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_141e6d72-5bd2-4b42-af85-c16387c69cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1c5781a9-d85f-4d37-8828-7146051e4f50" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_141e6d72-5bd2-4b42-af85-c16387c69cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7e609a6b-d5a4-4b59-bc5e-423a9fc285f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1c5781a9-d85f-4d37-8828-7146051e4f50" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7e609a6b-d5a4-4b59-bc5e-423a9fc285f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsperShareTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#EarningsperShareTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2299e30e-0015-4014-8478-b2b5a745e864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_218cf831-2d04-4194-97ad-5c75cdbaf91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2299e30e-0015-4014-8478-b2b5a745e864" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_218cf831-2d04-4194-97ad-5c75cdbaf91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d916c264-4744-4262-bd2b-abde6dfd7197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_b9e52b5b-03ea-4b93-8a40-7c975cc961fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d916c264-4744-4262-bd2b-abde6dfd7197" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_b9e52b5b-03ea-4b93-8a40-7c975cc961fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_54fd094e-e878-4464-bd7e-6382b1198838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d916c264-4744-4262-bd2b-abde6dfd7197" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_54fd094e-e878-4464-bd7e-6382b1198838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_223c8e3f-5ac9-4592-a870-7ac191889682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d916c264-4744-4262-bd2b-abde6dfd7197" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_223c8e3f-5ac9-4592-a870-7ac191889682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e37b99c9-c74d-44cd-b4e2-eb23bb0963ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e37b99c9-c74d-44cd-b4e2-eb23bb0963ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1abf8faf-6e3d-48f6-a5bd-fa55efbff352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1abf8faf-6e3d-48f6-a5bd-fa55efbff352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_b5fa4f99-ca0d-4d94-8a3c-f74b43d4ffae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_b5fa4f99-ca0d-4d94-8a3c-f74b43d4ffae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock_a9a9f98d-c1db-4d4f-818a-a788fb27eb84" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock_a9a9f98d-c1db-4d4f-818a-a788fb27eb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_998a5983-0858-41fe-a173-0254276246ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_998a5983-0858-41fe-a173-0254276246ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock_abd62a90-05a9-4e3e-9f13-48f687390aaa" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock_abd62a90-05a9-4e3e-9f13-48f687390aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock_731b1bff-f403-4a3b-909b-86d5d5e64e58" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_53aa99ff-a42f-4bf3-b839-ce3d6a20eb0c" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock_731b1bff-f403-4a3b-909b-86d5d5e64e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_84e6917c-43e3-47ed-b90d-789e6047508f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_84e6917c-43e3-47ed-b90d-789e6047508f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_f94db65b-05ad-4a67-a061-613b8a7491e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_f94db65b-05ad-4a67-a061-613b8a7491e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_8f495414-97d3-4be7-a74a-9f08c07c5cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_8f495414-97d3-4be7-a74a-9f08c07c5cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_a38b52f2-a5af-4bef-b89e-6dc8f806dd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_a38b52f2-a5af-4bef-b89e-6dc8f806dd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_3b685664-44f7-41fe-8423-e0aab1846f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_3b685664-44f7-41fe-8423-e0aab1846f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ff425b27-2fe5-4103-aac7-ca37a9079b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ff425b27-2fe5-4103-aac7-ca37a9079b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock_aa92b18f-5d5a-424a-ac30-a7618a78a0f2" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4ba6a31d-254c-4223-98a4-990108b9a4fd" xlink:to="loc_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock_aa92b18f-5d5a-424a-ac30-a7618a78a0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#BusinessRestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_30580331-a43b-4992-994c-958afb027cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_cd6d9382-9e46-4cfe-81c4-e8b74b953e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_30580331-a43b-4992-994c-958afb027cd6" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_cd6d9382-9e46-4cfe-81c4-e8b74b953e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_afa92c62-6fce-418f-82a3-ecc7292d7eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ab40dc5e-7acc-43e1-8b1e-008f2a210079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_afa92c62-6fce-418f-82a3-ecc7292d7eb7" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ab40dc5e-7acc-43e1-8b1e-008f2a210079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_0402dd6a-6880-4414-b0d7-26c8d893c23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_afa92c62-6fce-418f-82a3-ecc7292d7eb7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_0402dd6a-6880-4414-b0d7-26c8d893c23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e39e6259-79fe-46fc-9187-90df3db2c826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_bfb463d7-63d5-4960-9556-27e07c03f3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e39e6259-79fe-46fc-9187-90df3db2c826" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_bfb463d7-63d5-4960-9556-27e07c03f3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_250ee449-3518-44f0-87e4-e50ef60098bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e39e6259-79fe-46fc-9187-90df3db2c826" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_250ee449-3518-44f0-87e4-e50ef60098bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e887f331-cf1e-4940-8b6d-c0bdbd09f959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_7f79bf4f-2210-47b2-8a32-23cfc750a2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e887f331-cf1e-4940-8b6d-c0bdbd09f959" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_7f79bf4f-2210-47b2-8a32-23cfc750a2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5bd7a0ae-b29a-4579-98bc-4bde2183410b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e887f331-cf1e-4940-8b6d-c0bdbd09f959" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5bd7a0ae-b29a-4579-98bc-4bde2183410b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_586263a6-d8ed-49ca-b26a-bb3e843d7a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e887f331-cf1e-4940-8b6d-c0bdbd09f959" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_586263a6-d8ed-49ca-b26a-bb3e843d7a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_40fab52c-8d2f-44b8-bfe1-7b955df46f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_4e4755db-78eb-46c7-83f3-5e997e1c0dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40fab52c-8d2f-44b8-bfe1-7b955df46f51" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_4e4755db-78eb-46c7-83f3-5e997e1c0dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0af3355b-259a-42b9-b3fd-abf58b6b80bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40fab52c-8d2f-44b8-bfe1-7b955df46f51" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0af3355b-259a-42b9-b3fd-abf58b6b80bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfDebtIssuancesTableTextBlock_c022d9fb-3c3e-4872-9b37-2c6b66538d38" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfDebtIssuancesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40fab52c-8d2f-44b8-bfe1-7b955df46f51" xlink:to="loc_bdx_ScheduleOfDebtIssuancesTableTextBlock_c022d9fb-3c3e-4872-9b37-2c6b66538d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_67f76168-5f76-496e-baac-300015abb098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40fab52c-8d2f-44b8-bfe1-7b955df46f51" xlink:to="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_67f76168-5f76-496e-baac-300015abb098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterestCostsIncurredTableTableTextBlock_eef6c954-3cfe-4519-babb-e955708c3384" xlink:href="bdx-20220930.xsd#bdx_InterestCostsIncurredTableTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40fab52c-8d2f-44b8-bfe1-7b955df46f51" xlink:to="loc_bdx_InterestCostsIncurredTableTableTextBlock_eef6c954-3cfe-4519-babb-e955708c3384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4951fdaa-1ac6-44a7-875a-7c92d275cd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4951fdaa-1ac6-44a7-875a-7c92d275cd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_da55aed6-50c7-4133-aec1-f1304b6cf433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_da55aed6-50c7-4133-aec1-f1304b6cf433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_5ecfd38e-52ef-4da5-b891-3d9b150cd4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_5ecfd38e-52ef-4da5-b891-3d9b150cd4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_908ea251-41ad-426e-aee5-c248b54a845e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_908ea251-41ad-426e-aee5-c248b54a845e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b7e8ac79-7392-4f6f-95d1-c2c19fceb198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b7e8ac79-7392-4f6f-95d1-c2c19fceb198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxHolidayTextBlock_e254c247-606c-4a9b-af09-683271599dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxHolidayTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_249a27d1-60c4-4935-b570-7afc6bb63ac5" xlink:to="loc_us-gaap_SummaryOfIncomeTaxHolidayTextBlock_e254c247-606c-4a9b-af09-683271599dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e17032af-f969-42b0-8aff-59b7107bf668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock_25f995cd-e2da-42f8-be33-87114f4a58e2" xlink:href="bdx-20220930.xsd#bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e17032af-f969-42b0-8aff-59b7107bf668" xlink:to="loc_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock_25f995cd-e2da-42f8-be33-87114f4a58e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8e237198-b8f1-4344-a541-3c0d28e6baaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e17032af-f969-42b0-8aff-59b7107bf668" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8e237198-b8f1-4344-a541-3c0d28e6baaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d991c335-cb62-41b4-b69d-f839e62aaa29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_4b2bb9b0-08b8-48f3-8c10-6dae88d5532c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d991c335-cb62-41b4-b69d-f839e62aaa29" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_4b2bb9b0-08b8-48f3-8c10-6dae88d5532c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_49a81640-bd7b-4a9f-a0e7-f63fad5c2808" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d991c335-cb62-41b4-b69d-f839e62aaa29" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_49a81640-bd7b-4a9f-a0e7-f63fad5c2808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_95ef94c7-04d7-43cc-b509-8cfe1c315547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d991c335-cb62-41b4-b69d-f839e62aaa29" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_95ef94c7-04d7-43cc-b509-8cfe1c315547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_57a514a6-7f13-41a9-8c84-571ea675d44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d991c335-cb62-41b4-b69d-f839e62aaa29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_57a514a6-7f13-41a9-8c84-571ea675d44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a1aa3865-b156-4f25-8de2-9a8009d57011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1aa3865-b156-4f25-8de2-9a8009d57011" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc35113d-66a8-45ce-a45f-1e934e579672" xlink:to="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_19bc2b58-ec63-48fc-b675-1b48803e9b97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:to="loc_srt_MinimumMember_19bc2b58-ec63-48fc-b675-1b48803e9b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_830d25f0-3816-4f78-a858-a9ffe1eb8a34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d1db60ba-6b06-4b17-b8b8-a1e4a3a73033" xlink:to="loc_srt_MaximumMember_830d25f0-3816-4f78-a858-a9ffe1eb8a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ef7c33f-3ab0-43d3-9017-02fd98247c3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8a552795-77db-4f6a-adfa-7379500d0f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:to="loc_us-gaap_BuildingMember_8a552795-77db-4f6a-adfa-7379500d0f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1cbd4e86-00b4-46a6-82db-afbf5420eade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1cbd4e86-00b4-46a6-82db-afbf5420eade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_558cfb4d-ab62-4d36-871f-dbba5e28a907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dc18ded-bdb4-43f6-b217-114842b677c6" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_558cfb4d-ab62-4d36-871f-dbba5e28a907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1f69a750-1dac-4a1d-ba4f-7168adf78838" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CoreTechnologiesMember_9cfef7a6-49f2-4df0-90ad-abf61554de23" xlink:href="bdx-20220930.xsd#bdx_CoreTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:to="loc_bdx_CoreTechnologiesMember_9cfef7a6-49f2-4df0-90ad-abf61554de23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_77488fe1-7183-4fab-b419-8c3bfd423b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:to="loc_us-gaap_CustomerRelationshipsMember_77488fe1-7183-4fab-b419-8c3bfd423b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PatentsAndTrademarksMember_ce8dee36-1736-484b-a9ce-29ff2c4cd6a1" xlink:href="bdx-20220930.xsd#bdx_PatentsAndTrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_baec168b-ac6b-431a-b08d-96d0efbe1501" xlink:to="loc_bdx_PatentsAndTrademarksMember_ce8dee36-1736-484b-a9ce-29ff2c4cd6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1ae25d18-3cd6-4708-85c4-e7a98235cdc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_eafe69d1-6b9e-4d1b-aefe-7c371ed7213d" xlink:to="loc_srt_ProductsAndServicesDomain_1ae25d18-3cd6-4708-85c4-e7a98235cdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_897ff289-8387-459b-bcc5-3548e78bcd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1ae25d18-3cd6-4708-85c4-e7a98235cdc0" xlink:to="loc_us-gaap_ShippingAndHandlingMember_897ff289-8387-459b-bcc5-3548e78bcd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_71486c64-8189-4d63-bec6-19b81763ac1b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_15e13846-85f0-4638-a2d1-d7d6c06e9e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_15e13846-85f0-4638-a2d1-d7d6c06e9e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_29e10c8c-b2dd-48fe-912c-c0ddb714216f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_Depreciation_29e10c8c-b2dd-48fe-912c-c0ddb714216f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6c978a4b-4bde-4e0e-bed4-c43ec998229a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6c978a4b-4bde-4e0e-bed4-c43ec998229a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94bb0a98-0791-4fdd-97dd-87412880d528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a098f6b-9ea2-409d-82e7-8e3485bd8405" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94bb0a98-0791-4fdd-97dd-87412880d528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0111016c-b463-4352-a9f1-9ff07e13286c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0111016c-b463-4352-a9f1-9ff07e13286c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d3bf3d1-831f-4076-8613-5d4ff51fa454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f26e9707-3e5e-4aad-8ea9-7ddf1c4d214e" xlink:to="loc_us-gaap_EquityComponentDomain_7d3bf3d1-831f-4076-8613-5d4ff51fa454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86480aea-50ca-4329-865a-79da0aab8ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7d3bf3d1-831f-4076-8613-5d4ff51fa454" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_86480aea-50ca-4329-865a-79da0aab8ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb0f126c-ff8a-44c4-b5f8-2fe0905718d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fc82c3ca-a648-4185-b876-3e96233ee26b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb0f126c-ff8a-44c4-b5f8-2fe0905718d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member_f6f7ef7f-1273-46ba-b7a2-69e8588cbb3c" xlink:href="bdx-20220930.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eb0f126c-ff8a-44c4-b5f8-2fe0905718d3" xlink:to="loc_bdx_Notes6750DueFebruary152030Member_f6f7ef7f-1273-46ba-b7a2-69e8588cbb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_36da3015-03ae-43b9-ac3a-497283a85fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8607a250-b376-4936-b0fc-d59ccdec60e9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_36da3015-03ae-43b9-ac3a-497283a85fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_122d38e9-7a56-42e9-a9cd-48b3e07ffa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_36da3015-03ae-43b9-ac3a-497283a85fe2" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_122d38e9-7a56-42e9-a9cd-48b3e07ffa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_958049e0-fea0-4614-97e6-7a424165afb6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3dacda18-be9c-4da8-9c61-64e5e9b9688b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3dacda18-be9c-4da8-9c61-64e5e9b9688b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_c0a91375-f275-4547-9c40-52ca1656b73e" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash_c0a91375-f275-4547-9c40-52ca1656b73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_f3438110-9b45-41dd-8659-73f94397687c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_f3438110-9b45-41dd-8659-73f94397687c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_71f01905-4df2-4ff1-9f86-a62fe8ad615d" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationDebt_71f01905-4df2-4ff1-9f86-a62fe8ad615d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CashTransferRelatedToSpinoffTransaction_0aa70c1a-1306-4f04-a96b-7aa7520211f8" xlink:href="bdx-20220930.xsd#bdx_CashTransferRelatedToSpinoffTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_bdx_CashTransferRelatedToSpinoffTransaction_0aa70c1a-1306-4f04-a96b-7aa7520211f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_194c4d3b-e182-4fb9-853b-1faca1cd4ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68d8ea68-b787-4508-8b19-4b821ca30816" xlink:to="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_194c4d3b-e182-4fb9-853b-1faca1cd4ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_91f0c2b5-e13f-475c-9ca4-72f035f5318e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_91f0c2b5-e13f-475c-9ca4-72f035f5318e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_aac25e55-e8ed-4cef-b534-d733afb340e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d6ef9748-7012-4516-9d91-04f9477480a3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_aac25e55-e8ed-4cef-b534-d733afb340e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d5fa0fda-a8c4-433b-abbf-8ab3fcddc791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_aac25e55-e8ed-4cef-b534-d733afb340e8" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d5fa0fda-a8c4-433b-abbf-8ab3fcddc791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_689ec997-4028-4164-8466-3db554a3e62f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_75707b76-aa71-4ecb-b9ba-a14644ea0c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_75707b76-aa71-4ecb-b9ba-a14644ea0c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_099c2872-fa42-49b8-a916-6a5699f8b7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_099c2872-fa42-49b8-a916-6a5699f8b7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_99bc70fa-b990-466a-a22d-9741ae2a432d" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense_99bc70fa-b990-466a-a22d-9741ae2a432d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_394cac2f-025b-451b-8057-e7b127de1bc6" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense_394cac2f-025b-451b-8057-e7b127de1bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_16584a61-c629-446f-ba6e-6ab71a931fef" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges_16584a61-c629-446f-ba6e-6ab71a931fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_551c82f1-c218-48f2-8d5c-8d71604f7ff0" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet_551c82f1-c218-48f2-8d5c-8d71604f7ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_cbd4bc55-285c-4bcf-b354-97ac0b73ae5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_cbd4bc55-285c-4bcf-b354-97ac0b73ae5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_43d846f6-9369-46cd-b040-134dfd6728f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_43d846f6-9369-46cd-b040-134dfd6728f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_6c875795-b625-4f10-a71d-461a7776af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_6c875795-b625-4f10-a71d-461a7776af1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_51093a71-46a7-4ef2-b973-e943e73eac07" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense_51093a71-46a7-4ef2-b973-e943e73eac07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9d4509c8-12ef-4e22-904d-16da95540465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9d4509c8-12ef-4e22-904d-16da95540465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_75196883-0198-4e47-8864-5b0fee42a84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_75196883-0198-4e47-8864-5b0fee42a84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2d2070a4-9ca9-4565-89c4-4e7c677d2945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5e4be078-fd0d-4091-ae80-7ed9cb9d1c97" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2d2070a4-9ca9-4565-89c4-4e7c677d2945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_079bfd65-a1ca-4aae-a2e0-c9712e62a7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_079bfd65-a1ca-4aae-a2e0-c9712e62a7c5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0ad123cd-41d5-4274-adf0-90dfe340dffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9426a833-1925-47e9-a7ea-c0885a0a512b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0ad123cd-41d5-4274-adf0-90dfe340dffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember_5086c307-ac73-4b73-82b3-43a0fbe03237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0ad123cd-41d5-4274-adf0-90dfe340dffb" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember_5086c307-ac73-4b73-82b3-43a0fbe03237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_13a6ad69-2b65-4da5-a985-bb8bf1d81f52" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_e2f97fd3-7f51-45b9-be7b-ac9c261b0863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_e2f97fd3-7f51-45b9-be7b-ac9c261b0863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_43fa64b8-9da8-4e71-8214-efd98de6bb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_43fa64b8-9da8-4e71-8214-efd98de6bb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_ece5b093-524d-47c8-bb5f-26a08d953f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_ece5b093-524d-47c8-bb5f-26a08d953f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_aef3a941-6221-467e-82dc-327fac6bd2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_aef3a941-6221-467e-82dc-327fac6bd2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_8f4d5d54-939c-49cc-be5f-bac820d1ef21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_8f4d5d54-939c-49cc-be5f-bac820d1ef21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fdbacb6d-525d-4310-af7d-228483617589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_fdbacb6d-525d-4310-af7d-228483617589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_3bfc2df1-0deb-4a7a-b755-8c9fa1eb503e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_3bfc2df1-0deb-4a7a-b755-8c9fa1eb503e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_236afec1-b4c8-4937-881b-bdc5aaf22077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_236afec1-b4c8-4937-881b-bdc5aaf22077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_1f52b476-9d0a-4434-9d08-702613e078f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_1f52b476-9d0a-4434-9d08-702613e078f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bb079a73-96b1-4007-8db3-6b112c6989dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_bb079a73-96b1-4007-8db3-6b112c6989dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_519038e7-0f5c-4a36-9a16-adb43cda5f87" xlink:href="bdx-20220930.xsd#bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent_519038e7-0f5c-4a36-9a16-adb43cda5f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4b326db9-6716-41d0-9ef1-d37445cd5871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4b326db9-6716-41d0-9ef1-d37445cd5871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_4aef5ffc-3af3-4572-8ba8-c35f4902a712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_4aef5ffc-3af3-4572-8ba8-c35f4902a712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_be0e28e5-517c-4bae-afd4-a70832187be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_925e79b0-93aa-4c3a-8b4b-2d81e2bc2a74" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_be0e28e5-517c-4bae-afd4-a70832187be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_9b1f7720-8caa-4e8f-85cb-04ee5a5e9110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9b1f7720-8caa-4e8f-85cb-04ee5a5e9110" xlink:to="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6a506bd1-e4a4-4b75-be56-c4c39dbc7c71" xlink:to="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4c41b16c-33db-42c6-a520-091278429a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_CommonStockMember_4c41b16c-33db-42c6-a520-091278429a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_02be0dc6-4b49-42c3-b9fd-bbfbdc6969d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_02be0dc6-4b49-42c3-b9fd-bbfbdc6969d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_39ae885f-48a0-493e-b411-58d320d726a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_RetainedEarningsMember_39ae885f-48a0-493e-b411-58d320d726a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_69505be6-10c9-4a92-8afc-241f2d9eaab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_69505be6-10c9-4a92-8afc-241f2d9eaab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b1f355b9-c540-45c6-a2db-3f1c1465463c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4b5f9bf9-12c8-42e5-b295-f68e9b70fb47" xlink:to="loc_us-gaap_TreasuryStockMember_b1f355b9-c540-45c6-a2db-3f1c1465463c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4a87b359-3461-4804-bb6d-e8f69432bcc3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_47011dde-2b5d-4995-8162-675dc1ed4d10" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4a87b359-3461-4804-bb6d-e8f69432bcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c072d1a5-030c-4263-8fe7-10ec20824608" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4a87b359-3461-4804-bb6d-e8f69432bcc3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c072d1a5-030c-4263-8fe7-10ec20824608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6af1d011-8d78-4a82-8551-3904eaf2083e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_91274961-04ae-4d79-9690-c856e143f9dc" xlink:to="loc_us-gaap_StatementLineItems_6af1d011-8d78-4a82-8551-3904eaf2083e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6af1d011-8d78-4a82-8551-3904eaf2083e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_320b17cf-2fae-4463-b55c-465c932b6095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquity_320b17cf-2fae-4463-b55c-465c932b6095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_7bc3fe4a-77b6-4f00-8b96-1b2bda760b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockShares_7bc3fe4a-77b6-4f00-8b96-1b2bda760b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6926dca7-4c83-41c2-aaa2-bdff14317877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_NetIncomeLoss_6926dca7-4c83-41c2-aaa2-bdff14317877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3458c82b-09b9-47d5-9020-f0a66832d9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_DividendsCommonStockCash_3458c82b-09b9-47d5-9020-f0a66832d9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_0bcf1b31-a01a-4d54-ba18-fa6b35608805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_DividendsPreferredStock_0bcf1b31-a01a-4d54-ba18-fa6b35608805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_54e15013-b168-49db-b213-381067b11564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_54e15013-b168-49db-b213-381067b11564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10daf19a-d8ab-4e84-a73c-a75c07093dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10daf19a-d8ab-4e84-a73c-a75c07093dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2eb06574-9b74-40ca-bdfc-586ee6216a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2eb06574-9b74-40ca-bdfc-586ee6216a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c5018b9a-a788-46fb-b368-e28481023b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c5018b9a-a788-46fb-b368-e28481023b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4937b991-e816-4602-8f0e-9366996c40af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4937b991-e816-4602-8f0e-9366996c40af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CommonStockHeldInTrustsNetShares_38f2d80a-9900-4ff7-bf1d-d87a3c9684c1" xlink:href="bdx-20220930.xsd#bdx_CommonStockHeldInTrustsNetShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_bdx_CommonStockHeldInTrustsNetShares_38f2d80a-9900-4ff7-bf1d-d87a3c9684c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_28479278-3703-422d-93f4-046b12429bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_28479278-3703-422d-93f4-046b12429bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b3468e99-8e07-4f9a-8b36-a233c570429f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b3468e99-8e07-4f9a-8b36-a233c570429f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_97a78c4a-8398-43fc-b7b2-cefbc0cc346c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquityOther_97a78c4a-8398-43fc-b7b2-cefbc0cc346c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_76bb0173-142d-4a2c-8635-5e4c4d7cbbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_76bb0173-142d-4a2c-8635-5e4c4d7cbbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1499d166-9564-48b8-9d5e-a12a744108f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_StockholdersEquity_1499d166-9564-48b8-9d5e-a12a744108f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_617b91a4-8bd3-4e25-99e4-8334a5b2539b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_10a9259c-b648-4764-bac5-f8aa7e9f0d4c" xlink:to="loc_us-gaap_TreasuryStockShares_617b91a4-8bd3-4e25-99e4-8334a5b2539b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5c2d787c-3baf-4ada-be9d-8fa4f24837cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_17707b9d-6eda-452c-90ca-a41c92b33909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5c2d787c-3baf-4ada-be9d-8fa4f24837cf" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_17707b9d-6eda-452c-90ca-a41c92b33909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6bcf6758-b7f0-48a6-a803-f2e529daa3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6bcf6758-b7f0-48a6-a803-f2e529daa3f7" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8ee70158-d1aa-46e4-be59-e4c68fc728f8" xlink:to="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_657cfdc0-dfd2-47c7-a70c-acd51d835971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_657cfdc0-dfd2-47c7-a70c-acd51d835971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ebfbdff9-dc1c-495f-8553-84593ec298ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3d61d337-1a2e-46fc-981f-265d3dfc1268" xlink:to="loc_us-gaap_CommonStockMember_ebfbdff9-dc1c-495f-8553-84593ec298ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d804214c-8d58-4128-b15d-2ade98522b07" xlink:to="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b43eb176-4381-4e77-82b9-3b8bfac91af0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:to="loc_srt_MinimumMember_b43eb176-4381-4e77-82b9-3b8bfac91af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7efd489-5fce-4ed4-a53b-c39cba6f38a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_50d5187d-b54c-46ec-a35a-cfd3feb030e3" xlink:to="loc_srt_MaximumMember_a7efd489-5fce-4ed4-a53b-c39cba6f38a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_81393483-a7b2-4b65-b7e7-344177e21949" xlink:to="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_9f0571a4-687e-49ef-9122-6b1be203182b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:to="loc_us-gaap_TreasuryStockMember_9f0571a4-687e-49ef-9122-6b1be203182b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2cdd83e6-4d0b-46cc-8a79-14c31cef3666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_201ac1e1-7de5-4ee0-9b5e-8f2298d7419f" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2cdd83e6-4d0b-46cc-8a79-14c31cef3666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5792090e-0e45-4ff7-9e05-cd642cc6ffef" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcceleratedShareRepurchaseProgramMember_5f17fd35-0e6e-490c-95de-346396223ded" xlink:href="bdx-20220930.xsd#bdx_AcceleratedShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:to="loc_bdx_AcceleratedShareRepurchaseProgramMember_5f17fd35-0e6e-490c-95de-346396223ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OpenMarketRepurchasesMember_fa2ecace-9bd1-4577-b918-fb408d28ac17" xlink:href="bdx-20220930.xsd#bdx_OpenMarketRepurchasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f898d84f-1f8f-44bb-b99e-c1128d47fefa" xlink:to="loc_bdx_OpenMarketRepurchasesMember_fa2ecace-9bd1-4577-b918-fb408d28ac17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c7778e38-b7c0-4ab3-a271-36c7937bf75a" xlink:to="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_ef890f64-5141-444c-9710-55dcf70f037f" xlink:href="bdx-20220930.xsd#bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram_ef890f64-5141-444c-9710-55dcf70f037f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bd01146b-d8da-4c7a-84cb-d581387c56ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bd01146b-d8da-4c7a-84cb-d581387c56ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfTransactions_63a48dfd-d29e-49de-b56d-54b51e9aee5e" xlink:href="bdx-20220930.xsd#bdx_NumberOfTransactions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_NumberOfTransactions_63a48dfd-d29e-49de-b56d-54b51e9aee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_363d301a-8903-4860-8d77-7b7b9998c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_363d301a-8903-4860-8d77-7b7b9998c7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ebe45267-13fc-42cd-8c8d-ce0f1b2c0015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ebe45267-13fc-42cd-8c8d-ce0f1b2c0015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c76e5c79-fd2b-4d50-b195-190fc25ed385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c76e5c79-fd2b-4d50-b195-190fc25ed385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_09181398-e030-4c42-9eaa-548970908c44" xlink:href="bdx-20220930.xsd#bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased_09181398-e030-4c42-9eaa-548970908c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d70696be-85e2-4da8-9d47-059129e5fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d70696be-85e2-4da8-9d47-059129e5fbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e90f1111-c905-44bd-a81e-23ef94ef922b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e90f1111-c905-44bd-a81e-23ef94ef922b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ca5adb48-cd08-4651-abfd-8145088dbced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ca5adb48-cd08-4651-abfd-8145088dbced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GrossProceedsFromIssuanceOfEquity_edb5cb80-2bd4-469a-a97b-c989f40f239a" xlink:href="bdx-20220930.xsd#bdx_GrossProceedsFromIssuanceOfEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_GrossProceedsFromIssuanceOfEquity_edb5cb80-2bd4-469a-a97b-c989f40f239a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_df946d2d-f367-4d3e-9dc7-eaa6ddbd8d0f" xlink:href="bdx-20220930.xsd#bdx_PreferredStockDepositaryShareOwnershipInterestPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage_df946d2d-f367-4d3e-9dc7-eaa6ddbd8d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_9c1d5683-8310-4eb4-a26b-0c18766befab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_9c1d5683-8310-4eb4-a26b-0c18766befab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_05b07e0d-9d54-4f27-addf-8371dca1a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_05b07e0d-9d54-4f27-addf-8371dca1a1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_840fdf31-0be6-4d2a-83b0-44d70a068ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_840fdf31-0be6-4d2a-83b0-44d70a068ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DepositaryShareLiquidation_30fba6ac-76c0-4a07-a59a-ae3d611936ca" xlink:href="bdx-20220930.xsd#bdx_DepositaryShareLiquidation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_bdx_DepositaryShareLiquidation_30fba6ac-76c0-4a07-a59a-ae3d611936ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5d19d4fd-1b49-4273-a53a-f11254066b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d95fc84b-6dbf-42eb-b037-56268c9890d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5d19d4fd-1b49-4273-a53a-f11254066b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7ed2374b-c901-417e-a299-bdba85ad50d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7ed2374b-c901-417e-a299-bdba85ad50d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f657ae3-4305-4881-9f72-f94180abc595" xlink:to="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8ce90628-0e51-4e70-8b94-de869e025862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8ce90628-0e51-4e70-8b94-de869e025862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0e98bbe9-e75a-4bc7-badf-35e4cd286f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0e98bbe9-e75a-4bc7-badf-35e4cd286f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15dd2d7c-d5f4-4487-a889-db3a8f00b822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_88f54a4d-41ef-47dd-ac17-fa22fa358991" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15dd2d7c-d5f4-4487-a889-db3a8f00b822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7288483f-8f67-409d-ae5d-e37aee05f5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e1dd315-9317-4eb4-b919-f9a5de11cdbc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7288483f-8f67-409d-ae5d-e37aee05f5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7288483f-8f67-409d-ae5d-e37aee05f5e0" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_185eed77-0616-47a9-888d-b81257131b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_185eed77-0616-47a9-888d-b81257131b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52a342aa-f185-4a65-81c0-e45f71c6260c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52a342aa-f185-4a65-81c0-e45f71c6260c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bbe407a3-4b59-4cb0-84d3-4c6f400881f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bbe407a3-4b59-4cb0-84d3-4c6f400881f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_c3fd0c17-3a74-460f-b7b6-4727cfeccb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_StockholdersEquityNoteSpinoffTransaction_c3fd0c17-3a74-460f-b7b6-4727cfeccb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5396a60f-9159-4296-8462-4273c7123c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c9bc28ee-2359-4686-a64a-e71da85ca030" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5396a60f-9159-4296-8462-4273c7123c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_31b9c98f-66a3-4d4e-a824-b8fe3609482b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_6ea0c2fe-c8a4-4218-afc3-f7701688f0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_31b9c98f-66a3-4d4e-a824-b8fe3609482b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_6ea0c2fe-c8a4-4218-afc3-f7701688f0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2f31ada6-57ff-4942-a733-82f4b71a7d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_70208289-c778-4cbe-9ad6-db865e9b5a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f31ada6-57ff-4942-a733-82f4b71a7d71" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_70208289-c778-4cbe-9ad6-db865e9b5a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_413621f2-3f38-4bd8-97e8-f6a3a8dee76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f31ada6-57ff-4942-a733-82f4b71a7d71" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_413621f2-3f38-4bd8-97e8-f6a3a8dee76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_baddc9f2-cb7a-46e3-bcb5-8c1c66ea0418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f31ada6-57ff-4942-a733-82f4b71a7d71" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_baddc9f2-cb7a-46e3-bcb5-8c1c66ea0418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6864a176-1189-4d15-8950-cf80a924d76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f31ada6-57ff-4942-a733-82f4b71a7d71" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6864a176-1189-4d15-8950-cf80a924d76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2f1d9e27-1465-4dbd-8550-f4a0f4ac0391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2f1d9e27-1465-4dbd-8550-f4a0f4ac0391" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b472458a-f892-4264-aa87-261a942611c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b90424a6-54df-468a-b7ee-dd80a3b926a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b472458a-f892-4264-aa87-261a942611c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_9ad34bce-4530-41b0-8967-2f57a7eb591e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b472458a-f892-4264-aa87-261a942611c2" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_9ad34bce-4530-41b0-8967-2f57a7eb591e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be8f0c9a-9315-4326-ab35-a1e4f555085f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_beb28adb-705e-4a52-a8fa-a4094939fe29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be8f0c9a-9315-4326-ab35-a1e4f555085f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7e5f32a6-4b9b-4370-ade1-d60512e89d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be8f0c9a-9315-4326-ab35-a1e4f555085f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7e5f32a6-4b9b-4370-ade1-d60512e89d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_42ca21ca-f151-4338-8b3b-37bab49b164f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_42ca21ca-f151-4338-8b3b-37bab49b164f" xlink:to="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0a47d1a8-b61b-439a-b03e-fa8815a810d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5e6d3b69-2800-4c6e-8dfb-614be2f055e0" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0a47d1a8-b61b-439a-b03e-fa8815a810d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_HerniaProductClaimsMember_fc83a546-e0a7-4703-a06e-ca3173b1bc4b" xlink:href="bdx-20220930.xsd#bdx_HerniaProductClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0a47d1a8-b61b-439a-b03e-fa8815a810d7" xlink:to="loc_bdx_HerniaProductClaimsMember_fc83a546-e0a7-4703-a06e-ca3173b1bc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0448c2a8-3c38-4b1f-98e8-ad990bc1cc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1f03c556-1f51-423b-845e-9ea189f51bfc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0448c2a8-3c38-4b1f-98e8-ad990bc1cc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_cc780a04-8b51-4da2-93f7-0066956fbe05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0448c2a8-3c38-4b1f-98e8-ad990bc1cc10" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_cc780a04-8b51-4da2-93f7-0066956fbe05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8fa6ee67-8a7a-4320-9a1f-5bd73e1e72f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8318ef8e-4363-44cd-89b5-39af163b3153" xlink:to="loc_srt_SegmentGeographicalDomain_8fa6ee67-8a7a-4320-9a1f-5bd73e1e72f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GwinnettCountyGeorgiaMember_9a0583ee-455c-411a-898b-68d21d806366" xlink:href="bdx-20220930.xsd#bdx_GwinnettCountyGeorgiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8fa6ee67-8a7a-4320-9a1f-5bd73e1e72f6" xlink:to="loc_bdx_GwinnettCountyGeorgiaMember_9a0583ee-455c-411a-898b-68d21d806366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea1bf39c-8bdd-4450-9506-7671d3be9b72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_46d5c3ae-5afd-4fbf-87fc-437e9a60d189" xlink:to="loc_srt_RangeMember_ea1bf39c-8bdd-4450-9506-7671d3be9b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b803c66f-04b6-4e14-81e6-a76afcf8328f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ea1bf39c-8bdd-4450-9506-7671d3be9b72" xlink:to="loc_srt_MaximumMember_b803c66f-04b6-4e14-81e6-a76afcf8328f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_10b31d5d-4108-4b88-88ea-88d3d04f23ad" xlink:to="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_f767e4b7-0bd4-4c80-801d-640fd5790c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_f767e4b7-0bd4-4c80-801d-640fd5790c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_61dd1653-c262-4be1-bfce-9af1583ae1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_61dd1653-c262-4be1-bfce-9af1583ae1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_05e07075-8e3e-4d44-86e6-a928bd89f98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_05e07075-8e3e-4d44-86e6-a928bd89f98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a67ee596-e3d5-4d04-bf8c-f077510e6263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a67ee596-e3d5-4d04-bf8c-f077510e6263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuits_5068ad67-cdc3-4f11-9965-fc5ddb641dcb" xlink:href="bdx-20220930.xsd#bdx_NumberOfEtOSterilizationLawsuits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuits_5068ad67-cdc3-4f11-9965-fc5ddb641dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_fe656934-99e1-4a69-8407-12743b3aa774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_fe656934-99e1-4a69-8407-12743b3aa774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_dd2d35fd-c70f-4d88-964b-31135aab2378" xlink:href="bdx-20220930.xsd#bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants_dd2d35fd-c70f-4d88-964b-31135aab2378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_b61b81ad-9f17-42da-b516-2e45a207de97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_b61b81ad-9f17-42da-b516-2e45a207de97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bfb04b2b-42de-4745-ac8d-e8c77b097f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_688f0440-d66a-4a34-9d84-a011381bc3a6" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bfb04b2b-42de-4745-ac8d-e8c77b097f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#RevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/RevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7088404f-7866-48ba-8cf5-ce1c8f444a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7088404f-7866-48ba-8cf5-ce1c8f444a9e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8120956f-63cc-4072-a45f-483d0fa4d0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8120956f-63cc-4072-a45f-483d0fa4d0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:to="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d290b6a1-e174-473e-a08a-2e295e28594d" xlink:to="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductsandorServicesMember_9536ce9a-0a1d-4918-a6d9-fcf797c70b36" xlink:href="bdx-20220930.xsd#bdx_ProductsandorServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:to="loc_bdx_ProductsandorServicesMember_9536ce9a-0a1d-4918-a6d9-fcf797c70b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ConsumablesMember_92405b7b-079f-4d4b-8822-8b7d71ed005c" xlink:href="bdx-20220930.xsd#bdx_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df8693fb-4956-42ee-8383-ea73c18faf8a" xlink:to="loc_bdx_ConsumablesMember_92405b7b-079f-4d4b-8822-8b7d71ed005c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3d8042fa-1486-49df-8d45-3c90c84527bd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ContractWithCustomerRebateLiability_b7d7bc89-c0e0-4995-afe8-f0031d20564e" xlink:href="bdx-20220930.xsd#bdx_ContractWithCustomerRebateLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_bdx_ContractWithCustomerRebateLiability_b7d7bc89-c0e0-4995-afe8-f0031d20564e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_08b929ef-7570-4a70-bd08-9e24da5da5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_08b929ef-7570-4a70-bd08-9e24da5da5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b9e06cb7-d209-451d-a37a-5f68ab63a469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_be2a55b1-f88a-4c07-954a-cd05593719f1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b9e06cb7-d209-451d-a37a-5f68ab63a469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/RevenuesDetails_1" xlink:type="simple" xlink:href="bdx-20220930.xsd#RevenuesDetails_1"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/RevenuesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6200299a-ee01-4898-9904-60b71ee286f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6200299a-ee01-4898-9904-60b71ee286f5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_41e7dd0c-191c-4f4f-a44c-a9c71dfff6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fa31c4ef-1502-440b-ab87-afa451528290" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_41e7dd0c-191c-4f4f-a44c-a9c71dfff6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_7f26a43d-d630-4a19-815b-7f2a730de30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_41e7dd0c-191c-4f4f-a44c-a9c71dfff6c2" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_7f26a43d-d630-4a19-815b-7f2a730de30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82986ecf-505b-4c73-a1c0-fe60349e1d18" xlink:to="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_fd75bef8-05a3-43a0-b473-48f86b5c4c25" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:to="loc_bdx_MedicalMember_fd75bef8-05a3-43a0-b473-48f86b5c4c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_e34446b8-241d-4fca-a84a-f7824367857c" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1e90cc8e-26fe-4dfd-a8ae-4ac4e1ca0103" xlink:to="loc_bdx_LifeSciencesMember_e34446b8-241d-4fca-a84a-f7824367857c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd2f1113-b98e-485d-acee-ce05c8370429" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_895ab66d-19cb-415a-96bf-abb0afe1d3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_NumberOfOperatingSegments_895ab66d-19cb-415a-96bf-abb0afe1d3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_659036f0-20f9-4147-86a0-87365061acb1" xlink:href="bdx-20220930.xsd#bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue_659036f0-20f9-4147-86a0-87365061acb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_0745ce82-e828-4f98-8e94-943710d6666d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_InventoryRecallExpense_0745ce82-e828-4f98-8e94-943710d6666d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e328ebf2-1b39-48f7-b13b-776e35a79eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e328ebf2-1b39-48f7-b13b-776e35a79eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_9982e1b1-c091-460c-8008-b1bc5e2c4fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_AssetImpairmentCharges_9982e1b1-c091-460c-8008-b1bc5e2c4fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_7b5c5397-664e-487e-a126-fd54e34388ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_949626af-a9a1-444e-a7e0-e50aa8a389b0" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_7b5c5397-664e-487e-a126-fd54e34388ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bfa06972-b325-4d8e-aa3d-1f935d2e3278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bfa06972-b325-4d8e-aa3d-1f935d2e3278" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:href="bdx-20220930.xsd#bdx_OrganizationalUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitAxis_b41cf3ba-aa1e-4634-b8a9-cf183acb79e5" xlink:to="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationDeliverySolutionsMember_b193c07a-21e0-43df-8cc0-4db1a85418da" xlink:href="bdx-20220930.xsd#bdx_MedicationDeliverySolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_MedicationDeliverySolutionsMember_b193c07a-21e0-43df-8cc0-4db1a85418da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicationManagementSolutionsMember_edcfeb42-3a17-4a7b-b491-96b0b457d1e3" xlink:href="bdx-20220930.xsd#bdx_MedicationManagementSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_MedicationManagementSolutionsMember_edcfeb42-3a17-4a7b-b491-96b0b457d1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PharmaceuticalSystemsMember_440e0352-f6d0-4542-9918-60b036048b55" xlink:href="bdx-20220930.xsd#bdx_PharmaceuticalSystemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_PharmaceuticalSystemsMember_440e0352-f6d0-4542-9918-60b036048b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IntegratedDiagnosticSolutionsMember_7e15c9a4-2823-4679-bb77-c11f0fbfe017" xlink:href="bdx-20220930.xsd#bdx_IntegratedDiagnosticSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_IntegratedDiagnosticSolutionsMember_7e15c9a4-2823-4679-bb77-c11f0fbfe017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BiosciencesMember_f6e406aa-300b-4fa0-8920-859022163843" xlink:href="bdx-20220930.xsd#bdx_BiosciencesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_BiosciencesMember_f6e406aa-300b-4fa0-8920-859022163843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SurgeryMember_572c4f63-ae83-4879-9723-9e6360417f2a" xlink:href="bdx-20220930.xsd#bdx_SurgeryMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_SurgeryMember_572c4f63-ae83-4879-9723-9e6360417f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PeripheralInterventionMember_b02ab10a-f7e1-4716-b72c-a182816f8d13" xlink:href="bdx-20220930.xsd#bdx_PeripheralInterventionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_PeripheralInterventionMember_b02ab10a-f7e1-4716-b72c-a182816f8d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UrologyandCriticalCareMember_19459fa4-08a4-4773-ade2-c611483eae31" xlink:href="bdx-20220930.xsd#bdx_UrologyandCriticalCareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_OrganizationalUnitDomain_7b2b5510-52df-4804-b6e6-f3fa98134a5e" xlink:to="loc_bdx_UrologyandCriticalCareMember_19459fa4-08a4-4773-ade2-c611483eae31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_aec4fa0d-d251-4b59-9ecb-4ca3a64b4b9e" xlink:to="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4f9eb52e-6ecd-47d3-a036-c679e2620f07" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:to="loc_country_US_4f9eb52e-6ecd-47d3-a036-c679e2620f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_38723988-6772-479b-9269-5312f64250c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_342b4a94-e34c-493b-b0e5-474373acf0d6" xlink:to="loc_us-gaap_NonUsMember_38723988-6772-479b-9269-5312f64250c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cf840c5f-ae91-4c90-a8ad-9be856a8cead" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_24f1e3ea-69a8-4af4-9a48-5a48f11694c8" xlink:to="loc_srt_ConsolidationItemsDomain_cf840c5f-ae91-4c90-a8ad-9be856a8cead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5c099191-4b36-4e47-a0bf-bc090e38984a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cf840c5f-ae91-4c90-a8ad-9be856a8cead" xlink:to="loc_us-gaap_OperatingSegmentsMember_5c099191-4b36-4e47-a0bf-bc090e38984a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_925bcd27-f066-4483-b5fc-73246ccf0ad7" xlink:to="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_d2760679-e0a3-4e44-a97b-f74ff724ab04" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:to="loc_bdx_MedicalMember_d2760679-e0a3-4e44-a97b-f74ff724ab04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_82286364-1ff8-46a3-a54d-11a87c8469d8" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:to="loc_bdx_LifeSciencesMember_82286364-1ff8-46a3-a54d-11a87c8469d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_907d428d-a6f2-4cd3-b9aa-255a4d8af90e" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8769b9e1-c507-4da3-8679-cd49c19f9ef8" xlink:to="loc_bdx_InterventionalMember_907d428d-a6f2-4cd3-b9aa-255a4d8af90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_680ae127-cf7b-4573-92bd-89b7e0e33a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e2e91bd1-d2df-4abd-b1aa-9e8a85d11c26" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_680ae127-cf7b-4573-92bd-89b7e0e33a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_eb32bcf4-f87b-44ce-9929-4609ce2e38f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_680ae127-cf7b-4573-92bd-89b7e0e33a60" xlink:to="loc_us-gaap_Revenues_eb32bcf4-f87b-44ce-9929-4609ce2e38f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataFinancialInformationforCompanysSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f9fd3071-cc4d-4387-9c7b-ba1d82f04cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f9fd3071-cc4d-4387-9c7b-ba1d82f04cb6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:to="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_83efca39-75bd-484b-81b9-46152533353b" xlink:to="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_015a137e-afa6-401c-a7d6-cd43f3348dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:to="loc_us-gaap_OperatingSegmentsMember_015a137e-afa6-401c-a7d6-cd43f3348dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_1e409dea-7662-483a-9906-dbf0d0aaa674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_1e409dea-7662-483a-9906-dbf0d0aaa674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c55b53c8-49ed-4eeb-9ff8-567bb24e9e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_734162d7-1245-49ce-888d-a9f8fd8e75e0" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c55b53c8-49ed-4eeb-9ff8-567bb24e9e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_93bb9105-48e6-42d7-ae5d-6a07f2fad2c0" xlink:to="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_3c8c235e-504a-4cc7-8f84-97b6750c57d0" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:to="loc_bdx_MedicalMember_3c8c235e-504a-4cc7-8f84-97b6750c57d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_1636f9b9-fd68-4608-bc7c-27d28037891a" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:to="loc_bdx_LifeSciencesMember_1636f9b9-fd68-4608-bc7c-27d28037891a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_67e8cfe5-4224-4803-8ae1-ade988a3a4c2" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1422b509-ee6c-4311-8500-c53524f4e5f9" xlink:to="loc_bdx_InterventionalMember_67e8cfe5-4224-4803-8ae1-ade988a3a4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55595f0f-9aea-43b0-a3d2-0939de25661e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a49d39a-0e5e-4e1a-bb82-1d69d82be0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a49d39a-0e5e-4e1a-bb82-1d69d82be0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_0d9e9093-f31f-41b2-9886-028df220587b" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringCharges_0d9e9093-f31f-41b2-9886-028df220587b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ef9112b2-65e7-4235-a404-4a2cb7c33f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ef9112b2-65e7-4235-a404-4a2cb7c33f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5265a135-842e-4747-aa6a-e46dc23a9f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5265a135-842e-4747-aa6a-e46dc23a9f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5218b282-7dbd-4ccc-b8c0-8401bfa5018a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5218b282-7dbd-4ccc-b8c0-8401bfa5018a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_be06599a-1a93-4106-a335-d6c14bc80e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_17b4e305-2611-4041-9e84-618855233a35" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_be06599a-1a93-4106-a335-d6c14bc80e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8475df95-1736-4352-a9e4-e6466bd8347c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8475df95-1736-4352-a9e4-e6466bd8347c" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:to="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c1706c19-83bd-4ee6-a765-19272a78e4b7" xlink:to="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_64f51422-0d11-435a-8c55-6240426f91e0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_country_US_64f51422-0d11-435a-8c55-6240426f91e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_21b89a84-58d6-4c5c-b65e-e91e34d46ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_us-gaap_EMEAMember_21b89a84-58d6-4c5c-b65e-e91e34d46ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_71f845b3-62c8-47d9-8e05-464c4f6dfe5f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_srt_AsiaMember_71f845b3-62c8-47d9-8e05-464c4f6dfe5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OthersCountryMember_e2ea61fc-bdc6-4f21-af1b-bbea701f022c" xlink:href="bdx-20220930.xsd#bdx_OthersCountryMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533e472b-a1d3-44f1-92d0-63ef40a50f3f" xlink:to="loc_bdx_OthersCountryMember_e2ea61fc-bdc6-4f21-af1b-bbea701f022c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e31f9119-2de8-4583-9b05-b9778a12082f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bec2ed3-3f9e-44e6-815c-60eebe867cc0" xlink:to="loc_us-gaap_SegmentDomain_e31f9119-2de8-4583-9b05-b9778a12082f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_b5aca7d3-5c1e-4308-9220-a8ccd0ec1a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e31f9119-2de8-4583-9b05-b9778a12082f" xlink:to="loc_us-gaap_CorporateMember_b5aca7d3-5c1e-4308-9220-a8ccd0ec1a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b6cc189-c3f8-47cc-b60e-9da92668aa1f" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dea7c51c-a6dd-48fa-9fd6-2f0af671f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:to="loc_us-gaap_Revenues_dea7c51c-a6dd-48fa-9fd6-2f0af671f30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_ab4ee424-3b6b-477e-916d-0601047cf711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_bc71bccc-5cfc-4b7a-8a91-a0b26d0df0e0" xlink:to="loc_us-gaap_NoncurrentAssets_ab4ee424-3b6b-477e-916d-0601047cf711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91384d1d-bcd6-4c6c-bbe2-5c12837e0f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91384d1d-bcd6-4c6c-bbe2-5c12837e0f23" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29785beb-6648-409d-bdd6-d3c146ab50c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2891fd37-7c8e-4bd8-99e4-87ec4fc1e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_us-gaap_CostOfSalesMember_2891fd37-7c8e-4bd8-99e4-87ec4fc1e05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_297d1245-c414-4787-bc49-1b76b3d1e9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_297d1245-c414-4787-bc49-1b76b3d1e9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_811c54ae-99ab-42e5-b282-4d96f8af795f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_811c54ae-99ab-42e5-b282-4d96f8af795f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_2bcbfc25-7add-49bb-ab07-2016a9d77c53" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e61cc1-967e-4504-8822-091c466a30b3" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_2bcbfc25-7add-49bb-ab07-2016a9d77c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1631af0-dfe6-40cd-b271-440b22649a96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0586f7fb-62e5-432e-a63a-d0c27f4925e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0586f7fb-62e5-432e-a63a-d0c27f4925e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_569dd5d7-81a0-4474-a841-6826f1cca701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12355b7f-53d9-4a09-b357-40e93fdaac1f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_569dd5d7-81a0-4474-a841-6826f1cca701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8ced457-70c6-4d3e-ad0c-01f3ea31f400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8ced457-70c6-4d3e-ad0c-01f3ea31f400" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_466f91bd-0024-4c37-b513-6a149962d1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8cab8844-2ec7-4784-a0c9-11b6f58a92e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_466f91bd-0024-4c37-b513-6a149962d1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_425c87ad-455b-418a-96bc-ce95587b167d" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_466f91bd-0024-4c37-b513-6a149962d1ac" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_425c87ad-455b-418a-96bc-ce95587b167d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a3b428b-6c16-4bfb-aadf-30fd5e122e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe5d000e-97e8-4038-9e2a-5979fca2ab90" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a3b428b-6c16-4bfb-aadf-30fd5e122e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_CRBardIncMember_4c20f79e-ce43-45ba-96b8-ef43b5d2ffdc" xlink:href="bdx-20220930.xsd#bdx_CRBardIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a3b428b-6c16-4bfb-aadf-30fd5e122e16" xlink:to="loc_bdx_CRBardIncMember_4c20f79e-ce43-45ba-96b8-ef43b5d2ffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1ecf2333-52d8-4f5c-8fe8-67786f090d49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_871ded36-5e3b-4a0d-a2f8-b3f06217beb9" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_871ded36-5e3b-4a0d-a2f8-b3f06217beb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_38bef3f7-0b37-4980-b98c-ab34af16844b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e8431e7d-8017-4a24-8b57-bdf8fbaca86b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_38bef3f7-0b37-4980-b98c-ab34af16844b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_80338de8-48ae-415a-a403-88de0158f6c8" xlink:to="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31bd7158-89b1-412c-aa32-a9beba090e28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:to="loc_srt_MinimumMember_31bd7158-89b1-412c-aa32-a9beba090e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e946fd09-93f6-4252-9df6-7aafb1f57727" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5f781a26-79a0-450e-9035-c59712dedecb" xlink:to="loc_srt_MaximumMember_e946fd09-93f6-4252-9df6-7aafb1f57727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_dd67a20e-0abe-44a4-b051-56238d4ce6a2" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_304ed344-fb65-4722-8d38-26756da4f271" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:to="loc_srt_ExecutiveOfficerMember_304ed344-fb65-4722-8d38-26756da4f271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_514caf1a-60e0-4228-9337-b0437a078449" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5bddb6e1-8385-4c04-badc-5dcec6aeaa2d" xlink:to="loc_srt_DirectorMember_514caf1a-60e0-4228-9337-b0437a078449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47c5197e-186a-42df-b5f9-fd97db1a2b4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b98dc00-7877-47e9-9ca0-7fba87342d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b98dc00-7877-47e9-9ca0-7fba87342d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_a4d92b75-c7a8-4768-a3c3-90f1c5ee5b69" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod_a4d92b75-c7a8-4768-a3c3-90f1c5ee5b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_db1845dd-a0c0-4ba5-a379-4861cbcf93cf" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward_db1845dd-a0c0-4ba5-a379-4861cbcf93cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_StockIssuedUnderStockAppreciationRightsExercised_1c5089ee-4180-48b2-a8ec-0d40694fbe62" xlink:href="bdx-20220930.xsd#bdx_StockIssuedUnderStockAppreciationRightsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_StockIssuedUnderStockAppreciationRightsExercised_1c5089ee-4180-48b2-a8ec-0d40694fbe62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fbf1ef4d-a9a6-40ec-a3f0-303380b8b071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fbf1ef4d-a9a6-40ec-a3f0-303380b8b071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_7b5ba99e-9f00-46b5-984c-d033fdb3e9a1" xlink:href="bdx-20220930.xsd#bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod_7b5ba99e-9f00-46b5-984c-d033fdb3e9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_d5d3b2a1-2e66-4a87-acdf-caea5fa72999" xlink:href="bdx-20220930.xsd#bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent_d5d3b2a1-2e66-4a87-acdf-caea5fa72999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_2c601fa7-654c-4b21-bd2e-00f3a802e37a" xlink:href="bdx-20220930.xsd#bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased_2c601fa7-654c-4b21-bd2e-00f3a802e37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_0124817a-c235-4948-941b-1fae4346d46a" xlink:href="bdx-20220930.xsd#bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased_0124817a-c235-4948-941b-1fae4346d46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_f53098a0-43cf-42ea-adb6-9e16c974407a" xlink:href="bdx-20220930.xsd#bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits_f53098a0-43cf-42ea-adb6-9e16c974407a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_UnitsInExcessOfExpectedPerformancePayout_0adcb9be-71ca-474a-9012-69d903f1d4c1" xlink:href="bdx-20220930.xsd#bdx_UnitsInExcessOfExpectedPerformancePayout"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_UnitsInExcessOfExpectedPerformancePayout_0adcb9be-71ca-474a-9012-69d903f1d4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_a25bb369-ee5c-46a2-b753-d7ac226f30be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_a25bb369-ee5c-46a2-b753-d7ac226f30be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4f6eaee8-475b-4b6c-96b9-f699ec072774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4f6eaee8-475b-4b6c-96b9-f699ec072774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f3ef871c-b47b-4478-8530-d6bb6f3ccd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f3ef871c-b47b-4478-8530-d6bb6f3ccd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8dda14db-3d23-49f8-a7b3-75c9b85a8550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8dda14db-3d23-49f8-a7b3-75c9b85a8550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_3f69d517-56b9-4541-bf2e-8bf6e990d90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrustShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_3f69d517-56b9-4541-bf2e-8bf6e990d90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SharesIssuableUnderDeferredCompensationPlan_3f862e84-d811-4c9a-a543-1c3bbcfc8b06" xlink:href="bdx-20220930.xsd#bdx_SharesIssuableUnderDeferredCompensationPlan"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd61ef71-2d32-4a52-9d35-0c95a25f3135" xlink:to="loc_bdx_SharesIssuableUnderDeferredCompensationPlan_3f862e84-d811-4c9a-a543-1c3bbcfc8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ffed377-223b-46ab-9fee-d2474ae02d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ffed377-223b-46ab-9fee-d2474ae02d4e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:to="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_696563c3-b1ef-4220-8239-90efa3844a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8a4ed511-ae08-475c-b2f0-45f8cfe6560f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_696563c3-b1ef-4220-8239-90efa3844a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_59304d6e-d5bf-4f93-9f09-00b41366607c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_696563c3-b1ef-4220-8239-90efa3844a44" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_59304d6e-d5bf-4f93-9f09-00b41366607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d05b3ff0-66e1-4241-bdc2-7acdd3f37ce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8589c264-b5e0-4c29-8d92-7d693913981e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8589c264-b5e0-4c29-8d92-7d693913981e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_254baadf-6b3f-47b5-9df0-c1b8185b7949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_254baadf-6b3f-47b5-9df0-c1b8185b7949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8d945e60-a413-42e1-82f4-ea98c62e75ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8d945e60-a413-42e1-82f4-ea98c62e75ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_378c6ca1-c6b7-454b-9b79-ca922e6634ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_378c6ca1-c6b7-454b-9b79-ca922e6634ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_191dc535-848c-4a8b-b326-0d3ebe889a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_990b9724-11e1-43ed-9c2d-02a4f5a4b804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_191dc535-848c-4a8b-b326-0d3ebe889a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationSummaryofSARsOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_09e63efc-baf5-4d9b-b6b2-93de53326e04" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_09e63efc-baf5-4d9b-b6b2-93de53326e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod_5e916404-7d21-4269-bfd2-e8c0dd3892be" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod_5e916404-7d21-4269-bfd2-e8c0dd3892be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod_b2b4d013-64b8-44d2-8981-51540a030a84" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod_b2b4d013-64b8-44d2-8981-51540a030a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod_254ccf31-e963-4940-85e3-e9d2a4667051" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod_254ccf31-e963-4940-85e3-e9d2a4667051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction_0a65327c-0e19-4241-bd59-3cfb4757902f" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction_0a65327c-0e19-4241-bd59-3cfb4757902f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment_d4e1e86e-7526-4b06-8277-32b891dc890e" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment_d4e1e86e-7526-4b06-8277-32b891dc890e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_e93ffa1e-6c40-4fe9-9f5c-a3333b689765" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6f12025e-6ebf-4f4e-b524-9471f2e5ed3c" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber_e93ffa1e-6c40-4fe9-9f5c-a3333b689765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber_1d8f3c59-5a07-4285-baac-ec1f22e00340" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber_1d8f3c59-5a07-4285-baac-ec1f22e00340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber_5887852e-e658-4b2d-a683-702e840922e7" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber_5887852e-e658-4b2d-a683-702e840922e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_27603138-c195-4117-84b1-dc0d39557973" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_27603138-c195-4117-84b1-dc0d39557973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice_3aa0c531-2467-44ed-8154-700d8bd44750" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice_3aa0c531-2467-44ed-8154-700d8bd44750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice_e7f05f19-83db-4f7a-8490-5e7e74c8dadf" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice_e7f05f19-83db-4f7a-8490-5e7e74c8dadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice_4904f6eb-51fb-4b9e-b23c-18a5b4cbb442" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice_4904f6eb-51fb-4b9e-b23c-18a5b4cbb442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice_a4a36f57-c6cd-4618-b18d-9d98d21d2e0a" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice_a4a36f57-c6cd-4618-b18d-9d98d21d2e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_66b698cc-aba1-466c-a96a-a187743f0b2d" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b9f045a-7835-448e-a068-ced8f5ae0eb4" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice_66b698cc-aba1-466c-a96a-a187743f0b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_ceda558a-f9ed-403e-8486-a1da930db089" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_ceda558a-f9ed-403e-8486-a1da930db089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice_bb6b3de8-84a1-40ce-8b22-69400d679682" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice_bb6b3de8-84a1-40ce-8b22-69400d679682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_091915f8-0fd1-4b6e-ab39-e7c567ed36ef" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_091915f8-0fd1-4b6e-ab39-e7c567ed36ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_db4ef850-437d-40d4-ad8e-09729720a680" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_db4ef850-437d-40d4-ad8e-09729720a680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm_7bc123a4-e839-44b5-ae74-e71fa9021575" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm_7bc123a4-e839-44b5-ae74-e71fa9021575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue_b78634f7-0396-4cc3-a0a8-1e64b5c9ae74" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue_b78634f7-0396-4cc3-a0a8-1e64b5c9ae74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_d8e1f962-afc8-4a37-8c66-4f8bfa3d7d6e" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_d8e1f962-afc8-4a37-8c66-4f8bfa3d7d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue_a121e63d-7afe-41ee-9242-8bfd1bf547e6" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b1aa4d5-38b1-4b34-a0c0-c214c646d912" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue_a121e63d-7afe-41ee-9242-8bfd1bf547e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationSummaryofSARsExercisedDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd0af4e8-efed-4483-83c0-c7aeaa785935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue_9539d26f-3ab3-43e9-8a82-d4819b0c404e" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd0af4e8-efed-4483-83c0-c7aeaa785935" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue_9539d26f-3ab3-43e9-8a82-d4819b0c404e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfStockAppreciationRights_0e4e91cc-69b7-4f2c-bce4-fbe5fd332ca8" xlink:href="bdx-20220930.xsd#bdx_FairValueOfStockAppreciationRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd0af4e8-efed-4483-83c0-c7aeaa785935" xlink:to="loc_bdx_FairValueOfStockAppreciationRights_0e4e91cc-69b7-4f2c-bce4-fbe5fd332ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1bc63a91-b4ee-4744-bfb7-09010b50851d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1bc63a91-b4ee-4744-bfb7-09010b50851d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:to="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c3724202-510c-44a7-84ff-155cb58067d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_c5f3f7ca-3c2a-415b-9ae8-dddab674be6c" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_c5f3f7ca-3c2a-415b-9ae8-dddab674be6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f595b2-3fed-48e6-b20a-3848f14063a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6eb6b08a-4eb5-41ef-a4ca-dc50f9faf501" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f595b2-3fed-48e6-b20a-3848f14063a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac9259bb-c128-466b-b812-267779a67132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bb632b95-4a28-4e9e-8728-d2f1f5b82465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bb632b95-4a28-4e9e-8728-d2f1f5b82465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2f62e736-f36c-470e-9813-bbc865716ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2f62e736-f36c-470e-9813-bbc865716ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9f91ad6e-7ed2-42cc-864a-e0cb3186b2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9f91ad6e-7ed2-42cc-864a-e0cb3186b2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c34c102-d151-43bf-8984-e4098d26879b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c34c102-d151-43bf-8984-e4098d26879b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_3ec8b63f-b540-4e20-a548-f0f888ea1671" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction_3ec8b63f-b540-4e20-a548-f0f888ea1671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_0b7deb32-4af0-4b07-abca-57fdb1f54c8a" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment_0b7deb32-4af0-4b07-abca-57fdb1f54c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75230209-0108-4d1c-847d-b02efb848f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30860a4b-9e23-455c-8122-51ccc1c2375b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_75230209-0108-4d1c-847d-b02efb848f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_502d3ffc-10ef-4e79-9b68-4f6f8d778417" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest_502d3ffc-10ef-4e79-9b68-4f6f8d778417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ec48c39-881e-4a46-b52e-8bc2ea211aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ec48c39-881e-4a46-b52e-8bc2ea211aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e96dfd4-bdef-417d-898e-1d2a30ce7c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e96dfd4-bdef-417d-898e-1d2a30ce7c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6a1cc7a8-366d-4404-8ab3-e5ad65c56a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6a1cc7a8-366d-4404-8ab3-e5ad65c56a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_900c19c4-80d0-416f-a7c5-6c797f724366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_900c19c4-80d0-416f-a7c5-6c797f724366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_160476b5-e6ff-46ad-9433-15cd09626308" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue_160476b5-e6ff-46ad-9433-15cd09626308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3006952-8c69-4a60-a04a-49bf88f42436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d39ec0e6-0c62-4bb4-9b52-c15a003db077" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3006952-8c69-4a60-a04a-49bf88f42436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_23da7571-a943-43a1-8c84-b653d6fef082" xlink:href="bdx-20220930.xsd#bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7995a786-ad73-424b-acd1-2a2c28eefcaf" xlink:to="loc_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest_23da7571-a943-43a1-8c84-b653d6fef082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_429deaec-681c-419b-a3fc-c800d6f90be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_429deaec-681c-419b-a3fc-c800d6f90be6" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:to="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a1ca524e-510a-4a2d-8a19-39fc26e23c19" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_102058cc-36e7-424d-b42f-45a5c13c9d53" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_102058cc-36e7-424d-b42f-45a5c13c9d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e05d6329-2262-40ee-ac1a-dcb0fd3bdc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_319f6d12-74c5-46e6-8fcb-70df194f3ad1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e05d6329-2262-40ee-ac1a-dcb0fd3bdc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_3252108e-ef44-4ea9-aceb-d202bf0ebb5d" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable_13a96229-bc73-46ad-b12e-1eceea6e28db" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_3252108e-ef44-4ea9-aceb-d202bf0ebb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c6a3464a-6155-4876-bfe6-d8af6a9ce0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems_3252108e-ef44-4ea9-aceb-d202bf0ebb5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c6a3464a-6155-4876-bfe6-d8af6a9ce0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#ShareBasedCompensationFairValueofStockUnitsVestedDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e18bc8ec-adb2-4187-9da2-e3376e035cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e18bc8ec-adb2-4187-9da2-e3376e035cd6" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:to="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_dd79a646-9d35-4380-9df9-28402eae28a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_RestrictedStockUnitsPerformancePsuMember_a401cbbe-1640-4fe6-a86c-733da8ec9175" xlink:href="bdx-20220930.xsd#bdx_RestrictedStockUnitsPerformancePsuMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:to="loc_bdx_RestrictedStockUnitsPerformancePsuMember_a401cbbe-1640-4fe6-a86c-733da8ec9175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0254eac8-39b3-4ef5-896a-318baa0f7040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_645a61ab-b147-4792-ba1b-2ea544957a24" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0254eac8-39b3-4ef5-896a-318baa0f7040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_b738fa6b-f2e0-43aa-bf16-9e5b754955de" xlink:href="bdx-20220930.xsd#bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable_cadb7f36-c334-4fb5-b795-de1fea9563b4" xlink:to="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_b738fa6b-f2e0-43aa-bf16-9e5b754955de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_16bae132-697f-4b88-8a01-2ccf9b41b133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems_b738fa6b-f2e0-43aa-bf16-9e5b754955de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_16bae132-697f-4b88-8a01-2ccf9b41b133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansNetPensionandOtherPostretirementCostDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_27be98ae-5b07-44cd-bda1-961b8c2d0492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_27be98ae-5b07-44cd-bda1-961b8c2d0492" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7eaddb55-064a-46d9-9803-3d4e25d2bcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_631985fa-9274-401f-ba27-854109af4750" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7eaddb55-064a-46d9-9803-3d4e25d2bcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_01b5fd9f-abee-4082-9ea2-03e048e5bd11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7eaddb55-064a-46d9-9803-3d4e25d2bcc1" xlink:to="loc_us-gaap_ForeignPlanMember_01b5fd9f-abee-4082-9ea2-03e048e5bd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_db3855ba-86b8-47e0-b679-eec3ddd5cd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0da79012-8859-458e-ae9e-10bec7fc2a38" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_db3855ba-86b8-47e0-b679-eec3ddd5cd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9f66a495-a7e4-48b8-bb92-41afca1f1fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_db3855ba-86b8-47e0-b679-eec3ddd5cd7c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9f66a495-a7e4-48b8-bb92-41afca1f1fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f5d02e-1cfe-43a6-828d-ec277e5a17cf" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_82e33f2f-a09f-4925-8544-6dcecdf05627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_82e33f2f-a09f-4925-8544-6dcecdf05627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_793dac2d-cae9-4d6c-a8f6-c73ec1d74e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_793dac2d-cae9-4d6c-a8f6-c73ec1d74e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ac68e775-2ff4-4616-8673-f3f843bbabb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ac68e775-2ff4-4616-8673-f3f843bbabb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_96a997f8-596e-410d-b233-180b8ecb86d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_96a997f8-596e-410d-b233-180b8ecb86d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e0f7aa84-a85c-4fdb-8a46-56f23a7b4b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e0f7aa84-a85c-4fdb-8a46-56f23a7b4b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_8d7c305a-9c5a-4081-966d-30de911545f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_8d7c305a-9c5a-4081-966d-30de911545f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0d3d3d65-1e6d-4c6d-824c-4d87f1966515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01dc30bd-77ed-41e5-91d9-72fe47c3fe72" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0d3d3d65-1e6d-4c6d-824c-4d87f1966515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_26cdd898-243d-4e8d-80bc-774a10f2dece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_26cdd898-243d-4e8d-80bc-774a10f2dece" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3ad59a36-42f1-4594-a611-b5073f6005ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ff037e85-553d-4890-85c2-f1b0bb06a32b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3ad59a36-42f1-4594-a611-b5073f6005ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d565626c-6e06-486d-9179-383794e18a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3ad59a36-42f1-4594-a611-b5073f6005ef" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d565626c-6e06-486d-9179-383794e18a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac85e2db-57d2-4c19-af6e-aa0138f1e1f1" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3497ca6d-19ce-4c2f-989f-206d1bf090f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3497ca6d-19ce-4c2f-989f-206d1bf090f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_20ddba74-472d-4bd1-949a-fd0cd0302686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_20ddba74-472d-4bd1-949a-fd0cd0302686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_4a2d4cf1-1608-4509-a5bc-15baa3a98949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_4a2d4cf1-1608-4509-a5bc-15baa3a98949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f15197ce-65e5-45a2-938f-e113d138fa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_f15197ce-65e5-45a2-938f-e113d138fa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_81955605-526c-4c51-908d-e0a64db53451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_81955605-526c-4c51-908d-e0a64db53451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_6c0ed20d-c062-44b6-93a3-db2d7c3ed5a5" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation_6c0ed20d-c062-44b6-93a3-db2d7c3ed5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7f30fee3-a531-4824-be49-9533fe6228a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7f30fee3-a531-4824-be49-9533fe6228a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_9b37d8b6-d91b-4526-bc4c-7e77eda51f37" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment_9b37d8b6-d91b-4526-bc4c-7e77eda51f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_b5fec210-2d08-4eaf-9c13-fa76678aa751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_b5fec210-2d08-4eaf-9c13-fa76678aa751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherChanges_102df230-4ae1-4ffa-900a-e31b2e63dc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherChanges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherChanges_102df230-4ae1-4ffa-900a-e31b2e63dc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e7454c11-6250-4e60-b923-41e11e5fe03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_5694c79a-68e2-4a34-a5a8-8a87f9381f37" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e7454c11-6250-4e60-b923-41e11e5fe03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ff0374c5-8909-494a-9a2c-8a7d23b3e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ff0374c5-8909-494a-9a2c-8a7d23b3e30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_6065f1f7-9ea8-4e9f-b4d0-ce5fdfe0ce78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_6065f1f7-9ea8-4e9f-b4d0-ce5fdfe0ce78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5527aac3-dfb4-4845-be22-9de4a986224a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5527aac3-dfb4-4845-be22-9de4a986224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0f21d805-2b95-46c9-b44e-228be065b4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0f21d805-2b95-46c9-b44e-228be065b4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_6bab9c95-7853-42a3-bd0d-4bade7af1035" xlink:href="bdx-20220930.xsd#bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets_6bab9c95-7853-42a3-bd0d-4bade7af1035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3fe9f58a-e7f3-46b9-bcfc-316b91420ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3fe9f58a-e7f3-46b9-bcfc-316b91420ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ca34a860-6967-4181-a80f-fc170473a1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_ca34a860-6967-4181-a80f-fc170473a1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e925b633-83b9-45a4-8b4c-1408fe36fbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_78d8be72-e540-46ef-a9ea-1c9c02add50d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e925b633-83b9-45a4-8b4c-1408fe36fbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_4646f67f-123d-498e-9778-7b8f12932dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_4646f67f-123d-498e-9778-7b8f12932dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_a3ffa520-41ec-4c9b-a609-6285304d7c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract_4646f67f-123d-498e-9778-7b8f12932dde" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_a3ffa520-41ec-4c9b-a609-6285304d7c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f9318467-6097-428f-9b70-d6f6fd121bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f9318467-6097-428f-9b70-d6f6fd121bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_5f5071ff-7b1b-4772-9fe3-259987a02d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_5f5071ff-7b1b-4772-9fe3-259987a02d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d364f5a7-22f5-4b52-87df-878418da73d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d364f5a7-22f5-4b52-87df-878418da73d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7479f9ef-bf07-4c36-a8d4-bfa967d40417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a53eb8d4-dc64-4416-bacc-c58f515faccb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7479f9ef-bf07-4c36-a8d4-bfa967d40417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_17e9b0e8-8f3a-4744-bb48-c4fe107a0625" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_001ad0ea-c55d-42cb-90db-15e60d0fd3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_001ad0ea-c55d-42cb-90db-15e60d0fd3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_22e04109-9f9c-42f4-87f7-275ccf67aa05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_22e04109-9f9c-42f4-87f7-275ccf67aa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e6e81f29-550d-4e86-844b-ad70d7123bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract_c95bc576-48ff-4499-94e7-8c88e986ae4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e6e81f29-550d-4e86-844b-ad70d7123bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fce8f362-53c7-4bca-8ba3-d746502c8b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fce8f362-53c7-4bca-8ba3-d746502c8b40" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6766a6ce-76b9-4ac8-aadb-e57e2133cbcf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0b800883-3ffa-4751-b329-808d163cc5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:to="loc_us-gaap_ForeignPlanMember_0b800883-3ffa-4751-b329-808d163cc5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c32548cf-2f87-4f3a-b9ad-308994660006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b031deeb-4de8-43bc-9eee-46541863f1af" xlink:to="loc_us-gaap_DomesticPlanMember_c32548cf-2f87-4f3a-b9ad-308994660006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1dba32de-1099-4cc3-b361-faca5c4ca1aa" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_c32548cf-2f87-4f3a-b9ad-308994660006" xlink:to="loc_country_US_1dba32de-1099-4cc3-b361-faca5c4ca1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c225f444-a066-4f1c-a03d-3f723b015bfe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_47681b73-1f6d-4423-a272-f16e4c931820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_47681b73-1f6d-4423-a272-f16e4c931820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5132a4c3-6392-4d2c-a21f-1eeb3e4fa0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f240a39a-8865-4e3c-ac85-df272fa60bee" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5132a4c3-6392-4d2c-a21f-1eeb3e4fa0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_36adf0b7-13bb-4bbb-959f-1777bbd33b8e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_c85e357b-7bd3-4acb-a5a5-190a889b083d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:to="loc_us-gaap_FixedIncomeFundsMember_c85e357b-7bd3-4acb-a5a5-190a889b083d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DiversifiedMember_fb70eae3-9153-41b4-86c7-cd22f484ad22" xlink:href="bdx-20220930.xsd#bdx_DiversifiedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:to="loc_bdx_DiversifiedMember_fb70eae3-9153-41b4-86c7-cd22f484ad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d037674b-961a-42c0-a787-10bcc6fcf30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_09d8abee-ed99-4a2e-987d-2e863749433e" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d037674b-961a-42c0-a787-10bcc6fcf30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e680c5c5-8350-4e3c-9458-f31eeeb7a8a6" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b815f95d-e1e8-48de-a9f3-9c05d0cf5be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b815f95d-e1e8-48de-a9f3-9c05d0cf5be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_da0b486e-b0e5-4475-ab14-6808f42f94d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_da0b486e-b0e5-4475-ab14-6808f42f94d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a4a5a1c9-85d8-4483-933b-4ed242e74b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_a4a5a1c9-85d8-4483-933b-4ed242e74b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentOfAssetsDomesticPlans_cf6aa992-3bd8-4c45-97a6-30d68456c60b" xlink:href="bdx-20220930.xsd#bdx_PercentOfAssetsDomesticPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_bdx_PercentOfAssetsDomesticPlans_cf6aa992-3bd8-4c45-97a6-30d68456c60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d6b0c2c2-78b2-4a57-b839-5664b147806c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d6b0c2c2-78b2-4a57-b839-5664b147806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PercentOfPlanAssetsForeignPlans_59965110-03f9-424a-84dc-b3f850db97aa" xlink:href="bdx-20220930.xsd#bdx_PercentOfPlanAssetsForeignPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_bdx_PercentOfPlanAssetsForeignPlans_59965110-03f9-424a-84dc-b3f850db97aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_0cf8c5f7-8f63-4dd1-b0ba-85255776a118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7749c6f5-8d1e-4d2f-a101-8bf85c09b2f5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_0cf8c5f7-8f63-4dd1-b0ba-85255776a118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4601600-3b5a-47d9-a3da-7045797396f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_8a17ce7b-4ca5-430c-bca6-d00fd7adce4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4601600-3b5a-47d9-a3da-7045797396f9" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_8a17ce7b-4ca5-430c-bca6-d00fd7adce4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_2d956bb0-ab2a-4ef9-a6df-57de86e21dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4601600-3b5a-47d9-a3da-7045797396f9" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_2d956bb0-ab2a-4ef9-a6df-57de86e21dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_aea07d7d-ebe6-4c53-8300-057672c57cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4601600-3b5a-47d9-a3da-7045797396f9" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_aea07d7d-ebe6-4c53-8300-057672c57cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_e35c4ec0-7430-4a97-aa83-72195c366a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4601600-3b5a-47d9-a3da-7045797396f9" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_e35c4ec0-7430-4a97-aa83-72195c366a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_c1d3328b-8684-45c9-9c5a-52de288149bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4601600-3b5a-47d9-a3da-7045797396f9" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_c1d3328b-8684-45c9-9c5a-52de288149bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4c0cf13-b7eb-41f6-8dc9-7ad88df927a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b4c0cf13-b7eb-41f6-8dc9-7ad88df927a8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1cbb20b2-7e6d-42b1-99a2-41737f57e76b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_fba893df-99c4-4205-8534-2df456dbdb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:to="loc_us-gaap_DomesticPlanMember_fba893df-99c4-4205-8534-2df456dbdb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6431c6b3-741c-480a-8216-5d53e416e441" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_fba893df-99c4-4205-8534-2df456dbdb7d" xlink:to="loc_country_US_6431c6b3-741c-480a-8216-5d53e416e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_7d1b27d5-4f11-41a3-b7f5-a68f34cb95b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf823d2f-5e43-4580-b590-41e285a4495f" xlink:to="loc_us-gaap_ForeignPlanMember_7d1b27d5-4f11-41a3-b7f5-a68f34cb95b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_36adff9f-b489-4a76-a9fc-3f9a642fc590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7a839fbd-709d-4c9b-ac1e-9780ba3956ab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_36adff9f-b489-4a76-a9fc-3f9a642fc590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4b97f51c-3129-43c7-a0cb-f96e234b4726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_36adff9f-b489-4a76-a9fc-3f9a642fc590" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4b97f51c-3129-43c7-a0cb-f96e234b4726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8776ac8c-44b2-47ba-bc25-91687f8bfd16" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8c364dde-a4d4-4600-85a7-0a00c006ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8c364dde-a4d4-4600-85a7-0a00c006ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_91d08e25-8151-4a5f-a96a-53247fe24b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_91d08e25-8151-4a5f-a96a-53247fe24b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_76cb9177-22fb-49fc-b4c5-de75590905f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_76cb9177-22fb-49fc-b4c5-de75590905f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_89240bc1-253b-4ee1-9eb1-a6336d197b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_5d66cf04-cb37-436f-a4c7-017383ccbd83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_89240bc1-253b-4ee1-9eb1-a6336d197b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c7ae7019-75ec-4886-b511-f2f37bba8051" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_cfd187f0-2c0c-4f70-9477-3c8ffb6e7c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_cfd187f0-2c0c-4f70-9477-3c8ffb6e7c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ee9cfa0b-fbe6-4e88-8cf8-178e78f6987e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ee9cfa0b-fbe6-4e88-8cf8-178e78f6987e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate_68b033d4-e6cf-44a4-8b8b-8d75817788c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_75fc3a7c-032e-45e4-b732-d51a647b42c1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate_68b033d4-e6cf-44a4-8b8b-8d75817788c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansExpectedBenefitPaymentsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_abd6f029-4513-40c3-819c-cb288d068ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_abd6f029-4513-40c3-819c-cb288d068ea0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a787d44e-1aa3-474d-b58c-15f3247dbf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cddc97bf-0f5f-449a-a8ba-3b3b62ffe8f4" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a787d44e-1aa3-474d-b58c-15f3247dbf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2112aed0-47eb-4160-84c5-c7370961bb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a787d44e-1aa3-474d-b58c-15f3247dbf96" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2112aed0-47eb-4160-84c5-c7370961bb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_14b48421-fcce-481f-84e8-00d3142b9c76" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_95796897-7fcd-4063-b7ba-fd921e5ac944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_95796897-7fcd-4063-b7ba-fd921e5ac944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3f768a91-ecfa-43ed-a947-1425279d0de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3f768a91-ecfa-43ed-a947-1425279d0de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e6f62bd4-392b-44de-bb9a-4eba4e09d111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e6f62bd4-392b-44de-bb9a-4eba4e09d111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_054799c1-b435-4f6f-94bf-59eccbc6bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_054799c1-b435-4f6f-94bf-59eccbc6bc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c3c293b7-9909-4bf8-82e4-0a1d533110c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c3c293b7-9909-4bf8-82e4-0a1d533110c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_edcae0eb-d1f5-43a2-a6a4-ac2eaf81e50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1af79b46-eb30-4e64-b72c-16965e769c02" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_edcae0eb-d1f5-43a2-a6a4-ac2eaf81e50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BenefitPlansFairValueMeasurementsofPlanAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5b0d68f4-2b20-4752-974b-0bf2a8687fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5b0d68f4-2b20-4752-974b-0bf2a8687fca" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_eb7eb0db-e8ea-46ee-84d1-41f89ee55071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0c6070dd-563a-4054-8fa2-806076b4df11" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_eb7eb0db-e8ea-46ee-84d1-41f89ee55071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a5f61642-b32e-484d-93f9-cb44b5e57fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_eb7eb0db-e8ea-46ee-84d1-41f89ee55071" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a5f61642-b32e-484d-93f9-cb44b5e57fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ff81307-6855-44c1-8cea-e5c7556da1df" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bcc62903-94dc-4c5f-a1f9-126ebefa5d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bcc62903-94dc-4c5f-a1f9-126ebefa5d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_08c3f102-1212-42ea-9f5c-78f0c49b07ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_08c3f102-1212-42ea-9f5c-78f0c49b07ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_94b176d5-0ead-4a92-9d3c-988c5d787fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f1d8392-8f6a-400e-a57a-540aae799428" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_94b176d5-0ead-4a92-9d3c-988c5d787fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_79fface5-40a4-4f5e-9459-49426afdf80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4283038f-a181-4fc9-b93c-fd498aaf2bb9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_79fface5-40a4-4f5e-9459-49426afdf80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_0d048d40-6304-4dc7-99e9-afa871d4bcd3" xlink:href="bdx-20220930.xsd#bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_79fface5-40a4-4f5e-9459-49426afdf80e" xlink:to="loc_bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember_0d048d40-6304-4dc7-99e9-afa871d4bcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_8c9016a8-d394-4877-9945-97ae50d483f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_86791123-408d-42c0-9a70-3de1306c90f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:to="loc_us-gaap_DomesticPlanMember_86791123-408d-42c0-9a70-3de1306c90f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cacdc5b3-ff91-4531-b45b-c0fada3ee40b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_86791123-408d-42c0-9a70-3de1306c90f2" xlink:to="loc_country_US_cacdc5b3-ff91-4531-b45b-c0fada3ee40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_acfb2dd1-969f-428e-b53c-959484cae276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_31156971-d72b-4129-9b95-324317ac7407" xlink:to="loc_us-gaap_ForeignPlanMember_acfb2dd1-969f-428e-b53c-959484cae276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_4c9f5f5e-a57f-4cbd-b615-1cbc7f086495" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_31218dda-8ba6-4fcc-9f78-4498c06bceb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_31218dda-8ba6-4fcc-9f78-4498c06bceb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_93da106b-da73-49ad-9ec0-dda03901b6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_93da106b-da73-49ad-9ec0-dda03901b6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_196943cc-5ab7-4c67-9e35-4468336b5b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_196943cc-5ab7-4c67-9e35-4468336b5b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherFixedIncomeMember_882e0beb-4cc2-48aa-8775-4550098bf8e3" xlink:href="bdx-20220930.xsd#bdx_OtherFixedIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_bdx_OtherFixedIncomeMember_882e0beb-4cc2-48aa-8775-4550098bf8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e803304a-5f09-42c4-8847-7da44e6452e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e803304a-5f09-42c4-8847-7da44e6452e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_656d5df3-8bd6-4abb-baf1-92f5d840b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_656d5df3-8bd6-4abb-baf1-92f5d840b0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherPensionPlanInvestmentsMember_c6b702f0-f7ee-4d3b-b242-4e6115779b4c" xlink:href="bdx-20220930.xsd#bdx_OtherPensionPlanInvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_bdx_OtherPensionPlanInvestmentsMember_c6b702f0-f7ee-4d3b-b242-4e6115779b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_cba15bdb-2391-43fe-8209-df060ac72042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_cba15bdb-2391-43fe-8209-df060ac72042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InsuranceContractInvestmentsMember_a15aba19-a34e-4054-a7ce-6a78effdc73b" xlink:href="bdx-20220930.xsd#bdx_InsuranceContractInvestmentsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_b22ecda0-88a0-4aba-a8b1-07cbb74fb1fa" xlink:to="loc_bdx_InsuranceContractInvestmentsMember_a15aba19-a34e-4054-a7ce-6a78effdc73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f4f26abd-c4b9-40d7-9e6d-45851b6e705e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b822db2-0646-41c6-ae0b-8ca55d257ed4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f4f26abd-c4b9-40d7-9e6d-45851b6e705e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b6b7c905-6865-4c34-950c-7038575138a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f4f26abd-c4b9-40d7-9e6d-45851b6e705e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b6b7c905-6865-4c34-950c-7038575138a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/AcquisitionsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#AcquisitionsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/AcquisitionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9d11dee1-3770-4080-8b1d-9cbfbbf5e362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9d11dee1-3770-4080-8b1d-9cbfbbf5e362" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36d5ec9e-67c5-4e29-b70b-f63a6b72f626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_354c88de-183e-4665-b456-436deed8754d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36d5ec9e-67c5-4e29-b70b-f63a6b72f626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ParataSystemsMember_c5b9d509-e4d6-4c42-9dd6-c86f5129989d" xlink:href="bdx-20220930.xsd#bdx_ParataSystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36d5ec9e-67c5-4e29-b70b-f63a6b72f626" xlink:to="loc_bdx_ParataSystemsMember_c5b9d509-e4d6-4c42-9dd6-c86f5129989d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86c4b010-50ac-4ada-91ff-b95ae2da4f99" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_bb2b84fb-bc9b-40f6-b9d9-287f65d12834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_bb2b84fb-bc9b-40f6-b9d9-287f65d12834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_63b87b00-199d-4e1b-bc06-a9ee80aca5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5889d22-73e7-4a45-94fa-0de3a12295cf" xlink:to="loc_us-gaap_CustomerRelationshipsMember_63b87b00-199d-4e1b-bc06-a9ee80aca5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a12d74e9-d7c4-412a-8188-ea2f971ee03c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_83940ea1-692d-4da1-ba29-321987c631f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_83940ea1-692d-4da1-ba29-321987c631f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9cb4d066-4be9-4062-83b3-969fdc687414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9cb4d066-4be9-4062-83b3-969fdc687414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_37147963-1de3-43fc-b0d9-9beaa882eb19" xlink:href="bdx-20220930.xsd#bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets_37147963-1de3-43fc-b0d9-9beaa882eb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b74f4efa-1446-4723-9dfe-03551d3704ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ceb8a2da-9679-49de-9bf9-7a7ec60125a0" xlink:to="loc_us-gaap_Goodwill_b74f4efa-1446-4723-9dfe-03551d3704ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#BusinessRestructuringChargesChangesinRestructuringBalanceDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9bd375bf-2629-4427-8ebc-19059af7f557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9bd375bf-2629-4427-8ebc-19059af7f557" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c0e6a58f-62ba-4ed5-9788-41e636bc895c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_ff91d64d-400a-4895-a454-fc8e88449eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_ff91d64d-400a-4895-a454-fc8e88449eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_68801588-a56c-4094-841b-b7ef5f6a496e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_962f5b88-e762-4781-848c-dad2a0757ad7" xlink:to="loc_us-gaap_OtherRestructuringMember_68801588-a56c-4094-841b-b7ef5f6a496e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c03a58d5-423a-4647-95ee-63e5f08d3679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_736336c2-bfad-443b-aef6-a4d199794981" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c03a58d5-423a-4647-95ee-63e5f08d3679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c03a58d5-423a-4647-95ee-63e5f08d3679" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_935300cd-3f7b-4a0a-b84f-e2118c509dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserve_935300cd-3f7b-4a0a-b84f-e2118c509dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d76c6838-c034-4217-9f5e-dd177836847f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringCharges_d76c6838-c034-4217-9f5e-dd177836847f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_da43760e-c0e4-45f9-88dd-6ea52f18e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_PaymentsForRestructuring_da43760e-c0e4-45f9-88dd-6ea52f18e5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_725521bd-a67e-4ad4-9f53-b12462bb98b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_725521bd-a67e-4ad4-9f53-b12462bb98b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_eb226c6b-cee1-45c5-a0ec-52a6d62c41e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_eb226c6b-cee1-45c5-a0ec-52a6d62c41e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_743447b4-cc9c-4878-8d76-4e7ac11958bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e8536be4-6d60-44d4-b5c9-a720dc18eabc" xlink:to="loc_us-gaap_RestructuringReserve_743447b4-cc9c-4878-8d76-4e7ac11958bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsComponentsofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_99aa4de3-b37c-412f-9987-03f701969a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:href="bdx-20220930.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_99aa4de3-b37c-412f-9987-03f701969a04" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_494ec741-c25b-4f69-919e-28a72e8905fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ec9725cd-d31c-4861-86ea-fba93fe00f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ec9725cd-d31c-4861-86ea-fba93fe00f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3c9b26c1-cafb-4b71-b38e-2b1d20ec8b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3c9b26c1-cafb-4b71-b38e-2b1d20ec8b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ProductRightsMember_ab4d9eb1-0ac0-4dbf-bede-615e95dacc5a" xlink:href="bdx-20220930.xsd#bdx_ProductRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_bdx_ProductRightsMember_ab4d9eb1-0ac0-4dbf-bede-615e95dacc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_2772efc5-41c7-4eeb-9b62-ade9e584832f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_TrademarksMember_2772efc5-41c7-4eeb-9b62-ade9e584832f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_b2d29d5d-de48-4606-bea9-27c393a6854e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_934f1766-44da-43ed-bc10-a149d9761fea" xlink:to="loc_us-gaap_IntellectualPropertyMember_b2d29d5d-de48-4606-bea9-27c393a6854e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2f9ccc3b-76a9-4bc9-b3b7-7e55872e7d35" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_8b3c6181-c8e3-43be-83fd-0d889dde8f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_8b3c6181-c8e3-43be-83fd-0d889dde8f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_38b8f8fe-b6ec-482f-8c75-e86b7a159a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e869a59-36d9-4b36-8836-bdcd48d32cac" xlink:to="loc_us-gaap_TrademarksMember_38b8f8fe-b6ec-482f-8c75-e86b7a159a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:href="bdx-20220930.xsd#bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable_6c8723f9-5e6b-4b2c-bb7f-1d9a901337a2" xlink:to="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f26dd884-d5b7-4fde-897c-7989a1d453ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f26dd884-d5b7-4fde-897c-7989a1d453ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dbeb6a11-f3f5-4e6c-9274-3a0398b63670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dbeb6a11-f3f5-4e6c-9274-3a0398b63670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5e6b4e4-90b8-48a9-bd27-c9bcce4da5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5e6b4e4-90b8-48a9-bd27-c9bcce4da5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9bcbb868-fbc8-4395-b0b2-937a66912b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems_1d6221e7-6095-40e0-80ce-79550a0c24d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_9bcbb868-fbc8-4395-b0b2-937a66912b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5853802c-bf84-4a83-aa41-d72b6685e472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5853802c-bf84-4a83-aa41-d72b6685e472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2ba615af-1c3e-4f1f-8af1-29a94662ad9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2ba615af-1c3e-4f1f-8af1-29a94662ad9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c52434b9-2a68-40fc-947e-5cabec118957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c52434b9-2a68-40fc-947e-5cabec118957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0fde2aa4-687b-4b58-b2ab-d354b9b7c8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0fde2aa4-687b-4b58-b2ab-d354b9b7c8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e1a214ad-ba8c-4570-8a4b-2e16753e22d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e1a214ad-ba8c-4570-8a4b-2e16753e22d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9a1313cd-ab73-43d5-91f7-7edbc6286d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9d1cde7-6c8f-49af-a917-0e71372cf76c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9a1313cd-ab73-43d5-91f7-7edbc6286d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6bd3cc94-4df2-4670-b235-fac76a5a53c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6bd3cc94-4df2-4670-b235-fac76a5a53c3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_986fc34f-815f-448f-8ace-735664efd485" xlink:to="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_dcc2eb1b-3ed7-45ff-95a8-e4767146a309" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:to="loc_bdx_MedicalMember_dcc2eb1b-3ed7-45ff-95a8-e4767146a309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_fc9810a4-0741-4976-92a9-d2b307f73214" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:to="loc_bdx_LifeSciencesMember_fc9810a4-0741-4976-92a9-d2b307f73214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_InterventionalMember_27516294-0254-4d5a-a831-d91e4fb41155" xlink:href="bdx-20220930.xsd#bdx_InterventionalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_969a53ca-72e4-4d4e-a59d-cfe015ec0ab0" xlink:to="loc_bdx_InterventionalMember_27516294-0254-4d5a-a831-d91e4fb41155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_410fbb8f-cb25-42fe-a148-f02701245f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6c3e8897-060d-4717-b6be-55c0cf7daf36" xlink:to="loc_us-gaap_GoodwillLineItems_410fbb8f-cb25-42fe-a148-f02701245f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_410fbb8f-cb25-42fe-a148-f02701245f1b" xlink:to="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_155cdc16-119c-4b06-bd44-bfa54523ec08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_Goodwill_155cdc16-119c-4b06-bd44-bfa54523ec08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_7df26021-f299-4c42-8bfa-a4a68fd785ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_7df26021-f299-4c42-8bfa-a4a68fd785ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3c6339de-c079-4428-80f5-26eba3584043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3c6339de-c079-4428-80f5-26eba3584043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_30300f7b-d198-4ed4-b96b-e21bed52c320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_30300f7b-d198-4ed4-b96b-e21bed52c320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_226c23a2-e4dd-4fa5-8d1b-37a7455193e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2b5f2bb9-0f37-4a83-9a42-c9263c6bc418" xlink:to="loc_us-gaap_Goodwill_226c23a2-e4dd-4fa5-8d1b-37a7455193e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7b21e93-54b4-428c-9da8-01d409ddd6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7b21e93-54b4-428c-9da8-01d409ddd6b9" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e5ef757c-0c01-4c41-90f4-5d427574238d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3ecfc078-1d9b-49a4-98a0-d71377c45ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3ecfc078-1d9b-49a4-98a0-d71377c45ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2da2edae-5833-4bc1-ba8a-c02172ab98a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_us-gaap_CurrencySwapMember_2da2edae-5833-4bc1-ba8a-c02172ab98a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FixedToFloatingMember_245f39b4-22ec-4062-8965-6923f46a18e8" xlink:href="bdx-20220930.xsd#bdx_FixedToFloatingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_bdx_FixedToFloatingMember_245f39b4-22ec-4062-8965-6923f46a18e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_87c6aa11-fb86-4dbb-b496-a6edab8bb98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06ff1527-c2d6-436d-811f-dcf621c3ea68" xlink:to="loc_us-gaap_InterestRateSwapMember_87c6aa11-fb86-4dbb-b496-a6edab8bb98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e410e7e-5637-4d33-8e23-2b6f391ad967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_249f8ba0-03b8-4f36-b2e6-0e8c9364b67b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e410e7e-5637-4d33-8e23-2b6f391ad967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_8dca3105-faeb-4b2a-8213-f41795527c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e410e7e-5637-4d33-8e23-2b6f391ad967" xlink:to="loc_us-gaap_DebtMember_8dca3105-faeb-4b2a-8213-f41795527c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d57a9f31-11a6-4fab-b8a1-5e20612dbe8a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e8350076-f723-43f8-8e6a-c8a21d8c27eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e8350076-f723-43f8-8e6a-c8a21d8c27eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_550d8c47-8d0d-469f-8fd6-be919fa8e5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:to="loc_us-gaap_FairValueHedgingMember_550d8c47-8d0d-469f-8fd6-be919fa8e5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e9a14fb0-7651-48ea-b65e-60d2fe77c52d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d89978e5-7635-4122-9e46-b7b90a699b3f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e9a14fb0-7651-48ea-b65e-60d2fe77c52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_27fbd8d7-7701-4bdd-80f9-6e3db04ab900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_76dd2b6f-c5f1-4583-bcf2-184620dce585" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_27fbd8d7-7701-4bdd-80f9-6e3db04ab900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4ddb7a5a-b4ba-4d30-8e42-ffab184f4a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_27fbd8d7-7701-4bdd-80f9-6e3db04ab900" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4ddb7a5a-b4ba-4d30-8e42-ffab184f4a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6807d8dc-98d6-4d26-aff9-3090b7b38161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6807d8dc-98d6-4d26-aff9-3090b7b38161" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1de69d60-fb11-431e-8ad8-004421c31914" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d0274ea7-6567-49fb-af8d-5bc9f85b3c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:to="loc_us-gaap_InterestRateSwapMember_d0274ea7-6567-49fb-af8d-5bc9f85b3c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_757eec52-8e8f-4fdc-bf4d-e4a339e07df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e193ced-1792-44fc-b65c-d8cedb8aba54" xlink:to="loc_us-gaap_CommodityContractMember_757eec52-8e8f-4fdc-bf4d-e4a339e07df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7e47c0d0-7c36-4e9b-a71f-7a0046f35973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8aebbab-5bf1-4583-b618-81477fb3334a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7e47c0d0-7c36-4e9b-a71f-7a0046f35973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_026765a4-2b06-44f0-98c9-d7e17221b611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7e47c0d0-7c36-4e9b-a71f-7a0046f35973" xlink:to="loc_us-gaap_CashFlowHedgingMember_026765a4-2b06-44f0-98c9-d7e17221b611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_6538f206-87e1-48e3-a544-298116f7f6c4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_0e754dd9-94ba-473f-a3c4-0cf2904e3b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_0e754dd9-94ba-473f-a3c4-0cf2904e3b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_af95ae32-3aaa-4d34-a20c-9caa02278e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_us-gaap_DerivativeNotionalAmount_af95ae32-3aaa-4d34-a20c-9caa02278e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_cc1467c3-89db-446d-9de9-071d450a2b3e" xlink:href="bdx-20220930.xsd#bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_4596be17-eabe-485b-9f98-80ac8dfe55dc" xlink:to="loc_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent_cc1467c3-89db-446d-9de9-071d450a2b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ffcdd227-6a07-4133-82ae-c569ba827d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ffcdd227-6a07-4133-82ae-c569ba827d33" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7c03d75b-74c4-4e66-8007-8d3d42433145" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_86429815-127e-46d9-82d8-78b382078a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:to="loc_us-gaap_ForeignExchangeContractMember_86429815-127e-46d9-82d8-78b382078a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_e5a54d65-b2ff-438f-8405-48d5c1e78bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:to="loc_us-gaap_CurrencySwapMember_e5a54d65-b2ff-438f-8405-48d5c1e78bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TerminatedCurrencySwapMember_886b5738-3597-4fc0-a711-046c7db30ab2" xlink:href="bdx-20220930.xsd#bdx_TerminatedCurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35586e0f-b818-4597-9eba-27845eca6a29" xlink:to="loc_bdx_TerminatedCurrencySwapMember_886b5738-3597-4fc0-a711-046c7db30ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1c85c38a-438b-4567-8aaf-7bb0e3c1e89b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_131d0abe-92f8-4606-ab00-6d3f45d7dbec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_131d0abe-92f8-4606-ab00-6d3f45d7dbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_45d8a473-314f-4082-8c86-f6120e3a1f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1bb7a3b7-bac3-40ad-8a49-e0deedf5400f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_45d8a473-314f-4082-8c86-f6120e3a1f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_160a7438-6267-4503-b66a-a9750d9faee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd72cb92-69a3-490c-9341-3e43d444fd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_160a7438-6267-4503-b66a-a9750d9faee6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd72cb92-69a3-490c-9341-3e43d444fd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_c6583132-2181-41c4-9213-3d16bad0f5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_160a7438-6267-4503-b66a-a9750d9faee6" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_c6583132-2181-41c4-9213-3d16bad0f5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1bf46d5b-465b-46a2-aad9-ac0c37b15b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_160a7438-6267-4503-b66a-a9750d9faee6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1bf46d5b-465b-46a2-aad9-ac0c37b15b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_35570326-799e-445a-8d37-e4a39e74a4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4813b5b9-362d-4d73-b649-f7e679178c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_35570326-799e-445a-8d37-e4a39e74a4e1" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4813b5b9-362d-4d73-b649-f7e679178c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_7f597393-b9ec-4f69-88a2-21e3f0a4fa10" xlink:href="bdx-20220930.xsd#bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_35570326-799e-445a-8d37-e4a39e74a4e1" xlink:to="loc_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm_7f597393-b9ec-4f69-88a2-21e3f0a4fa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableFairValueDisclosure_e045f234-584e-4a87-bcee-60d4db8b1beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_35570326-799e-445a-8d37-e4a39e74a4e1" xlink:to="loc_us-gaap_LoansPayableFairValueDisclosure_e045f234-584e-4a87-bcee-60d4db8b1beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cd91a919-1193-444b-a136-103de144fb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cd91a919-1193-444b-a136-103de144fb32" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1718fc64-1a68-4dc7-ad94-01f5f7ecea1e" xlink:to="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LifeSciencesMember_3785468a-abe4-4251-b58c-e22840f76dba" xlink:href="bdx-20220930.xsd#bdx_LifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:to="loc_bdx_LifeSciencesMember_3785468a-abe4-4251-b58c-e22840f76dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MedicalMember_0c3448cc-c703-41d1-bb19-71fdd1b48405" xlink:href="bdx-20220930.xsd#bdx_MedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e03ef24c-bf91-4f50-af74-6ea8816dfcd5" xlink:to="loc_bdx_MedicalMember_0c3448cc-c703-41d1-bb19-71fdd1b48405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8c261eb0-c0f8-4704-9940-2f0763175130" xlink:to="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55bb036c-2740-4733-bbe6-a6e82f57be80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:to="loc_srt_MinimumMember_55bb036c-2740-4733-bbe6-a6e82f57be80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ee97a82f-bb6f-416a-8ebc-c577b2ad39e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d042f5da-7b11-42e5-b0ca-a6e84a2ff1cc" xlink:to="loc_srt_MaximumMember_ee97a82f-bb6f-416a-8ebc-c577b2ad39e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3cc0c874-6ef0-4610-bb6e-09ae0eadbce9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3aa2f21f-f21d-451f-ab82-95f0b481fa71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:to="loc_us-gaap_CostOfSalesMember_3aa2f21f-f21d-451f-ab82-95f0b481fa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_6cba8c4d-9cf6-4cdd-b12c-84e13238e464" xlink:href="bdx-20220930.xsd#bdx_AcquisitionRelatedCostsAndRestructuringChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_35e9636e-edb0-4e41-a3b0-2c524f9f20b4" xlink:to="loc_bdx_AcquisitionRelatedCostsAndRestructuringChargesMember_6cba8c4d-9cf6-4cdd-b12c-84e13238e464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_daf1b631-9dc6-4ff3-8a2d-4a7f2492a97e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_MaturityPeriodOfShortTermInvestment_1bccfc35-1ada-4ce5-a9a6-061b28b644db" xlink:href="bdx-20220930.xsd#bdx_MaturityPeriodOfShortTermInvestment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_bdx_MaturityPeriodOfShortTermInvestment_1bccfc35-1ada-4ce5-a9a6-061b28b644db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5d705a6d-b364-49ce-a511-4f1c7fbb4689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_us-gaap_AssetImpairmentCharges_5d705a6d-b364-49ce-a511-4f1c7fbb4689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1315cf02-fe2c-46fa-b925-5ca8492350d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1bb74682-7da6-48d9-b220-945a80e1b502" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1315cf02-fe2c-46fa-b925-5ca8492350d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6ca623f4-d02a-4dc3-a027-3dcc752cf9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod_c1fffaba-dd52-4e36-be34-a13c233b2c20" xlink:href="bdx-20220930.xsd#bdx_TransfersOfFinancialAssetsDuringThePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6ca623f4-d02a-4dc3-a027-3dcc752cf9a8" xlink:to="loc_bdx_TransfersOfFinancialAssetsDuringThePeriod_c1fffaba-dd52-4e36-be34-a13c233b2c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_26356cbd-3229-45d4-a3da-7e35ec1f4927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6ca623f4-d02a-4dc3-a027-3dcc752cf9a8" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_26356cbd-3229-45d4-a3da-7e35ec1f4927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtSummaryofShortTermDebtDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtSummaryofShortTermDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_faf62778-7372-4520-aa4c-f15893b7a174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_faf62778-7372-4520-aa4c-f15893b7a174" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:to="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3212911a-28ef-405c-967b-7e9bd2bbcc39" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_86f1fdc7-7d15-48f2-8a5c-c997108d50d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_us-gaap_CommercialPaperMember_86f1fdc7-7d15-48f2-8a5c-c997108d50d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_1a857745-2f8c-4720-95a5-9a77bfcb816f" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_1a857745-2f8c-4720-95a5-9a77bfcb816f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member_03b01cf7-3352-44bd-9489-a39ca0e5fd67" xlink:href="bdx-20220930.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_FloatingRateNotesDueJune62022Member_03b01cf7-3352-44bd-9489-a39ca0e5fd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1401DueMay232023Member_4dd094cb-b3b3-4f23-8dbf-c4b428f1a83f" xlink:href="bdx-20220930.xsd#bdx_Notes1401DueMay232023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes1401DueMay232023Member_4dd094cb-b3b3-4f23-8dbf-c4b428f1a83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_988d768a-fb3e-46ae-ac24-d8abfd6fb8bc" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes0.632dueJune42023Member_988d768a-fb3e-46ae-ac24-d8abfd6fb8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_430bb8c3-899e-4e5d-9fe8-fc6e8f1523ab" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96fb5f83-c3ad-4bf2-b821-80eaaa3e8018" xlink:to="loc_bdx_Notes0000DueAugust132023Member_430bb8c3-899e-4e5d-9fe8-fc6e8f1523ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_582ccb75-c5c6-44a9-81d3-08ce6c4dd21f" xlink:to="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a5463fc-0b9c-4a56-98a7-fc096e3365c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a5463fc-0b9c-4a56-98a7-fc096e3365c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c725d678-d116-4dd8-84ce-b0a872163abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_ShortTermBorrowings_c725d678-d116-4dd8-84ce-b0a872163abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e3e2fa4f-ce18-43c5-b54a-0a06ca214f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_LongTermDebtCurrent_e3e2fa4f-ce18-43c5-b54a-0a06ca214f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_24b84cab-665d-4eaf-9c81-ffaa815a7718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_889738fd-474a-41ee-995f-d0dcc25ecaaf" xlink:to="loc_us-gaap_DebtCurrent_24b84cab-665d-4eaf-9c81-ffaa815a7718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6945ccd7-a181-43e2-b81a-c23a4c50fe36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6945ccd7-a181-43e2-b81a-c23a4c50fe36" xlink:to="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_41597adc-c3b4-46da-9ba2-4900ff8cbe32" xlink:to="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ff44ba1b-b34d-4da1-afc1-6465ecbf9d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ff44ba1b-b34d-4da1-afc1-6465ecbf9d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_TermLoanFacilityMember_98ed6a2f-169e-4ee4-b302-90ab0214f7fc" xlink:href="bdx-20220930.xsd#bdx_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cdfaa152-17db-4ce9-b902-35b3018634bf" xlink:to="loc_bdx_TermLoanFacilityMember_98ed6a2f-169e-4ee4-b302-90ab0214f7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5987233a-c13f-4d7b-9060-df72fd921353" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_01582799-7c37-4114-8428-0d9832b08245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_us-gaap_CommercialPaperMember_01582799-7c37-4114-8428-0d9832b08245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes5000DueFebruary152030Member_91e67d21-598f-494b-a595-a8ac5eb69dff" xlink:href="bdx-20220930.xsd#bdx_Notes5000DueFebruary152030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_bdx_Notes5000DueFebruary152030Member_91e67d21-598f-494b-a595-a8ac5eb69dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6750DueFebruary152030Member_f17c9732-a4aa-4f47-80ae-1c313421c876" xlink:href="bdx-20220930.xsd#bdx_Notes6750DueFebruary152030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_bdx_Notes6750DueFebruary152030Member_f17c9732-a4aa-4f47-80ae-1c313421c876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_FloatingRateNotesDueJune62022Member_c296f695-9d86-491e-b305-6dd47db7b827" xlink:href="bdx-20220930.xsd#bdx_FloatingRateNotesDueJune62022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8902d2f-f8d6-48bd-b4ce-67cc66ae91d0" xlink:to="loc_bdx_FloatingRateNotesDueJune62022Member_c296f695-9d86-491e-b305-6dd47db7b827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94b65371-cd74-4a71-b321-6869f57da0ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_77c3e473-dd53-4805-a352-604bb4cc90dc" xlink:to="loc_srt_RangeMember_94b65371-cd74-4a71-b321-6869f57da0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d85ba27-c9ba-49e9-a3b1-1dd28fbadb49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_94b65371-cd74-4a71-b321-6869f57da0ac" xlink:to="loc_srt_MaximumMember_2d85ba27-c9ba-49e9-a3b1-1dd28fbadb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_8faa661c-d6ac-4a1b-8e18-0152fb6e1380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_a49e0840-19c1-4353-a886-158c892a41c2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_8faa661c-d6ac-4a1b-8e18-0152fb6e1380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_9f54e9a2-df55-427f-9aea-02c321c4b971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_8faa661c-d6ac-4a1b-8e18-0152fb6e1380" xlink:to="loc_us-gaap_LongTermDebtMember_9f54e9a2-df55-427f-9aea-02c321c4b971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2ac89117-ac07-47eb-8ad6-f400720bccde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2e98c293-ac46-43d3-9319-69c86f3807cd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2ac89117-ac07-47eb-8ad6-f400720bccde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d6d4dcb3-5ac3-4018-8511-5f0278497c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2ac89117-ac07-47eb-8ad6-f400720bccde" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_d6d4dcb3-5ac3-4018-8511-5f0278497c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4ad578df-d3d5-45a2-b2c1-a8bc4ba2f2cf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_db99a554-3ceb-4ae0-bb28-b2d383ff18ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_db99a554-3ceb-4ae0-bb28-b2d383ff18ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_eb769fa6-6525-43a8-b2e9-c8a4f8724886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_ShortTermBorrowings_eb769fa6-6525-43a8-b2e9-c8a4f8724886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_67604e24-b73a-4dd8-95ce-cd1ead30b9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_67604e24-b73a-4dd8-95ce-cd1ead30b9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_54c17a36-b0f3-47e1-b460-978366220047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_54c17a36-b0f3-47e1-b460-978366220047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ac01c3a8-3911-426e-b5ad-abf45f132ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ac01c3a8-3911-426e-b5ad-abf45f132ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d41ced65-94a9-4154-90bc-7bd939af3fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d41ced65-94a9-4154-90bc-7bd939af3fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5fe72d7c-a255-4f04-8456-20caa8a5ec01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5fe72d7c-a255-4f04-8456-20caa8a5ec01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_0f3427b2-e890-4019-b062-cf7940b7332f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentTerm_0f3427b2-e890-4019-b062-cf7940b7332f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_e13cf6db-5616-4178-9e2f-58f53883fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_e13cf6db-5616-4178-9e2f-58f53883fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LettersOfCreditIssuableUnderCreditFacility_8f8fb8db-bef4-4ada-ac31-36e04e072f9f" xlink:href="bdx-20220930.xsd#bdx_LettersOfCreditIssuableUnderCreditFacility"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_bdx_LettersOfCreditIssuableUnderCreditFacility_8f8fb8db-bef4-4ada-ac31-36e04e072f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SwinglineLoansIssuableUnderCreditFacility_0f6cb89c-d6c4-48e5-bba2-c2b9878a9e95" xlink:href="bdx-20220930.xsd#bdx_SwinglineLoansIssuableUnderCreditFacility"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_bdx_SwinglineLoansIssuableUnderCreditFacility_0f6cb89c-d6c4-48e5-bba2-c2b9878a9e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_6d75991a-5f04-49bc-9d20-dc6f23fb2c66" xlink:href="bdx-20220930.xsd#bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments_6d75991a-5f04-49bc-9d20-dc6f23fb2c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac8becc3-1e1d-4a79-a0d5-80d042c6ea67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac8becc3-1e1d-4a79-a0d5-80d042c6ea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_961435a0-4bad-43e0-af52-af4ca629fd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LineOfCredit_961435a0-4bad-43e0-af52-af4ca629fd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_41e8cd77-69f8-4c43-aeca-f6943b90888f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_41e8cd77-69f8-4c43-aeca-f6943b90888f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c5fc6a6a-19ce-479a-80d7-373d9d9a9622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c5fc6a6a-19ce-479a-80d7-373d9d9a9622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_8e97050f-bfd9-4a94-b388-163174c94f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_8e97050f-bfd9-4a94-b388-163174c94f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5e69850f-2b59-4548-81e3-b61e1077c0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5e69850f-2b59-4548-81e3-b61e1077c0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_82cfc766-446b-4455-b384-b33da7e0eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_82cfc766-446b-4455-b384-b33da7e0eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2254894d-239b-4d90-9df9-c4331c100ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b7614a21-7cd9-425c-8972-ed93c5a8d112" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2254894d-239b-4d90-9df9-c4331c100ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtSummaryofLongTermDebtDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtSummaryofLongTermDebtDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtSummaryofLongTermDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ff23abfb-2850-4a0f-b428-e3f713cb0132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ff23abfb-2850-4a0f-b428-e3f713cb0132" xlink:to="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:to="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_306547db-b1d0-48e5-b6f0-6d365835d66a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.000dueDecember152022Member_97738ab7-d812-459f-a32c-a8d88a9cba30" xlink:href="bdx-20220930.xsd#bdx_Notes1.000dueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.000dueDecember152022Member_97738ab7-d812-459f-a32c-a8d88a9cba30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.401dueMay242023Member_5205bb5b-1158-4587-be77-58190a606e25" xlink:href="bdx-20220930.xsd#bdx_Notes1.401dueMay242023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.401dueMay242023Member_5205bb5b-1158-4587-be77-58190a606e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.632dueJune42023Member_1939324a-7706-4c20-8374-e04667b59f24" xlink:href="bdx-20220930.xsd#bdx_Notes0.632dueJune42023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0.632dueJune42023Member_1939324a-7706-4c20-8374-e04667b59f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_c2ffaf02-9dac-4bec-832a-0c2a48c79a34" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0000DueAugust132023Member_c2ffaf02-9dac-4bec-832a-0c2a48c79a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.875dueMay152024Member_8fb78981-583c-4889-aa04-07487bb593c6" xlink:href="bdx-20220930.xsd#bdx_Notes3.875dueMay152024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.875dueMay152024Member_8fb78981-583c-4889-aa04-07487bb593c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.363DueJune62024Member_7d48e2b3-b78a-4350-a997-512db5490add" xlink:href="bdx-20220930.xsd#bdx_Notes3.363DueJune62024Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.363DueJune62024Member_7d48e2b3-b78a-4350-a997-512db5490add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.734DueDecember152024Member_4c0e86ea-7944-4364-bbd6-0edda6de849e" xlink:href="bdx-20220930.xsd#bdx_Notes3.734DueDecember152024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.734DueDecember152024Member_4c0e86ea-7944-4364-bbd6-0edda6de849e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.02dueMay242025Member_d5371464-3980-4f72-9b2f-080d8a91e8b5" xlink:href="bdx-20220930.xsd#bdx_Notes3.02dueMay242025Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.02dueMay242025Member_d5371464-3980-4f72-9b2f-080d8a91e8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_e6e82782-83e5-4e67-9e57-0a5717bf3d5d" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0034DueAugust132025Member_e6e82782-83e5-4e67-9e57-0a5717bf3d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_b142a5f8-21f1-4c7d-94e1-7c1166e3b49a" xlink:href="bdx-20220930.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.208dueJune42026Member_b142a5f8-21f1-4c7d-94e1-7c1166e3b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes6.700dueDecember12026Member_21d00cf8-4569-4cfc-91d1-1c2d35374b54" xlink:href="bdx-20220930.xsd#bdx_Notes6.700dueDecember12026Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes6.700dueDecember12026Member_21d00cf8-4569-4cfc-91d1-1c2d35374b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_919fa1d0-5491-4560-ba91-ca2a461393d2" xlink:href="bdx-20220930.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_919fa1d0-5491-4560-ba91-ca2a461393d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.700dueJune62027Member_105f7f79-6d49-4990-b256-a2005d485c95" xlink:href="bdx-20220930.xsd#bdx_Notes3.700dueJune62027Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3.700dueJune62027Member_105f7f79-6d49-4990-b256-a2005d485c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2027Member_6dc5d97d-3cb1-410e-9e0e-f472171de799" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2027Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_DebenturesDue2027Member_6dc5d97d-3cb1-410e-9e0e-f472171de799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2028Member_a22b4903-1714-4261-bba2-5e8ef0d752c8" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2028Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_DebenturesDue2028Member_a22b4903-1714-4261-bba2-5e8ef0d752c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0334DueAugust132028Member_8cfde1d5-24a4-494a-bc5e-269f3877a865" xlink:href="bdx-20220930.xsd#bdx_Notes0334DueAugust132028Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes0334DueAugust132028Member_8cfde1d5-24a4-494a-bc5e-269f3877a865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes2823DueMay202030Member_7337c7f6-5a41-40a4-80a0-f940f827f61e" xlink:href="bdx-20220930.xsd#bdx_Notes2823DueMay202030Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes2823DueMay202030Member_7337c7f6-5a41-40a4-80a0-f940f827f61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1957DueFebruary112031Member_0ea54f5e-38a5-43b3-94cf-a7c8f6305ec5" xlink:href="bdx-20220930.xsd#bdx_Notes1957DueFebruary112031Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1957DueFebruary112031Member_0ea54f5e-38a5-43b3-94cf-a7c8f6305ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4298DueAugust222032Member_d99a49b1-6619-46f4-a627-db7e36e3fbcb" xlink:href="bdx-20220930.xsd#bdx_Notes4298DueAugust222032Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4298DueAugust222032Member_d99a49b1-6619-46f4-a627-db7e36e3fbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_2781274b-d2bb-4e3d-8f0c-1d067507501f" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_2781274b-d2bb-4e3d-8f0c-1d067507501f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2039Member_0ae05f62-54d1-477d-8159-a55c749334f7" xlink:href="bdx-20220930.xsd#bdx_NotesDue2039Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_NotesDue2039Member_0ae05f62-54d1-477d-8159-a55c749334f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2040Member_47d7b065-9cf5-4564-b058-06fc15d8a8c9" xlink:href="bdx-20220930.xsd#bdx_NotesDue2040Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_NotesDue2040Member_47d7b065-9cf5-4564-b058-06fc15d8a8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1336DueAugust132041Member_79f5a281-0dc0-4025-aef0-bbe33ec91809" xlink:href="bdx-20220930.xsd#bdx_Notes1336DueAugust132041Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes1336DueAugust132041Member_79f5a281-0dc0-4025-aef0-bbe33ec91809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.875dueMay152044Member_2c5a6ee1-22dd-4e16-840e-51aab3a12cd6" xlink:href="bdx-20220930.xsd#bdx_Notes4.875dueMay152044Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4.875dueMay152044Member_2c5a6ee1-22dd-4e16-840e-51aab3a12cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.685dueDecember152044Member_1de24ab0-d572-4e95-905b-526028a8d742" xlink:href="bdx-20220930.xsd#bdx_Notes4.685dueDecember152044Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4.685dueDecember152044Member_1de24ab0-d572-4e95-905b-526028a8d742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.669DueJune62047Member_675a48e0-99c1-45a8-bcac-d839e9dc2181" xlink:href="bdx-20220930.xsd#bdx_Notes4.669DueJune62047Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes4.669DueJune62047Member_675a48e0-99c1-45a8-bcac-d839e9dc2181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3794DueMay202050Member_24d1dc4f-3059-4435-9a63-159a8d52c8f6" xlink:href="bdx-20220930.xsd#bdx_Notes3794DueMay202050Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f2928c1f-9c5e-4203-8ca1-03de1a39f495" xlink:to="loc_bdx_Notes3794DueMay202050Member_24d1dc4f-3059-4435-9a63-159a8d52c8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_13246f1a-5183-42f2-b1f2-d7da3c8605e6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6176be5e-44ec-46d5-99dd-73fd8121293d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6176be5e-44ec-46d5-99dd-73fd8121293d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e985b197-cbbf-48a9-99e4-c8e35a50f501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a409d39a-318f-4715-9e5f-75d387bfc346" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e985b197-cbbf-48a9-99e4-c8e35a50f501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtScheduleofDebtIssuancesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_54276cc4-9050-4276-8928-0578412f131d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_54276cc4-9050-4276-8928-0578412f131d" xlink:to="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:to="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b79f2b8-dd8e-4746-a6c5-4d0fc674c63e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4298DueAugust222032Member_91c2c310-ce3d-442b-a4bf-3213f9d00357" xlink:href="bdx-20220930.xsd#bdx_Notes4298DueAugust222032Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes4298DueAugust222032Member_91c2c310-ce3d-442b-a4bf-3213f9d00357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1957DueFebruary112031Member_7a446249-30bd-416e-9b80-32411768e0ef" xlink:href="bdx-20220930.xsd#bdx_Notes1957DueFebruary112031Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes1957DueFebruary112031Member_7a446249-30bd-416e-9b80-32411768e0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3125DueNovember82021Member_438a6223-e800-4089-9524-4fc2985c30d7" xlink:href="bdx-20220930.xsd#bdx_Notes3125DueNovember82021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes3125DueNovember82021Member_438a6223-e800-4089-9524-4fc2985c30d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0000DueAugust132023Member_4f197726-98d8-4531-a468-5848d70cbf07" xlink:href="bdx-20220930.xsd#bdx_Notes0000DueAugust132023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0000DueAugust132023Member_4f197726-98d8-4531-a468-5848d70cbf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_e71c6d18-05da-4e83-a61d-56a4d07b17ce" xlink:href="bdx-20220930.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0034DueAugust132025Member_e71c6d18-05da-4e83-a61d-56a4d07b17ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0334DueAugust132028Member_f23c464d-6dd4-4f5c-8ce7-42ee6753b425" xlink:href="bdx-20220930.xsd#bdx_Notes0334DueAugust132028Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0334DueAugust132028Member_f23c464d-6dd4-4f5c-8ce7-42ee6753b425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1336DueAugust132041Member_a1ebaacc-75ca-49b7-92f6-abf6de91adff" xlink:href="bdx-20220930.xsd#bdx_Notes1336DueAugust132041Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes1336DueAugust132041Member_a1ebaacc-75ca-49b7-92f6-abf6de91adff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_6a9fa2d5-bc86-40d7-8cc0-0536948fade9" xlink:href="bdx-20220930.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_6a9fa2d5-bc86-40d7-8cc0-0536948fade9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.174dueJune42021Member_b4cb4240-aea2-430b-b6df-13257fa82e5e" xlink:href="bdx-20220930.xsd#bdx_Notes0.174dueJune42021Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_298e8491-2103-4bf6-a5af-0a6e1036540a" xlink:to="loc_bdx_Notes0.174dueJune42021Member_b4cb4240-aea2-430b-b6df-13257fa82e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:to="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_cc7113c4-812d-4fbb-8055-dded1121f18a" xlink:to="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_3f9c4e13-ce6b-45ff-a9e9-580f3aad4a34" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:to="loc_currency_EUR_3f9c4e13-ce6b-45ff-a9e9-580f3aad4a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_90d6f58d-f0ab-4709-afd5-e8de0965dec4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_e8bef37e-cbdd-435a-889c-0be36bdb7ee9" xlink:to="loc_currency_USD_90d6f58d-f0ab-4709-afd5-e8de0965dec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_306fdc96-cf6a-4976-b816-5327680708c5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5ea2e61d-5d8e-4562-aea9-bb6a900d7c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5ea2e61d-5d8e-4562-aea9-bb6a900d7c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3a1dc614-a9b1-4496-9b89-2828ca4471e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_613b3b85-7475-4878-96d1-11434ccd7044" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3a1dc614-a9b1-4496-9b89-2828ca4471e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtExtinguishmentsofDebtDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtExtinguishmentsofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtExtinguishmentsofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_142285c0-c6a8-444b-9859-173ceda7a6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_142285c0-c6a8-444b-9859-173ceda7a6d9" xlink:to="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_91867228-abc0-48ef-9c38-e13e2c08a573" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3794DueMay202050Member_a41d7bb7-9ded-4d05-a5f0-c8c3d67fd210" xlink:href="bdx-20220930.xsd#bdx_Notes3794DueMay202050Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3794DueMay202050Member_a41d7bb7-9ded-4d05-a5f0-c8c3d67fd210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2027Member_4945187c-4bd0-4678-8e92-1f0f7c5367ad" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_DebenturesDue2027Member_4945187c-4bd0-4678-8e92-1f0f7c5367ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DebenturesDue2028Member_bd30f2fd-2800-43f8-97fe-4d85d1dd010e" xlink:href="bdx-20220930.xsd#bdx_DebenturesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_DebenturesDue2028Member_bd30f2fd-2800-43f8-97fe-4d85d1dd010e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2039Member_384f0567-c1eb-4024-bdcb-81b72dc398cf" xlink:href="bdx-20220930.xsd#bdx_NotesDue2039Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_NotesDue2039Member_384f0567-c1eb-4024-bdcb-81b72dc398cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_NotesDue2040Member_538afa31-e54c-480f-9d6c-ca7db63f5154" xlink:href="bdx-20220930.xsd#bdx_NotesDue2040Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_NotesDue2040Member_538afa31-e54c-480f-9d6c-ca7db63f5154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes4.685dueDecember152044Member_089db4b3-015a-472a-8f00-7ce623e6627d" xlink:href="bdx-20220930.xsd#bdx_Notes4.685dueDecember152044Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes4.685dueDecember152044Member_089db4b3-015a-472a-8f00-7ce623e6627d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes2894DueJune62022Member_286c78d2-5d63-45e2-8287-d9814be81e37" xlink:href="bdx-20220930.xsd#bdx_Notes2894DueJune62022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes2894DueJune62022Member_286c78d2-5d63-45e2-8287-d9814be81e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.300dueMarch12023Member_a9a4feff-9f7d-447b-a5e8-b1c08459f8b6" xlink:href="bdx-20220930.xsd#bdx_Notes3.300dueMarch12023Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.300dueMarch12023Member_a9a4feff-9f7d-447b-a5e8-b1c08459f8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.875dueMay152024Member_56917ea9-70fe-4018-a6b5-5c53b46f8c33" xlink:href="bdx-20220930.xsd#bdx_Notes3.875dueMay152024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.875dueMay152024Member_56917ea9-70fe-4018-a6b5-5c53b46f8c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.734DueDecember152024Member_725573f5-dcb5-4d6b-b4a1-3988f4fb5548" xlink:href="bdx-20220930.xsd#bdx_Notes3.734DueDecember152024Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.734DueDecember152024Member_725573f5-dcb5-4d6b-b4a1-3988f4fb5548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.363DueJune62024Member_fdba2013-ffea-4a8f-9ef6-8cea94408437" xlink:href="bdx-20220930.xsd#bdx_Notes3.363DueJune62024Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3.363DueJune62024Member_fdba2013-ffea-4a8f-9ef6-8cea94408437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3125DueNovember82021Member_3a77c564-1898-421a-8196-a8146ac071d7" xlink:href="bdx-20220930.xsd#bdx_Notes3125DueNovember82021Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes3125DueNovember82021Member_3a77c564-1898-421a-8196-a8146ac071d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0.174dueJune42021Member_f25c9ef9-1207-43eb-ba7b-60ef4f9de1e9" xlink:href="bdx-20220930.xsd#bdx_Notes0.174dueJune42021Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_504e63da-bb31-4ed2-b411-5451dd30e5d4" xlink:to="loc_bdx_Notes0.174dueJune42021Member_f25c9ef9-1207-43eb-ba7b-60ef4f9de1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_315c0455-55e8-4b70-aff2-0f7c609d3fc0" xlink:to="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7c2f001d-364a-4be8-a1ac-821ab0899a3c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:to="loc_currency_EUR_7c2f001d-364a-4be8-a1ac-821ab0899a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_29558ea0-9496-4892-95d9-6f6bdba110f8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_447f4335-504a-41cb-b652-b911f75d9c66" xlink:to="loc_currency_USD_29558ea0-9496-4892-95d9-6f6bdba110f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1bb0698e-79d3-427c-9efa-a68be35fa7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_6bb132ab-7ba5-41c1-834a-80479c48a325" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1bb0698e-79d3-427c-9efa-a68be35fa7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_31f93121-ba68-4952-b730-c27f16a89ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1bb0698e-79d3-427c-9efa-a68be35fa7ed" xlink:to="loc_us-gaap_LongTermDebtMember_31f93121-ba68-4952-b730-c27f16a89ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_6012c367-2745-4680-a83b-2a8b38b66ce8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_a47f6ddb-a465-4ce5-b1c3-dde33a5f25e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_a47f6ddb-a465-4ce5-b1c3-dde33a5f25e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d8068aa5-ef92-4263-9d30-0281253f9223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d8068aa5-ef92-4263-9d30-0281253f9223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_33605fdb-958a-4c9a-8f09-73e5e3938b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_33605fdb-958a-4c9a-8f09-73e5e3938b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_3e3335bd-35bf-4039-9727-6e4190506925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_3e3335bd-35bf-4039-9727-6e4190506925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_acad96c3-48c3-41f8-8696-33dba8cbfe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_acad96c3-48c3-41f8-8696-33dba8cbfe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_BdxGainlossfromreversetrasurylocks_fa05c7d2-351f-4a09-9526-5c266554522f" xlink:href="bdx-20220930.xsd#bdx_BdxGainlossfromreversetrasurylocks"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_c8e5a14c-0eb3-45ad-aabc-16a33dacf193" xlink:to="loc_bdx_BdxGainlossfromreversetrasurylocks_fa05c7d2-351f-4a09-9526-5c266554522f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#DebtSummaryofInterestCostsandPaymentsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b2a320e3-dc25-4ca0-917a-f110873067fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b84cbef0-187f-4485-804a-56963203ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2a320e3-dc25-4ca0-917a-f110873067fa" xlink:to="loc_us-gaap_InterestExpense_b84cbef0-187f-4485-804a-56963203ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_1080d71b-1695-48ef-89c7-11585e1eca21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2a320e3-dc25-4ca0-917a-f110873067fa" xlink:to="loc_us-gaap_InterestCostsCapitalized_1080d71b-1695-48ef-89c7-11585e1eca21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred_e134e14c-6242-49a0-8a72-1ec1abeb6915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2a320e3-dc25-4ca0-917a-f110873067fa" xlink:to="loc_us-gaap_InterestCostsIncurred_e134e14c-6242-49a0-8a72-1ec1abeb6915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6ba3d04c-2a1c-4153-a15f-df501c911c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2a320e3-dc25-4ca0-917a-f110873067fa" xlink:to="loc_us-gaap_InterestPaidNet_6ba3d04c-2a1c-4153-a15f-df501c911c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b0aa0496-54a2-4e2a-af0a-34a2dcc5adde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b0aa0496-54a2-4e2a-af0a-34a2dcc5adde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b52bdfaf-6781-4830-ad56-615d720827f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b52bdfaf-6781-4830-ad56-615d720827f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_83efb21b-d59b-4cd1-8440-58cedbe9b2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_83efb21b-d59b-4cd1-8440-58cedbe9b2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_343c3d09-3a28-46eb-989a-fae93e7e6631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_343c3d09-3a28-46eb-989a-fae93e7e6631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a06c86c5-e479-44d9-809a-de764d50bc13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a06c86c5-e479-44d9-809a-de764d50bc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_988d0b11-9150-433c-8160-9758edaba5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_988d0b11-9150-433c-8160-9758edaba5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c0ebe98a-b922-4e0c-82dc-9a4e942b0136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c0ebe98a-b922-4e0c-82dc-9a4e942b0136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ddb0e46-6935-4475-a4f2-7b268516d53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ddb0e46-6935-4475-a4f2-7b268516d53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_ffaae6d6-0507-46b7-ad4a-5bdb77dd936c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53570502-df31-41d3-97d1-b75b02076e70" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_ffaae6d6-0507-46b7-ad4a-5bdb77dd936c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1f4f4e18-a89e-408a-b860-7879ada886c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0b73ad45-c4b1-4d3b-9d7b-e762ba0772c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1f4f4e18-a89e-408a-b860-7879ada886c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0b73ad45-c4b1-4d3b-9d7b-e762ba0772c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b1d9bbb6-7c74-4bd4-a407-39a2d107f834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1f4f4e18-a89e-408a-b860-7879ada886c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b1d9bbb6-7c74-4bd4-a407-39a2d107f834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5cd7b481-1694-4e1c-b7d8-ffcada7a6bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1f4f4e18-a89e-408a-b860-7879ada886c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5cd7b481-1694-4e1c-b7d8-ffcada7a6bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f0ebffe6-b5f6-4545-aa51-c5e9afe6ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:href="bdx-20220930.xsd#bdx_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0ebffe6-b5f6-4545-aa51-c5e9afe6ac30" xlink:to="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1779f514-3417-4c8f-a742-5a3b6872fc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03b07416-9c63-4635-a4e3-5468fe79ee81" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1779f514-3417-4c8f-a742-5a3b6872fc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_656b4dee-6a8f-4171-93e1-9c637f2673ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1779f514-3417-4c8f-a742-5a3b6872fc9a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_656b4dee-6a8f-4171-93e1-9c637f2673ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IncomeTaxLineItems_33a8809f-b1eb-4ea9-bc52-c07d37f4ac11" xlink:href="bdx-20220930.xsd#bdx_IncomeTaxLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_IncomeTaxTable_a371bed5-df54-4f6d-b658-51d2cbc42405" xlink:to="loc_bdx_IncomeTaxLineItems_33a8809f-b1eb-4ea9-bc52-c07d37f4ac11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_IndemnificationLiabilityNoncurrent_9f231d44-c08e-44d9-9ecf-bd7dc5fb7eaa" xlink:href="bdx-20220930.xsd#bdx_IndemnificationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdx_IncomeTaxLineItems_33a8809f-b1eb-4ea9-bc52-c07d37f4ac11" xlink:to="loc_bdx_IndemnificationLiabilityNoncurrent_9f231d44-c08e-44d9-9ecf-bd7dc5fb7eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0f8e97e4-dd7c-43c4-a8bc-fcce9f9a9eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0f8e97e4-dd7c-43c4-a8bc-fcce9f9a9eef" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7c7a1d96-fa7e-4172-8887-01144c8a1019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7c7a1d96-fa7e-4172-8887-01144c8a1019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_d208ae56-db8a-4883-9849-a4564e618f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_d208ae56-db8a-4883-9849-a4564e618f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a8d566b7-c29d-4e28-8ec1-a5554b03b53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_a8d566b7-c29d-4e28-8ec1-a5554b03b53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_747ee991-365c-40ea-b218-f0f071edaab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_747ee991-365c-40ea-b218-f0f071edaab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_39924c57-8d3e-4bd5-bb05-6e5cf5e6a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_39924c57-8d3e-4bd5-bb05-6e5cf5e6a5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_8f97f498-ed8c-47ff-a959-1904952cc689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_8f97f498-ed8c-47ff-a959-1904952cc689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ccf90591-d77c-4d27-9b24-0f62ff9a39dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ccf90591-d77c-4d27-9b24-0f62ff9a39dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b8c68a5c-a206-4bce-aded-9e7f2402dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b8c68a5c-a206-4bce-aded-9e7f2402dc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_01be4695-ca37-49a7-9696-9160037718df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be0ff35a-3eeb-4358-96b3-f3f24faa7e6e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_01be4695-ca37-49a7-9696-9160037718df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesDeferredIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_8317262e-02e9-4eca-b9fc-fd9c6c1a5f18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_8317262e-02e9-4eca-b9fc-fd9c6c1a5f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_ed092625-1a82-453c-bbd4-c8e702d22d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_ed092625-1a82-453c-bbd4-c8e702d22d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_ce4e9d94-e4bd-45bd-90d2-0808f674ef14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_ce4e9d94-e4bd-45bd-90d2-0808f674ef14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_80cc4f00-fa6b-4197-82bb-1f45100edb36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_80cc4f00-fa6b-4197-82bb-1f45100edb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_fe9d34bf-fc3e-47c6-b599-19c8e45412ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_fe9d34bf-fc3e-47c6-b599-19c8e45412ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_51778f99-97fa-4041-b2a0-0b284ffe0d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_51778f99-97fa-4041-b2a0-0b284ffe0d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_980f945c-49c0-4766-9f55-10aee5030648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_980f945c-49c0-4766-9f55-10aee5030648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_33698576-9d98-42f6-afad-5dc9ceef6781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_33698576-9d98-42f6-afad-5dc9ceef6781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_8bfb1a27-64df-478b-b9a3-471daf148118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_8bfb1a27-64df-478b-b9a3-471daf148118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_b8103e23-d68d-42f3-a419-b09061e74af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_b8103e23-d68d-42f3-a419-b09061e74af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredTaxLiabilitiesGross_61605a9b-75ea-485d-b5f8-2dcf1a16cdd3" xlink:href="bdx-20220930.xsd#bdx_DeferredTaxLiabilitiesGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_bdx_DeferredTaxLiabilitiesGross_61605a9b-75ea-485d-b5f8-2dcf1a16cdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1926521e-8935-47ee-96ee-8002d8e309f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b9755dc-ee65-4cee-9df4-a08d95e47ee8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1926521e-8935-47ee-96ee-8002d8e309f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1eb700d8-9b77-4c9b-93cf-69a1e76b01b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1eb700d8-9b77-4c9b-93cf-69a1e76b01b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f537108d-0125-4989-b6eb-60626e77e345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f537108d-0125-4989-b6eb-60626e77e345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6ed337b2-90cc-4fcc-937e-24ee16e21fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6ed337b2-90cc-4fcc-937e-24ee16e21fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_420ecb8f-1ada-402a-8380-4ce25d3b825b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_420ecb8f-1ada-402a-8380-4ce25d3b825b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_62c2d500-bb9a-42d9-aa91-a50a65cc1587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_62c2d500-bb9a-42d9-aa91-a50a65cc1587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_1e111979-e86c-4dd8-b90f-86f702b14a2d" xlink:href="bdx-20220930.xsd#bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation_1e111979-e86c-4dd8-b90f-86f702b14a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_59f5f5f7-4327-4190-b886-05bf2d99f439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets_59f5f5f7-4327-4190-b886-05bf2d99f439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7eacf8f2-e37b-4d2a-883b-a71664c6e2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7eacf8f2-e37b-4d2a-883b-a71664c6e2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f2c70c52-ec6f-4454-8aae-56edd54c76ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f2c70c52-ec6f-4454-8aae-56edd54c76ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_508a8c7f-94a9-43b0-b003-0d9cc8843c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6524bbf7-7ad7-4627-a104-921871dcd66a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_508a8c7f-94a9-43b0-b003-0d9cc8843c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#IncomeTaxesSummaryofIncomeTaxHolidayDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5d435163-de5e-470e-bd98-38e1b9d37223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_11e86fa1-bedf-4f54-a048-1b9fda514dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d435163-de5e-470e-bd98-38e1b9d37223" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_11e86fa1-bedf-4f54-a048-1b9fda514dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_7bf79570-293e-4657-9fc6-a9d8f7826946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d435163-de5e-470e-bd98-38e1b9d37223" xlink:to="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_7bf79570-293e-4657-9fc6-a9d8f7826946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_904fd87c-2acb-4913-a7d9-52689b37ddfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d435163-de5e-470e-bd98-38e1b9d37223" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_904fd87c-2acb-4913-a7d9-52689b37ddfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4fe4b22c-6765-4075-a65e-30c65d0b89d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fe4b22c-6765-4075-a65e-30c65d0b89d9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_aa46488f-de0b-45b5-8ee7-f5384b568d40" xlink:to="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1a582fea-93e8-4ea4-93ff-cdc3a8856a5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:to="loc_srt_MinimumMember_1a582fea-93e8-4ea4-93ff-cdc3a8856a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5314a736-9b49-4452-bc2a-5123f504f3ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_08e91df3-5bba-4cfd-abe1-958baa50fb59" xlink:to="loc_srt_MaximumMember_5314a736-9b49-4452-bc2a-5123f504f3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8641c613-f192-456a-86b6-22d1686bb36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2cf9ef00-9a0d-43d8-a899-2b57803e4f84" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8641c613-f192-456a-86b6-22d1686bb36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_abfc917f-76e1-418b-85c5-5b2b3e36a816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8641c613-f192-456a-86b6-22d1686bb36e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_abfc917f-76e1-418b-85c5-5b2b3e36a816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNameDomain_f9681a5e-a3e9-4875-8e1d-3460bb082fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleLeasebackTransactionDescriptionAxis_1fb531a0-ef57-4bdf-99e1-5df75e2b8073" xlink:to="loc_us-gaap_SaleLeasebackTransactionNameDomain_f9681a5e-a3e9-4875-8e1d-3460bb082fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_SaleLeasebackTransactionTermOfContractMember_d75162d1-6bf5-4f2c-b695-b0d1b5832e5b" xlink:href="bdx-20220930.xsd#bdx_SaleLeasebackTransactionTermOfContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleLeasebackTransactionNameDomain_f9681a5e-a3e9-4875-8e1d-3460bb082fbd" xlink:to="loc_bdx_SaleLeasebackTransactionTermOfContractMember_d75162d1-6bf5-4f2c-b695-b0d1b5832e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c5fabdba-911d-438a-aba1-f054c82d118d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_934de97a-3034-4afa-a232-5242f4766a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_934de97a-3034-4afa-a232-5242f4766a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7be7c7ad-ef48-4a33-9a55-ca8d9db87788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7be7c7ad-ef48-4a33-9a55-ca8d9db87788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5ece3c30-145c-4ab2-94ac-2b903364510d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5ece3c30-145c-4ab2-94ac-2b903364510d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_32714957-29d7-4b40-816c-d600ba6d67dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_OperatingLeaseCost_32714957-29d7-4b40-816c-d600ba6d67dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_GrossProceedsFromSaleLeasebackTransaction_cf209eaf-02f2-48c6-a870-8652ae747e50" xlink:href="bdx-20220930.xsd#bdx_GrossProceedsFromSaleLeasebackTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_bdx_GrossProceedsFromSaleLeasebackTransaction_cf209eaf-02f2-48c6-a870-8652ae747e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_f473f27b-85f1-40df-ae78-4c68b0a742c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_f473f27b-85f1-40df-ae78-4c68b0a742c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_79a163cb-14ee-46da-b0cc-8f5fd6c104f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_872b6f7f-b7b7-4e27-9c29-453b0be5742d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_79a163cb-14ee-46da-b0cc-8f5fd6c104f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3924ce99-0805-42e9-bd9e-77842deb6f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3924ce99-0805-42e9-bd9e-77842deb6f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_07e2e230-b84c-41fb-8e75-4943bdbadde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_07e2e230-b84c-41fb-8e75-4943bdbadde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4d631493-ad11-4e72-b7ac-558bde61ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4d631493-ad11-4e72-b7ac-558bde61ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_99cab35a-ff45-45cc-9e58-bd616db81f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_99cab35a-ff45-45cc-9e58-bd616db81f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_5d1157fe-941e-490e-a169-78120e325d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_5d1157fe-941e-490e-a169-78120e325d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21643038-e739-483c-8381-11a64bb31cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_22e50bf6-1e12-4854-ae12-e6297345b963" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21643038-e739-483c-8381-11a64bb31cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesLesseeOperatingLeaseLiabilityMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_89de71c4-a3d4-43a5-9a00-89654ee8ad1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_89de71c4-a3d4-43a5-9a00-89654ee8ad1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3c9ec650-acd5-46cd-a4b5-1d4916274e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3c9ec650-acd5-46cd-a4b5-1d4916274e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_310fa19f-697d-4fcc-b212-3d59990f10b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_310fa19f-697d-4fcc-b212-3d59990f10b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7e9b16e6-8e81-4f90-ba46-0e1114925712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7e9b16e6-8e81-4f90-ba46-0e1114925712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d056e332-8040-41c6-8460-826bf0824c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d056e332-8040-41c6-8460-826bf0824c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8c7baf6d-13fa-4a20-a5b2-2150af935ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8c7baf6d-13fa-4a20-a5b2-2150af935ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_69a6aaa3-27a7-43cf-bdf2-b4e744418e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_69a6aaa3-27a7-43cf-bdf2-b4e744418e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e28c6501-700a-4339-81d4-733a27d69ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e28c6501-700a-4339-81d4-733a27d69ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_662ee67b-eba8-489c-87e8-24f9fc110820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8048fbbb-4e42-4c11-a7c8-cbe9a411223e" xlink:to="loc_us-gaap_OperatingLeaseLiability_662ee67b-eba8-489c-87e8-24f9fc110820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1" xlink:type="simple" xlink:href="bdx-20220930.xsd#LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationOtherIncomeExpenseNetDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16357cd3-a7a0-4368-b4c5-cb1377a1f4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16357cd3-a7a0-4368-b4c5-cb1377a1f4b5" xlink:to="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cfe32228-7e8a-4b44-87f2-d707a27e3f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0e1ae31c-b4b8-4fa5-85a2-2aee66ec823b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cfe32228-7e8a-4b44-87f2-d707a27e3f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_f223fbfe-42d9-4bfc-bf21-f967447696bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cfe32228-7e8a-4b44-87f2-d707a27e3f39" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_f223fbfe-42d9-4bfc-bf21-f967447696bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:to="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_842f967d-d41e-4893-8efb-09f7b8d22785" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_44a46646-9cb8-4ae0-b47e-44d3de1868c2" xlink:to="loc_srt_SegmentGeographicalDomain_842f967d-d41e-4893-8efb-09f7b8d22785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_18466986-3a5a-4a04-9020-c1f82307e503" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_842f967d-d41e-4893-8efb-09f7b8d22785" xlink:to="loc_country_US_18466986-3a5a-4a04-9020-c1f82307e503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3c3ab6ff-2f5e-4485-b0ad-6d93a5506c00" xlink:to="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4e8d9b68-9638-41fa-91b2-f366f038c058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4e8d9b68-9638-41fa-91b2-f366f038c058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_DeferredCompensationInvestmentIncomeExpense_e485c5ff-ee4a-4a67-8955-eefbea38ddad" xlink:href="bdx-20220930.xsd#bdx_DeferredCompensationInvestmentIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_bdx_DeferredCompensationInvestmentIncomeExpense_e485c5ff-ee4a-4a67-8955-eefbea38ddad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a42a14a-6727-467d-9e46-65c23c6fbc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a42a14a-6727-467d-9e46-65c23c6fbc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_0f9a7131-2324-46f0-971a-0a94a2488ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_0f9a7131-2324-46f0-971a-0a94a2488ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_5821edcb-0e1a-4694-95e6-53d648ce0d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_5821edcb-0e1a-4694-95e6-53d648ce0d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_EmbectaServicesAgreementIncomeLossNet_bebf9ec2-26a1-4e39-837e-f401e596874d" xlink:href="bdx-20220930.xsd#bdx_EmbectaServicesAgreementIncomeLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_bdx_EmbectaServicesAgreementIncomeLossNet_bebf9ec2-26a1-4e39-837e-f401e596874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_befacdba-a627-46f4-a0d1-900176ed6057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_OtherNonoperatingExpense_befacdba-a627-46f4-a0d1-900176ed6057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_31ebe132-5425-4cbe-82b7-601d032cd66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_31ebe132-5425-4cbe-82b7-601d032cd66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_PensionSettlementExpense_9a9ea472-9210-4c0d-8779-85112f292410" xlink:href="bdx-20220930.xsd#bdx_PensionSettlementExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_337a1e7c-78c9-4559-8e9d-fe8395f67509" xlink:to="loc_bdx_PensionSettlementExpense_9a9ea472-9210-4c0d-8779-85112f292410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c32fa49-b16d-4f00-ad22-1593f21ae149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c32fa49-b16d-4f00-ad22-1593f21ae149" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_0d42d80f-ed8f-4389-966e-aad030289ac7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_cb4ed2e5-2dd7-4224-b38c-cc6a8c309567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_cb4ed2e5-2dd7-4224-b38c-cc6a8c309567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_ReserveforCashDiscountsMember_3d83634e-9c3c-4187-ab76-236f17b271b7" xlink:href="bdx-20220930.xsd#bdx_ReserveforCashDiscountsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_085501eb-4b6c-4515-a6cd-0dc0157fdb31" xlink:to="loc_bdx_ReserveforCashDiscountsMember_3d83634e-9c3c-4187-ab76-236f17b271b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_13871325-1c5b-4351-a809-5b235c8dcbdd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_fc52ef90-7f9d-4241-a95c-a63612de4483" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_13871325-1c5b-4351-a809-5b235c8dcbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_13871325-1c5b-4351-a809-5b235c8dcbdd" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b517dac8-e23b-45d6-9787-7190997b830f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b517dac8-e23b-45d6-9787-7190997b830f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8997af5d-e24e-4abf-b6fa-78d599e7a68c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8997af5d-e24e-4abf-b6fa-78d599e7a68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_ee39128a-6ee1-49d3-9b12-d54859b30277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_ee39128a-6ee1-49d3-9b12-d54859b30277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_33652afe-063c-43d1-abf3-a2b013e4a983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_921e66e3-d005-4c4d-9e06-6d8051268ca7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_33652afe-063c-43d1-abf3-a2b013e4a983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_356a9827-04bb-4ccf-aeab-1eb44ebe7acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c16e0c8e-3f7d-4511-a4e5-bd277fcd5d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_356a9827-04bb-4ccf-aeab-1eb44ebe7acf" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c16e0c8e-3f7d-4511-a4e5-bd277fcd5d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2a63155f-7fbf-4ac6-8338-921d8a75a943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_356a9827-04bb-4ccf-aeab-1eb44ebe7acf" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2a63155f-7fbf-4ac6-8338-921d8a75a943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5fd422e9-d342-4dcc-8e04-2c5fdf33dcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_356a9827-04bb-4ccf-aeab-1eb44ebe7acf" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5fd422e9-d342-4dcc-8e04-2c5fdf33dcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8ae87f7e-b659-4a50-be02-6aaecf20a019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_356a9827-04bb-4ccf-aeab-1eb44ebe7acf" xlink:to="loc_us-gaap_InventoryNet_8ae87f7e-b659-4a50-be02-6aaecf20a019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail" xlink:type="simple" xlink:href="bdx-20220930.xsd#SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_bc9941af-f6a9-424f-877d-319a58932755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_Land_bc9941af-f6a9-424f-877d-319a58932755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_d291e34c-aa33-49f4-ae0b-45613c9dc3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_d291e34c-aa33-49f4-ae0b-45613c9dc3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_b9181ed6-e64f-4582-b623-457304dac272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_b9181ed6-e64f-4582-b623-457304dac272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_03e476b4-5422-40b0-a7eb-bcd7478d293f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_03e476b4-5422-40b0-a7eb-bcd7478d293f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_846ff951-fb70-4936-875f-c65e21afd677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_846ff951-fb70-4936-875f-c65e21afd677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5ff6869b-227f-4096-b2ba-80aa7637422e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5ff6869b-227f-4096-b2ba-80aa7637422e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f355d8a3-1448-41d0-a324-09dd8bf0b8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2df17597-a3bb-46aa-845c-270ef9faa5f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f355d8a3-1448-41d0-a324-09dd8bf0b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@   #,    S" 8    ZH3 J    "7!(67,  $SE
M  !,Y0%USO"5    54E$051XG.W/ 0D , S L/DW_9LXO(Q$03MGD?D=\)*9
M*C-59JK,5)FI,E-EILI,E9DJ,U5FJLQ4F:DR4V6FRDR5F2HS56:JS%29J3)3
<9:;*3-6JF0N85GVUN;JN'P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127518021968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document period end date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current fiscal year end date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-4802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity registrant name</a></td>
<td class="text">BECTON, DICKINSON AND COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity central index key</a></td>
<td class="text">0000010795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document fiscal year focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document fiscal period focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0760120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Becton Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin Lakes,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07417-1880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-6800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity well-known seasoned issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity voluntary filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity current reporting status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity filer category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity small business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity emerging growth company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity shell company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity public float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,865,947,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock, shares outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,375,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock&#160; Issued at&#160;Par&#160;Value | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_DepositarysharesMember', window );">Depositary shares [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDXB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.000dueDecember152022Member', window );">1.000% Notes due December 15, 2022 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due December 15, 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX22A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member', window );">1.900% Notes due December 15, 2026 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.900% Notes due December 15, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member', window );">1.401% Notes due May 24, 2023 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.401% Notes due May 24, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX23A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member', window );">3.020% Notes due May 24, 2025 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.020% Notes due May 24, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member', window );">0.632% Notes due June 4, 2023 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.632% Notes due June 4, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/23A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member', window );">1.208% Notes due June 4, 2026 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.208% Notes due June 4, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/26A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213DueFebruary122036Member', window );">1.213% Notes due February 12, 2036 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.213% Notes due February 12, 2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member', window );">0.000% Notes due August 13, 2023 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Notes due August 13, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX23B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member', window );">0.034% Notes due August 13, 2025 | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.034% Notes due August 13, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_DepositarysharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_DepositarysharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.000dueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.000dueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.401dueMay242023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0.632dueJune42023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213DueFebruary122036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1213DueFebruary122036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0000DueAugust132023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520863856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">ERNST&#160;& YOUNG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127522794224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 18,870<span></span>
</td>
<td class="nump">$ 19,131<span></span>
</td>
<td class="nump">$ 16,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">10,393<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
<td class="nump">9,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">4,709<span></span>
</td>
<td class="nump">4,719<span></span>
</td>
<td class="nump">4,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Operating Costs and Expenses</a></td>
<td class="nump">16,588<span></span>
</td>
<td class="nump">16,881<span></span>
</td>
<td class="nump">15,161<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="nump">2,282<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(398)<span></span>
</td>
<td class="num">(469)<span></span>
</td>
<td class="num">(528)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net Income from Continuing Operations</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">1,779<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred stock dividends</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income applicable to common shareholders</a></td>
<td class="nump">$ 1,689<span></span>
</td>
<td class="nump">$ 2,002<span></span>
</td>
<td class="nump">$ 767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic Earnings per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="nump">$ 5.42<span></span>
</td>
<td class="nump">$ 5.23<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">1.69<span></span>
</td>
<td class="nump">1.87<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="nump">5.93<span></span>
</td>
<td class="nump">6.92<span></span>
</td>
<td class="nump">2.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted Earnings per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income (Loss) from Continuing Operations, Per Diluted Share</a></td>
<td class="nump">5.38<span></span>
</td>
<td class="nump">5.18<span></span>
</td>
<td class="nump">0.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">1.67<span></span>
</td>
<td class="nump">1.85<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Earnings per Share (USD per share)</a></td>
<td class="nump">$ 5.88<span></span>
</td>
<td class="nump">$ 6.85<span></span>
</td>
<td class="nump">$ 2.71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517862976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 1,779<span></span>
</td>
<td class="nump">$ 2,092<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pension and postretirement plans</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="nump">$ 2,379<span></span>
</td>
<td class="nump">$ 2,552<span></span>
</td>
<td class="nump">$ 609<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517698736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">2,191<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,224<span></span>
</td>
<td class="nump">2,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,559<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">8,141<span></span>
</td>
<td class="nump">8,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">6,012<span></span>
</td>
<td class="nump">6,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">24,621<span></span>
</td>
<td class="nump">23,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CoreAndDevelopedTechnologyNet', window );">Developed Technology, Net</a></td>
<td class="nump">9,108<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteLivedCustomerRelationshipsNet', window );">Customer Relationships, Net</a></td>
<td class="nump">2,683<span></span>
</td>
<td class="nump">2,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other Intangibles, Net</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">1,848<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Noncurrent Assets of Discontinued Operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">52,934<span></span>
</td>
<td class="nump">53,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">2,179<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="nump">1,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,605<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries, wages and related items</a></td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">7,811<span></span>
</td>
<td class="nump">6,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">13,886<span></span>
</td>
<td class="nump">17,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-Term Employee Benefit Obligations</a></td>
<td class="nump">902<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Liabilities</a></td>
<td class="nump">5,052<span></span>
</td>
<td class="nump">5,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Noncurrent Liabilities of Discontinued Operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (See Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock (See Note 4)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; $1 par value: authorized &#8212; 640,000,000 shares; issued &#8212; 364,639,901 shares in 2022 and 2021.</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">19,553<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">15,157<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CommonStockSharesHeldInEmployeeTrust1', window );">Deferred compensation</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock &#8212; 81,283,191 shares in 2022 and 80,163,949 shares in 2021.</a></td>
<td class="num">(8,330)<span></span>
</td>
<td class="num">(7,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,488)<span></span>
</td>
<td class="num">(2,088)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="nump">25,282<span></span>
</td>
<td class="nump">23,677<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 52,934<span></span>
</td>
<td class="nump">$ 53,866<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockSharesHeldInEmployeeTrust1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockSharesHeldInEmployeeTrust1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CoreAndDevelopedTechnologyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CoreAndDevelopedTechnologyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FiniteLivedCustomerRelationshipsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FiniteLivedCustomerRelationshipsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517917744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">640,000,000<span></span>
</td>
<td class="nump">640,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">364,639,901<span></span>
</td>
<td class="nump">364,639,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common stock in treasury, shares (shares)</a></td>
<td class="nump">81,283,191<span></span>
</td>
<td class="nump">80,163,949<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127516045744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 1,779<span></span>
</td>
<td class="nump">$ 2,092<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net Income from Continuing Operations</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">2,230<span></span>
</td>
<td class="nump">2,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
<td class="num">(308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Trade receivables, net</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(631)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="num">(436)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, income taxes and other liabilities</a></td>
<td class="num">(473)<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_IncreaseDecreaseinPensionBenefitObligation', window );">Pension obligation</a></td>
<td class="num">(55)<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities', window );">Excess tax benefits from payments under share-based compensation plans</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Product liability-related charges</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(414)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Provided by Continuing Operating Activities</a></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">2,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(973)<span></span>
</td>
<td class="num">(1,194)<span></span>
</td>
<td class="num">(769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(2,070)<span></span>
</td>
<td class="num">(508)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net Cash Used for Continuing Investing Activities</a></td>
<td class="num">(3,220)<span></span>
</td>
<td class="num">(1,843)<span></span>
</td>
<td class="num">(1,190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Change in short-term debt</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Change in credit facility borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt and term loans</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">4,869<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ProceedsFromSpinoffTransaction', window );">Distribution from Embecta Corp. (see Note 2)</a></td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CashTransferRelatedToSpinoffTransaction', window );">Net transfer of cash to Embecta upon spin-off</a></td>
<td class="num">(265)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of debt and term loans</a></td>
<td class="num">(805)<span></span>
</td>
<td class="num">(5,112)<span></span>
</td>
<td class="num">(4,664)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance of equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(500)<span></span>
</td>
<td class="num">(1,750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(1,082)<span></span>
</td>
<td class="num">(1,048)<span></span>
</td>
<td class="num">(1,026)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net Cash (Used for) Provided by Continuing Financing Activities</a></td>
<td class="num">(736)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used for investing activities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Net cash provided by financing activities</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations', window );">Net Cash Provided by Discontinued Operations</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and equivalents and restricted cash</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (Decrease) Increase in Cash and Equivalents and Restricted Cash</a></td>
<td class="num">(1,233)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="nump">2,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Opening Cash and Equivalents and Restricted Cash</a></td>
<td class="nump">2,392<span></span>
</td>
<td class="nump">2,917<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Closing Cash and Equivalents and Restricted Cash</a></td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="nump">$ 2,392<span></span>
</td>
<td class="nump">$ 2,917<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CashTransferRelatedToSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Transfer Related to Spinoff Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CashTransferRelatedToSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_IncreaseDecreaseinPensionBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_IncreaseDecreaseinPensionBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ProceedsFromSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Spinoff Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ProceedsFromSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in cash associated with the entity's discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523752592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:5pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the "Company" or "BD") have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company and the historical results of the Diabetes Care business that was contributed in the spin-off have been reflected as discontinued operations in the Company&#8217;s consolidated financial statements for all periods prior to the spin-off date. Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet as of September 30, 2021. Additional disclosures regarding the spin-off are provided in Note 2.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the Company&#8217;s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash restricted from withdrawal and usage and largely represents funds that are restricted for certain product liability matters assumed in the acquisition of C.R. Bard, Inc. ("Bard"), which are further discussed in Note 6.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#8217;s estimate of expected credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is  not collectable.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which range from 20 to 45 years for buildings, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd">four</span> to 13 years for machinery and equipment and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1">one</span> to 20 years for leasehold improvements. Depreciation and amortization expense was $672 million, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$689 million and $608 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in fiscal years 2022, 2021 and 2020, respectively.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unamortized intangible assets include goodwill that arises from acquisitions of businesses. The Company reviews goodwill for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  The Company&#8217;s reporting units generally represent one level below reporting segments. The Company reviews goodwill for each reporting unit by comparing the fair value of the reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2022 indicated that all identified reporting units&#8217; fair values exceeded their respective carrying values. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d">one</span> to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#8217;s carrying value exceeds its calculated fair value.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, foreign subsidiaries&#8217; functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates.  The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss).</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from product sales when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized upon customer acceptance of these installed products. Revenue for certain service arrangements, including extended warranty and software maintenance contracts, is recognized ratably over the contract term. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Variable consideration such as rebates, sales discounts and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices, and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease transactions with customers are evaluated and classified as either operating or sales-type leases. Generally, these arrangements are accounted for as operating leases and therefore, revenue is recognized at the contracted rate over the rental period defined within the customer agreement.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the Company's accounting for revenue recognition are provided in Note 7.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers its shipping and handling costs to be contract fulfillment costs and records them within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and administrative expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping expense was $751 million, $641 million and $538 million in 2022, 2021 and 2020, respectively. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries).  Additional disclosures regarding the Company's accounting for contingencies are provided in Note 6.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met. Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows. Cash flows for all other derivatives, including undesignated hedges, are classified in the same line item as the cash flows of the related hedged item, which is generally within operating or financing activities. Additional disclosures regarding the Company's accounting for derivative instruments are provided in Note 14.</span></div><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reviewed its needs in the United States for possible repatriation of undistributed earnings of its foreign subsidiaries and continues to invest foreign subsidiaries earnings outside of the United States to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. As a result, the Company is permanently reinvested with respect to all of its historical foreign earnings as of September 30, 2022. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable because of the complexities associated with its hypothetical calculation. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Additional disclosures regarding the Company's accounting for income taxes are provided in Note 17.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act was enacted on December 22, 2017 and subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to account for its GILTI tax due as a period expense in the year the tax is incurred.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share are computed by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In computing diluted earnings per share, only potential common shares that are dilutive (i.e., those that reduce earnings per share or increase loss per share) are included in the calculation.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#8217;s fair value measurements are provided in Notes 10 and 15.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212; Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Level 2 &#8212; Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Level 3 &#8212; Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523555584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp.<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Spin-Off of Embecta Corp.</a></td>
<td class="text">Spin-Off of Embecta Corp.<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (&#8220;Embecta&#8221;) through a distribution of Embecta&#8217;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;) to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes.  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embecta&#8217;s distributions on March 31, 2022 to the Company in connection with the spin-off included the issuance of $200&#160;million of senior unsecured notes to the Company and a</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash distribution of approximately $1.266&#160;billion. Additional disclosures regarding the various financing transactions entered into by Embecta and related to the spin-off are provided in Note 16.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#8217;s consolidated statements of income during the fiscal year ended September 30, 2022 as a result of these agreements were immaterial.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment) that was contributed to Embecta in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#8217;s consolidated financial statements for all periods prior to the spin-off date of April 1, 2022.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:54.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   &#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended September 30, 2022, the Company incurred </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$30&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of expense which included costs to execute the spin-off and other costs for related residual activities. These costs are recorded within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income from Discontinued Operations, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended September 30, 2022. Separation costs incurred by the Company prior to the spin-off date, including those for consulting, legal, tax and other advisory services associated with the spin-off, were previously recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are now included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from continuing operations were recast to reflect previously eliminated intercompany transactions that occurred between BD and Embecta and that resulted in a third party sale in the same period. The impacts of these transactions to Embecta are also reflected as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet at September 30, 2021:   </span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"><tr><td style="width:1.0%"/><td style="width:79.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets of Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and Other Intangibles, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Assets of Discontinued Operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities of Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Liabilities of Discontinued Operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its distribution of net liabilities to Embecta as an increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retained earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amount recorded reflected the carrying amounts, as of April 1, 2022, of the net liabilities distributed and included $1.650&#160;billion of debt issued by Embecta, as further discussed above and in Note 16, as well as $265&#160;million of cash. The Company also recorded a net decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $251&#160;million to derecognize foreign currency translation losses which were attributable to Embecta.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520770800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Changes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Accounting Changes</a></td>
<td class="text">Accounting Changes<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Principles Adopted</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2022, the Company early-adopted an accounting standard update issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), which requires an entity to apply the provisions of Accounting Standard Codification Topic 606, "Revenue from Contracts with Customers,&#8221; (&#8220;ASC 606&#8221;) when recognizing and measuring contract assets and contract liabilities acquired in a business combination. The Company&#8217;s adoption of this accounting standard update for business combinations that occurred during fiscal year 2022 did not have a material impact on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard which requires earlier recognition of credit losses on loans and other financial instruments held by entities, including trade receivables.  The new standard requires entities to measure all expected credit losses for financial assets held at each reporting date based on historical experience, current conditions, and reasonable and supportable forecasts.  The Company&#8217;s adoption of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">this accounting standard on October 1, 2020, using the modified retrospective method, did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Principles Not Yet Adopted</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued a new accounting standard update that requires additional qualitative and quantitative disclosures surrounding supplier finance programs intended to help investors better consider the effect of these programs on a company's working capital, liquidity, and cash flows over time. This update is effective for fiscal years beginning after December 15, 2022, including interim periods, except for the disclosure. Early adoption is permitted. The Company is currently evaluating the impact this update will have on its disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520542032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders&#8217; equity were as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.737%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76,260)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($3.16 per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares converted to common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public equity offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,623)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($3.32 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of change in accounting principle (see Note 3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80,164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($3.48 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off of Embecta (See Note 2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,283)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,330)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.  </span></div><div style="margin-top:9pt;padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal year 2022, the Company executed an accelerated share repurchase (&#8220;ASR&#8221;) agreement in which 1.953&#160;million common shares were repurchased and delivered in fiscal year 2022 for $500&#160;million, which was recorded as an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, the Company executed two ASR agreements to repurchase common shares totaling $1.250&#160;billion, of which $1.100&#160;billion settled in fiscal year 2021 and $150&#160;million settled in fiscal year 2022. Total shares delivered in 2021 under the ASR agreements were 4.577&#160;million shares. At September 30, 2021, the pending delivery of 462&#160;thousand shares on one of the agreements was reflected as a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital in excess of par value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to recognize a net share-settled forward sale contract indexed to the Company's own common stock. Upon final settlement of the repurchase agreement and the forward sale contract during the first quarter of fiscal year 2022, the final settlement amount was recorded as an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and an offsetting increase to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Capital in excess of par value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also repurchased approximately 2.066&#160;million shares of its common stock during fiscal year 2021 through open market repurchases, which were recorded as a $500&#160;million increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The share repurchases discussed above were made</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 10&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares, which has been fully utilized, and a repurchase program authorized by the Board of Directors in November 2021 for up to an additional 10&#160;million shares of BD common stock, for which there is no expiration date.</span></div><div style="margin-top:9pt;padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common and Preferred Stock Conversions and Offerings</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with their terms, the Company's 2.475&#160;million mandatory convertible preferred shares that were issued in May 2017 in connection with the Company's acquisition of Bard were converted into 11.703&#160;million shares of BD common stock on the mandatory conversion date of May 1, 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in May 2020, the Company completed registered public offerings of equity securities including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.250&#160;million shares of the Company's common stock for net proceeds of $1.459&#160;billion (gross proceeds of $1.500&#160;billion).</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1.500&#160;million shares of the Company's mandatory convertible preferred stock (ownership is held in the form of depositary shares, each representing a 1/20th interest in a share of preferred stock) for net proceeds of $1.459&#160;billion (gross proceeds of $1.500&#160;billion).  If and when declared, dividends on the mandatory convertible preferred stock will be payable on a cumulative basis at an annual rate of 6.00% on the liquidation preference of $1,000 per preferred share ($50 per depositary share).  The shares of preferred stock are convertible to a minimum of 5.3&#160;million and up to a maximum of 6.4&#160;million shares of Company common stock at an exchange ratio, based on the market price of the Company&#8217;s common stock at the date of conversion, and no later than the mandatory conversion date of June 1, 2023.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.333%"><tr><td style="width:1.0%"/><td style="width:47.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,283)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,548)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,416)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off of Embecta (See Note 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,488)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of foreign currency translation recognized in other comprehensive income during the years ended September 30, 2022, 2021 and 2020 included net gains (losses) relating to net investment hedges, as further discussed in Note 14. Other comprehensive income relating to benefit plans during the year ended September 30, 2021 included a net gain of $24&#160;million recognized as a result of the Company&#8217;s remeasurement, as of October 31, 2020, of the legacy Bard U.S. defined pension benefit plan upon its merger with the BD defined benefit cash balance pension plan in the first quarter of fiscal year 2021. The amounts recognized in other comprehensive income relating to cash flow hedges in 2022, 2021 and 2020 related to forward starting interest rate swaps. Additional disclosures regarding the Company's derivatives are provided in Note 14.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income before reclassifications were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"><tr><td style="width:1.0%"/><td style="width:55.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for cash flow hedges recognized in other comprehensive income before reclassifications in 2022, 2021 and 2020 were immaterial to the Company's consolidated financial results.  The tax impacts for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges in 2022, 2021 and 2020 were also immaterial to the Company's consolidated financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521191760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text">Earnings per Share<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.666%"><tr><td style="width:1.0%"/><td style="width:65.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans (a) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8212; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,089&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">In 2022, 2021 and 2020, dilutive share equivalents associated with mandatory convertible preferred stock of 6 million, 6 million and 9 million, respectively, were excluded from the diluted shares outstanding calculation because the result would have been antidilutive. The issuance of the convertible preferred stock is further discussed in Note 4.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">In both 2021 and 2020, 1&#160;million of certain share-based compensation awards were excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2022, no such awards were excluded from the diluted earnings per share calculation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the Company&#8217;s share-based compensation are provided in Note 9.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517986944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain future purchase commitments entered in the normal course of business to meet operational and capital requirements. As of September&#160;30, 2022, these commitments aggregated to approximately $1.521 billion and will be expended over the next several years.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company is defending approximately 31,445 product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;).  The </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions.  In addition, those claims include multiple putative class actions in Canada.  Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  </span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The second hernia MDL bellwether resulted in a $255&#160;thousand verdict in April 2022. </span></div><div style="padding-left:54pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">The first bellwether trial in RI resulted in a $4.8 million verdict in August 2022, which the Company plans to appeal. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in state and/or federal courts, including two additional bellwether trials in the MDL in February 2023 and May 2023.  The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation. As of September&#160;30, 2022, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also as of September&#160;30, 2022, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. The plaintiff filed a second amended complaint to add certain additional factual allegations on February 3, 2021. This complaint was dismissed on the Company&#8217;s motion on September 15, 2021. The court&#8217;s dismissal order, however, gave plaintiff an opportunity to replead, which it did on October 29, 2021. The Company moved to dismiss the newly amended pleading on December 16, 2021. That motion was granted in part and denied in part, as the court permitted certain aspects of the case to proceed. An answer with affirmative defenses was thereafter filed on October 3, 2022. The Company believes that it has strong defenses to the remaining allegations and it intends to defend itself vigorously. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, a civil action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, Ronald Jankowski, derivatively on behalf of the Company, against its individual directors and certain of its officers.  The complaint seeks recovery for breach of fiduciary duties by directors and various officers; violations of the Securities Exchange </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Act of 1934, including sections 10(b), 14(a) and 21D; and insider trading.  In general, the complaint also alleges, among other things, that various directors and/or officers caused the Company to issue purportedly misleading statements and SEC filings regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, and issue a purportedly misleading proxy statement.  The complaint seeks damages, including restitution and disgorgement of profits, and an injunction requiring the Company to undertake remedial measures with respect to certain corporate governance and internal procedures.  A second derivative action, Schranz v. Polen, et al., Civ. No 2:21-cv-01081 (D. N.J.), was filed on January 24, 2021, and the two actions were consolidated.  In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the Jankowski and Schranz consolidated actions, and demanded, among other things, that the Board of Directors pursue civil action against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters.  Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands.  The special committee&#8217;s determination has been communicated to counsel for the shareholders.  Should the shareholders continue to pursue their claims in court, the Company will take appropriate steps to seek dismissal of the complaints.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics has filed a notice of appeal. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps. The Company is cooperating with the SEC and responding to these requests.  The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests.  </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018. The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters.  The Company&#8217;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation.  As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has been sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place.  The plaintiffs in those cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $250,000 per claimant.  The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. There are currently approximately 210 of such suits involving approximately 310 plaintiffs; approximately 44 of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Company.  The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.  The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows.  Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal years 2022, 2021, and 2020, the Company recorded pre-tax charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of approximately $21&#160;million, $361 million, and $378&#160;million, respectively, related to certain of the product liability matters discussed above under the heading &#8220;Product Liability Matters,&#8221; including the related legal defense costs. The Company recorded these charges based on additional information obtained during fiscal years 2022, 2021, and 2020 including, but not limited to: the nature, quantity, and quality of unfiled and filed claims; the continued rate of claims being filed in certain product liability matters; the status of certain settlement discussions with plaintiffs&#8217; counsel; the allegations and documentation supporting or refuting such allegations; publicly available information regarding similar medical device mass tort settlements; historical information regarding other product liability settlements involving the Company; and the stage of litigation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately $2.1 billion and $2.5 billion at September&#160;30, 2022 and 2021, respectively. These accruals, which are generally long-term in nature, are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the Company's consolidated balance sheets.  </span></div>In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and /or consolidated cash flows<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521807856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">RevenuesThe Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Timing of Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized when customer acceptance of these installed products has been confirmed. For certain service arrangements, including extended warranty and software maintenance contracts, revenue is recognized ratably over the contract term. The majority of revenues relating to extended warranty contracts associated with certain instruments and equipment is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over a longer period.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. The Company considers its shipping and handling costs to be costs of contract fulfillment and has made the accounting policy election to record these costs within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms extended to the Company's customers are based upon commercially reasonable terms for the markets in which the Company's products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectable. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company's agreements with its end-user customers. Additional factors considered in the estimate of the Company's rebate liability include the quantification of inventory that is either in stock at or in transit to the Company's distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. The Company&#8217;s rebate liability at September&#160;30, 2022 and 2021 was $525&#160;million and $500&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues. Additional disclosures relating to sales discounts and sales returns are provided in Note 19.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's agreements with customers within certain organizational units including Medication Management Solutions, Integrated Diagnostic Solutions and Biosciences, contain multiple performance obligations including both products and certain services noted above. The transaction price for these agreements is allocated to each performance obligation based upon its relative standalone selling price. Standalone selling price is the amount at which the Company would sell a promised good or service separately to a customer. The </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company generally estimates standalone selling prices using its list prices and a consideration of typical discounts offered to customers. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the majority of the Company's products and services, the Company typically does not incur costs to fulfill a contract in advance of providing the customer with goods or services. Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's consolidated balance sheets. The Company's costs to obtain contracts are comprised of sales commissions which are paid to the Company's employees or third party agents.  The majority of the sales commissions incurred by the Company relate to revenue that is recognized over a period that is less than one year and as such, the Company has elected a practical expedient provided under ASC 606 to record the majority of its expense associated with sales commissions as it is incurred. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's consolidated balance sheets.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records contract liabilities for unearned revenue that is allocated to performance obligations such as extended warranty and software maintenance contracts, which are performed over time as discussed further above. These contract liabilities are immaterial to the Company's consolidated financial results. The Company's liability for product warranties provided under its agreements with customers is not material to its consolidated balance sheets. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts, which are further discussed above, and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided, are estimated to be approximately $2.5 billion at September&#160;30, 2022. The Company expects to recognize the majority of this revenue over the next three years.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$1.9 billion&#160;at&#160;September&#160;30, 2022. This revenue will be recognized over the customer relationship periods. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 8.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521807856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Data</a></td>
<td class="text">Segment DataThe Company's organizational structure is based upon three worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional ("Interventional"). The Company&#8217;s segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical produces a broad array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The primary customers served by Medical are hospitals and clinics; physicians&#8217; office practices; consumer and retail pharmacies; governmental and nonprofit public health agencies; pharmaceutical companies; and healthcare workers. Medical consists of the following organizational units: Medication Delivery Solutions; Medication Management Solutions; Pharmaceutical Systems.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Life Sciences</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. In addition, Life Sciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases. The primary customers served by Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians&#8217; office practices; retail pharmacies; academic and government institutions; and pharmaceutical and biotechnology companies. With the emergency use authorization approval of the BD Veritor&#8482; At-Home COVID-19 Test, Life Sciences also serves patients directly. Life Sciences consists of the following organizational units: Integrated Diagnostic Solutions and Biosciences.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional provides vascular, urology, oncology and surgical specialty products that are intended, with the exception of the V. Mueller</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical and laparoscopic instrumentation products, to be used once and then discarded or are either temporarily or permanently implanted. The primary customers served by Interventional are hospitals, individual healthcare professionals, extended care facilities, alternate site facilities and patients via the segment's Homecare business. Interventional consists of the following organizational units: Surgery; Peripheral Intervention; Urology and Critical Care.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Segment Information</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. No customer accounted for 10% or more of revenues in any of the three years presented.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment disclosures are on a performance basis consistent with internal management reporting.  The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income, which represents revenues reduced by product costs and operating expenses. The Company&#8217;s chief operating decision maker does not receive any asset information by business segment and, as such, the Company does not report asset information by business segment.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet as of September 30, 2021. See Note 2 for further information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for the Company&#8217;s segments is detailed below. The Company has no material intersegment revenues.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:13.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.746%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgery </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Company revenues from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,870&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,074&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of segment operating income to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Continuing Operations before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and segment information for both capital expenditures and depreciation and amortization.  Certain prior-period amounts have been recast to reflect the spin-off of the Diabetes Care business in fiscal year 2022, as noted above.</span></div><div style="margin-top:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.661%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.661%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a) (b) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,668)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Capital Expenditures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Depreciation and Amortization</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts in 2022, 2021 and 2020 include charges of $72&#160;million $56&#160;million and $244&#160;million, respectively, recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the estimate of costs associated with remediation efforts for BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps in the Medication Management Solutions unit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The amount in 2022 includes a charge of $54&#160;million to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit.  The amount in 2020 included $41&#160;million of charges to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units.  These charges were recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amount in 2020 included charges of $57&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts in 2022, 2021 and 2020 also include pre-tax charges of $21&#160;million, $361&#160;million and $378 million, recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, related to certain product liability matters, which is further discussed in Note 6. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The countries in which the Company has local revenue-generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, and Australia and New Zealand); and Other, which is comprised of Latin America (which includes Mexico, Central America, the Caribbean and South America) and Canada.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues to unaffiliated customers are generally based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows revenues from continuing operations and long-lived assets of continuing operations by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,074&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,792&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521802000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (&#8220;2004 Plan&#8221;), which provides long-term incentive compensation to employees and directors consisting of: stock appreciation rights (&#8220;SARs&#8221;), performance-based restricted stock units, time-vested restricted stock units and other stock awards.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based payments is recognized as compensation expense in net income.  BD estimates forfeitures based on experience at the time of grant and adjusts expense to reflect actual forfeiture</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"/><td style="width:49.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and other restructurings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit associated with share-based compensation costs recognized</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense includes pre-tax compensation expense included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that was not material in 2022, 2021 and 2020. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the Company's acquisition of Bard in 2018, certain pre-acquisition equity awards of Bard were converted into either BD SARs or BD restricted stock awards, as applicable. These awards have substantially the same terms and conditions as the converted Bard awards immediately prior to the acquisition date. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense of $16&#160;million associated with these replacement awards was recorded in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and other restructurings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2020.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs generally vest over a period of four years and have a term of ten years.  The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.42%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value derived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$49.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$44.38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48.82</span></td></tr></table></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility is based upon historical volatility for the Company&#8217;s common stock and other factors. The expected life of SARs granted is derived from the output of the lattice-based model, using assumed exercise rates based on historical exercise and termination patterns, and represents the period of time that SARs granted are expected to be outstanding. The risk-free interest rate used is based upon the published U.S. Treasury yield curve in effect at the time of grant for instruments with a similar life. The dividend yield is based upon the most recently declared quarterly dividend as of the grant date. The Company issued 0.7 million shares during 2022 to satisfy the SARs exercised.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of SARs outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SARs (in<br/>thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual&#160;Term<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(Millions<br/>of dollars)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards transferred to Embecta at spin-off (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to BD awards related to the spin-off of Embecta  (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at September&#160;30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,377&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.10&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD SARs which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.</span></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of SARs exercised during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.666%"><tr><td style="width:1.0%"/><td style="width:60.552%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.132%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of SARs exercised</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of SARs vested</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based and Time-Vested Restricted Stock Units</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance-based restricted stock units cliff vest three years after the date of grant. These units are tied to the Company&#8217;s performance against pre-established targets over a performance period of three years. The performance measures for fiscal years 2022, 2021 and 2020 were average annual currency-neutral revenue growth and average annual return on invested capital, with the combined factor subject to adjustment based on the Company's relative total shareholder return (measures the Company&#8217;s stock performance during the performance period against that of peer companies). Under the Company&#8217;s long-term incentive program, the actual payout under these awards may vary from zero to 200% of an employee&#8217;s target payout, based on the Company&#8217;s actual performance over the performance period of three years. In fiscal years 2021 and 2020, the Company also issued additional performance-based time-vested units to certain key executives, which cliff vest three years after the date of grant and are tied to the Company&#8217;s performance against average annual growth in the Company&#8217;s Adjusted EPS over a performance period of three years. No shares will be issuable if the performance targets have not been met. The fair value is based on the market price of the Company&#8217;s stock on the date of grant. Compensation cost initially recognized assumes that the target payout level will be achieved and is adjusted for subsequent changes in the expected outcome of performance-related conditions. For units for which the performance conditions are modified after the date of grant, any incremental increase in the fair value of the modified units, over the original units, is recorded as compensation expense on the date of the modification for vested units, or over the remaining performance period for units not yet vested.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time-vested restricted stock unit awards vest on a graded basis over a period of three years, except for certain key executives of the Company, including the executive officers, for which such units generally vest one year following the employee&#8217;s retirement. The related share-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all time-vested restricted stock units is based on the market value of the Company&#8217;s stock on the date of grant.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock units outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.166%"><tr><td style="width:1.0%"/><td style="width:40.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Units&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Grant<br/>Date&#160;Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Units&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Grant<br/>Date&#160;Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards transferred to Embecta at spin-off (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to BD awards related to the spin-off of Embecta (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at September&#160;30</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD restricted stock units which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Based on 200% of target payout for performance based restricted units and 100% of the performance based time-vested units.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net of expected forfeited units and units in excess of the expected performance payout of 65 thousand and 386 thousand shares, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of restricted stock units granted during the years 2022, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"><tr><td style="width:1.0%"/><td style="width:35.156%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.343%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.60&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.94&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of stock units vested during 2022, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:37.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of units vested</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the weighted average remaining vesting term of performance-based and time vested restricted stock units is 1.23 and 0.90 years, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Compensation Expense and Other Stock Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of unrecognized compensation expense for all non-vested share-based awards as of September&#160;30, 2022, is approximately $253 million, which is expected to be recognized over a weighted-average remaining life of approximately 1.9 years. At September&#160;30, 2022, 7.2 million shares were authorized for future grants under the 2004 Plan. The Company has a policy of satisfying share-based payments through </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">either open market purchases or shares held in treasury. At September&#160;30, 2022, the Company has sufficient shares held in treasury to satisfy these payments.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, 101 thousand shares were held in trust relative to a Director's Deferral plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis. Also as of September&#160;30, 2022, 231 thousand shares were issuable under a Deferred Compensation Plan that allows certain highly-compensated employees, including executive officers, to defer salary, annual incentive awards and certain equity-based compensation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523758064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> on its consolidated statements of income, with the exception of certain amounts for termination benefits, curtailments and settlements related to the spin-off of Embecta, which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income from Discontinued Operations, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and were not material. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of employees to Embecta in connection with the spin-off triggered remeasurements of some of the Company&#8217;s benefit plans. These remeasurements, which were calculated using discount rates and asset values as of the date of the spin-off, did not materially impact the Company&#8217;s benefit obligation. The remeasurements also resulted in a related adjustment to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive loss.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. Postretirement healthcare and life insurance benefits provided to qualifying domestic retirees as well as other postretirement benefit plans in international countries are not material. The measurement date used for the Company&#8217;s employee benefit plans is September&#160;30.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Company&#8217;s conclusion to merge the legacy Bard pension plan into the BD defined benefit cash balance pension plan, the assets and liabilities of the legacy Bard U.S. defined pension benefit plan were remeasured as of October 31, 2020. Amendments to this plan were approved and communicated to affected employees in the first quarter of fiscal year 2021. The legacy Bard U.S. pension plan has been frozen to prevent new participants since January 1, 2011. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2018, the legacy BD U.S. pension plan was frozen to limit the participation of employees who are hired or re-hired by the Company, or who transfer employment to the Company, on or after January 1, 2018.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost for the years ended September&#160;30 included the following components:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.500%"><tr><td style="width:1.0%"/><td style="width:59.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost included in the preceding table that is attributable to international plans</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in prior periods. The settlement loss recorded in </span></div><div style="margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 included lump sum benefit payments associated with Company&#8217;s U.S. pension plan. The Company recognizes pension settlements when payments from the plan exceed the sum of service and interest cost components of net periodic pension cost associated with the plan for the fiscal year. A curtailment loss in 2021, related to freezing a pension plan in Europe, was recorded when the loss was probable and estimable. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in benefit obligation, change in fair value of pension plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.666%"><tr><td style="width:1.0%"/><td style="width:70.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Embecta spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments/settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, includes translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at September&#160;30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Embecta spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, includes translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at September&#160;30</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status at September&#160;30:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfunded benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized in the Consolidated Balance<br/>Sheets at September&#160;30:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized in Accumulated other<br/>comprehensive income (loss) before income taxes at September&#160;30:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International pension plan assets at fair value included in the preceding table were $705 million and $1.033 billion at September&#160;30, 2022 and 2021, respectively. The international pension plan projected benefit obligations were $772 million and $1.320 billion at September&#160;30, 2022 and 2021, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The benefit obligation associated with postretirement healthcare and life insurance plans provided to qualifying domestic retirees, which was largely recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Employee Benefit Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$101 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $138 million at September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated&#160;Benefit<br/>Obligation&#160;Exceeds&#160;the<br/>Fair&#160;Value&#160;of&#160;Plan&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Projected&#160;Benefit<br/>Obligation&#160;Exceeds&#160;the<br/>Fair&#160;Value&#160;of&#160;Plan&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average assumptions used in determining pension plan information were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.333%"><tr><td style="width:1.0%"/><td style="width:56.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.259%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.197%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance plan interest crediting rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance plan interest crediting rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company calculated the service and interest components utilizing an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expected Rate of Return on Plan Assets</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers many factors, including historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expected Funding</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s funding policy for its defined benefit pension plans is to contribute amounts sufficient to meet legal funding requirements, plus any additional amounts that may be appropriate considering the funded status of the plans, tax consequences, the cash flow generated by the Company and other factors. The Company made discretionary contributions to its BD U.S. pension plan of $134 million during fiscal year 2022. The Company did not make any required contributions in 2022 and does not anticipate any significant required contributions to its pension plans in fiscal year 2023.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.333%"><tr><td style="width:1.0%"/><td style="width:63.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension<br/>Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments associated with postretirement healthcare plans are immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s primary objective is to achieve returns sufficient to meet future benefit obligations. It seeks to generate above market returns by investing in more volatile asset classes such as equities while at the same time controlling risk through diversification in non-correlated asset classes and through allocations to more stable asset classes like fixed income.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">U.S. Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. pension plans comprise 69% of total benefit plan investments, based on September&#160;30, 2022 market values, and have a target asset mix of 45% fixed income, 21% diversifying investments and 34% equities. This mix was established based on an analysis of projected benefit payments and estimates of long-term returns, volatilities and correlations for various asset classes. The asset allocations to diversifying investments include high-yield bonds, hedge funds, real estate, infrastructure, leveraged loans and emerging markets bonds.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The actual portfolio investment mix may, from time to time, deviate from the established target mix due to various factors such as normal market fluctuations, the reliance on estimates in connection with the determination of allocations and normal portfolio activity such as additions and withdrawals. Rebalancing of the asset portfolio on a quarterly basis is required to address any allocations that deviate from the established target allocations in excess of defined allowable ranges. The target allocations are subject to periodic review, including a review of the asset portfolio&#8217;s performance, by the named fiduciary of the plans. Any tactical deviations from the established asset mix require the approval of the named fiduciary.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. plans may enter into both exchange traded and non-exchange traded derivative transactions in order to manage interest rate exposure, volatility, term structure of interest rates, and sector and currency </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exposures within the fixed income portfolios. The Company has established minimum credit quality standards for counterparties in such transactions.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021. The categorization of fund investments is based upon the categorization of these funds&#8217; underlying assets.  </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.490%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total U.S.<br/>Plan Asset<br/>Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt">As per applicable disclosure requirements, certain investments that were measured at net asset value per share or its equivalent have not been categorized within the fair value hierarchy.  Values of such assets are based on the corroborated net asset value provided by the fund administrator.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Income Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. pension plan assets categorized above as fixed income securities include fund investments comprised of corporate and government and agency investments. Investments in corporate bonds are diversified across industry and sector and consist of investment-grade, as well as high-yield debt instruments. U.S. government investments consist of obligations of the U.S. Treasury, other U.S. government agencies, state governments and local municipalities. Assets categorized as foreign government and agency debt securities included investments in developed and emerging markets.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The values of fixed income investments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. A portion of the fixed income instruments classified within Level 2 are valued based upon estimated prices from independent vendors&#8217; pricing models and these prices are derived from market observable sources including: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. pension plan assets categorized as equity securities consist of fund investments in publicly-traded U.S. and non-U.S. equity securities. In order to achieve appropriate diversification, these portfolios are invested across market sectors, investment styles, capitalization weights and geographic regions. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments are traded or have a readily determinable fair value based on published prices obtained from fund managers which represent the price at which the instruments can be redeemed at period end. The U.S. pension plan has no future funding commitments associated with these investments and has the right to redeem them upon one day&#8217;s notice, at any time and without restriction.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the U.S. plans&#8217; assets consists of investments in cash and cash equivalents, primarily to accommodate liquidity requirements relating to trade settlement and benefit payment activity, and the values of these assets are based upon quoted market prices.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other U.S. pension plan assets include fund investments comprised of hedge funds. The values of such instruments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">International Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International plan assets comprise 31% of the Company&#8217;s total benefit plan assets, based on market value at September&#160;30, 2022. Such plans have local independent fiduciary committees, with responsibility for development and oversight of investment policy, including asset allocation decisions.  In making such decisions, consideration is given to local regulations, investment practices and funding rules.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value measurements of international plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.333%"><tr><td style="width:1.0%"/><td style="width:18.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;International<br/>Plan Asset<br/>Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3 (a)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Changes in the fair value of international pension assets measured using Level 3 inputs for the years ended September&#160;30, 2022 and 2021 were immaterial.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed Income Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income investments held by international pension plans include corporate, U.S. government and non-U.S. government securities. The values of fixed income securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Values of investments classified within Level 2 are based upon estimated prices from independent vendors&#8217; pricing models and these prices are derived from market observable sources.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities included in the international plan assets consist of publicly-traded U.S. and non-U.S. equity securities. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded or have a readily determinable fair value based on published prices obtained from fund managers which represent the price at which the instruments can be redeemed at period end. The international plans holding these securities have no future funding commitments associated with these investments and has the right to redeem them upon one day&#8217;s notice, at any time and without restriction.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The international plans hold a portion of assets in cash and cash equivalents, in order to accommodate liquidity requirements and the values are based upon quoted market prices. Real estate investments consist of investments in funds holding an interest in real properties and the corresponding values represent the estimated fair value based on the fair value of the underlying investment value or cost, adjusted for any accumulated earnings or losses.  The values of insurance contracts approximately represent cash surrender value. Other investments include fund investments for which values are based upon either quoted market prices or market observable sources.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of voluntary defined contribution plans which provide for a Company match or contribution was $178 million in 2022, $153 million in 2021 and $111 million in 2020. As a short term measure to preserve cash and reduce costs, the Company's matching contributions were temporarily suspended effective May 1, 2020 and matching contributions were reinstated in October 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520723632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 18, 2022, the Company completed the acquisition of Parata Systems (&#8220;Parata&#8221;), an innovative provider of pharmacy automation solutions, for total cash consideration of $1.548&#160;billion. Since the acquisition date, financial results for Parata's product offerings are being reported within results for the Medical segment&#8217;s Medication Management Solutions unit. The acquisition was accounted for under the acquisition method of accounting for business combinations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary allocations of the purchase price provide a reasonable basis for estimating the fair values of assets acquired and liabilities assumed. These provisional estimates may be adjusted upon the availability of further information regarding events or circumstances that existed at the acquisition date. Such adjustments may be significant. The fair value of the assets acquired and the liabilities assumed resulted in the recognition of developed technology intangible assets of $628&#160;million, customer relationships intangible asset of $161&#160;million, and $12&#160;million of other net assets. The excess of the purchase price over fair value of the acquired net assets was recorded as goodwill of $746&#160;million, which related to synergies expected to be gained from leveraging the existing presence of the Company&#8217;s sales and marketing teams in pharmacies and acute care facilities, the broader coverage of the Company&#8217;s legacy sales and marketing teams, and revenue and cash flow projections associated with future technologies. A portion of the goodwill is deductible for tax purposes.</span></div>In addition to the Parata acquisition discussed above, the Company has completed various other acquisitions during fiscal years 2022 and 2021 which were not material individually or in the aggregate, including Parata.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520716560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Business Restructuring Charges</a></td>
<td class="text">Business Restructuring Charges<div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company's simplification and other cost saving initiatives that are part of its strategic objectives, along with the 2018 acquisition of Bard, the Company incurred restructuring costs which were largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and other restructurings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on its consolidated statements of income. The simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments.  Restructuring liability activity in 2022, 2021 and 2020&#160;was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:400.50pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:78.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:78.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:78.25pt"/><td style="width:1.0pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other (a)(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total (a)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Restructuring costs in 2022, 2021 and 2020 included expenses primarily related to simplification and other cost saving initiatives.  Restructuring costs in 2021 and 2020 also included expenses related to the acquisition of Bard in fiscal year 2018.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Expenses in 2020 largely represented the costs associated with the conversion of certain pre-acquisition equity awards of Bard which, to encourage post-acquisition employee retention, were converted to BD equity awards with substantially the same terms and conditions as were applicable under such Bard awards immediately prior to the acquisition date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520717952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets related to the former Diabetes Care business have been reclassified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncurrent Assets of Discontinued Operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for prior year periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, see Note 2.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets at September&#160;30 consisted of:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.409%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,979)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,723)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense was $1.430 billion, $1.402 billion and $1.384 billion in 2022, 2021 and 2020, respectively.  The estimated aggregate amortization expense for the fiscal years ending September&#160;30, 2023 to 2027 are as follows: 2023 &#8212; $1.385 billion; 2024 &#8212; $1.382 billion; 2025 &#8212; $1.381 billion; 2026 &#8212; $1.350 billion; 2027 &#8212; $1.292 billion.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</span></div>(b)Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521811824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">Derivative Instruments and Hedging Activities<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.  The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at September&#160;30, 2022 and 2021 were not material. The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments&#160;with certain instruments such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts.  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.000%"><tr><td style="width:1.0%"/><td style="width:36.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the years ending September&#160;30, 2022, 2021 and 2020 are detailed in Note 19.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the termination of a net investment hedge, any net gain or loss included in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges as of September&#160;30, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.166%"><tr><td style="width:1.0%"/><td style="width:49.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts in 2022 and 2021 include a gain of $46&#160;million and a loss of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$35&#160;million, respectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recognized on terminated cross-currency swaps.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a mix of fixed and variable rate debt, which is further discussed in Note 16, to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.  These swaps are designated as either cash flow or fair value hedges.  </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;attributable to those derivatives is reclassified into earnings over the remaining life of the hedged debt.&#160;The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during 2022, 2021 and 2020, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded net after-tax gains (losses) of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$92&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $72&#160;million and $(75)&#160;million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate-related cash flow hedges during the years ended September&#160;30, 2022, 2021 and 2020, respectively. The gains recorded during fiscal year 2022 included a net after-tax gain of $41&#160;million that was realized upon the Company&#8217;s termination of $500&#160;million of forward starting interest rate swaps.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates. The amounts recorded during the years ended September&#160;30, 2022 and 2021 for changes in fair value of these hedges were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows: </span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company&#8217;s commodity derivative forward contracts at September&#160;30, 2022 were not material, and there were no outstanding commodity derivative forward contracts at September 30, 2021. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521811824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">Financial Instruments and Fair Value Measurements<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September&#160;30, 2022 and 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"/><td style="width:166.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts and ultra-short bond fund (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets. The institutional money market accounts permit daily redemption.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than three months and less than one year. All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonrecurring Fair Value Measurements</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2022, the Company recorded non-cash asset impairment charges of $11&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Life Sciences segment, $19&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Medical segment and $54&#160;million to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Medical segment to write down the carrying value of certain fixed assets. In fiscal year 2021, the Company recorded charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $40&#160;million to write down the carrying value of certain fixed assets.  In fiscal year 2020, the Company recorded charges to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $57&#160;million to write down the carrying values of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units, and $41&#160;million to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units. The amounts recognized in 2022, 2021 and 2020 were recorded&#160;to adjust the carrying amount of assets to the assets' fair values, which were estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company&#8217;s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company&#8217;s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its accounts receivables for potential collection risks, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received. The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results. The amounts transferred and yet to be remitted under factoring arrangements are provided below. </span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520717952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current debt obligations</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current debt obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of unamortized debt issuance costs, at September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"><tr><td style="width:1.0%"/><td style="width:52.959%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000% Notes due December 15, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate Notes due June 6, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.401% Notes due May 24, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.632% Notes due June 4, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000% Notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All of the aggregate principal amount outstanding was retired during 2022, as further discussed below.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average interest rates for current debt obligations were 1.00% and 1.15% at September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, the Company may access the commercial paper market as it manages working capital over the normal course of its business activities. The Company utilized commercial paper borrowings in the fourth quarter of  fiscal year 2022 of which $230&#160;million was outstanding as of September&#160;30, 2022. There were no such borrowings outstanding as of September 30, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term debt</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of unamortized debt issuance costs, at September&#160;30 consisted of:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"><tr><td style="width:1.0%"/><td style="width:52.959%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000% Notes due December 15, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.401% Notes due May 24, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.632% Notes due June 4, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000% Notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875% Notes due May 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.363% Notes due June 6, 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.734% Notes due December 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.020% Notes due May 24, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.034% Notes due August 13, 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.208% Notes due June 4, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.700% Notes due December 1, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900% Notes due December 15, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.700% Notes due June 6, 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000% Debentures due August&#160;1, 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.700% Debentures due August&#160;1, 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.334% Notes due August 13, 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.823% Notes due May 20, 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.957% Notes due February 11, 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.298% Notes due August 22, 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.213% Notes due February 12, 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.000% Notes due May&#160;15, 2039</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% Notes due November&#160;12, 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.336% Notes due August 13, 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% Notes due May 15, 2044</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.685% Notes due December 15, 2044</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.669% Notes due June 6, 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.794% Notes due May 20, 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-Term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">A portion of the aggregate principal amount outstanding was retired during 2022, as further discussed below.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents notes issued during 2022, as further discussed below.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate annual maturities of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including interest during the fiscal years ending September&#160;30, 2023 to 2027 are as follows: 2023 &#8212; $439 million; 2024 &#8212; $1.574 billion; 2025 &#8212; $2.019 billion; 2026 &#8212; $951 million; 2027 &#8212; $2.801 billion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current credit facilities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal year 2021, the Company refinanced its five-year senior unsecured revolving credit facility that was to expire in December 2022, with a new five-year senior unsecured revolving credit facility that will expire in September 2026. The credit facility provides borrowings of up to $2.75&#160;billion, with separate sub-limits of $100&#160;million for letters of credit and swingline loans. The expiration date of the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">credit facility may be extended for up to two additional one year periods, subject to certain restrictions, including the consent of the lenders. The credit facility provides that the Company may, subject to additional commitments by lenders, request an additional $500&#160;million of financing, for a maximum aggregate commitment under the credit facility of up to $3.25&#160;billion. Proceeds from this facility may be used for general corporate purposes. There were no borrowings outstanding under the Company&#8217;s revolving credit facilities as of September&#160;30, 2022 and 2021. In addition, the Company has informal lines of credit outside of the United States. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Spin-off-related debt transactions</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, Embecta, as a wholly-owned subsidiary of the Company, issued $500&#160;million of 5.000% senior secured notes due February 15, 2030, in advance of the Company&#8217;s spin-off of Embecta, which is further discussed in Note 2.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, Embecta entered into an indenture dated April 1, 2022 to issue $200&#160;million of 6.750% senior secured notes due February 15, 2030. These notes were issued to the Company as part of the consideration for assets transferred to Embecta in connection with the spin-off. After the spin-off was effective on April 1, 2022, the Company exchanged these notes for $199&#160;million of the aggregate principal amount outstanding on the Company&#8217;s Floating Rate Notes due June 6, 2022, which were purchased through a tender offer. The carrying value of the long-term notes tendered was $199&#160;million, and the Company recognized a loss on this debt extinguishment of $2&#160;million, which was recorded in the third quarter of fiscal year 2022 within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on the Company&#8217;s consolidated statements of income.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in connection with the spin-off, on March 31, 2022, Embecta issued a senior secured term loan facility with an aggregate principal amount of $950&#160;million and a senior secured revolving credit facility providing borrowings of up to $500&#160;million that was undrawn at March 31, 2022 and at the spin-off date. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The senior secured notes and credit agreement for the term loan and revolving credit facilities were guaranteed on an unsecured, unsubordinated basis solely by the Company prior to the spin-off date.  The Company&#8217;s guarantees automatically and unconditionally terminated upon the consummation of the spin-off on April 1, 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, Embecta used a portion of the proceeds from the financing transactions discussed above to make a cash distribution of approximately $1.266&#160;billion to the Company.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt issuances</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued the following U.S. dollar-denominated debt during fiscal years 2022 and 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.298% notes due August 22, 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.957% notes due February 11, 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of 3.125% notes due November 8, 2021</span></div></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued the following Euro-denominated debt during fiscal year 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of Euros)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000% notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;0.034% notes due August 13, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in fiscal year 2021, Becton Dickinson Euro Finance S.&#224; r.l., a private limited liability company (soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e), which is an indirect, wholly-owned finance subsidiary of the Company, issued Euro-denominated notes, listed below, which are fully and unconditionally guaranteed on a senior unsecured basis by the Company.  No other of the Company's subsidiaries provide any guarantees with respect to these notes.  The indenture covenants included a limitation on liens and a restriction on sale and leasebacks, change of control and consolidation, merger and sale of assets covenants.  These covenants are subject to a number of exceptions, limitations and qualifications.  The indenture does not restrict the Company, Becton Dickinson Euro Finance S.&#224; r.l., or any other of the Company's subsidiaries from incurring additional debt or other liabilities, including additional senior debt.  Additionally, the indenture does not restrict Becton Dickinson Euro Finance S.&#224; r.l. and the Company from granting security interests over its assets.  The notes issued by Becton Dickinson Euro Finance S.&#224; r.l included the following:</span></div><div style="margin-top:6pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of Euros)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.334% notes due August 13, 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.336% notes due August 13, 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.213% notes due February 12, 2036</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of  0.174% notes due June 4, 2021</span></div></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt retirements</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2022, the Company commenced a series of tender offers to purchase for cash, certain of its outstanding senior notes. Proceeds from the notes issued in the fourth quarter of fiscal year 2022 plus cash on </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hand were used to pay for the tender offers. As a result of the tender, the Company&#8217;s retirements of debt in fiscal year 2022 included the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"><tr><td style="width:1.0%"/><td style="width:39.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.651%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal, interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market price of retirement (a)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) loss recognized to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$190&#160;million of 3.794% notes due 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52&#160;million  of 7.000% debentures due 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55&#160;million of 6.700% debentures due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$127&#160;million of 6.000% notes due 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34&#160;million of 5.000% notes due 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$42&#160;million of 4.685% notes due 2044</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included accrued interest, related premiums, fees and expenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Debt retirement was accounted for as an early debt extinguishment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To mitigate the impact of rate volatility on the total tender cash spend, the Company executed reverse Treasury locks that were unwound concurrent with the tender at a loss of $17&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s retirements of debt in fiscal year 2021 included the following:</span></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"><tr><td style="width:1.0%"/><td style="width:39.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.651%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(Millions of dollars)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal, interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market price of retirement (a)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loss recognized to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.535 billion of 2.894% notes due June 6, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$294 million of 3.300% notes due March 1, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33&#160;million of 3.875% notes due May 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million of 3.734% notes due December 15, 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$752&#160;million of 3.363% notes due June 6, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.0 billion of 3.125% notes due November 8, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 million Euros ($728 million) of 0.174% notes due June 4, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$265 million of 2.894% notes due June 6, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included accrued interest, related premiums, fees and expenses.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">All debt retirements in fiscal year 2021 were accounted for as early debt extinguishments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Capitalized interest</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes interest costs as a component of the cost of construction in progress. A summary of interest costs and payments for the years ended September&#160;30 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.833%"><tr><td style="width:1.0%"/><td style="width:48.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.254%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of amounts capitalized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520710992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes the years ended September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Continuing Operations Before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the years ended September&#160;30 consisted of:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, including Puerto Rico</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company believes it is reasonably possible that the amount of unrecognized benefits will change due to one or more of the following events in the next twelve months: expiring statutes, audit activity, tax payments, other </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activity, or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:62.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases due to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to settlements with tax authorities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits that would affect the effective tax rate if recognized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the Company's acquisition of CareFusion in 2015, the Company became a party to a tax matters agreement with Cardinal Health resulting from Cardinal Health's spin-off of CareFusion in fiscal year 2010.  Under the tax matters agreement, the Company is obligated to indemnify Cardinal Health for certain tax exposures and transaction taxes prior to CareFusion&#8217;s spin-off from Cardinal Health.  The indemnification payable is approximately $124 million at September 30, 2022 and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following were included for the years ended September&#160;30 as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision (benefit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated statements of income.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and penalties associated with unrecognized tax benefits</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. The IRS has completed its audit for the BD legacy fiscal year 2014, BD combined company fiscal years 2015 and 2017 and CareFusion legacy fiscal years 2010 through short period 2015. With regard to Bard, all examinations have been completed through short period 2017. The IRS has commenced its review of BD&#8217;s fiscal years 2018 through 2020. For the other major tax jurisdictions where the Company conducts business, tax years are generally open after 2015.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes at September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:48.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.920%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.920%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.920%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product recall and liability reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (a)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Net deferred tax assets are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and net deferred tax liabilities are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated balance sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. The Company asserts indefinite reinvestment for all historical unremitted foreign earnings as of September 30, 2022. Deferred taxes have not been provided on undistributed earnings of foreign subsidiaries as of September&#160;30, 2022 since the determination of the total amount of unrecognized deferred tax liability is not practicable.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, deferred tax assets have been established as a result of net operating losses and credit carryforwards with expiration dates from 2023 to an unlimited expiration date. Valuation allowances have been established as a result of an evaluation of the uncertainty associated with the realization of certain deferred tax assets on these losses and credit carryforwards. The valuation allowance at September 30, 2022 is primarily the result of foreign losses due to the Company&#8217;s global re-organization of its foreign entities and these generally have no expiration date. Valuation allowances are also maintained with respect to deferred tax assets for certain state carryforwards that may not be realized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rate Reconciliation</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory tax rate to the Company&#8217;s effective income tax rate for continuing operations was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"><tr><td style="width:1.0%"/><td style="width:61.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Research Credits and FDII/Domestic Production Activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of gain on divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of valuation allowance release</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuations in the Company&#8217;s reported tax rates are primarily due to the geographical mix of income attributable to foreign countries that have income tax rates that vary from the U.S. tax rate.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Holidays and Payments</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approximate tax impacts related to tax holidays in various countries in which the Company does business are provided below. The tax holidays expire at various dates through 2028. The Company&#8217;s income tax payments, net of refunds are also provided below.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.666%"><tr><td style="width:1.0%"/><td style="width:45.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact related to tax holidays</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of tax holiday on diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payments, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520715168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases real estate, vehicles and other equipment which are used in the Company&#8217;s manufacturing, administrative and research and development activities.  The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration.  The Company&#8217;s lease arrangements are generally classified as operating leases.  These arrangements have remaining terms ranging from less than one year to approximately 25 years and the weighted-average remaining lease term of the Company&#8217;s leases is approximately 6.8 years.  An option to renew or terminate the current term of a lease arrangement is included in the lease term if the Company is reasonably certain to exercise that option.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.  For the longer-term lease arrangements that are recognized on the Company&#8217;s consolidated balance sheet, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease.  These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#8217;s short-term leases, as well as variable costs relating to the Company&#8217;s lease arrangements, are not material to its consolidated financial results.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. The weighted-average incremental borrowing rate that has been applied to measure the Company&#8217;s lease liabilities is 2.3%.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease costs recorded in its consolidated statements of income for the years ended September&#160;30, 2022, 2021 and 2020 were $138&#160;million, $132&#160;million and $131&#160;million, respectively.  Cash payments arising from the Company&#8217;s lease arrangements are reflected on its consolidated statement of cash flows as outflows used for operating activities.  The right-of-use assets and lease liabilities recognized on the Company&#8217;s consolidated balance sheet as of September&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9">Other Assets</span></span></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108">Accrued expenses</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce">Deferred Income Taxes and Other Liabilities</span></span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.166%"><tr><td style="width:1.0%"/><td style="width:64.156%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total payments due</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale-Leaseback Transactions</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2021, the Company sold certain properties and concurrently entered into operating lease arrangements for each property, which met the requirements for sale-leaseback accounting.  The Company recorded gross proceeds of $225&#160;million related to the transactions and pre-tax gains of $158&#160;million were recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The lease agreements have initial lease terms between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwNzQ_6fc3030e-d694-47a3-b19e-733ab8915c12">two</span> and three years and include options for the Company to extend the leases for an additional <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNTk_49d1d0da-0358-48d3-bfc1-913d11e54289">six</span>-to-twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520706816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text">Supplemental Financial Information<div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.666%"><tr><td style="width:1.0%"/><td style="width:68.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.882%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investment (losses) gains, net (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension and postretirement benefit cost (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses on undesignated foreign exchange derivatives, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impacts of debt extinguishment (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta service agreements income, net (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts include gains (losses) recognized on changes to the fair value of certain equity investments.  The amounts in 2022 and 2020 also include a loss and gain, respectively, on the sale of equity investments. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents all components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, including U.S. pension settlement expense of $73&#160;million in fiscal year 2022.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents losses recognized upon the extinguishment of certain senior notes, as further discussed in Note 16.   </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Consists of net income from transition and logistics service agreements with Embecta following the spin-off of the former diabetes care business in fiscal year 2022, as further discussed in Note 2.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables, Net</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in 2022, 2021 and 2020 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance&#160;for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance&#160;for<br/>Cash<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Accounts written off.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at September&#160;30 consisted of:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, Net</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, Plant and Equipment, Net at September&#160;30 consisted of:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,090&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517707200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the "Company" or "BD") have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company and the historical results of the Diabetes Care business that was contributed in the spin-off have been reflected as discontinued operations in the Company&#8217;s consolidated financial statements for all periods prior to the spin-off date. Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet as of September 30, 2021. Additional disclosures regarding the spin-off are provided in Note 2.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the Company&#8217;s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash restricted from withdrawal and usage and largely represents funds that are restricted for certain product liability matters assumed in the acquisition of C.R. Bard, Inc. ("Bard"), which are further discussed in Note 6.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade and Financing Receivables</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Receivables</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#8217;s estimate of expected credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is  not collectable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, </span></div>which range from 20 to 45 years for buildings, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd">four</span> to 13 years for machinery and equipment and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1">one</span> to 20 years for leasehold improvements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unamortized intangible assets include goodwill that arises from acquisitions of businesses. The Company reviews goodwill for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  The Company&#8217;s reporting units generally represent one level below reporting segments. The Company reviews goodwill for each reporting unit by comparing the fair value of the reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2022 indicated that all identified reporting units&#8217; fair values exceeded their respective carrying values. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d">one</span> to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#8217;s carrying value exceeds its calculated fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, foreign subsidiaries&#8217; functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates.  The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from product sales when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized upon customer acceptance of these installed products. Revenue for certain service arrangements, including extended warranty and software maintenance contracts, is recognized ratably over the contract term. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Variable consideration such as rebates, sales discounts and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices, and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease transactions with customers are evaluated and classified as either operating or sales-type leases. Generally, these arrangements are accounted for as operating leases and therefore, revenue is recognized at the contracted rate over the rental period defined within the customer agreement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text">ContingenciesThe Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries). Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved. In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and /or consolidated cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial InstrumentsAll derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met. Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows. Cash flows for all other derivatives, including undesignated hedges, are classified in the same line item as the cash flows of the related hedged item, which is generally within operating or financing activities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reviewed its needs in the United States for possible repatriation of undistributed earnings of its foreign subsidiaries and continues to invest foreign subsidiaries earnings outside of the United States to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. As a result, the Company is permanently reinvested with respect to all of its historical foreign earnings as of September 30, 2022. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable because of the complexities associated with its hypothetical calculation. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Additional disclosures regarding the Company's accounting for income taxes are provided in Note 17.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act was enacted on December 22, 2017 and subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to account for its GILTI tax due as a period expense in the year the tax is incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share are computed by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In computing diluted earnings per share, only potential common shares that are dilutive (i.e., those that reduce earnings per share or increase loss per share) are included in the calculation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#8217;s fair value measurements are provided in Notes 10 and 15.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212; Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Level 2 &#8212; Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Level 3 &#8212; Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Principle Adopted and New Accounting Principles Not Yet Adopted</a></td>
<td class="text">Accounting Changes<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Principles Adopted</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2022, the Company early-adopted an accounting standard update issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), which requires an entity to apply the provisions of Accounting Standard Codification Topic 606, "Revenue from Contracts with Customers,&#8221; (&#8220;ASC 606&#8221;) when recognizing and measuring contract assets and contract liabilities acquired in a business combination. The Company&#8217;s adoption of this accounting standard update for business combinations that occurred during fiscal year 2022 did not have a material impact on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued a new accounting standard which requires earlier recognition of credit losses on loans and other financial instruments held by entities, including trade receivables.  The new standard requires entities to measure all expected credit losses for financial assets held at each reporting date based on historical experience, current conditions, and reasonable and supportable forecasts.  The Company&#8217;s adoption of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">this accounting standard on October 1, 2020, using the modified retrospective method, did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Principles Not Yet Adopted</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued a new accounting standard update that requires additional qualitative and quantitative disclosures surrounding supplier finance programs intended to help investors better consider the effect of these programs on a company's working capital, liquidity, and cash flows over time. This update is effective for fiscal years beginning after December 15, 2022, including interim periods, except for the disclosure. Early adoption is permitted. The Company is currently evaluating the impact this update will have on its disclosures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Timing of Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#8217;s ability to use and benefit from the product, are recognized when customer acceptance of these installed products has been confirmed. For certain service arrangements, including extended warranty and software maintenance contracts, revenue is recognized ratably over the contract term. The majority of revenues relating to extended warranty contracts associated with certain instruments and equipment is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over a longer period.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. The Company considers its shipping and handling costs to be costs of contract fulfillment and has made the accounting policy election to record these costs within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms extended to the Company's customers are based upon commercially reasonable terms for the markets in which the Company's products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectable. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company's agreements with its end-user customers. Additional factors considered in the estimate of the Company's rebate liability include the quantification of inventory that is either in stock at or in transit to the Company's distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. The Company&#8217;s rebate liability at September&#160;30, 2022 and 2021 was $525&#160;million and $500&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues. Additional disclosures relating to sales discounts and sales returns are provided in Note 19.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's agreements with customers within certain organizational units including Medication Management Solutions, Integrated Diagnostic Solutions and Biosciences, contain multiple performance obligations including both products and certain services noted above. The transaction price for these agreements is allocated to each performance obligation based upon its relative standalone selling price. Standalone selling price is the amount at which the Company would sell a promised good or service separately to a customer. The </span></div>Company generally estimates standalone selling prices using its list prices and a consideration of typical discounts offered to customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments, Policy</a></td>
<td class="text">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company&#8217;s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company&#8217;s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</span></div>The Company continually evaluates its accounts receivables for potential collection risks, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases</a></td>
<td class="text">The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration.  The Company&#8217;s lease arrangements are generally classified as operating leases.  These arrangements have remaining terms ranging from less than one year to approximately 25 years and the weighted-average remaining lease term of the Company&#8217;s leases is approximately 6.8 years.  An option to renew or terminate the current term of a lease arrangement is included in the lease term if the Company is reasonably certain to exercise that option.The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.  For the longer-term lease arrangements that are recognized on the Company&#8217;s consolidated balance sheet, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease.  These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeasesPolicyTextBlock', window );">Short-term Leases</a></td>
<td class="text">The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy election for short-term lease to recognize lease payments on straight-line basis over lease term and variable lease payments as incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918418-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523777776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities of Discontinued Operations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:54.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>   <div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#8217;s consolidated balance sheet at September 30, 2021:   </span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"><tr><td style="width:1.0%"/><td style="width:79.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets of Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and Other Intangibles, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Assets of Discontinued Operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities of Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Liabilities of Discontinued Operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127519814736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Changes in Certain Components of Shareholders' Equity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders&#8217; equity were as follows:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.737%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76,260)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($3.16 per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares converted to common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public equity offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74,623)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($3.32 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of change in accounting principle (see Note 3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80,164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common ($3.48 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off of Embecta (See Note 2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,283)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,330)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated Other Comprehensive (Loss) Income</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.333%"><tr><td style="width:1.0%"/><td style="width:47.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,283)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,548)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,416)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of<br/>taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off of Embecta (See Note 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,488)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Other Comprehensive Income (Loss), Tax</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income before reclassifications were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"><tr><td style="width:1.0%"/><td style="width:55.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127519659056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.666%"><tr><td style="width:1.0%"/><td style="width:65.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans (a) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from Series C preferred shares (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8212; assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,089&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:1pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">In 2022, 2021 and 2020, dilutive share equivalents associated with mandatory convertible preferred stock of 6 million, 6 million and 9 million, respectively, were excluded from the diluted shares outstanding calculation because the result would have been antidilutive. The issuance of the convertible preferred stock is further discussed in Note 4.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">In both 2021 and 2020, 1&#160;million of certain share-based compensation awards were excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2022, no such awards were excluded from the diluted earnings per share calculation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional disclosures regarding the Company&#8217;s share-based compensation are provided in Note 9.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#8217;s spin-off of its Diabetes Care business on April 1, 2022 was completed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520812400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for the Company&#8217;s segments is detailed below. The Company has no material intersegment revenues.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:13.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.746%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgery </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Company revenues from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,870&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,074&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Financial Information for Company's Segments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of segment operating income to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Continuing Operations before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and segment information for both capital expenditures and depreciation and amortization.  Certain prior-period amounts have been recast to reflect the spin-off of the Diabetes Care business in fiscal year 2022, as noted above.</span><div style="margin-top:3pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.661%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.661%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical (a) (b) </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,668)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Capital Expenditures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Depreciation and Amortization</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts in 2022, 2021 and 2020 include charges of $72&#160;million $56&#160;million and $244&#160;million, respectively, recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the estimate of costs associated with remediation efforts for BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps in the Medication Management Solutions unit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The amount in 2022 includes a charge of $54&#160;million to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit.  The amount in 2020 included $41&#160;million of charges to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units.  These charges were recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amount in 2020 included charges of $57&#160;million recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to write down the carrying value of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units.  </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts in 2022, 2021 and 2020 also include pre-tax charges of $21&#160;million, $361&#160;million and $378 million, recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net </span>respectively, related to certain product liability matters, which is further discussed in Note 6.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues to unaffiliated customers are generally based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows revenues from continuing operations and long-lived assets of continuing operations by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,074&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,792&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512670128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Compensation Cost Relating to Share-Based Payments</a></td>
<td class="text">The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"/><td style="width:49.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and other restructurings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit associated with share-based compensation costs recognized</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods</a></td>
<td class="text">The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.42%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value derived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$49.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$44.38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48.82</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock', window );">Summary of SARs Outstanding</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of SARs outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SARs (in<br/>thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual&#160;Term<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(Millions<br/>of dollars)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards transferred to Embecta at spin-off (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to BD awards related to the spin-off of Embecta  (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at September&#160;30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,377&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.10&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD SARs which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock', window );">Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised</a></td>
<td class="text"><div style="margin-top:4pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of SARs exercised during </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.666%"><tr><td style="width:1.0%"/><td style="width:60.552%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.132%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of SARs exercised</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of SARs vested</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Performance-Based Restricted Stock Units Outstanding</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock units outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.166%"><tr><td style="width:1.0%"/><td style="width:40.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Units&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Grant<br/>Date&#160;Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Units&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Grant<br/>Date&#160;Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards transferred to Embecta at spin-off (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to BD awards related to the spin-off of Embecta (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at September&#160;30</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD restricted stock units which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Based on 200% of target payout for performance based restricted units and 100% of the performance based time-vested units.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net of expected forfeited units and units in excess of the expected performance payout of 65 thousand and 386 thousand shares, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock', window );">Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of restricted stock units granted during the years 2022, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"><tr><td style="width:1.0%"/><td style="width:35.156%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.343%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.60&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.94&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of stock units vested during 2022, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:37.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance-Based</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Vested</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of units vested</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the intrinsic value, tax benefits, and fair value of stock appreciation rights exercised during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517419216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Pension and Other Postretirement Cost</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost for the years ended September&#160;30 included the following components:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.500%"><tr><td style="width:1.0%"/><td style="width:59.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost included in the preceding table that is attributable to international plans</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock', window );">Change in Benefit Obligation, Change in Fair Value of Plan Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in benefit obligation, change in fair value of pension plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.666%"><tr><td style="width:1.0%"/><td style="width:70.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Embecta spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments/settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, includes translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at September&#160;30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Embecta spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, includes translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at September&#160;30</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status at September&#160;30:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfunded benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized in the Consolidated Balance<br/>Sheets at September&#160;30:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized in Accumulated other<br/>comprehensive income (loss) before income taxes at September&#160;30:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Pension Plans with Accumulated Benefit Obligations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated&#160;Benefit<br/>Obligation&#160;Exceeds&#160;the<br/>Fair&#160;Value&#160;of&#160;Plan&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Projected&#160;Benefit<br/>Obligation&#160;Exceeds&#160;the<br/>Fair&#160;Value&#160;of&#160;Plan&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted Average Assumptions Determining Pension Plan</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average assumptions used in determining pension plan information were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.333%"><tr><td style="width:1.0%"/><td style="width:56.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.259%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.197%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance plan interest crediting rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance plan interest crediting rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International plans </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company calculated the service and interest components utilizing an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Expected Benefit Payments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.333%"><tr><td style="width:1.0%"/><td style="width:63.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension<br/>Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Fair Value Measurements of U.S. Plan Assets</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021. The categorization of fund investments is based upon the categorization of these funds&#8217; underlying assets.  </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.490%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total U.S.<br/>Plan Asset<br/>Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt">As per applicable disclosure requirements, certain investments that were measured at net asset value per share or its equivalent have not been categorized within the fair value hierarchy.  Values of such assets are based on the corroborated net asset value provided by the fund administrator.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock', window );">Fair Value Measurements of Foreign Plan Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value measurements of international plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.333%"><tr><td style="width:1.0%"/><td style="width:18.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;International<br/>Plan Asset<br/>Balances</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3 (a)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government and agency-Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other fixed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Changes in the fair value of international pension assets measured using Level 3 inputs for the years ended September&#160;30, 2022 and 2021 were immaterial.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of foreign pension plans and/or other foreign employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523612640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Summary of Restructuring Accrual Activity</a></td>
<td class="text">Restructuring liability activity in 2022, 2021 and 2020&#160;was as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:400.50pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:78.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:78.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:78.25pt"/><td style="width:1.0pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other (a)(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total (a)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Restructuring costs in 2022, 2021 and 2020 included expenses primarily related to simplification and other cost saving initiatives.  Restructuring costs in 2021 and 2020 also included expenses related to the acquisition of Bard in fiscal year 2018.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Expenses in 2020 largely represented the costs associated with the conversion of certain pre-acquisition equity awards of Bard which, to encourage post-acquisition employee retention, were converted to BD equity awards with substantially the same terms and conditions as were applicable under such Bard awards immediately prior to the acquisition date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523635168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Components of Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets at September&#160;30 consisted of:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.409%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,979)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,723)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Reconciliation of Goodwill by Business Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</span></div>(b)Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127518407840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.000%"><tr><td style="width:1.0%"/><td style="width:36.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the years ending September&#160;30, 2022, 2021 and 2020 are detailed in Note 19.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries. </span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows: </span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div>(b)Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges as of September&#160;30, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.166%"><tr><td style="width:1.0%"/><td style="width:49.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts in 2022 and 2021 include a gain of $46&#160;million and a loss of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$35&#160;million, respectively,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recognized on terminated cross-currency swaps.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523613968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September&#160;30, 2022 and 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"/><td style="width:166.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement (See Note 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts and ultra-short bond fund (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets. The institutional money market accounts permit daily redemption.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales</a></td>
<td class="text">The amounts transferred and yet to be remitted under factoring arrangements are provided below. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127519730704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Summary of Short-Term Debt</a></td>
<td class="text">The carrying value of <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current debt obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of unamortized debt issuance costs, at September&#160;30 consisted of:</span><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"><tr><td style="width:1.0%"/><td style="width:52.959%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000% Notes due December 15, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate Notes due June 6, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.401% Notes due May 24, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.632% Notes due June 4, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000% Notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All of the aggregate principal amount outstanding was retired during 2022, as further discussed below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Long-Term Debt</a></td>
<td class="text">The carrying value of <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of unamortized debt issuance costs, at September&#160;30 consisted of:</span><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"><tr><td style="width:1.0%"/><td style="width:52.959%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.357%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000% Notes due December 15, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.401% Notes due May 24, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.632% Notes due June 4, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000% Notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875% Notes due May 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.363% Notes due June 6, 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.734% Notes due December 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.020% Notes due May 24, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.034% Notes due August 13, 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.208% Notes due June 4, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.700% Notes due December 1, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900% Notes due December 15, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.700% Notes due June 6, 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000% Debentures due August&#160;1, 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.700% Debentures due August&#160;1, 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.334% Notes due August 13, 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.823% Notes due May 20, 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.957% Notes due February 11, 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.298% Notes due August 22, 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.213% Notes due February 12, 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.000% Notes due May&#160;15, 2039</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% Notes due November&#160;12, 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.336% Notes due August 13, 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% Notes due May 15, 2044</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.685% Notes due December 15, 2044</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.669% Notes due June 6, 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.794% Notes due May 20, 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-Term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,886&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">A portion of the aggregate principal amount outstanding was retired during 2022, as further discussed below.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents notes issued during 2022, as further discussed below.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfDebtIssuancesTableTextBlock', window );">Schedule of Debt Issuances</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued the following U.S. dollar-denominated debt during fiscal years 2022 and 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.298% notes due August 22, 2032</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.957% notes due February 11, 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of 3.125% notes due November 8, 2021</span></div></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued the following Euro-denominated debt during fiscal year 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of Euros)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000% notes due August 13, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;0.034% notes due August 13, 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr></table></div>The notes issued by Becton Dickinson Euro Finance S.&#224; r.l included the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of Euros)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount issued (Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Use of proceeds</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.334% notes due August 13, 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.336% notes due August 13, 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021 retirements detailed below</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.213% notes due February 12, 2036</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of  0.174% notes due June 4, 2021</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock', window );">Schedule of Extinguishment of Debt</a></td>
<td class="text">On August 8, 2022, the Company commenced a series of tender offers to purchase for cash, certain of its outstanding senior notes. Proceeds from the notes issued in the fourth quarter of fiscal year 2022 plus cash on <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hand were used to pay for the tender offers. As a result of the tender, the Company&#8217;s retirements of debt in fiscal year 2022 included the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"><tr><td style="width:1.0%"/><td style="width:39.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.651%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal, interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market price of retirement (a)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) loss recognized to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$190&#160;million of 3.794% notes due 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52&#160;million  of 7.000% debentures due 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55&#160;million of 6.700% debentures due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$127&#160;million of 6.000% notes due 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34&#160;million of 5.000% notes due 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$42&#160;million of 4.685% notes due 2044</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included accrued interest, related premiums, fees and expenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Debt retirement was accounted for as an early debt extinguishment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To mitigate the impact of rate volatility on the total tender cash spend, the Company executed reverse Treasury locks that were unwound concurrent with the tender at a loss of $17&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s retirements of debt in fiscal year 2021 included the following:</span></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"><tr><td style="width:1.0%"/><td style="width:39.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.651%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(Millions of dollars)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal, interest rate and maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market price of retirement (a)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loss recognized to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Other (expense) income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.535 billion of 2.894% notes due June 6, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$294 million of 3.300% notes due March 1, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33&#160;million of 3.875% notes due May 15, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million of 3.734% notes due December 15, 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$752&#160;million of 3.363% notes due June 6, 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.0 billion of 3.125% notes due November 8, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 million Euros ($728 million) of 0.174% notes due June 4, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$265 million of 2.894% notes due June 6, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included accrued interest, related premiums, fees and expenses.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">All debt retirements in fiscal year 2021 were accounted for as early debt extinguishments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_InterestCostsIncurredTableTableTextBlock', window );">Summary of Interest Costs and Payments</a></td>
<td class="text">A summary of interest costs and payments for the years ended September&#160;30 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.833%"><tr><td style="width:1.0%"/><td style="width:48.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.254%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of amounts capitalized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_InterestCostsIncurredTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest costs and payments for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_InterestCostsIncurredTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfDebtIssuancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Issuances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfDebtIssuancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7516071&amp;loc=d3e13374-112631<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517825312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Taxes from Continuing Operations</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes the years ended September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following were included for the years ended September&#160;30 as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision (benefit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated statements of income.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.966%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and penalties associated with unrecognized tax benefits</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of Income from Continuing Operations Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Continuing Operations Before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the years ended September&#160;30 consisted of:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic, including Puerto Rico</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of Gross Amounts of Unrecognized Tax Benefits</a></td>
<td class="text">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company believes it is reasonably possible that the amount of unrecognized benefits will change due to one or more of the following events in the next twelve months: expiring statutes, audit activity, tax payments, other <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activity, or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:62.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October&#160;1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases due to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to settlements with tax authorities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits that would affect the effective tax rate if recognized</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes at September&#160;30 consisted of:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:48.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.920%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.920%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.920%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.923%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product recall and liability reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (a)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Net deferred tax assets are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and net deferred tax liabilities are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated balance sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory tax rate to the Company&#8217;s effective income tax rate for continuing operations was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"><tr><td style="width:1.0%"/><td style="width:61.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Research Credits and FDII/Domestic Production Activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of gain on divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of valuation allowance release</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxHolidayTextBlock', window );">Summary of Income Tax Holiday</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approximate tax impacts related to tax holidays in various countries in which the Company does business are provided below. The tax holidays expire at various dates through 2028. The Company&#8217;s income tax payments, net of refunds are also provided below.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.666%"><tr><td style="width:1.0%"/><td style="width:45.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact related to tax holidays</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of tax holiday on diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payments, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxHolidayTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the income tax exemptions and reductions which have been granted by taxing authorities for a specified period, applicable term of the exemptions and reductions, estimated dollar value of tax benefits, and per share benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxHolidayTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521832672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock', window );">Supplemental Balance Sheet Information Related to Leases</a></td>
<td class="text">The right-of-use assets and lease liabilities recognized on the Company&#8217;s consolidated balance sheet as of September&#160;30, 2022 and 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9">Other Assets</span></span></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108">Accrued expenses</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce">Deferred Income Taxes and Other Liabilities</span></span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.166%"><tr><td style="width:1.0%"/><td style="width:64.156%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total payments due</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information Related to Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520216976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Nonoperating Income (Expense)</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.666%"><tr><td style="width:1.0%"/><td style="width:68.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.882%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investment (losses) gains, net (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension and postretirement benefit cost (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses on undesignated foreign exchange derivatives, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impacts of debt extinguishment (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta service agreements income, net (d)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The amounts include gains (losses) recognized on changes to the fair value of certain equity investments.  The amounts in 2022 and 2020 also include a loss and gain, respectively, on the sale of equity investments. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents all components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, including U.S. pension settlement expense of $73&#160;million in fiscal year 2022.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents losses recognized upon the extinguishment of certain senior notes, as further discussed in Note 16.   </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Consists of net income from transition and logistics service agreements with Embecta following the spin-off of the former diabetes care business in fiscal year 2022, as further discussed in Note 2.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in 2022, 2021 and 2020 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance&#160;for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance&#160;for<br/>Cash<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Accounts written off.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at September&#160;30 consisted of:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, Plant and Equipment, Net at September&#160;30 consisted of:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,090&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127516977472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 672<span></span>
</td>
<td class="nump">$ 689<span></span>
</td>
<td class="nump">$ 608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">4,709<span></span>
</td>
<td class="nump">4,719<span></span>
</td>
<td class="nump">4,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">$ 751<span></span>
</td>
<td class="nump">$ 641<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Core and Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Patents, Trademarks, and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Core and Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Patents, Trademarks, and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible assets, useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">45 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_CoreTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_CoreTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_PatentsAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_PatentsAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517167328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CashTransferRelatedToSpinoffTransaction', window );">Cash Transfer Related to Spinoff Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash', window );">Disposal Groups, Including Discontinued Operation, Consideration, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense', window );">Disposal Group, Including Discontinued Operation, Other Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationDebt', window );">Disposal Group, Including Discontinued Operation, Debt</a></td>
<td class="nump">$ 1,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CashTransferRelatedToSpinoffTransaction', window );">Cash Transfer Related to Spinoff Transaction</a></td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member', window );">Notes 6.750% due February 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation | Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CashTransferRelatedToSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Transfer Related to Spinoff Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CashTransferRelatedToSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operation, Consideration, Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 60<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6406278&amp;loc=d3e26268-112671<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517461200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Disposal Group, Including Discontinued Operation, Revenue</a></td>
<td class="nump">538<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense', window );">Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense', window );">Disposal Group, Including Discontinued Operations, Research and Development Expense</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges', window );">Disposal Groups, Including Discontinued Operation, Acquisition Related Costs and Restructuring Charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet', window );">Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Disposal Group, Including Discontinued Operation, Operating Expense</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Disposal Group, Including Discontinued Operation, Interest Expense</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense', window );">Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Discontinued Operation, Tax Effect of Discontinued Operation</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from Discontinued Operations, Net of Tax</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Research and Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1063-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1060-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517098816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Spin-Off of Embecta Corp. - Assets and Liabilities of Discontinued Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets of discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Noncurrent Liabilities of Discontinued Operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember', window );">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Disposal Group, Including Discontinued Operation, Inventory, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Disposal Group, Including Discontinued Operation, Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Disposal Group, Including Discontinued Operation, Accounts Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Disposal Group, Including Discontinued Operation, Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent', window );">Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Disposal Group, Including Discontinued Operation, Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Noncurrent Liabilities of Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127518152544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 23,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares)</a></td>
<td class="num">(80,163,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 1,779<span></span>
</td>
<td class="nump">$ 2,092<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 25,282<span></span>
</td>
<td class="nump">$ 23,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares)</a></td>
<td class="num">(81,283,191)<span></span>
</td>
<td class="num">(80,163,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock&#160; Issued at&#160;Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital in Excess&#160;of Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">19,272<span></span>
</td>
<td class="nump">19,270<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation and other plans, net</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="nump">150<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">19,553<span></span>
</td>
<td class="nump">19,272<span></span>
</td>
<td class="nump">19,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">13,826<span></span>
</td>
<td class="nump">12,791<span></span>
</td>
<td class="nump">12,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">1,779<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends, common</a></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(958)<span></span>
</td>
<td class="num">(888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends, Preferred Stock</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation and other plans, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="nump">634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">15,157<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
<td class="nump">12,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Stockholders' Equity, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="num">$ (6,138)<span></span>
</td>
<td class="num">$ (6,190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares)</a></td>
<td class="num">(80,164,000)<span></span>
</td>
<td class="num">(74,623,000)<span></span>
</td>
<td class="num">(76,260,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation and other plans, net</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation plans, net (shares)</a></td>
<td class="nump">1,271,000<span></span>
</td>
<td class="nump">1,068,000<span></span>
</td>
<td class="nump">1,597,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_CommonStockHeldInTrustsNetShares', window );">Common stock held in trusts, net (shares)</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="num">$ (650)<span></span>
</td>
<td class="num">$ (1,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="num">(2,415,000)<span></span>
</td>
<td class="num">(6,643,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (8,330)<span></span>
</td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="num">$ (6,138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares)</a></td>
<td class="num">(81,283,000)<span></span>
</td>
<td class="num">(80,164,000)<span></span>
</td>
<td class="num">(74,623,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_CommonStockHeldInTrustsNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common stock shares held in trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_CommonStockHeldInTrustsNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 60<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6406278&amp;loc=d3e26268-112671<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127516053424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail II) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Common stock dividend per share (USD per share)</a></td>
<td class="nump">$ 3.48<span></span>
</td>
<td class="nump">$ 3.32<span></span>
</td>
<td class="nump">$ 3.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513343760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Additional Information (Detail)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>agreement </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 01, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 24, 2013 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 306,000,000<span></span>
</td>
<td class="nump">$ 383,000,000<span></span>
</td>
<td class="num">$ (338,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bdx_AcceleratedShareRepurchaseProgramMember', window );">Accelerated Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram', window );">Total Shares to be Delivered Under Accelerated Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_NumberOfTransactions', window );">Number of Transactions | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">4,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=bdx_OpenMarketRepurchasesMember', window );">Open Market Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
<td class="nump">6,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock | Accelerated Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock | Open Market Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes | $</a></td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,000,000<span></span>
</td>
<td class="nump">$ 187,000,000<span></span>
</td>
<td class="num">$ (101,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible Preferred Stock, Shares Issued upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible Preferred Stock, Shares Issued upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_GrossProceedsFromIssuanceOfEquity', window );">Gross Proceeds from Issuance of Equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage', window );">Preferred Stock, Depositary Share Ownership Interest, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,459,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DepositaryShareLiquidation', window );">Depositary Share Liquidation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock&#160; Issued at&#160;Par&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible Preferred Stock, Shares Issued upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_GrossProceedsFromIssuanceOfEquity', window );">Gross Proceeds from Issuance of Equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,459,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DepositaryShareLiquidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of depositary shares (which represent nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer and that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DepositaryShareLiquidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_GrossProceedsFromIssuanceOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross cash proceeds from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_GrossProceedsFromIssuanceOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_PreferredStockDepositaryShareOwnershipInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest per depositary share of the Company's preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_PreferredStockDepositaryShareOwnershipInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Shares to be Delivered Under Accelerated Share Repurchase Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bdx_AcceleratedShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bdx_AcceleratedShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=bdx_OpenMarketRepurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=bdx_OpenMarketRepurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517073232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,088)<span></span>
</td>
<td class="num">$ (2,548)<span></span>
</td>
<td class="num">$ (2,283)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="num">(338)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,488)<span></span>
</td>
<td class="num">(2,088)<span></span>
</td>
<td class="num">(2,548)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(1,416)<span></span>
</td>
<td class="num">(1,256)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(987)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(1,416)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit&#160;Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(784)<span></span>
</td>
<td class="num">(1,040)<span></span>
</td>
<td class="num">(1,005)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="num">(784)<span></span>
</td>
<td class="num">(1,040)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss before reclassifications, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified into income, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Spin-off of Embecta (See Note 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (91)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 60<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6406278&amp;loc=d3e26268-112671<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523624992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Other Comprehensive Income (Loss), Tax (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income</a></td>
<td class="num">$ (47)<span></span>
</td>
<td class="num">$ (42)<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520517072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average common shares outstanding (shares)</a></td>
<td class="nump">285,005<span></span>
</td>
<td class="nump">289,288<span></span>
</td>
<td class="nump">278,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive share equivalents from share-based plans (shares)</a></td>
<td class="nump">2,333<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
<td class="nump">3,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Dilutive share equivalents from Series C preferred shares (in shares)</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average common and common equivalent shares outstanding - assuming dilution (shares)</a></td>
<td class="nump">287,364<span></span>
</td>
<td class="nump">292,089<span></span>
</td>
<td class="nump">282,402<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520582800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share Footnotes (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517447632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>lawsuit </div>
<div>plaintiff </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Aggregate future purchase commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Product Liability Accrual, Period Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember', window );">Gwinnett County, Georgia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_NumberOfEtOSterilizationLawsuits', window );">Number of EtO Sterilization Lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants', window );">Number of lawsuits, allege injury from unrelated defendants | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember', window );">Gwinnett County, Georgia | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages Sought, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Product Liability Accrual, Period Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 361,000<span></span>
</td>
<td class="nump">$ 378,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember', window );">HerniaProductClaims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfEtOSterilizationLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of EtO Sterilization Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfEtOSterilizationLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bdx_GwinnettCountyGeorgiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=bdx_HerniaProductClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512784496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ContractWithCustomerRebateLiability', window );">Rebate liability</a></td>
<td class="nump">$ 525<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01 | Products and/or Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01 | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ContractWithCustomerRebateLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Rebate Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ContractWithCustomerRebateLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-10-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bdx_ProductsandorServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bdx_ProductsandorServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bdx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bdx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127515998464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>customer </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of principal business segments (segments) | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue', window );">Number of customers accounted for 10% or more of revenues (customers) | customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Product Liability Accrual, Period Expense</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember', window );">Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Product Liability Accrual, Period Expense</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 361<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Customer Accounted For Ten Percent Or More Of Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512070144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data Segment Data - Revenues by Geographic Areas (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 18,870<span></span>
</td>
<td class="nump">$ 19,131<span></span>
</td>
<td class="nump">$ 16,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,841<span></span>
</td>
<td class="nump">8,361<span></span>
</td>
<td class="nump">7,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">5,564<span></span>
</td>
<td class="nump">6,530<span></span>
</td>
<td class="nump">4,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,464<span></span>
</td>
<td class="nump">4,239<span></span>
</td>
<td class="nump">3,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">10,722<span></span>
</td>
<td class="nump">10,371<span></span>
</td>
<td class="nump">9,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,950<span></span>
</td>
<td class="nump">4,544<span></span>
</td>
<td class="nump">4,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,732<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="nump">2,847<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,148<span></span>
</td>
<td class="nump">8,760<span></span>
</td>
<td class="nump">6,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,833<span></span>
</td>
<td class="nump">3,550<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,308<span></span>
</td>
<td class="nump">4,101<span></span>
</td>
<td class="nump">3,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,483<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">1,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember', window );">Medication Delivery Solutions | Non-US | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,825<span></span>
</td>
<td class="nump">1,848<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">2,432<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">1,863<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember', window );">Medication Management Solutions | Non-US | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">598<span></span>
</td>
<td class="nump">570<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | United States | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember', window );">Pharmaceutical Systems | Non-US | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,468<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,185<span></span>
</td>
<td class="nump">5,225<span></span>
</td>
<td class="nump">3,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,190<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">1,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember', window );">Integrated Diagnostic Solutions | Non-US | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">2,748<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | United States | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember', window );">Biosciences | Non-US | Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="nump">678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,094<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember', window );">Surgery | Non-US | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,759<span></span>
</td>
<td class="nump">1,711<span></span>
</td>
<td class="nump">1,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">960<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="nump">871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember', window );">Peripheral Intervention | Non-US | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">780<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">1,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | United States | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">986<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember', window );">Urology and Critical Care | Non-US | Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">$ 338<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_MedicationDeliverySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_MedicationManagementSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_PharmaceuticalSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_IntegratedDiagnosticSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_BiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_BiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_SurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_SurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_PeripheralInterventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OrganizationalUnitAxis=bdx_UrologyandCriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127516123984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Financial Information for Company's Segments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total Capital Expenditures</a></td>
<td class="nump">973<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total Depreciation and Amortization</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">2,230<span></span>
</td>
<td class="nump">2,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">5,006<span></span>
</td>
<td class="nump">5,311<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">2,215<span></span>
</td>
<td class="nump">1,985<span></span>
</td>
<td class="nump">1,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total Capital Expenditures</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">740<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total Depreciation and Amortization</a></td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="nump">2,391<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total Capital Expenditures</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total Depreciation and Amortization</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">933<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total Capital Expenditures</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total Depreciation and Amortization</a></td>
<td class="nump">789<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges', window );">Acquisition-related integration and restructuring expense</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Net interest expense</a></td>
<td class="num">(382)<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="num">(2,668)<span></span>
</td>
<td class="num">(2,981)<span></span>
</td>
<td class="num">(2,573)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total Capital Expenditures</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total Depreciation and Amortization</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_AcquisitionRelatedCostsAndRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_AcquisitionRelatedCostsAndRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517074016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 18,870<span></span>
</td>
<td class="nump">$ 19,131<span></span>
</td>
<td class="nump">$ 16,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">44,792<span></span>
</td>
<td class="nump">44,606<span></span>
</td>
<td class="nump">44,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">10,722<span></span>
</td>
<td class="nump">10,371<span></span>
</td>
<td class="nump">9,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">36,617<span></span>
</td>
<td class="nump">35,896<span></span>
</td>
<td class="nump">36,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,043<span></span>
</td>
<td class="nump">4,548<span></span>
</td>
<td class="nump">3,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">5,126<span></span>
</td>
<td class="nump">5,778<span></span>
</td>
<td class="nump">5,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Greater Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,047<span></span>
</td>
<td class="nump">3,069<span></span>
</td>
<td class="nump">2,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">1,528<span></span>
</td>
<td class="nump">1,607<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bdx_OthersCountryMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">$ 1,079<span></span>
</td>
<td class="nump">$ 860<span></span>
</td>
<td class="nump">$ 753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bdx_OthersCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bdx_OthersCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517055664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost relating to share-based payments</a></td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit recognized</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost relating to share-based payments</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost relating to share-based payments</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost relating to share-based payments</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember', window );">Acquisitions and other restructurings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost relating to share-based payments</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512485760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Additional Information (Detail) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod', window );">SARs vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward', window );">SARs terms of award</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_StockIssuedUnderStockAppreciationRightsExercised', window );">Stock Issued under SARs exercised (in shares)</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased', window );">Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased', window );">Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits', window );">Expected forfeited performance-based restricted stock units (shares)</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_UnitsInExcessOfExpectedPerformancePayout', window );">Units In Excess Of Expected Performance Payout</a></td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense for all non-vested share-based awards</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average remaining life non-vested share-based awards</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares were authorized for future grants</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_SharesIssuableUnderDeferredCompensationPlan', window );">Shares issuable under deferred compensation plan</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesHeldInEmployeeTrustShares', window );">Deferral plan, shares held in trust</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod', window );">Performance period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining vesting term</a></td>
<td class="text">1 year 2 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember', window );">Performance-Based Restricted Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent', window );">Performance payout, percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember', window );">Performance-Based Restricted Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent', window );">Performance payout, percent</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Time-Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining vesting term</a></td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Time-Vested Restricted Stock Units | Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock units vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember', window );">Acquisitions and other restructurings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember', window );">Acquisitions and other restructurings | CR Bard Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment of expected forfeitures to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target payout on which performance-based restricted stock units are based.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the period of time over which an employee's right to exercise an stock appreciation right is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, which may be expressed in a variety of ways (for example, in years, month and year).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The date when stock appreciation rights expire as specified in the award agreement, which may be presented in a variety of ways (for example, year, month and year, day, month and year, quarter of a year).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Payout, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_SharesIssuableUnderDeferredCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable under the Company's Deferred Compensation Plan that allows highly-compensated employees to defer salary, annual incentive awards and certain equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_SharesIssuableUnderDeferredCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_StockIssuedUnderStockAppreciationRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued to satisfy stock appreciation rights exercised during the current year's period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_StockIssuedUnderStockAppreciationRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_UnitsInExcessOfExpectedPerformancePayout">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment of units in excess of expected performance to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_UnitsInExcessOfExpectedPerformancePayout</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesHeldInEmployeeTrustShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16701-113920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesHeldInEmployeeTrustShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bdx_CRBardIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bdx_CRBardIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127522747808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail) - Stock Appreciation Rights (SARs) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.41%<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
<td class="nump">1.69%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.42%<span></span>
</td>
<td class="nump">1.46%<span></span>
</td>
<td class="nump">1.24%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value derived (USD per share)</a></td>
<td class="nump">$ 49.45<span></span>
</td>
<td class="nump">$ 44.38<span></span>
</td>
<td class="nump">$ 48.82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517440144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of SARs Outstanding (Detail)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber', window );">SARs, beginning balance (shares)</a></td>
<td class="nump">6,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod', window );">SARs, granted (shares)</a></td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod', window );">SARs, exercised (shares)</a></td>
<td class="num">(1,408)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod', window );">SARs, forfeited, canceled or expired (shares)</a></td>
<td class="num">(191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction', window );">Embecta spin-off adjustment (shares)</a></td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment', window );">Adjustments to BD awards related to the spin-off of Embecta (shares)</a></td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber', window );">SARs, ending balance (shares)</a></td>
<td class="nump">5,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber', window );">SARs, Vested and expected to vest at ending balance (shares)</a></td>
<td class="nump">5,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber', window );">SARs, Exercisable at ending balance (shares)</a></td>
<td class="nump">3,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, beginning balance (USD per share) | $ / shares</a></td>
<td class="nump">$ 179.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, granted (USD per share) | $ / shares</a></td>
<td class="nump">245.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, exercised (USD per share) | $ / shares</a></td>
<td class="nump">125.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, forfeited, canceled or expired (USD per share) | $ / shares</a></td>
<td class="nump">234.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice', window );">Embecta spin-off adjustment (USD per share) | $ / shares</a></td>
<td class="nump">239.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, ending balance (USD per share) | $ / shares</a></td>
<td class="nump">197.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, vested and expected to vest (USD per share) | $ / shares</a></td>
<td class="nump">196.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice', window );">SARs, weighted average exercise price, exercisable (USD per share) | $ / shares</a></td>
<td class="nump">$ 180.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm', window );">SARs, weighted average remaining contractual term</a></td>
<td class="text">5 years 7 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm', window );">SARs, weighted average remaining contractual term, vested and expected to vest</a></td>
<td class="text">5 years 6 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm', window );">SARs, weighted average remaining contractual term, exercisable</a></td>
<td class="text">4 years 6 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue', window );">SARs, aggregate intrinsic value | $</a></td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">SARs, aggregate intrinsic value, vested and expected to vest | $</a></td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue', window );">SARs, aggregate intrinsic value, exercisable | $</a></td>
<td class="nump">$ 183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of exercisable stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of stock appreciation rights outstanding and currently exercisable under the award plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock appreciation rights exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of stock appreciation rights that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of stock appreciation rights granted during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for stock appreciation rights issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate intrinsic value for outstanding stock appreciation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of stock appreciation rights that validly exist and are outstanding as of the balance sheet date, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price of shares reserved for issuance under stock appreciation right incentive compensation plan that validly exist and are outstanding as of the balance sheet date, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual term for outstanding stock appreciation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Spin-Off Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate intrinsic value for stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate intrinsic value for stock appreciation rights that are exercisable as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual term for stock appreciation rights that are exercisable as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price at which option holders exercised stock appreciation awards during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price of stock appreciation rights that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual term for stock appreciation rights that are fully vested or are expected to vest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520216976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Summary of SARs Exercised (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue', window );">Total intrinsic value of SARs exercised</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FairValueOfStockAppreciationRights', window );">Total fair value of SARs vested</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FairValueOfStockAppreciationRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total fair value of stock appreciation rights that have vested during the fiscal year period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FairValueOfStockAppreciationRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total accumulated difference between fair values of underlying shares on dates of exercise and exercise price on stock appreciation rights which were exercised during the reporting period under the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517786704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Stock units, beginning balance (shares)</a></td>
<td class="nump">957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, sock units (shares)</a></td>
<td class="nump">390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Distributed, stock units (shares)</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, canceled or expired, stock units (shares)</a></td>
<td class="num">(369)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction', window );">Awards transferred to Embecta at spin-off (shares)</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment', window );">Embecta spin-off adjustment (shares)</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Stock units, ending balance (shares)</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest', window );">Stock units, vested and expected to vest at ending balance (shares)</a></td>
<td class="nump">483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock units exercise price, beginning balance (USD per share)</a></td>
<td class="nump">$ 231.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, stock units weighted average grant date fair value (USD per share)</a></td>
<td class="nump">242.39<span></span>
</td>
<td class="nump">$ 216.39<span></span>
</td>
<td class="nump">$ 245.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Distributed, stock units exercise price (USD per share)</a></td>
<td class="nump">237.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, canceled or expired, stock units exercise price (USD per share)</a></td>
<td class="nump">235.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue', window );">Awards transferred to Embecta at the spin-off of Embecta (USD per share)</a></td>
<td class="nump">234.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock units exercise price, ending balance (USD per share)</a></td>
<td class="nump">230.46<span></span>
</td>
<td class="nump">$ 231.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest', window );">Stock units, vested and expected to vest at ending balance, exercise price (USD per share)</a></td>
<td class="nump">$ 229.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Time-Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Stock units, beginning balance (shares)</a></td>
<td class="nump">1,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, sock units (shares)</a></td>
<td class="nump">969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Distributed, stock units (shares)</a></td>
<td class="num">(524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, canceled or expired, stock units (shares)</a></td>
<td class="num">(378)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction', window );">Awards transferred to Embecta at spin-off (shares)</a></td>
<td class="num">(88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment', window );">Embecta spin-off adjustment (shares)</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Stock units, ending balance (shares)</a></td>
<td class="nump">1,561<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest', window );">Stock units, vested and expected to vest at ending balance (shares)</a></td>
<td class="nump">1,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock units exercise price, beginning balance (USD per share)</a></td>
<td class="nump">$ 221.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, stock units weighted average grant date fair value (USD per share)</a></td>
<td class="nump">239.39<span></span>
</td>
<td class="nump">$ 223.60<span></span>
</td>
<td class="nump">$ 249.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Distributed, stock units exercise price (USD per share)</a></td>
<td class="nump">224.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, canceled or expired, stock units exercise price (USD per share)</a></td>
<td class="nump">228.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue', window );">Awards transferred to Embecta at the spin-off of Embecta (USD per share)</a></td>
<td class="nump">237.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock units exercise price, ending balance (USD per share)</a></td>
<td class="nump">224.87<span></span>
</td>
<td class="nump">$ 221.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest', window );">Stock units, vested and expected to vest at ending balance, exercise price (USD per share)</a></td>
<td class="nump">$ 224.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Spin-Off Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred due to Spinoff Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred in Spinoff Transaction, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520271808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Weighted Average Grant Date Fair Value of Restricted Stock Units (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems', window );"><strong>Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, stock units weighted average grant date fair value (USD per share)</a></td>
<td class="nump">$ 242.39<span></span>
</td>
<td class="nump">$ 216.39<span></span>
</td>
<td class="nump">$ 245.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Time-Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems', window );"><strong>Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, stock units weighted average grant date fair value (USD per share)</a></td>
<td class="nump">$ 239.39<span></span>
</td>
<td class="nump">$ 223.60<span></span>
</td>
<td class="nump">$ 249.94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512871168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Fair Value of Stock Units Vested (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems', window );"><strong>Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted stock units</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Time-Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems', window );"><strong>Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted stock units</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517089792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Net Pension and Other Postretirement Cost (Detail) - Pension Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(187)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of loss</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailment/settlement loss</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net pension cost</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net pension cost</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513249968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts recognized in the Consolidated Balance Sheets at September&#160;30:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term Employee Benefit Obligations</a></td>
<td class="num">$ (902)<span></span>
</td>
<td class="num">$ (1,228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Beginning obligation</a></td>
<td class="nump">3,889<span></span>
</td>
<td class="nump">3,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation', window );">Impact of Embecta spin-off</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(1,007)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment', window );">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherChanges', window );">Other, includes translation</a></td>
<td class="nump">143<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Ending obligation</a></td>
<td class="nump">2,634<span></span>
</td>
<td class="nump">3,889<span></span>
</td>
<td class="nump">3,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in fair value of plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning fair value</a></td>
<td class="nump">3,222<span></span>
</td>
<td class="nump">3,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(740)<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets', window );">Impact of Embecta spin-off</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(241)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Other, includes translation</a></td>
<td class="num">(127)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending fair value</a></td>
<td class="nump">2,242<span></span>
</td>
<td class="nump">3,222<span></span>
</td>
<td class="nump">$ 3,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract', window );"><strong>Funded Status at September&#160;30:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Unfunded benefit obligation</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts recognized in the Consolidated Balance Sheets at September&#160;30:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other Assets</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Salaries, wages and related items</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term Employee Benefit Obligations</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Net amount recognized</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract', window );"><strong>Amounts recognized in Accumulated other comprehensive income (loss) before income taxes at September&#160;30:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service credit</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="num">(728)<span></span>
</td>
<td class="num">(972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Net amount recognized</a></td>
<td class="num">$ (704)<span></span>
</td>
<td class="num">$ (931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes to benefit obligation which arose from business combination and/or divestiture transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change to plan assets which arose from business combination and/or divestiture transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512712928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_PercentOfAssetsDomesticPlans', window );">Percent of total assets domestic plans</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Cost of the savings incentive plan</a></td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember', window );">Fixed Income Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Company's Target allocation percentage for asset mix</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_DiversifiedMember', window );">Diversified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Company's Target allocation percentage for asset mix</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Company's Target allocation percentage for asset mix</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Pension plan assets at fair value</a></td>
<td class="nump">$ 2,242<span></span>
</td>
<td class="nump">3,222<span></span>
</td>
<td class="nump">3,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Pension plan projected benefit obligations</a></td>
<td class="nump">2,634<span></span>
</td>
<td class="nump">3,889<span></span>
</td>
<td class="nump">$ 3,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plans | Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Pension plan assets at fair value</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Pension plan projected benefit obligations</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_PercentOfPlanAssetsForeignPlans', window );">Percent of total plan assets foreign plans</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plans | Pension Plans | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Pension plan assets at fair value</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Pension plan assets at fair value</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Pension Plans | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Pension plan assets at fair value</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Other&#160;Postretirement&#160;Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Pension plan projected benefit obligations</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_PercentOfAssetsDomesticPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to domestic pension plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_PercentOfAssetsDomesticPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_PercentOfPlanAssetsForeignPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to foreign pension plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_PercentOfPlanAssetsForeignPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_DiversifiedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_DiversifiedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520791232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Accumulated benefit obligation exceeds the fair value of plan assets, projected benefit obligation</a></td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="nump">$ 3,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation', window );">Projected benefit obligation exceeds the fair value of plan assets, projected benefit obligation</a></td>
<td class="nump">2,182<span></span>
</td>
<td class="nump">3,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation exceeds the fair value of plan assets, accumulated benefit obligation</a></td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">3,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Accumulated benefit obligation exceeds the fair value of plan assets, fair value of plan assets</a></td>
<td class="nump">1,644<span></span>
</td>
<td class="nump">2,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets', window );">Projected benefit obligation exceeds the fair value of plan assets, fair value of plan assets</a></td>
<td class="nump">$ 1,720<span></span>
</td>
<td class="nump">$ 2,780<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127522755680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail) - Pension Plans<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.89%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.21%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
<td class="nump">7.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">4.31%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.29%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit Obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.62%<span></span>
</td>
<td class="nump">2.89%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">4.51%<span></span>
</td>
<td class="nump">4.31%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.44%<span></span>
</td>
<td class="nump">1.39%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">4.84%<span></span>
</td>
<td class="nump">4.92%<span></span>
</td>
<td class="nump">5.05%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.63%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</a></td>
<td class="nump">2.02%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.97%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit Obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.26%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.44%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.86%<span></span>
</td>
<td class="nump">2.63%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</a></td>
<td class="nump">1.98%<span></span>
</td>
<td class="nump">2.02%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127522947744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Expected Benefit Payments (Detail) - Pension Plans<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">$ 945<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127508435312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans - Fair Value Measurements of Plan Assets (Detail) - Pension Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 2,242<span></span>
</td>
<td class="nump">$ 3,222<span></span>
</td>
<td class="nump">$ 3,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plans | Insurance contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Net Asset Value | United States | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | United States | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1 | Foreign Plans | Insurance contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | United States | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;2 | Foreign Plans | Insurance contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | United States | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Government and agency-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Government and agency-Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Other fixed income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level&#160;3 | Foreign Plans | Insurance contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherFixedIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherFixedIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherPensionPlanInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherPensionPlanInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_InsuranceContractInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_InsuranceContractInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127515984704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 18, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,621<span></span>
</td>
<td class="nump">$ 23,886<span></span>
</td>
<td class="nump">$ 23,604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bdx_ParataSystemsMember', window );">Parata Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 1,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets', window );">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bdx_ParataSystemsMember', window );">Parata Systems | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bdx_ParataSystemsMember', window );">Parata Systems | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bdx_ParataSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bdx_ParataSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127518393824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Restructuring Charges - Changes in Restructuring Balance (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash settlements</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Other adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to expense</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash settlements</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Other adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512392080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Components of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 20,987<span></span>
</td>
<td class="nump">$ 20,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(8,723)<span></span>
</td>
<td class="num">(7,381)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">12,264<span></span>
</td>
<td class="nump">12,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">15,087<span></span>
</td>
<td class="nump">14,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5,979)<span></span>
</td>
<td class="num">(4,983)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">9,108<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">4,853<span></span>
</td>
<td class="nump">4,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,170)<span></span>
</td>
<td class="num">(1,838)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">2,683<span></span>
</td>
<td class="nump">2,815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember', window );">Product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Patents and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite And Indefinite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite And Indefinite Lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520926944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible amortization expense</a></td>
<td class="nump">$ 1,430<span></span>
</td>
<td class="nump">$ 1,402<span></span>
</td>
<td class="nump">$ 1,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated aggregate amortization expense in 2022</a></td>
<td class="nump">1,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated aggregate amortization expense in 2023</a></td>
<td class="nump">1,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated aggregate amortization expense in 2024</a></td>
<td class="nump">1,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated aggregate amortization expense in 2025</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated aggregate amortization expense in 2026</a></td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512488176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 23,886<span></span>
</td>
<td class="nump">$ 23,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(337)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">24,621<span></span>
</td>
<td class="nump">23,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">10,240<span></span>
</td>
<td class="nump">10,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">814<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(145)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">10,909<span></span>
</td>
<td class="nump">10,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember', window );">Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">836<span></span>
</td>
<td class="nump">837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember', window );">Interventional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">12,810<span></span>
</td>
<td class="nump">12,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 12,824<span></span>
</td>
<td class="nump">$ 12,810<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_InterventionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520752064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_DebtMember', window );">Debt | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 2,140<span></span>
</td>
<td class="nump">$ 2,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">2,766<span></span>
</td>
<td class="nump">2,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">1,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember', window );">Fixed To Floating | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_DebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_DebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513288320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="num">$ (67)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent', window );">Net after-tax gain upon termination of contract</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss) Upon Termination Of Derivative Instrument, After Reclassification And Tax, Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520201472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="num">$ (161)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">173<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">$ (109)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_TerminatedCurrencySwapMember', window );">Terminated Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bdx_TerminatedCurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bdx_TerminatedCurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520948864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurement - Cash and Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted Cash and Investments, Current</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="nump">$ 2,392<span></span>
</td>
<td class="nump">$ 2,917<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523810032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Institutional money market investments</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm', window );">Fair value of debt classified from long term to short term</a></td>
<td class="nump">1,927<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableFairValueDisclosure', window );">Fair value of long-term debt</a></td>
<td class="nump">$ 12,119<span></span>
</td>
<td class="nump">$ 18,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Debt Classified From Long Term To Short Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127522733408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_MaturityPeriodOfShortTermInvestment', window );">Maturity period of short-term investments at the time of purchase</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_MaturityPeriodOfShortTermInvestment', window );">Maturity period of short-term investments at the time of purchase</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember', window );">Life Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember', window );">Life Sciences | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember', window );">Medical | Acquisitions and other restructurings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_MaturityPeriodOfShortTermInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_MaturityPeriodOfShortTermInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedCostsAndRestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127523810160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_TransfersOfFinancialAssetsDuringThePeriod', window );">Transfers of financial assets during the period.</a></td>
<td class="nump">$ 1,215<span></span>
</td>
<td class="nump">$ 1,189<span></span>
</td>
<td class="nump">$ 1,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="nump">$ 323<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_TransfersOfFinancialAssetsDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfers of financial assets during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_TransfersOfFinancialAssetsDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512485408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Short-Term Debt (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">$ 2,179<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.000dueDecember152022Member', window );">1.000% Notes due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 487<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member', window );">Floating Rate Notes Due June 6, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1401DueMay232023Member', window );">Notes 1.401% due May 23, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.401%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.632dueJune42023Member', window );">0.632% Notes due June 4, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.632%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 779<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member', window );">0.000% Notes due August 13, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.000dueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1.000dueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1401DueMay232023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1401DueMay232023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.632dueJune42023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0.632dueJune42023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513014656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Short-term debt, weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.15%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate annual maturities of long-term debt, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate annual maturities of long-term debt, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Aggregate annual maturities of long-term debt, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Aggregate annual maturities of long-term debt, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Aggregate annual maturities of long-term debt, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_LettersOfCreditIssuableUnderCreditFacility', window );">Letters Of Credit Issuable Under Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_SwinglineLoansIssuableUnderCreditFacility', window );">Swingline Loans Issuable Under Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments', window );">Line Of Credit Facility Maximum Additional Principal Amount Commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
<td class="nump">13,886<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes5000DueFebruary152030Member', window );">Notes 5.000% due February 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member', window );">Notes 6.750% due February 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member', window );">Floating Rate Notes Due June 6, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member', window );">Floating Rate Notes Due June 6, 2022 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility due December 29, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings under credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility due December 29, 2022 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of Credit Facility, Current Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember', window );">Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_LettersOfCreditIssuableUnderCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Letters of credit amount issuable under credit facility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_LettersOfCreditIssuableUnderCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional funding available, subject to additional commitments made by lenders, under Company's syndicated credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_SwinglineLoansIssuableUnderCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Swingline Loans Issuable Under Credit Facility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_SwinglineLoansIssuableUnderCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes5000DueFebruary152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes5000DueFebruary152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes6750DueFebruary152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_FloatingRateNotesDueJune62022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512068864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Long-Term Debt (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 13,886<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.000dueDecember152022Member', window );">1.000% Notes due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.401dueMay242023Member', window );">1.401% Notes due May 24, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.401%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.632dueJune42023Member', window );">0.632% Notes due June 4, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.632%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member', window );">0.000% Notes due August 13, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member', window );">3.875% Notes due May 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member', window );">3.363% Notes due June 6, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.363%<span></span>
</td>
<td class="nump">3.363%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">$ 994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member', window );">3.734% Notes due December 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.734%<span></span>
</td>
<td class="nump">3.734%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 873<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.02dueMay242025Member', window );">3.020% Notes due May 24, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member', window );">0.034% Notes due August 13, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.034%<span></span>
</td>
<td class="nump">0.034%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.208dueJune42026Member', window );">1.208% Notes due June 4, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.208%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes6.700dueDecember12026Member', window );">6.700% Notes due December 1, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.900dueDecember152026Member', window );">1.900% Notes due December 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.700dueJune62027Member', window );">3.700% Notes due June 6, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 1,718<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member', window );">7.000% Debentures due August&#160;1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member', window );">6.700% Debentures due August&#160;1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member', window );">0.334% Notes due August 13, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.334%<span></span>
</td>
<td class="nump">0.334%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 872<span></span>
</td>
<td class="nump">$ 1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes2823DueMay202030Member', window );">2.823% Notes due May 20, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">2.823%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 745<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1957DueFebruary112031Member', window );">1.957% Notes due February 11, 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.957%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.957%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 992<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4298DueAugust222032Member', window );">4.298% Notes due August 22, 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.298%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member', window );">1.213% Notes due February 12, 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.213%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member', window );">6.000% Notes due May&#160;15, 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member', window );">5.000% Notes due November&#160;12, 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member', window );">1.336% Notes due August 13, 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.336%<span></span>
</td>
<td class="nump">1.336%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 869<span></span>
</td>
<td class="nump">$ 1,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.875dueMay152044Member', window );">4.875% Notes due May 15, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member', window );">4.685% Notes due December 15, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.685%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.669DueJune62047Member', window );">4.669% Notes due June 6, 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.669%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="nump">1,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member', window );">3.794% Notes due May 20, 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.794%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">$ 742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.000dueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1.000dueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.401dueMay242023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1.401dueMay242023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.632dueJune42023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0.632dueJune42023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.02dueMay242025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.02dueMay242025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.208dueJune42026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1.208dueJune42026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes6.700dueDecember12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes6.700dueDecember12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1.900dueDecember152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1.900dueDecember152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.700dueJune62027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.700dueJune62027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes2823DueMay202030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes2823DueMay202030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1957DueFebruary112031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1957DueFebruary112031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4298DueAugust222032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4298DueAugust222032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.875dueMay152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4.875dueMay152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.669DueJune62047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4.669DueJune62047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513179856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt Issuances (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4298DueAugust222032Member', window );">4.298% Notes due August 22, 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.298%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1957DueFebruary112031Member', window );">1.957% Notes due February 11, 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.957%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.957%<span></span>
</td>
<td class="nump">1.957%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member', window );">Notes 3.125% due November 8, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member', window );">0.000% Notes due August 13, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member', window );">0.000% Notes due August 13, 2023 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member', window );">0.000% Notes due August 13, 2023 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member', window );">0.034% Notes due August 13, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.034%<span></span>
</td>
<td class="nump">0.034%<span></span>
</td>
<td class="nump">0.034%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member', window );">0.034% Notes due August 13, 2025 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member', window );">0.034% Notes due August 13, 2025 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member', window );">0.334% Notes due August 13, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">0.334%<span></span>
</td>
<td class="nump">0.334%<span></span>
</td>
<td class="nump">0.334%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member', window );">0.334% Notes due August 13, 2028 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member', window );">0.334% Notes due August 13, 2028 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member', window );">1.336% Notes due August 13, 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.336%<span></span>
</td>
<td class="nump">1.336%<span></span>
</td>
<td class="nump">1.336%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member', window );">1.336% Notes due August 13, 2041 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member', window );">1.336% Notes due August 13, 2041 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member', window );">1.213% Notes due February 12, 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.213%<span></span>
</td>
<td class="nump">1.213%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member', window );">1.213% Notes due February 12, 2036 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member', window );">1.213% Notes due February 12, 2036 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member', window );">Notes 0.174% due June 4, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.174%<span></span>
</td>
<td class="nump">0.174%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4298DueAugust222032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4298DueAugust222032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1957DueFebruary112031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1957DueFebruary112031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0000DueAugust132023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0034DueAugust132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0334DueAugust132028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1336DueAugust132041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes1213DueFebruary122036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127509633072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Extinguishments of Debt (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 13,886<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,886<span></span>
</td>
<td class="nump">$ 17,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_BdxGainlossfromreversetrasurylocks', window );">bdx:Gain(loss)fromreversetrasurylocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member', window );">3.794% Notes due May 20, 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.794%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.794%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member', window );">3.794% Notes due May 20, 2050 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member', window );">7.000% Debentures due August&#160;1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member', window );">7.000% Debentures due August&#160;1, 2027 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member', window );">6.700% Debentures due August&#160;1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member', window );">6.700% Debentures due August&#160;1, 2028 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member', window );">6.000% Notes due May&#160;15, 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member', window );">6.000% Notes due May&#160;15, 2039 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member', window );">5.000% Notes due November&#160;12, 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member', window );">5.000% Notes due November&#160;12, 2040 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member', window );">4.685% Notes due December 15, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.685%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.685%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member', window );">4.685% Notes due December 15, 2044 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes2894DueJune62022Member', window );">Notes 2.894% due June 6, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.894%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.894%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.894%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes2894DueJune62022Member', window );">Notes 2.894% due June 6, 2022 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.300dueMarch12023Member', window );">Notes 3.300% due March 1, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.300dueMarch12023Member', window );">Notes 3.300% due March 1, 2023 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member', window );">3.875% Notes due May 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member', window );">3.875% Notes due May 15, 2024 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member', window );">3.734% Notes due December 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.734%<span></span>
</td>
<td class="nump">3.734%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.734%<span></span>
</td>
<td class="nump">3.734%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 873<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member', window );">3.734% Notes due December 15, 2024 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member', window );">3.363% Notes due June 6, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.363%<span></span>
</td>
<td class="nump">3.363%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.363%<span></span>
</td>
<td class="nump">3.363%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">$ 994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">$ 994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member', window );">3.363% Notes due June 6, 2024 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member', window );">Notes 3.125% due November 8, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member', window );">Notes 3.125% due November 8, 2021 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member', window );">Notes 0.174% due June 4, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.174%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.174%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member', window );">Notes 0.174% due June 4, 2021 | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member', window );">Notes 0.174% due June 4, 2021 | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member', window );">Notes 0.174% due June 4, 2021 | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, Repurchased Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_BdxGainlossfromreversetrasurylocks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>bdx:Gain(loss)fromreversetrasurylocks</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_BdxGainlossfromreversetrasurylocks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3794DueMay202050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_DebenturesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_NotesDue2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_NotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes4.685dueDecember152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes2894DueJune62022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes2894DueJune62022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.300dueMarch12023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.300dueMarch12023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.875dueMay152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.734DueDecember152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3.363DueJune62024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes3125DueNovember82021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bdx_Notes0.174dueJune42021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127519965840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Summary of Interest Costs and Payments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Charged to operations</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
<td class="nump">$ 528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsIncurred', window );">Total interest costs</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of amounts capitalized</a></td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 515<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total interest costs incurred during the period and either capitalized or charged against earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512515872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision for Income Taxes from Continuing Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="num">$ (68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local, including Puerto Rico</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total, Current</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Domestic</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total, Deferred</a></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits interest and penalties reflected in current year</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127512419968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic, including Puerto Rico</a></td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="num">$ (579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from Continuing Operations Before Income Taxes</a></td>
<td class="nump">$ 1,783<span></span>
</td>
<td class="nump">$ 1,692<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127521986752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Deferred Income Taxes and Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_IndemnificationLiabilityNoncurrent', window );">Indemnification liability, non-current</a></td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_IncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_IncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_IndemnificationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indemnification Liability, Non-current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_IndemnificationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517463104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at October&#160;1</a></td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Increase due to acquisitions</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase due to current year tax positions</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase due to prior year tax positions</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases due to prior year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Decrease due to settlements with tax authorities</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease due to lapse of statute of limitations</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at September&#160;30</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">$ 348<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 719<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127519970256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation and benefits, assets</a></td>
<td class="nump">$ 430<span></span>
</td>
<td class="nump">$ 524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards', window );">Loss and credit carryforwards, assets</a></td>
<td class="nump">2,185<span></span>
</td>
<td class="nump">2,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other, assets</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred income taxes, assets, gross</a></td>
<td class="nump">3,271<span></span>
</td>
<td class="nump">3,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, assets</a></td>
<td class="num">(2,093)<span></span>
</td>
<td class="num">(2,036)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred income taxes, assets</a></td>
<td class="nump">1,178<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment, liabilities</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Deferred Tax Liabilities, Other Finite-Lived Assets</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">2,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other, liabilities</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DeferredTaxLiabilitiesGross', window );">Deferred income taxes, liabilities, gross</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">2,684<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred income taxes, liabilities</a></td>
<td class="nump">$ 2,674<span></span>
</td>
<td class="nump">$ 2,684<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DeferredTaxLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total cumulative amount of all deferred tax liabilities as presented in the table of deferred income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DeferredTaxLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherTaxCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513292032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal tax benefit</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(2.70%)<span></span>
</td>
<td class="num">(5.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign income tax at rates other than 21%</a></td>
<td class="num">(7.30%)<span></span>
</td>
<td class="num">(6.40%)<span></span>
</td>
<td class="num">(17.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Effect of foreign operations</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">44.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Effect of Research Credits and FDII/Domestic Production Activities</a></td>
<td class="num">(2.20%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="num">(11.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation', window );">Effect of share-based compensation</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(10.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets', window );">Effect of gain on divestitures</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(10.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effect of valuation allowance release</a></td>
<td class="num">(5.50%)<span></span>
</td>
<td class="num">(2.20%)<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">14.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Benefit From Share-Based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517987216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax Holiday (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Tax reductions related to tax holidays</a></td>
<td class="nump">$ 284<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare', window );">Income Tax Holiday, Income Tax Benefits Per Share</a></td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520540416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_GrossProceedsFromSaleLeasebackTransaction', window );">Gross Proceeds from Sale Leaseback Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Sale and Leaseback Transaction, Gain (Loss), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Sale Leaseback Transaction, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Sale Leaseback Transaction, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_GrossProceedsFromSaleLeasebackTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Proceeds from Sale Leaseback Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_GrossProceedsFromSaleLeasebackTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionDescriptionAxis=bdx_SaleLeasebackTransactionTermOfContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionDescriptionAxis=bdx_SaleLeasebackTransactionTermOfContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127513219696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Assets<span></span>
</td>
<td class="text">Other Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets recorded in Other Assets</a></td>
<td class="nump">$ 482<span></span>
</td>
<td class="nump">$ 446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued expenses<span></span>
</td>
<td class="text">Accrued expenses<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities recorded in Payables, accrued expenses and other current liabilities</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Deferred Income Taxes and Other Liabilities<span></span>
</td>
<td class="text">Deferred Income Taxes and Other Liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities recorded in Deferred Income Taxes and Other Liabilities</a></td>
<td class="nump">$ 384<span></span>
</td>
<td class="nump">$ 344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517470624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lessee, Operating Lease, Liability, Maturity (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">$ 128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, after Year Five</a></td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, to be Paid</a></td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127520048224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Other Income (Expense), Net (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity Securities, FV-NI, Unrealized Gain (Loss)</a></td>
<td class="num">$ (35)<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign Currency Transaction Gain (Loss), Realized</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Losses on debt extinguishment</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Nonoperating Income (Expense)</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_PensionSettlementExpense', window );">Pension Settlement Expense</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_DeferredCompensationInvestmentIncomeExpense', window );">Deferred Compensation Investment Income (Expense)</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bdx_EmbectaServicesAgreementIncomeLossNet', window );">Embecta services agreement income, net</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_DeferredCompensationInvestmentIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Investment Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_DeferredCompensationInvestmentIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_EmbectaServicesAgreementIncomeLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Embecta Services Agreement Income (Loss), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_EmbectaServicesAgreementIncomeLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdx_PensionSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension Settlement Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdx_PensionSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127516916624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions charged to costs and expenses</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions and other</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance&#160;for Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions charged to costs and expenses</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions and other</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=bdx_ReserveforCashDiscountsMember', window );">Allowance&#160;for Cash Discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions charged to costs and expenses</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions and other</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=bdx_ReserveforCashDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=bdx_ReserveforCashDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127517121952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information - Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Materials</a></td>
<td class="nump">$ 707<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">2,120<span></span>
</td>
<td class="nump">1,734<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 3,224<span></span>
</td>
<td class="nump">$ 2,743<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140127516144400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information - Property, Plant and Equipment, Net (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">3,252<span></span>
</td>
<td class="nump">3,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery, equipment and fixtures</a></td>
<td class="nump">8,769<span></span>
</td>
<td class="nump">8,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, gross</a></td>
<td class="nump">12,415<span></span>
</td>
<td class="nump">12,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">6,402<span></span>
</td>
<td class="nump">6,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">$ 6,012<span></span>
</td>
<td class="nump">$ 6,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>bdx-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bdx="http://www.bd.com/20220930"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:exch="http://xbrl.sec.gov/exch/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bdx-20220930.xsd" xlink:type="simple"/>
    <context id="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:DepositarysharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if549031f297645189d2c585e3072d96b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5dcf0c18b4fd4e3e980d4799086c4754_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i53c38993858547f68214ac6f1981c2a9_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ic042a8d8207c492790faedff680aa856_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5b40bf72179e46d89af6a51aac9400a0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if1596d6db35a42fba0359a8e52d30677_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibb0301f3d94544d0a0b72086db59dd14_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3d85f871f7b24bc5989ba58c61917188_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i72d7bdb2703948fb9aea56ffc9e2f630_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id56b178e0a304ca0929d00a2da01572b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1a48157deb98419da4fff13ef30cc91e_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1682e37dc1c64a0493b113eb3051c55d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i73746dfe5c0f4de7970ccce7ad10430a_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i29f71c0bff93492c9a06e0d87133987e_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:CoreTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if83533f337ff4fffadbe9a69dc3a40cc_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:CoreTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i50001881e1d74dcdb3045e71518d4167_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icb8199c4ea0048a5b80be3d9e50c0d1d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i872f6917a0d147b687cc33b9b703c9e5_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id34e1facad0e439181f5dcf5d5566e02_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic33b9e6159d048938c04eefaef08044d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4396e0c37dc446598a1bfa55a31434e6_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i14247198e9224028bedb55ce3b8f7e27_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i55f01eb74e224d3b859c08b736035bcc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6750DueFebruary152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i779c08f21c7145b69a3c73a02acd692f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i03436c961ff34525b6bc41434568957f_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie11ec78990674c6894d07a12d457c3a3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5c2d5aa49a1e44eaa4bf7f704ff1fbb1_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i296c4706cc7a49a38687e154af3f932b_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i2a2da253f41c4177934228a9aaffc195_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="idbef8604488846208cd4c70898654711_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ic5e1811b72dc462ca90c421e6c5b1693_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i96ac652372b54cc2b0a28ed29bff1415_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5a2a86003dc74c1f8a87c4d5eea38dc7_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i6cd3830836d74dc384331da111f121e9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2fe86ad3207e44eaab5c717b3adfdfd5_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i695e557a6ab54dc6a2b984723d1f5b0d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5c5190a2663a43e8b69d8a097c812132_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib70db9b9f4a14ac4a63c9c3d7e73bb79_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0ec7a113781f4fb4aa433f0602bfde3f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id25b1e6a88754b688a61cedebd045efe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6a446f7eaf1a4201a25d9a14323ee4b7_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3278eb4fc9fd4ab78a70936efe09c5ff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i20eaab7a249a452bba784a0d97d26368_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6bcfc9afd93e4406acde7e87e4c91af9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if823837bff994f53b3a5363db592ef45_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if05103d8441f420687709be717eefd05_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3372701f199e43b4a16aa17859655059_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9dfe8ef22e494c38b101738e66ab9aeb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i61b63e5f040e4730acddca14376db61c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id268265b76c749d98058721c42dd6cb5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifbfab1f7a9b4460bbb2f2a22a0ed163b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia491d443536f43b2af506a739dee74b6_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie55426e09f694ffa9902855677354b87_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6e686d9a958e4abfa40bfcc0f5d10cc0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c6dfb0a55d44433a2844ec28c42f5aa_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i87fdf496dd9c4a699a19e0513d7508e2_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2926409bcc984aedaa96af46597e2232_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7dee112885e048f6a1cef87525afc79a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:OpenMarketRepurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i332d46aaf70f439cb962e214fd3556a0_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bdx:OpenMarketRepurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ad38254f42f4c66b77c1874165accec_I20130924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2013-09-24</instant>
        </period>
    </context>
    <context id="i9ab8c2436670412a85779aa99a37f277_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i50429935632644db80c7dc6d4f800a3c_I20200501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="i874a17754f954b0aaac2d06381e5d650_I20200501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="id918b6957659494e9efb8db5e471b658_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i6c47e1c7c8914741831ba4850ee25a8d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1ad1063cff2d4269b4177860de2bbad9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7ff86925da2a4bdbb08d87f5bf1b9465_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i57dbdcd63dc545d4baab7bc7c3def523_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i78c005f6696a4b2a8f4b480077d64866_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie20e47c06987495d84a42d36f5689682_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iaf2fd6969bcd47aea595469cbf1b4625_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i10fb59521c574bcb96b82afd9f75ede2_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i628f61d1728942a88bd889c7c55ed5f4_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifdf1f5eafac44cf9a31dc274fe75fe4d_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacfb3dc5bbdd43f1abaff2e47b4b3e33_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if78c1bc79b104d2495d52f06e7adbeb8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iebe826a47e2d4911b649299e360599da_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib2d4272367454973a102f31f0e0b1d5b_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8624f6524b87417d877a3fbc3734696a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id99c576cb7f54d77a264bc0be07c9bf4_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2a15e922161c4d5dac1d1b05a8cd6abb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i65b38b186e5043618d914e134f92606d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idd731e1f79d247e8ae5e661b7d8187be_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iad3be5ebcb0a4e7da15aa197384cbb6d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i43597b9d90b04086b5e4094193e3b542_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i22ca936d1eee4110babd87515b79a272_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0caad212afff4342a5acce2a8aa1d437_D20201031-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-31</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i19750515c4a74e798e893d0d862cff94_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i4e27cb8b41d348d5b69f42feadb89ef6_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i395595affb2f4499b423f227d60c2864_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3faee5241614bc983e8159206dea8d8_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie9b42263d2584a45bc56b83ecc8101d4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i512eb62a6b814cd0946e34a3d047f29f_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ide1ced632f4c4c4da4b51289c20a7f1f_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i2cf37d2f9a26470d958d196cc629fd83_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i55a754ef030a48b1aab1469d1d78d783_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie414e39c203f4c4382406af500826854_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i08f59c7321f84d4abd684a04e126995a_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a8c12f02b6648b68f67c0af95c1adf6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i05606745f26d460ab811bbfdfa341821_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib7ba30fee8c84bc8a2dbb50e36515c04_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5f132fdd2c874a8ea74c3db787eff159_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8be3457e675a41b8a5e579e487b37547_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7af1f356b20e49379832866f40ae6116_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id5bb7c3f33f14b26877a5ad97b466f75_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0818d4aa51794a308ee5ea7be2a3a7bf_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5df34fd9a8fb4515a6d4f206a9b62bbf_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2beda1c25ab64fb6be6cc0c3ea77c714_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia6964534d6074e42bf64a587550cf196_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a6ab2283f1148cdb39df341b7bab34c_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4aedd1e139b541e98f03ec93291aad7b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaefde29495b1437da1094baba80dcc28_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic4044de927e14db4b4cdce3edf5fe533_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0226cc65ff074b9cb210e20467df9c6c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa8ecc6259cf4f9e9dcaa8280e0c1e38_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7354695f422344c2ba6f5510554cf892_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if82cf0e2b8114957a8de4ed614f509d9_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbe3d23b34c44614b6bfae0c5d45b788_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic8c683a785824afeaad05fc9abf980e8_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4cceb75d2179413db04451287ff26d63_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1a2212a30e9348f29aec9f73842587fd_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i91213219f96b4e26aca1922999345c5b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8d3bb31dc01f431bbbe77ccd87e88642_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9d656df397a54965af2508ec9e8b3a88_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i682ce949e79b4a869956e036cd9bbabf_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i75503ddf3285429bbb602ab773ba94ce_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8bb11d08c5e6468d9b86ce13b8fb8672_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if3183d1ded7447c9addc009095eff141_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28f35065e14842b2982be7930f62d9a7_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i648c7b7f63e14fff8db4327cf366bf0c_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i547ae1919acd49f194300b3f92921e7c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibbbdd8603eed4090a62b2e5f722efe1d_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf12495d432e44f0ac940dc4cd4a1bf3_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6d2acdc038e1415886e86c9c35738e32_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied344f3898da40c787f80afb27167829_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i216e3978b71a433ea3ecaed35cef49df_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i083aac29dff54d05b5ab473be2896793_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8ed5952700034df3acc6ffaab543b2b7_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20d0df9f4974473aab54f9423735e45c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1ac87ce71d824958b1a47906a97cb26d_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i11561312578a41cd8558a5081f0c997a_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibd17f4c74ddd45aa9d4c2660931a2cbd_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3a84f9891e141d490be8fb0dbc5a1b2_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0adb04ada42a45edb77b3846d949a297_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie44752f5a1ac45f9905b7477cb8d8150_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5edc49a9068445e690657c19b9757ed7_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9d856fcb0a2148e18bb6926e29e6de05_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8c44be99e502431faec4f344ca7026e7_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i612cd43d382c4a63a4498b9c0925333a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i28d137b4783048aa9d0a5092249d0c19_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5a850278578a41d7920dd6f66b22ec55_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05325a1bdf804752849157781245e34b_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5cf241dca0b84231aacab9d4db1bf47e_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i116d0d51fa5f4ad8b5f121a6aa909b47_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i14f6db0dfcd4424ab591090a6f110ddc_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc2bd86d8f5245e596ba87a9603d3935_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic9bb88f9b2cb4d1d895fc3044878e01d_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if62d47452c1b4b0d95b99aad7c976bc0_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6146d44a3e1a4c6fb1e3f608f1d1772d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5917d24437144be6a23c46c167d8dfee_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4ffb12715a314f46bf61eff967b00a1c_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic90104d61c104e8b8865d7d2f9e10896_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id51d737eb47f4b3b9da6d19bc2611a64_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i18417c03d14049dea16257ba06dc47fe_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia2f9183974c94388a49de9124319a764_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5d68a774d0014ef1abfeda302c81fae1_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e67d37c2bb94c2b801879dcd7a19a15_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i605b912cf85647a9bb587ef76f45e2a1_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id920980d4c7449ea8825bf277a0b1ac2_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie5d0087bcc4b4ddebf55ddab6f10de11_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia8e5f71dc1cd426cae0de4618593bcf1_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb4a41270d5b4661a5a303eececadc77_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib5ada28ecbf74a4395c3277f87c00cdf_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i95ed2fe03fc548a8a71570a5afe88eb6_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f3166ef7bf441d88c8166e8bda58fc7_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idb7c4592ec094ac2bf07eb5e61394cce_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3a5c15ae71594004b4fb831a208ea9b4_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3aa16b425c5d484e8fd114f782a112f5_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ide0078adc3714de98cb99a9ec2f7004d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee2d0c4137b14439a21515cf1257e833_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i756a093d417b4e5d9930034095f6c8a0_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i718323b7442949ebaae15d9d98b8e56e_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i053e66e661bf401da0e58b9ee1ce56a3_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i33e64a7564cd48a185c5cfb1671f55a4_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia26a2ea3671e4bbda2393ffce1464f31_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibcfa5db82af24e78ae9358db41c6e7b5_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i770e87f1fd6a40d7ab6f0cf8f9423ff9_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0c32fb02472b41579f71cf3a6edb41c8_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib0d63e4e362e403b8e8e33d15aeb4129_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6faafb39d1af4514a46e525041b2d4ea_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib84d4ce3a1704c82a573ffc14f62e02f_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic07db86337a54d37b2f1f39b5c7a798d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c554f2bb4764f148a7b5f7e8b47a21e_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if9464fd80b304787a7572a9a2904106a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2274cfe1148048b1a906c0b62d5b0ff1_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic7a0912d23474f249022aec3aba2e54d_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1feff546e94e4e799fd1e5ff2a6122b1_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4f424962ed74433ca2e842f15385c7ce_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e92a6ff8c554267a457b7ddb0579546_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20f6ebe1084e4654990728705d852739_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i087866702b1043ad930869066b7ebb1c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica689edbbe6c4cfdab402371fb6c387e_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib65439a3c12d453385854062d6818ee7_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe2818605fc44918a60597464387f709_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i938377c8c70a4325b957640e0929f503_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8cf30fdbac78429f9a446f70c25b7be1_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id40539fa62924c86bbbb010189f67b04_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iad4eeacf775b49548f56b317cb763ba4_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10191e30c4364d2eaeff9b074fad7661_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18583ef90cc241e4bf98d850f3c5ecbd_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f992e63e5074f08920c5d9d5d2dcfad_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i96fc867ea3a54208a98744fec84eb274_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9e483eb99c7c4b6497a405226527c370_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iba39a8a5d76549f5869166e9f4200fc3_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic1de7b15fe4d4f0daa2e984903815934_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idf717fc531104fa8afeb2f4134bf483d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if71d28c3e62a46c9a905d0174d34dce7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i00d2afe4861c4a3e9820f0da284c2e26_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id4663fdc221d47b9a6c6e31fa080b355_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i11eb132003cd49cf9c750bee96c9d6ba_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5afb79183c5543d798cf072178bc024a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1e3d42c7945a4497a141565ec8971e5d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icc73ad9d66924344a539a3a87b464261_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i820d3d2264834cbebc2fa459cd563e8c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i68c8e2684ba049d78fb1ad3565e6b339_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae50cb57e95446c6b92fb35fafe9f9da_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:OthersCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i81362db95912497e859aa74adfeff72b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0b105c0c4f50427f8410867a9ec1bf65_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6968aa8bf59f445c9ff26455961aed57_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5ee987dab8c144399f2ff0d88aa15f7b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i032efb1d86ce48d0909296f8cca53459_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if421c3b8ea2a4e7ab527e52a891f26c5_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54aab8ed6b4e47aebcac9e9c927310b7_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8660d76f8bf1403894faec3ddd4176a0_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5645bcb73774a2284d8ac4c0ac3dea0_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6835087ad8c4728bb6473612b2cf0bf_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3d179fae935c4c82a01090f5b56e975c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd69a3a2f71e4c5fa5e480606c3addb6_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieb8b9befe2884f62abaad02f5835561b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6bf08a9c8e8b4394a3000593ba05da14_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b9f84be28aa4054929a2360fb4e6192_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i91be43483d0f4b4b8867902706c778e4_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:CRBardIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1878f37315d04b1a98cbf4c1d0819498_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0817d59aef3845269f35d7e2afcd203d_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79c2acdab6234d67848433db1d1dbd37_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie6f651512be74e1d93a7c0f9cac1e296_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i15ef9393893346008a24448385a34a5c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i033e6a9eb88b43d980fc575fa72123e5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i873b906d317a431aa87a7b6cf2fd045c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i358a67c5d4ed43109765477c30e7c234_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0326d51b048d49febfbe800191bb36de_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdx:RestrictedStockUnitsPerformancePsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4349c1158a974223aa831dfcf0b2cbc7_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5d3a7a2e0c64e4d98235396301e0718_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifedfc8723a1240dfbd527fddd8610509_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i779f01d1bdf44e59a10a0b1546c8a526_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1f6fba700db34620b0019217a8d9bd97_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6511aa94aeb44439b11a1d4ec335a78e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i77101b3b3d014aba884daaeaf179c10d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i61da2eb734a14d15a43cbf10837c8938_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8eca0f828ddd427091f4d296a8e807d2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i53f9080405314d2e819b92e79feeced8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifdb88817d6194a5599afdee43da767bf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5e39bf2e8f1844b993cce4161a84bbff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i85a5bc5228934abba8c145aa315e0721_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i79c926c9a5c9445eb3a6bf1d48ed24dd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:DiversifiedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i582bf51e2db142748e01d1a6c1978b1e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i239cacefc1034e98bffbb2d59ac35059_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6210559eed0744c68524b1092620ea9b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie4c7d62af45d419593ad86b92e3629e7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if9a3bd23935f48b7a00e226a1a8352d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia338360d4785452caa35968390747a10_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i73449f7073ff4ea4b40ee726a2e5769c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7a3349146ec64e71add05da653f9c92a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1f4fd5eb5f494b16af19555193bf5090_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7cb9c8a5a3d44e929e8cda49c3e35a5d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifa7674e8eddd403f9b0b11baa9aca925_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia6dfbd58f525441b9ab54c2dea102ed7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iecbe41070dc14cd6a796c56f4121218b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id6780e627c7f4ad7a05cef6b81219d95_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i973ba4ea52044ec7867cce4732e8a723_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1f1806f061cb417cace44cee66ae6850_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if56a1e5bf0a745c08a12f76dc30bd149_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idd94643846d24bf3b6f8c33987fc6390_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i673ea0978cf446da9469a52c417caebb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia149edac1bcb40f2af757eed837bd3b9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iba651878aa3c4951be900f73b0631b94_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae4848b2eb0143ee85a0d7c2d47b4988_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic5d9bb16f4d74508bc6dbaf0a2455b14_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib3c3151253d64e2d96bee25ce449a710_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i719813f3bd404e79b168659b6c3aa573_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1efe0d2e80664df283e57a2eb36423d4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id6bb763598f346d88eb4b80147200d91_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2b9f12bdbc124812844603fbd09891ed_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i455fc00619a649a694accccb414c0a84_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3d921cd67c5a4c2eb5567320f4476c60_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6535e7d25cd749aa8937a2539be0e13f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6fb2f87afa95408a8c56d4a9cd130b30_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27cde783e1a94eea98b321d147b8ec5f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4291d87672cd4a8981f4a360a1a9cab7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie3c8f69ef20e449fa397139f39242dee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib0e5c0cdc22a4b0e8ba6a3fb3f6e98c5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8407f1e21df94016a5bb2c0aedad66ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i667449f6ee774b11a6b45b97aab6b6b3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i14c2adc69ec24c689ad7bfe5695d5c71_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i036c7ba8e62a4a75a8b86e314ed59903_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib1d858f56b814ba1b31e8997945e8cdb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibfc3d5d859364765991baf5fbdaaf07d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i273c42bd2bf74bef9f62c4b634918468_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i014f9d02b0cb4bbe8c31fc0740a83fc0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic16f46d749384f4e91a03d0dc970acd5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib0ad93bd71254bd594fee877344663f1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2764df47883b467ba943ad7a7c3151c6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i08b479cb794b4b389dd8f0417d748da4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82d4bc96a4b642139265cbec59eef4cb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie85e1a6e235d47cdbf1b177b7f97c4af_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i81c0de9d4d0e4fae8c6fc8ec55fd02b0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75b3ba666c714449895f2c46717ad2d3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id58ed1b77b8640d0b897e7b00007953f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0333656249994d2e8cb26e6f79d7e84d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4cfd65d075cf414585bf6fc6b7f9c5b0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibce10790ce4c4090abab20b16d6ee85f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7e3a877768014f80bca7f2823c09c2fd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9e30739c488347d5afed7d7c698d4c16_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2705f413b5fa4853aa0711dca58567d1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5a14e8e06e8e4781bb2fc8daf0319362_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia616e09bfcf3438ca18d99c58fbeb7de_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7cac4e61a856422aa1854bbcaadf4fd6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic923216224064e2989e7625f0081c9a2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib37ee945ff0c49afa819e5fd6c33170a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8db92b9a655f421789d5d94454ef800c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaf30a237339b4595ae6d08ec2d172296_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibf8adc411abc471c8fab1c8a0b21f5ed_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i444540566d5f4120ba0a990210e5f64d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibafc5baf0e3d4db98950714ff7bbaccd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24356b45f51845f99b3c235579c7c492_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i36e04951f0304cc297da29bf9cb5603f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i35528802fb404e6bbcbb6b97543f94ef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8598d43c36df40e0aa15aa3578b1c46e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bdx:InvestmentsMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if1bc9fbebdd24e2688fede6c4875c0bb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5291e425d6544e199671d3329659b30f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i73098c61ad6b497e9b56e6e64edc8560_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9f2ac9dc44f64a518a26cb809ccb8ba3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i04064a31b8074c7cbf784060b303d4db_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie92c7234473544eebb1751ee0a1eabc0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c0a623813ee4a369e7ef5993fdb798f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i93d9e0ee20514594b6508a2572ce4abd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i28aae561f41544a7804bc0b0cb92a718_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i70be1a5baac547589f9472c81e2340e1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie45261a2b5664434b82d1b3f8454fa79_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7cfc59ab57674136bbe1362cca826076_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic3fc09f7eb6045808fa6cfccba5222f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8fde7c7c7d5e4fbe8a6182d7ed99551a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48a14466de2744d68148b941f153e261_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i94f673aa33144145a0153caf0934a902_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i47af4c545a444e8795cd4b3e68071385_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i44cb6133b3eb45ca89b4fae7bb30718a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5a8d05e1487049f8b27438df7c030bc3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idedc37ddaff7492cb156a22eaef9b092_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2cec3d47afff4c80b568b9f7e523a109_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i262df50ecd024aa69410723c273b05e8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib914a13ded684ed08743c7d0696e8553_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5c9f5a16ace249d18941f898a5576de4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0056a4535007448985354b76b514a039_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i73ee0fc2accb4da6a9e43977a7b69739_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i12cd1badd0ce408c9dcafe27cdd0b20d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i51bf8cb12ca749c1bd187ce00a9784dd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib6a1882f3af34faa9ad2c58364443d10_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5d771de4a2a64a89be0c9be153b39a3e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id8c753d7231b4002823e9b6267dacc21_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifa45c1dcfeb64edfa242186776836f16_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5e03a1a02086479b88a10af5e3588934_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ieedb758d47d44d4ebe6fcf3edd65171b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7f6a0f7f5b6d447ea7d5613cd52fe51e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib0ed4b3cc36b4b0f8e5f2f0c8bf77444_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i13fc5e1747844a0b806dfd7f80523096_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2f8d9c2809b447ae90dc16848ca76dbf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75eff2d032c147f597c9f1aceaa27650_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifb13d84cf3d4430cacae3505887fce63_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i31345d49e9284acfb9ed91fd24ff7205_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib609d1579e1d40deb0c57bde81e1c157_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i05f502cd5c7c4fdcb18d0d7479d2adcd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2f30bff63dd044afa703c76950e345a9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic59dde4d198a4f0c9421510d392f0fe6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8b3c1ec961624dc6a6e82d3a6d0655f5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia77e1ad42f2446289384890caf166680_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ide2b5962b6fc4b6cab48b61c74e89ee3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0f02684e4ee849debf8d23e25e6b3324_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie43bdb14f100444eba25dc4dae16f103_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4c02b9046aeb43f39af9743b56405a07_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i958a0bea104d4e37948dbed0e1c77969_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4d2c088bf8424db2abcf78de54392802_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1b70728ec7204a2ebbcda87de7fe7488_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic7f9e7335b7e40cba7435a11709f59c8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i35a64d513dfc400f813fa199a196be91_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic432f2c8faa84d159c41bc4deaa713ab_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i132718db1a49414a9da23528a50fcd53_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia7f5c87ee09245789101d5ca6586a174_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic76c5930de334d2983e06187d224acc8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4c6fe3a69bb248dfbf2c20fb3768e09b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i53f72fdffe684f18a08ab20e7ef102ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i838c06881c964d85af7dbc6c561a7832_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3184ac9582b94e1aad158d05fb2af57d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6d4dcca7281c4dc4a61fcb80d9cd4ba9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7c273f849dd44f598cb4953836e7f267_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f5a4ae568f84d1bb02bfe3259a2505a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ice7bd76a6d1e431ab6c836a81216e1f4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifeb0e474760e4334840048d6bbea75b2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6720785a53e1430586156e7d0d274c13_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:InsuranceContractInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1733e031b7cf47a58f991e2e2c3bba38_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id08d119384b84ecd9c631a9d7482199d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i52b537bc93854335acc883c0be1997c8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9fbe9e927d274f4f83ca7d77571c65bb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2bc5d9a9b2b444698454e67d6b6125b5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i680d42b90e8248cb8ec139cafaa4fd6f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9d4ba4121b644ba8b30f226395dad876_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ieee3af2d2f704f59849f8185896c26d9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">bdx:OtherPensionPlanInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i519814dded634cab821a6e70f12b6b5a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie04b3467aa854cb9aafaccbd60d72ba5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i68b0d1120e5a41fca6070da9daf0aaa1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id38fa75e726e4beda0abe761dee7c2d5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0ed18c587c624003af2e081a0af4732f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27cfd7e9cd8640a3853756ce9e70e604_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1b0f58312f094de18638daec1ed57a5b_D20220718-20220718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-18</startDate>
            <endDate>2022-07-18</endDate>
        </period>
    </context>
    <context id="i16146e90cf574d438dbf17e714f1b029_I20220718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-18</instant>
        </period>
    </context>
    <context id="iaead122bd3794f52a9b62332837beb42_I20220718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-18</instant>
        </period>
    </context>
    <context id="ic5e7b819e08c4816b263b7a5251235af_I20220718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bdx:ParataSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-18</instant>
        </period>
    </context>
    <context id="iafe15d6e33ea490590f7e9a69b2b17d9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib61a5ebabc2b43e6bc2cd5e8d0c216f2_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="idebc6318303940928ab393f2213c259c_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic952af233f8f4bc18cc9102330586496_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i783d4c7f3e5a45edbd97c95a6a89786e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iea7227b64729441fa3f00eb141b51740_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17e9dff542174b32865501500ace45c5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie4ae8b1d50eb4bc6a284a520fe49663b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0ad5a700227d4b0e92d99a7616f2178b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3ba567a48b404c3ab9acaa56ed5af44b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib122ecb689334b1fb324ee12c1cc2522_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i22adc29e67d0453da5b441bc62d60fad_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic7898a78b2b045e0a8fbcc5061436d03_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i27b8a27c308b4a97925c0a22163ab63a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id9123b3bda6243a2a49be47ee2010afe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if296896edaf84700a94f43cf10109fd1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i28d9ef80e7d740e98803dffc38dc1875_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id08fc3788b4f494fab5bba68fdd3f971_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i83079dddc9604de9b744f8de96e981e8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i313ea0dffdb34c468e5b8d9fb727160e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09cbfdc3b91b4f0a938cae0e75b85bbc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie95aa9d4507c48a8aa4ecf6660ad1bb8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i10a8586120ec4ee3b816bd6e84c99d26_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9b06cbe7ebf74441ad1135e8a4099d4c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i154a1248141a444db4764c62730b8fe8_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4e7b422811cd4eacbfca8abd88d6e929_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id2e02302174c424e83e466e2024ad82a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia3b8ceb1a99f4a2db99cb4f7b7466475_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i755a5d90f3814df4b21a068f5395ce3f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1ad49caca1134d10b7917ed7da76c3c1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7be2a3f223eb4dd1a902692b9d00ee3c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if9aae2ecc3b743ee8b3b99bcb96a572c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id9b65da53d1249ec90a0398fbf799f3b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4b1e06b3f4724fbe8ed56758a473c1d6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0362b4098b8b4067bb006f7b4a31ae00_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i21cb6aa32d1f481981628ab9194b1087_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i46bfa1d6a2ed48c58d0b334930a15be9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8a796cfd479247d9aed9717103f579c5_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i636b7d8d6ac1434884437455e4abece1_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20ba69d3b809426383ff74cd52d2d5d6_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i82fb06354e254a39957ee2c588fb1109_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79d5a944ccec4ed6a09939ea678a2ce2_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8cb3f4d815394a569ef25a97b6547ade_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ad6655541f44f868773ab9598f2389a_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i711fe8ef0e6b434ba332d1783ca67ae8_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:TerminatedCurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia06bc3660c334df6ad4d8fb329decb0d_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaac60c046f35441f9fedd46ad3c40d4d_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i477ce66329a84971b9ed1654697676df_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i713da180c69b463b9d60a20b18530ae8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i47367bb6b2924151bb0cb2e2a24e2c4c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icb49035180454921878d3e554660eafb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i492a77d89eef44f5a423a69591c4fcb1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idd49df5862fc48f89ee6373a56f0a57d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i330f829063eb4447ad6bc4456ceff4ec_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ide9bbd27a0cd44dcb98a452d6c22b67f_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i648b8dfd6eb548adbbd2d21365d6cde8_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i277928b220f44e7784ead40b68440c9f_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">bdx:AcquisitionRelatedCostsAndRestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i312ec77e4d634c4ea325786b43d11b2f_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i73e86db53cbf48f1950b3278e95c83d9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i03fb827478bd461a8787df84f27802af_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d5f7f7d4aa34c8a8fe7242aaf64fce7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.000dueDecember152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i30a8bd1261794f438b0bd13c92aeb774_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id3617b6fd6934a64af7e251d421562bc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i19f42f3eb9b7429faccfa0ee07b6c3d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1401DueMay232023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3348e3185c3a4d8faf23b030ca9b058a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1401DueMay232023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib92d3fd233174393a0c8985d57b80ac0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i702a0883d82245dfb5727457b4bf121e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i12bf8edf84ca4a9490012af58b404885_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib6b7239cbb2b4caa96217145ed318c6a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i95c59b4820ac446795f35fc603f13926_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9a63b521162435da95e767ab599c1d3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic410939d905842db8f020e0dd78f97ad_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1935866626bf4551abb766287f4f12bb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iad2f735852d14c1aa5af472705bd220f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifd801a10d19e41d48e55e40566722456_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5eaa388c48eb48529b863b1dad0c7c66_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.02dueMay242025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icb65fb27ea394d7bab72c0b7eacb98e7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.02dueMay242025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i83c4aa1f41194aa4802d0e4036ca000d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia9406b7f8b0d4bcb819b52eef9ed6c98_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i68bc0f1d591947e198044880214c84e2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i365b69b186eb4841aeadfd7470683467_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i071e4371c19b435eabf32db0df89d6b8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6.700dueDecember12026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia0d41b365cba499bbdc2091259476a27_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6.700dueDecember12026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i05fd68b08a7b426eb6811e05f0b4a888_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5eb793b910104ba58a06b3d19b079980_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i53130d0da5f34bd5a6206bb574cd0646_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.700dueJune62027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idcea25fd00bb44f49a60939195013440_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.700dueJune62027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i38ea59a9bc0045368162126cf4bedf68_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i05399f1c63e149d4950728ad77213bd5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib1712e718c2c4f059e63b730ad6912b7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i985f9c0cd4e740d3aa74db4e83626a95_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifd7ed43ce46648ddad0381b46f2d1b52_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ief27c89ab80f4c94b4ad781ba05245ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i597528406ad4432080c7b790975f5a70_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2823DueMay202030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if9850b5968694db493ee80a1a80fc434_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2823DueMay202030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3605fcabb8994cffb101c033d2307325_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1957DueFebruary112031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id7bccee58c364c979aa7b39b610a38ab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1957DueFebruary112031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4298DueAugust222032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie17bfcc9d30b4c22988228770a9646df_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4298DueAugust222032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i686038d3973d4dd3b99c9b7c97fdda7a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i23650c82023d4075b7451afcab116d86_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i602de84cb42e475798daa51154634938_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6ac145c8106242f789a62759ee65edc0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic4f072271fd54749be6519ce7a4cb656_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id83e438c828a47659e4ba879ee36b614_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia5ad1135b73947ef9ed5193babf7878e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6229439c652442adbe136afeff494f38_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9f5624d7d8e14e90943f68d463e69f40_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifaa71c7f48a44190bbfc9f05ea58cfb9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.875dueMay152044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib71ac3489c92480f87da9461658618ea_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.875dueMay152044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i372bc258ba0740cb8d556e4188e7d392_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i569682f1363b43b89ccf1234c5278a9f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6a74c7bd3dcf442eae90093915052162_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.669DueJune62047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia718f431cd534f328b232c9f48b09e22_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.669DueJune62047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3695003b616b4e0d81066f1f96ec98c6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9f0d22cd43c3455081ebb8c94a57c5b9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic7ea78107cfd48079574408788ac59cf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i74d9c4caf0fe4fe0890096aea18a076d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9bbe00aadffe4e36a0990b8bfd4542ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b97cd83431a46e9b8ff128d63380b1e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i763be4649bed40309ea0a989f6d8495f_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes5000DueFebruary152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="ief9c3d8df6124fd9ae43c6a9f513637b_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes6750DueFebruary152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i0969e888373e4049877b7174d7c5bddd_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="ida7543d2dde946539fa775f189e5666f_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="ia025880105b44439b3c131cb16841016_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:FloatingRateNotesDueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7c3cc867b1a746999043d8c1873c5582_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bdx:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2153de5b147d447da55f5389dd07896d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib82c168f755943beb76474f81ed94633_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1957DueFebruary112031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3125DueNovember82021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if092f20bc6ba47ee829e82597aec9760_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i26010aaa94984bc6b48f50c2340e67af_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie33b2738d7da4d69943646d03c93abc3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia31af2fbf9574b50a43cb3846510c6a5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i96c8b23a3f8e4af4ae8c1da6663b9bdc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3860e3f6433948fe91197f9214f8ee03_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0334DueAugust132028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iebef67ca020b4e9190319bea0f3427b3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0c6939f1f5044d25973438c5911a2a59_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1336DueAugust132041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6f7d0235eba84a0698944deb7ab704a7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9c474d65be064b50ab5658c993941100_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i51961b234cd24495af06e60749af2c1c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id280f6f5f1b54db287e925bcaab334b3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idfdde262f537472fb65210d2b884f533_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3794DueMay202050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iafab5391deac4533b6a6ac832b19ac87_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d239a7d2eab44538b07a8dbbcd8458d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if530e7153ede42babf75d9614ea2fed3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic7602efcbb12497fa6ca035a193d108a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:DebenturesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic32b723311b347478e48a35ca4f68e40_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibfd421b62f5a4ac2bf277725abb3c4dd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i68d32099e1bf4a3fa5b0b39913d35e39_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6ca62f76cd424ac899783fac2a96e623_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:NotesDue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1b9cf2d374194df6ae4c79f04396b60d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic4c7f7af69c647e89fe2fbce62dcc9e0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes4.685dueDecember152044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if0ffa05b17304f47881712e6c344e328_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i49e5fbb72ed545d0a517f8558fbba67b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c1049aeeb644c24b6c34fb4411c861a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i18f59f936a894ffba8eb3a14ba54e55b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.300dueMarch12023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1906af748d804698a67a96838cf98239_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.300dueMarch12023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id102f0302f614bf08fe037344bc095d2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.300dueMarch12023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i198b3d81101443ecbb89d876818dc429_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5ce76d4d39314f31a725cb2fb4405f44_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.875dueMay152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d69b67e36644b9aafbaf1de869fc363_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic5115502651348ca9ad2cab73680d5c2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.734DueDecember152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b0ec6988641447b8dbfe586f04fa9c5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4ff9e2355d1b44a4856d7f25dd014220_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3.363DueJune62024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4b17ea17825849b884fccaffccfcd7c8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3125DueNovember82021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i524df8ec8e694ff09698ff2542b4ace8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes3125DueNovember82021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i35d044f774d64179a6b3b2b850e72570_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaad9390901e9440ab8f2487e7732dd8f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic9861ef1ad04469090e0fb052180295c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i33f931afdb7747e393d4a4978e51673e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes0.174dueJune42021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i98e35f9e011d44588b3b8b920a77a0bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3cc4f6959fee4f399833aef85a382ac2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b78638dd6be44b198ad670fa48ac3d0_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bdx:Notes2894DueJune62022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib3f4c3f3aeef48c7a0b365d3718eba1a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i812d0cfe92a74e4c926610f6e5a3cbba_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SaleLeasebackTransactionDescriptionAxis">bdx:SaleLeasebackTransactionTermOfContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i28abfbeeca0f4ef0a684b8b4d60fd993_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SaleLeasebackTransactionDescriptionAxis">bdx:SaleLeasebackTransactionTermOfContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i644ae4d7f0334a60b2e4791644ea5968_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9c659996ff364a5889ca74df9594897c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i84b4aeecbf34445895456d33566115a6_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0089a582278743878e90b9ca5e0e2c89_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ia9f9865f93104f3ea7954370b74f7d79_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i329bff29919e4afd9a9bdec6c58ae755_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba943512d69048e5bf48aa7426358b78_D20191001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05b402904eee4442982827a336b690c8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d9ee8a265ed45f7bcd1a5b2a45da743_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4026aaac83c04f90b25918ecc8f53b9a_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idc5c357468b445299d75577a1038cd20_D20201001-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i686e25e2d18c4aad801c33d834ed7b23_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i26517beec32f4052bdb7d8b798ad21eb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i722514c7a4114a04aa38c850c0f296e7_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6dfe227a5f864820bdf92afbd17f990a_D20211001-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i02b12d1fd67f455baf6f93c8c91f52ef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia98b2ad1fc1143869d44f1bd24b9aaec_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">bdx:ReserveforCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="agreement">
        <measure>bdx:agreement</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>bdx:claim</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bdx:lawsuit</measure>
    </unit>
    <unit id="plaintiff">
        <measure>bdx:plaintiff</measure>
    </unit>
    <unit id="segment">
        <measure>bdx:segment</measure>
    </unit>
    <unit id="customer">
        <measure>bdx:customer</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV8zLTEtMS0xLTczNTM1_3ee468e2-259b-48e7-bc10-316196574b76">0000010795</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV81LTEtMS0xLTczNTM1_ca2711db-8082-4080-b6ae-7b61498ecaae">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV82LTEtMS0xLTczNTM1_cbb3af46-ac58-478a-8776-3f2ed019993a">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV80L2ZyYWc6MGQwODU3ZjlhNWEyNGU5ZWJiYjA4NjI3NDJlMjA0MTUvdGFibGU6NDVmZDgzNzBlMDM1NDgzZGE4ODM4NWY5YmQ1ZWQ4ZjUvdGFibGVyYW5nZTo0NWZkODM3MGUwMzU0ODNkYTg4Mzg1ZjliZDVlZDhmNV83LTEtMS0xLTczNTM1_ef971635-e8f8-4296-aa3c-06e9ab58185f">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id56b178e0a304ca0929d00a2da01572b_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1682e37dc1c64a0493b113eb3051c55d_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i872f6917a0d147b687cc33b9b703c9e5_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <bdx:PreferredStockDepositaryShareOwnershipInterestPercentage
      contextRef="i19750515c4a74e798e893d0d862cff94_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84NS9mcmFnOjRiMmEwNmQwNWQ5ZTQxYmQ4N2MwNDQ3ZTI2YmE3YTJjL3RleHRyZWdpb246NGIyYTA2ZDA1ZDllNDFiZDg3YzA0NDdlMjZiYTdhMmNfODI_a8101646-60b5-4a14-8484-086a2e4d83aa"
      unitRef="number">0.05</bdx:PreferredStockDepositaryShareOwnershipInterestPercentage>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i812d0cfe92a74e4c926610f6e5a3cbba_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwNzQ_6fc3030e-d694-47a3-b19e-733ab8915c12">P2Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i644ae4d7f0334a60b2e4791644ea5968_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNTk_49d1d0da-0358-48d3-bfc1-913d11e54289">P6M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dei:DocumentType
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYy_e4601e3d-f7c4-43db-ba1a-2e0a67db192e">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY3_21937dd1-002c-4326-8f2c-9021099bacaf">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yMTU_be7e5956-afb5-4061-ab4b-4734c14d832c">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yMTU_f5260b0f-c915-4ded-852a-d3e72a25e475">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYz_834c7637-3099-457f-b8f2-535fbc77b4ed">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY4_eadd0b02-a401-4052-80e8-50291cf9c261">001-4802</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY0_f0722e52-8a8f-401f-b75a-c0bc32f765a5">BECTON, DICKINSON AND COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8wLTAtMS0xLTczNTM1_a51c6a9f-882e-4024-9296-128bd7ad6285">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8wLTQtMS0xLTczNTM1_bd56623c-dcae-430e-9e8e-238cbc38440e">22-0760120</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTAtMS0xLTczNTM1_8859cc2f-26b4-4b60-8dee-32d84b656d6a">1 Becton Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTEtMS0xLTczNTM1_7ba0f25d-db69-4d33-a507-3167412fc4d4">Franklin Lakes,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTItMS0xLTczNTM1_ec69485d-6bed-41cf-8cd8-733a0cd0e1a8">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6ZjgzYjc5NGExZWIzNGUxNDgwNTlmNzA0ZDU5MGRkMDEvdGFibGVyYW5nZTpmODNiNzk0YTFlYjM0ZTE0ODA1OWY3MDRkNTkwZGQwMV8yLTQtMS0xLTczNTM1_216ad604-c04d-4d92-bad3-0e7e3e9256a4">07417-1880</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY1_7815ed04-14b3-491a-9a44-19eadb539f49">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY2_a1d4cb92-7938-4c09-babb-35d3d792335c">847-6800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xLTAtMS0xLTczNTM1_5b091959-ad73-406d-a833-a06bb6f3cce0">Common stock, par value $1.00</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xLTItMS0xLTczNTM1_c1c9bb7d-1eac-42b1-a557-41ce61f235b7">BDX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icca2fc1fb7e04a35b2659a87d15d54bf_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xLTQtMS0xLTczNTM1_5e56d021-921e-4271-837c-225f22871355">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8yLTAtMS0xLTczNTM1_f2dd0eac-b51f-4a0d-a3ea-8e3e6937b484">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8yLTItMS0xLTczNTM1_7a611e6c-003f-4219-a18f-8335fd7b45f5">BDXB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5a417257135249c1a260fb1c414ca8c9_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8yLTQtMS0xLTczNTM1_68d92f44-1eeb-42fc-9af6-6433a9759e92">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8zLTAtMS0xLTczNTM1_2a675ef6-e858-405a-986d-bd6082de3c0a">1.000% Notes due December 15, 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8zLTItMS0xLTczNTM1_9f65e95d-25a3-4905-8808-179f61ebb52b">BDX22A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6a8b4f460a8c4aab98d36a7e9a08c9fd_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8zLTQtMS0xLTczNTM1_c7d1c49e-1902-40fb-a554-cc4635f5a58a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV80LTAtMS0xLTczNTM1_216f6b68-df74-49c0-9386-8fdbdacdd6f6">1.900% Notes due December 15, 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV80LTItMS0xLTczNTM1_f9c163d0-2bd6-43ed-82c9-5d689daae472">BDX26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iac377a9d14c849ebacf5ed28d5e490bc_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV80LTQtMS0xLTczNTM1_5e0be22d-3604-4109-aeb5-d4bdc5e85abe">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV81LTAtMS0xLTczNTM1_b8074a28-ea8b-4d7a-8c82-e1f68ca3ace2">1.401% Notes due May 24, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV81LTItMS0xLTczNTM1_d9b5feff-7f78-4b5b-bbb8-1b2efacb7297">BDX23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i427cf060c1334c5c977e266e5ace9a72_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV81LTQtMS0xLTczNTM1_123cfcbd-691b-449f-b387-cef8c4daa9f6">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV82LTAtMS0xLTczNTM1_0721b1b9-e789-45c5-8b46-ab133a873b49">3.020% Notes due May 24, 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV82LTItMS0xLTczNTM1_c297dc31-fe62-4b15-9960-bbe7de798500">BDX25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i37acbd1332334e23be06c7c9ce0cbcf8_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV82LTQtMS0xLTczNTM1_351eb472-a075-4f8b-8224-d297f92df7f9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV83LTAtMS0xLTczNTM1_91abafa3-094a-4dba-97a4-b32e4537df83">0.632% Notes due June 4, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV83LTItMS0xLTczNTM1_ae568c08-b2ac-4b25-a178-4020b80a5391">BDX/23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4d54544f6db445ea97f22b1ddb32007a_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV83LTQtMS0xLTczNTM1_ba71ad55-0529-4aa2-b305-0db6fa200ceb">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV84LTAtMS0xLTczNTM1_3aaea639-b0d8-485d-aa34-54374d172e66">1.208% Notes due June 4, 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV84LTItMS0xLTczNTM1_4f0bf7cd-6979-4c54-b9dd-074c8e316f57">BDX/26A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i97b1452cb2104d82ac148c433738bb53_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV84LTQtMS0xLTczNTM1_ea7b46c8-ede4-4968-8600-a852007edc48">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV85LTAtMS0xLTczNTM1_42fc5329-0dff-4c80-b123-de7a4863b9ac">1.213% Notes due February 12, 2036</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV85LTItMS0xLTczNTM1_575ce098-86ff-4fa4-b10c-bd2a048db136">BDX/36</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iffb0cba8b39a459bb6e24890d5d9b9d3_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV85LTQtMS0xLTczNTM1_317e70e8-1c95-4deb-852c-07490b414c29">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if549031f297645189d2c585e3072d96b_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMC0wLTEtMS03MzUzNQ_8fb464c5-ae53-4d56-99a5-e8a97ab1b67f">0.000% Notes due August 13, 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if549031f297645189d2c585e3072d96b_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMC0yLTEtMS03MzUzNQ_14348461-d5e8-4660-bf80-ceb9cee8c15d">BDX23B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if549031f297645189d2c585e3072d96b_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMC00LTEtMS03MzUzNQ_aaa4e451-a49f-4d70-abaa-6f425244bbb8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMS0wLTEtMS03MzUzNQ_73ba1c5c-6034-4a84-a11d-af5f923406f0">0.034% Notes due August 13, 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMS0yLTEtMS03MzUzNQ_0c0cb20f-6021-4b81-aafd-5e8f98bc4170">BDX25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4a147f82e2af4faf88e0d9acd2bf26c9_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6YWQzOTE2NGIwNjcyNGFlMWEzMTA0NWI1NGQyNjZhMTEvdGFibGVyYW5nZTphZDM5MTY0YjA2NzI0YWUxYTMxMDQ1YjU0ZDI2NmExMV8xMS00LTEtMS03MzUzNQ_19cb8944-400e-41e2-912b-0a184f04aad6">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzY5_0161ba0c-8bdf-4960-a772-8400eb3821d1">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzU4_425f57c1-224a-48ab-b472-0d75ef574a4f">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzU5_845cf6a1-a449-4b2d-acc0-a8970a36b30c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzU3_9a5ca62e-77d4-461a-9224-e8b2b73e2cb6">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6MWY0MzVjNWJhOWM2NDkxM2IyZjE5OGE1MDViYmI3YmIvdGFibGVyYW5nZToxZjQzNWM1YmE5YzY0OTEzYjJmMTk4YTUwNWJiYjdiYl8wLTAtMS0xLTczNTM1_5ab72f0c-7906-43a6-a8f0-f47bc6dda9c3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6MWY0MzVjNWJhOWM2NDkxM2IyZjE5OGE1MDViYmI3YmIvdGFibGVyYW5nZToxZjQzNWM1YmE5YzY0OTEzYjJmMTk4YTUwNWJiYjdiYl8yLTItMS0xLTczNTM1_e86ef5fc-9401-435e-b168-21a98d722083">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGFibGU6MWY0MzVjNWJhOWM2NDkxM2IyZjE5OGE1MDViYmI3YmIvdGFibGVyYW5nZToxZjQzNWM1YmE5YzY0OTEzYjJmMTk4YTUwNWJiYjdiYl80LTEwLTEtMS03MzUzNQ_3649b115-9640-4cf1-bf3e-12c5d00a7b5d">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYw_bd59e729-2201-4d82-8bfe-3a55b25afc51">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNzYx_f0b33235-e1fd-466d-8cd7-920ccab6d19d">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i5dcf0c18b4fd4e3e980d4799086c4754_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNDgx_1dea42de-1204-46d2-b3ea-7dc2d87b0891"
      unitRef="usd">74865947637</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i53c38993858547f68214ac6f1981c2a9_I20221031"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xL2ZyYWc6MzNlYmVlNTMzMjMzNGM0OWEzMDllNzczYmVmYjQzNGMvdGV4dHJlZ2lvbjozM2ViZWU1MzMyMzM0YzQ5YTMwOWU3NzNiZWZiNDM0Y18yNDk1_353f2e95-dd7c-4508-994c-a25628b989dc"
      unitRef="shares">283375793</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV81OC9mcmFnOmQ3YmNlOTIzZTRmNjQzYTJhNTllYWVmMDA4MTVjNjM2L3RhYmxlOjkwYzhlYjgyM2VhNzQxZmI4NTUzMzVlNzNiMmY3MGUyL3RhYmxlcmFuZ2U6OTBjOGViODIzZWE3NDFmYjg1NTMzNWU3M2IyZjcwZTJfMC0xLTEtMS05MDU3MQ_46805cee-88db-4127-bb9e-09aaa32294ca">ERNST&#160;&amp; YOUNG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV81OC9mcmFnOmQ3YmNlOTIzZTRmNjQzYTJhNTllYWVmMDA4MTVjNjM2L3RhYmxlOjkwYzhlYjgyM2VhNzQxZmI4NTUzMzVlNzNiMmY3MGUyL3RhYmxlcmFuZ2U6OTBjOGViODIzZWE3NDFmYjg1NTMzNWU3M2IyZjcwZTJfNC0wLTEtMS05MDUzOA_1d91d7a9-e6aa-473d-b90e-e7c6bd2f7c8f">New York, New York</dei:AuditorLocation>
    <us-gaap:Revenues
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMS0xLTEtMS03MzUzNQ_44189e68-120b-4fe6-9452-777dba53f376"
      unitRef="usd">18870000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMS0zLTEtMS03MzUzNQ_1d0f925f-b9c1-4725-99c8-30a0533b5271"
      unitRef="usd">19131000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMS01LTEtMS03MzUzNQ_2d6b80a0-d699-4253-95f8-56a2c827ad53"
      unitRef="usd">16074000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMy0xLTEtMS03MzUzNQ_984b7130-d3e6-415a-a585-4f92c89e6c4f"
      unitRef="usd">10393000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMy0zLTEtMS03MzUzNQ_936fb879-b350-4634-8f26-83e6ef92a54a"
      unitRef="usd">10500000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMy01LTEtMS03MzUzNQ_9642db15-ee21-4d47-948d-151761f27378"
      unitRef="usd">9276000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNC0xLTEtMS03MzUzNQ_91de4963-ddac-4af8-9a91-18f9e5c50f5d"
      unitRef="usd">4709000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNC0zLTEtMS03MzUzNQ_f98a24aa-e749-4f49-ad29-e7ae0cbec6ce"
      unitRef="usd">4719000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNC01LTEtMS03MzUzNQ_2100713e-3826-457f-aea2-a2a2dd6678bc"
      unitRef="usd">4185000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNS0xLTEtMS03MzUzNQ_e13f6184-1ef3-4975-a935-c9feb0d952ae"
      unitRef="usd">1256000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNS0zLTEtMS03MzUzNQ_218dd718-053c-4f2a-a9b0-799259f475b6"
      unitRef="usd">1279000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNS01LTEtMS03MzUzNQ_7e3b13f1-64f4-44f0-b15e-8d2df1653220"
      unitRef="usd">1039000000</us-gaap:ResearchAndDevelopmentExpense>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNi0xLTEtMS03MzUzNQ_c6e37a40-2d37-4fdd-9d61-c7567292ac38"
      unitRef="usd">192000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNi0zLTEtMS03MzUzNQ_5d19084a-f662-4340-ad0e-b3a2dfb1e0ed"
      unitRef="usd">179000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNi01LTEtMS03MzUzNQ_96c320f1-34ba-460b-a5d9-2cecd8990a68"
      unitRef="usd">299000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNy0xLTEtMS03MzUzNQ_9d5653d7-0612-4197-b5f2-212f79eef2f1"
      unitRef="usd">-37000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNy0zLTEtMS03MzUzNQ_fb0c9ec4-32df-4306-9b6c-d8842ab135ac"
      unitRef="usd">-203000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfNy01LTEtMS03MzUzNQ_a4ef703e-5e8c-42f1-bd8c-4c6f791f2dcd"
      unitRef="usd">-363000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOC0xLTEtMS03MzUzNQ_674e5e80-5d5d-456c-b69e-7069c3a20ee3"
      unitRef="usd">16588000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOC0zLTEtMS03MzUzNQ_a4ecdf77-c860-4547-bfe6-611cc8a0d34c"
      unitRef="usd">16881000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOC01LTEtMS03MzUzNQ_eceb538a-58e6-4c20-ad6e-94f27180d5a5"
      unitRef="usd">15161000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOS0xLTEtMS03MzUzNQ_f7181e5d-a9fb-407b-891d-d17bdb2b2a7e"
      unitRef="usd">2282000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOS0zLTEtMS03MzUzNQ_52bfc691-ee81-4106-ad84-8c14fc7c1532"
      unitRef="usd">2250000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfOS01LTEtMS03MzUzNQ_5ab0ca80-e622-45bc-9d20-8640553587f4"
      unitRef="usd">912000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTAtMS0xLTEtNzM1MzU_559acaeb-c2a6-4cbd-92cd-65c3a68af00a"
      unitRef="usd">398000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTAtMy0xLTEtNzM1MzU_bce3a65b-483d-4223-a312-badcdc7c4238"
      unitRef="usd">469000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTAtNS0xLTEtNzM1MzU_dd755fc7-70e6-4d61-ad01-0a133f8ab3ad"
      unitRef="usd">528000000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTEtMS0xLTEtNzM1MzU_5e56f61c-ef9f-406c-8450-81f871167736"
      unitRef="usd">16000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTEtMy0xLTEtNzM1MzU_db9fb261-7509-41a7-b35d-9e99e25b183d"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTEtNS0xLTEtNzM1MzU_5de96577-bd95-48af-9a10-c1a3297d0614"
      unitRef="usd">7000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTItMS0xLTEtNzM1MzU_b2c7c434-20ad-4367-9213-9176ea185cc2"
      unitRef="usd">-117000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTItMy0xLTEtNzM1MzU_8391fbc8-75b5-4635-8a31-e47ef8cfcd83"
      unitRef="usd">-99000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTItNS0xLTEtNzM1MzU_ef555dc3-9c1e-41e1-97d3-f8ce9d20a7aa"
      unitRef="usd">23000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTMtMS0xLTEtNzM1MzU_637521ec-374f-4caa-8946-2f489374be03"
      unitRef="usd">1783000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTMtMy0xLTEtNzM1MzU_07efcf59-28f1-405d-aec3-4a8d1a88feef"
      unitRef="usd">1692000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTMtNS0xLTEtNzM1MzU_bc0fedd1-48c7-48b2-b876-fd56970d468c"
      unitRef="usd">414000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTQtMS0xLTEtNzM1MzU_24f8e29f-e869-4f95-8384-c06505804633"
      unitRef="usd">148000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTQtMy0xLTEtNzM1MzU_5dde8b03-dcf1-4e6d-9476-3f502a990951"
      unitRef="usd">88000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTQtNS0xLTEtNzM1MzU_04747fbf-6d36-4cac-8915-5dc654f72d95"
      unitRef="usd">62000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMS0xLTEtODg0NDk_c2250b6f-5f72-4425-8408-89997da2e982"
      unitRef="usd">1635000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMy0xLTEtODg0NDk_ed9b959b-863d-44bf-992b-844f816f12e4"
      unitRef="usd">1604000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtNS0xLTEtODg0NDk_49d1116c-81e6-4ccc-8401-158bf642c8a7"
      unitRef="usd">352000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMS0xLTEtODg0NDk_19d082c5-9314-4c91-87fb-3382f433b779"
      unitRef="usd">144000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMy0xLTEtODg0NDk_ea13bdf0-204c-425e-90fb-ee3d96626284"
      unitRef="usd">488000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtNS0xLTEtODg0NDk_798a4838-b89b-42e8-8e8c-c4662b29dcd9"
      unitRef="usd">522000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMS0xLTEtNzM1MzU_db749c14-a1a8-44d1-83a1-43843d623486"
      unitRef="usd">1779000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtMy0xLTEtNzM1MzU_13a252f8-51d8-4a5f-b6ac-70acba885c2b"
      unitRef="usd">2092000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTUtNS0xLTEtNzM1MzU_4a9b7f8c-32e0-498c-a2c7-5249163688b3"
      unitRef="usd">874000000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMS0xLTEtNzM1MzU_6320e8d0-86f2-4047-9402-4a2ea2a8424e"
      unitRef="usd">90000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtMy0xLTEtNzM1MzU_17f000fe-e861-456e-a469-6bc85f6d80d7"
      unitRef="usd">90000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTYtNS0xLTEtNzM1MzU_b9d99587-6cc3-4083-b2af-b9eb509240d8"
      unitRef="usd">107000000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTctMS0xLTEtNzM1MzU_28f2ae26-19e9-4472-bc35-bcf9e7cbbc36"
      unitRef="usd">1689000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTctMy0xLTEtNzM1MzU_45a1a4de-a914-4c29-b138-d8bcd95fd141"
      unitRef="usd">2002000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTctNS0xLTEtNzM1MzU_cc2027f8-8959-463f-ac79-3333ad8a131f"
      unitRef="usd">767000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjItMS0xLTEtODg0ODM_e069835c-44a8-4400-9223-d5cd2878f276"
      unitRef="usdPerShare">5.42</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjItMy0xLTEtODg0ODM_4e6d87cb-0a1b-4dc0-88b2-107cf2fcd44b"
      unitRef="usdPerShare">5.23</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjItNS0xLTEtODg0ODM_7e527e5e-e9e1-4b98-8d90-23360b048598"
      unitRef="usdPerShare">0.88</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjMtMS0xLTEtODg0ODM_f3f65bbb-70f5-4a36-a255-61924027d4d8"
      unitRef="usdPerShare">0.50</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjMtMy0xLTEtODg0ODM_a2bbf542-4fea-4269-aadf-595a7b9136bb"
      unitRef="usdPerShare">1.69</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjMtNS0xLTEtODg0ODM_a684dda4-a7a3-49f7-b102-a6c704046323"
      unitRef="usdPerShare">1.87</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTktMS0xLTEtNzM1MzU_d318e350-269a-4b5c-82a0-0a053617e0ab"
      unitRef="usdPerShare">5.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTktMy0xLTEtNzM1MzU_4450eb6a-0c6e-4500-9852-08027b78c3fc"
      unitRef="usdPerShare">6.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMTktNS0xLTEtNzM1MzU_a56a1e78-dfbe-449e-86c3-859adaf25b57"
      unitRef="usdPerShare">2.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjctMS0xLTEtODg0ODk_c637bc87-7a15-45a0-af28-45b2313cc9ae"
      unitRef="usdPerShare">5.38</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjctMy0xLTEtODg0ODk_6eeb3d4c-2982-4254-8f35-58f755571943"
      unitRef="usdPerShare">5.18</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjctNS0xLTEtODg0ODk_66018d40-e6b3-498f-9108-927c578dae01"
      unitRef="usdPerShare">0.87</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjgtMS0xLTEtODg0ODk_0c4c2f16-5547-470c-93c6-c06e288e6853"
      unitRef="usdPerShare">0.50</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjgtMy0xLTEtODg0ODk_2c2ca8e5-ed01-4ce1-97e0-4ebf501c7be7"
      unitRef="usdPerShare">1.67</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjgtNS0xLTEtODg0ODk_3ce82fae-0d89-4139-9cc6-0afe9b83be07"
      unitRef="usdPerShare">1.85</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjEtMS0xLTEtNzM1MzU_99faff64-2855-491d-a48a-81af6d687745"
      unitRef="usdPerShare">5.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjEtMy0xLTEtNzM1MzU_b7fb5074-d008-4364-b845-19ccadf3f295"
      unitRef="usdPerShare">6.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82MS9mcmFnOjEyYjgyZDliMWE0MTQwZjRiNjNhZDdjNjZhZTA0NmViL3RhYmxlOmFkMzAzZjU5NDBhZjRkOWY5Y2M5YWEwZjFjYWZjZDE2L3RhYmxlcmFuZ2U6YWQzMDNmNTk0MGFmNGQ5ZjljYzlhYTBmMWNhZmNkMTZfMjEtNS0xLTEtNzM1MzU_e3c830a9-d453-48f4-b6be-d009905144ef"
      unitRef="usdPerShare">2.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMS0xLTEtMS03MzUzNQ_db749c14-a1a8-44d1-83a1-43843d623486"
      unitRef="usd">1779000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMS0zLTEtMS03MzUzNQ_82a47aaa-a53f-4d93-acb3-25a3507a4fa2"
      unitRef="usd">2092000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMS01LTEtMS03MzUzNQ_e24e207c-0841-4b62-b3a8-969e44f992a2"
      unitRef="usd">874000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMy0xLTEtMS03MzUzNQ_c883e940-b963-465a-acad-eaa366f640b3"
      unitRef="usd">305000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMy0zLTEtMS03MzUzNQ_7d6b3553-2134-4f48-9032-f37f3a19c302"
      unitRef="usd">124000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfMy01LTEtMS03MzUzNQ_c7848e36-2416-4c85-87c2-f061a606f721"
      unitRef="usd">-161000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNC0xLTEtMS03MzUzNQ_e3bc0d29-71f8-4aeb-b882-01b599fbe780"
      unitRef="usd">-210000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNC0zLTEtMS03MzUzNQ_605b9c42-9d28-4fd7-8089-0a023169edd8"
      unitRef="usd">-255000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNC01LTEtMS03MzUzNQ_11f6188f-5b51-44cd-8fca-4eca4dfc638e"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNS0xLTEtMS03MzUzNQ_5891c3c4-d0f6-4e3a-9925-e9dc904928d7"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNS0zLTEtMS03MzUzNQ_ad979cbf-d5eb-40c5-b47e-e7ca7df5c7ad"
      unitRef="usd">81000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNS01LTEtMS03MzUzNQ_fd1bf89c-a9f8-4010-be24-329b9f975095"
      unitRef="usd">-67000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNi0xLTEtMS03MzUzNQ_00c8495d-fffa-45f3-9a71-1e3015703eff"
      unitRef="usd">600000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNi0zLTEtMS03MzUzNQ_9c5e4864-b3d9-4c59-b7f0-96d3ed374f7e"
      unitRef="usd">460000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNi01LTEtMS03MzUzNQ_24179c5a-3e31-4d20-b5cb-9c7f4e5e698f"
      unitRef="usd">-265000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNy0xLTEtMS03MzUzNQ_b2ce1beb-9783-42f7-9041-355c61cb95c2"
      unitRef="usd">2379000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNy0zLTEtMS03MzUzNQ_823e8b2e-218a-4daa-9cae-433996eface0"
      unitRef="usd">2552000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82NC9mcmFnOjhlZTBiMDVjZDUwNjQwM2I5YTU3MTQ2YWVmNWMyNTdhL3RhYmxlOmUwNjNlMzZhOTUwNjQxZWY5ZWNlZjk3ZWMyYjA3MzQyL3RhYmxlcmFuZ2U6ZTA2M2UzNmE5NTA2NDFlZjllY2VmOTdlYzJiMDczNDJfNy01LTEtMS03MzUzNQ_4013846f-ceac-429e-8838-2a2074d73c36"
      unitRef="usd">609000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMy0xLTEtMS03MzUzNQ_8ae72a17-1bcd-4b87-a748-d6f63628c0aa"
      unitRef="usd">1006000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMy0zLTEtMS03MzUzNQ_9cf34f64-de8c-4d32-8508-86e00b63eb0b"
      unitRef="usd">2283000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNC0xLTEtMS03MzUzNQ_8f25294b-d6a2-4148-b7c6-d86775734f1e"
      unitRef="usd">153000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNC0zLTEtMS03MzUzNQ_7756253c-6019-4c91-846b-c21283395c68"
      unitRef="usd">109000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:OtherShortTermInvestments
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNS0xLTEtMS03MzUzNQ_54f40e96-a676-42d2-a9d9-98f78001e968"
      unitRef="usd">8000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNS0zLTEtMS03MzUzNQ_91b27f60-95ef-4ce6-9ac0-bba827bf99bc"
      unitRef="usd">12000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNi0xLTEtMS03MzUzNQ_fa3dc557-6fd4-48d6-b28d-0f8c78910e31"
      unitRef="usd">2191000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNi0zLTEtMS03MzUzNQ_7e750694-fce8-41dc-be77-b666e7788b1e"
      unitRef="usd">2350000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNy0xLTEtMS03MzUzNQ_ca411e3a-9423-42d9-afc0-7e6ef33144c2"
      unitRef="usd">3224000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNy0zLTEtMS03MzUzNQ_0b2d3be9-23cf-4d6c-bac1-4a341e37d5f6"
      unitRef="usd">2743000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfOS0xLTEtMS03MzUzNQ_052137a0-130f-4d5d-b15b-114991a25ec0"
      unitRef="usd">1559000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfOS0zLTEtMS03MzUzNQ_de7c1f3e-39d9-4fc1-b92b-878dd1657fca"
      unitRef="usd">1048000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMS0xLTEtODg1MzA_9fd3493e-bfd9-46a8-ad5c-e96a28f5521a"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMy0xLTEtODg1MzA_3575e5c7-4175-40dd-91d1-122bf75a864c"
      unitRef="usd">293000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMS0xLTEtNzM1MzU_a7225ed4-237e-4b83-8ea5-e7fa5618861b"
      unitRef="usd">8141000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTAtMy0xLTEtNzM1MzU_08001b86-65f8-47b1-9082-a7e7bae14822"
      unitRef="usd">8838000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTEtMS0xLTEtNzM1MzU_948d2386-5231-4092-b8dc-672a5dff3142"
      unitRef="usd">6012000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTEtMy0xLTEtNzM1MzU_c7ceb3bf-44ab-4127-8d6f-063e7aaa0a23"
      unitRef="usd">6003000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTItMS0xLTEtNzM1MzU_ed55e76d-ef21-4153-9c87-39533a30c90c"
      unitRef="usd">24621000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTItMy0xLTEtNzM1MzU_f237df1a-ae3b-422e-bc3f-1fd4759a4afc"
      unitRef="usd">23886000000</us-gaap:Goodwill>
    <bdx:CoreAndDevelopedTechnologyNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTMtMS0xLTEtNzM1MzU_ddea7063-117c-4d23-a9ae-5174ed5a2ac3"
      unitRef="usd">9108000000</bdx:CoreAndDevelopedTechnologyNet>
    <bdx:CoreAndDevelopedTechnologyNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTMtMy0xLTEtNzM1MzU_ba73e22a-1e05-414e-ab4d-7e14c56261b8"
      unitRef="usd">9417000000</bdx:CoreAndDevelopedTechnologyNet>
    <bdx:FiniteLivedCustomerRelationshipsNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTQtMS0xLTEtNzM1MzU_499eb812-54dc-44a8-9d3f-3fb1c54c599f"
      unitRef="usd">2683000000</bdx:FiniteLivedCustomerRelationshipsNet>
    <bdx:FiniteLivedCustomerRelationshipsNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTQtMy0xLTEtNzM1MzU_07ca28ad-f350-40b8-9b81-ac205becb9fc"
      unitRef="usd">2815000000</bdx:FiniteLivedCustomerRelationshipsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTUtMS0xLTEtNzM1MzU_aba35967-1645-4479-82e2-955851dc18c7"
      unitRef="usd">519000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTUtMy0xLTEtNzM1MzU_d5536f64-854b-4533-b611-27192308152b"
      unitRef="usd">541000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTYtMS0xLTEtNzM1MzU_29edb1a7-9f2f-41fd-8bea-f39a3e3af6fd"
      unitRef="usd">1848000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTYtMy0xLTEtNzM1MzU_f9adbe33-fb06-4e62-a9a8-2b0c6d9b2916"
      unitRef="usd">1945000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTgtMS0xLTEtODg1NDQ_d145e81c-5a7a-44e1-b63d-2183c51842a8"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTgtMy0xLTEtODg1NDQ_1790bffb-9b54-4c22-ab23-146f2ceed074"
      unitRef="usd">423000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTctMS0xLTEtNzM1MzU_c4b9f27c-5141-4c26-b045-1acd60c62e0a"
      unitRef="usd">52934000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMTctMy0xLTEtNzM1MzU_6ec8998a-32cd-42ac-8ec1-27bd9c6e8e9d"
      unitRef="usd">53866000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjAtMS0xLTEtNzM1MzU_bb070eb6-44cd-4d60-b048-f6d4c81cbb30"
      unitRef="usd">2179000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjAtMy0xLTEtNzM1MzU_a596f471-1f12-48dd-814a-6807a323e3e0"
      unitRef="usd">500000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjEtMS0xLTEtNzM1MzU_67faa10a-a7b0-4185-8719-ac2402c2fabb"
      unitRef="usd">1699000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjEtMy0xLTEtNzM1MzU_d2b08c4a-8e07-4516-87c1-08e2d3b6c7ae"
      unitRef="usd">1739000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjItMS0xLTEtNzM1MzU_7d32d06a-5db4-4e7e-8fe2-bfaadcc509c1"
      unitRef="usd">2605000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjItMy0xLTEtNzM1MzU_b11a0b36-1473-434d-b5b8-5c4da05121fe"
      unitRef="usd">2867000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjMtMS0xLTEtNzM1MzU_9f29fea8-f44c-4774-b4d2-5de766660a3c"
      unitRef="usd">1171000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjMtMy0xLTEtNzM1MzU_9cb9e066-c157-47b9-8998-c1ba06c9dba8"
      unitRef="usd">1186000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjQtMS0xLTEtNzM1MzU_5204d1fa-01ab-4e4b-92d3-2c2c36cdf75e"
      unitRef="usd">157000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjQtMy0xLTEtNzM1MzU_3e1347b7-6925-4133-82e4-dc1834e6576e"
      unitRef="usd">178000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMS0xLTEtODg1NTc_de095094-ce99-404c-9b6a-c0ab4858e1da"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMy0xLTEtODg1NTc_2ff4e87e-47f9-4eeb-afc7-46e07dfa2b3f"
      unitRef="usd">157000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjYtMS0xLTEtNzM1MzU_1c889b25-c6ff-4bd3-9e58-8ebe805b42c7"
      unitRef="usd">7811000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjYtMy0xLTEtNzM1MzU_b76705a6-64b9-4867-87c2-0b4676a1389a"
      unitRef="usd">6626000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjctMS0xLTEtNzM1MzU_b3768978-de2e-4e81-8716-d941e5c8555a"
      unitRef="usd">13886000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjctMy0xLTEtNzM1MzU_206e1dc4-9706-487a-af84-e49083a9a1a0"
      unitRef="usd">17110000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMS0xLTEtNzM1MzU_99874d97-d1ab-4ef0-b711-5aa70f2c23ec"
      unitRef="usd">902000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjgtMy0xLTEtNzM1MzU_fcccfd54-e0e3-419d-9e59-b4faabd3c000"
      unitRef="usd">1228000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjktMS0xLTEtNzM1MzU_8fca1dfa-e386-4722-9900-bf08d10a25f3"
      unitRef="usd">5052000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMjktMy0xLTEtNzM1MzU_3189cb52-d308-472c-8d5a-fab347e6765d"
      unitRef="usd">5209000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMS0xLTEtODg1NzI_74a53240-5dbb-4064-be20-842a6c2fe6a8"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMy0xLTEtODg1NzI_b17ac9bf-3eb4-46fc-9869-fb192eabaaf3"
      unitRef="usd">17000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzAtMS0xLTEtNzM1MzU_0916c063-144d-4b7f-b0ec-7eec77a92031"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzAtMy0xLTEtNzM1MzU_d7ff0481-6e4b-410b-a01b-c21dda4ddc7d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzItMS0xLTEtNzM1MzU_00a98e78-5f8f-44c8-a896-6dd404a65d7b"
      unitRef="usd">2000000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzItMy0xLTEtNzM1MzU_98383f1b-6401-4ed7-904f-716553c43405"
      unitRef="usd">2000000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl8xOQ_3618169b-0e9e-4944-8023-d1cbad0233f0"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl8xOQ_4ed03f50-4a7b-40c8-93ff-d7815cb9956a"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl80Ng_18994d94-4ebc-4b66-a6ef-afd89028462b"
      unitRef="shares">640000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl80Ng_b97a53b1-9e6f-4343-bdd6-1253ea0ca4e0"
      unitRef="shares">640000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl82Ng_4c4180bc-1d16-4f16-98ff-b11eee92aae7"
      unitRef="shares">364639901</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo3NmVlZjQ1ZGI5ZjU0NGFiOWExOGYzMDViNDRkMDEwYl82Ng_793add55-733c-450e-b372-fc82d0b86226"
      unitRef="shares">364639901</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMS0xLTEtNzM1MzU_af197474-d2fb-4572-9ca2-c99e3db2106a"
      unitRef="usd">365000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzMtMy0xLTEtNzM1MzU_600ee642-34c0-423a-ae41-670af6ae311c"
      unitRef="usd">365000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzQtMS0xLTEtNzM1MzU_5985752a-269b-43a0-a991-e533b88c7254"
      unitRef="usd">19553000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzQtMy0xLTEtNzM1MzU_23b08b57-9c00-4725-91cb-c582a1fffc9f"
      unitRef="usd">19272000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzUtMS0xLTEtNzM1MzU_0faad345-9937-487a-86b0-9b2341dde1f5"
      unitRef="usd">15157000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzUtMy0xLTEtNzM1MzU_0511a1a9-f4eb-4558-8639-0dc865211fee"
      unitRef="usd">13826000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <bdx:CommonStockSharesHeldInEmployeeTrust1
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzYtMS0xLTEtNzM1MzU_a3c77d9e-3ada-49a3-b8e6-f5961951cf8c"
      unitRef="usd">23000000</bdx:CommonStockSharesHeldInEmployeeTrust1>
    <bdx:CommonStockSharesHeldInEmployeeTrust1
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzYtMy0xLTEtNzM1MzU_c448f3c5-bd3d-4d59-a893-762e48b8545a"
      unitRef="usd">23000000</bdx:CommonStockSharesHeldInEmployeeTrust1>
    <us-gaap:TreasuryStockShares
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplODg0YmJlYTZiZTc0MTU5OTA5OTIwOWVhZWNjNTI1Y180MQ_cced015f-d66d-4000-b3f8-fb60982f9af9"
      unitRef="shares">81283191</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplODg0YmJlYTZiZTc0MTU5OTA5OTIwOWVhZWNjNTI1Y182Mw_0e8c0966-5227-451c-b6be-14c06c808b09"
      unitRef="shares">80163949</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMS0xLTEtNzM1MzU_f3f94b9c-29b5-4cc8-bc5c-5c689ec39fc5"
      unitRef="usd">8330000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzctMy0xLTEtNzM1MzU_fffce676-ad79-4108-8873-e8191504b34e"
      unitRef="usd">7723000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzgtMS0xLTEtNzM1MzU_46387707-7a07-4f41-b7a2-fb2dfd1f9ed1"
      unitRef="usd">-1488000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzgtMy0xLTEtNzM1MzU_30db0d1b-d4ee-4c4f-adde-622d02e28dec"
      unitRef="usd">-2088000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzktMS0xLTEtNzM1MzU_8b19774d-5912-464e-8e9d-58a6645bb4ea"
      unitRef="usd">25282000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfMzktMy0xLTEtNzM1MzU_75241c34-31ab-4c4d-b34d-9bb346613c27"
      unitRef="usd">23677000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNDAtMS0xLTEtNzM1MzU_01e9f57b-cdc5-4ae1-80a1-9a09403f70f2"
      unitRef="usd">52934000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV82Ny9mcmFnOmI0Nzc3MTg5OWVmODQwNmY4MzBhNGY2ZTE1YmZkYmIwL3RhYmxlOjZmODE3MTIwYjJiMzRkYTJhMmViZWVjZTY5MWUzZGNiL3RhYmxlcmFuZ2U6NmY4MTcxMjBiMmIzNGRhMmEyZWJlZWNlNjkxZTNkY2JfNDAtMy0xLTEtNzM1MzU_3f33459c-a105-4dda-aa61-6a2067414ab3"
      unitRef="usd">53866000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMi0xLTEtMS03MzUzNQ_db749c14-a1a8-44d1-83a1-43843d623486"
      unitRef="usd">1779000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMi0zLTEtMS03MzUzNQ_13a252f8-51d8-4a5f-b6ac-70acba885c2b"
      unitRef="usd">2092000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMi01LTEtMS03MzUzNQ_4a9b7f8c-32e0-498c-a2c7-5249163688b3"
      unitRef="usd">874000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMy0xLTEtMS05MDMzMA_19d082c5-9314-4c91-87fb-3382f433b779"
      unitRef="usd">144000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMy0zLTEtMS05MDMzMA_ea13bdf0-204c-425e-90fb-ee3d96626284"
      unitRef="usd">488000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMy01LTEtMS05MDMzMA_798a4838-b89b-42e8-8e8c-c4662b29dcd9"
      unitRef="usd">522000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0xLTEtMS05MDMzMA_c2250b6f-5f72-4425-8408-89997da2e982"
      unitRef="usd">1635000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0zLTEtMS05MDMzMA_ed9b959b-863d-44bf-992b-844f816f12e4"
      unitRef="usd">1604000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC01LTEtMS05MDMzMA_49d1116c-81e6-4ccc-8401-158bf642c8a7"
      unitRef="usd">352000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0xLTEtMS03MzUzNQ_635d6f2f-947c-4d91-a9fe-5040c9bc1fc5"
      unitRef="usd">2229000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC0zLTEtMS03MzUzNQ_4404d39e-26bc-4048-921c-07732cfba6e5"
      unitRef="usd">2230000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNC01LTEtMS03MzUzNQ_4d82d971-22a8-4ca3-9d8e-16fb4634611e"
      unitRef="usd">2115000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNS0xLTEtMS03MzUzNQ_f36aa3de-cc29-4aa6-ae7d-2309bf682f4f"
      unitRef="usd">233000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNS0zLTEtMS03MzUzNQ_f1bcbc7d-5a0a-497e-9144-9470ebf54735"
      unitRef="usd">229000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNS01LTEtMS03MzUzNQ_29aaf0a1-95d8-4b7a-b1c0-bdcacf81af30"
      unitRef="usd">236000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNi0xLTEtMS03MzUzNQ_80bcedf9-b8cb-47ef-86b1-1bd8c5d4e2e9"
      unitRef="usd">-120000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNi0zLTEtMS03MzUzNQ_b918acf3-b303-4345-959e-aaf216fe1c5e"
      unitRef="usd">-301000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNi01LTEtMS03MzUzNQ_62310aae-bb11-458d-b642-772c186ea4bb"
      unitRef="usd">-308000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfOC0xLTEtMS03MzUzNQ_3ae609d7-f026-4375-a2a0-568b2939ceaf"
      unitRef="usd">-32000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfOC0zLTEtMS03MzUzNQ_b0f13fee-0a8e-4c92-8bcd-e3f487c5ffc2"
      unitRef="usd">61000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfOC01LTEtMS03MzUzNQ_d410e06d-8640-4f36-89e0-5d234ec845b1"
      unitRef="usd">53000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTAtMS0xLTEtNzM1MzU_8b794bb0-df84-45d3-be82-038de2d8d974"
      unitRef="usd">631000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTAtMy0xLTEtNzM1MzU_bf6a29ed-8104-46bb-a492-6d91d90de942"
      unitRef="usd">83000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTAtNS0xLTEtNzM1MzU_13d0b2ad-36ba-426d-94ad-53b459822ab4"
      unitRef="usd">120000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTEtMS0xLTEtNzM1MzU_e91ab48f-b2c0-445b-98b4-b92a810646c4"
      unitRef="usd">436000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTEtMy0xLTEtNzM1MzU_35fa68a3-6efc-4be1-bc5c-cabf8f1f0129"
      unitRef="usd">184000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTEtNS0xLTEtNzM1MzU_89c712ba-1ef6-4a11-af2a-c6eba117fdd1"
      unitRef="usd">-63000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTItMS0xLTEtNzM1MzU_9b155fd0-78d9-4225-ad13-f6ebd4827461"
      unitRef="usd">-473000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTItMy0xLTEtNzM1MzU_d232e329-1f52-40a6-840b-06cd9f767915"
      unitRef="usd">660000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTItNS0xLTEtNzM1MzU_9eb50800-7028-4fbe-ace5-2474649da623"
      unitRef="usd">195000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTMtMS0xLTEtNzM1MzU_75638ca8-2bf2-43e8-836e-d571435c0d38"
      unitRef="usd">-55000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTMtMy0xLTEtNzM1MzU_a7e85b6b-0a53-4103-8872-53ae7da35b6b"
      unitRef="usd">71000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <bdx:IncreaseDecreaseinPensionBenefitObligation
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTMtNS0xLTEtNzM1MzU_a1dc7fb6-ee3f-4b57-83e3-b6cd817f5d0d"
      unitRef="usd">95000000</bdx:IncreaseDecreaseinPensionBenefitObligation>
    <bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTQtMS0xLTEtNzM1MzU_81adc323-a1ae-4f9a-b175-710567fb31da"
      unitRef="usd">-32000000</bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities>
    <bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTQtMy0xLTEtNzM1MzU_d1e055fa-fed2-4c56-a0f5-9a90037eee55"
      unitRef="usd">-15000000</bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities>
    <bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTQtNS0xLTEtNzM1MzU_4b608f60-3321-4e51-b1e5-850f88070144"
      unitRef="usd">-52000000</bdx:ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTctMS0xLTEtNzM1MzU_13c21dd5-53c7-480a-b0db-2ca93f0c3d7e"
      unitRef="usd">21000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTctMy0xLTEtNzM1MzU_488dccec-50d1-4c35-9a23-84d44f785633"
      unitRef="usd">361000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTctNS0xLTEtNzM1MzU_0b97ae2b-f2ed-4fec-b0da-3089eff2cd4a"
      unitRef="usd">378000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTgtMS0xLTEtNzM1MzU_181db0fd-39ca-4e96-8992-d8c2db775b36"
      unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTgtMy0xLTEtNzM1MzU_ab893feb-6114-4cd7-b1c9-40ecfe79f53b"
      unitRef="usd">414000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTgtNS0xLTEtNzM1MzU_b671ebca-ee14-4658-8aea-102dcd551e2f"
      unitRef="usd">68000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTktMS0xLTEtNzM1MzU_2d1c0935-bb93-4678-930f-13fb3e4a0c47"
      unitRef="usd">2471000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTktMy0xLTEtNzM1MzU_eeb9346d-9d20-4e12-808d-1e21e3f20a72"
      unitRef="usd">4126000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMTktNS0xLTEtNzM1MzU_dc6f1064-2e1a-481c-9c6c-2dac3cde2eae"
      unitRef="usd">2937000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjEtMS0xLTEtNzM1MzU_7d7d06ba-c6c8-45cb-bee7-8c211211a482"
      unitRef="usd">973000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjEtMy0xLTEtNzM1MzU_f60354f1-9fa9-4b1e-9aee-64bff5a601c6"
      unitRef="usd">1194000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjEtNS0xLTEtNzM1MzU_4d8c341e-76f3-47d2-ba48-73b3c83e24e8"
      unitRef="usd">769000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjMtMS0xLTEtNzM1MzU_eafec5c2-dc9e-4a9f-9b70-68c003bf8825"
      unitRef="usd">2070000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjMtMy0xLTEtNzM1MzU_382bc0af-d4e0-44b6-81ba-315bc783140c"
      unitRef="usd">508000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjMtNS0xLTEtNzM1MzU_d7d933bd-7de3-4301-8dac-3b40db0f9d5f"
      unitRef="usd">164000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjUtMS0xLTEtNzM1MzU_2c8f38bf-f733-4abb-8879-3cdbe0cf996d"
      unitRef="usd">178000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjUtMy0xLTEtNzM1MzU_86364a80-cecd-4e6f-a579-5655f955e1e7"
      unitRef="usd">142000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjUtNS0xLTEtNzM1MzU_1026e1b3-2a85-489a-ae3c-1d12f5af3fbc"
      unitRef="usd">257000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjYtMS0xLTEtNzM1MzU_cd0eb0e7-e522-4b51-9110-25cf260b1415"
      unitRef="usd">-3220000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjYtMy0xLTEtNzM1MzU_35bde159-9de8-4746-a882-a91c04549308"
      unitRef="usd">-1843000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjYtNS0xLTEtNzM1MzU_66b8551f-62e0-478b-b287-3c916e2cf362"
      unitRef="usd">-1190000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMS0xLTEtMTIwMzcw_be9d7a54-3742-41b3-bed1-ef3c2dba933e"
      unitRef="usd">230000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMy0xLTEtMTIyOTgy_b40066fb-259b-4f63-8e7e-beec0e5138df"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtNS0xLTEtMTIyOTgy_06cdea4c-9519-41db-b069-ab251db0b51c"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjgtMS0xLTEtNzM1MzU_8f124427-fa60-45f9-98f3-df3a25205099"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjgtMy0xLTEtNzM1MzU_d5b50ca0-3afe-4632-a2fe-7b5a6983d117"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjgtNS0xLTEtNzM1MzU_4623131d-7495-4f23-9095-d9c96f3518b8"
      unitRef="usd">-485000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjktMS0xLTEtNzM1MzU_a744a027-73bb-41b8-8032-01a7dfc9ed74"
      unitRef="usd">497000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjktMy0xLTEtNzM1MzU_a0446dfa-70a6-4b63-8d95-8a6dba3d54ee"
      unitRef="usd">4869000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMjktNS0xLTEtNzM1MzU_9ad4d7a9-7a53-4f20-9927-a7040b5639d9"
      unitRef="usd">3389000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <bdx:ProceedsFromSpinoffTransaction
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMS0xLTEtMTAyNTEy_2d857ea0-2754-4398-a5b6-b0658638a0aa"
      unitRef="usd">1266000000</bdx:ProceedsFromSpinoffTransaction>
    <bdx:ProceedsFromSpinoffTransaction
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMy0xLTEtMTAyNTEy_48962d0f-cdca-46a1-a0d8-ff261d546d88"
      unitRef="usd">0</bdx:ProceedsFromSpinoffTransaction>
    <bdx:ProceedsFromSpinoffTransaction
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItNS0xLTEtMTAyNTEy_8f83e823-1dc9-42fa-9140-b1318227ddc1"
      unitRef="usd">0</bdx:ProceedsFromSpinoffTransaction>
    <bdx:CashTransferRelatedToSpinoffTransaction
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMS0xLTEtMTAyNTEy_8bec0e21-1454-4abe-a09a-6e68d562ba88"
      unitRef="usd">265000000</bdx:CashTransferRelatedToSpinoffTransaction>
    <bdx:CashTransferRelatedToSpinoffTransaction
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMy0xLTEtMTAyNTEy_c71a37fe-459e-44f7-9d1a-7e1efd4e3204"
      unitRef="usd">0</bdx:CashTransferRelatedToSpinoffTransaction>
    <bdx:CashTransferRelatedToSpinoffTransaction
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtNS0xLTEtMTAyNTEy_ff3ac70d-ce87-48d7-94ff-3df31d8fcf45"
      unitRef="usd">0</bdx:CashTransferRelatedToSpinoffTransaction>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMS0xLTEtNzM1MzU_b131774f-0bc3-423f-a104-7fcd00eba7b0"
      unitRef="usd">805000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtMy0xLTEtNzM1MzU_df6ef679-5942-443d-ac72-b3d1ebcfc6c2"
      unitRef="usd">5112000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzAtNS0xLTEtNzM1MzU_f39b1488-3d71-4e9d-8151-de369aab1fd0"
      unitRef="usd">4664000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzEtMS0xLTEtNzM1MzU_3ab0ed42-ab7c-4d87-ba2c-e6104450ce9a"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzEtMy0xLTEtNzM1MzU_5572dd1f-5ce3-4248-8135-488aec5c9153"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzEtNS0xLTEtNzM1MzU_e808c77a-39b3-4d4c-9ce2-4b8cc39c340b"
      unitRef="usd">2917000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMS0xLTEtNzM1MzU_ea51ab30-fa43-4969-9e61-dee7d1c0c32a"
      unitRef="usd">500000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItMy0xLTEtNzM1MzU_7820b48e-641c-432f-84d1-8d9d010730b4"
      unitRef="usd">1750000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzItNS0xLTEtNzM1MzU_5b9d497b-b346-41d1-9fb2-ee613330ffc0"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMS0xLTEtNzM1MzU_ca557321-ebe8-4f11-a370-0099ab2fd7bc"
      unitRef="usd">1082000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtMy0xLTEtNzM1MzU_d5a8f855-fdda-4323-9925-a15619398bb0"
      unitRef="usd">1048000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzMtNS0xLTEtNzM1MzU_8e7b157d-ef40-462b-afad-98544703e217"
      unitRef="usd">1026000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzQtMS0xLTEtNzM1MzU_0242a33a-1bd2-424e-93f1-34091470e5c2"
      unitRef="usd">-77000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzQtMy0xLTEtNzM1MzU_eb65649a-8fd4-4882-9752-7d25702db74e"
      unitRef="usd">-265000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzQtNS0xLTEtNzM1MzU_1f507694-838f-4120-a2d8-9bb0542cfad4"
      unitRef="usd">-109000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzUtMS0xLTEtNzM1MzU_bb441706-25be-4891-9e2a-fb98ec2ebcbd"
      unitRef="usd">-736000000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzUtMy0xLTEtNzM1MzU_da127f25-8069-4525-b26a-90c4270f44dc"
      unitRef="usd">-3306000000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzUtNS0xLTEtNzM1MzU_2e31b051-f4d1-4a1d-beb7-95aa34b152ba"
      unitRef="usd">22000000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMS0xLTEtOTA0MTY_d4da1177-ab7a-45e4-a574-a18efa4311eb"
      unitRef="usd">163000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMy0xLTEtOTA0MTY_a5a5fd87-9279-4e35-aad7-bd576e1fc31f"
      unitRef="usd">521000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktNS0xLTEtOTA0MTY_6507e3e2-359b-46b6-8754-1bba2c265595"
      unitRef="usd">602000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDAtMS0xLTEtOTA0MTY_ccaff83c-e60f-4ac5-a50b-9b816091b1c5"
      unitRef="usd">-11000000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDAtMy0xLTEtOTA0MTY_e5162487-3798-453a-9752-a2e0f9b54676"
      unitRef="usd">-37000000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDAtNS0xLTEtOTA0MTY_7826537a-ee8d-44c7-8f85-d7de8ddfbee7"
      unitRef="usd">-42000000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDEtMS0xLTEtOTA0MTY_b75f2e66-fe8a-43be-b396-1b572636bf1f"
      unitRef="usd">145000000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDEtMy0xLTEtOTA0MTY_6b06f8cb-39d1-4139-bbc6-dab4dd59c743"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDEtNS0xLTEtOTA0MTY_fb4438af-6675-4687-9685-6b21b46736ee"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDItMS0xLTEtOTA0MTY_019993a3-c5b1-4349-b0d2-d547951c0b96"
      unitRef="usd">298000000</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDItMy0xLTEtOTA0MTY_0deaf973-214e-47d1-9e57-7c631a1ae200"
      unitRef="usd">484000000</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfNDItNS0xLTEtOTA0MTY_f12fb87f-62ba-4f52-aa27-f3a90c628d6a"
      unitRef="usd">560000000</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzYtMS0xLTEtNzM1MzU_9940d3ce-2496-4e1b-8cd3-46ed4539069b"
      unitRef="usd">-45000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzYtMy0xLTEtNzM1MzU_ff5ead18-d60b-48cf-a98f-da7b100ba9e5"
      unitRef="usd">15000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzYtNS0xLTEtNzM1MzU_974b03ff-be0f-4b83-aceb-e6efd8a28234"
      unitRef="usd">-3000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzctMS0xLTEtNzM1MzU_8ed37445-d605-435c-b915-7f0d4c4a2933"
      unitRef="usd">-1233000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzctMy0xLTEtNzM1MzU_cfe1ba1b-ab7b-4324-a414-185d7fec642a"
      unitRef="usd">-525000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzctNS0xLTEtNzM1MzU_ce8f8ef5-6a4b-4abf-ae3d-35bffaeb90dc"
      unitRef="usd">2326000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzgtMS0xLTEtNzM1MzU_42e32abf-9253-4e10-b47e-fb7bc4a5ea82"
      unitRef="usd">2392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzgtMy0xLTEtNzM1MzU_270b90fd-359a-4ea9-a093-240ee8bdcd28"
      unitRef="usd">2917000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzgtNS0xLTEtNzM1MzU_1a4802fd-bfb3-456c-9fbf-36c1ab003926"
      unitRef="usd">590000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMS0xLTEtNzM1MzU_2b4bc647-f455-4473-8f59-56cd7ce99c46"
      unitRef="usd">1159000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktMy0xLTEtNzM1MzU_b4e2572d-a2eb-482d-913a-d5cfb1b87b54"
      unitRef="usd">2392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83MC9mcmFnOjc3NzQzZmJjMzY3YzRkNjY5MmU2ZjYwNDFjMTk5MzYxL3RhYmxlOjg5YjVkNmY5YzNkMzQzNDU5ODdkMzNjZjZhMjU3MjcwL3RhYmxlcmFuZ2U6ODliNWQ2ZjljM2QzNDM0NTk4N2QzM2NmNmEyNTcyNzBfMzktNS0xLTEtNzM1MzU_1eb25635-8887-4f08-9281-aaef72cedde6"
      unitRef="usd">2917000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0ODQ_dee6c126-6cba-4364-8b16-d2e6da4838da">Summary of Significant Accounting Policies&lt;div style="margin-top:5pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the "Company" or "BD") have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company and the historical results of the Diabetes Care business that was contributed in the spin-off have been reflected as discontinued operations in the Company&#x2019;s consolidated financial statements for all periods prior to the spin-off date. Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#x2019;s consolidated balance sheet as of September 30, 2021. Additional disclosures regarding the spin-off are provided in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the Company&#x2019;s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists of cash restricted from withdrawal and usage and largely represents funds that are restricted for certain product liability matters assumed in the acquisition of C.R. Bard, Inc. ("Bard"), which are further discussed in Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#x2019;s estimate of expected credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is  not collectable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which range from 20 to 45 years for buildings, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd"&gt;four&lt;/span&gt; to 13 years for machinery and equipment and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1"&gt;one&lt;/span&gt; to 20 years for leasehold improvements. Depreciation and amortization expense was $672 million, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$689 million and $608 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in fiscal years 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unamortized intangible assets include goodwill that arises from acquisitions of businesses. The Company reviews goodwill for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  The Company&#x2019;s reporting units generally represent one level below reporting segments. The Company reviews goodwill for each reporting unit by comparing the fair value of the reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2022 indicated that all identified reporting units&#x2019; fair values exceeded their respective carrying values. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d"&gt;one&lt;/span&gt; to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#x2019;s carrying value exceeds its calculated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, foreign subsidiaries&#x2019; functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates.  The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from product sales when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#x2019;s ability to use and benefit from the product, are recognized upon customer acceptance of these installed products. Revenue for certain service arrangements, including extended warranty and software maintenance contracts, is recognized ratably over the contract term. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Variable consideration such as rebates, sales discounts and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices, and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment lease transactions with customers are evaluated and classified as either operating or sales-type leases. Generally, these arrangements are accounted for as operating leases and therefore, revenue is recognized at the contracted rate over the rental period defined within the customer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional disclosures regarding the Company's accounting for revenue recognition are provided in Note 7.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers its shipping and handling costs to be contract fulfillment costs and records them within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling and administrative expense. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping expense was $751 million, $641 million and $538 million in 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries).  Additional disclosures regarding the Company's accounting for contingencies are provided in Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met. Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows. Cash flows for all other derivatives, including undesignated hedges, are classified in the same line item as the cash flows of the related hedged item, which is generally within operating or financing activities. Additional disclosures regarding the Company's accounting for derivative instruments are provided in Note 14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has reviewed its needs in the United States for possible repatriation of undistributed earnings of its foreign subsidiaries and continues to invest foreign subsidiaries earnings outside of the United States to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. As a result, the Company is permanently reinvested with respect to all of its historical foreign earnings as of September 30, 2022. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable because of the complexities associated with its hypothetical calculation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Additional disclosures regarding the Company's accounting for income taxes are provided in Note 17.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Tax Cuts and Jobs Act was enacted on December 22, 2017 and subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to account for its GILTI tax due as a period expense in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share are computed by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In computing diluted earnings per share, only potential common shares that are dilutive (i.e., those that reduce earnings per share or increase loss per share) are included in the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#x2019;s fair value measurements are provided in Notes 10 and 15.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2014; Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 2 &#x2014; Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 3 &#x2014; Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0Mzg_e96f15fc-b94d-4d73-ad5e-6e3ae6e452ad">&lt;div style="margin-top:5pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the "Company" or "BD") have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company and the historical results of the Diabetes Care business that was contributed in the spin-off have been reflected as discontinued operations in the Company&#x2019;s consolidated financial statements for all periods prior to the spin-off date. Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#x2019;s consolidated balance sheet as of September 30, 2021. Additional disclosures regarding the spin-off are provided in Note 2.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NDY_1f09dd37-e5d3-45f3-b279-ceb7a1c5d1da">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the Company&#x2019;s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzOTU_6428eb77-a01f-428c-a7e8-2dfca80a106b">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MjQ_0aed000d-5852-4206-97ad-bc919f93cf4c">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists of cash restricted from withdrawal and usage and largely represents funds that are restricted for certain product liability matters assumed in the acquisition of C.R. Bard, Inc. ("Bard"), which are further discussed in Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzODk_e4fee41d-a39b-453d-bb56-58f3e762e666">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#x2019;s estimate of expected credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is  not collectable.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NTQ_d5823119-66a5-4096-8714-5542a8fecd62">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MDU_65b3ebf5-9a56-4e9e-b7ee-418f556b27c6">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, &lt;/span&gt;&lt;/div&gt;which range from 20 to 45 years for buildings, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI4Nw_445ac0d1-0cb8-4caf-86c5-fb2432a884bd"&gt;four&lt;/span&gt; to 13 years for machinery and equipment and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjMzNA_4dbc909d-fe86-4e37-84c0-8fe4ea237ca1"&gt;one&lt;/span&gt; to 20 years for leasehold improvements.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3d85f871f7b24bc5989ba58c61917188_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjI1Nw_eb493ac4-f5c5-42f0-b70e-eb9e7542e475">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i72d7bdb2703948fb9aea56ffc9e2f630_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjA0NzMxMzk2NzY3OA_0d5142e7-08f7-4ce1-95e3-3c02dd0fe667">P45Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1a48157deb98419da4fff13ef30cc91e_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjA0NzMxMzk2NzY4MA_9d3a986f-31a5-4993-913b-803643d8e435">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i73746dfe5c0f4de7970ccce7ad10430a_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjA0NzMxMzk2NzY3OQ_92edf15d-7516-480f-9484-3f66292dbbd2">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjQyMA_fa767e9c-8d89-4e06-ae7b-0bf3d4bf4237"
      unitRef="usd">672000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjQyNA_15f6ff76-05e1-4dad-888e-91eb9b5b4c28"
      unitRef="usd">689000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMjQzMQ_affe5ff7-482d-414b-807b-ff62a34a3f1b"
      unitRef="usd">608000000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzOTc_5c92cedd-1140-45c4-a901-aaad57e43625">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unamortized intangible assets include goodwill that arises from acquisitions of businesses. The Company reviews goodwill for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  The Company&#x2019;s reporting units generally represent one level below reporting segments. The Company reviews goodwill for each reporting unit by comparing the fair value of the reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2022 indicated that all identified reporting units&#x2019; fair values exceeded their respective carrying values. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwMA_4a7c0a58-56db-4127-8cda-bbc19e57ca9d"&gt;one&lt;/span&gt; to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#x2019;s carrying value exceeds its calculated fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i29f71c0bff93492c9a06e0d87133987e_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzcwNA_8bb0e60e-f70f-4c73-8936-a50cf4f5cf8a">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if83533f337ff4fffadbe9a69dc3a40cc_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzcxMA_d84ca6b2-57f6-4c89-8ee5-fde78efc4b4c">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i50001881e1d74dcdb3045e71518d4167_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzgzMg_d1e42004-7f46-4014-9edb-fa75d591527a">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icb8199c4ea0048a5b80be3d9e50c0d1d_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMzgzOA_d6aa44d2-ef64-47e9-9df4-8cee56906773">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id34e1facad0e439181f5dcf5d5566e02_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNDAwNg_4a6a4251-862b-4313-bf64-230d6133f4ca">P40Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MTE_ac5b7f1b-1cf4-473f-abfc-2502d11b7f97">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, foreign subsidiaries&#x2019; functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates.  The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NjQ_93621524-b8e2-4189-afc4-ee733a248aa7">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from product sales when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#x2019;s ability to use and benefit from the product, are recognized upon customer acceptance of these installed products. Revenue for certain service arrangements, including extended warranty and software maintenance contracts, is recognized ratably over the contract term. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Variable consideration such as rebates, sales discounts and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices, and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment lease transactions with customers are evaluated and classified as either operating or sales-type leases. Generally, these arrangements are accounted for as operating leases and therefore, revenue is recognized at the contracted rate over the rental period defined within the customer agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic33b9e6159d048938c04eefaef08044d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNjk5OA_a2415480-3560-4883-a897-53895aed5842"
      unitRef="usd">751000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4396e0c37dc446598a1bfa55a31434e6_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNzAwMg_948515c6-9151-4d88-8f9a-6af714ba7e68"
      unitRef="usd">641000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i14247198e9224028bedb55ce3b8f7e27_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfNzAwOQ_fc4093b7-b264-4921-96a9-272c845c7590"
      unitRef="usd">538000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0ODY_37b38d10-2b63-44bc-a1ea-b71e56d7e47e">ContingenciesThe Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries). Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#x201c;CIDs&#x201d;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved. In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition, and /or consolidated cash flows.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MzM_baf92c66-0e8e-4a23-bd70-c6e85ae9b135">Derivative Financial InstrumentsAll derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met. Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows. Cash flows for all other derivatives, including undesignated hedges, are classified in the same line item as the cash flows of the related hedged item, which is generally within operating or financing activities.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTIzOTI_bd726176-bb18-4673-861f-64f140786e55">&lt;div style="margin-top:6pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has reviewed its needs in the United States for possible repatriation of undistributed earnings of its foreign subsidiaries and continues to invest foreign subsidiaries earnings outside of the United States to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. As a result, the Company is permanently reinvested with respect to all of its historical foreign earnings as of September 30, 2022. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable because of the complexities associated with its hypothetical calculation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Additional disclosures regarding the Company's accounting for income taxes are provided in Note 17.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Tax Cuts and Jobs Act was enacted on December 22, 2017 and subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to account for its GILTI tax due as a period expense in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0MTY_4b29e5bf-c58d-45bb-bdda-3d4a3ba0beeb">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share are computed by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. In computing diluted earnings per share, only potential common shares that are dilutive (i.e., those that reduce earnings per share or increase loss per share) are included in the calculation.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NzM_f01044f4-a77c-425b-8e98-984a30574c84">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#x2019;s fair value measurements are provided in Notes 10 and 15.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2014; Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 2 &#x2014; Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 3 &#x2014; Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83Ni9mcmFnOmFjZTkzMDZhMWVjYTQzZTc5ZDFjZmMyMTFkMTcwMmRmL3RleHRyZWdpb246YWNlOTMwNmExZWNhNDNlNzlkMWNmYzIxMWQxNzAyZGZfMTI0NzQ_9243f7e6-e52d-402c-b331-66cd025b2ae6">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18zMjk4NTM0ODk1ODEz_b13ef1cb-d8d0-4d97-a9fe-d161a750238c">Spin-Off of Embecta Corp.&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (&#x201c;Embecta&#x201d;) through a distribution of Embecta&#x2019;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#x201c;EMBC&#x201d;) to BD&#x2019;s shareholders of record as of the close of business on March 22, 2022 (the &#x201c;record date&#x201d;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embecta&#x2019;s distributions on March 31, 2022 to the Company in connection with the spin-off included the issuance of $200&#160;million of senior unsecured notes to the Company and a&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cash distribution of approximately $1.266&#160;billion. Additional disclosures regarding the various financing transactions entered into by Embecta and related to the spin-off are provided in Note 16.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#x2019;s consolidated statements of income during the fiscal year ended September 30, 2022 as a result of these agreements were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The historical results of the Diabetes Care business (previously included in BD&#x2019;s Medical segment) that was contributed to Embecta in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#x2019;s consolidated financial statements for all periods prior to the spin-off date of April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Details of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Millions of dollars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Operating Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended September 30, 2022, the Company incurred &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$30&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of expense which included costs to execute the spin-off and other costs for related residual activities. These costs are recorded within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income from Discontinued Operations, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the year ended September 30, 2022. Separation costs incurred by the Company prior to the spin-off date, including those for consulting, legal, tax and other advisory services associated with the spin-off, were previously recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating (expense) income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and are now included as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; from continuing operations were recast to reflect previously eliminated intercompany transactions that occurred between BD and Embecta and that resulted in a third party sale in the same period. The impacts of these transactions to Embecta are also reflected as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#x2019;s consolidated balance sheet at September 30, 2021:   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Millions of dollars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Assets of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and Other Intangibles, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent Assets of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries, wages and related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Liabilities of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent Liabilities of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded its distribution of net liabilities to Embecta as an increase in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retained earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amount recorded reflected the carrying amounts, as of April 1, 2022, of the net liabilities distributed and included $1.650&#160;billion of debt issued by Embecta, as further discussed above and in Note 16, as well as $265&#160;million of cash. The Company also recorded a net decrease to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $251&#160;million to derecognize foreign currency translation losses which were attributable to Embecta.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i55f01eb74e224d3b859c08b736035bcc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjQ0NTEw_4f1ddbf8-0e14-4c96-9528-873543b4135b"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash
      contextRef="i779c08f21c7145b69a3c73a02acd692f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjMyMDMy_69564494-aa3c-412e-96f3-8c3dffa6bba8"
      unitRef="usd">1266000000</bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjM0OTc0_b91b4428-f11e-4c5f-9b97-1c2d13782b34">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Details of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Millions of dollars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Operating Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;   &lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#x2019;s consolidated balance sheet at September 30, 2021:   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Millions of dollars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Assets of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and Other Intangibles, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent Assets of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries, wages and related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Liabilities of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent Liabilities of Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8yLTEtMS0xLTg4Njc1_ff670dd8-8ffb-4693-8204-0939feb8fd47"
      unitRef="usd">538000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8yLTMtMS0xLTg4Njc1_068cd45e-ac7d-4314-94a8-c8374d017cd1"
      unitRef="usd">1117000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xLTUtMS0xLTg4NzA0_e06168c9-bc8e-4ce6-bfab-b4157a606ee2"
      unitRef="usd">1043000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8zLTEtMS0xLTg4Njc1_dbeed85c-c8ff-425a-938c-d1b3e1d4bb8e"
      unitRef="usd">143000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8zLTMtMS0xLTg4Njc1_0578cc25-fb5a-4170-81c3-86e087189c93"
      unitRef="usd">320000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8yLTUtMS0xLTg4NzA0_3f761a4b-1225-4c05-bbd1-f5866e1ec8de"
      unitRef="usd">264000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV80LTEtMS0xLTg4Njc1_3a5b3aad-1b37-435d-86d6-b2774beb871d"
      unitRef="usd">78000000</bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV80LTMtMS0xLTg4Njc1_03656eec-0324-44ec-a7ae-cc84c7bf8d67"
      unitRef="usd">148000000</bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8zLTUtMS0xLTg4NzA0_4fc679fe-efcb-4557-ab3b-a7ca2a712eac"
      unitRef="usd">141000000</bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTEtMS0xLTg4Njc1_b768eccb-07e0-450d-89d0-4bfc8f4109e2"
      unitRef="usd">32000000</bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTMtMS0xLTg4Njc1_3333fe75-539c-40c6-8dd8-fb6fdafb815d"
      unitRef="usd">59000000</bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV80LTUtMS0xLTg4NzA0_f170253e-f90a-4bcd-9995-01c104e3b7ed"
      unitRef="usd">57000000</bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense>
    <bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTEtMS0xLTkxNjkx_f064d35a-89e5-4be4-9e68-54aaead7a1b5"
      unitRef="usd">0</bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTMtMS0xLTkxNjkx_7cdacda6-07b0-47b6-9053-4815bbdf551e"
      unitRef="usd">6000000</bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV81LTUtMS0xLTkxNjkx_29c9ca11-e1cf-4a61-b4d8-af3c9b8e9901"
      unitRef="usd">10000000</bdx:DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV83LTEtMS0xLTg4Njc1_3903f618-a067-435b-bbdd-d10c926011dc"
      unitRef="usd">-95000000</bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV83LTMtMS0xLTg4Njc1_bfb0071a-5745-4b9f-9cde-bd1f103bc931"
      unitRef="usd">-35000000</bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV82LTUtMS0xLTg4NzA0_424aae3c-04b0-4b54-bc50-7c209fa2958a"
      unitRef="usd">0</bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV84LTEtMS0xLTg4Njc1_adc20806-06f1-43eb-b87e-48b9a43a998e"
      unitRef="usd">348000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV84LTMtMS0xLTg4Njc1_92b7a680-959d-48dd-b94f-e0b2bb6976bf"
      unitRef="usd">569000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV83LTUtMS0xLTg4NzA0_2d25f32e-0887-4b4f-9188-7704936a6657"
      unitRef="usd">472000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV85LTEtMS0xLTg4Njc1_2bd0b600-ab02-4e3a-aab6-0922f9d03bfa"
      unitRef="usd">190000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV85LTMtMS0xLTg4Njc1_5c03cc2a-ffc9-4fe6-b124-162a8da04828"
      unitRef="usd">549000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV84LTUtMS0xLTg4NzA0_b3910d9d-c01c-4894-9c26-9363bc8940d7"
      unitRef="usd">571000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMC0xLTEtMS04ODY3NQ_dafed2e9-cf28-4d20-bc5a-02c0010184dd"
      unitRef="usd">4000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMC0zLTEtMS04ODY3NQ_703ef49e-3fd2-4f90-9cac-09039db87b19"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV85LTUtMS0xLTg4NzA0_bb469685-d31e-4151-bf47-45643f85dc30"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMi0xLTEtMS04ODY3NQ_7ea353d9-555e-4850-b8e1-e4aa4060fe1c"
      unitRef="usd">0</bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMi0zLTEtMS04ODY3NQ_ed6a470d-46b4-4291-889b-7aabb91be3c6"
      unitRef="usd">2000000</bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense>
    <bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMS01LTEtMS04ODcwNA_cf322216-b262-4bf2-9207-291e48e210c4"
      unitRef="usd">0</bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMy0xLTEtMS04ODY3NQ_59d85c86-e965-4f8a-8efb-9b1018471fa2"
      unitRef="usd">186000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMy0zLTEtMS04ODY3NQ_36bb72de-6883-46ca-9385-ab2b89e989ef"
      unitRef="usd">550000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMi01LTEtMS04ODcwNA_f8df7899-3a5c-4637-b468-f37754d6d8bb"
      unitRef="usd">571000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNC0xLTEtMS04ODY3NQ_7beb30b5-6501-4f20-b1e6-7e716d6d17e7"
      unitRef="usd">42000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNC0zLTEtMS04ODY3NQ_0c090903-439e-4306-9233-84ab41300742"
      unitRef="usd">62000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xMy01LTEtMS04ODcwNA_54bb6ba2-a965-417c-ab79-bd826d8670d8"
      unitRef="usd">50000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNS0xLTEtMS04ODY3NQ_95c2420b-19e7-42ef-8238-05229d13aede"
      unitRef="usd">144000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="id819d2c988ed412c86dcd24e9117b89a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNS0zLTEtMS04ODY3NQ_958e9bc8-3b8c-4484-b2b7-9d010e8939fb"
      unitRef="usd">488000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i6db55becf69b41979f32edbfca1cc2c8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6NmE2YTk2YTE1ZTlhNDBiZmExMGE0ZTg5ZjI0MmIwN2UvdGFibGVyYW5nZTo2YTZhOTZhMTVlOWE0MGJmYTEwYTRlODlmMjQyYjA3ZV8xNC01LTEtMS04ODcwNA_438d706b-83ff-4a26-acb8-ebd71ca10a04"
      unitRef="usd">522000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense
      contextRef="i03436c961ff34525b6bc41434568957f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjQ3ODIx_2f5d7a59-514c-4643-87a4-2f68e5093387"
      unitRef="usd">30000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8yLTEtMS0xLTg4NzM2_5cea9d00-a84c-40c1-b26b-1bde36be07e0"
      unitRef="usd">147000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8zLTEtMS0xLTg4NzM2_479c4813-5964-4247-94f3-ab31124565bb"
      unitRef="usd">123000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF80LTEtMS0xLTg4NzM2_129e3c40-5a86-4181-a2c4-c92b8035e3b7"
      unitRef="usd">23000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF81LTEtMS0xLTg4NzM2_0f1d5812-ad4b-427e-a55f-4484fd9b620a"
      unitRef="usd">293000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF82LTEtMS0xLTg4NzM2_b90657f6-c14d-42d7-95a7-d14a152a40f3"
      unitRef="usd">390000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF83LTEtMS0xLTg4NzM2_d8defe68-7ad5-4fc5-bb8f-2edb6f7c7c65"
      unitRef="usd">27000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xMS0xLTEtMS04ODczNg_ce29639e-08d5-4ec7-8bc0-fcc21b8dfe02"
      unitRef="usd">6000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xMi0xLTEtMS04ODg3Mg_af640346-3ce5-40c2-aed5-85d8c971d47e"
      unitRef="usd">423000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xNC0xLTEtMS04ODczNg_c47ee0fa-fc4e-4ec0-aec2-225245da4c74"
      unitRef="usd">54000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xNS0xLTEtMS04ODczNg_555845e6-2c01-440c-962f-a2be7f3a90b7"
      unitRef="usd">75000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <bdx:DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xNi0xLTEtMS04ODczNg_962fae31-d06c-4df8-9066-cd593765441e"
      unitRef="usd">28000000</bdx:DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xOC0xLTEtMS04ODczNg_4348443a-7b78-4042-9b0c-6edd2e3c4b6f"
      unitRef="usd">157000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8xOS0xLTEtMS04ODczNg_92792a0e-2625-4b39-bfb6-47a1914599ba"
      unitRef="usd">16000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="ie11ec78990674c6894d07a12d457c3a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGFibGU6ZjkyMjc5ZmRjNDM4NGI5YTliMjFlOGZhNDUyMDgxMzAvdGFibGVyYW5nZTpmOTIyNzlmZGM0Mzg0YjlhOWIyMWU4ZmE0NTIwODEzMF8yMC0xLTEtMS04ODg3Mg_1ad301ba-0f51-4f88-8eeb-4e7d5a100a51"
      unitRef="usd">17000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <bdx:DisposalGroupIncludingDiscontinuedOperationDebt
      contextRef="i5c2d5aa49a1e44eaa4bf7f704ff1fbb1_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjM0ODcx_f8b5e401-6544-4fa0-9be0-91dd0ebcf814"
      unitRef="usd">1650000000</bdx:DisposalGroupIncludingDiscontinuedOperationDebt>
    <bdx:CashTransferRelatedToSpinoffTransaction
      contextRef="i296c4706cc7a49a38687e154af3f932b_D20220401-20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjQ4MDU3_ff6b95dd-dae4-4556-91c7-22ec3f2d8469"
      unitRef="usd">265000000</bdx:CashTransferRelatedToSpinoffTransaction>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="i2a2da253f41c4177934228a9aaffc195_D20220401-20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDY3L2ZyYWc6NmVmZmEyMzI5ZDFjNGVlMTg2ZjJlZDY2ZWM3MmRjMzMvdGV4dHJlZ2lvbjo2ZWZmYTIzMjlkMWM0ZWUxODZmMmVkNjZlYzcyZGMzM18xMDk5NTExNjM0OTM2_0b692ffa-3a7b-4f68-a1f4-b81577acdf19"
      unitRef="usd">251000000</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83OS9mcmFnOjQ5ZDk2ZWYzMGM2YTQwODI4OTYyYTQzMDY1YTVhYTQ1L3RleHRyZWdpb246NDlkOTZlZjMwYzZhNDA4Mjg5NjJhNDMwNjVhNWFhNDVfNTMyOA_a3b3e210-5f89-4c49-a6e8-60abdd8826e6">Accounting Changes&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Principles Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 1, 2022, the Company early-adopted an accounting standard update issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), which requires an entity to apply the provisions of Accounting Standard Codification Topic 606, "Revenue from Contracts with Customers,&#x201d; (&#x201c;ASC 606&#x201d;) when recognizing and measuring contract assets and contract liabilities acquired in a business combination. The Company&#x2019;s adoption of this accounting standard update for business combinations that occurred during fiscal year 2022 did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued a new accounting standard which requires earlier recognition of credit losses on loans and other financial instruments held by entities, including trade receivables.  The new standard requires entities to measure all expected credit losses for financial assets held at each reporting date based on historical experience, current conditions, and reasonable and supportable forecasts.  The Company&#x2019;s adoption of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;this accounting standard on October 1, 2020, using the modified retrospective method, did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Principles Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the FASB issued a new accounting standard update that requires additional qualitative and quantitative disclosures surrounding supplier finance programs intended to help investors better consider the effect of these programs on a company's working capital, liquidity, and cash flows over time. This update is effective for fiscal years beginning after December 15, 2022, including interim periods, except for the disclosure. Early adoption is permitted. The Company is currently evaluating the impact this update will have on its disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV83OS9mcmFnOjQ5ZDk2ZWYzMGM2YTQwODI4OTYyYTQzMDY1YTVhYTQ1L3RleHRyZWdpb246NDlkOTZlZjMwYzZhNDA4Mjg5NjJhNDMwNjVhNWFhNDVfNTMyOQ_61b3a80f-6121-41d5-84a6-43954e8975aa">Accounting Changes&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Principles Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 1, 2022, the Company early-adopted an accounting standard update issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), which requires an entity to apply the provisions of Accounting Standard Codification Topic 606, "Revenue from Contracts with Customers,&#x201d; (&#x201c;ASC 606&#x201d;) when recognizing and measuring contract assets and contract liabilities acquired in a business combination. The Company&#x2019;s adoption of this accounting standard update for business combinations that occurred during fiscal year 2022 did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued a new accounting standard which requires earlier recognition of credit losses on loans and other financial instruments held by entities, including trade receivables.  The new standard requires entities to measure all expected credit losses for financial assets held at each reporting date based on historical experience, current conditions, and reasonable and supportable forecasts.  The Company&#x2019;s adoption of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;this accounting standard on October 1, 2020, using the modified retrospective method, did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Principles Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the FASB issued a new accounting standard update that requires additional qualitative and quantitative disclosures surrounding supplier finance programs intended to help investors better consider the effect of these programs on a company's working capital, liquidity, and cash flows over time. This update is effective for fiscal years beginning after December 15, 2022, including interim periods, except for the disclosure. Early adoption is permitted. The Company is currently evaluating the impact this update will have on its disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNjA0NzMxMzk3NDY0OA_4c5a122f-efe8-4405-bc5c-525c4ee9a93a">Shareholders&#x2019; Equity&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in certain components of shareholders&#x2019; equity were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76,260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash dividends:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common ($3.16 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issued for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred shares converted to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Public equity offerings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash dividends:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common ($3.32 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of change in accounting principle (see Note 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash dividends:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common ($3.48 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off of Embecta (See Note 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:45pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt"&gt;Common stock held in trusts consists of the Company&#x2019;s shares held in rabbi trusts in connection with deferred compensation under the Company&#x2019;s employee salary and bonus deferral plan and directors&#x2019; deferral plan.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of fiscal year 2022, the Company executed an accelerated share repurchase (&#x201c;ASR&#x201d;) agreement in which 1.953&#160;million common shares were repurchased and delivered in fiscal year 2022 for $500&#160;million, which was recorded as an increase to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal year 2021, the Company executed two ASR agreements to repurchase common shares totaling $1.250&#160;billion, of which $1.100&#160;billion settled in fiscal year 2021 and $150&#160;million settled in fiscal year 2022. Total shares delivered in 2021 under the ASR agreements were 4.577&#160;million shares. At September 30, 2021, the pending delivery of 462&#160;thousand shares on one of the agreements was reflected as a decrease to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capital in excess of par value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to recognize a net share-settled forward sale contract indexed to the Company's own common stock. Upon final settlement of the repurchase agreement and the forward sale contract during the first quarter of fiscal year 2022, the final settlement amount was recorded as an increase to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and an offsetting increase to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Capital in excess of par value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also repurchased approximately 2.066&#160;million shares of its common stock during fiscal year 2021 through open market repurchases, which were recorded as a $500&#160;million increase to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The share repurchases discussed above were made&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 10&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares, which has been fully utilized, and a repurchase program authorized by the Board of Directors in November 2021 for up to an additional 10&#160;million shares of BD common stock, for which there is no expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common and Preferred Stock Conversions and Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with their terms, the Company's 2.475&#160;million mandatory convertible preferred shares that were issued in May 2017 in connection with the Company's acquisition of Bard were converted into 11.703&#160;million shares of BD common stock on the mandatory conversion date of May 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in May 2020, the Company completed registered public offerings of equity securities including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;6.250&#160;million shares of the Company's common stock for net proceeds of $1.459&#160;billion (gross proceeds of $1.500&#160;billion).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;1.500&#160;million shares of the Company's mandatory convertible preferred stock (ownership is held in the form of depositary shares, each representing a 1/20th interest in a share of preferred stock) for net proceeds of $1.459&#160;billion (gross proceeds of $1.500&#160;billion).  If and when declared, dividends on the mandatory convertible preferred stock will be payable on a cumulative basis at an annual rate of 6.00% on the liquidation preference of $1,000 per preferred share ($50 per depositary share).  The shares of preferred stock are convertible to a minimum of 5.3&#160;million and up to a maximum of 6.4&#160;million shares of Company common stock at an exchange ratio, based on the market price of the Company&#x2019;s common stock at the date of conversion, and no later than the mandatory conversion date of June 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components and changes of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of&lt;br/&gt;taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of&lt;br/&gt;taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of&lt;br/&gt;taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off of Embecta (See Note 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of foreign currency translation recognized in other comprehensive income during the years ended September 30, 2022, 2021 and 2020 included net gains (losses) relating to net investment hedges, as further discussed in Note 14. Other comprehensive income relating to benefit plans during the year ended September 30, 2021 included a net gain of $24&#160;million recognized as a result of the Company&#x2019;s remeasurement, as of October 31, 2020, of the legacy Bard U.S. defined pension benefit plan upon its merger with the BD defined benefit cash balance pension plan in the first quarter of fiscal year 2021. The amounts recognized in other comprehensive income relating to cash flow hedges in 2022, 2021 and 2020 related to forward starting interest rate swaps. Additional disclosures regarding the Company's derivatives are provided in Note 14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impacts for amounts recognized in other comprehensive income before reclassifications were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impacts for cash flow hedges recognized in other comprehensive income before reclassifications in 2022, 2021 and 2020 were immaterial to the Company's consolidated financial results.  The tax impacts for reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to benefit plans and cash flow hedges in 2022, 2021 and 2020 were also immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDUxNA_250d7648-b752-4ced-896b-32e182e5ee19">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in certain components of shareholders&#x2019; equity were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common&lt;br/&gt;Stock&#160; Issued&lt;br/&gt;at&#160;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Capital in&lt;br/&gt;Excess&#160;of&lt;br/&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred&lt;br/&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76,260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash dividends:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common ($3.16 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issued for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred shares converted to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Public equity offerings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash dividends:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common ($3.32 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of change in accounting principle (see Note 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash dividends:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common ($3.48 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Preferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issued for share-based compensation and other plans, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock held in trusts, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off of Embecta (See Note 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)Common stock held in trusts consists of the Company&#x2019;s shares held in rabbi trusts in connection with deferred compensation under the Company&#x2019;s employee salary and bonus deferral plan and directors&#x2019; deferral plan.</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="idbef8604488846208cd4c70898654711_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi0xLTEtMS03MzUzNQ_b02fee57-6edc-4165-98a4-746acdbb21ae"
      unitRef="usd">347000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5e1811b72dc462ca90c421e6c5b1693_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi0zLTEtMS03MzUzNQ_bf1e0112-33ec-455e-9ac7-89135d7bce73"
      unitRef="usd">16270000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96ac652372b54cc2b0a28ed29bff1415_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi01LTEtMS03MzUzNQ_662f777c-9ae2-4ffa-8bc2-46e2e906bf08"
      unitRef="usd">12913000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a2a86003dc74c1f8a87c4d5eea38dc7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi03LTEtMS03MzUzNQ_6836863f-24f4-42e2-9740-48f9c3585410"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i6cd3830836d74dc384331da111f121e9_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi05LTEtMS03MzUzNQ_794673f8-05b5-484b-894f-7adc849b9f9b"
      unitRef="shares">76260000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i6cd3830836d74dc384331da111f121e9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMi0xMS0xLTEtNzM1MzU_2b30c29d-f1a2-4128-85e1-2d7134ac86d7"
      unitRef="usd">-6190000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMy01LTEtMS03MzUzNQ_1c74067d-3c5e-4e83-acd8-1ffa40aa82b1"
      unitRef="usd">874000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNS0wLTEtMS03MzUzNS90ZXh0cmVnaW9uOmEwYjIxZTk5YzFjYzRkZjhiNDQ3MjNhMGIyYjNjNDMwXzEy_42f86689-e91f-4eef-8bba-51c054340886"
      unitRef="usdPerShare">3.16</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNS01LTEtMS03MzUzNQ_9852bc9e-c060-4aed-8dd0-14e7d1f3763d"
      unitRef="usd">888000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i89bb18eb2f9d499e998cf622876331ff_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNi01LTEtMS03MzUzNQ_8ac28522-8299-4274-9cd0-5b8227e5a18b"
      unitRef="usd">107000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="i2fe86ad3207e44eaab5c717b3adfdfd5_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOC0xLTEtMS03NDQ4Ng_5faaf0b1-1dba-4e2f-9377-6179e16d3eab"
      unitRef="usd">12000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOC0zLTEtMS03NDQ4Ng_12972e77-a910-4f44-aeab-1ca15ea13de1"
      unitRef="usd">-9000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2fe86ad3207e44eaab5c717b3adfdfd5_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOS0xLTEtMS03NDQ4Ng_633ed340-9d27-499f-8ee6-8ecc216ba794"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOS0zLTEtMS03NDQ4Ng_a34c94df-8497-495f-8c55-a13f55190c5c"
      unitRef="usd">2909000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNy0zLTEtMS03MzUzNQ_d36bb279-6da5-4d09-b570-f29d544bf684"
      unitRef="usd">-143000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNy05LTEtMS03MzUzNQ_f706d8ad-f127-445a-a06e-1d07c2b8a32e"
      unitRef="shares">1597000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfNy0xMS0xLTEtNzM1MzU_40f21b45-5c38-4947-91dd-2b19801a461e"
      unitRef="usd">52000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i05751f9c8efb41329f40ed804c8a82f0_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOC0zLTEtMS03MzUzNQ_bde9780f-4110-4db5-ba18-895d0f1ee1e8"
      unitRef="usd">244000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i4251a8d6851246aca175296d4191fd1c_D20191001-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfOS05LTEtMS03MzUzNQ_de5b8ae5-a64a-4bae-a384-ef016061bae3"
      unitRef="shares">41000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:StockholdersEquity
      contextRef="i695e557a6ab54dc6a2b984723d1f5b0d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtMS0xLTEtNzM1MzU_c583c8c3-b656-4559-b4c9-2fab40ea74e3"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5c5190a2663a43e8b69d8a097c812132_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtMy0xLTEtNzM1MzU_2a982d5a-d1a0-46bf-bbed-0190a2cc3fb3"
      unitRef="usd">19270000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib70db9b9f4a14ac4a63c9c3d7e73bb79_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtNS0xLTEtNzM1MzU_7f059ee2-d144-4620-875a-723da37d17f7"
      unitRef="usd">12791000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ec7a113781f4fb4aa433f0602bfde3f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtNy0xLTEtNzM1MzU_b55e5171-713c-4480-a814-a14155c7da05"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="id25b1e6a88754b688a61cedebd045efe_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtOS0xLTEtNzM1MzU_81411d1f-504d-4abc-b7aa-de5ca9d0786f"
      unitRef="shares">74623000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="id25b1e6a88754b688a61cedebd045efe_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTEtMTEtMS0xLTczNTM1_8e249e48-88e0-4565-a9a2-102fb162354a"
      unitRef="usd">-6138000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTItNS0xLTEtNzM1MzU_82848d5a-15ae-4bef-b2c6-5d9a256c97c5"
      unitRef="usd">2092000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyZDRkYmEzMTlhZDU0MzI2OWE4ZmZlOGQ5ZjIzYTk2NF8xMg_ed7824a8-4d62-4836-9739-8976f7fcfe88"
      unitRef="usdPerShare">3.32</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTQtNS0xLTEtNzM1MzU_5096ba69-b199-41a3-8b11-a5b85aae7733"
      unitRef="usd">958000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i7fbe13d847304b1c89722d6c6ac75e29_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTUtNS0xLTEtNzM1MzU_772e0633-3eaf-46a6-95ee-83e66ebdefe8"
      unitRef="usd">90000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTktMy0xLTEtNzM1MzU_3e686dc9-4d93-40aa-a010-8e51f1cfb232"
      unitRef="usd">-85000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTktOS0xLTEtNzM1MzU_1a8a7f05-063e-41a8-8a41-a54d291ad527"
      unitRef="shares">1068000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMTktMTEtMS0xLTczNTM1_08af3f8f-9ba1-41ae-b4b9-ed0290eeb259"
      unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjAtMy0xLTEtNzM1MzU_c3d13b29-b908-4736-80f6-f845425d3a05"
      unitRef="usd">237000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjEtOS0xLTEtNzM1MzU_35c94542-d063-4ced-9409-3f016ce657db"
      unitRef="shares">33000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0354b0ab518a4d91b3373d3e64a75c6f_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMy0xLTEtNzQ1NDM_b22cd731-75ab-427a-aad1-16b43deed251"
      unitRef="usd">150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItOS0xLTEtNzQ1NDM_41119f51-ac56-414a-8f77-adf91fb288be"
      unitRef="shares">6643000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifb80d24cf51142c08618d55ddeff4dc1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMTEtMS0xLTc0NTQz_47e4ba1d-23f2-47fe-85e1-ff4b9ae3be73"
      unitRef="usd">1600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i6a446f7eaf1a4201a25d9a14323ee4b7_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjMtNS0xLTEtNzQ1NDM_9601d546-f448-4279-8caa-24e59bf3e62b"
      unitRef="usd">9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquity
      contextRef="i3278eb4fc9fd4ab78a70936efe09c5ff_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMS0xLTEtNzM1MzU_b07cd145-0a79-4a1f-92fe-1092b45d61e0"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20eaab7a249a452bba784a0d97d26368_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMy0xLTEtNzM1MzU_8bcdbcb3-e8b5-426b-99e3-f17e12045187"
      unitRef="usd">19272000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6bcfc9afd93e4406acde7e87e4c91af9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItNS0xLTEtNzM1MzU_ea4e8d10-35dd-44cf-8839-8e177d245f1c"
      unitRef="usd">13826000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if823837bff994f53b3a5363db592ef45_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItNy0xLTEtNzM1MzU_8a92d98b-87b8-444e-a25e-1d8b3da63cba"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="if05103d8441f420687709be717eefd05_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItOS0xLTEtNzM1MzU_fd1b0a48-8fe4-4e7e-b89c-84ca9f0c9e25"
      unitRef="shares">80164000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="if05103d8441f420687709be717eefd05_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjItMTEtMS0xLTczNTM1_6c4e479a-6e33-4316-a1a2-5599aa090262"
      unitRef="usd">-7723000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjMtNS0xLTEtNzM1MzU_d38e109c-ea99-464d-93e0-ce6fbaced37f"
      unitRef="usd">1779000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjUtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpkMmQzYjE3YWJmMjQ0NzA4OGQyNWNhMjE3NmYwOThiZl8xMg_0952d7a2-01b2-439f-90da-00cef407c6f2"
      unitRef="usdPerShare">3.48</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjUtNS0xLTEtNzM1MzU_6138c245-5910-485e-87e6-911f0ee466d0"
      unitRef="usd">992000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsPreferredStock
      contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjYtNS0xLTEtNzM1MzU_f023886f-5fde-4d68-adf4-01fa617d7e00"
      unitRef="usd">90000000</us-gaap:DividendsPreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctMy0xLTEtNzM1MzU_946c4ead-021c-41db-9a11-76b543a89519"
      unitRef="usd">-108000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctNS0xLTEtNzM1MzU_4361e8e0-b428-463d-8997-8af8b9e43c81"
      unitRef="usd">-1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctOS0xLTEtNzM1MzU_8663424c-01fd-43d8-80c6-7a79e9074661"
      unitRef="shares">1271000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjctMTEtMS0xLTczNTM1_54387096-a6be-4b6c-8474-e655b084ab21"
      unitRef="usd">44000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjgtMy0xLTEtNzM1MzU_44fa2a46-3a23-4075-9640-57d230eb8dd8"
      unitRef="usd">239000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <bdx:CommonStockHeldInTrustsNetShares
      contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMjktOS0xLTEtNzM1MzU_ecd23a70-4655-4917-b3a4-bc0be6009a2d"
      unitRef="shares">25000</bdx:CommonStockHeldInTrustsNetShares>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia62b5fa3e52a44ee8085bed7f12881e9_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzAtMy0xLTEtNzM1MzU_6cd8e92b-9fbe-48b7-a9e6-4a97d2f5e241"
      unitRef="usd">-150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzAtOS0xLTEtNzM1MzU_8f071122-0bfa-4f67-add5-ed6ea124419d"
      unitRef="shares">2415000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6961fbfbc998439e95598f8d79a63f8b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzAtMTEtMS0xLTczNTM1_b9b29271-8082-45a6-9c25-4f39a751752c"
      unitRef="usd">650000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="i2cd9cfdad8ae44168dffd49ee47d522c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzMtNS0xLTEtODkyNjM_9018f531-d665-4d0c-bfbc-125f6c281d66"
      unitRef="usd">634000000</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:StockholdersEquity
      contextRef="i3372701f199e43b4a16aa17859655059_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItMS0xLTEtNzM1MzU_c615b6ab-8693-468f-b24f-458f8b218449"
      unitRef="usd">365000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9dfe8ef22e494c38b101738e66ab9aeb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItMy0xLTEtNzM1MzU_78be678e-6fca-44d9-b046-3a84773873f8"
      unitRef="usd">19553000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61b63e5f040e4730acddca14376db61c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItNS0xLTEtNzM1MzU_e974fbcb-9600-42bb-b820-c907af5fa3b1"
      unitRef="usd">15157000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id268265b76c749d98058721c42dd6cb5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItNy0xLTEtNzM1MzU_ac781160-9fe6-4c8a-9e45-ac3a621c4fd6"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ifbfab1f7a9b4460bbb2f2a22a0ed163b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItOS0xLTEtNzM1MzU_472c56bb-e5d4-4cda-bbf9-62dd7e542813"
      unitRef="shares">81283000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="ifbfab1f7a9b4460bbb2f2a22a0ed163b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOmRkOTZkMTc3YjUxMDQ0NDVhZmE4ODFkNjlkNTQxODJmL3RhYmxlcmFuZ2U6ZGQ5NmQxNzdiNTEwNDQ0NWFmYTg4MWQ2OWQ1NDE4MmZfMzItMTEtMS0xLTczNTM1_6bc94031-ba26-471d-9bea-a0a476fa6a35"
      unitRef="usd">-8330000000</us-gaap:StockholdersEquity>
    <bdx:TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram
      contextRef="ia491d443536f43b2af506a739dee74b6_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzI2Nw_b50890b9-667b-4eba-9c1c-d550e580c051"
      unitRef="shares">1953000</bdx:TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie55426e09f694ffa9902855677354b87_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzI4Mg_d0bd894b-1be4-489e-a12c-218ec9ed1858"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <bdx:NumberOfTransactions
      contextRef="i6e686d9a958e4abfa40bfcc0f5d10cc0_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzQxMw_f061b682-d82e-4ce9-944c-e2fc365a072c"
      unitRef="agreement">2</bdx:NumberOfTransactions>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i6e686d9a958e4abfa40bfcc0f5d10cc0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzI5Nw_a4677e89-bced-42ac-b590-706768b2578a"
      unitRef="usd">1250000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2c6dfb0a55d44433a2844ec28c42f5aa_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzMxMw_41ce9bf4-2027-47b8-9b96-6d4b098b274b"
      unitRef="usd">1100000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i87fdf496dd9c4a699a19e0513d7508e2_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzMyOQ_188ca0d8-64e0-4d03-9a88-c3354009d3a8"
      unitRef="usd">150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2926409bcc984aedaa96af46597e2232_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM0Mw_c258ce0a-ac25-489b-8b4a-a65d762482bc"
      unitRef="shares">4577000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia491d443536f43b2af506a739dee74b6_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM1OA_ddb9c52c-4cef-4338-bd07-461aa1ca5ac4"
      unitRef="shares">462000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7dee112885e048f6a1cef87525afc79a_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM3Mg_0e205325-b4c6-4e56-adc4-13f212e263c8"
      unitRef="shares">2066000.000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i332d46aaf70f439cb962e214fd3556a0_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzM4Nw_4203c97b-5cbc-4863-a67f-500bbb6b58b3"
      unitRef="usd">500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i4ad38254f42f4c66b77c1874165accec_I20130924"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNjA0NzMxMzk3NDY2OA_d0bf4ffb-d145-4647-b914-9ca6ef62b4f5"
      unitRef="shares">10000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased
      contextRef="i9ab8c2436670412a85779aa99a37f277_I20211130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDM5ODA0NjUyNzQwMQ_2636c4de-ae5b-47cd-9d56-c65dfb4b132e"
      unitRef="shares">10000000</bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i50429935632644db80c7dc6d4f800a3c_I20200501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMTkwOA_c8bcc6aa-be25-4f77-8aef-c8da3121e5b7"
      unitRef="shares">2475000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i874a17754f954b0aaac2d06381e5d650_I20200501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjA1Mg_51d8e475-30b8-4c7d-b2ea-83f46a4304f3"
      unitRef="shares">11703000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id918b6957659494e9efb8db5e471b658_D20200501-20200531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjIzMA_611a0564-eed2-4900-a8b6-40015540f65e"
      unitRef="shares">6250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="id918b6957659494e9efb8db5e471b658_D20200501-20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjI5MA_d4994ff9-b382-4707-95cb-533e22b9f0f9"
      unitRef="usd">1459000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <bdx:GrossProceedsFromIssuanceOfEquity
      contextRef="id918b6957659494e9efb8db5e471b658_D20200501-20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjMxMg_ac988c70-96ca-442a-93d6-75691549a7b4"
      unitRef="usd">1500000000</bdx:GrossProceedsFromIssuanceOfEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjMxNw_b8cad03c-cdb7-476b-a5b9-3dba9c3cd11a"
      unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjUyMg_0c0c8d24-f44d-4221-91b6-8cc4622ff3d6"
      unitRef="usd">1459000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <bdx:GrossProceedsFromIssuanceOfEquity
      contextRef="ie3562b86182245298fdf0b2cf251b7ce_D20200501-20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjU0NA_c137ee6a-8921-4095-b8aa-39c85a4fbcd2"
      unitRef="usd">1500000000</bdx:GrossProceedsFromIssuanceOfEquity>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i6c47e1c7c8914741831ba4850ee25a8d_D20211001-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjY4Ng_1daa2637-8928-4f7c-a5a3-2d0e024e61b4"
      unitRef="number">0.0600</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i1ad1063cff2d4269b4177860de2bbad9_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjcyMg_b362f173-1f44-493f-b914-50e79d99be25"
      unitRef="usdPerShare">1000</us-gaap:PreferredStockLiquidationPreference>
    <bdx:DepositaryShareLiquidation
      contextRef="i1ad1063cff2d4269b4177860de2bbad9_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjc0Ng_bf69944c-90ea-4a08-bbb6-f95dc2a66724"
      unitRef="usd">50</bdx:DepositaryShareLiquidation>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i7ff86925da2a4bdbb08d87f5bf1b9465_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjgzNQ_476a0136-1bce-40bf-8c21-6690d16c0564"
      unitRef="shares">5300000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i57dbdcd63dc545d4baab7bc7c3def523_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMjg2MQ_90bc7b5f-0bfe-43f8-9332-65bd14d86ffd"
      unitRef="shares">6400000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDUxNg_b9a61b4d-9326-4a61-80a8-ac1fe4856383">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components and changes of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of&lt;br/&gt;taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of&lt;br/&gt;taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified into income, net of&lt;br/&gt;taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off of Embecta (See Note 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS0xLTEtMS03MzUzNQ_1d507651-e19b-4a7c-ba0a-748aff11989c"
      unitRef="usd">-2283000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i78c005f6696a4b2a8f4b480077d64866_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS0zLTEtMS03MzUzNQ_115fcea6-17bc-4c2e-ad40-09fcd934aa95"
      unitRef="usd">-1256000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie20e47c06987495d84a42d36f5689682_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS01LTEtMS03MzUzNQ_4913c04d-d0ac-49d4-a74a-cb395727623d"
      unitRef="usd">-1005000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf2fd6969bcd47aea595469cbf1b4625_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMS03LTEtMS03MzUzNQ_09978b0b-9de0-4b2a-9d7d-436b17c615fa"
      unitRef="usd">-23000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi0xLTEtMS03MzUzNQ_1d84816c-538e-40b8-ab96-c9fa798132e3"
      unitRef="usd">-338000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i10fb59521c574bcb96b82afd9f75ede2_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi0zLTEtMS03MzUzNQ_045f286c-6797-4555-92fb-0264df0fe8ef"
      unitRef="usd">-161000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i628f61d1728942a88bd889c7c55ed5f4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi01LTEtMS03MzUzNQ_385ce652-10a6-476f-bbd7-7fbf15469527"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifdf1f5eafac44cf9a31dc274fe75fe4d_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMi03LTEtMS03MzUzNQ_e849fad1-0551-4600-898e-41f4af545f3d"
      unitRef="usd">-76000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy0xLTEtMS03MzUzNQ_f4ba6a41-44da-4091-a9ad-9e24e27ea616"
      unitRef="usd">-74000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i10fb59521c574bcb96b82afd9f75ede2_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy0zLTEtMS03MzUzNQ_fc89765e-4cf2-40ce-8bc4-9a077aee35e2"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i628f61d1728942a88bd889c7c55ed5f4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy01LTEtMS03MzUzNQ_2874d719-ee89-4ebf-8946-f1972a0b768b"
      unitRef="usd">-66000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifdf1f5eafac44cf9a31dc274fe75fe4d_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMy03LTEtMS03MzUzNQ_a46c347f-b308-4699-b711-a0f94e8d1cb7"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC0xLTEtMS03MzUzNQ_6994d158-2c15-4468-9408-70607a939482"
      unitRef="usd">-2548000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iacfb3dc5bbdd43f1abaff2e47b4b3e33_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC0zLTEtMS03MzUzNQ_68b3614e-1be1-4f4b-afca-c4d10ba98d1d"
      unitRef="usd">-1416000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if78c1bc79b104d2495d52f06e7adbeb8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC01LTEtMS03MzUzNQ_a3ee0bb3-5aa0-47c0-9a2a-f9982b941e52"
      unitRef="usd">-1040000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iebe826a47e2d4911b649299e360599da_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNC03LTEtMS03MzUzNQ_366d5e9b-1cf4-4787-9d55-2ca8e5260bae"
      unitRef="usd">-91000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS0xLTEtMS03MzUzNQ_3033cfd7-08f9-454a-a360-58843774673c"
      unitRef="usd">383000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib2d4272367454973a102f31f0e0b1d5b_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS0zLTEtMS03MzUzNQ_8ae5133b-5802-4e80-9338-b16b84100f2e"
      unitRef="usd">124000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8624f6524b87417d877a3fbc3734696a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS01LTEtMS03MzUzNQ_9824fa83-14f8-48e1-a5ae-3c600292e24e"
      unitRef="usd">187000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id99c576cb7f54d77a264bc0be07c9bf4_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNS03LTEtMS03MzUzNQ_aaf3b708-08d7-4703-b537-ce8483d39e7e"
      unitRef="usd">72000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi0xLTEtMS03MzUzNQ_d5e451a7-4cb8-4657-8f02-c7948a4bf985"
      unitRef="usd">-77000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib2d4272367454973a102f31f0e0b1d5b_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi0zLTEtMS03MzUzNQ_4b5b4b0d-6203-42a8-9bf9-2a742a5ab003"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8624f6524b87417d877a3fbc3734696a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi01LTEtMS03MzUzNQ_dfd09be3-1b56-4a83-a23b-3a189a295cc8"
      unitRef="usd">-68000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id99c576cb7f54d77a264bc0be07c9bf4_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNi03LTEtMS03MzUzNQ_14f07df9-447a-4870-861d-2c199286ca22"
      unitRef="usd">-9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy0xLTEtMS03MzUzNQ_86110eae-179a-44b3-b157-566094851624"
      unitRef="usd">-2088000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2a15e922161c4d5dac1d1b05a8cd6abb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy0zLTEtMS03MzUzNQ_e33c5a79-8359-4ef4-8450-8e93885cc600"
      unitRef="usd">-1292000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i65b38b186e5043618d914e134f92606d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy01LTEtMS03MzUzNQ_0b1611d3-cd4b-429a-84df-fd4760078912"
      unitRef="usd">-784000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idd731e1f79d247e8ae5e661b7d8187be_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfNy03LTEtMS03MzUzNQ_45efef35-79a9-4306-8310-be1e1ccb50bb"
      unitRef="usd">-10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC0xLTEtMS03MzUzNQ_634dc464-87aa-43d6-be2d-1c8aa963a453"
      unitRef="usd">306000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC0zLTEtMS03MzUzNQ_c8650f13-9bee-4be5-94ce-49bb2a2d955c"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC01LTEtMS03MzUzNQ_f8eb7d30-64d9-4f19-b0f9-9494fdf6cc57"
      unitRef="usd">169000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOC03LTEtMS03MzUzNQ_c5c1e39d-30c1-44cd-b19e-06821c27bce5"
      unitRef="usd">83000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS0xLTEtMS03MzUzNQ_643df64e-9b75-4bdf-8914-909b2542d543"
      unitRef="usd">-43000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS0zLTEtMS03MzUzNQ_db83b176-6cd8-4061-bb9c-f959fc003311"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS01LTEtMS03MzUzNQ_0c3a9452-3107-46f8-b18e-490e2004ab56"
      unitRef="usd">-41000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfOS03LTEtMS03MzUzNQ_87793ff5-3f22-4994-bea4-ed774343324f"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMS0xLTEtODkzMDY_52d65f72-5540-4c54-825d-04df65cf1507"
      unitRef="usd">251000000</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="i0e81b225732b44f1bb7d70364c856e3b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMy0xLTEtODkzMDY_a6b7892c-9bff-4c86-b772-dfdee0920abd"
      unitRef="usd">251000000</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="i8a3d5dcf62d34e30ae0cde5378d9e43d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNS0xLTEtODkzMDY_c4568075-0016-4ee1-a214-8604330f040f"
      unitRef="usd">0</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="i143b9e5d4bb54ad4b7da7aeaf048265b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNy0xLTEtODkzMDY_d0cd8c4b-71aa-49b1-8837-ea81d7573a30"
      unitRef="usd">0</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMS0xLTEtNzM1MzU_415353d0-fb67-4fdd-9833-7eb9166b1be1"
      unitRef="usd">-1488000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iad3be5ebcb0a4e7da15aa197384cbb6d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtMy0xLTEtNzM1MzU_a4c09b6c-d084-460e-a43e-927f3b2f405c"
      unitRef="usd">-987000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i43597b9d90b04086b5e4094193e3b542_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNS0xLTEtNzM1MzU_1a2c2b94-10c7-4718-bd45-bfb496d32ee0"
      unitRef="usd">-574000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i22ca936d1eee4110babd87515b79a272_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjUyNGQyMzRjMTdiZDQ4ZGZhNDI3Zjc2MTljNzIzMWI4L3RhYmxlcmFuZ2U6NTI0ZDIzNGMxN2JkNDhkZmE0MjdmNzYxOWM3MjMxYjhfMTAtNy0xLTEtNzM1MzU_f794e091-ea92-4602-9252-72136bcbf818"
      unitRef="usd">75000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0caad212afff4342a5acce2a8aa1d437_D20201031-20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfMzQ5Nw_1fb466c1-1847-4b38-96cb-aee47d5e74a4"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RleHRyZWdpb246YjZiZWY1ZTIzNTk5NGU1MzhlOGRkNjhmNmQzMWY4OWFfNDUyMw_422eac48-9262-4181-aaf8-d15407d85a04">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impacts for amounts recognized in other comprehensive income before reclassifications were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjYxMDVhYjM2YjFjMjQ2ZWM5YmU3NjNmN2QyOGFiZGVkL3RhYmxlcmFuZ2U6NjEwNWFiMzZiMWMyNDZlYzliZTc2M2Y3ZDI4YWJkZWRfMi0xLTEtMS03MzUzNQ_ca1fafe8-f2a5-4f41-9e24-61e71a6a64d2"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjYxMDVhYjM2YjFjMjQ2ZWM5YmU3NjNmN2QyOGFiZGVkL3RhYmxlcmFuZ2U6NjEwNWFiMzZiMWMyNDZlYzliZTc2M2Y3ZDI4YWJkZWRfMi0zLTEtMS03MzUzNQ_653267f2-73bc-4cac-a32a-7c8c3a231ab0"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84Mi9mcmFnOmI2YmVmNWUyMzU5OTRlNTM4ZThkZDY4ZjZkMzFmODlhL3RhYmxlOjYxMDVhYjM2YjFjMjQ2ZWM5YmU3NjNmN2QyOGFiZGVkL3RhYmxlcmFuZ2U6NjEwNWFiMzZiMWMyNDZlYzliZTc2M2Y3ZDI4YWJkZWRfMi01LTEtMS03MzUzNQ_22ebf0d6-b95b-44a2-972b-a5606fcb1b22"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfOTYx_32d59694-6efa-4ab5-9fcd-07f8dc735c66">Earnings per Share&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from share-based plans (a) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from Series C preferred shares (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common and common equivalent shares outstanding &#x2014; assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;In 2022, 2021 and 2020, dilutive share equivalents associated with mandatory convertible preferred stock of 6 million, 6 million and 9 million, respectively, were excluded from the diluted shares outstanding calculation because the result would have been antidilutive. The issuance of the convertible preferred stock is further discussed in Note 4.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;In both 2021 and 2020, 1&#160;million of certain share-based compensation awards were excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#x2019;s common shares.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In 2022, no such awards were excluded from the diluted earnings per share calculation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional disclosures regarding the Company&#x2019;s share-based compensation are provided in Note 9.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business on April 1, 2022 was completed.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfOTYz_93279cae-70b0-4d78-9bb7-e7afab2a810a">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from share-based plans (a) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive share equivalents from Series C preferred shares (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average common and common equivalent shares outstanding &#x2014; assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;In 2022, 2021 and 2020, dilutive share equivalents associated with mandatory convertible preferred stock of 6 million, 6 million and 9 million, respectively, were excluded from the diluted shares outstanding calculation because the result would have been antidilutive. The issuance of the convertible preferred stock is further discussed in Note 4.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"&gt;In both 2021 and 2020, 1&#160;million of certain share-based compensation awards were excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#x2019;s common shares.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In 2022, no such awards were excluded from the diluted earnings per share calculation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional disclosures regarding the Company&#x2019;s share-based compensation are provided in Note 9.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company&#x2019;s spin-off of its Diabetes Care business on April 1, 2022 was completed.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMS0xLTEtMS03MzUzNQ_7793e532-47ab-401e-8fd2-9209e171cba9"
      unitRef="shares">285005000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMS0zLTEtMS03MzUzNQ_3b70d9fd-56af-4fca-8cef-81571ed47271"
      unitRef="shares">289288000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMS01LTEtMS03MzUzNQ_9334c167-0992-4810-93fe-939707d6ee62"
      unitRef="shares">278971000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMi0xLTEtMS03MzUzNQ_c2bc98c4-ddab-4aed-9385-c451f4331a02"
      unitRef="shares">2333000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMi0zLTEtMS03MzUzNQ_dec37260-75b0-4953-aacc-111b57ca13fb"
      unitRef="shares">2801000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMi01LTEtMS03MzUzNQ_a63202e7-ff74-49f1-b4be-2da9e1f8f1e9"
      unitRef="shares">3431000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0xLTEtMS0xMDY3NDY_6a5a2b65-922b-4afa-aaa8-9a2ef3a83372"
      unitRef="shares">26000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0zLTEtMS0xMDY3NTM_be36983a-f86b-4832-8e75-bd76ed42621b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy01LTEtMS0xMDY3NjA_b3539873-0cca-40ff-8c36-f7d0d7168984"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0xLTEtMS03MzUzNQ_9eb731c7-ff68-4a17-a2d0-5bae0d15ea94"
      unitRef="shares">287364000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy0zLTEtMS03MzUzNQ_e1615816-56d0-4dad-a3d7-5e91b9d4bada"
      unitRef="shares">292089000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RhYmxlOjVmMTNjYjY0ZDdiODRiNmNiM2ZmOWNmZjMxZGIzMjY2L3RhYmxlcmFuZ2U6NWYxM2NiNjRkN2I4NGI2Y2IzZmY5Y2ZmMzFkYjMyNjZfMy01LTEtMS03MzUzNQ_2ab1acad-10e4-4d0b-8e8b-a9c0419f5e55"
      unitRef="shares">282402000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4e27cb8b41d348d5b69f42feadb89ef6_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfMzEw_e8de9aef-9e31-446f-9112-34b986e1da90"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i395595affb2f4499b423f227d60c2864_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfMzE0_432da32d-d0cf-4322-9552-d50a98a7e608"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic3faee5241614bc983e8159206dea8d8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfMzIx_56887461-c0af-4fea-8511-9199e985d1a4"
      unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfNTUz_16d5967b-9e2c-4705-a863-de77acdcdf95"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfNTUz_27fa7885-bafd-48d5-8f93-5a75337d4b1a"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV84OC9mcmFnOmUxMjQ0YWY0ZTBhMTRmNGRiMWM5MGQzZGFkM2Q1M2NkL3RleHRyZWdpb246ZTEyNDRhZjRlMGExNGY0ZGIxYzkwZDNkYWQzZDUzY2RfNzgy_de509e71-4288-4404-b830-cc5ceb51d09f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjEyNTY_db607bf0-6075-4ecb-a3ec-f7beba586bac">Commitments and Contingencies&lt;div style="margin-top:6pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain future purchase commitments entered in the normal course of business to meet operational and capital requirements. As of September&#160;30, 2022, these commitments aggregated to approximately $1.521 billion and will be expended over the next several years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#x201c;CIDs&#x201d;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Liability Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company is defending approximately 31,445 product liability claims involving the Company&#x2019;s line of hernia repair devices (collectively, the &#x201c;Hernia Product Claims&#x201d;).  The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#x201c;RI&#x201d;) and in a federal multi-district litigation (&#x201c;MDL&#x201d;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions.  In addition, those claims include multiple putative class actions in Canada.  Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#x2019; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:54pt;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt"&gt;The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt"&gt;The second hernia MDL bellwether resulted in a $255&#160;thousand verdict in April 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt"&gt;The first bellwether trial in RI resulted in a $4.8 million verdict in August 2022, which the Company plans to appeal. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trials are currently scheduled in state and/or federal courts, including two additional bellwether trials in the MDL in February 2023 and May 2023.  The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also continues to be a defendant in certain other mass tort litigation. As of September&#160;30, 2022, the Company is defending product liability claims involving the Company&#x2019;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also as of September&#160;30, 2022, the Company is defending product liability claims involving the Company&#x2019;s line of inferior vena cava (&#x201c;IVC&#x201d;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 and Securities and Exchange Commission (&#x201c;SEC&#x201d;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; infusion pumps, allegedly rendering certain public statements about the Company&#x2019;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. The plaintiff filed a second amended complaint to add certain additional factual allegations on February 3, 2021. This complaint was dismissed on the Company&#x2019;s motion on September 15, 2021. The court&#x2019;s dismissal order, however, gave plaintiff an opportunity to replead, which it did on October 29, 2021. The Company moved to dismiss the newly amended pleading on December 16, 2021. That motion was granted in part and denied in part, as the court permitted certain aspects of the case to proceed. An answer with affirmative defenses was thereafter filed on October 3, 2022. The Company believes that it has strong defenses to the remaining allegations and it intends to defend itself vigorously. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2020, a civil action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, Ronald Jankowski, derivatively on behalf of the Company, against its individual directors and certain of its officers.  The complaint seeks recovery for breach of fiduciary duties by directors and various officers; violations of the Securities Exchange &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Act of 1934, including sections 10(b), 14(a) and 21D; and insider trading.  In general, the complaint also alleges, among other things, that various directors and/or officers caused the Company to issue purportedly misleading statements and SEC filings regarding Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps, and issue a purportedly misleading proxy statement.  The complaint seeks damages, including restitution and disgorgement of profits, and an injunction requiring the Company to undertake remedial measures with respect to certain corporate governance and internal procedures.  A second derivative action, Schranz v. Polen, et al., Civ. No 2:21-cv-01081 (D. N.J.), was filed on January 24, 2021, and the two actions were consolidated.  In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the Jankowski and Schranz consolidated actions, and demanded, among other things, that the Board of Directors pursue civil action against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters.  Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#x2019; demands.  The special committee&#x2019;s determination has been communicated to counsel for the shareholders.  Should the shareholders continue to pursue their claims in court, the Company will take appropriate steps to seek dismissal of the complaints.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#x2019;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics has filed a notice of appeal. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps. The Company is cooperating with the SEC and responding to these requests.  The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#x2019;s contracts with the Department of Veteran&#x2019;s Affairs for certain products, including Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Pyxis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018. The requests concern sales and marketing practices with respect to certain aspects of the Company&#x2019;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#x2019;s consumer protection laws in connection with the sales and marketing of its IVC filters.  The Company&#x2019;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation.  As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has been sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#x201c;EtO&#x201d;) sterilization activities take place.  The plaintiffs in those cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $250,000 per claimant.  The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. There are currently approximately 210 of such suits involving approximately 310 plaintiffs; approximately 44 of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Company.  The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.  The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#x2019;s consolidated results of operations and/or consolidated cash flows.  Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#x201c;Superfund,&#x201d; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#x2019;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal years 2022, 2021, and 2020, the Company recorded pre-tax charges to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of approximately $21&#160;million, $361 million, and $378&#160;million, respectively, related to certain of the product liability matters discussed above under the heading &#x201c;Product Liability Matters,&#x201d; including the related legal defense costs. The Company recorded these charges based on additional information obtained during fiscal years 2022, 2021, and 2020 including, but not limited to: the nature, quantity, and quality of unfiled and filed claims; the continued rate of claims being filed in certain product liability matters; the status of certain settlement discussions with plaintiffs&#x2019; counsel; the allegations and documentation supporting or refuting such allegations; publicly available information regarding similar medical device mass tort settlements; historical information regarding other product liability settlements involving the Company; and the stage of litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately $2.1 billion and $2.5 billion at September&#160;30, 2022 and 2021, respectively. These accruals, which are generally long-term in nature, are largely recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes and Other Liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the Company's consolidated balance sheets.  &lt;/span&gt;&lt;/div&gt;In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition, and /or consolidated cash flows</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjUy_d68927fe-0614-4444-97fd-153eb1f320fa"
      unitRef="usd">1521000000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie9b42263d2584a45bc56b83ecc8101d4_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjU1Nw_71b802d5-6d53-41f6-bfbd-d6d72f8fea06"
      unitRef="claim">31445</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i512eb62a6b814cd0946e34a3d047f29f_D20220401-20220430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTA5OTUxMTY2ODUwMA_5ed672d0-db3f-41ee-8e26-4723d85322a6"
      unitRef="usd">255000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ide1ced632f4c4c4da4b51289c20a7f1f_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfOTM0NTg0ODg3NzY0NA_03cc7f9c-0676-4cef-bd3e-e554c797d1af"
      unitRef="usd">4800000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i2cf37d2f9a26470d958d196cc629fd83_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfNjA0NzMxNDAxMDM3OQ_06848fc3-8ba7-4532-b670-c7afa5f558d4"
      unitRef="usd">250000</us-gaap:LossContingencyDamagesSoughtValue>
    <bdx:NumberOfEtOSterilizationLawsuits
      contextRef="i55a754ef030a48b1aab1469d1d78d783_D20211001-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTgxMzc_824f60ad-0b31-410e-bf7b-9d247559dd41"
      unitRef="lawsuit">210</bdx:NumberOfEtOSterilizationLawsuits>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMzg0ODI5MDc0ODU4Mw_7ff48805-55ae-4ed6-b953-9550a4897ecf"
      unitRef="plaintiff">310</us-gaap:LossContingencyNumberOfPlaintiffs>
    <bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants
      contextRef="i55a754ef030a48b1aab1469d1d78d783_D20211001-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMzg0ODI5MDc1NDgxNA_02999eb0-1d29-4daa-8e54-4d0d62f2ed80"
      unitRef="lawsuit">44</bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="ie414e39c203f4c4382406af500826854_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTkyMTU_391ab6db-3281-4e30-8cd0-618986f16a72"
      unitRef="usd">21000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTkyMTk_e0fe9d31-a1da-40eb-89db-a6a4e3eb0436"
      unitRef="usd">361000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i08f59c7321f84d4abd684a04e126995a_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMTkyMjc_00b33e5f-3a89-49aa-8406-59dbc8560100"
      unitRef="usd">378000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfMjAxNzc_14d6895e-3a5d-4949-b407-0547e13c0f06"
      unitRef="usd">2100000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85MS9mcmFnOjQ2ZDM1Yjg1MzIxYjQxMWM4NmY0ZDk3ZGYwYjc2NjRhL3RleHRyZWdpb246NDZkMzViODUzMjFiNDExYzg2ZjRkOTdkZjBiNzY2NGFfNDM5ODA0NjU1MjQyOQ_7d26252b-ff67-4181-b707-70b36f066847"
      unitRef="usd">2500000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfODAwMA_ec979ad4-3b6a-426e-86a4-28315ce245a8">RevenuesThe Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Timing of Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#x2019;s ability to use and benefit from the product, are recognized when customer acceptance of these installed products has been confirmed. For certain service arrangements, including extended warranty and software maintenance contracts, revenue is recognized ratably over the contract term. The majority of revenues relating to extended warranty contracts associated with certain instruments and equipment is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over a longer period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. The Company considers its shipping and handling costs to be costs of contract fulfillment and has made the accounting policy election to record these costs within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment terms extended to the Company's customers are based upon commercially reasonable terms for the markets in which the Company's products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectable. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company's agreements with its end-user customers. Additional factors considered in the estimate of the Company's rebate liability include the quantification of inventory that is either in stock at or in transit to the Company's distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. The Company&#x2019;s rebate liability at September&#160;30, 2022 and 2021 was $525&#160;million and $500&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues. Additional disclosures relating to sales discounts and sales returns are provided in Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's agreements with customers within certain organizational units including Medication Management Solutions, Integrated Diagnostic Solutions and Biosciences, contain multiple performance obligations including both products and certain services noted above. The transaction price for these agreements is allocated to each performance obligation based upon its relative standalone selling price. Standalone selling price is the amount at which the Company would sell a promised good or service separately to a customer. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company generally estimates standalone selling prices using its list prices and a consideration of typical discounts offered to customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effects of Revenue Arrangements on Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature of the majority of the Company's products and services, the Company typically does not incur costs to fulfill a contract in advance of providing the customer with goods or services. Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's consolidated balance sheets. The Company's costs to obtain contracts are comprised of sales commissions which are paid to the Company's employees or third party agents.  The majority of the sales commissions incurred by the Company relate to revenue that is recognized over a period that is less than one year and as such, the Company has elected a practical expedient provided under ASC 606 to record the majority of its expense associated with sales commissions as it is incurred. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records contract liabilities for unearned revenue that is allocated to performance obligations such as extended warranty and software maintenance contracts, which are performed over time as discussed further above. These contract liabilities are immaterial to the Company's consolidated financial results. The Company's liability for product warranties provided under its agreements with customers is not material to its consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's obligations relative to service contracts, which are further discussed above, and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided, are estimated to be approximately $2.5 billion at September&#160;30, 2022. The Company expects to recognize the majority of this revenue over the next three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$1.9 billion&#160;at&#160;September&#160;30, 2022. This revenue will be recognized over the customer relationship periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 8.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfODAwMQ_4fb8e81e-61b4-4952-94c8-7b35f307cab0">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Timing of Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement.  Revenues associated with certain instruments and equipment for which installation is complex, and therefore significantly affects the customer&#x2019;s ability to use and benefit from the product, are recognized when customer acceptance of these installed products has been confirmed. For certain service arrangements, including extended warranty and software maintenance contracts, revenue is recognized ratably over the contract term. The majority of revenues relating to extended warranty contracts associated with certain instruments and equipment is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over a longer period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. The Company considers its shipping and handling costs to be costs of contract fulfillment and has made the accounting policy election to record these costs within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment terms extended to the Company's customers are based upon commercially reasonable terms for the markets in which the Company's products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectable. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company's agreements with its end-user customers. Additional factors considered in the estimate of the Company's rebate liability include the quantification of inventory that is either in stock at or in transit to the Company's distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. The Company&#x2019;s rebate liability at September&#160;30, 2022 and 2021 was $525&#160;million and $500&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues. Additional disclosures relating to sales discounts and sales returns are provided in Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's agreements with customers within certain organizational units including Medication Management Solutions, Integrated Diagnostic Solutions and Biosciences, contain multiple performance obligations including both products and certain services noted above. The transaction price for these agreements is allocated to each performance obligation based upon its relative standalone selling price. Standalone selling price is the amount at which the Company would sell a promised good or service separately to a customer. The &lt;/span&gt;&lt;/div&gt;Company generally estimates standalone selling prices using its list prices and a consideration of typical discounts offered to customers.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <bdx:ContractWithCustomerRebateLiability
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfMzk0Ng_5fd0243f-1564-496d-9378-f465212c1d0a"
      unitRef="usd">525000000</bdx:ContractWithCustomerRebateLiability>
    <bdx:ContractWithCustomerRebateLiability
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfMzk1Mw_a2a18ebe-6e9c-472e-8685-3de3db069b5c"
      unitRef="usd">500000000</bdx:ContractWithCustomerRebateLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4a8c12f02b6648b68f67c0af95c1adf6_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfNzEyNA_f2f642f3-4574-4c2f-b546-b6eae3ab0533"
      unitRef="usd">2500000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i05606745f26d460ab811bbfdfa341821_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfNzIxMQ_0536fca9-9754-415c-8f0f-6ae8ddf251c7">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib7ba30fee8c84bc8a2dbb50e36515c04_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85NC9mcmFnOjNlZjM0MWMxMWE3MjQyNWZhYzUxZTAxMWZjMGY3NWRlL3RleHRyZWdpb246M2VmMzQxYzExYTcyNDI1ZmFjNTFlMDExZmMwZjc1ZGVfNzc3MA_0d2e9628-f7ad-4960-828c-aa8d14ad37d9"
      unitRef="usd">1900000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM1Mg_0db7143d-f8ff-42c5-a8d2-46f2485e1714">Segment DataThe Company's organizational structure is based upon three worldwide business segments: BD Medical (&#x201c;Medical&#x201d;), BD Life Sciences (&#x201c;Life Sciences&#x201d;) and BD Interventional ("Interventional"). The Company&#x2019;s segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical produces a broad array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The primary customers served by Medical are hospitals and clinics; physicians&#x2019; office practices; consumer and retail pharmacies; governmental and nonprofit public health agencies; pharmaceutical companies; and healthcare workers. Medical consists of the following organizational units: Medication Delivery Solutions; Medication Management Solutions; Pharmaceutical Systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Life Sciences&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. In addition, Life Sciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases. The primary customers served by Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians&#x2019; office practices; retail pharmacies; academic and government institutions; and pharmaceutical and biotechnology companies. With the emergency use authorization approval of the BD Veritor&#x2122; At-Home COVID-19 Test, Life Sciences also serves patients directly. Life Sciences consists of the following organizational units: Integrated Diagnostic Solutions and Biosciences.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interventional&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interventional provides vascular, urology, oncology and surgical specialty products that are intended, with the exception of the V. Mueller&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; surgical and laparoscopic instrumentation products, to be used once and then discarded or are either temporarily or permanently implanted. The primary customers served by Interventional are hospitals, individual healthcare professionals, extended care facilities, alternate site facilities and patients via the segment's Homecare business. Interventional consists of the following organizational units: Surgery; Peripheral Intervention; Urology and Critical Care.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Additional Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. No customer accounted for 10% or more of revenues in any of the three years presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment disclosures are on a performance basis consistent with internal management reporting.  The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income, which represents revenues reduced by product costs and operating expenses. The Company&#x2019;s chief operating decision maker does not receive any asset information by business segment and, as such, the Company does not report asset information by business segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Assets and liabilities associated with the Diabetes Care business are classified as assets and liabilities of discontinued operations in the Company&#x2019;s consolidated balance sheet as of September 30, 2021. See Note 2 for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for the Company&#x2019;s segments is detailed below. The Company has no material intersegment revenues.&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgery &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Company revenues from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of segment operating income to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Continuing Operations before Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and segment information for both capital expenditures and depreciation and amortization.  Certain prior-period amounts have been recast to reflect the spin-off of the Diabetes Care business in fiscal year 2022, as noted above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical (a) (b) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Segment Operating Income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other unallocated items (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amounts in 2022, 2021 and 2020 include charges of $72&#160;million $56&#160;million and $244&#160;million, respectively, recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to the estimate of costs associated with remediation efforts for BD Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps in the Medication Management Solutions unit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The amount in 2022 includes a charge of $54&#160;million to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit.  The amount in 2020 included $41&#160;million of charges to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units.  These charges were recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amount in 2020 included charges of $57&#160;million recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to write down the carrying value of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts in 2022, 2021 and 2020 also include pre-tax charges of $21&#160;million, $361&#160;million and $378 million, recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense (income), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively, related to certain product liability matters, which is further discussed in Note 6. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The countries in which the Company has local revenue-generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, and Australia and New Zealand); and Other, which is comprised of Latin America (which includes Mexico, Central America, the Caribbean and South America) and Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues to unaffiliated customers are generally based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below shows revenues from continuing operations and long-lived assets of continuing operations by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfODA_65ef4f24-6eab-48e8-a8cd-57a74c217598"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMjgzNg_2ec10256-ff9e-4cc7-ac64-daaa9a142250"
      unitRef="customer">0</bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue>
    <bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMjgzNg_3c4a981d-97c6-420a-9e87-e0f6ac4baaa9"
      unitRef="customer">0</bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue>
    <bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMjgzNg_814a1b17-dbbc-49b5-89f6-63dc3645b2ad"
      unitRef="customer">0</bdx:NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM1Mw_9353496d-a813-416a-8880-ae5f2c4e7a38">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for the Company&#x2019;s segments is detailed below. The Company has no material intersegment revenues.&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medication Delivery Solutions (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medication Management Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Systems (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Integrated Diagnostic Solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Biosciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgery &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Peripheral Intervention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Urology and Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Company revenues from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="i5f132fdd2c874a8ea74c3db787eff159_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xLTEtMS03MzUzNQ_18e21fee-6a2d-4e56-9f91-64c5b8a860ab"
      unitRef="usd">2483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8be3457e675a41b8a5e579e487b37547_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0zLTEtMS03MzUzNQ_cef74b0c-fa48-4110-b76b-253af9048528"
      unitRef="usd">1825000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7af1f356b20e49379832866f40ae6116_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy01LTEtMS03MzUzNQ_3f24ce78-1d09-4195-9515-f85d8602fe7d"
      unitRef="usd">4308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5bb7c3f33f14b26877a5ad97b466f75_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy03LTEtMS03MzUzNQ_2bd542cf-c8c5-4872-9f34-061cb52e8c1a"
      unitRef="usd">2253000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0818d4aa51794a308ee5ea7be2a3a7bf_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy05LTEtMS03MzUzNQ_096d6aec-8eae-4d57-871b-63a937068b1d"
      unitRef="usd">1848000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5df34fd9a8fb4515a6d4f206a9b62bbf_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xMS0xLTEtNzM1MzU_de9e22fe-9adb-4e10-ace9-a3209fb51185"
      unitRef="usd">4101000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2beda1c25ab64fb6be6cc0c3ea77c714_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xMy0xLTEtNzM1MzU_4560f685-4149-446c-86f0-c62ed8f6a69f"
      unitRef="usd">1979000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6964534d6074e42bf64a587550cf196_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xNS0xLTEtNzM1MzU_80696a73-bc64-4257-ab27-eec0da4a592f"
      unitRef="usd">1617000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a6ab2283f1148cdb39df341b7bab34c_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMy0xNy0xLTEtNzM1MzU_e57b2edd-083e-409a-8e37-ee705892b747"
      unitRef="usd">3596000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4aedd1e139b541e98f03ec93291aad7b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xLTEtMS03MzUzNQ_db94e1cc-6eca-4963-a67d-ac74b4863076"
      unitRef="usd">1935000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaefde29495b1437da1094baba80dcc28_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0zLTEtMS03MzUzNQ_4ba0e759-2f7c-4382-9b95-de435fa793f0"
      unitRef="usd">598000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4044de927e14db4b4cdce3edf5fe533_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC01LTEtMS03MzUzNQ_54ec07e1-e612-4d1d-9f6f-f6f7d4907eb1"
      unitRef="usd">2533000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0226cc65ff074b9cb210e20467df9c6c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC03LTEtMS03MzUzNQ_7761e0af-c64f-47f0-a1e3-0ef82bb1b848"
      unitRef="usd">1863000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa8ecc6259cf4f9e9dcaa8280e0c1e38_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC05LTEtMS03MzUzNQ_09683440-31a1-465a-b440-85e92e94de3c"
      unitRef="usd">570000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7354695f422344c2ba6f5510554cf892_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xMS0xLTEtNzM1MzU_67d0b206-25bc-473f-9608-b304cfc7caf5"
      unitRef="usd">2432000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if82cf0e2b8114957a8de4ed614f509d9_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xMy0xLTEtNzM1MzU_a52fb3dd-4190-4cc4-8283-e3dcd425092c"
      unitRef="usd">1865000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibbe3d23b34c44614b6bfae0c5d45b788_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xNS0xLTEtNzM1MzU_eabc1ea5-d259-4571-baf9-e73bb702ab6a"
      unitRef="usd">589000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8c683a785824afeaad05fc9abf980e8_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNC0xNy0xLTEtNzM1MzU_40e6e520-11cc-44d4-b1ad-0eafddb2b7a9"
      unitRef="usd">2454000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4cceb75d2179413db04451287ff26d63_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xLTEtMS03MzUzNQ_43a9178d-5a04-4f1d-af57-2fff2e15919f"
      unitRef="usd">533000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a2212a30e9348f29aec9f73842587fd_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0zLTEtMS03MzUzNQ_4e5e73ed-6a82-4853-994b-655c5ca905c1"
      unitRef="usd">1468000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i91213219f96b4e26aca1922999345c5b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi01LTEtMS03MzUzNQ_5b06339f-5ed8-48ba-b5c2-7d5e86980d9f"
      unitRef="usd">2001000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d3bb31dc01f431bbbe77ccd87e88642_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi03LTEtMS03MzUzNQ_3edf5869-0f4f-449a-b6bb-678eb3a38bc3"
      unitRef="usd">428000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d656df397a54965af2508ec9e8b3a88_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi05LTEtMS03MzUzNQ_85e1b064-089d-472c-b1b7-ab71208d17e1"
      unitRef="usd">1400000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i682ce949e79b4a869956e036cd9bbabf_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xMS0xLTEtNzM1MzU_a96c3230-c58d-404d-b0d0-e9fd555ac879"
      unitRef="usd">1828000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i75503ddf3285429bbb602ab773ba94ce_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xMy0xLTEtNzM1MzU_b636d17f-4edf-43bd-b8a8-b378e05c886f"
      unitRef="usd">404000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bb11d08c5e6468d9b86ce13b8fb8672_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xNS0xLTEtNzM1MzU_e1ccbd96-df1e-429b-98fd-6f05a01637f6"
      unitRef="usd">1183000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3183d1ded7447c9addc009095eff141_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNi0xNy0xLTEtNzM1MzU_e7a43383-337b-4d73-84ba-7060f3c064b7"
      unitRef="usd">1587000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28f35065e14842b2982be7930f62d9a7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xLTEtMS03MzUzNQ_92103eb0-5004-4e70-a2be-8297602032ba"
      unitRef="usd">4950000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i648c7b7f63e14fff8db4327cf366bf0c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0zLTEtMS03MzUzNQ_10abadbe-d02e-470e-8a0c-77898c997855"
      unitRef="usd">3891000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy01LTEtMS03MzUzNQ_76ae0d8f-a1db-4adf-8e92-ea218b1476a3"
      unitRef="usd">8841000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i547ae1919acd49f194300b3f92921e7c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy03LTEtMS03MzUzNQ_d4929fc9-5a0a-4b8a-aec4-cba5d041f39e"
      unitRef="usd">4544000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibbbdd8603eed4090a62b2e5f722efe1d_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy05LTEtMS03MzUzNQ_11969c68-d47d-4db4-8668-b6bc091fea77"
      unitRef="usd">3817000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xMS0xLTEtNzM1MzU_770599cb-9686-4aaa-840d-ba6e30e7ce42"
      unitRef="usd">8361000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf12495d432e44f0ac940dc4cd4a1bf3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xMy0xLTEtNzM1MzU_6c69f8d9-0441-44c7-87ba-af42a3841ea7"
      unitRef="usd">4247000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d2acdc038e1415886e86c9c35738e32_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xNS0xLTEtNzM1MzU_f642bed9-676d-4385-aedf-5a1149db7795"
      unitRef="usd">3389000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfNy0xNy0xLTEtNzM1MzU_258fd45d-1725-46a5-85c7-b31788c9bd1c"
      unitRef="usd">7637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied344f3898da40c787f80afb27167829_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMS0xLTEtNzM1MzU_4a4c2880-bfae-4812-b918-e873e1f4ba90"
      unitRef="usd">2190000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i216e3978b71a433ea3ecaed35cef49df_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMy0xLTEtNzM1MzU_62637033-c455-4673-adde-1a98438f0687"
      unitRef="usd">1995000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i083aac29dff54d05b5ab473be2896793_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtNS0xLTEtNzM1MzU_6882ce2a-4162-41c5-ab35-5bb966be2561"
      unitRef="usd">4185000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ed5952700034df3acc6ffaab543b2b7_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtNy0xLTEtNzM1MzU_58ec17e4-4c05-47b2-bd27-538869d8f885"
      unitRef="usd">2477000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i20d0df9f4974473aab54f9423735e45c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtOS0xLTEtNzM1MzU_9becea2c-9451-4b00-b3fd-50aba151c606"
      unitRef="usd">2748000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1ac87ce71d824958b1a47906a97cb26d_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTEtMS0xLTczNTM1_551d4414-cd22-4872-89a1-46c01a8526e8"
      unitRef="usd">5225000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i11561312578a41cd8558a5081f0c997a_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTMtMS0xLTczNTM1_ee0072eb-d548-4c47-b558-d3411d5ef157"
      unitRef="usd">1872000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd17f4c74ddd45aa9d4c2660931a2cbd_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTUtMS0xLTczNTM1_4961e36d-5007-4b35-9fb7-6c8b7f555120"
      unitRef="usd">1659000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia3a84f9891e141d490be8fb0dbc5a1b2_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTAtMTctMS0xLTczNTM1_3840b89c-49a0-4935-94c2-8825f350e6e9"
      unitRef="usd">3532000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0adb04ada42a45edb77b3846d949a297_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMS0xLTEtNzM1MzU_9b7bdf98-2706-4e43-a2df-b1f2fd534111"
      unitRef="usd">542000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie44752f5a1ac45f9905b7477cb8d8150_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMy0xLTEtNzM1MzU_b267803b-7576-4801-a3af-7dea43ca2f37"
      unitRef="usd">838000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5edc49a9068445e690657c19b9757ed7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtNS0xLTEtNzM1MzU_755d4302-f466-48d0-9334-77d27b791230"
      unitRef="usd">1379000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d856fcb0a2148e18bb6926e29e6de05_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtNy0xLTEtNzM1MzU_ec237afb-97ab-4fe2-8758-ca8605c0dc33"
      unitRef="usd">503000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c44be99e502431faec4f344ca7026e7_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtOS0xLTEtNzM1MzU_ed2dfc41-a0d4-49f5-a671-8c7b178e4063"
      unitRef="usd">802000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i612cd43d382c4a63a4498b9c0925333a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTEtMS0xLTczNTM1_e2add7c8-612b-4676-a8e1-309546573ab5"
      unitRef="usd">1305000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28d137b4783048aa9d0a5092249d0c19_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTMtMS0xLTczNTM1_72d4d8c1-a8d9-4b9c-acdb-75e60c550d4d"
      unitRef="usd">465000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5a850278578a41d7920dd6f66b22ec55_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTUtMS0xLTczNTM1_74911f6b-6cc5-4cd9-8e0b-044f8dfd0e93"
      unitRef="usd">678000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05325a1bdf804752849157781245e34b_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTEtMTctMS0xLTczNTM1_b03c65a1-f8bc-4736-8412-af2f0591b146"
      unitRef="usd">1143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cf241dca0b84231aacab9d4db1bf47e_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMS0xLTEtNzM1MzU_5d98ed52-9c6e-41b4-8995-f675e285ea52"
      unitRef="usd">2732000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i116d0d51fa5f4ad8b5f121a6aa909b47_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMy0xLTEtNzM1MzU_7120a4a8-222b-49ed-a555-c58a25f1b6a7"
      unitRef="usd">2833000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItNS0xLTEtNzM1MzU_609adc07-ccda-4307-878f-0f057c2453b6"
      unitRef="usd">5564000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14f6db0dfcd4424ab591090a6f110ddc_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItNy0xLTEtNzM1MzU_f81e9e99-3491-44d2-9239-a88f2ec780c9"
      unitRef="usd">2980000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icc2bd86d8f5245e596ba87a9603d3935_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItOS0xLTEtNzM1MzU_eb1b50ec-1c2e-4aa3-a5a0-f3ad4a92290b"
      unitRef="usd">3550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTEtMS0xLTczNTM1_497a7fff-0fb4-44f5-9a57-d706da055de7"
      unitRef="usd">6530000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic9bb88f9b2cb4d1d895fc3044878e01d_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTMtMS0xLTczNTM1_9520123a-58bd-4366-a110-7958b31aab04"
      unitRef="usd">2337000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if62d47452c1b4b0d95b99aad7c976bc0_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTUtMS0xLTczNTM1_8c6e4e4d-0d3c-4c64-a650-56bbc8ecf4b7"
      unitRef="usd">2337000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTItMTctMS0xLTczNTM1_59b192d5-d081-4953-85ff-e007f31040ac"
      unitRef="usd">4675000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6146d44a3e1a4c6fb1e3f608f1d1772d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMS0xLTEtNzM1MzU_5d37e141-a189-4f7e-b971-912481c5a37d"
      unitRef="usd">1094000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5917d24437144be6a23c46c167d8dfee_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMy0xLTEtNzM1MzU_bc521191-d7c6-4581-a5a2-3dfb568ef353"
      unitRef="usd">306000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ffb12715a314f46bf61eff967b00a1c_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtNS0xLTEtNzM1MzU_0855923f-7272-4070-96c8-b4af0be6ca3d"
      unitRef="usd">1400000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic90104d61c104e8b8865d7d2f9e10896_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtNy0xLTEtNzM1MzU_5752dc2d-bf4c-48b7-ba7a-c27ec589fe93"
      unitRef="usd">1023000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id51d737eb47f4b3b9da6d19bc2611a64_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtOS0xLTEtNzM1MzU_ece5dd49-87e7-463e-a69e-544b048e1e3f"
      unitRef="usd">274000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18417c03d14049dea16257ba06dc47fe_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTEtMS0xLTczNTM1_8a133323-c7a9-4b9f-af5b-5bdbffacad78"
      unitRef="usd">1296000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2f9183974c94388a49de9124319a764_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTMtMS0xLTczNTM1_e3257817-98fb-43ff-865c-7cd5b779441c"
      unitRef="usd">891000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d68a774d0014ef1abfeda302c81fae1_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTUtMS0xLTczNTM1_0658774b-6055-4fc7-a585-baedc3747fec"
      unitRef="usd">230000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e67d37c2bb94c2b801879dcd7a19a15_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTUtMTctMS0xLTczNTM1_f2e36a14-aa5b-46ab-978c-d73e4015e44c"
      unitRef="usd">1121000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i605b912cf85647a9bb587ef76f45e2a1_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMS0xLTEtNzM1MzU_f30475ed-7e77-410f-b03b-74de001d03fc"
      unitRef="usd">960000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id920980d4c7449ea8825bf277a0b1ac2_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMy0xLTEtNzM1MzU_87d48691-7d60-4431-ab92-cff6360fae3f"
      unitRef="usd">799000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5d0087bcc4b4ddebf55ddab6f10de11_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtNS0xLTEtNzM1MzU_3a603d34-8ee3-4aa7-aac5-0ec661d09359"
      unitRef="usd">1759000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8e5f71dc1cd426cae0de4618593bcf1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtNy0xLTEtNzM1MzU_a3eb33f4-5f86-450d-858e-aa939179c715"
      unitRef="usd">931000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb4a41270d5b4661a5a303eececadc77_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtOS0xLTEtNzM1MzU_ff69b07d-52f8-4c01-90d3-a79e818250fa"
      unitRef="usd">780000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib5ada28ecbf74a4395c3277f87c00cdf_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTEtMS0xLTczNTM1_53dfbd47-0016-48b4-9357-36d629b64024"
      unitRef="usd">1711000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95ed2fe03fc548a8a71570a5afe88eb6_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTMtMS0xLTczNTM1_6192aeb4-9727-4494-b13f-5c238fc89185"
      unitRef="usd">871000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5f3166ef7bf441d88c8166e8bda58fc7_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTUtMS0xLTczNTM1_823fe3fa-d8b3-4039-b0f6-fc448b93b279"
      unitRef="usd">640000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb7c4592ec094ac2bf07eb5e61394cce_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTYtMTctMS0xLTczNTM1_6a0a9dcd-030f-4d9d-913e-996c7f3ebc94"
      unitRef="usd">1511000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a5c15ae71594004b4fb831a208ea9b4_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMS0xLTEtNzM1MzU_2d94f241-623f-40d3-b4c3-c4e29c445a41"
      unitRef="usd">986000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3aa16b425c5d484e8fd114f782a112f5_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMy0xLTEtNzM1MzU_bd1dcce1-a30d-4cd5-9e59-f014c87ca558"
      unitRef="usd">319000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide0078adc3714de98cb99a9ec2f7004d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctNS0xLTEtNzM1MzU_b19d45cf-5d25-4b08-af50-630b39c473a4"
      unitRef="usd">1305000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee2d0c4137b14439a21515cf1257e833_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctNy0xLTEtNzM1MzU_1882a67b-f060-4671-b445-2ef435f6b87a"
      unitRef="usd">894000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i756a093d417b4e5d9930034095f6c8a0_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctOS0xLTEtNzM1MzU_e04a8fd8-3928-48f9-80d2-3601eaa30f75"
      unitRef="usd">338000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i718323b7442949ebaae15d9d98b8e56e_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTEtMS0xLTczNTM1_12748355-0027-4219-b16e-026a7483942c"
      unitRef="usd">1232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i053e66e661bf401da0e58b9ee1ce56a3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTMtMS0xLTczNTM1_7931443f-0475-47bd-92c0-3d42449b57ac"
      unitRef="usd">815000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33e64a7564cd48a185c5cfb1671f55a4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTUtMS0xLTczNTM1_630a92b9-9611-48bc-91e9-5258f9314fa9"
      unitRef="usd">315000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia26a2ea3671e4bbda2393ffce1464f31_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTctMTctMS0xLTczNTM1_fb925b28-b65a-4f7f-80b8-bc7723226262"
      unitRef="usd">1130000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibcfa5db82af24e78ae9358db41c6e7b5_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMS0xLTEtNzM1MzU_1312a565-abfa-4dd8-9d68-2b208ab74aee"
      unitRef="usd">3040000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i770e87f1fd6a40d7ab6f0cf8f9423ff9_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMy0xLTEtNzM1MzU_bf025ee2-f43b-45ec-8335-cf4e0b9f42d7"
      unitRef="usd">1424000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtNS0xLTEtNzM1MzU_88481912-b9b9-46c1-a892-18b330e69d22"
      unitRef="usd">4464000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c32fb02472b41579f71cf3a6edb41c8_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtNy0xLTEtNzM1MzU_a2ed89c8-f59a-4a0b-8e0d-69b443c452b6"
      unitRef="usd">2847000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0d63e4e362e403b8e8e33d15aeb4129_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtOS0xLTEtNzM1MzU_fb9fef48-0a0e-4c6d-af50-68c706c32788"
      unitRef="usd">1392000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTEtMS0xLTczNTM1_3d44423e-c043-47c5-9bc8-ca0060b96e77"
      unitRef="usd">4239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6faafb39d1af4514a46e525041b2d4ea_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTMtMS0xLTczNTM1_dc514c07-ae00-4da4-9486-f1edc3aca88d"
      unitRef="usd">2577000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib84d4ce3a1704c82a573ffc14f62e02f_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTUtMS0xLTczNTM1_76cba5bb-b2df-42f9-86ea-da3f689918ca"
      unitRef="usd">1186000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMTgtMTctMS0xLTczNTM1_5faf9590-1d51-410b-9dbc-f34dad8ae5cf"
      unitRef="usd">3762000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMS0xLTEtNzM1MzU_f6e7ed5a-7658-46a9-a538-39260456ce5d"
      unitRef="usd">10722000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic07db86337a54d37b2f1f39b5c7a798d_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMy0xLTEtNzM1MzU_8ad71f48-7312-4c7b-8302-7e72245b567f"
      unitRef="usd">8148000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtNS0xLTEtNzM1MzU_44189e68-120b-4fe6-9452-777dba53f376"
      unitRef="usd">18870000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c554f2bb4764f148a7b5f7e8b47a21e_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtNy0xLTEtNzM1MzU_77287b10-e196-4136-a9fd-47044a7b3fad"
      unitRef="usd">10371000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if9464fd80b304787a7572a9a2904106a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtOS0xLTEtNzM1MzU_5162e55d-87d0-4a0a-b33b-9771fd9a4b2d"
      unitRef="usd">8760000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTEtMS0xLTczNTM1_1d0f925f-b9c1-4725-99c8-30a0533b5271"
      unitRef="usd">19131000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2274cfe1148048b1a906c0b62d5b0ff1_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTMtMS0xLTczNTM1_f3f40162-b661-45f6-86c5-e26bafdf8319"
      unitRef="usd">9161000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7a0912d23474f249022aec3aba2e54d_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTUtMS0xLTczNTM1_327745c2-f564-46e2-856c-ace52861ca1b"
      unitRef="usd">6912000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjQwYjdhNWFhNjYyNzQwYzBiZWZhZTBkZmEyNDk3Y2RiL3RhYmxlcmFuZ2U6NDBiN2E1YWE2NjI3NDBjMGJlZmFlMGRmYTI0OTdjZGJfMjAtMTctMS0xLTczNTM1_2d6b80a0-d699-4253-95f8-56a2c827ad53"
      unitRef="usd">16074000000</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM0OA_32e960ba-c72d-4e20-baa1-ae2d1605f803">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of segment operating income to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Continuing Operations before Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and segment information for both capital expenditures and depreciation and amortization.  Certain prior-period amounts have been recast to reflect the spin-off of the Diabetes Care business in fiscal year 2022, as noted above.&lt;/span&gt;&lt;div style="margin-top:3pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical (a) (b) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Segment Operating Income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other unallocated items (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Capital Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amounts in 2022, 2021 and 2020 include charges of $72&#160;million $56&#160;million and $244&#160;million, respectively, recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to the estimate of costs associated with remediation efforts for BD Alaris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infusion pumps in the Medication Management Solutions unit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The amount in 2022 includes a charge of $54&#160;million to write down the carrying value of certain fixed assets in the Pharmaceutical Systems unit.  The amount in 2020 included $41&#160;million of charges to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units.  These charges were recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amount in 2020 included charges of $57&#160;million recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to write down the carrying value of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units.  &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.  The amounts in 2022, 2021 and 2020 also include pre-tax charges of $21&#160;million, $361&#160;million and $378 million, recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense (income), net &lt;/span&gt;respectively, related to certain product liability matters, which is further discussed in Note 6.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMi0xLTEtMS03MzUzNQ_bec8a172-f5dc-463f-a4e9-7b01beb72e0b"
      unitRef="usd">2215000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMi0zLTEtMS03MzUzNQ_93d22ed4-9cb3-4c65-a38c-d952945bf9af"
      unitRef="usd">1985000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMi01LTEtMS03MzUzNQ_42fba268-0b6d-417a-b092-1bd6b0b48967"
      unitRef="usd">1675000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMy0xLTEtMS03MzUzNQ_ffa2a336-5255-4b8f-b5fa-33060cf42b6e"
      unitRef="usd">1710000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMy0zLTEtMS03MzUzNQ_6c0dabba-33d6-40de-8723-b8108c1a5876"
      unitRef="usd">2391000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMy01LTEtMS03MzUzNQ_386f1181-635e-41f0-925c-0ea3eb0d9d83"
      unitRef="usd">1405000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNC0xLTEtMS03MzUzNQ_f4c6500a-3d22-4249-ac6b-31f5b6c5a3d3"
      unitRef="usd">1081000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNC0zLTEtMS03MzUzNQ_c6ee9d10-776f-4517-a9d8-41f668e70de6"
      unitRef="usd">933000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNC01LTEtMS03MzUzNQ_6d1f438c-0470-4648-bd98-51cf3bf30d5b"
      unitRef="usd">724000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1feff546e94e4e799fd1e5ff2a6122b1_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNS0xLTEtMS03MzUzNQ_a9267339-ec7c-42b9-98ef-04bfd49d4c5e"
      unitRef="usd">5006000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4f424962ed74433ca2e842f15385c7ce_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNS0zLTEtMS03MzUzNQ_7d8e9378-76a0-4fa4-ac24-ba1a35678ed9"
      unitRef="usd">5311000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7e92a6ff8c554267a457b7ddb0579546_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNS01LTEtMS03MzUzNQ_1c3b5ea0-409e-4062-8549-f61affcfc664"
      unitRef="usd">3806000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i20f6ebe1084e4654990728705d852739_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNi0xLTEtMS03MzUzNQ_dea345c4-3ec5-4700-bbed-6fef40628dfa"
      unitRef="usd">173000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="i087866702b1043ad930869066b7ebb1c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNi0zLTEtMS03MzUzNQ_f5e4fe38-27b5-4c8f-ba35-b843d8271a31"
      unitRef="usd">179000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <bdx:AcquisitionRelatedCostsAndRestructuringCharges
      contextRef="ica689edbbe6c4cfdab402371fb6c387e_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfNi01LTEtMS03MzUzNQ_a8bf6d18-d56f-473a-a903-52666ea683b9"
      unitRef="usd">299000000</bdx:AcquisitionRelatedCostsAndRestructuringCharges>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i20f6ebe1084e4654990728705d852739_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOC0xLTEtMS03MzUzNQ_b4eef166-4990-4da4-b676-4c10aef9111b"
      unitRef="usd">-382000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i087866702b1043ad930869066b7ebb1c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOC0zLTEtMS03MzUzNQ_23762f33-1ebf-4311-bd13-46b85fc5c837"
      unitRef="usd">-460000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ica689edbbe6c4cfdab402371fb6c387e_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOC01LTEtMS03MzUzNQ_20356612-b035-45f3-8a9c-75b69f5f57c9"
      unitRef="usd">-521000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib65439a3c12d453385854062d6818ee7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOS0xLTEtMS03MzUzNQ_3a4fa76f-f70e-4999-90b8-b6a6e24ee387"
      unitRef="usd">-2668000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibe2818605fc44918a60597464387f709_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOS0zLTEtMS03MzUzNQ_d858e2c1-f388-4218-be9e-8c69df867cd5"
      unitRef="usd">-2981000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfOS01LTEtMS03MzUzNQ_b13ec3b4-8ed1-42c0-b9e2-6961361a5714"
      unitRef="usd">-2573000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTAtMS0xLTEtNzM1MzU_637521ec-374f-4caa-8946-2f489374be03"
      unitRef="usd">1783000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTAtMy0xLTEtNzM1MzU_07efcf59-28f1-405d-aec3-4a8d1a88feef"
      unitRef="usd">1692000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTAtNS0xLTEtNzM1MzU_bc0fedd1-48c7-48b2-b876-fd56970d468c"
      unitRef="usd">414000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTItMS0xLTEtNzM1MzU_9ce5c149-ad7b-4267-ae63-bf3fe9ea19dc"
      unitRef="usd">602000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTItMy0xLTEtNzM1MzU_75bc10f2-9fcc-4c7a-9768-0a1f22862539"
      unitRef="usd">740000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTItNS0xLTEtNzM1MzU_6115fa7c-55f8-4bc8-9c26-eb99e78c8aef"
      unitRef="usd">435000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTMtMS0xLTEtNzM1MzU_5a22f3b5-3315-4c4b-b37b-dacdd121791b"
      unitRef="usd">213000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTMtMy0xLTEtNzM1MzU_676d0b2a-5242-4f25-b655-d3b2387cb48e"
      unitRef="usd">297000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTMtNS0xLTEtNzM1MzU_5f947c0d-90f2-46e6-8e3a-cf9229e1d1d9"
      unitRef="usd">192000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTQtMS0xLTEtNzM1MzU_ce4751ec-cc18-4f81-8348-cfce6f337fe0"
      unitRef="usd">130000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTQtMy0xLTEtNzM1MzU_e7ba38b2-b09f-480c-84d5-433063d8c7c4"
      unitRef="usd">125000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTQtNS0xLTEtNzM1MzU_cf347415-6a23-4a2f-abdc-34efd82a129a"
      unitRef="usd">119000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib65439a3c12d453385854062d6818ee7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTUtMS0xLTEtNzM1MzU_d07a3f19-f9b4-4288-8cde-ac2f3be438a9"
      unitRef="usd">28000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibe2818605fc44918a60597464387f709_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTUtMy0xLTEtNzM1MzU_78c5f9d5-fa8d-4449-a6c7-7126f4511bec"
      unitRef="usd">32000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTUtNS0xLTEtNzM1MzU_0c8282d8-47f7-484b-be1e-68ec860f8b4b"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTYtMS0xLTEtNzM1MzU_4ee70ee0-e8b6-4b4f-9dca-0cf702b7e272"
      unitRef="usd">973000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTYtMy0xLTEtNzM1MzU_7e589d01-7487-4555-8dc7-43bac5c570ce"
      unitRef="usd">1194000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTYtNS0xLTEtNzM1MzU_66bc0bc7-f1a6-4439-b693-5f1e9fe2124e"
      unitRef="usd">769000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTgtMS0xLTEtNzM1MzU_c934d31b-5155-435d-bb4b-29210265ebb6"
      unitRef="usd">1144000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5d02da58d81a4fc89864a1f61a5f6ca1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTgtMy0xLTEtNzM1MzU_4d65ad3d-e61c-44f3-af5f-32c65398491a"
      unitRef="usd">1097000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia8f893ce1b754fb19290fd53524c0a85_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTgtNS0xLTEtNzM1MzU_472da3eb-f1c9-45ec-9f6a-a448588c56a4"
      unitRef="usd">1064000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic1ca97591b0f44c79d55d2b4697437cf_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTktMS0xLTEtNzM1MzU_2af8e625-38c8-4d20-a352-1aab764043d3"
      unitRef="usd">283000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic5443ae3296f4dc4a9ee34972d47f33c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTktMy0xLTEtNzM1MzU_223dd3aa-4b51-4997-95e4-73c65feb8a9f"
      unitRef="usd">352000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i11a0e692c49f4145afcecd35ccf13c43_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMTktNS0xLTEtNzM1MzU_544d83f5-6b41-49e0-a1bf-8e55ea70c7bc"
      unitRef="usd">286000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2bd9bd6512804922991b789f8d5233ed_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjAtMS0xLTEtNzM1MzU_8ec7701d-f7ce-4520-8b0f-cf07d0d81e45"
      unitRef="usd">789000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8f0d97a47a364c36afba735fed0f8451_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjAtMy0xLTEtNzM1MzU_3443d7e6-0610-4851-b21b-255f22404298"
      unitRef="usd">769000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7a6bf1edc06a4aea836aeffc96352be3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjAtNS0xLTEtNzM1MzU_87b38ef8-ff62-4bbb-802e-375c87810f85"
      unitRef="usd">750000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib65439a3c12d453385854062d6818ee7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjEtMS0xLTEtNzM1MzU_4561471b-7851-4764-a976-c12f15345d07"
      unitRef="usd">13000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibe2818605fc44918a60597464387f709_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjEtMy0xLTEtNzM1MzU_57cd3288-7d1d-4e2e-928b-f143b44ef1f8"
      unitRef="usd">12000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id7f14facbc6a4bcb8851c29cb5f475df_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjEtNS0xLTEtNzM1MzU_4b9b087c-20c8-49e3-928a-1def5470fbd9"
      unitRef="usd">14000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjItMS0xLTEtNzM1MzU_635d6f2f-947c-4d91-a9fe-5040c9bc1fc5"
      unitRef="usd">2229000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjItMy0xLTEtNzM1MzU_4404d39e-26bc-4048-921c-07732cfba6e5"
      unitRef="usd">2230000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOmZkNzRmYzZiMTU0ZTRjNjI5NTAyYTMxNDNjOTAxZTZmL3RhYmxlcmFuZ2U6ZmQ3NGZjNmIxNTRlNGM2Mjk1MDJhMzE0M2M5MDFlNmZfMjItNS0xLTEtNzM1MzU_4d82d971-22a8-4ca3-9d8e-16fb4634611e"
      unitRef="usd">2115000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InventoryRecallExpense
      contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMzU4Ng_cfd621e0-365f-42b5-b1aa-50b3ab8e1310"
      unitRef="usd">72000000</us-gaap:InventoryRecallExpense>
    <us-gaap:InventoryRecallExpense
      contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMTA5OTUxMTYzNDk4Mw_d2aecd96-545a-4f76-b96b-79a07d4852be"
      unitRef="usd">56000000</us-gaap:InventoryRecallExpense>
    <us-gaap:InventoryRecallExpense
      contextRef="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMzU5Mw_f3ea7228-a02f-40c0-ba8b-183cbd7dc9c8"
      unitRef="usd">244000000</us-gaap:InventoryRecallExpense>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMTA5OTUxMTYzNTgyMQ_0ea7ceef-9a48-4ff9-bcb9-5590cdc11092"
      unitRef="usd">54000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfMzgyMQ_0a5e9627-1e9e-4f4a-b6d2-276bd03959b4"
      unitRef="usd">41000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i938377c8c70a4325b957640e0929f503_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDMzMg_80340cc2-b5c9-4659-9794-7172d226bb89"
      unitRef="usd">57000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDczNg_e3611ce9-3f3d-472b-a1ad-9a0aede62dfa"
      unitRef="usd">21000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDc0MA_72e4ec1d-d4d7-4301-907e-1ff27dcf1cd2"
      unitRef="usd">361000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i08f59c7321f84d4abd684a04e126995a_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNDc0Nw_4ea2fdeb-c7fc-4c10-bb11-a4036d46f276"
      unitRef="usd">378000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RleHRyZWdpb246MWZiNDQzZDFlNjdhNDEyMmFkYmQ1NjNjYWJhMDNmOGNfNjM1MA_ce72221b-73c4-49c0-a8d5-79f224b43dea">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues to unaffiliated customers are generally based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below shows revenues from continuing operations and long-lived assets of continuing operations by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMi0xLTEtMS03MzUzNQ_603fa2b1-a66a-46ae-ba66-96f6712dc5de"
      unitRef="usd">10722000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c554f2bb4764f148a7b5f7e8b47a21e_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMi0zLTEtMS03MzUzNQ_29818c75-758c-48a8-ac11-ee45c45e0a54"
      unitRef="usd">10371000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2274cfe1148048b1a906c0b62d5b0ff1_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMi01LTEtMS03MzUzNQ_b1227002-0f10-4523-8b54-e49592e4e610"
      unitRef="usd">9161000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8cf30fdbac78429f9a446f70c25b7be1_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMy0xLTEtMS03MzUzNQ_7913a21e-b4b8-44fb-9576-4a25edce6566"
      unitRef="usd">4043000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id40539fa62924c86bbbb010189f67b04_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMy0zLTEtMS03MzUzNQ_27f73c2f-e956-47b1-a636-e53cd71599b9"
      unitRef="usd">4548000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad4eeacf775b49548f56b317cb763ba4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMy01LTEtMS03MzUzNQ_338b63f8-7c8c-43d2-a2ba-7b04e984579a"
      unitRef="usd">3734000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i10191e30c4364d2eaeff9b074fad7661_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNC0xLTEtMS03MzUzNQ_54427644-20bc-48c9-a50c-f7d578318cb7"
      unitRef="usd">3047000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18583ef90cc241e4bf98d850f3c5ecbd_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNC0zLTEtMS03MzUzNQ_d45c293f-72c7-4de2-8502-04bfb5953d5f"
      unitRef="usd">3069000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f992e63e5074f08920c5d9d5d2dcfad_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNC01LTEtMS03MzUzNQ_47911770-7a2d-42dc-b501-96eee3fc8ec5"
      unitRef="usd">2384000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i96fc867ea3a54208a98744fec84eb274_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNS0xLTEtMS03MzUzNQ_597a0ed2-acfd-4994-b0f1-385d5fd766e8"
      unitRef="usd">1058000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e483eb99c7c4b6497a405226527c370_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNS0zLTEtMS03MzUzNQ_5c49a8c3-6889-49b5-b005-109988e42bfc"
      unitRef="usd">1142000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba39a8a5d76549f5869166e9f4200fc3_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNS01LTEtMS03MzUzNQ_d48cff29-80e0-4820-a3af-7be45fad8807"
      unitRef="usd">794000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNi0xLTEtMS03MzUzNQ_44189e68-120b-4fe6-9452-777dba53f376"
      unitRef="usd">18870000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNi0zLTEtMS03MzUzNQ_1d0f925f-b9c1-4725-99c8-30a0533b5271"
      unitRef="usd">19131000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfNi01LTEtMS03MzUzNQ_2d6b80a0-d699-4253-95f8-56a2c827ad53"
      unitRef="usd">16074000000</us-gaap:Revenues>
    <us-gaap:NoncurrentAssets
      contextRef="ic1de7b15fe4d4f0daa2e984903815934_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOC0xLTEtMS03MzUzNQ_04dbef14-b683-47e9-8d65-0bb28aa96c5f"
      unitRef="usd">36617000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="idf717fc531104fa8afeb2f4134bf483d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOC0zLTEtMS03MzUzNQ_b5014511-9b37-46ec-8ebf-932454f8d49d"
      unitRef="usd">35896000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if71d28c3e62a46c9a905d0174d34dce7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOC01LTEtMS03MzUzNQ_797a0959-7b3a-48c8-ab46-df66c8efd125"
      unitRef="usd">36317000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i00d2afe4861c4a3e9820f0da284c2e26_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOS0xLTEtMS03MzUzNQ_c9aaa72d-b911-4f49-ae11-f530aa1a933d"
      unitRef="usd">5126000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id4663fdc221d47b9a6c6e31fa080b355_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOS0zLTEtMS03MzUzNQ_8aab214a-1773-452a-a083-fe62aed58afc"
      unitRef="usd">5778000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i11eb132003cd49cf9c750bee96c9d6ba_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfOS01LTEtMS03MzUzNQ_718bf4bf-997c-445a-adbd-17ba2cbbd270"
      unitRef="usd">5660000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5afb79183c5543d798cf072178bc024a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTAtMS0xLTEtNzM1MzU_18be1c4f-1723-4f9d-9aa8-9db52d9feef5"
      unitRef="usd">1528000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i1e3d42c7945a4497a141565ec8971e5d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTAtMy0xLTEtNzM1MzU_a30d6271-04be-4ac5-85ba-7e9548a8b422"
      unitRef="usd">1607000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="icc73ad9d66924344a539a3a87b464261_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTAtNS0xLTEtNzM1MzU_18aa40b0-cc37-47cc-908c-f389a925ed89"
      unitRef="usd">1466000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i820d3d2264834cbebc2fa459cd563e8c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTEtMS0xLTEtNzM1MzU_d8d2acf0-2854-4870-8f79-cc78c2328ed5"
      unitRef="usd">1079000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i68c8e2684ba049d78fb1ad3565e6b339_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTEtMy0xLTEtNzM1MzU_58d0fe71-2b4c-44c8-9259-d80201904d7c"
      unitRef="usd">860000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="iae50cb57e95446c6b92fb35fafe9f9da_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTEtNS0xLTEtNzM1MzU_32f0d100-aa82-4a7a-9205-1032e3da068e"
      unitRef="usd">753000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i81362db95912497e859aa74adfeff72b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTItMS0xLTEtNzM1MzU_8208dd89-b27b-42de-942d-951e39031bc4"
      unitRef="usd">442000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0b105c0c4f50427f8410867a9ec1bf65_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTItMy0xLTEtNzM1MzU_7ceb78f2-898b-47af-957a-c5ac6e0f38b2"
      unitRef="usd">465000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6968aa8bf59f445c9ff26455961aed57_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTItNS0xLTEtNzM1MzU_d4ec7428-1a2c-45ed-8839-9f2e66cc00b6"
      unitRef="usd">411000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTMtMS0xLTEtNzM1MzU_a51946aa-1fee-463c-8945-7720434b4210"
      unitRef="usd">44792000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTMtMy0xLTEtNzM1MzU_99d6c4f9-5f58-4bd7-9499-83efd5157829"
      unitRef="usd">44606000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV85Ny9mcmFnOjFmYjQ0M2QxZTY3YTQxMjJhZGJkNTYzY2FiYTAzZjhjL3RhYmxlOjcxMWJjNTM0OTY2NzRhMmU4YjMxOWM5MTA3NDhmZTQ0L3RhYmxlcmFuZ2U6NzExYmM1MzQ5NjY3NGEyZThiMzE5YzkxMDc0OGZlNDRfMTMtNS0xLTEtNzM1MzU_2e4223e2-e7ec-44bf-95be-fa6297343bfa"
      unitRef="usd">44606000000</us-gaap:NoncurrentAssets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MjQ_a2e40e7e-8d43-4274-a844-990974f00fb3">Share-Based Compensation&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (&#x201c;2004 Plan&#x201d;), which provides long-term incentive compensation to employees and directors consisting of: stock appreciation rights (&#x201c;SARs&#x201d;), performance-based restricted stock units, time-vested restricted stock units and other stock awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of share-based payments is recognized as compensation expense in net income.  BD estimates forfeitures based on experience at the time of grant and adjusts expense to reflect actual forfeiture&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and other restructurings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit associated with share-based compensation costs recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense includes pre-tax compensation expense included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Discontinued Operations, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; that was not material in 2022, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the Company's acquisition of Bard in 2018, certain pre-acquisition equity awards of Bard were converted into either BD SARs or BD restricted stock awards, as applicable. These awards have substantially the same terms and conditions as the converted Bard awards immediately prior to the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense of $16&#160;million associated with these replacement awards was recorded in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and other restructurings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Appreciation Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs generally vest over a period of four years and have a term of ten years.  The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.42%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.24%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value derived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$49.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$44.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$48.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility is based upon historical volatility for the Company&#x2019;s common stock and other factors. The expected life of SARs granted is derived from the output of the lattice-based model, using assumed exercise rates based on historical exercise and termination patterns, and represents the period of time that SARs granted are expected to be outstanding. The risk-free interest rate used is based upon the published U.S. Treasury yield curve in effect at the time of grant for instruments with a similar life. The dividend yield is based upon the most recently declared quarterly dividend as of the grant date. The Company issued 0.7 million shares during 2022 to satisfy the SARs exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of SARs outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SARs (in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Term&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(Millions&lt;br/&gt;of dollars)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards transferred to Embecta at spin-off (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to BD awards related to the spin-off of Embecta  (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD SARs which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of SARs exercised during &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of SARs exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of SARs vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-Based and Time-Vested Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance-based restricted stock units cliff vest three years after the date of grant. These units are tied to the Company&#x2019;s performance against pre-established targets over a performance period of three years. The performance measures for fiscal years 2022, 2021 and 2020 were average annual currency-neutral revenue growth and average annual return on invested capital, with the combined factor subject to adjustment based on the Company's relative total shareholder return (measures the Company&#x2019;s stock performance during the performance period against that of peer companies). Under the Company&#x2019;s long-term incentive program, the actual payout under these awards may vary from zero to 200% of an employee&#x2019;s target payout, based on the Company&#x2019;s actual performance over the performance period of three years. In fiscal years 2021 and 2020, the Company also issued additional performance-based time-vested units to certain key executives, which cliff vest three years after the date of grant and are tied to the Company&#x2019;s performance against average annual growth in the Company&#x2019;s Adjusted EPS over a performance period of three years. No shares will be issuable if the performance targets have not been met. The fair value is based on the market price of the Company&#x2019;s stock on the date of grant. Compensation cost initially recognized assumes that the target payout level will be achieved and is adjusted for subsequent changes in the expected outcome of performance-related conditions. For units for which the performance conditions are modified after the date of grant, any incremental increase in the fair value of the modified units, over the original units, is recorded as compensation expense on the date of the modification for vested units, or over the remaining performance period for units not yet vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Time-vested restricted stock unit awards vest on a graded basis over a period of three years, except for certain key executives of the Company, including the executive officers, for which such units generally vest one year following the employee&#x2019;s retirement. The related share-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all time-vested restricted stock units is based on the market value of the Company&#x2019;s stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of restricted stock units outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.166%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock&#160;Units&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Grant&lt;br/&gt;Date&#160;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock&#160;Units&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Grant&lt;br/&gt;Date&#160;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards transferred to Embecta at spin-off (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to BD awards related to the spin-off of Embecta (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD restricted stock units which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Based on 200% of target payout for performance based restricted units and 100% of the performance based time-vested units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net of expected forfeited units and units in excess of the expected performance payout of 65 thousand and 386 thousand shares, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of restricted stock units granted during the years 2022, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of units granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of stock units vested during 2022, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of units vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the weighted average remaining vesting term of performance-based and time vested restricted stock units is 1.23 and 0.90 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unrecognized Compensation Expense and Other Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of unrecognized compensation expense for all non-vested share-based awards as of September&#160;30, 2022, is approximately $253 million, which is expected to be recognized over a weighted-average remaining life of approximately 1.9 years. At September&#160;30, 2022, 7.2 million shares were authorized for future grants under the 2004 Plan. The Company has a policy of satisfying share-based payments through &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;either open market purchases or shares held in treasury. At September&#160;30, 2022, the Company has sufficient shares held in treasury to satisfy these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, 101 thousand shares were held in trust relative to a Director's Deferral plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis. Also as of September&#160;30, 2022, 231 thousand shares were issuable under a Deferred Compensation Plan that allows certain highly-compensated employees, including executive officers, to defer salary, annual incentive awards and certain equity-based compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MzE_04e44452-d340-4d54-b1bb-27f4dfae6c68">The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and other restructurings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit associated with share-based compensation costs recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5ee987dab8c144399f2ff0d88aa15f7b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzEtMS0xLTEtNzM1MzU_b96cc44d-7ee6-4565-86e6-c038608cb6af"
      unitRef="usd">46000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i032efb1d86ce48d0909296f8cca53459_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzEtMy0xLTEtNzM1MzU_5c6c5b7f-2df2-4ca2-9ce8-0a6c554506ac"
      unitRef="usd">43000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if421c3b8ea2a4e7ab527e52a891f26c5_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzEtNS0xLTEtNzM1MzU_49b55297-5b7b-4a52-bbd2-922af25a4f3c"
      unitRef="usd">40000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i54aab8ed6b4e47aebcac9e9c927310b7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzItMS0xLTEtNzM1MzU_c16e6b36-3e1a-4aba-a9c1-e7a802f193e9"
      unitRef="usd">156000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8660d76f8bf1403894faec3ddd4176a0_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzItMy0xLTEtNzM1MzU_93816f52-ae14-459d-aad8-52858353752a"
      unitRef="usd">158000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5645bcb73774a2284d8ac4c0ac3dea0_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzItNS0xLTEtNzM1MzU_95460adf-5083-4c11-b652-5c5d3c89ef88"
      unitRef="usd">150000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id6835087ad8c4728bb6473612b2cf0bf_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzMtMS0xLTEtNzM1MzU_2f87768c-c037-4c95-a6b9-067a283d7044"
      unitRef="usd">37000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3d179fae935c4c82a01090f5b56e975c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzMtMy0xLTEtNzM1MzU_76db3702-f6d8-47b1-83b8-463dfcb46864"
      unitRef="usd">36000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icd69a3a2f71e4c5fa5e480606c3addb6_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzMtNS0xLTEtNzM1MzU_edf1a035-924a-4506-a08a-408b5a5764f8"
      unitRef="usd">34000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ieb8b9befe2884f62abaad02f5835561b_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzQtMS0xLTEtNzM1MzU_be6fb239-a623-4554-a399-5635ab665278"
      unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6bf08a9c8e8b4394a3000593ba05da14_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzQtMy0xLTEtNzM1MzU_f3eecb29-3714-43ad-8011-39c7d669f051"
      unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b9f84be28aa4054929a2360fb4e6192_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzQtNS0xLTEtNzM1MzU_b728cae8-6297-4b75-bb6d-5bd92ec0ac01"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzUtMS0xLTEtNzM1MzU_072bd0a7-2ddf-4a90-8de9-679355d7e07f"
      unitRef="usd">240000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzUtMy0xLTEtNzM1MzU_56e8ac5c-2631-4b16-8ba6-68126c7cf441"
      unitRef="usd">238000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzUtNS0xLTEtNzM1MzU_f8fe5082-6da5-4af7-9710-b5cebc05fc8e"
      unitRef="usd">245000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzctMS0xLTEtNzM1MzU_2cceec4f-6c0d-4425-ae88-a157f561003f"
      unitRef="usd">55000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzctMy0xLTEtNzM1MzU_040e91b1-b792-4d9d-b518-067e95c655d0"
      unitRef="usd">55000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTphNGM2ZDg2N2ZhNWE0ODkyYmFlNDgyNmJiMTY0MmNlMy90YWJsZXJhbmdlOmE0YzZkODY3ZmE1YTQ4OTJiYWU0ODI2YmIxNjQyY2UzXzctNS0xLTEtNzM1MzU_50c283f3-36fa-4957-8eed-cd2f437194a5"
      unitRef="usd">57000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i91be43483d0f4b4b8867902706c778e4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzEwNzk_ef441527-9738-4674-a45a-2756b7541ee2"
      unitRef="usd">16000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzE1MDQ_a0b21342-42f1-4372-a446-944cd27796fe">P4Y</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzE1MjY_341b3af7-b519-4b91-955c-0b2653963559">P10Y</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MjA_33082a7a-54e9-4ca9-b978-63a31161aab9">The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.42%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.24%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value derived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$49.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$44.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$48.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzEtMS0xLTEtNzM1MzU_8347a8d5-bd22-4f6f-ba79-22d3cec2b7e8"
      unitRef="number">0.0141</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzEtMy0xLTEtNzM1MzU_54783abd-db24-44cf-85e1-fcb87bf4c4f2"
      unitRef="number">0.0068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzEtNS0xLTEtNzM1MzU_bf9bcc72-d56c-40b0-af53-f5bc27bfa560"
      unitRef="number">0.0169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzItMS0xLTEtNzM1MzU_2e0511f1-ae44-4965-9de1-9fd5b81404e3"
      unitRef="number">0.220</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzItMy0xLTEtNzM1MzU_7e4b2072-31bc-4ae2-b888-fec649518c90"
      unitRef="number">0.230</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzItNS0xLTEtNzM1MzU_7a2ba21a-a3c5-4863-8bda-08a8b5f08940"
      unitRef="number">0.190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzMtMS0xLTEtNzM1MzU_b6fb4825-e562-465a-be63-e64ea7451518"
      unitRef="number">0.0142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzMtMy0xLTEtNzM1MzU_5ea7ce00-65fc-4375-a372-d81e7a3b7ab8"
      unitRef="number">0.0146</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzMtNS0xLTEtNzM1MzU_d630358a-0978-4b25-b753-079749e90482"
      unitRef="number">0.0124</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzQtMS0xLTEtNzM1MzU_4e71a8b2-8a89-4256-8209-178a3e7a71b6">P7Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzQtMy0xLTEtNzM1MzU_2a655a1e-4f3c-41ad-94a4-bd2d847d85e7">P7Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzQtNS0xLTEtNzM1MzU_ece52012-db62-45a0-9669-1a6f42ccd811">P7Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzUtMS0xLTEtNzM1MzU_5c424f9b-c5df-449e-9f36-6be4cf24f653"
      unitRef="usdPerShare">49.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0eeab2d46b8b40c3a210b9731f3d5dd9_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzUtMy0xLTEtNzM1MzU_da29a56d-5f11-4139-8d24-37c948fa1e2b"
      unitRef="usdPerShare">44.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i028c4775e17241939ebf0bd57a6fa85b_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTowOTIyYWZjYmJlZTk0NGY1YTkzZjg5MzFmMmI1NmU1MC90YWJsZXJhbmdlOjA5MjJhZmNiYmVlOTQ0ZjVhOTNmODkzMWYyYjU2ZTUwXzUtNS0xLTEtNzM1MzU_d12ccfa7-bc98-4dab-93cc-704bb2b6fda3"
      unitRef="usdPerShare">48.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <bdx:StockIssuedUnderStockAppreciationRightsExercised
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzIzNzk_3afdc518-ca75-481f-ad40-5d508b361f34"
      unitRef="shares">700000</bdx:StockIssuedUnderStockAppreciationRightsExercised>
    <us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MDY_76315b3c-55ce-4e14-b71a-d45112fb66c9">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of SARs outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SARs (in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Term&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(Millions&lt;br/&gt;of dollars)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards transferred to Embecta at spin-off (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to BD awards related to the spin-off of Embecta  (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD SARs which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzEtMS0xLTEtNzM1MzU_6945bc25-5e80-48b0-955f-af04b4c696e1"
      unitRef="shares">6295000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzEtMy0xLTEtNzM1MzU_b1dd4767-675e-42bf-8081-66d1d25735b9"
      unitRef="usdPerShare">179.64</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzItMS0xLTEtNzM1MzU_20916e5e-00ce-4322-a0a1-81d9adf0bc53"
      unitRef="shares">909000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzItMy0xLTEtNzM1MzU_306b9f1e-3f78-4c38-8822-308a39d723a7"
      unitRef="usdPerShare">245.09</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzMtMS0xLTEtNzM1MzU_67ce2f3e-cb94-40cb-8fde-0d33cc689ae6"
      unitRef="shares">1408000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzMtMy0xLTEtNzM1MzU_dab6cab6-aad0-4900-9b83-8216b0f4a99a"
      unitRef="usdPerShare">125.57</bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzQtMS0xLTEtNzM1MzU_cfa18d29-0347-4d8e-aad4-2114571d3a23"
      unitRef="shares">191000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzQtMy0xLTEtNzM1MzU_00df0804-4516-48cf-bf99-f245c7ae5241"
      unitRef="usdPerShare">234.50</bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMS0xLTEtMTEwMjA0_62e3994e-b9ef-44cc-9e11-8d7ebf4ee9ef"
      unitRef="shares">159000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMy0xLTEtMTEwMTkw_1c0e33af-ecc9-485e-80a9-81d8d951687d"
      unitRef="usdPerShare">239.77</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtMS0xLTEtMTEwMTk3_434efd62-e928-4a4d-b2fa-1b4e010aa271"
      unitRef="shares">97000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMS0xLTEtNzM1MzU_1072d220-282a-4865-bcef-fb333ecc945a"
      unitRef="shares">5544000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtMy0xLTEtNzM1MzU_6f91e3fc-4252-44cf-9880-89f47bb2c2b8"
      unitRef="usdPerShare">197.31</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtNS0xLTEtNzM1MzU_ba73f28b-450b-4627-b804-d3e4d286cb98">P5Y7M28D</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzUtNy0xLTEtNzM1MzU_679ce25f-77ed-4dc1-92bc-1725728d5bcc"
      unitRef="usd">183000000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtMS0xLTEtNzM1MzU_eeab8606-b9d0-4829-be0b-ae1783ac287c"
      unitRef="shares">5377000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtMy0xLTEtNzM1MzU_472fa890-880d-4855-9676-7c591b56a5a8"
      unitRef="usdPerShare">196.10</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtNS0xLTEtNzM1MzU_16c825a9-81d0-4a6f-be6f-c6d05e1f6f9f">P5Y6M29D</bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzYtNy0xLTEtNzM1MzU_8ed0cfea-5bb2-4948-b8a8-1cbb25226826"
      unitRef="usd">183000000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctMS0xLTEtNzM1MzU_6d823f5a-1664-4c82-9e7b-a82b7e3a2124"
      unitRef="shares">3877000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctMy0xLTEtNzM1MzU_9c2ab6fc-39bb-47a1-b181-d7bb291870d5"
      unitRef="usdPerShare">180.47</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctNS0xLTEtNzM1MzU_2b28e633-ad3d-4867-98b0-309802ddd934">P4Y6M3D</bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo4MjJiYjJjZjRkZDc0YzVjODBiZjMyMzRjMjM1OWQ4MC90YWJsZXJhbmdlOjgyMmJiMmNmNGRkNzRjNWM4MGJmMzIzNGMyMzU5ZDgwXzctNy0xLTEtNzM1MzU_6568159c-ecdc-4099-a65b-24a5d18ad580"
      unitRef="usd">183000000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue>
    <bdx:ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY3OTY_f94a7610-fbc4-4ffd-9238-a6e779d675b8">&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of SARs exercised during &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of SARs exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of SARs vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bdx:ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzEtMS0xLTEtNzM1MzU_9b537d2c-8e15-48dc-97a6-144342b49b4e"
      unitRef="usd">184000000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzEtMy0xLTEtNzM1MzU_2d3766da-d73a-4dc4-a25f-37a009f7008c"
      unitRef="usd">102000000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzEtNS0xLTEtNzM1MzU_b6aa344e-fa28-40ee-8d71-b126b53970f1"
      unitRef="usd">212000000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue>
    <bdx:FairValueOfStockAppreciationRights
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzMtMS0xLTEtNzM1MzU_1a016a0b-2de6-4db6-8945-335133e33fdf"
      unitRef="usd">36000000</bdx:FairValueOfStockAppreciationRights>
    <bdx:FairValueOfStockAppreciationRights
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzMtMy0xLTEtNzM1MzU_2183e18a-5496-4985-9dc1-8cda8a30d8b3"
      unitRef="usd">39000000</bdx:FairValueOfStockAppreciationRights>
    <bdx:FairValueOfStockAppreciationRights
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTo0MTJhYmRlMzVhNGI0YTJmODZlZmFkMmQyM2YyZTcyMC90YWJsZXJhbmdlOjQxMmFiZGUzNWE0YjRhMmY4NmVmYWQyZDIzZjJlNzIwXzMtNS0xLTEtNzM1MzU_941c799f-be8f-4714-9b48-400e2fa3e03e"
      unitRef="usd">46000000</bdx:FairValueOfStockAppreciationRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzI3MDI_92c3d6ab-f3d0-484d-b4e2-fd818c00e21f">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzI4NDI_f92bc812-fdc5-4f07-ad5c-06af0e64772c">P3Y</bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod>
    <bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent
      contextRef="i1878f37315d04b1a98cbf4c1d0819498_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzM0NDA_a58b3602-aeb8-42d5-a29a-5bd683394952"
      unitRef="number">0</bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent>
    <bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent
      contextRef="i0817d59aef3845269f35d7e2afcd203d_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzM0NDY_c85a6028-abd8-4e47-b555-b726999b5182"
      unitRef="number">2</bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent>
    <bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzM1NTQ_f92bc812-fdc5-4f07-ad5c-06af0e64772c">P3Y</bdx:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzQ2NTI_c98e6c3d-8b1f-49b5-a8de-f58f43903d92">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i79c2acdab6234d67848433db1d1dbd37_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzQ3NzY_9a26e5d9-25c0-4f4b-a5e6-f274c8bf89be">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4Mjc_9c34725c-e057-4979-82b0-d5066032378a">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of restricted stock units outstanding as of September&#160;30, 2022 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.166%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock&#160;Units&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Grant&lt;br/&gt;Date&#160;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock&#160;Units&#160;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Grant&lt;br/&gt;Date&#160;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards transferred to Embecta at spin-off (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to BD awards related to the spin-off of Embecta (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD restricted stock units which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Based on 200% of target payout for performance based restricted units and 100% of the performance based time-vested units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Net of expected forfeited units and units in excess of the expected performance payout of 65 thousand and 386 thousand shares, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie6f651512be74e1d93a7c0f9cac1e296_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItMS0xLTEtNzM1MzU_96f4a51e-7865-4065-a999-3389a5e9528d"
      unitRef="shares">957000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie6f651512be74e1d93a7c0f9cac1e296_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItNC0xLTEtNzM1MzU_93160aa3-7cc1-4b97-a7ca-466b76258848"
      unitRef="usdPerShare">231.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i15ef9393893346008a24448385a34a5c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItNi0xLTEtNzM1MzU_d01b3b38-ebe6-4cad-8b47-37bf3aa51082"
      unitRef="shares">1556000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i15ef9393893346008a24448385a34a5c_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzItOC0xLTEtNzM1MzU_b64d5eb8-643e-4724-beba-b75cf51ea294"
      unitRef="usdPerShare">221.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtMS0xLTEtNzM1MzU_16657256-ebb5-4f66-891c-345ac72cb3e1"
      unitRef="shares">390000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtNC0xLTEtNzM1MzU_bae0045f-65c8-4de1-ac95-5d30ab651595"
      unitRef="usdPerShare">242.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtNi0xLTEtNzM1MzU_44b59bdd-1ca3-40db-8a6f-2189682531c9"
      unitRef="shares">969000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzMtOC0xLTEtNzM1MzU_0ecb8371-ff2c-4e76-b60e-3823e3620258"
      unitRef="usdPerShare">239.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtMS0xLTEtNzM1MzU_7a190ea9-69c2-4fd8-aa3a-1c7d19c55389"
      unitRef="shares">39000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtNC0xLTEtNzM1MzU_c16cb404-86e6-4d2c-a743-4773b6785920"
      unitRef="usdPerShare">237.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtNi0xLTEtNzM1MzU_13d45120-7155-4b36-a7ba-51946ee4a857"
      unitRef="shares">524000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzQtOC0xLTEtNzM1MzU_f69679ea-d92a-4682-9e8d-3b7a62751037"
      unitRef="usdPerShare">224.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtMS0xLTEtNzM1MzU_f21d157d-61c5-4cb3-8049-5fc7c6c69b3d"
      unitRef="shares">369000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtNC0xLTEtNzM1MzU_76997aab-b865-4ef9-bb14-6b2d807c881f"
      unitRef="usdPerShare">235.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtNi0xLTEtNzM1MzU_04461bb9-cdd2-4155-a0f2-fbf67b9e0e31"
      unitRef="shares">378000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzUtOC0xLTEtNzM1MzU_88f79685-fa95-4ce8-b43f-043e30c00bb1"
      unitRef="usdPerShare">228.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtMS0xLTEtMTEwMjYz_9f5703c8-b56f-4e53-bf30-67b7e644deaa"
      unitRef="shares">21000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNC0xLTEtMTEwMjcw_6b6b9627-7464-4d3a-b318-8ea94d3b200c"
      unitRef="usdPerShare">234.18</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNi0xLTEtMTEwMjc3_d424663e-6a89-467a-86fb-2b1d2394fe06"
      unitRef="shares">88000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtOC0xLTEtMTEwMjg0_ec9b3c75-824f-4774-907c-e30736e5aa00"
      unitRef="usdPerShare">237.60</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctMS0xLTEtMTEwMjYz_ac94bda8-3511-4c23-bdbe-30b40e953aae"
      unitRef="shares">16000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctNi0xLTEtMTEwMjc3_1f0f863f-f1a8-4796-99aa-1d826e594c3e"
      unitRef="shares">27000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i033e6a9eb88b43d980fc575fa72123e5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtMS0xLTEtNzM1MzU_96d47ec4-a0de-4d99-a499-047038d91142"
      unitRef="shares">934000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i033e6a9eb88b43d980fc575fa72123e5_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNC0xLTEtNzM1MzU_34741610-c542-4b74-a868-ffd9ba8f52a1"
      unitRef="usdPerShare">230.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i873b906d317a431aa87a7b6cf2fd045c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtNi0xLTEtNzM1MzU_a77c4e80-036c-48b6-b7a3-4e097c003059"
      unitRef="shares">1561000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i873b906d317a431aa87a7b6cf2fd045c_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzYtOC0xLTEtNzM1MzU_605b25d0-6a3b-4a6d-97bd-4e5e634b9cff"
      unitRef="usdPerShare">224.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctMS0xLTEtNzM1MzU_5700ec0b-45a0-4619-b43d-ca29faa504b7"
      unitRef="shares">483000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctNC0xLTEtNzM1MzU_d345b6a0-2b21-4388-a964-05314add2624"
      unitRef="usdPerShare">229.32</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctNi0xLTEtNzM1MzU_4b279333-0a31-4efc-af8d-3ca88a3885b6"
      unitRef="shares">1453000</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest>
    <bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpkZjUwYTFmZDhhOTM0NDA5YmVlMDVjZTYwMGE2MDhmYy90YWJsZXJhbmdlOmRmNTBhMWZkOGE5MzQ0MDliZWUwNWNlNjAwYTYwOGZjXzctOC0xLTEtNzM1MzU_3fdff769-22f5-45a2-b0d3-66f4dcbb3072"
      unitRef="usdPerShare">224.31</bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest>
    <bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzUyMzE_d2f17a1b-14e9-4acb-899a-de4550de916e"
      unitRef="number">2</bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased>
    <bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzUyOTQ_58279074-fdf8-4af4-abec-2911198c63b6"
      unitRef="number">1</bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased>
    <bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzUyOTQ_851d35d3-9a86-4e5d-9e01-ac61f91584f4"
      unitRef="number">1</bdx:PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased>
    <bdx:ExpectedForfeitedPerformanceBasedRestrictedStockUnits
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU0MzE_fb6a9a12-62f2-45b3-bd1e-d88bc3dec15f"
      unitRef="shares">65000</bdx:ExpectedForfeitedPerformanceBasedRestrictedStockUnits>
    <bdx:UnitsInExcessOfExpectedPerformancePayout
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU0Mzg_aeeaac38-114f-449a-8473-270f189d9f4d"
      unitRef="shares">386000</bdx:UnitsInExcessOfExpectedPerformancePayout>
    <bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MTg_98354745-4577-4e9b-8e03-9ed36205a394">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of restricted stock units granted during the years 2022, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of units granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItMS0xLTEtNzM1MzU_4320abdf-580a-4ab5-ad14-a176df125b80"
      unitRef="usdPerShare">242.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i358a67c5d4ed43109765477c30e7c234_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItMy0xLTEtNzM1MzU_04102c58-ca6e-45bb-8a47-b563cf0061f2"
      unitRef="usdPerShare">216.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0326d51b048d49febfbe800191bb36de_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItNS0xLTEtNzM1MzU_48b83de0-848e-40bb-afca-3679889761da"
      unitRef="usdPerShare">245.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItNy0xLTEtNzM1MzU_e023796b-0e05-432a-a74d-ce7974dd078e"
      unitRef="usdPerShare">239.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4349c1158a974223aa831dfcf0b2cbc7_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItOS0xLTEtNzM1MzU_b95d2b32-c156-49ca-9f83-b73ce5fe2850"
      unitRef="usdPerShare">223.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5d3a7a2e0c64e4d98235396301e0718_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTpjNzYyZjU0MjU1OWY0ZGI4YTVjZjlhMjU2NzBhNzZjZC90YWJsZXJhbmdlOmM3NjJmNTQyNTU5ZjRkYjhhNWNmOWEyNTY3MGE3NmNkXzItMTEtMS0xLTczNTM1_3a796a2f-f92b-43c8-b29f-2e3264a32b55"
      unitRef="usdPerShare">249.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY4MzY_f7105fa0-eb74-42d8-8692-f93f9c286f09">&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of stock units vested during 2022, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of units vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItMS0xLTEtNzM1MzU_6cde339a-2f4d-4efe-9206-512afa81f706"
      unitRef="usd">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i358a67c5d4ed43109765477c30e7c234_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItMy0xLTEtNzM1MzU_f7c240bd-793e-4a50-b42c-15c374876f1b"
      unitRef="usd">16000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i0326d51b048d49febfbe800191bb36de_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItNS0xLTEtNzM1MzU_3436a43e-70c1-4b76-838b-432f2a5db19e"
      unitRef="usd">27000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItNy0xLTEtNzM1MzU_1b896447-96db-474a-b93d-2793a97e9404"
      unitRef="usd">169000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i4349c1158a974223aa831dfcf0b2cbc7_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItOS0xLTEtNzM1MzU_061dc87b-0008-426f-b2a6-38588335fa83"
      unitRef="usd">203000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie5d3a7a2e0c64e4d98235396301e0718_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90YWJsZTplOTU3YjgzNDk4ODE0ZTI2YmI4NWEyNzEzN2M3OGFhMC90YWJsZXJhbmdlOmU5NTdiODM0OTg4MTRlMjZiYjg1YTI3MTM3Yzc4YWEwXzItMTEtMS0xLTczNTM1_07181088-66a5-4a6a-9b65-24305ef48a13"
      unitRef="usd">211000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU3ODU_bf136da2-72de-47e7-aef8-bbd8b8859300">P1Y2M23D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ie28a116f43b3444b807b817c4cdd29a5_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU3OTI_7873821a-0f97-472f-89d8-40b84a0db172">P0Y10M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzU5ODU_d0f57821-d2d1-43d3-886e-c647fb94e2d4"
      unitRef="usd">253000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzYwODA_5d39d256-fcd7-4a2c-86cc-24c296400ddc">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzYwOTg_824423eb-7a03-4a94-ae1c-146df67281b9"
      unitRef="shares">7200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockSharesHeldInEmployeeTrustShares
      contextRef="ifedfc8723a1240dfbd527fddd8610509_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzYzODU_3b73bbc6-7155-4115-a459-01d46e1a2b94"
      unitRef="shares">101000</us-gaap:CommonStockSharesHeldInEmployeeTrustShares>
    <bdx:SharesIssuableUnderDeferredCompensationPlan
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDAvZnJhZzpjNDY4NmNlNGQwYTE0MGIxYTdmZmI0Yzc5Zjg2OWI5My90ZXh0cmVnaW9uOmM0Njg2Y2U0ZDBhMTQwYjFhN2ZmYjRjNzlmODY5YjkzXzY1Nzg_258a00b0-d963-49ee-b89b-a2042fe5aa9b"
      unitRef="shares">231000</bdx:SharesIssuableUnderDeferredCompensationPlan>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzAy_6d0e52f1-8ca4-4fa0-a5d9-ee95fe655f3b">Benefit Plans&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;All components of the Company&#x2019;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; on its consolidated statements of income, with the exception of certain amounts for termination benefits, curtailments and settlements related to the spin-off of Embecta, which are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income from Discontinued Operations, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;and were not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transfer of employees to Embecta in connection with the spin-off triggered remeasurements of some of the Company&#x2019;s benefit plans. These remeasurements, which were calculated using discount rates and asset values as of the date of the spin-off, did not materially impact the Company&#x2019;s benefit obligation. The remeasurements also resulted in a related adjustment to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. Postretirement healthcare and life insurance benefits provided to qualifying domestic retirees as well as other postretirement benefit plans in international countries are not material. The measurement date used for the Company&#x2019;s employee benefit plans is September&#160;30.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Company&#x2019;s conclusion to merge the legacy Bard pension plan into the BD defined benefit cash balance pension plan, the assets and liabilities of the legacy Bard U.S. defined pension benefit plan were remeasured as of October 31, 2020. Amendments to this plan were approved and communicated to affected employees in the first quarter of fiscal year 2021. The legacy Bard U.S. pension plan has been frozen to prevent new participants since January 1, 2011. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January 1, 2018, the legacy BD U.S. pension plan was frozen to limit the participation of employees who are hired or re-hired by the Company, or who transfer employment to the Company, on or after January 1, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pension cost for the years ended September&#160;30 included the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.500%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost included in the preceding table that is attributable to international plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;in prior periods. The settlement loss recorded in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022 included lump sum benefit payments associated with Company&#x2019;s U.S. pension plan. The Company recognizes pension settlements when payments from the plan exceed the sum of service and interest cost components of net periodic pension cost associated with the plan for the fiscal year. A curtailment loss in 2021, related to freezing a pension plan in Europe, was recorded when the loss was probable and estimable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation, change in fair value of pension plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of Embecta spin-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailments/settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, includes translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in fair value of plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of Embecta spin-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, includes translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded Status at September&#160;30:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unfunded benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized in the Consolidated Balance&lt;br/&gt;Sheets at September&#160;30:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries, wages and related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term Employee Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized in Accumulated other&lt;br/&gt;comprehensive income (loss) before income taxes at September&#160;30:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International pension plan assets at fair value included in the preceding table were $705 million and $1.033 billion at September&#160;30, 2022 and 2021, respectively. The international pension plan projected benefit obligations were $772 million and $1.320 billion at September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The benefit obligation associated with postretirement healthcare and life insurance plans provided to qualifying domestic retirees, which was largely recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Employee Benefit Obligations,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$101 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $138 million at September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&#160;Benefit&lt;br/&gt;Obligation&#160;Exceeds&#160;the&lt;br/&gt;Fair&#160;Value&#160;of&#160;Plan&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Projected&#160;Benefit&lt;br/&gt;Obligation&#160;Exceeds&#160;the&lt;br/&gt;Fair&#160;Value&#160;of&#160;Plan&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average assumptions used in determining pension plan information were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash balance plan interest crediting rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash balance plan interest crediting rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The Company calculated the service and interest components utilizing an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Expected Rate of Return on Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers many factors, including historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Expected Funding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s funding policy for its defined benefit pension plans is to contribute amounts sufficient to meet legal funding requirements, plus any additional amounts that may be appropriate considering the funded status of the plans, tax consequences, the cash flow generated by the Company and other factors. The Company made discretionary contributions to its BD U.S. pension plan of $134 million during fiscal year 2022. The Company did not make any required contributions in 2022 and does not anticipate any significant required contributions to its pension plans in fiscal year 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments associated with postretirement healthcare plans are immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s primary objective is to achieve returns sufficient to meet future benefit obligations. It seeks to generate above market returns by investing in more volatile asset classes such as equities while at the same time controlling risk through diversification in non-correlated asset classes and through allocations to more stable asset classes like fixed income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;U.S. Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s U.S. pension plans comprise 69% of total benefit plan investments, based on September&#160;30, 2022 market values, and have a target asset mix of 45% fixed income, 21% diversifying investments and 34% equities. This mix was established based on an analysis of projected benefit payments and estimates of long-term returns, volatilities and correlations for various asset classes. The asset allocations to diversifying investments include high-yield bonds, hedge funds, real estate, infrastructure, leveraged loans and emerging markets bonds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The actual portfolio investment mix may, from time to time, deviate from the established target mix due to various factors such as normal market fluctuations, the reliance on estimates in connection with the determination of allocations and normal portfolio activity such as additions and withdrawals. Rebalancing of the asset portfolio on a quarterly basis is required to address any allocations that deviate from the established target allocations in excess of defined allowable ranges. The target allocations are subject to periodic review, including a review of the asset portfolio&#x2019;s performance, by the named fiduciary of the plans. Any tactical deviations from the established asset mix require the approval of the named fiduciary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. plans may enter into both exchange traded and non-exchange traded derivative transactions in order to manage interest rate exposure, volatility, term structure of interest rates, and sector and currency &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exposures within the fixed income portfolios. The Company has established minimum credit quality standards for counterparties in such transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021. The categorization of fund investments is based upon the categorization of these funds&#x2019; underlying assets.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement (See Note 1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total U.S.&lt;br/&gt;Plan Asset&lt;br/&gt;Balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;As per applicable disclosure requirements, certain investments that were measured at net asset value per share or its equivalent have not been categorized within the fair value hierarchy.  Values of such assets are based on the corroborated net asset value provided by the fund administrator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. pension plan assets categorized above as fixed income securities include fund investments comprised of corporate and government and agency investments. Investments in corporate bonds are diversified across industry and sector and consist of investment-grade, as well as high-yield debt instruments. U.S. government investments consist of obligations of the U.S. Treasury, other U.S. government agencies, state governments and local municipalities. Assets categorized as foreign government and agency debt securities included investments in developed and emerging markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The values of fixed income investments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. A portion of the fixed income instruments classified within Level 2 are valued based upon estimated prices from independent vendors&#x2019; pricing models and these prices are derived from market observable sources including: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. pension plan assets categorized as equity securities consist of fund investments in publicly-traded U.S. and non-U.S. equity securities. In order to achieve appropriate diversification, these portfolios are invested across market sectors, investment styles, capitalization weights and geographic regions. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investments are traded or have a readily determinable fair value based on published prices obtained from fund managers which represent the price at which the instruments can be redeemed at period end. The U.S. pension plan has no future funding commitments associated with these investments and has the right to redeem them upon one day&#x2019;s notice, at any time and without restriction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the U.S. plans&#x2019; assets consists of investments in cash and cash equivalents, primarily to accommodate liquidity requirements relating to trade settlement and benefit payment activity, and the values of these assets are based upon quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other U.S. pension plan assets include fund investments comprised of hedge funds. The values of such instruments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;International Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International plan assets comprise 31% of the Company&#x2019;s total benefit plan assets, based on market value at September&#160;30, 2022. Such plans have local independent fiduciary committees, with responsibility for development and oversight of investment policy, including asset allocation decisions.  In making such decisions, consideration is given to local regulations, investment practices and funding rules.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the fair value measurements of international plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.013%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement (See Note 1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;International&lt;br/&gt;Plan Asset&lt;br/&gt;Balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3 (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Changes in the fair value of international pension assets measured using Level 3 inputs for the years ended September&#160;30, 2022 and 2021 were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income investments held by international pension plans include corporate, U.S. government and non-U.S. government securities. The values of fixed income securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Values of investments classified within Level 2 are based upon estimated prices from independent vendors&#x2019; pricing models and these prices are derived from market observable sources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities included in the international plan assets consist of publicly-traded U.S. and non-U.S. equity securities. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded or have a readily determinable fair value based on published prices obtained from fund managers which represent the price at which the instruments can be redeemed at period end. The international plans holding these securities have no future funding commitments associated with these investments and has the right to redeem them upon one day&#x2019;s notice, at any time and without restriction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The international plans hold a portion of assets in cash and cash equivalents, in order to accommodate liquidity requirements and the values are based upon quoted market prices. Real estate investments consist of investments in funds holding an interest in real properties and the corresponding values represent the estimated fair value based on the fair value of the underlying investment value or cost, adjusted for any accumulated earnings or losses.  The values of insurance contracts approximately represent cash surrender value. Other investments include fund investments for which values are based upon either quoted market prices or market observable sources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost of voluntary defined contribution plans which provide for a Company match or contribution was $178 million in 2022, $153 million in 2021 and $111 million in 2020. As a short term measure to preserve cash and reduce costs, the Company's matching contributions were temporarily suspended effective May 1, 2020 and matching contributions were reinstated in October 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzA3_7034217a-cb63-46f2-960b-d93d202f6d98">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net pension cost for the years ended September&#160;30 included the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.500%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension cost included in the preceding table that is attributable to international plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzItMS0xLTEtNzM1MzU_e276d922-273b-4b46-b65f-c7ce80b25196"
      unitRef="usd">134000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzItMy0xLTEtNzM1MzU_6153dc78-1607-48a5-a43c-8efe85cd3c7b"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzItNS0xLTEtNzM1MzU_a1aae394-49ec-475c-b5bb-4682fca955e5"
      unitRef="usd">153000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzMtMS0xLTEtNzM1MzU_03b7c8b4-29eb-453d-aa25-7be35b2d31f6"
      unitRef="usd">77000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzMtMy0xLTEtNzM1MzU_7196e039-4fd0-4ebe-8fd4-fe7b3fc30737"
      unitRef="usd">71000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzMtNS0xLTEtNzM1MzU_63671f1d-4508-428f-8d2c-3f1d4b1545b7"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzQtMS0xLTEtNzM1MzU_0c1c8678-da53-440e-98a7-6480d38e3c3b"
      unitRef="usd">187000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzQtMy0xLTEtNzM1MzU_0d257c30-f607-4a4e-85e7-3c0fd23f5474"
      unitRef="usd">174000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzQtNS0xLTEtNzM1MzU_a493afac-8fa3-4567-8bc2-ef321cb95844"
      unitRef="usd">188000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzUtMS0xLTEtNzM1MzU_a864cc08-eb8e-484f-8f4a-8b71d833d06e"
      unitRef="usd">-15000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzUtMy0xLTEtNzM1MzU_a8ccdafc-4429-439f-8be9-96d207c63dde"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzUtNS0xLTEtNzM1MzU_90019ddc-76f8-4904-a774-36a5788813e3"
      unitRef="usd">-13000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzYtMS0xLTEtNzM1MzU_455f8294-c0b0-4434-ba29-fd27b42a0f5d"
      unitRef="usd">-61000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzYtMy0xLTEtNzM1MzU_6e572237-ca04-4804-8a7a-051ff2c589b5"
      unitRef="usd">-97000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzYtNS0xLTEtNzM1MzU_48f2de81-aaac-478e-b751-228d40ef13eb"
      unitRef="usd">-97000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzctMS0xLTEtNzM1MzU_fcaf9072-81ac-4c25-aebc-fc0e622af865"
      unitRef="usd">-73000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzctMy0xLTEtNzM1MzU_5713ecab-3903-47cb-9b7b-5c9ea083e2fa"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzctNS0xLTEtNzM1MzU_69c828eb-1c37-42c9-a42a-4ad435c9f9af"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzgtMS0xLTEtNzM1MzU_a628eeb5-6a85-4174-b63a-6832fadea2c7"
      unitRef="usd">143000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzgtMy0xLTEtNzM1MzU_3437c09f-77e1-46a8-877d-7aa48671f643"
      unitRef="usd">137000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i9775a4289064401ca21e97353fb8e0c4_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzgtNS0xLTEtNzM1MzU_b9f41fae-8da3-4282-8bb5-e578fe7ec604"
      unitRef="usd">137000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzEwLTEtMS0xLTczNTM1_dc455733-aaf0-433c-962f-6f9850b783e9"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzEwLTMtMS0xLTczNTM1_85ebe404-2b55-4bbd-b3d8-a79748bd1d60"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozNjY5ZjYwZWZhMzc0MDdiYjlmM2JhMDUwOTEyODQ0My90YWJsZXJhbmdlOjM2NjlmNjBlZmEzNzQwN2JiOWYzYmEwNTA5MTI4NDQzXzEwLTUtMS0xLTczNTM1_2cdb2a76-e16b-492a-8ea4-7718ab1963c8"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfNetFundedStatusTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNjk4_be76c1bf-6959-4e0b-a092-cca9303c64dd">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation, change in fair value of pension plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of Embecta spin-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailments/settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, includes translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in fair value of plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of Embecta spin-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, includes translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded Status at September&#160;30:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unfunded benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized in the Consolidated Balance&lt;br/&gt;Sheets at September&#160;30:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries, wages and related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term Employee Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized in Accumulated other&lt;br/&gt;comprehensive income (loss) before income taxes at September&#160;30:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMtMS0xLTEtNzM1MzU_b6747c11-6628-4c18-a0cf-c7b1544a23c5"
      unitRef="usd">3889000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1f6fba700db34620b0019217a8d9bd97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMtMy0xLTEtNzM1MzU_dbebb74a-876c-4ae2-a1d0-91125c8d693f"
      unitRef="usd">3953000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzQtMS0xLTEtNzM1MzU_d86f0b80-7645-4616-901b-ce60c29ab7ec"
      unitRef="usd">134000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzQtMy0xLTEtNzM1MzU_d88cfe89-e33b-40cc-886c-c81310554dd0"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzUtMS0xLTEtNzM1MzU_0fa84920-4494-4b20-84ee-cdb62d13936c"
      unitRef="usd">77000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzUtMy0xLTEtNzM1MzU_b03e8d2d-11f5-4b81-9e26-e7bd8b8e7170"
      unitRef="usd">71000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzYtMS0xLTEtNzM1MzU_554ad3df-2c01-4f38-99f0-5eaec4e46c99"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzYtMy0xLTEtNzM1MzU_7e647c59-4319-4f55-8bfe-5dfcac4e67a5"
      unitRef="usd">-30000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzctMS0xLTEtNzM1MzU_4ae954ed-ba2c-4495-9f76-1659f15c95d7"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzctMy0xLTEtNzM1MzU_7bd028d3-fa43-412e-8a16-1a6cdc82fd4b"
      unitRef="usd">156000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <bdx:DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzgtMS0xLTEtNzM1MzU_079ce041-3747-412d-9df9-94f132dd530d"
      unitRef="usd">7000000</bdx:DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation>
    <bdx:DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzgtMy0xLTEtNzM1MzU_6274488d-2703-4ee1-b84b-703196f9c145"
      unitRef="usd">0</bdx:DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzktMS0xLTEtNzM1MzU_6c2bc9b9-1e55-459a-a12a-86a586284bb9"
      unitRef="usd">1007000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzktMy0xLTEtNzM1MzU_db995a65-2ea1-4c6e-a287-a38564f51475"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <bdx:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEwLTEtMS0xLTczNTM1_4e6d227f-ffc1-40a0-86ee-8fdc9e3c7b40"
      unitRef="usd">246000000</bdx:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEwLTMtMS0xLTczNTM1_c880be59-c811-4999-9e45-426b8570e57b"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanOtherChanges
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzExLTEtMS0xLTczNTM1_faef3212-495c-4e24-a6aa-1f6226d7e89f"
      unitRef="usd">-143000000</us-gaap:DefinedBenefitPlanOtherChanges>
    <us-gaap:DefinedBenefitPlanOtherChanges
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzExLTMtMS0xLTczNTM1_5907f507-af94-41d5-98df-7b765f84031d"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanOtherChanges>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEyLTEtMS0xLTczNTM1_17b38a55-c483-419b-9089-e214daa5e8a7"
      unitRef="usd">2634000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzEyLTMtMS0xLTczNTM1_658109e9-6faa-461b-befb-67774e2af851"
      unitRef="usd">3889000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE0LTEtMS0xLTczNTM1_eb72978b-9632-4a38-a81d-aef489f36077"
      unitRef="usd">3222000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f6fba700db34620b0019217a8d9bd97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE0LTMtMS0xLTczNTM1_bad6dca4-634c-4a24-892e-8389e7a36510"
      unitRef="usd">3045000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE1LTEtMS0xLTczNTM1_477dea7e-f356-4c7e-b410-86a10b6d3523"
      unitRef="usd">-740000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE1LTMtMS0xLTczNTM1_aa2addc7-c004-433a-a336-e6bd09114781"
      unitRef="usd">317000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE2LTEtMS0xLTczNTM1_4d69ebd6-74e8-4920-8018-afa8ac6f2e26"
      unitRef="usd">198000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE2LTMtMS0xLTczNTM1_f65cf02b-4b6b-471a-a6b8-17448afc1ef3"
      unitRef="usd">66000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE3LTEtMS0xLTczNTM1_ae6424d7-c464-4aca-8681-831065610fa9"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE3LTMtMS0xLTczNTM1_7602dcd6-c6db-4e9f-b3eb-42aa7b537d04"
      unitRef="usd">156000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <bdx:DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE4LTEtMS0xLTczNTM1_ff50151f-580f-417a-9a2c-65d800995a62"
      unitRef="usd">-6000000</bdx:DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets>
    <bdx:DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE4LTMtMS0xLTczNTM1_47c2e7e8-2faf-4209-bd65-716058023c0e"
      unitRef="usd">0</bdx:DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE5LTEtMS0xLTczNTM1_9c9b9d06-147d-41af-a639-30f78fa4ee9d"
      unitRef="usd">241000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzE5LTMtMS0xLTczNTM1_dd785f3d-46bb-4a3f-84e1-73056b762715"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIwLTEtMS0xLTczNTM1_52f746c0-428d-490c-9931-7ab9ae6bce02"
      unitRef="usd">-127000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ie84ffb63ff3e45bb99fdfa7191f7abad_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIwLTMtMS0xLTczNTM1_f27cb4f1-7285-479d-a958-638949d412b0"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIxLTEtMS0xLTczNTM1_7cd88371-5ea9-4cef-a1ef-40e26a328bf5"
      unitRef="usd">2242000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIxLTMtMS0xLTczNTM1_bc8b7b7a-bf3e-43d7-bb1f-7df3e3f283dd"
      unitRef="usd">3222000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIzLTEtMS0xLTczNTM1_c12905d3-f60c-4a9e-9dae-f14aa849506d"
      unitRef="usd">-392000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzIzLTMtMS0xLTczNTM1_ad0e05f3-8ff7-4dcd-ab91-1aa14fb1c223"
      unitRef="usd">-667000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI1LTEtMS0xLTczNTM1_b265ac69-5cee-4d1e-a923-0541bac99c9a"
      unitRef="usd">70000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI1LTMtMS0xLTczNTM1_6ac21028-fa26-4230-bb2d-2cc1ac3bcc71"
      unitRef="usd">29000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI2LTEtMS0xLTczNTM1_1ebad84f-8456-42db-a820-12c49d99ed6f"
      unitRef="usd">15000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI2LTMtMS0xLTczNTM1_096597bd-7e02-4ceb-b7e3-a8b75918d0a8"
      unitRef="usd">29000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI3LTEtMS0xLTczNTM1_8047a30d-776d-45bb-bf89-dee0aaeb4fc2"
      unitRef="usd">447000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI3LTMtMS0xLTczNTM1_3464a433-5bde-4ac9-94ef-10278b0f465c"
      unitRef="usd">667000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI4LTEtMS0xLTczNTM1_b927bd2b-9803-4ea7-979b-9b6478531393"
      unitRef="usd">-392000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzI4LTMtMS0xLTczNTM1_14245e37-54c9-4cd3-9325-9418c4dacd3f"
      unitRef="usd">-667000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMxLTEtMS0xLTczNTM1_d9df7bcc-d6ed-4e01-a381-43a36fe4a01d"
      unitRef="usd">-24000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMxLTMtMS0xLTczNTM1_c58c2bc0-6a2a-4abe-a286-e11a34b1bcbb"
      unitRef="usd">-41000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMyLTEtMS0xLTczNTM1_6c03c108-ea42-4e78-b16a-8031e6bcb5ff"
      unitRef="usd">-728000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMyLTMtMS0xLTczNTM1_4dca8f32-4857-4240-8c2b-91c5de4263e6"
      unitRef="usd">-972000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMzLTEtMS0xLTczNTM1_79aa1140-0575-405a-8e57-c1153fa14a88"
      unitRef="usd">704000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i779f01d1bdf44e59a10a0b1546c8a526_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZToxNGNkOWYzNWY3OWQ0NDdlYWUxMzMzOTJiNDFhMTA5YS90YWJsZXJhbmdlOjE0Y2Q5ZjM1Zjc5ZDQ0N2VhZTEzMzM5MmI0MWExMDlhXzMzLTMtMS0xLTczNTM1_aa880a0e-9f38-4bc8-ae2a-4e6f2a5bc15c"
      unitRef="usd">931000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI0MDU_fb4057b5-4f30-4f2f-90ee-37e46b6f9949"
      unitRef="usd">705000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI0MTI_29613373-9809-405a-b1f7-40b123296314"
      unitRef="usd">1033000000.000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI1MTA_de889454-a4d8-46ad-a337-3b14c471d6cb"
      unitRef="usd">772000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI1MTc_fb01c205-6e49-462f-96d7-ee7b76b13950"
      unitRef="usd">1320000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i61da2eb734a14d15a43cbf10837c8938_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI3NTU_eb0e244a-809d-4a5d-8161-f2d1cdbdc42a"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8eca0f828ddd427091f4d296a8e807d2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzI3NjI_78bbdbce-d872-4e44-b384-1f6edcdfb4cc"
      unitRef="usd">138000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzI4_162df7cd-06e0-4566-b5e7-13069b6cccae">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&#160;Benefit&lt;br/&gt;Obligation&#160;Exceeds&#160;the&lt;br/&gt;Fair&#160;Value&#160;of&#160;Plan&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Projected&#160;Benefit&lt;br/&gt;Obligation&#160;Exceeds&#160;the&lt;br/&gt;Fair&#160;Value&#160;of&#160;Plan&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItMS0xLTEtMTMxMjQ1_b65eacfb-213a-4e06-acfe-2d734242ce60"
      unitRef="usd">2104000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItMy0xLTEtMTMxMjQ3_53061d49-13ab-494b-bcd7-22c44afe6376"
      unitRef="usd">3406000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItNS0xLTEtNzM1MzU_4e149d61-7c2c-407f-a297-524fc5216ea6"
      unitRef="usd">2182000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzItNy0xLTEtNzM1MzU_bc5f3651-cff0-4a26-bd88-3e9a34f7bd2b"
      unitRef="usd">3475000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzMtMS0xLTEtNzM1MzU_5a1640dc-4921-415c-bc72-e2dba7ba6873"
      unitRef="usd">2059000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzMtMy0xLTEtNzM1MzU_51579041-3c89-40f3-bad6-d3b581ee06ce"
      unitRef="usd">3309000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtMS0xLTEtNzM1MzU_bd0632ed-edce-42c7-a9eb-8a4cc29d764f"
      unitRef="usd">1644000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtMy0xLTEtNzM1MzU_a89d7189-e74a-4b00-9bf6-32290c2524ef"
      unitRef="usd">2712000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtNS0xLTEtNzM1MzU_d0f2d1d9-3c4a-4016-9457-db1a7d635248"
      unitRef="usd">1720000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTplOGU5MjRkNzI1MTg0MTU4YmFjNTc5ZjYyNTQ4MmNiZi90YWJsZXJhbmdlOmU4ZTkyNGQ3MjUxODQxNThiYWM1NzlmNjI1NDgyY2JmXzQtNy0xLTEtNzM1MzU_d51e20c7-2130-438b-8212-3627d3501f0f"
      unitRef="usd">2780000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzMw_07832738-493d-4ba5-87ae-edf37ca35d79">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average assumptions used in determining pension plan information were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash balance plan interest crediting rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash balance plan interest crediting rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International plans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The Company calculated the service and interest components utilizing an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzMtMS0xLTEtNzM1MzU_3f810900-c2a4-4534-ab8c-98ce860f54fc"
      unitRef="number">0.0289</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzMtMy0xLTEtNzM1MzU_f0c775e0-a2fd-41a2-9bf5-fa6a2246254f"
      unitRef="number">0.0280</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzMtNS0xLTEtNzM1MzU_78f3fc2e-0f3c-4cff-aeb1-ad03e9df1b34"
      unitRef="number">0.0321</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzQtMS0xLTEtNzM1MzU_b9216138-501e-46dd-b417-4f2a11fd7783"
      unitRef="number">0.0175</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzQtMy0xLTEtNzM1MzU_8c7c4e3a-4c44-4427-a82a-cac12e7982de"
      unitRef="number">0.0144</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzQtNS0xLTEtNzM1MzU_c7591cc9-0370-4bf3-a024-765f010f1e06"
      unitRef="number">0.0139</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzYtMS0xLTEtNzM1MzU_1a6563cf-5605-4d07-9e56-e8b3f2362d83"
      unitRef="number">0.0625</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzYtMy0xLTEtNzM1MzU_b7f19975-1b5c-41fe-b141-28670a11efda"
      unitRef="number">0.0625</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzYtNS0xLTEtNzM1MzU_73871270-f190-4aa0-9d37-0d1cf1e5f2ae"
      unitRef="number">0.0725</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzctMS0xLTEtNzM1MzU_8f7932aa-77a7-4ccf-9218-532c9a9ee05d"
      unitRef="number">0.0484</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzctMy0xLTEtNzM1MzU_5eae6030-e359-47d2-b0df-b4048e7f237e"
      unitRef="number">0.0492</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzctNS0xLTEtNzM1MzU_c661e937-23a4-4b79-b305-978463eaf9a9"
      unitRef="number">0.0505</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzktMS0xLTEtNzM1MzU_261658d5-383e-4596-913e-de96453c94fe"
      unitRef="number">0.0431</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzktMy0xLTEtNzM1MzU_afc08e37-ed89-47ed-bfe5-d05fddff3766"
      unitRef="number">0.0430</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzktNS0xLTEtNzM1MzU_2e633b70-0c8f-4e2f-ad0f-cb866467b540"
      unitRef="number">0.0429</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEwLTEtMS0xLTczNTM1_d3ae365a-7ae0-4c27-a9ae-d54fa124ea26"
      unitRef="number">0.0263</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEwLTMtMS0xLTczNTM1_9ef71765-ace7-4cc2-ace0-08985c64b701"
      unitRef="number">0.0220</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEwLTUtMS0xLTczNTM1_1fc5d6dc-7154-4e59-886e-84bfe5b24b7f"
      unitRef="number">0.0235</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEyLTEtMS0xLTczNTM1_386c7ddd-7787-435d-8d58-cfa41b3d256f"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i9e3a40fe7eb64ead963306e1748e9958_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEyLTMtMS0xLTczNTM1_9fe83706-6af6-4ee9-8a91-33f9f76464b8"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i5115a5439bee4b7f9103cb5a5966d1e1_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEyLTUtMS0xLTczNTM1_40053ff7-5c55-4f21-8ef0-0546f5d16a68"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="id7d8bd2a90d545499de0fc990364d136_D20211001-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEzLTEtMS0xLTczNTM1_1697d93b-2f31-4abd-9ba3-6d92a44f0a62"
      unitRef="number">0.0202</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i8fbc33bf854742cfa47f320f0420b08f_D20201001-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEzLTMtMS0xLTczNTM1_3dfa42b8-83bd-4306-b89f-24dd19085653"
      unitRef="number">0.0195</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="idabebc2d467345c1b2e4309a2839347c_D20191001-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzEzLTUtMS0xLTczNTM1_7c88b5eb-b7b9-4baf-b248-2fd045dcccf0"
      unitRef="number">0.0197</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i53f9080405314d2e819b92e79feeced8_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE2LTEtMS0xLTczNTM1_1864fd33-731e-4fc9-8977-8a326cb3250b"
      unitRef="number">0.0562</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE2LTMtMS0xLTczNTM1_21249f31-e922-4c10-af0f-52dbd7b1d3bf"
      unitRef="number">0.0289</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE2LTUtMS0xLTczNTM1_0c5c81d3-8066-4f50-996c-b17d603a7ac9"
      unitRef="number">0.0280</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE3LTEtMS0xLTczNTM1_fbb91eae-1835-43a0-902c-a43f9337e023"
      unitRef="number">0.0426</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE3LTMtMS0xLTczNTM1_1de40278-d425-41e6-a9d9-6914bb8e15bd"
      unitRef="number">0.0175</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i5e39bf2e8f1844b993cce4161a84bbff_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE3LTUtMS0xLTczNTM1_8daa0f1a-5b7d-4262-835e-040c6ad35842"
      unitRef="number">0.0144</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i53f9080405314d2e819b92e79feeced8_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE5LTEtMS0xLTczNTM1_a8ad9e49-48a0-4c36-8bde-c946ca0c1d24"
      unitRef="number">0.0451</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE5LTMtMS0xLTczNTM1_715b8681-2699-47f5-ac35-b5c4201b60dd"
      unitRef="number">0.0431</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzE5LTUtMS0xLTczNTM1_bd4296f2-5867-430f-b378-fce84586b406"
      unitRef="number">0.0430</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIwLTEtMS0xLTczNTM1_a3c530bb-4e10-49fc-94e0-cc93554591a4"
      unitRef="number">0.0286</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIwLTMtMS0xLTczNTM1_8cce196c-fdc7-4257-a8fa-0e203c991715"
      unitRef="number">0.0263</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i5e39bf2e8f1844b993cce4161a84bbff_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIwLTUtMS0xLTczNTM1_17144f2e-0a29-4ef4-a825-7ccbb7d18f19"
      unitRef="number">0.0220</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate
      contextRef="i53f9080405314d2e819b92e79feeced8_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIyLTEtMS0xLTczNTM1_0895d97f-e44c-435c-b28b-125332c99816"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate
      contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIyLTMtMS0xLTczNTM1_514c25a6-e745-48b6-a2ff-489aa29f8254"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate
      contextRef="i75b3d6ceb1fb4599a8b5f4d22ea677de_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIyLTUtMS0xLTczNTM1_8eae5ad9-2992-47f4-9f3d-76abbe998b96"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIzLTEtMS0xLTczNTM1_d8a012db-71d1-4f61-bc91-22d45c2e136e"
      unitRef="number">0.0198</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate
      contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIzLTMtMS0xLTczNTM1_86e07997-43f3-4447-b5c8-69cc5a1100fb"
      unitRef="number">0.0202</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate
      contextRef="i5e39bf2e8f1844b993cce4161a84bbff_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTozMmI1ZDdmNzY5Mzk0YTVjODMxNjY4OTM3MDAyYWQ2MS90YWJsZXJhbmdlOjMyYjVkN2Y3NjkzOTRhNWM4MzE2Njg5MzcwMDJhZDYxXzIzLTUtMS0xLTczNTM1_8c20cab3-23c1-4be2-9ca3-4508c4d49122"
      unitRef="number">0.0195</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzQxNjg_659d8896-0f10-4096-8f8d-48f6d5085385"
      unitRef="usd">134000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzA5_96164cf3-1f36-4693-baa3-3f4467c1c4d6">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzEtMS0xLTEtNzM1MzU_888c735d-0e23-4797-afb6-b6da34e78255"
      unitRef="usd">317000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzItMS0xLTEtNzM1MzU_ced62cb0-7ad6-4607-a2b6-0c9e96481dd9"
      unitRef="usd">153000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzMtMS0xLTEtNzM1MzU_a0143463-2eed-4714-b7d2-247fb2b6998f"
      unitRef="usd">158000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzQtMS0xLTEtNzM1MzU_7160934d-24f0-42e4-bd1b-5e1f8ff875be"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzUtMS0xLTEtNzM1MzU_aed0314e-0679-49e3-af21-416eeb7fd562"
      unitRef="usd">171000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo3MzI3YjZkNzUzZTQ0ZWJhOGE3MGY2ZThlM2ZlYmU5Ni90YWJsZXJhbmdlOjczMjdiNmQ3NTNlNDRlYmE4YTcwZjZlOGUzZmViZTk2XzYtMS0xLTEtNzM1MzU_91ae805f-7219-4af9-a547-810f086b91af"
      unitRef="usd">945000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <bdx:PercentOfAssetsDomesticPlans
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzQ5OTA_27a96b24-586e-4ad6-8b25-243391bc2f91"
      unitRef="number">0.69</bdx:PercentOfAssetsDomesticPlans>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i85a5bc5228934abba8c145aa315e0721_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzUwODY_d1932588-ffaf-4020-9239-2e13f1372a89"
      unitRef="number">0.45</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i79c926c9a5c9445eb3a6bf1d48ed24dd_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzUxMDM_5c8e17e3-0fac-47e0-b616-2e433b1a58aa"
      unitRef="number">0.21</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i582bf51e2db142748e01d1a6c1978b1e_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzUxMzU_ed3781e5-6629-4df6-835b-f0289659e5ec"
      unitRef="number">0.34</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNjk5_5e51ab06-b494-4fc9-bae4-3f54b9bdf6b4">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021. The categorization of fund investments is based upon the categorization of these funds&#x2019; underlying assets.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement (See Note 1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total U.S.&lt;br/&gt;Plan Asset&lt;br/&gt;Balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;As per applicable disclosure requirements, certain investments that were measured at net asset value per share or its equivalent have not been categorized within the fair value hierarchy.  Values of such assets are based on the corroborated net asset value provided by the fund administrator.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i239cacefc1034e98bffbb2d59ac35059_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMS0xLTEtNzM1MzU_873f95e2-64de-468d-98e3-c814184a39c3"
      unitRef="usd">492000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6210559eed0744c68524b1092620ea9b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMy0xLTEtNzM1MzU_5be2c3fa-455e-4ac8-8c26-24a3e846ef89"
      unitRef="usd">679000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie4c7d62af45d419593ad86b92e3629e7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtNS0xLTEtNzM1MzU_7ba82d57-b514-476e-8648-5f307e6105e4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9a3bd23935f48b7a00e226a1a8352d6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtNy0xLTEtNzM1MzU_5430927b-021e-4d7c-9e24-81eaaa30d808"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia338360d4785452caa35968390747a10_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtOS0xLTEtNzM1MzU_0be654ef-5235-465f-adc0-9eaa03ccf7b8"
      unitRef="usd">258000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i73449f7073ff4ea4b40ee726a2e5769c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTEtMS0xLTczNTM1_f0e999c6-cc71-44c6-bbe4-50dafa3ff4a4"
      unitRef="usd">297000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7a3349146ec64e71add05da653f9c92a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTMtMS0xLTczNTM1_727d714f-6a9e-4350-ae5d-8587822f75ea"
      unitRef="usd">234000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f4fd5eb5f494b16af19555193bf5090_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTUtMS0xLTczNTM1_12ca041d-8107-423b-9d7c-495f98d7f1f7"
      unitRef="usd">382000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7cb9c8a5a3d44e929e8cda49c3e35a5d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTctMS0xLTczNTM1_a3583598-9ceb-4736-b0dd-d30b6448f3e1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifa7674e8eddd403f9b0b11baa9aca925_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzUtMTktMS0xLTczNTM1_3681f415-638f-4aa1-83af-b02f7464ea06"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia6dfbd58f525441b9ab54c2dea102ed7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMS0xLTEtNzM1MzU_91a6acdc-e364-4d5e-894e-cb51a3652304"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iecbe41070dc14cd6a796c56f4121218b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMy0xLTEtNzM1MzU_4825c1e8-337d-4c43-b710-f6cfb4c2acc2"
      unitRef="usd">184000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6780e627c7f4ad7a05cef6b81219d95_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtNS0xLTEtNzM1MzU_af6017c1-21fe-45f6-bf8c-19c81a3acf6e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i973ba4ea52044ec7867cce4732e8a723_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtNy0xLTEtNzM1MzU_139e66fe-0d82-44e6-8547-4447aab92a75"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f1806f061cb417cace44cee66ae6850_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtOS0xLTEtNzM1MzU_dfeabd16-c16c-436f-babb-5bf7c203b5e8"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if56a1e5bf0a745c08a12f76dc30bd149_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTEtMS0xLTczNTM1_1f013990-44af-417b-9352-f3e2a018017a"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idd94643846d24bf3b6f8c33987fc6390_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTMtMS0xLTczNTM1_ef5e27e7-2e71-4ec8-9098-594ad235545b"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i673ea0978cf446da9469a52c417caebb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTUtMS0xLTczNTM1_cb982a46-8a5b-48a8-8288-9404662840c4"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia149edac1bcb40f2af757eed837bd3b9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTctMS0xLTczNTM1_1ecaf50a-53b4-43df-abaf-05efd89fc7ed"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba651878aa3c4951be900f73b0631b94_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzYtMTktMS0xLTczNTM1_ca7a9311-d72b-4216-a2e6-cd41a5a6865c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iae4848b2eb0143ee85a0d7c2d47b4988_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMS0xLTEtNzM1MzU_97fed894-0413-41b7-bb6f-92e99aece15f"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic5d9bb16f4d74508bc6dbaf0a2455b14_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMy0xLTEtNzM1MzU_cc06f004-c9ce-4ac5-b753-a0592f1cf8d8"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib3c3151253d64e2d96bee25ce449a710_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctNS0xLTEtNzM1MzU_b69d8fe3-7b0b-4901-8481-b67721eeefc3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i719813f3bd404e79b168659b6c3aa573_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctNy0xLTEtNzM1MzU_e8fea6f6-ee53-4cc8-9cb7-f64ece88b90e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1efe0d2e80664df283e57a2eb36423d4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctOS0xLTEtNzM1MzU_7fee239b-38b8-4968-ad46-25c7f19934bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6bb763598f346d88eb4b80147200d91_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTEtMS0xLTczNTM1_fb358b2b-6ec9-459d-9ace-c443174c82be"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2b9f12bdbc124812844603fbd09891ed_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTMtMS0xLTczNTM1_556f64c1-835a-44cd-b5bd-54597af92115"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i455fc00619a649a694accccb414c0a84_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTUtMS0xLTczNTM1_8eadef85-b2a5-472e-bfed-808acb510ee2"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3d921cd67c5a4c2eb5567320f4476c60_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTctMS0xLTczNTM1_40e71335-51bf-4a9b-bd67-4f00eaab446a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6535e7d25cd749aa8937a2539be0e13f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzctMTktMS0xLTczNTM1_56c9b3c0-8aa7-4f6e-ad4f-415503ff66ba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6fb2f87afa95408a8c56d4a9cd130b30_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMS0xLTEtNzM1MzU_68fc0813-36fb-43ae-91ee-5c92ed5a10f9"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i27cde783e1a94eea98b321d147b8ec5f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMy0xLTEtNzM1MzU_f5540c05-8e6b-4937-938e-611485068587"
      unitRef="usd">141000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4291d87672cd4a8981f4a360a1a9cab7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtNS0xLTEtNzM1MzU_439b9ffe-0af3-4fde-bff2-e23d3727ca5f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie3c8f69ef20e449fa397139f39242dee_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtNy0xLTEtNzM1MzU_a457571d-1106-4dff-869b-fe115cf67b38"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib0e5c0cdc22a4b0e8ba6a3fb3f6e98c5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtOS0xLTEtNzM1MzU_5420d966-eb5b-457e-9d02-af514b827b6d"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8407f1e21df94016a5bb2c0aedad66ae_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTEtMS0xLTczNTM1_e0e89188-6d5d-489e-8577-0cb59ac9e164"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i667449f6ee774b11a6b45b97aab6b6b3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTMtMS0xLTczNTM1_4381471e-0c58-470f-8538-73df8a45621e"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i14c2adc69ec24c689ad7bfe5695d5c71_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTUtMS0xLTczNTM1_22726436-052e-4d0d-a67b-6239e40637f2"
      unitRef="usd">141000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i036c7ba8e62a4a75a8b86e314ed59903_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTctMS0xLTczNTM1_458fab68-8005-4f9e-ae25-2f9fea8ca4da"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1d858f56b814ba1b31e8997945e8cdb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzgtMTktMS0xLTczNTM1_13da3739-6c4c-4f4e-8f4e-7abff4135d1d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibfc3d5d859364765991baf5fbdaaf07d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMS0xLTEtNzM1MzU_030e3da0-5658-4295-b2b6-fef72a64aa2c"
      unitRef="usd">469000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i273c42bd2bf74bef9f62c4b634918468_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMy0xLTEtNzM1MzU_aa0c142d-058b-4b17-93e5-8ec6aa6dbd61"
      unitRef="usd">686000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i014f9d02b0cb4bbe8c31fc0740a83fc0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktNS0xLTEtNzM1MzU_8d113be4-93a6-4b11-beea-a4f648bbdff7"
      unitRef="usd">62000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic16f46d749384f4e91a03d0dc970acd5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktNy0xLTEtNzM1MzU_3b61cfbd-e6b6-4ccc-925d-8ece3b40c7e7"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib0ad93bd71254bd594fee877344663f1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktOS0xLTEtNzM1MzU_80b2ee00-7913-49ae-a7e3-a865fb624b5b"
      unitRef="usd">406000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2764df47883b467ba943ad7a7c3151c6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTEtMS0xLTczNTM1_391170dc-ca88-4503-866e-69f3946382ab"
      unitRef="usd">643000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i08b479cb794b4b389dd8f0417d748da4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTMtMS0xLTczNTM1_e2353292-b947-4597-a356-e7a15f8ea5fb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i82d4bc96a4b642139265cbec59eef4cb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTUtMS0xLTczNTM1_fe58acc4-9439-4910-8fe4-6bf481284dcb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie85e1a6e235d47cdbf1b177b7f97c4af_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTctMS0xLTczNTM1_fb6203ad-2e48-4523-83e0-9d2d9e4bd861"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i81c0de9d4d0e4fae8c6fc8ec55fd02b0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzktMTktMS0xLTczNTM1_36437ef0-620c-489c-bc37-e514b26f4a0e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i75b3ba666c714449895f2c46717ad2d3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTEtMS0xLTczNTM1_397fa244-d90d-443b-9bdf-611662b9f731"
      unitRef="usd">243000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id58ed1b77b8640d0b897e7b00007953f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTMtMS0xLTczNTM1_af7d8b21-d8c1-4f25-a44b-9bb4a4a3a000"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0333656249994d2e8cb26e6f79d7e84d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTUtMS0xLTczNTM1_f72b6998-6d89-4aa9-94a4-b04ae1b431f2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4cfd65d075cf414585bf6fc6b7f9c5b0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTctMS0xLTczNTM1_b9b59950-24af-4922-9a6c-5fe8c594893a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibce10790ce4c4090abab20b16d6ee85f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTktMS0xLTczNTM1_47c32f22-e185-47ab-944c-bbf7046513bc"
      unitRef="usd">243000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7e3a877768014f80bca7f2823c09c2fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTExLTEtMS03MzUzNQ_da72caab-c042-493c-abcd-e16f042ad2e7"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9e30739c488347d5afed7d7c698d4c16_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTEzLTEtMS03MzUzNQ_0ea000b7-2bc9-4f24-a34e-a0fcf51e30c5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2705f413b5fa4853aa0711dca58567d1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTE1LTEtMS03MzUzNQ_d23a9acc-c952-4e36-af7c-4e154c76b6a0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5a14e8e06e8e4781bb2fc8daf0319362_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTE3LTEtMS03MzUzNQ_e6e17b18-c9f1-4b57-916a-feca64e7ab5b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia616e09bfcf3438ca18d99c58fbeb7de_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEwLTE5LTEtMS03MzUzNQ_16bd4acd-5fab-4199-ad23-e5e6545733ec"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7cac4e61a856422aa1854bbcaadf4fd6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTEtMS0xLTczNTM1_18396aa1-b87e-4932-a708-abdd4477c54c"
      unitRef="usd">191000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic923216224064e2989e7625f0081c9a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTMtMS0xLTczNTM1_be6dbabf-2676-4a94-a3de-4889c8cb318f"
      unitRef="usd">286000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib37ee945ff0c49afa819e5fd6c33170a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTUtMS0xLTczNTM1_9aa4c76f-da55-4920-8ad7-a2b4605c19ba"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8db92b9a655f421789d5d94454ef800c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTctMS0xLTczNTM1_17efdbb6-4d18-4099-932f-36164b5bc2d8"
      unitRef="usd">152000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaf30a237339b4595ae6d08ec2d172296_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTktMS0xLTczNTM1_a8cad310-043d-4d65-bc1d-9f5fa4fcb66e"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibf8adc411abc471c8fab1c8a0b21f5ed_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTExLTEtMS03MzUzNQ_f8887c8d-fda7-4aff-b0a0-0dea7fac4a6e"
      unitRef="usd">135000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i444540566d5f4120ba0a990210e5f64d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTEzLTEtMS03MzUzNQ_a55d9102-cd0f-48a4-b199-7101d6677260"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibafc5baf0e3d4db98950714ff7bbaccd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTE1LTEtMS03MzUzNQ_427f8569-f3d2-49c3-a8bd-ce4f5097b0ee"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24356b45f51845f99b3c235579c7c492_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTE3LTEtMS03MzUzNQ_82b8252c-5a3b-4782-9c2d-4af08b2bf953"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i36e04951f0304cc297da29bf9cb5603f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzExLTE5LTEtMS03MzUzNQ_481244cb-3c69-4b27-9b7e-02efec31842c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i53f9080405314d2e819b92e79feeced8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTEtMS0xLTczNTM1_fda2b27b-1dd3-41db-a670-383030af7f06"
      unitRef="usd">1537000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifdb88817d6194a5599afdee43da767bf_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTMtMS0xLTczNTM1_92305139-648c-4172-a1cf-abfde0a8e101"
      unitRef="usd">2189000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i35528802fb404e6bbcbb6b97543f94ef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTUtMS0xLTczNTM1_a5a29cb5-5840-4a5a-801c-a7790605cab8"
      unitRef="usd">172000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8598d43c36df40e0aa15aa3578b1c46e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTctMS0xLTczNTM1_f3a4d587-f2a5-4a23-aaad-8a7269950b57"
      unitRef="usd">195000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if1bc9fbebdd24e2688fede6c4875c0bb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTktMS0xLTczNTM1_e5e21804-8aa2-40aa-b468-ac0849d7c1a0"
      unitRef="usd">1068000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5291e425d6544e199671d3329659b30f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTExLTEtMS03MzUzNQ_630a79af-0756-413d-9653-a1f94ec629fa"
      unitRef="usd">1405000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i73098c61ad6b497e9b56e6e64edc8560_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTEzLTEtMS03MzUzNQ_d22de54d-4004-4f4f-ba7e-0013d77a437b"
      unitRef="usd">297000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f2ac9dc44f64a518a26cb809ccb8ba3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTE1LTEtMS03MzUzNQ_1b68f7aa-77d5-4178-b129-b6d1e8819cb7"
      unitRef="usd">590000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i04064a31b8074c7cbf784060b303d4db_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTE3LTEtMS03MzUzNQ_e3b541f4-8ebc-42c1-adf3-2d4280cf584d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie92c7234473544eebb1751ee0a1eabc0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo5NTgwM2M0MWE4ZTc0ZDBhOTdmNDVhN2U3ODAwZjdjMy90YWJsZXJhbmdlOjk1ODAzYzQxYThlNzRkMGE5N2Y0NWE3ZTc4MDBmN2MzXzEyLTE5LTEtMS03MzUzNQ_9cc9d630-41d2-4710-8dda-9fbe499eba41"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <bdx:PercentOfPlanAssetsForeignPlans
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzk3NTA_573dfb76-9da0-4e95-a423-1da3dae4c64d"
      unitRef="number">0.31</bdx:PercentOfPlanAssetsForeignPlans>
    <bdx:ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNzAx_b5367e23-402c-499c-b481-90105ee6f3cd">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the fair value measurements of international plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.013%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement (See Note 1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;International&lt;br/&gt;Plan Asset&lt;br/&gt;Balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3 (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government and agency-Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other fixed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Changes in the fair value of international pension assets measured using Level 3 inputs for the years ended September&#160;30, 2022 and 2021 were immaterial.&lt;/span&gt;</bdx:ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2c0a623813ee4a369e7ef5993fdb798f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMS0xLTEtNzM1MzU_e84dcfc4-872b-4877-9302-805b6fd1ed4e"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i93d9e0ee20514594b6508a2572ce4abd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMy0xLTEtNzM1MzU_027935e6-c931-44a3-b27c-6fc33c19bce4"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28aae561f41544a7804bc0b0cb92a718_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtOS0xLTEtNzM1MzU_54873a3b-1ca5-4cff-9e69-877aec8c558a"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i70be1a5baac547589f9472c81e2340e1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTEtMS0xLTczNTM1_2daea339-b272-42a5-b4c9-b72f8cc7bb3b"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie45261a2b5664434b82d1b3f8454fa79_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTMtMS0xLTczNTM1_cc7cd55e-02eb-47d8-b9b9-ebb47840672a"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7cfc59ab57674136bbe1362cca826076_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTUtMS0xLTczNTM1_cf67904e-a6fa-43b1-8e6b-89b2e9faabae"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic3fc09f7eb6045808fa6cfccba5222f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTctMS0xLTczNTM1_97b3490c-511c-40ee-9a05-56f9cdcda39a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8fde7c7c7d5e4fbe8a6182d7ed99551a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzQtMTktMS0xLTczNTM1_74d65981-b5ee-45d7-9f0d-e23f27f37ade"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i48a14466de2744d68148b941f153e261_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMS0xLTEtNzM1MzU_9cfa2757-c628-4122-9ed2-14f4b741a9d0"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i94f673aa33144145a0153caf0934a902_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMy0xLTEtNzM1MzU_a542a553-fdef-49d7-a343-9b55438c784c"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i47af4c545a444e8795cd4b3e68071385_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtOS0xLTEtNzM1MzU_a7981065-e200-4f90-8c7d-ded7b7765c9e"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i44cb6133b3eb45ca89b4fae7bb30718a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTEtMS0xLTczNTM1_fda2c1d9-5c04-4875-906b-cde8758a0b61"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5a8d05e1487049f8b27438df7c030bc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTMtMS0xLTczNTM1_8ac4fc2d-a062-4ea2-85ab-8b54fb40de5e"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idedc37ddaff7492cb156a22eaef9b092_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTUtMS0xLTczNTM1_40e8c156-9654-42a7-a59d-fe793032c773"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2cec3d47afff4c80b568b9f7e523a109_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTctMS0xLTczNTM1_aa38b583-b5e3-494f-9054-b1f38be0d127"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i262df50ecd024aa69410723c273b05e8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzUtMTktMS0xLTczNTM1_c95b0d65-8352-4206-a3e7-290b8449a83d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib914a13ded684ed08743c7d0696e8553_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMS0xLTEtNzM1MzU_fc8b1a9a-7355-430f-a6f6-6176dda72f9a"
      unitRef="usd">180000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c9f5a16ace249d18941f898a5576de4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMy0xLTEtNzM1MzU_d2ea62f3-576d-45d0-baea-9be9eb5bf09a"
      unitRef="usd">264000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0056a4535007448985354b76b514a039_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtOS0xLTEtNzM1MzU_bb08c134-0cd3-476b-8643-77e8fd9770dd"
      unitRef="usd">167000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i73ee0fc2accb4da6a9e43977a7b69739_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTEtMS0xLTczNTM1_a74a3def-d6ba-4dfa-9215-7029b9c57d42"
      unitRef="usd">249000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i12cd1badd0ce408c9dcafe27cdd0b20d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTMtMS0xLTczNTM1_e5f6b035-5e1c-47aa-8602-f774b7cba723"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51bf8cb12ca749c1bd187ce00a9784dd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTUtMS0xLTczNTM1_c3a2279c-a03d-4c07-997b-43130eacee58"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib6a1882f3af34faa9ad2c58364443d10_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTctMS0xLTczNTM1_b44d82b1-9276-40a2-81c7-d2d5553df51f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5d771de4a2a64a89be0c9be153b39a3e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzYtMTktMS0xLTczNTM1_265fd959-666c-42e4-bc89-ed05efb1eb87"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id8c753d7231b4002823e9b6267dacc21_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMS0xLTEtNzM1MzU_7b1c2fff-2e52-45f4-b9ba-0612feeac3f6"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifa45c1dcfeb64edfa242186776836f16_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMy0xLTEtNzM1MzU_fc3e6a85-00ab-4951-b388-6edb7cc8969e"
      unitRef="usd">121000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5e03a1a02086479b88a10af5e3588934_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctOS0xLTEtNzM1MzU_a421134d-f08a-46ec-853d-73ce750a87f8"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieedb758d47d44d4ebe6fcf3edd65171b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTEtMS0xLTczNTM1_7e12e82f-f345-48b4-bdae-aad128f44c0e"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7f6a0f7f5b6d447ea7d5613cd52fe51e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTMtMS0xLTczNTM1_433a2786-422d-4358-a453-8cb1cfd88e6e"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib0ed4b3cc36b4b0f8e5f2f0c8bf77444_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTUtMS0xLTczNTM1_01d44fbd-1300-454a-a7e9-e43125672311"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i13fc5e1747844a0b806dfd7f80523096_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTctMS0xLTczNTM1_5815e3a9-6f4b-4eb6-b29c-c113e1c88d6e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f8d9c2809b447ae90dc16848ca76dbf_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzctMTktMS0xLTczNTM1_7ebae161-f93f-421f-ace4-6dd10d328e21"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i75eff2d032c147f597c9f1aceaa27650_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMS0xLTEtNzM1MzU_8516b74d-9e63-4a54-9ad7-322d28f0ac76"
      unitRef="usd">190000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifb13d84cf3d4430cacae3505887fce63_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMy0xLTEtNzM1MzU_8988ee76-cc20-45d4-9ca3-991e7376ae9a"
      unitRef="usd">297000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i31345d49e9284acfb9ed91fd24ff7205_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtOS0xLTEtNzM1MzU_768c08cc-73cd-4c4f-acf3-dfdb2dc16a74"
      unitRef="usd">190000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib609d1579e1d40deb0c57bde81e1c157_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTEtMS0xLTczNTM1_df7cbda0-e4a7-4e5f-92b3-ee00e9b92e10"
      unitRef="usd">297000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i05f502cd5c7c4fdcb18d0d7479d2adcd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTMtMS0xLTczNTM1_bec1c9bc-ca8e-4ec1-b3f4-b880f0f1a460"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f30bff63dd044afa703c76950e345a9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTUtMS0xLTczNTM1_dd3a434b-3fbe-44a0-aef2-8fe8ca14757a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic59dde4d198a4f0c9421510d392f0fe6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTctMS0xLTczNTM1_65a889d7-0171-4a61-9df3-f065a7005e49"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8b3c1ec961624dc6a6e82d3a6d0655f5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzgtMTktMS0xLTczNTM1_947e0630-e0ba-492b-a741-6b038c4116ce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia77e1ad42f2446289384890caf166680_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMS0xLTEtNzM1MzU_20f2a4c9-a228-4deb-aa92-8ff30d449fe7"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ide2b5962b6fc4b6cab48b61c74e89ee3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMy0xLTEtNzM1MzU_20329ee8-69fb-425e-8de6-57f4aa72d35a"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0f02684e4ee849debf8d23e25e6b3324_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktOS0xLTEtNzM1MzU_93d19f59-8a35-4d24-9d6b-31bcd7c42a04"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie43bdb14f100444eba25dc4dae16f103_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTEtMS0xLTczNTM1_16b63f2a-8fd8-426d-8035-27b9674533f7"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4c02b9046aeb43f39af9743b56405a07_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTMtMS0xLTczNTM1_312e9f4c-8e45-441f-a728-f3ee988dd4db"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i958a0bea104d4e37948dbed0e1c77969_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTUtMS0xLTczNTM1_1de68065-34f3-43d9-8ce6-7c78d3188ef7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4d2c088bf8424db2abcf78de54392802_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTctMS0xLTczNTM1_157734d2-4c57-499f-969e-1f742c214000"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b70728ec7204a2ebbcda87de7fe7488_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzktMTktMS0xLTczNTM1_3d23891e-13e5-4d72-8577-29fcdaed8f34"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic7f9e7335b7e40cba7435a11709f59c8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTEtMS0xLTczNTM1_f873a1af-eb99-4c4f-b3e4-e358fa95a541"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i35a64d513dfc400f813fa199a196be91_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTMtMS0xLTczNTM1_9322052a-6ebc-4288-a22a-71866cbb1555"
      unitRef="usd">44000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic432f2c8faa84d159c41bc4deaa713ab_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTktMS0xLTczNTM1_7c147cec-ed4f-42fd-bba5-02cc127d1181"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i132718db1a49414a9da23528a50fcd53_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTExLTEtMS03MzUzNQ_7d70d626-07b9-4db4-8b32-938f122416fa"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7f5c87ee09245789101d5ca6586a174_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTEzLTEtMS03MzUzNQ_ffe81089-68b2-4916-970d-11ada1fa8af5"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic76c5930de334d2983e06187d224acc8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTE1LTEtMS03MzUzNQ_6fa4e520-21cc-4d31-8c02-96202028853c"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4c6fe3a69bb248dfbf2c20fb3768e09b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTE3LTEtMS03MzUzNQ_6c385e32-d8f5-420f-9285-8df3347fdaec"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i53f72fdffe684f18a08ab20e7ef102ee_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEwLTE5LTEtMS03MzUzNQ_142d6c47-1518-438b-a668-37d4157be9cf"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i838c06881c964d85af7dbc6c561a7832_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTEtMS0xLTczNTM1_c2cb79bb-4368-4e72-a883-3db44481dca3"
      unitRef="usd">96000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3184ac9582b94e1aad158d05fb2af57d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTMtMS0xLTczNTM1_506163a1-91e4-43aa-9b81-6fd1dcbfef57"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6d4dcca7281c4dc4a61fcb80d9cd4ba9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTktMS0xLTczNTM1_959329eb-e568-41b4-ba0a-07096a1acbb8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7c273f849dd44f598cb4953836e7f267_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTExLTEtMS03MzUzNQ_746a2a7d-5449-4b2c-acdf-d971b2a49fd7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3f5a4ae568f84d1bb02bfe3259a2505a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTEzLTEtMS03MzUzNQ_23c2b1d0-3433-47dd-bdf0-aa9624400ecd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ice7bd76a6d1e431ab6c836a81216e1f4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTE1LTEtMS03MzUzNQ_c30ef1cf-893a-43e2-8a05-14fdf7cdf010"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifeb0e474760e4334840048d6bbea75b2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTE3LTEtMS03MzUzNQ_8f7bf132-ff9c-458c-8aa0-622f4b243be9"
      unitRef="usd">96000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6720785a53e1430586156e7d0d274c13_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzExLTE5LTEtMS03MzUzNQ_0b76f44d-e5d9-4465-94e4-81927d8b1506"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1733e031b7cf47a58f991e2e2c3bba38_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTEtMS0xLTczNTM1_8515549f-dc47-4cf1-93a0-374d4185723a"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id08d119384b84ecd9c631a9d7482199d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTMtMS0xLTczNTM1_c413e534-540a-42c0-a4d1-6378675685ce"
      unitRef="usd">107000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i52b537bc93854335acc883c0be1997c8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTktMS0xLTczNTM1_071f31b0-8074-456e-8d95-53d8d976120e"
      unitRef="usd">48000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9fbe9e927d274f4f83ca7d77571c65bb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTExLTEtMS03MzUzNQ_f97eb2a0-84a5-49e3-926e-d6174de8ee85"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2bc5d9a9b2b444698454e67d6b6125b5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTEzLTEtMS03MzUzNQ_d469712d-4d4c-4cf6-8ac1-63df94cb7e8b"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i680d42b90e8248cb8ec139cafaa4fd6f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTE1LTEtMS03MzUzNQ_18aebca1-3f53-4f0f-ae84-d2e2f5b513e6"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d4ba4121b644ba8b30f226395dad876_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTE3LTEtMS03MzUzNQ_ae2ce45e-8993-488a-a29e-6f7c7b895cc7"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieee3af2d2f704f59849f8185896c26d9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEyLTE5LTEtMS03MzUzNQ_a117993d-adf9-4576-972f-ac45237c80fe"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6511aa94aeb44439b11a1d4ec335a78e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTEtMS0xLTczNTM1_a185d066-8e0b-43f4-b0e9-89c3e98b0e0a"
      unitRef="usd">705000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i77101b3b3d014aba884daaeaf179c10d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTMtMS0xLTczNTM1_c4de945f-380c-4a03-9664-bcf0924922d8"
      unitRef="usd">1033000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i519814dded634cab821a6e70f12b6b5a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTktMS0xLTczNTM1_1487804e-9abf-4a8a-a06b-7587c2465ebc"
      unitRef="usd">508000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie04b3467aa854cb9aafaccbd60d72ba5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTExLTEtMS03MzUzNQ_85c1e7c8-92bc-43c4-931a-4a6a2f73e69e"
      unitRef="usd">765000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i68b0d1120e5a41fca6070da9daf0aaa1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTEzLTEtMS03MzUzNQ_87cd9f74-1b00-4b92-8fd8-253f75fcc52b"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id38fa75e726e4beda0abe761dee7c2d5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTE1LTEtMS03MzUzNQ_4f12dabe-6192-4a7e-a603-6daf68dc8850"
      unitRef="usd">124000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ed18c587c624003af2e081a0af4732f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTE3LTEtMS03MzUzNQ_d11bc932-f71f-4cc9-a515-c83c47e2d9e1"
      unitRef="usd">128000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i27cfd7e9cd8640a3853756ce9e70e604_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90YWJsZTo0ZTdhNDM0NmFhYjQ0NWY0YTA0MGIyMzBlOTQ1YmI2MS90YWJsZXJhbmdlOjRlN2E0MzQ2YWFiNDQ1ZjRhMDQwYjIzMGU5NDViYjYxXzEzLTE5LTEtMS03MzUzNQ_65a0f25d-803f-461e-8273-1a6ba151fe73"
      unitRef="usd">145000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNDQ2_b8636e3c-717a-4139-90d8-d040f6fcb9be"
      unitRef="usd">178000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNDU2_3bbc8270-d092-4868-b343-05b3d5743b2e"
      unitRef="usd">153000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDMvZnJhZzo2NGY3Zjg0N2Q5OGY0YTA5OWE2NjExMzNjYTU5ZTBmZi90ZXh0cmVnaW9uOjY0ZjdmODQ3ZDk4ZjRhMDk5YTY2MTEzM2NhNTllMGZmXzEyNDY5_defc72e8-289a-42f6-9a57-173ae7ecb6e2"
      unitRef="usd">111000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF8xMDk5NTExNjI4NDEw_5bd599e6-ef4e-4261-a597-1dcf6700d266">Acquisitions&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 18, 2022, the Company completed the acquisition of Parata Systems (&#x201c;Parata&#x201d;), an innovative provider of pharmacy automation solutions, for total cash consideration of $1.548&#160;billion. Since the acquisition date, financial results for Parata's product offerings are being reported within results for the Medical segment&#x2019;s Medication Management Solutions unit. The acquisition was accounted for under the acquisition method of accounting for business combinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary allocations of the purchase price provide a reasonable basis for estimating the fair values of assets acquired and liabilities assumed. These provisional estimates may be adjusted upon the availability of further information regarding events or circumstances that existed at the acquisition date. Such adjustments may be significant. The fair value of the assets acquired and the liabilities assumed resulted in the recognition of developed technology intangible assets of $628&#160;million, customer relationships intangible asset of $161&#160;million, and $12&#160;million of other net assets. The excess of the purchase price over fair value of the acquired net assets was recorded as goodwill of $746&#160;million, which related to synergies expected to be gained from leveraging the existing presence of the Company&#x2019;s sales and marketing teams in pharmacies and acute care facilities, the broader coverage of the Company&#x2019;s legacy sales and marketing teams, and revenue and cash flow projections associated with future technologies. A portion of the goodwill is deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;In addition to the Parata acquisition discussed above, the Company has completed various other acquisitions during fiscal years 2022 and 2021 which were not material individually or in the aggregate, including Parata.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1b0f58312f094de18638daec1ed57a5b_D20220718-20220718"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF8xMDk5NTExNjI4Mzk1_633b2e29-a9d0-4c34-a92d-18bb77d935ff"
      unitRef="usd">1548000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i16146e90cf574d438dbf17e714f1b029_I20220718"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODYw_f8581caa-1e79-440d-9b6a-687c5d008c5f"
      unitRef="usd">628000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iaead122bd3794f52a9b62332837beb42_I20220718"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODI3_f2fb13b1-ac39-460e-b744-a39865952565"
      unitRef="usd">161000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <bdx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets
      contextRef="ic5e7b819e08c4816b263b7a5251235af_I20220718"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODQ0_b5af150b-742f-401e-80d0-b97e3c6d9074"
      unitRef="usd">12000000</bdx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets>
    <us-gaap:Goodwill
      contextRef="ic5e7b819e08c4816b263b7a5251235af_I20220718"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNDg2L2ZyYWc6YWZlZTZmNjk3NWE2NDhkNGI2MGZhMWRiNGExYTZiZjAvdGV4dHJlZ2lvbjphZmVlNmY2OTc1YTY0OGQ0YjYwZmExZGI0YTFhNmJmMF85MzQ1ODQ4ODQ5ODEw_97993e14-6dd7-480f-81e0-45e19f10252a"
      unitRef="usd">746000000</us-gaap:Goodwill>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90ZXh0cmVnaW9uOjVmZDA5ZTQzOGY2YTQxOTlhM2YwOWE4ZGQyZWE4NTgxXzEwOTk_4b79ead9-cc29-40dd-86a8-794762500dd5">Business Restructuring Charges&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company's simplification and other cost saving initiatives that are part of its strategic objectives, along with the 2018 acquisition of Bard, the Company incurred restructuring costs which were largely recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and other restructurings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on its consolidated statements of income. The simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#x2019;s segments.  Restructuring liability activity in 2022, 2021 and 2020&#160;was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:400.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:78.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:78.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:78.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Termination (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other (a)(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Restructuring costs in 2022, 2021 and 2020 included expenses primarily related to simplification and other cost saving initiatives.  Restructuring costs in 2021 and 2020 also included expenses related to the acquisition of Bard in fiscal year 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Expenses in 2020 largely represented the costs associated with the conversion of certain pre-acquisition equity awards of Bard which, to encourage post-acquisition employee retention, were converted to BD equity awards with substantially the same terms and conditions as were applicable under such Bard awards immediately prior to the acquisition date.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90ZXh0cmVnaW9uOjVmZDA5ZTQzOGY2YTQxOTlhM2YwOWE4ZGQyZWE4NTgxXzExMDM_009c19c2-9d92-46a3-86a2-9b551bda50b0">Restructuring liability activity in 2022, 2021 and 2020&#160;was as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:400.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:78.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:78.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:78.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Termination (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other (a)(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Restructuring costs in 2022, 2021 and 2020 included expenses primarily related to simplification and other cost saving initiatives.  Restructuring costs in 2021 and 2020 also included expenses related to the acquisition of Bard in fiscal year 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Expenses in 2020 largely represented the costs associated with the conversion of certain pre-acquisition equity awards of Bard which, to encourage post-acquisition employee retention, were converted to BD equity awards with substantially the same terms and conditions as were applicable under such Bard awards immediately prior to the acquisition date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="iafe15d6e33ea490590f7e9a69b2b17d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzItMy0xLTEtNzM1MzU_e9a77a0b-e2af-4148-ac6c-3ec7029cbb25"
      unitRef="usd">53000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib61a5ebabc2b43e6bc2cd5e8d0c216f2_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzItNy0xLTEtNzM1MzU_8ff9dc83-ebf3-4d25-a14e-976d56a8f70d"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzItMTEtMS0xLTczNTM1_ef8c4bd4-482b-4493-bd83-0590425aaee6"
      unitRef="usd">57000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="idebc6318303940928ab393f2213c259c_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzMtMy0xLTEtNzM1MzU_a0a4905f-5b9e-49c8-8f3b-1bd9c72d7450"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic952af233f8f4bc18cc9102330586496_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzMtNy0xLTEtNzM1MzU_c0a04305-5be5-4dce-a210-07e5ab23e185"
      unitRef="usd">65000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzMtMTEtMS0xLTczNTM1_d4e9dfdd-dbc9-45c1-b261-7baa169258d0"
      unitRef="usd">84000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="idebc6318303940928ab393f2213c259c_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzQtMy0xLTEtNzM1MzU_f20a82bd-01a1-48a0-b2e6-d7f59b77e5ee"
      unitRef="usd">41000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic952af233f8f4bc18cc9102330586496_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzQtNy0xLTEtNzM1MzU_dd3f3c03-5cf3-4089-89c1-cc3c525f683d"
      unitRef="usd">39000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzQtMTEtMS0xLTczNTM1_22fa36ca-192b-411a-a566-d3168f3056f3"
      unitRef="usd">80000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="idebc6318303940928ab393f2213c259c_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzUtMy0xLTEtNzM1MzU_7b3ec0e8-0c9e-4589-9283-2254b7b72087"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic952af233f8f4bc18cc9102330586496_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzUtNy0xLTEtNzM1MzU_59d8d1f2-bf09-4166-b5d5-25d7e8218b73"
      unitRef="usd">26000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzUtMTEtMS0xLTczNTM1_98da9f60-cb65-4e91-8314-4329c7568042"
      unitRef="usd">26000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="i783d4c7f3e5a45edbd97c95a6a89786e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzctMy0xLTEtNzM1MzU_c44e62f1-b4d9-4197-bd78-4b57d20c0f07"
      unitRef="usd">32000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iea7227b64729441fa3f00eb141b51740_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzctNy0xLTEtNzM1MzU_3af4a303-27df-48cd-8553-5cc50201c473"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzctMTEtMS0xLTczNTM1_d6a5a583-97de-4ec5-94c0-d7a8e44ade58"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzgtMy0xLTEtNzM1MzU_44de8182-4d53-4ba0-b174-364048b22bc1"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzgtNy0xLTEtNzM1MzU_cea7dfa4-2c6a-4a84-a0f0-1e2d8eae17b7"
      unitRef="usd">30000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzgtMTEtMS0xLTczNTM1_97889532-9bc2-44e0-ad50-a4d725b679be"
      unitRef="usd">44000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzktMy0xLTEtNzM1MzU_bbbed433-6fea-4c26-8026-2682a42d45a7"
      unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzktNy0xLTEtNzM1MzU_2359f74a-6588-4c71-921a-ce3dbd4431d9"
      unitRef="usd">25000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzktMTEtMS0xLTczNTM1_f4bdf6b5-2792-427c-8a50-e5e05106491d"
      unitRef="usd">56000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i7b00fc353bfa4af69a6021a8aba9a6b3_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEwLTMtMS0xLTczNTM1_254503e5-fce2-46be-a004-add1d1f7de55"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i20b7199234cf46d782b12687b1148f9a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEwLTctMS0xLTczNTM1_95f628e6-19bd-408c-94f9-abd96b594b24"
      unitRef="usd">4000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEwLTExLTEtMS03MzUzNQ_a1c0d113-53ac-430c-a969-9205d49c212b"
      unitRef="usd">4000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="i17e9dff542174b32865501500ace45c5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEyLTMtMS0xLTczNTM1_67b8f496-acae-417d-9842-f574ba9ebc12"
      unitRef="usd">14000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie4ae8b1d50eb4bc6a284a520fe49663b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEyLTctMS0xLTczNTM1_269ab07f-072d-42a5-80b2-d2ba95641c52"
      unitRef="usd">5000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEyLTExLTEtMS03MzUzNQ_b4676ff7-dba4-4302-abde-2f7ddfcd77e9"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEzLTMtMS0xLTczNTM1_6512312f-0785-49ff-834f-5516a8087dc8"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEzLTctMS0xLTczNTM1_4f163d22-3405-4b52-8fd6-fda2f722a61f"
      unitRef="usd">103000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzEzLTExLTEtMS03MzUzNQ_5908a72e-74e1-4b5a-a64b-5ba42faf718c"
      unitRef="usd">123000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE0LTMtMS0xLTczNTM1_be410049-5609-47ba-8655-d6f99a31385e"
      unitRef="usd">11000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE0LTctMS0xLTczNTM1_8c98f8c2-cbf2-4474-b398-4a7e40adcb4b"
      unitRef="usd">71000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE0LTExLTEtMS03MzUzNQ_2fbb3f60-6b08-4a97-b8af-2eae99c2aada"
      unitRef="usd">82000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE1LTMtMS0xLTczNTM1_24929c40-f14d-4f40-bfed-fc5a17c26be9"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE1LTctMS0xLTczNTM1_c70a0c9b-4c4a-4498-9c70-b9fd9b3c0f94"
      unitRef="usd">25000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE1LTExLTEtMS03MzUzNQ_52b8c7e2-d781-477f-8c72-bdccb4f1737b"
      unitRef="usd">25000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i8ec06036097f4b83a1669a4dd281088f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE2LTMtMS0xLTczNTM1_bc0459e6-3b86-47dd-969f-880d39e86727"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ia62dfc62c9c84178a94bb6dd95b6e4aa_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE2LTctMS0xLTczNTM1_e99398b9-5692-43f7-a015-4c53ecf2a9e8"
      unitRef="usd">1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE2LTExLTEtMS03MzUzNQ_141ef01a-5330-432e-8dae-5d19ffe88107"
      unitRef="usd">1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i0ad5a700227d4b0e92d99a7616f2178b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE3LTMtMS0xLTczNTM1_c3537ad1-4a4a-4c57-92dc-c4acaaada003"
      unitRef="usd">24000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3ba567a48b404c3ab9acaa56ed5af44b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE3LTctMS0xLTczNTM1_0ae5071e-2a8a-4bb7-b664-8836ee6393ab"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMDkvZnJhZzo1ZmQwOWU0MzhmNmE0MTk5YTNmMDlhOGRkMmVhODU4MS90YWJsZTpjOGM4NmYyYjlmODE0NGMyOTQxZTg2YmM2MjM3ZmI5NS90YWJsZXJhbmdlOmM4Yzg2ZjJiOWY4MTQ0YzI5NDFlODZiYzYyMzdmYjk1XzE3LTExLTEtMS03MzUzNQ_e0d7e5af-7dbe-411f-b4d4-f657fac9f9f5"
      unitRef="usd">35000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzUyOQ_3a806860-b760-4946-b9fa-9ecfefff8fe2">Intangible Assets&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other intangible assets related to the former Diabetes Care business have been reclassified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncurrent Assets of Discontinued Operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for prior year periods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information, see Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible amortization expense was $1.430 billion, $1.402 billion and $1.384 billion in 2022, 2021 and 2020, respectively.  The estimated aggregate amortization expense for the fiscal years ending September&#160;30, 2023 to 2027 are as follows: 2023 &#x2014; $1.385 billion; 2024 &#x2014; $1.382 billion; 2025 &#x2014; $1.381 billion; 2026 &#x2014; $1.350 billion; 2027 &#x2014; $1.292 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.&lt;/span&gt;&lt;/div&gt;(b)Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzUzMw_07e6c148-4f71-4d3d-927c-5524b45d758a">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtMS0xLTEtNzM1MzU_91431bb8-a60c-4bd5-ae55-754906e57e29"
      unitRef="usd">15087000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtMy0xLTEtNzM1MzU_4e68da77-c581-4fac-9927-ebe1050a0159"
      unitRef="usd">5979000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i71b9a78ca26a407ca555ff8e5796c2c5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtNS0xLTEtNzM1MzU_b26daef4-e8e8-4086-a25e-96ceb24d0f50"
      unitRef="usd">9108000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib122ecb689334b1fb324ee12c1cc2522_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtNy0xLTEtNzM1MzU_c944b1f4-8e81-40db-9229-8b314da95ceb"
      unitRef="usd">14399000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib122ecb689334b1fb324ee12c1cc2522_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtOS0xLTEtNzM1MzU_45652438-a846-4c02-8b29-3d1dd481235d"
      unitRef="usd">4983000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib122ecb689334b1fb324ee12c1cc2522_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzMtMTEtMS0xLTczNTM1_fef97bd1-eb2a-4fae-b2db-ddde1944899f"
      unitRef="usd">9417000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i22adc29e67d0453da5b441bc62d60fad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtMS0xLTEtNzM1MzU_5d46c6d5-cb98-459d-beef-2473768643c4"
      unitRef="usd">4853000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i22adc29e67d0453da5b441bc62d60fad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtMy0xLTEtNzM1MzU_b0978e54-7637-4986-ae42-abfaa08eef9f"
      unitRef="usd">2170000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i22adc29e67d0453da5b441bc62d60fad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtNS0xLTEtNzM1MzU_cd83858b-3bd9-487b-a1d6-4b710540e159"
      unitRef="usd">2683000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtNy0xLTEtNzM1MzU_70aaabf4-5337-4568-9f9e-3a5acfd801d0"
      unitRef="usd">4653000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtOS0xLTEtNzM1MzU_df262dc2-d3b7-44eb-bf13-ff0f09601618"
      unitRef="usd">1838000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibb5166878e6c4d32a5bfa1d8c58caed5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzQtMTEtMS0xLTczNTM1_f2152c33-15f3-4f28-a4ac-cbfacf30c687"
      unitRef="usd">2815000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic7898a78b2b045e0a8fbcc5061436d03_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtMS0xLTEtNzM1MzU_12c8b58a-7379-48c3-91ea-d38d75390a42"
      unitRef="usd">97000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic7898a78b2b045e0a8fbcc5061436d03_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtMy0xLTEtNzM1MzU_4fe4662a-4858-4982-ac6a-9d682a6032f8"
      unitRef="usd">72000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic7898a78b2b045e0a8fbcc5061436d03_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtNS0xLTEtNzM1MzU_9e743372-8c3a-40fd-a2d6-ae15692375da"
      unitRef="usd">25000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtNy0xLTEtNzM1MzU_625a77e4-093b-4229-936b-9da804a3ee59"
      unitRef="usd">123000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtOS0xLTEtNzM1MzU_ac22c3e8-32a3-4ded-99e9-a20d26f1b99b"
      unitRef="usd">83000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib0275f9bd5ac44d8b0faf8d632bd109d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzUtMTEtMS0xLTczNTM1_72008402-da48-4142-8e38-f2ed7aed2208"
      unitRef="usd">40000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i27b8a27c308b4a97925c0a22163ab63a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtMS0xLTEtNzM1MzU_9693d111-4cd9-4315-86c8-b6a8abbd216d"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i27b8a27c308b4a97925c0a22163ab63a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtMy0xLTEtNzM1MzU_796d8e83-af9f-46ae-9b59-fc7ca47adbbb"
      unitRef="usd">155000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i27b8a27c308b4a97925c0a22163ab63a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtNS0xLTEtNzM1MzU_aec38b2e-0886-4e1e-acaa-de295293e006"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id9123b3bda6243a2a49be47ee2010afe_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtNy0xLTEtNzM1MzU_a656eac1-e708-4391-b677-c266f5315ec4"
      unitRef="usd">409000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id9123b3bda6243a2a49be47ee2010afe_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtOS0xLTEtNzM1MzU_00cb41f1-aa68-48ea-8aa6-68df5e5d5d26"
      unitRef="usd">137000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id9123b3bda6243a2a49be47ee2010afe_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzYtMTEtMS0xLTczNTM1_9a7c3970-e886-483a-bfb9-21aaa226edea"
      unitRef="usd">271000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if296896edaf84700a94f43cf10109fd1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctMS0xLTEtNzM1MzU_546570c6-1d6d-44c9-bc51-8b9582a8123d"
      unitRef="usd">542000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if296896edaf84700a94f43cf10109fd1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctMy0xLTEtNzM1MzU_08afbef2-aea8-4e89-a64e-b24c278b37b2"
      unitRef="usd">346000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if296896edaf84700a94f43cf10109fd1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctNS0xLTEtNzM1MzU_47fbba7c-b232-484d-bfa8-6498bc4ba557"
      unitRef="usd">196000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i28d9ef80e7d740e98803dffc38dc1875_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctNy0xLTEtNzM1MzU_1efe0c65-8e19-446c-bf47-7b0a74c4ddbc"
      unitRef="usd">523000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i28d9ef80e7d740e98803dffc38dc1875_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctOS0xLTEtNzM1MzU_e208a2f1-dd3a-44da-9183-b9821c21294d"
      unitRef="usd">339000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i28d9ef80e7d740e98803dffc38dc1875_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzctMTEtMS0xLTczNTM1_7712372e-6eb2-4d59-8c02-b9fb8d891250"
      unitRef="usd">184000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtMS0xLTEtNzM1MzU_b815172d-ba71-4b90-961e-44664b2d61b7"
      unitRef="usd">20987000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtMy0xLTEtNzM1MzU_962c76aa-78b8-49c9-9ccd-adfff56243ad"
      unitRef="usd">8723000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtNS0xLTEtNzM1MzU_5bba0269-c7ee-4be1-a0c9-c4dee1c078d9"
      unitRef="usd">12264000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtNy0xLTEtNzM1MzU_343f07e5-340f-4fd8-873f-4548a277ff24"
      unitRef="usd">20106000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtOS0xLTEtNzM1MzU_109a2856-9461-4abe-9d55-1514e0232000"
      unitRef="usd">7381000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzgtMTEtMS0xLTczNTM1_7f4d4980-f32a-418c-9913-5a0d75ea39df"
      unitRef="usd">12726000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id08fc3788b4f494fab5bba68fdd3f971_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzExLTEtMS0xLTczNTM1_8f01bc99-7699-4d89-83bb-5100f4c2866f"
      unitRef="usd">44000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i83079dddc9604de9b744f8de96e981e8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzExLTctMS0xLTczNTM1_ab0111e5-1166-4ef9-8f4d-a31444055b0d"
      unitRef="usd">44000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i313ea0dffdb34c468e5b8d9fb727160e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEyLTEtMS0xLTczNTM1_98cb7282-3b45-49f0-8663-e92edde9e9f1"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i09cbfdc3b91b4f0a938cae0e75b85bbc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEyLTctMS0xLTczNTM1_e91969c2-c466-4492-9cae-5b411c7a9739"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEzLTEtMS0xLTczNTM1_3eb99c06-63b5-4809-8fc6-454cd4f84e4d"
      unitRef="usd">46000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTpiZWQxZmNjMGI5NjQ0NTQ0YjY5ZmU2ZWEzMDE1NjcwZS90YWJsZXJhbmdlOmJlZDFmY2MwYjk2NDQ1NDRiNjlmZTZlYTMwMTU2NzBlXzEzLTctMS0xLTczNTM1_3f1e19c2-ef5a-48cb-a31d-ac6d8adb1f96"
      unitRef="usd">46000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzEyMA_29fdbc9d-2092-48ed-9245-9abe571bdc24"
      unitRef="usd">1430000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzEyNA_2d7bedc5-69ae-4223-ba9f-02b2ba943ce9"
      unitRef="usd">1402000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzEzMQ_bae30488-1820-4efd-bb98-dbabf1192967"
      unitRef="usd">1384000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzI4NA_d7b62bb9-2b7a-4efb-ac6a-91557f521941"
      unitRef="usd">1385000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzI5Mw_6cf79f4b-6bfb-4eb2-bf2d-307caa3c1acc"
      unitRef="usd">1382000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzMwMg_4bf7357e-f0cb-435b-946e-0623a98165cf"
      unitRef="usd">1381000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzMxMQ_449d30c2-cdc1-4778-81f8-72ca66705830"
      unitRef="usd">1350000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzMyMA_02b2c656-c29a-4534-b6a5-2c8896c188bc"
      unitRef="usd">1292000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90ZXh0cmVnaW9uOmU3MzMyYmM3NDQ4ODQyZWJhM2ExNTYxMGM4MzAxNjNlXzUyMg_4940c53d-0648-4d48-9b70-f46737a98f07">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interventional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.&lt;/span&gt;&lt;/div&gt;(b)Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ie95aa9d4507c48a8aa4ecf6660ad1bb8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtMS0xLTEtNzM1MzU_677889bc-7a6d-4ca2-876b-6c7030af6768"
      unitRef="usd">10028000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i10a8586120ec4ee3b816bd6e84c99d26_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtMy0xLTEtNzM1MzU_cb6b0f21-9c18-4dea-99be-8a5cbbd8217a"
      unitRef="usd">837000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9b06cbe7ebf74441ad1135e8a4099d4c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtNS0xLTEtNzM1MzU_f5a5ee8b-2ca8-4b4b-8af4-aa15fc845875"
      unitRef="usd">12739000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEtNy0xLTEtNzM1MzU_0502169c-b99c-4fdf-8803-9daaf51d1607"
      unitRef="usd">23604000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItMS0xLTEtNzM1MzU_e8434f8a-4b12-4139-af9a-73fdea216979"
      unitRef="usd">193000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItMy0xLTEtNzM1MzU_36bab7f6-846e-4652-b7dc-6186358514f6"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i154a1248141a444db4764c62730b8fe8_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItNS0xLTEtNzM1MzU_e28cfee9-b839-47e9-b0e4-d89e3061d431"
      unitRef="usd">72000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzItNy0xLTEtNzM1MzU_4f1d12f7-cfd7-40cc-8ada-464ff45dfa4e"
      unitRef="usd">264000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtMS0xLTEtNzM1MzU_fcd35baf-a0ae-47f5-832a-e609dfe257b5"
      unitRef="usd">4000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtMy0xLTEtNzM1MzU_bbb15b96-d404-4345-93f8-4e4d6980522e"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i154a1248141a444db4764c62730b8fe8_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtNS0xLTEtNzM1MzU_60eb33ab-580c-44a7-88a0-cd682a2e265f"
      unitRef="usd">1000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzUtNy0xLTEtNzM1MzU_91f8cca8-d222-44be-9cbb-e921d5e4d6d1"
      unitRef="usd">6000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i51db36a0f4eb4b178687a2055dc20666_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtMS0xLTEtNzM1MzU_f177fc68-a67d-4927-9b64-b67d73ea2036"
      unitRef="usd">-15000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i10790f11a2bf4707a78bef05b3f7f200_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtMy0xLTEtNzM1MzU_66216710-306b-4c4e-81de-cda9205dcf73"
      unitRef="usd">1000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i154a1248141a444db4764c62730b8fe8_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtNS0xLTEtNzM1MzU_33992315-8527-4282-be6d-1f1e0c6a7c18"
      unitRef="usd">2000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzYtNy0xLTEtNzM1MzU_dad0b94d-39dd-4804-86e9-b83e0a10a659"
      unitRef="usd">-12000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i4e7b422811cd4eacbfca8abd88d6e929_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctMS0xLTEtNzM1MzU_b3607229-d665-4678-95ee-c22138231586"
      unitRef="usd">10240000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id2e02302174c424e83e466e2024ad82a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctMy0xLTEtNzM1MzU_41ff844e-3ad7-4620-b816-648f720b672d"
      unitRef="usd">836000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia3b8ceb1a99f4a2db99cb4f7b7466475_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctNS0xLTEtNzM1MzU_67f1a1ac-f46c-4895-95d5-cc5f8b7676da"
      unitRef="usd">12810000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzctNy0xLTEtNzM1MzU_18f11ae4-bfeb-4c02-a323-2025bc6d0a8f"
      unitRef="usd">23886000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtMS0xLTEtNzM1MzU_78ab3741-2903-4431-b543-21e36a63f974"
      unitRef="usd">814000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtMy0xLTEtNzM1MzU_8a035284-0ae4-40ed-8483-c41bbc8ae944"
      unitRef="usd">71000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtNS0xLTEtNzM1MzU_f44438db-22d5-41a2-ac56-addfda08609a"
      unitRef="usd">188000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzgtNy0xLTEtNzM1MzU_11f703cf-b090-447c-ad6b-842e5b6f4a6a"
      unitRef="usd">1073000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTEtMS0xLTczNTM1_87b8e27c-ed8e-4048-89ea-82f92a04baf7"
      unitRef="usd">1000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTMtMS0xLTczNTM1_7451db28-96b5-4cdb-8a9d-36d20d9e1682"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTUtMS0xLTczNTM1_a51b38d7-af71-4efe-b966-1d0c3e1b06ea"
      unitRef="usd">-2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEwLTctMS0xLTczNTM1_5d17ebda-df7e-4411-a030-62f95b40881b"
      unitRef="usd">-1000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ice0fa7728410436abb9f00bb4f806d73_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTEtMS0xLTczNTM1_051a23e3-d58d-4433-9e96-8c54411eee39"
      unitRef="usd">145000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i46ca37f623fd4a91a124ee0d06425d84_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTMtMS0xLTczNTM1_2af77623-6440-40db-a722-966f91363f58"
      unitRef="usd">20000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id1ecea8586a84364b72edf5a00d79e63_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTUtMS0xLTczNTM1_48892bca-74b8-4e0e-abbb-46f531489515"
      unitRef="usd">171000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzExLTctMS0xLTczNTM1_0c05e882-4e86-42ba-9a68-8e9bdf7d214a"
      unitRef="usd">337000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i755a5d90f3814df4b21a068f5395ce3f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTEtMS0xLTczNTM1_f8e2041b-df29-4dfc-880d-cf78dcb0a2b7"
      unitRef="usd">10909000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1ad49caca1134d10b7917ed7da76c3c1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTMtMS0xLTczNTM1_aa07cb58-7ac6-4484-895b-0cc88f3228a5"
      unitRef="usd">888000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7be2a3f223eb4dd1a902692b9d00ee3c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTUtMS0xLTczNTM1_5544f705-a9b3-472a-a2f2-76db52aa181a"
      unitRef="usd">12824000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTIvZnJhZzplNzMzMmJjNzQ0ODg0MmViYTNhMTU2MTBjODMwMTYzZS90YWJsZTo0OTBkMjc1OWRkYWU0MDA1YTk4OTFkMmViZWZhODNmYy90YWJsZXJhbmdlOjQ5MGQyNzU5ZGRhZTQwMDVhOTg5MWQyZWJlZmE4M2ZjXzEyLTctMS0xLTczNTM1_c0593dee-6e07-4810-af29-ca296ede8d81"
      unitRef="usd">24621000000</us-gaap:Goodwill>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY3NDQ_7eca1307-d45c-42bb-b9db-947a2f4558df">Derivative Instruments and Hedging Activities&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.  The effects these derivative instruments and hedged items had on the Company&#x2019;s balance sheets and the fair values of the derivatives outstanding at September&#160;30, 2022 and 2021 were not material. The effects on the Company&#x2019;s financial performance and cash flows are provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments&#160;with certain instruments such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, during the years ending September&#160;30, 2022, 2021 and 2020 are detailed in Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents foreign currency-denominated notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Upon the termination of a net investment hedge, any net gain or loss included in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains (losses) recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the Company's net investment hedges as of September&#160;30, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.166%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amounts in 2022 and 2021 include a gain of $46&#160;million and a loss of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$35&#160;million, respectively,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; recognized on terminated cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a mix of fixed and variable rate debt, which is further discussed in Note 16, to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.  These swaps are designated as either cash flow or fair value hedges.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. If interest rate derivatives designated as cash flow hedges are terminated, the balance in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;attributable to those derivatives is reclassified into earnings over the remaining life of the hedged debt.&#160;The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during 2022, 2021 and 2020, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded net after-tax gains (losses) of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$92&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, $72&#160;million and $(75)&#160;million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to interest rate-related cash flow hedges during the years ended September&#160;30, 2022, 2021 and 2020, respectively. The gains recorded during fiscal year 2022 included a net after-tax gain of $41&#160;million that was realized upon the Company&#x2019;s termination of $500&#160;million of forward starting interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates. The amounts recorded during the years ended September&#160;30, 2022 and 2021 for changes in fair value of these hedges were immaterial to the Company's consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s interest rate-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt"&gt;Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Risk Exposures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company&#x2019;s commodity derivative forward contracts at September&#160;30, 2022 were not material, and there were no outstanding commodity derivative forward contracts at September 30, 2021. &lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY3Mzg_9fe51948-4ae1-4c50-b365-fd2addccb959">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income.  These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, during the years ending September&#160;30, 2022, 2021 and 2020 are detailed in Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents foreign currency-denominated notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of the Company&#x2019;s interest rate-related derivative instruments as of September&#160;30, 2022 and 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  &lt;/span&gt;&lt;/div&gt;(b)Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if9aae2ecc3b743ee8b3b99bcb96a572c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzEtMy0xLTEtNzM1MzU_c2579e6f-2741-4cfc-962f-a227bdd6c326"
      unitRef="usd">2766000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9b65da53d1249ec90a0398fbf799f3b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzEtNS0xLTEtNzM1MzU_6b0d9f8a-019c-484e-81f1-d11e527e0865"
      unitRef="usd">2735000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4b1e06b3f4724fbe8ed56758a473c1d6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzItMy0xLTEtNzM1MzU_6786a998-019b-4e72-bbb5-0e7f9ebefe09"
      unitRef="usd">2140000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0362b4098b8b4067bb006f7b4a31ae00_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzItNS0xLTEtNzM1MzU_e9cb0b5b-b6a1-4038-888b-980b269914e3"
      unitRef="usd">2543000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21cb6aa32d1f481981628ab9194b1087_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzMtMy0xLTEtNzM1MzU_7636b48e-9956-4bdb-bd30-27dd2b061a5d"
      unitRef="usd">910000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i46bfa1d6a2ed48c58d0b334930a15be9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTowN2IwZjY0YWQ3Y2Q0ZmY5YTg2YTI5MTBlYTQ2YzRiNC90YWJsZXJhbmdlOjA3YjBmNjRhZDdjZDRmZjlhODZhMjkxMGVhNDZjNGI0XzMtNS0xLTEtNzM1MzU_5eddd70d-dc19-4b03-9f35-d1f73b88e073"
      unitRef="usd">1958000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY3NDI_0e07e0a1-d7db-4de1-b69f-df63bf2d5d48">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains (losses) recorded to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the Company's net investment hedges as of September&#160;30, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.166%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amounts in 2022 and 2021 include a gain of $46&#160;million and a loss of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$35&#160;million, respectively,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; recognized on terminated cross-currency swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8a796cfd479247d9aed9717103f579c5_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzEtMS0xLTEtNzM1MzU_70cdc4d7-6c17-45ae-adfa-ecd0ed864b7d"
      unitRef="usd">320000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i636b7d8d6ac1434884437455e4abece1_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzEtMy0xLTEtNzM1MzU_72de11f6-713f-4e0b-b6b8-30d668abdae5"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i20ba69d3b809426383ff74cd52d2d5d6_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzEtNS0xLTEtNzM1MzU_e063bb35-15eb-4fd0-98c5-c8812bd4163b"
      unitRef="usd">-106000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i82fb06354e254a39957ee2c588fb1109_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzItMS0xLTEtNzM1MzU_1844f08c-ef74-421a-9fb0-f2b4f6f3eb86"
      unitRef="usd">173000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i79d5a944ccec4ed6a09939ea678a2ce2_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzItMy0xLTEtNzM1MzU_d4b9096e-3269-477c-a02b-1d3eb459baf6"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8cb3f4d815394a569ef25a97b6547ade_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZToxMzdiNjJhNTg1MmI0ZjM5YTFlYmMwYzUyZGRiZTk5Yy90YWJsZXJhbmdlOjEzN2I2MmE1ODUyYjRmMzlhMWViYzBjNTJkZGJlOTljXzItNS0xLTEtNzM1MzU_64d9fefa-6460-4db5-bd12-ee60631dd3b3"
      unitRef="usd">-109000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0ad6655541f44f868773ab9598f2389a_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzkzNDU4NDg4NDU0MDM_0f0ba3f8-9bfb-462c-8df1-e1b86f75b1c6"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i711fe8ef0e6b434ba332d1783ca67ae8_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzI5Mzc_4c185401-68cf-4f91-b432-efef50e716c3"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzEwOTk1MTE2MzU4ODQ_8e88ce51-391f-4ca0-a592-13d16b583322"
      unitRef="usd">92000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ia06bc3660c334df6ad4d8fb329decb0d_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzQ1NTA_d27e8e81-ba8e-41aa-a9c0-9ecdd159e513"
      unitRef="usd">72000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="iaac60c046f35441f9fedd46ad3c40d4d_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzQ1NTc_f51bb714-d046-41aa-8322-e077a299898c"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <bdx:OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent
      contextRef="i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzM4NDgyOTA3MDU3Njk_954a2890-219c-4699-9d1e-9e69927c2d5f"
      unitRef="usd">41000000</bdx:OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i477ce66329a84971b9ed1654697676df_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzM4NDgyOTA3MDU3ODU_75c7a852-8567-4070-af34-cff07fee456f"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i713da180c69b463b9d60a20b18530ae8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzEtMy0xLTEtNzM1MzU_1a84a813-e422-4cd8-98c7-0c623e078cb7"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i47367bb6b2924151bb0cb2e2a24e2c4c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzEtNS0xLTEtNzM1MzU_edc11bfc-cd0c-4a80-a1a9-bb5abb69ed48"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i477ce66329a84971b9ed1654697676df_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzItMy0xLTEtNzM1MzU_fcaad659-b4b7-4893-9edb-64ce15fe3296"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icb49035180454921878d3e554660eafb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90YWJsZTpjNjEyNGEzNzMxMWU0ZjkwYjQ0YTk3YjhlOWZiOWI1NC90YWJsZXJhbmdlOmM2MTI0YTM3MzExZTRmOTBiNDRhOTdiOGU5ZmI5YjU0XzItNS0xLTEtNzM1MzU_94d552e8-cefb-482e-a7c9-ee43623ebe4d"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i492a77d89eef44f5a423a69591c4fcb1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY2NTI_48b14d71-d871-45a8-a9cb-ecc9665d5772"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idd49df5862fc48f89ee6373a56f0a57d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTUvZnJhZzpmM2UwMzM4NGRmYzQ0NTRjYWIzMzYyY2I3NzMxYmFlOC90ZXh0cmVnaW9uOmYzZTAzMzg0ZGZjNDQ1NGNhYjMzNjJjYjc3MzFiYWU4XzY2NTI_876c9c2c-555b-475c-8034-16bb5d55e12c"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODI_146ae8d4-a856-4df8-ab96-175fcc3a57fd">Financial Instruments and Fair Value Measurements&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September&#160;30, 2022 and 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s financial instruments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement (See Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional money market accounts and ultra-short bond fund (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;These financial instruments are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets. The institutional money market accounts permit daily redemption.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments are held to their maturities and are carried at cost, which approximates fair value.  The short-term investments consist of instruments with maturities greater than three months and less than one year. All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nonrecurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal year 2022, the Company recorded non-cash asset impairment charges of $11&#160;million to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the Life Sciences segment, $19&#160;million to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-related integration and restructuring expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the Medical segment and $54&#160;million to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the Medical segment to write down the carrying value of certain fixed assets. In fiscal year 2021, the Company recorded charges to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $40&#160;million to write down the carrying value of certain fixed assets.  In fiscal year 2020, the Company recorded charges to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $57&#160;million to write down the carrying values of certain intangible and other assets in the Biosciences and Integrated Diagnostic Solutions units, and $41&#160;million to write down the value of fixed assets primarily in the Medication Delivery Solutions and Pharmaceutical Systems units. The amounts recognized in 2022, 2021 and 2020 were recorded&#160;to adjust the carrying amount of assets to the assets' fair values, which were estimated, based upon a market participant's perspective, using Level 3 inputs, including values estimated using the income approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company&#x2019;s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company&#x2019;s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its accounts receivables for potential collection risks, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#x2019; national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transfers of trade receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and a decrease to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade receivables, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when proceeds from the transactions are received. The costs incurred by the Company in connection with factoring activities were not material to its consolidated financial results. The amounts transferred and yet to be remitted under factoring arrangements are provided below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables transferred to third parties under factoring arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts yet to be collected and remitted to the third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODY_1cb78b5b-2d0c-4216-87ee-33c5ff121397">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at September&#160;30, 2022 and 2021 to the total of these amounts shown on the Company's consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzEtMS0xLTEtNzM1MzU_8ae72a17-1bcd-4b87-a748-d6f63628c0aa"
      unitRef="usd">1006000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzEtMy0xLTEtNzM1MzU_9cf34f64-de8c-4d32-8508-86e00b63eb0b"
      unitRef="usd">2283000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzItMS0xLTEtNzM1MzU_8f25294b-d6a2-4148-b7c6-d86775734f1e"
      unitRef="usd">153000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzItMy0xLTEtNzM1MzU_7756253c-6019-4c91-846b-c21283395c68"
      unitRef="usd">109000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzMtMS0xLTEtNzM1MzU_2564121e-d9e8-4d49-bcac-4347391ad2f8"
      unitRef="usd">1159000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpiZjExYThiNWQwZjA0NWE4ODc4ZjdkNGViMTVhMTI5OS90YWJsZXJhbmdlOmJmMTFhOGI1ZDBmMDQ1YTg4NzhmN2Q0ZWIxNWExMjk5XzMtMy0xLTEtNzM1MzU_80191670-867b-43dd-8ae1-de5d4e3180ee"
      unitRef="usd">2392000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3NzA_912ffae2-095d-498e-9661-73e82b49bebb">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s financial instruments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement (See Note 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Institutional money market accounts and ultra-short bond fund (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;These financial instruments are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets. The institutional money market accounts permit daily redemption.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzEtMy0xLTEtNzM1MzU_10da611f-d243-4e3a-a3a7-4279df726b8b"
      unitRef="usd">1000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzEtNS0xLTEtNzM1MzU_6e06f925-dee9-4b6d-9f69-44baf6020b8e"
      unitRef="usd">200000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzItMy0xLTEtNzM1MzU_270a1b0c-fb96-4220-9453-06430e5b2de2"
      unitRef="usd">1927000000</bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm>
    <bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzItNS0xLTEtNzM1MzU_46dfad1d-7bb6-4259-8260-46b99a2e3fc0"
      unitRef="usd">503000000</bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm>
    <us-gaap:LoansPayableFairValueDisclosure
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzMtMy0xLTEtNzM1MzU_622d9eb4-ef87-4388-955d-e96b0914c83a"
      unitRef="usd">12119000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:LoansPayableFairValueDisclosure
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTozY2JiOGY2Mjg3MjI0NjFkYTA5MTUwYzc2NjgwZDk4MS90YWJsZXJhbmdlOjNjYmI4ZjYyODcyMjQ2MWRhMDkxNTBjNzY2ODBkOTgxXzMtNS0xLTEtNzM1MzU_b1092140-2ef5-420c-846d-0c819fff29c3"
      unitRef="usd">18537000000</us-gaap:LoansPayableFairValueDisclosure>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODE_4d9ee795-d76e-41fe-8e90-0ddb3145d486">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <bdx:MaturityPeriodOfShortTermInvestment
      contextRef="i330f829063eb4447ad6bc4456ceff4ec_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzk5Nw_f8996a3c-bc08-45fe-8959-54ce7aa9b5c3">P3M</bdx:MaturityPeriodOfShortTermInvestment>
    <bdx:MaturityPeriodOfShortTermInvestment
      contextRef="ide9bbd27a0cd44dcb98a452d6c22b67f_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwMTQ_53822d16-2ce7-4896-b9af-374fa9edf830">P1Y</bdx:MaturityPeriodOfShortTermInvestment>
    <us-gaap:AssetImpairmentCharges
      contextRef="i648b8dfd6eb548adbbd2d21365d6cde8_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwOTk1MTE2MzQwNzU_97917e1c-272a-46d5-ac27-b154a3f5c38a"
      unitRef="usd">11000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i277928b220f44e7784ead40b68440c9f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwOTk1MTE2MzQwODg_d8c0de21-e8b3-4139-8006-84a67fd41bfd"
      unitRef="usd">19000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i312ec77e4d634c4ea325786b43d11b2f_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEwOTk1MTE2MzMxODE_1a97096c-e484-410b-9b74-9308fce66b56"
      unitRef="usd">54000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i032efb1d86ce48d0909296f8cca53459_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzEzMjA_74b507fb-a215-48a4-9547-4f0ad87be66d"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i938377c8c70a4325b957640e0929f503_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzE0NjA_80340cc2-b5c9-4659-9794-7172d226bb89"
      unitRef="usd">57000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib0914146934c4a468cf609ab437f9bcd_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzE2MDI_0a5e9627-1e9e-4f4a-b6d2-276bd03959b4"
      unitRef="usd">41000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3ODc_67ffd4d4-bed3-4519-af12-718f2079b4a9">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company&#x2019;s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company&#x2019;s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.&lt;/span&gt;&lt;/div&gt;The Company continually evaluates its accounts receivables for potential collection risks, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#x2019; national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90ZXh0cmVnaW9uOmZiNDk1YTEyODkwYjRkNTA4YzRmNDliMGRjNDk2NmZlXzQ3NzQ_c67111d8-85c2-4e1b-b97a-b5bf1c887fe6">The amounts transferred and yet to be remitted under factoring arrangements are provided below. &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables transferred to third parties under factoring arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts yet to be collected and remitted to the third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzEtMS0xLTEtNzM1MzU_d52a9b3d-a06d-4c69-ba39-ca9f49c02c3b"
      unitRef="usd">1215000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzEtMy0xLTEtNzM1MzU_a4713eb7-8ec4-43cb-b882-c86572d02d36"
      unitRef="usd">1189000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <bdx:TransfersOfFinancialAssetsDuringThePeriod
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzEtNS0xLTEtNzYyNTI_b0a021a4-f735-41ac-b87b-b949a324ab52"
      unitRef="usd">1941000000</bdx:TransfersOfFinancialAssetsDuringThePeriod>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzItMS0xLTEtNzM1MzU_ec3be924-c2f8-4504-a74d-eb6a29fa7371"
      unitRef="usd">323000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMTgvZnJhZzpmYjQ5NWExMjg5MGI0ZDUwOGM0ZjQ5YjBkYzQ5NjZmZS90YWJsZTpjZWQzMWJlOTFkY2U0ZTMyYjU2NzZkMTQ4NjQ5NmZkMS90YWJsZXJhbmdlOmNlZDMxYmU5MWRjZTRlMzJiNTY3NmQxNDg2NDk2ZmQxXzItMy0xLTEtNzM1MzU_b3b44156-63ef-4f8c-bda4-bb09e1b301ad"
      unitRef="usd">118000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMjE_aa2fcdeb-050c-4f32-b758-c40d57eec58e">Debt&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Current debt obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current debt obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net of unamortized debt issuance costs, at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating Rate Notes due June 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.401% Notes due May 24, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.632% Notes due June 4, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000% Notes due August 13, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;All of the aggregate principal amount outstanding was retired during 2022, as further discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average interest rates for current debt obligations were 1.00% and 1.15% at September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;From time to time, the Company may access the commercial paper market as it manages working capital over the normal course of its business activities. The Company utilized commercial paper borrowings in the fourth quarter of  fiscal year 2022 of which $230&#160;million was outstanding as of September&#160;30, 2022. There were no such borrowings outstanding as of September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net of unamortized debt issuance costs, at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.401% Notes due May 24, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.632% Notes due June 4, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000% Notes due August 13, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.875% Notes due May 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.363% Notes due June 6, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.734% Notes due December 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.020% Notes due May 24, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.034% Notes due August 13, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.208% Notes due June 4, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.700% Notes due December 1, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900% Notes due December 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.700% Notes due June 6, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000% Debentures due August&#160;1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.700% Debentures due August&#160;1, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.334% Notes due August 13, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.823% Notes due May 20, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.957% Notes due February 11, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.298% Notes due August 22, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.213% Notes due February 12, 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.000% Notes due May&#160;15, 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.000% Notes due November&#160;12, 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.336% Notes due August 13, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.875% Notes due May 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.685% Notes due December 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.669% Notes due June 6, 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.794% Notes due May 20, 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;A portion of the aggregate principal amount outstanding was retired during 2022, as further discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents notes issued during 2022, as further discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate annual maturities of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; including interest during the fiscal years ending September&#160;30, 2023 to 2027 are as follows: 2023 &#x2014; $439 million; 2024 &#x2014; $1.574 billion; 2025 &#x2014; $2.019 billion; 2026 &#x2014; $951 million; 2027 &#x2014; $2.801 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current credit facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal year 2021, the Company refinanced its five-year senior unsecured revolving credit facility that was to expire in December 2022, with a new five-year senior unsecured revolving credit facility that will expire in September 2026. The credit facility provides borrowings of up to $2.75&#160;billion, with separate sub-limits of $100&#160;million for letters of credit and swingline loans. The expiration date of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;credit facility may be extended for up to two additional one year periods, subject to certain restrictions, including the consent of the lenders. The credit facility provides that the Company may, subject to additional commitments by lenders, request an additional $500&#160;million of financing, for a maximum aggregate commitment under the credit facility of up to $3.25&#160;billion. Proceeds from this facility may be used for general corporate purposes. There were no borrowings outstanding under the Company&#x2019;s revolving credit facilities as of September&#160;30, 2022 and 2021. In addition, the Company has informal lines of credit outside of the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Spin-off-related debt transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, Embecta, as a wholly-owned subsidiary of the Company, issued $500&#160;million of 5.000% senior secured notes due February 15, 2030, in advance of the Company&#x2019;s spin-off of Embecta, which is further discussed in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2022, Embecta entered into an indenture dated April 1, 2022 to issue $200&#160;million of 6.750% senior secured notes due February 15, 2030. These notes were issued to the Company as part of the consideration for assets transferred to Embecta in connection with the spin-off. After the spin-off was effective on April 1, 2022, the Company exchanged these notes for $199&#160;million of the aggregate principal amount outstanding on the Company&#x2019;s Floating Rate Notes due June 6, 2022, which were purchased through a tender offer. The carrying value of the long-term notes tendered was $199&#160;million, and the Company recognized a loss on this debt extinguishment of $2&#160;million, which was recorded in the third quarter of fiscal year 2022 within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on the Company&#x2019;s consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in connection with the spin-off, on March 31, 2022, Embecta issued a senior secured term loan facility with an aggregate principal amount of $950&#160;million and a senior secured revolving credit facility providing borrowings of up to $500&#160;million that was undrawn at March 31, 2022 and at the spin-off date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The senior secured notes and credit agreement for the term loan and revolving credit facilities were guaranteed on an unsecured, unsubordinated basis solely by the Company prior to the spin-off date.  The Company&#x2019;s guarantees automatically and unconditionally terminated upon the consummation of the spin-off on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2022, Embecta used a portion of the proceeds from the financing transactions discussed above to make a cash distribution of approximately $1.266&#160;billion to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt issuances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued the following U.S. dollar-denominated debt during fiscal years 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Use of proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.298% notes due August 22, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.957% notes due February 11, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement of 3.125% notes due November 8, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued the following Euro-denominated debt during fiscal year 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of Euros)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Use of proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000% notes due August 13, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;0.034% notes due August 13, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in fiscal year 2021, Becton Dickinson Euro Finance S.&#xe0; r.l., a private limited liability company (soci&#xe9;t&#xe9; &#xe0; responsabilit&#xe9; limit&#xe9;e), which is an indirect, wholly-owned finance subsidiary of the Company, issued Euro-denominated notes, listed below, which are fully and unconditionally guaranteed on a senior unsecured basis by the Company.  No other of the Company's subsidiaries provide any guarantees with respect to these notes.  The indenture covenants included a limitation on liens and a restriction on sale and leasebacks, change of control and consolidation, merger and sale of assets covenants.  These covenants are subject to a number of exceptions, limitations and qualifications.  The indenture does not restrict the Company, Becton Dickinson Euro Finance S.&#xe0; r.l., or any other of the Company's subsidiaries from incurring additional debt or other liabilities, including additional senior debt.  Additionally, the indenture does not restrict Becton Dickinson Euro Finance S.&#xe0; r.l. and the Company from granting security interests over its assets.  The notes issued by Becton Dickinson Euro Finance S.&#xe0; r.l included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of Euros)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Use of proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.334% notes due August 13, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.336% notes due August 13, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.213% notes due February 12, 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement of  0.174% notes due June 4, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt retirements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 8, 2022, the Company commenced a series of tender offers to purchase for cash, certain of its outstanding senior notes. Proceeds from the notes issued in the fourth quarter of fiscal year 2022 plus cash on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hand were used to pay for the tender offers. As a result of the tender, the Company&#x2019;s retirements of debt in fiscal year 2022 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal, interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period of retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market price of retirement (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) loss recognized to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other (expense) income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$190&#160;million of 3.794% notes due 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$52&#160;million  of 7.000% debentures due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$55&#160;million of 6.700% debentures due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$127&#160;million of 6.000% notes due 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34&#160;million of 5.000% notes due 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$42&#160;million of 4.685% notes due 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included accrued interest, related premiums, fees and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Debt retirement was accounted for as an early debt extinguishment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;To mitigate the impact of rate volatility on the total tender cash spend, the Company executed reverse Treasury locks that were unwound concurrent with the tender at a loss of $17&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s retirements of debt in fiscal year 2021 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal, interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period of retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market price of retirement (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Loss recognized to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other (expense) income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.535 billion of 2.894% notes due June 6, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$294 million of 3.300% notes due March 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$33&#160;million of 3.875% notes due May 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million of 3.734% notes due December 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$752&#160;million of 3.363% notes due June 6, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.0 billion of 3.125% notes due November 8, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600 million Euros ($728 million) of 0.174% notes due June 4, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$265 million of 2.894% notes due June 6, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included accrued interest, related premiums, fees and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;All debt retirements in fiscal year 2021 were accounted for as early debt extinguishments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%"&gt;Capitalized interest&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes interest costs as a component of the cost of construction in progress. A summary of interest costs and payments for the years ended September&#160;30 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid, net of amounts capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMDc_39d87bae-28f6-4f12-a689-46c67af680f4">The carrying value of &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current debt obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net of unamortized debt issuance costs, at September&#160;30 consisted of:&lt;/span&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating Rate Notes due June 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.401% Notes due May 24, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.632% Notes due June 4, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000% Notes due August 13, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;All of the aggregate principal amount outstanding was retired during 2022, as further discussed below.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i73e86db53cbf48f1950b3278e95c83d9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzEtMy0xLTEtMTI3NDIw_f44fabb4-a2d6-4f37-8148-198274e6f562"
      unitRef="usd">230000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i03fb827478bd461a8787df84f27802af_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzEtNS0xLTEtMTI3NDIw_72373cc1-ba92-43b4-8c28-8dfab48189bb"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzItMC0xLTEtNzYzMjYvdGV4dHJlZ2lvbjo0MmRhYzhkODQ5Mzg0YTlhOGQxZDM1ZmY5NjFhOGQ5M180_188879fb-2e87-4856-b76d-959e5f805dd0"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzItMy0xLTEtNzYzODg_b28e3cce-31e4-4406-aa1b-d62eb8a89dc6"
      unitRef="usd">487000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2d5f7f7d4aa34c8a8fe7242aaf64fce7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzItNS0xLTEtNzYzODg_f012142e-9419-4b9c-9722-38fcd3f56250"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i30a8bd1261794f438b0bd13c92aeb774_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzMtMy0xLTEtNzM1MzU_e4a808c4-d7f7-4122-9fad-54abdb0fcb89"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="id3617b6fd6934a64af7e251d421562bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzMtNS0xLTEtNzM1MzU_a518a267-fc8b-403a-acbb-47bc813c6a5b"
      unitRef="usd">500000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i19f42f3eb9b7429faccfa0ee07b6c3d8_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzQtMC0xLTEtMTIyMDk0L3RleHRyZWdpb246ZjlkOTU5N2E3ZjdkNDFhY2JmOWExYmNmNjI1ZmZlMThfMzg0ODI5MDY5NzI1NQ_c1729f36-a103-4014-bce0-4236e30e3a13"
      unitRef="number">0.01401</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="i19f42f3eb9b7429faccfa0ee07b6c3d8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzQtMy0xLTEtMTIyMDc5_f704baef-fcbf-49f0-a479-ae460ac6428c"
      unitRef="usd">292000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3348e3185c3a4d8faf23b030ca9b058a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzQtNS0xLTEtMTIyMDc5_71b5848c-477e-4d28-aa18-6ccdb94578f2"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtMC0xLTEtMTIyMTAwL3RleHRyZWdpb246ZmQyMjY4NDA1ZDVmNGExZGJjODUzYzNiY2I3MDFiZjdfMzg0ODI5MDY5NzI1NQ_d52a3b63-5e8b-4d3d-9af7-3bc9fa0fd643"
      unitRef="number">0.00632</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtMy0xLTEtMTIyMDc5_93ca9b23-9190-47f8-8fbf-98fda6369753"
      unitRef="usd">779000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i702a0883d82245dfb5727457b4bf121e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtNS0xLTEtMTIyMDc5_f055919e-ef92-4d90-884a-8f396cf71f9b"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzYtMC0xLTEtMTIyMTEzL3RleHRyZWdpb246MzY0MWVjZmE0ZWE5NGYyMzk5ZjhjODNhOGU1MDIxNzJfMzg0ODI5MDY5NzI1OA_170a9416-d5a8-4f3b-953f-a2f8acc71eb3"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzYtMy0xLTEtMTIyMDc5_fec9596d-69b7-494c-af9d-86b761fe5266"
      unitRef="usd">390000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib6b7239cbb2b4caa96217145ed318c6a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzYtNS0xLTEtMTIyMDc5_925828b4-f4f2-4889-b76b-41412837c487"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtMy0xLTEtNzM1MzU_3cb165d4-192e-4d1b-90ea-bd3919abd345"
      unitRef="usd">2179000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTphYjZhNjJlZjk1MGU0MWZkYjkxYWRlNThhODA2NDdlMy90YWJsZXJhbmdlOmFiNmE2MmVmOTUwZTQxZmRiOTFhZGU1OGE4MDY0N2UzXzUtNS0xLTEtNzM1MzU_c1362cfa-4ad7-45fd-81fd-43c2fcb625e5"
      unitRef="usd">500000000</us-gaap:DebtCurrent>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzMxNA_96c0ff20-920c-4e5e-b663-129968ac4742"
      unitRef="number">0.0100</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzMyMQ_0fc2f372-e33b-4337-bca8-6d05df2f852b"
      unitRef="number">0.0115</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermBorrowings
      contextRef="i73e86db53cbf48f1950b3278e95c83d9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzY1OTcwNjk3Nzc0Njk_99472741-44b8-4c66-9eac-33232fc36ede"
      unitRef="usd">230000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i03fb827478bd461a8787df84f27802af_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzkzNDU4NDg4NDQyOTc_d25aca54-3c02-4202-8173-d234be562605"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMTE_06f82cbb-9ae0-4c60-822b-ca955c37a64a">The carrying value of &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net of unamortized debt issuance costs, at September&#160;30 consisted of:&lt;/span&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.959%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.401% Notes due May 24, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.632% Notes due June 4, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000% Notes due August 13, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.875% Notes due May 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.363% Notes due June 6, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.734% Notes due December 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.020% Notes due May 24, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.034% Notes due August 13, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.208% Notes due June 4, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.700% Notes due December 1, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900% Notes due December 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.700% Notes due June 6, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000% Debentures due August&#160;1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.700% Debentures due August&#160;1, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.334% Notes due August 13, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.823% Notes due May 20, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.957% Notes due February 11, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.298% Notes due August 22, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.213% Notes due February 12, 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.000% Notes due May&#160;15, 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.000% Notes due November&#160;12, 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.336% Notes due August 13, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.875% Notes due May 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.685% Notes due December 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.669% Notes due June 6, 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.794% Notes due May 20, 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;A portion of the aggregate principal amount outstanding was retired during 2022, as further discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents notes issued during 2022, as further discussed below.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo4NGQwMGNlZTdkOGM0M2JhYjVlZjI3NDFkOTExMzVjOV80_188879fb-2e87-4856-b76d-959e5f805dd0"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzQtMy0xLTEtNzM1MzU_89aa34f2-534e-408b-b1b9-01ac3804ca68"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2d5f7f7d4aa34c8a8fe7242aaf64fce7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzQtNS0xLTEtNzM1MzU_345bbc79-b0d2-4c2b-aac0-a78c2a7e6e2b"
      unitRef="usd">579000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i95c59b4820ac446795f35fc603f13926_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjZmI5MDllZGVkODM0MTlmYmIxY2Y1MTAwMTE3Y2IwN180_e5cddbbc-40fb-416f-9214-966da652113d"
      unitRef="number">0.01401</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i95c59b4820ac446795f35fc603f13926_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzctMy0xLTEtNzM1MzU_7efe7ae2-0906-4be9-82b5-19c507fe8bc2"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic9a63b521162435da95e767ab599c1d3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzctNS0xLTEtNzM1MzU_d095e6a8-ab81-4ade-bd94-63a39f91ced4"
      unitRef="usd">347000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjowOGNiZDk1YjRmYmM0ZTI3YThmNjUxNzUxYjg5NzJkYV80_9e6c51a8-5ba9-43f4-b181-95685fd7a3b3"
      unitRef="number">0.00632</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib92d3fd233174393a0c8985d57b80ac0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzgtMy0xLTEtNzM1MzU_c710c5b0-14de-4c22-bf67-b9e19575b206"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i702a0883d82245dfb5727457b4bf121e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzgtNS0xLTEtNzM1MzU_6a113ba7-7325-40bf-8271-e98212177ab8"
      unitRef="usd">926000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzktMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1MWZlZDFkNGY0Y2Y0OWVjODY2OGE4Zjc3MWIxNWJhN180_87f85af1-012f-4360-85a6-f52eabff4739"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i12bf8edf84ca4a9490012af58b404885_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzktMy0xLTEtNzM1MzU_b1a19c37-2dbe-4750-aad9-8f7710ccbe36"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib6b7239cbb2b4caa96217145ed318c6a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzktNS0xLTEtNzM1MzU_8191cb3a-89e2-4559-a309-e1a4a1f1ac53"
      unitRef="usd">463000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic410939d905842db8f020e0dd78f97ad_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEwLTAtMS0xLTczNTM1L3RleHRyZWdpb246MTcyYjA0NTVlZGM1NDE3ZGJlOTFlMjkzMTBkYjQ5YzFfNA_92e58b20-d08b-4e5a-9252-0c35b1fa8d6e"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic410939d905842db8f020e0dd78f97ad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEwLTMtMS0xLTczNTM1_63d4a532-6247-4f52-9680-2a3f5d144ce9"
      unitRef="usd">145000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEwLTUtMS0xLTczNTM1_9f88f56b-8acc-4a11-a948-9c57d3da45c0"
      unitRef="usd">146000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1935866626bf4551abb766287f4f12bb_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzExLTAtMS0xLTczNTM1L3RleHRyZWdpb246NjQ5YzJjY2RkZTA2NDhjZmE2MTg3N2M2OTg0MzE1OTJfNA_c12aef63-e20e-47cc-9a50-fe77176dae5e"
      unitRef="number">0.03363</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1935866626bf4551abb766287f4f12bb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzExLTMtMS0xLTczNTM1_34ebf06b-2d86-47bf-b504-c27d7ac2a52a"
      unitRef="usd">996000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzExLTUtMS0xLTczNTM1_f0d0ed38-4498-45b4-87f0-1366520a84f7"
      unitRef="usd">994000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd801a10d19e41d48e55e40566722456_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEyLTAtMS0xLTczNTM1L3RleHRyZWdpb246MzdjNDY3NDlkZWE0NDMwOWJiYWIxZGViODg5YzRkNzVfNA_02e78ac2-9285-4f91-ae16-8046f9b10975"
      unitRef="number">0.03734</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifd801a10d19e41d48e55e40566722456_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEyLTMtMS0xLTczNTM1_9e5da7f2-4985-45c9-b442-36cebaf9308f"
      unitRef="usd">873000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEyLTUtMS0xLTczNTM1_7a1d4f57-4349-41b1-9303-c31e143a38c3"
      unitRef="usd">873000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5eaa388c48eb48529b863b1dad0c7c66_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEzLTAtMS0xLTczNTM1L3RleHRyZWdpb246OTc5Mjk1OGRlMmJmNDMyOTliYTc1OTA5YWJlNzZlNGFfNA_208497c9-bec8-4b12-8d57-06ce3bdaeb4f"
      unitRef="number">0.03020</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5eaa388c48eb48529b863b1dad0c7c66_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEzLTMtMS0xLTczNTM1_ad4a6db5-efb7-40f0-bc56-3c3d995dd436"
      unitRef="usd">275000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icb65fb27ea394d7bab72c0b7eacb98e7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzEzLTUtMS0xLTczNTM1_d0747207-2e1a-48f1-a139-023dcba8c7c0"
      unitRef="usd">336000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i83c4aa1f41194aa4802d0e4036ca000d_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE0LTAtMS0xLTczNTM1L3RleHRyZWdpb246NDMzYjQxYThjMTcwNGU5Y2EyOTE4ZDM4MDYxODE3NGZfNA_b7507579-adcc-453e-9db7-570cf0d0eb2e"
      unitRef="number">0.00034</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i83c4aa1f41194aa4802d0e4036ca000d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE0LTMtMS0xLTczNTM1_9a2bd7a9-8991-42a1-8cb2-6924f770c662"
      unitRef="usd">485000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia9406b7f8b0d4bcb819b52eef9ed6c98_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE0LTUtMS0xLTczNTM1_3fd718e0-2145-4806-a1e5-e970ff57fbdd"
      unitRef="usd">577000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i68bc0f1d591947e198044880214c84e2_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE1LTAtMS0xLTczNTM1L3RleHRyZWdpb246MjQ5NTE3MmRmNDE3NDQwZTk1M2RhZDhjNGNjNzM1ZGRfNA_6e6c91d5-59f6-4fac-beb3-ae8d296d796f"
      unitRef="number">0.01208</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i68bc0f1d591947e198044880214c84e2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE1LTMtMS0xLTczNTM1_2f164cac-8ea9-451d-b41f-43fa93dfe386"
      unitRef="usd">583000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i365b69b186eb4841aeadfd7470683467_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE1LTUtMS0xLTczNTM1_0da616b6-b53d-41a3-acdb-5944c12dd90c"
      unitRef="usd">693000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i071e4371c19b435eabf32db0df89d6b8_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE2LTAtMS0xLTczNTM1L3RleHRyZWdpb246NTkzZTczZWFlZmEzNDhlMDhmZTk1ZDM2NDBhMDFlNzVfNA_2251c8d6-fe79-4cc0-aedd-b1a3cafc997c"
      unitRef="number">0.06700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i071e4371c19b435eabf32db0df89d6b8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE2LTMtMS0xLTczNTM1_6acc201b-f6f1-420e-a4cc-d722561e4fa6"
      unitRef="usd">165000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia0d41b365cba499bbdc2091259476a27_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE2LTUtMS0xLTczNTM1_8db4fd40-3864-41a0-b9e3-2edf13134d78"
      unitRef="usd">168000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i05fd68b08a7b426eb6811e05f0b4a888_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE3LTAtMS0xLTczNTM1L3RleHRyZWdpb246M2U4NmNjZTc0MmMxNDUxYWIwZTMzY2IzYWE1YmE1N2RfNA_c6416ab4-1caa-4bdf-9f5d-fd5d1af95cdf"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i05fd68b08a7b426eb6811e05f0b4a888_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE3LTMtMS0xLTczNTM1_a69e8de4-1dc8-411b-b56c-51c14318bef5"
      unitRef="usd">485000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5eb793b910104ba58a06b3d19b079980_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE3LTUtMS0xLTczNTM1_689d08f0-1e6e-4692-a449-5693af62b451"
      unitRef="usd">577000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i53130d0da5f34bd5a6206bb574cd0646_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE4LTAtMS0xLTczNTM1L3RleHRyZWdpb246MjBiOWU4MDhhMDI0NGRlY2FjYTI4YTAwN2IzMDkyNTlfNA_12371d29-3d5b-432a-bb42-5f36ec628d20"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i53130d0da5f34bd5a6206bb574cd0646_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE4LTMtMS0xLTczNTM1_07833df0-d0da-41f0-8b8d-4d878ddf9c4d"
      unitRef="usd">1718000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idcea25fd00bb44f49a60939195013440_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE4LTUtMS0xLTczNTM1_973948c5-747a-43ea-8b83-77e50aeffd6e"
      unitRef="usd">1716000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE5LTAtMS0xLTczNTM1L3RleHRyZWdpb246NDVlZDg3NDEyNTkzNDRiZjgyZDNiZDgyNTcxMTBlYTlfNA_babfac03-1470-44e3-b244-47d4c7ed5aff"
      unitRef="number">0.07000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE5LTMtMS0xLTczNTM1_1494cc94-eab5-4a60-865e-ab7c9062ed7d"
      unitRef="usd">119000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i05399f1c63e149d4950728ad77213bd5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzE5LTUtMS0xLTczNTM1_2f0ceb90-4129-4938-85b4-b5f33c7af49b"
      unitRef="usd">174000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTAtMS0xLTczNTM1L3RleHRyZWdpb246YjFjODNiMWIyYjYyNGFmNDg5N2E0ODk4ZGUxZTAyMzZfNA_034a0f23-193c-448b-b6c9-5fe34b930326"
      unitRef="number">0.06700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTMtMS0xLTczNTM1_de863a15-7d65-451b-847f-a4dd01e17e55"
      unitRef="usd">116000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i985f9c0cd4e740d3aa74db4e83626a95_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTUtMS0xLTczNTM1_feace972-5a39-4b8b-bf0c-4957fe8fc64f"
      unitRef="usd">173000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd7ed43ce46648ddad0381b46f2d1b52_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIxLTAtMS0xLTczNTM1L3RleHRyZWdpb246NDkxY2U3NTJhMmE4NGE4NDk4ZDhlNGM1MTgzYzNiMGFfNA_4a1874f8-7bf1-4a3f-8931-3cb3a4bb8853"
      unitRef="number">0.00334</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifd7ed43ce46648ddad0381b46f2d1b52_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIxLTMtMS0xLTczNTM1_76b98c10-e551-4c3b-9924-dd0e521463c3"
      unitRef="usd">872000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ief27c89ab80f4c94b4ad781ba05245ae_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIxLTUtMS0xLTczNTM1_c7c7cbc0-cede-4d35-aa88-5b558f89eab9"
      unitRef="usd">1037000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i597528406ad4432080c7b790975f5a70_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIyLTAtMS0xLTczNTM1L3RleHRyZWdpb246NTc0ZjU3ODliNjRhNDc4MzlhMGNlMWU4ZTQ3MDVkY2NfNA_4ce6c54b-7ba3-4f35-a157-7045db18b410"
      unitRef="number">0.02823</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i597528406ad4432080c7b790975f5a70_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIyLTMtMS0xLTczNTM1_bba3374d-5946-4211-bc7a-889255b5bfa7"
      unitRef="usd">745000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if9850b5968694db493ee80a1a80fc434_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIyLTUtMS0xLTczNTM1_43d88abf-505c-412c-8e87-f37e031dae20"
      unitRef="usd">744000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3605fcabb8994cffb101c033d2307325_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIzLTAtMS0xLTczNTM1L3RleHRyZWdpb246ZDJkMWU4M2RhNjY4NDM3Yjk2YWE0Yjk4ZDJmYjc0ZmJfNA_b11cf45e-e3c0-4465-b1db-72776616a317"
      unitRef="number">0.01957</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3605fcabb8994cffb101c033d2307325_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIzLTMtMS0xLTczNTM1_621b31ca-ec68-45b5-84c4-9be9d3a669d3"
      unitRef="usd">992000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id7bccee58c364c979aa7b39b610a38ab_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIzLTUtMS0xLTczNTM1_1cd0516b-fdce-42ad-982a-373af81daf0b"
      unitRef="usd">992000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTAtMS0xLTEwNTc3MS90ZXh0cmVnaW9uOjYzNjg3OTNkM2QwZDQ4ZWY4MzllZGM4Yjk0ODdiNmNmXzQ_c6a29db4-b8e1-48a7-91c3-b21055859ebe"
      unitRef="number">0.04298</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTMtMS0xLTEwNTc2NQ_e6dd4f32-0585-40a9-abd1-f6a14e682c92"
      unitRef="usd">495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie17bfcc9d30b4c22988228770a9646df_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzIwLTUtMS0xLTEwNTc2NQ_a8b0ed12-da6a-4a74-bce8-a073b1c4981e"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i686038d3973d4dd3b99c9b7c97fdda7a_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI0LTAtMS0xLTczNTM1L3RleHRyZWdpb246NDVlMWI2NTViZWJjNDMwNWI1NGFiZjczN2UzMjJlOTdfNA_283e8047-9049-45cd-bf67-e2462da6d8ac"
      unitRef="number">0.01213</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i23650c82023d4075b7451afcab116d86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI0LTMtMS0xLTczNTM1_fdd09068-4e11-438a-859f-14e6b4dc5630"
      unitRef="usd">580000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i602de84cb42e475798daa51154634938_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI0LTUtMS0xLTczNTM1_d8e18978-128b-407e-a612-31d0b200a091"
      unitRef="usd">690000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI1LTAtMS0xLTczNTM1L3RleHRyZWdpb246ZmRkNzJkNzRjNjVjNGY3ZGFlM2Q2OTk2MWYxZWY4NDZfNA_a7c2a846-cd8e-4c16-ba62-c4a9b7310fcb"
      unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI1LTMtMS0xLTczNTM1_1efe9cf5-fa05-4584-9c82-f6cdc7c3dd99"
      unitRef="usd">121000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic4f072271fd54749be6519ce7a4cb656_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI1LTUtMS0xLTczNTM1_01c85f1f-5616-4615-87f3-97e3731c1e89"
      unitRef="usd">246000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id83e438c828a47659e4ba879ee36b614_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI2LTAtMS0xLTczNTM1L3RleHRyZWdpb246MWRlYWVlZDA1ODYwNGZkZmIzZjQ5NmQ0ZDk3YjBhNjRfNA_3101370d-b855-48c9-bbd0-e170e9547f2a"
      unitRef="number">0.05000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id83e438c828a47659e4ba879ee36b614_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI2LTMtMS0xLTczNTM1_8e1fb521-8f1e-42f1-9815-ba5144c12b93"
      unitRef="usd">90000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia5ad1135b73947ef9ed5193babf7878e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI2LTUtMS0xLTczNTM1_04198951-e93e-4f66-aa41-8729f35b09f8"
      unitRef="usd">124000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6229439c652442adbe136afeff494f38_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI3LTAtMS0xLTczNTM1L3RleHRyZWdpb246YmFjYjg5ZGI2NDk3NDgzZGJkNzNjMjU3N2NjOTk5NzdfNA_fb610759-e385-4125-991b-2f312a48483b"
      unitRef="number">0.01336</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6229439c652442adbe136afeff494f38_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI3LTMtMS0xLTczNTM1_97066453-3736-4358-9c95-6476a0dca0ed"
      unitRef="usd">869000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9f5624d7d8e14e90943f68d463e69f40_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI3LTUtMS0xLTczNTM1_9e9bf3aa-ef6e-492c-ac78-4f9e2583af95"
      unitRef="usd">1034000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifaa71c7f48a44190bbfc9f05ea58cfb9_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI4LTAtMS0xLTczNTM1L3RleHRyZWdpb246YTNjNDI0ZGJlYTQ0NDNlNjlmOWY0ZDljYjhlYzJkNjJfNA_d31f285c-e18b-427b-a77b-b04e28d5631c"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifaa71c7f48a44190bbfc9f05ea58cfb9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI4LTMtMS0xLTczNTM1_f18d7264-db1a-483a-a2cf-122faa2693c1"
      unitRef="usd">246000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib71ac3489c92480f87da9461658618ea_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI4LTUtMS0xLTczNTM1_4c15a358-9193-4cde-9033-a5e1bcb6cf12"
      unitRef="usd">246000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI5LTAtMS0xLTczNTM1L3RleHRyZWdpb246MDUxOGFjMTgwMGRhNDdhOTliNmY3NGYyODg0OTNhOWNfNA_7e149b21-79c1-47a6-ab2e-a9aa2658b716"
      unitRef="number">0.04685</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI5LTMtMS0xLTczNTM1_7bee6db7-7e9e-48a3-872b-a2f9d978f0ef"
      unitRef="usd">911000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i569682f1363b43b89ccf1234c5278a9f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzI5LTUtMS0xLTczNTM1_9d647fea-bbfe-4fd7-b87c-5ffb7da7ba0f"
      unitRef="usd">1033000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a74c7bd3dcf442eae90093915052162_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMwLTAtMS0xLTczNTM1L3RleHRyZWdpb246ZmUwMDgzYjRiMTZhNDFmZmEzOGQ4NjEwNDA0NDU1YTJfNA_dffeb5ae-4f97-453b-a3fb-bd7632976ac2"
      unitRef="number">0.04669</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6a74c7bd3dcf442eae90093915052162_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMwLTMtMS0xLTczNTM1_644deafd-2096-4274-9cc1-db97c1951559"
      unitRef="usd">1449000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia718f431cd534f328b232c9f48b09e22_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMwLTUtMS0xLTczNTM1_7f400e84-5e82-4a54-92b1-9088e84dd78e"
      unitRef="usd">1481000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMxLTAtMS0xLTczNTM1L3RleHRyZWdpb246MmFlMGZjZjk5YjIyNDJjYWEyMTk4NGQzYWE5MjdlYzZfNA_e6befd63-82e0-4051-a481-dd823b88b1f6"
      unitRef="number">0.03794</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMxLTMtMS0xLTczNTM1_4a90b918-cacd-4f33-935e-1063602c2f09"
      unitRef="usd">554000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9f0d22cd43c3455081ebb8c94a57c5b9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMxLTUtMS0xLTczNTM1_3eb3ac7a-ef28-4adf-8e6a-1f15fd9361cc"
      unitRef="usd">742000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMzLTMtMS0xLTczNTM1_2d2f5e05-23ae-4b36-a117-fe046db2fa8f"
      unitRef="usd">13886000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTpmNWM1ZDhkYmMyNWI0OWEyYWU1ZmJlNzk1NmY4YmMyMi90YWJsZXJhbmdlOmY1YzVkOGRiYzI1YjQ5YTJhZTVmYmU3OTU2ZjhiYzIyXzMzLTUtMS0xLTczNTM1_1e9c5437-69c7-485c-8d78-c06798982804"
      unitRef="usd">17110000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgwNA_95f1d146-caa3-4d60-9a1b-ae71538cd672"
      unitRef="usd">439000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgxMw_e3c4b223-8501-4446-8349-a9452309d77f"
      unitRef="usd">1574000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgyMg_d9931236-6b07-4ecd-bbf6-79b3e94d0934"
      unitRef="usd">2019000000.000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzgzMQ_8bef8f93-fd80-4a30-b0a1-c098c1c42b90"
      unitRef="usd">951000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzg0MA_0143882c-092a-4ad1-8f43-366998bb1c49"
      unitRef="usd">2801000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic7ea78107cfd48079574408788ac59cf_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQyOTY_89bec9e3-14bf-4915-8581-9fcef71fe174">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic7ea78107cfd48079574408788ac59cf_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMTg_0a3642e5-bba1-49fe-8919-ad8c0dbc4ceb">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i74d9c4caf0fe4fe0890096aea18a076d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzExODc_454b7e52-ea14-4f88-894f-26cd0ed3a819"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <bdx:SwinglineLoansIssuableUnderCreditFacility
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEyMTk_02f52338-0f74-4f0e-814d-9433109a6344"
      unitRef="usd">100000000</bdx:SwinglineLoansIssuableUnderCreditFacility>
    <bdx:LettersOfCreditIssuableUnderCreditFacility
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEyMTk_b1b5316f-af22-4d84-af90-54580a3fec0d"
      unitRef="usd">100000000</bdx:LettersOfCreditIssuableUnderCreditFacility>
    <bdx:LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE1NTk_cb1acf9b-2dc1-4851-a2e6-f29bb8e228e9"
      unitRef="usd">500000000</bdx:LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE2NDY_08df4860-bdec-4d81-8a5b-5857d4676b8b"
      unitRef="usd">3250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i9bbe00aadffe4e36a0990b8bfd4542ca_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE3MzM_647abdd1-2ec2-448a-91eb-f99634be31d2"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i5b97cd83431a46e9b8ff128d63380b1e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzE3MzM_8f0d4265-c644-4376-925f-28ad0cc639ac"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i763be4649bed40309ea0a989f6d8495f_I20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyMzQ_fc0a4d5f-8c4a-4d1a-86a5-e7d34510e22f"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i763be4649bed40309ea0a989f6d8495f_I20220228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNDg_07a21121-a07d-4a29-a30f-56a58a817522"
      unitRef="number">0.05000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ief9c3d8df6124fd9ae43c6a9f513637b_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNTY_eafbcf01-710c-4a53-a33a-13b7aab5c7b6"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ief9c3d8df6124fd9ae43c6a9f513637b_I20220401"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNzA_32f7a58b-9d54-4393-883f-ab31a6e745dd"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i0969e888373e4049877b7174d7c5bddd_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyNzg_ccfc8911-4e69-4274-b1a5-6191723b5fed"
      unitRef="usd">199000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ida7543d2dde946539fa775f189e5666f_I20220401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUyOTI_97c5fee8-e9e1-4bd9-9365-1a92d4d61532"
      unitRef="usd">199000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ia025880105b44439b3c131cb16841016_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzMDY_81cacedb-3095-4bd6-83d2-fb2ea476125c"
      unitRef="usd">-2000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7c3cc867b1a746999043d8c1873c5582_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzNDA_dd2ecddd-616a-4be2-b8b1-8b1d3cecadd7"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i2153de5b147d447da55f5389dd07896d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzMjY_de461cf3-93c7-4914-a4b8-74d7537c8370"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i779c08f21c7145b69a3c73a02acd692f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzEwOTk1MTE2MzUzNTQ_58070dfd-94ed-4de8-a34b-fcdfe4e51555"
      unitRef="usd">1266000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bdx:ScheduleOfDebtIssuancesTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMTI_b021b9a6-9f9c-434f-91a6-7a84e8b8dd35">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued the following U.S. dollar-denominated debt during fiscal years 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Use of proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.298% notes due August 22, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.957% notes due February 11, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement of 3.125% notes due November 8, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued the following Euro-denominated debt during fiscal year 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of Euros)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Use of proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000% notes due August 13, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;0.034% notes due August 13, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The notes issued by Becton Dickinson Euro Finance S.&#xe0; r.l included the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of Euros)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount issued (Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Use of proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.334% notes due August 13, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.336% notes due August 13, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021 retirements detailed below&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.213% notes due February 12, 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement of  0.174% notes due June 4, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bdx:ScheduleOfDebtIssuancesTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtMC0xLTEtMTA0MzMwL3RleHRyZWdpb246YWVjY2FhYjliMzNjNDkwNDg3MjNiOTY4YTM1NTE0ZDlfNDM5ODA0NjUxMTE2Mw_aac1a020-e1e3-4ac9-97da-047ac4d5b877"
      unitRef="number">0.04298</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if2b4350bb9ae4ba0857cd83d2243daa2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtNC0xLTEtMTA0MzI0_e25c00b3-35b5-47b7-a41c-9fc4fa07bf8c"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib82c168f755943beb76474f81ed94633_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyMjAwOTgzYTc1ZWE0Nzk0YjQ1MGYwMjgyMmExMTlmYV80Mzk4MDQ2NTExMTc3_a02271ea-6333-4e90-97bc-b22bbe72adca"
      unitRef="number">0.01957</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib82c168f755943beb76474f81ed94633_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtNC0xLTEtNzM1MzU_3d95e92c-5424-4f80-8f9d-f93204caf27f"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3ODZhNTNmZTk5Y2E0ZWQ1OTUyMTBhMDg4ZDMwMjU0OS90YWJsZXJhbmdlOjc4NmE1M2ZlOTljYTRlZDU5NTIxMGEwODhkMzAyNTQ5XzEtNi0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplYzMwMWQzM2U4ZTU0YTE1YWNkYzQxOTUzNzA4NDNiMF8xMDk5NTExNjI3ODI1_9efe08e9-095c-445c-9127-a499c7632c5f"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6b7239cbb2b4caa96217145ed318c6a_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjOWZlMDI5MjY4ZDc0MmI5YjA4MDJjZjRiM2UyZTQ2YV80OTQ3ODAyMzI1MDI0_a3152ef2-958b-47d6-bfbb-2fb70b44a1a9"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if092f20bc6ba47ee829e82597aec9760_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzEtNC0xLTEtNzM1MzU_5c60914f-103e-4953-ac1f-38f28a2c68c8"
      unitRef="eur">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i26010aaa94984bc6b48f50c2340e67af_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzEtNi0xLTEtNzM1MzU_41314b8b-e502-4169-a381-fecf92de4c00"
      unitRef="usd">470000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia9406b7f8b0d4bcb819b52eef9ed6c98_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpmMDQ1Mzg0ZTMzYzI0ZGU1YjIwNjdkNWFmNjhkY2Y4NV80OTQ3ODAyMzI1MDQ0_5eaac8ec-bc5d-4094-b216-e6bd50d641e8"
      unitRef="number">0.00034</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie33b2738d7da4d69943646d03c93abc3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzItNC0xLTEtNzM1MzU_44d47cf4-708c-4e32-8f45-0b8fdf09d070"
      unitRef="eur">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia31af2fbf9574b50a43cb3846510c6a5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo0OTU2ODcxY2ZlY2M0YmJmYTdiOTAwYmRiZWZmYjMwYy90YWJsZXJhbmdlOjQ5NTY4NzFjZmVjYzRiYmZhN2I5MDBiZGJlZmZiMzBjXzItNi0xLTEtNzM1MzU_6657799c-2582-417d-8657-8c1aa43f393e"
      unitRef="usd">587000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ief27c89ab80f4c94b4ad781ba05245ae_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxODkxNWM1ZGE3Y2Y0N2IwYWQ3NmZmNTY2ZGY1YmU5OF80Mzk4MDQ2NTExMTM2_82e3891f-3b1e-494c-a7a6-7c9e06c60b0b"
      unitRef="number">0.00334</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i96c8b23a3f8e4af4ae8c1da6663b9bdc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzEtNC0xLTEtNzM1MzU_ce51a60b-9b0d-4bca-bb64-0da708a19bc0"
      unitRef="eur">900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3860e3f6433948fe91197f9214f8ee03_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzEtNi0xLTEtNzM1MzU_082addd5-1c19-4aef-9d61-f304178ff582"
      unitRef="usd">1055000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9f5624d7d8e14e90943f68d463e69f40_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplOGE5MzgyNzE3YTQ0OTk0YjFmZWVmMTRhNGYzMDIzY180OTQ3ODAyMzI1MDI0_fa86c2e9-6e1d-484b-8739-f1f479a63b7c"
      unitRef="number">0.01336</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iebef67ca020b4e9190319bea0f3427b3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzItNC0xLTEtNzM1MzU_3065da83-30b5-4a88-b945-5e5a5535c8b1"
      unitRef="eur">900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0c6939f1f5044d25973438c5911a2a59_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzItNi0xLTEtNzM1MzU_3377a420-de67-4925-b66c-bb16c53e1032"
      unitRef="usd">1055000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i686038d3973d4dd3b99c9b7c97fdda7a_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1M2VjNjc3NDY2NjA0MTdhODJhZDIxZDRmODA5MGEwMV80OTQ3ODAyMzI1MDM0_3a490424-58c3-4d83-8ff4-5c1d2add39e8"
      unitRef="number">0.01213</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6f7d0235eba84a0698944deb7ab704a7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtNC0xLTEtNzM1MzU_716c2912-80f0-44ea-8fad-fe37f3d800b5"
      unitRef="eur">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9c474d65be064b50ab5658c993941100_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtNi0xLTEtNzM1MzU_fce3bc40-2d0c-489f-99bb-72b8626cf45a"
      unitRef="usd">728000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i51961b234cd24495af06e60749af2c1c_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTo3YjIxZDNjZTVhYzU0MGEwYjcwNGUxZWJlZDcxNjc4Mi90YWJsZXJhbmdlOjdiMjFkM2NlNWFjNTQwYTBiNzA0ZTFlYmVkNzE2NzgyXzMtOC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo4ODdjMTc3YzIzMDE0NmMwOGI2Y2QwN2M0MTU4MGE4OF8xMDk5NTExNjI3ODIy_1f9b562c-39d2-42c0-b7cb-0fafcafa5418"
      unitRef="number">0.00174</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQyOTk_fb1bb396-c00a-4cac-aa75-b284e610a0c8">On August 8, 2022, the Company commenced a series of tender offers to purchase for cash, certain of its outstanding senior notes. Proceeds from the notes issued in the fourth quarter of fiscal year 2022 plus cash on &lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hand were used to pay for the tender offers. As a result of the tender, the Company&#x2019;s retirements of debt in fiscal year 2022 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal, interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period of retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market price of retirement (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) loss recognized to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other (expense) income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$190&#160;million of 3.794% notes due 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$52&#160;million  of 7.000% debentures due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$55&#160;million of 6.700% debentures due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$127&#160;million of 6.000% notes due 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$34&#160;million of 5.000% notes due 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$42&#160;million of 4.685% notes due 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included accrued interest, related premiums, fees and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Debt retirement was accounted for as an early debt extinguishment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;To mitigate the impact of rate volatility on the total tender cash spend, the Company executed reverse Treasury locks that were unwound concurrent with the tender at a loss of $17&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s retirements of debt in fiscal year 2021 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal, interest rate and maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Period of retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market price of retirement (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Loss recognized to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other (expense) income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.535 billion of 2.894% notes due June 6, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$294 million of 3.300% notes due March 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$33&#160;million of 3.875% notes due May 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million of 3.734% notes due December 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$752&#160;million of 3.363% notes due June 6, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fourth quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.0 billion of 3.125% notes due November 8, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600 million Euros ($728 million) of 0.174% notes due June 4, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$265 million of 2.894% notes due June 6, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First quarter 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included accrued interest, related premiums, fees and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;All debt retirements in fiscal year 2021 were accounted for as early debt extinguishments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItMC0xLTEtNzY0MzIvdGV4dHJlZ2lvbjpiMGU1YjU0YjMyMGE0MTc1YTE2YTdlZTI1YzUwN2UyNF8xMDk5NTExNjI3ODI5_bc86da77-3938-479f-9464-5bce3660246a"
      unitRef="usd">190000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItMC0xLTEtNzY0MzIvdGV4dHJlZ2lvbjpiMGU1YjU0YjMyMGE0MTc1YTE2YTdlZTI1YzUwN2UyNF8xMDk5NTExNjI3ODQx_e6befd63-82e0-4051-a481-dd823b88b1f6"
      unitRef="number">0.03794</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id280f6f5f1b54db287e925bcaab334b3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItNC0xLTEtMTA1NzI1_5a99f8ef-e895-4734-9f75-9199ad968af1"
      unitRef="usd">188000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i3695003b616b4e0d81066f1f96ec98c6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItNi0xLTEtMTA1NzI1_a359cc2e-4c2f-478f-a20e-f0522b747fec"
      unitRef="usd">163000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="idfdde262f537472fb65210d2b884f533_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzItOC0xLTEtMTA1NzI1_fab162dc-b770-4c04-8138-c2ef7a785134"
      unitRef="usd">25000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtMC0xLTEtMTA1NjY1L3RleHRyZWdpb246MmM0OTBiYzgyNDAwNDUxZTlkYzdiM2RiNWQxMzM1ZmJfMTA5OTUxMTYyNzgzMg_23d19f4c-2d86-417f-b92e-7a465aaf1f06"
      unitRef="usd">52000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtMC0xLTEtMTA1NjY1L3RleHRyZWdpb246MmM0OTBiYzgyNDAwNDUxZTlkYzdiM2RiNWQxMzM1ZmJfMTA5OTUxMTYyNzg0NQ_babfac03-1470-44e3-b244-47d4c7ed5aff"
      unitRef="number">0.07000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iafab5391deac4533b6a6ac832b19ac87_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtNC0xLTEtMTA1NzI3_ab95b95c-209a-4240-8567-fa440c841d86"
      unitRef="usd">54000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i38ea59a9bc0045368162126cf4bedf68_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtNi0xLTEtMTA1NzI3_bf79d714-3d6b-4b52-bc1b-43e563744676"
      unitRef="usd">59000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i2d239a7d2eab44538b07a8dbbcd8458d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzMtOC0xLTEtMTA1NzI3_2a24057c-74d6-417b-b68c-546ea16bd319"
      unitRef="usd">-5000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtMC0xLTEtMTA1NjcxL3RleHRyZWdpb246MDBiYTk0Njk3Y2FjNGJkYzg4Y2FkZWIwNzA5YTE2ZGNfMTA5OTUxMTYyNzgzMg_345e0058-3971-4775-9809-bb3084530c67"
      unitRef="usd">55000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtMC0xLTEtMTA1NjcxL3RleHRyZWdpb246MDBiYTk0Njk3Y2FjNGJkYzg4Y2FkZWIwNzA5YTE2ZGNfMTA5OTUxMTYyNzg0NA_034a0f23-193c-448b-b6c9-5fe34b930326"
      unitRef="number">0.06700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if530e7153ede42babf75d9614ea2fed3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtNC0xLTEtMTA1NzI3_3395a1d5-7cdc-450d-a31c-c4a109deac90"
      unitRef="usd">56000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="ib1712e718c2c4f059e63b730ad6912b7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtNi0xLTEtMTA1NzI3_e5c5b613-5505-4839-a78b-3355a34e1161"
      unitRef="usd">62000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ic7602efcbb12497fa6ca035a193d108a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzQtOC0xLTEtMTA1NzI3_bef00d71-fb85-42d9-8ef6-49fe14d8693a"
      unitRef="usd">-5000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtMC0xLTEtMTA1Njc3L3RleHRyZWdpb246OWQ3M2M1ZmY0ZjAyNGRhZWE5YjllMmVhYzIyMmY5YjRfMTA5OTUxMTYyNzgyOQ_2ff4f8cb-faed-4e7d-8b3d-7ee2e5d8fb47"
      unitRef="usd">127000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtMC0xLTEtMTA1Njc3L3RleHRyZWdpb246OWQ3M2M1ZmY0ZjAyNGRhZWE5YjllMmVhYzIyMmY5YjRfMTA5OTUxMTYyNzg0MQ_a7c2a846-cd8e-4c16-ba62-c4a9b7310fcb"
      unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic32b723311b347478e48a35ca4f68e40_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtNC0xLTEtMTA1NzI3_7750e866-c470-42e9-9fd6-879b0e6b58b3"
      unitRef="usd">125000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i6ac145c8106242f789a62759ee65edc0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtNi0xLTEtMTA1NzI3_77896ec1-2939-42d2-921c-d390840db761"
      unitRef="usd">145000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ibfd421b62f5a4ac2bf277725abb3c4dd_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzUtOC0xLTEtMTA1NzI3_36e3a222-c0a8-46b8-9b7f-c3437ac7e2e3"
      unitRef="usd">-20000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="id83e438c828a47659e4ba879ee36b614_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtMC0xLTEtMTA1NjgzL3RleHRyZWdpb246MGNhMWIyOGI1MjhjNDA5NGJmY2YxZDNmOTY3NTQ5ZDFfMTA5OTUxMTYyNzgyNw_3a2cce11-32d3-4ac3-974c-660e3b6065c1"
      unitRef="usd">34000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id83e438c828a47659e4ba879ee36b614_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtMC0xLTEtMTA1NjgzL3RleHRyZWdpb246MGNhMWIyOGI1MjhjNDA5NGJmY2YxZDNmOTY3NTQ5ZDFfMTA5OTUxMTYyNzgzOQ_3101370d-b855-48c9-bbd0-e170e9547f2a"
      unitRef="number">0.05000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i68d32099e1bf4a3fa5b0b39913d35e39_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtNC0xLTEtMTA1NzI3_888d2109-fdbf-437f-82bb-1e9d52ec96f3"
      unitRef="usd">34000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="id83e438c828a47659e4ba879ee36b614_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtNi0xLTEtMTA1NzI3_d3fe19c6-c84e-4a65-8647-6807360d1d5f"
      unitRef="usd">35000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i6ca62f76cd424ac899783fac2a96e623_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzYtOC0xLTEtMTA1NzI3_113bb3f2-da7e-4449-826a-0d030ac0c2c5"
      unitRef="usd">-1000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctMC0xLTEtMTA1Njg5L3RleHRyZWdpb246YzFmYWI4MGI3M2YzNDA5ZmFiOGNmZjhiYjU0MWE3YjVfMTA5OTUxMTYyNzgyNw_e23c354d-dbd8-4ce6-9832-b4821c821a57"
      unitRef="usd">42000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctMC0xLTEtMTA1Njg5L3RleHRyZWdpb246YzFmYWI4MGI3M2YzNDA5ZmFiOGNmZjhiYjU0MWE3YjVfMTA5OTUxMTYyNzgzOQ_7e149b21-79c1-47a6-ab2e-a9aa2658b716"
      unitRef="number">0.04685</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1b9cf2d374194df6ae4c79f04396b60d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctNC0xLTEtMTA1NzI3_0adef942-df11-44df-b442-1beee4af0273"
      unitRef="usd">43000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i372bc258ba0740cb8d556e4188e7d392_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctNi0xLTEtMTA1NzI3_6649b3df-4a14-4024-87f8-762419e9b7e2"
      unitRef="usd">42000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ic4c7f7af69c647e89fe2fbce62dcc9e0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozOGYyNDBjN2Y1MWU0NDA5YmIxYzQxNzBjM2FiODJiYy90YWJsZXJhbmdlOjM4ZjI0MGM3ZjUxZTQ0MDliYjFjNDE3MGMzYWI4MmJjXzctOC0xLTEtMTA1NzI3_2581f754-2e87-491c-856a-f1e43e4b6503"
      unitRef="usd">1000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <bdx:BdxGainlossfromreversetrasurylocks
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzM4NDgyOTA3MDcwMDY_248c2332-546d-49b8-a981-d4349ead4118"
      unitRef="usd">-17000000</bdx:BdxGainlossfromreversetrasurylocks>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="if0ffa05b17304f47881712e6c344e328_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNjI3ODFjNDAwMzQ0ZjczYTU3NWIwNGUzMTM0NTAzY18xMDk5NTExNjI3ODEy_0145e7ac-9caa-4d97-af25-389b45fe1ec7"
      unitRef="usd">1535000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if0ffa05b17304f47881712e6c344e328_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNjI3ODFjNDAwMzQ0ZjczYTU3NWIwNGUzMTM0NTAzY18xMDk5NTExNjI3ODIx_72a101fd-a51b-42e6-aa0f-3ef61a3135f6"
      unitRef="number">0.02894</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i49e5fbb72ed545d0a517f8558fbba67b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItNC0xLTEtNzM1MzU_5f676a42-89f0-4cc3-a2ea-6e9698f12035"
      unitRef="usd">1534000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="if0ffa05b17304f47881712e6c344e328_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItNi0xLTEtNzM1MzU_811520ff-3fc0-46e5-96a8-0ed2f35e926e"
      unitRef="usd">1566000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i2c1049aeeb644c24b6c34fb4411c861a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzItOC0xLTEtNzM1MzU_ea871daa-de7f-4b5f-b53f-4001c860c96d"
      unitRef="usd">-32000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i18f59f936a894ffba8eb3a14ba54e55b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphNjhkNTJmNDdhZDE0Zjk3ODRlOTM2YWY4ZTkzOGMzN18xMDk5NTExNjI3ODEz_8b67ee6b-2014-4a9a-97f1-3d48448590a4"
      unitRef="usd">294000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i18f59f936a894ffba8eb3a14ba54e55b_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphNjhkNTJmNDdhZDE0Zjk3ODRlOTM2YWY4ZTkzOGMzN18xMDk5NTExNjI3ODE5_de452fa6-b483-4e65-a463-be9c62d5dcb7"
      unitRef="number">0.03300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1906af748d804698a67a96838cf98239_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtNC0xLTEtNzM1MzU_071754e8-06c0-4ce9-9c29-7a599160b9cd"
      unitRef="usd">295000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i18f59f936a894ffba8eb3a14ba54e55b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtNi0xLTEtNzM1MzU_71f32fdc-9e1b-44fb-a77f-ea516e3743c5"
      unitRef="usd">307000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="id102f0302f614bf08fe037344bc095d2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzMtOC0xLTEtNzM1MzU_79a94cc0-6fca-4877-9bd2-4b6a324d0e71"
      unitRef="usd">-12000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphZjdlYzM5NWI1NDg0MzJjOTIyMjI3ZDg2NmFhNzA5MF80_612a91d0-8d08-4d84-ba14-b7c2b875040f"
      unitRef="usd">33000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjphZjdlYzM5NWI1NDg0MzJjOTIyMjI3ZDg2NmFhNzA5MF80Mzk4MDQ2NTExMTM5_5425c3f7-cbee-4984-b551-59b46913b8ac"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i198b3d81101443ecbb89d876818dc429_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtNC0xLTEtNzM1MzU_9d9d1dc6-1d85-451b-b612-66747e8e8f13"
      unitRef="usd">33000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i614f4a3de65e4a7e9240b2e58eb9a6a8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtNi0xLTEtNzM1MzU_61b933c8-0acf-4729-a81c-2c961ec8ab7f"
      unitRef="usd">35000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i5ce76d4d39314f31a725cb2fb4405f44_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzQtOC0xLTEtNzM1MzU_d280cfca-f3e4-4dba-a47e-45847e83f4cb"
      unitRef="usd">-2000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo2ODdlYTc5NzA2MmQ0YTQyODMwOTFjZTJhZmM0MTkzOF80_2854e5cc-cd4d-404c-86e3-2f0281abdebe"
      unitRef="usd">500000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo2ODdlYTc5NzA2MmQ0YTQyODMwOTFjZTJhZmM0MTkzOF80Mzk4MDQ2NTExMTQ0_203770a4-ec89-43bf-9e4a-87fe300d0445"
      unitRef="number">0.03734</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0d69b67e36644b9aafbaf1de869fc363_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtNC0xLTEtNzM1MzU_c9877d6e-6b1f-45db-a3ef-25d8dbdf49f1"
      unitRef="usd">499000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i99bdd887c2634ba8a0a10b54a86c3ade_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtNi0xLTEtNzM1MzU_ec554180-57e2-4118-abc2-e65523bc5cf5"
      unitRef="usd">546000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ic5115502651348ca9ad2cab73680d5c2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzUtOC0xLTEtNzM1MzU_f084d728-07f5-4f3b-b22a-623378ff9c18"
      unitRef="usd">-48000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjYjY3NjQ1MTI0ZTg0MDdlYjczNjFhNmM2MmFhNTVjY180_a1464d24-96d3-4c00-82c1-bec2ff644068"
      unitRef="usd">752000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpjYjY3NjQ1MTI0ZTg0MDdlYjczNjFhNmM2MmFhNTVjY180Mzk4MDQ2NTExMTM5_7c0fef19-0944-409f-bee8-f0999a7c6e3a"
      unitRef="number">0.03363</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6b0ec6988641447b8dbfe586f04fa9c5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtNC0xLTEtNzM1MzU_47acba9b-21e0-47c6-be6f-1057116deb78"
      unitRef="usd">750000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="iad2f735852d14c1aa5af472705bd220f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtNi0xLTEtNzM1MzU_9770631a-7e89-47aa-895a-e2c46a018cf2"
      unitRef="usd">808000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i4ff9e2355d1b44a4856d7f25dd014220_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzYtOC0xLTEtNzM1MzU_86a6840e-49b3-4f56-9057-b2f0f277675b"
      unitRef="usd">-58000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1ODZjZTdiMmRhMmI0NTdlOTE3NjdkYmJjN2ZhZDljM18xMDk5NTExNjI3ODE2_cf3e73bd-466f-4e54-8ad7-3481a03c5816"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1ODZjZTdiMmRhMmI0NTdlOTE3NjdkYmJjN2ZhZDljM180Mzk4MDQ2NTExMTU2_a885ac03-cd74-4787-bbbd-906e812c79ed"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4b17ea17825849b884fccaffccfcd7c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctNC0xLTEtNzM1MzU_2767b1cd-161c-408e-bddf-f5e5fe50c44b"
      unitRef="usd">1005000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i2da0f617b24a43c59dcc1b7bd3a38f84_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctNi0xLTEtNzM1MzU_261bced5-acfe-4556-8a24-3922f188e131"
      unitRef="usd">1019000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i524df8ec8e694ff09698ff2542b4ace8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzctOC0xLTEtNzM1MzU_3a4b9fc5-1841-444e-9bf3-1a4553627181"
      unitRef="usd">-14000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i35d044f774d64179a6b3b2b850e72570_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxNDIwMzRiMGM0ODg0MWY4OTFhYTkzMzJiOGI0NTk1YV8xMDk5NTExNjI3ODI0_3e55239f-8ca4-4a94-8d69-fec85e5294d5"
      unitRef="eur">600000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="iaad9390901e9440ab8f2487e7732dd8f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxNDIwMzRiMGM0ODg0MWY4OTFhYTkzMzJiOGI0NTk1YV8xMDk5NTExNjI3ODMx_6b399a7d-837c-489f-ba9f-1e025317ba62"
      unitRef="usd">728000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i51961b234cd24495af06e60749af2c1c_I20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoxNDIwMzRiMGM0ODg0MWY4OTFhYTkzMzJiOGI0NTk1YV80Mzk4MDQ2NTExMTY4_9d2c8b0b-b14f-49e4-8ffc-f99428cc1bed"
      unitRef="number">0.00174</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic9861ef1ad04469090e0fb052180295c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtNC0xLTEtNzM1MzU_51aebea7-9a39-4745-b439-4aa4060cb573"
      unitRef="usd">728000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i51961b234cd24495af06e60749af2c1c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtNi0xLTEtNzM1MzU_e8164cb1-7f3f-4736-8e4c-3ee1455e1882"
      unitRef="usd">730000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i33f931afdb7747e393d4a4978e51673e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzgtOC0xLTEtNzM1MzU_d9f7b816-1414-4638-9518-7cc5182d7bbb"
      unitRef="usd">-1000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i98e35f9e011d44588b3b8b920a77a0bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplNTMzNDM1YWY0ODc0OGYzYmQxZGMwMGNjZjQ5ZjM2Y18xMDk5NTExNjI3ODEy_bbee86f8-9f8a-4407-9465-184d114bd98a"
      unitRef="usd">265000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i98e35f9e011d44588b3b8b920a77a0bf_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjplNTMzNDM1YWY0ODc0OGYzYmQxZGMwMGNjZjQ5ZjM2Y180Mzk4MDQ2NTExMTQ5_6e71028f-1421-427b-ae5c-0c00f3b1ca01"
      unitRef="number">0.02894</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3cc4f6959fee4f399833aef85a382ac2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktNC0xLTEtNzM1MzU_60b1c5c8-6f2e-4972-99b2-e6811ff85e08"
      unitRef="usd">265000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i98e35f9e011d44588b3b8b920a77a0bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktNi0xLTEtNzM1MzU_1395614c-ea0f-42c0-8029-7ee3263193d1"
      unitRef="usd">275000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i5b78638dd6be44b198ad670fa48ac3d0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZTozM2FhMDAxMTVjOTE0YTA5YWE2M2UxYWIxZmM4MzNmZC90YWJsZXJhbmdlOjMzYWEwMDExNWM5MTRhMDlhYTYzZTFhYjFmYzgzM2ZkXzktOC0xLTEtNzM1MzU_be161ce3-0800-47d9-bd38-bf9d62b3847e"
      unitRef="usd">-10000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <bdx:InterestCostsIncurredTableTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90ZXh0cmVnaW9uOjFlNDliNGQ4ZTA3NjQzYjg5NTg3MTE3MDZhYmRhZTFhXzQzMDI_63ae35f3-1293-4f67-8af2-e8ba840bb0d8">A summary of interest costs and payments for the years ended September&#160;30 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.906%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid, net of amounts capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bdx:InterestCostsIncurredTableTableTextBlock>
    <us-gaap:InterestExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzEtMS0xLTEtNzM1MzU_ac7805fa-a8a2-4d00-a0dd-f1782075275f"
      unitRef="usd">398000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzEtMy0xLTEtNzM1MzU_54c55a12-9da7-4e18-827d-b3922b8cf628"
      unitRef="usd">469000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzEtNS0xLTEtNzM1MzU_bc03cf8f-4ced-462c-91e0-c9e6087b1119"
      unitRef="usd">528000000</us-gaap:InterestExpense>
    <us-gaap:InterestCostsCapitalized
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzItMS0xLTEtNzM1MzU_6c29c59c-58c2-4179-917b-4289bc9584ae"
      unitRef="usd">46000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzItMy0xLTEtNzM1MzU_f121a867-7c49-497a-ba70-d58a71b2abf4"
      unitRef="usd">44000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzItNS0xLTEtNzM1MzU_3a1b8bdd-259b-4046-8c54-e75bd73c5f81"
      unitRef="usd">43000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsIncurred
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzMtMS0xLTEtNzM1MzU_d005a5d9-0ea2-480d-9cab-69eb7bbc0d42"
      unitRef="usd">444000000</us-gaap:InterestCostsIncurred>
    <us-gaap:InterestCostsIncurred
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzMtMy0xLTEtNzM1MzU_3ac7976a-a9d9-40ad-a68f-af154211fa32"
      unitRef="usd">512000000</us-gaap:InterestCostsIncurred>
    <us-gaap:InterestCostsIncurred
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzMtNS0xLTEtNzM1MzU_ef34780c-e418-4fd6-b666-18c33bce3b6c"
      unitRef="usd">571000000</us-gaap:InterestCostsIncurred>
    <us-gaap:InterestPaidNet
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzQtMS0xLTEtNzM1MzU_33e0cdfe-7f0c-4e5f-9b17-8d10e5473dd1"
      unitRef="usd">390000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzQtMy0xLTEtNzM1MzU_386c70f4-b3ba-49a2-946d-1003ec0d8641"
      unitRef="usd">474000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjEvZnJhZzoxZTQ5YjRkOGUwNzY0M2I4OTU4NzExNzA2YWJkYWUxYS90YWJsZToyODdhN2VhOTM0NjE0NTUwOTU2ODVkNThkY2UzMTNmOS90YWJsZXJhbmdlOjI4N2E3ZWE5MzQ2MTQ1NTA5NTY4NWQ1OGRjZTMxM2Y5XzQtNS0xLTEtNzM1MzU_bbbcf3f0-f69c-4d7e-a9a3-41b41e2d794c"
      unitRef="usd">515000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MjQ_841b2c0b-e90b-476e-9462-a26c2685e7f3">Income Taxes&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes the years ended September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local, including Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the years ended September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic, including Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company believes it is reasonably possible that the amount of unrecognized benefits will change due to one or more of the following events in the next twelve months: expiring statutes, audit activity, tax payments, other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;activity, or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to settlements with tax authorities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits that would affect the effective tax rate if recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the Company's acquisition of CareFusion in 2015, the Company became a party to a tax matters agreement with Cardinal Health resulting from Cardinal Health's spin-off of CareFusion in fiscal year 2010.  Under the tax matters agreement, the Company is obligated to indemnify Cardinal Health for certain tax exposures and transaction taxes prior to CareFusion&#x2019;s spin-off from Cardinal Health.  The indemnification payable is approximately $124 million at September 30, 2022 and is included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following were included for the years ended September&#160;30 as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income tax provision (benefit) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and penalties associated with unrecognized tax benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. The IRS has completed its audit for the BD legacy fiscal year 2014, BD combined company fiscal years 2015 and 2017 and CareFusion legacy fiscal years 2010 through short period 2015. With regard to Bard, all examinations have been completed through short period 2017. The IRS has commenced its review of BD&#x2019;s fiscal years 2018 through 2020. For the other major tax jurisdictions where the Company conducts business, tax years are generally open after 2015.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product recall and liability reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Net deferred tax assets are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and net deferred tax liabilities are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes and Other Liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the consolidated balance sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. The Company asserts indefinite reinvestment for all historical unremitted foreign earnings as of September 30, 2022. Deferred taxes have not been provided on undistributed earnings of foreign subsidiaries as of September&#160;30, 2022 since the determination of the total amount of unrecognized deferred tax liability is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, deferred tax assets have been established as a result of net operating losses and credit carryforwards with expiration dates from 2023 to an unlimited expiration date. Valuation allowances have been established as a result of an evaluation of the uncertainty associated with the realization of certain deferred tax assets on these losses and credit carryforwards. The valuation allowance at September 30, 2022 is primarily the result of foreign losses due to the Company&#x2019;s global re-organization of its foreign entities and these generally have no expiration date. Valuation allowances are also maintained with respect to deferred tax assets for certain state carryforwards that may not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Rate Reconciliation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory tax rate to the Company&#x2019;s effective income tax rate for continuing operations was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.044%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of Research Credits and FDII/Domestic Production Activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of gain on divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of valuation allowance release&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fluctuations in the Company&#x2019;s reported tax rates are primarily due to the geographical mix of income attributable to foreign countries that have income tax rates that vary from the U.S. tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Holidays and Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The approximate tax impacts related to tax holidays in various countries in which the Company does business are provided below. The tax holidays expire at various dates through 2028. The Company&#x2019;s income tax payments, net of refunds are also provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax impact related to tax holidays&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of tax holiday on diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payments, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MDY_e78ca752-1ae0-4303-92a6-295d42225412">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes the years ended September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local, including Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following were included for the years ended September&#160;30 as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income tax provision (benefit) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and penalties associated with unrecognized tax benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzItMS0xLTEtNzM1MzU_abc879f6-9da7-4800-9fdc-f54234ad0219"
      unitRef="usd">17000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzItMy0xLTEtNzM1MzU_c4fbe605-be43-4a92-980c-db8a4e298e63"
      unitRef="usd">72000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzItNS0xLTEtNzM1MzU_ce6ff8c1-bd62-4c1e-a843-1b5f383abdfe"
      unitRef="usd">-68000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzMtMS0xLTEtNzM1MzU_945f3c40-31dc-444b-9183-f30c7b980109"
      unitRef="usd">32000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzMtMy0xLTEtNzM1MzU_2d1c4351-b55c-4b33-afe0-1a06b8fbdb90"
      unitRef="usd">42000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzMtNS0xLTEtNzM1MzU_a8fcedcf-c7f4-4f27-8feb-7b1b27957847"
      unitRef="usd">43000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzQtMS0xLTEtNzM1MzU_148d1b16-8d3d-4e51-9b09-4007cc42083d"
      unitRef="usd">228000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzQtMy0xLTEtNzM1MzU_3bd64c1f-6228-4c31-ac7b-60e848adc23f"
      unitRef="usd">254000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzQtNS0xLTEtNzM1MzU_682c235e-13d8-4b00-9075-47883a7d5ef5"
      unitRef="usd">372000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzUtMS0xLTEtNzM1MzU_7766985d-9e72-4a0b-b6dd-db4fb0963b6a"
      unitRef="usd">277000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzUtMy0xLTEtNzM1MzU_de5a916b-8454-41b7-8785-592b80e3ee2c"
      unitRef="usd">368000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzUtNS0xLTEtNzM1MzU_50f34145-5175-45bb-ba95-7fc7e1df3e1d"
      unitRef="usd">347000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzctMS0xLTEtNzM1MzU_bf67550e-b1a0-476d-afb8-e3a93945af95"
      unitRef="usd">-96000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzctMy0xLTEtNzM1MzU_cb25b5f7-f190-428a-b641-98bff8ca89eb"
      unitRef="usd">-284000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzctNS0xLTEtNzM1MzU_dc525058-7d51-48fd-886d-472456b3cdb4"
      unitRef="usd">-182000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzgtMS0xLTEtNzM1MzU_9d0f70ba-5522-4c45-a784-70f8fb9354f1"
      unitRef="usd">-33000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzgtMy0xLTEtNzM1MzU_2877ae7b-cdf7-4301-9c6c-0837160aab93"
      unitRef="usd">4000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzgtNS0xLTEtNzM1MzU_23016bc7-4e50-444a-af6e-f5f7cacd762d"
      unitRef="usd">-103000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzktMS0xLTEtNzM1MzU_1b966d84-40b0-4a6a-8da4-ec8952240234"
      unitRef="usd">-129000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzktMy0xLTEtNzM1MzU_05b64d7c-84f7-4e5c-97bd-6e01bca5df96"
      unitRef="usd">-280000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzktNS0xLTEtNzM1MzU_7fa379a5-0fc3-4d03-ab5e-84252422bd4b"
      unitRef="usd">-285000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzEwLTEtMS0xLTczNTM1_24f8e29f-e869-4f95-8384-c06505804633"
      unitRef="usd">148000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzEwLTMtMS0xLTczNTM1_c48f886b-0a98-400b-9be7-dc50e0da7c01"
      unitRef="usd">88000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo5MWU5MDNkYjQxMzQ0Y2M4OGQzMDQwNzEwYWRkMGYzNi90YWJsZXJhbmdlOjkxZTkwM2RiNDEzNDRjYzg4ZDMwNDA3MTBhZGQwZjM2XzEwLTUtMS0xLTczNTM1_62d8fdb2-815f-4968-89e5-fe3e393ad229"
      unitRef="usd">62000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MDM_ef29c55b-19a0-4219-a641-6a241ce5833f">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the years ended September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic, including Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from Continuing Operations Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzEtMS0xLTEtNzM1MzU_c72b048e-10c5-4b1f-a864-f89fa97dacec"
      unitRef="usd">496000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzEtMy0xLTEtNzM1MzU_52d0241b-119e-485e-b2ea-894ffdb7ce79"
      unitRef="usd">70000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzEtNS0xLTEtNzM1MzU_b0f9ed22-9c2a-4ff8-89b2-5261056d7122"
      unitRef="usd">-579000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzItMS0xLTEtNzM1MzU_576e76f7-250e-4462-aa6a-812014a9bd0e"
      unitRef="usd">1287000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzItMy0xLTEtNzM1MzU_3d27e0d9-032b-4d54-a699-688c650ed3c0"
      unitRef="usd">1623000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzItNS0xLTEtNzM1MzU_fef3262f-460f-4f20-a25c-b21f8a1e149b"
      unitRef="usd">993000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzMtMS0xLTEtNzM1MzU_637521ec-374f-4caa-8946-2f489374be03"
      unitRef="usd">1783000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzMtMy0xLTEtNzM1MzU_82d7cc1f-fe8f-4e8f-bea5-e0ee07143755"
      unitRef="usd">1692000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo0ZmI4MmExNTU5MDU0NjNkYTQwNGRjZTY0MTVlZjhlYi90YWJsZXJhbmdlOjRmYjgyYTE1NTkwNTQ2M2RhNDA0ZGNlNjQxNWVmOGViXzMtNS0xLTEtNzM1MzU_f1e3df70-4dca-4eed-a11e-282601508b72"
      unitRef="usd">414000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU0OTQ_0d346ee4-fca6-4944-91a8-0d34bd430a5d">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company believes it is reasonably possible that the amount of unrecognized benefits will change due to one or more of the following events in the next twelve months: expiring statutes, audit activity, tax payments, other &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;activity, or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at October&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to settlements with tax authorities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits that would affect the effective tax rate if recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEtMS0xLTEtNzM1MzU_ba64a2d9-3eec-4d61-bab5-3f053ef70d9b"
      unitRef="usd">354000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEtMy0xLTEtNzM1MzU_0d45d17e-e455-4b62-97e2-26124325b3a1"
      unitRef="usd">611000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEtNS0xLTEtNzM1MzU_95b28381-a012-41cc-87b3-58065d56ac1f"
      unitRef="usd">568000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzItMS0xLTEtNzM1MzU_dd0a8c3b-c46f-4e25-b872-661680068415"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzItMy0xLTEtNzM1MzU_acad2fd3-0647-4ee8-802a-97d97d30e9ca"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzItNS0xLTEtNzM1MzU_13f74e0a-c3d5-41bd-b2bf-c27c03a7417a"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzMtMS0xLTEtNzM1MzU_2b8e9f44-706c-42fc-9b68-3e2f4f3ee684"
      unitRef="usd">40000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzMtMy0xLTEtNzM1MzU_d40d1a6a-2f8c-4345-9a7d-b917aa3ca61a"
      unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzMtNS0xLTEtNzM1MzU_4f36dfc2-6926-447e-8624-5b6a8fe4b12a"
      unitRef="usd">35000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzQtMS0xLTEtNzM1MzU_513f2732-448e-42ce-965a-18c24a3371b2"
      unitRef="usd">60000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzQtMy0xLTEtNzM1MzU_865c70dd-007f-4dd0-ad7b-f800f91d70bc"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzQtNS0xLTEtNzM1MzU_dc57f633-fc81-4cca-99d6-adeb74a371ea"
      unitRef="usd">76000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzUtMS0xLTEtNzM1MzU_cc0d30f3-9bfe-4716-a97f-ba538d9be348"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzUtMy0xLTEtNzM1MzU_6a78cff6-82a9-44a8-a96d-3c9a38053b72"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzUtNS0xLTEtNzM1MzU_8277d27e-3f52-412b-8cfd-036fb5116968"
      unitRef="usd">49000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzYtMS0xLTEtNzM1MzU_ddd6c1ac-3222-4dcd-8f1a-ad2dcc469cec"
      unitRef="usd">77000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzYtMy0xLTEtNzM1MzU_e97a27ac-b4a5-4671-8a33-c0548bef8f62"
      unitRef="usd">183000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzYtNS0xLTEtNzM1MzU_e2279713-72ba-41f7-b9bf-9f97a59f9a2e"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzctMS0xLTEtNzM1MzU_20c60ba3-dc8b-42f5-92fd-c3e78d372c15"
      unitRef="usd">112000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzctMy0xLTEtNzM1MzU_11083b01-cc9c-42f3-b49f-f81631c44fd2"
      unitRef="usd">100000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzctNS0xLTEtNzM1MzU_8e968558-acd7-4fe8-979d-0953b830d979"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzgtMS0xLTEtNzM1MzU_95671279-6596-46c6-b912-cf5f337219b1"
      unitRef="usd">267000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzgtMy0xLTEtNzM1MzU_300dcf33-ca47-4216-925e-99c7ec314e74"
      unitRef="usd">354000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzgtNS0xLTEtNzM1MzU_f4d943c4-ad93-4247-81a9-f319fe3f1acb"
      unitRef="usd">611000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEwLTEtMS0xLTczNTM1_15685dcc-c64a-42af-9729-dc97861e04d3"
      unitRef="usd">348000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEwLTMtMS0xLTczNTM1_eddadba6-95c7-4e47-a3fc-9d1f84334f30"
      unitRef="usd">447000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpmMzM2ZDZkMzM3Mzg0MWQ0ODc1YTcyZGQzNWRjOTg2Yy90YWJsZXJhbmdlOmYzMzZkNmQzMzczODQxZDQ4NzVhNzJkZDM1ZGM5ODZjXzEwLTUtMS0xLTczNTM1_07883ddb-ae30-4d70-80b3-69afd75ec375"
      unitRef="usd">719000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <bdx:IndemnificationLiabilityNoncurrent
      contextRef="ib3f4c3f3aeef48c7a0b365d3718eba1a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzI1NjU_2cfceeea-82fc-4f41-8023-a78abf1f1551"
      unitRef="usd">124000000</bdx:IndemnificationLiabilityNoncurrent>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo3NWNmZDI5OGQwZjk0YjcwOTkxMGM3ZWMxNDI3ZWMzNi90YWJsZXJhbmdlOjc1Y2ZkMjk4ZDBmOTRiNzA5OTEwYzdlYzE0MjdlYzM2XzEtMS0xLTEtNzM1MzU_8fd044d5-beb9-4ae4-8ad5-8a280d7aff9a"
      unitRef="usd">-6000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo3NWNmZDI5OGQwZjk0YjcwOTkxMGM3ZWMxNDI3ZWMzNi90YWJsZXJhbmdlOjc1Y2ZkMjk4ZDBmOTRiNzA5OTEwYzdlYzE0MjdlYzM2XzEtMy0xLTEtNzM1MzU_e3a5f7a7-f89e-4440-ad6a-89c4d3bb4f76"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo3NWNmZDI5OGQwZjk0YjcwOTkxMGM3ZWMxNDI3ZWMzNi90YWJsZXJhbmdlOjc1Y2ZkMjk4ZDBmOTRiNzA5OTEwYzdlYzE0MjdlYzM2XzEtNS0xLTEtNzM1MzU_8c16957b-b85a-4ec7-8acb-524870c5dd7e"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MTk_a457b594-366f-4cd4-85bb-fbdce48d529b">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.920%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product recall and liability reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Net deferred tax assets are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and net deferred tax liabilities are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes and Other Liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the consolidated balance sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzItMS0xLTEtNzM1MzU_181c6e4f-ea01-4773-92fb-a378b7ab2da0"
      unitRef="usd">430000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzItNS0xLTEtNzM1MzU_ef8c365f-aea2-4f6b-b198-1b858f303d7a"
      unitRef="usd">524000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzMtMy0xLTEtNzM1MzU_f0c86665-3e36-425c-bdfa-34d86c78160b"
      unitRef="usd">412000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzMtNy0xLTEtNzM1MzU_0a3a27dd-b417-431d-a9db-41ec71482753"
      unitRef="usd">400000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzQtMy0xLTEtNzM1MzU_1138a6fc-8358-4b62-9022-b4c8344a9827"
      unitRef="usd">2002000000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzQtNy0xLTEtNzM1MzU_1e3c15ba-e144-414f-ab1c-549a49369760"
      unitRef="usd">2161000000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxAssetsOtherTaxCarryforwards
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzUtMS0xLTEtNzM1MzU_aa6adcb6-a51e-4b50-8e3a-1d92081bd5e4"
      unitRef="usd">2185000000</us-gaap:DeferredTaxAssetsOtherTaxCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherTaxCarryforwards
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzUtNS0xLTEtNzM1MzU_a87ec130-2c43-45c7-9df0-6271e17d9a77"
      unitRef="usd">2107000000</us-gaap:DeferredTaxAssetsOtherTaxCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzYtMS0xLTEtNzM1MzU_711b77b5-eca6-4796-80ef-33cfa4b2e7b3"
      unitRef="usd">133000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzYtNS0xLTEtNzM1MzU_34518b3a-4c8e-4f03-a52c-c969bd396a33"
      unitRef="usd">191000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctMS0xLTEtNzM1MzU_000f2b99-d9c5-4c1f-b63f-0ad9c42179a2"
      unitRef="usd">524000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctMy0xLTEtNzM1MzU_93fb89fa-4b1f-49e4-9fa6-603daff1af94"
      unitRef="usd">260000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctNS0xLTEtNzM1MzU_f9bce7a8-48e4-4a86-a4d3-41b62c6cfefc"
      unitRef="usd">549000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzctNy0xLTEtNzM1MzU_55acab35-52b3-432d-9869-d75c83468faa"
      unitRef="usd">123000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtMS0xLTEtNzM1MzU_2e022a11-7d54-41d8-93a3-4cdabdb73cbe"
      unitRef="usd">3271000000</us-gaap:DeferredTaxAssetsGross>
    <bdx:DeferredTaxLiabilitiesGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtMy0xLTEtNzM1MzU_c759f10c-cc5d-45d9-b945-d5f00495d641"
      unitRef="usd">2674000000</bdx:DeferredTaxLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtNS0xLTEtNzM1MzU_bf1bf2c4-12ed-42da-9510-74d7d19d6a87"
      unitRef="usd">3370000000</us-gaap:DeferredTaxAssetsGross>
    <bdx:DeferredTaxLiabilitiesGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzgtNy0xLTEtNzM1MzU_2fffba6d-0c2b-44c8-95e3-c49926d8f31f"
      unitRef="usd">2684000000</bdx:DeferredTaxLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzktMS0xLTEtNzM1MzU_0a670138-3e44-4400-b19e-842aa93da5d5"
      unitRef="usd">2093000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzktNS0xLTEtNzM1MzU_d6c05525-fc0d-43bc-8e1a-9e919085e1da"
      unitRef="usd">2036000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTEtMS0xLTczNTM1_0419ccf0-6645-4555-81d1-3456951d03d8"
      unitRef="usd">1178000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTMtMS0xLTczNTM1_8d33004e-1de5-4aa7-9fb8-f5edb171403c"
      unitRef="usd">2674000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTUtMS0xLTczNTM1_e7c20ba9-4132-4352-8d29-90512e5a5558"
      unitRef="usd">1334000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTpjZTU0N2UyNmFiYWE0MmFiYjM5NDk5ZjYwZTdkN2Q0Zi90YWJsZXJhbmdlOmNlNTQ3ZTI2YWJhYTQyYWJiMzk0OTlmNjBlN2Q3ZDRmXzEwLTctMS0xLTczNTM1_8c335e82-5c93-4e1c-8942-d13f103077a5"
      unitRef="usd">2684000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU1MjE_79bf6947-ca1d-45b0-953c-5a9bf6c8c307">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory tax rate to the Company&#x2019;s effective income tax rate for continuing operations was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.500%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.044%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of Research Credits and FDII/Domestic Production Activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of gain on divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of valuation allowance release&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEtMS0xLTEtNzM1MzU_b2327b65-e90a-47b2-865c-505976d3d758"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEtMy0xLTEtNzM1MzU_41c8ca2f-3ed5-479f-9123-979262d08645"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEtNS0xLTEtNzM1MzU_a0b96974-7cce-444c-a5ee-d02e27614ac7"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzMtMS0xLTEtNzM1MzU_e8221e27-c8a5-419c-9642-71fee524e9eb"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzMtMy0xLTEtNzM1MzU_9296f023-1f6c-413e-83e8-5582a173db5d"
      unitRef="number">-0.027</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzMtNS0xLTEtNzM1MzU_4242eb55-02d5-4c78-9fc2-cc0ada625d14"
      unitRef="number">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzQtMS0xLTEtNzM1MzU_2932a9f0-840c-4545-ba27-81bbfe1181f2"
      unitRef="number">-0.073</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzQtMy0xLTEtNzM1MzU_3a9f7e61-cfee-4e01-9b69-cfeecaa26359"
      unitRef="number">-0.064</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzQtNS0xLTEtNzM1MzU_8ec6a0ce-07a6-4659-b894-0f5730dd4f6e"
      unitRef="number">-0.176</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzUtMS0xLTEtNzM1MzU_75a1418a-cf96-4791-a66a-db88fface81d"
      unitRef="number">-0.056</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzUtMy0xLTEtNzM1MzU_0707b786-e6eb-4d1d-9eab-7f8470d70db2"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzUtNS0xLTEtNzM1MzU_61d8019d-7898-49fd-b5a0-4a13cf044d4c"
      unitRef="number">-0.445</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzYtMS0xLTEtNzM1MzU_6fa14109-2f5e-4d90-a478-2b547f78ffd8"
      unitRef="number">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzYtMy0xLTEtNzM1MzU_205c8024-05c0-45eb-a9e8-3f25cd5ae9e9"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzYtNS0xLTEtNzM1MzU_cf1abbd5-a997-4c5f-9cf5-3ed8426320d3"
      unitRef="number">0.111</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzctMS0xLTEtNzM1MzU_cffe3170-a716-42bd-b78f-37e73fade1f0"
      unitRef="number">-0.017</bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation>
    <bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzctMy0xLTEtNzM1MzU_47de1f51-9882-40d5-b517-b8128f0358dd"
      unitRef="number">0.001</bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation>
    <bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzctNS0xLTEtNzM1MzU_f6160a6d-0285-45ce-a820-5ca03dff5010"
      unitRef="number">-0.107</bdx:EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzgtMS0xLTEtNzM1MzU_74a11de7-97da-459c-b4b1-f34ff3f5a7f9"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzgtMy0xLTEtNzM1MzU_b2561f00-2082-42a3-9305-c0105ebeb50f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzgtNS0xLTEtNzM1MzU_133d7843-3b8d-49fb-b766-19aca1d1d3ea"
      unitRef="number">-0.106</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfAssets>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEwLTEtMS0xLTczNTM1_b18c3270-a8da-4363-a61d-17a0e519ef52"
      unitRef="number">-0.055</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEwLTMtMS0xLTczNTM1_90b6a3a5-f7bc-4482-b29e-70874b617fb4"
      unitRef="number">-0.022</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzEwLTUtMS0xLTczNTM1_6a1f21e6-8d04-4c75-862d-89aa626f0594"
      unitRef="number">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE0LTEtMS0xLTczNTM1_ef34bffa-93fd-460a-87c4-601322fe0deb"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE0LTMtMS0xLTczNTM1_ad960d75-0531-4af1-95a1-533cf0a4aeaa"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE0LTUtMS0xLTczNTM1_97b4c38e-f092-45ba-bdb5-8f50709cd169"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE1LTEtMS0xLTczNTM1_31d4e4bf-e16e-4173-8e9f-c34f86328468"
      unitRef="number">0.083</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE1LTMtMS0xLTczNTM1_f5f4d792-2a83-46af-9930-809ed4c98c97"
      unitRef="number">0.052</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1YTg3N2Y4NzdjMmM0YjMxYWU3ZTJjYmQzZmM4MzIzZS90YWJsZXJhbmdlOjVhODc3Zjg3N2MyYzRiMzFhZTdlMmNiZDNmYzgzMjNlXzE1LTUtMS0xLTczNTM1_75a57368-639e-4a1b-9ced-a0c338966796"
      unitRef="number">0.149</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SummaryOfIncomeTaxHolidayTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90ZXh0cmVnaW9uOjNiYTNjNzM1OWY2MzRiOGJhMGFkZjlkZjg2YWM1ODdiXzU0OTI_a94ef7ea-fe77-4c9c-9903-d126bede7daa">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The approximate tax impacts related to tax holidays in various countries in which the Company does business are provided below. The tax holidays expire at various dates through 2028. The Company&#x2019;s income tax payments, net of refunds are also provided below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax impact related to tax holidays&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of tax holiday on diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payments, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxHolidayTextBlock>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzEtMS0xLTEtNzM1MzU_d977904a-b028-414a-a71b-c297512ee586"
      unitRef="usd">284000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzEtMy0xLTEtNzM1MzU_47151e70-a72b-4d7b-9718-7af4c5e6cc2b"
      unitRef="usd">243000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzEtNS0xLTEtNzM1MzU_42fd6f0f-1048-4b64-a364-99cea5b6d803"
      unitRef="usd">132000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzItMS0xLTEtNzM1MzU_3c9426ff-7858-4a04-9135-0fa51cabf907"
      unitRef="usdPerShare">0.99</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzItMy0xLTEtNzM1MzU_7db4d0d4-4bd2-47ce-a885-21f2b8791d38"
      unitRef="usdPerShare">0.83</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzItNS0xLTEtNzM1MzU_30d3ff14-47e6-4b9b-a7ef-94e82bd6ba79"
      unitRef="usdPerShare">0.47</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzMtMS0xLTEtNzM1MzU_dc57e864-88c4-430c-9f0d-93b1fa416ef4"
      unitRef="usd">532000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzMtMy0xLTEtNzM1MzU_70d522d6-4cbf-4198-9227-4e1cb8fa86f6"
      unitRef="usd">671000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjQvZnJhZzozYmEzYzczNTlmNjM0YjhiYTBhZGY5ZGY4NmFjNTg3Yi90YWJsZTo1ZmFmMTk1Nzc5NDU0ZDM5OGU4MzAyNDBkZGExZDNhYS90YWJsZXJhbmdlOjVmYWYxOTU3Nzk0NTRkMzk4ZTgzMDI0MGRkYTFkM2FhXzMtNS0xLTEtNzM1MzU_110a18ab-5190-42bc-bf09-981d17efe8de"
      unitRef="usd">523000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzg_1536350a-9126-4fa6-9212-e1c5c599d879">Leases&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases real estate, vehicles and other equipment which are used in the Company&#x2019;s manufacturing, administrative and research and development activities.  The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration.  The Company&#x2019;s lease arrangements are generally classified as operating leases.  These arrangements have remaining terms ranging from less than one year to approximately 25 years and the weighted-average remaining lease term of the Company&#x2019;s leases is approximately 6.8 years.  An option to renew or terminate the current term of a lease arrangement is included in the lease term if the Company is reasonably certain to exercise that option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.  For the longer-term lease arrangements that are recognized on the Company&#x2019;s consolidated balance sheet, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease.  These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#x2019;s short-term leases, as well as variable costs relating to the Company&#x2019;s lease arrangements, are not material to its consolidated financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The implicit interest rates of the Company&#x2019;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. The weighted-average incremental borrowing rate that has been applied to measure the Company&#x2019;s lease liabilities is 2.3%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease costs recorded in its consolidated statements of income for the years ended September&#160;30, 2022, 2021 and 2020 were $138&#160;million, $132&#160;million and $131&#160;million, respectively.  Cash payments arising from the Company&#x2019;s lease arrangements are reflected on its consolidated statement of cash flows as outflows used for operating activities.  The right-of-use assets and lease liabilities recognized on the Company&#x2019;s consolidated balance sheet as of September&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9"&gt;Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payments due under its operating leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.166%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total payments due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year 2021, the Company sold certain properties and concurrently entered into operating lease arrangements for each property, which met the requirements for sale-leaseback accounting.  The Company recorded gross proceeds of $225&#160;million related to the transactions and pre-tax gains of $158&#160;million were recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other operating expense, net. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The lease agreements have initial lease terms between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwNzQ_6fc3030e-d694-47a3-b19e-733ab8915c12"&gt;two&lt;/span&gt; and three years and include options for the Company to extend the leases for an additional &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNTk_49d1d0da-0358-48d3-bfc1-913d11e54289"&gt;six&lt;/span&gt;-to-twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzk_f9b51496-228c-45b4-a86f-ff3eeee47669">The Company identifies a contract that contains a lease as one which conveys a right, either explicitly or implicitly, to control the use of an identified asset in exchange for consideration.  The Company&#x2019;s lease arrangements are generally classified as operating leases.  These arrangements have remaining terms ranging from less than one year to approximately 25 years and the weighted-average remaining lease term of the Company&#x2019;s leases is approximately 6.8 years.  An option to renew or terminate the current term of a lease arrangement is included in the lease term if the Company is reasonably certain to exercise that option.The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.  For the longer-term lease arrangements that are recognized on the Company&#x2019;s consolidated balance sheet, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease.  These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i7ff86925da2a4bdbb08d87f5bf1b9465_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzUyMw_12b3aa4d-b995-4272-b8f5-3e73cf66d168">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i57dbdcd63dc545d4baab7bc7c3def523_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzU0Mw_fa71f400-9faa-4f55-ae8d-1313ee48fc86">P25Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzYzMw_ced8452f-e3a0-4f74-9ebd-72eb87cbc188">P6Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:ShortTermLeasesPolicyTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzY_351294cb-7aee-4855-9584-ea60a606c493">The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months or less, on its consolidated balance sheet.</us-gaap:ShortTermLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzIwMDI_d63fb745-4b89-4cf8-9e43-fae16c17d371"
      unitRef="number">0.023</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzEwOTk1MTE2MzA5Nzg_16c7e74e-4ab6-4cb5-9f19-b66704a39011"
      unitRef="usd">138000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzIxMTc_7abcbbd7-4f4f-4707-ac0f-08d9720e8cc3"
      unitRef="usd">132000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzIxMjQ_57b790f5-cb95-444c-b6e0-300406430a2a"
      unitRef="usd">131000000</us-gaap:OperatingLeaseCost>
    <bdx:SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzc_b43c2122-5f32-4afd-96b5-9a6fcca63592">The right-of-use assets and lease liabilities recognized on the Company&#x2019;s consolidated balance sheet as of September&#160;30, 2022 and 2021 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_143774d7-9782-4556-8319-828a27920252"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjpiOWNjNDliYWYzNDY0MGZiOGFkODFhODU3ZWJkNGY4Yl8zNg_3fa5132c-d696-45a6-bc3d-a86a0bc3f1a9"&gt;Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_680e5752-e41f-4236-94bf-996512d3cd75"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjoyNGFmMzA5NTMzYzg0ZTY5ODk5NjlkYjM2OGMzZTIxY180Mg_900a5f0a-6e34-463c-9e98-74dc56887108"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_44aaa400-f60f-4e00-b9fd-1e7ee9ef6576"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMC0xLTEtNzM1MzUvdGV4dHJlZ2lvbjo1NzQxMjMyNDIyMGQ0ZGRhOTBiNzFmNmMwMTBmYjAzZl80Ng_de60d9b7-dc6b-492c-8bf0-1fdfb149b9ce"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bdx:SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMS0xLTEtNzM1MzU_d78153d8-8ae0-46f8-9e38-ef494b974aaf"
      unitRef="usd">482000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzEtMy0xLTEtNzM1MzU_bb9ad178-c764-46fe-9a6e-c4027212b612"
      unitRef="usd">446000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMS0xLTEtNzM1MzU_7a285269-01f4-4ead-8d5d-b2c7db079a98"
      unitRef="usd">118000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzItMy0xLTEtNzM1MzU_5214ead2-799f-4efd-861a-6bbd775988ce"
      unitRef="usd">126000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMS0xLTEtNzM1MzU_956298bc-bf19-4510-8b55-c65b26e81c42"
      unitRef="usd">384000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo4MjZjYmE4NTg3NTU0NzQ1YWEwMjQ0OGQxOGI0OGU5Yi90YWJsZXJhbmdlOjgyNmNiYTg1ODc1NTQ3NDVhYTAyNDQ4ZDE4YjQ4ZTliXzMtMy0xLTEtNzM1MzU_47c073a6-48cd-4b72-a6b3-eb277f61fe37"
      unitRef="usd">344000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMxNzQ_f06a0ab1-786e-4d30-bb17-c06b73bc9cd3">&lt;div style="margin-top:4pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payments due under its operating leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.166%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total payments due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzEtMS0xLTEtNzM1MzU_9f96364b-d029-4626-9b6b-89b8af569d8a"
      unitRef="usd">128000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzItMS0xLTEtNzM1MzU_443b7ed4-07c7-4d70-ba73-0bb2c3b09326"
      unitRef="usd">99000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzMtMS0xLTEtNzM1MzU_9a0d93d9-571e-47ef-83d2-6b09cc1c3c7c"
      unitRef="usd">77000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzQtMS0xLTEtNzM1MzU_f10dbb83-ecfa-47bb-9941-da7541cf0751"
      unitRef="usd">58000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzUtMS0xLTEtNzM1MzU_43bead46-59d6-44a5-900a-fbcbe4b635cd"
      unitRef="usd">46000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzYtMS0xLTEtNzM1MzU_047352bd-8ddf-4c81-88a4-35ff1878997f"
      unitRef="usd">143000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzctMS0xLTEtNzM1MzU_951c61d8-a5ed-4ad8-bb4c-7ccd6037a859"
      unitRef="usd">552000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzgtMS0xLTEtNzM1MzU_c8d70c9c-f82e-41a7-92f0-4ebed800ee05"
      unitRef="usd">50000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90YWJsZTo5ZmQyNmQwNmM1MzE0Y2Y2YjdhYzIzZjFjYTBjNTc1Yy90YWJsZXJhbmdlOjlmZDI2ZDA2YzUzMTRjZjZiN2FjMjNmMWNhMGM1NzVjXzktMS0xLTEtNzM1MzU_571f2aad-e528-4f85-9fcb-c92a2369f231"
      unitRef="usd">502000000</us-gaap:OperatingLeaseLiability>
    <bdx:GrossProceedsFromSaleLeasebackTransaction
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzI5MjI_406f7f34-a47c-4442-81a0-d42d1ea7aa82"
      unitRef="usd">225000000</bdx:GrossProceedsFromSaleLeasebackTransaction>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i2d422d609a5b47f4a788004ac2c698bb_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzI5NzQ_32729754-0353-4f86-a916-3487623b454e"
      unitRef="usd">158000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i28abfbeeca0f4ef0a684b8b4d60fd993_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzMwODE_81ce6713-614b-484d-b56b-a3b3fc400d14">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i9c659996ff364a5889ca74df9594897c_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMjcvZnJhZzozNTdjMmFmYTMyM2I0MmNjOGRjNDgyMWFlM2FlNjk5Ni90ZXh0cmVnaW9uOjM1N2MyYWZhMzIzYjQyY2M4ZGM0ODIxYWUzYWU2OTk2XzE0ODQzNDA2OTc4MzY2_2f10c17b-9773-4b79-9240-0033a88fbbbe">P12M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExODQ_2c3c8cec-b616-46f6-8486-c70a2f13e6b4">Supplemental Financial Information&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income (Expense), Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investment (losses) gains, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension and postretirement benefit cost (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Losses on undesignated foreign exchange derivatives, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impacts of debt extinguishment (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Embecta service agreements income, net (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                                                                                                                                                                                                                                                                                                                                                                  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amounts include gains (losses) recognized on changes to the fair value of certain equity investments.  The amounts in 2022 and 2020 also include a loss and gain, respectively, on the sale of equity investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents all components of the Company&#x2019;s net periodic pension and postretirement benefit costs, aside from service cost, including U.S. pension settlement expense of $73&#160;million in fiscal year 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents losses recognized upon the extinguishment of certain senior notes, as further discussed in Note 16.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Consists of net income from transition and logistics service agreements with Embecta following the spin-off of the former diabetes care business in fiscal year 2022, as further discussed in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Receivables, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in 2022, 2021 and 2020 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance&#160;for&lt;br/&gt;Doubtful&lt;br/&gt;Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance&#160;for&lt;br/&gt;Cash&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Accounts written off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment, Net at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExOTY_de0b093b-e8e8-4b0c-aa0c-add6cca05e14">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income (Expense), Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investment (losses) gains, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension and postretirement benefit cost (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Losses on undesignated foreign exchange derivatives, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impacts of debt extinguishment (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Embecta service agreements income, net (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                                                                                                                                                                                                                                                                                                                                                                  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The amounts include gains (losses) recognized on changes to the fair value of certain equity investments.  The amounts in 2022 and 2020 also include a loss and gain, respectively, on the sale of equity investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents all components of the Company&#x2019;s net periodic pension and postretirement benefit costs, aside from service cost, including U.S. pension settlement expense of $73&#160;million in fiscal year 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Represents losses recognized upon the extinguishment of certain senior notes, as further discussed in Note 16.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Consists of net income from transition and logistics service agreements with Embecta following the spin-off of the former diabetes care business in fiscal year 2022, as further discussed in Note 2.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEtMS0xLTEtNzM1MzU_006088df-bd5a-477b-96a1-7972a6e1f32d"
      unitRef="usd">-35000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEtMy0xLTEtNzM1MzU_68af35a5-b21e-4e06-9b79-eb4db9ccc8ce"
      unitRef="usd">57000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEtNS0xLTEtNzM1MzU_c2897569-b9c0-41d6-b12a-43e342ab293e"
      unitRef="usd">13000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <bdx:DeferredCompensationInvestmentIncomeExpense
      contextRef="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzItMS0xLTEtNzM1MzU_e9901593-26d3-446e-8c88-272c70d60e5c"
      unitRef="usd">-46000000</bdx:DeferredCompensationInvestmentIncomeExpense>
    <bdx:DeferredCompensationInvestmentIncomeExpense
      contextRef="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzItMy0xLTEtNzM1MzU_ec023c34-fcb8-4e81-884d-6307b0efdd47"
      unitRef="usd">43000000</bdx:DeferredCompensationInvestmentIncomeExpense>
    <bdx:DeferredCompensationInvestmentIncomeExpense
      contextRef="i84b4aeecbf34445895456d33566115a6_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzItNS0xLTEtNzM1MzU_d4b8f6e4-e144-412a-88a4-e6871319c8c4"
      unitRef="usd">24000000</bdx:DeferredCompensationInvestmentIncomeExpense>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzMtMS0xLTEtNzM1MzU_ecfc2f51-1331-4b58-9fd9-0d87a84bc6b0"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzMtMy0xLTEtNzM1MzU_c58eaf3d-bedf-4143-a068-979d64d16908"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i84b4aeecbf34445895456d33566115a6_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzMtNS0xLTEtNzM1MzU_abf1d3ff-dfe1-4b65-968a-53ad11481b0b"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzQtMS0xLTEtNzM1MzU_e85b4f63-b0ba-4d21-bbb7-e8ae24205819"
      unitRef="usd">-28000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzQtMy0xLTEtNzM1MzU_11216193-df15-4add-8f29-920b8432b046"
      unitRef="usd">-13000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzQtNS0xLTEtNzM1MzU_8efe681c-fe7d-4f2d-afba-ce1ef04ce473"
      unitRef="usd">-17000000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzUtMS0xLTEtNzM1MzU_5f2241e6-bbee-4407-b1fb-da06eabebc62"
      unitRef="usd">-24000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzUtMy0xLTEtNzM1MzU_7c61b2cd-e1b4-4e10-b837-f5df74f960f5"
      unitRef="usd">-178000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzUtNS0xLTEtNzM1MzU_12139a3b-75a8-462c-a9f5-89c4b44cfeae"
      unitRef="usd">-8000000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <bdx:EmbectaServicesAgreementIncomeLossNet
      contextRef="i72ea16100875420bbb9238d2144f9bf2_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzctMS0xLTEtNzM1MzU_797e48dd-10d3-4a93-968e-04809278b9d6"
      unitRef="usd">33000000</bdx:EmbectaServicesAgreementIncomeLossNet>
    <bdx:EmbectaServicesAgreementIncomeLossNet
      contextRef="i39439adf4691466e9844370e2c9bbe6c_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzctMy0xLTEtNzM1MzU_d35fb089-0ee8-46ae-a1b4-83424c35053b"
      unitRef="usd">0</bdx:EmbectaServicesAgreementIncomeLossNet>
    <bdx:EmbectaServicesAgreementIncomeLossNet
      contextRef="i84b4aeecbf34445895456d33566115a6_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzctNS0xLTEtNzM1MzU_26eca5c4-9709-4aec-abdc-8ba4e7de71b0"
      unitRef="usd">0</bdx:EmbectaServicesAgreementIncomeLossNet>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEwLTEtMS0xLTczNTM1_79cacc9d-ab8b-4949-974a-5216dee44165"
      unitRef="usd">-1000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEwLTMtMS0xLTczNTM1_3f7d6c07-661c-48bb-9f7f-73c71bc50d25"
      unitRef="usd">6000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzEwLTUtMS0xLTczNTM1_c5dea3db-52b4-42ea-b6c4-e5f2e73d2215"
      unitRef="usd">-5000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzExLTEtMS0xLTczNTM1_b2c7c434-20ad-4367-9213-9176ea185cc2"
      unitRef="usd">-117000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzExLTMtMS0xLTczNTM1_8391fbc8-75b5-4635-8a31-e47ef8cfcd83"
      unitRef="usd">-99000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo5NjkxMTYzZmRlOWM0YjQxOTA2YTcwZDU1ZjM5MWM0NS90YWJsZXJhbmdlOjk2OTExNjNmZGU5YzRiNDE5MDZhNzBkNTVmMzkxYzQ1XzExLTUtMS0xLTczNTM1_ef555dc3-9c1e-41e1-97d3-f8ce9d20a7aa"
      unitRef="usd">23000000</us-gaap:OtherNonoperatingIncomeExpense>
    <bdx:PensionSettlementExpense
      contextRef="i63e65eb05ef7404c83e007d6d92760e3_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzkzNDU4NDg4MzgxMjA_6910cff8-7cb6-41a3-af72-d136144394bc"
      unitRef="usd">73000000</bdx:PensionSettlementExpense>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExOTc_ee617b5b-e0fb-4b1d-afb6-b6909b07c386">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in 2022, 2021 and 2020 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance&#160;for&lt;br/&gt;Doubtful&lt;br/&gt;Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance&#160;for&lt;br/&gt;Cash&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Accounts written off.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0089a582278743878e90b9ca5e0e2c89_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEtMS0xLTEtNzM1MzU_87245f79-a073-45e8-9b69-f1e35f221c7e"
      unitRef="usd">72000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia9f9865f93104f3ea7954370b74f7d79_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEtMy0xLTEtNzM1MzU_348be280-c540-44d6-9060-f8adac9220e3"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEtNS0xLTEtNzM1MzU_44fc7821-3e6a-41ee-839b-d107d44b1c60"
      unitRef="usd">83000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i329bff29919e4afd9a9bdec6c58ae755_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzItMS0xLTEtNzM1MzU_7d7dd623-adcc-470d-8d14-3253ecc2d10a"
      unitRef="usd">39000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iba943512d69048e5bf48aa7426358b78_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzItMy0xLTEtNzM1MzU_2a975877-6078-45fa-9bad-60d15e1b3287"
      unitRef="usd">23000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzItNS0xLTEtNzM1MzU_0f9e232e-ea84-42b1-85c8-d664cd6251f3"
      unitRef="usd">62000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i329bff29919e4afd9a9bdec6c58ae755_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzMtMS0xLTEtNzM1MzU_bb8108fd-baa7-4708-bc96-a1f4d538448e"
      unitRef="usd">35000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iba943512d69048e5bf48aa7426358b78_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzMtMy0xLTEtNzM1MzU_cbbe412a-9fdb-43b0-bfd3-d4b3ec1d5a76"
      unitRef="usd">22000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzMtNS0xLTEtNzM1MzU_8c461d9f-bf41-420e-905b-43e8b2c8b1f2"
      unitRef="usd">57000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i05b402904eee4442982827a336b690c8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzQtMS0xLTEtNzM1MzU_916ade21-62ae-44df-a7af-948ffb7c1120"
      unitRef="usd">76000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i4d9ee8a265ed45f7bcd1a5b2a45da743_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzQtMy0xLTEtNzM1MzU_4ddd506d-cf0e-4345-bb6d-782e83768c65"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibb0301f3d94544d0a0b72086db59dd14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzQtNS0xLTEtNzM1MzU_5305d7cf-0767-4df4-a538-b8aaa2bcd2c8"
      unitRef="usd">88000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4026aaac83c04f90b25918ecc8f53b9a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzUtMS0xLTEtNzM1MzU_bdc1b406-e493-4eab-a28b-1e982f325699"
      unitRef="usd">17000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="idc5c357468b445299d75577a1038cd20_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzUtMy0xLTEtNzM1MzU_bc39d541-7252-4478-9718-fb266cbd3b8a"
      unitRef="usd">84000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzUtNS0xLTEtNzM1MzU_37f4a3c8-654b-4da2-a951-2f19c0664400"
      unitRef="usd">101000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4026aaac83c04f90b25918ecc8f53b9a_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzYtMS0xLTEtNzM1MzU_a168d429-399b-4eaa-adb2-6783c1abbc8a"
      unitRef="usd">20000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="idc5c357468b445299d75577a1038cd20_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzYtMy0xLTEtNzM1MzU_1b8436ec-a93d-4701-8b90-9368c0ec490d"
      unitRef="usd">77000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic042a8d8207c492790faedff680aa856_D20201001-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzYtNS0xLTEtNzM1MzU_b0defda3-0ae1-476e-aea6-d589c9f82aa7"
      unitRef="usd">97000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i686e25e2d18c4aad801c33d834ed7b23_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzctMS0xLTEtNzM1MzU_e9e85b30-eb01-4c92-a3f6-60cfca06b6c6"
      unitRef="usd">73000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i26517beec32f4052bdb7d8b798ad21eb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzctMy0xLTEtNzM1MzU_473c2b4a-89a6-4197-b98b-3bf4565b5a75"
      unitRef="usd">18000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzctNS0xLTEtNzM1MzU_cb37f828-6e39-4b1f-aa9d-4d8fd4f63d54"
      unitRef="usd">91000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i722514c7a4114a04aa38c850c0f296e7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzgtMS0xLTEtNzM1MzU_721a23ff-5411-460e-8cf1-ce00126879e7"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6dfe227a5f864820bdf92afbd17f990a_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzgtMy0xLTEtNzM1MzU_3537c382-9b11-404c-addc-1a7a0310cbaf"
      unitRef="usd">73000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzgtNS0xLTEtNzM1MzU_b158c38f-a264-483b-aac0-1896ae6eba57"
      unitRef="usd">77000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i722514c7a4114a04aa38c850c0f296e7_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzktMS0xLTEtNzM1MzU_f80671ab-4805-4af5-8539-6b4dfe7df2be"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6dfe227a5f864820bdf92afbd17f990a_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzktMy0xLTEtNzM1MzU_a89778a0-e07a-4323-b348-542713af81fb"
      unitRef="usd">75000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzktNS0xLTEtNzM1MzU_b8391266-ecf3-43f2-822c-3b718a7a1b56"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i02b12d1fd67f455baf6f93c8c91f52ef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEwLTEtMS0xLTczNTM1_2064c2cc-0890-4278-a080-911f151730b9"
      unitRef="usd">65000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia98b2ad1fc1143869d44f1bd24b9aaec_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEwLTMtMS0xLTczNTM1_a441cf8f-26fb-438d-ba66-585bb413d0a4"
      unitRef="usd">16000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTphN2VlYTRjYWE5N2I0OGU1YjU5YmQ0OTg5MTg3NDliMS90YWJsZXJhbmdlOmE3ZWVhNGNhYTk3YjQ4ZTViNTliZDQ5ODkxODc0OWIxXzEwLTUtMS0xLTczNTM1_3fa20758-52f0-4818-b5f3-7b9123e62261"
      unitRef="usd">81000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExODU_228c16fb-823a-4d9f-863e-9ab8c0ed27f7">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzEtMS0xLTEtNzM1MzU_56badc5b-83ae-4878-8af1-2b7785fe8f08"
      unitRef="usd">707000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzEtMy0xLTEtNzM1MzU_645d21f4-a0ac-4455-8986-7cade74f1501"
      unitRef="usd">628000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzItMS0xLTEtNzM1MzU_abbe580f-bc3e-4877-9447-a5a9df8ceff5"
      unitRef="usd">397000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzItMy0xLTEtNzM1MzU_b4ddb25b-74fd-426a-ba8f-71891db38855"
      unitRef="usd">381000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzMtMS0xLTEtNzM1MzU_a43acf96-18a9-48cb-a951-5beeff0b7f46"
      unitRef="usd">2120000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzMtMy0xLTEtNzM1MzU_10e6d18f-c31e-4ef5-a7bf-41077e024690"
      unitRef="usd">1734000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzQtMS0xLTEtNzM1MzU_7b3f582b-c81b-49b2-8c08-e8fbd73bb9a6"
      unitRef="usd">3224000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTowZTI1NDQ0MzEyYTM0MGZiOGVlYjIyYWY2MmJhMDY3Yi90YWJsZXJhbmdlOjBlMjU0NDQzMTJhMzQwZmI4ZWViMjJhZjYyYmEwNjdiXzQtMy0xLTEtNzM1MzU_0dd160e4-ac93-4d23-8e84-3dc0eaac8fd4"
      unitRef="usd">2743000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90ZXh0cmVnaW9uOjhmYzgwZWE3ODQyNzRhMDBhNjIzMTU1MGQ1NDkxMDM1XzExOTM_a74a3086-71db-4ad7-b150-b5dbd95251e1">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment, Net at September&#160;30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Millions of dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzEtMS0xLTEtNzM1MzU_2f42b069-e8f2-43b5-b88c-8a608c4e410d"
      unitRef="usd">127000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzEtMy0xLTEtNzM1MzU_9f9ddb19-4616-4e76-98e9-11b1c95d8ea2"
      unitRef="usd">133000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzItMS0xLTEtNzM1MzU_1e9fbe33-9f1b-4ad6-b902-ceeff126b8f5"
      unitRef="usd">3252000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzItMy0xLTEtNzM1MzU_8566fb28-1f44-45bf-859f-373089e8622d"
      unitRef="usd">3140000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzMtMS0xLTEtNzM1MzU_9847f6ce-4b31-4b6b-aa7f-5c421680305b"
      unitRef="usd">8769000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzMtMy0xLTEtNzM1MzU_c89347e7-27c1-4346-b3e8-781ae5d49498"
      unitRef="usd">8585000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzQtMS0xLTEtNzM1MzU_d4ae9e62-133c-4238-bc7c-f46ce96adf2c"
      unitRef="usd">266000000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzQtMy0xLTEtNzM1MzU_504bb383-a844-416f-8e89-481f80108b99"
      unitRef="usd">234000000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzUtMS0xLTEtNzM1MzU_8eafbadf-5820-4c7c-96c6-5c4b4362e2d9"
      unitRef="usd">12415000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzUtMy0xLTEtNzM1MzU_40bd2a4c-e0a5-40aa-bf61-add79a9f3534"
      unitRef="usd">12093000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzYtMS0xLTEtNzM1MzU_37ff3039-efcb-46e9-91f2-03496928038d"
      unitRef="usd">6402000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzYtMy0xLTEtNzM1MzU_b1800e0e-826b-474b-a641-070d2487a74d"
      unitRef="usd">6090000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5b40bf72179e46d89af6a51aac9400a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzctMS0xLTEtNzM1MzU_632d17de-b4b6-477e-a5b4-5c0eed9fda82"
      unitRef="usd">6012000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if1596d6db35a42fba0359a8e52d30677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xMzAvZnJhZzo4ZmM4MGVhNzg0Mjc0YTAwYTYyMzE1NTBkNTQ5MTAzNS90YWJsZTo4MTM2YjMxMmRiZjg0MzNkYjM2Y2M4ODU3ZmEwN2UxNy90YWJsZXJhbmdlOjgxMzZiMzEyZGJmODQzM2RiMzZjYzg4NTdmYTA3ZTE3XzctMy0xLTEtNzM1MzU_e95063b3-5fce-4c69-b24c-02b5ec03c296"
      unitRef="usd">6003000000</us-gaap:PropertyPlantAndEquipmentNet>
    <dei:AuditorFirmId
      contextRef="i84f75f49afbd4c71aa0404983704de65_D20211001-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE4N2RiOWU0MGQyODQ4OTBiZGI5OTYyY2EyMzNkY2ExL3NlYzphODdkYjllNDBkMjg0ODkwYmRiOTk2MmNhMjMzZGNhMV8xNjYvZnJhZzoyZDE1ODQ5MTYxYWQ0NDM4OTNhMjMyM2FjNzM2ZDY4Yi90ZXh0cmVnaW9uOjJkMTU4NDkxNjFhZDQ0Mzg5M2EyMzIzYWM3MzZkNjhiXzgyNDYzMzcyMDk0MzE_493afaa8-c86e-4d99-a8d0-140aec7ecf75">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>122
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M$*O(&DD0>ZE!"@)A Y0!()R$,*>XYQ2_,K,$S?EBU9 JU#2KV*8I4P>CV,X
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M_0'5G-KU!T3'\^74@&$J'(:J!\GV&2\0>]$YAW4C6S1;)D$_L5N)^"AI]'X
M%9[;2S:@2GS]83@+AT'K+L_%0:_8^^RG'E@?3O*0,7<\>4&C+B:-XYF=90%5
MDMC+!2#""\]R@0URX3!S/?2;<[$J^<:[5&"7B\93&[  T<R9/:[&Z\$ %@X2
MPNW]2\[J6G<-6K&*K;GJMY:M5.=UW'50VTB):L_BB/9EYMFFSL[(&JX&3VW;
MKL:'E=B0"PZCRX,4Q2%OAB'X<RQ9V>[0<V5TXQF0$'78CEP-=?,@()KYEDJ#
M+SC,+[_I2>5/XBYJV%L70#*.L9,S %7BJ3PQS$+"S*+W+^UQR,,1JKN;F#>W
M[<3%$!+;4VD)J&),K!R:0K$6=.:Q:I"&A)%&KU?U.58NRBX7C99>*MII$QIV
M(6%V669[WF1EMV(6O#E(3Q,"P+%PEA!(A?'"'OB0;)8L/,/!X L)X\M=_N>!
MU[P_@*BZ XAVUYKIOTC[#*]W!J (B68VNT.R:62?1T JG'C.6XCA&A+FFG!"
M(A"AS.:V 4@5V\=%D(I,?3/5D P)D\R0E+[K96\MY'%&.GL: QA#B;/+@F0*
MV&P$!65XX6%08EB&),&D])E7696?X2:(1'\Y*5TR6GJI:*=-:%"*A%'*;%7K
MK9#-N&%RAPJV@D>_2S7.*<<2$-ED&Y2<&C%P1,)P9(SD*OOP!JVSO(4DM!)2
M15.C!!X;+M8XCMZ4I(!D',\]H$L,'9$P'2FNR!DK>KHM1;4Q'=3N2=IOI?#0
M+ 'P:3&SW0&B>6*?^0 J2N>>=80:@J)OG/KPNI%\=6BIO#5YOUNQO,E4TI+[
MC^A=S1CZ*AJ&R'OPA8=+.PJ)['TEH+([,"@Y-6>8B0:!HLW$C51]LU9[D=?U
ML1&#Q<->F:[WO!J+]1ITAX$5(K&W88#*<1>2G+HS.$/#.//PNM=2SLX<CQ2
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MB@=4!V*&S-#S=H VB*[&8@G5>@EZ02OB39H\C!0SA)4S1NU#X8>C-N)5@QJ
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M:W-H965T<R]S:&5E=#$P+GAM;*56;6_;-A#^*P<5Z#; BU_RTJ))##AIBW9
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M@&NHF_5!\2(O,_4(GC)@-91.B*V%*FK32():"T%&]U.I82G5%VM;0Z867X.
M&O:AH$67JM:@VX^:0Z&@T=*E- G,>Q1<DULG0^68>!!)C24%)P*")DOSJBTY
MH%GK$#-&33SGU?7=5[IR7UTPOM)"0&.'W, V:YFLF3N=0ZAR6P[N%"E4:?8B
M4VNIR*";0S>"C%U=*3E?A([32IPTRVR@8 4/*9VB&(/: SUA42JP..K*4\+!
M%)VS(]H]XH9JHQB8V)MF4-[ #]LF50I*9&3L%^[4@]Q9M&J"XZVF\,!UN@?,
MB*K*#AKKDCM>8 ;F9P=[4_8'+MWJL>5%$M;C<,<<BD(P#>.X7X>$3-GUH;W"
M.@H GJ*=S4)8/+(@\N"9J@TJWB@"TJ#K:#-LN"Q%;(E-?!,RD-5';-!MB(=$
M&$K2$HR]YUDM; P2M2KDOT$JD9_E[-9% )0-URGF%L:HH$80I*406:J7!]'^
M#81OBBT"G+)OT"V!EPOT*<DD7#=V#.+?8QZMMBEW:.FTQM+:#I#:5.=3<F]Q
M;INF9V&=M((1P- H"548#C[C9D#5("EX9M1VOI:E5@\R!X;('IDW=:)H!T,H
M3A+5#FBX<<4>WJNU5O5JS?!@BN5<?X>H]LN9+M<M;0P<L$4)IYQA[=GE,D@7
M4*4V9-)"W0N[1,Y3P'FM3<W!ZPUD!I$'VU>:YXS7 'H-0 3Z?J1!-PKC#Z:_
M;6D;\Z!/)2^@#M<G.G.='9^U=L(B;"' %<LZ _?6E<QPD8D-Z4]K J'^!#9:
M1=#MJ$1=HH'(^6DJ<=^"P.PIAG)NWF[%<D*SK;Y8%D'A:EBA $REU'8#3 $=
MTW8?1M7[6LT>%MQ2&VOHN "??^[:T ^V"-8I%06TR<(B$FA,Z-Q,=G+8FP9Q
MV*F<@R@.!C^V;;)<9.BIG1ZZ6D.ML;&*4_D'[OG('S$\\:%-?GM)GD#G;,AA
MY!QT-@GK6W-9@&-==QH[_GEW(DQPA5WE3>M(G(/JN;;Q!(K&G.QT]ISM;0PK
MD4R@&EJLH-2A':&T37_?[8/,Y@3 P*ZGP1PZ.DJR&BG^)55G7@25&VUI^T9L
M^V3+'D0'DC,@-!$BI>&P P;AO-L!QRNM@'=V1H3]'GDQ[32P]\]I<#;T]HP*
M.!\\NY8E8K8K#2V!YW1P)4H%P<7:K,U,P0'HD'EX)FA;,\[<2\\!9$"@P;V&
M:A_>< R2Z?:R%W^62SXL*5DV:R (V#BA@D1JZ#JK8T@Z[(L-B 6N >9_Y/@<
M,Y4E=5YG',_6\7@<?,0K8HBBJ($==(/&:.HX?VE7RR3@*+5Y;]<0F+FD_\0!
M_;'!V\E!Z/U"^V#7WQ<#NC8'?,EXGVED%E(8GJ7+O*8 AM,^Y]!9#<OA,7L[
M))H&!_ TR)\>R]9\V"9MAT[T-F&VI^N\39L6M.N)8$>ZBEV9.*9-[3[;+<L#
MDT($J&[C3V"&O]50:EEJ\*WO!J>^*"]ISH5A['72Q%>T'2V.U6*-O\O<B[:[
M'V> Q(O]0^'#)[RV!GVOM)"K@MV(0BQEQ;Y@JVP[__<P^^RI+S28;2<'/5T8
M-5>.$](5GC]\/J Q:@H@AORB\B#CQLBE3 B-38.,(>$/> ;M^]2J1R[^=_!_
M#.O88VDSF-XRN'5')V5PG PUS^SL\2"8% :SQI# [4P*[ 'VW#UL4A.$)QKE
MSWSF>@%S9S&+O6<8TQ^<13,V/WM4!,8XL]88#X]E\&!H9@^(7.=/,<6)6 B6
M1',&1CW9DJ _F@M<YIT_G/!"E_Z>>Q"!46Q<,)_%]!G&Y  H03#QFEH=B_LF
M&V!G13:$NDQ#.F26)+LFAC:?$WDX:!^P8#9,X.]Q!Y2;]+TC8<_NXS 47;3B
M$C*1<EI NFJ!:J!818\E,(JIJ-=8BW2%&Q[F/)X@(#UW13*5D.! -YB>BO50
M_*+A CHVV[7FF#%NKSWO]*?=Q.M9>^!"Z@6 PNNL.L:^&EHI[ BHHR+S8.!G
MJ(QIV::LFK2S,['B$#&JZ[Y-[Z9X[$(_?)7-K]=#LV![P>X#<)H+O0)Q7<$(
M55X[L9V0(!LN&I2UTDA*6X2<:1+=Z0!GYNE &@:%E%@B)=MP-X<%>QBB.;9M
M[II;V*:;;K(I>Z@@,!M>XL%!WT4@:@!O->ZL4(3"W#;R?<&60B%Z3Y6&H3T=
M"A\L8[:!AM8".3 )LY+*4!WU;.N/T<]3-SA*?W(..69[A_M@UT EQV0"!O6B
M"WE;^.TE8=/)GM8<&":P1!,0X?K.08_LA?2_=\T14-BF*<?F7TL(]-Z9"AZO
MJ@S+03R/D05 '<?9_#2' [J_NJJKYY<KQYF'JJ GPMYB@AJLGS?ST.L"EX/7
M.H@K\.45E 1@MF]X='>[]V.N[6LA_7#[<LU'KE<(ITPL8:HSC<,1T_:%%?NE
M4B6])+)05:5RNEP+#AF' ^#Y4D&"-5]P@>ZMH:O_ %!+ P04    " !,AW95
M+@=50X $  #,"@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6RM5MMN
MVS@0_15"!8H$4&U9=A([L0TX:1?M0Q=!LI>'Q3[0TM@B0HDJ2<7QW^\92G:<
MPDEV@7V1>)DY<V8X,^1T8^R#*XB\>"IUY691X7U]V>^[K*!2NIZIJ<+.RMA2
M>DSMNN]J2S(/2J7NITERWB^EJJ+Y-*S=VOG4-%ZKBFZM<$U92KN])FTVLV@0
M[1;NU+KPO-"?3VNYIGORO]>W%K/^'B57)55.F4I86LVBQ>#R>L3R0> /11MW
M,!;LR=*8!YY\RV=1PH1(4^890>+W2#>D-0.!QH\.,]J;9,7#\0[]E^ [?%E*
M1S=&_ZER7\RB<21R6LE&^SNS^4J=/V>,EQGMPE=L6MEA$HFL<=Z4G3(8E*IJ
M__*IB\.!PO@UA;132 /OUE!@^5EZ.9]:LQ&6I8'&@^!JT 8Y5?&AW'N+704]
M/_\B;:6JM1,U67%?2$O3O@<N[_:S#N.ZQ4A?P1BDXKNI?.'$ERJG_"5 'X3V
MK-(=J^OT3<1[JGMBF,0B3=+T#;SAWLMAP!N^Y^7MSDOQUV+IO$52_'W,X19N
M=!R."^72U3*C681*<&0?*9I__# X3Z[>(#O:DQV]A?XOC^2_8HC?"A*;D*24
M"_E(%C4G,E.6J W'$DXT#ENJ$KX(.W7C)9>.$V;%J:\R(:M<Y$HWC$&'-@*"
M..F  H9I',3=J4#K")!;:#A!G",")^RI7$)SF( 6=*6#H$:3<)?AV/DSX$\B
M%D?9HL4X#PO@(-+Q69PD9_A/XG0\%NG%.)Y<#,1GYHJR[_C1CT8]2DV5AS%K
MRG;Y$Y=U+FHMX>J)/!4GRU.1QL/A$-]Q,A##>#1\'^N>K *M&X&<6)&U@.R8
MGF3 .Q<?/XS307JU___D%L>V&SYC'W-VIR\=6BDOA!/A'I>.+^+A^4BDDS1.
MQA/,TWB4I,&I;U4(:]S&E8UQ;.-.^:A;,& R)?FP-\H7Z#M5+KVQ6_"L0-ZK
MI:9#=[W)'CA9SM&JM :C^'D83$Z>-^!53:$GZVW<I@ ]9;KA[ CQY)39Y=J1
M*&129XT."2J6E$DD;U"!'#HR+H-&YZ) HF.7V+I7.U=[H1@4PB>KC)APF_&O
M^Z1PQHV%E 4EA[[<5<JOQI,8]4+&(,!+@RC]%-_!/@"PD\$ ;LH7><>5AENN
M]41NI,W=>^$X4GJ'X4 IL30]D<V48V]41J[S$_-#(VM<Y9ZX0&5;^+O6@#OZ
M 8^"H+L+T0VHRFH;$O#BRKTLR-YSBE4&MWQ6_"_>],0BSQ6/I [!U\8UG R6
MUD#G5#A&[?4(6PZ(>53YP1%.>J%([RCT<\[]-\KBG6I')+U <ZN-E5;I+8BB
MM60'6;S:!RXD5T&Z;;L6]SWTC9!YP2'#**P! >8ME<%\@TS6QWVN5?7)K%9L
M04'RLY)+\LR275@V#K>$@_U*+'"L6@S:"U9L9#C*6D,X[QV[POH'+XR2[#J\
MHU@)9-K'QGYU_U1;M"^49_'VG?==VK5"H]6T@FK2NSB+A&W?3NW$FSJ\5U!,
M>/V$88'G)ED6P/[*X,2Z"1O8/V#G_P!02P,$%     @ 3(=V5;(5"3=P%@
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MI@'X?6KA3OD'VB#^T8:W_P-02P,$%     @ 3(=V59:CA*MK#   DR,  !D
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M=IN=)F2G8/S8$U5[K.B96'3[E6)I$[/#A]$/E-)H=3BBRD\*K.*1P#*8$;Y
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M:&"?8./5LEHI.J51+<5"8_6WK34!LH,;53?,.:@O=@/'1'%MFJUN96D9RN&
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M/KL0?U4&=MIB[=[4]!N_Q()B^.T,UEMJ[4%S3>FS[&O><VN8]J#:'0LH"+9
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M%D8AO\::#6%9VW/"0V;6%EH18$9(I3+!?MQ'"D,)T/23IQ ;;S#+@TWV[4Y
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MTMNBJ:#_KJCW@KB!CU%DQ0=DP*RQ>\!6_2LJ:ER(1;3MGM6"%\%"PCIT:K3
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MBS5?KB1Z84T+<']9%*7_0@?4+PJ__2]02P,$%     @ 3(=V5807Q&3:%@
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MQ$>@IQM2<5P9I@TY_L6<3/:RV*&\!Q*S4?!T*W7%"2%I84@(^XN1V#;D[Q
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M4[%QM[J*P 4T:N@B@CEP,IT=V77K\V2"Q_^5<[M3+3*.GF7<IV<*J<X?IV=
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M\S[P:,W%UT1MY&V#LE6@D5,6U@C>BF-QDJ@P@+@XUI$3^[.3,(6R/;M86TN
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MI5;)OM"_-=8CZ^+0>*S)5F9;]_8F>&?)3W"QEF>WR$ *.T _[68M.N&NU^[
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MPT1$%Z412H8&7-#DT)2C_;?SR?'1F5AJ8W R$??:*OJ&:"4C 0M9M4H#"]E
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MO=D& 7Q?&N.W+\' ;IJ?_0502P,$%     @ 3(=V5=)W/*R$!0  >@P  !D
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M_(CN0SF^<5J.Q:W,92QYIY\1IES<9/ WDO#7RMQ)9G\XM%,W@BBM1DH3:[(
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MX^TAI]$9!IGJSKX[6_'*JHD1S@PF?NO[,"[D)DB:]I2:FGQY3'11'<RY90T
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M,BYX;6RM65USVS86_2L8-=.D,XHD2G9CI[9G;*>99B;>9N*T^["S#Q )26A
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M! W;G#[1GV2>JXF<B[T\;9D.)RA!];AD7!'[NB%7Z$I)!WOY%1D+Z<'LZ#&
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M75V6<AV:%&R#J'9\+XD!&92:&E8=](3@H+O[C\R$3%THTHOXA/;5..GF5A3
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M]6TJE+Y.4@+&K$S7R^JH_T*74)K+PAE!I^YDL\:JD'[+$\_Q XD^6&=D^"2
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MRD:'3W;]&[7QS%A?;K6/OV*=]HZQ.6]\L'4K# ]J9=)5;MH\' C,1R\(9*U
M%OU.AJ*7[V20=S?.KH7CW=#&-S'4* WGE.&B? X.JPIRX>X](21_,PS0Q6^&
M>2OW-LEE+\B-,_'!FE!Y\8LIJ#A6,(03.T^RSI.WV5F-GVDU$)-17V2C+#NC
M;[*+;!+U3<Y&)OZZ7_C@4/S_G HRJ9B>5L$-<>U7,J?;'A#OR3U2[^ZG'\:7
MHS=G')SN')R>TWXF]=\C)[Y4)!YLO9)F*W1ZA:[4@GR0@?KBD2J5:[R5IA V
M5.0$?6O4"AT5Q!IKE9".1..I$,J(L%?WTP_S;'SUQ@-GIBF1NL8IL^P+60"
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M1T0CN0-BE L%Z[3HUI%*;!W I&.2ZF5FPC=W+-]MB\[<T"8KTC^M6_:=\,P
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M2(XO)['Y#A:)3Z\^#6FLMW9EB:_@#8R1YR$+9DL,A'!#X@EF)1_'=; 1$@T
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MS4/Q80IZJ-Z<PH',0GI3(Y2WPDC*73'B#.>/2,L@,D7Y:Q_2 O3\1>:$2:P
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MI63.H>PX?!NF)5.J6!2I*8\.UV"K9H_8.GJ>J;#0Q7\'_R-8I^TFU98XQ]J
MKJ@-1Z]EJPL,0Q(?W-7!I<"/.T=\MW?);_O.Q!UVJ4O",YWR8@_Z!9^X<42
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M6]!Q&1+N]T2  @#>0>]QQSEC=P]=Y@F[[!W _2D<"-KZ:$>8NM#D>",R''.
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MI/V/P-YH49OW\@NAM2C-<,UHSB1.@-^70NCN!C?H_ZFY^1=02P,$%     @
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MK+2?J.U-I7;FL_!2597*S>56<-2/- "_KQ5XH+DA!=T_"ES^!U!+ P04
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M(DII.:,HC)Z $8<]C)3WI]4S,)@"] [ 6&)813\,8\9B:?H$B"C>@V!2EL^
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MNAA 1+RX42T>),OR.\8EDY(E^<\5)0'E"@#O0\;D[D%-4-UK3_\%4$L#!!0
M   ( $R'=E5PH?FAG@0  !<8   9    >&PO=V]R:W-H965T<R]S:&5E=#0U
M+GAM;-5977.;.!3]*QJVL]/.. ')'_E8VS.)DW8STS2>>-I]V-D'&42LJ4!4
M$G;S[U<""G@ );3LP[[$"'2OSCE(ER-E?N#BJ]P1HL#WB,5RX>R42BY=5_H[
M$F%YRA,2ZR<A%Q%6NBF>7)D(@H,L*&(N\KR9&V$:.\MY=F\MEG.>*D9CLA9
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M)!?/([#J+N_V8?M2+[(=<>_Z%L":*X0#<U\+DF :9),@+UOYQZY5 >O@O16
M#04Z!:AL'K1ZG5]S(_;<O?FA)K\NZP(KMP7M=NMGWK!AK?3D7NN*FY?:VV\I
M3:*NB6Y%T%N&<4.&\877(4-EX>#0'NX#Y\%!;V=:&5L'Z\VX:?-05U6K;!ZT
M^[S^A%]<S=8!>Y-NFL19!^?*(T*[2?ROC+I]V-[,FR:ST]7#RF;"?C[S]9]U
ML,;/YA/>RGQ00UEDJS.?3CJ(5T816MW2SQ$7YE9M(]'*?5#+5V2K<S^;=G"O
MK!P<VLO=1@GCSX2<",*TM3X2P>YF!C5RL.GDT'F[&J@R<LANY'Y]:VL?H/<I
M2XMEZ]H'H\JRH:$M6U[87YCM]E%[4V]Z-=A1WE'M2,[NU08Y ["/T9LG:API
M- X,W-JIK3DRO\?BB>K-$R.A#O).SW2TR$^A\X;B27:0N^5*\2B[W!$<$&$Z
MZ.<AU]NPHF'.ALO_!2S_!5!+ P04    " !,AW952]"1R70(  !;.   &0
M 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6R]6UUSV[@5_2L8=:=-9NR( $B*
M2FW-Q(([S4.RGFAW^]#I RU"%AM^:$G(3F;ZXPN0M,"/2TB*$;\DDGQPB'M
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M_'A0V@2SOQ3F>^P">T#_*TO_ U!+ P04    " !,AW95L*0SSVP+  !FBP
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M58?!4</@2,O@O8*U@C3.%=]J"=_P@ACG>;2. EQL7_DE2*M%P/ 3496O.VW
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MB<AWL.4GBF^R'5=/7"D>9X=K@D,BT@+Z]R7GZNTD35#N(YS^!U!+ P04
M" !,AW95*X]U*#H#  #M#@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6S-5VM/VS 4_2M6AB:0@#SZH'1M)&@W#6EH%1W;!\0'-[E-+9PXL]T'TG[\
M;">$1H2,HC#QI;7C>T[N.?9U[,&:\3NQ )!H$]-$#*V%E&G?MD6P@!B+8Y9"
MHD;FC,=8JBZ/;)%RP*$!Q=3V'*=KQY@DEC\PSR;<'["EI"2!"4=B&<>8WY\#
M9>NAY5H/#ZY(M)#Z@>T/4AS!%.1U.N&J9Q<L(8DA$80EB,-\:)VY_9'K:8")
M^$E@+;;:2$N9,7:G.Q?AT')T1D AD)H"J[\5C(!2S:3R^)V36L4[-7"[_<#^
MQ8A78F98P(C17R24BZ'5LU (<[RD\HJMOT(NJ*/Y D:%^47K/-:Q4+ 4DL4Y
M6&40DR3[QYO<B"V VWX&X.4 [Z6 5@YH&:%99D;6&$OL#SA;(ZZC%9MN&&\,
M6JDAB9[&J>1JE"B<]*]@!<D2!-H?@\2$B@-TA*ZG8[2_=X#V$$G0):%4&2X&
MME3OTR@[R+G/,V[O&>XII,>HY1PBS_&\"OCHY7"W#+>5RD*J5TCU#%_K&;XQ
M$3B*.$38+" V1[EX=/--A:(+";&XK9*9\;:K>76A]46* QA:JI($\!58_L</
M;M?Y5"6Z(;*2!:W"@E8=NYKM&9: *,$S0HF\KQ*;,70,@]X$5G['ZPSLU;:&
MBAC'*6)*J;6+U-K_2,W,Q:&:%+W[D"1"$^!FGTH"0-]GE&03=X@^;U*U"4"(
M?I!8QZF9G*HA,<=!%C"5F$LTUE)OSC9$W/;-$CQRG2/'K=)<F]JN$]P06<G%
M3N%BYXW6>*=)"QHB*UG0+2SH_K>%I("$A55VU>?00O> >=66.:H%OM*:D\*:
MD_=18^@/FG 6+@,I$$Y"FW$T55I( )6?D=JL=UU[#9&5#.X5!O?>J/QZ35K0
M$%G)@M/"@M.FUMA9S):)K'+C],GWQ=O^P&0J:_-XI4K7>3PW.>^FED;J^+6,
M\8Q6ET]]IKLNGJ;8RKYNG4?=-RJAG+@I&QIB*]OP>%9U:\^!S911_H[M.G)/
MG]11?2:[*K6W[B+Z(GB)>402@2C,%;US?**RX=G=*NM(EIKKR8Q)==DQS86Z
MCP+7 6I\SIA\Z.@;3W'#]?\"4$L#!!0    ( $R'=E7T:#5T800  %L6   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;+58VV[C-A#]%4+=%@FPC2Z^
M):EM(+;2-D#2#6)L^U#T@9;&-K&4J"6I. 'Z\24E6;9LF8E1YL42Z9G#F</A
M:#C#->/?Q I HI>$IF+DK*3,KEU71"M(L+A@&:3JGP7C"99JR)>NR#C@N%!*
MJ!MX7M]-,$F=\;"8>^3C(<LE)2D\<B3R),'\=0*4K4>.[VPFGLAR)?6$.QYF
M> DSD%^S1ZY&;HT2DP1205B*."Q&SHU_'?H#K5!(_$E@+7;>D79ESM@W/;B+
M1XZG+0(*D=006#V>80J4:B1EQ_<*U*G7U(J[[QOT7POGE3-S+&#*Z%\DEJN1
M<^F@&!8XI_*)K7^'RJ&>QHL8%<4O6E>RGH.B7$B65,K*@H2DY1._5$3L*'2N
MCB@$E4*PK^ ?4>A4"IWW*G0KA6[!3.E*P4.()1X/.5LCKJ45FGXIR"RTE?LD
MU?L^DUS]2Y2>',]@J791(JV,?D8W<4ST?F"*[M(RJO3NG(4@,:'GZ!,B*7H@
ME*I9,72ELD#CN%&UVJ1<+3BRFA^@!Y;*E4"W:0QQ$\!5IM?V!QO[)X$1<0;9
M!>IXGU'@!0'Z.@O1V:?SBCA0\5VZUV+I]/VX_@%N"U[X?CSO#;P&$9UZ(SO%
M ITW-O(),L8E29>-#?S[7HFC.PF)^*=MVTKL;CNVSCW7(L,1C!R57 3P9W#&
M/_W@][U?VIBU"19: FMPVJTY[9K0QW_DR5P%$5N@C),T(IDZ%O-<*"DA-J$E
MT-GF[1S]:PBX2;E6OUA+I^/G<6?H/N\29[3F5.(L@36(Z]7$]=Y)W";"A<KP
M$<M3"3%288E\[T>D'@GCH,4X/$.:@R*S5M!L&L[;I'= I[='YYL2H4FBX7B_
M=KQO=/R1LSB/)+HG>$XHD:_H)HIXCNEG] B<L!C=OJA/MH VCTKHWHXU@;_G
MDG'U4R/$$EB#J$%-U,!(U /$),*TC0:CXJFYR"98: FL0=AE3=CE!^;W2YN<
MV@0++8$U.+VJ.;TR!N%=JK*.9/Q5L:J"D9H.Y]5!JA@$>X?SZN#\]OI[">=0
M).AVVU..[VU+.,_L1I)APHOH4*GT+I4X79(Y!70C!.@/U.U+1/-8Q\QOC,5K
M5;Z=M]9NWH&/O>Z>CV933MU\6VA-XG9J7]](7,$/VJ%ONL)\">V%K1'JU"-D
M%2VLT'8WKNL?B:I@2TY@).>>+ #-(@)I=(01H_[)C-A$"VVA-;G;UN+^1Q;C
MOM5JW"I:: NM2>RV(/?-%;FU5&>SU)Y:10O]PXM";W#D-&\+<M]<D7^1*U60
M?\F XRH>(U58:[Z*+UX[24;(DTFRB1;:0FO2N2WS_?Y''G";9?S4*EIH"ZU)
M[/9:X)OO!?_K E5A&V]0+3*=_IY0V"8TN-P[@^Y.UTW=49=%]U*@XI9;-K#J
MV;I#>E/T!??F)[IS6G3SMC!EV_5!E2,D%8C"0D%Z%P-E$2\[F>5 LJSH[<V9
M5!?EXG4%. :N!=3_"\;D9J 7J/O)X_\ 4$L#!!0    ( $R'=E7/FYT&5 P
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MFZ?KMV0,YSM0ZX(V#Z@95RT76AXQB]$_WR0DNA:0\7]-ZU/./S3/KQY+E[S
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MPA^_MV>MOH)810MMH;7%/[V%^+W-MBW/3IZ\*/M=RSX;$AI"@NX?K-LXDLN
M[?31)I>5[W-1GE75=^OCTZ4^-.S<7ZEC57W4=X(ISV1O,-L1:>\4MA+2NYC(
M@EAYS%D.!"WTP=^&"D$S?9D CH&I /G[EE+Q.% 3U(?-B_\!4$L#!!0    (
M $R'=E5%RK?7@ <  $(X   9    >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM
M;,6;6V^C.!B&_XJ5':TZ4CL!0]+#MI':,*NMM-54[1PN5GOA@I.@X9"Q3=.N
M]L>O#2G&"7'"SA?EI@5BO]@//GRO,9>+G'WG,TH%>DF3C%_U9D+,+_I]'LYH
M2OB'?$XS^<LD9RD1\I1-^WS.*(G*3&G2QXXS[*<DSGJCR_+:/1M=YH5(XHS>
M,\2+-"7L]88F^>*JY_;>+CS$TYE0%_JCRSF9TD<JOLSOF3SKURI1G-*,QWF&
M&)U<]:[=B\#'*D.9XFM,%[QQC%15GO+\NSJYC:YZCBH136@HE 21_Y[IF":)
M4I+E^+$4[=7W5!F;QV_JOY>5EY5Y(IR.\^1;'(G95>^LAR(Z(44B'O+%'W19
MH8'2"_.$EW_18IG6Z:&PX")/EYEE"=(XJ_Z3ER6(1@8\V) !+S/@E0RNOR&#
MM\S@[9K!7V;P2S)554H. 1%D=,GR!6(JM513!R7,,K>L?IRIY_XHF/PUEOG$
MZ'%&&#VYD>0B-,Y3V9PX*1_(";J.HE@=D@3=9E4+4S\<!520.'DO4WQY#-#1
MN_>(*Q&.X@Q]GN4%)UG$C]$[=7X7)XG,Q"_[0A96W;(?+@MV4Q4,;RB8B]%=
MGHD91Q^SB$:F0%_6LJXJ?JOJ#;8J/M+Y!^0YQP@[&+<4:+Q[=K<E>[![=L=2
M&Z]^<%ZIYUD?W-/Z@[MFC&13*ONF0$^OJ)GNGKR6EZ\7A$7HKS^E)+H5-.5_
MMSV?ZOY^^_W5>'3!YR2D5STYX'#*GFEO].LO[M#YK8TMI%@ )&9P]VONODU]
MU,I3(S]&'U_4LZ!M1"OE0:FL!N3G$?9E6WAN@FI)XYV9:8(VG4&=QJC6H*[6
MP%ZMZP>.GBD7<39%<\KB/&JK@5W$1Z^4L+;./K9F[/K\@<0,4,,:U' [*$%9
MRE$^043UI#90=A'7V4S*FK,K*2 Q@]1I3>K43DKDX7=TRWDANTHA!W&&2GCT
MA;(P5OWG2,X0U=SQOHUA)3]L-/-39[6[6(O0E1:0F$'KK*9U9J5U+Z'(\4/&
M6NC3!'TF;"J#/CG R%@-?<K0MUD<SI!,5$[$64A1-6<_R"[+XE#(PXKWERP6
M7(Y(RP1M7*N"G#>'CQ6JUJ)VI0HD9E ]KZF>[THU7Z4JY\K%!JJ?96A[HD;#
MS82)C?#Y&F%WA;"UV%T) XD9A%U'1Y".E;&:\$H\$N*$QNIHKHDNITJF*?*2
M8E%2/+)T_^5MF_U_.%C!:"]:5XY0:B;(1BCN6D%6#>LVDR%$2#E7XT#-MME&
MJ_;;BLQ=0^:=#5>964O1F1F0FLD,:V9X"S-&PWR:Q?](2&$S#J95'*9:)2))
M@K(\>^O2O!'#E3-XNS_!ZV'6P%N%:2U>9YA :B9,;2E<:^0\^E:Z9!J=D&?*
MU)C)J%HZ4"%A$D_H_T!HOY];1D%(1D-I9?6PCR+RVAH6V:4Z@]Z'A7"UAW!W
M,!$<+:B<1$@A9CDKVZ]JJI-"%/+J5#H*T<[47P^+\%I<9"] 9UQ :B8N[4W<
M+>9DN;X@0TGRE-!E,!G1"65LM=O/$Y*U8ANL8</>ZJQL+T=G:OOP*:XV*J[=
M9 2Q'!I%SEII0+J,,:A: *5F8M.NQ3T]\,**"VE:QJ!J 92:"5^;(-?N@H*R
M3Y.D[,;';PN+,YI$:C51L(*WQSUG:YW;==8Z-ZBK@5(S06E?XVXU-G6$;7."
MK;0@S<<85"V 4C-7B+67P<Z!.S^&="QC4+4 2LV$K_T/MON?QX8QW+X4N47,
MV[S"9L_9&=H^#!#6!@C;#5#3&%I@V45LL$ -#I2:"4L;'+R;P4'K!N>MP:FE
MW5:".UD97#L9;Z.3L2MU)KH/)X.UD\%V)[/K/(3^17<2=%JTPX5T*V-0M0!*
MS02LO0\>''I&@C0]8U"U $K-A*\M%+9;*&-P+5?=CM4@JY:46TD.U]9]5WVY
M_8:=\>S#*F%ME;#]#4^7SD]>-G9^4#L$JA9 J9F M1W"9X?N_)"F: RJ%D"I
MF?"UQ<([6ZR=.O_Z2Y_5UVKV&W;&LP^KY&FKY-E?^Y3OR+[:WI&U;BH!M3^@
M:@&4F@E4VQ_//?2.'DCC,P95"Z#43/C:1GEV!]3->VX1L]@I>\[.T/9AI[S&
M%K2]V:DMRCN]$K)K=&:Y#R/E:2/EV8W4]N%41E$?7VA8J(VRZ--D$H>T=6W?
M?J/.O1S43$&IF9"UF?(.;:8\4#,%JA9 J9GPM9GRMNR<ZS;$;ME!5PZQK<Q
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MXC@0_952=K7JD;;)E4OW0B0N/1=I1T*@F7T8S8-)"K ZB;.V@>;OI^Q %MB
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MO(E8W@;G T%3W1@^42';3/VXE/\<D*D ^7Y.J=@,U +E?Y'1'U!+ P04
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MXFTN/M/=KZ06-%3^$IKSZG^PJVV#'DBV7-"B+BPC*+)R_Q=_JQ-Q4 ".3A1
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ME3XNZV:F+S0@3( >3SE7FXXY,[LK4O074$L#!!0    ( $R'=E6O6Z>6; 0
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MGP;?:-2@V5K!4=?1V(!1;_-8@*'E\(>-6X.N[1HT^ZMHW*L+%N $==69@8/
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MP23 RZ!![2 HW[\;I=&G-[+'0_;X+?<2'T7LR]2I$J>RUVU7QJ.L"'<>U'A
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MYJ[8B()%7!3(]3K)EA1_E^0]!6TSH-!LAHT(6>2U)2V@H@.*1B@TFUHC.A9
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M9TI_YO'/0!?3"&9_ =TMV\"@RNW!"M.:O7"F 81TYM>K-C%;'!6X/+('[3O
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M7UERD6.EFV+ERD( SDI13MW \R(WQX0YTW%Y[DY,QWRC*&%P)Y#<Y#D6#]=
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M0'HTT#_?ZI./[N0O@0-(X@ Z)0X@HSA@2JW_.EGB #:$ UBQT(\H5ADT\8R
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M:67VR:9O@ODVVPL7('OB^<9H>;7<;[_.=ID;UV_@U3+?-:]D\DW\^X"K52I
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M&AF\/'PW."RTV!6OW@]"FQ?YXG*+-$9I \SSM1#ZN+!O\]77F]E_4$L#!!0
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MU2%BFH4S*?8@C36AF0<KIO4F^CPW^WZG);WEY*?#""7?,:,]7.=*RRWMJ5;
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M0NQDV9F6 RT*VZO="TV=GWU,J)M':0SH_5H(_3@P"]3_#X3_ %!+ P04
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M7;[WPE\ZE88DBP8B:\EV5LMV]NI%>C:DLD.210.1M91UG8>]I/-KEFGE5[/
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MB)P@%)A9Q\#HML(I"N&(2,;OEC/H7NF V^L-^Z7W3E[FS.!4B1\\M\M)<!Q
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M2[/.+Y?T-T+M NB\4,IN-F[@=?^W] ]02P,$%     @ 3(=V51JIW9LE!0
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M:&5E=#@U+GAM;*U6;6_:,!#^*Z>LFCJI(R] UW: !,VJ]0-25=;NP[0/)KF
M5<?.; >Z_?K93DB! J)2OQ"_W//XGO/YCMY2R"<U1]3PG#.N^MY<Z^+*]U4R
MQYRHEBB0FYU,R)QH,Y4S7Q422>I .?.C(#CW<T*Y-^BYM3LYZ(E2,\KQ3H(J
M\YS(OR-D8MGW0F^U<$]G<VT7_$&O(#.<H'XH[J29^0U+2G/DB@H.$K.^-PRO
MXJZU=P:/%)=J;0Q6R52()SNY3?M>8!U"AHFV#,1\%GB-C%DBX\:?FM-KCK3
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MVM1Y-YR;UHW2&IC]3 B]FM@#FC\#@_]02P,$%     @ 3(=V52O%42L^!
MS1<  !D   !X;"]W;W)K<VAE971S+W-H965T.#8N>&ULM5AMC]HX$/XK5JZM
M6NE*8@<"; &I"ZJZIVZU6JYW'ZI^,#! U"3..<[2_OMSG#2OX 7D?H$XF7D\
MCSV3>>+)@?'OR1Y H!]A$"53:R]$?&/;R7H/(4UZ+(9(/MDR'E(AAWQG)S$'
MNE%.86 3Q_'LD/J1-9NH>P]\-F&I"/P('CA*TC"D_.<M!.PPM;#UZ\:CO]N+
M[(8]F\1T!TL07^('+D=VB;+Q0X@2GT6(PW9JO<<W<S+(')3%/SX<DMHURJBL
M&/N>#>XV4\O)(H( UB*#H/+O">80!!F2C.._ M0JY\P<Z]>_T#\H\I+,BB8P
M9\&__D;LI];(0AO8TC00C^SP$0I"*L U"Q+UBPZYK3>TT#I-! L+9QE!Z$?Y
M/_U1+$3- ?=/.)#"@9SKX!8.KB*:1Z9H+:B@LPEG!\0S:XF67:BU4=Z2C1]E
MV[@47#[UI9^8+6 ET%NTS'<1L2U:[AD7;_\&'B+U\/4"!/6#-]+JRW*!7K]X
M@UX@/T+W?A#(C4@FMI!Q9&CVNICS-I^3G)AS"7$/N<Z?B#B$''&?G^^.F^ZV
M9%\N 2F7@"@\]Q2>(BQ*PE\_20-T)R!,OATCEZ/UCZ-E97>3Q'0-4TO650+\
M":S9JS^PY[P[1M406(.X6Q)W=>BS><HY1$)FO63-5H&_H^+4CN9( X64O1J>
M9@0/QQ/[J4ZF:S1PG-*F$6._C+&OCY&%(?"U3P/T0&/@QV+3(ERZ(8; &F0'
M)=F!T4P<F"1N"*Q!W"N)>]I=;A$_QM7K)J#KM/(OM_%J-B>R;UC&-=3&A7N.
MX[Q$GYF !&U2D-&M(5P!1WAP\O5UJ\6\=%L,@37HCTKZ(Z/Y.#))W!!8@_BX
M)#[6[OM=)$E#(A"G HXQS=W']4SK.;B5CMHYKF2 G:JQ.V>]W6.YAYE@DJT]
M8-$NW\[-B2HK,.MEUA\-6[P*HS/J#-=D"-9&^R%@LOE$._0H5[PHN(4LN+]2
MF7'>Z5K3PUZ:<Z;0FHM0"1%L5HE@HU+$%%J3?"5&\'EJY+)\[4J.=E,H3+QS
M5 FN9 G6ZY(\0W&O[^"7JC/<TY^(N"I1W:.1&E4IIM":["N=@LT*%6Q4J9A"
M:Y*OM K6BY5GFT/ACW&K/?0['4(_T[5,*G6#]?+FNI(;=I78F+2)#<]N$948
MP=J6+Y?0<TE=C*G>T->4G%$]8@JMR;Y2)'ALMN0,J8^"_._0,J32,D2O99XM
MN<*_77*.S)A69NIGNI9)I7.(7N=<57(%9KWDAIV/[R-&)TJ.U$Y&M#U?+6'C
M^^=]NDOE-F!-H]-#7GP^\CM$":E$"7'-G@UI-<[%Y VA-<E7&H?H-<[S5=?O
M?@:ULU)GTHRK4A]$V^"OK*%!ISS<<2?:KE$[6KMVUIH==-]3OO.C! 6PE3Y.
M;RB=>7YVG \$B]7QZXH)P4)UN0>Z 9X9R.=;)JNK&&0GNN4)_NQ_4$L#!!0
M   ( $R'=E4;=QT6H@H  #]^   9    >&PO=V]R:W-H965T<R]S:&5E=#@W
M+GAM;+6=6W.CR!F&_TJ7LDGM5GDM<=!I8KO*-O1AR]Z9LG>2BU0NL-2RJ$6@
M +)GJO;'IT%8J!%JB<V;FQD=^)X/V8]1PPO-U7N2_IXMI<S)MU449]>]99ZO
M/_7[V6PI5T%VF:QEK-Y9).DJR-73]+6?K5,9S,NB5=2W!X-1?Q6$<>_FJGSM
M2WISE6SR*(SEEY1DF]4J2+_?R2AYO^Y9O8\7GL+795Z\T+^Y6@>O\EGF7]=?
M4O6LOZ/,PY6,LS")22H7U[U;ZY-P1T5!N<0_0OF>[3TFQ4=Y29+?BR=B?MT;
M%&LD(SG+"T2@_GN3]S**"I):C_]4T-ZN9U&X__B#3LL/KS[,2Y#)^R3Z9SC/
ME]>]28_,Y2+81/E3\LYE]8&&!6^61%GY+WG?+CNV>V2VR?)D516K-5B%\?;_
MX%OU@]@K4)SV KLJL)L%[I$"IRIPF@6C(P5N5>">VV%8%0S/+1A5!:-S"\95
MP?C<@DE5,#FW8%H53$L=MK^_\I?O!7EP<Y4F[R0MEE:TXD%I4%FM?N=A7,C^
MG*?JW5#5Y3>>?,G)S^1V/@\+^8*(B'C[)U2H^*,G\R",?E)+?'WVR(\__$1^
M(&%,'L,H4N]G5_U<K4-!ZL^J?G?;?O:1?@YY3.)\F1$_GLMY2[UGKK=L Z"O
M/OSN)V!__ 3N;"/QETU\29S!!;$'MMVR0O?F\F>YWI5;;9_G_/*V[O[_UIV>
M7SYH*6?F\MMU>DD&UM&5Y^;RQT"5.\?+A;F<RI=+8D_:RC41G-V?@E/R'-.?
M@HBS/-VHK7E._O6@%B BEZOLWVVB;VEN.ZWXDOJ4K8.9O.ZI;Z%,IF^R=_.W
MOUBCP=_;)$/"/"3,1\(H$L:0,(Z$"1!,T]C=:>R:Z#?/RR3-?\YENE)?^B_Y
M!7DOO_#EG 1O,E4#&+4!5^_*+"=ID,LVLXT-NIJ]A5F#DE:,O=YN!I<#RQI>
M]=_VI=TN-VTLIB_DGPFCR$_ D#".A D03/-LN/-L:/3L]O4UE:_*(!+$\48-
M'-2889.J483,2+(@41*_[EMX9!M_9VS2U34DS-O"AGNJN<ZTX2.R(47"&!+&
MD3 !@FG2CG;2CL#2.FW2&IMTE18)\[:PT9ZTUG#L-JQ%=J1(&$/".!(F0##-
MVO'.VC'86K?-6F.3KM8B8=[XP%I[8#6WM<B.% EC2!A'P@0(IED[V5D[ 5L[
M;+/6V*2KM4B8-SFP=CIL#EB1#2D2QI PCH0)$$R3=KJ3=@J6=M0FK;%)5VF1
M,&]ZN*F='.QF(3M2)(PA81P)$R"89JTUJ _C#HS>/LA<:9F1SPMRG\IYF!.1
M99O@)9+D:SR7Z<>K-)B%49A_;SUR:VS1U5HHS:MHVL!V,&AH"VU)H30&I7$H
M3:!HNKM[$81E/F+U'L:OQ8OD(0GB[,^8:VS0V5PDS:MH)\Q%MJ10&H/2.)0F
M4#3=7+LVUS9O=0MIZTWNAZ+D,?@6KC:K_5CM2QK&LW"M'MVNDDV<D_MDM0KS
M(FEHC]&,G3LKC:1Y%6U?Z>&ATLB6%$IC4!J'T@2*IBM=AV"6,9S8*IT<*'VQ
M<_HN2154;;')?:#6X]@6&9J.06E>1=O7U[&'!_Y"@R\HC4%I'$H3*)KN;YU^
M6>;XZZ'80_NMV$,K\MQ6-:'Q5D7;CPFLL64U;/*JQ;11@#.9C)K2G46CT(_
MH#0.I0D43;>ISK@L<\CUD&19L><?E_O[1'[+U89O$V;+XGN[52YHG@6E>15-
MV_=O1@,MRUCC25._PVBLL0B#KCF'T@2*ICM51U"6.8/RPFR6Q$JDC9R3SVN9
MEN=:91=$O;%.,O6B^OI]48-(6>P,?<Z7:A\H7P8Q>0XB>4&>UV&<+!:M\D%S
M*2C-@])\*(U":0Q*XU":0-%T]>L<RQI#3[&RH)$5E.9!:3Z41J$T!J5Q*$V@
M:+K0=<1EF3.N[29;[=2S--FL+Y3;LV@S+W:.VK?R%VJW/\[">?6TU7EHX 6E
M>5":#Z51*(U!:;RB:<-Z>]08_ M43]WE.OFRS-%7<4!*IK.P.%@5*&%;Y80&
M6U":!Z7Y4!J%TAB4QJ$T@:+IY_+7.9@]@(XP;&CF!:5Y4)H/I5$HC4%I'$H3
M*)HN=!V.V2?"L?IT[F,'M,R$S@Y;!]]5S8-9]F&D93O-XZ<M"S4/8T%7G$%I
M'$H3*)HN49U3V>:<ZM<DEQD97@X&@[^2^482*E_239!^)]:P.(G%:;OXY\X,
M[>P5-(*"TGPHC4)I#$KC4)I T72MZZS*QEZQ94-#*2C-@])\*(U":0Q*XU":
M0-%TH>OPRC:'5Z70X4[H"[)0O4A0GC#0*C0TRH+2/"C-A](HE,:@- ZE"?LP
M4-P_54/WM([%;',L)DY=06BN[RPF- :#TGPHC4)I#$KC4)JH:(WK/8='S*S#
M-=L<KFU'NJ/+\;#32!<:G$%I'I3F0VD42F-0&H?2!(JF:UT'9S8V.+.AP1F4
MYD%I/I1&H30&I7$H3:!HNM!U<&:?",ZZCG2AJ1B4YD%I/I1&H31F'^98=O/$
M7VX?7A=WL)! K9>N7YUUV>:LZ_0 %AIT06D>E.9#:11*8Q6M.=_':#QL.@?-
ML% T?1JB.L-RS-=RT2@)BO,,R5-Q'>)V1.NIH>PO&_6=/SH^E889V]59*,V#
MTGPHC4)I#$KC4)I T72QZRS+L:"C6 <:;$%I'I3F0VD42F-0&H?2!(JF"UWG
M:HXY5VL(?4&>Y'J3SI9!<18O+4:TMT='M&9T9[FAZ1J4YD-I%$IC%4T[,VO:
MF'F$0UL*%$UW=F^6PQ,7>'6]I*'B:8-^_0=T;V[9V3[L_(78"0RQ,QABIS#$
MSF'X_XC"G#H*<\Q1V#F#8/('>=A-R''L[!ASG\[;66A&!J7Y4!J%TAB4QJ$T
M@:+IIM=AFC/$CHJAV1J4YD%I/I1&H30&I7$H3:!HNM!U!N>8,[C3E^": 9T5
MAN9M4)H/I5$HC56T$V-?:(R&HNEFUC&:8YY(\4F^)=%;.7=!8\:.(BKVY$RN
M7F1*[*GA(!LT68/2/"C-A](HE,:@- ZE"11-=[Q.UIP)=C@!3=:@- ]*\Z$T
M"J4Q*(U#:0)%TX6NLSK'G-4='&0KAA:M)D,SNQ-K-23?99"V3=WD0=?#A](H
ME,:@- ZE"11-OPE#'>*YYA!O-TU21C;E-':S[8AC89C&SHSL*G!%,UW(XQ[.
MJMB\C.<TA4)7FT%I'$H3*)KN5)V?N>9KP3H.7\D?'Y-VM<H&#=>@- ]*\Z$T
M"J4Q*(U#:0)%TVVOPS77A@YD76B@!J5Y4)H/I5$HC4%I'$H3*)HN=)V\N7]R
M:L7[39H6AI\WM:*Y2V?/H=&=VY(5C@^F5H3VI% :@]*X>SC5Y,%,J0+54M=R
M[WYAYJ2M/%);S+QLG&+9#.EL'31&@])\*(U":0Q*XU":0-%TC>L8S<7&:"XT
M1H/2/"C-A](HE,:@- ZE"11-%[J.T=P3\T1VO$3"C.LL-#14@])\*(U":0Q*
MX^YA1#=M#J<$JN76T_[>S:17,GTM[T2>D5FAW?9FNKM7=W<[ORWO\=UX_<[Z
M=&^UO.Y9G^CV7N8U?GMK]<<@?57"DT@N5*O!Y5A][G1[M_+MDSQ9E[>R?DGR
M/%F5#Y<RF,NT6$"]OTB2_.-)T6!WS_B;_P)02P,$%     @ 3(=V57R$BJ(0
M#   B($  !D   !X;"]W;W)K<VAE971S+W-H965T.#@N>&ULM5U;;^.X&?TK
M@KLM=H&N+8K4;9H$V#&QZ!0[B\%.MWTH^N D2F*,+ZFL3';^?659,<6+/UGB
M\3Q,;(<\Y'<L?CD\HLBKUVWY9?=4%%7PQWJUV5U/GJKJ^=ULMKM[*M:+W73[
M7&SJWSQLR_6BJM^6C[/=<UDL[IM*Z]4L"L-DMEXL-Y.;J^:S3^7-U?:E6BTW
MQ:<RV+VLUXORV_MBM7V]GK#)VP>_+1^?JOT'LYNKY\5C\;FH?G_^5-;O9D>4
M^^6ZV.R6VTU0%@_7DY_8.\E84Z,I\J]E\;KKO [VL=QNMU_V;S[<7T_"?9>*
M57%7[3$6]8^OQ;Q8K?90=4?^UZ).CHWN*W9?OZ'_W$1?1W.[V!7S[>K?R_OJ
MZ7J238+[XF'QLJI^V[[^O6@CBO=X=]O5KOD_>#V439))</>RJ[;KMG+=@_5R
M<_BY^*-EHE.!B1,5HK9"=&X%WE;@YU80;071,',(I>%!+JK%S56Y?0W*?>D:
M;?^B(;.I78>_W.R_^,]56?]V6=>K;F1Q6P4_!I\/WWNP?0A^V6X>?_QG4:Z#
MYG??RZ):+%<_U(5^_RR#[[_[(?@N6&Z"C\O5JO[B=E>SJN[&'FQVUS;Y_M!D
M=*+)S\7S-.#A7X,HC")']?GYU9FCNJ2K?UR4=77FJCZKN3L2&!T)C!H\3A'X
M8;.KRI=Z/%3!?WZI"P0?JF*]^Z^+FP.:<*/MA_F[W?/BKKB>U.-X5Y1?B\G-
M7_[$DO!O+J:08!($IK'(CRQR"OU&O^A<O!WJQTW]?3;[>L-XEB57LZ]=0ARE
M4L9"O90D^S(R4G&,5)"1LFD8AG\.?MU6Q2ZX?RGJ@.^*]6U1!BP^.23>DYA#
MKQHDF 2!:5S&1RYCZ-B+D2PBP20(3&,Q.;*8D%?DATU5U*A54"ZJPD7;H7K>
M&53A-&3&R"/;&$H'"$RC(SW2D7JFHM1*,D:"F1]*))T2<9H;28CLQ<@8LV.,
M64\2$B'K)J&/BV]!))K\PUTADW!#1PX23(+ -!KS(XTY-/_D2!:18!($IK'(
M0J5!0[\,U-9GS,A!PDI#=$M#:4&AZ;QTM#GS3$4M )6+VB+=9,1%:B0CNB-C
M U4:FI'BLOXN$QYU\]$_7NJ!1.0C&F_H4(*B212:SJ52THQ#DQ(#J>&62B2:
M1*'I5"JISFBMWI^7A#,OA?75;(Y"J.A&H>F\*-G-2#UZ3EZ*^_.2722/$C,O
M74(8,Z6,&2V-0W.R]M/+XTM]/3!.I":D$IY#T20*3:=3*6N68E,32".W5"+1
M) I-IU()>$8K^/[4E-FS-G,$]A:1="_&1JGT-2.%YSF))N]/-'81D7 ST$LH
MX$@IX(A6P'R:I;$Y(6L-(>&T$9$Z=PY%DR@TG4NEFB.&=61!VK>E$HDF46@Z
ME1UOF];EO5FFK6\*(%Y?S<8H/+NDI/LT-F:EGR-?*SIRN,S"BM=5R)0W=%?&
MAJKT;43K6S[E";>F70F1=: ^-!1-HM!T+I4FCK!>= 0UHZ%H$H6F4ZE4=^1I
M2+?UK5S"S3_K\[-+2KI/8V-6TCCR=9TCVW;.<_/^E[.0,$.]A'2-E'2-:.G*
MIRD7U!TP=^J!6M!0-(E"TPE5*CG"VM 1U(>&HDD4FGX76NEP[NE$<[<3S>M+
MVKP5?6Y)2?=I;,Q*+W-?EYG;+G.6FJGVG$*2[LK84)6>Y;2>Y=,P"D_<]XJ=
MD4-]9BB:1*'I7'96;&!]9@[UF:%H$H6F4ZET./?TF=OZ^]M16BX)39N9;F@P
M+9>0U%Q):NYK,W/;0XZLF:>C4*W_S,1T"<G+E>3EO4:SKHETH]F=FZ!&,Q1-
MHM!T.I6:YEBCF4.-9BB:1*'I5"JUSCV-YK:^=0\LM!71N24EW:>Q,2M!S7UM
M9^[PE#,K\=B%XM2\\TYW9>QB1"5X!2UXV30*LQ-WWA/G2D2H\0Q%DR@TG4LE
MI 76>!90XQF*)E%H.I5*J M/XUFX[6167\W&**1;&LS+)42W4*);^)K3PO:=
MX\R<J[6%NFN"DMR<J]%=&1MJ9YTT+8J3:7IJH321G: &-11-HM!T/I6:%EB#
M6D -:BB:1*'I5"JU+CP-ZK:^.5]+4G,<0D4W"DUG18ENX6MA"]N=9HFIFH2]
M>)HEF9F;+B&*A1+%HF_]=$X_Q.%.3E +&XHF46@ZH4IQ"ZR%+: 6-A1-HM#T
M1V*4HH\]+>RVOIF<F/& PIQN9_ 3+I?0YK'2YK&OR1W;_K4]I8OMQ=3VE([N
MRMA0E7:.^TQN0SAU[NJGSLBA)C<43:+0="Z5WHZQ)G<,-;FA:!*%IE.I]'SL
M:7+')TQN4S31[0QFY1*J/.X\P>CK<<>V?<U29LYRVU*)7LITN>G.C U6Z>:8
MULWI83EU'6D]EEY*S>H^-,.(+ 6UNZ%H$H6F\ZJ4=XRUNV.HW0U%DR@TG4JE
M[&-/NSMV+)J>AO5?W.X_\ZDTNM'!%%U"J\=*J\>^[GAL&]_,EI>Y(V.9-P+H
MKHQ],%IIZ836TJT'U9NP,A<+-/;0409%DR@TG5>EQA.L4YY G7(HFD2AZ50J
MM9]X.N5M_5XOBFYG,"N7T.V)TNV)KT^>.-9GFWII[BIDK6FBNS(V5*6K$UI7
MAU-.+1UPIR:H30Y%DR@TG4XER!.L39Y ;7(HFD2AZ51V]A7QW5C$O3H[Y-;2
M@;-+2KI/8V-64CSQ-<$3VP3/4G,=EZ,0LV;"DN[+V%B55DYHK1Q-LXA;JRF;
MG;EXZ P=:H!#T20*3>=2B>H$:X G4 ,<BB91:/KV/4JTIYX&>.I>F1UED7F?
MG&YI*"\H-)T7);I37PL\M2WPU'JP+;4M\%2869CNRMA0E2A.:5',IGF<=C/3
MS\5M^;+?X) U$S;NVCCP/0TZ=$Q!T20*32=4Z>D4ZX.G4!\<BB91:#J52J^G
MGCYX6]]:VE1?TN90A KO<]K58U:B.O5UN5/';B"YJ8I2V^2V"DFZ*V._7B5Z
M4UKTBFF49X[I6!0UB<>YNR,-.7BT0*UM%)I.9V<S/JRUG4*M;2B:1*'I5"JY
MGGI:VZE[?;:H+VAS($*E-PI-YT5)[]37STX=J[US2Q?9?K:YFPK=D9&!9DH8
M9[UKO1EWJZ)#<G*N6J)!AXXH*)I$H>F$*D6=86WL#&IC0]$D"DVG4BGVS-/&
MINL/Y@XJSK-3B]$9=RNG3 GOS-?(SEP+OLT]D#+7@F\S/=%=&7L)*&&<T<(X
M,3=;^[CXUMYD:Q95\MP9/M3*AJ))%)I.J%+=&=;*SJ!6-A1-HM!T*I6JSSRM
M[,RY2;9Y/XEN93 GEY#FF9+FF:_5G3E<[,A<&Y'9Z[TC:Z,DNBMC0^ULETU+
MY]A,3;]NOS;KO=O\U,@GX?2\:>3!@PJ[=_8EA'>FA'>&];PSJ.<-19,H-'T?
M<B7M<T_/NZUOY"=S#D.W,I03%)K.B5+GN:_?G=M^MRF*YHXR+#+M;KHG8R-5
MXCGOL[LY3TXN 1!.LYN&'#J8H&@2A:;3J31WCC6[<ZC9#463*#2=2J7I<T^S
M.S]A.EL[=,S/+BGI/HV-6<GNW-?LSFVS.TO,]9&.0LS>*8'NR]A8E2[.^]SN
MD_O6"N<V;C3>X+$"U=,H-)U+I:=SK-6=0ZUN*)I$H>E4*KV>>UK=^0FKV]ZW
MEFYI,"\7.:ZF<UZ-K]6=VU:W-1N;Y[;5;4_9Z*Z,#)6%W4-E:$TLIDD6$P_I
MNA-4#^K0886%DS X@]7.D30AUO-^PX/Q"76]87 &GU&'3T_C^PW RE6)]71J
M3UO#R;G(239AYRB;T-?]?D/0YG#,/A7*]K_KSZQ# .CNC ZX<^!,2.OE.F<E
MN?O97>%\*JX'</CP@AK@,#B#T,Y)-2'6 W_#@_$)=<%A< :?G0-Q0D\C_ W
M3E?6#*>GK>'D7.1TF[!SO$WHZXB_(>C' @B;&<<F*")C5KZZR"$T8><4FK!W
M+^]<N)> QTX[O =P^/B"RG,8G$%HY\";$.N)O^'!^(2ZXC XXP#%SB3 ^VC)
M$V=+\M3<-W_>T]9@<BYTNF3W>$G_\R5M^SN.;6)<"\?-A9D]O1D:[ZQSZ/WS
MXK'XN"@?EYM=L"H>:OAPNE\'6BX?GXYOJNUS3<\DN-U6U7;=O'PJ%O=%N2]0
M__YA6V>Q]LVLQG_=EE^:-F[^#U!+ P04    " !,AW95>Q[FMQD)   [<0
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M&7#5I-$P.C@>V::RWH&SI*8;6(%]JI?:6;AG*9@ :9B22$.91G?#Z6SLXT/
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MW:'7E[D^=8$P GU_S;G:#<P#NG/<_%]02P,$%     @ 3(=V5<6=*ENQ P
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M;#WVL+<Y<9?,%[(XX4]&2SJ'>Y!?EK=<'?FU2IQDD(N$Y8C#;.Q=X/.0](L
MW>*O!-9BZSLJAO+ V+?BX"H>>T&1$:00R4*"JH]'F$*:%DHJC^^5J%?W601N
M?]^H_Z8'KP;S0 5,6?HUB>5B[)UZ*(897:7RCJU_AVI @T(O8JG0?]&Z;#LX
M\5"T$I)E5;#*($OR\I,^52"V LA@1P"I LB+ -S?$="K GIO#>A7 1JU7PY%
M<PBII),19VO$B]9*K?BB8>IH-?PD+^[[O>3J:J+BY.0:%#2!#D*0-$G%(?H%
M?;D/T<&'0_0!)3FZ2=)4W1\Q\J7JK8CQHTKYLE0F.Y0Q03<LEPN!/N8QQ*:
MK]*L<R6;7"^)5?$>EL>H%QPA$A#2DM#T[>&X)3Q\>WA@&4VO)M_3>KV=Y(4
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MJ9:+YHQN L4K>RY.N=*GK&TN]+T&A!F@^V><JY? '+7M32G[!5!+ P04
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MJFUZ+FW''CVHL/Q:CTYA"?B8160B$N/ K*JZYSM0.KU[G_*O7TTPK5+&G%A
MK?*39L$</"?'%(-WBL%'%'$E(F/@.-)D%E.>E8<SD$Q$+"P^383"HG&"_F#:
MSC2H?71SIC90F6D5<^+M]M]++_^#VBM98,-"B;DE+,1WG*XD9!F$I:?8(!RL
MS[A?K96:Y31BP7AE4G60C)1[T TD(%=I5Z5(*+9<9S5SL5IT;E_3?J6T/C8=
M7=IEO*O)VL$'*E>,*Q+#$E5ZUUVT1V8=5C;18I/V' NAL8-)AVOL2D$: 'Y?
M"J'?)F:#HL\=_0=02P,$%     @ 3(=V5>=]A5ET!   ,A4  !H   !X;"]W
M;W)K<VAE971S+W-H965T,3 S+GAM;,5876_;-A3]*X16#"V01*)LRW9F&XBC
M%NU#@"!>NX=A#XQT;1.E1$^D[>S?CY04V:(HS4$U],76Q[E']UR21U><'7GV
M76P!)'I)6"KFSE;*W:WKBF@+"1$W? >INK/F64*D.LTVKMAE0.(\*&&N[WF!
MFQ":.HM9?NTQ6\SX7C*:PF.&Q#Y)2/;/$A@_SAWLO%YXHINMU!?<Q6Q'-K "
M^77WF*DSMV*):0*IH#Q%&:SGSAV^#?%4!^2(;Q2.XNP8:2G/G'_7)U_BN>/I
MC(!!)#4%47\'N ?&-)/*X^^2U*F>J0//CU_9/^7BE9AG(N">LS]H++=S9^*@
M&-9DS^03/WZ&4M!(\T6<B?P7'4NLYZ!H+R1/RF"504+3XI^\E(4X"\!!2X!?
M!OAFP+ E8% &#"X-&)8!P[PRA92\#B&19#'+^!%E&JW8]$%>S#Q:R:>I'O>5
MS-1=JN+D8K7?[1BH@92$H4\T)6E$U=&7M)A2>FBNT>\9B0$]003T0)X9B"MT
MQ]2,46 02"%1R/?/<KUGZ"Z*^#Z5 I$T1O=$;%%(17GI?0B24/9!,7Y=A>C]
MNP_H':(I>J",J0>)F2N5(IV7&Y79+XOL_9;LL8\>>"JW GU,8XCK!*XJ154/
M_[4>2[^3<06[&S3PKI#O^;XEH?O+P[$E/+P\W.M0,ZA&=Y#S#=KX/MZCE;**
M>,_@"F'_VIM>J8H=\@'7I?]&V+X8Y;,!U4/W! *R@SKY\XDS-3-X=B19_)=M
MB(H4AO84M&_=BAV)8.XH8\I)G<6OO^# ^\U6WC[)PI[(:J4?5J4?=K$OEK"A
M:4K3#5H2INMJ*UU!,<HIM$,?%E,U:P[G!6E")I,Z)+1 !A6DEORH2G[4F?Q=
M'%,]*P2*MB3;0(PD1Q$7Y;J&%_7:$6!=L 5Q<);,>&Q(:D*P9\@.FYC MVL*
M*DU!IZ90K8*H$*4U<+F%S"8@:#SY>F(JL&"F!B:T8$9CNX1Q)6'<*4&9W'],
MJ''CH1-S0C4AYIP++2P3>^:3*O-)]X1Z=9=B?5E?&38]G:QO]98^R<*>R&K5
MG%;5G/Y\6Y_V6?H^R<*>R&JEQ]ZI8?)^W-A+CIH-#HR%:,,$QDJT85I\$)^U
M?/C_<O>2^3R?H2FK"<&F-UHP@VF++/\DR^_%X$N:FC-CWU1A >F6K"[# AJ,
M6G2<>C;<V9=<X/(E0>WM.#(%-#'F# QMF* E_5/?@[L;'XO5U[\#K(HZ.=_J
M-KVRA7VQU>MY:L7PZ.>;/>[L!]]<_S[9PK[8ZO4_M8VXNV^\S.^;W1Z>F"O2
M@O'-%6G!X)85>>H:<7?;^"-^WVP%F^\Q2[LX-'4U,7[+-PH^]92XNZF\V/ G
M39L>-_S2!FJ\MRP@O^U]?.KF<&?'<HGA3QN?>#@P!5@PYI>B#6.F[YYM)B6@
MIHO>E%-31WMWL8]27:TV_N[R[2[C^E)O".:;5">:8C?Q0<U"JD:-P5I1>C=C
ME5!6;- 5)Y+O\BVK9RXE3_+#+9 8,@U0]]><R]<3_8!JFW3Q+U!+ P04
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M[?@3;*\;-X=5&XO+E*U8.JZG>CZMAH$=V*CU!81]Y*JZ_ C&<9@? 0R+@RG
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M6]-P8'W9SYW  ',VQ3=@$HOG)^B-L"FO^(/=;H7F[5[1&W>R:#9%=V-.R5?
M80OU? <4W9PYI2X"H:"! XINT)Q2EX%0T- !17=N3JD+02AHY("BVSFGK8(F
M[=O-A_>96$DELL_V0XP]GO(\O=.L^=%>RPO"9KO>JL[S2WOL5MV4/-O_@XW]
M/P?Y\!]02P,$%     @ 3(=V5>)5#QSX @  L#T  !H   !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<\W;RV[:0!B&X5M!OH!XSH<JR:J;;*O< "(&HG 2
M=M7D[HN2!7RC+KJ)_*[0&#&\&S]"9O[[7\-N.;T>#^/V]30NWO>[P_C0;:?I
M]*/OQ]5VV"_'N^-I.%S>61_/^^5T69XW_6FY>EMNAMX9D_KS[1[=X_WMGHOG
MC]/P/SL>U^O7U?#SN/J]'P[3/S;N_QS/;^-V&*9N\;P\;X;IH>O?=]?+8__Y
M8N\N.W>+IY>'[OST8KM^[B G06[^("]!?OZ@($%A_J H07'^H"1!:?Z@+$%Y
M_J B067^H"I!=?X@:U1& TAJL 9H;95K"_#:*M@6(+95LBW ;*MH6X#:5MFV
M +>MPFT!<ENEVP+LMHJW!>CM5&\'T-NIW@Z@MVM^; /T=JJW ^CM5&\'T-NI
MW@Z@MU.]'4!OIWH[@-Y.]78 O9WJ[0!Z>]7; _3VJK<'Z.U5;P_0VS</2P!Z
M>]7; _3VJK<'Z.U5;P_0VZO>'J"W5[T]0&^O>GN WD'U#@"]@^H= 'H'U3L
M] ZJ=P#H'9J'W0"]@^H= 'H'U3L ] ZJ=P#H'53O - [J-X!H'=4O2- [ZAZ
M1X#>4?6. +VCZAT!>D?5.P+TCLV?E0"]H^H= 7I'U3L"](ZJ=P3H'57O"- [
MJ=X)H'=2O1- [Z1Z)X#>2?5. +V3ZIT >B?5.P'T3LUA$X#>2?5. +V3ZIT
M>B?5.P'TSJIW!NB=5>\,T#NKWAF@=U:],T#OK'IG@-Y9]<X O;/JG0%ZY^:P
M($#OK'IG@-Y9]<X O8OJ70!Z%]6[ /0NJG<!Z%U4[P+0NZC>!:!W4;T+0.^B
M>A> WD7U+@"]2W/8&Z!W4;T+0.^J>E> WE7UK@"]J^I= 7I7U;L"]*ZJ=P7H
M757O"M"[JMX5H'=5O2M [ZIZ5X#>M1G6 >AM33NN _#;FF9@QP $MZ89V3$
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $R'=E4(G[[ XPL  %%P   8
M          " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !,AW95D>;)*#L"  "_!0  &               @($E%   >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 3(=V51YXF\59!@  XQP
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M965T-RYX;6Q02P$"% ,4    " !,AW95*Q>B>\P2  !6-   &
M    @($U-   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M3(=V56_0]2@L"@  #AL  !@              ("!-T<  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( $R'=E6H.=R3)04   D,   9
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M970Q-"YX;6Q02P$"% ,4    " !,AW9520"&F\</  #X*   &0
M    @(&\B@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M $R'=E6TSV]_QPX  #0L   9              " @;J:  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ 3(=V5807Q&3:%@  ]TD  !D
M             ("!N*D  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !,AW95P0Q?R,P$  #*"@  &0              @(')P   >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( $R'=E7W BN:Z 0
M -D+   9              " @<S%  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ 3(=V5=)W/*R$!0  >@P  !D              ("!
MZ\H  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !,AW95
MN@F'-GX*  !S(   &0              @(&FT   >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $R'=E5Y#XW5L@D   ,:   9
M      " @5O;  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ 3(=V5?,XM^Z<#P  TS   !D              ("!1.4  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !,AW95^C@P(HX+  "/'@
M&0              @($7]0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( $R'=E4-?5GC]P8   P2   9              " @=P  0!X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 3(=V560F,DE!
M!@  O X  !D              ("!"@@! 'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " !,AW95C*5]RF$>  ! 90  &0
M@(&"#@$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( $R'
M=E7/8\"4C@0  (H*   9              " @1HM 0!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ 3(=V5>BX]!D+!@  O!,  !D
M         ("!WS$! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " !,AW95HB\))YL$   +"P  &0              @($A. $ >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( $R'=E7X C[*I0D  !\8
M   9              " @?,\ 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ 3(=V5?1:9OZ!"   M1D  !D              ("!ST8!
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !,AW95$1-B
M[H0*   T(   &0              @(&'3P$ >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( $R'=E5"UL>')00  *\)   9
M  " @4): 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M3(=V5?/=[&;#!   W H  !D              ("!GEX! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " !,AW95.J?HN'@%  !W#@  &0
M            @(&88P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( $R'=E48EN<KL 0  -H+   9              " @4=I 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 3(=V5:VU3$^8"0
MR1X  !D              ("!+FX! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " !,AW95])=ST[T(  ##%P  &0              @(']
M=P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( $R'=E6
M2\(!7@,  -\'   9              " @?&  0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ 3(=V55EJQO*3!@  3A   !D
M     ("!AH0! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $R'=E5+T)')= @  %LX   9              "
M@>6A 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 3(=V
M59$I/Q&. @  U@8  !D              ("!D*H! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " !,AW95L*0SSVP+  !FBP  &0
M        @(%5K0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( $R'=E5H]^CN+@8  .8I   9              " @?BX 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 3(=V55S!7/6R @  ^ 8
M !D              ("!7;\! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " !,AW95UM;UL$$#  #I"0  &0              @(%&P@$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( $R'=E5\^$0R
M!0,  !,+   9              " @;[% 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ 3(=V54B+3SR<!0  4R@  !D
M ("!^L@! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !,
MAW95*X]U*#H#  #M#@  &0              @('-S@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( $R'=E7T:#5T800  %L6   9
M          " @3[2 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#
M%     @ 3(=V5<^;G094#   $($  !D              ("!UM8! 'AL+W=O
M<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !,AW95)&[79! &   /
M)@  &0              @(%AXP$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM
M;%!+ 0(4 Q0    ( $R'=E6Y,-Z5S@0  .(;   9              " @:CI
M 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 3(=V54B@
M_58>!   >!8  !D              ("!K>X! 'AL+W=O<FMS:&5E=',O<VAE
M970U.2YX;6Q02P$"% ,4    " !,AW951<JWUX '  !".   &0
M    @($"\P$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M $R'=E5?]?Y3? ,  .,*   9              " @;GZ 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ 3(=V5=^# R\T!0  >A4  !D
M             ("!;/X! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " !,AW95JLD$=:X"  "+!P  &0              @('7 P( >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( $R'=E6@M3/Q,P<
M )LR   9              " @;P& @!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ 3(=V57QU!MH\ P  EPP  !D              ("!
M)@X" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " !,AW95
M^_I 6A #   4#   &0              @(&9$0( >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( $R'=E4!=^Q!P ,  +L.   9
M      " @> 4 @!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ 3(=V5;9WG6\P!P  )2D  !D              ("!UQ@" 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !,AW95AR4E;5H&  !L+@
M&0              @($^( ( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( $R'=E5I[%Y^R (  "X)   9              " @<\F @!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 3(=V5:];IY9L
M!   $A@  !D              ("!SBD" 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " !,AW95B]]V3V<"  !8!@  &0
M@(%Q+@( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( $R'
M=E7A9<1_%Q8  *LM 0 9              " @0\Q @!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ 3(=V5;DG-4;\ P  A!@  !D
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M=#<X+GAM;%!+ 0(4 Q0    ( $R'=E5]XGASH@,  ,D1   9
M  " @7%> @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @
M3(=V50ABF(RE P  *Q   !D              ("!2F(" 'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6Q02P$"% ,4    " !,AW954!&*X> #    $@  &0
M            @($F9@( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4
M Q0    ( $R'=E5\"5__VP(  ,<)   9              " @3UJ @!X;"]W
M;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ 3(=V531>M%O$ @
MZP8  !D              ("!3VT" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX
M;6Q02P$"% ,4    " !,AW95&JG=FR4%  # )0  &0              @(%*
M< ( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( $R'=E4)
MZ/KTW0(  !@(   9              " @:9U @!X;"]W;W)K<VAE971S+W-H
M965T.#4N>&UL4$L! A0#%     @ 3(=V52O%42L^!   S1<  !D
M     ("!NG@" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $R'=E49\P?/]0(  .H(   9              "
M@?^S @!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ 3(=V
M52!UP9W% P  W@P  !D              ("!*[<" 'AL+W=O<FMS:&5E=',O
M<VAE970Y,BYX;6Q02P$"% ,4    " !,AW95<:3\FN$"  !K"   &0
M        @($GNP( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0
M   ( $R'=E7 4+>D+P(  .0$   9              " @3^^ @!X;"]W;W)K
M<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ 3(=V518U4VW[ P  TPT
M !D              ("!I< " 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q0
M2P$"% ,4    " !,AW95Q9TJ6[$#  #$#   &0              @('7Q (
M>&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( $R'=E4L\FB2
M-@0  *D/   9              " @;_( @!X;"]W;W)K<VAE971S+W-H965T
M.3<N>&UL4$L! A0#%     @ 3(=V5=?6K'OH @  ; @  !D
M ("!+,T" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " !,
MAW95WC7*%M8$   Z(   &0              @(%+T ( >&PO=V]R:W-H965T
M<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( $R'=E7DL6G).P,  )L*   :
M          " @5C5 @!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4
M Q0    ( $R'=E5[K 'MO (  #4)   :              " @<O8 @!X;"]W
M;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( $R'=E7!CZ&@$P0
M /,.   :              " @;_; @!X;"]W;W)K<VAE971S+W-H965T,3 R
M+GAM;%!+ 0(4 Q0    ( $R'=E7G?859= 0  #(5   :              "
M@0K@ @!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4 Q0    ( $R'
M=E4#'8!XHP(   X'   :              " @;;D @!X;"]W;W)K<VAE971S
M+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( $R'=E5R.4^5)@,  %()   :
M          " @9'G @!X;"]W;W)K<VAE971S+W-H965T,3 U+GAM;%!+ 0(4
M Q0    ( $R'=E6D10F51@,  ,X3   -              "  >_J @!X;"]S
M='EL97,N>&UL4$L! A0#%     @ 3(=V59>*NQS     $P(   L
M     ( !8.X" %]R96QS+RYR96QS4$L! A0#%     @ 3(=V57GBQ;EH!P
MH$0   \              ( !2>\" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( $R'=E7B50\<^ (  + ]   :              "  =[V @!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $R'=E4.2"\Y:@(  '4[
M   3              "  0[Z @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !Q '$ %!\  *G\ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>694</ContextCount>
  <ElementCount>560</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>156</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Spin-Off of Embecta Corp.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorp</Role>
      <ShortName>Spin-Off of Embecta Corp.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Accounting Changes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/AccountingChanges</Role>
      <ShortName>Accounting Changes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Earnings per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsperShare</Role>
      <ShortName>Earnings per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Segment Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentData</Role>
      <ShortName>Segment Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Business Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringCharges</Role>
      <ShortName>Business Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Financial Instruments and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements</Role>
      <ShortName>Financial Instruments and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Supplemental Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SupplementalFinancialInformation</Role>
      <ShortName>Supplemental Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bd.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Spin-Off of Embecta Corp. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpTables</Role>
      <ShortName>Spin-Off of Embecta Corp. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/SpinOffofEmbectaCorp</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/ShareholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Earnings per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsperShareTables</Role>
      <ShortName>Earnings per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/EarningsperShare</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Segment Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataTables</Role>
      <ShortName>Segment Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/SegmentData</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/ShareBasedCompensation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/BenefitPlans</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Business Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringChargesTables</Role>
      <ShortName>Business Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/BusinessRestructuringCharges</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/IntangibleAssets</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables</Role>
      <ShortName>Financial Instruments and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/Debt</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bd.com/role/SupplementalFinancialInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Spin-Off of Embecta Corp. - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails</Role>
      <ShortName>Spin-Off of Embecta Corp. - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Spin-Off of Embecta Corp. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpDetails</Role>
      <ShortName>Spin-Off of Embecta Corp. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/SpinOffofEmbectaCorpTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Spin-Off of Embecta Corp. - Assets and Liabilities of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails</Role>
      <ShortName>Spin-Off of Embecta Corp. - Assets and Liabilities of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail</Role>
      <ShortName>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail II)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII</Role>
      <ShortName>Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail II)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Shareholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail</Role>
      <ShortName>Shareholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail</Role>
      <ShortName>Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Shareholders' Equity - Other Comprehensive Income (Loss), Tax (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail</Role>
      <ShortName>Shareholders' Equity - Other Comprehensive Income (Loss), Tax (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share Footnotes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails</Role>
      <ShortName>Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share Footnotes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/RevenuesDetails</Role>
      <ShortName>Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Revenues</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Segment Data - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataAdditionalInformationDetail</Role>
      <ShortName>Segment Data - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Segment Data Segment Data - Revenues by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails</Role>
      <ShortName>Segment Data Segment Data - Revenues by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail</Role>
      <ShortName>Segment Data - Financial Information for Company's Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail</Role>
      <ShortName>Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail</Role>
      <ShortName>Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Share-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Share-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail</Role>
      <ShortName>Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Share-Based Compensation - Summary of SARs Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail</Role>
      <ShortName>Share-Based Compensation - Summary of SARs Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Share-Based Compensation Summary of SARs Exercised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails</Role>
      <ShortName>Share-Based Compensation Summary of SARs Exercised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail</Role>
      <ShortName>Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Share-Based Compensation Weighted Average Grant Date Fair Value of Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails</Role>
      <ShortName>Share-Based Compensation Weighted Average Grant Date Fair Value of Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Share-Based Compensation Fair Value of Stock Units Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails</Role>
      <ShortName>Share-Based Compensation Fair Value of Stock Units Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Benefit Plans - Net Pension and Other Postretirement Cost (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail</Role>
      <ShortName>Benefit Plans - Net Pension and Other Postretirement Cost (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail</Role>
      <ShortName>Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Benefit Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansAdditionalInformationDetail</Role>
      <ShortName>Benefit Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail</Role>
      <ShortName>Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail</Role>
      <ShortName>Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Benefit Plans - Expected Benefit Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail</Role>
      <ShortName>Benefit Plans - Expected Benefit Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Benefit Plans - Fair Value Measurements of Plan Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail</Role>
      <ShortName>Benefit Plans - Fair Value Measurements of Plan Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Acquisitions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/AcquisitionsDetail</Role>
      <ShortName>Acquisitions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/Acquisitions</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Business Restructuring Charges - Changes in Restructuring Balance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail</Role>
      <ShortName>Business Restructuring Charges - Changes in Restructuring Balance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets - Components of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Intangible Assets - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail</Role>
      <ShortName>Intangible Assets - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail</Role>
      <ShortName>Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Financial Instruments and Fair Value Measurement - Cash and Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurement - Cash and Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Debt - Summary of Short-Term Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtSummaryofShortTermDebtDetail</Role>
      <ShortName>Debt - Summary of Short-Term Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtAdditionalInformationDetail</Role>
      <ShortName>Debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Debt - Summary of Long-Term Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtSummaryofLongTermDebtDetail</Role>
      <ShortName>Debt - Summary of Long-Term Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Debt - Schedule of Debt Issuances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails</Role>
      <ShortName>Debt - Schedule of Debt Issuances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Debt - Extinguishments of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtExtinguishmentsofDebtDetails</Role>
      <ShortName>Debt - Extinguishments of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Debt - Summary of Interest Costs and Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail</Role>
      <ShortName>Debt - Summary of Interest Costs and Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Income Taxes - Provision for Income Taxes from Continuing Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail</Role>
      <ShortName>Income Taxes - Provision for Income Taxes from Continuing Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Income Taxes - Deferred Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Deferred Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Income Taxes - Summary of Income Tax Holiday (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails</Role>
      <ShortName>Income Taxes - Summary of Income Tax Holiday (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bd.com/role/LeasesTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Leases - Supplemental Balance Sheet Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Leases - Lessee, Operating Lease, Liability, Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails</Role>
      <ShortName>Leases - Lessee, Operating Lease, Liability, Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Supplemental Financial Information - Other Income (Expense), Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail</Role>
      <ShortName>Supplemental Financial Information - Other Income (Expense), Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail</Role>
      <ShortName>Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Supplemental Financial Information - Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail</Role>
      <ShortName>Supplemental Financial Information - Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="bdx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Supplemental Financial Information - Property, Plant and Equipment, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail</Role>
      <ShortName>Supplemental Financial Information - Property, Plant and Equipment, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: bdx:PreferredStockDepositaryShareOwnershipInterestPercentage, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:LesseeOperatingLeaseRenewalTerm, us-gaap:LesseeOperatingLeaseTermOfContract, us-gaap:PropertyPlantAndEquipmentUsefulLife -  bdx-20220930.htm 4</Log>
    <Log type="Warning">[dqc-0015-Negative-Values] Fact us-gaap:OtherNonoperatingExpense has a value of -1000000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:OtherNonoperatingExpense fact are: Context: i84f75f49afbd4c71aa0404983704de65_D20211001-20220930, Unit: usd, Rule Element Id: 1880. bdx-20220930.htm 4</Log>
    <Log type="Warning">[dqc-0015-Negative-Values] Fact us-gaap:OtherNonoperatingExpense has a value of -5000000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:OtherNonoperatingExpense fact are: Context: ib19be9eb6e964d878bdcd89ba1a51b28_D20191001-20200930, Unit: usd, Rule Element Id: 1880. bdx-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="bdx-20220930.htm">bdx-20220930.htm</File>
    <File>a09-30x2022ex21.htm</File>
    <File>a09-30x2022ex22.htm</File>
    <File>a09-30x2022ex23.htm</File>
    <File>a09-30x2022ex31.htm</File>
    <File>a09-30x2022ex32.htm</File>
    <File>a09-30x2022ex4ll.htm</File>
    <File>advisoryboardconsultingagr.htm</File>
    <File>bdperformanceincentiveplan.htm</File>
    <File>bdx-20220930.xsd</File>
    <File>bdx-20220930_cal.xml</File>
    <File>bdx-20220930_def.xml</File>
    <File>bdx-20220930_lab.xml</File>
    <File>bdx-20220930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1770">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="66">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>128
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bdx-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 36,
   "contextCount": 694,
   "dts": {
    "calculationLink": {
     "local": [
      "bdx-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bdx-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bdx-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bdx-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bdx-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bdx-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd"
     ]
    }
   },
   "elementCount": 886,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 11,
    "http://www.bd.com/20220930": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 16
   },
   "keyCustom": 93,
   "keyStandard": 467,
   "memberCustom": 72,
   "memberStandard": 72,
   "nsprefix": "bdx",
   "nsuri": "http://www.bd.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.bd.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Accounting Changes",
     "role": "http://www.bd.com/role/AccountingChanges",
     "shortName": "Accounting Changes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Leases - Supplemental Balance Sheet Information Related to Leases (Details)",
     "role": "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Leases - Lessee, Operating Lease, Liability, Maturity (Details)",
     "role": "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails",
     "shortName": "Leases - Lessee, Operating Lease, Liability, Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Supplemental Financial Information - Other Income (Expense), Net (Detail)",
     "role": "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail",
     "shortName": "Supplemental Financial Information - Other Income (Expense), Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail)",
     "role": "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail",
     "shortName": "Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Supplemental Financial Information - Inventories (Detail)",
     "role": "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail",
     "shortName": "Supplemental Financial Information - Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Supplemental Financial Information - Property, Plant and Equipment, Net (Detail)",
     "role": "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail",
     "shortName": "Supplemental Financial Information - Property, Plant and Equipment, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Shareholders' Equity",
     "role": "http://www.bd.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Earnings per Share",
     "role": "http://www.bd.com/role/EarningsperShare",
     "shortName": "Earnings per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Commitments and Contingencies",
     "role": "http://www.bd.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Revenues",
     "role": "http://www.bd.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Segment Data",
     "role": "http://www.bd.com/role/SegmentData",
     "shortName": "Segment Data",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Share-Based Compensation",
     "role": "http://www.bd.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Benefit Plans",
     "role": "http://www.bd.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Acquisitions",
     "role": "http://www.bd.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Business Restructuring Charges",
     "role": "http://www.bd.com/role/BusinessRestructuringCharges",
     "shortName": "Business Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "role": "http://www.bd.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Intangible Assets",
     "role": "http://www.bd.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Derivative Instruments and Hedging Activities",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Financial Instruments and Fair Value Measurements",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements",
     "shortName": "Financial Instruments and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Debt",
     "role": "http://www.bd.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Income Taxes",
     "role": "http://www.bd.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Leases",
     "role": "http://www.bd.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Supplemental Financial Information",
     "role": "http://www.bd.com/role/SupplementalFinancialInformation",
     "shortName": "Supplemental Financial Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Spin-Off of Embecta Corp. (Tables)",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpTables",
     "shortName": "Spin-Off of Embecta Corp. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.bd.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Income",
     "role": "http://www.bd.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Earnings per Share (Tables)",
     "role": "http://www.bd.com/role/EarningsperShareTables",
     "shortName": "Earnings per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Segment Data (Tables)",
     "role": "http://www.bd.com/role/SegmentDataTables",
     "shortName": "Segment Data (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.bd.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.bd.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Business Restructuring Charges (Tables)",
     "role": "http://www.bd.com/role/BusinessRestructuringChargesTables",
     "shortName": "Business Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.bd.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables",
     "shortName": "Financial Instruments and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Debt (Tables)",
     "role": "http://www.bd.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.bd.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bdx:SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Leases (Tables)",
     "role": "http://www.bd.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bdx:SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Supplemental Financial Information (Tables)",
     "role": "http://www.bd.com/role/SupplementalFinancialInformationTables",
     "shortName": "Supplemental Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:CashTransferRelatedToSpinoffTransaction",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Spin-Off of Embecta Corp. - Additional Information (Details)",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
     "shortName": "Spin-Off of Embecta Corp. - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i779c08f21c7145b69a3c73a02acd692f_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bdx:DisposalGroupsIncludingDiscontinuedOperationConsiderationCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Spin-Off of Embecta Corp. (Details)",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpDetails",
     "shortName": "Spin-Off of Embecta Corp. (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i03436c961ff34525b6bc41434568957f_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Spin-Off of Embecta Corp. - Assets and Liabilities of Discontinued Operations (Details)",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails",
     "shortName": "Spin-Off of Embecta Corp. - Assets and Liabilities of Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "ie11ec78990674c6894d07a12d457c3a3_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail)",
     "role": "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail",
     "shortName": "Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "idbef8604488846208cd4c70898654711_I20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail II)",
     "role": "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII",
     "shortName": "Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail II)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i4ad38254f42f4c66b77c1874165accec_I20130924",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Shareholders' Equity - Additional Information (Detail)",
     "role": "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
     "shortName": "Shareholders' Equity - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i4ad38254f42f4c66b77c1874165accec_I20130924",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail)",
     "role": "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
     "shortName": "Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.bd.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Shareholders' Equity - Other Comprehensive Income (Loss), Tax (Detail)",
     "role": "http://www.bd.com/role/ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail",
     "shortName": "Shareholders' Equity - Other Comprehensive Income (Loss), Tax (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Details)",
     "role": "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails",
     "shortName": "Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share Footnotes (Details)",
     "role": "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails",
     "shortName": "Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share Footnotes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "role": "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ContractWithCustomerRebateLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Revenues (Details)",
     "role": "http://www.bd.com/role/RevenuesDetails",
     "shortName": "Revenues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ContractWithCustomerRebateLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Segment Data - Additional Information (Detail)",
     "role": "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
     "shortName": "Segment Data - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Segment Data Segment Data - Revenues by Geographic Areas (Details)",
     "role": "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails",
     "shortName": "Segment Data Segment Data - Revenues by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "ia3c54e2da3b84403b338d82b3105ac2e_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:AcquisitionRelatedCostsAndRestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail)",
     "role": "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
     "shortName": "Segment Data - Financial Information for Company's Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i1feff546e94e4e799fd1e5ff2a6122b1_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail)",
     "role": "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
     "shortName": "Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail)",
     "role": "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail",
     "shortName": "Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Share-Based Compensation - Additional Information (Detail)",
     "role": "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
     "shortName": "Share-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail)",
     "role": "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail",
     "shortName": "Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5193767ce88145aea1c7e3a58e99996b_D20211001-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Share-Based Compensation - Summary of SARs Outstanding (Detail)",
     "role": "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail",
     "shortName": "Share-Based Compensation - Summary of SARs Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bdx:ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Share-Based Compensation Summary of SARs Exercised (Details)",
     "role": "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails",
     "shortName": "Share-Based Compensation Summary of SARs Exercised (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bdx:ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "ie6f651512be74e1d93a7c0f9cac1e296_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail)",
     "role": "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
     "shortName": "Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Share-Based Compensation Weighted Average Grant Date Fair Value of Restricted Stock Units (Details)",
     "role": "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails",
     "shortName": "Share-Based Compensation Weighted Average Grant Date Fair Value of Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Share-Based Compensation Fair Value of Stock Units Vested (Details)",
     "role": "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails",
     "shortName": "Share-Based Compensation Fair Value of Stock Units Vested (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bdx:ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i540864978cf046b79f6bcabafbe03e7e_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Benefit Plans - Net Pension and Other Postretirement Cost (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
     "shortName": "Benefit Plans - Net Pension and Other Postretirement Cost (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
     "shortName": "Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i2f9abd07d6034a0cae3d9dac424fd486_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAmendments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "bdx:PercentOfAssetsDomesticPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Benefit Plans - Additional Information (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
     "shortName": "Benefit Plans - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "bdx:PercentOfAssetsDomesticPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail",
     "shortName": "Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail",
     "shortName": "Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i1a431ffb2abf436ba24bcf4ac193d894_D20211001-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Benefit Plans - Expected Benefit Payments (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail",
     "shortName": "Benefit Plans - Expected Benefit Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5e5ae7d9e2124c6682347469bd7b2a0f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Benefit Plans - Fair Value Measurements of Plan Assets (Detail)",
     "role": "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
     "shortName": "Benefit Plans - Fair Value Measurements of Plan Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i239cacefc1034e98bffbb2d59ac35059_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Acquisitions (Detail)",
     "role": "http://www.bd.com/role/AcquisitionsDetail",
     "shortName": "Acquisitions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i1b0f58312f094de18638daec1ed57a5b_D20220718-20220718",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Business Restructuring Charges - Changes in Restructuring Balance (Detail)",
     "role": "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail",
     "shortName": "Business Restructuring Charges - Changes in Restructuring Balance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail)",
     "role": "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail",
     "shortName": "Intangible Assets - Components of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Intangible Assets - Additional Information (Detail)",
     "role": "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail",
     "shortName": "Intangible Assets - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)",
     "role": "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
     "shortName": "Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i4b1e06b3f4724fbe8ed56758a473c1d6_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i4b1e06b3f4724fbe8ed56758a473c1d6_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.bd.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i8f75da8137ff4f2e861df59a6e7398fa_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)",
     "role": "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
     "shortName": "Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i8a796cfd479247d9aed9717103f579c5_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Financial Instruments and Fair Value Measurement - Cash and Equivalents and Restricted Cash (Details)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails",
     "shortName": "Financial Instruments and Fair Value Measurement - Cash and Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i032efb1d86ce48d0909296f8cca53459_D20201001-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Financial Instruments and Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i032efb1d86ce48d0909296f8cca53459_D20201001-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:TransfersOfFinancialAssetsDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)",
     "role": "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:TransfersOfFinancialAssetsDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Debt - Summary of Short-Term Debt (Detail)",
     "role": "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail",
     "shortName": "Debt - Summary of Short-Term Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtWeightedAverageInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Debt - Additional Information (Detail)",
     "role": "http://www.bd.com/role/DebtAdditionalInformationDetail",
     "shortName": "Debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtWeightedAverageInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Debt - Summary of Long-Term Debt (Detail)",
     "role": "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
     "shortName": "Debt - Summary of Long-Term Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "idf4dbe29d1824505bd1b5f5e6d7daa66_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if2b4350bb9ae4ba0857cd83d2243daa2_I20220930",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Debt - Schedule of Debt Issuances (Details)",
     "role": "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
     "shortName": "Debt - Schedule of Debt Issuances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bdx:ScheduleOfDebtIssuancesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if2b4350bb9ae4ba0857cd83d2243daa2_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Spin-Off of Embecta Corp.",
     "role": "http://www.bd.com/role/SpinOffofEmbectaCorp",
     "shortName": "Spin-Off of Embecta Corp.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Debt - Extinguishments of Debt (Details)",
     "role": "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
     "shortName": "Debt - Extinguishments of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bdx:BdxGainlossfromreversetrasurylocks",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Debt - Summary of Interest Costs and Payments (Detail)",
     "role": "http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail",
     "shortName": "Debt - Summary of Interest Costs and Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InterestCostsCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Income Taxes - Provision for Income Taxes from Continuing Operations (Detail)",
     "role": "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail",
     "shortName": "Income Taxes - Provision for Income Taxes from Continuing Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail)",
     "role": "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail",
     "shortName": "Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "ib3f4c3f3aeef48c7a0b365d3718eba1a_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:IndemnificationLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "ib3f4c3f3aeef48c7a0b365d3718eba1a_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bdx:IndemnificationLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "if1596d6db35a42fba0359a8e52d30677_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail)",
     "role": "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail",
     "shortName": "Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "id4968fe4efb24bf38b4d8ea90a4a23ab_I20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Income Taxes - Deferred Income Taxes (Detail)",
     "role": "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail",
     "shortName": "Income Taxes - Deferred Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)",
     "role": "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail",
     "shortName": "Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxHolidayTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxHolidayAggregateDollarAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Income Taxes - Summary of Income Tax Holiday (Details)",
     "role": "http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails",
     "shortName": "Income Taxes - Summary of Income Tax Holiday (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxHolidayTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i84f75f49afbd4c71aa0404983704de65_D20211001-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxHolidayAggregateDollarAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Leases (Details)",
     "role": "http://www.bd.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdx-20220930.htm",
      "contextRef": "i5b40bf72179e46d89af6a51aac9400a0_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 156,
   "tag": {
    "bdx_AcceleratedShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Program",
        "label": "Accelerated Share Repurchase Program [Member]",
        "terseLabel": "Accelerated Share Repurchase Program"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_AcquisitionRelatedCostsAndRestructuringCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Acquisition Related Costs And Restructuring Charges",
        "terseLabel": "Acquisition-related integration and restructuring expense"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsAndRestructuringCharges",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_AcquisitionRelatedCostsAndRestructuringChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about Acquisition And Other Restructuring costs have been included.",
        "label": "Acquisition Related Costs And Restructuring Charges [Member]",
        "terseLabel": "Acquisitions and other restructurings"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsAndRestructuringChargesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]",
        "terseLabel": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.bd.com/20220930",
     "xbrltype": "stringItemType"
    },
    "bdx_BdxGainlossfromreversetrasurylocks": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "bdx:Gain(loss)fromreversetrasurylocks",
        "label": "bdx:Gain(loss)fromreversetrasurylocks",
        "terseLabel": "bdx:Gain(loss)fromreversetrasurylocks"
       }
      }
     },
     "localname": "BdxGainlossfromreversetrasurylocks",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_BiosciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biosciences [Member]",
        "label": "Biosciences [Member]",
        "terseLabel": "Biosciences"
       }
      }
     },
     "localname": "BiosciencesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Net Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNetAssets",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CRBardIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C.R. Bard Inc. [Member]",
        "label": "CR Bard Inc [Member]",
        "terseLabel": "CR Bard Inc"
       }
      }
     },
     "localname": "CRBardIncMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_CashTransferRelatedToSpinoffTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Transfer Related to Spinoff Transaction",
        "label": "Cash Transfer Related to Spinoff Transaction",
        "negatedTerseLabel": "Net transfer of cash to Embecta upon spin-off",
        "terseLabel": "Cash Transfer Related to Spinoff Transaction"
       }
      }
     },
     "localname": "CashTransferRelatedToSpinoffTransaction",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CommonStockHeldInTrustsNetShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock shares held in trust.",
        "label": "Common Stock Held In Trusts Net Shares",
        "terseLabel": "Common stock held in trusts, net (shares)"
       }
      }
     },
     "localname": "CommonStockHeldInTrustsNetShares",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_CommonStockSharesHeldInEmployeeTrust1": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.",
        "label": "Common Stock, Shares Held in Employee Trust1",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "CommonStockSharesHeldInEmployeeTrust1",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ContractWithCustomerRebateLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Rebate Liability",
        "label": "Contract With Customer, Rebate Liability",
        "terseLabel": "Rebate liability"
       }
      }
     },
     "localname": "ContractWithCustomerRebateLiability",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CoreAndDevelopedTechnologyNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.",
        "label": "Core And Developed Technology Net",
        "terseLabel": "Developed Technology, Net"
       }
      }
     },
     "localname": "CoreAndDevelopedTechnologyNet",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_CoreTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Core Technologies [Member]",
        "label": "Core Technologies [Member]",
        "terseLabel": "Core and Developed Technology"
       }
      }
     },
     "localname": "CoreTechnologiesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_DebenturesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures due 2027.",
        "label": "Debentures Due 2027 [Member]",
        "terseLabel": "7.000% Debentures due August\u00a01, 2027"
       }
      }
     },
     "localname": "DebenturesDue2027Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_DebenturesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures due 2028.",
        "label": "Debentures Due 2028 [Member]",
        "terseLabel": "6.700% Debentures due August\u00a01, 2028"
       }
      }
     },
     "localname": "DebenturesDue2028Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_DeferredCompensationInvestmentIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Investment Income (Expense)",
        "label": "Deferred Compensation Investment Income (Expense)",
        "terseLabel": "Deferred Compensation Investment Income (Expense)"
       }
      }
     },
     "localname": "DeferredCompensationInvestmentIncomeExpense",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DeferredTaxLiabilitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total cumulative amount of all deferred tax liabilities as presented in the table of deferred income taxes.",
        "label": "Deferred Tax Liabilities Gross",
        "totalLabel": "Deferred income taxes, liabilities, gross"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGross",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement and Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForSettlementAndCurtailment",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes to benefit obligation which arose from business combination and/or divestiture transactions.",
        "label": "DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation",
        "negatedTerseLabel": "Impact of Embecta spin-off"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsDivestituresBenefitObligation",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change to plan assets which arose from business combination and/or divestiture transactions.",
        "label": "DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets",
        "terseLabel": "Impact of Embecta spin-off"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsDivestituresPlanAssets",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DepositaryShareLiquidation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of depositary shares (which represent nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer and that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares).",
        "label": "Depositary Share Liquidation",
        "terseLabel": "Depositary Share Liquidation"
       }
      }
     },
     "localname": "DepositaryShareLiquidation",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DepositarysharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depositary shares [Member]",
        "label": "Depositary shares [Member]",
        "terseLabel": "Depositary shares [Member]"
       }
      }
     },
     "localname": "DepositarysharesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Debt",
        "label": "Disposal Group, Including Discontinued Operation, Debt",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDebt",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Employee-related Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)",
        "label": "Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net",
        "label": "Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Disposal Group, Including Discontinued Operation, Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense",
        "label": "Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Research and Development Expense",
        "label": "Disposal Group, Including Discontinued Operations, Research and Development Expense",
        "terseLabel": "Disposal Group, Including Discontinued Operations, Research and Development Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Additionally includes the amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Disposal Groups, Including Discontinued Operation, Acquisition Related Costs and Restructuring Charges",
        "terseLabel": "Disposal Groups, Including Discontinued Operation, Acquisition Related Costs and Restructuring Charges"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationAcquisitionRelatedCostsAndRestructuringCharges",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DisposalGroupsIncludingDiscontinuedOperationConsiderationCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Groups, Including Discontinued Operation, Consideration, Cash",
        "label": "Disposal Groups, Including Discontinued Operation, Consideration, Cash",
        "terseLabel": "Disposal Groups, Including Discontinued Operation, Consideration, Cash"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationConsiderationCash",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_DiversifiedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diversified [Member]",
        "label": "Diversified [Member]",
        "terseLabel": "Diversified"
       }
      }
     },
     "localname": "DiversifiedMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Benefit From Share-Based Compensation",
        "label": "Effective Income Tax Rate Reconciliation, Benefit From Share-Based Compensation",
        "terseLabel": "Effect of share-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_EmbectaServicesAgreementIncomeLossNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Embecta Services Agreement Income (Loss), Net",
        "label": "Embecta Services Agreement Income (Loss), Net",
        "terseLabel": "Embecta services agreement income, net"
       }
      }
     },
     "localname": "EmbectaServicesAgreementIncomeLossNet",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.",
        "label": "Excess Tax Benefit From Payments Under Share Based Compensation Operating Activities",
        "negatedTerseLabel": "Excess tax benefits from payments under share-based compensation plans"
       }
      }
     },
     "localname": "ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment of expected forfeitures to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.",
        "label": "Expected Forfeited Performance Based Restricted Stock Units",
        "terseLabel": "Expected forfeited performance-based restricted stock units (shares)"
       }
      }
     },
     "localname": "ExpectedForfeitedPerformanceBasedRestrictedStockUnits",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Of Debt Classified From Long Term To Short Term",
        "label": "Fair Value Of Debt Classified From Long Term To Short Term",
        "terseLabel": "Fair value of debt classified from long term to short term"
       }
      }
     },
     "localname": "FairValueOfDebtClassifiedFromLongTermToShortTerm",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FairValueOfStockAppreciationRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total fair value of stock appreciation rights that have vested during the fiscal year period.",
        "label": "Fair Value Of Stock Appreciation Rights",
        "terseLabel": "Total fair value of SARs vested"
       }
      }
     },
     "localname": "FairValueOfStockAppreciationRights",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite And Indefinite Lived Intangible Assets [Line Items]",
        "label": "Finite And Indefinite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite And Indefinite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite And Indefinite Lived Intangible Assets [Table]",
        "label": "Finite And Indefinite Lived Intangible Assets [Table]",
        "terseLabel": "Finite And Indefinite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_FiniteLivedCustomerRelationshipsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.",
        "label": "Finite Lived Customer Relationships Net",
        "terseLabel": "Customer Relationships, Net"
       }
      }
     },
     "localname": "FiniteLivedCustomerRelationshipsNet",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_FixedToFloatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed To Floating [Member]",
        "label": "Fixed To Floating [Member]",
        "terseLabel": "Fixed To Floating"
       }
      }
     },
     "localname": "FixedToFloatingMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_FloatingRateNotesDueJune62022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due June 6, 2022 [Member]",
        "label": "Floating Rate Notes Due June 6, 2022 [Member]",
        "terseLabel": "Floating Rate Notes Due June 6, 2022"
       }
      }
     },
     "localname": "FloatingRateNotesDueJune62022Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_GrossProceedsFromIssuanceOfEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross cash proceeds from the additional capital contribution to the entity.",
        "label": "Gross Proceeds from Issuance of Equity",
        "terseLabel": "Gross Proceeds from Issuance of Equity"
       }
      }
     },
     "localname": "GrossProceedsFromIssuanceOfEquity",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_GrossProceedsFromSaleLeasebackTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Proceeds from Sale Leaseback Transaction",
        "label": "Gross Proceeds from Sale Leaseback Transaction",
        "terseLabel": "Gross Proceeds from Sale Leaseback Transaction"
       }
      }
     },
     "localname": "GrossProceedsFromSaleLeasebackTransaction",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_GwinnettCountyGeorgiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gwinnett County, Georgia",
        "label": "Gwinnett County, Georgia [Member]",
        "terseLabel": "Gwinnett County, Georgia"
       }
      }
     },
     "localname": "GwinnettCountyGeorgiaMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_HerniaProductClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HerniaProductClaims [Member]",
        "label": "HerniaProductClaims [Member]",
        "terseLabel": "HerniaProductClaims"
       }
      }
     },
     "localname": "HerniaProductClaimsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_IncomeTaxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax.",
        "label": "Income Tax [Line Items]",
        "terseLabel": "Income Tax [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxLineItems",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_IncomeTaxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax.",
        "label": "Income Tax [Table]",
        "terseLabel": "Income Tax [Table]"
       }
      }
     },
     "localname": "IncomeTaxTable",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_IncreaseDecreaseinPensionBenefitObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension benefits.",
        "label": "Increase (Decrease) in Pension Benefit Obligation",
        "terseLabel": "Pension obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseinPensionBenefitObligation",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_IndemnificationLiabilityNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification Liability, Non-current",
        "label": "Indemnification Liability, Non-current",
        "terseLabel": "Indemnification liability, non-current"
       }
      }
     },
     "localname": "IndemnificationLiabilityNoncurrent",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_InsuranceContractInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments held in insurance contracts.",
        "label": "Insurance Contract Investments [Member]",
        "terseLabel": "Insurance contracts"
       }
      }
     },
     "localname": "InsuranceContractInvestmentsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_IntegratedDiagnosticSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated Diagnostic Solutions",
        "label": "Integrated Diagnostic Solutions [Member]",
        "terseLabel": "Integrated Diagnostic Solutions"
       }
      }
     },
     "localname": "IntegratedDiagnosticSolutionsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_InterestCostsIncurredTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest costs and payments for the periods presented.",
        "label": "Interest Costs Incurred Table [Table Text Block]",
        "terseLabel": "Summary of Interest Costs and Payments"
       }
      }
     },
     "localname": "InterestCostsIncurredTableTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_InterventionalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional [Member]",
        "label": "Interventional [Member]",
        "terseLabel": "Interventional"
       }
      }
     },
     "localname": "InterventionalMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_InvestmentsMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments measured at net asset value per share or its equivalent. [Member]",
        "label": "Investments Measured At Net Asset Value Per Share [Member]",
        "terseLabel": "Net Asset Value"
       }
      }
     },
     "localname": "InvestmentsMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_LettersOfCreditIssuableUnderCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Letters of credit amount issuable under credit facility",
        "label": "Letters Of Credit Issuable Under Credit Facility",
        "terseLabel": "Letters Of Credit Issuable Under Credit Facility"
       }
      }
     },
     "localname": "LettersOfCreditIssuableUnderCreditFacility",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_LifeSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Sciences [Member]",
        "label": "Life Sciences [Member]",
        "terseLabel": "Life Sciences"
       }
      }
     },
     "localname": "LifeSciencesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional funding available, subject to additional commitments made by lenders, under Company's syndicated credit facility.",
        "label": "Line Of Credit Facility Maximum Additional Principal Amount Commitments",
        "terseLabel": "Line Of Credit Facility Maximum Additional Principal Amount Commitments"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_MaturityPeriodOfShortTermInvestment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.",
        "label": "Maturity Period Of Short Term Investment",
        "terseLabel": "Maturity period of short-term investments at the time of purchase"
       }
      }
     },
     "localname": "MaturityPeriodOfShortTermInvestment",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical.",
        "label": "Medical [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MedicationDeliverySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication Delivery Solutions [Member]",
        "label": "Medication Delivery Solutions [Member]",
        "terseLabel": "Medication Delivery Solutions"
       }
      }
     },
     "localname": "MedicationDeliverySolutionsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_MedicationManagementSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication Management Solutions [Member]",
        "label": "Medication Management Solutions [Member]",
        "terseLabel": "Medication Management Solutions"
       }
      }
     },
     "localname": "MedicationManagementSolutionsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0.174dueJune42021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.174% due June 4, 2021 [Member]",
        "label": "Notes 0.174% due June 4, 2021 [Member]",
        "terseLabel": "Notes 0.174% due June 4, 2021"
       }
      }
     },
     "localname": "Notes0.174dueJune42021Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0.632dueJune42023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.632% due June 4, 2023 [Member]",
        "label": "Notes 0.632% due June 4, 2023 [Member]",
        "terseLabel": "0.632% Notes due June 4, 2023"
       }
      }
     },
     "localname": "Notes0.632dueJune42023Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0000DueAugust132023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.000% due August 13, 2023",
        "label": "Notes 0.000% due August 13, 2023 [Member]",
        "terseLabel": "0.000% Notes due August 13, 2023"
       }
      }
     },
     "localname": "Notes0000DueAugust132023Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0034DueAugust132025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.034% due August 13, 2025",
        "label": "Notes 0.034% due August 13, 2025 [Member]",
        "terseLabel": "0.034% Notes due August 13, 2025"
       }
      }
     },
     "localname": "Notes0034DueAugust132025Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes0334DueAugust132028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 0.334% due August 13, 2028",
        "label": "Notes 0.334% due August 13, 2028 [Member]",
        "terseLabel": "0.334% Notes due August 13, 2028"
       }
      }
     },
     "localname": "Notes0334DueAugust132028Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.000dueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.000% due December 15, 2022 [Member]",
        "label": "Notes 1.000% due December 15, 2022 [Member]",
        "terseLabel": "1.000% Notes due December 15, 2022"
       }
      }
     },
     "localname": "Notes1.000dueDecember152022Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.208dueJune42026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.208% due June 4, 2026 [Member]",
        "label": "Notes 1.208% due June 4, 2026 [Member]",
        "terseLabel": "1.208% Notes due June 4, 2026"
       }
      }
     },
     "localname": "Notes1.208dueJune42026Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.401dueMay242023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.401% due May 24, 2023 [Member]",
        "label": "Notes 1.401% due May 24, 2023 [Member]",
        "terseLabel": "1.401% Notes due May 24, 2023"
       }
      }
     },
     "localname": "Notes1.401dueMay242023Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1.900dueDecember152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.900% due December 15, 2026 [Member]",
        "label": "Notes 1.900% due December 15, 2026 [Member]",
        "terseLabel": "1.900% Notes due December 15, 2026"
       }
      }
     },
     "localname": "Notes1.900dueDecember152026Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1213DueFebruary122036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.213% due February 12, 2036",
        "label": "Notes 1.213% due February 12, 2036 [Member]",
        "terseLabel": "1.213% Notes due February 12, 2036"
       }
      }
     },
     "localname": "Notes1213DueFebruary122036Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1336DueAugust132041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.336 due August 13, 2041",
        "label": "Notes 1.336 due August 13, 2041 [Member]",
        "terseLabel": "1.336% Notes due August 13, 2041"
       }
      }
     },
     "localname": "Notes1336DueAugust132041Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1401DueMay232023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.401% due May 23, 2023",
        "label": "Notes 1.401% due May 23, 2023 [Member]",
        "terseLabel": "Notes 1.401% due May 23, 2023"
       }
      }
     },
     "localname": "Notes1401DueMay232023Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes1957DueFebruary112031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 1.957% due February 11, 2031",
        "label": "Notes 1.957% due February 11, 2031 [Member]",
        "terseLabel": "1.957% Notes due February 11, 2031"
       }
      }
     },
     "localname": "Notes1957DueFebruary112031Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes2823DueMay202030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 2.823% due May 20, 2030",
        "label": "Notes 2.823% due May 20, 2030 [Member]",
        "terseLabel": "2.823% Notes due May 20, 2030"
       }
      }
     },
     "localname": "Notes2823DueMay202030Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes2894DueJune62022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 2.894% due June 6, 2022",
        "label": "Notes 2.894% due June 6, 2022 [Member]",
        "terseLabel": "Notes 2.894% due June 6, 2022"
       }
      }
     },
     "localname": "Notes2894DueJune62022Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.020dueMay242025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.020% due May 24, 2025 [Member]",
        "label": "Notes 3.020% due May 24, 2025 [Member]",
        "terseLabel": "3.020% Notes due May 24, 2025"
       }
      }
     },
     "localname": "Notes3.020dueMay242025Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.02dueMay242025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.02% due May 24, 2025 [Member]",
        "label": "Notes 3.02% due May 24, 2025 [Member]",
        "terseLabel": "3.020% Notes due May 24, 2025"
       }
      }
     },
     "localname": "Notes3.02dueMay242025Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.300dueMarch12023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.300% due March 1, 2023 [Member]",
        "label": "Notes 3.300% due March 1, 2023 [Member]",
        "terseLabel": "Notes 3.300% due March 1, 2023"
       }
      }
     },
     "localname": "Notes3.300dueMarch12023Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.363DueJune62024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.363% Due June 6, 2024 [Member]",
        "label": "Notes 3.363% Due June 6, 2024 [Member]",
        "terseLabel": "3.363% Notes due June 6, 2024"
       }
      }
     },
     "localname": "Notes3.363DueJune62024Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.700dueJune62027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.700% due June 6, 2027 [Member]",
        "label": "Notes 3.700% due June 6, 2027 [Member]",
        "terseLabel": "3.700% Notes due June 6, 2027"
       }
      }
     },
     "localname": "Notes3.700dueJune62027Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.734DueDecember152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.734% Due December 15, 2024 [Member]",
        "label": "Notes 3.734% Due December 15, 2024 [Member]",
        "terseLabel": "3.734% Notes due December 15, 2024"
       }
      }
     },
     "localname": "Notes3.734DueDecember152024Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3.875dueMay152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.875% due May 15, 2024 [Member]",
        "label": "Notes 3.875% due May 15, 2024 Member",
        "terseLabel": "3.875% Notes due May 15, 2024"
       }
      }
     },
     "localname": "Notes3.875dueMay152024Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3125DueNovember82021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.125% due November 8, 2021",
        "label": "Notes 3.125% due November 8, 2021 [Member]",
        "terseLabel": "Notes 3.125% due November 8, 2021"
       }
      }
     },
     "localname": "Notes3125DueNovember82021Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes3794DueMay202050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 3.794% due May 20, 2050",
        "label": "Notes 3.794% due May 20, 2050 [Member]",
        "terseLabel": "3.794% Notes due May 20, 2050"
       }
      }
     },
     "localname": "Notes3794DueMay202050Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes4.669DueJune62047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 4.669% Due June 6, 2047 [Member]",
        "label": "Notes 4.669% Due June 6, 2047 [Member]",
        "terseLabel": "4.669% Notes due June 6, 2047"
       }
      }
     },
     "localname": "Notes4.669DueJune62047Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes4.685dueDecember152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 4.685% due December 15, 2044 [Member]",
        "label": "Notes 4.685% due December 15, 2044 [Member]",
        "terseLabel": "4.685% Notes due December 15, 2044"
       }
      }
     },
     "localname": "Notes4.685dueDecember152044Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes4.875dueMay152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 4.875% due May 15, 2044 [Member]",
        "label": "Notes 4.875% due May 15, 2044 [Member]",
        "terseLabel": "4.875% Notes due May 15, 2044"
       }
      }
     },
     "localname": "Notes4.875dueMay152044Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes4298DueAugust222032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 4.298% due August 22, 2032",
        "label": "Notes 4.298% due August 22, 2032 [Member]",
        "terseLabel": "4.298% Notes due August 22, 2032"
       }
      }
     },
     "localname": "Notes4298DueAugust222032Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes5000DueFebruary152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 5.000% due February 15, 2030",
        "label": "Notes 5.000% due February 15, 2030 [Member]",
        "terseLabel": "Notes 5.000% due February 15, 2030"
       }
      }
     },
     "localname": "Notes5000DueFebruary152030Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes6.700dueDecember12026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 6.700% due December 1, 2026 [Member]",
        "label": "Notes 6.700% due December 1, 2026 [Member]",
        "terseLabel": "6.700% Notes due December 1, 2026"
       }
      }
     },
     "localname": "Notes6.700dueDecember12026Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_Notes6750DueFebruary152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes 6.750% due February 15, 2030",
        "label": "Notes 6.750% due February 15, 2030 [Member]",
        "terseLabel": "Notes 6.750% due February 15, 2030"
       }
      }
     },
     "localname": "Notes6750DueFebruary152030Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_NotesDue2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes due 2039.",
        "label": "Notes Due 2039 [Member]",
        "terseLabel": "6.000% Notes due May\u00a015, 2039"
       }
      }
     },
     "localname": "NotesDue2039Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_NotesDue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes due 2040.",
        "label": "Notes Due 2040 [Member]",
        "terseLabel": "5.000% Notes due November\u00a012, 2040"
       }
      }
     },
     "localname": "NotesDue2040Member",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Customer Accounted For Ten Percent Or More Of Revenue",
        "label": "Number Of Customer Accounted For Ten Percent Or More Of Revenue",
        "terseLabel": "Number of customers accounted for 10% or more of revenues (customers)"
       }
      }
     },
     "localname": "NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_NumberOfEtOSterilizationLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of EtO Sterilization Lawsuits",
        "label": "Number of EtO Sterilization Lawsuits",
        "terseLabel": "Number of EtO Sterilization Lawsuits"
       }
      }
     },
     "localname": "NumberOfEtOSterilizationLawsuits",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants",
        "label": "Number of EtO Sterilization Lawsuits, Allege Injury From Unrelated Defendants",
        "terseLabel": "Number of lawsuits, allege injury from unrelated defendants"
       }
      }
     },
     "localname": "NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_NumberOfTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Transactions",
        "label": "Number of Transactions",
        "terseLabel": "Number of Transactions"
       }
      }
     },
     "localname": "NumberOfTransactions",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "bdx_OpenMarketRepurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Repurchases",
        "label": "Open Market Repurchases [Member]",
        "terseLabel": "Open Market Repurchases"
       }
      }
     },
     "localname": "OpenMarketRepurchasesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_OrganizationalUnitAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organizational Unit",
        "label": "Organizational Unit [Axis]",
        "terseLabel": "Organizational Unit [Axis]"
       }
      }
     },
     "localname": "OrganizationalUnitAxis",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_OrganizationalUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Organizational Unit [Axis]",
        "label": "Organizational Unit [Domain]",
        "terseLabel": "Organizational Unit [Domain]"
       }
      }
     },
     "localname": "OrganizationalUnitDomain",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss) Upon Termination Of Derivative Instrument, After Reclassification And Tax, Parent",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss) Upon Termination Of Derivative Instrument, After Reclassification And Tax, Parent",
        "terseLabel": "Net after-tax gain upon termination of contract"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossUponTerminationOfDerivativeInstrumentAfterReclassificationAndTaxParent",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_OtherFixedIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Fixed Income [Member]",
        "label": "Other Fixed Income [Member]",
        "terseLabel": "Other fixed income"
       }
      }
     },
     "localname": "OtherFixedIncomeMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_OtherPensionPlanInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in securities other than equity or debt instruments.",
        "label": "Other Pension Plan Investments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPensionPlanInvestmentsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_OthersCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Others Country [Member]",
        "label": "Others Country [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OthersCountryMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ParataSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Parata Systems",
        "label": "Parata Systems [Member]",
        "terseLabel": "Parata Systems"
       }
      }
     },
     "localname": "ParataSystemsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PatentsAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents And Trademarks [Member]",
        "label": "Patents And Trademarks [Member]",
        "terseLabel": "Patents, Trademarks, and Other"
       }
      }
     },
     "localname": "PatentsAndTrademarksMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PensionSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension Settlement Expense",
        "label": "Pension Settlement Expense",
        "terseLabel": "Pension Settlement Expense"
       }
      }
     },
     "localname": "PensionSettlementExpense",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_PercentOfAssetsDomesticPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to domestic pension plans.",
        "label": "Percent Of Assets Domestic Plans",
        "terseLabel": "Percent of total assets domestic plans"
       }
      }
     },
     "localname": "PercentOfAssetsDomesticPlans",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_PercentOfPlanAssetsForeignPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to foreign pension plans.",
        "label": "Percent Of Plan Assets Foreign Plans",
        "terseLabel": "Percent of total plan assets foreign plans"
       }
      }
     },
     "localname": "PercentOfPlanAssetsForeignPlans",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target payout on which performance-based restricted stock units are based.",
        "label": "Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based",
        "terseLabel": "Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based"
       }
      }
     },
     "localname": "PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based",
        "label": "Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based",
        "terseLabel": "Percentage of Target Payout on which Performance Based Time-vested Restricted Stock Units are Based"
       }
      }
     },
     "localname": "PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_PeripheralInterventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Peripheral Intervention [Member]",
        "label": "Peripheral Intervention [Member]",
        "terseLabel": "Peripheral Intervention"
       }
      }
     },
     "localname": "PeripheralInterventionMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PharmaceuticalSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Systems [Member]",
        "label": "Pharmaceutical Systems [Member]",
        "terseLabel": "Pharmaceutical Systems"
       }
      }
     },
     "localname": "PharmaceuticalSystemsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_PreferredStockDepositaryShareOwnershipInterestPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest per depositary share of the Company's preferred stock.",
        "label": "Preferred Stock, Depositary Share Ownership Interest, Percentage",
        "terseLabel": "Preferred Stock, Depositary Share Ownership Interest, Percentage"
       }
      }
     },
     "localname": "PreferredStockDepositaryShareOwnershipInterestPercentage",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_ProceedsFromSpinoffTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Spinoff Transaction",
        "label": "Proceeds From Spinoff Transaction",
        "terseLabel": "Distribution from Embecta Corp. (see Note 2)"
       }
      }
     },
     "localname": "ProceedsFromSpinoffTransaction",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ProductRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired technological intellectual property and know how, as well as product marketing rights.",
        "label": "Product Rights [Member]",
        "terseLabel": "Product rights"
       }
      }
     },
     "localname": "ProductRightsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ProductsandorServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products and/or Services [Member]",
        "label": "Products and/or Services [Member]",
        "terseLabel": "Products and/or Services"
       }
      }
     },
     "localname": "ProductsandorServicesMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ReserveforCashDiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of sales revenue which the Entity expects that it will not receive because customers may pay a reduced price if they make their payment within a certain timeframe offered by the Entity.",
        "label": "Reserve for Cash Discounts [Member]",
        "terseLabel": "Allowance\u00a0for Cash Discounts"
       }
      }
     },
     "localname": "ReserveforCashDiscountsMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_RestrictedStockUnitsPerformancePsuMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time and when specified performance conditions are met.",
        "label": "Restricted Stock Units Performance Psu [Member]",
        "terseLabel": "Performance-Based Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsPerformancePsuMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_SaleLeasebackTransactionTermOfContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Leaseback Transaction, Term of Contract",
        "label": "Sale Leaseback Transaction, Term of Contract [Member]",
        "terseLabel": "Sale Leaseback Transaction, Term of Contract"
       }
      }
     },
     "localname": "SaleLeasebackTransactionTermOfContractMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of foreign pension plans and/or other foreign employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule Of Allocation Of Foreign Plan Assets Table [Table Text Block]",
        "terseLabel": "Fair Value Measurements of Foreign Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_ScheduleOfDebtIssuancesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Issuances",
        "label": "Schedule of Debt Issuances [Table Text Block]",
        "terseLabel": "Schedule of Debt Issuances"
       }
      }
     },
     "localname": "ScheduleOfDebtIssuancesTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]",
        "label": "Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Line Items]",
        "terseLabel": "Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedLineItems",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]",
        "label": "Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]",
        "terseLabel": "Schedule Of Share Based Compensation, Restricted Stock Units Award, Grant Date Fair Value of Units Granted [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardGrantDateFairValueofUnitsGrantedTable",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]",
        "label": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Line Items]",
        "terseLabel": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedLineItems",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]",
        "label": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]",
        "terseLabel": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTable",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table]",
        "label": "Schedule Of Share Based Compensation, Restricted Stock Units, Fair Value of Stock Units Vested [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsFairValueofStockUnitsVestedTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted [Table]",
        "label": "Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsGrantDateFairValueofUnitsGrantedTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the intrinsic value, tax benefits, and fair value of stock appreciation rights exercised during the year.",
        "label": "Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSummaryofStockAppreciationRightsExercisedTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest",
        "terseLabel": "Stock units, vested and expected to vest at ending balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest",
        "terseLabel": "Stock units, vested and expected to vest at ending balance, exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Spin-Off Adjustment",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Spin-Off Adjustment",
        "terseLabel": "Embecta spin-off adjustment (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSpinOffAdjustment",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred due to Spinoff Transaction",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred due to Spinoff Transaction",
        "negatedTerseLabel": "Awards transferred to Embecta at spin-off (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredDueToSpinoffTransaction",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred in Spinoff Transaction, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Transferred in Spinoff Transaction, Weighted Average Grant Date Fair Value",
        "terseLabel": "Awards transferred to Embecta at the spin-off of Embecta (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTransferredInSpinoffTransactionWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the period of time over which an employee's right to exercise an stock appreciation right is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, which may be expressed in a variety of ways (for example, in years, month and year).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Award Vesting Period",
        "terseLabel": "SARs vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of exercisable stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Number",
        "terseLabel": "SARs, Exercisable at ending balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of stock appreciation rights outstanding and currently exercisable under the award plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Weighted Average Exercise Price",
        "terseLabel": "SARs, weighted average exercise price, exercisable (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock appreciation rights exercised during the current period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period",
        "negatedLabel": "SARs, exercised (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total accumulated difference between fair values of underlying shares on dates of exercise and exercise price on stock appreciation rights which were exercised during the reporting period under the plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value",
        "terseLabel": "Total intrinsic value of SARs exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsExercisedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stock appreciation rights that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Forfeited In Period",
        "negatedLabel": "SARs, forfeited, canceled or expired (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stock appreciation rights granted during the period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period",
        "terseLabel": "SARs, granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for stock appreciation rights issued during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period Weighted Average Exercise Price",
        "terseLabel": "SARs, weighted average exercise price, granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate intrinsic value for outstanding stock appreciation rights.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Intrinsic Value",
        "terseLabel": "SARs, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stock appreciation rights that validly exist and are outstanding as of the balance sheet date, including vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Number",
        "periodEndLabel": "SARs, ending balance (shares)",
        "periodStartLabel": "SARs, beginning balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price of shares reserved for issuance under stock appreciation right incentive compensation plan that validly exist and are outstanding as of the balance sheet date, including vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "SARs, weighted average exercise price, ending balance (USD per share)",
        "periodStartLabel": "SARs, weighted average exercise price, beginning balance (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average remaining contractual term for outstanding stock appreciation rights.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term",
        "terseLabel": "SARs, weighted average remaining contractual term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Spin-Off Adjustment",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Spin-Off Adjustment",
        "terseLabel": "Adjustments to BD awards related to the spin-off of Embecta (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsSpinOffAdjustment",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date when stock appreciation rights expire as specified in the award agreement, which may be presented in a variety of ways (for example, year, month and year, day, month and year, quarter of a year).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Terms Of Award",
        "terseLabel": "SARs terms of award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction",
        "negatedTerseLabel": "Embecta spin-off adjustment (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransaction",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Stock Appreciation Rights, Transferred in Spinoff Transaction, Weighted Average Exercise Price",
        "terseLabel": "Embecta spin-off adjustment (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTransferredInSpinoffTransactionWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate intrinsic value for stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "SARs, aggregate intrinsic value, vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Number",
        "terseLabel": "SARs, Vested and expected to vest at ending balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average exercise price of stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Exercise Price",
        "terseLabel": "SARs, weighted average exercise price, vested and expected to vest (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate intrinsic value for stock appreciation rights that are exercisable as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Intrinsic Value",
        "terseLabel": "SARs, aggregate intrinsic value, exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average remaining contractual term for stock appreciation rights that are exercisable as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term",
        "terseLabel": "SARs, weighted average remaining contractual term, exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price at which option holders exercised stock appreciation awards during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "SARs, weighted average exercise price, exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price of stock appreciation rights that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Forfeited In Period Weighted Average Exercise Price",
        "terseLabel": "SARs, weighted average exercise price, forfeited, canceled or expired (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average remaining contractual term for stock appreciation rights that are fully vested or are expected to vest.",
        "label": "Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term",
        "terseLabel": "SARs, weighted average remaining contractual term, vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Payout, Percent",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Payout, Percent",
        "terseLabel": "Performance payout, percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bdx_SharesIssuableUnderDeferredCompensationPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable under the Company's Deferred Compensation Plan that allows highly-compensated employees to defer salary, annual incentive awards and certain equity-based compensation.",
        "label": "Shares Issuable Under Deferred Compensation Plan",
        "terseLabel": "Shares issuable under deferred compensation plan"
       }
      }
     },
     "localname": "SharesIssuableUnderDeferredCompensationPlan",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_StockIssuedUnderStockAppreciationRightsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued to satisfy stock appreciation rights exercised during the current year's period.",
        "label": "Stock Issued Under Stock Appreciation Rights Exercised",
        "terseLabel": "Stock Issued under SARs exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedUnderStockAppreciationRightsExercised",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased",
        "label": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Additional Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information Related to Leases [Table Text Block]",
        "label": "Supplemental Balance Sheet Information Related to Leases [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information Related to Leases"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationRelatedtoLeasesTableTextBlock",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdx_SurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgery [Member]",
        "label": "Surgery [Member]",
        "terseLabel": "Surgery"
       }
      }
     },
     "localname": "SurgeryMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_SwinglineLoansIssuableUnderCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swingline Loans Issuable Under Credit Facility",
        "label": "Swingline Loans Issuable Under Credit Facility",
        "terseLabel": "Swingline Loans Issuable Under Credit Facility"
       }
      }
     },
     "localname": "SwinglineLoansIssuableUnderCreditFacility",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_TerminatedCurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terminated Currency Swap",
        "label": "Terminated Currency Swap [Member]",
        "terseLabel": "Terminated Currency Swap"
       }
      }
     },
     "localname": "TerminatedCurrencySwapMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdx_TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Shares to be Delivered Under Accelerated Share Repurchase Program",
        "label": "Total Shares to be Delivered Under Accelerated Share Repurchase Program",
        "terseLabel": "Total Shares to be Delivered Under Accelerated Share Repurchase Program"
       }
      }
     },
     "localname": "TotalSharesToBeDeliveredUnderAcceleratedShareRepurchaseProgram",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_TransfersOfFinancialAssetsDuringThePeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfers of financial assets during the period.",
        "label": "Transfers of financial assets during the period.",
        "terseLabel": "Transfers of financial assets during the period."
       }
      }
     },
     "localname": "TransfersOfFinancialAssetsDuringThePeriod",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdx_UnitsInExcessOfExpectedPerformancePayout": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment of units in excess of expected performance to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.",
        "label": "Units In Excess Of Expected Performance Payout",
        "terseLabel": "Units In Excess Of Expected Performance Payout"
       }
      }
     },
     "localname": "UnitsInExcessOfExpectedPerformancePayout",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdx_UrologyandCriticalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Urology and Critical Care [Member]",
        "label": "Urology and Critical Care [Member]",
        "terseLabel": "Urology and Critical Care"
       }
      }
     },
     "localname": "UrologyandCriticalCareMember",
     "nsuri": "http://www.bd.com/20220930",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail",
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r940",
      "r941",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r940",
      "r941",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r940",
      "r941",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current fiscal year end date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r940",
      "r941",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document fiscal period focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document fiscal year focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document period end date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity central index key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity common stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity emerging growth company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity filer category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity current reporting status"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity public float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity registrant name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity shell company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity small business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity voluntary filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r968"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity well-known seasoned issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r940",
      "r941",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Asia.",
        "label": "Asia [Member]",
        "terseLabel": "Greater Asia"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r164",
      "r234",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r254",
      "r258",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r379",
      "r381",
      "r382",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r164",
      "r234",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r254",
      "r258",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r379",
      "r381",
      "r382",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r176",
      "r187",
      "r193",
      "r287",
      "r614",
      "r615",
      "r616",
      "r652",
      "r653",
      "r728",
      "r731",
      "r734",
      "r735",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r176",
      "r187",
      "r193",
      "r287",
      "r614",
      "r615",
      "r616",
      "r652",
      "r653",
      "r728",
      "r731",
      "r734",
      "r735",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r176",
      "r187",
      "r193",
      "r287",
      "r614",
      "r615",
      "r616",
      "r652",
      "r653",
      "r728",
      "r731",
      "r734",
      "r735",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of executive officer.",
        "label": "Executive Officer [Member]",
        "terseLabel": "Executive Officer"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r358",
      "r360",
      "r361",
      "r362",
      "r387",
      "r424",
      "r569",
      "r574",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r886",
      "r889",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r358",
      "r360",
      "r361",
      "r362",
      "r387",
      "r424",
      "r569",
      "r574",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r886",
      "r889",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r261",
      "r360",
      "r361",
      "r470",
      "r472",
      "r829",
      "r885",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r261",
      "r360",
      "r361",
      "r470",
      "r472",
      "r829",
      "r885",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r337",
      "r358",
      "r360",
      "r361",
      "r362",
      "r387",
      "r424",
      "r508",
      "r569",
      "r574",
      "r604",
      "r605",
      "r606",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r886",
      "r889",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r337",
      "r358",
      "r360",
      "r361",
      "r362",
      "r387",
      "r424",
      "r508",
      "r569",
      "r574",
      "r604",
      "r605",
      "r606",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r886",
      "r889",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r262",
      "r263",
      "r470",
      "r473",
      "r888",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r946",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r262",
      "r263",
      "r470",
      "r473",
      "r888",
      "r918",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r946",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r268",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r169",
      "r170",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r75",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r269",
      "r270"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r50",
      "r844",
      "r869"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r92",
      "r97",
      "r105",
      "r106",
      "r107",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit\u00a0Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43",
      "r329"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r97",
      "r105",
      "r106",
      "r107",
      "r108",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r62",
      "r94",
      "r96",
      "r97",
      "r871",
      "r897",
      "r901"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated other comprehensive (loss) income, ending balance",
        "periodStartLabel": "Accumulated other comprehensive (loss) income, beginning balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r91",
      "r97",
      "r105",
      "r106",
      "r107",
      "r694",
      "r764",
      "r765",
      "r766",
      "r767",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Supplemental Financial Information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r614",
      "r615",
      "r616",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess\u00a0of Par\u00a0Value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r577",
      "r617",
      "r618"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Compensation cost relating to share-based payments",
        "verboseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance\u00a0for Doubtful Accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r142",
      "r309",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Intangible amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r142",
      "r324"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset Impairment Charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r47",
      "r157",
      "r242",
      "r249",
      "r256",
      "r283",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r382",
      "r383",
      "r690",
      "r695",
      "r748",
      "r812",
      "r814",
      "r842",
      "r868"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r38",
      "r74",
      "r157",
      "r283",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r382",
      "r383",
      "r690",
      "r695",
      "r748",
      "r812",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r28",
      "r32",
      "r326",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Current assets of discontinued operations",
        "totalLabel": "Current assets of discontinued operations"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail",
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r708",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r565",
      "r570",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r565",
      "r570",
      "r671",
      "r672",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r684",
      "r685",
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r676",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r673",
      "r674"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r36",
      "r41",
      "r144"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Institutional money market investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r146",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r138",
      "r144",
      "r148"
     ],
     "calculation": {
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Closing Cash and Equivalents and Restricted Cash",
        "periodStartLabel": "Opening Cash and Equivalents and Restricted Cash",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r138",
      "r762"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (Decrease) Increase in Cash and Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Cash Provided by (Used in) Financing Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r25",
      "r138"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "terseLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r25",
      "r138"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r154",
      "r157",
      "r199",
      "r200",
      "r203",
      "r206",
      "r208",
      "r218",
      "r219",
      "r220",
      "r283",
      "r369",
      "r374",
      "r375",
      "r376",
      "r382",
      "r383",
      "r422",
      "r423",
      "r427",
      "r431",
      "r439",
      "r748",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r85",
      "r848",
      "r875"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (See Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r363",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r366",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r509",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity forward contracts"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Common stock dividend per share (USD per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetailII"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock\u00a0 Issued at\u00a0Par\u00a0Value"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesHeldInEmployeeTrustShares": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned.",
        "label": "Common Stock, Shares Held in Employee Trust, Shares",
        "terseLabel": "Deferral plan, shares held in trust"
       }
      }
     },
     "localname": "CommonStockSharesHeldInEmployeeTrustShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r59",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock \u2014 $1 par value: authorized \u2014 640,000,000 shares; issued \u2014 364,639,901 shares in 2022 and 2021."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r100",
      "r102",
      "r103",
      "r116",
      "r855",
      "r881"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r223",
      "r864"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r149",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r422",
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r57",
      "r58",
      "r434",
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r509",
      "r558",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r258",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and All Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r121",
      "r829"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Operating Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r646",
      "r659"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r646"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r646",
      "r659",
      "r661"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total, Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r646",
      "r659"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local, including Puerto Rico"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Current debt obligations",
        "totalLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r153",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r401",
      "r408",
      "r409",
      "r411",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r49",
      "r50",
      "r52",
      "r156",
      "r164",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r412",
      "r413",
      "r414",
      "r415",
      "r778",
      "r843",
      "r846",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r384",
      "r412",
      "r413",
      "r776",
      "r778",
      "r779"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r82",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r83",
      "r156",
      "r164",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r412",
      "r413",
      "r414",
      "r415",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Debt Instrument, Repurchase Amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt Instrument, Repurchased Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r83",
      "r156",
      "r164",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r410",
      "r412",
      "r413",
      "r414",
      "r415",
      "r440",
      "r444",
      "r445",
      "r446",
      "r775",
      "r776",
      "r778",
      "r779",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtScheduleofDebtIssuancesDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Debt [Member]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-Based Payments [Member]",
        "terseLabel": "Deferred Compensation"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r647",
      "r659"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r647",
      "r659"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r142",
      "r158",
      "r647",
      "r659",
      "r660",
      "r661"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total, Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r54",
      "r55",
      "r638",
      "r845",
      "r865"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Deferred income taxes, liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred income taxes, assets, gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred income taxes, assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other, assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOtherTaxCarryforwards": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax carryforwards, classified as other.",
        "label": "Deferred Tax Assets, Other Tax Carryforwards",
        "terseLabel": "Loss and credit carryforwards, assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsOtherTaxCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Compensation and benefits, assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r640"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance, assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 3.0,
       "parentTag": "bdx_DeferredTaxLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other, liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "bdx_DeferredTaxLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "terseLabel": "Deferred Tax Liabilities, Other Finite-Lived Assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "bdx_DeferredTaxLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Property and equipment, liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r93",
      "r97",
      "r529"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "negatedTotalLabel": "Net amount recognized"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]",
        "terseLabel": "Amounts recognized in Accumulated other comprehensive income (loss) before income taxes at September\u00a030:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r97",
      "r529"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "terseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r97",
      "r529"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "negatedTerseLabel": "Prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r498",
      "r558"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedLabel": "Actuarial gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r484",
      "r524",
      "r552",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r484",
      "r525",
      "r553",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r482",
      "r506"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Net amount recognized"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Amounts recognized in the Consolidated Balance Sheets at September\u00a030:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r482",
      "r483",
      "r506",
      "r558",
      "r841",
      "r867"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r533",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Ending obligation",
        "periodStartLabel": "Beginning obligation",
        "terseLabel": "Pension plan projected benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r493",
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r536",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in fair value of plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r500",
      "r509",
      "r511",
      "r556",
      "r558",
      "r559"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r509",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028-2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r484",
      "r523",
      "r551",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r497",
      "r509",
      "r511",
      "r512",
      "r558"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Ending fair value",
        "periodStartLabel": "Beginning fair value",
        "terseLabel": "Fair value of plan assets",
        "verboseLabel": "Pension plan assets at fair value"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r482",
      "r506",
      "r558"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Unfunded benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]",
        "terseLabel": "Funded Status at September\u00a030:"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r484",
      "r489",
      "r522",
      "r550",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r520",
      "r548",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "negatedTerseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change",
        "negatedLabel": "Other, includes translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": {
     "auth_ref": [
      "r544",
      "r558"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Projected benefit obligation exceeds the fair value of plan assets, fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": {
     "auth_ref": [
      "r544",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Projected benefit obligation exceeds the fair value of plan assets, projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r544",
      "r545",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation exceeds the fair value of plan assets, accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r544",
      "r545",
      "r558"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Accumulated benefit obligation exceeds the fair value of plan assets, fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation exceeds the fair value of plan assets, projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansPensionPlanswithAccumulatedBenefitObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "negatedLabel": "Plan amendments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r502",
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Other, includes translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r508",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Company's Target allocation percentage for asset mix"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRealEstateMember": {
     "auth_ref": [
      "r509",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Real Estate [Member]",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r485",
      "r527",
      "r555"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Curtailment/settlement loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r487",
      "r521",
      "r549",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedLabel": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Net Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Cost of the savings incentive plan"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r142",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r142",
      "r237"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Total Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r88",
      "r709",
      "r710",
      "r712",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r723",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r706",
      "r709",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r706",
      "r709",
      "r712",
      "r718",
      "r719",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r700",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r163",
      "r699",
      "r701",
      "r706",
      "r707",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r579",
      "r580",
      "r610",
      "r611",
      "r613",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r12",
      "r15",
      "r23",
      "r113",
      "r878"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "totalLabel": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r15",
      "r23",
      "r29",
      "r625",
      "r658",
      "r666"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "terseLabel": "Discontinued Operation, Tax Effect of Discontinued Operation"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of in a spinoff and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Means Other than Sale, Spinoff"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember": {
     "auth_ref": [
      "r323",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is disposed of in a spinoff. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff [Member]",
        "terseLabel": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsSpinoffMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r28",
      "r32",
      "r322",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent",
        "terseLabel": "Noncurrent Assets of Discontinued Operations",
        "totalLabel": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r24",
      "r32"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "auth_ref": [
      "r13",
      "r14",
      "r24",
      "r33"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "negatedTerseLabel": "Disposal Group, Including Discontinued Operation, Interest Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r326",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "totalLabel": "Disposal Group, Including Discontinued Operation, Operating Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "totalLabel": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Other Expense",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r24",
      "r32"
     ],
     "calculation": {
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r34",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Spin-Off of Embecta Corp."
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends, common"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStock": {
     "auth_ref": [
      "r447",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Preferred Stock",
        "negatedTerseLabel": "Dividends, Preferred Stock"
       }
      }
     },
     "localname": "DividendsPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r564",
      "r568",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r117",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r196",
      "r199",
      "r206",
      "r207",
      "r208",
      "r213",
      "r214",
      "r735",
      "r736",
      "r856",
      "r882"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Earnings Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r117",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r199",
      "r206",
      "r207",
      "r208",
      "r213",
      "r214",
      "r735",
      "r736",
      "r856",
      "r882"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Diluted Earnings per Share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r209",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r209",
      "r211",
      "r212",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r762"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r160",
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effect of valuation allowance release"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent",
        "terseLabel": "Effect of gain on divestitures"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign income tax at rates other than 21%"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent",
        "negatedTerseLabel": "Effect of foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r626",
      "r663"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Effect of Research Credits and FDII/Domestic Production Activities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesReconciliationofFederalStatutoryTaxRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries, wages and related items"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense for all non-vested share-based awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average remaining life non-vested share-based awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r105",
      "r106",
      "r107",
      "r173",
      "r174",
      "r175",
      "r180",
      "r190",
      "r192",
      "r217",
      "r287",
      "r439",
      "r447",
      "r614",
      "r615",
      "r616",
      "r652",
      "r653",
      "r734",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r769",
      "r809",
      "r892",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.",
        "label": "Extinguishment of Debt, Gain (Loss), Net of Tax",
        "negatedLabel": "Losses on debt extinguishment",
        "negatedTerseLabel": "Losses on debt extinguishment",
        "terseLabel": "Losses on debt extinguishment"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Extinguishment of Debt [Line Items]",
        "terseLabel": "Extinguishment of Debt [Line Items]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r742",
      "r743",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r399",
      "r412",
      "r413",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r558",
      "r743",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r399",
      "r509",
      "r511",
      "r516",
      "r558",
      "r743",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r399",
      "r412",
      "r413",
      "r509",
      "r511",
      "r516",
      "r558",
      "r743",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r399",
      "r412",
      "r413",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r558",
      "r743",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r399",
      "r412",
      "r413",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r558",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments, Policy"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible assets, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r45",
      "r315"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated aggregate amortization expense in 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated aggregate amortization expense in 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated aggregate amortization expense in 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated aggregate amortization expense in 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated aggregate amortization expense in 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r310",
      "r312",
      "r315",
      "r319",
      "r830",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r315",
      "r837"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r310",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r315",
      "r830"
     ],
     "calculation": {
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FixedIncomeFundsMember": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments.",
        "label": "Fixed Income Funds [Member]",
        "terseLabel": "Fixed Income Funds"
       }
      }
     },
     "localname": "FixedIncomeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r760",
      "r761"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), Realized"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r88",
      "r509",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Forward exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r509",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Government and agency-Foreign"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r564",
      "r568",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r44",
      "r296",
      "r297",
      "r304",
      "r308",
      "r814",
      "r840"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail",
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r298",
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r305",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Goodwill, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r303",
      "r670"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r142",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r120",
      "r143",
      "r185",
      "r186",
      "r187",
      "r188",
      "r204",
      "r208",
      "r688"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      },
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net Income from Continuing Operations",
        "totalLabel": "Net Income from Continuing Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r159",
      "r662"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic, including Puerto Rico"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r112",
      "r242",
      "r248",
      "r252",
      "r255",
      "r258",
      "r838",
      "r851",
      "r859",
      "r883"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      },
      "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from Continuing Operations Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r159",
      "r662"
     ],
     "calculation": {
      "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesComponentsofIncomefromContinuingOperationsBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r242",
      "r248",
      "r252",
      "r255",
      "r258"
     ],
     "calculation": {
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income from Continuing Operations Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r109",
      "r117",
      "r179",
      "r185",
      "r186",
      "r187",
      "r188",
      "r199",
      "r206",
      "r207",
      "r736",
      "r850",
      "r852",
      "r856",
      "r877"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income (Loss) from Continuing Operations, Per Basic Share"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r109",
      "r117",
      "r179",
      "r185",
      "r186",
      "r187",
      "r188",
      "r199",
      "r206",
      "r207",
      "r208",
      "r736",
      "r856",
      "r877",
      "r880",
      "r882"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income (Loss) from Continuing Operations, Per Diluted Share"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r12",
      "r15",
      "r23",
      "r29",
      "r689"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from Discontinued Operations, Net of Tax",
        "totalLabel": "Income from Discontinued Operations, Net of Tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r113",
      "r117",
      "r200",
      "r206",
      "r207",
      "r856",
      "r878",
      "r880",
      "r882"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r200",
      "r206",
      "r207",
      "r697"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r7",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r27",
      "r30",
      "r31",
      "r32",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.bd.com/role/SpinOffofEmbectaCorpDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r331",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r160",
      "r627",
      "r636",
      "r643",
      "r657",
      "r664",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r161",
      "r191",
      "r192",
      "r240",
      "r625",
      "r658",
      "r665",
      "r884"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      },
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision",
        "totalLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "terseLabel": "Tax reductions related to tax holidays"
       }
      }
     },
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.",
        "label": "Income Tax Holiday, Income Tax Benefits Per Share",
        "terseLabel": "Income Tax Holiday, Income Tax Benefits Per Share"
       }
      }
     },
     "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r623",
      "r624",
      "r636",
      "r637",
      "r642",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofIncomeTaxHolidayDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "negatedLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, income taxes and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r201",
      "r202",
      "r208"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Dilutive share equivalents from Series C preferred shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r311",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Unamortized intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r311",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Patents and other"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsIncurred": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings.",
        "label": "Interest Costs Incurred",
        "terseLabel": "Total interest costs"
       }
      }
     },
     "localname": "InterestCostsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r110",
      "r236",
      "r773",
      "r777",
      "r858"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Charged to operations"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r857"
     ],
     "calculation": {
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Net interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r136",
      "r139",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid, net of amounts capitalized"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofInterestCostsandPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r66",
      "r294"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished products"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r37",
      "r72",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r40",
      "r70",
      "r150",
      "r216",
      "r292",
      "r293",
      "r295",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r68",
      "r294"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r67",
      "r294"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r124",
      "r235"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement.",
        "label": "Leaseholds and Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdsAndLeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Lessee, Operating Lease, Liability, to be Paid"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year One"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lessee, Operating Lease, Renewal Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r65",
      "r157",
      "r283",
      "r748",
      "r814",
      "r847",
      "r873"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r81",
      "r157",
      "r283",
      "r369",
      "r370",
      "r371",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r382",
      "r383",
      "r691",
      "r695",
      "r696",
      "r748",
      "r812",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r28",
      "r32",
      "r326",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Current liabilities of discontinued operations",
        "totalLabel": "Current liabilities of discontinued operations"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r26",
      "r28",
      "r32",
      "r322",
      "r332"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent",
        "terseLabel": "Noncurrent Liabilities of Discontinued Operations",
        "totalLabel": "Noncurrent Liabilities of Discontinued Operations"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r52",
      "r846",
      "r866"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings under credit facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Current Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Loans Payable, Fair Value Disclosure",
        "terseLabel": "Fair value of long-term debt"
       }
      }
     },
     "localname": "LoansPayableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r164",
      "r368",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Aggregate annual maturities of long-term debt, 2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r164",
      "r368",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Aggregate annual maturities of long-term debt, 2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r164",
      "r368",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Aggregate annual maturities of long-term debt, 2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r164",
      "r368",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Aggregate annual maturities of long-term debt, 2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r164",
      "r368",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Aggregate annual maturities of long-term debt, 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails",
      "http://www.bd.com/role/DebtSummaryofLongTermDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-Term Purchase Commitment, Amount",
        "terseLabel": "Aggregate future purchase commitments"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r355",
      "r357",
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r355",
      "r357",
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss Contingency, Damages Sought, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Product liability-related charges"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r357",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r357",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Loss Contingency, Pending Claims, Number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery, equipment and fixtures"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations.",
        "label": "Net Cash Provided by (Used in) Discontinued Operations",
        "totalLabel": "Net Cash Provided by Discontinued Operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations",
        "totalLabel": "Net Cash (Used for) Provided by Continuing Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "totalLabel": "Net Cash Used for Continuing Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "auth_ref": [
      "r138",
      "r140",
      "r143"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "totalLabel": "Net Cash Provided by Continuing Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r32",
      "r98",
      "r101",
      "r107",
      "r114",
      "r143",
      "r157",
      "r179",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r204",
      "r242",
      "r248",
      "r252",
      "r255",
      "r258",
      "r283",
      "r369",
      "r370",
      "r371",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r382",
      "r383",
      "r736",
      "r748",
      "r853",
      "r879"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r196",
      "r197",
      "r205",
      "r208",
      "r242",
      "r248",
      "r252",
      "r255",
      "r258"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income applicable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r5",
      "r177",
      "r178",
      "r181",
      "r182",
      "r193",
      "r194",
      "r195",
      "r280",
      "r281",
      "r288",
      "r289",
      "r654",
      "r655",
      "r656",
      "r732",
      "r738",
      "r739",
      "r740",
      "r755",
      "r756",
      "r757",
      "r785",
      "r786",
      "r804",
      "r810",
      "r834",
      "r835",
      "r836",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Accounting Changes"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AccountingChanges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Summary of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r176",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r187",
      "r193",
      "r213",
      "r278",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r290",
      "r291",
      "r614",
      "r615",
      "r616",
      "r650",
      "r651",
      "r652",
      "r653",
      "r681",
      "r682",
      "r683",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r758",
      "r759",
      "r771",
      "r772",
      "r781",
      "r782",
      "r783",
      "r784",
      "r803",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r831",
      "r832",
      "r833",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Principle Adopted and New Accounting Principles Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of principal business segments (segments)"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r242",
      "r248",
      "r252",
      "r255",
      "r258"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating Income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r794",
      "r799"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesLesseeOperatingLeaseLiabilityMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current lease liabilities recorded in Payables, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current lease liabilities recorded in Deferred Income Taxes and Other Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r788"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets recorded in Other Assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesSupplementalBalanceSheetInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r797",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r796",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r35",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r73",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "negatedTerseLabel": "Income tax (provision) benefit for net gains (losses) recorded in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityOtherComprehensiveIncomeLossTaxDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r97",
      "r105",
      "r106",
      "r108",
      "r763",
      "r765",
      "r769"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive loss before reclassifications, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r713"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r99",
      "r102",
      "r105",
      "r106",
      "r108",
      "r115",
      "r439",
      "r763",
      "r768",
      "r769",
      "r854",
      "r880"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Defined benefit pension and postretirement plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other Intangibles, Net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Deferred Income Taxes and Other"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "totalLabel": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other Operating Income (Expense)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/LeasesDetails",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r481",
      "r482",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r543",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other\u00a0Postretirement\u00a0Benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r340",
      "r341",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r73",
      "r849",
      "r876"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Other Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r126",
      "r129"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r137",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Total Capital Expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r508",
      "r510",
      "r516",
      "r535",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r558",
      "r560",
      "r561",
      "r563",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r50",
      "r482",
      "r483",
      "r506",
      "r558"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedLabel": "Salaries, wages and related items"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r53",
      "r482",
      "r483",
      "r506",
      "r558"
     ],
     "calculation": {
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      },
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedLabel": "Long-term Employee Benefit Obligations",
        "terseLabel": "Long-Term Employee Benefit Obligations"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r480",
      "r482",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r543",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r563",
      "r564",
      "r570",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r536",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r58",
      "r154",
      "r427",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r58",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock (See Note 4)"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from long-term debt and term loans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
        "label": "Proceeds from Issuance of Preferred Stock and Preference Stock",
        "terseLabel": "Proceeds from Issuance of Preferred Stock and Preference Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Proceeds from issuance of equity securities"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r132",
      "r135"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r131",
      "r134",
      "r145"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Change in short-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).",
        "label": "Proceeds from (Repayments of) Lines of Credit",
        "terseLabel": "Change in credit facility borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualPeriodExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss reported during the period pertaining to product liability.",
        "label": "Product Liability Accrual, Period Expense",
        "terseLabel": "Product Liability Accrual, Period Expense"
       }
      }
     },
     "localname": "ProductLiabilityAccrualPeriodExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r328"
     ],
     "calculation": {
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, Plant and Equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r330",
      "r814",
      "r861",
      "r874"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantandEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r330",
      "r923",
      "r924"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r97",
      "r105",
      "r106",
      "r108",
      "r763",
      "r767",
      "r769"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified into income, net of taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Payments of debt and term loans"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r621",
      "r828",
      "r936"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "auth_ref": [
      "r74",
      "r919",
      "r920"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Current",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted Cash and Investments, Current"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementCashandEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Time-Vested Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r339",
      "r341",
      "r344",
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Business Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r142",
      "r338",
      "r345",
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charged to expense"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r340",
      "r341",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r341",
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r341",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r341",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash settlements"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r61",
      "r447",
      "r814",
      "r872",
      "r896",
      "r901"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r173",
      "r174",
      "r175",
      "r180",
      "r190",
      "r192",
      "r287",
      "r614",
      "r615",
      "r616",
      "r652",
      "r653",
      "r734",
      "r892",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r544",
      "r545",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r564",
      "r568",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r544",
      "r545",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r564",
      "r568",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r543",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r570",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r543",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r570",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r461",
      "r471",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/RevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r111",
      "r157",
      "r233",
      "r234",
      "r247",
      "r253",
      "r254",
      "r261",
      "r262",
      "r266",
      "r283",
      "r369",
      "r370",
      "r371",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r382",
      "r383",
      "r748",
      "r859"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility due December 29, 2022"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r795",
      "r799",
      "r801"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Sale and Leaseback Transaction, Gain (Loss), Net"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleLeasebackTransactionDescriptionAxis": {
     "auth_ref": [
      "r780",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertinent to a sale and leaseback transaction, by transaction.",
        "label": "Sale Leaseback Transaction, Description [Axis]",
        "terseLabel": "Sale Leaseback Transaction, Description [Axis]"
       }
      }
     },
     "localname": "SaleLeasebackTransactionDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleLeasebackTransactionNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the significant provisions of the transaction involving the sale of property to another party and the lease of the property back to the seller.",
        "label": "Sale Leaseback Transaction, Name [Domain]",
        "terseLabel": "Sale Leaseback Transaction, Name [Domain]"
       }
      }
     },
     "localname": "SaleLeasebackTransactionNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r544",
      "r545",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Pension Plans with Accumulated Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r97",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Fair Value Measurements of U.S. Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareFootnotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Weighted Average Assumptions Determining Pension Plan"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r671",
      "r672",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/AcquisitionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Compensation Cost Relating to Share-Based Payments"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for Income Taxes from Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Other Comprehensive Income (Loss), Tax"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r83",
      "r164",
      "r412",
      "r414",
      "r440",
      "r444",
      "r445",
      "r446",
      "r775",
      "r776",
      "r779",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r542",
      "r543",
      "r546",
      "r547",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansAdditionalInformationDetail",
      "http://www.bd.com/role/BenefitPlansChangeinBenefitObligationChangeinFairValueofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail",
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail",
      "http://www.bd.com/role/BenefitPlansNetPensionandOtherPostretirementCostDetail",
      "http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r27",
      "r30",
      "r31",
      "r32",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities of Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SpinOffofEmbectaCorpTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTable": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to debt extinguished, including the amount of gain (loss) on the debt extinguished, the income tax effect on the gain (loss), and the amount of gain (loss), net of the related income tax.",
        "label": "Schedule of Extinguishment of Debt [Table]",
        "terseLabel": "Schedule of Extinguishment of Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfExtinguishmentOfDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtExtinguishmentsofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.",
        "label": "Schedule of Extinguishment of Debt [Table Text Block]",
        "terseLabel": "Schedule of Extinguishment of Debt"
       }
      }
     },
     "localname": "ScheduleOfExtinguishmentOfDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Reconciliation of Goodwill by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Components of Income from Continuing Operations Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Components of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r40",
      "r69",
      "r70",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Pension and Other Postretirement Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Change in Benefit Obligation, Change in Fair Value of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r341",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Summary of Restructuring Accrual Activity"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r119",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r111",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r242",
      "r245",
      "r251",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r242",
      "r245",
      "r251",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Financial Information for Company's Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r576",
      "r578",
      "r580",
      "r581",
      "r582",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Performance-Based Restricted Stock Units Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]",
        "terseLabel": "Summary of SARs Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Summary of Short-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r154",
      "r218",
      "r219",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r431",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Changes in Certain Components of Shareholders' Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r635",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Summary of Gross Amounts of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r229",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r266",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r308",
      "r343",
      "r349",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r229",
      "r231",
      "r232",
      "r242",
      "r246",
      "r252",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Data"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofIncome",
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock units vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited, canceled or expired, stock units (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited, canceled or expired, stock units exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted, sock units (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value derived (USD per share)",
        "verboseLabel": "Granted, stock units weighted average grant date fair value (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Stock units, ending balance (shares)",
        "periodStartLabel": "Stock units, beginning balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Stock units exercise price, ending balance (USD per share)",
        "periodStartLabel": "Stock units exercise price, beginning balance (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofSARsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted average remaining vesting term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Distributed, stock units (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of restricted stock units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Distributed, stock units exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail",
      "http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingtoShareBasedPaymentsDetail",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares were authorized for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail",
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail",
      "http://www.bd.com/role/ShareBasedCompensationFairValueofStockUnitsVestedDetails",
      "http://www.bd.com/role/ShareBasedCompensationSummaryofPerformanceBasedRestrictedStockUnitsOutstandingDetail",
      "http://www.bd.com/role/ShareBasedCompensationWeightedAverageGrantDateFairValueofRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r48",
      "r814",
      "r843",
      "r870"
     ],
     "calculation": {
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail",
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtSummaryofShortTermDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Short-term debt, weighted average interest rate"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermLeasesPolicyTextBlock": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy election for short-term lease to recognize lease payments on straight-line basis over lease term and variable lease payments as incurred.",
        "label": "Short-Term Leases [Policy Text Block]",
        "terseLabel": "Short-term Leases"
       }
      }
     },
     "localname": "ShortTermLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r16",
      "r229",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r266",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r308",
      "r333",
      "r343",
      "r349",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail",
      "http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail",
      "http://www.bd.com/role/SegmentDataAdditionalInformationDetail",
      "http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail",
      "http://www.bd.com/role/SegmentDataRevenuestoUnaffiliatedCustomersandLonglivedAssetsIncludingPropertyPlantandEquipmentDetail",
      "http://www.bd.com/role/SegmentDataSegmentDataRevenuesbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r154",
      "r157",
      "r199",
      "r200",
      "r203",
      "r206",
      "r208",
      "r218",
      "r219",
      "r220",
      "r283",
      "r369",
      "r374",
      "r375",
      "r376",
      "r382",
      "r383",
      "r422",
      "r423",
      "r427",
      "r431",
      "r439",
      "r748",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/CoverPage",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r87",
      "r105",
      "r106",
      "r107",
      "r173",
      "r174",
      "r175",
      "r180",
      "r190",
      "r192",
      "r217",
      "r287",
      "r439",
      "r447",
      "r614",
      "r615",
      "r616",
      "r652",
      "r653",
      "r734",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r769",
      "r809",
      "r892",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r217",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail",
      "http://www.bd.com/role/SupplementalFinancialInformationOtherIncomeExpenseNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareBasedCompensationAssumptionsforEstimationofFairValuesofStockAppreciationRightsGrantedDuringReportingPeriodsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r58",
      "r59",
      "r439",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r58",
      "r59",
      "r439",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation plans, net (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments",
        "terseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r58",
      "r59",
      "r439",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r58",
      "r59",
      "r447",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation and other plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r59",
      "r63",
      "r64",
      "r157",
      "r276",
      "r283",
      "r748",
      "r814"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r423",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r447",
      "r451",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteSpinoffTransaction": {
     "auth_ref": [
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.",
        "label": "Stockholders' Equity Note, Spinoff Transaction",
        "terseLabel": "Spin-off of Embecta (See Note 2)"
       }
      }
     },
     "localname": "StockholdersEquityNoteSpinoffTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail",
      "http://www.bd.com/role/SpinOffofEmbectaCorpAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Stockholders' Equity, Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SummaryOfIncomeTaxHolidayTextBlock": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the income tax exemptions and reductions which have been granted by taxing authorities for a specified period, applicable term of the exemptions and reductions, estimated dollar value of tax benefits, and per share benefits.",
        "label": "Summary of Income Tax Holiday [Table Text Block]",
        "terseLabel": "Summary of Income Tax Holiday"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxHolidayTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Trade and Financing Receivables"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r824"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r86",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r86",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Common stock in treasury, shares (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r59",
      "r439",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury Stock, Shares, Acquired"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r86",
      "r448",
      "r449"
     ],
     "calculation": {
      "http://www.bd.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock \u2014 81,283,191 shares in 2022 and 80,163,949 shares in 2021."
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r439",
      "r447",
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail",
      "http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r340",
      "r341",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BusinessRestructuringChargesChangesinRestructuringBalanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r162",
      "r509",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Government and agency-U.S."
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/BenefitPlansFairValueMeasurementsofPlanAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-Lived Intangible Assets [Member]",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r622",
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at September\u00a030",
        "periodStartLabel": "Balance at October\u00a01"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decreases due to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Decrease due to settlements with tax authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized tax benefits interest and penalties reflected in current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesProvisionforIncomeTaxesfromContinuingOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Increase due to acquisitions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase due to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase due to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Decrease due to lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/IncomeTaxesSummaryofGrossAmountsofUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r221",
      "r222",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r165",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Deductions and other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesforDoubtfulAccountsandCashDiscountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Dilutive share equivalents from share-based plans (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r198",
      "r208"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Average common and common equivalent shares outstanding - assuming dilution (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r196",
      "r208"
     ],
     "calculation": {
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Average common shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bd.com/role/EarningsperShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1060-107759"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1063-107759"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "60",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6406278&loc=d3e26268-112671"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16701-113920"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123416376&loc=d3e50796-112755"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918418-209957"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r937": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r938": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r939": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r940": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r941": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r942": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r943": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r944": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r945": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r946": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r947": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r948": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r949": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r950": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r951": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r952": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r953": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r954": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r955": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r956": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r957": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r958": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r959": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r960": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r961": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r962": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r963": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r964": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r965": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r966": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r967": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r968": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>129
<FILENAME>0001628280-22-030686-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-030686-xbrl.zip
M4$L#!!0    ( $R'=E72GE7?]A8  -!8 @ 3    83 Y+3,P>#(P,C)E>#(Q
M+FAT;>V=[5/;.M; OS]_A9;.TZ4S8 (I;2_M[4Q>@*:$DL% ]^Z7G1-;Q%H<
MR2O)H>&O7\EV0E)H+[W;0'VD>SLEQ8GCXY]U='1T7M[]K7O2.?MCL$\2/4[)
MX+S=[W7(VN;6UN=F9VNK>]8E'\Z.^^1ET-@F9Q*X8IH)#NG6UOZG-;*6:)WM
M;6U=7U\'U\U R-'6V>F6/=7+K50(18-8QVOOW]G?F+\IQ.__[]W?-C=)5T3Y
MF')-(DE!TYCDBO$1^1Q3=44V-ZMW=40VE6R4:++3V-DAGX6\8A,HCVNF4_I^
M=IYW6^6_WVT57_)N*.+I^W<QFQ 6_[[&&LW=X6YC^*JYVX"7N_'EFYU7KUYO
M1R]_HZ\O+YO#^%_;YB*WS-O+SR@]3>GO:V/&-Q-JOW_O]4ZFWUZS6"=[VXW&
M_Z\MOP_DR+QU*+06X[U&T'B3:?..2\&UN1)ISER^++_@[M?<_W$-PY3.WC,4
M,J9R,Q)I"IFB>[,7;V.FLA2F>XRGC-/-XD-OE\^X:RY]0J5F$:2;D+(1W]/T
MBZX.WTH5-$K)M+EB'<^^N3H<%(>V='SWV.Z;8'=[]YN'&\'V-X]][[3-WX*=
M-P\[[59QR>5EFSNC,N"_K[U:FWT@@S@V3]?>3O:%;)N;44A?WHC(/#M4?GU[
MRCM3(9R=Q9Q8R+UGC>*_M_;(YB6,63K=^WO'?&PHV=\WE!D@FXI*=EF^0;$;
MNK=MGYWBG]?5PV0^7]"J'J[M'2OF>4C"?*A8S$ RJHBX)&T::<$W2)=%5XPK
MP0GPV(R*L1%P.G^J%N[ [%IG)VZ63])W[TK#WI.UU9QG^3/-AQ!)Z>6=Q_4G
M\]A^ (_RDF(:"0E6X^WEW Q ^ZZU]_O<*)OE^__#8M[_X&F1_3)2?LPE4S&+
M[.__VK-V]T8L/2,_\-8?>YR(_=D,7K]^\B?KY;TCO15%YMZ2SM1\-35/@=H@
M/1X%=7N@[A>N2U.X!DGO>V2P\(LATS0BQS2VET*Z=,(BH['[_8YG6!>&J;D*
M]L6/O%I1:X.,B5&?5"D23I6F8U2Z\UQ#@I_>?W)6KB*MO8L)GS,#,.SV,''[
M1*_)1V.&T7O75)C(M25$R50G5$(VQ830E:%7F9H>7?W0':9B:!8+'T1J+UV1
MGE\OU!ZA9XB H8=8.XB]P0) /Q/6C-X'"JE.(B,I)COFC'X!A1U=S]YK#N4>
M,"9ZKHR]X]/^D@NF(V3F$=8*X<!\-K-+^)1<@(KR%"2FD=B2[,9H%\P4N^3"
MW.Q<8MHS<L.)UOT'Z7TZP4/-!9U9!-$LQ-"TF5 1H[SPHU6[2$5@S2F%D>&"
M:4EA3W(I)&>H]>G7A.^ZVO 0=7'$>K\;<IX7GB<FGAXG+IQ>W2+CZ8%B ^J)
MUIIHCU_FROICS\K8G/FZU"]<ZHSU2$@*LW&*R4GK(LQC2&&J&&#B>"+IZ/[T
M'KP4M:1?YG,G)I@N#LJ3B=US $5"*JLL'!TCX?F)3B!VRG%;;8MY6[9.$"6+
M1U3:;94QC3'ITV/S#D"]$]T)R&E ;%0!)FY.;$5W##1(2:^WX;5EO;#1@W*I
MO[/==(+=5E&4Y/W=PB>+M54R40:D[4ES'LTF])O55F9U4FX_ D,ETEQ_^R-_
MI4!+^7<B;Q&,Z.;0+.>O-N'2W/$]2*_-<G#-5XQ!4S$&A5+9:30PS>6.30D[
MC6U/KZ[TFHT=)R9TG.R:?N#5%9Y-8J@J6'E\]<-W##R_A$CGLM@E\QJTEA1/
MJ1*Y+(*J/<%:$@SM*MJ\\ 3K19"F*6EQ2*>*+9?%PH&PEYK?"88YM]8BM'E\
M5HE2D%'B;=%Z\4OR>$H.I<@SKSMK!>ZT%_;FA3P1EA1T@>%4BQ$7/E:R5M2Z
M,!&I1U8K9!=]7[ZSW@2G8_B"SUTVH)RK:3H!W'G.^U$B%HHG>4.S3NQL8*.Y
M"(Y)8QZ9SZ*N>77P$6_%*_2A_P>IN+91<K@R-AS0E8O@_!Q7+VX?!1YD^#6D
M!'YE?DWZ<$45V;>W/9-,%7MX03_H(-&93@2$'T(*FH)9E<N1O18_Z=4+'U61
MP&MM'H-2$"6YHEIC7C'<BQ'-C.@,Q;"_& V!9QA^!I682]2HS1I+#V-^MQ/P
M/@"/IWWP.POUPM9K=V_K$:&9[UP 9]XALD1(:BY%X=L;0MY3\:/X(,:(MH+0
M^USZ;$C-^!*RVLDK*D_OQWD$Y9YZ5<8$T_1W8$[/4!<RN1?J9YJFG"J/LJ8H
M9U&!&)<2Z$L+W<48YEF6HFIZZL!@%&,@%TQIF&'$Q,^!U<5] -'8JB[PR[7@
M[(L?=;6B9H8:7 I47<&.&3>VM-"89SN#K9/0,1E(8=:#&I7!^2<[1[Y&E*\1
MM7S,UXCZZ<J%CBA'9'[9DZ#O;6:P;7:I,M^/SS7OAB5&*GP]/J%*C\V]1^E1
M<@,FXZITT >1&&/"AWR;S**; (]0=9QW8\AMAG!),:;F.V&_?&J=D2X#FY]?
MQ!?@P>? Z/L$$Y"25J7]D7EO7? HW0L037\4)PA20XZC:L_@@N(\^3S?=^XR
MI24;%K'D'B,2C&AF00<HGHSI".P4J&Y[:E:N-!I[BC6A. ##"V[7@7X$UH@=
M'0^EN#)V:"JB*RH]O#K".Q"26D>VAUACB$:-VAT(SZY&[!*09JD[HDBV_9SP
M>PZD""FN=IA.5-$8Y))^9M$5OMUV)X;=J1B:JU"D#T-1A/\S7*E4+<EN!.J6
MM*<B2JA9X]TF;J ;B2[XK>VFK9Z:Y;KMZ4-]7G'-^6'2H4Y,A&$$_-HVAJD2
M4O'@<V#%%U(N3GW233VA>==*C9@EC*;Q8DWU3G'S4<UW+G!DDA7)#7BHN6&E
M9#1BYD0W-#8K!)'9E'TVH7ZU4&..E<$Y2V+$6]+4!;WZ<*[>[$&!%=, Q:YT
MJT+?)&2:(BU7RU1D1&*8"\*%4T[E:#IW=Y^'+40$'="F9R!M?&$^I=)/@_4#
MMV3'%*FYD<"D0YT!684VW297^[%8(X0T2WR?KIHQDVRS(W*N;XV7Y\^:;]Z2
M$V4N9EI67$06@'%&[=Z]HLBY#L#N&8YA9"Y[=?B>I@?N-P>F+T+EBU M'_-%
MJ'ZR9KEHK;Z0ZR^F5=# NP 5Y2E(8B<'JU(\PMHA-")R068D/<#Z >11*M0*
MRQAY<BLC1S6-'FL[U&-\5(PK<C5YBJL1\8_-XU7F9GEL*\7FRF#[ROVPW2P7
MS]^5MF%E77O0C5EZZU-]Y3=]+LL+_>^Z'6KU*>]+<M27]*H1O&R^^?F^I-=!
M\]7.7_<EO?HUO.\[7VG+U_>G( N^>1Z2,!\J%C.PV9U$7)(VC;2MRM1ET17C
M2O"B_UI'C(V$]R8KNZ!9'SSK_]E4O\I-EOLPE]<3TZB* -[+N1G4]EUK[_>Y
M9GI:MZVD'Y7R8RZ9BEET)_[YEW^6?L""?/R]NS;(F*R?)<!2HQ]>D#X;,S0E
MP&9B/8[Y_T3P6KG2TIP-R$!/ UP Y[)M$%MI(Q2Y3LAG2.D][7)^=:2-AR-M
M2U L-4OQ^/FSG=W&6UME$8A- 1F;7S2;;V7$!(EI&:&LA;)Q/D" A%!^P!SJ
MZQB0Q!>8VW'#T@TCG3""FB^K'_P?&,\=X! #HO"04J -<L*UL4YQP^OF0W.$
M],XZN!1QSZ[&D4^D!XS;;ABD'5P$5=!61P3DZ!#)./Q$=6*L:8.QAK/G#W!<
MR%P^+3!VB]Q)7 .RDYBGU4R)"?"1L7*1 TU34"0,6DA&XJ&D-,*\*5%BJX+.
M<0V\?3YZO)GP%X"W,&L4,R,.BH\^%SXE23XB1_8O5.-P+A9V?CT>F\7_@E$S
MF.@ 4<>:0KX-<@P)2%")EIB+>U1$O\ZN*W.SO'JM(4Q42M41X^884IBJ9:T:
MQCP@[02+5IV)B![EK!41M1UH%5EO4_9O(\0+Z[O!U-BM6/"[0G/FMUF?^3=P
MXGQL_\W3@PU;9'T@1289U2"GR/:;R_W)UJ4T5[%!/@H#EU,US.5H@QQ"KBG^
MU<HQ_<(B04[MQ#HUSW=@MRE/@W[QLX/&P"W%W"!F&"<YF#_8N0X@8I<LFI7&
MZA1U0<M@,D1:^0S8-6 NK%2RG$<-I& [4)M7M-30YA6ZN '46R.G=,J%LH9$
MT$*J8L]@#'G*,D#O2O!+T'IBLV:>X+A,V4<-^'A"=B*7D;EH<G)IK!M*0O,:
M,F&][)IB\K+/!<-,M#MSIB-?=^!FV..7M CS-X8JG9@;;U^V+W  ;--TQ/(Q
M;H(?J!P+Q=)4(+9+;X4TUK?@ O>^99<<,6J#\=&,1$?V*+OD%#(6DRZ#D5DJ
MF@LBZV%^DX@<IT\=-\L0S#HC9XH,A#;*!_.Z?R8J<J#73-^4:LA(+%,<#!>D
MPHWOLYD3JPT?7.O_PP1PZ](B/7XA.[X58,GS<&3PW0'X_-G+UV]#1%5P^!CD
M%7J$WRA1L3K#]$ED_:8_U1=8]D5QEH_]HD5Q:JYF%F<*.;)>10YF]61=Q&B4
MS%PP])/&(LTBD'>>:X9ITC@TIX!4@W2.YPK74D\BI1/92G=(YF7ADL/Q\ ,:
MDI50+G*<*UD/M-Y VY33-/]"/JW(:?Q$4J+?6;VS7EY5QN"3B.?(AMR=P6C+
MS820QVQF]=Q;I;/.9$OI6A*&;NE9I*6\W$(HV9!BVB2'Z1@XZ2GG%&U'"M#&
MC(T#8?Y'HUPKL9PB>4.CQ)!4@41%THI%3FEFBPA&+@&U 2SF.\=#Z_I950+2
MTS"MQ'*,YCR(9\7A24\B,/X@[+M$4W(N\U$.TY65X7L222NA7&+992JC7-DL
MB<IE0MH7[18:I*[X@>Y'6D6-^&@85%0/9%&9.&SA 5J*Y"C/*AH(W3:G UFC
MWZ'Z2<AKP..UO4<<=UB&&3!N;-U^<(['VBV$<A3H^1&NV*!S7FP5'9DKC85K
MUJZ6;)@7><&=@HC?R:XYTWU8R*/!-$R/*)\ZY?S;SZ68MU)954;;DXC:S[_0
M\5#DTJD@/LLSH[>Q7];]%^(9G^XM0P^$-,>-;6O;Z!6=<:INFVB8MD$.(19.
M;6[//$1^=-:;X_H\YO^%3VK B16;T\]YH,? 843'AHAGBX$MJO2&0RK'7\<2
M8^<7MDB;:LK248XN7<5%GCEH.H84<,6>S,5RB>7<INU29:X*K ^[%6DV87J*
M+N_!P>W0.=^!7EW4_--LGKE00?<.3C.!@IR2HTN-)/^ADL@EB&4'R8%D$["#
M$E.9,K>:1][)_S3BE]G+BG28S.7(7*+:\#T\:@=UB>EEKNS6]EE")613TFKC
M0!E>TY@Z%7YR!^7<.K+1*,A<17\6D.(+G?E"9\O'?*&SAX[ QD_2/^%4:3I6
M148ZZN0L%TKR_RGM\R,T5-V-=NQQE:<V%'DJC1@465E4=ZL1]"P#7@3>0.K=
M9D[ [?4\7]Q\/6 D@)4$FB(J^U,*Y!1";4YKMXPS3)O&5BJW-B]T BEHTDLD
M1#"/L"(ADU=4,S1@SW(CCU-D#U,Q-+-G2.6$1384W<"0=+5=D)_&)>% (^2O
MX1X9@V%UJ5R//W\6\K@$$)4-^XE>DW]2<"T8YS9C[38C+X! 8NIYX696W@+9
M:AJ]3=#S.9>(Z"[ZCJJQZ^$BA.OIXJ5[8=@^?[:S\_(MD4&*Q"!V$^]"JI?-
M*B'/GS7?O+5]M,G1(9J1ZV"*R?HQY))IEBM\^9EST5P">DQC>TUD/7SAMV10
M$>W2TEVX'B; 1PFP%U;_8HN+2!SKXGB7;GZ3B-RS1<1V($6<1[H(<@EP,75:
M(Y_1*.'FRT=3LOZ1&:6LRG%K$:,A[-RH76C'=L?'V.OA"AIVM/7<(N(Y6]]3
M$"E8,V@]6P1LB[+<!%$K /<*C9\$?^ 9AP>,N[:Q/H KIC1PLCZ8Z!>XEC(S
MV9SBF;"499EYH]I86;O6IZ%Y*YE30(U(5T#"++C!U>W3".::KA52YR-(-\@Y
M9QE52MC7?4Q-(F<B.H553Y'Y %NV%(LYD5->HG7#$9D!%(I<)U4S"I=0GE)%
M04;)+!#?-RG#@U9< ZG".GPY5 PPBSPP$B(*]74NLPU5,5OG6LN%,,[2HFU]
M:@XQ;&7#PVNF;TKONE-4(Z&K7!DC!ND/\  UDMU/TQ=F\X79EH_YPFR/K&:<
MT#.(<?J4=0P44S&!*P9$!1+3EL%,+J=8%K6&5U0Z^8D,<M>J)U<,Y_%+'F:M
M8<[7D_=EK.-)>W5TX;P0 ]Z!<9:KLNL$&JQWI4$.=/TL 6:?8GP)D3/)7,)Y
M?K2PWNRA0[I4']JIB749+'*R3E7^/@^. H\3#<X+RNE-3E/8(!U,.W]SN=R"
M*:\AU;Z]+ :60FEQ1?K]#AJ*I[ERS'G[6<@TOF8Q->O."57:ENBQG@5?[+#^
M;/\)XR$#=*90*19JD)Q^P14;_*BQHX]?U*T3D-. M$'&I"M(6X)B5=D.+519
M[\'\].U%ZX(3)#TH>X*UC#U UC\<K=2;]P3=G 4?D2/S%V(UND!QW0S-(<1"
MO2 AHCV3F51N0&Q_(,WF+HF+Q$32,0J(XR$I%$=MTUB.I +9I1.:BJRH!OH(
MW=7]OM=JQV4W,+;/3J.)RV)M4SG.XWHB?%C;V\7Y<;$FY'A,9<0@)3;FX$R"
ME:DL2X9LC&(O3;8 ^$ 672R:C=^*])D0SS@M)7.#8M5=K]ELX-*UZ)OL+3(L
M$A";VSN^P]Y?9CAF<9S2IV-8]DHG.]N[)&P5G> OT& L97-C+"Z6^VONO/%E
M_M#0W#7+$4\3#\V7GF9]?>B+*&]C[G;>-'TQY%H/T2+0KMG81><8<";8[B[,
M5QYFC6&.:4H&B?D)/NNK3N12"E)I26%\FQ#$J"*'4N09NA&)OY#8-X%ZE+5#
M>;SOG:VU(S9O8W>^VL@=;]&LFN3Y$5F?93Q[E/5%*60FI*V )4B[:WWFI:-Y
M@X2!_==IT"]^HO((?,N7[BN'^<IAR\=\Y;"?K&ZF6HRX4*2HKVET3#\XQZ-7
ML!<-G=,SDS\JV]N9Z;[;[Y+U*H0.69G[.@<&/A >3$1*>O:.<[#VA%E(83.\
M]_D(N>.BI!CFQHRQ*^$>YV)2T%0;10P@4FM[@W02EN1@_F"&RY26;)BSV"RJ
M[(+J=C6%EBQFG+F.$M(:4]L[A9-CX/DE1#J75"JRWC5,CX,7/@2B9B$0^U$B
MR <*J4XBF_[2 0XQD'-$!1-*D1"/S/WQ4,R]R=B,(/R[-_O<*%$&A;_Q^;.=
M9O-M$;GKH,\1#=)#,-,DZ8/YN+9;J^S*5Q*J&4'*.S1-29L)-56:CA4N#P%^
MM6H(TI-D3,*(41Y1Y4V;&D(\@F&N$G;%R!$PE4!5IX23]>I%V=+Y!1JB'R%#
MW9Z[,D^-F0I#EC(]M<F\F6U=6%2F.<T5&I1EH39.#FA,9>'50LSU$\LR6__B
MZ_I>%=T-7+,G]E$ZD+3%(9UJ]@]<AJL;%?P'DBEM?DM:D3%\U%)X9SEAH@%:
MWTC!WQZ&,C@-.L%ZS\PDZ=26AA+&G-64 )%4&8VKRFF449(6,RLEZ[=O :7L
M:Y)S]I^<XC&2T-=3&$AA!JY0) ,)9-^L/Z6A? ,1LQ:OWS^I*=,XCVRMQ<+2
M78HN1,MS8U:'H&-,?2?@#NR(I2GIY"R&6%BN*9 0TCQ&3CH47$C,SHC!V=WU
M38_'@M.O"W+7&>?]$N$B&5(>0[KA8RYKAHU)-J+<M\*I-4.[FP)JMM=9EIUN
M]5NGO1#Y!-F&?Z-6JEI"/IP'(K0.T0!TPVL43CF5H^D<8/OT$)>O"/UNV=<$
M]W,I,HK+]>[,1'G&E,KIN-@KPV7K5''M1>W>SY!2S*6(SBY:\^&(:B?E44.
M'C\N]@+49@=T8F? *BT8T0@L9\(-<L(U2':OUW5V*;//-<MDU>\*W; BKSWH
M_BR]]?L)Q\M9KM_-N?V?/U6#Y.:MH8BGYD>BQ^G[_P)02P,$%     @ 3(=V
M59V\D3+G @  IPH  !,   !A,#DM,S!X,C R,F5X,C(N:'1MU99M3]LP$,??
M[U,<1< F-4].@9*62M"6C8DQ1#NAO9J<^-I:)'9E.X3NT\])6E'&JCU($VI>
M1#GG[OS_V6?KNCN#S_WQUYLAS$R6PLV7\ZO+/C0<S[L+^YXW& _@P_C3%;1<
M/X"QHD)SPZ6@J><-KQO0F!DSCSRO* JW"%VIIM[XUBM3M;Q42HTN,ZS1ZY8C
M]HV4]=YT=QP'!C+),Q0&$H74((-<<S&%.X;Z'AQGZ=67\X7BTYD!XA,"=U+=
M\P=:_S?<I-A;Y>EZM=WUJDFZL62+7I?Q!^#LM,&3XPGS"?J30WK<(H<GE)S0
MX"1&'P\3BNSD6V!%>M:]CM%FD>)I(^/"F6$Y?W1,YJ93<&9F4>#[>XWG?E1-
MK6LLC9%9Y+M^>VZLQT0*8Y4HF[G^K"=X.<VS<!O;,?AH')KRJ8@J_&6R54 B
M4ZFB7;]Z.N4?9T(SGBZB@S'/4,,U%G K,RH.FMINF:-1\4GMJ/EWC(*2IC*+
M)9[-DW*!*]R '%K&X>.,Q]PN/GE.\*?:$[LQJ%Y%?"V#82(5+0LVR@5#57HU
M>J,\UIQQJA9PJ76."N0$WN?45K=!6XHC3')ERQSU"^S_C=+Z&<4_MOMPIDN%
M(YP;S&(K-_2;U8%HPCDF1HHF#'ARSX66 JA@]MAD<RH6\'9_MTV(WSD?5!]!
MYQUP#6:&,*UI985>#F@4W%JYT"6\702%4Z[M[ME/(8UE24N308RI+&P:NV[6
M6"P5K D8YDK"!1=4) @C=W^7D%8'E)NZ:WI6#BM=+M@Q60C=!,:539DNP,KA
M8F4UH3QVI=JG8'?#]OSBS&UYQ?[-(O\.W,AY=/0JU"^*FY07J>^&86L/KJLB
M8SG"63[-M8$@K(J\O6T\@>4YVLC3"K:/AP3A.L\%QBHO+\^ E$3AT182^>UU
MHH^Y0&A5Y;9U,+Y[%)(-,.%&F/6N9B[KGBY2F-J;YP$W]CFK!N<IA,9:IKG9
M'/(OK='R7;=P53/9^P%02P,$%     @ 3(=V56-#IF'" P  "0P  !,   !A
M,#DM,S!X,C R,F5X,C,N:'1MU59M;]LV$/Z^7W&UL;0%K!?JQ9)LUT!C*ZFQ
M5 EL%5D^#;)%V5QD4J#HN-ZO'RE9B3?'2S"@:Z</Q)&\>WAWU'.\P9OQ]2B^
MNPEA)=8YW'PYOYJ,H*49QJT],HQQ/(9/\><K<'030<P36A)!&$URPPBC%K16
M0A0]P]ANM_K6UAE?&O'44%".D3-68CT5:6LX4"MRQ$DZ_&GP1M-@S!:;-:8"
M%APG J>P*0E=PFV*RWO0M+W6B!4[3I8K 99I67#+^#UY2.I]042.APW.P*CG
M Z,Z9#!GZ6XX2,D#D/1#BY@)=K-NX"*,7 <G7F"CKIFE?M?UYI[K)+\AZ:0A
MU6N;4NQR_*&U)E1;875^S[%TSRU$?TM2L>HAT_RY5:D.!QFC0I['I7TMUC!'
M8 )_%5J2DR7M52&U:M-F>\%RQGMML_KZ:D?+DC7)=[VW,5GC$B*\A2E;)_1M
MIY37H)68DZQ6+,D?6/HDW:NFV]IE3^+DA.(F!&0II\-?/TW.)S%8]E_]/0P[
MX4L9N6!%+Y"8!XXO9*8Q_TZ>CZZC61C%<'T!DV@<WH1RD--I>#F9Q>$T'#=_
M[\?1Z/I+%$^B2[B83#__BSA_WY2"9+MO'JCS;*"W&!:,EHH=@H%882!TP7C!
M>**X!_,=<)QACNE";54:&<MSME44FN(E*<5>=28DN10_RK.VZ_?A-;EP=/='
MRL8[]/Y43"!G%XRO8:;Y$+%2!]O6+-MTW8Z2;-L+4"5U'82J-5M#R/<;L6O6
M^]6J93?+CN<&3J."D!4\RM8CBF?Z5F,;!+YMUK(EC?U'V4?>WM:R@BYJ9-<,
MNB8D-'V:(F 9G..%8+0#8[*X)[24P2F=$5L7"=W)^POZ:N'_>(76J2L\N$%;
MWJ"^SXCK6\&+&:GD6N- (=QP!A>$)HH<,_VL;5E.'[B>ZU4&C[)WLH _[OW7
MV9)QLPV7%)>$E_]X6CV/$7O ZSGF8%F=ZC'LP):(E=0J"YF"IE"HNL%R4MMD
M519(DLL(GBCSFJPJ*)QE4H\\8(K+RHRHVB]??G6(X"P'Z1(_.*1V6)6@%\^0
M]2S?I-+%JGJ1$CY2NI$0TPH"WJE?XJPM^=E'IO;+^Y<!,\8KIW<XX8"I@I[A
M0M0I4^14*=-KR./Q-922A&K]T[_RC ERBF__RC__#YVU':]?5B.$TV@6PUG;
MEO7_3CZ,EW!U=?/*1_$[N:]@[F2SUX%&^D&X>43#DWG\6]]8L+IQ[G&<)XI5
M1YUD8SAG0K!USWPR2>:2TQMQVN14AW:R+=V/=9-<M>O#/P%02P,$%     @
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MH+"$QGBEB<J$)5:%>6L3<AYS8ZB>N2D9O>/8=X6FP3L&9K"E]+"(/=R$6&C
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MR'# ?C^>\2B+,,C,</N4(T QUV#!NJWA1##!P/JZ\5$@3,(8."1;N%*HGDN
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MQ"[C7%!-.3$/?:\.2Q13XPO$/1^ACE1F ^\!YD57@JB@]O76.M5YA@5[.-4
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M/ HL31>Q)\AZDE;5731>5OO)4J9R-$R;<L:9LC5.1>9JBG*$.H)KCL3\)E_
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M%QTJ_9*'%[9T==JOB<B (:%LKYUM<BO3W80)E 9= Z7IH1FLT#6:54,["LH
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MHMZSM3T?I-@NIV:;), NIZ:O:WOLG)H=^Z]Y(+TV#7?LW[.U/5Z>P&-#J[S
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M>@KY*2<'A\>'/W1DQ5_A&%D9 $<88F1%B&2,K(R1E9[(RM'SD]^.3\?TE#'
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M$- B_HM;A@O+C3FW2*?7ZEJJFR. /*(CM16=8D'+-_BE>Z?[UXV*F&I@+3@
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MH]@E,;RMDGI)KAG,,PRP-?V\F@>1-UDR947!@(=#F!@M"%V U]AB=UXE9;S
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M/4#V_91DQ_G/-EO,GY,AD((,V>T,9?3_Z3R!NTZ\4*Q W%:<792KNU3,?RH
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ME42KCD[VHOV]$QL3>F-JGYQ-R_U]WZZ%P6&BN)-,^,WI$C9CI/V'I/VFC4_
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M5PGU]Q,3EDJ+1HQ'DL(@VSD86@O;DF?%,[]R'+ COW J.C"I'L!DZ14[<]D
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MOQAJU1>=2&.V1%]'XJ8/?Y6M@_@VF1DK:Q!O]TP\@?\-\U'R[C]02P,$%
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ML.#O:L!^TZJ<LGTK>@8*C5EE@R(@>BU/.GF )G0" S2&-XBN[>/(# 82!S"
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MH!5<GNU3G'$4*\T(6HJDU0*RU5:6HN6AD:1%Q'Z2P/K*^6$]:14:B' @*IL
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MG4Z%ZW)>+EW?V'(6/TZ#<L1ECGDQ[B ?<^K*G*/"*Z06-C=#M?\WH&K BP-
MK<O!?:M\<.M$)OWWE(ORO9JNX"LT>';P9I$&"\'K5.K+*&+[M8IL884:IPNM
MXHL.\LC]2?F\RO7$.9%NK7<4)_,;<77X"2^QY=PWBSG)5MW3E:(Y04#"Z*&0
MQ:(-_PB#UCV\(JNZ? KO1:N0.D"G@QM+#@TT1C5[%9EA71]\M7"'A'-0"._$
M,I(<':[!TTD_G7G@]"C-[U@G>-2#J)HU\K""#[YX 5M+&4->8E21]@TVC&4/
MCR1:EV@8! $&*Y5^W^8NUCK]&[!2;>$1TEXE7?TQNJ12A6K@]%32;2 KN=I=
MZ.$E3WQ</]HV*^M)#$" @WTE07H87W=<OP@.=@MV++7*/)XP"4H!]GKK>FO3
M,D'M,CKQ 6MZ,":"Q43]2GFP$ZL[\-Y;X"E@J"N\R:9,"N*%Q6AY2[TX+LM>
MGK!K<0.Z%1_9J\=LHJ)&"2!?2'\T@KI"=)$5VJC_5JB_F(:JDN>@ I?V1J7S
M"\U!R]UJ]KXTP),J 6$FDDN@XW.T^VLWS-0#/Y&P:FA3*N*:L% S42MK]Q*N
M)JE;8[DMW7&+S7'!ZZ;J<5>,'IV<;4>XVR:BBU0 (7RD^73<:9.=JPO1[E^"
M$[Z\8=C:'>%4V@]/GOWR"<["URIAUB7&H^M<11V03;SL[O9<02>AQ85P3533
M:4!Y9Z%BP95-5FVT;>)GL=*!$E3X_9&[?A  4WKU'$%HU-UK+V9('U%&P-_K
MV;Y?>Q,5P/28"*:%8EHUP"=1376R#0P;R>V,SSHQ060*!80N,[R38:I1F"3V
M5P5ZLM3^J@8\[,*Y6C:SK<HL#3</VVO'T.D3WC@IV/H7SM?2C =X8:=,[G 2
M8FOTL4GKSTH)A-0!X9#;^D&I4K/1=#L;U8X(GMZJ9D/MXQ5E7N H^Y2RLRE/
M$ZXK1?WK8]+@*9)^MS?KV<AMK0+<W3CYYVU*CD"5*!>&X.=3AR_=@%GUVU;W
M?E7-_;7KU@"R.'5H-6ZLRBV?X,)%YNSJ.PF83H718:E]=+]P88CHLN5Y-$FD
MM?&J-7?YJ>NPQA;W 55#+#86XB26CTP0G%.R_;C6F,X/T0O@/@N&%G3-G5F$
MA^[K8^NN4=K?7Y=$4=$--%M\0URU'EW7BJ8& 04S/J;LZ.+%VZY 5HP4F>^U
M3(^L,CQWOCT68S2A\H@BR\LVH#VY>E=Y=:F@ZT;W<;(8)!]'H._L):_^* ,9
MC;2HB"@B*B>*N5G.2[E^P^^Y'T\D^U]3[N<KCXBL:)T(=1[W4"OZP+!RE,^7
M\K=#ES6:.M-*>>/O1AI[Q>JP,NTFL"V7[*7$6!I,^N;"*=N,7-5LZH8\\5+6
MK^VN:H;@1Z#6BZ-"UAP7\1HW+K&^4W+QBUV3\OWVK04:O>H>7[SI7KU;:-0^
M>O<*?KV'MNR'8CH<U0S $(/RVG3Q0MS@>9G6&ZV6;S^XM.528*)S'8P-+)P'
MXXTR!C$S=!C%Y"@*AW<+N(@PV:-_E((N,> H0##/AJ/\GX6A1?P?AJD[%1UK
M)^3*OFDM!R<Y+&S.QDUO\&YC7 $L^L1:R_2'.XP+/U:1I\7+Y1OQZ#V$@,_&
M:))';HB-4Q@A@/K@>??[:PM_;VWU2X_.\GS6;GENVS^@1W_*[\7_ U!+ P04
M    " !,AW95HX&=DPL;!0!GQ#H $    &)D>"TR,#(R,#DS,"YH=&WLO6UW
M$\?2+OS]_(H\>;X>)_U2_5)9>^<L@H'-/K$A0,*&+UE5W=4@8LO<LDPPO_Y4
MRYBWL ,DLC4C#R18ED8STEQ755U5W5W]C__S\O#@JQ>R.)X=S?_YM?W&?/W5
M__G^'__?SLY_?KCWXU>[1^7D4.;+KZXOA)92O_I]MGSZU<,JQ[]]U19'AU\]
M/%K\-GM!.SNK]UP_>GZZF#UYNOS*&><^>''Q'3KQ;&/=29+R#K06=S!2VBDF
MMN*8;,GE?S_YKI")*3?<R1[-#J3B=[+-82=%EZL'0BCM?]?O**?**&"JRY#1
ML/Z&T15RWM="ME_VZ5*_G7[#^?%W+P]F\]_^^?73Y?+Y=]]^^_OOOW_SN__F
M:/'D6XN(WZY>_?KUH2?'.T^(GK\YN-$QKPY]_<*W_=N='_R2%P>S]\[;GUD=
M[HSQW\[FQTN:%WES_/'L8Y]"C[7?_F?OQ_OEJ1S2SH?OFKU<?OP:L[E^<NE@
M?;M<T/RX'2T.::E@]@]I=HS;L6\^ZO%B^<?OI$^^]WVXOGSO2ER_*4>'JT,,
M>G-^6)6W7V/U88ZE?//DZ,6W^L)[YRLGBX7,R^G'CSY_]0^WM'YP^M?W*'Y[
M]N+YH?*R//WXF?LK[W^0HY/Y<O'?/L?9B^^]X0^$>1_8_C+3\3E$_YU:G81O
M<?QO9[3^'2S?''Y\!,ZF/Z/7V1'O\&1'O]-[;SC_CG]&%1MV3-[Q=G6>[PYH
M_N2?7\M\Y^?[7ZL1"=7O_W$H2_JJGW5'_N=D]N*?7U\_FB_5->P\.'VN]Z"<
M_?;/KY?R<OGMZBM_^_W_^E__ZQ_+V?) OE=6[9Q3Z!_?GCWWCV_/SLQ']?3[
M?]39BZ^.EZ<'\L^OZ^SX^0&=?C<_FHM>?_;RNWZ@+,X>SFJ5^>JAOKZO[FDQ
M*V>7?[F\)^V?7\\RM!0:(#6N4)(E,F  LT\&JL3PZZY^%&O5XG;>TGI.A_W2
M,OONQEP_W^EU_38+.K@]K_+R_\KIUU_-JIZZ^E].>??HQ8_NWHM'?N^D/KOQ
MXO$M?';G\ ;LNWNS.P]_-GNW?CJ]L_L3W'GPP^SQK=OASH-'IX_<C=.]5_N_
MZ<^7/_K]@T>OGC^]LUM_>_3LX&!_]X??]IX],7=V?_O]T:&>X\%O;N]P_^G>
ML[U7CV_ISU^R^=$]/GWTL$0]]^]W=G_VCY\=/-U_>.-T_];/X?'#?\\>/;L&
M^\]N^_W=?Q_L/;MF]A[\_*+>NCGC6S_'_=U?#A_O/GFU_^J'@[W=/;NOCQ_?
MN@%W=O=@_^&C\.CP)_OXX4_P^-GY>W[1:X7YXP='9O_AX]_T.+]WZ^??]U[]
MK)]1O\.#)[#WZHG5SS![O/O+P>/=IX?[O^17/SZXL=R[;U[^^*"\VG^P9W_U
M(A"SN!T7D'<@2]KA8HW2+%J,(0&G^/7WIO^Q)F'XQ[?O@7J1&)\'MINSXT('
MCX06-_69XPGE3Z%L_X"R!MQD;>6=;++; 9/-#D>2G<31*B!2B-2*.P@;P_>N
MGO^H3@A_%L+NCP@S>VH0=Z@$U6TITTY.*>[XYJ2:'N0\??W]S4>7B.\U!;>N
M #Z@)U]_=1;*]+0OE]^UV4NI.XT.>FB>P/YSL/T?P):&R48?=B0W!=NAPDZ^
M[)@H2!RZ$F\*]K4?[]_X$KQKB&Q3%D/>@"I\=%B-(5=)M4=R_"=XOU;=W]U=
M'#V7Q?+TKLJ3Y;5YO:$ZY'GGP,_'TDX.?IRU#0/N]V=X6 YOSN\<WGSV^,%O
MK_9V'S_=>_C+LT</?GKU^$$)CW?U^<.]T[T'-W_;>U!^WSN\=_BCOW<@_[IW
M^OAA?<X.XJ.'^P=W'NS]OG]XX^7CA_M/]W?W#_9?'?RV]W#_\-&KVR_W'O[T
M<O_5M=/'MQZWO6>W8?_W7P$"%5/MCBFLD!5J.SF6L-/T?-Y1SL#UZ^_OPA<9
MJ(U9T[54BRT1U#A14S?KA;T)MH10)\#^$F#Z::_]"I4+&E0O)3GN@-[FG0S%
M[.0F()J_)DU?%3#[91XUN1;1)E(F@ ;?G$KQGI&3\07ESSSJ.6 W9_/94GZ<
MO9!Z>Z[YYY,9'\BUXV.YNHCM[U[[?4\1HU0,:?0+494.6*>(E4H[K()6[ZT"
MAO7/$+NYH-)3K:].] ZO\)J?'+(LOO[ Z# %M:]0]'H@2=531E]-S=&5UA!^
MO=VS>A-ZHE:ES XUROWSZ]O[-\^1U#Q+S4Z::%I=[R^/RF^[\OSH>+:DQ>G]
MI[20.[_/97'\=/9< 9:%'"]5&Q4U27JBR':MI"<QF\48]N^_QOC9O=G>X0W%
MZ:??]Q_^%!X_^.FEQCV]MF*W^Y-__."V>W1XPS]Z\.]G'V*\?^OVZ:,'U]SC
MW6OV\6Z_[DV->T_\HU?7S/YNU7C[>/;H07VJUVYW=F__2MD:&U7C1,-A!\B"
MFF0&S8HC.8&:/:G&,=^8-UG*.:1_:I2!P7!+FJ&CYD(UJ]Z)%%3M% 0-?V8%
MZ$=M\8ZZ3LW.YT]^%#J6>[VJ=J>I&:[,\?Z2EM(]Z9VF-DOS,E.1VV'6SW/C
MI2;BQ]UR?YP=+S<+Y<N]9^7%X_F_GSY^=:3RHC[;.[QY^.B!FJ>[;?389W=N
MW7NFTN9T[^'-@SUW\V#_V6]!3=P\>OCO8Y4RH# ]>]0_XX,G?O_!SV;_U4_V
MT<,;O^\]^\G<N?73RSNW;NO/G\.C\_?\Y]]/^; >W'GVY'3_<%\A?F+O[!:[
M_^ GE5F_/%5*G"IUX/'N#7CT3'\^.)C]YY5*H.M= MU8[K_:LRJ95%+] O5?
M_SYX[ Y>\+/G>G_V]7,>S!X]?/1J?_>1WJO'LSNW;JK,NOET)>T>_ONW_5N/
MX-%!?K7_Y%<+/B6H:0=3SXE"B#O96]S)+FNVA(IY<%]__V?EQ?__SO*I+%9@
M'^\?S<_J9,LOB0?-!HQ5W94/!*XQ&1^0L@17O8DIK:AG)^IM&?5\4__B7=FI
M4:6[*L.XP\77'5)'9O11LX1CH=Z/,^+902_&G7V&B7MKY=[M3W#O2#/5FX=[
MKZX%S0Q?/7KUQ#Q^\"CH]P[[SP[T7NRY.[?T.S^X_?*1S6;OR:\Q&]5"P>T(
MV*:YHX\["-QV$&.PBGVI*7R">]=*69Q(/4=^)L?7OYQ_ZXJZ$__&Q3]4<$,S
MM!/%PPY$7W90,.]H*"XAYIRLR:/DWULW/%%PK13<^Q0%K5Y7O\N>OO?VJ=XG
M\_C6O:?]/NV_NGFX?[CW^]Z#'PX?/;OVZO%!-AI^ 8A(0=YIT:@+%'W$V.J.
ME22"TF+H8QZ?#K_O$' @,7CBX%@X6"6:BIQV:HF\ ZAB,',S.[;5QA:0L<BE
M<#!KT#>E";I>SH""+D9K6I1 OC#3?^?@CZ+R4]YGX@-9'-YI?=BY9]XCI=;C
M_SPUY?"7.3W$DSO/]NR^VSM]]/#QT[U7MU\I)?1S[<'C6WMZ;8UJ#W]^I?^[
M?GVER>]*@U]C*]YX(UW>:XA+Y'?8HNPD[XDSVE"L9I9WW1>5#J-Z+=%TM1GO
M@:)A)Y#0ZM-"ZD7RE^%T3^;R.QUTN*X>2"_W'_SV*V"UU53:49^;=R!7!:D5
MNX/65VLE@,N:@]V->W\ Z=OW9SBL*GDR+W+\D7D9?0+*=\>K^4(*XU>K*4S?
M+4^?*SS'L\/G!WUFRNJYIXN.\KM3,+YY>5SU#-^^?XJSR[^]YNN/<'QTLEC]
MMIKJ]-UKYIPA^U>&\<Y/)*MY%N>_S6K_O<UD\=7J \E'Y[!<O_U_WY\Q\.&;
MOS]_ZOVS/U^- )__=KRDQ7)7@U@?EK8[UNP8>_Z^MZ^]^9CU_%"W8W"G3V!Y
M_Y7SW\\O\NU[-^JC]ZT4<LJ(QDD,D _L8H_.J=I0@Z9,&[AOK[^^/.F1_>S7
MJA=[^?Q@5F;+/>GEZJ_J[+"']SY7\.U4F1[IU?B/;[PL3Y6A<NWE[/CK[_L$
MK._^L__H_C^^_>BY/N,2YU[FC>"X?D#'QW?:JK!]=I7S0ZX?'1X>S5<OG)WG
MOU[UVP^^Z"CXHAK.)A>2]<$!%DM.Y27; A8*Y8(37SZ3+WV Y.V0R'$?$CG>
M1L)$R@P-HE%V:$K"J$$H4A(DHW1I'QV^G0CS7PBS?[248_N-?KEZ(KM25N>Q
MH=^X;>0.%9\2J8:!D@&%J;0@U>4:!-!PF;CSY=S!/W(G;B-WP*723#3%:BI1
M0L&41+,^S?B*^I[D)NY\.7? 6.7.'ITZT'OFMY$V/E'AJIQQ2AMQGL7$D@H6
M,85+RQ-MOI0V_AOCS#NT"=M(&]!D*0"T6!D@"&%JSK&ME;TS)M%$FR^EC?DF
M>J>T^??)7+;6VV!B"\$5=M9 S8Z*!97)WB>?F8.?://E0<J9_ YMME+;M,8:
MC32Q\D@0D#F*ZRL/:ZC(6,= FR_"U%F_>R(WA1<GFBM;_4;^4[A> F_'29V@
MF9.WS6&*$&S&ZDK(0;Q)KF+\Z/3W$5.G7UBI<^WDR<GQTOK/B",3<?Z+PB$+
MJ64GCAHT:CF+J4BE.FXN3H6_O\)-#^]S<RNE<:B:AQ?;JX 5Q MF4R$AFAP+
MI "OYZ!X;P<P('.VW'WY^@[X'?_F9IV_\GEWH,^N7WW]D]7XUMF3AT+')POY
M_O52Z>]^OK][_O;SE\Y_[^__^-WTQ6=$G]5IJSW&["Q0B<UBML41GMU-:X9W
M-U?K;?_FW3PKD__AAKZF\^K%+[ZCQ8"CK.+;I +H$II&4IO>6D.40UPY-G/N
MV.P01P[-Y]NU79M=LT46%-6>&#5W29EKJ1F9+ 7+;E4IL7A^W\P [YO%S[]O
MYN_<MW>]P5U9K-:_O+D7=?9"O\.[AZX&X6EYM/B+CN,/[^]/[LK\Z' V_]AI
M/]=\WCO%M^]_^D_ZK<^?B;AYDKP?!=[%_<O\UOO*^_/GP0WJ#MBUW0%FXXUM
MOF*OE55%G9-FZWI+ M9JSQ>5#>X.F+7=@0H85VLK^XI8;EY%4<U": C(>>)^
M!RP.[@ZHHUS7'? UAY:3;:G?@1*P1XR02]10D6P>0WW]>+'\[M[;K*'_NC>;
MSPY/#O]N:OG)]<H_G/8F-^]/./GA9*9GG3_9QMPAN9JXLDO&(^3&2$(AME90
M7(O>C)0M]')BRP6PY:^T=A@!6S;H6_:H/)W-97'Z[H';2!U+D)4C51@S6*P$
MK37KI7E3"EH9*74VZ&BN#G7^0G^2$5!G@UYG-7G_Z=%!/=8CW_QR^_#YXNC%
MJJBZE1,EDT^:&#<)Q32HDC"IZRF2J%H#WHQA"L' 7-#5Y)'#EFPQW!KZON0*
MR40Q57,N[S&G,82R3[<!.O[A=(^>'2U6PRMOQU6N'RWD@92G\Z.#HR>S3TZH
MOCC'.$KFM.R#]\W[U%K7/U19D"+6X@G4&8V .1?O@2Z:DZ-D3N@8YFS%UK[$
MO:KX@2#)!ILKV)A&RISU:J O8LZ;Y40GQ\NC0UG<DX-5B^3>,6LK*50X6\0"
M0L9 IL#9L/B*$DQO*3A6&;U!YW/E*/17&@\.C$)_.<K<I=[UO O=!PNJ<DB+
MWR;U\V750P]B&Q6J1L"CS;;UJ2NAAA!50(]AP<C@V?-9WG"4[%DY&HDV8-7P
MA3X7 R*-I)EL ,82OC2_KB=E>6=Q7Q8O9N6#A/J^1H[GL_D3Y<F_:%X/MG0<
M0:U?#;[TFAY #)C)<J,0R%M0)[&)&4';@.5&9BE9<) L9D'GP+C,4CF$(IYS
M2^+2!F8I;0&6ES9SZOTL,S1CA1.(8ED5P8#%9$X^&A^XE,N;2?I7 _.N\/+V
M_'BY..EO_& ^<$S!O+O,(>A7,>O'<5U37-\O7J<.17.V) N!(Y(OR9-Q5&I$
MUT8 S>SX^=$Q'=Q:')T\7\DC/6%9)4SO&YL>V+_Z;'XB]76_(<VISMZNSS15
M6$+SXU7CJ@=/:7Z?#N2^6N=1:R,!TWCPL6"TK7D(3N'DWM]#'\>,(8VA)\RX
M4=V\!*K9]I5!F+-4L*[D6$MU(&AMXHPT @FT1138B'+JTS(#2VD1&2PF;-ZI
M>&J%;"G*B!$HI^VAP&8$EU@K)65$$Q,4=?Y032+K*H14//G+F[)\&<B_/?#/
M 5>Q]G&>7$:47]]L[%!<#42 9*7W5R3@EEHRT)IMS/:U9 ,S2;8+E&SPCE'_
M#3 =]L5T)I:2.J(^QYS$!J#F&_K74Q]78.Y,J%YXO/X UT](MG</_3OS/OI$
M5Q=\@]Z-3Q,R#\YE0J+6BL4P(@J\63W;I_<L3Z\?'3X_FJ\*U.\1X%HI)X<G
M!WIL+UO/C\^&MZ[59R?'R\^8;3@Q\H(965E:C@8@YPS1F5QZ:U:3,<< R=K+
M6^URP42\T)Z?%[(,IP2QV5I.KA;H>Y6C*>"LQ!+81O1; \VU6E?MX.G@+LWJ
M[?EU>CY;TL%(8,)()0;GD^, FG6Q(:<9N4-6D08V; U,]V1)L[G4&[28]\8,
M(\$GD"/U<,;7H@F2;9ER*E"#B$HP?6YK\-E]O9-??UU/L0ILJV7,/Y!&MKMT
M>D'3:2\$M5BJS]YD'U>SU7P&[VTE:VVSZ@-Q:U![L%BMXCX=4V3*J+EG%G8-
M*R *8BXMJI)-45%J;41EI\'XOLU7DES?8):J=R:=%1LXE&03>ZI-_X;M0_72
M^L!O!E 34K -2Y;&8+W#!D9J-E T!KIFM@_02U.2FP<77+"4:\S!.E )2C8%
MA[&"(MJJ+=L'[@5'RLU#&C%("(FB>E[5/)%<7^F:G*^V!3;U\GIOC-GO7DA3
MD%""JDUR,7H"+YDCUDP&4\F]\Z7;&F@VD(NO$29.IC*R!CKJ+=> HB]8?$V2
M/'/"K8'I,G/Q->)CI"3-X7S*MH&*$E)C\GT' ,>MBF];@\_F<_%U=D1R@:U$
MRCD%X)@S15ND"M>^@JS)UJ!V:;GX&L%)C<7ZJCK!&V!;,B;G:E3U4%(0AR.:
M!308W[?YB3W&JZ49U8$V$U2TW-O-5R\1*(42V_:ANI'4;3/@-LZF.B@M6 NN
MF!QMKB'4*JVI[K?;!^XEIFX;FHA' +$EH68)%#MRH:)J4.^\"' : :1]"</U
ML['ZV0NYT9J4Y=W5';C3KM6CYV^'TC_KR+6/\$_1X6V#1I>R,+2^-Q\0ITQ)
M&155BADLH;7AS_D;6*%@?3/VG.F%\T0.^K8?CIE2!C(54W71O[<[\KBAV42A
M8'TP12YJ/=0J>@$P*I:K),FI[SMNJ>'6P'2IA8+UX=.R\]FGWB )H07/GH*/
MOG<A=M(@; T^ R@4K!$U$ZSIN2C8IBHHYJ1QB279)-*JV1[4+J]0L,;(5"J6
M5JEF4I=G8ZY-U0.J/$TU.#>&SE&#\WV;7P1&T7%HY"4X34%$LLF!I:9F7>_U
M-(8M?X8J/#8/;NSK.[EQ0<S@43 $S"W7A!1]RV-HECPLQ[IY2+U/+AG;+**
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M'*RCOD^<BP,?8S)@'>60U#=JLDT^-7>^N;>U ]O8N4L&NZ95; 8<H@_1JQZ
MRMF45#6G@9:-(5]>+^0((^@ZM6KQ=*>M?,6' T_S%[)8]NT4[BY>EV@O94%'
M6$^;.+5)LBFII>)J#0!1<=5$GZV$&H/9$I N;07HFF"I:/NJSY!4-0."H#3.
ME8- LAS#V:;H*UC.UEN'X;;1WC0^'P3#]Q#ZQ$KK\$[W[+]3<%4?Z+BONW .
M@L.LN;=A5YH+EE.1;0/STCSBYJ'M/3;%EE0R6E!YD[UE@AR,B*9#>0R;O(P
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M=6(;#&7_OLX99<$Q0BZ)4XM>*=I:RY7!NU2:CY&;*1-!1T+0+Y$<HV0J^1)
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M&RE\Y@+ @BC!./"VD11H?;L02D;M8AH''KQ!7 %ALYDV8]:5"K[Z[ I0] 2
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M23Q5^"<E,H@Z94I&<FJVU4A@:NJ+2TQIN2$X=;4X\732!(,BK..*7&.P+AM
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M3%R=S146/?:/'O'\E;^2EK=D4RO!:_#2-"!3TWC6P'J5E^HKZPJ#,3K""\?
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M6@>F-J[!I59KS=&:8'"XPN83Z?WN;"%E>?2IM'XH2L8U)*XFU6@T"S.%1'.
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MV7:366.YK,]T \G25X0856-LV%HF0BJ$+ER-*#.9S-:;S!HK9G'5H"ZWX *
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MUUJ*I$2J#7A<I?<%"J,'77;..)FLB7U;]!Y!&XF@Y?D@%9/) 4-4$0!L\&"
MK,LV6JE,O"%=K&[JM.W-1= 2IYR\R% KRI%7X%/TE*0."0LBE&QO2/O:'D$W
M#4'+\T&A9GJ!5#):X-]\U*(H974P&;-W?5>0'D$;B: E%@4FTEA45L6)-@4,
M0O'2&Q]L4C;?D)*,/8)N&H*6.!<G@Y>0,V6K(6'T2J(E)XI4T<:;D@&V(3,)
M:ZJM2[3W J(&ZQ"]@10#<K214LQ69*<BWI#63[VV=L.V6A]%EE(),DSS2T(K
MG,BU<D\1B"AOAFW=D AY3;5UB4O)VA=TAIRR!)$R"HSDK,Q$+JE\0VQKKZW=
ML*V"LO3)>)>L B%J%$C"2U;: DZK<C-LZX9$?FNJK4MLINU2R8Y"RMZ"0.V-
M=L8F"AQID14W9)- KZW=L*TRBF*\EJJ( )FDM]IGI"0I&X<F_O&@M:U.^L'Q
M+^NJMC\?S'C\9[-[Z7\/AK/A1_VH\T>_XA3G^.)P-J>]OYHQ^@;9\/A/YP]P
M3D>VQ VD/[G.R7<GXY8_<^CQ-]\B2"O!4A"I& <96(JQ2$>N=E&+0AUO,E]C
M^3T:CH=S>C)\2_GQF/7Y]3".J)T0G/U\^!3_G$SOCW#V22D:-C:3?<H[E';'
MD]'D]>'SX>O=Y<T*7J=6G?5/IQ7E>ZIB$F:I5,RUJU$Q"D.T2FOEM8L40:V_
MHBQ-)%>KFO</9O/)'DV?TZAU5K/=X7Y7E"1Q;!B]#,RS$WAIH[(ZLC]01BIM
ML-P@)5D7D6 A:;(EK0DA"!-$8999ZPFJ*-UB_4N&=>:5SVDVGQZD^<%T.'Y]
M?S*;WQMG_HRF;\^QJH=[^Z/)(=$+-N[M7I>K%)$,2R-3T4HT%#$F%4&3Y7]3
M-N2S2$K:HC9(1.UZW)FC.R*C3+'NF_!:Z  B*(]1!UV4DCHI$U(EO#)('MM*
M>,5&"&L%>#I-@%E:4@R$O P!%F<%^QT$. 7F,H693/$%8I(^)18C_UUW2$*P
MFRC85:#P^B7KO,Z07-%U;<50CCDXEC9:],%YNRCYN1D"7:GG.R^B[UFL1:>4
MBQ:<"@"RH"Y"4)0@HY$.Q :):+6>;XDR<E&(DK31L2!@L<P=A9+(#A#YUZC;
MJ1YQ;"#7>H9RG?!T9NI'7-X^RJ791R6BDR$H#:F S<YS0*"L=U%*\"7@)@IV
MU9[O>B0K.<++I1A0;$2C5MX:(Z01 A.!21U8IUTGI%[)!#H!DH\R&W9W3#LM
M*@]HE"C$G-/J#FS/6RO,74VQ:TK""FU%<!P:>(W2LO>#G)67POO2&DAY;"#7
M>B5YG?!TQC[*R]M'M33[B%;EDJQ*(7F0SF. &&W.P43+P,1-%.S*/=^U2%9@
M-N@$7])EB(*"RB&@LW4:C07=@6XIZX34JRG&'M%8A^ C"$@:8\"$_!&QY K
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M2S4"UUBVUU,ET*L2A=4&2!D.#4(P=7,,NW0.^MD4AXVSR5?K-Z_?$+N0#0:
ME&J"'=MC$8(.A-9Y5(G4QAGB%0KT6JRO3W6F)WMI=  T-E!1+&$7K0&'F3;.
M^JY.H-=C<@5F:XTQP#$W%&^]<[4,C F^*.U#E\HO?5F@=;%BAZ9[PS&/5-YX
MPRME(4]%D(W,@"/J.JWBO$YL>[%3F7UK*M;K,;_%F8Q>:E<*%$7>REQ,J"V
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M*-&!#4SX&?4^2>]T,L8?SPJO<<KJ1;RRBK*"Z\D$QZLB^LM*5)5&9S)1@LO
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MS?Z7$>QL8C SBGT(SK,B)(7!DE4;$S1?646ZZT>QC"$5E;4#&2 7BP3)A2)
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M8F^8\X@VU(;?RWE*L]G1/T_X 61OO__*?A]^PJJ\-R$E50;*1AA M&+@,]%
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MUT*>Q@%"J7[C$J#K(E[>[1+K\O0\:'Z0/RY>;9?=2(5+;G T.L',:3!%.CJ
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MT^N#4=N3K7DQV+EJR[!XGA.LT^S'ZT/RJ0&LXW<$[)N'9/U'0)/0*AHXEV$
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M5BKKH=D%:/H>FAL'32U/0Q.VFJ=\?O,""\T/FP?#61I-9@?3WG=V :!5ECU
M-PV@4%-X%XE,-:_J7IP<S)MG!]/FX7M*!VT9T6>E#!/U$T.= "G+4\%J0=H#
M<1E =,?+E/TZ91=PQN)2MG>&&X5!$*?9JMFJF?HU%[\F-S[_- =RD1S<//S?
M@^'\\#8?,6HS%MMLX47"(U]@/J]YCW5KVJ*U2O/KP33MXFR1V[HX]U1A_A[[
MZX_]JB8]]C<-^_HT]NU6\\-SXJ=Y2_G''I,=P*3N,;EYF#R3..2J/_YD*W>=
M1#J8S89'^[_OC7%T.!NVSO71R4;M^Y-Q7A2OJ,<PL ]&\\5NHWU:/%_O>+L
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M=5;U=L./<5 PS>OFESJ0,UPX*VSB=(*YF=;-X_6#X^O/:JV'=G3Y.E7W;C,
M8@7%9,JW^M^#X?Y)PA$+XO5XT@II?SK)!XG%=C!;C/XNX6B^FQ:]H?F0^<%1
M,L/^[N&L9C+5WT?#0LTL#=M&T5.:$4X3RY*_23P@[?.<W+Q]IOI^^[LXW<-$
M!RV_KC(_F,VG"\6IW[]>V*QF_R"R+=YJFM^H/M[;869]X$-9KZ9-2^ ^;OFI
MCUDFJ7UXUL?A7GO"^/71L+1EJ/;.9EOM\Z?U]UE;&/VG=N!J#VX^:3@NBWU#
M?-]V*]'BUYK/P0/ZTV(4]^N1LP/6OOH6K=97)G!T>'W^DYV^/YUZH#P]X!\T
M8MQ/^:XXS(N-_(R579H-CS2#WX=O,]ZMT^S\=:L6"V$MRFP=/^$!XXR!TY:V
MK(^0:O+VE&]8_\#\]NC\1*/1P0BG)S):?%\U93$XE_-C[MK\V+&[;5[0ZZ-F
M3'_]N'K-[,&)?YB<5$"K!HY%.E_XIRE1\VXR'>5W5=<_NIJC=[[S_]G[]N>V
MK27-?P65F9VQ:RC%CSR<Z]VM4BP[\<Y-[&OG4;N_@21(XAH$> %",O/7;_?7
MW>?T 4%)3AQ+<KQ5.]>A2. \^O3IQ]=?TQV3_2#G?,+__CL?O]=R_&3_Z</G
MB10>^Y+6[)SI)$@&N"P.FCR.:>]MK+WH1JWZN:BF'QNZ.1_QKU0QHXLYE/4B
MY(.Z2#S#JCNG1^+'OY>G1N^\P=VNE[]O4W]5.^QQDGSXLTV>=S4JP_;>1O&V
ML>M=PA*IEU3>MOG.7U+A$BQ5;O6NBLH<FAQV7K51[5GX.\DT*&A3,IR7<!5V
MQ9;5>'><_<3735MR[B-<'2SA3#'*XN,&S0]=-=V&-TMU*:XPTJ7QQM/3HF:=
MOQ+X//1K _:V!8E^93==R5]8HK8&LBVW1=W4-*M%N=6+3F>7T1U5RT\&%Z68
M"_@+_]XM!NF,-_3J8S\?52S!\ETT5=6<\V70M$MZS&^Y7E-]3=;:W_8$[A:U
M/W_P\/C>5U^]]_;G7]-Y>OC%N[0_?T^QQG4YGU?%9V/G7E?TJ_0A?W8,XJ :
M>]<@T8M4]'XFT?NS K8?[R)&F.)+,=K)#JB+[@/E+C[PW0*-\$,TXD]5[R-$
M^]J<@##W/R_>G_J9U[00+^EGFQ6\(W(VVIS,/'8![GSV_)?/[I+Q3XH>U/=W
M2/L'$W"B+L[=Q^H1T-VWB0]ROUKV=(^>E^QJ=GQY)%^L^*ZE<?.G^M[P4_)3
MRSD/UW_$WE26(XQ"K^;CQ:_C;]&KQI]K7PI/X3'/^BV\'^$8#G]ZG)WEW0Q>
MC;S$N]9W^HH>U#5T@9/UD-/.+>E1\1>X-N]4S>Q-]"0G[.TMRJIBB[;JNU76
M[>BH+>%+EYVZ7.Q-T<5WU[V>?K;)Y9QF=[HW('+;DE>V(8'BWY+!W;$]0AO!
M14(P<.GW=5&0ACI:L-7__!>^L&NIU,7U3N)9U!U\!+)GV,*H&K*)CKI=QP /
MN)'<&J'CH(R:3X^S5?Y;WL[A%HJ?N15'%@9*=$TEDH"&8*O=IB'5LJ:%LNF*
M>8+1H7A!7=/</J-)DO/+@E5L2G)P\^JN..]DY;%WS'J4?0%]G)@K'1DS&WBK
MFZ;#7WD>0[_S8U%;#P9JRU5Z7:?F>G@MFNM+CO/_XD,Q*GL2-%GT8!+G(&"^
MV47+7B5DHEZH!F;DRYM^O4&(R^*%*E=3%=DYGR@ZQ.6<Q,^]F&WHANY2?AA;
MS0NRB>U%)*<]V05XG/L)/YE/8KW41$3\%F)M.Q]8"H]R#RAQ\#CZUI!&6*OY
M8R>&0ZC+^+O2O/69',.<N=7Q7S'BQ:U1<,C(M>F*\1"7'#KU('8V,ZS]ASUX
M'R"S-'[Z7J;>TXB#<QVC>BVK_\%@"M=^^+$5<J_"GTSBGR:,V9'=O>)SAGM7
M% 7][ZHLJKE1GG9%M3@JZW]JD-8>@C])%!<^/B(*9 JMIW1;:0Q7#.8M9R;J
MY41,AA# ;8LE7>A\5.]B1(@Y(PQQR!7'6>P[-IA"P*N53V5\F,_@UQ9KGV3G
MJY)CL62+D/:CX57Y3 +8[+&OA6,]E[O\<[GC,S>=PV?X^A 4UY<A'S]O]P_#
M.#XA,CXB1,;AL.X8FN?/_>&-""0GN8'+PLDN4.<NC$<W+<"<YCM4/W<Q=\EJ
MES4GWQI\F59Z0:BI57>X&DBP8N*3[*I-,:-Q6ITV)SO;/N8D2"LLG67'EX%X
M5?LIV)&DW,2%:8_(J6YF92ZH <TP)FF[XRQ[3J.=2]^<D11/B*PG>;R0:]TV
MS#*,&/HBGY7HWU'(BFS[.2+PG G4F4H:A^SA&I.-?Z0I+G/$U:<%LT\(EJ+;
MYF(WTQ=KME$KS2%CII+M[&C*-(F?> 2ERSN570CHY^5<TYG=K($-H/%_RWGC
M^20R?.G)ZIR1?\]1 QUV$_(!:5J4_^A,<6RS[ *&=&DF8)!-\_F 29+&3K,#
MTZIIZ!%Y_8;][[V@_.,+PON7IQ5&$@GY+)\7:\55Q*Q"DJ5/K'\S._BC:=GL
M 1!*7B 0S?-ZTN*U/,2=F#7]=D5S-I=EP^M.C]*<PLDV^YX6,GORXI?GIT?W
MOX%=-9:99/0.UKJSM#L?$29$J';'^]__*^4NOCG^YO[7[SUW\=77QX\>/7P?
MN8LI>:C+EGWF(]7T"_R_QQ=X)F+Q?=! S-6CZY< X2]*41QVT_YJJW19#N)/
M$JP;$]_#86>DQ5(0":<12?4NH;WWNP;7$=2X_V6Z$&8FL2EFEI4SQ1ZK1W]4
MU*1DBX+1G'*!.G,MV'-PZ/>#<_J#OMKVK84$MOVT:.DC6 +Q3S$>U]#3$:U7
MWS\9Z2$XU3G=;G6 R,@-3L\J9VTC-U&WSDJVC<N%A>!@S7",H^N[&:< IFR'
M[>)(JO)??3D_FN9L$,UV6[F*?0SC^Y>_8)0RMADB&4B*L)&8=;.V*&J;-UW5
MS7;'6#0R%O)-F8#ZR. D-U;,8ITUW:B,_RD5#^CMT*V@\YI2C"?!H&&N4X6E
M.2!A#"BJK5&%N&DNPS:C5(QJ8/P8\G,!Z.ROH36^+9MNZ)9]0 TQ[OD]3#V_
M:PD50I4\J_J&!'3&ZW/$9O!9+HG!JLHZ\MX,88.X^&\*=:1#ULS-,']3ZL'9
M%"U[((9_E)^0>GB\Y]/QMT>AK(\'4?<5C?1HNZ+]6*XV/3V 'EX51W@\PU:S
MXNT&V3XH GM=XJ,U]0R':4)>S+H7$!1_?N?[Y[_<=9YJ1=.R!(0=Z,_7#9DC
M#32;SF&P&K_C1)D1C$*N"V5Q[)L7AQLO#"]<#;]V\ !<:W0E!5E>%7MX,V9[
M693E^1Z,6<(LEN^>9'VK(FS"K*%WQ4+CWJ>K<A=O\H#K8XPT+<!\(EA4>)QO
M<4^2I*N[]\MQ]D-/1ZIHZ>K]XM&#QRG,FGRWO"4=VFPXN1_"-4F$7Z(84\41
M-GRF->2!A![=;1S8IQ/-8RI*]'XA5<  TY86-1/U0:M)#V: PAKGL9A?+9(P
M6,%!*(&+'&A%>_J+"Q<P%E T![Z$]#^/$7_4: X@]/0+)NG>DK8JMX,_15@[
M;1==Q$W?PD/'0PSA2W/8'^,?=[FO$#+]RV4?'GS*/MR L?SYV8<Q/9\X^>.:
M_]9$J1[>^U,0ME]]_0$0MK<YS/+[@E$?Z6*\AYC3K7$27Y/!PRC7/PD==AV>
MW?=DM9!) DNQ66RS;=EU/;M:F[PDFU)B###REBW=@QT^(F>J::=0D^[33E9'
M#!Y4CT8+,1J 9.0\6='<\I?TCCU+\D"-G_V8G_P^[-#CCU(\'0[9VY%_(ICQ
M>F3V)<<4M^0%<&00?GG5KTM!T"[+AJYE&E!VAR.$#^X]?OG3"?YU__'=;)J3
M_<R PXB';O-YV62+MOA7C_P:2;6"$AUF.BYL@!=WL$(F@GHJWFXT#8MTGKQ%
M/U5K@B,;=EC"0^P#A"9GC<11Y=<*U9:CM>GH6,U6+9#3!KJ>9(NBF ,PQ<>F
MI7/)$/ \C#Q;E)5,@)R6)KQT01X%_2.;D7$KH0PM\Y(@:5YRLG9PZ/B)8$I?
M6T5PVZRG^L''#1K&T?JYC1[UD[:4U.V3G'MZ?SQWP<\MUPJX9/U_Y.L-@V;S
M3O'QL7I=@@U8AA&10<WUNMQ"ZMU!>E/.ZX($9MND+PJ/_8D,Z )4_>3V<SDN
M5]A'F+8((UT17+J_]W/'1W#E(-B'JAP9CUF=S/[5E^(^_RXJA>OD!GG!73ZK
M77;_T21[<._! USMC%VHL($<KLCC]-AU>\GE&'FF8-NHH/&QZ6C>8I*?FO05
MN#HTT-7R T:!T[%0!!F59HND3+>2X,E<:[KYY_]^__C++QX)7'Q:5A5]?)QE
MKTN.0PV'RR74$U="329/7VD(6P;\GP'BQ B1@L._@D^9%A()9O5-"\$1M;).
M'L OLXI0+>P.Z:SQ\H20OD2DAT9]HG DL9D"I*<-G5A!*>)G5 Z*OU$Y?O_^
M'R@=S]ZU:ER M;^K;OS"2-8'/[Q0EZ\W="Q?+!8L6J=E/B6Q[]([X=:PHM!9
M/MFT997=/WB6NUA-I0"S;5M.>SM;3V$-Y&A;>!R.MGX:SS9+*GF.'(^E\Y.L
M6HB$XOI@>A]])9U# 6M5NR.R]A!^%8X6C?N2I'/Z9>:.J<9+QU^0W6'G@O/*
MJ'*+9 J.>&%P/.^"?N@<":M.KK>BVW)BJ:@[=I<DT<HH.-K/*?T;+Z*']^!&
M(N&V%=K 4--3QR5;1Z0^5-^L\C/6'P4?Y 4GWIF8J!-4'C>^Z#D\'FDJ:,@<
M2[[\Z++2(;,2AFPS[RX8 Z]<(@K'7M7,0\_GSJD:'D-XR,4KKS%U0?";$GKP
MP>DK_H B&CG+WUR;_0 WK[9 U(L@&>\O]74-/"P1:-(6GFEIKE&*:A[I6(Z9
M-4OO6A;%34^["83O>6$YD@("ZHY-TV_9,(#(<? .S=UR%M:\TQ1+][?LZ0]/
M3[([*BFB)+KL*=F]FT(8DWY +7OVE+Q-C.QDP3KH[N/L.W:LR&(YX>K,X1/0
MP@9X51(U^^83LA!(+/]/3BL_H<N^WZ[P:_UWP:^0__[OAGXB9O )@S?(9Y#H
M#>_#_RORBOY-0_@[395T.NE:&M+>&'XHWI:S9I(]T<)>_9Y,BPYL.9T6N>AY
M'8M\X:YDS9^073+/@1!=T8K%+8(RN,HZLZYM.@L\?5^TOQ5+)F*B(7S;YK^5
MU41?,K&E.6W62-5S>R^Y#82?;4:;\1UR@N0A?]_7I)/H'\_)&:<?/6>]7,_I
M'UV;%_30YV0<[L(Z_T"KM<.JVH+P2'\LV-?EWY$4D7&XS$FXZ"VO-Z1X(D9;
M)_3?](5YLSZF033DS6]6B#I=B=O'*W)'ZA,I\FC?H5_U,G5O<.Q!>K?^'BX@
M?_7]#GONRN0^-T?+/%/"NX(6IV&T-OVO7&Y6WCU;H6X C9<7%:FA7K<(5_,L
M%\#\2C+#)3F7@B-S!H"1ZB%^V1>H3; GD3YK4%:6UQ<_)-#TV5-PVJ9%518,
MUV8P#6 X2#'S_G6,^(ZZY:*C=]949QRX%=73EMT;&5!"#QAN['E?F$3Q(>="
M^%D9;\O$+@)NP):VJ,_*MJG%;6>6113HD2*!=&&U[:L;DM.9(87X/R2^TC.R
MCJ_[+<#PKPL:0M\BL,R&2"^('C$XV BCF71!EN^?'&>O>&[/9-3O05H_Y='3
MT_3P4Q[]!HSE@^;1K\_4/74.Y^V[> Z;MUQ-K*9M\*DCZ^C /#4Z2S/YJUVF
MN$?XG=+ =)LZYWRCU07*RZ*FMC(?D+DE_&J2N',0*+N5?"63(JH41!S>RS2H
M[!@RVE)R;F=Z<_7 ;H,SAA\Z89ZU(__?'L1L6.WS54//HV>V<49\_S"&C&O\
M:/A66 X+_PS$-8YT(@3HYL4:@>.V6>.K-%X>4NN@8F,+#D>Q$O]AEF.1'%<K
M&6WKIN-%A$\B2\J#&W^#E!$FVZ?;#XX;)Q1>#A0%%_8+T4/9<;\F#KAG=6K9
M&1EJ;#Y.=VH8[(ZS%XQFR1C/6#5+GD'=;&F</42)<?Q @Q_@H"33L%OW7-Y(
M!@8_2 (+M+UA^,H22P\3T9D5Y9E*MW+X</PH0U2$EG":=V67D#1'HDT1)GX,
MCS$^F L!A$!I'*NH-D-@-;3LEF[P"&N5BZZ&N7*85;,-53]*R:O/.U!NHC'N
MP?/HLE_Q&,4?DY/%JVUSBG4.G:XS^1)57]2_Y4P9*JLN/P"1 FRV(&$3HS)A
M5NMEV0G1$7FSG H,@$02ABY4T7+=*CL'9;<JN&Z1@T.1&:7B^D_)V8NSHE6
MP:U(%(U[A; K<Q7AS8Z?O,K/N9<[I+X+?-E2>GL;+QF.?Y"^9P%BCYCV9X%
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MKG\HL'6-)I;G1#F-TG8KS2L^LV+\;P=L+_X<6?;[%?!3IP%]Z"*VS,2R#2D
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MCR4J;M=J:BVHJNO4:H#HQW"-)'#4KI C%&_E868XA58.T(CP[3CD:C7&EO&
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M7@5**9\N?_KR-.9M%TGE YD[RLF7NP0Q\KB-E%B@XPNS_DDHE0U1.8HR SU
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MJ-L.Z*8\?B3:7SC@0>X'C:3X:WJ1TR#U,(OV8 @+P/=,6:I&%K;&SM*)*98
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M>7&%<6R%SNQ,!BV(8#9@V%0D,F:0P'3V0&@\)32"H66KLT<H0WDI2+,?3'0
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MZ#"VU@@:!\-Z(=XUJ_),8%:=.#Z&>A.B\Z&U"?, @1#6#\FMF0J78NA&)2N
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MY@T8R\>4WGQ'G^ DK6="K,0":VKPJ':ZHNEU!:_"7;VWSL#_U1F2N  YY5(
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M#079 ])[0N9XV?W'OSWZXM$#[ONWD.=L^O7&]SV(I8\Z=J$U#^'-O:D,9%N
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M%0^2J&TJ.\G=@J>-Y6;)B34DHKC=72,=/N+=B)1IP7U!0F9'@57\LCDI6RU
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M[PS-.J*R^Q=%"Z6I6AG3W.1>8?[FFY:IGY'N3!742 *%"T)Z:7"F' />Q8[
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M@&OZ$$@8=V$T"\G9 M''2I:4I>M&9!.6(269Y3*^!>".NC$M78(\Q)Y&'O#
ME8(T5$MVKRIR<A=HM&@S2N&5^P&[$^%IC-"A[YW=0(7!/?/BXN[BIL'*#+Q-
M/B VP)6T?A46D,=I$?)4%1LTCQ)J1 KJ&ID,43O3V%/$%EEU>NY&-#]S&-C$
MN"8&F3%R&X2YY9>7M#R6,9FD-,F^>0"":L[3L!S:*8R@A#Q.P[%+1!7%L] W
M/[B[F =WA8B&T@NU+OD#I=P,9$V1/Z.0C"L1Z+ J3G@M@A!*'H)$L:'(( <!
M IEF^4TDK=S^*E/CTW94%; ZP@JXO[1?JP-,+ZS380H)6M/VA,N8D2S;U@J/
M!2J!.CJ+Q%%Y\8"[Q*0L(+G:)VPM,P'R?@EGGBX?)E0>HW;:+&PM[*5NV((F
MTFI]G?/4<+&\VX<5$QH(*/PZ"SPW$#E#&S8G<0F>YU+*XT1PD92]'BX4SN1S
M1,V^JX6GMM$O(Q!'ZXOF9J.G]@$6=A+S*5V\U& (VY>EEQ3W*RHBRF69R;R#
M;)S-$_X_E ]M$1L-R!S\.Z?L=CPLID(H D!Y_B3:OR*T2HF MIO$:G/7\2T*
MQ6."- &O6A(L]'8ID4^]9^4U*27$8D(.VAM*,$PSY16)G3"H"PZ[X[2L;ZI;
M(I4\&S'+(*K Z/G!PG5:>>\%;\/5]2$&00-Y[W*?9PA7A%=2*&1].]GS,$UT
MS_'?:I2WBH!"Y;DK>T[ T6G!0E$&B\(G#N>)1!/3T6?NLA1Z<<$M I5TGJ9P
M+B;Z*0![/?&P)?99G15*?*LE*&.EN:/;(6''5KM5SCTL]2HC]]4WMLDCA[O"
M:/<0:L^NX,WY*^!R/)!L9E+.*](4! _(0,]"O426RG.W\.QJ8S2_SG.^"XFX
M.'BM+E]97AL]0&>H4F)3Y:7G#[[-,[K;3)/$_"2<?;JL *-)%R#2.*41-<2F
M\5G:'LQB*Y?O*=W<?(XQ8M&HE$6);$NG^RRON$ KAO@8[M1EH031%HG+)- J
MNTA[.)$QQXUME.?&D>)Z+O?U@ZX\?LH@)?&;JQ)0"7ZJLK%3N"4*!XI$1<^3
M7[[%$OQ\GU14(1#/^BK] Z.D-W@6U:Y+*/=4!4S%^V!1/)<JM6F\BB2!"ZX.
M7HS6K,(HZ?*0*VA/TH.@*@)6W=!-E5QZ_=992[I$<Q6)PF*=#:6P6&7+6R@^
MCB0)HRC3E:9:A[&1$<T)OP^D84YWPO=K2YHC77A7@@I^=ND^Y3-&=U=DX5M8
M)(;&%B10W#+>,<PA38F(8&OQ,H.!2,LR\*!!=!7OQ40<0[Y(5/FI9G K$-GM
MJF(W73&II)10%L)1XD(UD,V6;?VFE0(4HL*X<U!I<'JDTYPCW..T"'N*U" 8
M?6,WFMWK_J@VNL=;QA__/@E?_FAN]=);O:ZYU:M!7T[P5J_JT1J-]O42NA;,
M9I24N)B ]64PMG!9ATC!EAZC&*!^11>M&USS(IW6)]^Z6H:N9W5:5#8FH8@Q
M[T[5-ZX?[G/YZPOK^:]7UV^O_K]7UKN//[UYH0XX\\";"E0"3(F!G>&MRR8<
M?1"$-\CSO!%$XYV>/4T9Q&GJK4=@J#$"-_&+)1X'IZHQ#98\Q^B3-B(R>=-Q
MN**<@8 4$&T!CU\Q^WXQ0SP"S76B&"65":D+9=>GN"-\65!(4"*U(@S&LS=%
M^Z-DD?FL$KL[K7+PIWIEOXQ:2!XV-;OY$J,TJ4?APLK,0C%-;J@@UX@Q*[ML
MRZ*XX(O'BF\>1T!YS@2#!GMY%E05.[6+[DENV=6)D?+98">G\H%LNCB+!?Y=
M^96+[LVOFTL]C5&CI2,B#*2003FBK-"5(L/RR(4\8$ S:;Q"'G7!5YI+I%=.
MI9>6(+FY<9T"'MJ$^W L5F<5JC]0N*1Q>@F?YARIR:J#?=MHS53I0THXW%Q^
M&UAX%,L"JJMV\ZPMK0-'E4@Q1(K4D8S$VQ/IO%ET*XOY-._D_D=V\Q2E%!GY
M\C.LW:%SC;B?KC)-=,Q0\R3S#W.'3&%;1%8F@GN 5-UGY3RR"BC%J8(U\OF=
M=W]!;Z0,0B6/:=EQ+@R -^^RBB8S]FC6_+1^4*V:>H$V&'TL^HJ7G0]U)J$T
MFIJ=60OQ'G'B]U3--_7PEGF)S!U( 7#3X06$(I<0<##:T4 3-@)?$1/%Q=V8
M>DK&[>1L"9 @NJ-1\;KLV/Y .!>;+=Q4ZSM>B09L'>1;<R*KB^50K,I3-V*1
MH/Z\8WJ5[MH(04:'@H60JU2UI1D5*AT 6TW4MIPB*XE-L'E6IF02M^#=Y2R,
MY^!.?.,Y$E[:@)&%5W=>>('S5ZZ.!NLK\PTP+TVDQ^1@9U_0\K94^8LL\G'
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M:-N/N"1+[_?OT(@+C,?)?7'/R-&7R9J+U*8*-@[YA,0.QCP9E;(OJ5,D-(N
MDBM/=RF MA3 7&CC>"MR'.^MZY0U#5_[.4_KK-9;OBM74T)O*MTHTO<A5_)-
M2'O$VVQ+R-Z(S38O8Z[ =BL*X39#/675&G'B?+O #"Z-+J>ED]RF:/\B)0[S
MQU-@>%7,D>;+J^PQJ7 "6TX@5@FB'I&GIX-2"A1!DB@/Y(V2HA2KSQUHH$Q%
MP@V;67ZRF(B4[Y)<I +<I48"16*>H0QIF%KI.#'!38WT10J^EO*$P=BTD<OT
MP-RL*U)&G3]!\!V(#+8"\&*.7<%&=TC-W4J*F4K2VU"#H.,3">L-RI<6+TQ%
M%Y5/N09,15(,YXLEUZ7S%=+-"L63ZDT:CEMA5'8NV9'REGW,@O,#!(=+0@(E
ME2B&0@S@0SHDX,JJN8-!IAG!9-775<FF%0<2:$FF=R+2F28QP6R&1!7EC< C
M1/LG5 NM7"O/A;!VK"IY=TJPBQ520AL(ZO<IET2K?(F4Z%CL)2VQ&VNIAK0?
M.UD56:8]3$!<NU3]B4E[\+<?NG9_U$G3U-+$V:O8NN9+V!C -H@[JEY;(:+=
M82'P%+?TSG"D/TJ](- 0,'RW!,(HLU33W$R]IE@W-*HD@XNT25%NG#O'22@]
M0:DL<XPU6JMTN\(L45Q[6&)WBCA2F-FZ!D[B#L]/KLS43!^0_DK[LJL&I_?T
MA_&XJYPB\305CBP66&.G]P<'_L.XO?)=$/\9)Z0T_>L9JF'(EPGL,%1&0&"_
MWUW,?08A_V'0SIJ3+H-Z<QPXWU3=U$K-5'/<+9+\=\@O"-, 0B-3?\' T&K-
M& $KR_LOPL%"$R38?A%A5T7#U<V8-+FZ38!)2Q&U<@#_(H_Y-_O:MJ:8WAA:
ME.WL4%F)K FB-\T\K*!%"YF>X"=@IGRB*T8D'K2;*HG3NI*J"ON0UK;F3ZLZ
MF6+T7B4<BQQ@6(;$G[';0#"9SS9<!FK XL(@2E==BH?0< +Z HM!.W^Q,94>
M+5N /OE4Y"(<!]JKU(:DTKCS3@.JN4_41:BU >U*!6<B+3_7Z2:+"&:499_/
M_5NXWU-_6<"%TBI, D)93VLL$3<[<[DT-%Z%E* ZGIMD:\,,9[.:S8<^HPW3
M,D2I0&M*2(AK2RF0DDK,K%!("4S'5J;GPH<310AK""=9-\J@Z@C-+1*.3UH-
MH#0H99(LSG5>[<B9*V@BL>*0J&.9$/AR8CVQ-0J9@@_L3S/S@0CJ4H"$XKD1
MN>5WJ+N>RV^Y5$(0#3].JSS22?$?'+)>M"$V+#E?JHTY]Y9I1;[<"(,P/>QI
MJI$-8 U('FVR^N)IY1&T$Z=#%#L.EN-)/\VVBGD$Z3">/WO_[U^?O=#!=I65
MRIB65:F.PM?$@^*LN#CH'PA'A<IN_8A6:+F21T>[7A+QK>:9X=>XPD$@?5PS
M%=0\;(5X=HY7-3IM%Q[!"Q8J-IM0[0]%9Z0M*]@?K-WV,DE=J7.RDA2&69AT
M^=P#,IZ"5K$P0U5AT_\D5&_)%ABU3@WR2CHTO5E9-M41<+O02Y[P%"E96KE,
M2EM46P4SRK!:1I0*TD1EU2ZI'-.1UD%V7Y0R\CMI0\OPGY$&>$G==2C*+J)!
ML#.X2PPF/W_V\]75YV<O[ S0\^'EEB$)I9DX,;+"!WM.8\,Y4P<9"1B-69=N
MC'!X"BY#1.9A=44-L(#5=>6\IT5LZLN@^KI*R9=OF 0<V985.88^-;\A]=KF
MFK$&?3DY:+#R:K2=,87K5%*GHL#7(BI;I?N#6@4YON9*V2*J$(3',U#R]/""
MEGN5:*52U5NG<XR"MK$]$.9FVX*VSM >C]=_O&M!V] >C78KD]O\V; W,GUM
M2%\O[7Y_MU:?OJ\CZ&M3YA4TMK^;QIIYW=S78:<Y\]KI5&NU8FUOQ4SEPR2"
M7E;* RTO7SFS,3VN!ML,_T2'WQG4K02_. /E%?B4XG(;V92[<^83T5$3T<Y-
M1!,->-D8-T4DGG\4%XUT0A9W5M%*841]X29&E67]R4Q=+8>_%PUO[O#;^QW^
M-G4^]9Z;KY@A0@%J :M889XJ#?ZL)O%=%%/NQI0F\OV_Z9\/= MJYG.'^7S_
M[U^MRN)XEC-DU-:H;>WF<XW:-A?59%SI*+DY%?\YV[7,>,=:ZZ<[>E0L(O[A
M<..O=_5TO]5K7^Z&_'+(0O)-MNA1_2D:.R/GYR+GG7;'R+F1\Q.7\UYK,!Z>
ML9SO "AS,G@Q [M=OY6O*R2,$;L]PA1='N[\8$3.B%P):'(-SRQ&[$Y=[#I]
ML\,:N3L&.&_/B)T1NR<W=QU[9.1N5>Z:B^Z\]67!QY0B,+LN.#-\YVYKT-O6
M_.X'Y7DK(U=XY4YVK,F+U.]M"V!O%NGI%VG0-XM4[T7JV]M>DYPVI+V1CY5H
MGV'2,;*QY@)BVZLG(Q_G)!_/V_;8V XC&Z7!!OLXKJ&1CV;(QWG2+)UZ7NH:
M .B2A-1M K$-%.]NJ[UK?MH14G/V$2UOX")U6I?='2^>S2(]W2(-+G>\MC"+
M]%2+-+8'AF[4R,=Z;V]@M[?.*3.R<1:RT>D;XV$$9). # R9M1&0C7=<1CZ,
M?&Q,?-HQS[/Q G+JN4T$2K""Z+IM7/' 5-0-+J?;_P356WLN6Y?]'1,FCLK4
MO<^;!Z,M1ENJ:DMO:+3%:(O1EBHS,VH->]M&LD]-6[:YU3ZPYM1/0 9;UV?4
M03R.?\@QLODD^1K]K?,UC%P:N3RT"[IK?KN132.;!Y[Q[6_%C6P:V7RB!#4C
MFT8V:SKCHZVO:XQLII<]+XE6[L=5UCJ=F>^BT[,S9KX'V$+EO%Q@J.E5KV,7
M:?XNQ-^>?@HZ SR89+G%3__ZU[FYZ;;M/JGY9YV<5_'KWO$0^7,=%L6"PWGF
M<2=&BMH%1V[IF(>".582KC-'H/D2$>R[Q02^S-;3P.H+TKFLNK1KGGKJ-42J
MQLV0QDC(*-FL(W7-9X$-N(.Y<7UB25<SRM%.A(%_DS*_(Y4[4HU \W,.TRR(
M>6]9A.3-(?PYY(K</647I]5:,E3U1)#^3D/HE"](G!=+'KM(EFO=,!>Z-Y,D
MV,NYI"N&/W+); R+"<\AG[UZ/[U^YB71/'VM;;UW([S"O.?0(SD<24\)XXOS
M$U0&XT!35#('Z1S)V5AZS*%'!?N*&RVY3ZS2D4C6;XE1TRB"V2SB,0Z9(?5Y
M1F"?)P'/^*BI]T+NU41.N,]G+O9H%@8+:!RD;>$Z%T0W#'^%WV@ZB%]]ED0X
MOF6R6(I%@M?#W%B?$I@TY[^)*XB'L>>?6<ABEI88*"%@7A0@)W4<NI,$VR=5
M*\I+U?F$5Z-LKBEKR FEG.\'91/[YL(WIM8<-$ ?/C&,PQ==SQ-THFE79(_Q
M@0O9\(*%WV!NZ,&)"WIZXSH@HLF-$F[' 36+3MY@@'H+@MK-UJ%CW2$3N3L5
M1-W,6B?+2-R2V@ DH"=L?O'4FT^_?WA[T1F7";&#G53*HTR&7+???)+_ZS@E
M8W\S=WVF.-5UU5G7<-8/E)*';>6*/>D\K 5KFEJU*069=8(0:9IG'-GE80I<
MW_$2W!4%?;GV[6H&F$C9/0__S1MRK:7H'E_&(TDECR\C\Y(ND5  ,3 ^@T?0
MCGRHKODMRPM@#\A983F-:C8VVD1=C@HF4!GBXEKGS)]%GFID5[8_&\2>^]A!
M$F&'@1BY\;W%O\/[(VUV:$GPV_H^ITQ5^<*#L;I :T5R>NLZ/-T]LTG"^;Z%
MW03G9.7[^ :0..J&;LB@'67 6M2O )K!_>$_Z 3A9).E6V_<\IS:-2*E+A@M
M*Q#\X#"WH#7!@@LS%4GBZJ@R!_4J2P<,\&E9J>%$8K=WHZ7N7]K]=F_OM*F=
MOMT=[Y^3N&./![NQW)Y69\<GRTA[9H2&U<D[3Y+1KSIEYWD/?RNBTGV5LA\U
MO/;0;FU8E@XU_GJ'7;NM;F?'FK7:)&H9]ADCYP\6SK3&ET;.C9R?OIP/1W65
M<^EGJ8ZH?HL0QKYOHRNTL3<.4M/)K3MY(CXWM?C*C>%M3@7MO%X7*V.1]5<\
M<3]4_M?\\M8M9ZP[V#HKLM8%KUL.W]1([T6(>KO211@A,D*DA*ACCXT05<K/
MTF]TX'7YS*)1U0OZ#3=?Q[FOIVNODOOZOT6K&[K*ELA?0[J+91C<\BE>;481
M7A3/W-@2 Z7;07%3F[7&OV-."Z?$D?)7B'O19>A"*VXNMV?3RRK?-^8SYHKK
M<''$A<#KXN[P]9$RYJ +^;E!["><BTWY')CU LM;MOA*7L35.RP:Y<K1^F9K
MF[^+%A>K:%C6+J;L[:B+*QF(C*-7=$D/0I)==N(-E_:4O"IM9X^P"67PK'^D
M[,[V&$+1Z^3G0O_O/#UY+MD-OYB$G'V[8#/H["OFW;'[Z-G+O": &N@36!S[
MVA'.9H>3N0U7=W]GM>F+-0=1_<>SO[CL<C2=C'F_/>U>]B_'[0G\-AYV'=;M
M]:8.Z_QOIPTJ0Y?[</IY V_$=+Z_OV0_EJWCNDQ>6I[ZV*7QJ-VMDUWJ#W$R
MWJ?I/3(_R5JXWX69D78IS2ZE=+Y;YB7\ IH"<Z,RFC:F6LE4'MS&JJ0E5<]Y
M,6N][5K_0FX$M)W,F!,GF& &.TL4KR29R;PH3.F5[@*M%/R$^4F1S('B_ISY
MCMQVP*-U'9?[#B;54O*4=%=@87,9;UD^F<CXBV3:;(CI4C+Y"D;B6TX2AM0>
M)8M[U-3KLMS=&@O,@QA/-9672SK5_5,8@)#=@=# AHA9;K1"(3TJ9 <6U_(#
MWV'1')875P37U0U)8IPY+ $9\1\&?; LE$2"-0(8&:34Y;O0C;DU#>Z$"7%8
M&-ZC')*=H9QV./\P,# S]SNF).(;\@(EWD$6ZH=1=_4ERH?"_#L>Q>Z"<A%G
M"2@ E^*/YFZ;)'3H1>"XU Y9RA"^-75SN9B62GJ$,5YYF#9YD.4=4K'*P^N[
MXN6A4EQ0C<S*"9-%7+@.7S\>3R2?_5C(EF\5G&!]V0?#=-GE\<><9&IYDNFL
MGF3:CSG)'-_"-]PEN*I<)Y!E@M_G:@9<WX$C4P2_>/R6>Z20>1<#W(=PSME4
M&MMXSN*T5BRX\6$(4^5!RHJR"7=8$I'YQ[^NE"6T8$^BA&EHR\>4;XI7_2FE
MBJ3M%E8\".]%=O4/W7ZV^T"C/H]3^U'8)]K;V9D6;2O&_C^%_<?$<2Q^FKJ1
MDT0H<6P"LO7:6(=3.S"8)3W8DN+VK1?UY YAFXY>+3*J42PJ*\'\1?"HY\Z4
MMYQ5L:"$6!&[%4%IL#MD<4"!YQ7/$YEOKV(2_TW -L7W>4.;!<$MX^T=R-N[
MAH7 =<1E8M,%+&<4A[2>:O[)+./&C1%>)@Y[A9HR<=\A+C%6(]FK)55J"XU%
MH2N>_M0I,!+]:5E4=.QI4E?H'1:7WX+L\37UOBJX-7>7R]2L@2CM9<#B]F4&
MBK/9WYW"$5>6%RLW"ELHMM9:[?=#PQ=6>O7E:RKV2&7E7)/E7D!?X'Q,I76.
MJ-U#F[\,< )DEU?<,G/H.I0:?N$19R&L&R[X%/WL8$GK5$4F,^5;?YVTJH2%
M<DORVH,DAMU";N"QNR#O?J:V>0LK[;'OH$:/[K"4\_7'QM4>BU+=Q<*E/4K4
MQ:_I13P/@^1FKA6 PA:4;F^(:1!0<VFM:;J+V:M[S<9KZZ>_J%\I;R'!_L6=
M<>N:'"YXC<PX:UYYZ5<]+F!%R0(MZ9_0?GY\J2B!Q0S"&P:'3'(:P.'  %[E
MJM,FU9AVQO:HM_\:T^'.K6[^;&CZ:OIZ@+Z.['Y[_:?UZFN3YK5)?1T=J*_C
MX? @\WJZA>;E68/E"9-G-J;'%5";X9_H\#N#QM;/=ZU;.!_M"T>@P1/141.Q
M%:+ KN*^_U-F%9G?E'.8UX8G7X/=D4Q$5F'M$2U&YXUG4GGXIXEG4GGX[?T.
M?YM*X'K/#9$J4KSNS9SY-RLP)[L._JPF\9W*I:.)?/]O^N<#72>:^=QA/M__
M^U>KLCB>Y0P9M35J6[OY7*.VC48RJ$9-_ &6XB:D)+>W+KOQ Y L)TN5-MAA
MAQK_T8N$-Y/5MSHGCZED )7.7,@'K6[7"+D1\I,6\EYKT.N>N)!7\ELK@)F<
M&D75\\[8'E?G0WV"93_&+#P*(^=X,M=(@>O:W?W)FQ$V(VP;K=O('AEI,]+V
M-"?BT:X884;BC,3MY+G;ET;@C, ]H8GK[PK(>L(2M_4=0 %[N0%W #^Y022+
M+G8")2X9<4,DOM/JC;;=U<O7]Z#QCSW2=#=SD=H[TL";17JZ1>KT>V:1ZKU(
M@ZVQLO>S1,??Q8U\5(JH].Q>]8"*D8USDHVQW3:VP\C'>@>@;V][S6@$Y)P$
MI+=U<,'(QSG)1Z=SM@)R!GFFE/:]!N!CQVBCA.3HP8I/@P0!/BCB:!*7]C,[
M]5:@06LP[#\J6/W8"7JBI*='YN\9)3EC)1FV!KUM3VU&28R2G)62]!]-J]MP
M)=GAOKM\Q(_7F?I)QW,DTM@UR6P/T]3(\XP1S"=)M>T;N31R6;<9?]XQ@FD$
MLX8SWAOORA1MA-,(YZ&%TQX:V32R6<L9[PT?F19\KL)9SJ1>B2#]_-B=N_FY
M,.S.)\KNG,?37R$FZ-K'Y25X  ^'F =2JL24H4#CB5.$*A>!C^0P61LQ\I8B
MUX9@R?OIK?4[=#,.0L,IMR6GW&<OB5IF G>?P*OXXI_!0C UPS1^9-_-%&XY
MA8H27;'Q$+-DIZ.H)5N"'%,P]K BB5-J-XBW*4J<>6H==#IV B'&ACOV>#"T
M)J)IV]K:3LW<")E>[SD+16\S:I4\A13LE-QR8+C$#,NFP3*6;)M(I#,) S9%
M[C<>+5UX=Q#>(VV4I+ B/L#O2Z21FEJX3OB8ZT=QF BZN3M.OS+/@R],!1&A
MX MEWS3>4?J3)*-"@SICCNNY,0RU8%OEE-G6]A.2CI^X*#/VH90JR(J8)_A"
M<>#1DCL@/3ZR*"HVZ72A)/\7(Q)2$%>B0@1O&/H& L FZ=+"EY8AOTC')H8L
MEE,KP:*>_BTJ<C?I+&S3$+3$1UX<F-T FE[3;W"4;FCJ<7VTI4 :0,=+IK0=
MT??0]X,I]5CB.W-B4I*D2]I3MO66+R2YN]C""IW6IE<^G7;@3B.-SU//9NQ-
MNKC%Q'"H-<DOD!4*J::L)5@)Z,*B,E-9K1R,? J4)%_^6[3*/E?&J,PJ,_U&
M8"V)UY'659]P)7\7RFD!1Q"[2F\&MVQ.$P^K_65% ..*>D8]$#2OF:228!I'
MZ:D=);/)/WJ3!U60YKQ$2N7&M8UV9"8/U$!2[1+!-C7A@$46FR>9 ;6UTI.%
M[1KY]4!]4Z.\=J\*0K"8X#RT+); L8OZ-_&"8&HYB1<31R2V\>'MRZOKK^G0
M(M7M[?:H3K&;<I/2.JJ[!?BW;*.*:,N$UWJ2[0T^@P[Z8K)\,/O@F,B=LWG,
M=Z7&7W$F$].N@WXYF<](<N1%E8GN5C%V89A/2WTW'MN7@K5I6^:[0<>&K7[O
MS$P=L##C7:FB-KVRU^Z:SHZK$70UD?1JOYPDM>>CJ,X/=))T'-59@<Y[^%MQ
M(=6[;J7BE4ZU+=O@I!]J_/6^\.NT1IW'9=C7)CUX)ZPL(^?G(>?=5F^\;VPP
M(^=&SNLFYYU6?VNLJ:>2<^EM%5)$.B*:L>\:\PIM[(U&R'1RZTZ>B.=-+;YR
M8WB;4T$[K]<%S%AD_17/W=7JR[?)]JMGOMZ6\]9K[YKZ7,\<O"V'?_24T=,0
MHN&N.<I&B(P0999HQ^/R"0I1>7YPV>4.9@&+\5_@-OVJ.TJOL!Y()-YP%=:Y
MK&4BQ,KF7I[Y(E*K0%2B"'-Q9FYLB;'2A2+>C,+'65O\^Y+[$:=[-68M,9'$
MC]D-W;,J/\&V/I6_NZ.E8,C[VNG:5Z^\$]^&^2H,!EKYSC*WW+WBTET<<>TP
M):<[/ PQ?+7TY=S<=/HBH6>M2*4I1.LE1DE8/DMO;18.7L>+NUDT2#NM*.6E
MUV=%QZ-VMTXKVA^J)97)2;A$I=E_6=Y4?O$HBS!T@_ "M,\-IBU4_#ON>?BO
MM XAN[,P%R)TF4AAG(74)V@JBJ/7%C07PT<>9O3-(AZ#V5F[V+5<W4[WZ*L+
M75BSNE=K<]FRM:.,5;6 (KE-2X9;@A9_)QYD6*(?QCV5?(LVG7\'$R"22P*L
M@>$QRA"("F6MIKO!VGPT)5[I,SD!RGHN,NNR/&!*>)$)/D$2J>U"I8S^A\LO
M8ZH.S&LR@Z=%*JS,<W5YU,+1.[RE<DQA7-];F#<#<^I;3A*&8."@BR$LB2>2
M9'"<S HP=0,63B7@B-Z :P*#S38ULP<=;P^2EF?-)E3(T^ZL;DAMLR$=<4.Z
M6E%\3%+5M%0H7-5$0'!VUV;%I@9(Y?_IV>5ZRE^,\I0FHY.<2"$3RPW[F&4D
MXBDDHL(FIB5H)WYY/CS8Z)"S"'[)2B+R&P6*P9RSJ7!3X$4L%M4F*"(W/@QI
MJM)1Y5LGW&&)R"G%OZ8RIE+!6^ *D1Q!6[#!L"4=:/^4=H=LD]P%7QM1.J2W
MFPE%YEG HCVX]2L# :NO*BCVX!V1R^,'Y&M-0.K6.P[G5Z[<,^7*->C+DY4K
M&Y=X1Y?X&DY,RHUA4Q!U-XI#,@MI>&Q#1"X7^Y-NS<8@C2S&HSH*,I:Q//_K
M@80LWK=;[\IO&:%E$=FF+F&'1<!IHP^O]5=M_'H/5?RQ51:+4!,"/;Z5-9C"
M&RR,1+@)J]U0)^I"M09^G4ZPS/7IV+J 7E&)"/>%ET(=C)8!3H_L?(E+L1IO
MB>;N<HG3+7J$'8[D HB_J&@KBZ+ <<DEIMZN.,5998HYRQY(<;^H&DY<IBFZ
MHL&2Q*&*VFKJNCZVVMI=;ZU']4Z*F=#638JZIH?;:RI.,,HK'.[1S8IB4?JD
M!37+BJXJRO81;K=6\L-)DO',&Z(3*48JLS6:5Z7U50^G6%&R0!'X$]HO##"K
MHH>U#F^8+TO6X",\WC>L;JLS'.Y2M]6YM-N#\=ZKBT9VIS?8>R54VQ[VU[_3
M]-7TU?35]/5,^MJOUI\F%F^69]^4)QZ=V9@>5Y1HAG^BP^\,&EN3VK5NX;"T
MK]K<!D]$1TW$5E6ZNXK[ILCTX61^4V ZKPU/O@:[HP.(T'/MJ\1'YXT14'GX
MIXD14'GX[?T.?YNZNGK/#7%@4KKVFSGS;U9  W8=_%E-XKLHIDOM*4WD^W_3
M/Q_HKMS,YP[S^?[?OUJ5Q?$L9\BHK5';VLWG&K5]HKI@F,!]#[L:C?1U$M[P
M\+XH,@\-S\ SG X\@X';,7)^^G+>'3^.$,K(N9'S)LAYIWO.L%+;U/^?&JW8
MY:Y( *=-&F;$[K"S_;QC]W:EIS4B9T1NA]D>VSUCZ8S8/;ES-7@DX;&1.R-W
MN\B=,7=&[(X@=GV[;^1N#<K8-E<"!6#3NE\)?(:GEG,>,B]7G[$3Z&?)T)LB
M_:W18+RE^)<O]$&#)55!<T]VD3K;AKO,(CWY(@W,(M5]D;KVY5&6Z/C;N9&/
M2E&^KMVN'N4SLG%.LM$WML/(QR8'H&=WC8 8 5D[9[VM;RZ-?)R3?'3:9VM
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M\J*ZK^LG>F;UC=$Q1N<TQ:[3V[7RT,B=D3NSV9G5-U;'$+AO!QKH,U&^N!,
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M7C^A;]QT^9"E1".\Q@R8D61E7'#ZJ5B(J5+#L2RB'I(XM)]LUS/&(D^#,&:
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M @,-@W#H*HVJ!^I5WPX](Y(:%G+Q3\-!6*E<J\LT>JKK*G#H:-%K'/4C*OL
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M5T^+''6-"K>Z-#QZF#W8&?SJ]8#5U]C)_4&Z/L1M_""W<0, W<8L@[VC\M?
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M9NA!9;N_UMP+KP4[?: *U$W-4K]IEOJ[Y/9_#]1>Z_526A1B>I62*;\ HN5
M#_#RC\AQ0)S&_V/CZ:_&'WE>_$^I5@7T^.(\0Z_&<U+5@!GILC_HD_WKBYYQ
ME.?) NX0/D$0^?*6Z@YY@;J#UOYM-H-#6[U$74G?5M>U*H OL2HV+@Y>+I^[
M]W+A0=#WA6/]NN7"G@5W^ELO:G7ZUL#=?JFLWW>LF]7N=H.]>K";58UO6(3\
MH'4G[<K2=9ADJU(+'L.<MC&SW:L$EJ=$MV'[LF%T2,N4BB5TVB=4PDXJR-.J
M89=:V"\WRGJ[V63WB(NW6RW:K>ENK.EMGG']05Y/#]L8M_3A1,9'$>K\JPIU
M'EY6;-8=]O=VR&VX?Z]>O>IV:W]VB[''":IT0VJ];WSHAY.SKVMG^1_H+.]4
MM&U->0?)_,#<A,N[_=W7_?UC._M[1R;%#B[86^<Z8G]O[.WW\]DHS[]U"MC>
M$.)'BO9T&_9X-^S1Z<PK5F!UG>)U:MU6UG(\9,3[W<3X]WS"9?%&PX==Q:/+
MU0%I=5T5;IY/3S$C0]0W+.=R5SC5:(V)!!OXR^VWWDKY._.I2,]X=5A]OY3V
M4C\0] +QO#],5Q83G&>8KTLIVN*PH$J%>5%%\\7U5+1V3DD^8K_[E!&#>1_:
MLFP2:]]X\J]>R;F_>F7>>K#OZK1I-4Q6EL [\+RY3%E@:Y<N3XVW3M^X.NMA
MPPR']?D%(A5A/HG/V.04ZWGR\93APM#C]:GJSS#D[?;ZA)JG5[7H=E6+.S"6
MNZM:W/43X_?\@NOR@JJ@*^[%BO#\8D*RL%0)A&N%"Y8&S,[P<<WOL>8BF\"7
M#+,0Z0D"F*U*=:1,S8B/,G[.1?W)*3#\I*[+EH_JT3=UEI_(S:3"A&D^RF+*
M9<1+1%G[ H6KJ/"8<:VB#><E\B,G9KR(L:9@U(,+<YCH] P_C18&;!XORBS-
M0*Y-&)75M3(H9>+D13X?)3(?ODJLT\I?M.)"?/$HGYR*3RJ5%"[ )]"(..+7
M%7""P-&E!#O0YHC'>)Y,8%QX&=4R4D:PGKTF6J%D)970,4REQ),"1#TE$&,A
MW1PK>OAHA%N%L %:H_9^=0#$0(41KPZR^?0"SPJX TF!_L9*O<E")-1&BZ51
M9*E1SN'L:GX+C%>7%\59$<_'I:P0A(<66-!(=\$!1\?*WA7WH30H6#R;PY:^
MC^!L$:62^U<0_&ZR.GM8T3U1/9V:P-98BB8G+@2&7AM&>YV+M<"B*R3",?O&
M07%9B"MD/6HZ1P9##8B2O(E@F_ ,>;VB,N%8-0_N21@KY"T2,41-IWP]BD-I
M#'J(Y$#-?@(L6RNG'+.A^6C1>W!\A_LF\\N)&J4#UB@<Q#&63>-V_"%%[=Z9
M1R>-BC3,1Y^#>IUC5;+:%E$1 '(J+K+I3+4OH".E7@!UUC0I0"2FWS?Y&%3,
M.2U$.:NL%-EL +*<J]2/41C]'%@(+$6JP1>O!2-D/I:K(>JTTY2*0JGJ$90!
M0EVELGI:+I&YWVO"R\!YPB=S^40J5J<#E(HLX$1B<N6K(@&J\,AIP7%@JAH
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MU/$(W@2UP8D\H\5/!MI2I8$:G##6))&)PK*J%@WLFVHB99D#=<V4PTH5O#7
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M> WO6F6&J"%@0+*5OGE:L#$<-RIE\(CR4PLZR\3?6?*BNK^";A6>'&&F*??
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MXUSA=[B)?W1W=O/D,DML\^6L+5<Z6@3+O"DFY4PZ>]AX^JOQ&0[74^/WW_]
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MHV*N2B!T9%.YOEKV&E[QYKM :=0Y53V2YK2?(KU.NJLW=G.A3O/&6%FI_ZJ
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MR$I>KPTJD)7'2WA<,0XD,=_/,(FR( VPY+.9 *51QK)00F&*I[2)=?,G@M-
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MN$LUKE+(0ZNQI>HV/EM=[*7)7*_.?R<(]N$1G*Z <6L$! CWZ'%AM75@3I>
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M=[HUG#HG6VP\+18LY2B1/J]:*10ZG5+95H*![ID,?,5C)FLT!(RM+#D9U4=
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MN+%Z;NANZ;C9(:VYX^<[,X@[?KX7?FZ;R*$[2*-@&)J1ZUNF-W ],TB=@1D
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M@.3: 7=]RP3-"O2KR(_-P&&6:3'+=P?VD%N,'-'AMAS1NP$9?TL7=2?0GJ!
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ML7W3ZJ)'(:L>.+&]DUHWEEJG2S:?%7NQD]H#T_>]H>D-K=@,W7A@QM: .T'
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MBJ$K)LTF;!)G; 1#DNTMR[V;GC]LCEC_+XZ>Y"(+ADD4<L]*G, +0BN"3^'
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M,D%'1&1R7#(N"8D9UX0T92MOFW+<=LVB*I*)G!TUT1;Z.80J-*Y45#OP2]Z
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M,#6CP'HML%[NHRR<P-YBQ&R*B$M&D:7PDW+"2B#K0(@JL'ZBL&Z'1^Z6 "]
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M$GW4*S;CY/8O\MS4/">T8TM1>V[+/'6C[C4S)T?5YY>^VS!=TW=MTLQWZ@M
MR;-<P-PDHYI"U<L/S.7PHY:KEVY\]3HSA<9U^-E.S?GU'(R?N/?E;KTCN+CM
M!U>\4GF')N8^M]^C>:L1G*C>>8SS"VZT6S$BYS[;:+T;>R?32YDYAU"JT<?
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M5CO4-W%HX8^A%6V_"Y1?:H_AC59I/]NT?+O8\HOFLKDEF[?]_OE49[CUO,=
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M#IF4T_O:*61-E(C;/!$TB4AYKM01\R<*JPBOM A7H*U4JE1:RERO!Z]OO6+
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MQKHK7Y,9E)3\(GYLSNQ6CJ5.9(SBRY6#^=Q:)V:QZ<>C]F!84O*G9P[T7P[
M-RHK[T L)WA;@^C/^B!^,5N9OG-6SG+>=D<N*7<VNT>(Z*5M4BFVE[^LS!'(
ML9FS$(H%0[231B@I##<\FIB<#BX?'R5."MT$'#.*H>8'=@.<%>AJ0&N[A%+_
MA*7UFM+^ 2R[?'3+?AC/#\%>?]W9.I2$6"PD1S$&BKC!&%D@$@(>($)PG*0
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ME?(Z ,9W\KR]\KSJ6HDJ !H7E)3"@\T1F2:61@U"K47TL71.8D.K<IL8$)U
MWW;K"%%8':07UDIAX)_*&^R1':E0O)3= ;W% KWJ1'#2L5!H3PKJL!^,\\0R
M'0@M%6>.5]8%^>#1UU<WN'N,II\AU^JG2 V]!0=!Q\S<,B!;K]-2@B892Q'
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MU&'+]\.6@\._/[]C)9:RJBPVTW-$5%02H\H")J>JC -;.VKYO6WV;A-\YTW
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M*CB+2GAAK"^5,%0$QDNMI<%MP'2S#6BW#;[Q-CAQ[RBU11%D)(51F@B-T3*
M:")A+S@E2Q1*V ;5>OWE%3BH.:AU,[ -B6/++3W6RR>N^EA:5O%QG:)<V[(7
M-OB;V[;M]AEA/IBL%38.KE:)M#5UH=:;:F4A&T:CX44U(W,E3OB*OZ:2TNZ
MNTZW^2W7?$H-8W=Z_SM+F7GG^6KX;5"7A9T-:YH+,NG23UG/>UCG.M:.[U[*
MB)[7(:U[<LX+^JRD:JPOR\,5M;NYH*4M7Z/+2IT<^G!S_FS-*LZS.9FE0EJ)
M7(I\OSA+/R<B1^O*AW6)-'1F?S#]03(Z-V>Z-%Z.16XB9@2TJBBWE.B'O>,^
M5CY+7]Q\N]K 7YNPMBJ^L4+PP[D=D)P9RVUW[Y[/K#$Z5S,E_WMR<>7D35U7
M:X\J9C"'P:"I17:)T.[4;8^_MBL]Z"+4Q@HVJ ZB]$J;6!K)C'$:WMC0S9TM
MB;J"OU//R^/I$S-.OJL;\!]_OH[TCS\=?';OF,"V]#+ ,20]'$-"$UB<BE I
MJL *1R.VM^2[5[2DO\GJ1R9UZ4$1+J01/%I#"ZF-"I+[@I95E59_717M5O\6
MV:][^_+%WF-Z</(WVS^!]_GK7>5YR26W),:R(H*!B6(KV @5Z"DE; )0&"O<
M"!N:G,XWPO2B6N_- <R6U97&SV)J0-MIP=0B!#H8#8\(5D+HS=NY[Z2O#%!+
M&+2T!SP#X3O;Y6! LMAXG$H2)Q_PH?E4QXOKDL\U5*,[ZD<Z'):]S_^]XNRU
M9I#*NDR.0]B07G8IAVI;S]'-W(9"61I*90LAI;!26^ZY"T*5%JPV2>5%UUW-
M<7@^[*52)K5"ONR)7#N6EW):DO,1E-?9>*X<8W_R3P[+.C2-W.<<ZW;/PT:V
M<IGWF@ '*Y"\K8W^MM-2&/K#R6R,:YUB/"EZ<=8?UNF9BV(P.^F923EL& QY
M8#NMZI YME+[9,W1$>IRF&F1W^=;A6?;Z>GS.O=9C;\D-+&^AW>OTZ8]K?V5
M)"V-E<XN4S 9_PYB<#'3JE?U:@)50\D]P 2UOKL% O;RJ?TR? A@'B&?]DF=
M:?L:8/O)#)1_>.(A/.OWP<B]_\$G\L&3YD0^&+P]V:=P"L-)_+3 T_+@]=OC
M-Y___O3V\#'\#3[]XTUQ\/KE8/5$WN?_G.Y__@M.83B)#]WYP=YS]O;TV<G!
MX;/!/IS.;T_W/[X]<>SM'_]$.(VQ;5IPNM+&"U+8TA#!RT!4:03AJF#2!2ZD
M6:NQ!]!42E]JQ@HF%.5:&<^%%8Z;&#23#P /G#E#]M<8%*)']0I,FH.\7NF+
M26.7A2;$;K5M '[U?"S/GPH \U4AG=,&]K=27C().%Y8SV*IW7*P#(QI!%.D
M$!B?>HLD>[(Q<=&('J3$GGGZ.R L\CLQ*0VKKIW- UV^;XZ&(RPOL6@ULF2G
MY<2>Y!;)U?5QUI%@5!O_^?-4;/C88!YY;=:G$E^#5/WW][WYQ3F+]#J8]M-R
MGT7'?=Z"L73<YX[[O+W<YRN/B]7V[PRV?X46-/7":VVI$)05M-2E8W#1=G&?
MT[*,0YT!GY >K+VG0T]FD[H@Y$:/XZ*A^7$P@^FQRRRR>8%2. ?/CL\G?=B_
M^/.@'\&6=(G5A$I\P)*;B3+B8#CI))T?F_V&6W8&!L:I<6$VK9W$J<7/^:(,
M3'89U/[I%;_N#]5J_P0A=N<_M6[[USL1K0J*!5(R*XC0DA,MG"*5+60L:.6,
MI6NZ&6!]C!R^:YWPEAG-JL!+#;8V+(/5J[KM'664':;J%"A<]4:"?]WH:)CT
MI[NGEQ\N(<2XMC=R"\5Q'X;=K[UV\(:?T6]W'+*M[VIYJ2-[=36TT6 UA@F'
MXJ+!RZ3E*TPDRLEQK62GRDNY'";JXPTU?]24BZTK9:)O<9+KL,;^HMU&777E
M:!R:NLPOYV\RF8Q<KC.4XFY-; X!;]PJU+/0]S%44X\7";.#07VBU)UTPJ=Y
M-2O0?9!$-H%S"H;C3,Z:3RZ1R=(DS3TBC><&RS=/0IUB,@RQWRI<4\]<=IRN
M3OU\VHUSX2S1>1<DMGJ\BP9\DS:[=X@=9[!P\K-6^3DLHX.!OE07-[N+EBH=
M)/=3<MCFRKD9PB>C./V(P\,J,O"%-(QY-:Z=9A_AG+5> (X(4 #/%YUKFRO2
MLJXW]9SOQE9=RPT#6I3AN_E:+^W(]EQG][3I11"S'*1.15),3OY(3N+F)=NC
MNWQB+GQ<FA&3W.<8-DW4C'O!O]W/!<F;@H@+?\8=QLE>O==J8059Z9_E#NR3
MF46&?4UI3WST7/II(;4M,<ML\%R 8V=E7XQ]"XQ1U^X=C4>31+/H@Y(W1[?P
M*6MRB;2:HA7S,N(+AS0@0NIOA@#3C&12%PT[[4_KQM*?>F8V/1[E/CS+G(^&
MQ#M)+X.8?=94*CN&_QFD.E(8=:[['>:?D0C1"'B<#6)_,)C[4^:Y-<G;[)#Z
MD(NV)>VK%P9U7:U45!RGHZ&;I#MO9?#H51@,FEE920"IB:H_,F3T96SF'RIR
M?YKSM%_RF3_'_3HNT@I^+;8T &\K0R.EHXQ=DV!BP&C-^2+IA@TC(]=I2T&:
M?.I?8#3AS5&92>U(L<K!DI0MQ'?>7'<T;ZE[5K])O6^1@(YG"BH] XP*U26R
M\RG=*%%FKD+!J0$[:3BISYUZ IK7OB"#9#$@XT]F=3.P.:0T+Q]J924]KP[%
M)&$^A0E,FM2F.G4&B_*GHRT7/)S9*0AX(\?XF#AHZ4 Y#P:K>IXV/"M,N)G"
M>3>9A$D]8_G-;,BQLW%S*N8B<S$T4(H=6T(]L[B: %6O,++5W-ZOW#SY9Q<]
M >8\M1:%";_92MU!R[:>6U)KFJZY*28G-*T#YOLI:429D95^ATD!'<"3P6BT
M6EMXI^9HI22%(5K$B;]UE ES.?6ASH7-M9JP^OMLO-!T5X?=NO=N[_%IGG^\
M^.,8.Q1@)# N);C.UVYRP>+--?SYEFIFKQG:DA**%^4FU/5!@U-0)ZM=L4W2
M)EQ=SB8_:QYJ7)?WMJ=M$3ZLXXMW+VUCV03+Y_R2(=;.+&Q7)@,TG#7M4>:Q
MB#G#8FX:G89:HUSH!MF!>YX[T[2>M%!):ZG"IZ4]O9S'4SN0<)S6I-R^;(&E
MPI.S1K?)?QL'V,##R1)LIC[Q\\'/?5AS(9X[KQJ&V\@.FF;S.[V3F3]JM/?<
M':>QCIJMVI *EPJCIYJ[665O/1S>9F7*<5L:'%3-L*S5<5"ZTKOF7&"_J%L[
M5PN73Y_4]'72QI[E%-:\W'.;M::%IH*9M0MO<;*!:"]W?QWEKB!I219KW8;8
MY<?D=5JB#F3%$;^6Z;-HP#:EG;$(\S"%P7)./8RIGQ@P_::UM)DV= $\F?K3
M=3&=![U&*;ULF;FX0.N!.4KI5H#\TX\A+.SY=OY:XS9L#M*D6HY;)6_K?;CY
MN%I[^6NPGU*-U>] E"S;5:XV^2/SKIO3N.\&4_][NRWW/[^G!T?O9/24BR(2
M)DMT6Y:>Z*)2)(I2<L8=\]0\>"3Y.C%NB:C_O6B2W=K?TMJS_8_O##=,!1M(
M&;0CHN)(QU"2%#X4WM)26^E@[3>4 [TD2:,NTCT_13*M'5<AG5";3\>E5H17
M'8L[5^L[S<&T= C@+0>CW.QMR0%UU0-KUVY]A/6Q.S)@(]-?QJW?%I_,AI-T
M81;69M<\R69\9(9U_4"8293K26O)]A,])(G\_J*?VJNF11/V6)J&HW$ZO/86
MM)#Y%]*4_]X?U2$SM";@3?#!\Q*Q6&8")3DY;Q>:3;O +%;669B>K7;-M<,V
M;9J&@9BW:3J):[!*RD>K5$EK<OK9?IOW)$L5;#:/J*W.9/,Q$THP-V/HS0 -
MV4GM]JA[W+^ZX)-DQ*)-D$P4/('7C.VZH-(DJ0GX\J=]?/K1"#375/8A>ZHG
MV&(E)S+DRH+U.N=)6.>Z+M&FNOJ!;0Z-[#@T6S"6CD/3<6BVET/SQ9R8']<6
M^@(RT%7\A$<;?+ES?\1%)]ZDAT7ICM+Q. "+M_EK+H.W[#5!J_S\+*=7SA6T
M48RA]NHNS/WU@^I:/5RV/1KX=.%M;L@3C]L!L=%P&0)^KS-97J5,EKL7P=C+
M+5L7J<J-8Z8=Y;XHW("*>ZWK+;OXZSTT:#G[ZW23)@171]OR!LP!. QF^P\-
M72#K_XV7;.[.37HSZEN3EL*%+8+-65IC#%7/[YB?MAIRSV']E7$L N";.M\U
MWJLK%.]->GLN@'9Z35_Q:F+4X<I7ZU%G0DN;5C#.?7''21_%@OG)H$I=@)N4
M[KG_]<ST-\2HYFV?>DDE[X]]724/7G,X;P2YNBW6GS./C:SX'K.?M.[!G 2K
M<=RMLPS:SF#X0HI P2^MN-128'JU)&**S:;>7G6'+9AW#)[X/B[7W++,SL['
MKY[T2EHNQW&7WC,Y/'-\=&TSK;\_=M.:YMY">2*P?_7BX[8EW&*/7# #-=UB
MY=W;/G23-GA8(ON#!3.>+NZ6W)+Y?NGWA5DS'T#+VY[%H_4^*T[W2R2M52XB
MQ9!6;_.E8G"G[?XY66(^68-6CB:BS0S;( U;=)UFWR\9P1=9Y$VT[LMH4"U4
MR/>?;QIT>)MV)F&<I>9W+7M^$C:_U(W6>CT\MH)Z"Z<X3E;C;Z_?LM^.=F2!
M1G&]V-.RP9>U5HMP%87O@V+S<MY.[<_61GJQV$AW3W=9WB9MF9A[@5(3^>R4
MV;CIFSV]7L8"&W[5#,\VQS)IAG-RWDZ+@=I?S7B^2EE [6"G%5F<I6*PDT0:
MO4C8EY6QIM5D&\0!!_JY#_=*[U\XSF 9ZY,P'8]^-E[<-M4:7#IGVO.TVA:J
MK0/^JZ6(9>B:MW$Z#W4KIP7M,XMPDM=,'UW$V3*WXLL+@0BC'..1<EN60ME2
MQ;)RU$0M'3,^EM<M!%(K_G.):0G,0E[N1BF([QWI./C\]/S@\;O(8REX+(B0
ME2#"\4BL%"6Q93"A,);*HOCB\@_+Q+]E+E/64C88,/UYD&*A$PUAYUR:H$PE
M*(:5D)&77I346,68M=%'4PBF.&MOJ"_80D]K0<Q\_1?Q51+_/!&Y]AE;VF6
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M\_IX@ =I\'@\[-HT>(SC_%4.&Q=UA+O-_*-01Z$QDVCW=#$(4()3 B5W&7V
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MRU0W; !=$: +#AO6JVJ,%%9C]1C8D)B7D3,20A+ !VUK 4,GFF%Z=^&I")V
M)( A)G HG(YDEA)/6U&TQI::Z!KAN>"P811'+X-GW@A1'1XC\R)[IJ4F'5SS
MBJ.OF[X-GG<7GDA:2694!,<,(224RJM28A9@H*C+)/-IVG>=V%W,KQ&\U(%,
MUF TUOHYA>S60+]&:TGO2D/_=?DU>I7KYPKR:YQYUQOSV'@QFN+>8))?[^>#
MZ6 \Q\+5E2B_6XF,5N[^76'A$ OJ%)S$(B%;A]DK[5( $4VVX3('XXV%U\7"
MKY=\6H02$K71#$,A$D[),9^,8S)([C!8P)Q)0&WRM?F\7GF!]C4YQ#:&:PQW
M>H_5\NQL$249!)YLS0/!8R$[ R3I3=\8KA\,M^@75+C4.4M60 4&.D?FE-(L
M%L@\^ (RV:Y>D;ST\65CN,9PMYGA9$@^)*.%=!R\E-Z+8)TO+FFI5&[N4_U@
MN$7W*>? "2\D"SYX5LMU,G1>,N&"4CP;GR09TK )IC%<8[A[S7 \*ED"EV E
M6:;:^F)%+ I-[BQ5U\[)^\%PBQF#9$[.1\>*]F2E(@_,99Z8\0% 1= RF(TM
MN>G -H9K#'>?&2[P9%2&K(S,P%5PV66E4HTH(X:3OC%<+QAN*>L26:*Y@&,<
M>68039J[P+MHN:G9=UQ7TDGY2SL"-89K#'>;&<X5GKQ%L*@,1&6P!+1*EYQX
M<: OD]BQ,=P:]^$6?1U5 @"I,HL<% ,;-?.!-%U$S@T/WF1KJYDJU;K2LC:*
M:Q37GWZO4K2A(+&:\DE@(48#!).UU!Q$D DR-I>6GE#<@K=HBC18D5N&F7,&
M"8%Y<(8548M7843G4K53M6UV:J.X>TUQP4&"F!4*RR$ZB=I6IST!A0Q7+DNC
MN)Y0W(+'K34QH Z!T4I4&,@:;68RLH2J&.>]<!$[K[W+IT%I%-<H[C93G$43
MNI6?&P3,Z,A6S<1QWB@M0[Y,6$^CN'52W()CLBY8O/:<B:1%+<P5F$\ALJ)(
MT26'6<=2?>*LN35[<7.OY9.&G,QHW1'8N@,2+G"-<SN\EJNW%K86MA:V%M[9
M%MZ3()3'HWVZ]?''()1!&8_V.XTU/#BB?@Q&AWF,==W]VOB4V2KY4-$S3Z.C
ML)?OGR"_X".X*Z+<J&QT#ESG8J'N/*B:,RZ9Y*4U?";*FX_CS8KR-X^6B^6:
M;'/2R*S1KA;C]@RUZG+>& [:Q*S3QI;@FU:N691?#!^W8^^AT=U]H[M(W!:<
M4<JBAJ1LD$44Y8..%JUWS:6[)W2W6'T8DQ75'<@J(1E$&YA37-92X5*"#MK8
MLK'E-@5<.JM7C]GNPFUJ=-CH\&*^0U"L+N"QEDF+5B!R$H'>*<LAD3!L=-@+
M.ER,< $0SF?CF) \,"C9, ^:Z-#2ZD8ZL"AK2/VY36?7'*;<*SYL=-?H;C5C
M-VH-188 UD AL8 VZ&*SHS^@%"TM9$_H;D']62N=#8*S++QA()1AZ$MB0*L4
MT!"J@C-C5ZVM4&"CNT9WMY[NBJ\9OY+C07&PCBQ<;25ZE)Z#X 8;W?6"[A9C
M7[0P,FN=F+.)U^@^9$&IP+PE&SAYA"!3-7:M:>*NL5UCNX];>R#1)2>YC>"E
M];Q@3J48QQ&=-HWM>L%VRSF_$R]>ZL*"CX(TG=3,U]AFQ9%KXCTMK2!UYS>%
M:NJN\5WCNY/L--)"+%F0&<O!!8&>F\B#D4D'7DK+\]H7OEL(BBFJ)K4WD@5C
MB.]T,<R9J%F6)F!)Q2GA-[:([DRCNT9WC>Y.Y)U%[H5,4H&M96<]EQ)S5!B0
MK*59+<-&=SV@NX4 &26M!1TE*]H  Y,E(S$>&<:LI3,BH@@;6V:3QK;17:.[
M1G?S>$#A0_8YF.P-)&==2#$Y'U"@%D&Z1G<]H;N%8!F93'!DN;)DO&<@M6)>
M%\>T01F=M)BT(FO6;'*[YNR#5\MWG8OU=U.DZ]*_:?AVZP?Z<=*V?1R_'AYT
M_MJ&D#"_(:O<\U"9$T(:'J1\,'W(A.LX<*T %/R?$"@K K_!;T\>[_7?_O1S
M,0]\MQ8\IL>.PX/!X7@X&K-#NO H#7"?!GHZ&;S+XSP8YXB3Z6 ZHE=E+\=I
M!^$\'@R),,9Q[A4^'5/#9A.)OC><[@Z>[@?Z,#[X.*&Z89M/NITCNL(PGC>,
M?F'0)#RPL_"H4U]?@SO):9IZ'G=S.MK+S\KS6<F%W_/AB.;EP>M?#F;$1?W[
M\7C^Y@NZ]8][H_CW[:2KO?Q_?S]^]6<Z#!+,]I^OACM/?OOPZLE/>SN5OIY0
MF_9_^OOE_F]BYPT1V9__WMU^LK/_[.>=LO-FFS][1-J*5@<>D$4K$X,L.0N(
M@F&6B9B$>(>KC9, @9P>5=('36^)K&T2!8*73A K9>%K9:_():U#F=: 0QJ2
MZ?@HWQ!,7^QFFN-[>Z-W-:RA8YT) 63T=ICR "L@1@=QN#?L9L-@5#[6YYA'
M0-"7A@<$C%Q!<\6 [Z[X<#@EUHP7Z-HOLW9UH1N//X5N//L8NC$(F29Z'LP_
M^ +??RHW<A-C,<"#]/'Y#C^!L)+0@!:)W0%-E]K]07Y_F _2<'HTIKO7;Z5\
M2$,U'Z7Z!Z(UPO*'[@\/!H,O4M\NOLWT+/+!&?PWI?DQ.22J&I52A[_^_F2(
M(4_ISH^1GEXXFE!/)A-J\: ,JZH9'&<<#RKO; YP,C@833/=+(S>YD\$N4"-
MGPASCJ&NX:<H<_ZHK*S+WF@RK!]X.,Y[],FW^?MWPS3=/1%_GWUKOE;S3U_!
M,!GM'4W/_\IGRW7,E?=O")K6+2PGG_W<_1A1>XBO,POCC'\S+-38A[CW#H\G
M&]^=7F]H!#]_@(M]/[>'I5S=(MT]:-+#HQD>'Y+@RN/Z*6H3]J8M@]UQ77+_
M-41G4_ 9>)(.G.>!?O-&1I1*)3*N_Q*<^+0R: 5*91R:/40HN'5Z'#\^[JT?
MPOB[Y3=O;A[:,^?ASJABG3B!NM3%!V+%\T_# Z25@=#^?$I_J)PUF:GJ__J7
MDT)^/_OEF\<G:^*WO>_HCT1XHX--XK?X]Y"Z.F/2>2S@RJW_RM$]ZVM?L@+4
MZ4V(V;5."<IJ%GSAX@N<.Y-WT0D;G09I5:S.7]4C(IGH>/!6@_=+6B>;$E5P
M)'(\D+WLJ@&M:DJ=H!&DV#CG/O^LD4[?A^Y@@4PQ0^*V5M$(7)#PI79Z2]:Z
M\1N7?DR=!/JT>G0&'TW /3R<Y(<G+[Y/P\GA'AX_'!YTTZC[TO?SV\V7'-+P
M2U&M]7:SMS\Q\ ,^8^%Y5.W\SO.W'W1O+=BGL_>T>L"E.?=M_D"<^]Z7+BO4
M V/._^J7+OOE][17K;'F8@/V#V'67XBFOKY-2/=/G-I-ZV^VAWM[G=BF-3%5
M^(PGWR[NNZS6Q3EV>]3)*G57Z-,%XO5O6_?%_>X^/]7]E9,DG%TE])]@?04Y
M$OY9*/&+6=8_GF]9KS5+Q>>;KKU-I7&[&[FFE!_=7KCMMC;[,+'//C;:SJFV
M8_ -?COX)GP[6/6 H$=GA!?L\<J'A'TX [Q@WU8IY:VBABP3D@T#M7J%4M7!
M-2C!-4:95P[/G#'??T:3R4_$DI](\A-'SBAR]KF.(+>'!Z/Q<'K\2UW@\F3Z
MZ""=OLK3_SVBM[?S='=$[[RECW16]STX9]Q_]??.A]_W7WYX-=Q^\0=_]>+W
M-SMO?M$[+QX=OWRQ_7[GR<Z;9R\>T?5>[2^>,[[:_TWM_/SJS<[^+^]W7OR^
MM_/SMMQ^\[?8?O+OW>T/3ZD=VWJ['@3LORK;PUE\P/9SKK8__/%AY[>_0HX.
MA:U.%2DR,*HPA.R9)<LSY& E&:$UL;(4>DV'C+?(9Z+179_ZM@+=Z<2)ZS11
MG$ HT7EG $4Q G4Q=2MS50_^1G>WD^X^+-"=5TG*G(#Y&%2M!J09*A=9\EIZ
MT*%X+#7)LG>-[AK=W1:Z0U><5S&+8#64(+STO"2MM(3(T>F57;P:W=U.NA,+
M= >R!)3&,1Y,8B LLL!K =N03. !G#==B6YC^T1W:]I?NA46^7^&)0^>QV$^
MB'31;^+Y>\=RM0=P)H'?:I:+(J*WVHO "T"T/FF=9 #C+2@;2[-A[P7+'2_9
ML*6@1*4,TU)K!L$5%G1!IA0W/!:0P>3*<E9<.LS]"TQS5:+NHINCC1\T@,*L
MI#<%4@3T.2OP5B:P1:G8C+Y[P@^+1I^)/&$(E1"28<!39LY*Q8(3W$6!VMFN
MR+7REXZ3;/S07WX0 GDV7D;P!01H+#''I'2,1:@(JU>-:?QP._EAT4I2SA0A
MG&!&Z4Q64N',2QT9SZARX,DG5R-M-H%?VDI:(S_<IW/+#BYO"0CTR'%OZ=CR
M0AQWT4VN6\UQ,B1/MKT6TG'P4GJREJSSQ24ME<JK9Z5N''<+.6[G\;*-5/>Z
M.2<-E*1D(,$SC"8P)8H.)FI4J>,X[M:5*Z)'&]^-'ZZLQ/NU\D.C@%4H8-$,
MBB9GGP1GUIK":+ M0Y(V5? 8X[(ENXC,(*]4(X"[2P!K+YW9"*"W!+!HYY@:
MA%)/NSE8SL" 8R07'=,B%A6*XDF'C2TKUY5.H$=G01<S;3X+K5D(L/]D'LVC
M:6XF\\!G)=SF<>LG3LD'K^?.R N155^Q"W2Y<LJWFAU%H0>@P60/&;+UOB21
M=2D2C9 RB&8^W0OJ?+YD/J&7QBKE68XVDOD4//,N%V+24!+X!%'GC2V]R?FE
MB[.OBL);M+]\CYD%2K6YC<S) B@5468'L@BMG*8IM7K!B,8LMY-9%JTRFUSV
MRCIF#9(H*P@,HP16\W,I;:S+R5=F46)=AU.-6>X4L]CL29Z4XFI)&EJE$+0-
M-J7 M?6D9?IMT35F61NS+)I[(JJ@<R45[C/],#5?)GA6W>#)XB_1&-C84ION
M]FB6^W3F]2@29F8Y?5B7!BBG+DW;Z_&G+$@5:^.C.#T:5P.PRYHTR??L=.R;
M58['>#$Y9,$=V7>F)OK@M2(4U\EI:96_L'T7TON'GPW0[[/Q>3R:3"?$?;]_
M/BR/=W'\.K?-JY78;#E0+654H",PE:.N!;LX"R$G9LADK]SF4L&-+6&7=Z^7
M7&K;QO5MQ"YWUAECN0R"@\)$V'3&<V."S2&(B[OW->Q>-787;9RB,Y2L'),V
M$'9C== EXX8%!RHY:<G2J859K&_8O9O8C6B<SXD(VT2()6$ +I45)9BHG,T7
MME$:=J\:NXM6!+I03!*.)5U/C:U"AIXKIJ4Q)M.XJN WMJ3O"7;O4^S03I[.
M$C?3M+^4^+^][K_7+/XGU&%ZM;QC,AN$V9['T]E(T.@T[EF!>YXM.ZT%H'DI
MC&%UK!@D!!:,I5^CX)B+%Z)6_%!NN=['Q;FG>>SW&+)KT/P-LE<*V46I3ZK.
MR*(4$SF07%!"L)"$8F""TR7JZ)3=V((S"LXVR-X)R*Y!ZC?(7BED%Q6^Y$H;
M(R0+]**6$53,H8_,ZF!\T47;6$\@Y?+YXXU ]CZ= 3R;[N8QH0WW]D9Q=@(P
MS?N3P3?IZ_($W(_=AD#B7GE44<@$6BFGG:Y;Q,DXX7*VEQ'Z[6CT]E'>LCN7
M0BA8O>"+Y;E:%YYY'AQ9%VBR)*N#5JH:$6R,Z\>V1MN27#M)Y)J,OY8VB@!>
M.*27WH(!&GJ:%?XRID4CB=M($HNF3*)U(\LH6%'.,9""^"'[S%PT/A5G;$RZ
MDH0_(V2ND<2=((EDBZ"5(H9H$$(,SFD1I8]!%[ ZE<L8,XTD;B-)+!I/0:@<
M50#F<A)$$I&SX+-DQANA:KY1*Z"2A.Z+8\)].B"91<JL)9O_U3J@WN+$FBOW
MO]^KPRJQU%]3HW3-CK=/WT_'2(]^>(#CXU_JWL#.Z*"V<CS:V^M*G<[6BK8&
MK"U_S(M'\SK-3Z<['[8%K0-_&66U%#DR9:$PB(C,>3!,%G">_A8R[Y(K6'?I
MV.I;YL/?:+/1YN(! 0>)M?@$MQ&\M)X7S*D4XSBBT^8Z(J$:;=X(;1Z?IDUN
M<XE%>R9=(>W,=6)(8IH!30^!SA6"2)>=V"\?\#?:;+1YKV@S"%]WGX+)WD!R
MUH444ZU"2C:F"-)=1YC7Q6FS,>-*S+BS("A#Y"6GNJ'@HJ4?0;+@K&$E:>,M
M3V!<W-@"<>E,';<L<*L/6PUGEPQ\/*]<__2SRO5?51%PWO'/1D31,T^CHUJV
M=RW5]BZZ_7N?6WF?=LGF10$OX\MQ1V7&W502:Z\%^"L>=P<-+T9=:,8X_SH>
MD8B8'O^ZAP?UF*(>3!S6CS1AL)(P^&5II\G'K*.HR3N3#:R&^Y/)9!0+1152
MARA\(F%@^+H,IEMD$S4^ZE/?;K)87^.CJ^.CA2T<JT,4O$CF2XP,HD7F;:TW
M10,HI3-2*[^Q9>$.%EYI?'1'^6CMU?0:'UT9'RUNG!@A=$$;F=;%,0C1,1^E
M83EXGZV+#NN6,JA6R*$'Y>[NF0O[39:Z:Q1T112TO62B:92RJ*"94J(FNX#
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MU.X_WF_3-7>>_ W;[_Y*$G-,WC -&AD4:UCP)C#KD=L$KKHK;6SI\]S<3Z9
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M \H80I*65^P:<VDGMQXY[=XFL=_2;UR$?#268+UPJF8@5LEZ%PNW4E@7(I>
M3?3?-/G0=2KQ=,)_YT/]SA]_$?ED,M(*T8TDY5!\+2:/COD4M$R^$&'H&M"C
MY:650_^V/1MX/RJ'K!+(:#TM/U!C\00(;72.SEN1=3NSZ =XCT^#%Q5/1EI1
M\VUD!A@U<[IF[LHU^1JZ %)6\!K>IWW"!MYU.S]$JS"1PC=>@@) K3PJ=#:
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MAD[S>'\P/(CTB(9O,SW\SZXW'0WRO F3K@UIWH9)':3)<$+C]'HP*@_I:1(
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MPK _.^P6]O\FKIU-E\GD_V?O2YO:2)IU_XJ"]YYS/1$44_OB>8,(>[#G>N(
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M1*Z0$T(@IV MC7&":)J#XV?[(OQ7!CS@Z:,\WC&R561E"%R;<Z%Z_-D1R$U
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MH[S7[_AO)=3U&F?'A3]N'-O0<#&V&U^KKNN3)9ABZ[39.8\PY+/8C?G)LB3
M9XKV9*&F,M]LJW%P''MQE'UV"C>-W>_Y>OGY ?;RE[I%NU?XQO<,/C" ?%T8
M!/S[-;8!HYJ-?NRV>N4(X&:A*/%L,X\Z7Z4#TEBTX5/C)+>ML;ZLE-RY)9([
MQA\J=Y<IAZ64V#)SHQ*DD124%[-?OW;C5]A_JO4?K>KPNR $K6A[@UP%K&BU
M8BC@D\USN$31Z4XG,:[HNOLE6O<*;TIVT8 EOY8-M8?1.U=/SGE2(G%CDPO<
M*V(MYI@;S13F(<H[$2'@6AY6!@C*?CJPW:^Q#VP'Y&N__3D#%+Q=6IMM7U&A
MO\9@]C%CV:<,96^&-&G,8!!=40IS])]C[%M_M^UG,]AO 76!]P[I)WRT [3D
M +Y_\OYXCQZU#D_^.MF[:+;V=P[%X<FWB_]<?(+G??<ET$24)0X1'@WBUCND
MC;%@G',A<(B&R)SJ@V=3M/^KU,=R_ANGY0)D*[]Q>CG]#5<*R\1N4NTC&:U7
M1GRR1E4M36I!NDZ0]@_^_"(T508KCH#3:A"DQ)$%_$?4$$*,]I)E+T2][&NV
M[%J0P 38+,9JF8-? C(1UL-Z29(A I:0;VR3.?AQ#:# ICT+(7U8#31DJR6&
M7+^?MV!M8<\?VB^_+/7V'I9H>Z]HW1Z .:Q"',7)I'$3FTOHKGXKVO I'WN]
MT:J-OS.Y?,.- 3YRQVCEAVG^5:_WR&LQKJ-^&XJPWC[K!Z@]SK0A.6F-)11)
MFBCBPN5R!R2BH+7S#&:)B+2Q+6<;4X*H= :]+$8WLH#'%XIRD3^TWY4RO)]&
M,C(A&M7^4,O!]7+P]8N-T5K/-"(D%_F!M4&:*X:HPHEH$TSBN6F/GLU+N12$
M:JTW,T_,:U!\!RMN"M^'7]X;M #J_(A%#%\N0$@FO*S^.(9!$TC"?'_K/*B8
M]9-VTN4;P"6RJ^L GO!M$[[RXB3ED.\>?/T"*R"XXMG-J100!0.&1L3 &V)@
MDF)AF>$;C0CZ= I+T>\.P.RX9E\W4WLXI7E;?Z9-_ "VOK.AW[QA*\=YY1IK
MA.RZ2" 3E_Z+:SQK(U=:&'2S@R1OI^?1=GN-+**;^2<I\1)^P0V;?28]@*5F
MLW/6>WT;)B2NGCIE(@QD>_O?I1-V[#.N/+\P<4U[VHNO1[_\$HK>:=.>OR[:
MY?#++_TRO/K0D9QO,!WEF^]7O?W+61'ZQZ^-WM*,Y9.488SQ\,;5NV2K/&29
M<F17[^6./$)>^S;>(M>^=]-E-; >=J^KWGQ'*?@C/"M1][OJTS^K@G56*_.L
M4NKZ61]#7O7MKOJ#K(,?!AD1,?/9.2?M%>8]S8&RGMHYU-SSY FJB4J><8LH
MVK6=C'PM5#E<KDS#0X5C(C;D#MDSRSU7F13<)N+Z-@-^:1-'ZHF[W\1=GQ95
M:V.MC;4V/J<V/E'1N6>-OOM\:QO[BDE]SQS;H5E[55#JU/_%3,[:A7FN3KOI
MTB/9&_61?3%5 D[V+@[/CT[@V4X^D?W/AQB>BQ\>_'UR=-*$^WRB>Q=OC_<N
MCDZ.?IV.\-QE>R>_M_8._CS?._@$U_X+GOGX>._S7FO_\SOX&\S";^\8/,^W
M_UQ\F$EUY8QBZT)"0F.+N'4"V4 XLD3)D @53N<B^)QNL=F^]@^J$O! )5V-
M(BPU3-<P?7N89D);J;P(/ ;."#9*"JZ49S@J3QDO81J/8)K4,+V^,'T^W0^<
M8.J%1M[*F(^S'=*6J]P1D\&>CB5).1"?R!JF:YBN8?JQ2Y]2&01QF.O 38H.
M:+0&4#;$.29#R:;AQ1"F<0W3:PO3>]-L6CO-0L1(<PTPC0&F;?(6,:F,UK"=
MDY [%7.QA1=<"+6&Z1JF:YA^E-S6&J97'J:GV'3$E"DC'<(1"\09M<@J#GH5
ME8%_ U8ZYY0P4[/I&J9KF'Y<F.:,&T^(T!9TCU)FK68D)+!J'?7.J]KI\5)@
M>G^*33LC G6,(D^$1" E%IFD&7**^2@2[.\B^Z8I6UR#UAJF:YBN87HNFQ:!
M665IQ%[RR(/1E EF),,D8D5T[?1X*3"]FSLQEE#M+_8.=LD7D LC+4TH&>J
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MVW5_GGWS^>1PO@$"^SM<#&@-#*ETL=E,<]X7;=OVA6V"T0%_*-6ZVH?^^U_
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M_N[.)W5A,[^7/SPF%=4U1GO>U8^V\Z?+4\SI06S-V(./Z"RX;+< W')HI>9
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MVHT^EIV#JS8>9>_AHM>P_7ZW<(/A'SM37;A.9ZKXWUZ-ALT^II;H!6VRMYF
MM=EE@PK:!6H-#H(+;DR(.'EC,),\$%;[2Y9DEWUWEG?8RF?B+_8.=LF7X+D0
MBC%D;<*(,^:1D30AF8P6V"G-HLD%^!>[R]Y".U;#EJAQ[B7AG$[.,^:2SB4)
MJ$^6J\0H3IA3[+!.M<MD>7!N]RK.:1%=Y)@CZH1 W+F ' L:6644A\V+!(DW
MMOFB(MAKG*MQ;G5Q+E@7G:>!2\6X\,31R!DVEFIF&%>^]IHL#\Y]NHISU ='
MK9(H$ND0-]0B'2U'2A%M'3&2>;U2.%=:[S^7)NJH<^7/5_JN7M?)4H)6#!\
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MD;BQR07N%;$6<\R-9@KS$*68ZW:_:IA]],<Q#)IQ/X%!]CZC=\BX-.B5@'P
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MHHV>1RZ],6"D+)&)4KL55KG!:JV^#U/?*>*@HN3*Y^AB1N!'$@)IER(2(7F
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MHB2)_>>6?Q2+ +1%!.64J+JH7%+)H)&Y7%X,OQ[K\1L%PW5MB$ 990TZE%)
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M.PG=%A+R.<4<T*(I !1UI) +0LR&C$7[D2TQ>LCZYLDIGR<G-#88&X.(F9(
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M[[+??>\QJS-E4YI76]FO#;+MN97:JKW5!AFK?95^7;&\M$J/:%C5!M,6VHR
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MFZ%O;JE61,@LB!01C>N [KH)QD;!K$VY7I;Z%!"-WE2@UJ(++#FR. <?,HI
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M#T;=\H'GP]3#3WY*/Y]TX_APAIP+WYH.F)Y_!3R.;3*^_BL7AA42HFQX]P3
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M7OE<(2'B,IO,A)/@/62;O X08J+&"'9/G/D3G(G9W3_^\GSJ3=>8_K\>0O\
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M?(*+E?XO&,(8.G^>HN-X-.K\5$#'Z<_MR\T?[.?_>=9ZO_W!IR;!8&:O#YM
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MX$P3SED8UE$:'PYB$S1K/UVZ6C[NIW):H#P3U._;,+F2IA83I7+SOY_O,FR
MYEBO6^+I0Z22'JK<=I2S -CQ9!@.8;:Q=!8Q:.+QHT$;A?<PZK9K. VQ3>/<
M%^)IHPLAR6;JRY9RL<EZ74"A:R/A^#YJG#:&/IH^:]1&.6>QNV(0GI;P^UG,
MK0E:-2OZ";J]MK'39I=P,IQ&Q5H"*2L]3 <P;"*$Z5,3#2M1CNXP3([0]NN7
M$-?X$,:=]+G;M WC*R& \)B$PVD7VJC:M%>C+GH:&46U/Q7'Q8CB59-07K]B
M(J;P.-\!&K:NS(S#8]F$&1P7!9/"81^%YJ#9C87^0;>LR_11R[*]9A+],AJR
M*C=Z(=7[S$PR3&94!-Q-,^&_A^3/7;'7!14X4T5^VH3.%],)>=&/_SR?BA?M
M3+P^&]0#*2!U#_I ;7]YRYIQO$1G\>7>R?MLE64!@+!DRN6.-!+G-1!M35"1
M4AL4Z@-];8+\U*M[U@DHYP.T!3MMJB/2PV'W>+0@:LM*&B2(C',?A7$R*P[8
M.W25.'H1/GG)JZ0]"$E[+=YGGCT3'OV2(%#2-$W$&XGFAW!6*Z>XT@HM#WU=
MI>LS25LVD!14,MXREU"8I67:<RT\VJ1<,2X4Y&^)D(^?5RH^S4;,3AH_I&)W
M]R]!;^E[CXO%%/7$2)Z)I"47G:(5ZYU)(NCHJ)'E,,_7!:@PT*#1^GVDHU;_
MM8HX?0[%D+O:JBE)1U>IZIF./F^LL2F+&AZ64!/^?C 8Q!-\^++<]Z.".^.^
MWZ?/KZ)V,U%[=?+>E3KAB4FB8S1$6IJ)90D=)I68RXQRU$0;6T9>=X/I&5G-
MDD?:C=[QH#,Z[2=T =""2Y^/4YB^BG;AP84$E!Y:;4,XF-G(C:W99LR4'=YP
M)GW3,,*9#S3"%1Q-XYAE#[9I(,%1LV<^C0;,=L0A3,8EP%KR2?#5EJ+:Z(0?
M#J X06'0=./:Q_705 ZGUS_UV31TBW;T))VG%^3>X*18[A]2:/V(^=R5:9K+
MF<7:)""]N)BY4'IS!BMT+&()#X\;,Z/Q$^%SP>_Q8+2PZ5S/;EST[ARM9S?6
MH"_U[$8]N[$69S<><J3JZEV';^\BO,8UB+&-F* $%M4RC;Q?"NIT1^CBEA0H
M\*@6+X?Q2UKE>2C_$PR[@\EH:F5>: 3UU&38! Z[Q=B:'HF8._G0& S-?F-_
M,.[,3D"41._NIVZ<0*]W6D)2TW /'!R4@%6)N;;I7*7YMON;5YV6F)>4&VY*
M4K?N>Y+\KO8D_R@)KVAL-"N)#MX?K6WWHNPG-S;4^NU0;K_\.$L78/M';T^:
MYWPY/-HY>D6W=\N6_\[1]LO>X9O?__BX??1O;/N=+&>)+Z<+_/MH_^4+M;_[
M]LN;W_?XWN[;SV]V>X?;? _;>R7WL=_[^._.[D$Y2WR"_7@OO7$)HB,A<'3Y
M:8S$:K#$.&DT5Q1?4/.[?DH"2I\Q5' NRY4=TOG,@\P(61_!S6]*SCSSSJ5U
MZ?R*QNY!^IYMRF]VX$%L.R*IX=#ZK85]EA%^(6EBU$6Z:N+0S2<*_[1\U>0(
MCN!3F\^*$MT8O].H=_$6CF'8IN2BJXM3CL)_@# ;^ ]M2D6Q^GL#_/+90SEE
M=GYO\Q<8QLL<BO154E9CFU%^MI!-QL=%5NR5A6WR7:<>]G2?Z);/TRV91GYQ
MK_S"Y%X:V^C^C@!N;)5\YNXTQ_K,X!J=F5EMSG$Y/=7&1KXJ+J.KY*5Q+ >H
M,]O<Z2:!9WIH ?7DY^[X]%DG]0^+@==XMNV.X/^B@FO>&I9LK>;SL\!R\9>'
MW>+^MGXE]JCL_DQEI.3T=$-YN^16#P?("-"&7*YTE-O-PY)G?<OJXL]PB"/O
MI3?Y$D']T28X_7*Z>WJ,[Y4DM">L+4I"VWM*76 N<.)BR374((JVP#^]4@R9
M5U%/Y[6%-5PY_(]ZSV1DSI<2(PFUBP\)_T_GM<5E)3';3RL2TVCOT_/4U;.<
MQ9+?U?H9S5YQV<3L]08GH^??H5N^V=WK=(NZ7![GS)H?M^GULSA$4QH#&:0'
MQZ/T?/;+S[-;(KK]A@>:+_T\;7T:O"@/F+\LKCRO?7OJRR.3;"K:Z+3I7773
M)T]=_4UZ50VAZ9N2;]*OO?_5+W_M33$[0+3B=HV]I89KA[^CP],;$N<B=5RV
MTOC5JTKOM;Z4^Y8/T\3'?MIN \:-WHT%M\/1>3#C!VYCO=%LM'1R3U6EKIZ0
M5V@D#$Y3ZNRV)SD;#KU0->$ISDE[@@LGX2?_I.=AM\E9G!>&JPF"J:\0Q*JN
M5;W7^FN_0*\Y%XC>V5E9C4Y;48.Y&XC)MTIQ?;W2UG?6#7SJ90&?4M4_R(FI
MJ),0":2CRM%LD@.-UJ]GIKTHF[EOG]^YRG]:FUWK[W6:VA)_QQ_>_+XM=XZP
M'Q]Z1V]>OJ([OV^?OD&G:7_W@.\=;7-\EM@_>JUVYDO\'6W+O2\'?/_#/W!L
M>W)[]RW=^X*?>_E;[\W+_>[>EST<5SS:^_"1_>?+Z_'V*6UN.=GYLLVVO[Q[
MCPMA#%!/$H=,)).60-"!B!0,Y2YXS]7&UA7GNWZHO-]C*7]::>SIT)C7#%3R
MX /W4B1TV7F(*ME( V<Z\TIC=TAC.W,T9G-V,5A!DL^"R,@5 59NOC,Z*@TV
M&QHWME9<)K^RV'J!N;+8#2X!D4[;G&3*GDO$BO4RV@2.@@0NP%<6NTMC;/[:
M^Y1MD#Y*(BWW1$HGB(^V'+=W5'(%D))&:\P\%!Y;B4\^32-Y2#YYN_O<9':6
M7:O^*'V7(SXW\FL#.7RYV;N2S1\VJR4?M&!64.$D==R"%TYDSID(7+FP=*V(
M2_0VS26H]+84O6TO^)I &_\_$^5=(M(%2VP6GC ?73 \&EEN,^+T1]GM:L*X
M54.L(O6F9QJ<XI"Y$-EFZ0.S(2 N\6^JK$;;I"+U/I Z[TX%"E3BDB!2DT)W
M*B0"G%%"35+@N4C,JHVM'[_WMB)U?9&Z\OI+%:FKT*GS+D.4R<4<(XD^.")5
M8,27ZB_& S#MN+(1E:K]X=#'"J'Z5'?J?BV'GX[A]*@]L_'].W,_1%Y73-P#
M(:^?[M,C^-=TW7X;#"\1666PI1CL[8)7D#D%RWTDE $CT@)% DN:1).5\P8M
MCI0VMN3BL?"%'(@EN>(^([,5J;?G$52DK@BI\UY!C"*+0 51H6RR4.N(=6AO
MA"""XBIK*^+&EG 5J8\3J2OW""I25Z53Y[T"SC,('8 P5S82& ,"2J-2%4S;
MC-2JLT"O8#'4=B]0?:K;!#N#/FF+]:?QN)>^WR^H08VUV"B8[H/^V:QF_*N]
M(:5X??QRZ97F<BKR)0T'E>F68KIW"]Z#\2(%FBRAH>PI*+1)<%4%X5Q);[SA
MU)J-K>G1X#6*@51DK[T?<6-H5P@O!>%YMT*Y:"/+G/A,'=HJ:*9X%17A*IJ$
MN+6^7#'-%TLMW=Q6J<!=8^#>[D9#!>[J=.^\E^%L!)<U)<%K161RC%C!))&"
MNV"4ME3R]4'NU,NX#L*S0[+8S_1UL#^-3S[579JOG*?B]#9V;;X[2^])I^@^
MTOQ<8T6I-)%%4B!5BCXZ@Y8M:+#.6)V:FI_?J0.KPEM*X84%9S-(F33/C'@9
MBZ7J#/'16"*],I'30#-%9U-<5X#V=F3_H9XQJ.SU^-@K@>'<>"T-=U*R#")3
MFCR3S"MF)*WL=8?L->]G"\@2!!6$FYB)M"$2JU39S0NJW*P89/&S;_V,5"6O
M2EYK25[>4T%9%M%))66D0)OPL8Y>N1B9K.1UEZ;70IZC!@7*"N),3$2FH(B3
M@9)HP"8I(29ET?:ZKB#[>M'74]WPK.>B[MB;])3F()3P&21D[4!3SL""!_S5
MBZ7O5*XYW#_,;0<+;B4JFV29Y41&-,>D+QF0:"T3H265UG/N ]O88NN4PEV1
MNF*D<EH*DSLN9,A21V.Y9UQ;XQF3-CNH2+T/I"Z<BT('-R*5$AXT$ E6$J"9
M$I9X.46?F/$E %1/,#YBI 8J.=AH.35!.FX<S9!BSMI2 *MT1>J]Z-2%O4EC
MK5.BE \.J%EEH@2BPA\R&JZ\-LZ78P7KI%2?ZHY;/1=U=\D6*_<(:@[W2ACL
MXX)7X+U/40I!=$YH:P2NB:7X ZU"#I)'J:#8&O5<U"-%ZLH]@HK4%2%UWBO@
M0KEL)!"MK"7EG@CBD%-)2"+Z**5@T6UL\<5J"16ICP*I*_<(*E)7I5/GO8(L
M?<S:*X*KA%X!-X%80*\@J405HUHZ%C>VU(]D+-9S4?5<U'I,X]IL%-1S4;?,
M=*]._KF[/7<"5$E%15(DAU1N4_*) *62H!BSR+*)2:EZ,.JA0OM>'8EZON*V
M,!SF8I@J:VZ3)LSY6 HN!.)D=@1\=&C$..FYO"ICJQZ,>A3 O=V=A@K<%0+W
M51,00/"*[2_OONR\?0\LT,B8($I (%+00,#I<CB9JBA=0*WKUP:Z]614/1GU
M@R>C6#T95=-S;]5%9:84NLQ*<F:D%]QJI2A3E$)(4@75I.=^IQ*L&F\YC7>Z
MX&YJXVV63A,(D(AD)A)G)2=9X6*!2SXPOHH<MGJZH-+7^HQZF:-1$I+U+"J:
MO/1! [<2%*<Y(6JT\)6^[I2^YCQMKAUX:C*AAJ.GS4$12STGD2-Y*2U94$A?
M/USOO+)79:_U&?42[)69<CKJZ(4"R;,'*I0#FQ2/@FIC*GO=*7LMA!N\U$;G
M;$CT4.JO4%Z"A(GP;&+,(1HTGM'\6BS-NHX$]E2W/>OIJ+LE-9L"U51HZDR6
MW@I@&LT &2.WC%J;F_@JF\57><WDO@MV^[+H6BK&!>/%-K.*2)<SL4)FHA33
M8*DU,=B-+;Z8"%DW,1\-5$%S5&.:!Q>L9,:"D][K&)WR&CTKJ%"]'ZC.N5$R
M,RTBYT1(JDI9'$YLCIKD"&B)< Z:931#Z ]?)UZQNKY8M3(;E:6#[$LI*P9
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M4$(I& XF!X<H7IU7D^'@.#WK_(YF=T'2BU$7_;9?H0\1FJGY)\IBO_.BX3A
M>2H9JFW$#@7FRK914M&[1-SDX>"H!6@1X :CX_.OCYYU#E(_#5O/K!@HY2-I
M&*9C\##JXF?PX4BRY/#TN#23V^18&)YVFN.MP^[Y(PMV^@-T#YJE[)Z-O'QD
MT'B?^,$6 GG27QA":6!&/['4#)KZR-/):KZ'[%5PBE-[ L/8L'4)7R)MO$:_
MMP0:+Y'8M4LP]6=Q5O#C781FMX]X;\_H-CV?LM^L@='$C[JQ"V6XSRZ"N%GI
M*0F5E\^>A OPL0.CT0"!7<9STAV7(2#'77Q62R3->[-'7F2XT01]ZBM$B5R<
M:-1@XY8MAH/1B)SU8'0"QZ-9"*!=G7)TN?D.MME/XPL]:<> '\=W3E*;&WIA
MU@(NW$&Z.-^=!75[B^;:GP&[-^FE-QGMQ$9L7AP5Z1N]R6_.*?K<>OC7U*T?
M-2[44[;<\'/O74Z*.6F)A,2(#(H2+[0B.7*(,03OE)NW?"#0S#5ED:DD<5F<
M33Q("\8#&GI"S%MNUZN?-6/H_E2 .M!*T$SM+RCE><@-IRKJ.F/D:[G4<Q9"
M@^A>4>O/OZ7FII&JLMFZH-6;+8_SD%:SS8)3V4/8I^>S7WZ>E9[K]IL):;[T
M\^762TA\/CN]+%K[]C3 X_0F;6,\T]SXZ8.GX9_-YJVY7:/V/:$WE1'7ODTW
MV;7O?:U9KC894]_5[-??T]JNO+,,9\^:A]19=Z-FOW%88LDS$;>S+6Z_%8%H
MCR-M=WN])I2-.(X%/</1]?<UW&B(;3!FG099O.C4>3DU!+Y6K&%Q@-<>3WN@
M<W'5(9>G-?S+%Q/?T;FG>TU]F;F@BQ9MY\+N^_>D95V;YO"U^;E+J;CA#+WK
MG[L)/S(?]1ZR>@_93>\A<P")IQ"$-U*D9+WPSGGT2S0HPV^<I'ON_UWV$A]*
MTMGW>8?3I+.3'?[Z9/_#'O[]5NSQMW3_:$_M[1[PO=W7:GOWE][>[EN^]^6/
M[LZO\TEG+\3>AU^.=C[\<;C_,G[8?_G'T?Z''O9]'_OW\?/V[_\^W'F)GN;O
MK^E_OKQ:N%<D<%4**&3"RWU ,N1 G.:9 .?&QZB#X!JUS3.C'\RU9)7J*M7=
MT@4LSFL508G(N'0I. I4.)M]-LYEX6]ZY6*ENKN@NH7K93V-+EL@E+ERO:Q,
MQ++,2&0L*6X2M5HU5"<6:X"M*=7=487"M3#ZKX^>?^UFQA^;C#6T\'>N"ORO
M8OA/K'[-,I7C/$M4>Y&EX3+[9%-4VB@+THC HJX6[OK0_NL%"U<;J\$Y6VC?
M$YD,)]Y[16@RV26?<J*NT#Z3/WRI>"U"M;X@ID)S+ZFSWN(_VGA/J<[&2Q ,
M$J75=ELG$,_;;LD%3[WRQ&M -Y4*2ZRUGCA+/=?.,9E$ ;&2#^CRK4<1D_WU
MBK2%SD_AAZ*Q3]4B>]H7 2Q!YIP%) (0/+(L+7.6:6[!.^;^/WM?VM36DJ3]
M5Q1,SSO=$2ZZ]N7.!!&^5YC!<27:OK(]TA>B5I"0$"T)L_SZ-^M(@"3$+D#@
MTQW7QDCGG#I5]60^F94+<#6LU=,962FO'R"O:]=(EY),.JXC,D9(Q%T R1T8
M1E2%0!V6Q(JPMF'(DRE7V:YC=5'*I4L6["-+8^#:"QVP8XP#*BT1+IJ2<JT2
MA.<IEX@A!(4#"IX8@#!FR"0F$(A<Q9S6$2N6^YT:L:QB2&4Z^1M))Y]PG"+X
M;B:@.<T?T%\%-L-_Q]TB9O<J-KB(<)Z)6CZR9WGIQF'E@^@C #__>[V2"_J.
M?]T%PADOPO&'<W%\17#P509NKQ=#CN"%AQ7!N?"<.$Y2@ OWYF^9K^["%LE?
M[Z<T!&+GSJY_;9((,$X,/,NO-)W',!.$F[^W/\E]\?UA$6DX'U1\4X;$>B4S
MRXM QYF\XEE\O71^P.(-NU/$B/\=5CP>#N,_)I/](4<JO]Y&7MOX4 E%B^QB
MHL^B'0PK<9P2<D.TYX=QJ.<DYA-/8J]'MMV=3KLV]\K?8*LN9-P*"9EQ-O]4
MS8I;X^8/BUS4Z12?J1SV<<I.QA-@$("3+_-34FLV>GXF9V VH/B_A@N3"*X%
MT+_1Y?<KM/S72I8L2HAXV46^O8S)6XB9SQIDK+_Z@POU-9T\DV?AAE22J\P3
M.QH-VNYX'+">*T@4NGUX40QB#J;M<8KXM_6_UB>!N)7A44XUO. $.4<L:\F)
MJAZ$<4:+]?ZX=SR.TK^6^3/5H&REU5_F,8.X#QIPK,RS"JS\/4_\*R)M;6.]
M\NVBZ B0K4*$3DJ-V(7+#ZL#9.QPLGDN]LY%C9%592 ?IW90?Y678Z8>2UZ4
M^?F'+_0*U.86E-T9E%U*J+/IJ]K#7!LFY^"&O*JY4LNP^"HHQU&[R!'LMO]]
M/*[8,"_87BS[*XZV+X=<Q+(/MP^G%JV T!_32[9=K%CNX_'+IX+5J]N[&&SN
MB"U!006'8 $(<M(D%))D+M$@ M=O,K7K2DW]?:RD_G&E&@ BI9AYBIBYTO17
M?&>ASK\]"V[>+GIH+MS,KILYS%F\#U\V/TZ3=2+E8_+CN%G7E"\_BPLF@CPV
MK>RVSS25SS%8@9\CF>_9!GN_M+LR/VY%CF++G+#'Y(3]<J^/?]F4N!NC8Y\O
MK+],:W@GY[3:*B-]"EP9RE4P-@:CB"*8):&,?WA[QML,N>M&X$6KQM]CMG&_
M1M^UPV$[P43F@7\\# U[^EY.<T]KYZ$-YMU^O;%':KUMW.K41+/QJ=OLU4Z:
MY]_.6EM?VZW&@;A>7'SSO$ZW83R;9*?Z[:S9^=JKG7?W:S^^MYOGOW?JC<\'
MK:W/W9U&MU/D><V=YBKL@^=!(>F)0ES8B&Q(%D4?< PZ=]0-:QML00?E%4U]
M*+.\2G'X/.(PARZIH(.TGG#&M>:<*2Y$Y-9%'TDA#O&%.+Q'_$HI#E]?',['
MI]$0"4D2*<)2;DF=(XN=1@P'*;5UP4:1Q6$I#4MI^ ZEX4.:=U/LK#2!.8T-
MIY)IEI+B/@@:LL=99G%(S(4XQ(O$8:Y( 3^5<G'EY.*U/ LLF7-,("*B0SP%
MC(SV GFM"76!$_@XMXB]7@S@_LV^R^38Y\Z^N*46SB^?!Z9I<K#)!8]4<,MR
MZ>@8J1=:)P<VKBF-W;<FQ;:O&;L$*'O"VJ,(F@IQ2BPRL.HH4<>33"PZ+4&*
MJ57*%2L3/I=-7)0)PAK.0=]X'L&<P\8P$ZU4VE(?Z3WLN)*XK"SDYPRZP)W!
M1D;$J#2(*^61Q=0A$G+O6&&<3;F.T?6^>??G+2785QCLVN?Z#$$3P0RW0IJ8
M**!?.2FXLB&65LH;!ONU2CX\F!2319)+C'AP KE *(I1 K4C 8S5G)J$S6J@
M_0Y#Y"*$!<89;Q<0;_F;]T[,XJL>-+]ZB5FY,OI%GE#[<*YF^21HMV(GL;RI
M\K>'E,VP04HA!"<).+666BEF<\EYG2C3QB[57)H<9E]T&)EJEI$%YU4(^,?0
M.1[+7!# .ZD0J>\Y%?3Q<:,'Y_7J-UZO[L%_N9-Q;1<G["Q+&AF7'.*2>J1#
M(B@2,(J2$HYX($K\IFJ/O7$84;&][#@J'';4(D#<*%)?"J@/V>:*D!1U3#A*
MQQF'&<JU!91F'LP%&_7SV KE?E_V?M\6M7._RSW1@L-:2>T3XLD0E'M_H0BD
M0>"HB/3 #VXL\S?9XQ]RSNK1.,6H>_;AE2-Y+[,_<Q[')(<C+NX:\Y3VR[]>
M1U9V<T?6LK=JV5MU^?NP[*VZRKU5%W:>?'0GR55JX+>=WS\.1Y6ON;G:^^W>
M5_3(M)5>^[1H-M<^S?FE\)X_[:!=R(W\FD5L[/TZK,L/15<Z>P@Z8-)M;C*1
MQ8TN2EQ\*!Z2V^SUBW[OW<E(9K\]/J&[NE_1(VZJ2V=NX#"X+&QQ[<K9[G47
M*;4YFW94-.1LIW8Q=+CP)S#3\==#.Z68^4&LN#@ZB?%P:E92MS_.$;I\VH4E
M">_@)VE.+O>ZO[@'#!X6V.X-8@RH:&9_V97K: #69OOHLC_79:F-\6M?;V,7
MV^,$JHM.F3ES\:JKYR0OZ9[9]JN5TO;'7)+TU4M-DL\7[8O9R;F:E4E^UM_;
MZW']PV5!D7R7RY:(L"KC#=[NMD=%M9-<B<,7V=3'H_R-J7:D1<M'V/7SF=VV
M<F2S(^LX9VWG'HC_F$W37LV\WQ5/O=Y.<VL]W:/VCA7/LW_%]L=POFB&NYJ+
M\6:R(\>3-X^ <8_/Z15J%[5W)F[\L7#M5Z(=' ($AY7^S[&XGF1L9UAVV^D2
MY)/"0%G9K(\?..VKF[EO40S)WF_VIA,[K^V92;V;!3F;UTH370SD4E3 _5R<
M'5>N4C018H<@72N$5GHPN?N3$@[3_9*OYYGZ:3)[U2EY7 QJWE!]"V)]FFA<
MBL6<35N8A6AD3^<3F=^#>TPG)8+5A*F4>*)12Q*2,%9&E?M?+-<+_ =LZ$^P
MGV?.TS[FZ5U\G/8OV(;OO1C@XSUBFR<P#E)K;-+:^3<.[[.KH]8^"H*8(0EQ
M;S&RPE!$6"#2"<T8I6L;YJ;8YXEW['5K>CUD\UHLG6=28L\8#TG:P(-.CE$#
MN\/AL-1X_G+S+G/SPF>-C[N!J@B;EB!G=42<6(NL\1B9Z$,@PL!>9FL;ZHX-
M6VC!OSTDIL!:#YL&<YF8X)PDDV(('/8/\QS#)GJ>F(+'[J!?>I/XW22(<XIP
M%&#!QIM$@R!#$2MEJ3':: ^;Y+K/_Q^SNP2HSFH1ZI6V;F:8Z(R5<]EQ^R9^
M.E./,;N?[E5V9/909CV[%R:$ZY*-3>Z?VAD1Q2/&)^*7U:OL L+VT'/QI3$B
M%TX?+@YR-:_&52&OG715(GG[LH!HJ74>*5!J^<#\;*?QD=6JWUB]<[!K!+=4
M&XQHT3I,&H-,(!$T$/Q(E:=!I+4-?CVZ<%:V%&Z7$YOW*H _'^8=7Y1EFV]@
M/U>F[2%;,P<_1BF!WUC-C2+.1"!V D:MI)(AE>V*7F+;[%2_[2KAE=6"(BVD
M0APK8-J)<>13PBK%R(6$;2/P34G7%_LFN['[@Q,[R/%JV4$W[:Z]<A_>;$[?
M;#_?Y_SDM0UO0L>%+N[A,KWF.Y[VF69_6J$K1M=<I_,E+6>\M=G;/<S%H&$(
MMM*]]+'F?^8#(IB<L:ODJ#\8C7$.PRP\0/=ULWZX?00W^8LG1:KOO';L[K\\
M]P 5.?_6/3LX*&J"33UD.%:OTQ6HIQ7L/17X520:[.'I1UX;YO!RT8K:8NW>
MDOQ*"X_TK,>)2DS @(@<AF=TI)YKJYP5.C V%JK%F>K'+.JP<)P*'F0@CAL<
MP836D8'P3]$PG?-)WHS_ZO*XYF)E9\OA7NJ@Q7QN<;'RVVO'7>V!^:IQ3SS9
M>=DB<4#GUO$XFN.A5>*86:>,+;^6F5D7\G$ETF[_3#['8-5;&ZPIJ\2]ORIQ
MA255J4YXPY0K\]>LF596S/O%2L9M+R"2MZ6,W^/U;\SE?V.M_#[-FP_/T<:O
M+++R:Q19>5#Z 0N6:.RE<5PR9X+$EF)'M& XIQ^4_0QSQN%1I][9/*MO;9[G
MSVHPQE8'GM7Y@IN- ];L['=W?K1@[-OD6C,T>%JML0W?J[':^>9IJ_&UE]^K
M7OVZO],([9VM;Z+5VQ;-SC>\J%X4L9IG;R\"6Y$B[H/.=5$4@A6C+&*EO5-K
M&^I&3\[*%4<I95DIRYZIZZ-BN;NV=-103O*I'/:.1FHISQX6__2NCZ4L>Y L
MNU;C*7A"7/+(!^P1B#6,++$&.2<LK)O)S3K?E"S[%0H]?;J'_[\RU<[M*64F
MW@97_V/N7'D9;_Z+%=A8J4/%4JH_0*I?+X"3O+5!"A#CW"G$M6$(EL@AR7TD
M(D58.7G;66-9!N<=H-3GHRDFP)+D@AM*M-*!10$PE3C:Y,J.VZL$X7EB9G@0
M@D:-?,RE&32-R"IO4(R<93/311YRQVV\4B N"[N\2#?4X@@?YA%=3]B[9(#C
MI+SQ>>Q,GF#QS4GJ2C[W[Q_F)9T-*SBR9^,K^U=]4KM]&%$.19JTVRUR5.8"
M"HIXAAL&Y>QP7+'@S^W?=[Y>R^.[M1+!BFZ5(AAE<4C!G2$"<R$%/G'K*8:+
MP.3"$:SD$*FD6*E ++=ITI_YVB2]SB:%%U_<L7GQ9-S]<E.;^^;\N/FMVVN/
MVGO3:;?7 D^+@)K*1;0"?#I)?RP"7]K#X7%.GLLA(O/S>N\LTY7)Z!Z'!N=,
M[LKF10KQVTZI.CH>^'T[[E(\;!_.M"'NM[MH+%!R,'3_L-@YQY-4[2R48"3'
M"?1A7NU^NA1B1X-^./:CX7KE+]!>121L[IAZZ ?1CA.T*R?]03?D!^0,9A\G
M";+=:,-X>TU]M1C7Y3AA*,.<*MT_ANO;\ Y^=+'?^D=Q,):)%U%)E4^%^(2Y
M*P*:X._9=&ZXX20M/(S'46SE'%HS[/MVL9US,MXD5 HFH=</.0[M:M)&^Z#E
M]_:G/IN*UKD((<R;/M.&27C7?-3/_:[-"><W!?L4,3[3>8'CU/@B*F[\X4,,
M3T,MR QM8LP5R(3EE%EIA"&>)^_(<J-9QUKV/ [ZEVP6OU$V^X1FL[3>V-[E
MVA$>%$%!PQ]<6)VS;AR*WALI11!*T0<9)R%P$Y+0DB;/=<HK*IEB5LB$K5!A
MN<9)N9*7*ZF5],93CX008%<HX9'&C",BG8-U%)%0O[9QV+]F5%S[1:5_/,HM
MI3,)>(R@J$QD!)EO0;V0";YT>)_1ZWH<2?;0Z#Y)U_68&"XYLLWHFQ_ZV,@V
MLZ[E<S26E7SY47AO::P$KU-\O^4J*\(^O'9L.5T/G*Z+KTS(-AL'3"\KON]7
M^.KMKJU%M<5>6&&)=?8XA:7HNL"/$YZWBD"R+N5SZ$&IGJ'#>A[L_=3 FQ-
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MVFSL=VJY)^36-Y'G9J>QR5O56NZ:?KI3W63UK59FOTX)K(0RR(8<NR181":
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M]^J]_SO_LNNEI2;D[ ,=">+:*F2(SUF(! NAA8DNKFWP=6IN[U\R"8^@M&#
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MW>I]/:B??X;_OG;JG>^=^E:3M;8^=6OT"RW>^T?S-/NVZ]6B-(=5GEK-)?(
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M)%1KM?(3W\D+X>"XG=*QYQ67)0KP5P!*S))H:*0<GW8K.18@+P\09A=$4.%
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MV*S$#(O I7HRSGYYN'3Y59$'F6 WH^U^OU'N:>K"G2\:?7=1DWL\CNY=95B
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MY:6KPZO^;'?]P2OE_)W_[F/?^79HOYN3K=9G>%>[6=O8YCOU#ZS6VAXT6GO
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MNF\OY;,M*TI-VP$7E"S!# G1>D ],/>MM%XSZHB!?U7IJGQ6A!MS5;)=ZXR
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M:;UH"N7\-:?%"((C3Y%<.?-BCJ_G6^M'/C'_Q8Y>>("6PDT4R3E%8Q!<! P
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M[?NV<[4>(H$-EC8IKH/&7!IMI;)&:J9],IJ.:NH]PMM9RM4'8=RX0Q,KHD
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MX7&'4L*:!T4UPBH)Q!-SR%%JD:2,*9V2\;D\-=<+Q,)E:-(M; A<EQ036M!
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MHL'B)(ER%'B0>6&"]\0I%YAE.FD^$IF,D;*D_@(QI+\O:H1LK>^T=NJA6>W
M<SJ;N%:'=]0_@=T/:]'YJU6C._L[Z^U6=;*8#=WUB47%7$!<@@[-H^!(VZ 0
MXYI8#&2BB<PE]2>UZ=D+ZL]&B:5?Z772W)A?Z2O=M5H+ZS%#/B@.6J$&8>*
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M"^)-E%@K1P@Q*VMB;GG'3XYESY0F]8(F\M6YT)VND3<?1_=D]F!Q&G1M"TH
M>A  ;4X8AM)3XX7Q2&B?V^4J P"D'.(4Q(0W0G,;LS*U0"%S9=3K:[%X2FY]
M++>.F3Z)4&*U5"AO5$XHL<A9A5$0VBI0Z*Q+'+AUD2I&EMSZ6G3ZDEL?R:WC
MRCVSQ,'N!$2% 8F*N43:"XZB$BXHYD7*]5WY9//1I:_O^G+J>[T+U#T6S%(>
M<)6.E!<U:"["VTK$?1#B5B>LF8"QL"(8A&,^YM(X(..M0Q+DI7+.X\!IUH\>
MK2"5KN$2T5XWHCVMT5<BVJR(=CZN0WIEE+3(&H UCFU 5NJ$;"*"@\1)E@&B
M"4)+1"L1[6TCVM,:QB6BS8AHXU9Q3(PKC3V*G&C$4Y#(22D1T9XQYR-ST@.B
MJ7D5_RN/O![+@Q=\4#FRS?"N<AB+K"!;U!WI7TLKFC@0NV\%1ELS2JM@L/ZA
M>Y*3-"[F=&WO;OEVF6'\"59H:8#^R8SQOX&^:W%I:ND\$\1O3YCAC$7L0XI(
M)<!Y'D5"QA&%=" X"JY8R+5TF)E7(8XY<LD+'W.4B%DBYFLR]DO$G!$QQ\U\
M+;W"B2/'G$4@VF@NF1L0; F+'@<M>3XJNJ4G3HF8)6*6B/EZG DE8LZ&F!.1
MLSG#GR6,DC2@8P85D366(4X<)Y$&97AV(Y!YU6M< ,2\62MNLKS5'66O<BV%
M@L3N+Q9$^<K/*S 0^@RE3.XN^5,AJC(JY?-4M4>N^-5W.[%NS]:;?=_N]D]Z
M"U1S9/N"90>-SJ=!8^ 'M7J[4VM5<:.UWVS4_]S?V6@(^)_7.I];N8Y(HSE>
M<Z0&U]5:F9VVOC=H[N>WM?'7?G7C\\%.JPW_[P&[PW?KH?G?P5<"[]S5P%O4
M8X<BT [B2L:LI%!DJ?14:A%58N,U1WRPGBCGI&6).TDLPY)%%J@/@E+#QFN.
M#)>] NL>^S\O$7)K&9#[7S=6$D59$9S-A\.8)ZN-UI8F!1:JB59Y>F>I(KD8
MI8H*SOB[U_W1[.<UR(58;J[@V(H](</\X_=C.&G'K?3QHI!0?RM=LM$H8^3/
M>!A3\WC!:OB\ #^M-W:CTMXJ01&Q$2/.,$.&6HFH$8%32@4G=)Q@#1-@S#G8
MKY X!Y/.)&RQ=%Q(HZ.4X_ST:JI4'5T2\:]N2"._%>3<')+S<2;G*8H,Y5I5
MS7XN!M=-[Z>L*319A>+9JP4!9ZWBH8[ZX')!9I7C)RAJ Q0QK%\T[PH\,S[U
MWMI&LZW!"PUVN@&5Y8)>6\&8LES06Y[^6RL7-.P3\WZ*37_<\?P\VG(_YAE+
M.L@Y12X4S@Q5*)"+2ZN?(RR.;3\FJ6))_;_+Z<"=>Y# ".Q&=#1AT2Z00W<V
M:W;DT!75[U]%=1W>W]H^JPZV,=BR?&LC5YW=/JT-/ITVOG\YJ&XT!K7FN$/W
MX&RG?G!:A;G5UC\-:NM?6HW!'M]9KY[6UC^P:O'>[=/<PN^V3&3KO%8FR5%9
ME]S!PZ3@41*<,FX#[)9962-J@;*EGND(J\2@19K;2QZ[EQ@T9PP:.X;W/+DH
ML4 N<H:X-129'*H:G+8\TNQA8RMKZM'!]B4&E1CTF+G]^KPGV7?T-"O1:+YH
M-'[$[:-,27N"7) 4<4\BLAIPB3B1F&;6A117UN1D;:@)Q]HK2AU_%<9DT5ZF
MZ('0[L)XWN53BO9)GD;E[Q,89+?RI>F[,]6'NF55EJ^&Q5,99\6^?#@,_\F[
M4@+2XP!I,KW:<  >SS%B! PSSKE#AFB&$L->.="40(5=66/SRD5<H'3#DG6?
MVJ8I67>^K#MFV=! /&<"= DA@'4=8\BFB!')P0,ZY5 PO++&2]9=8M:=>TQK
MR;I/P;KC9H#5R<?@$_(J<<0354BGZ)!RL&G*"*6YFD<9J3FR[ILZ6.KVX,_#
MLACLLY_$#!>^!)S' <YD^B;A.A!')-*!A9R^29!Q.%<? 9W/<XHU"RMK]/%%
MJ1?/#5IR[9.?791<.R>N'4\A=$%R3Q*2P)F(>T:0!:L<21PUUS9XRA)PK2B+
MPRXQUSZ5BE]R[9RX=ERYEYH"8XJ(" O M2Y'/6 E$%=:,ZN"B$FLK+&%.G)\
MK*>_K.55UO)Z(9OACG2D$L8>!&-?)TP&I:0T6@1DHJ*(6^R0DR&@X'@"TT$R
M)RTH'^K1T5MEF<(2VEXWM#V5855"VYR@;<RN"E%80Z1#F@N>RPLH!'JU0,)0
MIW%D,5(/&MHM81@EM)70]J:@[:FLSQ+:Y@-MX\:GP(EQP@'+2#8YA0.MS1J!
M5/(JDI 8_ !HXZ]&:UOZ4JSK,<5<A7BVE+N;I6SNJ50S4RK:M(ZZMSS*MQ0H
MN0ZXW8>A/.80>DGU@U>D CPDW'P.GIL[PLTOL&\4;UXJ!?-0"OR$*\<EJ83
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MP##D6X>QWP&LPO7\5QF(W\X1:3!<W6NAHE+2TE 1++4<-G&'02=42;A$G.$
ME??S;&H[T(SM]'H\61<*:0(E^8TPZA_W^F$0N\\.1)]/FL<@%#EF+0\(A"4!
M<J*B"/0X@5A4S"<I \F9V/)2/@$*G-ZW\CH]%\H(*^>ZF14@H(&F($$<R]CC
MSEJGG%>>A5S$B2U\9G.3G]^T8IC69!5)L*,BDZP%448(9$'D1X01X$:NDR]=
MO,7,A.8AJS;3S#O5UIR3PX#@;O?/X[OBD(SRTI_E*I89-(K!/$O$<>R2@@>
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ML.A1"84\THV=/CR]FI?!31R]Y5)YN6^-^F7]F")CN2Q*5I;-N%C@$!9".*L
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M@7;(UC:-J?FSYL^:/Y?W5*9FS7MES:DCF9B$$,&#G.ES42T2"3(J, 2,&4T
M6519N[9)%^6HN*34N7P'):MR9WF@\_O0NG9\<'*BF9P:]?_N^7]G& _%]\U_
MPX_)%(_QB/).OL'D9'LONB%VAQN(Z%+:>(Q%<:ZV\<.__H\+XR+732EU[1S$
MANT )5:1#^U1B%4UYI_%F?O1]_:[.0=*3B]7Y9$;-(:]!NR!C62+?N.[;8]B
MSGS@@>/@RXU8%F8[5^IYL-YH7'Q5(Q_TE,G \X[;@'VV=]8 V\CO+B_FMKR
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MXE6TZ("_%%^C*1\Q^.F'8(6H'TC#C8U3V+1C9O#KU(\\^"'<E@YGS"#P7T9
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M=BJ#+UD:\& DS"CA-([.$?Y^09(AB*P0'PZ[DN&C0OC11UP2<<^A:R/Y@,M
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M>(5[*V0#B@HHT"NF,H?K9P>VQ_CQ.=P,JX)F,R"[$%LY3Z<1&^'H]>KIT2=
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M/LN34[,GIRJ+3TZ==7Q[!#]Z4=_]]?\ 4$L#!!0    ( $R'=E4PE)Z?<2
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MW[_^\BZ=XT6 \72Q#--4'[ 8_V6Q>O&760K+U9P_BNO)O>^H/\'5VZ"^!%R
MY'_^O,@__.U/3YZLIV,^F^!;+$_JOW]_^^K:(V/^<YI=_%A_]>.SV70QFXQS
ME>N[)7VM@E[,RBLBQ$5%O_JTY9</^-<?%N.+#Y.OKYW/L?SUAY@_0Y4R\Y)5
M"/_[D0_\\1O$%";I<K*:D5_HY\W'5E1-T.+G)4XSKB?EZIF36;KVIDD5R6Q^
M]9>3$'&R>G5TN8"S$#Z,UA_]RVRQ>$E4)P#+\?225LKK#SA?85^,N)'2)&.
M*Z*GRD5!-"F"$-EZ7K+A@EV?M3J\!8UO)=H2%G$EW\TC?ZSS^2-.EHNK5U8S
MO)K=W5&M9[K/<?^$93;']?O>A\^X>/%Y.0^S.>TC8?[E%0EG\=N,?CM=DNSH
M,6>OIDN<XV(Y<L)9)Y@#&5P$%2RM\4!3E[.P(G&:-U:./F$'#^?Z3&^Q^ND\
M/:&_QSEMLC\\^81U2]SLM^NQA7FZ1??KJWWSCA\7EQ<7J\^$,0&Y^ONZ^?;*
MUN5LF*18DY@FIPW+">B+SQ]PNL"?<(IEO!S1?L:5P0#2"@M*) %.*$9@;,D%
MN8LQ]\+06U!V89?XQB[X_NG531K-J/$;+K\-=Z0]ERZ8 "7S ,I),D:L=Y"]
MBVB1RQ)T8T)< ]#_=CYR*#5#(8 709)+*H!+WI+XO$7A+2/C[,1J[+2;Z^&,
MV'\?W4L:C;?#*US/QXNTAH;Y&S*:A=>%UNC3Y7(^CI?+$"?X?O86/\SF]-:S
M%_0'RR\C;Q)FE@BOY[1D:2RT9(,'(VSF9.!SS6VO9.H ?L\M][ODW+%DVXR:
M+\)\2A 6;W#^[CS,\?EX<DE> *V3;+3+'GC290TF6J7 AB LS]R6:!H3[1XH
MQUQ\].C-4U<(1B%P1BK1 @:: !49[1;*"<BF^%BR*VC#"9?;#;A#VM1;\*K+
M4NLBR9[V_;OTT4V8.4NG1,Y 5COM1!P9!,8]Q.A%X2*Z8OHEW X@A[2/]T^S
MUE)K1JX-G.KJ?55D42MEHT80J83J)3B( 0VHPJ+'(),0L3%][H#1=61O\2/2
MJB9C321G$PHH526KH@IXYS4Y/5X(M"X&BXV'<_7L(>VE725]D^ 'S6\SWCZ;
M+9:+I].\<487(T6>)AG>A-TG^H+HP ?/:&2.*>62+*:UE&]B&%0TH+6X.TUX
M?V(GW(R>A:!H4P:E21D[R0H4+8V/7 @R>8\J]L/&]+K\/)OE^JGO</YQG'#Q
M;C;)HRQ9%HY\B&)T)'N#UE<(T0-&9S*31KCFD:[[T0QI,^O$@[NHW4  S4C^
M#E?!UY]Q2DMX0I">YHOQ=+Q8U@7]$3=C'B5R,Z5GY-\5D6DU9P7..0NIF$SV
MBI"9MZ;^;LB&9-HU)4H/@FE&FK>X0/J8<T+UG#3S9/:A'K]=06*&"UDL43C5
M_1X3;=9%UA PL5F7G!/CS6V@!P#M0A'Y/5*DG1@Z,R/FSZ.GZ5^7X\6XSL);
MG-23V:O1$M#E_#(M+^?$Z&?D@)S1R!G9 9%YK&?Y@A0[4Q"THCW/V\*"0F65
M?.2(>?^G[L(%]3UQH>>);^?[+<]Q?L-.W S\-UR.+!EQP0@)A:82E)$!O*&9
MT(Y[ H5D3;8V/AY&M M1]+'LZZ:[1D-)]!;3_2DLQFG$C?>AE B1.1IEJN'E
MJ!(PR5*Q3ACF6\<&[@1RE*#:ZDF;R)\OA2-*D"46VJ^1G-Q@(G"7,EF(T@7;
M[Y')HQ"'9)YWY\Y!X;0#Y762$[KK<*4ICK,D0&K+02DFP%LM@47&A(TL<MGO
M\>X>8(=DWO=-M+YDV$\BQ-./83Q9'PL^FUU<S*;OEK/TSW-R9'&^6$]-,L;*
MDI#FPI!O8DP-,@<&EMFL33;(2NOLKCTAMDT-D4:3B[ZRJ;@'Q50!1^P@?]X4
M710GS=Q:7SV0&C*@%(G&7+FYC Z70K.E\8;$B?-Y34:ED3T??QQGG.;%&M;7
M!-57%Q]"6H[(V-8\HP-+7PFA8^ 3UZ"U*9FL<\>%:LR3?? -*K1\3![U)L0C
M'L\>GG893"E"D:4OHDV@D)-*2T$ 63"Q*+39G,#J;)2+V^:LTDMOZ7\!G*^)
MJ9YS\+)DR$GJ4"1YSNB/?58Y]"SCX_#QEH_;47H-%^QZ-%=!.1XQ*<DE8/8T
M*"42>)8U<!J>5BADT:GY(KL&85"[^U#YTT5L#;GSD2"L5,YJ^%]'AH&)($4!
M74Q-%>$) C<6'(V*M!\WN;3.=+L/RY!BZ\,E4P,YM@W$TBAG=T8 1[0;.A&T
M >U*JF:-(G?66]HJA54BI^!T:Y_M841#BM@/E6$-97J#9__QX\UI_X5^;G>[
MD,SX#W,\)YCCC]C\JN%=G][/O<-'Q]'H$N(=S[D*$(T4KX'_6"7,)"@=#3C+
MZAF!BXP;07)N[58^ *=M:$5I5J0(EMRZZ$ YHG"D%R#$3#Z;(")C:[MIL*&5
M5AQX.(RRSXRW54YWC*\B^CK&X!(S7G@(+@I001$RQY&V,VV4-EY+V3H791=<
M0PI5]T61YO(Y+G-(SP6.R0!Z09S.QD'428'(3/DH1"K-=Y']F=-V["_)'!F?
M39]=SN<X35_>S\-T$=**EM.\^FE#TOP_EVLC]>MLH:)94L:#,R1"Q:K38W,&
MB2)PSC%'U_J<J)^1#&GS;L[3?9;HD<APE$7]IKZP KYZUYO98CG'Y7B^LL@V
M]X7?3&A(=PS&).LD,@U95W<^BPS>"]JAG!-%6O2R- _D]3.4045S3LKM8_'A
M*.1^%A;G+R>S3_^)^0Q_#N/IZO2CD*OX%M,D+!;C,EZ7D*D+-WQ^$VA!+T>9
M5FE"IZ&44I-!-0?G. >!7&0N63TL/B*O#QO%D$)*)V7T$4AP!&__IS"IY8_>
MG2,N%QU]^^N?U<Z3?P!C([]]^Z#RQ;\NZ^7I4I0P0@GPRC%02-QQ7FLRQI7G
M6A@F4^MB0;=1M#WW_J\PN<01\BC)Z/>@Q>J.%D;PHJ2:(!.Y1.5L\]M1=\ 8
MDM'74?H/GU/O/^D-;TA]/81?H]!1)2Y4AGJYE$:5 T1N$+3'8%,*0=OV-Z2N
M8QB2&]Y8[IVFNYG0G^:\2C4/DS=AG%]-GX4/XV68;($;A<AUT(3&1DW.0CW=
M"!(+*%(_:&71JGD1@L=1#<FN:$R,QB)I>$]H268+YJO,R:<I75Y<KFXH/"=[
M/(V7HR -]ZDFSR@M0&DN(&(DDT7PR)%([)KG>#^.:DAG3HVITE@D32X.;?%T
ME=VZ^$^<$(M?D'4X^X+X?D[^&A]E;J5)+-:D+H)%WX.W,=)F%TC",CJ5]".V
MY,X/V_/VQ_= @'XFNME6\7Z.87$Y_[*EW4*04OM:\16]!L601LDT0HXN"D:N
M>LBMXX^W4>S"!'.L $OCO:#CG+>S*+[M03LYW$5HJTT(0%L3Z;(D%>U-N@!9
MND9%)XPVK:W,/2'NPAK[?>T?QQ!6,T;],@YQ/"&;"!?K8/=RY%7Q4B@#+"1/
M6@U)OQ5+MC*+R5D4Z)O'?&^C:+!29I?3Y>)-^%+3H*_&9FR)2!LU%#1^?2>0
ME'@D>4;.@BQD[LGV"^(.)$-RNCMRX [>=YWZ=M<E-PI[<]OWCI$:5(*G[*L.
MIU4GT$#4C+ )328<>B--ZRJECX(:DF?>F!QM!=+'-OBZ/!\O/LP68?+S?';Y
M@3;JR66M\W_GI;,KT#+&R*W1((-RI"=6EJ HD(/564E>DF\=R>L(>4A.?F..
M'5.8S1CX'./R"H!+*D@?.(2,Y%RX6G< =0::$B=$+MB^0.?6XX?DTS=FQJ&3
MW-* GQ/EMM)>K^"0G2F=)B0EE$)[7\QD<_($W"NA0Q IEAXLD[O!#,FI;V^<
M-!! :S[<,4BN R^:' %1BJO5W,CS<(5#O7RCHF6H=0^NV]U@]G3MOT,^=!1
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MAG1=]SM:!*<F5-^;_IWW2$DO!<NQUL9@681Z#XL31'(G3:153? #;UZB:2^
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MC]OSPM?OSASJ2S*]:*I7B\4ES02^GK\+$S+6-E69E"M6&'2@8TV/ES% 4"J
MYHH;F\G+;!ZN?AS5D,IK#T1'-1!?O[2Z'J)@6DCND@==NT,H5(*&S?2JH[GQ
M)3C.6N?"/([J.[B]=3):'2Z^7FBUY6&N<LKNF)<1@7&F1BUXO<^C/ KPM4Z]
M,S)JIKE@J<^M:P>(^U[;^B,PKK5D3W7DQ<C^3T: =#:"$E* 8Z8 MRIY);GA
MHG4#F@Y'7H?E3NY E7MFQQ4ON'8)R!BFV4'#P86,8+U&DPQY[<T+!G<"/*1,
MO?YX>*M4]=%DW#2E=X?$P'L@6QX8=YC!LTS6DDBDUISB8*2Q,?J49?-#KDZ
MAY1E=UI:]B/C7FEY1U+??2LI\NQB,N!#/<^SQ4%=0Q"<23P4QK)H?<.K$^ A
M9<B=EI;]R+BG4L4U*O&ZE%EY<1$Q+<.SV?S#<UR&\>20(L4/?5JW\L0[XVQ4
MF/CZG=J[Y;>Z4/4^?'ZZ7,['\7)9KW6_G[W%#[4JY_3L!?T!>>,L9Z^$<Y S
M^G5E'X=$-%NT)T]=:='<[&D&OD%S[MN/IH=>I<3=^?N1<]$F;C-$K<C23TA>
M1;VL[+.I);RM<:J'MMS[ QU43LII"'M'4^^>!=ZNFMI=4':8Q9^PS.;XM9#7
M*)3(A>8:$GH.JI9WCM()")X)FD'E<FX=<6@$?4B6Y(#IVS,G6A)ZURXO7RWG
M366<D>()38P12JHAXY!I+?+L(?"BJX4B#6_M!'6 V^74;(_'UAQ<),&<?^MQ
M7:-45W,634+!/<V9XJPV]R*BF=K'"9,W3''OO'G$7FH*:$CQBF-Q<?O4[322
M;7*4N\]T7:N%N]YR-KAK1=RLC+">H*-1M3>EK+6#R.=%1GM.*-E(X=N2\F%
M@\JX'#@K&XKVV*Q\AQ/ZA+.?<4HO3&IMJWPQGHX7R_KKCU>C& 45A.?.@)6R
M@%*QU"JG&1+'(J(BZT_O4BFT.; A!2\&3M(>)-V>K(N'Q[ J@+(8UV\WZ1G/
M9HM5H>?5)9O+M+R<UT+CYV%^5HNRF40:024(,M-8>/3@O#50K+ ./0O![=*]
MHC^$0TH0/3E]3R?[4UCR*_"OR\^S65Z\FTWRB"5?'".+18C:R\-:1]/G)*!B
MHNA24HBMX\8=X XI\?38S#VVM$_J:'YSHD<N"J.BSV!J?Q!RR35XQ;%6+4 =
M<M)!-J]2WPGQ*1WS**)5+# HS@=00CEPR1;@+@2K2)&*FQ;3<!SS$T=$CTC3
M#DNZD\1/L:3?DK],+XQX+9$<2@23(Z]9AG5JM <I)%-.FJA"#U'Z/5$.*<3Y
M??#Q$/$.+B9/^M8758O<1EW[ E5U7$/"UD9=A/8EB-9G;KW$Y/N-(OTVF\[N
MC#:,G(E"%\=IF*5V(S'DO8EL 4/MK&N]9]+NZ_%T 32PT.;1.=HEH-1&RD,Q
M'J4U++F8@0=+LT9F+O@B$V3.<XI>\B):5P-M:3R>7 .=C+HGD/\I./MJNL0Y
M+KX=)601N$4!5B9&UEQ1$(TRI+H]S91348@36DDWT [J*OMW1M8N@C]B;M>Z
M]TF8;G>=F-V=EK%HFP=VR)/;YXQU'G^C_+*MQZ^R8G:E&6GS=#F?UYKQVA5I
MLI" R==23H6#8YFT>>*9.^ND9JVKJW1'?4SSH5H_V\U51'22"Y6A6%.+IG%;
M"P-DVA.2%+'D$O"420XWX [)YCTR6[O8#%V$?@J#8;TA;4U4<,SQD!ED$PJH
M6$_.;)# E5!%RES#O:=CZ4VXQU[/F]Y=1?L8A6)0(FEVE<EK\;:VR]%%,A]4
M\+9U):##D YI%1^+E5V7[P$R/L7*K:<PG\:3"1^1%6E-1@?%6P&*206!_&?(
MH>YK+M%L]1!NVAOGP%S1H7/Q,/F>@HGW]Q4BVD@I#8)D.H)*I?:I-A+(4T9#
MJC?$T$-R<F?<WVD^SJF8VD;^[5KW'F@M/MO,6DHJ%R=HX^>:-G[DM7X%4V!H
MVKQ/G'O16KEWA'RDJ/T+<KUG7Q WB2M;H*^F+I2<=#8)1(ZNUFN,X(03D')R
M6$P(Z':I]=,2TY LH&,R\\"8?5L9G\2CN=W6-'E!^Z SX- E4!8E>*54#<2)
MA,R@NYE!=U2?YJ NML>RE$[!V>-+_41$W>[(.^*>-'*4&6@W)&U=3[MI<05(
M3&6N2)-+=D*G\@;:(9E(WP]%#Y9W,WZN;<3#IDEY*Q$MQ) L**YI*<E #K'Q
MMB8"VIA*8WX>CO8$Z_BWV1)K(N\OLU!O^"0<?ZQRKG<G:A>D7'0"+FO; X\,
M2$U*8-K*& ,&;UO'RIL.8$A&U)$8W&"A-R+$:<Z1/]*$S>9?KJ8.O74F< XA
M5&5*NR)M5AK!L>0*;5:8;J;D'/<@^3K<(1E0P^=K)V&?)N"$'\(XT]+:#MB:
MPI3/A)7[D.O-:P>AQCW("BP"E=+9M:YNW17SD*RHX?.TN]A[RG1X$>93 KT@
MH._.PQS_L9(7YJ<?"?D9;GH0U-\L:HV>\91>^7"Y7!_SS\I/83%.89J?CR>7
M]%=7G_9F\VF'YT$<!U>W+(D3S%VC'(H;2'^[O(@XK^MGA60-^?7E<K$D>(1I
M1,ZG=#K3-BJU 15D 9<1(6I6G'9%^]*ZZ^2>$+MNX?<\[M9S5D(;&5N4DY*!
ML+SV>HD*/*=U; Q],D\V\M3ZJMA> (=D]/;)M9L[<G]2;&8KW GQOLEXFO_G
M<K%<G4>0;9U*, :DK0<B.7CPFM6Z?#(RYK/4NK45>R#4(5FP)R=?8\DVH^&J
MZ6%]?)ALZZGK!8*>S<B\GB]J=D$A"Z8@V4QYW9!(<B9<;4CD"&9M%2,@*F6(
M1+52#\-H5>N*Y!TA#\E@/28MCRGIOM)Q\:P.X'E8ADU!W3!Y-2VS^7JRZ9MJ
M687IE\7FG9L$U$/R;P]]5,>$VR8C[*6"X[.U,S/>+E]^(U,<%R\^+^>!%A%A
MGW]Y1=Q?G>737]+H)JM[".L<[U'2)G/K'/# B,F1F!R9]R!B(-<\<<UBZRO,
M/0ZG^RZ\_IQ;%6MD,3)E4@>Y* :U? UXXR(H;4T*4DDK6U_6N0_+D&S)H3#S
M]A[;0(XM=?N^L_3K>#J;CY=?K@;R=)JO?\JZ0<JON#RO#9-KF=[5+C1R*O%8
M$H.,M:>VP4R:B92%<")[SK.C23W]>CYT>$,R98?+_6&RK4EMI#UKW@C-$\L%
M@9M2.\SGVM]#:\C.>>?1.L-W:2C7OH;1T>Z>#8VE/0NQ)X/W)YQB&2]K5F*M
MW?J&U E]5MA$C]\0^CDNQVNSOH[E8'/WP =U,W9;C*Z1J?N<@$PQ;R%: 9J/
M9WF<-J]6""-EG%*J)(A)$2E4S<WATH'0/C.N<DZV>1[6CM@ZGU[=>L[3BUH7
M^-_K>P7D#XYG\W<X_SA.6)^W:>9ILN9,UTI-5LJZ3"Q]QP19.L4K6I":5FOO
M,[(+TB$9L+WP[=:Y5/\";7=T>@OK6TRSL^GXWYAI:GX.XVE5)L\O\?WL'2Z7
MD]6N4/?N9Y?SNBVL?N0C$Z1D7'-@HI2:"(4T7Z(6GN5"ZA*%5\VK/;6!/JPZ
MKZ?A9_\R[Y&PU=U+9%2\1;(CIJ^GJP6W/N!UD<M82Z@+&5<U$!6XH"S9J]*E
M' LWV/Q&XA[X!F4YGHAZC:37([^V=NJ1=";0DP/0HPF2CAYB]@Y0)U6R%RF4
MYKE,#P$:5/W4TQ#H4/'TR)@KCVF%R3%6@I8*DHL6E,@!O%$(01=MF4\QF_[W
MH&U$@ZI<>AK.'"R@'DESW4:L2GA1M7!UB)D,2M@ B5L.9 IJ")*F@HMZ;EE2
M<JIY=O_N\':AD_F=*[$VLCM",./9>9B>X7BZ>>UUG(S/UOEXFU^\#./Y?X7)
M)<[*-TW<)+S1Z='M A[M9J"W$ BQJ>: ?S/*7TU_"I/:U_K=.>)RY).,SAA/
M>Q4+H!(GN\A8"=S%XGU.WL3FV:K[@NQA?UP)XN5L7G_8O+Y]8UDEIDVAE<99
MJ0<\/H-3UD$L6IA<!'?MT\SW!3GL4$A+WNVP9S:49[NF[>M8Z-,[8Z&WQW!U
MLW7[[J TF+ D 4FK1+.4;,W<L*"]X@R3SM:U/CKNCGK@09 ^F7EDD9^,JEN
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M)8HKK2/].P$;DC;KGSD-A=2:/R]G<YKCZ6U0&9GA.IEZ%]Z0-T]Z/2CRYJ/
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MPS7-B[N A"EX%K),#'52R4(VV9E.!-\V\J/GN(E(;]*LFFRQ4R"KL<YSM;"
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M(U<B"4YP0HO;PLMC/GIV.XIQ38)+@^BN#Z=Q-$R_C28P']0\;BXL ;&%5A2
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M@>-&8FQ8%N82.,T%@?L=ODM-N-0*%T9#]D,$YJM1H6MH(F@,C!ME8S$*\O6
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MMF<X5GJ\"9(-[HTV8/C*N/N](6K)QJ2I*!N7HKZ&B#8$\J6Q9N/4Z_'@,HM
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MZPTC]]ZA[]GR;::MNS)_V%2D)>!WDW%:F3M262B8!(N:K'0=5(V]$Y'%G Q
MD9*[UE62.L!]UMP6IVE==."P&4AG!X$?X/LBGD,4(Z-V]9J5UQJ_2M>?ZOVK
MM*+6C?/ED-I[%>VS\C8\"MY% QIF(.V&?$J_7[H1&\3(:\4]Q8*-Y&MR3B]>
MCHK1;T(F&WS(!TQCO@GX68/;:' 7/6B8D;1E6M6O)U]&D^^(JX(8ER9P=G9B
M1.#*HV.\U)1L4/1:@K ,<M0J93#%-\ZDNQ?3L\IV3*9KRWH?R4:7(.UTXJ>C
MDC;'P*PCU%ID$B>2,9^5T]JD;+QK?5K6$?*S4M^V#N]3%_I(1=K6 ;V\BVC
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M(^,ZEM;O+J><V=C.>]A) QW* 1Y-S=D&UTO.;!RDMVVSV781^JCIKD*Q('T
MYXR^Y']-]H5<A!4E&!:Q_W%Q- 9_7RX,D?4A,AN5-8Y'*X$7DT$I(2$0,BC<
MH$JUZXGHU''A%#(;!VEO:&;C$-%W,/[7='"X<VNN@ZRY%$&1T6.D%S7B2_(0
MO #=FU&B*H%A:[]P!YC/A$"]%31*JM!/WV^>$]^&)7Z:S:>X6!VWTH1<6+3
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M/[T<9S[BCU;6.2=OR1I@1=?\7#)"@R,?6T89C2@%76D=*3GEM\-!FM]R(,
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MA&/S,0@K%6\DV/M:[@B8IUVLI]6HQQ[8U*Q-D.2U'^A=W>Z+9*4OF .0TJV
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M6U$ LA/0TG0SQ-K,<'./X,2\^DA@T$I\!5J9P5YH=Q:;'4:.[#7#06>UUNR
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M1B?(NBH1<Y$L\Y:.<0';04D9)P^UCZG032=U@;V_9M5M5WG^DZ#*QMOYO*N
MQ2A BE259QE#A'T*4\PDY%'*:2#"E,3&X7 &XRV-.QOQP+J3SSS2P 3<81*<
M +*I::Z5%FAQ=PTV=#_L&L5WTZ!H'K_A&,V9XCDN1M4JP,,"HX& #Y.GS!8
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M/@LU9+WQ\OH[6V^YX'5[J\W=_;99-3[(UZ30=2G+CZ*H^S/4C0M7(N91C&0
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MQROE:*J7=:VN59^L^'Y?NXX__/;Y%;A7CGQ]%&%Q&O;,[]7YA>>/\[;,$=<
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M:*TQ>*IR[:$KI4?XYV[?"PN/_MEF>Y8]@.>:Z'%[")/,A<M=![<"SK]/,0G
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M> 12' 20I4&@UHX4)T1:+1^SBK^TU>6O0L=S" [)5U&0&[V@Z&06O:^ZSJ0
M^2:'C>:@[I\.:1U*0&H8+%>=>=\3PT5IL;,_]:[NL<"0??_C*[!3NHL7T5KJ
M@G7@051@K^@N9TUOU/>4=;A@/<L<N5K/YA5^WN7N62;F8#5\'BE&EL&,?TH\
MCV_%*\'J4&Q?O3%QFRL0!'$<8N+#A#,?HD@DD*9<0)+BE KU9L7(*)+19+"E
M+42UJ/V"F)W,P*_K%,:6%1Z'<!Y>&ERC-S&1-XBU\!T#;FR-S"$$+0ME.D)R
MUFJ9%R%J7S+3 *)S=3.''C%O\4P#90XJ:)K<,\Y!J1/OMJRJ0Y75#VJ=4(M%
M5:T%UY7(-MOJ)2EO@U4J0BQ322"3-(1(J']1FG@PPF&(/9YB$:>KO*Y!QK^8
M.QB&PQM]"+CY$ Z$F/)CR*'.. 5E+7*]JVAG]YO";V:PNT1SQ@3K3F+0BGP%
M6J'K*H]*:J#%=F<S6\+DR-@U'756*]42BJ?FI>WM[N.7CT>OZ7"W#U('I"8(
M8XX\#",4*K-1)#XDD@=0)IQ0@K'P/*O&2Q?(LC2KL@E498\"5==*C2[VM'BJ
MR!7(1;W97NE8,W>QQN?FT(S\9IJ9B0G1('KX1&APV<05J^F9+3[8$-89 H'/
M2;*8B%]#R&Q">TT?.3:?N<B^U@5^ZIYYA%5?U(/:NE,R\%./"P8]+!6[AI$'
MTUC_B*+(YR&+?&)5EG%HL*71YUY6T EK6>#+"&(S\G,%W,3L-@JS$?G,Y\%P
MELT\,-3,N<SGE3[,9#:XQXXVN,A6K_,JJQX^B9M,%Y#-J_?JC5@QZ@7*AXRA
MX)@J0PQ12$600(EHC"B->!P:A9>>&F!I]-#(J(RH3DB@KS8CAI,@#I.!"VBF
MC@9H4-G+!]X/H6+\Z9]3_<CG7@KVT\WFZ\_JUN9+5__8?^ G'SC+1WU.G>Y#
M/GO=V#6?5F]WU;@^B7LU_;?ZU."-FM7KNMC62K(T48L^@HGD.C]'E]M+1 A3
MP;P0>2)2/]DM_6?'7-HGKD4&>YFO0$]JH,4&C=RVUL!Y\$V- J>03FX;7(CF
M"#O!&!]GYL+Y$6>V&HPA.#0>S&]U54I)I\WH(G%OMCK[HOM#<T)?_H<@Q1OU
M.JYH("(/$P3],%'4Q!,!L8P]2 /$6>('-(PO;-1D),?2Z,K\H/#2"3"EI\EA
MG9RRCE5IZK0 C1K[OS:*7 &M"="J3%G"R0K+R6H[F4GQS$6?K* Z7PW*[G$C
M,ZN/!G+T8I1>/!PO/+)K$-0K-M()_"K[FG&1<QTPN<(^BEGL>5!&W(?(3Y2_
MEJ  >G$8,AD$*0Y2J_SKJ25>&MWN:("W0H*'3*RY91[VY/-LQM6+FKV)6;T?
M_=?7MA\"".C#4/FH?:FP?L&HWM+0J5Y'PCO,_9YKFEQEB$\N[[QYY'/!?Y!M
M/MO (Y<KLA;O="X.)>QO7Y14)6%U!J<H69'5PUY_S\J5Q\+80YA"(5,$$>$<
M8J9^#!B-0I_Z,N56\>N&XRYMZ=!B@YW<H"?X%>B)#G[7PEL>-IA.A>&ZX![@
MJ=G=#;;VU&R'E"N"-1QU7IJT@^* ["QO=[7Y<-"*L_U%^9%D?)4(&C&",(Q$
MF$#DI1)B#R/(**)"!D0)BT<$R%F*L=! N4Y$<*]DO'0/8G@>QNX]7 [K<^XY
M''8_WOVN!!^'0'>PU6 $W61;#,.C/_/6@A$TY[<4S!XSCNC:YL/7.:^#3#YN
MRJH0558T=F,[SJNL9.M-N2UZ=;X4D5"D*P3A0$8012&&)$H2&,8DD!QC$B*K
M@D%C!5F:]=;_,BVCY$;/A1GKS8'PQ/3W:2?OGM]^GZ2.VJ5@.2*\T6+,RGR7
M@O64 B]^WLAT[5]?7[=9/))%B4P$TT7S!42<89@&/(&<>S3T24A#N_W/_:.7
MQE=:,LMLY3U,9L0S3OFI8U&44!,TY3G4U56V[/[!\V:R'BATD&5Z>,6X[Z]V
MZ\JN\;CAR_7XI@6]8(U@DS2T/ZZSHQ?MR<-G?=F.*_;TA3MQU4A/ORXC1]:_
M%)OM_=N<K;>Z6I1>7)HZNH+OJNA>,U:HGWL]HU8D"-.(4@E3/PH@8@&!F'DQ
M1"2529Q0)F.KCG$72;.TI:53!M3:Z 9&K3Z@K]"^2O$5:'7J-TZSW"^X:#8-
M=P_FFJ.I]Q(FG1[[G047L+K:9[A(EGEW'5S =K 'X>2AXPCYY28O-^N,UT__
MJ/[%'O:>;LPXCQ)$H/"HXEL_"B&-)((A5N8Z)A&.[78=A@9;&IU^++*<9??K
MI@'5(\GM2'(083,.=(7;Q!3W2,PKT @*?F__.\G&@0DRCEAJ<*A92<A$Z:<<
M8W2/'87HEO2_9GEVM[UK'=0T$$(R+X$DE!RBQ!,PU8<SH8ACQH*$^=2HHN;!
MDY=&#JUP9D1PB-/P5W^1]A-_XJU<#EWYD]H.?;;JIMXGJW[:?ZZ'SYOEVSRI
M1O<AGK[ OH#3F!"4<M\+K=]'L6FC^/J[*%BFW+RW>5-LJBO'=]U4X^O^KA9%
M)E:^D!'%.(:>)]1G'A,/I@@AR##G0@;,3Z11S/?SJ[(T7OE\_:F\ M]:B4%7
M"U&T,H-[+?35[F<.?OCM\RN@C,.F*.*/YI65GOD5&F; YQ=P091;:PG.A$B^
M:$,DP:,0R;*)D1QHG[H#1?FC7?W$#A?0 K.["-30_&'>,?/:8'^<=VVFRF-?
M;L4A"]7D T@%OMUF[!9LFMBMV\U:+5IECY/*^FTC_;>M*=,*>%-ZJ+K5!4^Z
M1KWW-4 _N2EAMHR9'"B0]LP"SE9^;1D3T2_NMA")QJ;XO[X3Q8WZ7GXI-M^J
M6ZT"R1]6F'M($J8[PGH>1"(,($Y1 G$28,%CPJ/ *#/XS#A+LY/:U';1R@IN
M:F'K^DI*6MO$_^/0#ILH#@&;^NBUP:H3$S1R@I=GL!I1#F 0B0NJ AQ_[LS%
M 0:5.ZP1,'SYV+W:N[M-7K/11U)\*#Y7.J:T3BE0!%23URJ1H<1Q$,,X94SY
M9C14U(!]&*1J'9)8,HE]NRW;LV,NC1P:D1LSY K<DZ)N6"+&^4HVV)MNYCI%
M=/(]W1K,SPV82F#UQH)&Y#;I2@G=^!XN=W6-(7*VN7M^Q)GW>(TA.-SJ-;_5
M?L=WW[8CY_]G2]:9?% T=\V8+D+0#Q/3?397% N2>H'NK$12B' 80Z(L%NB)
MR$^1(!Q'1IV%K4=>&BE]?OT2='U*KX ?0 ]?]?KLZ"9F>YU IQ38:]7VL37,
M0+*?J?-[TI/A/_4&RN306VUVCX+Q@LUPN_%FVRP?!4-_,WW< T9NMM,!OY$^
M["_IYWN^_J^M,@3W95O*.KRVNB7YAR;Y4[&QW!1WNO61NF^SK=H66RO&D<=]
MX4,:Q10B@@1,*4UAD""/"<E)[#&K#?99Q5\:]?;D5-:@%O1*FX&#S<R6\!88
M[I$O=F[GV!=OVT"=+QU CY4.:&#H%<(J05,36",!/G25!/HOT,?V!3K7#6\)
M+Y#E!OAB7Z29-KV7_4+9;X,_RWR>V_J>5ZAYM[N?!?"#+>[GD6+\CE96-3OM
M.7]9ASO>B)QEHF? [5(4PH2&E'D(AB$7$$4)@]1G'HQ]G%*>"AD&5K7FK$9?
MFE73$[YV81Z)_\AY.9\2X6!NS/>^)D%\AETP5V"/V@VS!LWAOICYV+/OD%G#
M<FROS/XAX\AN5_]G_^1R'PE,><0]'BLV$^K_4,H]B&480B\6:<@\YH?4J.>>
MT6A+([,W6:Z6EHRL'YE.^DOK5??Z51"MQ8C.3\/(FU&7,SPGIJH>8#U))\K;
M-@+%$14-CS4K]1BI_91JS&ZR#P_X4A"=+O+YX8YNUGK#W0MT1";G-($H\3G$
M@4=TM8@X8,A+4L\H!/O@R4NCC%8XT$AG?N3_&*[SA_RC09CX.S?4W^H8_ZBN
MHP[N'S]IMJ/ZHPKT#^>/7S V)N=-MA;OMW5(/XM)BCW?@Q)3Y9LD,E;+-PY@
M+$.?)J'OQ=+HH.O8PY?VZ;41)5I T$AH&W'3 ^[\%W@)'!-_A!9(C(BG.53Y
M@B":WL-FCIPY5.,P7.;(-2.KBD@I6+7KV?6%?-<E-77C;&5?KIOP/?7+EX7@
M657J-HIJB%OU^0:,H"2"(9<8(H^ISY?[5-OA3"8H8IZRONTKRHV3QN@%G[^P
M7*.,SH;L! 6MX(VE_NKMVY]?*2W+*F/@8['A6]9LGVH$1F27CYQ*,W-^PIF9
MB7HZ!;J6A4K:NL(Q>*S$5?V'1H^KW<PYW&]V@ZBKNBWCA)BWQLM%0!W4@[GL
M:?;GX4<JYFU+]9NR?+FYH\J1KS>,7RF)%!'HJOREON:Z+$55K@3R?9&$!'K$
M"YHM7-T7%DHAPU0(Z3%D5,'C4D&69E*]O;LG#;>^5HL@JP@H[[,<;J0T/V&\
M:&+.'S;/!??$O'F)&C/-A?FY[5QS,M,)[,M;?5 %J@VX5[\'I):S33<BQ:84
M0+,IH*V..MZ_4U*;(#]O"MT HM,55/MZQ:6C_"(7@ \<D5[T^-D..UV T#^V
M=/*\D7OR69Y5XIUZ-'^K7N_\)J-KT3SY^DXGJ/UW/;@NTY^78M=T*<%^1/R0
M0X3\"")!4DA\3B$A0>@E:AG#L564_3@QEK:(O5;3<U='AI.;FZ)V3 #IB0]$
M(S_(<J!>_<AR$W_<5!GN[D\^ 5-O^]<*P%H#L%<!U#KTFJ'TM9FD.]9E2+HZ
M*Q@GQ+R'"!<!=7"Z<-G3QK'G-5-FP7:M/_FAINGO%)>_K<1=N0HECP5/?!C%
MNH!?P'Q-F0$,0B8"QB,O)%:\:2O TABS)W\;*/9(@\ZU_T$K\2/X7>L!:D4L
M8SFL)\J,-:>$?V*^G !Y:ZH<"Y\CDK0>?E9Z' O.4V(<_1S[G1$UE%CK0GV"
MUV%V^SZM'XO-34&Z\D]<$,^7OH!)@%*(XDA 3!,,>1)R*1@+P]2HK)[%F LD
MOD[LMG#)7G#02F[N;9L"?WZ38P(XIR>RLTB>+]<U_ETVWJN8 -J9MB4N>EFM
MMA<L,1K823!]TFR;!I:J]?<';&\=W81*%(7@;S:%R&[RW79Z:S*WNQ,K3 (1
MAI) G. 8(ARGD*+0APGGON323YAG9<*:#;LT_FZEM6XO98*PF>WI'K?I-YYK
M@4$K<?_<KA4:_-"*?;HXP9@64A8XN>L<93+HW VC+( XTB?*YF[[O/HO6;46
M'^3;O&YAO"7KNC,D(=CG1%(H4\P@(CB .$QBR#%/%=_["4=&33I/CK T8JF%
MU.=@>S&M6F^>AG*85IP -#&#C,#&*C-]4/\+,M"//W>V3/-!M?H9Y<,7VON#
M[S>5*,.?$L_C6_&_M[F(%2Q):SB'B/,D"CE,TL2#2,;Z",%CD-+88UPB%(9&
M\?[G!EK:!UZ+^6=0BPR4N$#+"^(K?2*0F/LG@]B>]_-<(3;Q%]^@U$+V%*P1
M7MT@:N:NG"OT9O+?+D31RH,S@6; ;1N\?39?S42)OH-F=/U8KZS(OA(=WU0^
M[9U HR AVBPB0H=<AP3!5"@&E4QX 6:A"%.K=-#30RV-0_>2@J.94[9NV4F(
M35TQ%\!-[G[MA)RG-<5Y5)PY6R<'FMG!.J?PH5-U]HYQK#&FUNM (OR7?2+\
M+^H1U:[BZ\I+)!(QB6$<L%!Q4!) &BM*\J7PHP@S3X9&]5?G%GQIC%9+)_@5
M*'7MZ&VN@\I_J.LTEI:%&F>;>C-N7.*$3LRT37V4,P7K=W547EQ01Z6!0(<3
M-2"X(^^YI\W14C";V+,N+'-/QM-E:O;Q7:8^-34-MEE^LVLB5ZY2'$:((PH3
M[G.( IQ"0I /J9_@Q.<>]F.U;&TJLC9;MLR'MEIX=@),N*>FQW"1EW049[,U
M8AKT)F9Y\_RCF3*-AO":-+OHZ, +R"@: L0LBVCP"2,J:;9%6#_(XXSZ22BB
MS'28:EV\^#=M!=8\6M/D*R70KH;"1M9_;<W&=[NX-2+2&(=Q"GV4)A )JO<$
M*(:1Y $.,(LX-SJ=G4?<I5GAG<;@@WS43JBO=9U#V.K=-A:J=>M,MUI'H+7O
MUV[9R/:J%H(1L8PSO4'G]XZ7]5Y,;<S__Z^$31W-1;T:,VVO]^<-2-T>8,9W
MQE5E[GEG;ZA*YO1"S%<5<S9 'U7!G&_4<8[:;Z62K4N6*E=>1#T2$@&#"$MM
MLX00>\HMX[XRRC#RDCBUVD-\_/BEV1A*NCK-N9//SO=Z IV9?S4>D(D7UZ=8
MS',P<1P.1R[2DX?/Z@8=5^RIJW/BJG&?\I%$U5[G@=TYFH<(#E$:P<C7$?^"
M!)!(]8F+R/>(C(,X#(VJ0]D-N[1/_YK]US8KL]J-M/OL#6$VHP/WX$U,$YW
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M-CR(8^%!#V&>((PQQU8GYP9C+FUY[R0%]TW#!6O'XSS*IOZ'4^PF=T-:::_
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M"$YM)ET GKW!9 ***\-I<*QY#2@3M0\,*:.;1I8VW!W5'AME'S68A"R.8I+
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M:G%GG8(;E<0Z&+Z2&6BA+2N#7T#<C&P<XC@PU5P'H7U-<#-@7%4$OS#:N/7
MS50_J 9N>%OON(8C7JV;)=]QCI6;8CYZTY-Z80 CD080I93#5(82RHAC'_N,
MVU?MM1E_:@1TPOM<A3GM^K1+DQI 3J;(C*$&!'[H(V>WF/=Q__=!SIUSWVKT
ML5WW?: YXICO]9A^%%C7UFV*U&V^(D%"$::!!WD<8(@2/X1IDA(8$J&F! 4L
M- ML/SO*U.BL$:]7W?#C,)J1T=7@#$PYM7R;IG>#T,I9#!R1Q_$Q1J6(LVKN
M$\'YB_M][K\M"\'RAV7V3YV,^*.I$E-N3XW$DBQT143%-VVKVJ8:PYR2B$51
M[$$<^K$B!4] ["M2(+% .!;,P]*HU($#6:9&'5U5P(K\ +119MN$N6J_W&H$
MU!N]$%6Z<K;<U+35H>%VM'/-=)J1TTB3-#"%[<R/DAJT>LS ]O0:;'2I)FO3
MO+Q1QQW9.<#4$25>(\FHQ.D LGUZ=?'(GC87KU-+R.)3MB1+EI'%YV65>:)_
M^V'3Q'WK*T(A)S@-4X@0%A")R(,T#B(8A1[QO2A- V1GC]E*,#7"_;9^?JY+
MEZGMSD8'T%'"TGZSGA)#VVY(H(>V^S:R'T<8;,4'OP_BZ>N-GBN+T7K\<:W)
MOO <6)J]']37F_@BU/;VD]+HXP]%%VK@]^MRI7BW*-^]_B+RAX(\/V;L1E<J
MW"N7$V.B(PXX%#[7A0,%AI12#(6(A4=XZD6Q;^=G["W+U$BQ407H-P6TRH"-
M-CJ79*L/J!2R]4;VGS=3/^4HLS&X!]-Z(FRJ5/5P<%Z-JC/79W])1G:*7@W9
MH;OT^D?VCMX@NC[L1U(LL^5#></8^FE==:_7E6-9MIJC0"J4/ _&(M!M9=1/
M*0X%Y$2&W$L)1Y&5:^/RD--CSUIB(!J1K2,U+F%L'*KA$+GA8S5JT%IIP4\=
M>4$C\.DRMGUB-0S1<1>L<6G L:,U# $X$JYA>N>(U78^_N^Z:IJSZ:2U23V\
MK>I)E/?J$:441:'[T3<9A]7OZE(/?Q<ZYUWPFQ=1D =Q6(%M+A(_\-,001)Z
M&"(J.<0A\2'SN7J_11(SL\WSM-6<&IU66I=@M55+%_GX^$0%6Q% 5E61D%+I
M"76><BXW?_KIMV\?="D.4&H@#2M@3WMNABPE-*D7:^#5IENL[V0)(MJ4(&JN
MVRE!- ,U7-W.B]W,^@:R&>B ID_HVW3Z#FXST"('&NB.%QO]MWA_1RA_-*GW
M>*S:MO].[_,XE8M&>TV&J'@TO/#3KY0TV@0ZJ; TGK3]=O9J*"YT-;.R21I.
M_-@/**>0)"*!*/9CB%.,H0AB1@FA)(Z1S3Y^?X"IF9E;^>RVZP? F6W.KX%C
M8.-H*]H 57].Z>UHDWWP^%&WU*>4V]] G[S.OL7SA\; ^)25C"S^6Y#BD_I-
M.0_"A"+L<X@\SJ#NY J)2#!D(<-$H#!FS"BEX<P84_N"6S&!K.2LHF" U)*:
M]W0^!>?YC]H12 -_UQM\:A&!EA%\.HN/51/G"PCTZM]\ZIFCM6Z^H%2W:_.E
M2_LMS)_R0BW]2YT8U9;S2/P4Q32&0<1"B(A,8>IS!%G,?(R([R.2VJS,!R-,
M[<-N!*R2^"Q7YT/TS);GJS 9^#ONPC' "GU2=4=+].'S1UVC3ZJWOTB?OK!G
M73KUH"H2][TRVQ_R(A/EA_R)9,NY(()R+I65S0+]0=,$$N[[D/@B(<H,]ZB@
M-A_TR9&F]F$?;TU:O=>;6/%:A5?P>ZV"9=;/:=#->, )E$.OZRY1M"]&=PDA
M5S7H3HXS;NFY2^H>5)R[>,.4?&3ZX.%6RAO^/^MR57523J(@X2CR(>=A!%&D
MR D'F,$X0"3P)$E3WRA,:F2YIT9UK5-JXZ@B&U'!3Y6#JIR$A^KP!7A+E]-5
MT_IOXT/2*$ % ]CB,,U790K>G:M>F7\[=XW-JS,1O\O)"7P31\JA-/\&GI&3
M$(_CZC@]O+TI]&N^$F7X<YI$?"W^1E[]2+T<J-GK1W&2A#3U8>3Y:F,5!1RF
M@@3J/P*36&*:)L:%=\\--#5CHQ+S/T E<E4>5<D+_*BJN(O,EXZSV%XV"UPA
M-O Z7J/40+8/%JC%=829^?KH"KN1%K3S&+H[HS*%YLQ2<?;VT;C=1(DN&1M=
MWY,]48#3#VM1%^<.%%QAT+RO(L4L)"B%L4^03M26D,2Q#Q-$PU0QJ BP42SW
MY:&FQJ#H9R5IET%KD4$0Z'<Z#"P)X33$AC3J!+A1B+1![@AF/2J:7P#/DD^=
M@#@JHYX&TR&77H3E$IN>?L"X?'I1D0-&O7R'@SYGGY=LL>;9\N%H09[WRB#.
M>/./N0AIB%$BH,>P9MPXA432% :)%Z+$)PE*K?*S^PHR-3[>[VRU4>5$YZH9
MV%'GBM9D-K-GYE,88TZ&=CD,-!W7-1'K@>40O<)LQ'B[EF ]P#K;^:O/\WI&
M1+0AC^]>-S_^-5//+MCCZQ?QHC#4]8P9"21AG$'I(ZJH%#-(2)A"%HH@1LQ/
MHM3*JVHV[-2(<QMO#3;"5E5I?KWYKUZ%I W1-PRS<([IT+$75\!I'XEAA8ZK
M\ RS0<>-V; "XB"0P^[N?J3TJ_A^PUB^KAI)WQ7Y4OW(JF-27?;G_:,^-"T_
M+[O79$N6/2]$N2UMX-,(AXA3&#!)%&51'Z8>BV$D>2J%+]1NW"KFVH504R.T
MK;"@4<".OYQ,E!F[C0W_P-S70?[;2G%>E9;YVS/7:3V: FN%=%90Y\J-2@-5
M]G&)L2,&=2+2J/SJ$L1]]G7Z[)[E__.R?%^9I ]"/5K4-3'F(:)Q)",$)1$A
M1'X:0Q(2#V(2QSA*49P&TJKJ_]%AIL:?6DJP(V93,<;2#CP!JADS7@_5P%S7
M R7[(OYG07!5N__X(..6[#^KZ$&E_O-7]Z. IOCMIB9C4W^Q"9F<RQ2G22HY
M#"CS(!*40NS%'(H$H2@DV ]T1=I\119F5'!^."M*V PZW,M^K\?8E&6VHX$+
MP)K1@3NX!J:%MG)UI]9K(ROXJ9'688D:,U@<$<6%P48E##/%]XG#\*X1PVWK
M+HK/SX5@677/5YW$6]ZN5Z4VH!7#[:7U?A4Z,EC]7A.@KM*];OKE<!FF1&<'
MI$FH2\]@#$G 0IB(,$$)\HD0QI$L;Z_.U&RB;S=?RQGXWI8M($W9@J(5'["M
M_&!EW QI&F /&<#[)F_$P!Q?:0K>G0_.?-<$9S;7[01G-BULN[" &A?0 >:P
M2L8&&] !QZ+WUC1F<HP@X#=Y[49R_-\_"ALF C(O0-YYK<KJY2/=EZ^HT''4
M'GTZDS9$/+ [(:<?)NQ\0IQ$#[N7JG?G:ET^57P0]?]^7GY>OB@AJPRN.4\2
MQF)!E3VFRRL@Q"#Q(P$Q#R,48<%\/YDOQ8.NB6BV93P[GA%/X9JGNJ,.1U,=
MX:S;6)_!U6R_>#U6HS6TKN0#/[62_DD?CYM@UZ>9]65,W'6T/C/6V&VM+ZM]
MI+>UP4T]#YNSI;B5[PO!L]4GPK)%MGIM=J;O\J+(OVNF(NJ%4;^?"TD99IZ$
MD40^1#Q,(8[5MBY*8AX13IB/C+9U?0:?VB9,RZ[+=];2@U;\;;NPC0:@5<'R
MQ-IF9@S/L0?">^C3;8=0VQ][]\#,U6&XS=#C'I'W .7@X+S/,^Q/P^[47%1E
MZBI+[8-XSLML18K:G+O]OE14\9@]MXV.[H1Z9]6FZ4',L<?#&(4$^FF$M<WD
MPY2J?Z(8Q2E&B <A,3W#ZBO$U$AOHT=]:# #6U6: X:-,IL^8C.PU<?\9*#W
MM%T^/AIC,@9FQ'^!>3 _5QEC/D8Z#=GTSM-UO/EV3JJ*"7H)T\6_]0Z3+%__
M6(+GS316QR".CCRNQ?/,047O1X]VO'"M\MU#@:N?U<\D_R7/^?=LL9B'H1<)
MSA+(L.Y&'* 0TA G,.$R\B/L^UZ$;<SM]L%36U5:N>SLXPU,:CV./"9#&/M1
M!)$D*4QC+X91%/HTY,P/ CY7'V26JXDDQ6HXL/8'&1ZR&:#B(5M69ZV4J$N8
M(;<?H.A%*<-IJ!N*$;6W"R6!:8H%%(%D0IE!J?IS@^+'I>$A47\,VR'&0%#4
M)]'7P6>V >L#R,"FQ,6/SWK'M*^DH]W0YK&C[G3VE=G?Q1S\O7<]ZZJ<]JW<
M="*LBZ$U@8:"?\J+F_(;68C#QH A"N,XA$%(U2I!?*X^W,"#3& 9(R9%3*W:
M4_<796KK2JN)-KRVG3QK9<!&F\HE14I0*61=3+OOK)GQQ3AS,3##])B&0;L"
M7@^JN^K??049NT[XE8 =J2A^[1/[\JP@Y5J9\-JBK^SX4MF/C,@@568V2SA$
M:9! ZL4$JO^GE% 92V'56?7(&%-C1K4%?<J7C?,]6X)5(_*LWJF6EC7^SJ$K
M?;4"22XAX1%3Z/( XC22:J$*0I2D@D>(M:['.ULCO2_4N[['_6&'P_W=OK'N
M$&B1X#2-8@'#2"!=^5)!'I$ >MSC#&-".4EW@3:VXUW"/+QE_W''GG>(L.F:
M?=7G/_AB7$O7'AS6 KI<7$]J[VS5/!QAY.7PI(J'Z]SI2WN6Y2YRM4->O>HZ
MO:N;956][KD.4+E73ZQ3R6DH(LY2B)&NN)]H-VU",/3"$(=*XS04L56![LMC
M3FV!:T6N"TNOJH2_C=@SH,7NE4YN K\933@&=6@7;+Y\@%^R%V6GWZO?9]HX
MKRPVYUGD%KBX*M5M,.*X1;O-(3@HWVUQ:\]:077Y]B9-H2H77L6P?16K=;&\
M76X*B"O3CX@H#"B!,E+F-.*$Z'P !"E.0^8QR5EDY$&U'WIJ=%3+"8I*4* L
M[V==[IY4LEH6^S&'WXR'A@%U8#HRZ"%P+)A-'S$T4U&K!W[2Z7L.<Z#LT715
MTL=\X'&+^%@#<E"VQ_X)O4-HCR8%AASY2&H/7)10M6\5 J94<1F)(B82/Q$A
MLSH?<)%F.0)G-4F#*_(#/!?Y2U9:%R8[!:A/D9>B((1)E$J( BD@2077^'J<
MXX3[<6*3OOHODK<Z'*!F3#_]?-5Q\E3'25"=1&:J94JJVUS4LEC-OXD';7W^
M(O*'@CP_9HPLFH9&OI0B%#2$+*54%SN/(?$B#XI8AB))><Q]HW(69T>9&J=V
M);1L$74>S?,,X RC@;]_.WB,/WPC]<]]]NH!G4]>_6O[N9]_]B@?NY%Z[:=N
M=G'OK6$5+J4(I#;(=.VR.I%JL<B_Z]/8N>=13G%"H,=E"I%B 4A\I':'!!&>
MHI0)FMIE(AF,VN.P>F BV,@(2"ODK.]^\"+FQAM!)SB.M@.L(R>UL=#N^;:H
M;D1VNK4SQ<?=GN[BB&-OYDPA.+*+,[ZU+_L4V8MZXHOH]'+Y1;&:WN*_>_VK
MX _9\N&K6%2CZLC-ZK16XM!/14JA[Y- ^R<II&&H-R-ZUR<D"3RCSM/7B3$U
M0Z41$W3E['5@WG-63"EK:*P'9K$^,/<@KFM0<L9EO808F=ZN >J0\:YZFAT)
MZH;>'Y>K;/5ZMZ:+C'U:Y&2E#^"QY'$$2:#W6*%4>ZRJ5&N$N(AD%'#/:(]U
M].E3HZQ:0/!<20BD%M&,JHYC=YZ!KD9D8&)IP*B% Y_.@F%,*&>5/L(3I6 _
M/^0O?U;WU12A?M@RP_&GC?+!GU6D_8[/7]3/1GE7QZ1\>Q1B]47CK+[\9@<?
MR5C&(==^,A1#1/T 4HQ2Z"$:!R2)L,>MDCU.#S6U#[>1%%2B@E;6GAVTSR!L
M9E.XP6W@S[LO9-:VPV4T'-D'9P8:U0:XK/#^.F]P1\\BH'FYNI4ZP4"7'OXF
MBI>,B?);ON!S)C!E:FF':A'7IRB"0<4/''(I.):A3XBT\JR?'FIJ9*$EU8'D
MST7.UVQ5@E():5D#]#2N9A3A!JV!*:(%JA*SBG]J!07?SD%F7_;S(AJN2GZ>
M'FC<<I\7%3XH]7GY#OO"!A;M;+Z)A7K(PR]BJ7ZQ4"+<\*=LF:E=2;4_:;P]
M<TX1#VG,E G"%*L(3" 6(86$2YRD-/589-3-:Q#IID9$]CVE&CUGH-&T^BAW
M=6W=GN;Y^>[?@O,<^.9S._2Y\K_KM)K78WC3Z1VI4,/;3+-5&8?!IN%,?0?W
M8XY6^&$PN+H5(88;I-\6X8:IKV6]T [+#V);@U+]O!"5;T4-^Y07J^R?U>]/
M1@?/4X:]-*$)9"1 :NE'&!(92V4)Q%(PA$+)K5HYN1)L:JO^%U$J8WJKG"[R
MLJU<JRF!=-2RVY<XFTRS7<Q;3-' BW=')=#5J:J/5&M5TW9'KQG8RQ69[2:+
MN-LHN0;<T;;*F5BC;L)<@[F_97/^_)Y]',K/9;G6&="_+=5=K1>]6Z18#ZFC
MZ8B7T%!G6>@:.)3 E*$ >L)//"X\@LU*!5F..S5ZKD4'62,[6&OA%4<WL2*L
M6Q]?IV!85JHWG(S+.ZB!(!Z87AMT6[%!)3?81.+L=!^X&PQ=RX+][E$>:8OR
MZUIW=M='>.71MWJWE-SI65 7DE4=9E:"Q^SA<?$*-Q^"ND$\/2_R5Z$&6.7U
MIP*4A4MT,0"R7.I<F6RI"YOI#0[Y7G51U LD4W1'LB40BNE6KY!6C26Z'YC+
M OYVDWBITK[AT\8MB6^GXD'M>LO;'74F_)(MQ>>5>"KG =?A!&D((T9BB,(@
MA32(I-I%H"C&W(L8MDJ2.3W4U-:<8[WWM+"@DO;:-H5;A,VL>C>X#;R0](7L
M^IZ%!V@,U;=P.]#;]BX\4/AB_\+#.UPE"NLS#Z9K^ZQ7ZZ)-+FF::92_BA^K
M^^]B\2+^IJ1Y+.>1#+% .(1I&C*(&(LA(51"CGF,@\A/_,2JV/R5\DR-=M0K
M&%Z;.FPW(68$-"+,0[L"CB89M]J 6IWM7VN%9N"_!2G [=)MY+D+2 ?+-+:3
MYHW3CWM!=SDGN=]C^P:&Z.I=54T9'44OYDAP&>B296&D6!(A7T <"0*Y%P<A
M%_I-MXH=VQ]@:MRW4[[L/_^0!G[P%_#_^.!9?7DO6N#_ \AZ]9@7V3_5A]I>
M$"-OYGG5_S=;JK]4>ZK.)6&,9G&(9]CS-[NN)="?0+7G43_XI[<U9G-E&F+2
M?P8&#RRIP&_J1U72S:HS >$TJ.2X_LY"2?8>/W( R7'E#L-&3ES7XRR1/0J^
M7HA;>;S3V5=1KHI,$U@UW&_+;%5^(EE1C9O+[2__2UVHLWAVBIER&@EECF#H
MQUX D=";OU0F$%$6J_U@%*<L,#Y]'%+2J1%9JZP^Y:G4;<Y1N@K/P%;EIE>G
MYJ*#7U9*Z_(FV8MQKZ'A7PV#L]"I3/C0IZ?M7-_*G6:L%^:Z4FT&M,8UV5;O
M2F?&:[5M*N:.S0[F![93>15&.N(=Y95P<)PRVMR<.[D==/SQSGK'@''G='B4
M :^IN*1/H#XID(Z&T:B]T^I6WI,?=Z+XD"W66DZMQ]P/8Q8AIC8Y4ID;"'&U
M=@8L@=(77D0X]VC2HRI3+UFF9E4T973JVF9 OW\GHMIJ3\XF%DZQR(GK9D"I
MKO^NE*_Z2(%&_YJV^E0QZC?K9KNGD>9R8(-A.M/8L\3251/@M Q3/TG>H%33
M59 =+^=TW2/[GOW3U3;K^5?UDC<Y>+&0,>(QAZF4#*)$'^\G$D,>)R'S0H3]
MV*I9R:F!ID;)6DZP%51]B.KBGBF.)\$U/:"_'K+!3]Y[H=7C8/T\%,Y.S$\,
M,_)1^'EE#\^X+US?,P5Z769+498W['_769E5L73ZQT*TKS%C+$1!ZD/"$(?(
M"QE,0Q%"[+.(!8P$F%HE-UX<<6IDT0H,.A+/0"MSW\3HB[B;T8=3- ?FD6N!
MM$^7-@7'5=;TQ?'&39XV5?\@A]KXQGZD<[MZ%$5C]"P?:KNHR<!0!M!<<AQX
M5$9J!XF$VDNF,<0Q":# *?;5KS"/4%N4[MZ<>,Z/:O2=[!:ENQ^!?"JA0=Y*
M#40M\ PLA6$]%4/0S>C& 8;C<$V-VT92T.[>&F'_5.V]W#&-&2Z.:.;"8*-R
MC)GB^P1C>->@6=@7OH<@09[/D81QK ^TI#* J*?HR(]2YN.("101"Q)R*MQ$
MN<H^B_.ZKW3 V;_L)QMW,J>:;3W9"1PDO]K=1$XVKWJD=7,0X-UD4D]A=1T$
MGIZ9TX.LU=V8FFQ51>7=+/E.X/-=OLC8Z]9OG9(TE"1&,(A##R*2!)#22$ >
MAR%/8XRH6?5$^Z&G=B"Q(ZM]_)LAWF8;@F%0''B=ZPA=^6IVQ)Z!6G#P>_._
M@W0]ML?-8:R=X<"C1^'9 7(L/L_R"3V;/BKNJW..*VZ\R\M5(599(?38A['(
MY?MU4:B_?,D(S1;92LDSQSYG7/H)3(0GZC+7&$L"PX"'./5$$OO"KN[^]4+U
MV%4,3'3?=.)C]4E^)P^B_E8+41<4R'1.C&6WR.OGS8P41YJ+D;+#&JE>==F&
M8RD8C?0.>TXZ@\]52\KK!1JW8Z4S  \:6KI[LJLTMD:D:KB_9ZO'3JF(YJI;
MNL@>:O_ZY^7''TR4Y:W<]JF[>7@H*CH[=^<\\A.!XE2W[8V;QNDI%PQ&:1"P
MB'M(,_95^6_C*#(U8[9;)(8VO))OI 5":2EX6:772QUA^=)&6'9Z=LYV:@ =
M/N7:Q+R17C'3@('IOSB#!R2<[#?Z7>D/NN]4>\U6$9U#5&.@7Z.=+J7G;QPR
MA7#<.1PL]W D-=XX:7'<R;J<[3BR//9NF;IXRJW\N+K]IA8590K4=9J^D._E
M.E/C+Q;B07Q>_L^Z>-7!<;\M&S-?5\Y8<J*V=/, D3BE6,(TH!(B&B-(/:S^
MXR=1B%!"$#&NJ>1 GJFMH]OZ-(M&B9FN,J/44'RG]:A#5M>M)E5MF5H5\_-Y
M%_-XV;4R\NP,O%AM)T;I W84 E\V4U7K!&JE@-8*;-0"']YHJLR=*"-/V>@U
MGX:<.BNGB4.@S[A+7(PRFJ/$(21=%XG+Q_9TCI#R4?^_KEZHMCWZ8'.;'J3_
MH+;AN[_H7*FCJ'C":0KC5"V5"","4TDB-=F>)RF5$9%H_JP4R_FW%2E6AEZ3
M:V2R^<3W)1LP5.A9++6K4PN[*3;:2+R?VZNOL?2X7#6)L>_S-$TH3-4V&"+/
M"R!-8PJ]A'*4>$Q&/F\F\>/2\*1XY"ELY1K0G;/(RZE.H& !3Y6)JJS6E"NK
M-5+VJ_0BB/PPB@EF/!3^?-ON?CJ3MY5IP(E3XLWJ:>M(.=N?KV-SV+UAS/DT
M](J.-4M#.TK-)FC6>X;L_:8ND'7E2KU*EG&]JRY@.W"X.GGH%2'D.G&Z$(_Z
M]$.W]=RDU^6%R!Z6M>^!O=X79%D2UI2)KOY5-_F\X?^S+BN'<9MV-T>Q[P5>
MA*'$:M%%./ @C;D'(^9+1GWJA<*H=,JP8D[M[*'1!+!&%;#:2@_(1GQ+HAYH
MBLT8_.TG;F!JKP/]=C3<!/M5*<XST$YKJRCH:%HQ?D=7L%6VF];L.,)^L EQ
M&9GO7LCQ(_H' _IH)L!PH[DHA%%'$JW5#F.;I_U.2"5<?9T:3[2RSB7B7"14
MP)C1!**$^9!2G,+(HY$G/9PB:;6 ]!=EHHO$-<4IK&;"C.?'P7=@+C]2FF*K
M2;<P!:UT:7F^TF9#\T.5F^B#Z2#5)JP$><-B$WT .U]KHM<3[;U\G[(?@M_G
M56=N-=;?A#Y G7,_](2@*:2AHD44,0)3$2302Z1/*(\0B1-3O]W1$29'=%I(
M<)^#5DQSI\UQ!"][S*[&96"".H $_%[+:%$5[\3;9>RBNAJCD9Q./;"R\B"=
MQ>&,3^CX?:-Y><Z*W?7;G+^P9Z>-;?QB$]%X0W7K0+::8Q[(!$<$^H&/%+WI
M8JN)G\(@"J1,$$]#9E47__104^.Y1CS0D=BRN\9I5,V,-S=8#<Q]'2$WL=+@
M]U90E]TU+J+AJKO&Z8'&[:YQ4>&#[AJ7[^@1W)2O1(E^CM.(K\4'P2K"\:/
M0ZA9I 2+8NJ)"")!=>^,-(0X8!$4D1^*B L>>T8E=(Q&FQI-5++^!ZCD!DIF
MT H-_&@&M-P602T7H;YL*SD%<&#NJ$%K$#R*70]#ZC*(%G$_+L$<*ZK' :AV
M,3NF()V+R+GXC/'B;4S5V8FF,;ZIGX7V=9.%HJ-:[]5#FC):$LLD""2"- UC
MQ;TX@)2E!%*$J9")ASFR:L9Q:J"IT>Y6SCK$74O:LU;926S-K#07B W,L_W
MLK;0+B'AR#X[.<RHUMDE9?=MLXO77W.6_TTM*M6SO^A)4LM+RPZ<)SS@/DQ8
MDD"$1 I3+PEA0A13$;6/(]BJT?K9T:9&$<TQ\$9:T(K;DR?.0VUS'N\ P'&.
MW/M@U_,\_0(F3H_,3XWU!J?B%]0^?O!]Z:9^5'*\8O]-4:@7HQKMW>OVDJ;9
MV(UNT?NQ:LJ[K=Y:5E[/^T>RO'VN#N-OUZMR19:Z!LO?1?;PN!+\YD44Y$%\
M%5IP]7M]AJ\WJFNRN!?%4SD/TY2A6%&7'^@>XX0A2/PP@(3ZG'NI'WM1;$-=
MD])N:E39R@U(+3@H6LG!BRBK4UHEQI,=7TX*<4-^GI3,$UH/ZG91A_UB0 <:
M0%]!][H&'E#A,P,U0IU"VV53C6NE0 (-2C/0P6D&-N]E Q788 4Z8($*+7<+
MTB1? D<+X+1T&W7!G9;J)Q;X:0II9U!PD<UOE Q<R_%I01[F,DT$"V.UA >Q
M@ @S"=,HI6I%QQQ)R@-?4)/%_.#)4UM(-\(!J:0S6R\/X3J_5ET%PL#KQ%;_
M3^?T-Z;DD[H>H<-2L)\?\I<_JWMJ)E0_; GP\$FCD,])!=H/__0%_:SX3^I+
M7HDOV8O@GY?J>W_(Z$)4:?"_E4*N%U\R*>8>(G'D,0^BA%/MMA$0QY)#B;PH
M"7W,PL"JV*#)H%/[5&N9X4(+#;*-U)N:*^M*<K!0HMO9O48S8&:.NL9UX*^_
M@;22%VP%KNN/S$ M,_AR#E%K8\T&(D<VE-&0HYHV-B#L6QQ6]_;,9FG+JWX1
MRFQYGY>K>10R)C7O2 \3W7:%0*IH!^JJ@6E*N1=Q9I6)<C#$U/AF6W2X$G$&
MM)"6*2.'.)KQR'7H#,P:=L#89U:<U-U55L3A .-F-)Q4\" ;X?25/8V-MG7G
M7P5_V$8MDI!'2.JT (D01*'P8,HH@2'!7' 1^U$069D71X>9V@?>Z9#;R&EI
M-QP'T]!2N!JBH6V# W0<AB&8H>!J^3\^R+@+_EE%#Y;X\U?;QX3=%@]DV10,
M(0O=L/?F1U;.!24X$5(MY93HFAR1A#0-8AC3 "<I#8,D,MKFGQYB:M_\KI15
M0VSPNQ;4(F#I!)CGOWLW$ V]L@^'CGD,U_4HC12X=00M-P%:YQ$X$Y5UXL;1
M0K'."]Z-O[IP9=_8"NW\TC.OPS6JUR[&GN 28X@4L2G+)@X@B0F'+ X"/\*^
M2)!E_N/^$%-CN*V$3=B0Q?=[!D@SJ^8Z> 9F-TMD>L1%G%+>63#$P0 C1T"<
M4O P[.'DE>[K:VQ**6 AXBA)U.9%;6$@BK 'B1?H;Q\G7B@3Z4>)37$CDT&M
M/O\1:A@9U%$P*(?0?PX,SS<<(SNT7>0$5*<U)MZ@8L3TZC]<4\WARMH,VHCY
MO.3B:9G)K [JVG2F^%5I5J?SS 6/$,91 B6.4XA0%$&2*DHB?DS#B,<IP48G
M*V;#3<\6V9$8++:].Y;Y$K(+G3KZ 'YY%^86QL%MEET$.]U/?AT(0?.=FELD
M1]JU78FHU4;.'* SFSJ#AXRVP3-7J+O9L[BKGW7X2Y[S[]EBT70%YQ_61;9\
MN*OJ?<Y3YON,)3%,!([U(1>#F"*J>#CR0^(I$DZL8NK/#38U FYEW;2UYZ 6
M%]3RVAF 9V$V,_Q<@3<P[?;&S=K&,P'$D6UW=JA1;3H3I?=M.:-[[&VX.U*0
M%?GV6NK^;6U^M$0DY"&&44S5[I$$"<1IDL(T";V$!!0IJ\[4:#OR_*F11"TB
M:&0TMR6.07?9_+H2D($__%TL>F0S'P/%W**Z$IR13"C#%\;*5#JC^1G;Z-A=
MHQE#9T3N6C_G+NMG[JBMJZY>>U?D+QD7_-WK;Z6.!=I$"]RP5?925Y4X4FEK
MSCV9QF' 8!JR ")%:9 D*8*$\$2$-*8B(3;'9->),[4#-'V04]6+;O71:1*'
MY>O43UN][,RH*Z?/S- :;U(&9N2C\_&3U@9DRS\=G8[9\7*#[HPV-^ Z,NNN
M%&94P\\-</NFH:.G]LS") MQL^15A!8E[!^=LK"_D&S9'#7.I1<'PO,D3$GB
M021Y"K&//$@3RCEF'HVQ502WV;!3,S6UU%6IYHW<W2+.,Z!%[QZI6R8PFDV%
M&8&Z!WA@HG2&K7W^G154KA+CS 8=-V/-"HB#5#*[N^WWNA^R\CDOR>*7(E\_
MEY^7;+'6V67JUZSF1<$WM*B8LE1DVOQ#L>M<&8NAD$)WC>$ZE (I+DN%A+['
M1<P5N474Z!SM:DFF1FJM,J#69@8V^H"N0EM+I+)/MCK-++H 73^-EW?HHTW.
MP(3XKS4OYH<$H\W/2,<) \^3U3&$$VS/'%A<]_S1CC:<P- ]!''SP"N]0\O]
MA*E2C[_(RW4A-J5>?18G-,41C#%5:QU)?9CB,(!A0@+D1RE.:-C+760R^M26
MME;XRJ[<3Q LP58!DPJR#B;'TLGD&O*1O$Y.T.[OB;)!S;5KRFCLM_%5V<!R
MTGEE]9!^='>GID04A>#?5CG[QX=,GXDL>;E7B>KST[/^H!*$4>QA!AD6"41"
M,I@RQ"$3RIX/.8V3R)LOJU[L_-Z<]&QD,/H <?T!'D@RH).C50&46@? 6R7L
M^,UJ-LSHS3FX([G6-H!6<H.-X#-P4+VN%MX=M_6!S!&U60T]*K/U 66?V'H]
MXXH0\)HS.]%J7BI](>( IH3%$"6"0)I$*612^CXA/)2Q53W=HZ-,S2RKXY%K
M*7O$<!^ :,8[5T,S,,%T4:F"^9S%\ADAX#("^V",\4.N3ZEY-,;ZY,7.=VQW
M^2)CK_?BQ^J=$OD?\YBEL40D@"*6OMJNQ02F:42A%$P2YHDPD%:IZ^9#3XT4
M=G8/];=PL(=PMC?;GX:K-V97@/NFN[(9J"4'OS?_JU4 E0[C[,U. #?\QFQ_
MX*GLRDX 8K$E._6$?F3V03P7@F5UW5_QO!!-Q]";I[Q8-2FP<\P(3Y)4P@@+
MI,P8Y$',> J1E#)F<> +[MG0F,F@4R.PKLS5QT8ZPMHQEQ'FU&/,\R("0\D9
M1"E*='-M'X:A3!FAF"4)F[^(@N9OA7IW\.%PO]=15>  _9MAT3=;,5PC.K3+
MJ2/N#&P$-L?3>F6P <C1FF TY*BK@0T(^^N U;W]5H#W^=-3SK/5:UNOM8D+
MIH''9!0CJ.D=(E]*2$DL8$RE%\5^2#V[;@\GQID:SV_$!#(O="E<P!IY+>W3
M4[B:48L#M 9FDRU0K8@#E&"Z (,CSC@URJ@T<4'5?6:X='G/WIU"V9ABM[*;
M+MY\*]MAYDE$6.#1"/HR429@0!*8\E W\N1$D(A[:9I:]?"\..34***6>-:)
M[FU*#6JQ=9Y]*[AEA\_+V)MQAUM$!Z:1Z\&T[_UIC(^K'J"7!QRW%Z@Q  <]
M0<WO[$= -XRMG]8+[4<[5Q_AGJC]\)SYW/=C7?Y=2%T('E.8LH1#3(GT8DR"
M0%C53[(9?&JDU)$=7*P( GZO=+",AK":&S.J&@KQ@4G++=C6!-8'-4=49C7T
MJ*36!Y1]>NOUC'Y$]VY=9DO%IFH(FBVKC=Q7P?*'9?9/P3]SL5QE,B.;4[\V
ML5B'8&_[,JN_K9^ZE;9+M6U#"8JB ,K8DQ#%(H X"!D,>2QQC"4726+#B0/)
M.37Z;-4$'3UG8*LIZ*K:QCQMTN^KQ(:MNJ#1=P9.U+"WW$H.]:Z8<?0$WH"!
MZ7PJDV^]$ P\-8[6C*&D''5Y&1CJ_95HZ.'L>S!]5$/JEE L+Y[S.ORY"J%Y
MGZ^5Y?_Z/N=B'G-"(]TZ6KT#VB#G,:0>$U M/52D*8V"F)MV9C(8;VJ+2"TR
MV)%Y5@>.*9A!(SG0HILW<S+!_3R1#X#FP(3L DBKKE 6\/3J%67R_-$Z2%DH
MV^TK97.;??I?GU9U9=6KK@KNNWG>.DJ^ZGYTY7^)<E41XL<?SX+IN-Q<_\J^
M<=U<>%[,!5$F-4/*I&:)A"2)!4P$9Y[G>QPCHRB^::LY-3+]=O.UG('OIWO)
MLJW\53_96=5=MC'(1(,&6.75K\T3Y:8[0P;9D=,5?D*K2X4 N-!^]EW3?A;L
MM)\MZ_ZS39!X%RY0XP5JP(!"#+20@?N\^G6W&ZU-,]I_BW?7/(-TNDK8O,,C
MI:?>/PH;CM1.[29EA'1?WJ)^>5>/9 7T2R_7B\5KRZ?J%OV[?4K]V4U2Z_2G
M^TS&[(2%'RT==\(8[%FQ_R+2VAG/9;&:OZ\"V]EKU0R#22]E'DU@%-) %XAD
MD B!H$ DHI$OD$>--N'[#YZ:@=C*9M5$Y "M\S;5-1@,'7]CJ+XQ&9_2]=PI
MH+JG<P*H_K7=]AX\;A1".J5$2P$G_][/B_-5/#<4<2N_Y,L'_1U_$'0U]P*:
M1LP+81K'ZB.D)(8XBAB,21 $DL4)XVF;NFKFB#DUE-$KN9NA.O"'N;&5<PFX
MDK#:D%76QR(G9RK=V2%LYKRX"K5Q/N2MB!HP+22L8E^TF.Y<!9> <'36?W*8
M40_K+RF[?]I^\?J^R14R6PK^3BS5#ZL[->M[ID!U0/]<%?JKJP*^)PNF_<_*
M.FCNNJ6+[*&V4=HZ$U[D$23] %*<ZK3XE,!44@$%#3S$)!*4&2WPPXHY-7.A
M$11L);7-&QAD,LUH[.VG:& 2;!0$[2QI%6>'AR0=-4%3915T- 6'DSQ(-9)A
MI\-9)L0@0HZ<.S$DT(?9%H..UG,1R=57L\J8%J=)(8@\++E'*621+BL0DA!B
M/Q40L=3G/HUH*HG5 G PQ-3(NY6PX@5+WC[$SY!SKT)E:+[L C) XL5IY5VQ
MT^$ XS++204/6.'TE?V^Z/M"D')=O%8'2E4G[7DDI!?[RI"CH4<ADM2#6%(,
M1<Q2D7I^E'C<;KMX.,CT-HJMC,V)]'_^(0W\X"\@]6=!&LY\[(-2'\65>I77
M+U"UD4R]F1^',XSP[E_]T^?1IK-@Q@L]D1V'%S:05M+-0"6?.UHXK;LC6C@R
MP*BT<%K!?5HX<V7/W*O.QK-9J+Q0Q@E*4AA@M=HCX5-((^Y!$C.?AC)A(K*J
M'W0XQ-06^NKX8W7Q^,,40+,O^CI8!OZB=P^$!ECJ3VOO*OWI<(!QTYU.*GB0
MWG3Z2O>=H>_T+ZIL[NJJNUQM%\0J*VHOU'8/4M[P_UG7_:HWC8Q#%E/$9 "#
M! 7*[O<B2+GPH P8YRB5#+/ SEX82-+I&1WM20-MC@J>:^4JV^)Y1S/PO+ ^
MKAYJPLV(["TG\>V:7?]4*_DGH-74A2V.'241J585'=._(&6Y;;"Z5;:]9+0F
MV0XF9(2^VM=(.9E6W Z@MNG>[6*XGOU^>D0W5,$-GTA65$9LYXBK#6CXKUR?
M<.F>N%\5/\]IJJU1ED I$P*13QA,]4\<RY )C^,@8%;-@H:7>6I6[B8R\&4C
MIF4SH1'FV6S)F=CL#;S\5*K "Z&CM D=A3NAHW7DZ QHO>MM>=>;,=M&BVZ5
M!UI[AYV0QILJ5VV41I!XW!Y,XTW!00.G$8?NZ>GHMN$XWX5C4X%""[(LQ9PE
M$4\HHS#T= >[E >0HDA H39)4<0$%R2V:1MZA2Q6B\T(/4-W.]B8-+#9UF)I
M5++TN%PQCX:NF7%F9V@?SH 38^_PN1Y25YZA*R09UX5T/60'OB8'C^P=JU25
MRN\N#H>!T,VQ*I$AH:G T*>A8EM*A6Y#Q*$?$L$0YTCX5N?2-H-/S99O9=^Q
M!ZU#B\RQ-PX8&@31X<. #L&<'3.GRR&<WCU <Q>L8S[TV"$XUJ <":RQ?\85
MY4R7E5.N&J&\6:\>\T*739BS 'DRX2FDU$L@\N,0$BQ"&"04XYCRP$N%=4G3
MXV--C:5J46M'^ZQUG).-N."G^E=_ZE'C] 389CSE",*!::E!K_&IUX*"K:2.
MZYV>A\-ES=,3(XU?]_2\RD=KGUZXI7?YP6*M _OT4>X]^2'*]TT7FEA&@D="
M0"IY!!$A$J8Q1C!*?!P0EGHAL^J\>'*DJ3%'4\MNI46TKA=X DPS;G "T<#,
MT,C85ORKI)R!]ZY[^UR$PEUYOQ/CC%W+[[RZ1PKW7;BAIS^E;1)V*^MGWRSY
M$:?/)IJ?(9^E?B(A#CU?61@>AU@D/@QB0B*/)XD05JD9EN-/C3NV/?.J0KY'
M2F3V[<QJ.S&&SHSAX![:,>$":7N/0C^\7'D'+$<?]Z2_'S0'I_8]'V.?0_XW
M\B-[6C\UIPPX#11[2:0L':;,G2BAD 2(0X%BR;&71$%DE&)P\.2I450CG'GV
M^"Y.YWGE*NT'9HQ&+H?'*">UO2*#?/=YHZ60'U6CFT-^_(+!_5Z?E^J;$.6J
M=9<$'/O(YPQ&0L=B1+X',9*Z(X/GQ\@+11S('AV2^TO4(]YOC'[)]JZ65J_!
M76#[4^K< ]9GAJ;J #.>E2']7R< '=_]M2_(5+U?)P"[POEUZHD]=WGL4?#U
M0MS*MNQN54^WS*I8AW>OG7_5S0UB/^:13#GT$EUD/<($$DHPI"@ATB>$Q79%
MUFT%F)H1U<JO-Q^;8MI=%68Z**KSBWX-**SGR7#7-R#Z0V_[G -OOP?LB9ZK
M3:#M\./N GN"<[ -[/N<GDXT4C[JC:;ZGX_JP2]D455!6[TG1?&J.+E.EPR2
MF%$F%/<10B&* PYI(D.(0RI(&%,<$*O#+J-1IT9]6MJZXNQ69$LGFA'8ANXT
MUQ .[5AKT:M^Z(@\ V0%6JE=9[%:H>3*WV8TYKB>-QL8#GQP5C?WJ >N'EBU
M%Z.$_>.^(,N2L(K>=KJ--:<P+$IB+TX8%(*H;3#6)0]]/X8I8TG$4JI>0_,*
MW18#3XV,M.Q@(SSH2-^W.:'U5)SGJ2$!'MK4LL#V\J':=2!;%%,>".R1RAL[
M>:'MRA'W .Q<@6";QXU7LK>'DCM%=/O<W\\4U8O+ZO6;8.NBZFGSZ>77[!>2
M+76>W3R-F(\(2Z#:C&.( E_7VV0IC",L)1*>[U&K7K3G!IL:U]>R@JVP,_#I
MO^"OGV?@MV4AR*(*Z]+"-VT([8S2L[";V:*NP!R8UT_C: *>M>UI@HHCD_/L
M4*-:FB9*[QN81O?TXY1?Q4K;K7=%_I)QP=^]UL7<CIXTEG..HY!Z?@334/IJ
MFZOHAK"008Z%2"D-)=>17^:I15:C6['.",E$2OAZK]:*K\^7CI_66VZ#[2;%
MC((&@WI@3CJ*\D]-P<L_6>-M35*]<'/$6G9CCTICO6#9Y[5^#^E9?F:G47?5
MK^!6JO&JIH&=T))/V9(L6486=WE]B/CQQTJ'EU!EYF7E:AZD1.!$$Q]!'D2>
MU %N,8?"8QS'@:)$8N7O<"37U$RR@Q[VE68PEU#I5O<-;;K8M9%:&P5!JR'X
M?:LC^+A4FZSZ5;!TE;B:>3.>?8/Y')B!WV8J[>O+N 7>53T91U*-6S_&+90'
M]6(</_ZZKN,=?]$7]8O/:O1R'E 1IKI[JXRB5!FZNJA8&@L8BY#Q (6>(%99
MG><&FQIU'W.>@M^UN*"2UY)^S^)LQJFNT!N8*/L#U[O;]3E$'+>L/CK4F_2=
M/J?TJ>;19^]Q7]!0F[6?%OGWOPK^(-JM^HTNJK9?=NUFR>_)CSM2)0-%8>1'
MQ-<US 6!*)&QVFG'$GH>C[&0(26!56:5>Q&G1E;5UE J-<"CUL-AB<*>4VAH
M);[IQ QM,!XI3-AD7M1'B+-Z1Z^5!)66.P>,)PL4:N>XTG<&:HW'*4UXW6R,
M4)6PIX"3*4AX'< VM0BO'*F'XWX3JG2\XM174:Z*3!>/JA)X?UMFJW)38BJ7
MVU_6C14[YJF,@L23!%*4^A#A4$!"8@_ZGL=2RCPN?:/L_2&%G-I*L8D/O)4[
M[8QWRVMLM6T:&U>J[92J4QO<SI_:+L?V!O*@;XA![,$$YGWH.(7_7TVY123$
M!*9^I*B)[AQ5'9^'?B=<Q12/,4_G@C6&&GJ\P(Z!P=L) AEZK+XI^^JYC_E"
MW5'6/N1?\Y70[I5%7JX+<2]^K-XIO/XQ9Q*%,2((2J&VFTBHGRBA$>3*P!!,
M^HBE5AM/XY$G9R7H^6L$_R.H1;=-QS<%W6RK. B40R^\'9E;%($6&VSE5E2I
M) >5Z$[S\"WA<I:!;SKNR+GWEG <9MW;/N#:Q+-?15L8_GU>KLIJ0=U^-+X^
MC.<Q@:&($42(!)#@1&U]I,\#XG,ATY[Y9F?'G1I/Z;"(NTZ[COK,9;>\/M!Z
M]$TK.S\+AM3E'MNQ=@S*NM,0MXTS*JD;XPX,PUMV6#E/&3L_ZAMEBAE!<3I!
MS.SV'N<ZFA._BF?UUCTJ4^^NR!\*\O3K6L?XWLH;SBL_ UGL5V2[S]^)[6U\
M3I&/*!,^]/U$5Q9!(:2^G\*0HX1@&GDQ-ZHLXE"FJ?%<O<7:"@@:Q6:@5DU_
MJ%OE#NL1@E4.J.@\X'2%PL&FV> L9OS)&\,"_!>?-XL#E?'G;ZRLD_'FT>YH
MQ"WBYTY"'(TTWL&'6VAVSCD</[K?5N%37HCL85F7-62OG:2;UJGSM4GZF(N
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MY!QAS"(:^L0N;O#RF%-;(AJ1P0>R(I8VK ' AO:K6]B&WM@WB&W$':$,ICE
MKHQ5@Q''-53-(3@P4BUN[<LU"_77AU_4;J8@BYLEO^%ZBZB3JE?9BVB2]\IF
MY98<H82D,4Q370E"MWDF42PAEAY+(Q0R$=@=7MJ,/CW^J82O7!UD1VX@:L%M
M6<EF*DSY:2" !V>J2NX9:"2O0-Z5O4U.+AU:1U?!YHR_;,8>F<EZP'+(:7T>
MTK,XYF>UMQ?\MZ6ZI?KWS?-S(5A6%T/79V7EQQ^B8)DNLY>D?NQ['H54-U-%
M1$B81G$,8TQQB# /")5653 M!I\<MU7E]FH%P%IK +[=?%6;DE9@\%.V;#+*
M#-O8]YJ3RYOS(9$>FN2Z(/]6@US]JBM^W>6T!!L%!D3;LM#D0*B/55&R3MS+
M:OA7.=#E"DKY"LIJ#DAW#HIZ#K9O/U\7>NE?/0K JJ)<*_ J2/''4N_CLYS_
M[+"Z9 ^8+Y61M'GDN/4B>RA[4!BRSS.N=4]]5N_K\D&WA*T.!4JUKOV2Y_Q[
MMECL!P#HB*^4"!BG1-G0*<90UUB&D2=#' D42&Z5G]Q#AJFM-KI<2+X4C:]_
MJT9]1-G;QV\^)[;.JD&0'M&K?P!Q95^W*HSDP;(&T;DWRUR"-_)L64-TVLME
M_ZA^E/@E(S1;9*M,Z"$.NW9LROL1Y,<2,0D]7R*(*$Y@RBA2UG=,),()EF9%
MYVT'GAKY=>2NOL)NYY___$,:^,E?>O7_,9X(,_(; MZ!&6\?V:;_CT&12FM6
MLT7'$949#SLJ?]F"L4]:UO?;'P[<%3E?LU5M#38G:DD2RC#V"<1^BB%"<01)
MP&/H!YX,B, A94:!^B>>/S7>:41L]C;FN\ICT%W>IE\)R,!,T6+1[+7M?>#'
M0#'?35\)SEBE:W7K>NV]7@GVN,P7^4/&B()AN1*+A6"KM:XT5.1J ZQ(5O/M
M/Y:Z'7K^?09(";ZKB_3_/C=0/Y'B'Z+R0=4OH*,=\QDHSVR*C]TUVK[WC,C=
MK>VYRWKV+V@[/VXLP@[SMH[NV^57G9&OCSO4!;_F.OZS_N<[4F9-9J&/0DX]
MY$,AB%34&1)(F2^@^E<8RSCU0I9:M3=P)=G42'?;MU57WF_$K3Z6KOS]DD'=
M3:>91?@FDS3P0N!H?NQ[)KC&TE5+!6=RC=MQP36<!PT9G _0C\)U9-)2O5JO
MOXK57/(("8\@Z'/F066_II#&B0\C/U+6:RSB-+)BX>[#IT:DK6S6:: [B)'$
M"Q$-*$QI$D.4!ACBH&J!QT,O4>!QSZH:<&_$1BCIZP8QLZ6A+PX#L_M&K)D.
M@'7'WL?4=43 .X\>E4./*;5/@T>OZ<=D37YW>4=>-2_6K6[4%QJA2 9Q L-
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M/E(3XADGB+F<B#$C]37BK=R@$5Q/02,ZZ,CN?@+.+\ #P3KPXOFVB)K'J V
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M(_ .^FZ[>FX_"OYM6=2!D/^LSH3?B:60BO/O'\GJ[_EZP3\_J3=\]5%*H1<
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M[NX*'84"\'JM2MP^[#52#LI*Z@JE' ]Z.T5W0@GL..NZN3-CM,EF9&2^4WI
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MC9>\^,'%IGB+RWL5&ZGS_>M\ZC#& H6A#W44$A+(AUDBO9F$)TD4AR3Q/.,
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MBJ5Y)WXCBY4FX'DN8X*" $&&@QBB/ D@#3,*8\XC1#CFB.!YU8C^QMY*M9?
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M)WV=^,E$4=1/?B ;+5>Q-7%KCV2Y$_6?2B5_\=:OONLEL2H<<W3S*Q2/.:?
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M8H*402R2& 8A"?*,\3003DE3)\:8&@G4(I8U7MQXX!2$=A1P(3 #?_W/,1G
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M&']84:?&K-^OOA4S<*ME5!^^>R6A@2>V>V-L.M,U,&<;+4!'!M;;*@,+G,C
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MK^OE@CV5_[T1/[=O=5GM>9@RI*@A@EF648@"RB$-$(,8$Y0GF20)D2Z$X2K
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M27X7/:M?C*!NCR'XN]UF(U;LZ?L/\E#%(1#!12Y" FD:48@P"R%5OX)Y&))
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M"8*<I"B5*(X2;M6/O&N@J9&_$?.?0=G@4'<V5/)630T1<FP/>0[;=D;VB=C
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M5CIW@N$UW[O=/'I%<?U([/;I/X\E*#>9_+NDN^^_;U<\IG&H,(+*XQ(2_;6
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M.GS$?A_!OU#]54CI^ILTNJ?ZRKN\V7-9'3.B241D[$$<*KV'\A6#L5(Q1#1
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MSI7=E?NY$N_:U6@CWD%$)._'$_A]M:[O$%KE<D\G%"UW,PRC*00YP6]'%Y!
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MPW& >5F9U6HRKX:@?_[U@7B1V;\_?]99<VYNB>P^I4>-/'OP$2TGGQTFJ>4
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MH%COFAKSF(3GGC"FT<&-I?6(THIH< C[Y+53M7-A]RD83-JU#A)V[4H+<0_
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MU2&CM2,5#\>FMJN9&$&4PG,>B)/,HVR;Z0[,$*N,=,%Q/%EJ/X=L1W&_3O(
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M (GOFK7]LT&.6VZ0-Z#G E<7*AG.9?X]7^">_:7:&UR7"&6 2&8E<1C,D>#
M:LN"MZ;V<Y+':.FWN&\ QV45)0TB%[GWX)]_]1,\_C=MY*E.3@.C1#2EW1R
M>$4CX9JZ% U-F789VNZGJM_JO % L++BAA \W.7]<7^MYO'2+V =IM],K"N1
MN HA$4T!PZ%$#7'":X*FWD:904=;^U'RTU3U6WHW!"C65=QPSN+/MT;^[;A(
M=YH6VTQER@W%_Y'LRN-_XQ.*2W.2A0)@/J04:Y_(ARDZ"HGN_P=(K*"PP9W.
M6[NLN0K=(U>T^(XSAA8?9'DRJ(,GCED4(-?&0V+,56^F^TP2C\M&TW]DC':H
MTP&<XNTD/'*>6QXS)5&G1"3$5+@U)+&DI)=",]%!Z]T6%!\'Z'_D^Y4S:GP
MM]M'%E[O[_<ZRD$DJ[P@1AA%I$2)AV0D\3J@B .3R=5^XM2*X,$,:ZA[EWT^
M)0[ (A]9>O((LS9II14*ES=I?S! ;'"!Z.AB@@"25I]:T(K@O@<GGQ&QW2AQ
MH(C=<YP\PFSB'J <7LQS/% 8^.+E9R)=-BKX:+6K/MZM#<%]#VL^(V*[4>(
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MI_@C/W>-.^-(NY:<,&70#\W*$0^>$JK!B)S*GC&5H?48+?W.T^T(354$/P
M?9[/KF&^_%F>BR]+<VVTO-<E@;3+%P^Y7']%8I@-1!H/) 1=.FP[I6A2GE:?
MD7LL;?V.Q^T(8)TH9@" .U"+O\N93#(%[TK%JBKMU'TDP2I.A,N:^D253[6/
MQ^.IZW>*;4>@ZT@Y X#=^]D<QA?3-RM<>XI\S/UTX>/-Y)3FR\GZI>\NHZ!Y
MUN5BD9K2U)]%B@9="*(=39J9Y*2M/;[^9&+['1C;$2C/H[H!8'33BA!]TMG%
M=+PO-60A)6,9;C5*RUS0<KLB(B=:I C><@ZIME?W)%$]3W#M"'1U=3$ <!UH
MKON ,\4D4YEBY(,!M^0"_T:1T6PQ^C$6O(3:*#N>NI[GKG:6$.Y$.P/ W=W[
MH0><I&PE;B!+P >'?H2CQ$8MB,_@P$H.&#-5+WU^C)KC</72+AHJ27\ .+JM
MT-SE0V!<'9.2)(HL,> .@00&CC F)(C )#+457WL21AZ:;<)520_  3M3L5X
M8%@#*EJE5.*8,C[,QC(^C!)-A>')IB!T;4?_"9*.P]-+NP>HJ8<!P&K?&\HU
M2P\R-=Z#4R")T4H1J5%>0>#V,4%)+CG/45:/)(\E[CBHO;2<?S>Z&0#H_K:
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M!G<.!.\X[K!,5%(>!8JNB(^"HE.B&7KEUM.\4\WS1(;RN13TFW[L&GMGU,X
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MZG6]N/]!O"S.IN'J!9=I)[&^X.I$!XG3\?&.DD^7!<^.&6GN@.7A=8^/?V)
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MRU=UY!OF_PSG%W5G,#++K :'$NN\(G+FICIS+RA(<+Y0_M8OO!Z@:F17;;W
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M!I2+ 5PJ&A+RY(I2*OC6O?X=23O4VKR9+L/9V:*.C5XW66X_NWEWD-DQ)4H
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M%Z^<]!2HG0"P\Q2H7;0Q GA=">FWBR4E@LOEUJAO]L70*7,&4P'-B 65K(3
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MJ(W01X">9][B9(R>,Y*.P[IMF(054&<P@=DB2L@B-;^L?%DK#/:)HMOK9@Q
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M;)9??:NBW,QEFE"T:[2G8)@'"EP49X8R5CICV22N8G(,I6@,O2YTG<".D4-
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M88KG3U;IOX2Q@SLI[?[8P5TD.(+<\_<_?W^U?3 7/#H?*#'2+I.?3KJ:2HV
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M72.2XY \\-7)P '*"&'Q4YR6\&-^L:+?2/07)UEG&44@#:(A6T)Y/824"Z2
M09=@A?>=<]JC4M[I[-A?9^?8(!GX"&U)#F?XH7RIK::K#2L?9O_U=9J^WF!Q
MK9J'ZC1?;=4V$<DP3NR!T:JN#A$<8A8(C!49'!,H;>AP-AJ2U GT[@6"?BBU
MGA::OTR_88T5GQ$ XT(Y;@,D0:)77CGPBD<@H:"2RF1E>L!U-^(Z(=S_0G@/
MJAX8Z_75H7+QQWQ1<$K_TN503XJ6S+M:>2=3J9-] X0<#7CD)GFK%.MDH_?Z
M>+<W)/8"P=J_K@8&XYK@M[/?_TFX7'XHE_S>BY F+.04?42P/ 505@7P=.C
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MR^"S=UGP+)!UV;,W(I9>?/'+:$_S&##ZPHYVUSL!8Z+Q+B4(,7 2D:%_\R9
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M"H9!8"J \K$X5U0UGB<3!32^&SSE&I07$ /TA.*?X^7\69G=>245,@>K+8=
M)A.4#)QDZ11$HV4V!0OK=\-<;YR=:+1_$N_M?8+L5(9!/BN#>7EHW$7KD=('
MDM'+,,B6HAG',$@E?,: "8SCB3)-3V=1E@3)U=V*Q;-X=PC^B0Z#7!N09T9L
M/*2[M0%Y2-'K/UW_ 6[G;G 9*"87'F*J=JU&ZY$+!(X),1@4+L<N'J=7*D]Z
M#.0N:+WE.<:C^!&D:;?'Q06>@A8*Z[BX4!O8,[C /4A?DB#:9>*MGU%',!=R
M;*AX<E#D+BH: ;Z>C=/VF<XEN2\F<P%6)4W2I-S.E13!LERX5T6&_&M0Y&Z#
M(G>"U3$&1>ZBXU,9%,F98-JE!-*@K<D.60$E"B@==.(R^:QEAZ#@)QX4N1,J
M]AD4N8N*1F!>GYXUB$QG(\GK"%%OOA@B)=>\3C&,K&09<VK^"/JS#8K<!Y#M
ME3?TNU]?P=/U/9$46G#F$+ H!0J#)VE@A$P(C(5AC#H/F4^]&W9PY$A#V!&"
M8P1&>SQEALD$J>HP%L,U62]G#<1")BR[4$SP"<G2G,S[6!]ELZ>5:^YY(D9;
M!;L+/!M6P?9\IWY#>=?ZW50%MKXW[_"I7N[&=V5Q'/??R%U,#A.$'"GBXLZ"
MST$ 2FD-,JE3_KGOOY]0ZR9&2"0Y6Z2!)"69G1(U1.LU9.2%;) V,G;:^-X#
M;2=]U[T+,@^-O9HJ>031UNU[KISKU'-E2'Z27(ITC/ZM4)+E%!,8*(H-K;=V
MG? -=ULL/'FOO8MB1H"J7BX3C-+!\! IL5(6E/4"8N 1B'^ME-<V"'7L</S$
M[[5W@M51%B#MH.-3N=<.BO$4(P(W=899#=&#,PFLE#F0V_+<Z@YN_R>^U]X)
M%?O<:^^BHA&8UZ>O1IG0E-(F!]+7+<Y8-#AO D@*DT)@Q3+U:P'2\0'97GDG
M>*_]1,AT?3T3K70EF A%(*NE@@%BX>2D4$>K2;PZ=]I0WQ-]IW6'W4N0.AKU
MC\ 8'ZL7]LM\%<YO-KS$@%P*,-X64-$Y<(%Q$"D5'Q6/7+9>4CL,IR\F)]P3
MX0.U7A\ M_&5;_^&,RS35?7BR_>X^DABHY\59GDM@X]SD@FNIHNU_.IMTT,K
MZ3M=-._YH0.OF5NPU^B2^18H9_G3U7>O[_BN[NV$C>A=0-!U[*Q2*4/,@8,W
M/+HD,E.^]6W3#N0=[!>NK,<;4LX,\TTM77]NN?'"V1>=67TP3@6K23#@A,N
M25B+.G";FJ^!W(7 8;/*OE!US[CVIK,1!"K74JOL?/Y.)G^^>%?_:U6J]3K(
M2.Z=+@&\L!0*,EXHK1$6G%:<^5"4U>TSQV>(&O@ZHS] W$L+6VIG['#;YM$6
M0\Y1:V#U'5N9[,$[)D%FA4)G$5-J7:K<@:QA(=<8"+O ; ^MC !H?\P7.#V;
M57XN+U%XU(4.(]!?IG/(G*#0.@A@$IER%&1GWAI6]X@8,8CV4?.\I<Q' )K;
M KIZ$&$Y6,^X .>T!Z4=0J@[*CF+F&Q)(DC7JT':Z27T"!NVC^OV]M+#*-&T
M/6,Y2J=U#.!,=* LI?O16 ^(2>:<=<HV]8ZG\7FU_?3\+'3V$/H(P+--US=G
MZ]9QVYI67XP)RFL(%LG?.V(J1E\K74))@1=>FG<>/T?3V,"TC^;G/:IA!+"Z
M;[FO#??U523C.4D6,Y"ESL0*:O"<(@$K"BJ;9$';^@ZF$V$#S^H\FO]KKZ51
M0N\S+OZ>)JR7CQ,G4,HB*%)D%"XJ+W3-7!28G##EPK01K;=*/$G0P+6/[0'P
M+,3VU<8HH?5V1C\=E^N+[8GU,H<D,B0*(T!EDR"X8B!9B8EGJ_!NK4T/V+I)
MT;!Q_!#@VEL?HT37Y10C"CDN%K,/Z_#@U7*)J^4D)./06@VB%(H'#">S;ZR$
M(HM3,L808_]8>YR^83WH$,AKI*M1K-F^S]VK;_/%:OJ_:PU^*!\7T_GBAAU_
M341.5Q-O@O>V.-#>4"C"688HZAA,QZ+#%)W)K:L"]J-TV-%L0Z"SN?Y&:2]O
M<_DO2LJ6[^9T!I<39,6&X!0Y )U E1S!U44NVA0A@XTJ^M:/2SN0-^R X.'Q
MN*^F1FHL/V&:G\VF_XOY/:XJ;Y6US9)I7*W.-X6?KV;Y]<6BED*L?\DG+I,4
MF0[@$_U#,5=?C4T&R3)ZSK72I?_,9"_2AYUI.P1\^]?P2*&]+O"I%5K3M/W=
M=:3-LJ3_-1HXUD48B?[AA*+CFYTMG)C4O/]H]&':AETW/ 0X&^AH?^]>"_?Z
M+J)[_;66&TYGV]_[$,^G9^L???D'-^H@K\/P)F5U!WVZ8:%=.Q$,47IG4L[.
M.Q!*$A+1$1)93(1^%3@K(F/"QM9BM*5W(3F-@H(<;;.@4\D]A$+1=PB,2U<X
M\M)\7MX++;W; 56'E=[MHK,1Y$F/O'Z6PJ1%IT'K*B_G&5#$+>#_9^]-F^,X
MDC3A7^2]<1\?*4KJU6O482)[Q^83S.,B:Q=$<:H 2IQ?_WH4#N(H@)F5D951
MG!X;8U.4B/3C"0]W#S\*#RP$9E"*T!AY$ZH-.BFR&Z7Z8=4&8_30)9INQZUA
MTAZE 24*!Z4]A7"&<PB:65D,8SJW+B(^J6J#47H>6FTP1N@=@.>;S]Q)&VW(
MDH/)C)ARY*1Z;CU()ZU7F3O4K8W2B58;C-+\V&J#,6KH %;#HBQNLP\L.W!%
M4OAME8(0E(.H2N;,(C-B_B#UT&J#3JKMIMQ_[;74)?2N([!?GH9F]Q<?:>-5
MM![!N$QR1$FG5V-M:Z-@W$O'BYP_V3>$TE.H3Q@%F6^"LKG^ND3I$^[.I/(V
M(EEZ[F.FHRT*>.<+ <DD'@KS[ CYYR=D]8:_]NCX)B"GJ6KBUK&WE[BY/$)=
MEF I!:P=)5:0=QP2!Z](@B6QF)ADPKCF _XFUV4=L71F =P=JIXN[=V#PJ"Z
M0T%%<INY88Y\9T9>C X1N Z($NDLJ=:[5!H4:AVQ7&8!M!VLH"[A=OW&G2_2
M[NGOK'#-R61G,#KKNK!   FH0.9<INHXHVL]/>Y;-/56 [, Y"8HJ=/GV2?"
MN_F#[1^X2F>.>ZT-TZ!K:*^B)B/.:JDX0Z-2T%+IUF\-(TGLK1"F!V_O8!5.
MQ>B[)H.Z]G!XM:4_V6Y?KS^&U<6.Q^V/J[K8<W59,PU/_5T364[D@D!D==^&
M"H9.)DI(0=22BIPT#AEBV("4WDI=9@/H$JI;'K O%*S%RRO<K/#\MMKGS!;)
M2LZ29"DY*"<4A*P\>"UER48(A_-;TR=D]5;NLH %G::J16_V9T[=8]G]<A$W
M&;?YQWS]OS_7:M[;NK.'96=G/DB;'!V[Y'D@KT88"%%%L+D6&Z%^FFD<:CLG
M4#4(I>X[0.G""NTR-KI7(OGTO@BZY"@X Y%JY)>Q@(]<0D%KC'6(]@@^ZDL4
M#H*N_PZ@>P0%=AI%[0;77<MU6[<.IB(D(ZEENCM*G7S#&$*6/(AL9(IF_ES1
M?8J&9<39=XW @S74*>*>'J-LE5:1<S!"$V?9, A>R%H<S'FF,\9DZQK)9J\Q
M_].>8\;H:N)SS$\7<T'P5I)WA<._WRL<OB]-Z\C[R%9 UG5<O<D%T&<$'GUD
M E/2K/5BNL.I[>T9YWC/UTWUV*4?N9?#ZS*[NO#5>>9!>46W 8I(A]TF(8/,
MDK4>>C20M%Z?LMLBY9L G:ZVCI^T=[F'\ST]X(8977BQ=2Y==8M]@: 2@TCW
M0Z(;(F;;>K;;<.IZLY(+(;.)\KHTE:_7%Y>;5;C:)6Q_^/+3QT_GZR]Y<Z:U
ML(A10BJA3I52&D(6 GS*"KTS0BB<_R[?3URO;^)'!F4+U76)R:_">_#"Q8K@
MR3$-(OBZM3UZ.FLJ@Q D5#J'097Y9X+MIZW7)_,C([*!XGI,LG_C:>O^=1 P
M^$A,6J<IRA,H(216RZ(P98N%,SG/<^3(&WN!A_)9H'A4A75I*^]E7.^Q)0MY
M(MHA9%N(+1/HQ,4207+Z+5>"Y31_:G(O:;T^DQ_94DY76Z?YRJ_<W,SB?GU%
ME%W$+^\V>+$]WVGZ[O4UHE3H# /CC:T;DCF@8P5*Y)8I*Y&'^0O+QU#<ZQOZ
M8O=\8R4?;&(_YTU8'SF?E+W0P4@)3H8Z)!H5N* B<,5<R=*4@#WGDQ9X1.\B
MGS1&;=WFY'^^JI,YWI)2K[8WW-U..U!&F6)L 2YJ-[%W&;RU#FQPA0LO17J\
MIG(.6#Y+7V_!^_QY]T:ZZM+]?,K;&<I24 M6'[EJ(:H/@(9Y,()<;*:2C:)U
MM_\0NGK+L;="Q0'P&Z6B9@.?&H]SO"+7^>NPM5\N?L#SNCS[[8><+^\DB5KF
MX)*"%(T"I;@!LNX1HG9%<UWH]ZV'!AQ,;&\YI/D-XQQ:[-)*WOG*]ZH$MK^M
M+^+.;;X\*UYRI\@[ID-(+K)P!7RP#!*9@9*XX*',[TE^@\C>[.<LX/DV9!MJ
ML@.HWHS[>+5W)>N>J0_7<=[EFQ6&U?GJ<I6W9[IH9GDI=#O5HE-+SKLG-QJ$
M]MZ111#)SS2790+5O3UK'@/,1]9U%_FIL3S?8_;>H4[2J*+1@A!%@PI:@+.I
MT"].<9?0RM1Z1'03PGL+M7I$^72-=P'TT<(^L\KZXG.!4.H^XB@-8)5Y*.B-
M38HI/G_N]1M$]N82+^1S--1DG]%<C%<?K\[K8;@NWUY_).(^U)/\.?]R$=<?
M\P^YK#?Y'?Y])^/H=8C:UAED="$IY3UXE2VXZ%SVSF!6\Z>Y#J&\MP?:(\1Y
M<^NW T_Z(*[K/.Z]"S?NQ''&&,?$,I+MT(D"BAC LQ2 ZVQ88B7),/]\B":L
M=!= SH[*%@>C,43Z;J0>(HU[&T&^BD"(S.J2<0I'?*QS+Q6Y:H7<-ZMC+,8B
MLOD'.!Y.?W?AZ*D<C<E@.-6;XRNWV63'B_"@-=L--S?@E J R;)DN9 A'L&/
M'T%Q=U'I28#],(5/-O?'6-KQ*M%U1C\)SW^Y("8_[GYLDYT<+_WDABLW!C.P
MP$:-$C/Y\$: EI&"PQ 17*A35JPRFHGH@FJ=N^IVHT8VCD5=.XGDKAM31CJT
MVD&1/.<<+#IL/4GR.]VH,095TS9JC-%9!Y?YPZ'L;S^M+[;KS9OZUZI4Z[!_
M8XU!$S/86MZI,#I )&\]:YL%ES*&..\RA#U$G=*>C5& >'%9PE3M] ZWFW4
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M"S@L'(1'KXP1F'SK_/$TBI?-]!T/IT?4:^?A\U-N_S/CYMU?Z[.HA9)UWZ]
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MAS[^/'!X%H@3=-/?0*?!M9UMIX8W^>RQREJ//6=\2I&@<<P2Q"-X5Q^@DC"
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MWW!_!WUHZ1&=#='17K!+#^(X7Y,F+M[_B9=YQ]B/5_G_N[K(YAX[3 ;&8Z$
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M>^-&N8)H#(^0#-8Z2A[ U:HG"KI%"29S.6P?Q43\?*5HV;1&&ZT/@-*!*N@
M4/<KYFY-<M$J>SI=J6@Z9\(6\)@1F(ADF>FH^>8#P9]2T1]P#M7Q"R6*!PB\
M \C\N-I^6F_Q_)^;]=6GVXWA]V;MB^P=Q5QTI**B>$LF"5YR#\9'9PJ)QL;4
M&#_?(*FGOK &;S@-Y=\WG&Z.FT RRIQ;8HA94#;3<<-DH"C&K& AQM1ZP>LW
MB5HX7]\2 L/A=8 ^^@!87%^00;_*Z?=/>;-C97O-)OU)^>'+KQDOMK]??LB;
M=Q_PHHX[>_MI=;$NY7;GD4DJQ2!!8Z38E)&I=W7DKBY,6*>\C<T+6283W2U
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M)K2G,'<A5([6UTF"<O4YG^F2K4@V HKZ+E-8+576AJ 4$1WJ3"=S<5 2H8-
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MR1]5;<UL8-/] F^O/G[$S9=UN6_E)^T7>.DG-M@O,)C@>?<+E%*WJY4 @NY
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M1+B=NWN[KN2VLTLX$ZTCL>AD)"B=!3CA+"3ON K9\2P'-S/L_T2G):>3D-%
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M8=S(%(A$_U*DS"FV;PCT)%GC>C$=@;&1YGH"8ZTD< &=+18A&NUI(6D&$9D
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M\'>+NW^H7R(9*?_K?_Q_4$L! A0#%     @ 3(=V5=*>5=_V%@  T%@" !,
M             ( !     &$P.2TS,'@R,#(R97@R,2YH=&U02P$"% ,4
M" !,AW95G;R1,N<"  "G"@  $P              @ $G%P  83 Y+3,P>#(P
M,C)E>#(R+FAT;5!+ 0(4 Q0    ( $R'=E5C0Z9AP@,   D,   3
M      "  3\:  !A,#DM,S!X,C R,F5X,C,N:'1M4$L! A0#%     @ 3(=V
M5>NUS4<W"   ,CH  !,              ( !,AX  &$P.2TS,'@R,#(R97@S
M,2YH=&U02P$"% ,4    " !,AW95HOM5<N($  #&'   $P
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M !               ( !&RH! &)D>"TR,#(R,#DS,"YH=&U02P$"% ,4
M" !,AW95,)2>GW$@  "(B $ $               @ %4108 8F1X+3(P,C(P
M.3,P+GAS9%!+ 0(4 Q0    ( $R'=E6,-T2LM30  .0> @ 4
M  "  ?-E!@!B9'@M,C R,C Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( $R'=E4T
M_W"P&;<  #PX"  4              "  =J:!@!B9'@M,C R,C Y,S!?9&5F
M+GAM;%!+ 0(4 Q0    ( $R'=E4\[$9 CK@! !8D$@ 4              "
M 252!P!B9'@M,C R,C Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( $R'=E5.S"+G
M @X! )!\#  4              "  >4*"0!B9'@M,C R,C Y,S!?<')E+GAM
7;%!+!08     #@ . *,#   9&0H    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
